<SEC-DOCUMENT>0001628280-25-039265.txt : 20250808
<SEC-HEADER>0001628280-25-039265.hdr.sgml : 20250808
<ACCEPTANCE-DATETIME>20250808160555
ACCESSION NUMBER:		0001628280-25-039265
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20250808
DATE AS OF CHANGE:		20250808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Heartflow, Inc.
		CENTRAL INDEX KEY:			0001464521
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				260506743
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288733
		FILM NUMBER:		251198386

	BUSINESS ADDRESS:	
		STREET 1:		331 E EVELYN AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041
		BUSINESS PHONE:		650-241-1221

	MAIL ADDRESS:	
		STREET 1:		331 E EVELYN AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardiovascular Simulation, Inc.
		DATE OF NAME CHANGE:	20090519
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>heartflowinc-424b4.htm
<DESCRIPTION>424B4
<TEXT>
<html><head><title>HeartFlow, Inc. - 424B4</title></head><body><div style="background-color: #E4E4E4; font-family: Arial, Sans Serif; word-wrap: break-word;"><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 756pt;"><div style="width: 540pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 540pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_685" style="position: absolute; top: 36pt;"></div><div style="position: absolute; top: 36pt; width: 612pt;"><div style="font-size: 0pt; left: 366.75pt; position: absolute; top: 0pt; width: 209.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 209.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 209.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 209.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 56.76pt; position: absolute; text-decoration: none; white-space: pre;">Filed pursuant to Rule 424(b)(4)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 15.75pt; width: 209.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 209.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 73.33pt; position: absolute; text-decoration: none; white-space: pre;">Registration No. 333-288733<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 8.73pt; position: absolute; text-align: justify; text-align-last: var(--justify); top: 80.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre; width: 65.32pt;">Prospectus<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 18pt; line-height: 13.1pt; position: absolute; top: 102.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">16,666,667 <font style="display: inline-block; height: 13.1pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 131.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 132.5pt; width: 612pt;"><div style="left: 36pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 57.27pt; width: 331.2pt;" src="heartflowlogo.jpg" alt="heartflowlogo.jpg"></div></div></div><div style="font-size: 18pt; line-height: 13.1pt; position: absolute; top: 202.77pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">Common <font style="display: inline-block; height: 13.1pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 118.96pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 232.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">This <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.65pt; position: absolute; text-decoration: none; white-space: pre;">is<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.87pt; position: absolute; white-space: pre;"> an initial public offering of shares of common stock of Heartflow, Inc. We are offering 16,666,667 shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">common stock to be sold in this offering. The initial public offering price is $19.00 per share. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock. Our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.82pt; position: absolute; text-decoration: none; white-space: pre;"> common stock has been approved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 276.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">listing on the Nasdaq Global Select Market under the trading symbol &#8220;HTFL.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">Upon completion of this offering, our executive officers, directors, owners of 5% or more of our capital stock and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 308.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">respective affiliates will own, in the aggregate, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.87pt; position: absolute; text-decoration: none; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.87pt; position: absolute; text-decoration: none; white-space: pre;">50.1%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.21pt; position: absolute; text-decoration: none; white-space: pre;"> o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.54pt; position: absolute; white-space: pre;">f our common stock (assuming no exercise of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">underwriters&#8217; option to purchase additional shares and no purchases of shares in this offering by anyone in this group). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">These stockholders will be able to exercise significant control over matters requiring stockholder approval, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">election of directors, amendment of our organizational documents, and approval of any merger, sale of assets, and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">major corporate transactions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 376.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.91pt; position: absolute; text-decoration: none; white-space: pre;">as<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.47pt; position: absolute; white-space: pre;"> defined under the U.S. federal securities laws and, as such, have elected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">comply with certain reduced public company reporting requirements in this prospectus and may elect to do so in future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 400.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">filings. See the section titled &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#ica9aca2e3edd4ac39266d8c9cedc6eee_290985">Prospectus summary&#8212;Implications of being an emerging growth company</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.63pt; position: absolute; white-space: pre;">.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 420.37pt; width: 612pt;"><div style="font-size: 0pt; left: 36pt; position: absolute; top: 0pt; width: 540pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 366pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 84pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 84pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 369pt; position: absolute; top: 0pt; width: 84pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.5pt; position: absolute; text-decoration: none; white-space: pre;">Per share<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 456pt; position: absolute; top: 0pt; width: 84pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 31.26pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12pt; width: 366pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 366pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Initial public offering price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 115.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 115.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.81pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 369pt; position: absolute; top: 12pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 46.72pt;"></font></font><font style="left: 54.910000000000004pt; position: absolute;">19.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 456pt; position: absolute; top: 12pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.15pt;"></font></font><font style="left: 24.34pt; position: absolute;">316,666,673<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 26.25pt; width: 366pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 366pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Underwriting discounts and commissions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 183.74pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 191.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 192.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 193.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 193.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 369pt; position: absolute; top: 26.25pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 52.28pt;"></font></font><font style="left: 60.470000000000006pt; position: absolute;">1.33<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 456pt; position: absolute; top: 26.25pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 21.71pt;"></font></font><font style="left: 29.9pt; position: absolute;">22,166,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 40.5pt; width: 366pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 366pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds to Heartflow, Inc., before expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 201.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 202.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 202.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 203.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 203.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 203.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.21pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 369pt; position: absolute; top: 40.5pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 46.72pt;"></font></font><font style="left: 54.910000000000004pt; position: absolute;">17.67<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 456pt; position: absolute; top: 40.5pt; width: 84pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 84pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.15pt;"></font></font><font style="left: 24.34pt; position: absolute;">294,500,006<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 483.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54pt; position: absolute; text-decoration: none; white-space: pre;">See the section titled &#8220;<font style="display: inline-block; height: 5.46pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 128.14pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1434">Underwriting</a><font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 170.19pt; position: absolute; text-decoration: none; white-space: pre;">&#8221; for a description of the compensation payable to the underwriters.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">We have granted the underwriters an option for a period of 30 days to purchase up to 2,500,000 additional shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">Investing in our common stock involves a high degree of risk. Please see &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 391.28pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">Risk factors</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 448.49pt; position: absolute; white-space: pre;">&#8221; beginning on page <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 547.79pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">22</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 558.91pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">Neither the Securities and Exchange Commission (&#8220;SEC&#8221;) nor any state securities commission has approved or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">disapproved of these securities&#160;or determined if this prospectus is truthful or complete. Any representation to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">the contrary is a criminal offense.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">The underwriters expect to deliver the shares of common stock to the purchasers on or about August 11, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 616.12pt; width: 612pt;"><div style="font-size: 0pt; left: 36.37pt; position: absolute; top: 0pt; width: 539.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 21pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 165.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 21pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 166.5pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 165pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 165pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 186pt; position: absolute; top: 0pt; width: 165.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 165.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 23.35pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 372.75pt; position: absolute; top: 0pt; width: 166.5pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 166.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 60.79pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 641.37pt; width: 612pt;"><div style="font-size: 0pt; left: 36.37pt; position: absolute; top: 0pt; width: 539.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 178.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 181.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 179.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 178.5pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 178.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 0pt; width: 179.25pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 179.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 39.15pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 674.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">August 7<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.74000000000001pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 84.28pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.89pt; position: absolute; text-decoration: none; white-space: pre;">i<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_688" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Table of contents<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="position: absolute; top: 107.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 432.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.13pt; position: absolute; text-decoration: none; white-space: pre;">Page<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 18.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_691">Prospectus summary</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.06pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_691">1</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">Risk factors</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 54.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 54.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 55.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.11pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">22</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1039">Special note regarding forward-looking statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 225.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 226.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 227.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 227.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 227.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 227.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.43pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 59.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1039">72</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1064">Market and industry data</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 79.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1064">74</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1089">Use of proceeds</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 75.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 76.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 77.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 77.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 99.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1089">75</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1114">Dividend policy</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 70.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 70.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.11pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 120pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1114">76</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1139">Capitalization</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 64.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.9pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 140.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1139">77</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 160.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1164">Dilution</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 35.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 37.120000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 37.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 37.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.470000000000006pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 160.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1164">80</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_533">Management&#8217;s discussion and analysis of financial condition and results of operations</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 381.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.5pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 180.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_533">83</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 201pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1189">Business</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 44.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 44.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.940000000000005pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 201pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1189">103</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 221.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1233">Management</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 60.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 62.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 62.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.470000000000006pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 221.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1233">153</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 241.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1258">Executive and director compensation</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 166.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 167.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 167.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 167.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 167.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.53pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 241.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1258">163</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1286">Certain relationships and related-party transactions</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 228.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 229.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 229.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 229.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 261.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1286">179</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 282pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1309">Principal stockholders</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 99.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 100pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.11pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 282pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1309">185</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 302.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1337">Description of capital stock</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 121.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 122.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 122.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.52pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 302.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1337">190</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 322.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1360">Shares eligible for future sale</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 132.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 132.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 132.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 322.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1360">197</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 342.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1408">Material U.S. federal income tax consequences to non-U.S. holders</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 300.90999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 302.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 302.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 302.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 302.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.46999999999997pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 342.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1408">200</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 363pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1434">Underwriting</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 58.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 59.900000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 59.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 363pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1434">204</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 383.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1505">Legal matters</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.94pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 383.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1505">216</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 403.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1531">Experts</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 36.510000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 37.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 37.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 37.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 37.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 37.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.53pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 403.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1531">216</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 423.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1578">Where you can find additional information</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 186.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 187.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 187.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 423.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1578">216</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 444pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_77">Index to consolidated financial statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 188.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 189.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 189.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 189.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.94pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 444pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 17.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_77">F-1</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 578.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Through and including September 1, 2025 (the 25th day after the date of this prospectus), all dealers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effecting transactions in our common stock, whether or not participating in this offering, may be required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to deliver a prospectus. This delivery requirement is in addition to a dealer&#8217;s obligation to deliver a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have not, and the underwriters have not, authorized anyone to provide you any information or to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">make any representations other than those contained in this prospectus or in any free writing prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepared by or on behalf of us or to which we have referred you. Neither we nor the underwriters take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibility for, or provide any assurance as to the reliability of, any other information others may give <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">you. We and the underwriters are offering to sell only the shares offered hereby, and only under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances and in jurisdictions where it is lawful to do so. We are not, and the underwriters are not, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.78pt; position: absolute; text-decoration: none; white-space: pre;">ii<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information contained in this prospectus is accurate only as of the date of this prospectus, regardless of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the time of delivery of this prospectus or any sale of the shares of our common stock. Our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, and results of operations may have changed since that date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For investors outside the United States&#58; We have not, and the underwriters have not, done anything that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would permit this offering or the possession or distribution of this prospectus or any free writing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus in connection with this offering in any jurisdiction where action for that purpose is required, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than in the United States. Persons outside the United States who come into possession of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus must inform themselves about, and observe any restrictions relating to, the offering of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock and the distribution of this prospectus outside the United States. &#8220;Heartflow,&#8221; the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow logos, and other trade names, trademarks, or service marks of Heartflow appearing in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus are the property of Heartflow. Other trade names, trademarks, or service marks appearing in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus are the property of their respective holders. We do not intend our use or display of other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sponsorship of us, by these other companies. Solely for convenience, trade names, trademarks, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service marks referred to in this prospectus appear without the &#174;, &#8482;, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 398.72pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">SM<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.46pt; position: absolute; white-space: pre;"> symbols, but those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">references are not intended to indicate, in any way, that we will not assert, to the fullest extent under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable law, our rights or that the applicable owner will not assert its rights, to these trade names, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademarks, and service marks.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">1<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_691" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prospectus summary<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This summary highlights select information contained in greater detail elsewhere in this prospectus. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summary is not complete and does not contain all of the information you should consider in making your <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment decision. Before investing in our common stock, you should carefully read this entire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. You should carefully consider, among other things, the sections titled &#8220;Risk factors,&#8221; &#8220;Special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note regarding forward-looking statements,&#8221; &#8220;Business,&#8221; and &#8220;Management&#8217;s discussion and analysis of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition and results of operations&#8221; and our consolidated financial statements and the related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notes included elsewhere in this prospectus before making an investment decision. Unless the context <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise requires, the terms &#8220;Heartflow,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; in this prospectus refer to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow, Inc. and its wholly owned subsidiaries, or either or both of them as the context may req<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 502.43pt; position: absolute; text-decoration: none; white-space: pre;">uire.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have pioneered the use of software and AI to delive<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.78pt; position: absolute; text-decoration: none; white-space: pre;">r a more ac<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.32pt; position: absolute; white-space: pre;">curate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.44pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">As of March 31, 2025</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.42pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, our Heartflow Platform has been used to assess CAD in more than </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">400,000 patients, including 132,000 in 2024 alone. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.13pt; position: absolute; white-space: pre;">We believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 293.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.6pt; position: absolute; text-decoration: none; white-space: pre;">AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.03pt; position: absolute; white-space: pre;"> and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. In the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alone, the Centers for Disease Control (&#8220;CDC&#8221;) estimates that approximately 805,000 people suffer a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">heart attack each year. Despite significant advancements in therapeutic and interventional treatments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD remains a leading cause of death globally because healthcare systems generally lack scalable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods to efficiently detect, diagnose and quantify CAD at a personalized level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our analyses using Clarivate&#8217;s ProcedureFinder data repository, we estimate that there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137pt; position: absolute; text-decoration: none; white-space: pre;">9.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.89pt; position: absolute; white-space: pre;"> million non-invasive tests (&#8220;NITs&#8221;) in the United States in 2023 for patients experiencing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stable or acute chest pain, which we refer to as symptomatic CAD patients. These NITs primarily include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress tests, such as single-photon emission computed tomography (&#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.19pt; position: absolute; text-decoration: none; white-space: pre;">SPECT&#8221;), echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">positron emission tomography (&#8220;PET&#8221;),<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.62pt; position: absolute; white-space: pre;"> which infer the presence of heart disease based on how well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood is supplied to the heart, and do not measure the actual disease itself. Accordingly, these tests have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been shown to be unreliable and inconsistent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA has emerged as a leading non-invasive imaging method for evaluating CAD, offering direct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detailed visualization of the coronary arteries. Unlike traditional stress-based NITs, CCTA enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians to identify the presence and extent of coronary blockage. As a result, CCTA has become the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred first-line test for patients with suspected CAD, as evidenced by the AHA and ACC guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elevating CCTA to Class 1, Level A. However, while CCTA provides superior anatomical imaging, it does <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not independently quantify the severity of CAD, assess blood flow limitations, or characterize plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition&#8212;critical factors for determining the most appropriate, personalized course of treatment for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform builds upon the well established strengths of CCTA by going beyond its limitations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and providing new quantified insights and compelling visualizations of data. By applying our advanced AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered technology to a single CCTA scan, we generate a precise, patient-specific analysis that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quantifies blood flow, measures plaque burden, and characterizes plaque composition&#8212;at every point in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the major coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products (with a fourth product expected to launch in 2026) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the Heartflow Platform that provide physicians with the critical insights needed to effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review. We provide Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis to accounts as an integrated feature to enhance the efficiency of their CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">program and it is not a stand-alone product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a fractional flow reserve (&#8220;FFR&#8221;) value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.85pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, which we</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.5pt; position: absolute; white-space: pre;"> expect to launch in 2026, will <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">provide advanced visualization and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">clinical insights to optimize revascularization strategies, guide device selection, enhance procedural </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">efficiency, and improve patient care. We plan to provide Heartflow PCI Planner to accounts as an </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">integrated feature to enhance procedural efficiency, not as a stand-alone product.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe we are the first and most widely-adopted AI-powered test for CAD. With over a decade of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial presence, we have established a competitively differentiated data set of approximately 110 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million annotated images, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.1pt; position: absolute; text-decoration: none; white-space: pre;">which is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.42pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driving training and refinement of our algorithms for over 10 years and the ability to train new AI models <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for future products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe our Heartflow Platform delivers the following key benefits&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.68pt; position: absolute; text-decoration: none; white-space: pre;">, clinically validated to provide superior assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">blood flow, plaque volume and plaque characterization compared to traditional non-invasive methods. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments, personalized care, and better risk stratification<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 452.03pt; position: absolute; text-decoration: none; white-space: pre;">, positively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impacting physician decisions on which patients should receive an intervention, supporting more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficient intervention planning and driving more personalized medical management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency and enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.25pt; position: absolute; text-decoration: none; white-space: pre;">, accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying more patients who need interventional treatment while reducing unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures&#8212;significantly improving the efficiency of the catheterization lab and therefore hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">economics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Proprietary, secure bi-directional data communication with customers <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: absolute; text-decoration: none; white-space: pre;">that feeds a growing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">database of approximately 110 million annotated CCTA images that we leverage to improve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform&#8217;s accuracy, automation and clinical utility and seamlessly deliver new features and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">workflow efficiencies to our customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: absolute; text-decoration: none; white-space: pre;"> through our Heartflow RoadMap Analysis that, as demonstrated in our SMART-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CT study, reduces CCTA interpretation times by approximately 25% and reduces variability between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, leading to more consistent diagnoses and standardized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient care. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.66999999999996pt; position: absolute; text-decoration: none; white-space: pre;">, by leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.96pt; position: absolute; text-decoration: none; white-space: pre;"> approximately 20 mi<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.16999999999996pt; position: absolute; text-decoration: none; white-space: pre;">nutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; text-decoration: none; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.65pt; position: absolute; white-space: pre;">9.5 million unique stable chest pain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients receive NITs in the United States annually. In addition, based on our FORECAST randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial, we further estimate that 33% of patients have stenosis levels between 40% and 90%, which results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in approximately 2.8 million patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.68pt; position: absolute; white-space: pre;"> Analysis in the stable setting. Based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the Martin paper, where there were approximately 577,000 hospital discharges in the United States in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020 due to a principal diagnosis of acute chest pain, and the Bhatt paper, where No ST Elevation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSTE&#8221;) related acute chest pain accounted for approximately 70% of acute chest pain, we further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that the annual incidence of patients who have acute chest pain with NSTE is approximately 0.4 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million patients. Of these approximately 0.4 million patients, we estimate based on the Kofoed paper that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 70% have obstructive disease and are eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 439.17pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.83pt; position: absolute; white-space: pre;"> Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results in approximately 0.3 million acute chest pain patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 470.78pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, we believe there is a market opportunity of approximately 3.1 million patients eligible for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, which, at a U.S. average sales price of $1,067, translates to an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we believe our Heartflow Plaque Analysis is applicable to approximately 60% of those 9.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million NIT patients annually and the majority of patients experiencing acute chest pain. Based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PROMISE trial and the Hoffmann paper, we estimate that approximately 60% of CCTA patients have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque and are eligible for plaque analysis, which translates to approximately 5.1 million patients eligible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our Heartflow Plaque Analysis in a stable setting. Based on our internal analysis and the findings in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, where less than 5% of patients were expected to be contraindicated for CCTA, we also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that all of the approximately 0.4 million patients with acute chest pain with NSTE referred to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above will be eligible for our Heartflow Plaque Analysis. Therefore, we believe there is a market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of approximately 5.5 million patients eligible for our Heartflow Plaque Analysis, which, at an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated U.S. sales price of $300, translates to an estimated market opportunity of approximately an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incremental $1.7 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.26pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally, based on data from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Census Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.19pt; position: absolute; text-decoration: none; white-space: pre;">the Yang paper and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.01999999999998pt; position: absolute; white-space: pre;">. To unlock this potential, we are continuing to evaluate new product opportunities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and appropriate clinical evidence supporting eventual regulatory approval, payor coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most extensively studied AI-enabled test for CAD. Our belief is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounded in our analysis, including that the Heartflow Platform and its accuracy, clinical utility and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits have been evaluated in over 100 clinical studies and more than 130,000 patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our PRECISE and FORECAST trials, each a large randomized controlled trial, with results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published in over 600 peer-reviewed clinical publications. Our studies, including the PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials, have consistently demonstrated that the Heartflo<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.48pt; position: absolute; text-decoration: none; white-space: pre;">w Platform is more accu<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.1pt; position: absolute; text-decoration: none; white-space: pre;">rate than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">traditional no<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.22pt; position: absolute; text-decoration: none; white-space: pre;">n-invasive tests and highly concordant to invasive testing, reduces unnecessary<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.44pt; position: absolute; white-space: pre;"> invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">testing, and enables physicians to optimize treatment and ultimately provide more efficient care.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.52pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have developed a highly scalable, capital efficient commercial model that combines Territory Sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Managers (&#8220;TSMs&#8221;) who drive new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">4<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on increasing utilization by educating referring physicians. Our commercial team does not cover cases or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise spend time in an operating room or lab setting, which enables them to focus solely on driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial adoption and educational activities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily wo<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.01pt; position: absolute; text-decoration: none; white-space: pre;">rkflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current clinical guidelines strongly support the adoption of the Heartflow Platform. The CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis pathway is supported by the American Heart Association (&#8220;AHA&#8221;) and American College of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiology (&#8220;ACC&#8221;) guidelines, with CCTA identified as a Class 1, Level A test and Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 500.55pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis identified as a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Class 2a, Level B<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.18pt; position: absolute; white-space: pre;"> test for the diagnosis of CAD in certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD. The AHA and ACC guidelines utilize Classes and Levels to indicate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strength of a recommendation and the quality of supporting evidence, respectively. Class 1 represents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strongest recommendation, followed by Class 2a, which represents a moderate recommendation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, Level A signifies the highest quality of evidence, while Level B indicates moderate quality.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe current reimbursement policies support the adoption of the Heartflow Platform. Our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a dedicated Category I Current Procedural Terminology (&#8220;CPT&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">code, effective as of January 1, 2024, and has established coverage policies representing approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">99% of covered lives in the United States. A Category I CPT code was recently established for Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. It will go into effect on January 1, 2026, and is covered by all seven Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative contractor (&#8220;MACs&#8221;). A Category I CPT code designates a procedure or service that uses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device(s) with Food and Drug Administration (&#8220;FDA&#8221;) clearance or approval (when required), is performed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by many physicians across the United States for its intended clinical use, aligns with current medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice, and has documented efficacy in literature. The Category I CPT status for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 516.8399999999999pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis validates their widespread use and distinguish them from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">emerging technologies that are assigned Category III CPT codes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We primarily generate revenue on a &#8220;pay-per-click&#8221; basis each time a physician chooses to review either <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 153.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.24pt; position: absolute; white-space: pre;">Plaque Analysis, or both. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.97pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 429.39pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.05pt; position: absolute; white-space: pre;"> Analysis has served <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as our commercial foundation, representing 99% of our total revenue as of March 31, 2025. In the second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">half of 2023, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.37pt; position: absolute; white-space: pre;">Plaque Analysis, our second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial product. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.17pt; position: absolute; white-space: pre;">RoadMap Analysis is generally provided as a workflow efficiency tool <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to drive customer retention and loyalty and is not a stand-alone product. We expect to launch our next <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, Heartflow PCI Planner, in 2026 as an integrated feature to enhance procedural efficiency, not as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a stand-alone product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have experienced significant revenue growth since we began commercializing the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in 2015. We recognized revenue of $125.8&#160;million for the year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue of $87.2 million for the year ended December 31, 2023, representing&#160;44% year-over-year growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We recognized revenue of $37.2&#160;million for the three months ended March 31, 2025, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue of $26.8 million for the three months ended March 31, 2024, representing&#160;39% growth over the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior year period. The software-based nature of our Heartflow Platform produces an attractive gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">margin profile, which continues to expand as we leverage AI to automate an increasing portion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;human-in-the loop&#8221; quality control process, where learnings are fed back into our algorithms to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">them smarter and more efficient. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.43pt; position: absolute; text-decoration: none; white-space: pre;">For the twelve months ended December 31, 2024, we generated gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">margins of&#160;75%, an increase of&#160;8 percentage points year-over-year from December 31, 2023. Our net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">losses were $95.7 million and $96.4&#160;million for the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">respectively. Our accumulated deficit was $874.5 million and $971.0 million as of December 31, 2023 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024, respectively. Our net losses were $20.9 million and $32.3&#160;million for the three months ended March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">31, 2024 and 2025, respectively. Our accumulated deficit was $1.0 billion as of March 31, 2025. For the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">three months ended March 31, 2025, we generated gross margins of&#160;75%, an increase of&#160;3 percentage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">points over the three months ended March 31, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market overview and opportunity <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Key risk factors, including high cholesterol, hypertension, smoking, diabetes, obesity, physical inactivity, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and genetic predisposition, accelerate plaque formation and destabilization. In the United States alone, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the CDC estimates that approximately 805,000 people suffer a heart attack each year. CAD can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively treated with well-established therapeutics designed to reduce plaque progression and change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its composition, or interventional procedures used to open the arteries and restore blood flow. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieving an accurate diagnosis for the condition has historically been the primary roadblock for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective care and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">NITs are the first line approach for detecting CAD in symptomatic patients. Based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository, with 9.5 million tests performed for the diagnosis of CAD in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States in 2023, NITs are by far the most widely used method to diagnose CAD. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional NITs are not able to measure lesion-specific blood flow and are not an efficient or effective way <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to calculate plaque volume and composition. As a result, they lack the key metrics physicians need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guide treatment decisions and have been clinically shown to be unreliable and inconsistent for diagnosing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations of traditional non-invasive tests for CAD<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are two primary types of NITs&#58; (i) stress tests, which infer the presence of CAD based on blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perfusion, and (ii) CCTA, which directly images the patient&#8217;s coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stress-based NITs include SPECT, PET and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.3pt; position: absolute; white-space: pre;"> stress <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.5pt; position: absolute; text-decoration: none; white-space: pre;">echocardiography<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.24pt; position: absolute; white-space: pre;">. Stress-based NITs rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surrogate markers of CAD to deduce the disease in the coronary artery without actually assessing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary arteries or the disease itself. As a result, approximately 20&#8211;50% of patients who undergo stress-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">b<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.56pt; position: absolute; text-decoration: none; white-space: pre;">ased<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.24pt; position: absolute; white-space: pre;"> NITs go home with false negatives, or undetected CAD that should have required an intervention, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on the Nakanishi paper and the Yokota paper. In addition, based on the 2014 Patel paper, up to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">55% of patients receive false positives and are sent to the cardiac catheterization lab for an invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic angiography when an intervention was never needed exposing patients to unnecessary risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including vascular injury and bleeding complications. This results in significant additional costs to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare system and poor patient experience.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA is a high-resolution 3D imaging method that uses X-rays to produce detailed pictures of the heart's <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arteries and other structures. The analyses performed by our Heartflow Platform rely on CCTA images <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from third-party CT manufacturers. Because CCTA images are used across multiple medical practices, by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different medical professionals and others, CT scanners have historically and currently output CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">images in standard file formats rather than proprietary formats. Unlike stress tests that rely on indirect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measures to infer heart disease, CCTA provides direct visualization of the patient&#8217;s anatomy and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allow for a comprehensive visual assessment of coronary stenosis and plaque burden. CCTA has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinically demonstrated in the SCOT-HEART trial to have the highest diagnostic performance of all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional non-invasive imaging tests for CAD. In recognition of its superior diagnostic accuracy, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">October 2021 the AHA and ACC elevated CCTA to a first line Class 1, Level A test in the guidelines for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain patients with stable or acute chest pain and no known CAD, above stress testing which is Class 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level B. While CCTA accurately identifies stenosis in the coronary arteries, it does not calculate the blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">flow through the arteries to identify whether the stenosis is clinically significant and does not provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque quantification or composition without significant and time-consuming and variable manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculations. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform, which requires a CCTA image from a CT scanner to perform its analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly improves the clinical utility of CCTA and addresses the limitations of traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD testing by combining existing CCTA images with our AI algorithms to provide actionable data on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood flow, stenosis, plaque volume and plaque composition. This delivers superior clinical utility relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to other NITs and compelling economic benefits, which are supported by extensive clinical evidence. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, we believe the CCTA + Heartflow pathway will become the standard of care for the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosis of CAD over time<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 168pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 102.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 98.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 122.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 144.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="4"><div style="left: 0pt; position: absolute; top: 0pt; width: 468pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 468pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;">Traditional NITs vs. Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 15.75pt; width: 102.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 102.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 9.86pt; position: absolute; text-decoration: none; white-space: pre;">Stress Echocardiogram<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 102.75pt; position: absolute; top: 15.75pt; width: 98.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 98.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.22pt; position: absolute; text-decoration: none; white-space: pre;">SPECT and PET<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 15.75pt; width: 122.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 122.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 50.54pt; position: absolute; text-decoration: none; white-space: pre;">CCTA<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 323.25pt; position: absolute; top: 15.75pt; width: 144.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 144.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 27.41pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 78.89pt; position: absolute; text-decoration: none; top: 2.037pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 3.7830000000000004pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 85.81pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 185.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 0pt; position: absolute; top: 31.5pt; width: 323.25pt;"><div><div style="position: absolute; top: 5.04pt; width: 323.25pt;"><div style="left: 3.22pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 171.3pt; width: 316.8pt;" src="prospectussummary1b.jpg" alt="prospectussummary1b.jpg"></div></div></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 323.25pt; position: absolute; top: 31.5pt; width: 144.75pt;"><div><div style="position: absolute; top: 26.19pt; width: 144.75pt;"><div style="left: 3pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 129pt; width: 138.75pt;" src="prospectussummary2c.jpg" alt="prospectussummary2c.jpg"></div></div></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 401.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 1&#58; A comparison of the visual output of traditional non-invasive tests. Left&#58; Stress echocardiogram. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Center&#58; SPECT and PET. Right&#58; CCTA image.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 279.63pt; position: absolute; white-space: pre;">Far Right&#58; Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 390.66pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 399.32pt; position: absolute; white-space: pre;"> Analysis image which color <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 425.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">codes coronary blood flow to identify clinically significant <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 323.62pt; position: absolute; text-decoration: none; white-space: pre;">blockages<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 368.64pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our symptomatic CAD market opportunity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that there were approximately 9.5 million NITs in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States for the diagnosis of CAD in 2023. In addition, based on our FORECAST randomized trial and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 513.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, we believe there were approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.06pt; position: absolute; text-decoration: none; white-space: pre;">8.6<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.95pt; position: absolute; white-space: pre;"> million patients that were addressable with CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after accounting for layered testing and contraindications to CCTA. CCTA testing volumes have grown <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rapidly, and we believe they will continue to outpace the broader market growth driven by the recently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">established Class 1, Level A guidelines, superior clinical utility to stress tests and improved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 581.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.49pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis is reimbursed for use on any CCTA showing 40% to 90% stenosis, which, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 593.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">based on our FORECAST randomized trial, we estimate to be approximately 33% of all CCTAs annually. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 605.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We believe that CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 245.14pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.49pt; position: absolute; text-decoration: none; white-space: pre;">Analysis therefore is applicable to 33% of the NIT market and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 617.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">majority of patients experiencing acute chest pain, which represents 3.1 million patients and an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 629.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">market opportunity of approximately $3.3 billion in the United States. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.33pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 641.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reimbursed for plaque identified on CCTA with 1% to 69% stenosis, which, based on our PROMISE trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 653.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and the Hoffmann paper, we estimate to cover approximately 60% of all CCTAs annually and a majority of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 665.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">patients experiencing acute chest pain. We believe that CCTA + Heartflow Plaque Analysis is therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 677.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable to 60% of the NIT market, which represents 5.5 million patients and an estimated market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 689.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">opportunity of an incremental approximately $1.7 billion in the United State<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.39pt; position: absolute; text-decoration: none; white-space: pre;">s<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.39pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">7<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our current focus is on the United States and the Heartflow Platform has been cleared by the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(K213857), our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.42000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 205.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; white-space: pre;"> Analysis has commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom, European Union, Australia, Canada and Japan. The Heartflow Platform has also been cleared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the equivalent regulatory authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain. In the future we may expand our international presence beyond these markets and extend our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to additional indications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our technology<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow enhances CCTA, the most advanced non-invasive imaging modality for assessing CAD, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI-powered analysis to deliver more accurate and clinically actionable insights for diagnosing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing CAD. The Heartflow Platform applies deep learning, an advanced form of AI, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computational fluid dynamics to CCTA images to create a personalized 3D model of a patient&#8217;s heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on a single CCTA image. This model provides actionable insights into blood flow, stenosis, plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume and plaque composition allowing precise diagnosis, risk stratification, and treatment planning &#8211; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the need for an invasive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.31pt; position: absolute; text-decoration: none; white-space: pre;">procedure.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.1pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CCTA + Heartflow pathway addresses the limitations of traditional non-invasive tests that only assess <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures for coronary disease and therefore result in higher rates of false negative and false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive CAD diagnoses, as demonstrated by our PRECISE trial. We believe the differentiated accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and clinical utilit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: absolute; text-decoration: none; white-space: pre;">y of the CCTA + Heartflow pathway will continue to support our growth and advance the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">standard for the non-invasive diagnosis and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We designed our AI-powered software platform to be highly scalable, seamlessly integrate into existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">physician workflows for diagnosing CAD, and improve as we ingest more data over time. By leveraging AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to process massive volumes of cases and a &#8220;human-in-the loop&#8221; quality control process, where learnings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">are fed back into our algorithms to improve their performance and efficiency, we have rapidly scaled our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">platform to deliver accurate, timely results to benefit physicians and patients alike.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 402.4pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 166.22pt; width: 468pt;" src="prospectussummary3c.jpg" alt="prospectussummary3c.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 581.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;"> Figure 2&#58; The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 601.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our product portfolio <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have created three software products (with a fourth product expected to launch in 2026) in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unified platform and user experience that provide the critical data physicians need to effectively manage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.62pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients with suspected CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">8<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.47pt; position: absolute; text-decoration: none; white-space: pre;"> The Heartflow RoadMap Analysis provides <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 158.92pt; left: 410.4pt; position: absolute; top: 284.75pt; width: 120.96pt; z-index: 1;"><div><div><div style="position: absolute;"><img style="height: 158.92pt; width: 120.96pt;" src="ffrctanalysis2a.jpg" alt="ffrctanalysis2a.jpg"></div></div></div></div><div style="height: 165.84pt; left: 414pt; position: absolute; top: 90.57pt; width: 113.76pt; z-index: 2;"><div><div><div style="position: absolute;"><img style="height: 165.84pt; width: 113.76pt;" src="picture1number3a.jpg" alt="picture1number3a.jpg"></div></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">a highly intuitive anatomic visualization of the patient&#8217;s coronary anatomy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">based on CCTA images. It rapidly orients the imaging physician to clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">relevant areas of the patient anatomy and provides a preview of what they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">will review in the native CCTA images to aid the physician in accurately, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">efficiently and consistently identifying stenosis in the coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis supports more efficient radiology workflow, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">improving CCTA read times by 25% and increasing consistency between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.33000000000004pt; position: absolute; text-decoration: none; white-space: pre;">as demonstrated in<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.33pt; position: absolute; text-decoration: none; white-space: pre;"> our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">SMART-CT study. Physicians use <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.61pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.59000000000003pt; position: absolute; text-decoration: none; white-space: pre;">Roadmap Analysis as a first-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">line assessment tool along with CCTA interpretation to determine whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to order our more detailed <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.74pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 254.16pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.51pt; position: absolute; text-decoration: none; white-space: pre;">Analysis or <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.15999999999997pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.14pt; position: absolute; text-decoration: none; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis reports. We generally provide <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.12pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.1pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">accounts as an integrated feature to enhance the efficiency and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consistency of their CCTA programs and it is not a stand-alone product.&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We believe the efficiency that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.37pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.35pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis provides our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">customers has resulted in enhanced customer loyalty and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.77pt; position: absolute; text-decoration: none; white-space: pre;">re<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.66pt; position: absolute; text-decoration: none; white-space: pre;">tention<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.66pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 139.72pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 148.38pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 192.25pt; position: absolute; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.57999999999998pt; position: absolute; white-space: pre;"> Our flagship product, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.88pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.86pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 358.28pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, consists of a patient-specific, interactive, 3D anatomical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reconstruction of the coronary anatomy that identifies <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.73pt; position: absolute; text-decoration: none; white-space: pre;">clinically <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.72pt; position: absolute; white-space: pre;">significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD at every point in the major coronary arteries to determine the need <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for intervention. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.07pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.05pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 227.47pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.13pt; position: absolute; white-space: pre;"> Analysis has the highest diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accuracy for a non-invasive CAD test and has demonstrated a high level <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of concordance to invasive FFR, as seen in our PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials. Current AHA and ACC guidelines designated CCTA as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Class 1, Level A test for CAD in certain patients with stable or acute chest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pain and no known CAD, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.77pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.75pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 269.16999999999996pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.83000000000004pt; position: absolute; white-space: pre;"> Analysis as a Class 2a, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level B test to help physicians guide patient treatment decisions. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.97pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.39pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.05pt; position: absolute; white-space: pre;"> Analysis represented 99% of our total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.13pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">9<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">H<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 79.22pt; position: absolute; text-decoration: none; white-space: pre;">eartflow Plaque Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.02pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248pt; position: absolute; white-space: pre;">Plaque Analysis transforms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 167.94pt; left: 406.8pt; position: absolute; top: 72.31pt; width: 115.2pt; z-index: 3;"><div><div><div style="position: absolute;"><img style="height: 167.94pt; width: 115.2pt;" src="picture4.jpg" alt="picture4.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary plaque assessment from a time-consuming and variable manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">process, which is seldom clinically used, into a rapid, automated, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">highly precise AI-driven solution. The Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically provides a comprehensive 3D assessment of a patient&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary plaque, including a characterization of plaque types and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quantification of plaque volumes at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arteries. The <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.68pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.66pt; position: absolute; white-space: pre;">Plaque Analysis has been validated against the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reference standard of invasive i<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.88pt; position: absolute; text-decoration: none; white-space: pre;">ntrava<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.66pt; position: absolute; text-decoration: none; white-space: pre;">scular ultrasound<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.78pt; position: absolute; text-decoration: none; white-space: pre;"> (&#8220;IVUS&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.18pt; position: absolute; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shown to have a 95% agreement with IVUS in quantifying total coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque volume in our REVEALPLAQUE study. Moreover, o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.75pt; position: absolute; text-decoration: none; white-space: pre;">ur current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">findings from the DECIDE registry show the Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">led to medical management change in over half of patients beyond CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">alone.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.23pt; position: absolute; white-space: pre;"> Because coronary plaque volume is a strong predictor of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s risk of having a heart attack, this data offers incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predictive power over risk factors and stenosis alone and can aid the physician in optimizing medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.3pt; position: absolute; white-space: pre;">Plaque Analysis was cleared by the FDA in October 2022. We began our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.1800000000001pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">limited market education efforts<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.67pt; position: absolute; white-space: pre;"> in the second half of 2023, and we expect to broaden our market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">education efforts as payor coverage for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.91pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.89pt; position: absolute; white-space: pre;">Plaque Analysis increases. We also anticipate our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis to be included in updated cardiac imaging guidelines by radiology benefit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manager EviCore by Evernorth, which provides coverage guidelines to leading commercial health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurers, effective October 1, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.56pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner&#58;</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.69pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Heartflow PCI Planner, which we</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.40999999999997pt; position: absolute; white-space: pre;"> expect to launch in 2026, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.06pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">will enable pre-</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">percutaneous coronary intervention (&#8220;PCI&#8221;) assessment of coronary anatomy, lesion-specific physiology </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and plaque localization through an interactive 3D model, combined in a single interface. The tool will </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">provide interventional cardiologists with advanced visualization and clinical insights to help answer critical </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">questions for revascularization strategies, such as which lesions to treat, how to treat them, the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">complexity of PCI, the need for calcium modification, what ancillary tool to use and how to optimize stent </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">quantity, size and placement. We expect Heartflow PCI Planner to offer procedural efficiency through </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">advanced preparation, improved patient care by ensuring optimal treatment at the right time and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">increased clinician confidence with detailed pre-procedure knowledge. We plan to provide Heartflow PCI </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Planner to accounts as an integrated feature to enhance procedural efficiency, not as a stand-alone </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">product.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key benefits of our Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the unique features of our technology allow us to offer superior clinical utility and economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to our customers and the broader healthcare system. The key benefits offered by our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform include&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.78pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow products provide a more accurate non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">invasive assessment of blood flow, plaque characterization and plaque volume compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">traditional non-invasive tests. Our clinical trials have demonstrated that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 469.88pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.54pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis have a high level of concordance to the invasive reference standards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR and IVUS, respectively, and that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 321.35pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis has superior diagnostic accuracy to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA alone as well as both SPECT and PET.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments and personalized care&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 422.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.26pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis have been clinically demonstrated to improve physician decisions on intervention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and treatment planning. Multiple studies and registries have demonstrated that physicians changed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">their treatment approach after reviewing our AI-powered reports.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">10<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: absolute; text-decoration: none; white-space: pre;"> Our PRECISE prospective randomized controlled trial demonstrated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 191.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.70999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was 78% more likely to identify patients in need of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revascularization and showed a 69% reduction in unnecessary invasive tests as compared to a &#8220;usual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">care&#8221; pathway. The net effect of this pathway was 2x the yield of invasive coronary angiography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leading to a revascularization procedure. As a result, our internal analysis based on the PRECISE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">data demonstrated a 20% increase in net revenue for the cardiac catheterization lab, on average. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.36pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow RoadMap Analysis offers significant workflow benefits, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improving workflow efficiency by reducing CCTA interpretation times by approximately 25%, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated in our SMART-CT study. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Enhanced interventional treatment planning&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.03pt; position: absolute; text-decoration: none; white-space: pre;"> The additional detail on individual patient anatomy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and disease state provided by our Heartflow Platform allows for pre-operative selection of appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tools. We believe this saves valuable cardiac catheterization lab time and facilitates a more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedure.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276pt; position: absolute; text-decoration: none; white-space: pre;"> By leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the benefits of our Heartflow Platform add significant value across all the subspecialties that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact cardiovascular care including referring cardiologists, imaging physicians and interventionalists. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have structured our sales force to efficiently call on these key physician stakeholders, with a primary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">focus on the imaging physicians who are instrumental in new account adoption and the referring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians who are critical to driving volume growth at our existing accounts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our success factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the continued growth of our company will primarily be driven by the following success factors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Differentiated approach to the non-invasive diagnosis and management of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Market leader in AI-powered quantitative CAD <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 309.28999999999996pt; position: absolute; text-decoration: none; white-space: pre;">analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 348.73pt; position: absolute; text-decoration: none; white-space: pre;"> with <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 374.24pt; position: absolute; text-decoration: none; white-space: pre;">strong customer relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Attractive revenue model with significant operating leverage potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Large addressable market opportunity with a significant unmet need <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Robust and compelling portfolio of clinical evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Established reimbursement coverage and favorable society support<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 97.22pt; position: absolute; text-decoration: none; white-space: pre;">nique and scalable AI, data and R&#38;D capabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 327.58000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Experienced leadership team<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our growth strategies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.35pt; position: absolute; text-decoration: none; white-space: pre;">key<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.91pt; position: absolute; white-space: pre;"> strategies will play a critical role in our continued growth&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expand adoption of our Heartflow Platform by new accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Broaden awareness of the CCTA + Heartflow pathway to drive volume at existing accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Launch and drive adoption of our Heartflow Plaque Analysis product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Invest in additional clinical evidence to support adoption and expand our indications <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.81pt; position: absolute; text-decoration: none; white-space: pre;">11<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Extend our technology leadership through continued investment in our platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Leverage our platform to pursue adjacent and international markets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 112pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recent developments<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Preliminary estimated consolidated financial results as of and for the three months ended June <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">30, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our consolidated financial results as of and for the three months ended June 30, 2025 are not yet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complete and will not be available until after the completion of this offering. Accordingly, we are presenting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">below certain preliminary estimated and unaudited consolidated data as of and for the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended June 30, 2025. Actual results remain subject to the completion of our financial close processes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management&#8217;s final reviews of our consolidated financial data. Such estimated and unaudited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated data constitute forward-looking statements based solely on information available to us as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the date of this prospectus and may differ from actual results. This data should not be considered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substitute for the consolidated financial information to be filed with the SEC in our Quarterly Report on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Form 10-Q for the quarter ended June 30, 2025, when it is due after the completion of our initial public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering. For additional information, see &#8220;Special note regarding forward-looking statements&#8221; and &#8220;Risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">factors.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The preliminary consolidated financial data included in this prospectus as of and for the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended June 30, 2025, has been prepared by, and is the responsibility of, Heartflow, Inc.'s management. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PricewaterhouseCoopers LLP has not audited, reviewed, examined, compiled, nor applied agreed-upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures with respect to the preliminary consolidated financial data. Accordingly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PricewaterhouseCoopers LLP does not express an opinion or any other form of assurance with respect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thereto.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After our quarter-end financial closing process is completed, we may report consolidated financial results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and other data that could differ, although we do not expect the actual results to differ materially from those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflected in the preliminary estimates. While we believe that such information and estimates are based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasonable assumptions, our actual results may vary. Factors that could cause the preliminary estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and unaudited consolidated data to differ include, but are not limited to&#58; additional adjustments arising <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from discovery of new information that affects accounting estimates, management judgment, or impacts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valuation methodologies underlying these estimated results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following preliminary estimated and unaudited consolidated data as of and for the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">ended June 30, 2025 is presented below&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 510.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="5"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 201.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 201.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 110.71pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 201.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 163.14pt; position: absolute; text-decoration: none; white-space: pre;">June 30,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 266.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(dollars in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.66pt; position: absolute; text-decoration: none; white-space: pre;">(estimated <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.64pt; position: absolute; text-decoration: none; white-space: pre;">low)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.66pt; position: absolute; text-decoration: none; white-space: pre;">(estimated <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 40.66pt; position: absolute; text-decoration: none; white-space: pre;">high)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.66pt; position: absolute; text-decoration: none; white-space: pre;">(actual)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 60.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated statements of operations data&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 43.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 43.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.53pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">42,900<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">43,400<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">31,054<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 89.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross margin<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 62.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 63.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 63.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.53pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.04pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.04pt; position: absolute;">74.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.04pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.04pt; position: absolute;">75.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.04pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.04pt; position: absolute;">76.8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 103.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 114.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 115.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 115.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 115.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.91pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">46,500<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">47,500<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">38,016<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 644.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of June 30, 2025, our cash and cash equivalents balance is expected to be $80.2&#160;million as compared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to $109.8 million as of March 31, 2025. The decrease in cash and cash equivalents as of June 30, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to March 31, 2025, was primarily attributable to the payment of annual bonuses, as well as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment of IPO related offering costs and other professional fees and interest related to our debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">12<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information regarding comparisons to prior quarters is provided below for additional context.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect preliminary unaudited revenue for the three months ended June 30, 2025 to be approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$42.9&#160;million to $43.4&#160;million, as compared to $31.1 million for the same period in 2024, an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">38% to 40%, and our gross margin to be between&#160;74.5% and 75.5% for the three months ended June 30, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, as compared to 76.8% for the same period in 2024.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.98pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The estimated increase in revenue is primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">attributable to an increase in revenue case volume. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.87pt; position: absolute; white-space: pre;">We expect the number of revenue cases to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;48,420&#160;in the three months end<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.33000000000004pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ed June 30, 2025 as compared to 33,039 for the same </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">period in 2024, an increase of</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.67pt; position: absolute; white-space: pre;">&#160;47<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.56pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">%. The estimated decrease in our gross margin for the three months </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ended June 30, 2025 was primarily attributable to our investment in the hiring and training of additional </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">personnel in our production team to support our increasing revenue case volume. Although we expect to </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">continue to invest in the hiring and training of additional personnel in our production team, w</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.51pt; position: absolute; white-space: pre;">e expect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gross margin will increase over the longer term.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect preliminary unaudited operating expenses for the three months ended June 30, 2025 to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately $46.5&#160;million to $47.5&#160;million, as compared to $38.0 million for the same period in 2024, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase of 22% to 25%.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 143.97pt; position: absolute; text-decoration: none; white-space: pre;">su<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 157.97pt; position: absolute; text-decoration: none; white-space: pre;">mmary<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our business is subject to a number of risks and uncertainties, as more fully described in the section titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Risk factors&#8221; immediately following this prospectus summary. You should read these risks before you <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invest in our common stock. These risks include, among others, the following&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We have incurred significant net losses since our inception, we expect to incur additional substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">losses in the foreseeable future and we may not be able to achieve or sustain profitability. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue is currently generated almost entirely from the sales of only one product, Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, and we are therefore highly dependent on the success of this product, which makes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">it difficult to evaluate our current business, predict our future prospects and forecast our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance and any growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If healthcare providers are unwilling to change their standard practice regarding the evaluation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD, our business, financial condition, results of operations and prospects will be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If third-party payors, including government payors, do not cover and provide adequate, or any, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement for the Heartflow Platform, or if existing payment amounts are reduced or coding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes, adoption of the Heartflow Platform by healthcare providers will be negatively impacted, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business, financial condition, results of operations and prospects will be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with a concentrated customer base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face significant competition in an environment of rapid technological change, and there is a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">possibility that our competitors may develop products that are more effective, accurate, reliable, cost-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">effective or more advanced than ours, which may harm our financial condition. If we are unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compete successfully or our potential market share is reduced, we may be unable to increase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sustain our revenue or achieve profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The commercialization of the Heartflow Plaque Analysis product is nascent, and we may not be able <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to achieve or maintain sufficient market acceptance or the levels of utilization we expect from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis product or any other future product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with our use and development of artificial intelligence models, which may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">result in operational challenges, legal liability, reputational concerns and competitive risks.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to properly manage our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.51pt; position: absolute; text-decoration: none; white-space: pre;">future<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.06pt; position: absolute; text-decoration: none; white-space: pre;"> growth, our business could suff<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.41pt; position: absolute; text-decoration: none; white-space: pre;">er.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our business could be disrupted by catastrophic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">13<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our information technology systems, and any failure of these systems could harm our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">business and adversely affect our business and operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our networks and those of our third-party service providers may become the target of bad actors or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">security breaches that we cannot anticipate or successfully defend, which could have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face extensive, regulatory requirements to bring our products to market, and our failure to receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and maintain regulatory clearances or approvals of our current and future products in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">States or abroad or to comply with medical device regulatory requirements could adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to obtain and maintain sufficient intellectual property rights, or the scope of our rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">is not sufficiently broad, third parties could develop and commercialize technology and products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">similar or identical to ours, and our ability to successfully commercialize our technology and products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our credit agreement contains certain restrictions that may limit our ability to operate our business. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we raise additional capital through debt financing, the terms of any new debt could further restrict our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ability to operate our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The summary risk factors described above should be read together with the text of the full risk factors in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors&#8221; and the other information set forth in this prospectus, including our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and the related notes. The risks summarized above or described in full <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere in this prospectus are not the only risks that we face. Additional risks and uncertainties not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presently known to us, or that we currently deem to be immaterial, may also materially adversely affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations, and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Corporate information<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We were incorporated under the laws of the State of Delaware in 2007. On March 1, 2021, we completed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an internal reorganization in which a newly formed parent holding company was put in place. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previous holders of our common stock and preferred securities became holders of common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred securities of HeartFlow Holding, Inc. The equity incentive plan, outstanding equity awards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants and certain other equity-related agreements of HeartFlow, Inc. were assumed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. Our operations and business activities remained at HeartFlow, Inc., and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly-owned non-U.S. subsidiaries of HeartFlow, Inc. remained in place. On&#160;July 17, 2025, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated HeartFlow Holding, Inc. into HeartFlow, Inc. and the previous holders of HeartFlow Holding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc. common stock and preferred securities became holders of our common stock and preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities, and the equity incentive plan, outstanding equity awards, outstanding warrants and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other equity-related agreements of HeartFlow Holding, Inc. were assumed by us. In connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidation, we changed our name to Heartflow, Inc., whose name appears on the cover of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. Our principal executive offices are located at 331 E. Evelyn Avenue, Mountain View, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">California 94041, and our telephone number is (650) 241-1221. Our corporate website address is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">www.heartflow.com. Information contained on, or accessible through, our website shall not be deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporated into and is not a part of this prospectus or the registration statement of which it forms a part. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have included our website in this prospectus solely as an inactive textual reference.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Implications of being an emerging growth company<font style="display: inline-block; height: 8.73pt;"></font><font id="ica9aca2e3edd4ac39266d8c9cedc6eee_290985"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2012 (the &#8220;JOBS Act&#8221;). We will remain an emerging growth company until the earliest of&#58; (i) the last day of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fiscal year following the fifth anniversary of the completion of this offering&#59; (ii) the last day of the fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year in which we have total annual gross revenue of at least $1.235 billion&#59; (iii) the last day of the fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which would occur if the market <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">14<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the second fiscal quarter of such year&#59; or (iv) the date on which we have issued more than $1.0 billion in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-convertible debt securities during the prior three-year period. An emerging growth company may take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advantage of specified reduced reporting requirements and is relieved of certain other significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that are otherwise generally applicable to public companies. As a result, the information that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we provide to our stockholders may be different than you might receive from other public reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies in which you hold equity interests.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As an emerging growth company, we have elected to take advantage of certain reduced disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations in the registration statement that this prospectus is a part of, and may elect to take advantage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of other reduced reporting requirements in future filings. In particular&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will present in this prospectus only two years of audited financial statements, plus any required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unaudited financial statements, and related management&#8217;s discussion and analysis of financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">condition and results of operations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will avail ourselves of the exemption from the requirement to obtain an attestation and report from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our independent registered public accounting firm on the assessment of our internal control over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">financial reporting pursuant to the Sarbanes-Oxley Act of 2002&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will avail ourselves of relief from compliance with the requirements of the Public Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">report on the financial statements&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will provide less extensive disclosure about our executive compensation arrangements&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will not be required to hold stockholder non-binding advisory votes on executive compensation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">golden parachute arrangements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transition period for complying with new or revised accounting standards. This provision allows an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">emerging growth company to delay the adoption of some accounting standards until those standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would otherwise apply to private companies. We have elected to use the extended transition period for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other new or revised accounting standards during the period in which we remain an emerging growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company&#59; however, we may adopt certain new or revised accounting standards early. As a result of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elections, the information that we provide in this prospectus, including our financial statements, may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different than the information you may receive from other public companies in which you hold equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interests. In addition, it is possible that some investors will find our common stock less attractive as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result of these elections, which may result in a less active trading market for our common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">higher volatility in our share price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Basis of presentation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain monetary amounts, percentages, and other figures included elsewhere in this prospectus have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables or charts may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the percentages that precede them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The consolidated financial statements include the accounts of HeartFlow Holding, Inc. and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries. On&#160;July 17, 2025, we consolidated HeartFlow Holding, Inc. into HeartFlow, Inc., and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previous holders of HeartFlow Holding, Inc. common stock and preferred securities became holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock and preferred securities and the equity incentive plan, outstanding equity awards, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants and other equity agreements of HeartFlow Holding, Inc. have been assumed by us. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The consolidation did not have a material effect on our consolidated financial statements included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere in this prospectus. The consolidated financial statements of HeartFlow Holding, Inc. are that of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow, Inc., the registrant whose name appears on the cover of this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">15<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1008" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The offering<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="position: absolute; top: 107.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 300pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock offered by us<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 143.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 144.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 144.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 144.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 144.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.71pt; position: absolute; text-decoration: none; white-space: pre;">.......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 0pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">16,666,667&#160;shares.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 74.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 17.25pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Option to purchase additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 34.86pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 37.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.370000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.660000000000004pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 17.25pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We have granted the underwriters an option for a period of 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">days to purchase up to&#160;2,500,000 additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock from us at the public offering price, less underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">discounts and commissions on the same terms as set forth in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 63.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock to be outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">after this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.78pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 87.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 88.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 89.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 89.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.66pt; position: absolute; text-decoration: none; white-space: pre;">.............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 94.5pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 12.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">80,616,619&#160;shares (or&#160;83,116,619 shares if the underwriters <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 24.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise in full their option to purchase additional shares).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 390pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 132.75pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Use of proceeds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.36999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 83.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 84.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 84.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 84.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.72pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 132.75pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We estimate that the net proceeds from this offering will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">approximately $289.0 million (or approximately $333.2&#160;million if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the underwriters exercise in full their option to purchase up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to&#160;2,500,000 additional shares of common stock), based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">initial public offering price of $19.00&#160;per share, after deducting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 62.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">underwriting discounts and commissions and estimated offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 74.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">expenses payable by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">In connection with the completion of this offering, we are obligated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to use certain of the net proceeds from this offering to repay $50.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">million (or $55.0 million if the underwriters exercise any portion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">their option to purchase additional shares of common stock) of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">indebtedness outstanding under the amended credit agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and guaranty (as amended, the &#8220;2024 Credit Agreement&#8221;) with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Services, LLP (&#8220;Hayfin&#8221;) and to pay approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$6.2&#160;million of fees in connection therewith. In connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">issuance of the 2025 Convertible Notes (as defined below) in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">January 2025, we entered into Amendment No. 1 to the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Credit Agreement, pursuant to which entities affiliated with Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">converted $23.0 million of outstanding indebtedness under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Credit Agreement in connection with the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conversion (as defined in the section titled &#8220;Certain relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and related-party transactions&#8221;) and became holders of 5% or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">more of our capital stock as of March 31, 2025. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We expect to use the remainder of the net proceeds from this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">offering, together with our existing cash and cash equivalents, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">fund our sales and marketing efforts, fund research and product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">development activities and for other general corporate purposes, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">including working capital, operating expenses, and capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">expenditures. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">16<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 300pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 105.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 0pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We may also use a portion of the net proceeds from this offering to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acquire complementary businesses, products, services, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">technologies. We periodically evaluate strategic opportunities&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">however, we have no current understandings or commitments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">enter into any such acquisitions or make any such investments.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 70.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We will have broad discretion in the way that we use the net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 82.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">proceeds of this offering. See the section titled &#8220;Use of proceeds&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.84pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.66pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 108.75pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">You should read the section titled &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.57999999999998pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">Risk factors</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.78pt; position: absolute; text-decoration: none; white-space: pre;">&#8221; for a discussion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">factors to consider carefully, together with all the other information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">included in this prospectus, before deciding to invest in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 162pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nasdaq&#160;trading<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.35pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 78.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;">symbol<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.1pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 115.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 117.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 117.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.24pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 162pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;HTFL&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 182.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 179.25pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lock-up agreements<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.36pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 103.13pt; position: absolute; text-decoration: none; white-space: pre;">and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">standoff arrangements<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 112.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.24pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 179.25pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">In connection with this offering, we, our directors, our executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">officers, and the holders of substantially all of our common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock options, and other securities convertible into or exercisable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or exchangeable for our common stock, have entered into lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 63.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">agreements or are subject to market standoff arrangements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 75.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">have agreed that, without the prior written consent of J.P. Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 87.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 99.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Co. on behalf of the underwriters, subject to certain exceptions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 111.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">more fully described under the section titled &#8220;Underwriting&#8221;, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 123.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and they will not, among other things, sell or otherwise transfer or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 135.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">dispose of any of our securities during the period from the date of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 147.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">this prospectus continuing through the date 180 days after the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 159.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">date of this prospectus. See the section titled &#8220;Underwriting&#8221; for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 171.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 446.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The number of shares of our common stock to be outstanding after this offering is based on&#160;63,949,952 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 458.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock outstanding as of March<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.97pt; position: absolute; text-decoration: none; white-space: pre;"> 31, 2025, after giving effect to the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.61pt; position: absolute; text-decoration: none; white-space: pre;">Preferred Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 470.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Conversion (as defined below) and the Convertible Notes Conversion (as defined below),<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.88pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.65pt; position: absolute; white-space: pre;">and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">8,583,703&#160;shares of our common stock issuable upon the exercise of outstanding stock options as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 under our HeartFlow Holding, Inc. Amended and Restated 2009 Equity Incentive Plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 514.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(the &#8220;2009 Equity Incentive Plan&#8221;), with a weighted-average exercise price of $4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.61pt; position: absolute; text-decoration: none; white-space: pre;">.98<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 455.5pt; position: absolute; text-decoration: none; white-space: pre;">&#160;per share&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 534.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">212<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.68pt; position: absolute; text-decoration: none; white-space: pre;">,888<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.13pt; position: absolute; text-decoration: none; white-space: pre;">&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to March 31, 2025 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $13.64&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 578.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,647,667<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.46pt; position: absolute; text-decoration: none; white-space: pre;"> shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 held by Hayfin, with an exercise price of $0.03 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">323,173 shares, including 129,577 shares reserved subsequent to March 31, 2025, of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock reserved for future issuance under our 2009 Equity Incentive Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 642.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">17,346,193 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.79pt; position: absolute; text-decoration: none; white-space: pre;">shares of our common stock to be reserved for future issuance under our 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 654.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Performance Incentive Plan (the &#8220;2025 Plan&#8221;), which became effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 402.53pt; position: absolute; text-decoration: none; white-space: pre;">upon the commencement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 666.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">trading of our common stock on the Nasdaq Global Select Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.39pt; position: absolute; text-decoration: none; white-space: pre;">, from which we will grant restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 678.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock units (&#8220;RSUs&#8221;) covering approximately 506,579&#160;shares of common stock concurrently with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 690.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering (based on the initial public offering price of $19.00&#160;per share), as well as any future increases <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 702.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the number of shares of common stock reserved for issuance under the 2025 Pla<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.85pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">n&#59; an</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.07pt; position: absolute; text-decoration: none; white-space: pre;">d<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,233,964&#160;shares of our common stock reserved for future issuance under our 2025 Employee Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Purchase<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.23pt; position: absolute; text-decoration: none; white-space: pre;"> Plan (the &#8220;ESPP&#8221;), which became effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.4pt; position: absolute; white-space: pre;">upon the commencement of trading of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">common stock on the Nasdaq Global Select Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.74pt; position: absolute; text-decoration: none; white-space: pre;">, as well as any future increases in the number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock reserved for issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise indicated, all information contained in this prospectus assumes or gives effect to&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated certificate of incorporation, to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in effect upon the completion of this offering, and the adoption of our amended and restated bylaws, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to be in effect upon the effectiveness of the amended and restated certificate of incorporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the automatic conversion of 122,231,454 outstanding shares of our Series A, Series B-1, Series B-2, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Series C, Series D, Series E, Series F and Series F-1 redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(collectively, our &#8220;r<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.34pt; position: absolute; text-decoration: none; white-space: pre;">edeemable convertible preferred stock&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.68pt; position: absolute; text-decoration: none; white-space: pre;">) as of March 31, 2025 into an aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.1pt; position: absolute; white-space: pre;">51,226,348<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.12pt; position: absolute; text-decoration: none; white-space: pre;"> shares of our common stock, the conversion of which will occur immediately prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">completion of this offering (the &#8220;Preferred Stock Conversion&#8221;)&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the automatic conversion of $9<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.1pt; position: absolute; text-decoration: none; white-space: pre;">8.3 million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.86pt; position: absolute; text-decoration: none; white-space: pre;">of convertible promissory notes with original maturity dates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of 48 months from the dates of issuance into an aggregate of&#160;6,470,743&#160;shares of our common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which amount includes the $23.0 million aggregate principal amount of notes issued in the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Loan Conversion (collectively, the &#8220;2025 Convertible Notes&#8221;), at the initial public offering price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">$19.00 per share, issued by us in January and March 2025, which will be automatically converted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon the completion of this offering without interest (the &#8220;Convertible Notes Conversion&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a 1.0-for-2.92 reverse stock split of our common stock, which we effected on <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 429.72pt; position: absolute; text-decoration: none; white-space: pre;">July 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.17pt; position: absolute; text-decoration: none; white-space: pre;"> and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">corresponding adjustment to the Preferred Stock Conversion and adjustment to our outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">warrants&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no exercise, settlement or termination of the outstanding options or warrants described above&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no exercise by the underwriters of their option to purchase up to 2,500,000 additional shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">18<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_694" style="position: absolute; top: 72pt;"></div><div style="font-size: 16pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Summary<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 144.88pt; position: absolute; text-decoration: none; white-space: pre;"> consolidated financial data<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following tables summarize our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.87pt; position: absolute; text-decoration: none; white-space: pre;">financial<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.53999999999996pt; position: absolute; white-space: pre;"> data for the periods and as of the dates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indicated. The following summary consolidated statements of operations data for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024 have been derived from our audited consolidated financial statements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related notes included elsewhere in this prospectus. The following summary interim consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations data for the three months ended March 31, 2024 and 2025, and the summary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interim consolidated balance sheet data as of March 31, 2025, have been derived from our unaudited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interim consolidated financial statements included elsewhere in this prospectus. Our audited consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements and unaudited interim consolidated financial statements included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus have been prepared in accordance with U.S. generally accepted accounting principles <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;GAAP&#8221;). Our unaudited interim consolidated financial statements were prepared on a basis consistent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with our audited consolidated financial statements and include, in our opinion, all adjustments of a normal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and recurring nature that are necessary for the fair statement of the financial information set forth in those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements included elsewhere in this prospectus. Our historical results are not necessarily indicative of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the results that may be expected for any period in the future and results for the three months ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 275.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025 are not necessarily indicative of results to be expected for the year ended December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 287.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025. You should read the following summary consolidated financial data together with our audited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 299.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and unaudited interim consolidated financial statements and the related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notes included elsewhere in this prospectus and the section titled &#8220;Management&#8217;s discussion and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 323.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of financial condition and results of operations.&#8221; The summary consolidated financial data included in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section are not intended to replace the consolidated financial statements and the related notes included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 347.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere in this prospectus and are qualified in their entirety b<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.41pt; position: absolute; text-decoration: none; white-space: pre;">y the consolidated financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 359.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and the related notes thereto included elsewhere in this prospectus<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.66pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 462pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 189pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 192pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 82.4pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 72.39pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 328.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.46pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 89.39pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 189pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">operations data&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 74.25pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 43.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 43.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 43.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 43.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.77pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">26,843<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 74.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">37,205<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 88.5pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.81pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 88.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 88.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 88.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,420<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 88.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,264<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102.75pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 54.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 55.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 56.160000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.18pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">58,051<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">94,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">19,423<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 102.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">27,941<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 117pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.24pt; position: absolute; text-decoration: none; white-space: pre;">....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 131.25pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 136.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 138.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.69pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 131.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 131.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">43,517<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 131.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,443<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 131.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">13,924<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 145.5pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 167.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 168.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 168.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 168.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.74pt; position: absolute; text-decoration: none; white-space: pre;">.......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 145.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">95,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 145.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">112,154<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 145.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">26,038<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 145.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,519<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159.75pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.3pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">130,965<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">155,671<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,481<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">45,443<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 174pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 98.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.86999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(16,058)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(17,502)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 188.25pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 107.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 108.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 108.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 108.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.8pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(19,237)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(18,702)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,731)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,550)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 202.5pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 100.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 101.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 101.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 101.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 101.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.22pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 202.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,957)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 202.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(16,449)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 202.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(215)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 202.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(10,293)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 216.75pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision from income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 182.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 183.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 183.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 183.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 183.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.71pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(21,004)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 231pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(Provision for) benefit from income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 38.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 38.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.84pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 257.25pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 38.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 257.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 257.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 257.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 257.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 38.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 271.5pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 37.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 38.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 38.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 271.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,239)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 271.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 271.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 271.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 38.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 309.75pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 37.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 38.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 38.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 309.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(26,794)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 309.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 309.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 309.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 348pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 58.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 58.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 348pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(123,688)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 348pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 348pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 348pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 38.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 374.25pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">common stockholders, basic and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.08pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.25pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 374.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 32.83pt; position: absolute;">(25.32)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 374.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 32.83pt; position: absolute;">(17.98)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 374.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(4.23)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 374.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(5.25)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 50.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 412.5pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">compute net loss per share attributable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to common stockholders, basic and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 39.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.08pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.25pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192pt; position: absolute; top: 412.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,885,231<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 412.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">5,363,435<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 328.5pt; position: absolute; top: 412.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,943,430<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 412.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">6,164,617<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 38.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 462.75pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss per share attributable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to common stockholders, basic and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 32.08pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.25pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 462.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(1.49)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 462.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(0.35)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 50.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 501pt; width: 189pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma weighted-average shares used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to compute net loss per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">attributable to common stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 39.32pt; width: 189pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 77.64pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 85.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.3pt; position: absolute; text-decoration: none; white-space: pre;">........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 260.25pt; position: absolute; top: 501pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">63,060,526<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396.75pt; position: absolute; top: 501pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">63,861,708<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 631.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">See <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 105.42pt; position: absolute; text-decoration: none; white-space: pre;">Notes 2<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 131.25pt; position: absolute; text-decoration: none; white-space: pre;"> and 16 to our consolidated financial statements included elsewhere in this prospectus for an explanation of the calculation <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 640.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our basic and diluted net loss per share attributable to common stockholders and the weighted-average number of shares used in the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 649.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">computation of the per share amounts.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 666.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unaudited pro forma net loss per share attributable to common stockholders, basic and diluted, for the year ended December 31, 2024 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 675.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and for the three months ended March 31, 2025 is c<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 262.06pt; position: absolute; text-decoration: none; white-space: pre;">alculated by giving effect to (i) removal of the effect of interest expense related to <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 684.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the 2024 Term Loan Conversion of $23.0 million and the $50.0 million partial repayment of the indebtedness outstanding, (ii) loss on <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 693.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">extinguishment of debt related to the $6.2 million of fees payable in connection with the $50.0 million partial repayment of indebtedness <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 702.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding, (iii) the Preferred Stock Conversion, as if the shares resulting from the Preferred Stock Conversion were outstanding as of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 711.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">January 1, 2024, (iv) <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 160.39pt; position: absolute; text-decoration: none; white-space: pre;">the Convertible Notes Conversion at the initial public offering price of $19.00 per share, <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 450.57pt; position: absolute; text-decoration: none; white-space: pre;">as if the shares resulting <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">20<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">from the Convertible Notes Conversion were outstanding as of January 1, 2024, (v) the removal of other expense, net related to the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">change in fair value of the derivative liability, and (vi) stock-based compensation expense related to the grant of 506,579 RSUs <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">concurrent with this offering at the initial public offering price of $19.00&#160;per share, as if the RSUs had been granted on January 1, 2024. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The total stock-based compensation expense related to the concurrent RSU award is estimated to be $9.6&#160;million. The RSUs will be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">settled in shares of common stock and vest over four years in annual equal increments, subject to continued service, on the anniversary <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 117pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of the grant date. The following table summarizes our unaudited pro forma net loss per share for the year ended Decembe<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 494.34pt; position: absolute; text-decoration: none; white-space: pre;">r&#160;31, 2024 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and the three months ended March 31, 2025&#58;<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="position: absolute; top: 143pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 331.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 331.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.15pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.14pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.18pt; position: absolute; text-decoration: none; white-space: pre;">Three months <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 36.15pt; position: absolute; text-decoration: none; white-space: pre;">ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.14pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Numerator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 282.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.75pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to remove interest expense related to debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">conversion and repayment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 121.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.3pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">11,265<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,602<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to remove other expense, net related to the change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">in fair value of derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 143.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 143.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.81pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,045<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to add loss on debt extinguishment related to fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">paid in connection with debt repayment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 175.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 176.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 176.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.34pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,216)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 152.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to add stock-based compensation expense related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to the RSUs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 56.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 57.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 58.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 58.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 58.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 58.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.660000000000004pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,406)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(602)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 178.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss attributable to common stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 247.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 248.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 248.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 248.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 248.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.71pt; position: absolute; text-decoration: none; white-space: pre;">................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 178.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(93,783)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 178.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(22,300)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 192.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Denominator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 67.58pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 207pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used in computing net loss per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 243.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 243.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 243.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 243.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.87pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 207pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">5,363,435<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 207pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">6,164,617<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 233.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to reflect the Preferred Stock Conversion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 281.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 282.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 283.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 283.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 283.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.65pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 247.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to reflect the Convertible Notes Conversion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 291.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 292.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 293.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 293.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 293.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.65pt; position: absolute; text-decoration: none; white-space: pre;">..............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">6,470,743<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">6,470,743<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma weighted-average shares used in computing pro forma net loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">per share attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 288.71999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 288.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 288.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 288.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.87pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">63,060,526<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">63,861,708<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 288pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss per share attributable to common stockholders, basic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 51.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 52.690000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 53.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 53.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 53.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.660000000000004pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 288pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(1.49)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 288pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(0.35)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 473.25pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 263.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="5"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 201.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 201.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 110.17pt; position: absolute; text-decoration: none; white-space: pre;">As of March 31, 2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 263.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 11.81pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 38.21pt; position: absolute; text-decoration: none; white-space: pre;">Actual<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.53pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 56.27pt; position: absolute; text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 3.7830000000000004pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.15pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 13.78pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.43pt; position: absolute; text-decoration: none; white-space: pre;">adjusted<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.2pt; font-style: normal; font-weight: bold; left: 56.27pt; position: absolute; text-decoration: none; top: -2.037pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 3.7830000000000004pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 34.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated balance sheet data&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 122.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 123.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 48.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">109,786<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 48.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">109,786<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 48.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">343,568<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Working capital<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 70.77pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 78.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.44pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 63pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">101,231<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 63pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">101,231<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 63pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">337,338<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 77.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 55.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">184,441<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">184,441<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 77.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">414,900<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 91.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.55pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 91.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">113,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 91.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">113,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 91.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">62,132<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 105.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 107.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 107.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 107.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.03pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,824<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 105.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.56pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 120pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,945<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 120pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 120pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 134.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 180.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 180.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.56pt; position: absolute; text-decoration: none; white-space: pre;">................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 134.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 134.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 134.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 148.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 89.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.5pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 148.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 148.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 148.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,007,821)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 162.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; equity (deficit)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 162.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(888,995)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 162.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(13,660)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 162.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">270,823<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 658.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The pro forma column above reflects (a) the Preferred Stock Conversion, which will occur immediately prior to the completion of this <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 667.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering, as if it had occurred on March 31, 2025,<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 251.07pt; position: absolute; text-decoration: none; white-space: pre;"> (b) <font style="display: inline-block; height: 5.46pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 264.38pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">the Convertible Notes Conversion </font><font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 378.51pt; position: absolute; text-decoration: none; white-space: pre;">at the initial public offering price of $19.00 per <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 676.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share, and the resultant reclassification of our derivative liability to additional paid-in capital, a component of stockholders&#8217; equity <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 685.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(deficit), which will occur upon the completion of this offering, as if each had occurred as of March 31, 2025, and <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 462.65pt; position: absolute; text-decoration: none; white-space: pre;">(c) the adoption, filing, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 694.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and effectiveness of our amended and restated certificate of incorporation, to be in effect upon or following the completion of this <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 703.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">21<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The pro forma as adjusted column gives effect to (a) the pro forma adjustments set forth in (1) above, (b) the issuance and sale <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;16,666,667&#160;shares of our common stock in this offering at the initial public offering price of $19.00 per share, after deducting <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underwriting discounts and commissions and estimated offering expenses payable by us, and (c) the assumed repayment of <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 503.54pt; position: absolute; text-decoration: none; white-space: pre;">$50.0 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">million<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 111.22pt; position: absolute; text-decoration: none; white-space: pre;"> of the indebtedness outstanding under the 2024 Credit Agreement and payment of approximately $6.2&#160;million of fees in <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">connection therewith.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Working capital is defined as current assets less current liabilities. See our unaudited interim consolidated financial statements and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 135pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">22<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_697" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described below, as well as the other information in this prospectus, including our financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the related notes and &#8220;Management&#8217;s discussion and analysis of financial condition and results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations,&#8221; before deciding whether to invest in our common stock. The occurrence of any of the events <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or developments described below could have a material adverse effect on our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. In such an event, the market price of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could decline, and you may lose all or part of your investment. Additional risks and uncertainties not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presently known to us or that we currently believe are not material may also impair our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. Please also see the sections titled &#8220;Special note regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward-looking statements&#8221; and &#8220;Market and industry data.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our business and industry<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We have incurred significant net losses since our inception, we expect to incur additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">substantial losses in the foreseeable future and we may not be able to achieve or sustain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">profitability. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have incurred significant net losses since our inception in 2007, and we expect to incur additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 313.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial losses in the foreseeable future. For the fiscal years ended December 31, 2023 and 2024, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the three months ended March 31, 2025, we incurred net losses of $95.7 million, $96.4&#160;million and $32.3 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million, respectively. As of December 31, 2023 and 2024, we had an accumulated deficit of $874.5 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and $971.0&#160;million, respectively. As of March 31, 2025, we had an accumulated deficit of $1.0 billion. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Since inception, we have spent significant amounts of cash to develop the Heartflow Platform, to fund <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development, including our preclinical research and development activities and clinical trials <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to our products, to scale our commercial operations and to recruit and retain key talent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The net losses we incur may fluctuate significantly from quarter to quarter and year to year, such that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period-to-period comparison of our results of operations may not be a good indication of our future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance. We expect to continue to incur significant research and development, sales and marketing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory and other expenses as we expand our marketing efforts to increase adoption of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand existing relationships with our customers, obtain regulatory clearances or approvals for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">planned or future products, conduct clinical trials to extend applicability of our platform into new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indications or to develop new products or add new features to our existing products. The investments in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business may be more costly than we expect, and&#160;if we do not achieve the benefits anticipated from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these investments, or if the realization of these benefits is delayed, they may not result in increased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue or growth in our business. In addition to the anticipated costs of growing our business, we expect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our general and administrative expenses to increase following this offering due to the additional costs of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">being a public company. If our revenue growth does not increase to more than offset the anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increases in our operating expenses, we may not be able to achieve or sustain profitability and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects will be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our revenue may decline or our revenue growth, if any, may be constrained. Our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase sales is uncertain, and we may never be able to achieve or sustain profitability for many <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasons, including that&#58; our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.15999999999997pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.82pt; position: absolute; white-space: pre;"> Analysis may not achieve widespread adoption among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers and we may be unable to increase revenue generated from sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis&#59; our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; white-space: pre;">Plaque Analysis may not achieve widespread adoption among healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers and we may be unable to generate sufficient revenue from sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.67pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.65pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis&#59; payors, such as insurance companies and government insurance programs, may decide not to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimburse for our products, may set the amount of such reimbursement too low or reduce the amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such reimbursement&#59; healthcare industry trends, including growth in CCTA usage, may move in directions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that do not allow for adoption of our products or that do not provide adequate incentives for the adoption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products&#59; competitors may develop or acquire a product that successfully competes with ours&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">23<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturers of CT scanners may partner with our competitors or develop or acquire a competing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product and integrate one or more products that successfully competes with ours&#59; we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain regulatory approval for future versions of our products (including improved versions of our AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">algorithms), new indications for use of our products or other future products&#59; and there may be changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing or anticipated clinical guidelines, including the current ACC and AHA Class 1, Level A guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for CCTA and Class 2a, Level B guidelines for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.31pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.28999999999996pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 341.71pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.37pt; position: absolute; white-space: pre;"> Analysis for certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD, or the timing of adoption of positive clinical guidelines that support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the use of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.31pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.29000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 199.70999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.37pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Because of these and the other risks and uncertainties described in this prospectus, we are unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predict the extent to which we will be able to increase sales, if at all, or the timing for when or the extent to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which we will become profitable, if ever. We will need to generate significant additional revenue to achieve <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sustain profitability, and even if we do achieve profitability, we may not be able to sustain or increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability. Our failure to become and remain profitable would depress the value of our company and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock price and could impair our ability to raise capital, fund our research and development efforts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our business, diversify our product offerings or continue our operations. A decline in the value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our company could cause you to lose all or part of your investment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue is currently generated almost entirely from the sales of only one product, Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 91.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 100.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, and we are therefore highly dependent on the success of this product, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">makes it difficult to evaluate our current business, predict our future prospects and forecast our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial performance and any growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.43pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">of</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.76pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> March 31, 2025, our </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.74pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 254.14pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT</font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 262.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis represented </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.13pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">99% of our tota</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.89pt; position: absolute; white-space: pre;">l revenue. In the second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">half of 2023, we began limited market education efforts of our second product, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.53pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.51pt; position: absolute; white-space: pre;">Plaque Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Over the next several years, we expect to continue to devote a substantial amount of resources to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.97pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 231.39pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.05pt; position: absolute; white-space: pre;"> Analysis and also expand our commercialization efforts and drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increased adoption of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.56pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.54pt; position: absolute; white-space: pre;">Plaque Analysis. However, we may not succeed in increasing sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.32pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.3pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 164.72pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.38pt; position: absolute; white-space: pre;"> Analysis or in increasing adoption of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.58pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.56pt; position: absolute; white-space: pre;">Plaque Analysis. We expect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continue to derive almost all of our revenue from sales of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.83000000000004pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.81pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 390.23pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.89pt; position: absolute; white-space: pre;"> Analysis for the foreseeable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, so we are highly dependent on its success. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, because we plan to devote substantial resources to increase sales of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.41pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.39pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 495.81pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and rely on it as our main source of revenue, any factors that negatively impact these efforts, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis commercialization efforts or our ability to diversify our products would have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, it is difficult to predict our future prospects and forecast our financial performance and any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth, and any such forecasts are inherently limited and subject to a number of uncertainties. If our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions regarding the risks and uncertainties we face, which we use to plan our business, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorrect or change due to circumstances in our business or our markets, or if we do not address these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">risks successfully, our operating and financial results could differ materially from our expectations and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If healthcare providers are unwilling to change their standard practice regarding the evaluation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">CAD, our business, financial condition, results of operations and prospects will be adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our success depends on physicians, hospitals and other healthcare providers adopting and using the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform to aid in the evaluation of CAD. While we have had some recent success in achieving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broader adoption of the Heartflow Platform, we have in the past faced, and may in the future face, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenges in achieving higher rates of adoption. Many healthcare providers have extensive experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with existing non-invasive tests for CAD and have established relationships with the companies that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide these tests or in some instances own or manage the equipment for these tests in their offices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Existing tests are performed in a high enough volume that healthcare providers generate sufficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue from their use and are well versed in their use, reimbursement and outcomes. The outcomes and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">24<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">workflow efficiencies that we believe our Heartflow Platform provides may not be valued by healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers as highly as we expect or at all. In addition, healthcare providers have been, and may continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be, slower to adopt or recommend our products because we have a more limited commercial track <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">record and healthcare providers may feel they can generate more revenue from existing tests. Healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers also may not find our clinical data compelling and may not recommend or use our products until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they receive additional recommendations from other healthcare providers that our products have a clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefit, or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the Heartflow Platform relies on healthcare providers following the ACC and AHA guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by referring certain patients with stable or acute chest pain and no known CAD to undergo a CCTA, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the CCTA images to be analyzed by our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.67pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 315.07pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.73pt; position: absolute; white-space: pre;"> Analysis. Although the ACC and AHA guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support CCTA plus our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.12pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.1pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 239.52pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.18pt; position: absolute; white-space: pre;"> Analysis as the preferred pathway for diagnosing and managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD in certain patients with stable or acute chest pain and no known CAD, these guidelines may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">widely adopted by healthcare providers. Moreover, healthcare providers may choose not to adopt the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform if they are not able to obtain an adequate CCTA. Further, if future studies and trials or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other events, including reimbursement rates of CCTA, adversely impact the rate of use of CCTAs in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice, then healthcare providers may be less willing to adopt a technology that uses CCTAs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Also, the Heartflow Platform may be more difficult than we expect to integrate into standard practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because a provider may be resistant to introduce our embedded information technology and workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infrastructure. Due to different laws, policies and preferences of healthcare providers regarding patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy both in the United States and abroad, they may be averse to sending data externally (outside of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their facility) or abroad. Furthermore, if healthcare providers using the Heartflow Platform experience what <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they perceive to be false negative result or imprecise readings, including due to user error, they may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine not to continue using our platform going forward.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect that addressing these and similar issues will require a significant amount of our time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources, and if we are unsuccessful, we would be unable to achieve broader adoption of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform by healthcare providers. If our products do not gain broader acceptance by healthcare providers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations and prospects will be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If third-party payors, including government payors, do not cover and provide adequate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement for the Heartflow Platform, or if existing payment amounts are reduced or coding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">policies change, adoption of the Heartflow Platform by healthcare providers may be negatively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">impacted, and our business, financial condition, results of operations and prospects will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to grow sales and revenue from our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 344.13pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: absolute; white-space: pre;"> Analysis and to successfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize our Heartflow Plaque Analysis depend, in large part, on whether third-party payors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including private health insurers, managed care plans and government healthcare programs, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare and Medicaid, cover and adequately reimburse for the use of the Heartflow Platform and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underlying CCTA. Patients generally rely on payors to reimburse all or a significant part of the costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with their treatment. As a result, appropriate coding, coverage determinations, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement levels are critical to the commercial success of the Heartflow Platform. Reimbursement is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtained from a variety of sources, including government sponsored and private health insurance plans, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and varies by country and by region within some countries. These payors determine whether to provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage and payment for specific products and procedures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, payors continually review new technologies and can, without notice, change coverage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parameters, deny coverage, bundle services, or reduce payment amounts. As a result, the coverage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination process is often time consuming and costly, with no assurance that coverage and adequate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement will be obtained or maintained if obtained. If payors change their reimbursement policies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or if the current Category I CPT codes related to our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 368.9pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.56pt; position: absolute; white-space: pre;"> Analysis or future Category I CPT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">codes related to our Heartflow Plaque Analysis are not favorably categorized or priced, reimbursement for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform could be reduced to an amount that would make adoption of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform challenging.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">25<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, physicians, hospitals and other healthcare providers may decline to adopt or reduce usage of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform due to the economic impact a negative change in reimbursement may have on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their business and, as a result, we may experience a significant loss of revenue, which would have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Reimbursement for our Heartflow Platform, which includes the separately billable services, Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis, is subject to periodic changes to reimbursement levels by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government payors and private health insurers. For example, the Centers for Medicare and Medicaid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Services (&#8220;CMS&#8221;) adopts changes to reimbursement policies during the annual Medicare rulemaking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">process, which includes updates to Medicare payment levels to hospitals under the Medicare Hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Outpatient Prospective Payment System (&#8220;OPPS&#8221;) rule, and updates to Medicare payment rates to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physician offices, independent diagnostic testing facilities, and freestanding imaging centers under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare Physician Fee Schedule (&#8220;MPFS&#8221;) rule. In addition to risks associated with government <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement, our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 225.83pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.49pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis technologies face <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement uncertainty from commercial payors, such as UnitedHealthcare, Aetna, Cigna, Anthem, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and regional Blue Cross Blue Shield plans. Such commercial payors routinely reassess their medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policies, coverage criteria and payment policies and rates, and may choose to deny coverage or payment, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impose restrictive utilization management protocols (such as prior authorization), or reduce or bundle <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment amounts based on internal cost-effectiveness assessments or evolving clinical guidelines. Even <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if Medicare maintains favorable reimbursement, commercial payors may independently determine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whether Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 174.73000000000002pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.39pt; position: absolute; white-space: pre;"> Analysis or Heartflow Plaque Analysis meets their plans&#8217; medical necessity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards, which may vary among commercial payors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As part of their participation in the Medicare program and in support of the annual rulemaking process, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hospitals submit Medicare cost reports and report their charges for specific services provided in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hospital setting. These cost and charge data reported from hospitals can impact reimbursement rates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because CMS uses that data to determine future Medicare reimbursement levels on an annual basis.&#160; In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the aggregate, when costs associated with a specific service reported by the hospitals decrease, there is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a risk that CMS will reduce the reimbursement rate proportionately.&#160; These lower reported costs can be a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result of coding errors or erroneous denials of claims, the inclusion of lower-cost services within the APC, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reductions in costs for services within the APC, or other similar issues. For example, in July 2025, CMS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued the proposed 2026 OPPS rule, which, if finalized as proposed, could result in a reduction of up to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">15% in the Medicare reimbursement rate for the clinical APC that includes our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 482.43pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.09pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">along with other hospital services. CMS publishes final OPPS and MPFS rules in the fourth quarter each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year. We cannot be sure at this time whether the proposed hospital reimbursement rate for Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis for 2026 will be finalized, modified, or if CMS will increase the rate back to 2025 levels. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There is a risk that similar or other coding or claims issues may occur and lead CMS to lower the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement rate for the Heartflow Platform for 2027 or in future years. In addition, we may not become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aware of any such issues early enough to prevent any adverse impacts to the reimbursement for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, and our ability to remedy any such issues may be limited by applicable laws, regulations or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Given the evolving nature of the healthcare industry and ongoing healthcare cost reforms, we are and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continue to be subject to effects of changes in the level of reimbursement for our products. We cannot be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sure that third-party payors will maintain the current level of coverage and payment to our customers for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use of our existing products. A reduction in coverage or payment or change in policy by the Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">program could cause some commercial third-party payors to implement similar reductions in their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage or payment amounts for the Heartflow Platform. Unfavorable coverage or payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determinations at the national or local level could adversely affect our business, financial condition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with a concentrated customer base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Our Heartflow Platform had an installed base of more than 1,100 accounts in the United States as of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">December 31, 2024.</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.56pt; position: absolute; white-space: pre;"> We define an &#8220;account&#8221; as any individual facility that orders a Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 501.71pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">26<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, Heartflow Plaque Analysis, or both. We define an account as &#8220;new&#8221; if a unique facility begins <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generating revenue cases for our FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 240.87pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.53pt; position: absolute; white-space: pre;"> Analysis, Plaque Analysis, or both. Accounts may have more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than one reading physician or CT machine. Conversely, a &#8220;customer&#8221; can be either an individual account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or a health or hospital system with multiple accounts. While a single customer may include multiple <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounts, no single customer accounted for 10% or more of our revenue during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024 or for the three months ended March 31, 2024 and 2025. However, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decision-making function for some of these accounts is concentrated in a relatively small number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers, such that the loss of one customer could result in a disproportionate loss across our accounts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For example, for the year ended December 31, 2024, our top two largest customers, both large health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems with multiple accounts, collectively represented approximately 8% of our revenue.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot guarantee that that we will continue to generate revenue from these customers, whether due <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to increase in competition, new technologies, our customers&#8217; ability to terminate their contracts with us or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce order volumes, or other factors outside of our control. If we do not increase the number of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers and drive increased use of the Heartflow Platform as the preferred non-invasive testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">method for assessing CAD, we will continue to face risks associated with a more concentrated customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue from these customers may fluctuate from time to time due to demand for the Heartflow Platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the timing of which may be affected by seasonality or other factors outside of our control such as CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanner capacity, contrast availability and staffing availability. These customers could also potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pressure us to reduce the prices we charge for the Heartflow Platform, which could have a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on our margins and business. For example, during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our average sales price was impacted by customer pricing contracts that included utilization and volume <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rebates and by changes in the mix of customer accounts, which trend we expect to continue in the near <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term, and it is possible that similar trends in customer pricing contracts may continue to have a negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact on our average sales price in the future. In addition, if any of our largest customers terminates its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationship with us or otherwise reduces its FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 287.49pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.15pt; position: absolute; white-space: pre;"> Analysis volumes for any reason, we may be unable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to replace them with a customer who refers a similar number of patients for the Heartflow Platform, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such termination or reduction in volume could have a material adverse effect on our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face significant competition in an environment of rapid technological change, and there is a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">possibility that our competitors may develop products that are more effective, accurate, reliable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">cost-effective or more advanced than ours, which may harm our financial condition. If we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">unable to compete successfully or our potential market share is reduced, we may be unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increase or sustain our revenue or achieve profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The medical technology industry is highly competitive, subject to rapid change and significantly affected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the introduction of new products and technologies and other activities of industry participants. Because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the size of the market opportunity for the treatment of CAD, we believe current and potential future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors will dedicate significant resources to aggressively promote their products or develop new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or treatments. Our principal competition comes from companies that provide traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests that aid physicians in the evaluation of CAD, such as SPECT, stress echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PET. Established, traditional non-invasive tests for CAD have been used for many years and are therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficult to change or supplement. Many of the companies that sell these traditional non-invasive tests or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the equipment they require have established relationships with healthcare providers. One of the major <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hurdles to adoption of our products is overcoming established testing patterns, which requires education <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of physicians and supportive clinical data. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The companies that sell the traditional non-invasive tests for CAD include companies that offer&#58; (i) cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific tests to primary care and cardiology offices, such as manufacturers of capital equipment for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress echocardiography and SPECT, including GE Healthcare, Siemens Healthineers AG and Koninklijke <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Philips N.V.&#59; and (ii) products used for the invasive FFR testing market.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">27<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With the greater resources of some of these competitors and their more diversified product offerings, it is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possible that they or other entrants into the market may develop competing products or technologies that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could be more effective, accurate, reliable, cost-effective, more advanced or otherwise improved relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the Heartflow Platform, which could render our products obsolete or less competitive. In addition, one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more competitors could develop and market an on-premise solution, which may be more appealing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than our cloud-based offering. Moreover, new treatments, such as GLP-1s, may indirectly reduce stenosis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or plaque build-up, which could reduce the market opportunity for non-invasive CAD tests and, as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, our Heartflow Platform. In addition, we currently target our Heartflow Platform for use only on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptomatic patients and expanding the Heartflow Platform for asymptomatic patients may take years, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with potential delays due to the high-risk nature of the effort. Our competitors who offer traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests offer those tests to both symptomatic and asymptomatic patients, and this increased market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penetration could create additional price pressure for our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the field of cardiovascular genomics is subject to rapidly changing technology, and others may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invent and commercialize technology platforms such as next generation sequencing approaches that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could compete with our products or could make our products or any product we may sell in the future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obsolete. We also face competition and price pressure from companies that have developed or are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing AI-based platforms that leverage CCTA to diagnose CAD, including earlier-stage companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as Cleerly, Inc., Elucid Bioimaging Inc. and Keya Medical Technology Co., Ltd. We may also face <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition from companies developing AI-based platforms, even if they are not currently in the CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market and recent and future advances in AI may allow other companies to quickly create competing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, and they may be able to create such products less expensively and benefit from FDA and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement approvals we and others have obtained. For us to remain competitive, we must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continuously work on our products&#8217; design and features, improve our algorithms, and invest in and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">develop new technologies, including in the rapidly evolving area of AI. If we are unable to introduce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, features and improvements aimed at increasing the value proposition of the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our customers, or if the products, features and improvements we introduce are viewed less favorably <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than our competitors&#8217; products, we may be unable to compete successfully. If we are unable to compete <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully against our current or future competitors, we may be unable to increase market acceptance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our products, which could prevent us from increasing or sustaining our revenue or achieving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability and could cause the market price of our common stock to decline.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the Heartflow Platform relies on a CCTA first being performed, as the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires a CT image from a CT scanner to perform its analysis. A number of companies manufacture CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanners, including, among others, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., Samsung <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Electronics Co., Ltd., Siemens Healthineers AG and Canon Medical Systems Corporation. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies are more diversified than we are and have substantial financial, manufacturing, sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing distribution and other resources. Any of these companies or others could determine to develop, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partner with or acquire and offer a product that competes with ours or manufacture CT scanners that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no longer compatible with our Heartflow Platform. Further, these larger companies have market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penetration in the CT scanner market and understand the market for CAD and, if they are able to develop, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partner with or acquire a competing product, they may offer it as a bundle with the purchase of a CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanner, which could prevent us from increasing or sustaining our revenue or achieving profitability. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, three of these companies, Siemens Healthineers AG, Koninklijke Philips N.V. and Canon Medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Systems Corporation, considered development of a local workstation-based technology prototype aimed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at deriving CT-based blood flow data without an invasive procedure. If these companies decide to further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursue this technology and obtain regulatory approval or clinical validation, it may become competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with our products. In addition, we are reliant on these third-party CCTAs and CT scanners continuing to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support standard output file formats that our Heartflow Platform supports. If a CT manufacturer were to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change to a proprietary format or develop a novel method of performing CT scans, we would need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">further develop our existing technology to accommodate the images its scanners output, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">materially affect the ability of physicians to use the Heartflow Platform, increase our R&#38;D expenses, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">28<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The size and expected growth of our addressable market may be smaller than we estimate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our estimate of the addressable market for our current products and any future products is subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant uncertainty and is based on assumptions and estimates, including our internal analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">industry experience. While we believe our assumptions and the data underlying our estimates are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasonable, these assumptions and estimates may not be correct. As a result, our estimates of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addressable market for our current or future products may prove to be incorrect. Moreover, our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serve a significant portion of this estimated market is subject to many factors, including our success in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promoting the use of CCTA as a non-invasive diagnostic test that can be combined with the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which is subject to many risks and uncertainties, and relies on the availability and proximity of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare facilities with active CCTA programs to the patients in our estimated market. Accordingly, if we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are unable to increase the use of CCTA at the rates we estimate, if the actual number of patients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would benefit from our products is less than we estimate, or if the price at which we can sell future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or the reimbursement rate received by healthcare providers is less than we estimate, the size <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and expected growth of our addressable market would be smaller than our estimates, which could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be successful in updating or otherwise enhancing the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A part of our strategy is bringing new enhancements to our customers through updates to the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which may include offering new products, additional features, applications and improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our technology. We expect to make significant investments to advance these efforts, and enhancing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform is a complex and time-consuming endeavor. New products, additional features, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications and improvements to our technology that initially show promise may fail to achieve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">desired results or may not achieve acceptable levels of analytical accuracy, utility or user friendliness. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Product development and improvement is expensive, may take months or years to complete and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have uncertain outcomes. Failure can occur at any stage of the development or improvement process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may occur only after substantial work has been completed, or after completion. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if, after development, an updated product appears successful, we may, depending on the nature of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the update, need to obtain regulatory clearances, authorizations or approvals before we can market the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">updated product. Such regulatory clearances, authorizations or approvals are likely to require significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time and expenditures and the applicable regulatory authority may not clear, authorize or approve any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, update or new product we develop. Obtaining such clearances, authorizations or approvals may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require data from clinical trials, which can be costly and time-consuming to obtain. In certain jurisdictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or in certain cases, clinical data may also be required in order to obtain reimbursement coverage, and this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical data may be in addition to data required to obtain regulatory clearances, authorizations or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approvals. Some clinical studies may fail to meet their endpoints, introducing risk or delay in the ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize a new feature or product. In light of these requirements, we may choose to limit the scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any new products, additional features, applications and improvements we seek to develop. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if we develop a product update or new product that receives regulatory clearance, authorization or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval, and for which we obtain sufficient commercial third party and government reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage, we would need to commit substantial resources to commercialize and market the updated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, new product or new application of our existing product, which may never achieve market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptance among various stakeholders or be commercially successful. Further, the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations or the application of those regulations could change in ways that would impact the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform and our ability to successfully manufacture or market our products. The expenses or losses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with unsuccessful updates to or expansion of the Heartflow Platform could adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">29<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The commercialization of Heartflow Plaque Analysis is nascent, and we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">achieve or maintain sufficient market acceptance or the levels of utilization we expect from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis or any other future product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We began limited market education efforts for our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.24pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.22pt; position: absolute; white-space: pre;">Plaque Analysis in the second half of 2023, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we have generated very minimal revenue from this product. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.97pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.95pt; position: absolute; white-space: pre;">Plaque Analysis has taken <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time and significant resources to develop, and we may not be able to achieve customer acceptance or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broad commercial reimbursement coverage, which could limit its adoption. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The market for alternative plaque analysis products is competitive in terms of development, availability, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing, product quality and time-to-market. We face competition from companies that provide or are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing similar plaque analysis products, which may distinguish themselves from us through, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other things, perceived product quality, style and visuals, sleek design, enhanced user-friendliness and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">innovative features. In addition, some of these competitors are agile, early-stage companies that may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to respond more quickly and effectively than we can to new or changing opportunities, technologies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards or customer requirements in the plaque analysis category. Some of these competitors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercially launched competing plaque analysis products prior to our launch of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.55pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.53pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and may have a first-mover advantage as a result. For more information on risks related to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition, see the risk factor titled &#8220;We face significant competition in an environment of rapid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technological change, and there is a possibility that our competitors may develop products that are more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective, accurate, reliable, cost-effective or more advanced than ours, which may harm our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition. If we are unable to compete successfully or our potential market share is reduced, we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to increase or sustain our revenue or achieve profitability.&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our competitors may also be able to offer plaque analysis products similar or superior to ours at a more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attractive price than we can or may be better positioned to serve certain segments of our market, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could create additional price pressure. For example, our competitors have in the past, and may in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, offer plaque analysis and other products at a more attractive price than we can such that current or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential customers may select our competitors&#8217; products in lieu of purchasing and using our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.58pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. Moreover, our competitors have in the past, and may in the future, suggest that their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque analysis and other products could replace both our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.44pt; position: absolute; white-space: pre;">Plaque Analysis and our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis, which would adversely affect our ability to achieve sufficient market acceptance for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis, could affect sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.18pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 365.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.26pt; position: absolute; white-space: pre;"> Analysis and could cause our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis to lose market share. While we believe <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.09pt; position: absolute; white-space: pre;">Plaque Analysis represents a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant long-term opportunity for us, there can be no assurances that we will successfully compete in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such market and our business, financial condition, results of operations and prospects could be materially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with our use and development of AI models, which may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">operational challenges, legal liability, reputational concerns and competitive risks. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We use and develop AI and automated analysis and decision-making technologies, including proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI algorithms and models and computational fluid dynamics (collectively, &#8220;AI Technologies&#8221;) to power the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform. In addition, we use AI Technologies to drive improvements in the performance of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform. We expect that significant increased investment will be required in the future to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">improve our use and development of AI Technologies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As with many technological innovations, there are significant risks involved in developing, maintaining and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">deploying these technologies. In particular, if the AI Technologies underlying our Heartflow Platform are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">incorrectly designed or implemented&#59; trained or reliant on incomplete, inadequate, inaccurate or otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">poor quality data&#59; used without sufficient oversight and quality control&#59; misused or used outside of scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of applicable regulatory authorizations&#59; and&#47;or adversely impacted by unforeseen bugs, defects, technical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">challenges, cybersecurity threats or material performance issues, the performance of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Platform and business, as well as our reputation and the reputations of our customers, could suffer or we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could incur liability resulting from the violation of laws or contracts to which we are a party, regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">30<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">enforcement actions or civil claims. This could result in fines, penalties and damage awards and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">disgorgement of any output, development or technology developed as a result of such violations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we leverage a human-in-the-loop AI system that combines advanced algorithms with an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analyst-based quality inspection and monitoring process to create patient-specific reports based on CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">images. While we constantly work to improve our Heartflow Platform and algorithms, the AI Technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we work with are novel and complex, and we cannot assure you that our AI Technologies will be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perform as intended under all circumstances, or that our analyst-based review process will identify and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">correct any errors in the outputs of our AI Technologies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The regulatory framework for AI Technologies is rapidly evolving as many federal, state and foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government bodies and agencies have introduced or are currently considering additional laws, regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and guidance. For example, the FDA has issued guidance documents relating to the incorporation of AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Technologies into medical devices and marketing submissions for AI-enabled devices. Specifically, draft <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance issued on January 7, 2025, titled Artificial Intelligence-Enabled Device Software Functions&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Lifecycle Management and Marketing Submission Recommendations, proposes recommendations for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">design, development and implementation of AI-enabled devices that FDA encourages manufacturers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consider using throughout the total product lifecycle. In addition, the California Privacy Protection Agency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has approved for rulemaking regulations under the CCPA regarding the use of automated decision-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making that may require risks and providing notice and rights to opt-out and access to information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underlying the logic and outputs. Colorado passed the Colorado AI Act, which will go into effect in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">February 2026. This law creates duties for developers and deployers to use reasonable care to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consumers from any known or reasonably foreseeable risks of &#8220;algorithmic discrimination&#8221; arising from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the intended and contracted uses of &#8220;high-risk AI systems,&#8221; including those that impact healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services. Such additional laws, regulations and guidance may impact our ability to develop, use and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize AI Technologies in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">It is possible that further new laws and regulations will be adopted in the United States and in other non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. jurisdictions, or that existing laws and regulations, including competition and antitrust laws, may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpreted in ways that would limit our ability to use AI Technologies for our business, or require us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change the way we use AI Technologies in a manner that negatively affects the performance of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform and the way in which we use AI Technologies. We may need to expend resources to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjust our&#160;Heartflow Platform in certain jurisdictions if the laws, regulations or decisions are not consistent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">across jurisdictions. Further, the cost to comply with such laws, regulations or decisions and&#47;or guidance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpreting existing laws, could be significant and would increase our operating expenses (such as by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">imposing additional reporting obligations regarding our use of AI Technologies). Such an increase in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating expenses, as well as any actual or perceived failure to comply with such laws and regulations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could materially and adversely affect our business, financial condition, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow Platform and the data and models it generates could have bugs, defects or errors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">including human quality control errors, or otherwise fail to meet the expectations of patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">physicians and third-party payors, which could adversely affect our reputation, business and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot provide assurance that the proprietary technology and algorithms used in our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform do not contain undetected bugs, defects or errors or that our analyst-based review process will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identify and correct any errors in the outputs of our AI Technologies. We cannot provide assurance that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitations of the inbound CCTA images and image quality will always allow a true representation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient anatomy, and any such limitations in CCTA images could affect the results of our analyses. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have in the past, and may in the future, experience defects or errors in our Heartflow Platform or the data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and models it generates that remain undetected by our analyst-based review process, our reputation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business and operating results could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the success of the Heartflow Platform depends in part on patients&#8217;, physicians&#8217; and third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party payors&#8217; confidence that our platform can provide reliable, high-quality actionable data and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that will improve clinical decision making. We believe that patients, physicians and third-party payors are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely to be sensitive to product defects and errors in the use of our products, including if the defects and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">errors affect a physician&#8217;s ability to use the CCTA imaging results or result in a misdiagnosis. In the past, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have experienced software code defects and software release process defects that have resulted in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intermittent interruptions to the physician&#8217;s ability to use our Heartflow Platform, and we may experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such defects in the future. A subset of these defects were reported as part of the FDA&#8217;s Manufacturer and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">User Facility Device Experience (&#8220;MAUDE&#8221;) disclosure. For more information, see the risk factor titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;The Heartflow Platform may be subject to recalls, which could be costly and could harm our reputation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and business.&#8221; As a result, the failure of our Heartflow Platform to perform as expected, including to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce unnecessary invasive testing or fail to enable physicians to optimize treatment planning or provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more efficient care, could significantly impact a physician&#8217;s willingness to use and rely on the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which would impair our operating results and our reputation. In addition, we may be subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal claims arising from any such failures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bugs, defects or errors in the Heartflow Platform or the failure of third-party service providers we rely on, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as AWS or other cloud storage and telecommunications services providers, to block a virus or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent a security breach could harm our reputation and adversely impact our results of operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Defects may cause our products to be vulnerable to security attacks, cause them to fail to produce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate results or temporarily interrupt our commercial operations. Because the techniques used by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer hackers to access or sabotage networks change frequently and generally are not recognized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until launched against a target, we or our third-party services providers may be unable to anticipate these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">techniques and provide a corrective measure in time to protect the Heartflow Platform and our networks. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Potential defects may further cause the platform to be unavailable for a period of time, affect ability of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer to access information, result in a slow or suboptimal user experience, impact turnaround time of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an analysis, or provide other forms of degradation to the overall service. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">develop, motivate and retain our personnel, including highly qualified, technical personnel, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">may not be able to grow effectively and this could adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To execute our growth plan, we must attract and retain highly qualified, technical personnel. Competition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for these personnel is intense, especially for engineers with high levels of expertise in AI, cloud <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">architecture, 3D visualization, research scientists and senior sales executives with experience in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiology industry. We may experience difficulty in hiring and retaining employees with appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualifications. Many of the companies with which we compete for experienced personnel have greater <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources than we have. We also compete with companies that are believed to have high potential growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities or that have experienced rapid recent growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our future success depends in part on our ability to continue to retain our executive officers and other key <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees and to recruit and hire new employees, including engineers, research scientists, case analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and production team members. We do not maintain &#8220;key person&#8221; insurance for any of our executives or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other employees. The loss of the services of any of these persons could impede the achievement of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development, research and commercialization objectives. Any of our executive officers and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees may terminate employment with us at any time with no advance notice. The replacement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of our key personnel likely would involve significant time and costs, may significantly delay or prevent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the achievement of our business objectives and may harm our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, job candidates and existing employees often consider the value of the stock awards they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receive in connection with their employment. If the perceived value of our stock awards declines or is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perceived to be less valuable than stock awards of other competing employers, it may adversely affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our ability to recruit and retain highly skilled employees. In addition, many of our employees have become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or will soon become vested in a substantial amount of stock or number of stock options. Our employees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be more likely to leave us if the shares they own or the shares underlying their vested options have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly appreciated in value relative to the original purchase prices of the shares or the exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prices of the options, or if the exercise prices of the options that they hold are significantly below the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">32<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market price of our common stock. If we fail to attract new personnel, or fail to retain and motivate our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current personnel, our business and prospects could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to properly manage our future growth, our business could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to continue to grow and may experience periods of rapid growth and expansion, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">place a significant additional strain on our limited personnel, information technology systems and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources. Our future growth will impose significant added responsibilities on management, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">need to identify, recruit, train and integrate additional employees. In order to manage our operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth we will need to continue to improve our operational and management controls, administrative and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operational infrastructure, reporting and information technology systems and financial internal control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures. Due to our limited financial resources and the limited experience of our management team in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing a company with such future growth expectations, we may not be able to effectively manage the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected expansion of our operations or recruit and train additional qualified personnel. Moreover, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected expansion of our operations may lead to significant costs and may divert our management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business development resources. Any inability to manage growth could delay the execution of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business plans or disrupt our operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, as demand for the Heartflow Platform increases, we will need to scale our capacity, expand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer service and enhance our internal quality assurance program. We may fail to implement any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increases in scale, related improvements and quality assurance, and we may fail to find appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personnel to facilitate the growth of our business. Due to our limited resources, we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively manage this simultaneous execution and expansion of our operations. This may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">failures, loss of business opportunities, loss of employees and reduced productivity among remaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees. The expansion of our operations may lead to significant costs and may divert financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources from other projects, such as the development of any new products. If our management is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to effectively manage our expected development and expansion, our expenses may increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than expected, our ability to generate or increase our revenue could be reduced and we may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to implement our business strategy. Our future financial performance and our ability to compete <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively and commercialize our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.33000000000004pt; position: absolute; white-space: pre;">Plaque Analysis or any of our future products will depend in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part on our ability to effectively manage the future growth and expansion of our company. If we are unable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to manage our growth effectively, it may be difficult for us to execute our business strategy and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our business could be disrupted by catastrophic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The occurrence of any catastrophic event, including earthquake, fire, flood, tsunami or other weather <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event, power loss, telecommunications failure, software or hardware malfunctions, pandemics, political <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unrest, geopolitical instability, severe or prolonged economic downturn, cyberattack (including a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ransomware attack), war or terrorist attack, could result in lengthy interruptions in our ability to serve our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers. In addition, acts of terrorism could cause disruptions to the internet or the economy as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whole and could disproportionately affect us given our reliance on the internet and cloud-based services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Specifically, our corporate headquarters are located in Mountain View, California and our production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related computers are currently located in our Mountain View office and in Austin, Texas. California is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered to be an active earthquake zone, is prone to catastrophic fires, severe weather events and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follow-on effects thereof, including tsunamis, mudslides, flooding, power outages and other events that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could disrupt our business. Texas is also subject to severe weather events, power outages and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events that could disrupt our business. Any event that prevents our access to such facilities, physically or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">virtually, would prevent us from operating our business and have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we rely on our network and third-party infrastructure, including our cloud-based infrastructure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which we outsource to Amazon Web Services (&#8220;AWS&#8221;), and enterprise applications, internal technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems and our website, for our development, marketing, operational support hosted services and sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities. In the event of a catastrophic event, we may be unable to continue our operations and may <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">33<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">endure system interruptions, delays in our ability to generate reports and output them to physicians, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reputational harm, delays in our product development, breaches of data security and loss of critical data, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of which could have an adverse effect on our future operating results. If we are unable to develop <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adequate plans to ensure that our business functions continue to operate during and after a disaster and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to execute successfully on those plans in the event of a disaster or emergency, our business would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">harmed. Even with our disaster recovery arrangements and insurance coverage, the ability of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers to access and utilize our Heartflow Platform could be interrupted, or we could close critical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">data, which would have a negative impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the occurrence of a catastrophic event could impact providers of CCTAs, contrast agents for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTAs or suppliers of iodinated contrast media or similar supplies that are necessary to perform CCTAs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For example, in 2022, the shutdown of an iodinated contrast media manufacturing facility led to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant shortage of iodinated contrast media, which resulted in the cancellation or rescheduling of non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">urgent contrast-requiring cardiac procedures and imaging. Any of these events could affect demand for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform, which could have a material adverse effect on our business, financial condition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Consolidation&#160;among healthcare providers could have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, there has been a trend of consolidation among healthcare providers and purchasers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of medical technology devices, often to gain greater market power. As healthcare providers consolidate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they may try to use their market power to negotiate price concessions or reductions for the products and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services they purchase and use, including our Heartflow Platform. As result, it is unknown whether such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasers will decide to stop purchasing our Heartflow Platform or demand discounts on our prices. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce our prices in response to these industry trends, our revenue would decrease, which could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may acquire other companies, solutions or technologies, which could divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our operations and adversely affect our operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may in the future seek to acquire or invest in companies, solutions or technologies that we believe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could complement or expand our products, enhance our technical capabilities or otherwise offer growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities. The pursuit of potential acquisitions or other investment opportunities may divert the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attention of management and cause us to incur various expenses in identifying, investigating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuing suitable transactions, whether or not they are consummated. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we acquire any businesses, we may not be able to integrate the acquired personnel, operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technologies successfully, or effectively manage the combined business following the acquisition. We also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not achieve the anticipated benefits from the acquired business due to a number of factors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58; inability to integrate or benefit from acquired technologies or services in a profitable manner&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unanticipated costs or liabilities associated with the acquisition&#59; incurrence of acquisition related costs&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficulty integrating the accounting systems, operations and personnel of the acquired business&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficulties and additional expenses associated with supporting legacy products and hosting infrastructure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the acquired business&#59; diversion of management&#8217;s attention from other business concerns&#59; use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources that are needed in other parts of our business&#59; adverse effects to our existing business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships with business partners and customers as a result of the acquisition&#59; the potential loss of key <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees&#59; and use of substantial portions of our available cash to consummate the acquisition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, a significant portion of the purchase price of any companies, solutions or technologies that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may acquire may be allocated to acquired goodwill and other intangible assets, which must be assessed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for impairment at least annually. If our acquisitions do not yield expected returns, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">take charges to our operating results based on this impairment assessment process, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">34<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our operating results and cause the market price of our common stock to decline. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an acquired company, solution or technology fails to meet our expectations and does not complement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our products, enhance our technical capabilities or otherwise offer growth opportunities, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects may suffer. In addition, the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement restricts our ability to pursue certain mergers, acquisitions, amalgamations or consolidations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we may believe to be in our best interest.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sales to customers outside the United States or with international operations expose us to risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">inherent in international sales.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In our fiscal year<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.31pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">s ended December 31, 2023 and 2024 and three months ended March 31, 2024 and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">2025, sales to custom</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.20999999999998pt; position: absolute; text-decoration: none; white-space: pre;">ers outside the United States accounted for approximately&#160;11%,&#160;9%, 9% and 8% of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our revenue, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.7pt; position: absolute; white-space: pre;"> One element of our growth strategy is to further expand our international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and worldwide customer base. Operating in international markets requires significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources and management attention and subjects us to regulatory, economic and political risks that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different from those in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have limited operating experience in international markets, and we cannot assure you that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing presence in the United Kingdom, Europe and Japan or any expansion efforts into other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international markets will be successful. Our experience in the United States and international markets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be relevant to our ability to expand in other markets. Our international expansion efforts may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be successful in creating further demand for our products outside of the United States or in effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">selling our products in the international markets we enter. In addition, expansion into other international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">markets will be costly and will impose additional burdens on our executive and administrative personnel, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finance and legal teams, sales and marketing teams and general managerial resources. If our efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">introduce our products into other international markets are not successful, we may have expended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant resources without realizing the expected benefit. Ultimately, the investment required for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international expansion could exceed the results of operations generated from this expansion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we operate in an industry which is subject to significant enforcement scrutiny by both U.S. and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. government authorities. Our international business requires us to comply with U.S. and foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws and regulations, such as various anti-bribery and anti-corruption laws, including the U.S. Foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corrupt Practices Act (&#8220;FCPA&#8221;), the U.S. Fraud Act and in certain cases the U.K. Bribery Act of 2010. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compliance with these is costly and exposes us to significant civil and criminal penalties for non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance. Any failure to comply with applicable legal and regulatory obligations could impact us in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">variety of ways that include, but are not limited to, significant criminal, civil and administrative fines, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penalties and disgorgement of profits, including imprisonment of individuals, denial of export privileges, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">seizure of shipments, restrictions on certain business activities and exclusion or debarment from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government contracting. Our international operations expose us to risks inherent in operating in foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions that could adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we do not obtain and maintain international regulatory registrations, clearances or approvals for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our Heartflow Platform, we will be unable to market and sell our products outside of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any future sales of our products outside of the United States are subject to foreign regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that vary widely from country to country. While the regulations of some countries may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impose barriers to marketing and selling our products or only require notification, others require that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain the clearance or approval of a specified regulatory authority or a Certificate of Conformity of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notified body. Complying with foreign regulatory requirements, including obtaining registrations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances or approvals, can be expensive and time consuming and we may not receive regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances or approvals in each country in which we plan to market our products or we may be unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do so on a timely basis. The time required to obtain registrations, clearances or approvals, if required by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other countries, may be longer than that required for FDA clearance or approval, and requirements for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such registrations, clearances or approvals may significantly differ from FDA requirements. If we modify <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">35<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, we may need to apply for regulatory clearances or approvals before we are permitted to sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the modified product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, AI governing regulations around medical devices evolve rapidly and we may not continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meet the quality and safety standards required to maintain the authorizations that we have received. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are unable to maintain our authorizations in a particular country, we will no longer be able to sell the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable product in that country.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulatory registration, clearance, marketing authorization, or approval by the FDA does not ensure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration, clearance, marketing authorization, or approval by foreign regulatory authorities or authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives in other countries. Registration, clearance, marketing authorization, or approval by one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more foreign regulatory authorities or authorized representatives do not ensure registration, clearance, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing authorization, or approval by regulatory authorities in other foreign countries or by the FDA. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, a failure or delay in obtaining registration or regulatory clearance or approval in one country <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may have a negative effect on the regulatory process in others.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to data privacy and information technology<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Failure to comply with laws and regulations affecting the transmission, security and privacy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">personal information (including health information) could result in significant penalties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Federal, state and foreign government bodies and authorities have adopted, are considering adopting, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may adopt laws and regulations regarding the collection, use, processing, storage and disclosure of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personal information obtained from consumers and individuals. In the United States, federal, state, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">local governments have enacted numerous data privacy and security laws, including data breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Trade Commission Act), and other similar laws (e.g., wiretapping laws). Under these laws we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to obtain certain consents to process personal data. For example, some of our data processing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practices have been, and may in the future continue to be, subject to challenges or lawsuits under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy, security, and communications laws, including, for example, challenges based on wiretapping laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for sharing consumer information with third parties through various methods, such as via third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing pixels or software development kits. Our inability or failure to obtain consent for these practices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in adverse consequences, including class action litigation and mass arbitration demands. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, numerous federal and state laws and regulations, including the Health Insurance Portability and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology for Economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), govern the collection, dissemination, security, use and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confidentiality of patient identifiable health information. HIPAA and the HITECH Act require us to comply <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with standards for the use and disclosure of health information within our company and with third parties. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Standards for Privacy of Individually Identifiable Health Information (&#8220;Privacy Standards&#8221;), and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Standards for the Protection of Electronic Protected Health Information (&#8220;Security Standards&#8221;), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under HIPAA establish a set of basic national privacy and security standards for the protection of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">individually identifiable health information by health plans, healthcare clearinghouses and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers, referred to as covered entities, and the business associates with whom such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covered entities contract for services. As a result, both covered entities and business associates can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to significant civil and criminal penalties for failure to comply with the Privacy Standards or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Standards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA, the HITECH Act and the Affordable Care Act (&#8220;ACA&#8221;) also include standards for common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare electronic transactions and code sets, such as claims information, plan eligibility, payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information and the use of electronic signatures, unique identifiers, operating rules. Companies that bill <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors for healthcare-related services and device use are required to conform to the transaction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards. CMS, on behalf of HHS, has the authority to investigate complaints and audit for compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the HIPAA standards for transactions, code sets, unique identifiers and operating rules, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrative Simplification provisions of HIPAA and the ACA. Failure to comply with these standards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and any investigation or audit and penalties imposed may have an adverse impact on our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA requires covered entities and business associates to develop and maintain policies and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">36<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures with respect to protected health information that is used or disclosed, including the adoption of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative, physical and technical safeguards to protect such information. The HITECH Act expands <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the notification requirement for breaches of patient identifiable health information, restricts certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures and sales of patient identifiable health information and provides a tiered system for civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">monetary penalties for HIPAA violations. The Final HIPAA Omnibus Rule modifies the breach reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard in a manner that will likely make more data security incidents qualify as reportable breaches. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The HITECH Act also increased the civil and criminal penalties that may be imposed against covered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entities, business associates and possibly other persons and gave state attorneys general new authority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attorney fees and costs associated with pursuing federal civil actions. Additionally, states have adopted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable privacy and security laws and regulations that differ somewhat from federal and other states&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws, and that govern where more stringent than federal law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a business associate under HIPAA, if we do not comply with the requirements of HIPAA, the HITECH <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act or applicable state privacy and security laws, we could be subject to criminal or civil sanctions that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our financial condition. The costs of complying with privacy and security related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal and regulatory requirements are substantial and could have an adverse effect on our business. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we are unable to predict what changes to the HIPAA Privacy Standards and Security Standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">might be made in the future or how those changes could affect our business. Any new legislation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulation in the area of privacy and security of personal information, including personal health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, could also adversely affect our business operations. In addition, a security breach could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require reporting to federal and state government entities, notification to affected individuals, expensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation and remediation and mitigation. Government agencies could, in their discretion, impose fines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and penalties relating to the breach, that would have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Foreign data privacy regulations, such as the General Data Protection Regulation (E.U.) 2016&#47;679 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;GDPR&#8221;), the European Union&#8217;s Data Protection Directive (Directive 95&#47;46&#47;EC), and the country specific <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations that implement Directive 95&#47;46&#47;EC, also govern the processing of personally identifiable data, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and a number of these regulations are stricter than U.S. laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, many states have laws, regulations and other authorities that govern data privacy, security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and breach notification. While some of these laws exempt protected health information subject to HIPAA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they may apply to other personal information we collect, including personal information collected from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees or from visitors to our website. Failure to comply with these authorities may have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to expend significant resources to comply with these laws and regulations. The functional and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operational requirements and costs of compliance with such laws and regulations may adversely impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, and failure to enable our solutions to comply with such laws and regulations could lead to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant fines and penalties imposed by regulators, as well as claims, lawsuits and contractual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification obligations by or for our customers or third parties and significant reputational harm. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our information technology systems, and any failure of these systems could harm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our business and adversely affect our business and operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information technology and telecommunications systems are vulnerable to damage from a variety of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sources, including telecommunications or network failures, failures during the processes of upgrading or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">replacing software, power outages, hardware failures, user or human errors and natural disasters. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, despite network security and back up measures, some of our servers are potentially vulnerable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to cybersecurity incidents, including phishing attacks by computer hackers or other malicious human acts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer viruses, ransomware, malware and similar disruptive problems or other methods of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compromising employee or customer administrator credentials to access protected health information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our internal data. Failures or significant downtime of our information technology or telecommunications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems could prevent us from operating our business. Any disruption or loss of information technology or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">telecommunications systems on which critical aspects of our operations depend could have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect on our business and our operating results may suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">37<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our brand, reputation and ability to attract, retain and serve our customers are dependent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon the reliable performance of our Heartflow Platform, including our underlying information technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems and infrastructure. Our technical infrastructure may not be adequately designed with sufficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reliability and redundancy to avoid performance delays or outages that could be harmful to our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If our Heartflow Platform is unavailable when physicians attempt to access it, or if it does not load as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quickly as they expect, physicians may not use our Heartflow Platform as often in the future, or at all. As <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our customer base continues to grow, we will need an increasing amount of technical infrastructure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including network capacity and computing power, to continue to satisfy the needs of our users. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We rely upon AWS to operate our cloud offering&#59; any disruption of or interference with our use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">AWS would adversely affect our business, results of operations and financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We outsource all of our cloud-based infrastructure to AWS. Our customers need to be able to access our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cloud-based infrastructure at any time, without interruption or degradation of performance. AWS runs its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">own platform that we access, and we are, therefore, vulnerable to service interruptions at AWS. We may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience interruptions, delays and outages in service and availability from time to time as a result of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problems with our AWS provided infrastructure. For example, in September 2015, AWS suffered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant outage that had a widespread impact on cloud-based software and services companies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although our customers were not affected by that outage, a similar outage could render our cloud offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inaccessible to customers. Additionally, AWS has suffered outages at specific customer locations in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, rendering the customer unable to access our offering for periods of time. Lack of availability of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AWS infrastructure could be due to a number of potential causes including technical failures, natural <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disasters, fraud or security attacks that we cannot predict or prevent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, if the security of the AWS infrastructure is compromised or believed to have been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compromised, our business, results of operations and financial condition could be adversely affected. It is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possible that our customers and potential customers would hold us accountable for any breach of security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affecting the AWS infrastructure and we may incur significant liability from those customers and from third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties with respect to any breach affecting AWS systems. For more information, see the risk factor titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Failure to comply with laws and regulations affecting the transmission, security and privacy of personal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information (including health information) could result in significant penalties.&#8221; Because our agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with AWS limits AWS&#8217; liability for damages, we may not be able to recover a material portion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities to our customers and third parties from AWS. Customers and potential customers may refuse to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do business with us because of the perceived or actual failure of our cloud offering as hosted by AWS and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our operating results could be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our agreement with AWS allows AWS to terminate the agreement by providing 30 days&#8217; advance notice, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and allows AWS to terminate in case of a material breach of contract if such breach is uncured for 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days following receipt of notice of such breach, or to terminate immediately upon notice to us (i) if AWS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has the right to suspend our account&#59; (ii) if AWS&#8217; relationship with a third-party software or technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provider terminates, expires or requires AWS to change the way it provides its services&#59; or (iii) in order to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comply with the law or requests of governmental entities. Although we expect that we could receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar services from other third parties, if any of our arrangements with AWS are terminated, we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience interruptions on our platform and in our ability to make our platform available to customers, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">well as delays and additional expenses in arranging alternative cloud infrastructure services.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to offer high quality customer support, our business and reputation could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our customers rely on our customer support teams to resolve technical and operational issues if and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">when they arise. We may be unable to respond quickly enough to accommodate short-term increases in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer demand for customer support. We also may be unable to modify the nature, scope and delivery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our customer support to compete with changes in customer support services provided by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors or to adapt to product and industry developments. Increased customer demand for customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support, without corresponding revenue, could increase costs and harm our results of operations. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, as we continue to grow our operations and reach a large global customer base, we need to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to provide efficient customer support that meets our customers&#8217; needs globally at scale. The number <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our customers has grown significantly, and that growth has and will continue to put additional pressure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our support organization. As our business scales, we may need to engage third-party customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support service providers, which could negatively impact the quality of our customer support if such third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties are unable to provide customer support that is as effective as that we provide ourselves. Our sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are highly dependent on our business reputation and on positive recommendations from our existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers. Accordingly, high quality customer support is important for the renewal and expansion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with existing customers and any failure to maintain such standards of customer support, or a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market perception that we do not maintain high quality customer support, could harm our reputation, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to sell product to existing and prospective customers and our business, financial condition, results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We invest significantly in research and development, and to the extent our research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">development investments do not translate into new products, features or improvements to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">current products, or if we do not use those investments efficiently, our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">condition, results of operations and prospects would be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A key element of our strategy is to invest significantly in our research and development efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">introduce new products, features and improvements aim<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.87pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ed at increasing the value proposition of the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow Platform for our customers. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.25pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">For the years ended December 31, 2023 and 2024 and three </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">months ended March 31, 2024 and 2025, our research and development expenses were 41%,&#160;35%, 35% </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and 37% of our revenue, respectively</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.26pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">. If we do not spend our re</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.33pt; position: absolute; white-space: pre;">search and development budget efficiently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or effectively on compelling innovation and technologies, our business may be harmed and we may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">realize the expected benefits of our strategy. Moreover, research and development projects can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technically challenging and expensive. The nature of these research and development cycles may cause <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us to experience delays between the time we incur expenses associated with research and development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the time we are able to offer compelling solutions and generate revenue, if any, from such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment. For example, investments made to expand the Heartflow Platform to asymptomatic patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be expensive, technically challenging, experience delays and may not be successful. Additionally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">anticipated customer demand for a product or feature we are developing could decrease after the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development cycle has commenced, and we would nonetheless be unable to avoid substantial costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with the development of any such product or features. If we expend a significant amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources on research and development and our efforts do not lead to the successful introduction or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">improvement of products or features that are competitive in our current or future markets, it would harm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our networks and those of our third-party service providers may become the target of bad actors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">or security breaches that we cannot anticipate or successfully defend, which could have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform involves the storage and transmission of our customers&#8217; personal information or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identifying information of their patients. Increasingly, we and other companies are subject to a wide variety <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of attacks on their networks on an ongoing basis. In addition to attacks from traditional computer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;hackers,&#8221; malicious code (such as viruses and worms), employee theft or misuse, ransomware attacks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and denial of service attacks, sophisticated nation state and nation state supported actors now engage in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intrusions and attacks (including advanced persistent threat intrusions), and add to the risks to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal networks and the information they store and process. Additionally, such bad actors frequently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attempt to fraudulently induce employees or customers into disclosing sensitive information such as user <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">names, passwords or other information in order to gain access to our customers&#8217; data, their patient&#8217;s data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or our data, including our intellectual property and other confidential business information, or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information technology systems. Because techniques used to obtain unauthorized access or to sabotage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems change frequently and generally are not recognized until successfully launched against a target, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may be unable to anticipate these techniques or to implement adequate preventative measures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Despite significant efforts to create process and security barriers to such threats, it is virtually impossible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for us to entirely mitigate these risks. Any such breach could compromise our networks, creating system <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disruptions or slowdowns and exploiting security vulnerabilities of our products, and the information stored <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">39<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our networks could be accessed, publicly disclosed, lost or stolen, which could subject us to liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and cause us significant financial harm. Such breaches often result in reputational damage, negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publicity, loss of industry data security certifications, customers and sales, increased costs to remedy any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problem, costly litigation and contractual indemnification obligations by or for impacted customers or third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties any of which could adversely affect our business. In addition, although we have, and intend to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain, insurance with respect to any such indemnification obligations, the coverage limits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance policies may not be adequate and one or more successful claims brought against us may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also rely on third-party service providers, such as cloud storage and telecommunications services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers. Such service providers are also potentially vulnerable to cybersecurity incidents that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in the interruption of their services to us or unauthorized access, use or disclosure of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confidential information and confidential information of our customers and protected health information of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their patients. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are also targets for malicious cybersecurity acts. While some of our products contain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">encryption or security algorithms to protect third-party content or patient information or other data stored <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our products, these products could still be hacked or targeted by malicious software programs or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attacks or the encryption schemes could be compromised, breached or circumvented by motivated or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sophisticated hackers, which could harm our business and our reputation. In addition, see the risk factor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">titled &#8220;Our Heartflow Platform and the data and models it generates could have bugs, defects or errors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including human quality control errors, or otherwise fail to meet the expectations of patients, physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and third-party payors, which could adversely affect our reputation, business and operating results&#8221; for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more information on bugs, defects or errors in the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to legal and regulatory matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face extensive, regulatory requirements to bring our products to market, and our failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">receive and maintain regulatory clearances or approvals of our current and future products in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United States or abroad or to comply with medical device regulatory requirements could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to market any product, we must establish and comply with numerous and varying regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that vary by country and by region within certain countries. Approval, clearance or marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorization in the United States by the FDA or by a regulatory authority or other body in another country <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not ensure approval by the regulatory authorities in other countries or jurisdictions or ensure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval, clearance or other marketing authorization for the same conditions of use. Approval processes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vary among countries and can involve additional product testing and validation and additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative review periods. In general, unless an exemption applies, in the U.S. current and future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">versions of our products must receive pre-market notification (&#8220;510(k)&#8221;), de novo classification (&#8220;de novo&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or pre-market approval (&#8220;PMA&#8221;) from the FDA before they can be marketed in the United States. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot provide assurance that any of our future products, to the extent required, will be cleared, approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or otherwise authorized by the FDA through any of its pre-market review processes, or that the FDA will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide export certificates that are necessary to export certain products to certain countries. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the national health or social security organizations of certain foreign countries, including those outside <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Europe, require our products to be qualified before they can be marketed in those countries. Failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receive, or delays in the receipt of, relevant foreign qualifications in the European Economic Area or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign countries could have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pre-market notification, de novo classification request or PMA applications may require support by data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from clinical trials. We are subject to requirements to publicly register and report the results of our clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trials. We must also abide by good clinical practice (&#8220;GCP&#8221;) requirements in the conduct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documentation of our clinical trials and report to the FDA significant financial interests of investigators in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any clinical trials we submit to support marketing applications for our products. We, the FDA or an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">institutional review board (&#8220;IRB&#8221;), may suspend or terminate clinical trials at any time on various grounds, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including a finding that patients are being exposed to an unacceptable health risk or that the treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not have any effect. If the FDA considers data from our clinical trials to be actually or potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">biased due to investigators&#8217; financial interests, or unreliable due to GCP noncompliance, it can require us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to implement extensive data analyses or other corrective actions, or exclude data from consideration in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support of our marketing applications. These outcomes could result in delay or denial of FDA clearance or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval and could result in the need to conduct additional, costly and time-consuming clinical trials. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, we are required to obtain pre-market clearance or approval to market significantly modified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">versions of our currently cleared Heartflow Platform, as well as to market the existing product for new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indications. The FDA requires us to make and document a determination as to whether or not a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification requires a new 510(k) clearance, de novo classification or PMA approval&#59; however, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can review and disagree with our decision. Although we have received 510(k) clearance from the FDA for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the current version of the Heartflow Platform, we may not be successful in receiving clearances, de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classifications or approvals in the future or the FDA may not agree with our decisions not to seek <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances, de novo classifications or approvals for any new products or particular product modifications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or updates. The FDA may require us to obtain a new 510(k) clearance, de novo classifications or approval <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for any past or future modification or a new indication for our existing products. Such submissions may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require the development and submission of additional data, may be time consuming and costly, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ultimately may not be cleared or approved by the FDA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA requires us to obtain pre-market clearances, de novo classifications or approvals for any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed modification to a previously cleared version of the Heartflow Platform, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cease manufacturing and marketing of the modified product or to recall the modified product until we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain such FDA marketing authorization. The FDA may not clear, grant or approve such submissions in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">timely manner, if at all. The FDA also may change its policies, adopt additional regulations, or revise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing regulations, each of which could prevent or delay pre-market clearance, de novo classification or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval of our devices, or could impact our ability to market a device that was previously cleared. Any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the foregoing could adversely impact our business and financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the FDA and other comparable foreign regulatory authorities may delay, limit or deny <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance, de novo classification or approval of future versions of or future indications for our products or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other potential product for many reasons, including, among others&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the results of our clinical trials may not meet the level of statistically significant and clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">meaningful efficacy with an acceptable safety profile as required by FDA, or other comparable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">regulatory authorities in other countries, for marketing approval&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may disagree with the number, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">design, size, conduct or implementation of our clinical trials&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may disagree with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">interpretation of data from our clinical trials&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may not accept data generated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at one or more of our clinical trial sites&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">if our 510(k) notifications, de novo classification requests, PMA applications, or similar notifications or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications, if and when submitted, are reviewed by the FDA or other comparable regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">authorities, as applicable, the regulatory authorities may have difficulties scheduling the necessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">review meetings in a timely manner, or may recommend against clearance or approval of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">application&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA may determine that our 510(k) notifications for new indications, if and when submitted, must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">follow a different regulatory pathway than we have attempted, and there may be potentially extended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">standards, timelines, reviews (such as by an FDA Advisory Committee) and costs in order to pursue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approval. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any of these factors, many of which are beyond our control, could jeopardize our ability to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory clearance, de novo classification or approval for current or future versions of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform and could result in difficulties and costs for us. If we fail to comply with regulatory requirements in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international markets or to obtain and maintain required marketing authorizations, or if marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorizations in international markets are delayed, our ability to realize the full market potential of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new potential products will be limited.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">system could have an adverse effect on our business, financial condition, results of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, there have been and continue to be a number of legislative and regulatory initiatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to contain healthcare costs. Federal and state lawmakers regularly propose and, at times, enact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legislation that would result in significant changes to the U.S. healthcare system, some of which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intended to contain or reduce the costs of medical products and services, including our own products. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, on July 4, 2025, the annual reconciliation bill, the &#8220;One Big Beautiful Bill Act,&#8221; or OBBBA, was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">signed into law which is expected to reduce Medicaid spending and enrollment by implementing work <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements for some beneficiaries, capping state-directed payments, reducing federal funding, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limiting provider taxes used to fund the program. OBBBA also narrows access to ACA marketplace <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange enrollment and declines to extend the ACA enhanced advanced premium tax credits, set to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expire in 2025, which, among other provisions in the law, are anticipated to reduce the number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Americans with health insurance. Current and future legislative proposals to further reform healthcare or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce healthcare costs may limit coverage of or lower reimbursement for the diagnostic tests associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the use of our products. The cost containment measures that payors and providers are instituting and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effect of any healthcare reform initiative implemented in the future could impact our revenue from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale of our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect additional state and federal healthcare policies and reform measures to be adopted in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, particularly in light of the recent changes in the White House and Congress, any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limit reimbursement for healthcare products and services or otherwise result in reduced demand for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or additional pricing pressure and have a material adverse effect on our industry generally and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our customers. We cannot predict what other healthcare programs and regulations will ultimately be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implemented at the federal or state level or whether any future legislation or regulation in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States may negatively affect our business, financial condition, results of operations and prospects. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continuing efforts of the government, insurance companies, managed care organizations and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors of healthcare services to contain or reduce costs of healthcare may adversely affect our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set a price that we believe is fair for our products, our ability to generate revenue and achieve or maintain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability and the availability of capital.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any changes of, or uncertainty with respect to, future coverage or reimbursement rates could affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand for our products, which may prevent us from being able to generate additional revenue or attain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to many laws and governmental regulations affecting our marketed products, both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">domestically and internationally, and any adverse regulatory action may adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform is subject to regulation by numerous government authorities, including the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and comparable foreign authorities, after clearance or approval of current and future versions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product. To varying degrees, each of these authorities requires us to comply with laws and regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governing the development, design, testing, manufacture, labeling, advertising, promotion, distribution, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import and export of our products. The Heartflow Platform (also referred to as Heartflow Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of four main functions, the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 293.01pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.66999999999996pt; position: absolute; white-space: pre;"> Analysis, the Heartflow Plaque Analysis, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow RoadMap Analysis and the Heartflow PCI Planner (which we expect to launch in 2026)) has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been cleared by the FDA (K213857), and only the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.18pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 358.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.26pt; position: absolute; white-space: pre;"> Analysis function of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform is CE Marked in the European Economic Area, the United Kingdom and Australia, received <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">42<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical device licensing in Canada and has been approved for marketing authorization in Japan by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;), all for specific indications for use. The Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform has also been cleared by the equivalent regulatory authorities in Israel, Saudi Arabia, United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Arab Emirates, and licensed in Bahrain.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We currently have ongoing responsibilities under U.S., U.K., European Economic Area, Switzerland, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Canada, Australia, Japan, Saudi Arabia, United Arab Emirates, Bahrain and Israel (registered or licensed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regions) regulations, including requirements related to product and facility registration, device listing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse event reporting, reporting of recalls and field corrective actions, manufacturing, advertising, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promotion, distribution, import, and export. In certain jurisdictions outside of the United States, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract with third parties (i.e., notified bodies, authorized representatives, manufacturing authorization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders) who either oversee regulatory compliance or assume regulatory responsibilities for our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributed by those third parties. We are subject to periodic inspections and audits by the FDA, notified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bodies, authorized representatives and comparable foreign authorities to determine compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory requirements, including good manufacturing practices such as the Quality System Regulation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the FDA, Medical Device Single Auditing Program, ISO 13485&#58;2016, and EN ISO 13485&#58;2021 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concerning the EU, establishment registration and device listing, medical device reporting, vigilance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting of adverse events, notification of corrections, recalls, field safety corrective actions and product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">labeling and marketing. These inspections and audits can result in inspectional observations or reports, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warning letters or other forms of enforcement action. If the FDA or comparable foreign authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conclude, as a result of these inspections or audits or from any other source of information, that we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not in compliance with applicable laws or regulations, or that our products are ineffective or pose an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unreasonable health risk, such authorities could ban these products, suspend or cancel our marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorizations, impose &#8220;stop sale&#8221; and &#8220;stop import&#8221; orders, refuse to issue export certificates, detain or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">seize adulterated or misbranded products, order a recall, repair, replacement, correction or refund of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, require us to conduct post-market surveillance studies or change the labeling for our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or require us to notify health professionals and others that the products present unreasonable risks of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial harm to the public health. Failure to comply with regulatory requirements may also subject us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to additional administrative and judicially imposed sanctions, warning letters, civil and criminal penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">injunctions, interruption of manufacturing or clinical trials, total or partial suspension of production and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulting adverse publicity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Discovery of previously unknown problems with our products&#8217; design or manufacture may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions on the use of the Heartflow Platform, restrictions placed on us or our suppliers or withdrawal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the existing regulatory clearance of the Heartflow Platform. The FDA or comparable foreign authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may also impose operating restrictions, enjoin and restrain violations of applicable law pertaining to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical devices, assess civil or criminal penalties against our officers, employees or us or recommend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criminal prosecution of our company. Adverse regulatory action of a certain magnitude may restrict us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from effectively marketing and selling our products. In addition, negative publicity or product liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims resulting from any adverse regulatory action could have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In many of the foreign countries in which we market our products, we are subject to extensive medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device regulations that are similar to those of the FDA, including those in Europe. The regulation of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products in Europe falls within the European Economic Area, which consists of the 27 member states of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the European Union, as well as Iceland, Liechtenstein and Norway. Only medical devices that comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain conformity requirements of the Medical Devices Regulation (E.U.) 2017&#47;745 (&#8220;MDR&#8221;) concerning <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medical Devices, or the E.U. Medical Devices Directive, Directive 2006&#47;114&#47;EC are allowed to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed within the European Economic Area. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Foreign governmental regulations have become increasingly stringent and more extensive, and we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">become subject to even more rigorous regulation by foreign governmental authorities in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Penalties for a company&#8217;s noncompliance with foreign governmental regulation could be severe, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revocation or suspension of a company&#8217;s business license and civil or criminal sanctions. In some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions, such as Germany, any violation of a law related to medical devices is also considered to be <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">43<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a violation of unfair competition law. In such cases, governmental authorities, our competitors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business or consumer associations may then file lawsuits to prohibit us from commercializing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform in such jurisdictions. Our competitors may also sue us for damages. Any domestic or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign governmental law or regulation imposed in the future may have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Delays in the commencement or completion of future or ongoing clinical testing could result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increased costs to us and delay our ability to market the Heartflow Platform for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">indications. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are currently enrolling patients for our DECIDE clinical trial to evaluate our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.92pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.9pt; position: absolute; white-space: pre;">Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in a real-world setting. We do not know whether our DECIDE clinical trial will be completed on schedule, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or at all. The commencement or completion of clinical trials can be disrupted for a variety of reasons, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including difficulties in&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recruiting and enrolling patients to participate in, and investigators to conduct, a clinical trial&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reaching agreements on acceptable terms with prospective clinical research organizations and trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sites&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining approval of an investigational device exemption (&#8220;IDE&#8221;), application from the FDA or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">equivalent authorization from foreign regulatory authorities, if required&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining IRB approval to conduct a clinical trial at a prospective site.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A clinical trial may also be suspended or terminated by us, an IRB, the FDA or other regulatory authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">due to a number of factors, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">failure to conduct the clinical trial in accordance with regulatory requirements or in accordance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our clinical protocols&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the imposition of a clinical hold&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">safety or effectiveness issues&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lack of adequate funding to continue the clinical trial.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, changes in regulatory requirements and guidance may occur, and we may need to amend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical trial protocols to respond to such changes, which could impact the cost, timing or successful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of a clinical trial. If we experience delays in the commencement or completion of our clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trials, the commercial prospects for additional indications for our products will be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interim, &#8220;top-line&#8221; and preliminary data from our clinical trials that we announce or publish from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">time to time may change as more patient data become available and are subject to audit and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">verification procedures that could result in material changes in the final data. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our DECIDE clinical trial, which is based on a preliminary analysis of then-available data, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the results and related findings and conclusions are subject to change following a more comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review of the data related to the particular trial or additional data collected at a later time. We also make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have received or had the opportunity to fully and carefully evaluate all data. As a result, the interim, top-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">line or preliminary results that we report may differ from future results of the same trial, or different <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conclusions or considerations may qualify such results, once additional data have been received and fully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluated. Interim, top-line or preliminary data also remain subject to audit and verification procedures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that may result in the final data being materially different from the interim, top-line or preliminary data we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously announced. As a result, interim, top-line and preliminary data should be viewed with caution <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">44<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until the final data are available. Adverse differences between interim data and final data could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in volatility in our share price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, others, including the FDA and other regulatory authorities or other bodies, may not accept or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the importance of data differently, which could impact the value of the particular trial, or the approvability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or potential for commercialization of the particular medical device. In addition, the information we choose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, and others may not agree with what we determine is material or otherwise appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information to include in our disclosure. The interim, top-line or preliminary data that we report may differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from final results, and regulatory authorities and other bodies may disagree with the conclusions reached, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may harm our ability to obtain marketing authorization for, and commercialize, our future products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could harm our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may face product liability claims that could result in costly litigation and significant liabilities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be able to maintain adequate product liability insurance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Development, marketing and clinical testing of our products may expose us to product liability and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tort claims. Although we have, and intend to maintain, liability insurance, the coverage limits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance policies may not be adequate and one or more successful claims brought against us may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects. For example, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the U.S. Supreme Court declined to hear an appeal where the U.S. Court of Appeals for the Ninth Circuit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ruled that the 1976 Medical Device Amendments to the Federal Food, Drug and Cosmetic Act did not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preempt state laws in a product liability case involving a medical device company. If other courts in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States adopt similar rulings, we may be subject to increased litigation risk in connection with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products. Product liability claims could negatively affect our reputation, product sales, and our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain and maintain regulatory approval for our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, although we have product liability and clinical study liability insurance, this insurance is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to deductibles and coverage limitations. Our current product liability insurance may not continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be available to us on acceptable terms, if at all, and, if available, coverage may not be adequate to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us against any future product liability claims. If we are unable to obtain insurance at an acceptable cost, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on acceptable terms with adequate coverage, or at all, or otherwise protect against potential product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities could have an adverse effect on our reputation, business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform may be subject to recalls, which could be costly and could harm our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reputation and business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to ongoing medical device reporting regulations that require us to report to the FDA or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar governmental authorities in other countries if our products cause, or contribute to, death or serious <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">injury, or if they malfunction and would be likely to cause, or contribute to, death or serious injury if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">malfunction were to recur. We could voluntarily elect to, or the FDA and similar governmental authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in other countries could require us to, perform a correction, field safety corrective action, removal or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recall of our products in the event of material deficiencies or defects in design, manufacturing or labeling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that could cause harm. Our products have been in the past, and may in the future, be the subject of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical device reports of adverse events with the MAUDE database, including reports of false negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results and incorrect or imprecise results or readings. Between 2017 and 2025, 116 Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MAUDE reports were made, with 104 of those reports due to false negative results, 11 reports due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorrect, inadequate or imprecise results or readings, and one report due to an adverse event without an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identified device or use problem. While none of these MAUDE reports resulted in a mandated or voluntary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">correction, field safety action, removal or a recall, a government mandated or voluntary correction, field <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safety corrective action, removal or other recall could occur as a result of manufacturing errors or design <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">45<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defects, including defects in labeling. Any correction, field safety corrective action, removal or other recall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would divert managerial and financial resources and could lead to a substantial loss of physician and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient confidence in our products and, consequently, have an adverse effect on our growth prospects or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating results. A correction, field safety corrective action, removal or other recall could also result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial litigation, including product liability claims, with liabilities well in excess of our insurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage limits. Any of these events could have an adverse effect on our reputation, business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Off-label or other unlawful promotion of our products could result in costly investigations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">sanctions from the FDA and other regulatory bodies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform (also referred to as Heartflow Analysis, which consists of four main functions, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, the Heartflow Plaque Analysis, the Heartflow RoadMap Analysis and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow PCI Planner (which we expect to launch in 2026)) has been cleared by the FDA (K213857), and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.77000000000001pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.75pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 174.17000000000002pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.82999999999998pt; position: absolute; white-space: pre;"> Analysis function of the Heartflow Platform is CE Marked in the European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Economic Area, the United Kingdom and Australia, received medical device licensing in Canada and has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been approved for marketing authorization in Japan by the PMDA, all for specific indications for use. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform has also been cleared by the equivalent regulatory authorities in Israel, Saudi Arabia, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United Arab Emirates, and licensed in Bahrain. We may only promote or market our products for their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specifically cleared or approved indications. We train our marketing and sales force against promoting our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products for uses outside of the cleared or approved indications for use (&#8220;off-label use&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA determines that our promotional materials or training constitute promotion of an off-label use, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or of claims that are not adequately substantiated or that are otherwise false or misleading, it could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">request that we modify our training or promotional materials or subject us to regulatory or enforcement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criminal penalties. It is also possible that other federal, state or foreign enforcement authorities, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Federal Trade Commission or Department of Justice, might take action if they consider our business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities to constitute promotion of an off-label use or other unlawful promotion, which could result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant penalties, including criminal, civil and administrative penalties, damages, fines, disgorgement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusion from participation in government healthcare programs and the curtailment of our operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any of these events could significantly harm our business, results of operations, financial condition and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, the advertising and promotion of our products are subject to European Economic Area Member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States laws implementing the Medical Devices Directive concerning misleading and comparative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advertising, and Directive 2005&#47;29&#47;EC on unfair commercial practices, as well as other European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Economic Area Member State legislation governing the advertising and promotion of medical devices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">European Economic Area Member State legislation may also restrict or impose limitations on our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advertise our products directly to the general public. In addition, voluntary E.U. and national codes of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct provide guidelines on the advertising and promotion of our products to the general public and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may impose limitations on our promotional activities with healthcare professionals harming our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to numerous federal, state and foreign healthcare fraud and abuse, compliance, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">transparency and privacy laws and regulations, and a failure to comply with such laws and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">regulations could have an adverse effect on our business&#59; similarly, an investigation, inquiry or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">audit by a government agency that alleges violations of law or regulations may have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">effect on our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our operations are, and will continue to be, directly and indirectly affected by various federal, state and&#47;or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign healthcare laws, including those described below. In particular, because the use of our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are directly or indirectly reimbursed by U.S. federal health care programs, for example Medicare, we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the federal Anti-Kickback Statute, a criminal law that prohibits, among other things, any person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration in cash or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in-kind (including any kickback or bribe, but also common forms of remuneration, such as service or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">46<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consulting fees, service fees, meals, travel expenses, discounts or rebates), directly or indirectly, overtly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or covertly, in cash or in kind, in return for or to induce the referring, ordering, leasing, purchasing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arranging for or recommending the referring, ordering, purchasing or leasing of any good, facility, item or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service, for which payment may be made, in whole or in part, under federal healthcare programs, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Medicare and Medicaid programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">anything of value. Although there are a number of statutory exceptions and regulatory safe harbors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protecting certain common activities, the exceptions and safe harbors are drawn narrowly. Failure to meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of the requirements of a statutory exception or regulatory safe harbor does not make the conduct per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">se illegal under the Anti-Kickback Statute. Instead, the arrangement will be evaluated on a case-by-case <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis based on a cumulative review of all of its facts and circumstances. Several courts have interpreted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration is to induce referrals of (or purchases, uses or recommendations of prescriptions, uses or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchases related to) federal healthcare program covered business, the Anti-Kickback Statute has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implicated and potentially violated. Our practices may not in all cases meet all of the criteria for safe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">harbor protection from Anti-Kickback Statute liability. Further, the ACA, amends the intent requirement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the federal Anti-Kickback Statute and certain criminal healthcare fraud statutes. A person or entity no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government may assert that a claim for payment by a government health care program including items or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services resulting from a violation of the Anti-Kickback Statute constitutes a false or fraudulent claim for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purposes of the false claims laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. civil False Claims Act prohibits, among other things, any person or entity from knowingly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government or knowingly making, using, or causing to be made or used a false record or statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand&#8221; for money or property presented to the U.S. government. The civil False Claims Act also applies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to false submissions that cause the government to not receive a benefit to which it is entitled, such as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discounted sales price for products covered by federal healthcare programs. Intent to deceive is not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to establish liability under the civil False Claims Act. In addition, the civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes a whistleblower provision that allows private citizens to bring claims on behalf of the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government alleging violations of the law. Whistleblowers may be entitled to up to as much as thirty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">percent (30%) of the government&#8217;s financial recovery resulting from such claims. This incentivizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential whistleblowers to file complaints in federal court, which complaints are relied upon heavily by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government to investigate and prosecute allegations of violations of both the civil False Claims Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute. U.S. enforcement authorities or private whistleblowers acting on behalf of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. government may file complaints under the civil False Claims Act alleging that we have caused one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more of our customers to submit false submissions for reimbursement from federal health care programs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including Medicare, Medicaid, or the Veterans Affairs program due to alleged kickbacks, the sale of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adulterated or misbranded products, or the provision of false or misleading information to our customers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or other third parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, under the federal Civil Money Penalty Statute, the Department of Health and Human <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Services (&#8220;HHS&#8221;) may impose civil money penalties against entities that make offers to transfer or transfer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration, including gifts, payments or routine waivers of co-payments or deductibles, to any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare beneficiary in order to influence such individual to order or receive any item or service for which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment may be made, in whole or in part, under Medicare and&#47;or a State health care program.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Violations of these laws and regulations may result in significant criminal and&#47;or civil fines and penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as well as potential exclusion from participation in federal health care programs, that could significantly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact our business and operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to other federal and state fraud and abuse laws, including HIPAA&#8217;s fraud provisions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which among other things, are criminal laws that prohibit, among other actions, knowingly and willfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executing, or attempting to execute, a scheme or artifice to defraud any healthcare benefit program, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including private payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">47<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully preventing, obstructing, misleading, delaying or attempting to delay a criminal investigation of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare offense and knowingly and willfully falsifying, concealing or covering up a material fact or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making any materially false, fictitious or fraudulent statement or representation in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery of or payment for healthcare benefits, items or services. Many of these state laws closely mirror <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the federal Anti-Kickback Statute or civil False Claims Act, but apply more broadly to products and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services that are paid for in any way, whereas the federal law pertains only to those reimbursed by federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health care programs. In addition, many states have also adopted laws prohibiting fee-splitting (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sharing of professional fees with non-state licensed persons or entities), restricting marketing activities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with physicians and&#47;or prohibiting the practice of medicine (or the direction of the practice of medicine) by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporations or others that are not specifically licensed to practice medicine within the state. While under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our model, licensed practitioners independently are providing any and all medical treatment and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic services for which a state license is required, these state laws still may apply to us. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also are subject to foreign fraud and abuse laws and regulations, which vary by country, and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibit many of the same activities addressed by U.S. laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the federal and state transparency reporting laws and regulations, gift bans and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance reporting provisions. The Physician Payments Sunshine Act (also known as Open Payments) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires manufacturers of drugs, devices, biologics and medical supplies for which payment is available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under Medicare, Medicaid or the State Children&#8217;s Health Insurance Program to report annually to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Centers for Medicare and Medicaid Services information related to payments and other transfers of value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided directly or indirectly to physicians (defined to include doctors, dentists, optometrists, podiatrists <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and chiropractors), other healthcare providers (such as physician assistants and nurse practitioners) and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">teaching hospitals. Such manufacturers are also required to annually report certain ownership and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment interests held by such U.S. physicians and their immediate family members. Certain states, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">like Massachusetts and Vermont have similar reporting requirements. Some states, like Vermont, prohibit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gifts and certain benefits from being provided to physicians licensed within that state. Other states, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as California and Nevada mandate implementation of compliance programs to ensure compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fraud and abuse laws and regulations, as well as with industry codes of conduct, such as the AdvaMed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Code of Ethics on Interactions with Health Care Professionals. Our business is subject to these many <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, which can be nuanced and lacking in clear guidance. Our failure to comply with these laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or regulations could result in substantial fines or penalties. Further, our reports made pursuant to these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws may be used by enforcement authorities or whistleblowers to raise or substantiate allegations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the federal physician self-referral prohibitions, commonly known as the Stark Law, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which prohibits, among other things, physicians who have a financial relationship, including an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment, ownership or compensation relationship with an entity that submits claims for payment to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare or Medicaid programs, from referring Medicare or Medicaid patients for certain &#8220;designated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health services,&#8221; which include diagnostic imaging services related to our products, unless an exception <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applies. Similarly, entities may not bill Medicare or any other party for services furnished pursuant to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibited referral. Many states have their own self-referral laws as well, which in some cases apply to all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors, not just Medicare and Medicaid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If our operations are found to be in violation of any of the laws described above or any other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental regulations that apply to us now or in the future, we may be subject to significant penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare programs and the curtailment or restructuring of our operations, any of which could adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our ability to operate our business and our financial results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also note that there is risk of our being found in violation of these laws by the fact that many of them <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have not been fully, clearly or consistently interpreted by the regulatory authorities or the courts, and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we successfully defend against it, could cause us to incur significant legal expenses and divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management&#8217;s attention from the operation of our business. Moreover, to achieve compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">48<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable federal and state privacy, security and electronic transaction laws, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modify our operations with respect to the handling of patient information. Similarly, to achieve compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with other applicable federal and state anti-fraud, open payments or other healthcare regulations, we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be required to modify our operations. Implementing any of these modifications may prove costly. At this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time, we are not able to determine the full consequences to us, including the total cost of compliance, of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these various federal and state laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to U.S. and foreign anti-corruption and anti-money laundering laws with respect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our operations and non-compliance with such laws can subject us to criminal and&#47;or civil liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and harm our business.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 184.68pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S.&#160;Travel Act, the USA PATRIOT Act, the U.K. Bribery Act of 2010 and Proceeds of Crime Act 2002 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possibly other state and national anti-bribery and anti-money laundering laws in countries in which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees and third-party intermediaries from authorizing, promising, offering or providing, directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, improper payments or benefits to recipients in the public or private sector. We use third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives to support sales of our products abroad. In addition, as we increase our international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales and business, we may engage with additional business partners and third-party intermediaries to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell our products abroad and to obtain necessary permits, licenses and other regulatory approvals. We or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our third-party intermediaries may have direct or indirect interactions with officials and employees of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government agencies or state owned or affiliated entities. We can be held liable for the corrupt or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and agents, even if we do not explicitly authorize or have actual knowledge of such activities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Noncompliance with anti-corruption and anti-money laundering laws could subject us to whistleblower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">media coverage and other collateral consequences. If any subpoenas or investigations are launched, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation, our business, results of operations and financial condition could be materially harmed. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, responding to any action will likely result in a materially significant diversion of management&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attention and resources and significant defense and compliance costs and other professional fees. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain cases, enforcement authorities may even cause us to appoint an independent compliance monitor, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which can result in added costs and administrative burdens. As a general matter, enforcement actions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sanctions could harm our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to governmental export and import controls that could impair our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">compete in international markets due to licensing requirements and subject us to liability if we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">not in compliance with applicable laws. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are subject to export control and import laws and regulations, including the U.S. Export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administration Regulations, U.S. Customs regulations and various economic and trade sanctions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control. Exports of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products must be made in compliance with these laws and regulations. If we fail to comply with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws and regulations, we and certain of our employees could be subject to substantial civil or criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penalties, including&#58; the possible loss of export or import privileges&#59; fines, which may be imposed on us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and responsible employees or managers&#59; and, in extreme cases, the incarceration of responsible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees or managers. Obtaining the necessary authorizations, including any required license, for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular sale may be time consuming, is not guaranteed and may result in the delay or loss of sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities. In addition, changes in our products or changes in applicable export or import regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may create delays in the introduction and sale of our products in international markets, prevent our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers with international operations from deploying our products or, in some cases, prevent the export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or import of our products to certain countries, governments or persons altogether. Any change in export or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">49<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import regulations, shift in the enforcement or scope of existing regulations or change in the countries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governments, persons or technologies targeted by such regulations, could also result in decreased use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, or in our decreased ability to export or sell our products to existing or potential customers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with international operations. Any decreased use of our products or limitation on our ability to export or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell our products would likely adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, we incorporate encryption technology into certain of our products. Various countries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulate the import of certain encryption technology, including through import permitting and licensing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and have enacted laws that could limit our ability to distribute our products or could limit our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers&#8217; ability to implement our products in those countries. Encrypted products and the underlying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology may also be subject to export control restrictions. Governmental regulation of encryption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology and regulation of imports or exports of encryption products, or our failure to obtain required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import or export approval for our products, when applicable, could harm our international sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, including with respect to new releases of our products, may create delays in the introduction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products in international markets, prevent our customers with international operations from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deploying our products throughout their globally distributed systems or, in some cases, prevent the export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products to some countries altogether.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, U.S. export control laws and economic sanctions programs prohibit the shipment of certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and services to countries, governments and persons that are subject to U.S. economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embargoes and trade sanctions. Any violations of such economic embargoes and trade sanction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations could have negative consequences, including government investigations, penalties and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reputational harm.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Any future litigation against us could be costly and time-consuming to defend.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have been in the past, and we may become in the future, subject to legal proceedings and claims that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arise in the ordinary course of business, such as claims brought by our third-party vendors, our customers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or their patients in connection with contractual disputes or the use of our Heartflow Platform, claims <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">brought by us or by competitors related to intellectual property or employment claims made by our current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or former employees. Litigation might result in substantial costs and may divert management&#8217;s attention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and resources, which might seriously harm our business, financial condition, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects. Insurance might not cover such claims, might not provide sufficient payments to cover all the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs to resolve one or more such claims, and might not continue to be available at all or on terms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptable to us (including premium increases or the imposition of large deductible or co-insurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements). A claim brought against us that is uninsured or underinsured could result in unanticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, potentially harming our business, financial condition, results of operations and prospects. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we cannot be sure that our existing insurance coverage will continue to be available on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptable terms or at all or that our insurers will not deny coverage as to any future claim.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our intellectual property <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to obtain and maintain sufficient intellectual property rights, or the scope of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">rights is not sufficiently broad, third parties could develop and commercialize technology and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">products similar or identical to ours, and our ability to successfully commercialize our technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and products may be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our commercial success will depend, in part, on our ability to continue obtaining and maintaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property protection for our technology and products, in both the United States and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other countries, successfully defending this intellectual property against third-party challenges and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully enforcing this intellectual property to prevent third-party infringement. We rely upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combination of patents, trade secrets, know-how, copyrights, trademarks, license agreements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractual provisions to establish our intellectual property rights and protect our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">50<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to protect our technologies and products from unauthorized or infringing use by third parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depends in substantial part on our ability to obtain and maintain valid and enforceable patents in both the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States and certain other countries. The patent positions of medical technology and software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies can be highly uncertain and involve complex legal, scientific and factual questions for which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">important legal principles remain unresolved. In addition, the patent prosecution process is expensive, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce, defend or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">license all necessary or desirable patents or patent applications at a reasonable cost or in a timely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manner, or in all jurisdictions. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot guarantee that any patents will issue from any pending or future patent applications owned by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or licensed to us, or if issued, the breadth of such patent coverage. In particular, during prosecution of any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent application, the issuance of any patents based on the application may depend upon our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate additional preclinical or clinical data that support the patentability of our proposed claims. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be able to generate sufficient additional data on a timely basis, or at all. It is also possible that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may fail to identify patentable aspects of inventions made in the course of our development and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial activities before it is too late to obtain patent protection on such inventions. If we fail to timely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file for patent protection in any jurisdiction, we may be precluded from doing so at a later date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance of a patent is not conclusive as to its inventorship, ownership, scope, validity or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enforceability, and our owned or licensed patents may be challenged in the courts or the patent offices of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States or abroad. Such challenges may result in a loss of exclusivity or in the patent&#8217;s claims <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third parties from using or commercializing similar or identical products, or limit the duration of patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection for our technology and products. In addition, changes in either the patent laws, implementing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations or interpretations of patent laws in the United States or foreign countries may diminish the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our patent rights.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if unchallenged, our owned or licensed patents may not provide us with exclusivity or commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value for our products or any significant protection against competitive products or prevent others from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">designing around our claims. Our competitors might conduct research and development activities in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">countries where we do not have patent rights (or in those countries where we do, under safe harbor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions) and then use the information learned from such activities to develop competitive products for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale in our major commercial markets. Further, if we encounter delays in regulatory approvals, the period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of time during which we could market our products under patent protection could be reduced. Any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these outcomes could impair our ability to prevent competition from third parties, which may have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patent applications are generally maintained in confidence until publication. In the United States, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, patent applications are maintained in secrecy for up to 18 months after their filing. Similarly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publication of discoveries in scientific or patent literature often lag behind actual discoveries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consequently, we cannot be certain that we or our licensors were the first to invent, or the first to file <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications on our products. There is also no assurance that all of the potentially relevant prior art <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relating to our patents and patent applications has been found, which could be used by a third party to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenge validity of our patents or prevent a patent from issuing from a pending patent application. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to patents, proprietary trade secrets and unpatented know-how are important to our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For information about risks related to these intellectual property rights, see the risk factor titled &#8220;If we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to protect the disclosure and use of our confidential information and trade secrets, the value of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and technologies and our business and competitive position could be harmed&#8221; below. We also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rely on the trademarks we own to distinguish our products from the products of our competitors. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot guarantee that any trademark applications filed by us will be approved. Third parties may also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">oppose or attempt to cancel our trademark applications or trademarks, or otherwise challenge our use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the trademarks. In the event that the trademarks we use are successfully challenged, we could be forced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to rebrand our products, which could result in loss of brand recognition, and could require us to devote <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources to advertising and marketing new brands. Competitors or other parties may adopt trade names <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">51<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market confusion. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, we cannot provide assurance that competitors will not infringe the trademarks we use, or that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will have adequate resources to enforce these trademarks. If we attempt to enforce our trademarks and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assert trademark infringement claims, a court may determine that the marks we have asserted are invalid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or unenforceable, or that the party against whom we have asserted trademark infringement has superior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights to the marks in question. In this case, we could ultimately be forced to cease use of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademarks. We may license our trademarks and trade names to third parties, such as distributors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Though these license agreements may provide guidelines for how our trademarks and trade names may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be used, a breach of these agreements or misuse of our trademarks and trade names by our licensees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Over the long term, if we are unable to establish name recognition based on our trademarks and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">names, then we may not be able to compete effectively and our business may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For information about risks related to our inability to protect our intellectual property rights outside the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States, see the risk factor titled &#8220;We may not be able to adequately protect our intellectual property <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights throughout the world&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to protect the disclosure and use of our confidential information and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">secrets, the value of our products and technologies and our business and competitive position <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to patent protection, we also rely on other intellectual property rights, including trade secrets, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">know-how, and&#47;or other proprietary information that is not patentable or that we elect not to patent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, trade secrets can be difficult to protect, and some courts are less willing or unwilling to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secrets. Although we have taken steps to protect our trade secrets and unpatented know-how, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including by entering into confidentiality agreements with third parties, and proprietary information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invention agreements with our employees, consultants and advisors, third parties may still obtain this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information or we may be unable to protect our rights. There can be no assurance that binding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements will not be breached, that we would have adequate remedies for any breach, or that our trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets and unpatented know-how will not otherwise become known or be independently discovered by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our competitors. We also seek to preserve the integrity and confidentiality of our data and trade secrets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by maintaining physical security of our premises and physical and electronic security of our information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology systems. While we have confidence in these individuals, organizations and systems, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security measures may be breached, and we may not have adequate remedies for any such breach. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would have no right to prevent them, or those to whom they communicate it, from using that information to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compete with us. Any exposure of our trade secrets and other proprietary information would impair our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitive advantages and could have a material adverse effect on our business, financial condition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations and prospects. In particular, a failure to protect our proprietary rights may allow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors to copy our products or technologies, which could adversely affect our pricing and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or technologies that we consider proprietary. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costly and time-consuming litigation could be necessary to enforce and determine the scope of our trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secret rights and related confidentiality, non-disclosure and non-use provisions, and outcomes of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation are unpredictable. Enforcing a claim that a party illegally disclosed, used or misappropriated a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. While we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use commonly accepted security measures, trade secret claims are often based on a combination of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal and state law in the United States, and the criteria for protection of trade secrets can vary among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different jurisdictions. If the steps we have taken to maintain our trade secrets are deemed inadequate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may have insufficient recourse against third parties for misappropriating the trade secret. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">52<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be enforceable in certain cases. Even if we were to be successful in the enforcement of our claims, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be able to obtain adequate remedies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reliance on third parties requires us to share our trade secrets, which increases the possibility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">that a competitor will discover them or that our trade secrets will be misappropriated or disclosed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to others. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any collaboration or other engagement with third parties for the development of our products may require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us, at times, to share trade secrets with them. We may also conduct joint research and development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs that may require us to share trade secrets under the terms of our research and development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partnerships or similar agreements. We seek to protect our trade secrets and other proprietary technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in part by entering into confidentiality agreements with third parties prior to beginning research or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosing proprietary information. These agreements typically limit the rights of the third parties to use or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclose our confidential information, including our trade secrets. Despite the contractual provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employed when working with third parties, the need to share trade secrets and other confidential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information increases the risk that such trade secrets become known by our competitors, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inadvertently incorporated into the technology of others, or are disclosed or used in violation of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements. Given that our proprietary Heartflow Platform is based, in part, on our know-how and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets, a competitor&#8217;s discovery of our trade secrets or other unauthorized use or disclosure could have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors and consultants to publish data potentially relating to our trade secrets. Despite our efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protect our trade secrets, we may not be able to prevent the unauthorized disclosure or use of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technical know-how or other trade secrets by the parties to these agreements. Moreover, we cannot <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guarantee that we have entered into such agreements with each party that may have or have had access <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to our confidential information or proprietary technology and processes. Monitoring unauthorized uses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and disclosures is difficult, and we do not know whether the steps we have taken to protect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary technologies will be effective. If any of the collaborators, scientific advisors, employees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors and consultants who are parties to these agreements breaches or violates the terms of any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these agreements, we may not have adequate remedies for any such breach or violation, and we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lose our trade secrets as a result. Moreover, if confidential information that is licensed or disclosed to us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by our partners, collaborators, or others is inadvertently disclosed or subject to a breach or violation, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be exposed to liability to the owner of that confidential information. Enforcing a claim that a third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party illegally obtained and is using our trade secrets, like patent litigation, is expensive and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consuming, and the outcome is unpredictable. In addition, courts outside the United States are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sometimes less willing to protect trade secrets, and we may need to share our trade secrets and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary know-how with current or future partners, collaborators, contractors and others located in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">countries at heightened risk of theft of trade secrets, including through direct intrusion by private parties or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign actors, and those affiliated with or controlled by state actors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Obtaining and maintaining our patent protection depends on compliance with various procedural, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">document submission, fee payment and other requirements imposed by governmental patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">agencies, and our patent protection could be reduced or eliminated for noncompliance with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">requirements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) and various foreign governmental patent agencies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require compliance with a number of procedural, documentary, fee payment and other similar provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">during the patent application process. In addition, periodic maintenance fees, renewal fees, annuity fees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and various other government fees on patents and&#47;or applications will be due to be paid to the USPTO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and various governmental patent agencies outside of the United States over the lifetime of our patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and&#47;or applications and any patent rights we may obtain in the future. We have systems in place to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remind us to pay these fees, and we employ outside firms to remind us to pay annuity fees due to patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agencies on our patents and pending patent applications. In many cases, an inadvertent lapse can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cured by payment of a late fee or by other means in accordance with the applicable rules. However, there <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">53<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are situations in which noncompliance can result in abandonment or lapse of the patent or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event, our competitors might be able to enter the relevant market, which would have an adverse effect on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business. Noncompliance events that could result in abandonment or lapse of a patent or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application include failure to respond to official actions within prescribed time limits, non-payment of fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and failure to properly legalize and submit formal documents.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Changes in patent law, precedents and policies in the United States and other jurisdictions could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">diminish the value of patents in general, thereby impairing our ability to protect our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to obtain patents is highly uncertain because, to date, some legal principles remain unresolved, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and there has not been a consistent policy regarding the breadth or interpretation of claims allowed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents in the United States. Furthermore, the specific content of patents and patent applications that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to support and interpret patent claims is highly uncertain due to the complex nature of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant legal, scientific, and factual issues. The United States Supreme Court has ruled on several <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent cases in recent years, either narrowing the scope of patent protection available in certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances or weakening the rights of patent owners in certain situations. Changes in either the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws or interpretations of patent laws in the United States or other jurisdictions may diminish the value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our intellectual property. In the United States, in certain circumstances, court rulings may narrow the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scope of patent protection and weaken the rights of patent owners. We cannot predict how decisions by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the courts, the U.S. Congress, the USPTO or changes in the patent laws of other jurisdictions may impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the value of our patents. Changes in the laws, regulations, precedents and procedures governing patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our intellectual property in the future, which could have a material adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, patent coverage in medical devices and technologies is a subject of evolution and differences <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">between countries. This is especially true of the definition of patentable subject matter which affects both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer related inventions and biological inventions. This evolution may cause current granted patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be considered non-patent eligible or prevent us from protecting future inventions. U.S. Supreme Court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Federal Circuit decisions interpreting and&#47;or limiting the scope of patentable subject matter under 35 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S.C. &#167; 101, in addition to examination guidelines from the USPTO, have made it more difficult for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patentees to obtain and&#47;or maintain patent claims in the United States that are directed to medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technologies involving computer-implemented applications. Several precedential decisions regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patentable subject matter are of particular relevance to patents in the computer-implemented applications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">space. Our efforts to seek patent protection for our technologies and products may be impacted by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evolving case law and guidance or procedures issued by the USPTO or authorities in other jurisdictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on such evolving case law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, changes in patent laws and regulations in other countries or jurisdictions, changes in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental bodies that enforce them or changes in how the relevant governmental authority enforces <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent laws or regulations may weaken our ability to obtain new patents or to enforce patents that we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain in the future. For example, the complexity and uncertainty of European patent laws have also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increased in recent years. In Europe, a new unitary patent system took effect June 1, 2023, which will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly impact European patents, including those granted before the introduction of the new unitary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent system. Under the unitary patent system, European applications have the option, upon grant of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;UPC&#8221;). As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any litigation. Patents granted before the implementation of the UPC have the ability to opt out of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction of the UPC and remain as national patents in the UPC countries. The UPC will provide our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors with a new forum to centrally revoke European patents, and allow for the possibility of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitor to obtain pan-European injunctions, since patents that remain under the jurisdiction of the UPC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be potentially vulnerable to a single UPC-based revocation challenge that, if successful, could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invalidate the patent in all countries who are signatories to the UPC. We cannot predict with certainty the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">long-term effects of any potential changes.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">54<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, the laws of some foreign countries do not protect proprietary rights to the same extent or in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same manner as the laws of the United States and Europe. As a result, we may encounter significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problems in protecting and defending our intellectual property both in the United States and abroad. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, if the issuance in a given country of a patent covering an invention is not followed by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance in other countries of patents covering the same invention, or if any judicial interpretation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">validity, enforceability or scope of the claims or the written description or enablement, in a patent issued in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one country is not similar to the interpretation given to the corresponding patent issued in another country, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our ability to protect our intellectual property in those countries may be limited. Changes in either patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws or in interpretations of patent laws in the United States and other countries may materially diminish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the value of our intellectual property or narrow the scope of our patent protection.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, on September 16, 2011, the Leahy-Smith America Invents Act (the &#8220;Leahy-Smith Act&#8221;) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Assuming that other requirements for patentability are met, prior to March 16, 2013, in the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the first to invent the claimed invention was entitled to the patent, while outside the United States, the first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to file a patent application was entitled to the patent. On or after March 16, 2013, under the Leahy-Smith <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act, the United States transitioned to a first inventor to file system in which, assuming that other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements for patentability are met, the first inventor to file a patent application will be entitled to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent on an invention regardless of whether a third party was the first to invent the claimed invention. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under this system, a third party that files a patent application in the USPTO before us could be awarded a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent covering an invention of ours even if we had made the invention before it was made by such third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party. Since patent applications in the United States and most other countries are confidential for a period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of time after filing or until issuance, we cannot be certain that we or our licensors were the first to either (i) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file any patent application related to our products or (ii) invent any of the inventions claimed in our or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensors&#8217; patents or patent applications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Leahy-Smith Act also changed the way patent applications are prosecuted, including by allowing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-party submission of prior art to the USPTO during patent prosecution and additional procedures to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenge the validity of a patent by USPTO administered post-grant proceedings to attack the validity of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a patent. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard in U.S. federal courts necessary to invalidate a patent claim, a third party could potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same evidence might not be sufficient to invalidate the claim if presented in a district court action. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, third parties may use USPTO proceedings to invalidate our patent claims that would not have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been invalidated if first challenged in a district court action. Therefore, the Leahy-Smith Act and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation could increase the uncertainties and costs surrounding the prosecution of our patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications and the enforcement or defense of our issued patents, which could have a material adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be able to adequately protect our intellectual property rights throughout the world. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patent portfolio includes patents and patent applications in countries outside of the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including Japan, Korea, China, Canada, Australia, Israel, India and countries in Europe. The requirements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for patentability differ from country to country, the breadth of allowed patent claims can be inconsistent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the scope of coverage provided by these patents varies and the laws of some foreign countries may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protect our intellectual property rights to the same extent as laws in the United States. In addition, filing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecuting and defending patents on our products in all countries throughout the world would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibitively expensive. For those countries where we do not have granted patents, we may not have any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to prevent the unauthorized sale of our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we may decide to abandon national and regional patent applications before they are granted. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The examination of each national or regional patent application is an independent proceeding. As a result, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications in the same family may issue as patents in some jurisdictions, such as in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, but may issue as patents with claims of different scope or may even be refused in other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions. It is also quite common that depending on the country, the scope of patent protection may <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">55<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vary for the same product or technology. For example, certain jurisdictions do not allow for patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection with respect to methods of treatment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consequently, we may not be able to prevent third parties from practicing our inventions in all countries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outside the United States. Competitors may use our technologies in jurisdictions where we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtained patent protection to develop their own products and, further, may export otherwise infringing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products to territories in which we have patent protection that may not be sufficient to terminate infringing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">world may be inadequate to obtain a significant commercial advantage from the intellectual property that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we develop or license.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licenses to third parties, government agencies or government contractors. In these countries, the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owner may have limited remedies, which could materially diminish the value of such patent. If we or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our licensors is forced to grant a license to third parties with respect to any patents relevant to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, our competitive position may be impaired, and our business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not seek or have patent rights in certain foreign countries in which a market may exist. Accordingly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our efforts to protect our intellectual property rights in such countries may be inadequate, which may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our ability to successfully commercialize our products in all of our expected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant foreign markets. Moreover, in foreign jurisdictions where we do have patent rights, proceedings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to enforce such rights could result in substantial costs and divert our efforts and attention from other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications at risk of not issuing. Additionally, such proceedings could provoke third parties to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remedies awarded, if any, may not be commercially meaningful. Thus, we may not be able to stop a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitor from marketing and selling in foreign countries products that are the same as or similar to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, and our competitive position in the international market would be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be involved in lawsuits to protect or enforce our patents or other intellectual property, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the patents of our licensors, which could be expensive, time consuming and unsuccessful. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Competitors or other third parties may infringe, misappropriate or otherwise violate our owned or licensed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents, trade secrets or other intellectual property. To counter infringement or unauthorized use, we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be compelled to file infringement or misappropriation claims, which can be expensive and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consuming. We do not carry intellectual property insurance that would cover such claims. In certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances it may not be practicable or cost effective for us to enforce our intellectual property rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fully, particularly in certain developing countries or where the initiation of a claim might harm our business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships. If we initiate legal proceedings against a third party to enforce a patent covering our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, the defendant could counterclaim that our patent(s) are invalid and&#47;or unenforceable. In patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation in the United States, counterclaims alleging invalidity and&#47;or unenforceability are common, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In an infringement proceeding, a court may decide that a patent we own or license is not valid, is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unenforceable or is not infringed, or may refuse to stop the other party from using the technology at issue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the grounds that our patents do not cover the technology in question. The outcome following legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, we cannot be certain that there is no invalidating prior art. If a defendant were to prevail on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal assertion of invalidity and&#47;or unenforceability, we may lose some, and perhaps all, of the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection covering our products. An adverse result in any litigation or defense proceeding could put one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more of our patents at risk of being invalidated or interpreted narrowly, could put our patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications at risk of not issuing and could have a material adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our defense of litigation may fail and, even if successful, may result in substantial costs and distract our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and other employees. Even if we establish infringement, the court may decide not to grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an injunction against further infringing activity and instead award only monetary damages, which may or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">56<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be an adequate remedy. For example, the amount of any monetary damages may be inadequate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to compensate us for damage as a result of the infringement and the proceedings. We may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent, alone or with our suppliers, misappropriation of intellectual property rights important to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, particularly in countries where the laws may not protect those rights as fully as in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, because of the substantial amount of discovery required in connection with intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property litigation, there is a risk that some of our confidential information could be compromised by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure during this type of litigation. There could also be public announcements of the results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hearings, motions or other interim proceedings or developments. If securities analysts or investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perceive these results to be negative, it could have an adverse effect on the price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Third-party defendants may challenge any patent we own or in-license through adversarial proceedings in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the issuing offices, which could result in the invalidation or unenforceability of some or all of the relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent claims. If a third party asserts a substantial new question of patentability against any claim of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. patent we own or license, the USPTO may grant a request for reexamination, which may result in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loss of scope of some claims or a loss of the entire patent. The adoption of the Leahy-Smith Act has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">established additional opportunities for third parties to invalidate U.S. patent claims, including inter partes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review and post grant review, on the basis of lower legal standards than reexamination and additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounds. Outside of the United States, patents we own or license may become subject to patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opposition or similar proceedings, which may result in loss of scope of some claims or loss of the entire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent. Participation in adversarial proceedings is very complex, expensive and may divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management&#8217;s attention from our core business and may result in unfavorable outcomes that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our ability to prevent third parties from competing with us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be subject to claims challenging the inventorship or ownership of our patents and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">intellectual property rights or alleging that we have violated the intellectual property rights or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">other proprietary rights of third parties. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our commercial success depends, in part, upon our ability to develop, manufacture, market and sell our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and use our proprietary technologies without infringing the proprietary rights and intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property of third parties. The medical device industry is characterized by extensive and complex litigation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding patents and other intellectual property rights. We may be exposed to, or threatened with, future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation by third parties having patent or other intellectual property rights alleging that our products or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary technologies infringe on their intellectual property rights. There is a risk that third parties may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">choose to engage in litigation with us to enforce or to otherwise assert their patent rights against us. Even <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party patents are valid, enforceable and infringed, which could have a negative impact on our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize our products. This includes litigation, or threatened litigation, with non-practicing entities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that have no relevant product revenue and against whom our own patent portfolio may have no deterrent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect. The legal threshold for initiating litigation or contested proceedings is low, so that even lawsuits or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceedings with a low probability of success might be initiated and require significant resources to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defend. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also be subject to claims that former employees, collaborators or other third parties have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership interest in our patent rights or other intellectual property, for example, based on conflicting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations of consultants or others who are involved in developing our products. Although it is our policy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to require our employees and contractors who may be involved in the conception or development of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property to execute agreements assigning such intellectual property to us, we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unsuccessful in executing such an agreement with each party who, in fact, conceives or develops <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property that we regard as our own, and we cannot be certain that our agreements with such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not have an adequate remedy. The assignment of intellectual property rights may not be self-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executing or the assignment agreements may be breached, and litigation may be necessary to defend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against these and other claims challenging inventorship or ownership. If we fail in defending any such <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">57<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business. Even if we are successful in defending against such claims, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation could result in substantial costs and be a distraction to management and other employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We employ individuals who were previously employed at other medical technology companies. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we use publications that are subject to copyright, as well as proprietary information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">materials from third parties in our research. Some of the information and materials we use from third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties may be subject to agreements that include restrictions on use or disclosure. Although we strive to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ensure proper safeguards, we cannot guarantee strict compliance with such agreements, nor can we be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sure that our employees, consultants and advisors do not use proprietary information, materials or know-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">how of others in their work for us. In addition, we may be subject to claims that we or our employees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consultants or independent contractors have inadvertently or otherwise used or disclosed alleged trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets or other proprietary information of former employers or other third parties. Although we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures in place that seek to prevent our employees and consultants from using the intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property, proprietary information, know how or trade secrets of others in their work for us, we may in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future be subject to claims that we caused an employee to breach the terms of his or her non-competition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosed the alleged trade secrets or other proprietary information of a former employer or competitor. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also be subject to claims that former employers or other third parties have an ownership interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our future patents. In addition, we may be subject to claims that we are infringing other intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property rights, such as trademarks or copyrights, and to the extent that our employees, consultants or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors use intellectual property or proprietary information owned by others in their work for us, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disputes may arise as to the rights in related or resulting know-how and inventions. Litigation may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to defend against these claims. There is no guarantee of success in defending these claims, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and even if we are successful, litigation could result in substantial cost and be a distraction to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and other employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">An unfavorable outcome for any such claim could require us to cease using the related technology or to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party does not offer us a license on commercially reasonable terms. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If a third party claims that we infringe its intellectual property rights, we may face a number of issues, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">infringement and other intellectual property claims which, regardless of merit, may be expensive and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">time consuming to litigate and may divert our management&#8217;s attention from our core business&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">substantial damages for infringement, which we may have to pay if a court decides that the product at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issue infringes or violates the third party&#8217;s rights, and if the court finds that the infringement was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">willful, we could be ordered to pay treble damages and the patent owner&#8217;s attorneys&#8217; fees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a court prohibiting us from selling or licensing the product unless the third-party licenses its product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">rights to us, which it is not required to do&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">if a license is available from a third party, we may have to pay substantial royalties, upfront fees or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">grant cross licenses to intellectual property rights for our products&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redesigning our products or processes so they do not infringe, which may not be possible or may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">require substantial monetary expenditures and time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to successfully challenge the validity of a U.S. patent in federal court, we would need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">overcome a presumption of validity. As this burden is a high one requiring us to present clear and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of competent jurisdiction would invalidate the claims of any such U.S. patent. Foreign courts will have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar burdens to overcome in order to successfully challenge a third-party claim of patent infringement.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">58<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than we can because they have substantially greater resources. In addition, any uncertainties resulting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the initiation and continuation of any litigation could have an adverse effect on our ability to raise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional funds or on our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The terms of our patents may not be sufficiently long to effectively protect our products and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">years after its first effective non-provisional filing date, but can be shorter due to terminal disclaimers or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar term reductions in other jurisdictions. Although various extensions may be available, the term of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent, and the protection it affords, is limited. Even if patents covering our technologies or products are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtained, once the patent term has expired, we may be open to competition. In addition, although upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance in the United States, a patent&#8217;s term can be increased based on certain delays caused by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">USPTO, this increase can be reduced or eliminated based on certain delays caused by the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicant during patent prosecution. Given the amount of time required for the development, testing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory review of products, patents protecting such potential products might expire before or shortly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after such products are commercialized. If we do not have sufficient patent life to protect our technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and products, our business, financial condition, results of operations and prospects will be adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we do not obtain additional protection under the Hatch-Waxman Amendments or similar foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">legislation, our business may be materially affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Depending upon the timing, duration and specifics of FDA marketing approval for our future products, one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more of our U.S. patents may be eligible for limited patent term restoration under the Drug Price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Competition and Patent Term Restoration Act of 1984 (the &#8220;Hatch-Waxman Amendments&#8221;). The Hatch-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Waxman Amendments permit a patent term extension of up to five years beyond the normal expiration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the patent as compensation for patent term lost during product development and the FDA regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review process, which is limited to the approved indication (or any additional indications approved during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the period of extension). This extension is limited to one patent that covers the approved product, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved use of the product, or a method of manufacturing the product. A patent term extension cannot <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extend the remaining term of a patent beyond a total of 14 years from the date of product approval, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only those claims covering such approved product, a method for using it or a method for manufacturing it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be extended. However, the applicable authorities, including the FDA and the USPTO in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, and any equivalent regulatory authority in other countries or areas, may not agree with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment of whether such extensions are available, and may refuse to grant extensions to our patents, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or may grant more limited extensions than we request. We may not be granted an extension because of, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for example, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scope of patent protection afforded could be less than we request. If we are unable to obtain patent term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extension or restoration of the term of any such extension is less than we request, our competitors may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain approval for competing products following our patent expiration, and our ability to generate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenues may be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Open-source software licenses often impose unanticipated or unclear restrictions on us or could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">expose us to litigation, and using open-source software has inherent risks, any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">impair our ability to successfully commercialize the Heartflow Platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology platform implements software modules licensed to us by third parties under &#8220;open source&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licenses. The terms of many open source licenses have not been interpreted by U.S. courts, and there is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a risk that these licenses could be construed in ways that could impose unanticipated conditions or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions on our ability to commercialize our products. Moreover, we cannot be certain that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">processes for controlling our use of open-source software in connection with our products will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective. From time to time, we may face claims from third parties asserting ownership of, or demanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">release of, the open-source software or derivative works that we developed using such software (which <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">59<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could include our proprietary source code), or otherwise seeking to enforce the terms of the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open source license. These claims could result in litigation. If we are held to have breached the terms of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an open source software license, we could be required to seek licenses from third parties to continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering our products on terms that are not economically feasible, to re-engineer our proprietary code, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discontinue the sale of our products if re-engineering could not be accomplished on a timely or cost <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective basis, or to make generally available, in source code form, our proprietary code, any of which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The use of open-source software may entail greater risks than the use of third-party commercial software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as open source licensors generally do not provide warranties or other contractual protections regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infringement or the quality or ownership of the code. Many of these risks cannot be eliminated, and could, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if not properly addressed, negatively affect our business. We cannot be sure that all open source software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is submitted for approval prior to use in connection with our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, some open-source licenses contain requirements that we make available source code for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modifications or derivative works we create based upon the type of open-source software we use. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combine our proprietary software with open-source software in a certain manner, we could, under certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open-source licenses, be required to release portions of the source code of our proprietary software to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public. This would allow our competitors to create similar products with less development effort and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and ultimately could result in a loss of sales for us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Intellectual property rights do not necessarily address all potential threats to our competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">advantage. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The degree of future protection afforded by our intellectual property rights is uncertain because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property rights have limitations and may not adequately protect our business or permit us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain our competitive advantage. The following examples are illustrative&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">others may be able to make products that are similar to or otherwise competitive with our potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products but that are not covered by the claims of our current or future patents&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an in-license necessary for the manufacture, use, sale, offer for sale or importation of one or more of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our potential products may be terminated by the licensor&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we or future collaborators might not have been the first to make the inventions covered by our issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">or future issued patents or our pending patent applications&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we or future collaborators might not have been the first to file patent applications covering certain of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our inventions&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">others may independently develop similar or alternative technologies or duplicate any of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">technologies without infringing our intellectual property rights&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">it is possible that our pending patent applications will not lead to issued patents&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issued patents that we own or in-license may be held invalid or unenforceable as a result of legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">challenges by our competitors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issued patents that we own or in-license may not provide coverage for all aspects of our new potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products in all countries&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our competitors might conduct research and development activities in countries where we do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">have patent rights and then use the information learned from such activities to develop competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products for sale in our major commercial markets&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we may not develop additional proprietary technologies that are patentable&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the patents of others may have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Should any of these events occur, they could significantly harm our business, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to financing and tax matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may require additional capital to support business growth, and this capital might not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">available on terms favorable to us, or at all, and may dilute ownership of our common stock for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our stockholders, including purchasers of common stock in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to continue to make investments to support our business growth and may require additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funds to respond to business challenges and opportunities, including the need to develop new products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enhance our existing products, enhance our operating infrastructure, potentially expand internationally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and potentially acquire complementary businesses and technologies. In order to achieve these objectives, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may make future commitments of capital resources. Accordingly, we may need to engage in equity or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt financings to secure additional funds. If we raise additional funds through further issuances of equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or convertible debt securities, our stockholders, including any purchasers of common stock in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, could suffer significant dilution, and any new equity securities we issue could have rights, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferences and privileges superior to those of holders of our common stock. In addition, our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incur indebtedness is subject to limitations under the 2024 Credit Agreement and, if incurred, would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase our fixed obligations and could include covenants or other restrictions that would impede our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to manage our operations. Further, if additional financing is needed, we may not be able to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional financing on terms favorable to us or at all. Our inability to obtain adequate financing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing on terms satisfactory to us, when we require it, could significantly limit our ability to continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting our business growth and responding to business challenges and opportunities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our operating results may fluctuate significantly, which makes our future operating results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">difficult to predict and could cause our operating results to fall below expectations or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">guidance we may provide.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our quarterly revenue and results of operations may fluctuate from quarter to quarter due to, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">others, the following reasons&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the level of physicians&#8217; acceptance and adoption of our products, and changes in the rates at which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians order our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 247.18pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.84pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis or the percentage of CCTA scans for which our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is ordered&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determinations, including the timing of determinations, by payors concerning coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement of our products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in coverage amounts or government and payors&#8217; reimbursement policies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing, expense and results of research and development activities, clinical trials and any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">additional regulatory approvals&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in AHA or ACC guidelines, or guidelines in other countries, that lower support for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products or elevate alternative products as the preferred pathway for diagnosis and management of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fluctuations in our expenses associated with expanding our commercial operations and operating as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a public company&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients meeting their annual health insurance deductible later in the calendar year&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the introduction of new products and technologies by our competitors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in our pricing policies or in the pricing policies of our competitors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the productivity of our sales and marketing teams, and their ability to identify physicians who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistently refer appropriate patients for CCTAs in accordance with AHA and ACC guidelines&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">61<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quality problems with our products or the Heartflow Platform&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the impact of catastrophic events such as a pandemic.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Because of these and other factors, it is likely that in some future period our operating results will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meet investor expectations or those of public market analysts. Any unanticipated change in revenue or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating results is likely to cause our stock price to fluctuate. New information may cause investors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysts to revalue our business, which could cause a decline in our stock price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our credit agreement contains certain restrictions that may limit our ability to operate our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business. If we raise additional capital through debt financing, the terms of any new debt could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">further restrict our ability to operate our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The terms of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.51pt; position: absolute; text-decoration: none; white-space: pre;">2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.29pt; position: absolute; white-space: pre;"> and related collateral documents contain, and any future debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements would likely contain, a number of restrictive covenants that impose significant operating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial restrictions on us, including restrictions on our ability, and the ability of our subsidiaries, to take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">actions that may be in our best interests, including, among others, disposing of assets, entering into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change of control transactions, mergers or acquisitions, incurring additional indebtedness, granting liens <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our assets and declaring and paying dividends. Our ability to meet covenants can be affected by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events beyond our control, and we may not be able to continue to meet such covenants. We have in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, and may in the future, breach our covenants under the 2024 Credit Agreement. In March 2023, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into an agreement with Hayfin to temporarily waive certain covenant requirements that had not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been met pursuant to our prior credit agreement with Hayfin. In the future, a breach of the covenants or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the occurrence of other events (including, among others, a material adverse effect or the inability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate cash to service our obligations under our debt agreements) specified in the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and&#47;or the related collateral documents or a future debt agreement could result in an event of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">default. Upon the occurrence of an event of default, our lenders could elect to declare all obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owing under the debt documents, if any, to be immediately due and payable, terminate all commitments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extend further credit and&#47;or proceed against the collateral, if any, pledged to them to secure such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness. For example, we have pledged substantially all of our assets, including, among others, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property, all of Heartflow&#8217;s ownership interests in Heartflow, Inc. and our foreign subsidiaries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as collateral under the 2024 Credit Agreement and related collateral documents. For additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information on the 2024 Credit Agreement, see the section titled &#8220;Management&#8217;s discussion and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of financial condition and results of operations&#8212;Liquidity and capital resources&#8212;Hayfin credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement.&#8221; If lenders accelerate the repayment of borrowings, if any, we may not have sufficient funds to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repay our existing debt and the lenders could seize collateral that was pledged as guarantee for the loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which would harm our business and financial condition. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amounts borrowed under the 2024 Credit Agreement can be repaid at any time, subject to applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepayment fees, prior to the June 14, 2028 maturity date, at which time all obligations owing under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt documents will be due and payable. The 2024 Credit Agreement contains customary affirmative and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negative covenants, indemnification provisions and events of default. The affirmative covenants include, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">among others, covenants requiring us to deliver certain financial reports and to maintain our legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existence, regulatory authorizations and certain intellectual property rights. The negative covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include, among others, restrictions on changing our business activities, incurring additional indebtedness <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and creating liens on our assets, requirements to maintain certain levels of liquidity and minimum net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales, restrictions on making investments, paying dividends, issuing securities, engaging in mergers or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquisitions, licensing our assets or making other distributions, in each case subject to customary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceptions. If we default under the 2024 Credit Agreement, Hayfin will be able to declare all obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable and take control of our pledged assets, which may require us to renegotiate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our agreement on terms less favorable to us or to immediately cease operations. Any event of default by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us could significantly harm our business, financial condition, results of operations and prospects and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could cause the price of our common shares to decline. Further, if we are liquidated, Hayfin&#8217;s right to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repayment would be senior to the rights of the holders of our common shares to receive any proceeds <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the liquidation.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">62<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to repay indebtedness outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the 2024 Credit Agreement in an amount equal to the lesser of (i) net cash proceeds in excess of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$150.0 million and (ii) $50.0 million (or $55.0 million if the underwriters exercise any portion of their option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to purchase additional shares). While we currently anticipate paying off $50.0&#160;million of outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness under the 2024 Credit Agreement immediately following the completion of this offering, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">portion of the indebtedness under the 2024 Credit Agreement will remain outstanding and we will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the ongoing requirements of the 2024 Credit Agreement and related collateral documents. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to risks associated with currency fluctuations, and changes in foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">exchange rates could impact our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">All of our revenue and the majority of our expense and capital purchasing activities through the year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2024 and the three months ended March 31, 2025 were transacted in U.S. dollars. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Approximately&#160;11% of our 2023 revenue, approximately 9% of our 2024 revenue and approximately 8% of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our revenue for the three months ended March 31, 2025 was generated from customers outside the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States. However, because a portion of our operations consists of business activities outside of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States, we have foreign currency operating expenses as well as asset and liability balances. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the year ended December 31, 2024, we were exposed to foreign currency risks in connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our non-U.S. operations, and we anticipate that, over time, an increasing portion of our international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements may provide for payment denominated in foreign currencies. Changes in the exchange rates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">between such foreign currencies and the U.S. dollar could therefore materially impact our reported results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of operations and distort period-to-period comparisons. Fluctuations in foreign currency exchange rates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also impact the reporting of our receivables and payables in non-U.S. currencies. As a result of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations. In addition, to the extent that fluctuations in currency exchange rates cause our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations to differ from our expectations or the expectations of our investors, the trading price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not currently engage in currency hedging activities to limit the risk of exchange rate fluctuations. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future, we may engage in exchange rate hedging activities in an effort to mitigate the impact of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange rate fluctuations but we may not be successful in doing so. If our hedging activities are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective, changes in currency exchange rates may have a more significant impact on our results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our ability to use our net operating losses and tax credits to offset future taxable income and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">taxes may be subject to certain limitations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, we had net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $542.9 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $435.5&#160;million for federal and state income tax purposes, respectively, which may be utilized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against future federal and state income taxes. Federal NOL carryforwards we generated in tax years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through December&#160;31, 2017 generally may be carried forward for 20 years and may fully offset taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income in the year utilized, and federal NOLs we generated in tax years beginning after December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2017 generally may be carried forward indefinitely but may only be used to offset 80% of our taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income annually for tax years beginning after December&#160;31, 2017.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Section 382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change NOLs, carryforwards and other tax attributes, such as research and development tax credits, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offset future taxable income and taxes. In general, an ownership change occurs if the aggregate stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership of certain stockholders, generally stockholders beneficially owning five percent or more of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, applying certain look through and aggregation rules, increases by more than 50% over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such stockholders&#8217; lowest percentage ownership during the testing period, generally three years. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Purchases of our common stock in amounts greater than specified levels, which will be beyond our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control, could create a limitation on our ability to utilize our NOLs for tax purposes in the future. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.41pt; position: absolute; text-decoration: none; white-space: pre;">We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">completed a Section 382 study of our historic ownership changes through December 31, 2024 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 490.32pt; position: absolute; white-space: pre;">and no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant limitations were identified. In addition, this offering or future issuances or sales of our stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">63<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including certain transactions involving our stock that are outside of our control, could result in future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;ownership changes.&#8221; &#8220;Ownership changes&#8221; that have occurred in the past or that may occur in the future, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including in connection with this offering, could result in the imposition of an annual limit on the amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pre-ownership change NOLs and other tax attributes we can use to reduce our taxable income, potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increasing and accelerating our liability for income taxes, and also potentially causing those tax attributes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to expire unused.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we are limited in our ability to use our NOLs and tax credits in future years in which we have taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits, and we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be required to pay taxes earlier than we would otherwise be required, which could cause such NOLs to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expire unused. This could adversely affect our results of operations. Furthermore, we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate sufficient taxable income to utilize our pre-2018 NOLs before they expire beginning in 2030. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of these events occur, we may not derive some or all of the expected benefits from our NOLs, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations and prospects may be adversely affected as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our international operations subject us to potentially adverse tax consequences.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We currently report our taxable income in various jurisdictions based upon our business operations in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those jurisdictions, including in the United States, United Kingdom, and Japan. We may in the future be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to reporting requirements in other foreign jurisdictions. The international nature and organization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our business activities are subject to complex transfer pricing regulations administered by taxing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities in various jurisdictions. The relevant taxing authorities may disagree with our determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as to the income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and our position were not sustained, we could be required to pay additional taxes, interest and penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could result in one time tax charges, higher effective tax rates, reduced cash flows and lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">overall profitability of our operations. We believe that our consolidated financial statements reflect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adequate reserves to cover such a contingency, but there can be no assurances in that regard.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our effective tax rate may vary significantly from period to period. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Various internal and external factors may have favorable or unfavorable effects on our future effective tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate. These factors include, but are not limited to, changes in tax laws, regulations or rates, both within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and outside the United States, structural changes in our business, new accounting pronouncements or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes to existing accounting pronouncements, non-deductible goodwill impairments, changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpretations of existing tax laws or regulations, changes in the relative proportions of revenue and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income before taxes in the various jurisdictions in which we operate that have different statutory tax rates, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future levels of tax benefits of equity-based compensation, changes in overall levels of pretax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">earnings or changes in the valuation of our deferred tax assets and liabilities. Additionally, we could be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenged by state and local tax authorities as to the propriety of our sales tax compliance, and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results could be materially impacted by these compliance determinations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our effective tax rate may vary significantly depending on the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock. The tax effects of the accounting for share-based compensation may significantly impact our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective tax rate from period to period. In periods in which the market price of our common stock is higher <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than the grant price of the share-based compensation vesting in that period, we will recognize excess tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits that will decrease our effective tax rate. In future periods in which our stock price is lower than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the grant price of the share-based compensation vesting in that period, our effective tax rate may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase. The amount and value of share-based compensation issued relative to our earnings in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular period will also affect the magnitude of the impact of share-based compensation on our effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax rate. These tax effects are dependent on the market price of our common stock, which we do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control, and a decline in our stock price could significantly increase our effective tax rate and adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">64<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Taxing authorities may successfully assert that we should have collected or in the future should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">collect sales and use, value added or similar taxes, and we could be subject to tax liabilities with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">respect to past or future sales, which could adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not collect sales and use, value added and similar taxes in all jurisdictions in which we have sales, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our belief that such taxes are not applicable or that we are not required to collect such taxes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with respect to the jurisdiction. Sales and use, value added and similar tax laws and rates vary greatly by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction. Certain jurisdictions in which we do not collect such taxes may assert that such taxes are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable, which could result in tax assessments, penalties and interest, and we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">collect such taxes in the future. Such tax assessments, penalties and interest or future requirements may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our common stock and this offering<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">There may not be an active trading market for our common stock, which may cause shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">common stock to trade at a discount from the initial public offering price and make it difficult to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">sell the shares of common stock you purchase. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there was no public market for our common stock. It is possible that after this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, an active trading market will not develop or, if developed, that any market will not be sustained, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which would make it difficult for you to sell your shares of common stock at an attractive price or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The initial public offering price per share of common stock was determined by agreement among us and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the representatives of the underwriters and may not be indicative of the price at which shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock will trade in the public market, if any, after this offering. The market value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock may decrease from the initial public offering price. It is possible that in one or more future periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our results of operations may be below the expectations of public market analysts and investors, and, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a result of these and other factors, the price of our common stock may fall. Furthermore, an inactive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market may also impair our ability to raise capital in the future by selling shares of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The market price of our common stock may be volatile, which could cause the value of your <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">investment to decline and could result in substantial losses for investors purchasing shares in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This initial public offering price may vary from the market price of our common stock after the offering. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market price of our common stock may be highly volatile and could be subject to wide fluctuations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities markets worldwide experience significant price and volume fluctuations. This market volatility, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as well as general economic, market or political conditions, could reduce the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock regardless of our operating performance. These fluctuations may be even more pronounced in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trading market for our stock shortly following this offering. You may be unable to resell your shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock at or above the initial public offering price or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are an emerging growth company, and the reduced reporting requirements applicable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">emerging growth companies could make our common stock less attractive to investors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. We will remain an &#8220;emerging growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company&#8221; until the earliest to occur of&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the last day of the fiscal year during which our total annual revenue equals or exceeds $1.235 billion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(subject to adjustment for inflation)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the last day of the fiscal year following the fifth anniversary of this offering&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the date on which we have, during the previous three-year period, issued more than $1 billion in non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible debt&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Exchange Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">65<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of our &#8220;emerging growth company&#8221; status, we may take advantage of exemptions from various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting requirements that would otherwise be applicable to public companies including, but not limited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements and exemptions from the requirements of holding a nonbinding advisory vote on executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation and stockholder approval of any golden parachute payments not previously approved. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investors may find our common stock less attractive because we may rely on these exemptions. If some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors find our common stock less attractive as a result, there may be a less active trading market for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock and the market price of our common stock may be adversely affected and more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volatile.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We will incur increased costs and become subject to additional regulations and requirements as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">result of becoming a public company, which could lower our profits or make it more difficult to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">run our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a public company, we will incur significant legal, accounting and other expenses that we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred as a private company, including costs associated with public company reporting requirements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have also incurred and will continue to incur costs associated with the Sarbanes-Oxley Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related rules implemented by the SEC and the listing requirements of the Nasdaq Global Select Market. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The expenses generally incurred by public companies for reporting and corporate governance purposes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been increasing. We expect these rules and regulations to increase our legal and financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance costs and to make some activities more time-consuming and costly, although we are currently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to estimate these costs with any degree of certainty. These laws and regulations also could make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it more difficult or costly for us to obtain certain types of insurance, including director and officer liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">higher costs to obtain the same or similar coverage. These laws and regulations could also make it more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficult for us to attract and retain qualified persons to serve on our board of directors, on our board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">committees or as our executive officers. Furthermore, if we are unable to satisfy our obligations as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public company, we could be subject to delisting of our common stock, fines, sanctions, other regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action and potentially civil litigation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to design, implement and maintain effective internal control over financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reporting in the future, investors may lose confidence in the accuracy and completeness of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial reports and the market price of our common stock may decline.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a public company, we will be required to maintain internal control over financial reporting and to report <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any material weaknesses in such internal controls. In addition, beginning with our second annual report <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on Form 10-K, we will be required to furnish a report by management on the effectiveness of our internal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control over financial reporting, pursuant to the rules and regulations of the SEC regarding compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with Section 404 of the Sarbanes-Oxley Act. The process of designing, implementing and testing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal control over financial reporting required to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.75pt; position: absolute; text-decoration: none; white-space: pre;">comply<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.41999999999996pt; position: absolute; white-space: pre;"> with this obligation is time consuming, costly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and complicated. We<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.14pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> have in the past and may in the future identify control deficiencies, including </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">material weaknesses in our internal control over financial reporting. In connection with the preparation of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">our consolidated financial statements, material weaknesses in our internal control over financial reporting </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">were identified as of and prior to December 31, 2023, which were remediated in connection with the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">preparation of our consolidated financial statements as of and for the year ended December 31, 2024. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any failure to maintain effective internal control over financial reporting could severely inhibit our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurately report our financial condition, results of operations or cash flows. Further, if we identify one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more material weaknesses in our internal control over financial reporting, if we are unable to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner or if we and, if required, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our auditors, are unable to assert that our internal control over financial reporting is effective, investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may lose confidence in the accuracy and completeness of our financial reports and the market price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock could decline, and we could also become subject to investigations by the stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange on which our common stock is listed, the SEC or other regulatory authorities, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require additional financial and management resources. Failure to remedy any material weakness in our <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">66<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal control over financial reporting, or to implement or maintain other effective control systems <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required of public companies, could also restrict our future access to the capital markets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon effectiveness of the registration statement of which this prospectus forms a part, we became <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the periodic reporting requirements of the Exchange Act. Our disclosure controls and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures are designed to reasonably ensure that information required to be disclosed by us in reports <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we file or submit under the Exchange Act is accumulated and communicated to management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded, processed, summarized and reported within the time periods specified in the rules and forms of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SEC. We believe that our disclosure controls and procedures as well as internal control over financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting, no matter how well conceived and operated, can provide only reasonable, not absolute, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assurance that the objectives of the control system are and will be met. These inherent limitations include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the realities that judgments in decision making can be faulty and that breakdowns can occur because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the inherent limitations in our control system, misstatements due to error or fraud may occur and not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If our estimates or judgments relating to our critical accounting policies are based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">assumptions that change or prove to be incorrect, our operating results could fall below our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">publicly announced guidance or the expectations of securities analysts and investors, resulting in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">a decline in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The preparation of financial statements in conformity with the United States generally accepted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our estimates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on historical experience and various other factors that we believe are reasonable under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, the results of which form the basis for making judgments about the carrying value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assets and liabilities that are not readily apparent from other sources. Actual results may differ from these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates under different assumptions or conditions and any such differences may be material. If our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions change or if actual circumstances differ from our assumptions, our operating results may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affected and could fall below our publicly announced guidance or the expectations of analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and investors, resulting in a decline in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our principal stockholders and management own a significant percentage of our stock and will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">able to exert significant control over matters subject to stockholder approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prior to this offering, as of June 30, 2025, our executive officers, directors, owners of more than 5% of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">capital stock and their respective affiliates beneficially owned <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.44pt; position: absolute; text-decoration: none; white-space: pre;">approximately 68.3% of our outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">shares and, upon the completion of this offering, that same group will beneficially own approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">49.5% of our outstanding shares<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.89pt; position: absolute; text-decoration: none; white-space: pre;"> (assuming no exercise of the underwriters&#8217; option to purchase additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">shares). Therefore, even after this offering, these stockholders will have the ability to influence us through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">this ownership position. These stockholders may be able to determine all matters requiring stockholder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approval.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.12pt; position: absolute; white-space: pre;"> For example, these stockholders may be able to control elections of directors, amendments of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our organizational documents, or approval of any merger, sale of assets or other major corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock that you may feel are in your best interest as one of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">A significant portion of our total outstanding shares is restricted from immediate resale but may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">be sold into the market in the near future, and any sales of a substantial number of shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">common stock in the public market could cause our stock price to decline significantly, even if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our business is doing well.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Sales of a substantial number of shares of our common stock in the public market could occur at any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time. These sales, or the perception in the market that the holders of a large number of shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">67<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock intend to sell shares, could reduce the market price of our common stock. If our existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market after the lock-up agreements, market standoff and other legal restrictions on resale discussed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus, including as described under the section titled &#8220;Shares eligible for future sale&#8212;Lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements and market standoff arrangements,&#8221; lapse, the trading price of our common stock could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decline. Based upon the number of shares outstanding as of March 31, 2025 and assuming (i) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Preferred Stock Conversion, (ii) the Convertible Notes Conversion, (iii) no exercise of the underwriters&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option to purchase additional shares of our common stock, and (iv) no exercise of outstanding options or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants, upon the completion of this offering, we will have outstanding a total of 81,168,388 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. Of these shares, all of the shares of our common stock sold in this offering, plus any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares sold upon exercise of the underwriters&#8217; option to purchase additional shares, if any, will be freely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tradable, without restriction, in the public market immediately following this offering, other than shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchased by our &#8220;affiliates&#8221; (as such term is defined in Rule 144 under the Securities Act). See the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section titled &#8220;Shares eligible for future sale&#8221; in this prospectus for restrictions applicable to our affiliates. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We and each of our directors, our executive officers and substantially all of our other securityholders have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered or will enter into lock-up agreements with the underwriters prior to the completion of this offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or are subject to market standoff arrangements, which are described, including certain exceptions to such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements, in the section titled &#8220;Underwriting&#8221;. After the expiration of the lock-up agreements and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standoff arrangements, as of June 30, 2025, up to approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.67pt; position: absolute; text-decoration: none; white-space: pre;">64.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.22pt; position: absolute; white-space: pre;"> additional shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock will be eligible for sale in the public market, approximatel<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.6pt; position: absolute; text-decoration: none; white-space: pre;">y <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.37pt; position: absolute; text-decoration: none; white-space: pre;">60.5%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.71pt; position: absolute; white-space: pre;"> of which shares are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owned by directors, executive officers and other owners of more than 5% of our outstanding common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, stock options, warrants and securities convertible into our common stock and will be subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rule 144 under the Securities Act. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Approximately 6.5% of our outstanding common stock, stock options, warrants and other securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible into or exercisable or exchangeable for our common stock are subject to market standoff <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions with us that include restrictions on the sale, transfer or other disposition of shares, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other things and subject to certain exceptions, for a period of 180 days commencing on the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. As a result of the foregoing, substantially all of our outstanding common stock, stock options, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants and other securities convertible into or exercisable or exchangeable for our common stock are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to a lock-up agreement or market standoff provisions for a period of 180 days commencing on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of this prospectus. See the section titled &#8220;Shares eligible for future sale&#8221; for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After this offering, based upon the number of shares outstanding as of March 31, 2025, the holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137pt; position: absolute; text-decoration: none; white-space: pre;">55.8 million shares of our common stock, or approximately 68%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.07pt; position: absolute; white-space: pre;"> of our total outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, will be entitled to rights with respect to the registration of their shares under the Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act, subject to the lock-up agreements and market standoff restrictions described above. Registration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these shares under the Securities Act would result in the shares becoming freely tradable without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restriction under the Securities Act, except for shares purchased by affiliates. Any sales of securities by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these stockholders or any perception that these shares may be sold could have a material adverse effect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the trading price of our common stock. In addition, a security holder who is not subject to market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standoff restrictions with us nor a lock-up agreement with the underwriters may be able to sell, short sell, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer, pledge or otherwise dispose of their equity interests at any time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our amended and restated certificate of incorporation will provide that the Court of Chancery of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the State of Delaware (or, if such court does not have jurisdiction, Delaware federal district court) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">will be the exclusive forum for certain disputes between us and our stockholders, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">directors, officers or employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will provide that, unless we consent in writing to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware) is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">68<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim of breach of fiduciary duty owed by any of our current or former directors, officers, employees or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders to us or to our stockholders, any action asserting a claim against us arising pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Delaware General Corporation Law, our amended and restated certificate of incorporation, or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended and restated bylaws (as either may be amended from time to time) or as to which the Delaware <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">General Corporation Law confers jurisdiction on the Delaware Court of Chancery, or any action asserting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a claim against us that is governed by the internal affairs doctrine of the State of Delaware. Our amended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and restated certificate of incorporation will also provide that the federal district courts of the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Securities Act. Further, our amended and restated certificate of incorporation will provide that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foregoing choice of forum provisions will not apply to suits brought to enforce any liability or duty created <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the Exchange Act, or any other claim for which the federal courts of the United States have exclusive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that any person or entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notice of and consented to the foregoing provisions of the amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation. Although our amended and restated certificate of incorporation will contain the choice of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forum provision described above, it is possible that a court could find that such a provision is inapplicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for a particular claim or action or that such provision is unenforceable. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe these provisions may benefit us by providing increased consistency in the application of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Delaware law and federal securities laws by chancellors and judges, as applicable, particularly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experienced in resolving corporate disputes, efficient administration of cases on a more expedited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">schedule relative to other forums, and protection against the burdens of multi-forum litigation. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have waived our compliance with federal securities laws and the rules and regulations thereunder. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the enforceability of similar choice of forum provisions in other companies&#8217; certificates of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation has been challenged in legal proceedings, and it is possible that a court could find these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">types of provisions to be inapplicable or unenforceable. While the Delaware courts have determined that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a venue other than those designated in the exclusive forum provisions, and there can be no assurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that such provisions will be enforced by a court in those other jurisdictions. If a court were to find the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">choice of forum provision that will be contained in our amended and restated certificate of incorporation to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such action in other jurisdictions, which could adversely affect our business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">General risk factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We will have broad discretion in the use of net proceeds to us from this offering and may not use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">them effectively. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay $50.0 million (or $55.0 million if the underwriters exercise any portion of their option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to purchase additional shares of common stock) of the indebtedness outstanding under the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and to pay approximately $6.2&#160;million of fees in connection therewith. We expect to use the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remainder to fund our sales and marketing efforts, fund research and product development activities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for other general corporate purposes, including working capital, operating expenses, and capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenditures. We may also use a portion of the net proceeds from this offering to acquire complementary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">businesses, products, services, or technologies. See the section titled &#8220;Use of proceeds&#8221; for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information. We periodically evaluate strategic opportunities&#59; however, we have no current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">understandings or commitments to enter into any such acquisitions or make any such investments. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected use of net proceeds from this offering represents our intentions based upon our present plans <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">69<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and business conditions. We cannot predict with certainty all of the particular uses for the proceeds of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering or the amounts that we will actually spend on the uses set forth above. Accordingly, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management will have broad discretion in applying the net proceeds of this offering, including for any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the purposes described in the section titled &#8220;Use of proceeds,&#8221; and you will not have the opportunity as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part of your investment decision to assess whether the net proceeds are being used appropriately. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">timing and amount of our actual expenditures will be based on many factors, including cash flows from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and the anticipated growth of our business. Pending their use, we intend to invest the net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of this offering in a variety of capital-preservation investments, including government securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and money market funds. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we do not use the net proceeds that we receive in this offering effectively, our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects could be harmed, and the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock could decline. Pending their use, we intend to invest the net proceeds of this offering in a variety of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital-preservation investments, including government securities and money market funds. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments may not yield a favorable return to our investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Investors in this offering will experience immediate and substantial dilution. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The initial public offering price of our common stock is substantially higher than the pro forma as adjusted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net tangible book value per share of our common stock. Therefore, if you purchase shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock in this offering, you will pay a price per share that substantially exceeds our pro forma as adjusted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net tangible book value per share after this offering. Based on the initial public offering price of $19.00 per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share, you will experience immediate dilution of $15.83 per share, representing the difference between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our pro forma as adjusted net tangible book value per share after giving effect to this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">initial public offering price. In addition, purchasers of common stock in this offering will have contributed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">26% of the aggregate price paid by all purchasers of our common stock but will own only <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;21% of our total equity outstanding after this offering. Furthermore, you will experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional dilution if the underwriters exercise their option to purchase additional shares, outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options and warrants are exercised, upon the vesting of outstanding restricted stock awards or when we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise issue additional shares of common stock. For a further description of the dilution that you will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience immediately after this offering, see the section titled &#8220;Dilution&#8221; included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We do not intend to pay dividends in the foreseeable future. As a result, your ability to achieve a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">return on your investment will depend on appreciation in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available funds and any future earnings, if any, to fund the development and expansion of our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we do not anticipate paying any cash dividends in the foreseeable future. Any future determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the declaration and payment of dividends, if any, will be at the discretion of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to applicable law, and will depend upon then-existing conditions, including our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations, contractual restrictions, general business conditions, capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and other factors our board of directors may deem relevant. In addition, our ability to pay <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash dividends is currently restricted by the terms of the 2024 Credit Agreement. Our ability to pay cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dividends on our capital stock in the future may also be limited by the terms of any preferred securities we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may issue or agreements governing any additional indebtedness we may incur.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If our operating and financial performance in any given period does not meet any guidance that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">we provide to the public, the market price of our common stock may decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may, but are not obligated to, provide public guidance on our expected operating and financial results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for future periods. Any such guidance will be comprised of forward-looking statements subject to the risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and uncertainties described in this prospectus, including in the section titled &#8220;Risk factors,&#8221; and in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future public filings and public statements. Our actual results may not always be in line with or exceed any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance we have provided, especially in times of economic uncertainty. If actual circumstances differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from those in our assumptions, our operating and financial results could fall below our publicly announced <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">70<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance or the expectations of investors. If, in the future, our operating or financial results for a particular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period do not meet any guidance we provide or the expectations of investment analysts or investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally, or if we reduce our guidance for future periods, the market price of our common stock may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decline. Even if we do issue public guidance, there can be no assurance that we will continue to do so in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If securities or industry analysts do not publish research or reports about our business, or if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">issue an adverse or misleading opinion regarding our stock, our stock price and trading volume <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The trading market for our common stock will be influenced by the research and reports that industry or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities analysts publish about us or our business. We do not currently have and may never obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research coverage by securities and industry analysts. If no or few securities or industry analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commence coverage of us, the market price for our stock would be negatively impacted. In the event we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain securities or industry analyst coverage, if any of the analysts who cover us downgrade their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluations of our stock or issue an adverse opinion regarding us, our business model, our intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property or our stock performance, or if our results of operations fail to meet the expectations of analysts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stock price or trading volume to decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be subject to securities litigation, which is expensive and could divert management <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">attention.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the past, following periods of volatility in the overall market and the market price of a company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities, securities class action litigation has often been instituted against these companies. Because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the potential volatility of our stock price, we may become the target of securities litigation in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These events may also result in or be concurrent with investigations by the SEC. We may be exposed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such litigation or investigation even if no wrongdoing occurred. Such litigation, if instituted against us, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in substantial costs and a diversion of our management&#8217;s attention and resources, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could seriously harm our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Provisions in our charter documents and under Delaware law could discourage a takeover that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">stockholders may consider favorable and may lead to entrenchment of management. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">O<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.77pt; position: absolute; text-decoration: none; white-space: pre;">ur amended and restated certificate of incorporation, to be in effect upon the completion of this offering, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and our amended and restated bylaws, to be in effect upon the effectiveness of the amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">restated certificate of incorporation, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.84pt; position: absolute; white-space: pre;">will contain provisions that could delay or prevent changes in control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or changes in our management without the consent of our board of directors. These provisions will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include the following&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a classified board of directors with three-year staggered terms, which may delay the ability of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholders to change the membership of a majority of our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our directors may be removed by our stockholders only for cause&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no cumulative voting in the election of directors, which limits the ability of minority stockholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">elect director candidates&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the exclusive right of our board of directors to change the size of the board of directors and to elect a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">director to fill a new directorship created by the expansion of the board of directors or a vacancy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">created by the resignation, death or removal of a director, which prevents stockholders from being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">able to change the board&#8217;s size or fill new directorships and vacancies on our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the ability of our board of directors to authorize the issuance of shares of preferred stock and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determine the price and other terms of those shares, including preferences and voting rights, without <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">71<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adopt a stockholder rights plan&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the ability of our board of directors to alter our amended and restated bylaws without obtaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder approval&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the required approval of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">then-outstanding shares of capital stock entitled to vote generally in the election of directors to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">remove directors or to adopt, amend, alter or repeal our amended and restated bylaws and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provisions of our amended and restated certificate of incorporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an annual or special meeting of our stockholders&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the requirement that a special meeting of stockholders may be called only by our secretary at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">request of our board of directors, the chairman of our board of directors, or our chief executive officer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which may delay the ability of our stockholders to force consideration of a proposal or to take action, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including the removal of directors&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">advance notice procedures that stockholders must comply with in order to nominate candidates to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">own slate of directors or otherwise attempting to obtain control of us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the anti-takeover provisions contained in Section 203 of the Delaware General <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corporation Law (&#8220;Section 203&#8221;). Under Section 203, a corporation may not, in general, engage in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business combination (as defined in Section 203) with any interested stockholder (generally defined by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 203 to include holders of 15% or more of our capital stock) unless the interested stockholder has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">held the stock for three years or, among other exceptions and exclusions, the board of directors has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved the business combination transaction or the transaction that resulted in the stockholder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">becoming an interested stockholder. For a description of our capital stock, see the section titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Description of capital stock.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">72<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1039" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Special note regarding forward-looking statements<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus, including the sections titled &#8220;Prospectus summary,&#8221; &#8220;Risk factors,&#8221; &#8220;Management&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussion and analysis of financial condition and results of operations,&#8221; and &#8220;Business,&#8221; contains express <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or implied forward-looking statements about us and our industry that involve substantial risks and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertainties. All statements other than statements of historical facts contained in this prospectus, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including statements regarding our strategy, future financial condition, future operations, projected costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects, plans, objectives of management, and expected market growth, are forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements. In some cases, you can identify forward-looking statements by words such as &#8220;may,&#8221; &#8220;will,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;shall,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;target,&#8221; &#8220;projects,&#8221; &#8220;contemplates,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;goal,&#8221; &#8220;objective,&#8221; &#8220;seeks,&#8221; or &#8220;continue&#8221; or the negative of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these words or other similar terms or expressions that concern our expectations, strategy, plans, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intentions. Forward-looking statements contained in this prospectus include, but are not limited to, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements about&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business model and strategic plans for our products, technologies and business, including our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">implementation thereof&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to continue improving our products and technologies, including our AI Technologies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding government and third-party payor coverage and reimbursement&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the implementation of our business model and strategic plans&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to commercialize, manage and grow our business by increasing our sales to existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">customers or introducing our products to new customers&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to compete with other companies engaged in the development of products, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">algorithm-based diagnostic analysis products, that provide existing non-invasive tests that aid in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluation of CAD&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding the potential addressable market size for our products&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectation about market trends&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to attract, hire and retain key personnel and additional qualified personnel&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to effectively manage our growth&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including potential effects of evolving and&#47;or extensive government regulation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to obtain, maintain and expand regulatory clearances for our products and any new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products we create&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to establish and maintain intellectual property protection for our products or avoid claims of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">infringement&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding the use of the net proceeds from this offering and our existing cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">estimates of our expenses, future revenue, capital requirements, needs for additional financing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to obtain additional capital&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to expand internationally&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">general economic, industry, and market conditions, including rising interest rates and inflation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our future financial performance&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">73<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other risks and uncertainties, including those listed under the caption &#8220;Risk factors.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should not rely on forward-looking statements as predictions of future events. We have based the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward-looking statements contained in this prospectus primarily on our current expectations, estimates, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forecasts, and projections about future events and trends that we believe may affect our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations, and prospects. Although we believe that we have a reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future results, levels of activity, performance, or events and circumstances reflected in the forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements will be achieved or occur at all. The outcome of the events described in these forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements is subject to risks, uncertainties, and other factors described in the section titled &#8220;Risk factors&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and elsewhere in this prospectus. Moreover, we operate in a very competitive and rapidly changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all risks and uncertainties that could have an impact on the forward-looking statements contained in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. The results, events, and circumstances reflected in the forward-looking statements may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be achieved or occur, and actual results, events, or circumstances could differ materially from those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in the forward-looking statements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The forward-looking statements made in this prospectus relate only to events as of the date on which the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements are made. We undertake no obligation to update any forward-looking statements made in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus to reflect events or circumstances after the date of this prospectus or to reflect new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information or the occurrence of unanticipated events, except as required by law. We may not actually <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not place undue reliance on our forward-looking statements. Our forward-looking statements do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may make.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant subject. These statements are based upon information available to us as of the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, and while we believe such information forms a reasonable basis for such statements, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information may be limited or incomplete, and our statements should not be read to indicate that we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements are inherently uncertain, and you are cautioned not to unduly rely on these statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read this prospectus and the documents that we reference in this prospectus and have filed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as exhibits to the registration statement, of which this prospectus is a part, completely and with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">understanding that our actual future results may be materially different from what we expect. We qualify <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of the forward-looking statements in this prospectus by these cautionary statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">74<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1064" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market and industry data<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus contains estimates, projections, and other information concerning our industry and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, as well as data regarding market research, estimates, and forecasts prepared by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management or third parties, including but not limited to, Clarivate and the publications listed below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information that is based on estimates, forecasts, projections, market research, or similar methodologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is inherently subject to uncertainties, and actual events or circumstances may differ materially from events <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and circumstances that are assumed in this information. These data and the industry in which we operate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors.&#8221; These and other factors could cause results to differ materially from those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expressed in these estimates, publications, and reports made by third parties or us.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise expressly stated, we obtained such industry, business, market, and other data from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reports, research surveys, studies, and similar data prepared by market research firms and other third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties, industry and general publications, government data, and similar sources. In some cases, we do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more sources of this type of data in any paragraph, you should assume that other data of this type <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appearing in the same paragraph is derived from sources which we paid for, sponsored, or conducted, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unless otherwise expressly stated or the context otherwise requires. The content of these third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sources, except to the extent specifically set forth in this prospectus, does not constitute a portion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus and is not incorporated herein.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 339.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The sources of certain statistical data, estimates and forecasts contained in this prospectus are from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">following publications&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Martin et al., Circulation 149&#58;e347, 2024 (the &#8220;Martin paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Bhatt et al., JAMA 327&#58;662, 2022 (the &#8220;Bhatt paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Kofoed et al., Journal of the American College of Cardiology 77&#58;1044, 2021 (the &#8220;Kofoed paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hoffmann et al., Circulation 135&#58;2320, 2017 (the &#8220;Hoffman paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Yang et al., BMJ Open 2017&#59;7&#58;e011684, 2017 (the &#8220;Yang paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">MacDonald, Current Developments in Nutrition 6&#58;925, 2022 (the &#8220;MacDonald paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 491.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Nakanishi et al., The International Journal of Cardiovascular Imaging 33&#58; 2067, 2017 (the &#8220;Nakanishi <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 503.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Yokota et al., Netherlands Heart Journal 26&#58;192, 2018 (the &#8220;Yokota paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Patel et al., American Heart Journal 167&#58;846, 2014 (the &#8220;2014 Patel paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Patel et al., New England Journal of Medicine 362&#58;886, 2010 (the &#8220;2010 Patel paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Wang et al., American Journal of Roentgenology 191&#58;409, 2008 (the &#8220;Wang paper&#8221;)&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ni et al., American Heart Journal 157&#58;46, 2009 (the &#8220;Ni paper&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Forecasts and other forward-looking information with respect to industry, business, market, and other data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are subject to the same qualifications and additional uncertainties regarding the other forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements in this prospectus. See the section titled &#8220;Special note regarding forward-looking statements.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">75<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1089" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Use of proceeds<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that the net proceeds from this offering will be approximately $289.0 million (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately $333.2&#160;million if the underwriters exercise in full their option to purchase up to&#160;2,500,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares of common stock), based on the initial public offering price of $19.00&#160;per share, after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deducting underwriting discounts and commissions and estimated offering expenses payable by us.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 175.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.12pt; position: absolute; text-decoration: none; white-space: pre;">$50.0 million (or $55.0 million if the underwriters exercise any portion of their option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to purchase additional shares of common stock) o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.53999999999996pt; position: absolute; white-space: pre;">f the indebtedness outstanding under the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 199.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and to pay approximately $6.2&#160;million of fees in connection therewith. In connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance of the 2025 Convertible Notes in January 2025, we entered into Amendment No. 1 to the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Credit Agreement, pursuant to which entities affiliated with Hayfin converted $23.0 million of outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness under the 2024 Credit Agreement in connection with the 2024 Term Loan Conversion and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">became holders of 5% or more of our capital stock as of March 31, 2025. The 2024 Credit Agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bears interest equal to the sum of (i) 7.0% (or 6.0% if the alternative base rate is in effect) plus (ii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater of (x) the forward-looking term rate based on the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a respective tenor (or the alternative base rate, if applicable), and (y) 2.0%. The alternative base rate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equals to the sum of (i) 6.0% plus (ii) the greater of (1) the Wall Street Journal Prime Rate, plus 0.5%, (2) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Federal Reserve Bank of New York rate plus 0.5% or (3) CBA Term SOFR for one month tenor plus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1.0%. The 2024 Credit Agreement matures on June 14, 2028. Borrowings under the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement were used to refinance outstanding indebtedness. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to use the remainder of the net proceeds from this offering, together with our existing cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash equivalents, to fund our sales and marketing efforts, fund research and product development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities and for other general corporate purposes, including working capital, operating expenses, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital expenditures. With respect to funding research and product development activities, we plan to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deploy net proceeds from this offering into three main areas of research and development&#58; (i) new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products to drive greater efficiency and reduce manual involvement by the imaging physician, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 423.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">software tools that reduce imager time spent reading and reporting on CCTA images&#59; (ii) new features <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that enhance the clinical utility and ease of use of our existing products, including a more intuitive and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">simplified user interface&#59; and (iii) new clinical evidence to support expanded indications of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform into high risk asymptomatic patients and longer term, lower risk asymptomatic patients. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also use a portion of the net proceeds from this offering to acquire complementary businesses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 491.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, services, or technologies. We periodically evaluate strategic opportunities&#59; however, we have no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 503.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current understandings or commitments to enter into any such acquisitions or make any such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our current operating plan, we estimate that our existing cash and cash equivalents as of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 547.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of this prospectus, together with the estimated net proceeds from this offering, will be sufficient to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fund our planned operations for at least the next twelve months. We have based this estimate on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current assumptions, which may prove to be wrong, and we may exhaust our available capital resources <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sooner than we expect. The expected use of net proceeds from this offering represents our intentions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based upon our present plans and business conditions. We cannot predict with certainty all of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular uses for the proceeds of this offering or the amounts that we will actually spend on the uses set <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forth above. Accordingly, our management will have broad discretion in applying the net proceeds of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, and investors will be relying on the judgment of our management regarding the application of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these net proceeds. The timing and amount of our actual expenditures will be based on many factors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including cash flows from operations and the anticipated growth of our business. Pending their use, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intend to invest the net proceeds of this offering in a variety of capital-preservation investments, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government securities and money market funds.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">76<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1114" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividend policy<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available funds and any future earnings, if any, to fund the development and expansion of our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we do not anticipate paying any cash dividends in the foreseeable future. Any future determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the declaration and payment of dividends, if any, will be at the discretion of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to applicable law, and will depend upon then-existing conditions, including our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations, contractual restrictions, general business conditions, capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and other factors our board of directors may deem relevant. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.59pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">our ability to pay </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">cash dividends is currently restricted by the terms of our 2024 Credit Agreement. Our ability to pay cash </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">dividends on our capital stock in the future may also be limited by the terms of any preferred securities we </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">may issue or agreements governing any additional indebtedness we may incur.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">77<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1139" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Capitalization<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table sets forth our cash and cash equivalents and our capitalization, as of March 31, 2025&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 127.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on an actual basis&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 147.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on a pro for<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.1pt; position: absolute; text-decoration: none; white-space: pre;">ma basis, giving effect to (i) the Preferred Stock Conversion, which will occur immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 159.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prior to the completion of this offering, (ii) 6,470,743 shares issuable in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes Conversion at the initial public offering price of $19.00 per share, and the resultant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reclassification of our derivative liability to additional paid-in capital, a component of stockholders&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 195.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">equity (deficit), which will occur upon the completion of this offering, as if each had occurred as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 207.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025, and (iii) the adoption, filing, and effectiveness of our amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 219.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation, to be in effect upon the completion of this offering&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.09pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on a pro forma as adjusted basis, giving effect to (i) the pro forma adjustments discussed above, (ii) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the issuance and sale of&#160;16,666,667&#160;shares of common stock in this offering at the initial public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering price of $19.00&#160;per share, after deducting underwriting discounts and commissions and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 275.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">estimated offering expenses payable by us, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.26pt; position: absolute; text-decoration: none; white-space: pre;">(iii) the assumed repayment of $50.0 million of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 287.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">indebtedness outstanding under the 2024 Credit Agreement and payment of approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 299.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">$6.2&#160;million of fees in connection therewith.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read this table together with the sections titled &#8220;Summary consolidated financial data,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Management&#8217;s discussion and analysis of financial condition and results of operations&#8221; and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 343.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and the related notes included elsewhere in this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">78<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 263.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="5"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 201.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 201.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 176.65pt; position: absolute; text-decoration: none; white-space: pre;">As of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.43pt; width: 201.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 135.14pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 263.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.15pt; position: absolute; text-decoration: none; white-space: pre;">Actual<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.15pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">adjusted<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 122.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 123.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">109,786<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">109,786<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">343,568<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 62.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.55pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.97pt;"></font></font><font style="left: 25.599999999999998pt; position: absolute;">113,831<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">113,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">62,132<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 76.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 107.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 107.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 107.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.03pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,824<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 90.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.56pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,945<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 62.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 105pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock, $0.001 par <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">value&#59;&#160;122,231,454&#160;shares authorized&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454&#160;shares issued and outstanding, actual&#59; no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">shares authorized, issued or outstanding, pro forma and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">pro forma as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 100.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.5pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 167.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; equity (deficit)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 62.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 181.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Preferred stock, $0.001 par value&#59; no shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized, issued and outstanding, actual&#59;&#160;no shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized, no shares issued or outstanding, pro <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">forma&#59;&#160;50,000,000&#160;shares authorized and&#160;no&#160;shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">issued and outstanding, pro forma as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 219.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 220.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 220.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 220.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.53pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 181.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 181.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 181.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 86.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 243.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock, $0.001 par value&#59; 210,300,000&#160;shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized,&#160;6,252,861&#160;shares issued and outstanding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">actual&#59;&#160;210,300,000&#160;shares authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and&#160;63,949,952&#160;shares issued and outstanding, pro <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">forma&#59;&#160;250,000,000&#160;shares authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 62.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and&#160;80,616,619&#160;shares issued and outstanding, pro forma <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 74.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 53.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.910000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 55.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 55.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 55.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.46pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 75.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 52.98pt;"></font></font><font style="left: 55.61pt; position: absolute;">6<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 75.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">64<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 75.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">81<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 330pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Additional paid-in capital<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 112.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 330pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,311<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 330pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">990,588<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 330pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,279,571<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 344.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated other comprehensive loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 177.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 177.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 177.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.03pt; position: absolute; text-decoration: none; white-space: pre;">.................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 344.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,008)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 344.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,008)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 344.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,008)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 358.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 89.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.5pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 358.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 358.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 358.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 10.75pt;"></font></font><font style="left: 13.379999999999999pt; position: absolute;">(1,007,821)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 372.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; equity (deficit)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 372.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(888,995)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 372.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(13,660)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 372.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">270,823<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 387pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total capitalization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 85.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 85.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 387pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">100,171<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 387pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">100,171<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 387pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">332,955<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 498.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the underwriters exercise in full their option to purchase up to 2,500,000&#160;additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, pro forma as adjusted cash and cash equivalents, 2024 Term Loan, additional paid-in capital, total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders&#8217; equity (deficit), total capitalization, and shares of common stock outstanding as of March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 would be $382.7 million, $57.1 million, $1.3 billion, $315.0 million, $372.1 million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and&#160;83,116,619&#160;shares, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The number of shares of our common stock to be outstanding after this offering, pro forma and pro forma <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as adjusted, in the table above is based on&#160;63,949,952&#160;shares of our common stock outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025, after giving effect to (i) the Preferred Stock Conversion, which will occur immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to the completion of this offering, (ii) the Convertible Notes Conversion, which will occur upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, and (iii) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.76pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation, to be in effect upon the completion of this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.87pt; position: absolute; white-space: pre;">, as if each had occurred as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of March 31, 2025, and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">8,583,703&#160;shares of our common stock issuable upon the exercise of outstanding stock options as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 under our 2009 Equity Incentive Plan, with a weighted-average exercise price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">$4.98&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">79<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">212,888&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to March 31, 2025 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $13.64&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,647,667&#160;shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 held by Hayfin, with an exercise price of $0.03 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">323,173 shares, including 129,577 shares reserved subsequent to March 31, 2025, of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock reserved for future issuance under our 2009 Equity Incentive Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">17,346,193 shares of our common stock to be reserved for future issuance under the 2025 Plan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which became effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.47pt; position: absolute; white-space: pre;">upon the commencement of trading of our common stock on the Nasdaq <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Global Select Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.75pt; position: absolute; text-decoration: none; white-space: pre;">, from which we will grant RSUs covering approximately 506,579 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock concurrently with this offering (based on the initial public offering price of $19.00 per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share), as well as any future increases in the number of shares of common stock reserved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuance under the 2025 Plan&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,233,964 shares of our common stock reserved for future issuance under the ESPP, which became <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.8pt; position: absolute; white-space: pre;">upon the commencement of trading of our common stock on the Nasdaq Global Select <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.55pt; position: absolute; text-decoration: none; white-space: pre;">, as well as any future increases in the number of shares of common stock reserved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">80<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1164" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dilution<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If you purchase shares of our common stock in this offering, your ownership interest will be immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and substantially diluted to the extent of the difference between the initial public offering price per share of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock and the pro forma as adjusted net tangible book value per share of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately after this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, our historical net tangible book value (deficit) was $(939.9)&#160;million, or $(150.31)&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 175.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share of our common stock. Our historical net tangible book value (deficit) is the amount of our total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tangible assets less our total liabilities and the carrying values of our redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 199.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock. Our historical net tangible book value (deficit) per share represents historical net tangible book <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value (deficit) divided by the aggregate number of shares of our common stock outstanding as of March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025. Total tangible assets represents total assets less capitalized internal-use software, capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract costs, unamortized debt discount and issuance costs, and deferred initial public offering costs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 255.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our pro forma net tangible book value (deficit) as of March 31, 2025 was $(32.1)&#160;million, or $(0.50)&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share. Pro forma net tangible book value per share represents total tangible assets, less total liabilities, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 279.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">divided by the total aggregate number of shares of our common stock outstanding as of March 31, 2025, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after giving effect to&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Preferred Stock Conversion, which will occur immediately prior to the completion of this offering, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 323.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">as if it had occurred as of March 31, 2025&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 343.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Convertible Notes Conversion, which will occur upon the completion of this offering, as if it had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 355.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">occurred as of March 31, 2025&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated certificate of incorporation, to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in effect upon the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After giving further effect to the issuance and sale by us of&#160;16,666,667&#160;shares of our common stock in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering at the initial public offering price of $19.00&#160;per share, and after deducting underwriting discounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and commissions and estimated offering expenses payable by us <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.49pt; position: absolute; text-decoration: none; white-space: pre;">and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.94pt; position: absolute; text-decoration: none; white-space: pre;">the assumed repayment of $50.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 443.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">million of the indebtedness outstanding under the 2024 Credit Agreement and to pay approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 455.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$6.2&#160;million of fees in connection therewith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.3pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.07pt; position: absolute; white-space: pre;"> our pro forma as adjusted net tangible book value (deficit) as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of March 31, 2025 would have been $255.8&#160;million, or $3.17&#160;per share. This represents an immediate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase in pro forma net tangible book value to existing stockholders of $3.67&#160;per share and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 491.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediate dilution in pro forma net tangible book value to new investors of $15.83&#160;per share. Dilution per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 503.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share represents the difference between the price per share to be paid by new investors for the shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock sold in this offering and the pro forma as adjusted net tangible book value per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately after this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 547.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table illustrates this dilution on a per sh<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.83000000000004pt; position: absolute; white-space: pre;">are basis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 567.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Initial public offering price per share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 160.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 161.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 161.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 161.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 161.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.72pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">19.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 14.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Historical net tangible book value (deficit) per share as of March 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 326.46999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 326.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.84pt; position: absolute; text-decoration: none; white-space: pre;">..<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(150.31)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 38.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma increase in net tangible book value per share as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,&#160;2025 attributable to the pro forma adjustments described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">above<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.87pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.97pt;"></font></font><font style="left: 31.16pt; position: absolute;">149.81<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net tangible book value per share as of March 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 305.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 306.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 306.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 306.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.77pt; position: absolute; text-decoration: none; white-space: pre;">..........<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 35.620000000000005pt; position: absolute;">(0.50)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Increase in pro forma net tangible book value per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">new investors participating in this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 197.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 198.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 198.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 199.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 199.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.18pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 34.09pt;"></font></font><font style="left: 42.28pt; position: absolute;">3.67<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 107.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as adjusted net tangible book value per share after this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 327.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 329.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 329.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 329.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.25pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 107.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 34.09pt;"></font></font><font style="left: 42.28pt; position: absolute;">3.17<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 121.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dilution per share to new investors participating in this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 277.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 278.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 279.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 279.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.19pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 121.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">15.83<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">81<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the underwriters exercise in full their option to purchase up to&#160;2,500,000&#160;additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, the pro forma as adjusted net tangible book value (deficit) per share of our common stock after this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering would be $3.61&#160;per share, and the dilution per share to investors participating in this offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would be $15.39&#160;per share, assuming the initial public offering price of $19.00&#160;per share.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes, as of March 31, 2025, on a pro forma as adjusted basis as described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, the number of shares of our common stock, the total consideration and the average price per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share (i) paid to us by existing stockholders and (ii) to be paid by new investors acquiring our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock in this offering at the initial public offering price of $19.00&#160;per share, before deducting underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discounts and commissions and estimated offering expenses payable by us. As the table below shows, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors participating in this offering will pay an average price per share substantially higher than our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing stockholders paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 220pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 156pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 32.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 156pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 22.31pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.42pt; position: absolute; text-decoration: none; white-space: pre;">Shares purchased<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 282pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 22.31pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.46pt; position: absolute; text-decoration: none; white-space: pre;">Total consideration<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.93pt; position: absolute; text-decoration: none; white-space: pre;">Weighted- <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.38pt; position: absolute; text-decoration: none; white-space: pre;">average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.39pt; position: absolute; text-decoration: none; white-space: pre;">price per <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.38pt; position: absolute; text-decoration: none; white-space: pre;">share<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.4pt; position: absolute; text-decoration: none; white-space: pre;">Number<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.39pt; position: absolute; text-decoration: none; white-space: pre;">Percent<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.42pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.39pt; position: absolute; text-decoration: none; white-space: pre;">Percent<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Existing stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 98.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.21pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">63,949,952<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.91pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.91pt; position: absolute;">79<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 11.6pt;"></font></font><font style="left: 19.79pt; position: absolute;">878,756<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.91pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.91pt; position: absolute;">74<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">13.74<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">New investors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 65.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 65.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.84pt; position: absolute; text-decoration: none; white-space: pre;">...................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">16,666,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.91pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.91pt; position: absolute;">21<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.72pt;"></font></font><font style="left: 20.349999999999998pt; position: absolute;">316,667<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.91pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.91pt; position: absolute;">26<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">19.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 25.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.669999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.68pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">80,616,619<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 30.35pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 30.35pt; position: absolute;">100<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,195,423<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 30.35pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 30.35pt; position: absolute;">100<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">14.83<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 323.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Except as otherwise indicated, the above discussion and tables assume no exercise of the underwriters&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option to purchase additional shares. If the underwriters exercise in full their option to purchase up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 347.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to&#160;2,500,000 additional shares of common stock, our existing stockholders would own 77%, and our new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors would own 23% of the total number of shares of our common stock outstanding upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The foregoing tables and calculations (other than historical net tangible book value) are based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on&#160;63,949,952 shares of our common stock outstanding as of March 31, 2025, after giving effect to (i) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 415.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Preferred Stock Conversion, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.3pt; position: absolute; text-decoration: none; white-space: pre;">which will occur immediately prior to the completion of this offering, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.35pt; position: absolute; white-space: pre;"> (ii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes Conversion, which will occur upon the completion of this offering, as if it had occurred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of March 31, 2025 and (iii) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.19pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation, to be in effect upon the completion of this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.87pt; position: absolute; white-space: pre;">, and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">8,583,703&#160;shares of our common stock issuable upon the exercise of outstanding stock options as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 under our 2009 Equity Incentive Plan, with a weighted-average exercise price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">$4.98&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">212,888&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to March 31, 2025 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $13.64&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 559.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,647,667<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.46pt; position: absolute; text-decoration: none; white-space: pre;">&#160;shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 held by Hayfin, with an exercise price of $0.03 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 591.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">323,173 shares, including 129,577 shares reserved subsequent to March 31, 2025, of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock reserved for future issuance under our 2009 Equity Incentive Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">17,346,193 shares of our common stock to be reserved for future issuance under the 2025 Plan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which became effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.47pt; position: absolute; white-space: pre;">upon the commencement of trading of our common stock on the Nasdaq <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Global Select Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.75pt; position: absolute; text-decoration: none; white-space: pre;">, from which we will grant RSUs covering approximately 506,579 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 659.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock concurrently with this offering (based on the initial public offering price of $19.00&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share), as well as any future increases in the number of shares of common stock reserved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuance under the 2025 Plan&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">82<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,233,964 shares of our common stock reserved for future issuance under the ESPP, which became <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.8pt; position: absolute; white-space: pre;">upon the commencement of trading of our common stock on the Nasdaq Global Select <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Market<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.55pt; position: absolute; text-decoration: none; white-space: pre;">, as well as any future increases in the number of shares of common stock reserved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To the extent that any outstanding options are exercised, new options or other equity awards are issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under our equity incentive plans, or we issue additional shares in the future, there will be further dilution to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new investors participating in this offering. In addition, we may choose to raise additional capital because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of market conditions or strategic considerations, even if we believe that we have sufficient funds for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current or future operating plans. If we raise additional capital through the sale of equity or convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt securities, the issuance of these securities could result in further dilution to our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">83<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_533" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management&#8217;s discussion and analysis of financial condition <font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 16pt; line-height: 11.64pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and results of operat<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 230.12pt; position: absolute; text-decoration: none; white-space: pre;">ions<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read the following discussion and analysis of our financial condition and results of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in conjunction with our consolidated financial statements and the related notes and other financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information included elsewhere in this prospectus. This discussion and analysis and other parts of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus contain forward-looking statements based upon our current plans and expectations that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expectations, intentions and beliefs. Our actual results and the timing of events could differ materially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from those anticipated in these forward-looking statements as a result of various factors, including those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set forth under the section titled &#8220;Risk factors&#8221; and elsewhere in this prospectus. You should carefully read <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors&#8221; to gain an understanding of the important factors that could cause actual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results to differ materially from our forward-looking statements. Please also see the section titled &#8220;Special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note regarding forward-looking statements.&#8221; Our historical results are not necessarily indicative of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results that may be expected for any period in the future.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">400,000 patients, including 132,000 in 2024 alone</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.59000000000003pt; position: absolute; white-space: pre;">. We believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages AI and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.65999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> (with a fourth product expected to launch in 2026) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">under the Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.18pt; position: absolute; white-space: pre;"> that provide physicians with the critical insights needed to effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review. We provide Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis to accounts as an integrated feature to enhance the efficiency of their CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">program and it is not a stand-alone product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.64pt; position: absolute; white-space: pre;">ractional flow reserve (&#8220;FFR&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.58pt; position: absolute; text-decoration: none; white-space: pre;"> value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.85pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, which we</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.5pt; position: absolute; white-space: pre;"> expect to launch in 2026,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.38pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> will provide advanced visualization and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">clinical insights to optimize revascularization strategies, guide device selection, enhance procedural </font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">84<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">efficiency, and improve patient care. We plan to provide Heartflow PCI Planner to accounts as an </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">integrated feature to enhance procedural efficiency, not as a stand-alone product.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform has an existing commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, United Kingdom, European Union, Australia, Canada and Japan.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.41pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.18pt; position: absolute; white-space: pre;">We have developed a highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scalable, capital efficient commercial model that combines Territory Sales Managers (&#8220;TSMs&#8221;) who drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus on increasing utilization by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">educating referring physicians. Our commercial team does not cover cases or otherwise spend time in an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating room or lab setting, which enables them to focus solely on driving commercial adoption and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">educational activities. We also have small, direct commercial teams in our international markets. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, we may expand our international presence beyond these markets. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily workflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have experienced considerable revenue growth since we <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.06pt; position: absolute; text-decoration: none; white-space: pre;">began commercializing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.3pt; position: absolute; white-space: pre;"> the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform in 2015<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.76pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.3pt; position: absolute; white-space: pre;">driven primarily by growth in our account base and increasing test volumes at accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our installed base. We recognized revenue of $87.2 million for the year ended December 31, 2023, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to revenue of $125.8&#160;million for the year ended December 31, 2024. For the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended March 31, 2024 and 2025, we recognized revenue of $26.8 million and $37.2 million, respectively. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Substantially all of our revenue is generated on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.32pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> a &#8220;pay-per-click&#8221; basis </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.63pt; position: absolute; white-space: pre;">each time a physician chooses to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review either our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.65pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.63pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 213.05pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.71pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 266.69pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.66999999999996pt; position: absolute; white-space: pre;">Plaque Analysis, or both and we recognize usage-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driven fee revenue upon delivery of the requested analysis to the physician. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.65pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.63pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 473.05pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.71pt; position: absolute; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has served as our commercial foundation, representing 99% of our total revenue as of March 31, 2025. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 529.73pt; position: absolute; text-decoration: none; white-space: pre;">In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the second half of 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.89pt; position: absolute; white-space: pre;">, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.06pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.04pt; position: absolute; white-space: pre;">Plaque Analysis, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second commercial product.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Our </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.18pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">RoadMap Analysis is generally provided as a workflow </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">efficiency tool to drive customer retention and loyalty and is not a stand-alone product. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have primarily funded our operations with proceeds from sales of shares of our redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock, common stock and convertible promissory notes, borrowings under our term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loans and revenue received from our customers. As of March 31, 2025, we had $109.8&#160;million in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash equivalents. In January and March 2025, we issued $98.3 million in aggregate principal amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2025 Convertible Notes to investors, including related parties, with original maturity dates of 48 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months from the dates of issuance. The consideration for the issuance of the 2025 Convertible Notes was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprised of $74.0 million in cash, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.08pt; position: absolute; text-decoration: none; white-space: pre;">$1.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.63pt; position: absolute; white-space: pre;"> in aggregate principal amount of notes issued in lieu of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash compensation to certain employees, and the exchange of $23.0 million of outstanding indebtedness <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the 2024 Credit Agreement (as defined below).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have incurred significant operating losses and negative cash flows since our inception and we expect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to continue to incur losses as we grow and transition to operating as a public company. Our net loss for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.45pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.24pt; position: absolute; white-space: pre;"> and 2024 was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.02pt; position: absolute; text-decoration: none; white-space: pre;">$95.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 358.13pt; position: absolute; white-space: pre;"> and $96.4 million, respectively. For the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">three months ended March 31, 2024 and 2025, our net loss was $20.9 million and $32.3 million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively. As of December 31, 2023 and 2024, we had an accumulated deficit of $874.5 million and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$971.0&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.34pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million, respectively. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.24pt; position: absolute; white-space: pre;">As of March 31, 2025, we had an accumulated deficit of $1.0 billion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.85pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Based on our current operating plan, we believe that the expected cash generated from revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">transactions with customers and our existing cash and cash equivalents will be sufficient to fund our </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">planned operating expenses and capital expenditure requirements for at least the next 12 months. We </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">have based this estimate on assumptions that may prove to be wrong, and we could deplete our capital </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">resources sooner than we expect. We may experience lower than expected cash generated from </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and may need to raise additional capital to fund operations, further research and development activities, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">or acquire, invest in, or in-license other businesses, assets, or technologies. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">85<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key factors affecting our results of operations and performance <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe there are several important factors that have impacted and that we expect will continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact our operating performance and results of operations for the foreseeable future. These factors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include, among others&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Rate of adoption of CCTA in the market and our ability to increase adoption of the CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway among both referring and reading physicians.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ability to successfully introduce our Heartflow Plaque Analysis and other new products and the rate at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which they are adopted by physicians. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ability to automate an increasing number of the manual components of our production process and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the rate at which we hire and train analysts to full productivity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We experience seasonality throughout the year b<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.03999999999996pt; position: absolute; text-decoration: none; white-space: pre;">ased on a number of factors, including staff <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">availability, vacations, weather and other macro economic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Publications of clinical results by us and third parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow revenue cases</font><font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We regularly review a number of operating and financial metrics to evaluate our business, measure our </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">performance, identify trends affecting our business, formulate our business plan and make strategic </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">decisions. Substantially all of our revenue is generated on a &#8220;pay-per-click&#8221; basis each time a physician </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">chooses to review either our </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.74pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 264.15999999999997pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT</font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.82pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.8pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.78pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both and we </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">recognize usage-driven fee revenue upon delivery of the requested analysis to the physician. We define a </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">&#8220;Heartflow revenue case&#8221; as each time an account orders and we deliver the requested analysis to the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">physician. For example, the ordering of both an </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.61pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 348.03pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.69pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis and a </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.66pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis from a single CCTA counts as two revenue cases. We define an &#8220;account&#8221; as any individual </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">facility that orders a </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.4pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.38pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 225.8pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT</font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.46pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.41999999999996pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both. Accounts may have </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">more than one reading physician or CT machine. The following </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.16pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">table</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.83pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> lists these revenue cases in each of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.66pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">three month periods as indicate</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">d&#58;</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 448.8pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 42pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 42pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q1 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 75pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q2 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q3 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 141pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q4 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q1 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 207pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q2 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 240pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q3 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 273pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q4 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 306pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q1 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 339pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q2 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 372pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q3 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q4 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 438pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.04pt; position: absolute; text-decoration: none; white-space: pre;">Q1 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 11.81pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 20.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 20.25pt; width: 42pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.75pt; width: 42pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.15pt; width: 42pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cases<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 20.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 21.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 21.779999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 42pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">12,316<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 75pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">12,701<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">14,865<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 141pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">16,697<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">19,537<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 207pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">21,769<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 240pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">23,195<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 273pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">24,897<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 306pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">28,803<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 339pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">33,039<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 372pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">34,970<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">37,805<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 438pt; position: absolute; top: 20.25pt; width: 30pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 2.9pt;"></font></font><font style="left: 5.529999999999999pt; position: absolute;">40,336<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 505.3pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">The period-to-period change in Heartflow revenue cases is an indicator of our ability to drive adoption and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.3pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">generate sales revenue, and is helpful in tracking the progress of our business. We believe that Heartflow </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529.3pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">revenue cases are representative of our current business&#59; however, we anticipate this metric may be </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 541.3pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">substituted for additional or different metrics as our business grows.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 561.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Components of our results of operations<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Substantially all of our revenue comprises usage-driven fees from accounts who <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.63pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">order either our </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.02pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.23pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.77pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We recognize usage-driven fee revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 627.7pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">upon delivery of the requested analysis to the physician. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.09000000000003pt; position: absolute; text-decoration: none; white-space: pre;">Key factors that drive our revenue include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 639.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">revenue case growth from our installed base and the success of our sales force in expanding adoption of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 651.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the Heartflow Platform to new accounts and expanding the utilization of our system by accounts in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 663.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">installed base. We consider an account that has our Heartflow solution deployed with the ability to send <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 675.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">us CCTA images for processing as being part of our installed base. New accounts generally take 12 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 687.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">months to reach steady state revenue case volumes.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.87pt; position: absolute; text-decoration: none; white-space: pre;"> We consider steady state case volumes to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 699.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">attained once the account reaches FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 246.98pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.64pt; position: absolute; text-decoration: none; white-space: pre;"> utilization rates approaching 33% of CCTAs occurring at the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">86<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">account&#8212;a level that is generally sustained over time based on historical trends. Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 514.12pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.78pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is indicated for patients with stenosis levels between 40% and 90% and we believe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 33% of patients have this level of stenosis. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.06pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">For purposes of managing our business, we do </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">not separately track increases in revenue solely attributable to new accounts. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.29pt; position: absolute; text-decoration: none; white-space: pre;">Revenue cases generated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">from clinic or office-based accounts typically carry a lower pricing than hospital-based accounts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">commensurate with their lower reimbursement levels. We expect the percentage of our revenue cases <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">generated from clinic or office-based accounts to continue to increase over time. For the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024, the percentage of our U.S. revenue cases attributable to office and clinic-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">based accounts was 22% and 28%, respectively. For the three months ended March 31, 2024 and 2025, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the percentage of our U.S. revenue cases attributable to office and clinic-based accounts was 28% and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">30%, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">While a single customer may include multiple accounts, no</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: absolute; text-decoration: none; white-space: pre;"> single <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.51pt; position: absolute; text-decoration: none; white-space: pre;">customer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.62pt; position: absolute; text-decoration: none; white-space: pre;"> accounted for 10% or more of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our revenue during the years ended December 31, 2023 and 2024 or for the three months ended March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">31, 2024 and 2025. However, the decision-making function for some of these accounts is concentrated in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">a relatively small number of customers, such that the loss of one customer could result in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">disproportionate loss across our accounts. For example, for the year ended December 31, 2024, our top <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">two largest customers, both large health systems with multiple accounts, collectively represented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 8% of our revenue. As we expand the adoption of the Heartflow Platform, we expect a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">majority of new accounts to come from new customers, decreasing our customer concentration risk.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue has fluctuated, and we expect it to continue to fluctuate from quarter-to-quarter due to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">variety of factors includ<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.19pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ing the number of </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.73pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">accounts in our installed base</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.4pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, the volume of Heartflow Platform </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">usage by accounts in our installed base, changes in the mix of customer accounts and seasonality. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.67pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">may experience fluctuations in the volume of Heartflow Platform usage by our customers based on </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">seasonal factors that impact the number of radiologists and support staff available to conduct CCTAs at </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">customer accounts. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue and gross margin<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue consists of personnel and related expenses, including stock-based compensation costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily related to our production team. Additional costs include third-party hosting fees, amortization of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized internal-use software, amortization of contract fulfillment costs as well as royalties associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with technology licenses used in connection with the delivery of our product and allocated overhead, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which includes facilities expenses, equipment, depreciation and technology services. The role of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production team is to support our patient case volume revenue by performing defined quality-related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities on CCTA scans submitted by our customers for analysis. The portion of these costs that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supports patient case volume revenue is recorded as cost of revenue. The production team also supports <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities in our clinical trials and research and development, which are allocated as research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development expense. We expect cost of revenue to increase as we hire additional personnel in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production team to support our increasing patient case volume.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We calculate gross margin as gross profit divided by revenue.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.56pt; position: absolute; text-decoration: none; white-space: pre;"> Our gross margin has been and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">continue to be affected by a variety of factors, primarily by our production team costs, the timing of hiring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">new production team members and training them to full productivity, the timing of our acquisition of new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">customers and pricing and commercialization of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.87pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis and other new products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although, we expect our gross margin to fluctuate from period to period, based upon the factors described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, we believe our gross margin will increase over the long term as we leverage the AI-based nature <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our software platform to automate an increasing number of the manual components of our production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">teams&#8217; p</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.4pt; position: absolute; white-space: pre;">rocess, thereby lowering the cost of revenue per analysis. We also expect increased revenues <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.95999999999998pt; position: absolute; white-space: pre;">Plaque Analysis, to positively impact our gross margin, as it runs on the same CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scan as <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 173.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.28pt; position: absolute; white-space: pre;"> Analysis. In the short term, we expect gross margin to decrease as we hire and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">train additional personnel in our production team to support our increasing patient case volume.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">87<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Research and development expenses are incurred in connection with the advancement of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform with the goal to introduce products, features and improvements aimed at increasing the value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proposition for our custome<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">rs by expanding its applicability to additional disease states and patient </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">populations. Research and development expenses </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.26pt; position: absolute; white-space: pre;">consist primarily of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.01pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.78pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">engineering, product development, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consulting services, clinical studies to develop and support our products, regulatory activities, medical </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">affairs,</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.57pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and ot</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.35pt; position: absolute; text-decoration: none; white-space: pre;">her costs associated with products and technologies that are in development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.67pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.21pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Rese</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.55pt; position: absolute; white-space: pre;">arch and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development expenses consist of personnel and related expenses, including stock-based compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, clinical trials, third-party consulting costs, the portion of the costs incurred by our production team <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to support clinical trials and research and development efforts, and allocated overhead, including facilities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses, equipment and depreciation. Our research and development team is comprised of PhD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research scientists with expertise in AI-based algorithms and medical imaging, alongside software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engineers skilled in cloud architecture, AI algorithms, machine and deep learning and 3D visualization, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">well as product managers and designers who ensure optimal customer experience and design. We record <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development expenses in the periods in which they are incurred. We expect our research <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and development expenses to increase as we conduct clinical studies for expanded indications for use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and to hire additional personnel to develop new product offerings and product enhancements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses consist of personnel and related expenses, including stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation costs, related to selling and marketing, commercial operations, reimbursement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finance, legal, information technology and human resources functions. Other expenses include sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commission, marketing initiatives, professional service fees (including legal, audit, accounting and tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees), market access work to secure reimbursement for our technologies, travel expenses, conferences <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and trade shows, and allocated overhead, which includes facilities expenses, software licenses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depreciation and other miscellaneous expenses.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect that our selling, general and administrative expenses will increase in the future as a result of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expanding our operations, including hiring personnel, to both drive and support anticipated growth as well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as various incremental costs associated with operating as a public company. We expect that our costs will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase related to legal, audit, accounting fees, consulting fees, regulatory and tax-related services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with maintaining compliance with exchange listing and SEC requirements, director and officer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance costs, investor and public relations costs and other expenses that we did not incur as a private <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. However, we expect selling, general and administrative expenses to decrease as a percentage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of revenue primarily as, and to the extent, our revenue grows.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Interest expense, net consists primarily of interest expense on our 2024 Term Loan and related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of debt discount and debt issuance costs. Interest income is primarily interest earned on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash and cash equivalents. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other expense, net consists primarily of changes in fair value related to our Convertible Notes, common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock warrant and derivative liability as well as foreign exchange transaction gains or losses from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions and asset and liability balances denominated in currencies other than the U.S. dollar. We will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continue to record adjustments to the estimated fair value of the common stock warrant liability until the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants are exercised or expire and to the estimated fair value of the derivative liability until the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible notes are repaid or converted.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">88<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Provision for income taxes consists of income tax expense in foreign jurisdictions. To date, we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded any U.S. federal or state income tax expense. We have net deferred tax assets for U.S. federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income taxes for which we provide a full valuation allowance. Due to our history of net operating losses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since inception, we expect to maintain a full valuation allowance in the foreseeable future due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertainties regarding our ability to realize these assets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Results of operations<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Comparison of three months ended March 31, 2024 and 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table summarizes our results of operations for the three months ended March 31, 2024 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 234.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.46pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 89.39pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 97.91pt; position: absolute; text-decoration: none; white-space: pre;">Change<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(dollars in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 57.62pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 54.62pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.86pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">26,843<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">37,205<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">10,362<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">39<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.17999999999999pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">7,420<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">9,264<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">1,844<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">25<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 54.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 55.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.220000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.28pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">19,423<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">27,941<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">8,518<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">44<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 125.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 125.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.33pt; position: absolute; text-decoration: none; white-space: pre;">............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">9,443<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">13,924<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">4,481<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">47<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 155.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 157.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 157.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 157.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 157.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 157.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.65pt; position: absolute; text-decoration: none; white-space: pre;">...............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">26,038<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">31,519<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">5,481<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">21<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 122.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.22pt; position: absolute; text-decoration: none; white-space: pre;">................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">35,481<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">45,443<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">9,962<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">28<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 136.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.71pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(16,058)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(17,502)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(1,444)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 46.93pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 46.93pt; position: absolute;">9<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 150.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 97.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.69pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(4,731)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(4,550)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 42.07pt;"></font></font><font style="left: 44.7pt; position: absolute;">181<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 43.6pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 43.6pt; position: absolute;">-4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 165pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 87.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.86pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 35.41pt;"></font></font><font style="left: 38.04pt; position: absolute;">(215)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(10,293)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(10,078)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.49pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 179.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 173.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 174.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 175.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.22pt; position: absolute; text-decoration: none; white-space: pre;">........<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 179.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(21,004)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 179.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 179.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(11,341)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 179.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.16pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.16pt; position: absolute;">54<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 193.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(Provision for) benefit from income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 182.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 182.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 182.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 182.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 193.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 193.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 193.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(72)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 193.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.27pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.27pt; position: absolute;">-100<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 207.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 207.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 207.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 207.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(11,413)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 207.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">55<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 464.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">*&#58; &#160;&#160;&#160;Not Meaningful<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue increased $10.4&#160;million, or&#160;39%, to $37.2&#160;million during the three months ended March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, compared to $26.8 million during the three months ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.88pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">March 31, 2024. The increase in revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">was primarily attributable to a 40% increase in revenue case volume.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Cost of revenue and gross margin</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 565.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue increased $1.8&#160;million, or&#160;25%, to $9.3 million during the three months ended March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 577.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, compared to $7.4 million during the three months ended March 31, 2024. This increase was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 589.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to $0.7&#160;million in personnel and related expenses, $0.3&#160;million in amortization of capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal-use software, $0.3&#160;million in allocated overhead, and a net change of $0.2 million in capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and amortized contract fulfillment costs. Personnel and related expenses included $0.1&#160;million and $0.1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million of stock-based compensation costs during the three months ended March 31, 2025 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively. Gross margin for the three months ended March 31, 2025 increased to&#160;75% as compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">72% for the three months ended March 31, 2024. The gross margin increase during the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended March 31, 2025 was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.34pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">primarily driven by increased revenue cases as compared to the three months </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ended March 31, 2024</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.01999999999998pt; position: absolute; white-space: pre;">. The three months ended March 31, 2025 also benefited from efficiency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 685.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">improvements that were introduced throughout 2024 and were in place during the entire three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended March 31, 2025, which lowered the cost of revenue per analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">89<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Research and development expenses increased $4.5&#160;million, or&#160;47%, to $13.9&#160;million during the three <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months ended March 31, 2025, compared to $9.4 million during the three months ended March 31, 2024. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The increase in research and development expenses was primarily attributable to an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.9&#160;million in personnel and related expenses directly associated with an increase in headcount, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$0.7&#160;million in clinical trial expenses, $0.6&#160;million in consulting and professional fees, and $0.1&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">software-related costs. Personnel and related expenses included $0.5&#160;million and $0.5 million o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.09pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">f stock-</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">based compensation costs during the three months ended March 31, 2025 and 2024, respectively. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses increased $5.5&#160;million, or&#160;21%, to $31.5&#160;million during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">three months ended March 31, 2025, compared to $26.0 million during the three months ended March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024. The increase in selling, general and administrative expenses was primarily attributable to an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase of $2.8&#160;million in personnel and related expenses directly associated with an increase in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">headcount, $2.6&#160;million in professional fees, including legal, audit and consulting fees, and $0.9&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing expenses,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.23000000000002pt; position: absolute; text-decoration: none; white-space: pre;"> partially offset by a decrease of $0.3 million in allocated overhead<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.23pt; position: absolute; white-space: pre;"> and $0.6 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of capitalized commission costs. Personnel and related expenses included $1.9&#160;million and $2.1 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock-based compensation costs for the three months ended March 31, 2025 and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Interest expense, net decreased to an expense of $4.6&#160;million during the three months ended March&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, compared to an expense of $4.7 million during the three months ended March 31, 2024. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decreased expense was attributable to a lower aggregate outstanding principal balance under our 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan related to the conversion of $23.0 million in principal to convertible notes in January 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offset by lower interest rates earned on money market funds. As of March 31, 2025 and 2024, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate outstanding principal balance (including interest paid-in-kind) under our 2024 Term Loan was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$115.1 million and $138.1 million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other expense, net increased to an expense of $10.3&#160;million during the three months ended March&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, compared to an expense of $215,000 during the three months ended March 31, 2024. The increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was primarily attributable to the remeasurement and recognition of the change in fair value related to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock warrant liability of $1.6 million and the remeasurement and recognition of $9.0 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to the derivative liability during the three months ended March 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(Provision for) benefit from income taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Benefit from income taxes was $72,000 for the three months ended March 31, 2024 related to our foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">taxes. There was no provision for income taxes during the three months ended March 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">90<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Comparison of years ended December 31, 2023 and 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes our results of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.28pt; position: absolute; text-decoration: none; white-space: pre;">operations for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.61pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.4pt; position: absolute; text-decoration: none; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 124pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.42pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 72.39pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 97.91pt; position: absolute; text-decoration: none; white-space: pre;">Change<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(dollars in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 57.62pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 54.62pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.86pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.06pt;"></font></font><font style="left: 25.25pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 30.81pt; position: absolute;">38,634<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">44<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.17999999999999pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">2,236<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 46.93pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 46.93pt; position: absolute;">8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 54.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 54.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 55.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.220000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.28pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">58,051<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">94,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">36,398<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">63<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 125.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 125.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.33pt; position: absolute; text-decoration: none; white-space: pre;">............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">43,517<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">7,663<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">21<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 155.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 157.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 157.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 157.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 157.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 157.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.65pt; position: absolute; text-decoration: none; white-space: pre;">...............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">95,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.62pt;"></font></font><font style="left: 25.25pt; position: absolute;">112,154<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">17,043<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">18<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.22pt; position: absolute; text-decoration: none; white-space: pre;">................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">130,965<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">155,671<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">24,706<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 41.37pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 41.37pt; position: absolute;">19<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.71pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">11,692<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.04pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.04pt; position: absolute;">-16<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.489999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 97.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.69pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(19,237)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(18,702)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 42.07pt;"></font></font><font style="left: 44.7pt; position: absolute;">535<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 43.6pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 43.6pt; position: absolute;">-3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 87.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.86pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,957)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(16,449)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.52pt;"></font></font><font style="left: 24.15pt; position: absolute;">(13,492)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.81pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.81pt; position: absolute;">456<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 173.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 174.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 175.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.22pt; position: absolute; text-decoration: none; white-space: pre;">........<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,265)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">1.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 182.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 119.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 120.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 120.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 120.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.33pt; position: absolute; text-decoration: none; white-space: pre;">..............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">494<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 37.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 37.83pt; position: absolute;">-90<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 196.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 29.85pt;"></font></font><font style="left: 38.04pt; position: absolute;">(771)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.6pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.6pt; position: absolute;">0.8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 52.49pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 350.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue increased $38.6&#160;million, or&#160;44%, to $125.8&#160;million during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$87.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.44pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.01pt; position: absolute; white-space: pre;">. The increase in revenue was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily attributable to a 51% increase in revenue case volume, partially offset by a reduction in average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 406.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales price <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">due to a higher percentage of revenue cases generated from clinic and office-based accounts</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.71pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 426.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue and gross <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 200.79pt; position: absolute; text-decoration: none; white-space: pre;">margin<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue increased $2.2&#160;million, or&#160;8%, to $31.4 million during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 458.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$29.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.44pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.01pt; position: absolute; white-space: pre;">. This increase was attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 470.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$0.8&#160;million in allocated overhead, $0.5&#160;million in personnel and related expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.01pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.78pt; position: absolute; white-space: pre;"> $0.5&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of capitalized internal-use software, $0.4&#160;million in third-party hosting fees and a net change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of $0.3 million in capitalized and amortized contract fulfillment costs, partially offset by a $0.6&#160;million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decrease in royalties. Personnel and related expenses included $0.3&#160;million and $0.4 million of stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation costs during the year ended December 31, 2024 and 2023, respectively. Gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 530.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">margin for the year ended December 31, 2024 increased to&#160;75% as compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.43pt; position: absolute; text-decoration: none; white-space: pre;">67%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.44pt; position: absolute; white-space: pre;"> for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 542.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.15pt; position: absolute; text-decoration: none; white-space: pre;">The gross margin increase during the year ended December 31, 2024 was primarily <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 554.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">driven by increased revenue cases over the prior year and was aided by efficiency improvements, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 566.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">lowered the cost of revenue per analysis. The efficiency improvements included the release of new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 578.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">algorithms that automated the modeling of significant components of the coronary anatomy reducing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 590.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">manual components of our production teams&#8217; process, updated software that improved analyst efficiency, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 602.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">improved coaching and training, and other one-time efficiency projects. These improvements resulted in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 614.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">an approximate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.9pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.67000000000002pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">50% r</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.78pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">eduction to average per analyst case processing time, which lowered the cost of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 626.75pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">revenue per analysis. Gross margin during the year ended December 31, 2024, also benefited from a </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 638.75pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">temporary 100 b</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.78pt; position: absolute; text-decoration: none; white-space: pre;">asis point reduction in royalty rates. We expect that future new algorithm launches will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 650.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">have significantly less impact on automation increases and associated gross margin expansion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Research and development expenses increased $7.7&#160;million, or&#160;21%, to $43.5&#160;million during the year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 702.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.23pt; position: absolute; text-decoration: none; white-space: pre;">$35.9 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.34000000000003pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.12pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 500.91pt; position: absolute; white-space: pre;">. The <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">91<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase in research and development expenses was primarily attributable to an increase of $3.7&#160;million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 530.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in personnel and related expenses directly associated with an increase in headcount, $2.0&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consulting and professional fees, $1.2&#160;million in software-related costs, $0.5&#160;million in clinical trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">expenses and $0.5 million of capitalized internal-use software costs, partially offset by a $0.6 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">decrease in allocated overhead<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.92pt; position: absolute; white-space: pre;">. Personnel<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.47pt; position: absolute; text-decoration: none; white-space: pre;"> and related expenses included $2.2&#160;million and $3.3 million o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.25pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">f </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">stock-based compensation costs during the year ended December 31, 2024 and 2023, respectively. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses increased $17.0&#160;million, or&#160;18%, to $112.2&#160;million during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.45pt; position: absolute; text-decoration: none; white-space: pre;">$95.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.56pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.34pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.13pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The increase in selling, general and administrative expenses was primarily attributable to an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$13.5&#160;million in personnel and related expenses directly associated with an increase in headcount, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$5.3&#160;million in professional fees, including legal, audit and consulting fees, and $1.7&#160;million in marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses, partially offset by a decrease of $1.0 million in software-related costs and $2.9 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized commission costs. Personnel and related expenses included $7.8&#160;million and $8.7 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock-based compensation costs for the year ended December 31, 2024 and 2023, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense, net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Interest expense, net decreased to an expense of $18.7&#160;million during the year ended December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, compared to an expense of $19.2 million during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.56pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.35pt; position: absolute; white-space: pre;">. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decreased expense was attributable to more favorable interest rates under the 2024 Term Loan. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024 and 2023, the aggregate outstanding principal balance (including interest paid-in-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">kind) under our 2024 Term Loan was $138.1 million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.82pt; position: absolute; text-decoration: none; white-space: pre;">and $138.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.94pt; position: absolute; white-space: pre;">, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other expense, net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other expense, net increased to an expense of $16.4&#160;million during the year ended December&#160;31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to an expense of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.89pt; position: absolute; text-decoration: none; white-space: pre;">$3.0 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.44pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.01pt; position: absolute; white-space: pre;">. The increase was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily attributable to the remeasurement and recognition of the change in fair value related to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock warrant liability of $14.1 million. Other expense, net also included the remeasurement and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition of the changes in fair value related to our Convertible Notes through their conversion in March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023 and to the derivative liability through the 2024 Term Loan Refinancing (as defined below) in June <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Provision for income taxes was $547,000 and $53,000 for the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively, related to our foreign taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selected quarterly results of operations data<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth selected unaudited quarterly consolidated statements of operations data for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each of the four fiscal quarters during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.19pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.98pt; position: absolute; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.2pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.44pt; position: absolute; white-space: pre;"> and the fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarter ended March 31, 2025. The unaudited information for each of these quarters has been prepared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;), on the same basis as our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">audited annual consolidated financial statements included elsewhere in this prospectus and includes, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the fair statement of the results of operations for these periods. This data should be read in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conjunction with our consolidated financial statements and related notes included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">92<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. These historical quarterly operating results are not necessarily indicative of our operating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results for the full year or any future per<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.38pt; position: absolute; text-decoration: none; white-space: pre;">iod.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 108.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="17"><div style="left: 108.75pt; position: absolute; top: 0pt; width: 359.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.66pt; width: 359.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 292.76pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td></tr><tr style="height: 18.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 11.25pt; width: 108.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 11.25pt; width: 35.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 2.68pt; position: absolute; text-decoration: none; white-space: pre;">March 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 18.18pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 11.25pt; width: 35.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 6.64pt; position: absolute; text-decoration: none; white-space: pre;">June 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 18.18pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 3.57pt; position: absolute; text-decoration: none; white-space: pre;">September <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.86pt; position: absolute; text-decoration: none; white-space: pre;">30, 2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 5.73pt; position: absolute; text-decoration: none; white-space: pre;">December <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.86pt; position: absolute; text-decoration: none; white-space: pre;">31, 2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 11.25pt; width: 35.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 2.68pt; position: absolute; text-decoration: none; white-space: pre;">March 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 18.18pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 11.25pt; width: 35.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 6.64pt; position: absolute; text-decoration: none; white-space: pre;">June 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 18.18pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 3.57pt; position: absolute; text-decoration: none; white-space: pre;">September <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.86pt; position: absolute; text-decoration: none; white-space: pre;">30, 2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 5.73pt; position: absolute; text-decoration: none; white-space: pre;">December <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.86pt; position: absolute; text-decoration: none; white-space: pre;">31, 2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 11.25pt; width: 35.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 2.68pt; position: absolute; text-decoration: none; white-space: pre;">March 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 18.18pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 30pt; width: 108.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 30.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 30.779999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 30.86pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 30pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 4.26pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">18,844<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 30pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 4.26pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">21,412<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">22,753<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">24,165<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 30pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 4.26pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">26,843<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 30pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 4.26pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">31,054<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">32,934<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">34,977<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 30pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 4.26pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">37,205<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 108.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 39.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 39.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 39.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 39.550000000000004pt; position: absolute; text-decoration: none; white-space: pre;">......................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">11,314<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">13,978<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">15,851<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">16,908<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">19,423<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">23,839<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">24,937<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">26,250<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 41.25pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">27,941<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 108.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 80.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 81.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 81.52pt; position: absolute; text-decoration: none; white-space: pre;">..............<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 52.5pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">31,764<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 52.5pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">32,528<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 52.5pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">30,731<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 52.5pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">35,942<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 52.5pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">35,481<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 52.5pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">38,016<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 52.5pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">39,866<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 52.5pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">43,208<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 52.5pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 8.15pt;"></font></font><font style="left: 10.780000000000001pt; position: absolute;">45,443<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 108.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 67.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 69.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 69.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 69.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 69.25pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 63.75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 5.82pt;"></font></font><font style="left: 8.45pt; position: absolute;">(20,450)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 63.75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 5.82pt;"></font></font><font style="left: 8.45pt; position: absolute;">(18,550)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(14,880)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(19,034)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 63.75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 5.82pt;"></font></font><font style="left: 8.45pt; position: absolute;">(16,058)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 63.75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 5.82pt;"></font></font><font style="left: 8.45pt; position: absolute;">(14,177)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(14,929)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 63.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(16,058)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 63.75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 5.82pt;"></font></font><font style="left: 8.45pt; position: absolute;">(17,502)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 108.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 28.759999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 28.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 28.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 29.009999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 29.02pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 108.75pt; position: absolute; top: 75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 1.93pt;"></font></font><font style="left: 8.45pt; position: absolute;">(30,755)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 147pt; position: absolute; top: 75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 1.93pt;"></font></font><font style="left: 8.45pt; position: absolute;">(22,710)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 185.25pt; position: absolute; top: 75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(19,599)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 228pt; position: absolute; top: 75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(22,591)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 270.75pt; position: absolute; top: 75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 1.93pt;"></font></font><font style="left: 8.45pt; position: absolute;">(20,932)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 309pt; position: absolute; top: 75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 1.93pt;"></font></font><font style="left: 8.45pt; position: absolute;">(23,379)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 347.25pt; position: absolute; top: 75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(19,140)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390pt; position: absolute; top: 75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(32,975)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 75pt; width: 35.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 1.93pt;"></font></font><font style="left: 8.45pt; position: absolute;">(32,345)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 206.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Quarterly</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.43pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> trends</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Revenue</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Our quarterly revenue increased sequentially in each of the periods presented primarily due to revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">growth from the expansion of revenue cases volume within our existing installed base and the addition of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">new customers.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Cost of revenue and gross margin</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">With the exception of the three months ended September 30, 2023, cost of revenue generally increased </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">sequentially in each of the quarters presented, driven by increased sales. During the three months ended </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">September 30, 2023, cost of revenue decreased as we introduced the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.65pt; position: absolute; white-space: pre;">automation of certain manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">components of our production <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">teams p</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.55pt; position: absolute; white-space: pre;">rocess thereby resulting in decreased <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.44pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">personnel and related </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">expenses and allocated overhead.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Our quarterly gross margins have fluctuated between</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.98pt; position: absolute; white-space: pre;">&#160;60<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.87pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">% and</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.21pt; position: absolute; white-space: pre;">&#160;77<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">% in each period presented.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Total operating expenses have generally increased sequentially in each period presented with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exception of the three months ended September 30, 2023 and March 31, 2024. Operating expenses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fluctuated primarily due to t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">iming of consulting projects, legal and professional expenses, clinical studies, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 454.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">stock-based compensation and the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.79pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">capitalization of internal-use software costs</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.31pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 474.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidity and capital resources<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sources of liquidity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, we had $109.8&#160;million in cash and cash equivalents and an accumulated deficit of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$1.0&#160;billion, compared to $51.4 million in cash and cash equivalents and an accumulated deficit of $971.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million as of December 31, 2024. Since inception, we have primarily funded our operations with proceeds <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from sales of shares of our redeemable convertible preferred stock, common stock and convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promissory notes, borrowings under our term loans and revenue received from our customers, which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expect to be our primary source of future liquidity. During the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we incurred significant operating losses and net cash outflows from our operations, which resulted in an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase in stockholders&#8217; deficit, a reduction in working capital, and a net liabilities position as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024. On January 24, 2025 and January 31, 2025, we reduced our outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness under our 2024 Term Loan by $23.0 million, decreased our accrued cash compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within accrued expenses and other current liabilities to certain employees by $1.3 million, and also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received $24.0 million in cash in exchange for the issuance of $48.3 million in aggregate principal amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of 2025 Convertible Notes, as described below. In March 2025, we issued an additional $50.0 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate principal of 2025 Convertible Notes to an investor. As of March 31, 2025, we had $98.3 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding under our 2025 Convertible Notes and $115.1&#160;million outstanding under our 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which have respective maturities of 48 months from their issue date and June 14, 2028.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">93<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 105.31pt; position: absolute; text-decoration: none; white-space: pre;">credit agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, we entered into a Credit Agreement and Guaranty for a $138.1 million term loan to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">refinance the outstanding obligations under the initial credit agreement we entered into with Hayfin on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 19, 2021 and the additional term loans entered into with Hayfin on March 17, 2022 in exchange <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the payment of exit fees and early prepayment fees in the aggregate amount of $8.3 million payable in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sixteen equal quarterly installments, or immediately upon the occurrence of a financing event, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but not limited, to the completion of this offering. On January 24, 2025, in connection with the issuance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2025 Convertible Notes as further described below, we entered into Amendment No. 1 to the Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and Guaranty (as amended, the &#8220;2024 Credit Agreement&#8221;) to amend the terms and conditions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governing the term loan outstanding thereunder (as amended, the &#8220;2024 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.05pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan&#8221;). In connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the refinancing of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.09pt; position: absolute; text-decoration: none; white-space: pre;">original 2021 Credit Agreement with Hayfin<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.51pt; position: absolute; text-decoration: none; white-space: pre;"> with the 2024 Term Loan (the &#8220;2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan Refinancing&#8221;), we remeasured the fair value of the derivative liability immediately before the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan Refinancing and recognized a $0.2 million loss from the change in fair value in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consolidated statements of operations and comprehensive loss for the year ended December 31, 2024. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The associated current fair value of the derivative liability of $1.1 million, as remeasured at the date of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan Refinancing, was derecognized and recorded as a debt discount to the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">on the consolidated balance sheet.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan matures on June 14, 2028 and bears interest equal to the sum of (i) 7.0% (or 6.0% if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the alternative base rate (&#8220;ABR&#8221;) is in effect) plus (ii) the greater of (x) the forward-looking term rate based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on Secured Overnight Financing Rate (&#8220;SOFR&#8221;) for a respective tenor in effect on such day (or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alternative base rate, if applicable), and (y) 2.0%. The ABR equals to the sum of (i) 6.0% plus (ii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater of (1) the Wall Street Journal Prime Rate, plus 0.5%, (2) the Federal Reserve Bank of New York <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate plus 0.5% or (3) CBA Term SOFR for one month tenor plus 1.0%. We have an option to pay interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in-kind at the rate equal to the cash interest rate plus 1.0% through the last interest period ending before <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 18th month anniversary of the 2024 Credit Agreement. We have an option to prepay the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan subject to a prepayment fee of 1.5% for prepayments after the second anniversary but on or prior to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the third anniversary of the 2024 Term Loan and a prepayment fee of 3% for prepayments thereafter. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan must be repaid in full immediately upon the occurrence of a change in control. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay the 2024 Term Loan in an amount equal to the lesser of (i) the net cash proceeds of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering in excess of $150.0 million and (ii) $50.0 million (or $55.0 million if the underwriters exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any portion of their option to purchase additional shares).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Credit Agreement contains customary representations and warranties, events of default and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affirmative and negative covenants, including, among others, covenants that limit or restrict our (and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries) ability to incur additional indebtedness, grant liens, merge or consolidate, make acquisitions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pay dividends or other distributions or repurchase equity, make investments, dispose of assets and enter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into certain transactions with affiliates, in each case subject to certain exceptions. Financial covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require us to maintain a $15.0 million minimum liquidity balance in cash and cash equivalents at all times <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and minimum net sales for twelve consecutive month periods ending on the last day of a fiscal quarter, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which is not tested as long as the we maintain minimum liquidity of at least $60.0 million and there has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been no decline in net sales for two-consecutive fiscal quarters at the end of such fiscal quarter. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">minimum twelve months trailing net sales covenant increases each quarter and is $78.8 million for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarter ended June 30, 2024 up to a minimum net sales amount of $110.0 million for the quarter ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">June 30, 2025 and each quarter thereafter. Events of default in the 2024 Credit Agreement include, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representations and warranties, bankruptcy and insolvency events, material judgments, cross-defaults to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material contracts and events constituting a change of control. Upon the occurrence of an event of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">default, the interest rate applicable to the 2024 Term Loan shall increase by 3.0% per annum and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding principal balance, along with any accrued interest, shall become immediately due and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable. As of March 31, 2025, the aggregate outstanding principal balance under the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was $115.1 million and the effective interest rate was 15.2%. As of March 31, 2025, we were in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance with the 2024 Credit Agreement covenants.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">94<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the period from September 2022 through December 2022, we issued convertible promissory notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;2022 Convertible Notes&#8221;) to certain investors (the &#8220;2022 Convertible Notes Investors&#8221;), with an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate principal amount of $40.0 million. The 2022 Convertible Notes bore interest at a rate of 8% per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annum, compounded monthly. The aggregate principal amount and interest accrued on the 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes was due September 30, 2026, and could not be prepaid by us without the consent of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">majority of the 2022 Convertible Notes Investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, we completed a Qualified Financing (as defined in the 2022 Convertible Notes) and all of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2022 Convertible Notes, including principal and interest, were converted into 21,465,064 shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F-1 redeemable convertible preferred stock. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.74pt; position: absolute; text-decoration: none; white-space: pre;">In connection with the conversion of the 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes into the shares of our Series F-1 redeemable convertible preferred stock, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">derecognized the 2022 Convertible Notes in our consolidated balance sheet. We remeasured the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">value of the 2022 Convertible Notes immediately before the conversion and recognized a $5.1 million loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">from the change in fair value in the consolidated statements of operations and comprehensive loss for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.78999999999999pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.58pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, we issued convertible promissory notes to various investors and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees (the &#8220;Requisite Holders&#8221;) in the aggregate amount of $98.3 million,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.85pt; position: absolute; text-decoration: none; white-space: pre;"> which was comprised of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$74.0 million in aggregate principal amount of notes issued for cash consideration, $1.3 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate principal amount of notes issued in lieu of cash compensation to certain employees and $23.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million in aggregate principal amount of notes issued in the 2024 Term Loan Conversion (collectively, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;2025 Convertible Notes&#8221;). <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Th</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.46pt; position: absolute; white-space: pre;">e 2025 Convertible Notes are due and payable in full 48 months from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issue date. Upon completion of an IPO transaction, the 2025 Convertible Notes shall automatically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convert into shares of our common stock at the IPO price per share at the lower of a 20% discount and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valuation cap of $2.0 billion on a pre-money basis. In the event we complete a sale of shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, the Requisite Holders may elect to convert the outstanding 2025 Convertible Notes into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of such series of preferred stock at the same terms. Further, upon a change of control transaction, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Requisite Holders may elect to convert the outstanding 2025 Convertible Notes into shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock at the lower of a 20% discount to the implied price per share of common stock in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change of control transaction and a valuation cap of $2.0 billion on a pre-money basis, or receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment of all principal and any accrued but unpaid 2025 Convertible Notes paid in-kind (&#8220;PIK&#8221;) interest. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes do not accrue interest for one year following the date of issuance. Following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the one-year anniversary of the issue date and for the remainder of the term, the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest will accrue on an annual basis at the rate of 7.0% per annum. All PIK interest accrued and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable will be paid by capitalizing such interest on an annual basis and adding it to the outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal amount of the 2025 Convertible Notes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the issuance of the 2025 Convertible Notes, we entered into Amendment No.1 to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Credit Agreement, in which our lender, Hayfin, converted $23.0 million of principal under the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan to 2025 Convertible Notes under the same terms as the other purchasers of the 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance date estimated fair values of the derivative liability was $11.1 million and $20.8 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January and March 2025, respectively, which were recorded as debt discounts. The derivative liability was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasured to fair value of $40.9 million as of March 31, 2025, resulting in a loss of $9.0 million within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">95<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes our cash flows for each of the periods presented&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 112pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 82.4pt; position: absolute; text-decoration: none; white-space: pre;">Year ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 72.39pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.46pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 89.39pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 162.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 162.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.85999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(76,434)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(69,001)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(22,133)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(13,166)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 160.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 162.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 162.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.65pt; position: absolute; text-decoration: none; white-space: pre;">.............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,105)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(4,357)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(1,749)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(1,101)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 180.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 181.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 182.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 182.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 182.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.65pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">169,318<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">2,237<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.63pt;"></font></font><font style="left: 50.260000000000005pt; position: absolute;">77<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 28.18pt;"></font></font><font style="left: 30.81pt; position: absolute;">72,922<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 207.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 227.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.3pt; position: absolute; text-decoration: none; white-space: pre;">$76.4 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.40999999999997pt; position: absolute; white-space: pre;"> for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.06pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.85pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 239.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.95pt; position: absolute; text-decoration: none; white-space: pre;">$95.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.06pt; position: absolute; white-space: pre;"> and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.59pt; position: absolute; text-decoration: none; white-space: pre;">$8.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 251.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.33pt; position: absolute; white-space: pre;">, partially offset by non-cash charges of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.77pt; position: absolute; text-decoration: none; white-space: pre;">$27.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.88pt; position: absolute; white-space: pre;">. Non-cash charges primarily consisted of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 263.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$11.9 million in stock-based compensation expense, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.71000000000004pt; position: absolute; text-decoration: none; white-space: pre;">$5.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.26pt; position: absolute; white-space: pre;"> of change in fair value of convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 275.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.99pt; position: absolute; text-decoration: none; white-space: pre;">$4.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.54000000000002pt; position: absolute; white-space: pre;"> of depreciation and amortization, $2.8 million of amortization of debt discount and debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 287.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance costs, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.1pt; position: absolute; text-decoration: none; white-space: pre;">$2.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.65pt; position: absolute; white-space: pre;"> of change in fair value of common stock warrant and $0.9 million of non-cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 299.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest charges, partially offset by <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.21pt; position: absolute; text-decoration: none; white-space: pre;">$4.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.76pt; position: absolute; white-space: pre;"> of change in fair value of derivative liability. The net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 311.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in operating assets and liabilities primarily consisted of an increase of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.41pt; position: absolute; text-decoration: none; white-space: pre;">$9.4 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.96pt; position: absolute; white-space: pre;"> in accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 323.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receivable and a decrease of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.12pt; position: absolute; text-decoration: none; white-space: pre;">$1.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.67pt; position: absolute; white-space: pre;"> in operating lease liabilities, partially offset by an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 335.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$3.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: absolute; white-space: pre;"> in accrued expenses and other current liabilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 355.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities for the year ended December 31, 2024 was $69.0&#160;million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 367.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of $96.4&#160;million and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 379.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$10.9&#160;million, partially offset by non-cash charges of $38.3&#160;million.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.43pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The non-cash charges primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consisted of $10.2 million in stock-based compensation expense, $16.4 million of change in fair value of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">common stock warrant, $5.4 million of depreciation and amortization, $2.7 million of amortization of right-</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 415.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">of-use asset, $2.0 million of non-cash interest charges and $1.6 million of amortization of debt discount </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and debt issuance costs. The increase in net operating assets was primarily due to an increase of $3.8 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in accounts receivable, a $1.0 million increase in prepaid expenses and other current assets, a </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">$2.7 million increase in other non-current assets and a $3.2 million decrease in operating lease liabilities.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities during the three months ended March 31, 2024 was $22.1&#160;million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of $20.9&#160;million and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$6.8&#160;million, partially offset by non-cash charges of $5.6&#160;million.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.31pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The non-cash charges primarily consisted </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">of $2.7 million in stock-based compensation expense, $1.2 million of depreciation and amortization, $0.7 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million of amortization of right-of-use asset, $0.7 million of amortization of debt discount and debt </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">issuance costs, and $0.2 million of non-cash interest charges. The decrease in net operating assets was </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">primarily due to a $0.7 million increase in prepaid expenses and other current assets, a $0.3 million </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">increase in other non-current assets, a decrease of $1.5 million in accounts receivable, a $0.4 million </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">decrease in accounts payable, a decrease of $6.0 million in accrued expenses and other current </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">liabilities, and a $0.7 million decrease in operating lease liabilities.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities during the three months ended March 31, 2025 was $13.2&#160;million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of $32.3&#160;million and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.5&#160;million, partially offset by non-cash charges of $16.7&#160;million.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.87pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The non-cash charges primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consisted of $2.5 million in stock-based compensation expense, $9.0 million of change in fair value of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">derivative liability, $1.6 million of change in fair value of common stock warrant, $1.4 million of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 659.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">depreciation and amortization, $0.7 million of amortization of right-of-use asset, $0.5 million of non-cash </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">interest charges and $1.0 million of amortization of debt discount and debt issuance costs. The increase </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">in net operating assets was primarily due to an increase of $3.6 million in accounts receivable, a $0.4 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million increase in prepaid expenses and other current assets, a $0.3 million increase in other non-current </font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">assets, a $9.3 million increase in accrued expenses and other current liabilities, a $1.6 million decrease in </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">accounts payable and a $0.9 million decrease in operating lease liabilities.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in investing activities for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.4pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.19pt; position: absolute; white-space: pre;"> was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.51pt; position: absolute; text-decoration: none; white-space: pre;">$6.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.06pt; position: absolute; white-space: pre;"> consisting of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchases of property and equipment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash used in investing activities for the year ended December 31, 2024 was $4.4</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.96pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.73pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million consisting of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">purchases of property and equipment.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash used in investing activities for the three months ended March 31, 2024 was $1.7 million </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consisting of purchases of property and equipment.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash used in investing activities for the three months ended March 31, 2025 was $1.1 million </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consisting of purchases of property and equipment.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash provided by financing activities for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.41pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.2pt; position: absolute; white-space: pre;"> was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.52pt; position: absolute; text-decoration: none; white-space: pre;">$169.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.19pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily attributable to net proceeds of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.51pt; position: absolute; text-decoration: none; white-space: pre;">$169.0 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.18pt; position: absolute; white-space: pre;"> from the issuance of our Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash provided by financing activities for the year ended December 31, 2024 was $2.2</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.97pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.74pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">attributable to $4.6</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.76pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.53pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in proceeds from the exercise of stock options offset by payments of $2.3 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in exit, prepayment penalty and lender fees related to our 2024 Term Loan Refinancing.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash provided by financing activities during the three months ended March 31, 2024 consisted </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">primarily of $77,0</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.65pt; position: absolute; white-space: pre;">00 in proceeds from the exercise of stock options.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash provided by financing activities during the three months ended March 31, 2025 consisted </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.53999999999999pt; position: absolute; white-space: pre;">of $73.9 million in net proceeds from the issuance of our 2025 Convertible Notes, $0.6 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds from the exercise of stock options, offset by $0.5 million in exit and prepayment penalty fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to our 2024 Term Loan and $1.0 million in payments of deferred IPO offering costs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Future funding requirements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our current operating plan, we believe that the expected cash generated from revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions with customers and our cash and cash equivalents of $109.8 million as of March 31, 2025, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which includes the $75.3 million in proceeds from our January and March 2025 convertible promissory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notes offering, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.91pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">will be sufficient to fund our planned operating expenses and capital expenditure </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">requirements for at least the next 12 months. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.05pt; position: absolute; white-space: pre;">Our losses primarily resulted from the costs incurred in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development and sales and marketing of our products and providing general and administrative support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our operations. We expect to continue to incur losses and to expend significant amounts of cash in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future as we continue to scale our business, invest in research and development activities, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase sales and marketing efforts to support commercial expansion, and increase general and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative expenses to support being a publicly-traded company. Our ability to meet our short term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements and plans for cash do not include the net proceeds from this offering. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.54pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.12pt; position: absolute; white-space: pre;">have based our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate of future funding requirements on assumptions that may prove to be wrong, and we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deplete our capital resources sooner than we expect. We may experience lower than expected cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generated from operating activities or greater than expected capital expenditures, cost of revenue, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating expenses, and may need to raise additional capital to fund operations, further research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development activities, or acquire, invest in, or in-license other businesses, assets, or technologies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the long term, our ability to support our working capital and capital expenditure requirements will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depend on many factors, including the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the market acceptance of our products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">97<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing, scope, rate of progress, results and costs of our research and development activities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the number, scope and duration of current or future clinical studies and additional regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clearances or approval&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the effect of competing technological and market developments&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the costs and timing of future commercialization activities, including marketing and sales, f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.68pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">or </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.98pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis and any other new products&#894;</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the amount of revenue, if any, received from commercial sales of our Heartflow Plaque Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">any other new products&#894;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the impact of competitors&#8217; products and technological advances and other market developments&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the expenses needed to attract and retain skilled personnel&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the size of the markets and degree of market acceptance of any products in territories in which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">receive regulatory approval, including product pricing, product coverage, and the adequacy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement by third-party payors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Whether we acquire third-party companies, products or technologies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restructuring, refinancing or repayment of debt&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the increase in the number of our employees to support growth initiatives&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the cost of attaining, defending and enforcing our patents and other intellectual property rights&#894;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing of when we pay our operating expenses&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the costs associated with being a public company&#894; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other factors, including economic uncertainty, geopolitical tensions, healthcare reform <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.21pt; position: absolute; text-decoration: none; white-space: pre;">and changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">administration<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.22pt; position: absolute; text-decoration: none; white-space: pre;">, which may exacerbate the magnitude of the factors discussed above.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, our operating plans may change, and we may need additional funds to meet operational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">needs and capital requirements for clinical trials and other research and development expenditures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Should we obtain additional equity or debt financing to satisfy our liquidity needs, the issuance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional debt or equity securities could be dilutive to existing stockholders. Furthermore, any new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities could have rights that are senior to existing stockholders and could contain covenants that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would restrict operations. There can be no assurance that we will generate sufficient future cash flows <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from operations or that financing will be available on terms commercially acceptable to us or at all. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are unable to obtain future funding, we would curtail expenses by reducing some of our research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development programs and commercialization efforts in order to maintain liquidity, if necessary.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contractual obligations and commitments<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our contractual commitments will have an impact on our future liquidity. These commitments include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future payments on non-cancellable facility leases, purchase obligations related to research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development and professional services under non-cancellable contracts, royalty obligations for exclusive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology licensing agreements and future payments on our 2024 Term Loan and 2025 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes. Where applicable, we calculate our obligation based on termination fees that can be paid to exit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the contract. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Lease agreements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have operating lease arrangements for office space in Mountain View, California, Santa Rosa, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">California, San Francisco, California, Austin, Texas, and Tokyo, Japan. As of March 31, 2025 we had total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease payment obligations under non-cancelable leases of $27.5&#160;million, including $4.2&#160;million payable <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">98<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through December 31, 2025. See Note 6 to our consolidated financial statements included elsewhere in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Royalty payments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We entered into various exclusive technology licensing agreements that requires us to make annual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">royalty payments in fixed amounts as well as certain milestone and revenue-based payments. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025, the remaining aggregate royalty obligations under these agreements is $0.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 512.54pt; position: absolute; text-decoration: none; white-space: pre;">, of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">which minimum royalty obligations have been met for 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.98pt; position: absolute; white-space: pre;">. See Note 7 to our consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The principal balance on debt outstanding under our 2024 Term Loan as of March 31, 2025 was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$115.1&#160;million and approximately $10.0 million of interest is payable through December 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 500.68pt; position: absolute; white-space: pre;"> See <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Note 8 to our consolidated financial statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The principal balance outstanding under our 2025 Convertible Notes as of March 31, 2025 was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$98.3&#160;million. The 2025 Convertible Notes do not accrue interest for one year following the date of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance. See Note 9 to our consolidated financial statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recently issued accounting pronouncements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A description of recently issued accounting pronouncements that may potentially impact our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position, results of operations or cash flows is disclosed in Note 2 to our consolidated financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Critical accounting policies and estimates<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preparation of these consolidated financial statements requires us to make estimates and assumptions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates are based on our historical experience and various other factors that we believe are reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the circumstances, the results of which form the basis for making judgments about the carrying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of assets and liabilities that are not readily apparent from other sources. Actual results may differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from these estimates under different assumptions or conditions and any such differences may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our significant accounting policies are described in more detail in Note 2 to our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements included elsewhere in this prospectus, we believe that the following discussion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addresses our most critical accounting policies, which are those most important to our financial condition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and results of operations and require our most difficult, subjective and complex judgments.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have issued freestanding warrants to purchase shares of common stock in connection with our 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan. We classify these warrants as a liability because they do not meet the equity indexation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criteria. We record the fair value of the warrant on the consolidated balance sheet upon issuance and is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to remeasurement at each balance sheet date. The changes in the fair value of the warrants are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded in the consolidated statements of operations and comprehensive loss. We utilize the Black-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Scholes option-pricing model, which incorporates assumptions and estimates, to value the common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrant liability. Significant estimates and assumptions impacting fair value include the stock price, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractual term, expected volatility and weighted average risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The estimated aggregate fair value of the warrants issued in connection with the 2024 Term Loan in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 2021 and March 2022 was $4.3 million and $3.5 million, respectively. We recognized a $2.3 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $16.4 million loss from the change in fair value in the consolidated statements of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and comprehensive loss during the years ended December 31, 2023 and 2024, respectively. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized a $1,000 gain and $1.6 million loss from the change in fair value in the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss during the three months ended March 31, 2024 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the 2024 Term Loan Refinancing in June 2024, we determined that our 2024 Term Loan contained <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain prepayment features, default put option and default interest adjustment features that were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined to be embedded derivatives requiring bifurcation and separate accounting as a single <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compound derivative. The impact of bifurcation of the embedded derivative on the date of issuance was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflected as a debt discount. The instrument was classified as a liability on the consolidated balance sheet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and is subject to remeasurement at each balance sheet date. Any change in fair value of the derivative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability is recognized in the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We utilize both the Black-Scholes-Merton and option-pricing method, which incorporates certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions and estimates, to value the derivative liability. These include the estimated time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability of a business combination or IPO, default, change of control and incurrence of new debt, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">weighted common stock value, debt yield, expected volatility and risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The estimated fair value of the derivative liability was $2.1 million at the issuance date in January 2021. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We recognized a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.59pt; position: absolute; text-decoration: none; white-space: pre;">$4.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.14pt; position: absolute; white-space: pre;"> gain and $0.2 million loss from the change in fair value in the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.78pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.57pt; position: absolute; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.&#160; In connection with the 2024 Term Loan Refinancing on June 14, 2024, the associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current fair value of the derivative liability of $1.1 million, as remeasured at the date of 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Refinancing, was derecognized and recorded as a debt discount to the 2024 Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes were determined to contain certain settlement features and conversion put <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options which require bifurcation and separate accounting as a single compound embedded derivative. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the derivative liability was recorded at the issuance dates as debt discounts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reductions to the carrying value of the 2025 Convertible Notes on the consolidated balance sheet. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability is remeasured to fair value at each reporting period and the related changes in fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value are recorded on the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the derivative liability was estimated using a scenario-based analysis comparing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability-weighted present value of the 2025 Convertible Notes with and without the bifurcated features. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We utilize both the Monte Carlo Simulation and option-pricing method, which incorporates certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions and estimates, to value the derivative liability. These include the estimated time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability of an IPO and change of control, with resulting cash flows discounted using appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount rates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance date estimated fair values of the derivative liability was $11.1 million and $20.8 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January and March 2025, respectively, which were recorded as debt discounts. The derivative liability was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasured to fair value of $40.9 million as of March 31, 2025, resulting in a loss of $9.0 million within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stock-based compensation related to share-based awards granted to employees, consultants and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">members of our board of directors is measured at fair value. Compensation expense for those awards is <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">100<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized on a straight-line basis over the requisite service period, which is generally the vesting period. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For performance-based stock options, we assess the probability of performance conditions being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieved in each reporting period. The amount of stock-based compensation expense recognized in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one period related to performance-based stock options can vary based on the achievement or anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achievement of the performance conditions. We account for forfeitures of stock-based awards as they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">occur. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate the fair value of each option award on the date of grant using the Black-Scholes option -<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing model. This model requires the use of highly subject assumptions to determine the fair value, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Fair value of common stock.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> See the subsection titled &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.7pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">&#8212;</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.7pt; position: absolute; text-decoration: none; white-space: pre;">Determination of fair value of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected term.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.2pt; position: absolute; text-decoration: none; white-space: pre;"> The expected term represents the period that the stock-based awards are expected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be outstanding. The expected term for our stock options was calculated based on the weighted-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">average vesting term of the awards and the contract period, or simplified method.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.75pt; position: absolute; text-decoration: none; white-space: pre;"> Since we are not yet a public company and do not have any trading history for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock, the expected volatility was estimated based on the average historical volatilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock of comparable publicly traded entities over a period equal to the expected term of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock option grants. The comparable companies were chosen based on their size, stage of their life <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cycle or area of specialty. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.29000000000002pt; position: absolute; text-decoration: none; white-space: pre;"> The risk-free interest rate is based on the U.S. Treasury yield in effect at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">term of the awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected dividend yield.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.78pt; position: absolute; text-decoration: none; white-space: pre;"> The expected dividend yield is zero as we have not paid dividends nor do we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">anticipate paying any dividends on our common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to continue to grant equity-based awards in the future, and to the extent that we do, our stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation expense recognized in future periods will likely increase.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on the initial public offering price per share of $19.00, the aggregate intrinsic value of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding stock options as of March 31, 2025 was $120.5 million, with $93.1 million related to vested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock options.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">See Note 14 to our consolidated financial statements included elsewhere in this prospectus for further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">details.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Determination of fair value of common stock<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As there has been no public market for our common stock to date, the estimated fair value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock underlying our share-based awards was estimated on each grant date by our management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved by our board of directors. Our board of directors exercised reasonable judgment and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered a number of objective and subjective factors, as well as valuations prepared by independent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-party valuation firms. The methodologies used to estimate the enterprise value are performed using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methodologies, approaches and assumptions consistent with the American Institute of Certified Public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accountants Accounting and Valuation Guide, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 276.8pt; position: absolute; white-space: pre;">Valuation of Privately-Held-Company Equity Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Issued as Compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.01pt; position: absolute; white-space: pre;"> (the Practice Aid).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to considering the results of independent third-party valuations, our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered various objective and subjective factors to determine the fair value of common stock as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each grant date, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">contemporaneous valuations performed by independent third-party specialists&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">101<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the prices, rights, preferences and privileges of our redeemable convertible preferred stock relative to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">those of our common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the prices of common or preferred stock sold to third-party investors by us and in secondary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">transactions or repurchased by us in arms-length transactions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lack of marketability of our common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our actual operating and financial performance&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">current business conditions and projections&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our stage of development&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">likelihood of achieving a liquidity event, such as an initial public offering or a merger or acquisition of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our company given prevailing market conditions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the market performance of comparable publicly traded companies&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the U.S. and global capital market conditions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For our valuations performed, the allocation of these enterprise values to each our share classes utilized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the hybrid method. The hybrid method considered the stay private scenario and IPO exit scenario. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stay private scenario, three market methodologies were employed including (i) a market indexing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valuation analysis based on the Series F Preferred financing round, (ii) a guideline public company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysis based on historical and forecast operating metrics for us, and (iii) a guideline transaction analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on historical and forecast operating metrics for us. In the IPO exit scenario, the total equity value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was estimated based on the expected timing, offering size and pre-money valuation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The assumptions underlying these valuations represented management&#8217;s best estimate, which involved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly different assumptions or estimates, the fair value of our common stock and our stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation expense could be materially different.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Once a public trading market for our common stock has been established in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, it will no longer be necessary for our board of directors to estimate the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our common stock in connection with our accounting for share-based payments, as the fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock will be based on the quoted market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Off-balance&#160;sheet&#160;arrangements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the periods presented we did not have, nor do we currently&#160;have,&#160;any&#160;off-balance&#160;sheet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arrangements as defined in the rules and regulations of the SEC.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Quantitative and qualitative disclosures about market risks<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest rate risk<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, we had cash and cash equivalents of $109.8&#160;million. Our cash and cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents are held for working capital purposes. We do not enter into investments for trading or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">speculative purposes. Due to the short-term nature of our cash equivalents, we have not been exposed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to, nor do we anticipate being exposed to, material risks due to changes in interest rates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our exposures to market risk for changes in interest rates relate primarily to our 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(described above) which bears floating interest rates and a rising interest rate environment will increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the amount of interest paid on these loans. Each 100 basis point increase in these initial rates would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase annual interest expense by approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.78999999999996pt; position: absolute; text-decoration: none; white-space: pre;">$1.2&#160;million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 353.11pt; position: absolute; white-space: pre;">assuming the 2024 Term Loan remain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding for the annual period.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">102<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Credit risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our cash and cash equivalents, which at times may exceed federally insured limits, is maintained with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">large financial institutions. As of the issuance date of the financial statements included in this report, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have not experienced any losses on our deposits and all of our cash deposits have been accessible to us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our accounts receivable primarily relate to revenue from the sale of our products to medical providers.&#160;No <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer represented 10% or more of our accounts receivable as of December 31, 2023, 2024 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency exchange risk<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The vast majority of our cash generated from revenue is denominated in U.S. dollars, with a small amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">denominated in&#160;other foreign currencies. Our expenses are generally denominated in the currencies of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the jurisdictions in which we conduct our operations, which are primarily in the United States, United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom&#160;and&#160;Japan. Our results of operations and cash flows are, therefore, subject to fluctuations due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in foreign currency exchange rates. The effect of a hypothetical 10% change in foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange rates applicable to our business would not have had a material impact on our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements during any of the periods presented. As the impact of foreign currency exchange <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rates has not been material to our historical operating results, we have not entered into derivative or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hedging transactions, but we may do so in the future if our exposure to foreign currency becomes more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Effects of inflation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inflation generally affects us by increasing our cost of labor and overhead costs. We do not believe that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inflation has had a material impact on our business, results of operations, or financial condition, or on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Emerging growth company status<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company&#8221; under the JOBS Act, which permits us to take advantage of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extended transition period to comply with new or revised accounting standards applicable to public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies. We have elected to use this extended transition period until we are no longer an emerging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth company or until we affirmatively and irrevocably opt out of the extended transition period. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, our consolidated financial statements may not be comparable to companies that comply with new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or revised accounting pronouncements applicable to public companies. The JOBS Act also exempts us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from having to provide an attestation and report from our independent registered public accounting firm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2002.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We will remain an emerging growth company until the earliest of&#58; (i) the last day of the fiscal year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following the fifth anniversary of the completion of this offering&#59; (ii) the last day of the fiscal year in which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have total annual gross revenue of at least $1.235 billion&#59; (iii) the last day of the fiscal year in which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the last business day of the second fiscal quarter of such year&#59; or (iv) the date on which we have issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than $1.0 billion in non-convertible debt securities during the prior three-year period.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">103<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1189" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Business<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 129.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 141.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.25pt; position: absolute; white-space: pre;"> (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 153.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. As of March 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.42pt; position: absolute; text-decoration: none; white-space: pre;">, our Heartflow Platform has been used to assess CAD in more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 165.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">400,000 patients, including 132,000 in 2024 alone. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.13pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">W</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.38pt; position: absolute; white-space: pre;">e believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 177.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.6pt; position: absolute; text-decoration: none; white-space: pre;">AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.03pt; position: absolute; white-space: pre;"> and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 189.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 201.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 213.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 225.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 237.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 249.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 261.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.63pt; position: absolute; text-decoration: none; white-space: pre;">and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.38pt; position: absolute; white-space: pre;"> as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 285.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. In the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alone, the Centers for Disease Control (&#8220;CDC&#8221;) estimates that approximately 805,000 people suffer a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">heart attack each year. Despite significant advancements in therapeutic and interventional treatments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD remains a leading cause of death globally because healthcare systems generally lack scalable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods to efficiently detect, diagnose and quantify CAD at a personalized level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our analyses using Clarivate&#8217;s ProcedureFinder data repository, we estimate that there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 9.5 million non-invasive tests (&#8220;NITs&#8221;) in the United States in 2023 for patients experiencing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stable or acute chest pain, which we refer to as symptomatic CAD patients. These NITs primarily include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress tests, such as single-photon emission computed tomography (&#8220;SPECT&#8221;), echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positron emission tomography (&#8220;PET&#8221;), which infer the presence of heart disease based on how well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood is supplied to the heart, and do not measure the actual disease itself. Accordingly, these tests have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been shown to be unreliable and inconsistent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA has emerged as a leading non-invasive imaging method for evaluating CAD, offering direct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detailed visualization of the coronary arteries. Unlike traditional stress-based NITs, CCTA enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians to identify the presence and extent of coronary blockage. As a result, CCTA has become the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred first-line test for patients with suspected CAD, as evidenced by the AHA and ACC guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elevating CCTA to Class 1, Level A. However, while CCTA provides superior anatomical imaging, it does <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not independently quantify the severity of CAD, assess blood flow limitations, or characterize plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition&#8212;critical factors for determining the most appropriate, personalized course of treatment for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform builds upon the well established strengths of CCTA by going beyond its limitations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and providing new quantified insights and compelling visualizations of data. By applying our advanced AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered technology to a single CCTA scan, we generate a precise, patient-specific analysis that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quantifies blood flow, measures plaque burden, and characterizes plaque composition&#8212;at every point in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the major coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">104<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products (with a fourth product expected to launch in 2026) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the Heartflow Platform that provide physicians with the critical insights needed to effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review. We provide Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis to accounts as an integrated feature to enhance the efficiency of their CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">program and it is not a stand-alone product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.64pt; position: absolute; white-space: pre;">ractional flow reserve (&#8220;FFR&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.58pt; position: absolute; text-decoration: none; white-space: pre;"> value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.85pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, which we</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.5pt; position: absolute; white-space: pre;"> expect to launch in 2026,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.38pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> will provide advanced visualization and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">clinical insights to optimize revascularization strategies, guide device selection, enhance procedural </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">efficiency, and improve patient care. We plan to provide Heartflow PCI Planner to accounts as an </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">integrated feature to enhance procedural efficiency, not as a stand-alone product.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe we are the first and most widely-adopted AI-powered test for CAD. With over a decade of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial presence, we have established a competitively differentiated data set of approximately 110 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million annotated images, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.1pt; position: absolute; text-decoration: none; white-space: pre;">which is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.42pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driving training and refinement of our algorithms for over 10 years and the ability to train new AI models <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for future products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe our Heartflow Platform delivers the following key benefits&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.68pt; position: absolute; text-decoration: none; white-space: pre;">, clinically validated to provide superior assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">blood flow, plaque volume and plaque characterization compared to traditional non-invasive methods. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments, personalized care, and better risk stratification<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 452.03pt; position: absolute; text-decoration: none; white-space: pre;">, positively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impacting physician decisions on which patients should receive an intervention, supporting more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficient intervention planning and driving more personalized medical management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency and enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.25pt; position: absolute; text-decoration: none; white-space: pre;">, accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying more patients who need interventional treatment while reducing unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures&#8212;significantly improving the efficiency of the catheterization lab and therefore hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">economics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Proprietary, secure bi-directional data communication with customers <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: absolute; text-decoration: none; white-space: pre;">that feeds a growing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">database of approximately 110 million annotated CCTA images that we leverage to improve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.99pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, automation and clinical utility and seamlessly deliver new features and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">workflow efficiencies to our customers. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: absolute; text-decoration: none; white-space: pre;"> through our Heartflow RoadMap Analysis that, as demonstrated in our SMART-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CT study, reduces CCTA interpretation times by approximately 25% and reduces variability between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, leading to more consistent diagnoses and standardized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient care. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.66999999999996pt; position: absolute; text-decoration: none; white-space: pre;">, by leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">105<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; text-decoration: none; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.65pt; position: absolute; white-space: pre;">9.5 million unique stable chest pain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients receive NITs in the United States annually. In addition, based on our FORECAST randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial, we further estimate that 33% of patients have stenosis levels between 40% and 90%, which results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in approximately 2.8 million patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.68pt; position: absolute; white-space: pre;"> Analysis in the stable setting. Based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the Martin paper, where there were approximately 577,000 hospital discharges in the United States in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020 due to a principal diagnosis of acute chest pain, and the Bhatt paper, where No ST Elevation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSTE&#8221;) related acute chest pain accounted for approximately 70% of acute chest pain, we further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that the annual incidence of patients who have acute chest pain with NSTE is approximately 0.4 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million patients. Of these approximately 0.4 million patients, we estimate based on the Kofoed paper that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 70% have obstructive disease and are eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 439.17pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.83pt; position: absolute; white-space: pre;"> Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results in approximately 0.3 million acute chest pain patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 470.78pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, we believe there is a market opportunity of approximately 3.1 million patients eligible for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, which, at a U.S. average sales price of $1,067, translates to an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we believe our Heartflow Plaque Analysis is applicable to approximately 60% of those 9.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million NIT patients annually and the majority of patients experiencing acute chest pain. Based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PROMISE trial and the Hoffmann paper, we estimate that approximately 60% of CCTA patients have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque and are eligible for plaque analysis, which translates to approximately 5.1 million patients eligible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our Heartflow Plaque Analysis in a stable setting. Based on our internal analysis and the findings in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, where less than 5% of patients were expected to be contraindicated for CCTA, we also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that all of the approximately 0.4 million patients with acute chest pain with NSTE referred to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above will be eligible for our Heartflow Plaque Analysis. Therefore, we believe there is a market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of approximately 5.5 million patients eligible for our Heartflow Plaque Analysis, which, at an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated U.S. sales price of $300, translates to an estimated market opportunity of approximately an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incremental $1.7 billion in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.26pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally, based on data from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Census Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, the Yang paper and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the MacDonald paper. To unlock this potential, we are continuing to evaluate new product opportunities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and appropriate clinical evidence supporting eventual regulatory approval, payor coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most extensively studied AI-enabled test for CAD. Our belief is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounded in our analysis, including that the Heartflow Platform and its accuracy, clinical utility and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits have been evaluated in over 100 clinical studies and more than 130,000 patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our PRECISE and FORECAST trials, each a large randomized controlled trial, with results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published in over 600 peer-reviewed clinical publications. Our studies, including the PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials, have consistently demonstrated that the Heartflow Platform is more accurate than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional non-invasive tests and highly concordant to invasive testing, reduces unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">testing, and enables physicians to optimize treatment and ultimately provide more efficient care.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have developed a highly scalable, capital efficient commercial model that combines Territory Sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Managers (&#8220;TSMs&#8221;) who drive new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on increasing utilization by educating referring physicians. Our commercial team does not cover cases or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise spend time in an operating room or lab setting, which enables them to focus solely on driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial adoption and educational activities. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">106<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily workflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current clinical guidelines strongly support the adoption of the Heartflow Platform. The CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis pathway is supported by the American Heart Association (&#8220;AHA&#8221;) and American College of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiology (&#8220;ACC&#8221;) guidelines, with CCTA identified as a Class 1, Level A test and Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 500.55pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis identified as a Class 2a, Level B test for the diagnosis of CAD in certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD. The AHA and ACC guidelines utilize Classes and Levels to indicate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strength of a recommendation and the quality of supporting evidence, respectively. Class 1 represents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strongest recommendation, followed by Class 2a, which represents a moderate recommendation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, Level A signifies the highest quality of evidence, while Level B indicates moderate quality.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe current reimbursement policies support the adoption of the Heartflow Platform. Our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a dedicated Category I Current Procedural Terminology (&#8220;CPT&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">code, effective as of January 1, 2024, and has established coverage policies representing approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">99% of covered lives in the United States. A Category I CPT code was recently established for Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. It will go into effect on January 1, 2026, and is covered by all seven Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative contractor (&#8220;MACs&#8221;). A Category I CPT code designates a procedure or service that uses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device(s) with Food and Drug Administration (&#8220;FDA&#8221;) clearance or approval (when required), is performed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by many physicians across the United States for its intended clinical use, aligns with current medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice, and has documented efficacy in literature. The Category I CPT status for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 516.8399999999999pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 525.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis validates their widespread use and distinguish them from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">emerging technologies that are assigned Category III CPT codes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We primarily generate revenue on a &#8220;pay-per-click&#8221; basis each time a physician chooses to review either <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 153.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.24pt; position: absolute; white-space: pre;">Plaque Analysis, or both. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.97pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 429.39pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.05pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis has served <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">as our commercial foundation, representing 99% of our total revenue as of March 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.52pt; position: absolute; white-space: pre;">. In the second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">half of 2023, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.6pt; position: absolute; white-space: pre;"> Plaque Analysis, our second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial product. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.17pt; position: absolute; white-space: pre;">RoadMap Analysis is generally provided as a workflow efficiency tool <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to drive customer retention and loyalty and is not a stand-alone product. We expect to launch our next <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, Heartflow PCI Planner, in 2026 as an integrated feature to enhance procedural efficiency, not as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a stand-alone product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We have experienced significant revenue growth since we began commercializing the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in 2015. We recognized revenue of $125.8&#160;million for the year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">revenue of $87.2 million for the year ended December 31, 2023, representing&#160;44% year-over-year growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We recognized revenue of $37.2&#160;million for the three months ended March 31, 2025, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">revenue of $26.8 million for the three months ended March 31, 2024, representing&#160;39% growth over the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">prior year period. The software-based nature of our Heartflow Platform produces an attractive gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">margin profile, which continues to expand as we leverage AI to automate an increasing portion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;human-in-the loop&#8221; quality control process, where learnings are fed back into our algorithms to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">them smarter and more efficient. For the twelve months ended December 31, 2024, we generated gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">margins of&#160;75%, an increase of&#160;8&#160;percentage points year-over-year from December 31, 2023. Our net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">losses were $95.7 million and $96.4&#160;million for the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">respectively. Our accumulated deficit was $874.5 million and $971.0 million as of December 31, 2023 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024, respectively. For the three months ended March 31, 2025, we generated gross margins of&#160;75%, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increase of&#160;3&#160;percentage points over the three months ended March 31, 2024. Our net losses were $20.9 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">million and $32.3&#160;million for the three months ended March 31, 2024 and 2025, respectively. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">accumulated deficit was $1.0 billion as of March 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">107<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our success factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the continued growth of our company will primarily be driven by the following suc<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.53pt; position: absolute; text-decoration: none; white-space: pre;">cess factors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Differentiated approach to the non-invasive diagnosis and management of CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.25pt; position: absolute; text-decoration: none; white-space: pre;"> We are the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">first medical technology company authorized for marketing in the United States to leverage software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and AI to accurately and non-invasively diagnose and manage CAD using a single CCTA. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025, our Heartflow Platform has been used to assess CAD in more than<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.92pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> 400,000 patients, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including 132,000 in 2024 alone. Our Heartflow Platform applies AI and advanced computational fluid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">dynamics to generate a personalized 3D model of a patient&#8217;s heart, delivering actionable data on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">blood flow, stenosis, plaque volume and plaque composition. This enables physicians to diagnose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD, assess risk and develop individualized care plans without requiring an invasive procedure. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unlike traditional NITs that use surrogate measures to diagnose heart disease, which results in higher <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">rates of false negatives and false positives, as demonstrated by our PRECISE trial, the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform measures and quantifies the actual disease and has been proven to more accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnose CAD. Our proprietary database of approximately 110 million annotated CCTA images, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.99pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.49pt; position: absolute; text-decoration: none; white-space: pre;">growing daily, has fueled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ongoing AI-driven algorithm refinement for over a decade&#8212;enhancing our platform&#8217;s value for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients, physicians, and payors. Our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.42pt; position: absolute; white-space: pre;"> standard commercial agreements provide us with the right to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">use submitted images for product support and development. We perform regular updates and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">upgrades to the Heartflow Platform and don&#8217;t charge customers for the rollout of those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">enhancements. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.12pt; position: absolute; text-decoration: none; white-space: pre;">We believe the unique software technology attributes of our Heartflow Platform will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continue to support our commercial presence and help us establish the CCTA + Heartflow pathway as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the standard of care for the non-invasive diagnosis and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Market leader in AI-powered quantitative CAD analysis with strong customer relationships&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.35pt; position: absolute; text-decoration: none; white-space: pre;"> We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe our Heartflow Platform is the most widely adopted AI-powered test for CAD, to date, with an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">installed base of more than <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.76pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">1,100 a</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.1pt; position: absolute; text-decoration: none; white-space: pre;">ccounts in the United States as of December 31, 2024, reflecting a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAGR of 44% from December 31, 2021, including leading academic institutions, integrated delivery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">networks, physician offices and outpatient imaging centers. Our value proposition resonates across <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">multiple subspecialties, including radiology, cardiology, and interventional cardiology. Our deep <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">integration into customer workflows and IT infrastructure, including electronic medical record systems, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensures seamless utilization and efficiency. We believe our long-standing customer relationships, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continuously improving AI-powered software and the highly embedded nature of our customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">integrations will continue to support the rapid adoption of our Platform. Additionally, as we expand our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">AI capabilities, introduce new applications such as Heartflow Plaque Analysis, and further optimize <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">workflow integration, we expect our Platform&#8217;s value proposition to grow&#8212;deepening customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reliance on our solutions and accelerating broader market penetration.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Attractive revenue model with significant operating leverage potential&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.19pt; position: absolute; text-decoration: none; white-space: pre;"> We primarily generate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revenue on a scalable &#8220;pay-per-click&#8221; model, in which we charge per physician review of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, Heartflow Plaque Analysis, or both. Utilization rates for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 515.6800000000001pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.3399999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis typically scale rapidly after onboarding, approaching approximately 33% of CCTA tests within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an account&#8212;a level that is generally sustained over time. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.52pt; position: absolute; white-space: pre;">Utilization rates for an account are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">calculated as the number of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 279.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.6pt; position: absolute; white-space: pre;"> Analysis ordered divided by the total number of CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">tests performed at an account. Our TAMs measure this utilization rate in the first twelve months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">following the onboarding of a new account to ensure onboarding was successful. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.89pt; position: absolute; text-decoration: none; white-space: pre;">As CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow referral volumes increase, these stable utilization rates translate into increasing Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revenue cases. These aspects of our revenue model afford us significant predictability and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistency. Additionally, the AI-based nature of our software platform produces an attractive gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">margin profile that has improved over time as we have leveraged AI to automate an increasing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">number of the manual components of our &#8220;human-in-the loop&#8221; quality control process thereby <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lowering the cost of revenue per analysis.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.87pt; position: absolute; text-decoration: none; white-space: pre;"> For the twelve months ended December 31, 2024, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">generated gross margins of&#160;75%, an increase of&#160;8% year-over-year from December 31, 2023. For the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">three months ended March 31, 2025, we generated gross margins of&#160;75%, an increase of&#160;3 <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">108<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">percentage points over the three months ended March 31, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375pt; position: absolute; text-decoration: none; white-space: pre;"> Given our established relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and bi-directional data sharing infrastructure with customers, we also have the opportunity to add and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">rapidly scale revenue streams from new software products or indications, such as Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, with minimal additional setup and installation cost and effort for our customers. Since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis runs on the same CCTA scan as Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 418.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.26pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, we expect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">favorable operating and gross margin leverage as its adoption increases. We have also developed a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">highly scalable enterprise commercial model that combines TSMs who focus on driving new account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adoption with TAMs who educate referring physicians and drive increased volumes at accounts in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">installed base. Unlike traditional medical technology companies, our software is fully cloud-based, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">simple to implement, and does not require case coverage or on-site support. This streamlined, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">capital-light model enables us to scale efficiently while maintaining a lean commercial footprint. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe these structural advantages will enable us to continue investing in growth while advancing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">towards profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Large addressable market opportunity with a significant unmet need&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.07pt; position: absolute; text-decoration: none; white-space: pre;"> CAD is a leading cause of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">death and a highly prevalent condition worldwide with well-established pathways for diagnosis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">primarily through NITs. In the United States alone, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.25pt; position: absolute; white-space: pre;">based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.22pt; position: absolute; text-decoration: none; white-space: pre;">approximately 9.5 million NITs were performed for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnosis of CAD in 2023. However, the majority of these tests measure only surrogate markers for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD and are therefore often inaccurate leading to missed diagnosis or unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures. By contrast, CCTA imaging combined with our Heartflow Platform provides a more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accurate and actionable NIT for CAD, driving rapid adoption. We believe this approach will ultimately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">become the standard of care. Accordingly, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.68pt; position: absolute; white-space: pre;">based on our FORECAST randomized trial, our PROMISE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">trial, the Wang paper and the Hoffman paper, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.18pt; position: absolute; text-decoration: none; white-space: pre;">we believe our market opportunity represents the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155pt; position: absolute; text-decoration: none; white-space: pre;">8.6 million patients non-invasively tested for CAD in 2023 that are indicated for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis and Heartflow Plaque Analysis products based on their stenosis and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">levels, respectively, representing a market value of approximately $5&#160;billion in the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">alone. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120pt; position: absolute; text-decoration: none; white-space: pre;">While we have rapidly scaled the adoption of our Heartflow Platform to achieve $125.8&#160;million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of revenue in 2024, we believe the Heartflow Platform analyzed only approximately 10% of U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA volumes and represented less than 1% of all NITs in 2023, highlighting a substantial runway for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">growth. Looking ahead, we see the potential to expand both our geographic footprint and clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications. Beyond symptomatic CAD, we believe our technology can play a pivotal role in risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stratification and preventive therapy optimization for the approximately 200 million asymptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">individuals globally considered high risk for a cardiac event, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: absolute; text-decoration: none; white-space: pre;">based on data from the U.S. Census <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, the Yang paper and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.36pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Robust and compelling portfolio of clinical evidence&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.39pt; position: absolute; text-decoration: none; white-space: pre;"> We believe the Heartflow Platform is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">most extensively studied AI-enabled test for CAD. Our belief is grounded on our analyses, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.36pt; position: absolute; text-decoration: none; white-space: pre;">including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that the Heartflow Platform and its <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.25pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, clinical utility and economic benefits have been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluated in over 100 clinical studies and more than 130,000 patients,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.44pt; position: absolute; text-decoration: none; white-space: pre;"> including our PRECISE and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FORECAST trials, each a large randomized controlled trial, with results published in over 600 peer-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewed clinical publications. Our studies, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.52pt; position: absolute; white-space: pre;">including the PRECISE, NXT and PACIFIC trials,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.12pt; position: absolute; text-decoration: none; white-space: pre;"> have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistently demonstrated that the Heartflow Platform is more accurate than traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests and highly concordant to invasive testing, reduces unnecessary invasive testing, and enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians to optimize treatment and ultimately provide more efficient care. As a result, the clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evidence demonstrates that the Heartflow Platform reduces unnecessary invasive testing, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">enables physicians to make more informed revascularization decisions, delivering more efficient, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cost-effective care. For example, our PRECISE randomized controlled trial showed that our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was 78% more likely than traditional testing to identify patients in need of intervention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and 69% less likely to progress patients to unnecessary invasive testing, leading to 2x the yield of ICA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leading to revascularization such as percutaneous coronary intervention (&#8220;PCI&#8221;) or coronary artery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">bypass grafting (&#8220;CABG&#8221;), compared to standard care. This reduction in unnecessary diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures and higher rate of revascularization procedures represents a clinical benefit for patients <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">109<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and significant economic benefit for providers. We believe that our extensive body of clinical evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will drive continued adoption, and we expect to continue to invest in evidence generation that will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expand the applicability of our Heartflow Platform into new indications. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Established reimbursement coverage and favorable society support&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.92pt; position: absolute; text-decoration: none; white-space: pre;"> Our rapid growth is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underpinned by a favorable reimbursement landscape and strong clinical guidelines that drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adoption of the Heartflow Platform. Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 330.43pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.78pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is reimbursed under a dedicated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Category I CPT code, effective as of January 1, 2024, and has established coverage policies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">encompassing approximately 99% of covered lives in the United States. In addition, a Category I CPT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">code was also recently established for our Heartflow Plaque Analysis, set to take effect in January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2026. Heartflow Plaque Analysis is already covered by all seven local MAC regions, with five of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">seven MACs issuing final local coverage determinations (&#8220;LCD&#8221;). We expect to leverage our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">experience in establishing commercial policies for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 376.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.96pt; position: absolute; text-decoration: none; white-space: pre;">Analysis to efficiently establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">commercial coverage for our Heartflow Plaque Analysis. In addition, CCTA combined with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is supported by the AHA and ACC guidelines, with CCTA a Class 1, Level A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">test and FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 147.74pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.09pt; position: absolute; text-decoration: none; white-space: pre;">a Class 2a, Level B test for the diagnosis of CAD in <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.44pt; position: absolute; white-space: pre;">certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">acute chest pain and no known CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.66pt; position: absolute; text-decoration: none; white-space: pre;">. We believe our favorable reimbursement and society support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provides a strong foundation and tailwind for our continued growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unique and scalable AI, data and R&#38;D capabilities&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> We designed our AI-powered software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">platform to be high quality, highly scalable, integrate seamlessly with physician workflows and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improve as we ingest more data, and leverage that data to improve our algorithms&#8217; performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business efficiency. Our proprietary technology stack includes secure data transfer software, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">scalable cloud database, a web and mobile interface, quality review tools and an AI algorithm pipeline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that delivers diagnostic accuracy, utility, workflow efficiency, and operational scalability. By harnessing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">AI to process massive volumes of cases while maintaining a &#8220;human-in-the loop&#8221; quality control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">process, where learnings are fed back into our algorithms to improve their performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiency, we have been able to rapidly grow our platform while delivering accurate, timely results for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians and patients. We have also built a substantial and growing data asset that has driven <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ongoing refinement of our algorithms for more than 10 years with approximately 110 million annotated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA images. Additionally, our bi-directional data sharing relationship with our customers enables us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to deliver even greater value by ensuring they benefit from ongoing feature additions, workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">enhancements and performance improvements. Unlike traditional CAD diagnostic tools, our AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">platform can be updated with improved features, better performance and can improve from one of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">largest CCTA datasets globally, creating a competitive advantage that continues to grow over time. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We believe our differentiated AI, data and R&#38;D capabilities and proven dedication to improvement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensures that Heartflow remains at the forefront of precision coronary care. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Experienced leadership team&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.6pt; position: absolute; text-decoration: none; white-space: pre;"> Our senior management team consists of seasoned executives with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deep industry expertise across various disciplines, including biomedical and software engineering, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinical evidence, medical technology and medical imaging, AI, data science and sales and marketing. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">With backgrounds at leading medical technology companies, our leadership has a proven track <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">record of scaling businesses, securing market adoption and driving innovation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The convergence of AI advancements, cutting-edge imaging technologies, and broad-based guideline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adoption is accelerating a shift toward more precise, personalized approaches to cardiovascular care. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrating anatomical and physiological insights, our technology enables physicians to tailor therapies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more effectively, optimizing treatment decisions and improving patient outcomes. With Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 518.1600000000001pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.8199999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis reimbursement firmly established, growing physician acceptance, and a proven track record of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">real-world impact, Heartflow is well-positioned to lead the transformation of coronary care on a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scale.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">110<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our growth strategies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the following strategies will play a critical role in our continued growth&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expand adoption of our Heartflow Platform by new accounts&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.27pt; position: absolute; text-decoration: none; white-space: pre;"> We believe that all accounts with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an active CCTA program would benefit from adopting the Heartflow Platform into their workflow in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">order to improve efficiency and patient care. We estimate that as of December 31, 2023, there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approximately 2,700 hospitals and outpatient facilities in the United States that perform CCTA, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this target account base has grown at a 10% CAGR from 2018 to 2023, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.26pt; position: absolute; white-space: pre;">based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.84000000000003pt; position: absolute; text-decoration: none; white-space: pre;">. As of December 31, 2024, we have successfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deployed our Heartflow Platform in more than <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.84000000000003pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">1,100 ac</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.18pt; position: absolute; text-decoration: none; white-space: pre;">counts in the United States. Our TSMs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">responsible for acquiring new accounts. Our TSMs engage with physicians to communicate the value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">proposition of the Heartflow Platform, leveraging our large base of clinical evidence to extoll its clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and economic benefits. Once onboarded, providers typically reach utilization rates approaching 33% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of CCTAs eligible for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 248.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.4pt; position: absolute; text-decoration: none; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.62pt; position: absolute; text-decoration: none; white-space: pre;">. Unlike traditional sales models, our TSMs are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">required to support case coverage or ongoing account maintenance, allowing them to focus on new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">account acquisition efficiently.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.28pt; position: absolute; text-decoration: none; white-space: pre;"> We intend to drive further adoption by leveraging our existing 44 TSMs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">as of March 31, 2025, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;">while selectively expanding our team to capture additional geographic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Broaden awareness of the CCTA + Heartflow pathway to drive volume at existing accounts&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">While we have achieved significant commercial adoption to date, including 132<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.76pt; position: absolute; text-decoration: none; white-space: pre;">,000 patients <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.75pt; position: absolute; text-decoration: none; white-space: pre;">on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform in 2024 alone, we believe this represented less than 1% of our overall market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunity of 9.5 million total NITs, and approximately 10%, of current U.S. CCTA volumes. To <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expand adoption, we are actively educating physicians on the AHA and ACC chest pain guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that support CCTA plus Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.73pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.39pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis as the preferred pathway for diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management of CAD. Our commercial team includes TAMs who are responsible for educating the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cardiologists who refer patients to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.63pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">accounts in ou</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.08000000000004pt; position: absolute; text-decoration: none; white-space: pre;">r installed base and driving increasing Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform volumes. These TAMs utilize our extensive clinical compendium to educate and train <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians on the benefits of our platform. Similar to our TSMs, our TAM model is highly efficient and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">scalable. We also invest in robust medical education, including peer-to-peer discussions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">symposiums, podium presentations, and other educational events. These initiatives, combined with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">strong society support, our leading field presence, and continued technology investment, contribute to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the expansion of both the CCTA market and the CCTA + Heartflow pathway.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Launch and drive adoption of our Heartflow Plaque Analysis product&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.66pt; position: absolute; text-decoration: none; white-space: pre;"> We initiated l<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; text-decoration: none; white-space: pre;">imited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.1pt; position: absolute; text-decoration: none; white-space: pre;"> market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">education efforts for our second product, Heartflow Plaque Analysis, in the second half of 2023. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe there is broad recognition among the cardiology physician community of the importance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantifying and characterizing plaque composition as a key indicator of cardiovascular risk. Existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinical trials have demonstrated plaque volume and plaque composition correlate with heart attack <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">risk. There are also multiple pharmaceutical therapies that have proven to slow or halt plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">progression and reduce the risk of cardiovascular events. However, current non-invasive risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assessment methods are often inadequate due to their reliance on manual, time-consuming, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">largely visual assessments, leaving physicians with limited actionable data for prescribing optimal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">therapies. Our Heartflow Plaque Analysis fills this critical gap in care by enabling rapid and precise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantification of plaque volume and composition at the vessel and patient level, down to the cubic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">millimeter. We believe that broad commercial reimbursement coverage will be important for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">widespread adoption of Heartflow Plaque Analysis and are working to secure coverage. In 2024, CMS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assigned Heartflow Plaque Analysis a Category I CPT Code, which will be effective as of January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2026, and as of December 2024, Heartflow Plaque Analysis is covered by all MACs. We intend to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leverage our learnings from the successful reimbursement coverage expansion and commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">launch of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 197.73000000000002pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Analysis to drive commercial coverage and adoption of Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis. Since Heartflow Plaque Analysis runs on the same CCTA scan as Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 489.13pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.79pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, we expect favorable operating and gross margin leverage as its adoption increases.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.4pt; position: absolute; text-decoration: none; white-space: pre;">111<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Invest in additional clinical evidence to support adoption and expand our indications&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.66pt; position: absolute; text-decoration: none; white-space: pre;"> We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe we have developed the largest clinical evidence base supporting a non-invasive AI-powered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic for CAD and that our extensive evidence demonstrates the superior accuracy, clinical utility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and economic benefits of our Heartflow Platform relative to other non-invasive methods. We expect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continue to invest in clinical evidence to extend our leadership position. For example, we are currently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conducting the DECIDE registry, a 20,000-patient study which aims to demonstrate how Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis impacts physician decision-making. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.77pt; position: absolute; text-decoration: none; white-space: pre;">Beyond the commercialization of Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic CAD, we see a significant market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunity for our technologies in at-risk individuals who show no symptoms, a segment comprised <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of approximately 200 million people globally, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.14pt; position: absolute; text-decoration: none; white-space: pre;">based on data from the U.S. Census Bureau, CDC, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Eurostat, United Kingdom Office of National Statistics, the Yang paper and the MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.02pt; position: absolute; text-decoration: none; white-space: pre;">. To <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unlock this potential, we are continuing to evaluate new product opportunities and appropriate clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evidence supporting eventual regulatory approval, payor coverage and commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Extend our technology leadership through continued investment in our platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 470.71pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.04pt; position: absolute; text-decoration: none; white-space: pre;"> Our ongoing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">research and development initiatives are focused on introducing products, features and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improvements to maximize customer value. We prioritize advancements in four key areas including&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improving our algorithms by leveraging extensive clinical data to improve accuracy and efficiency&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimizing clinical utility to better support physicians in diagnosis, patient management, and treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">planning&#59; enhancing ease of use through seamless workflow integration to improve operational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiency&#59; and expanding our platform&#8217;s applications to serve a broader patient population. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">executing on these priorities, we aim to deepen engagement with existing customers, attract new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ones, and further solidify our leadership in AI-driven cardiovascular diagnostics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Leverage our platform to pursue adjacent and international markets&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.77pt; position: absolute; text-decoration: none; white-space: pre;"> We believe our installed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">base and deeply integrated <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.35pt; position: absolute; white-space: pre;">platform technology approach allows us to add on new analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">insights within the same product experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.88pt; position: absolute; text-decoration: none; white-space: pre;">. Our relationships with referring and imaging physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provide us with insights into unmet clinical and workflow needs, while our extensive database of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA images and AI capabilities enable us to develop and integrate new algorithm-based solutions. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Additionally, while our current commercial focus is on the U.S. market, we have an existing presence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the United Kingdom, European Union, Australia, Canada and Japan. In the future we may choose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to selectively expand our geographic footprint by strengthening our presence in existing international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">markets, entering new international markets, or exploring adjacent market opportunities in the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and abroad.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market overview and opportunity<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. Key risk factors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including high cholesterol, hypertension, smoking, diabetes, obesity, physical inactivity, and genetic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predisposition, accelerate plaque formation and destabilization. In the United States alone, the CDC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates that approximately 805,000 people suffer a heart attack each year<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.9pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.26pt; position: absolute; white-space: pre;">T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.36pt; position: absolute; text-decoration: none; white-space: pre;">he CDC estimates that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 1 in 20 adults over the age of 20 have CAD, which is approximately 12.5 million individuals <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">with CAD in the United States. The CDC also estimates that CAD killed 371,506 people in 2022. Given its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">morbidity and mortality, CAD places a significant cost burden on the healthcare system and is projected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reach $215 billion by 2035.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD is caused by the build-up of calcified and non-calcified plaque in the coronary arteries.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.29pt; position: absolute; text-decoration: none; white-space: pre;"> This plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">build-up results in a narrowing of the arteries, or stenosis, which may require an intervention<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.04pt; position: absolute; white-space: pre;"> if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction in blood flow caused by the stenosis is determined to be clinically significant. Effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosing CAD in order to inform the optimal treatment pathway requires a measurement of the blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">flow through the stenosis as well as quantifying the amount and type of plaque causing the stenosis. For <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">112<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, the foundational FAME 1 and FAME 2 randomized controlled trials showed that deferring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention is superior when blood flow, as measured by FFR, was greater than 0.80 but that when FFR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was below this same level, intervention was superior to optimal medical therapy. Similarly, a follow-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysis to the foundational SCOT-HEART trial showed that plaque volumes greater than 238 mm<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 503.77pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">3<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulted in a 7x greater risk of heart attack than lower plaque volumes and higher concentrations of low-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attenuation plaque burden were associated with a nearly 5x greater risk of heart attack. This is due to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unstable nature of low-attenuation plaque, which can result in a higher risk of rupture leading to occlusion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of coronary blood flow. Based on these trials, the cardiology community has recognized the importance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurately measuring FFR values and characterizing plaque, and has supported this perspective with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical guidelines that stratify treatment recommendations based on FFR values and plaque metrics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Traditional methods for the non-invasive diagnosis of CAD and their limitations<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When patients present with symptoms of CAD, such as chest pain, they are typically referred for a NIT. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are two primary types of NITs&#58; stress-based tests, which measure surrogate markers for CAD to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infer the presence of heart disease based on blood perfusion, or CCTA, which directly images the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s coronary arteries. Based on the output of a patient&#8217;s NIT, the imaging physician and managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physician determine the appropriate next step which can include sending the patient home with only <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lifestyle modifications if the disease is not determined to be significant, initiating pharmaceutical therapy if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">there is assumed plaque burden without significant stenosis, or sending the patient to catheterization lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for intervention if there is significant stenosis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When appropriately diagnosed and managed, CAD can be effectively treated with well-established <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">therapeutics and devices. These therapeutics, which include statins, PCSK-9s and GLP-1s, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">others, have been proven to effectively manage CAD by reducing plaque progression, changing plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition, and reducing the risks of a major adverse cardiovascular event. Similarly, when indicated, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures to open the arteries, including percutaneous coronary intervention with intravascular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lithotripsy, atherectomy and&#47;or stenting, and coronary artery bypass grafting, have been shown over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decades to be highly efficacious in reducing mortality risk and relieving the symptoms of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stress tests<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stress-based NITs include SPECT, PET and stress echocardiography. These tests use imaging to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluate heart function under exercise or pharmacologically-induced stress. The tests image the heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">muscles and identify the differences in blood perfusion to the myocardium between the rest and stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">state images to infer the presence of CAD. Stress-based NITs rely on surrogate markers of CAD to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deduce the disease in the coronary artery without actually assessing the coronary arteries or the disease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">itself. According to the 2010 Patel paper, which determined patterns of non-invasive testing and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic yield of catheterization among patients with suspected coronary artery disease, these NITs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inaccurate a majority of the time, and often result in either missed CAD diagnoses or <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.45pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">invasive<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.12pt; position: absolute; text-decoration: none; white-space: pre;"> procedures<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.91pt; position: absolute; white-space: pre;"> as demonstrated by our PRECISE trial. In the PRECISE trial, among those who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwent invasive catheterization, in the Usual Care arm (in which most patients initially underwent NIT) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">there was 60% incidence of finding no obstructive coronary disease upon catheterization, whereas in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Precision Care arm this incidence was only 20%. Finding no obstructive disease indicates that, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retrospect, the procedure was avoidable. As for missed CAD diagnoses, 5.2% of patients in the Usual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Care arm had diagnosis made of CAD requiring revascularization, where 9.2% of patients in the Precision <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Care arm had such diagnosis made. This indicates missed diagnosis of significant CAD in 4% of Usual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Care patients, and in approximately 43% of patients with significant CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result, approximately 20&#8211;50% of patients who undergo stress-based NITs go home with false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negatives, or undetected CAD that should have required an intervention, based on the Nakanishi paper <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Yokota paper. In addition, based on the 2014 Patel paper, up to 55% of patients receive false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positives and are sent to the cardiac catheterization lab for an invasive diagnostic angiography when an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention was never needed exposing patients to unnecessary risks including vascular injury and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">113<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bleeding complications. This results in significant additional costs to the healthcare system and poor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient experience.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 144pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 146.06pt; width: 324pt;" src="business1a.jpg" alt="business1a.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 263.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 3&#58; Traditional non-invasive tests. Left&#58; Stress echocardiogram. Right&#58; SPECT and PET<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">CCTA<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 303.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA is a high-resolution 3D imaging method that uses X-rays to produce detailed pictures of the heart&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 315.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arteries and other structures. CT imaging itself has been widely available and its use in cardiology is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 327.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growing rapidly. The analyses performed by our Heartflow Platform rely on CCTA images from third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CT manufacturers. Because CCTA images are used across multiple medical practices, by different <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical professionals and others, CT scanners have historically and currently output CCTA images in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard file formats rather than proprietary formats. In October 2021, the AHA and ACC elevated CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a first line Class 1, Level A test in the guidelines for certain patients with stable or acute chest pain and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no known CAD, above stress testing which is Class 1, Level B. This made CCTA a first line test for CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owing to the strong evidence supporting its differentiated clinical utility. As of December 31, 2023, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate there were approximately 2,700 sites with an active CCTA program in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 423.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, CCTA now has guideline support from the European Society of Cardiology Clinical Practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines on Chronic Coronary Syndromes (1B), is included in the National Institute for Health and Care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Excellence guidelines in the United Kingdom, and in the Japanese Circulation Society 2022 Guidelines in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Japan. We believe these guidelines further support the growth of CCTA tests outside the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and specifically in the European Union, United Kingdom and Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 491.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unlike stress-based NITs that rely on indirect functional assessments of heart muscle activity to infer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 503.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, CCTA enables direct visualization of the patient&#8217;s coronary anatomy and can allow for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive assessment of coronary stenosis and plaque burden. CCTA has been clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated in the SCOT-HEART trial to have the highest diagnostic performance of all traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive imaging tests for CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The foundational SCOT-HEART randomized controlled trial, highlighted the clinical superiority of CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over traditional stress-based NITs. The study found a significant 41% reduction in the rate of death or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-fatal heart attacks after five years in patients who underwent CCTA evaluations. The study also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated that patients in the CCTA group were more likely to be started on lipid lowering, anti-<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">114<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hypertensive, anti-platelet, and anti-anginal medication, which improved outcomes in patients with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disease that may not have been detected with stress-based testing alone. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 193.51pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 144pt; width: 224.98pt;" src="business2b.jpg" alt="business2b.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 261pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 4&#58; CCTA image<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With the elevation of CCTA to a Class 1, Level A guideline recommendation by the AHA and ACC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines in 2021, CCTA test volumes have grown at a 22% CAGR from 2018 to 2023 while SPECT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volumes have grown at a 2% CAGR over the same time period, based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 317pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.59pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.36pt; position: absolute; white-space: pre;"> We believe CCTA test volumes will continue to grow rapidly, ultimately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">replacing other NIT methods based on increasing awareness of the superior diagnostic accuracy, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">workflow efficiencies and clinical guideline recommendations. Furthermore, favorable reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trends are expected to accelerate adoption. In 2025, CMS reimbursement levels for hospital outpatient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA are set to increase by 104% based on the OPPS final rule, published in the Federal Register on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 27, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Catheterization lab-based invasive diagnostics for CAD<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Invasive methods of diagnosing CAD are typically performed in the catheterization lab and provide highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate assessments of blood-flow and plaque. However, they are not practical or cost-effective as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">first-line diagnostic due to procedural risks, patient discomfort, as well as cost and availability of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">catheterization lab time. As a result, these technologies are utilized downstream in the catheterization lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after a patient has been identified as having suspected CAD based on an NIT and referred for an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interventional procedure. Because of the invasive nature of these tests, they serve as valuable reference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">points for validating the accuracy of our technology, however, we do not directly compete with them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These invasive catheter-based procedures, which include FFR and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.87pt; position: absolute; text-decoration: none; white-space: pre;">Intravascular ultrasound (&#8220;IVUS&#8221;),<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been the reference standard for obtaining FFR values and assessing plaque burden for decades. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR requires inserting a pressure wire into the coronary arteries under stress conditions to assess the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">severity of blood flow restriction and IVUS uses a catheter-based ultrasound probe to directly image <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">plaque within the arteries.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 577pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our symptomatic CAD market opportunity<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that there were approximately 9.5 million NITs performed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the diagnosis of CAD in the United States in 2023. This includes an estimated 6.8 million SPECTs, 0.8 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million PETs, 1.2 million stress echocardiograms, and 0.7 million CCTAs, based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 659.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">115<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 181.01pt; width: 388.8pt;" src="business3e.jpg" alt="business3e.jpg"></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 266.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository&#59; &#126;73,000 U.S. Heartflow tests billed in FY23<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 283.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ZS NIT for CAD Market Assessment, Survey of 246 HCPs and 81 administrators, December 2024<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 5&#58; Pie chart of U.S. non-invasive test market<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA testing volumes have grown 22% between 2018 and 2023, based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, and we believe they will continue to outpace the broader NIT market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth driven by the recently established Class 1, Level A guidelines, due to superior clinical utility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to stress-based tests, and improved reimbursement. Of the approximately 9.5 million NITs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performed for the diagnosis of CAD in the United States in 2023, we believe, based on our FORECAST <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">randomized trial and the Wang paper, there were approximately 8.6 million patients that were addressable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for CCTA after accounting for layered testing due to the inconclusive nature of traditional tests and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 404.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">need for multiple re-tests and contraindications to CCTA<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.53pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform, which requires a CCTA image from a CT scanner to perform its analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly improves the clinical utility of CCTA and addresses the limitations of traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD testing by combining existing CCTA images with our AI algorithms to provide actionable data on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood flow, stenosis, plaque volume and plaque composition. This delivers superior clinical utility relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to other NITs and compelling economic benefits, which are supported by extensive clinical evidence. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, we believe the CCTA + Heartflow pathway will become the standard of care for the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosis of CAD over time.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">116<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Addressing the limitations of traditional CAD testing<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 92pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 180.1pt; width: 388.8pt;" src="business4f.jpg" alt="business4f.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 285.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 6&#58; Image of SPECT test result on left&#59; image of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 376.25pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 384.91pt; position: absolute; white-space: pre;"> Analysis result on right<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.49pt; position: absolute; white-space: pre;"> Analysis is reimbursed for use on any CCTA showing 40% to 90% stenosis, which, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our FORECAST randomized trial, we estimate to be approximately 33% of all CCTAs annually. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 245.14pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.8pt; position: absolute; white-space: pre;"> Analysis therefore is applicable to 33% of the NIT market and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">majority of patients experiencing acute chest pain, which represents 3.1 million patients and an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.33pt; position: absolute; white-space: pre;">Plaque Analysis is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursed for plaque identified on CCTA with 1% to 69% stenosis, which, based on our PROMISE trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Hoffmann paper, we estimate to cover approximately 60% of all CCTAs annually and a majority of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients experiencing acute chest pain. We believe that CCTA + Heartflow Plaque Analysis is therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable to 60% of the NIT market, which represents 5.5 million patients and an estimated market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of an incremental approximately $1.7 billion in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our current focus is on the United States and the Heartflow Platform has been cleared by the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(K213857), our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.42000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 205.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; white-space: pre;"> Analysis has commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom, European Union, Australia, Canada and Japan. The Heartflow Platform has also been cleared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the equivalent regulatory authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain. In the future we may expand our international presence beyond these markets and extend our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to additional indications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Asymptomatic CAD market opportunity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For asymptomatic patients, current clinical practice guidelines (Class 1, Level B) recommend using risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">factors such as age, sex, smoking status, hyperlipidemia, hypertension, and diabetes, among others, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculate a risk score, called an ASCVD score, for assessing overall cardiovascular event risk and guiding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventive therapy. However, this approach does not account for the actual disease state of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">individual&#8217;s arteries leading to imprecise risk assessment and suboptimal management. As a result, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">despite the widespread availability of proven, preventative pharmaceutical treatments, up to 25% of heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attacks occur in those with no symptoms and approximately 50% of sudden heart deaths occur without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any prior diagnosis or testing according to the Ni paper. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe there is a significant opportunity for our Heartflow Platform to materially improve risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stratification and patient management. Clinical data supports our belief that AI-based risk calculation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicated on the combination of individual-specific CAD measures enables more accurate and effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and preventative measures as compared to those based on an ASCVD score alone. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 685.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, our EMERALD 2 study showed that combining certain CCTA-derived quantitative features from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary physiology via <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.23000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.21pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 243.63pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.29pt; position: absolute; white-space: pre;"> Analysis and from plaque metrics via <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.03pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.01pt; position: absolute; white-space: pre;">Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicted future plaque rupture more accurately than CCTA alone. Serial AI-based risk assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">117<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">asymptomatic patients can also capture temporal changes in disease state and cardiovascular risk, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can be used to personalize preventative medical therapy over time. We estimate that there are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 200 million patients globally with a high risk of cardiovascular events, of which 71 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">live in the United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.5pt; position: absolute; white-space: pre;">based on data from the U.S. Census Bureau, CDC, Eurostat, United Kingdom <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Office of National Statistics, the Yang paper and the MacDonald paper. In the future, we believe certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sub-segments of this population may be appropriate candidates for our platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.95pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally. To unlock this potential, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are continuing to evaluate new product opportunities and appropriate clinical evidence supporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eventual regulatory approval, payor coverage and commercialization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our technology<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow enhances CCTA, the most advanced non-invasive imaging modality for assessing CAD, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI-powered analysis to deliver more accurate and clinically actionable insights for diagnosing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing CAD. The Heartflow Platform applies deep learning, an advanced form of AI, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computational fluid dynamics to CCTA images to create a personalized 3D model of a patient&#8217;s heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on a single CCTA image. This model provides actionable insights into blood flow, stenosis, plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume and plaque composition allowing precise diagnosis, risk stratification, and treatment planning &#8211; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the need for an invasive procedure. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CCTA + Heartflow pathway addresses the limitations of traditional non-invasive tests that only assess <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures for coronary disease and therefore result in higher rates of false negative and false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive CAD diagnoses, as demonstrated by our PRECISE trial. We believe the differentiated accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and clinical utility of the CCTA + Heartflow pathway will continue to support our growth and advance the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard for the non-invasive diagnosis and management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We designed our AI-powered software platform to be highly scalable, seamlessly integrate into existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physician workflows for diagnosing CAD, and improve as we ingest more data over time. By leveraging AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to process massive volumes of cases and a &#8220;human-in-the loop&#8221; quality control process, where learnings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are fed back into our algorithms to improve their performance and efficiency, we have rapidly scaled our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to deliver accurate, timely results to benefit physicians and patients alike. Our cloud-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology has enabled us to rapidly scale to an installed base of more than <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 410.87pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">1,100 accounts i</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 483.65pt; position: absolute; white-space: pre;">n the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States as of December 31, 2024, reflecting<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.4pt; position: absolute; text-decoration: none; white-space: pre;"> a CAGR of 44% from December 31, 2021<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.57pt; position: absolute; white-space: pre;">. We have also built <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a substantial and growing data asset that has driven refinement of our algorithms for over 10 years and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.33pt; position: absolute; text-decoration: none; white-space: pre;">of March 31, 2025, we have analyzed and annotated approximately 110 million annotated CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">images. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.22pt; position: absolute; white-space: pre;">Additionally, through our bi-directional data sharing relationship with our customers we ensure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform enhancements, delivering immediate and tangible benefits through new features, workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiencies, and improved performance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When a patient presents with symptoms of CAD and their physician follows the AHA and ACC Class 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level A chest pain guidelines by referring the patient for a CCTA, the patient will undergo standard CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">imaging at the relevant hospital or outpatient facility. At Heartflow-enabled accounts, CCTA images are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securely transmitted directly to our cloud-based platform through our embedded software in the hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or outpatient imaging center. Leveraging proprietary AI and advanced computational fluid dynamics, we <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">118<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized, 3D digital model of the patient&#8217;s coronary arteries, unlocking critical insights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beyond what is visible on standard imaging.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 148.88pt; width: 388.8pt;" src="business5d.jpg" alt="business5d.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 265.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 7&#58; The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 285.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform includes a suite of innovative, AI-powered products designed to deliver <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 297.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive coronary artery assessment&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.47pt; position: absolute; text-decoration: none; white-space: pre;"> Coronary anatomy modeling that enables clinicians to interpret CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accurately, efficiently and consistently while identifying whether the patient requires further evaluation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with our other products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 157.72pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 168.18pt; position: absolute; text-decoration: none; white-space: pre;">Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.61pt; position: absolute; text-decoration: none; white-space: pre;"> Accurate 3D model of blood flow that identifies clinically-significant CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at the lesion level to inform whether the patient requires revascularization and identifies which lesions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">should be addressed. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">3)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.25pt; position: absolute; text-decoration: none; white-space: pre;"> Precise quantification of plaque volume and plaque composition down <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to the cubic millimeter to help assess risk and determine optimal medical treatment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">4)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner&#58;</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.69pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Will provide advanced visualization and clinical insights to optimize </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.88pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">revascularization strategies, guide device selection, enhance procedural efficiency, and improve </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 461.88pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">patient care. We expect to launch this product in 2026</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.11pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These analyses provide the critical complementary data that are lacking from other non-invasive tests but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we believe physicians need to diagnose, assess risk and make optimal, patient-specific decisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.88pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about medical and interventional therapies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 525.88pt; width: 612pt;"><div style="left: 115.2pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 171.75pt; width: 381.6pt;" src="business6e.jpg" alt="business6e.jpg"></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 710.63pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 8&#58; The Heartflow Portfoli<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 210.26pt; position: absolute; text-decoration: none; white-space: pre;">o<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">119<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform seamlessly integrates into our customer workflows, providing clinically actionable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insights directly to the account in a median turnaround time of 1.6 hours, which we believe is sufficient for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the workflows of our customers. We deliver the Heartflow RoadMap Analysis automatically to the imaging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiologist or radiologist for every acceptable CCTA patient at our accounts to help drive more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA interpretation, workflows and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.65pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">revascularization strategies</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.76pt; position: absolute; white-space: pre;">. In conjunction with the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">RoadMap Analysis, we also provide physicians with a case list that catalogs all their CCTAs and identifies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the cases where our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.75pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 229.17pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.52pt; position: absolute; white-space: pre;">Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.26pt; position: absolute; white-space: pre;">Plaque Analysis or both would enable them to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurately diagnose clinically significant CAD and plan treatment. With a single click, Physicians can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">access these analyses on-demand, and we bill the account directly for each product selected. Because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.7pt; position: absolute; white-space: pre;">Plaque Analysis have distinct clinical indications and dedicated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">billing codes, our workflow helps ensure physicians can order the most appropriate analyses for each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient, supporting both high-quality care and efficient reimbursement processes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 224pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 168.5pt; width: 388.8pt;" src="business7e.jpg" alt="business7e.jpg"></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 405.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 9&#58; The Heartflow Platform and workflo<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 270.25pt; position: absolute; text-decoration: none; white-space: pre;">w<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform portfolio<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 445.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 120.3pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.14pt; position: absolute; text-decoration: none; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.72pt; position: absolute; text-decoration: none; white-space: pre;"> Heartflow RoadMap Analysis provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 167.94pt; left: 429.75pt; position: absolute; top: 452.33pt; width: 115.2pt; z-index: 1;"><div><div><div style="position: absolute;"><img style="height: 167.94pt; width: 115.2pt;" src="picture1number3a.jpg" alt="picture1number3a.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 457.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">highly intuitive anatomic visualization of the patient&#8217;s coronary anatomy based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">on CCTA images. It rapidly orients the imaging physician to clinically relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">areas of the patient anatomy and provides a preview of what they will review in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the native CCTA images to aid the physician in accurately, efficiently and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consistently identifying stenosis in the coronary arteries. Heartflow RoadMap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis supports more efficient radiology workflow, improving CCTA read <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">times by 25% and increasing consistency between reviewing physicians by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 541.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 40%, as demonstrated in our SMART-CT study. Physicians use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 553.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Roadmap Analysis as a first-line assessment tool along with CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 565.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">interpretation to determine whether to order our more detailed Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 577.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis or Heartflow Plaque Analysis reports. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.2pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow RoadMap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 589.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was cleared by the FDA in October 2022, and we began providing it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 601.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to our customers in the second quarter of 2023. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.74pt; position: absolute; text-decoration: none; white-space: pre;">We generally provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis to accounts as an integrated feature to enhance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the efficiency and consistency of their CCTA programs and it is not a stand-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">alone product. We believe the efficiency that Heartflow RoadMap Analysis provides our customers has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 649.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">resulted in enhanced customer loyalty and retention<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.89pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">120<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 139.72pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 150.18pt; position: absolute; white-space: pre;">Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.38pt; position: absolute; text-decoration: none; white-space: pre;">Our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.04pt; position: absolute; white-space: pre;"> flagship product, Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 357.31pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.66pt; position: absolute; white-space: pre;">Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 151.35pt; left: 429.75pt; position: absolute; top: 69.75pt; width: 115.2pt; z-index: 3;"><div><div><div style="position: absolute;"><img style="height: 151.35pt; width: 115.2pt;" src="ffrctanalysis2a.jpg" alt="ffrctanalysis2a.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of a patient-specific, interactive, 3D anatomical reconstruction of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary anatomy that identifies clinically significant CAD at every point in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">major coronary arteries to determine the need for intervention. The model is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">color-coded along vessel length, indicating Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 327.52pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.87pt; position: absolute; white-space: pre;">Analysis values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which assist the physician in rapidly and precisely assessing blood flow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through the coronary arteries. Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 289.7pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.05pt; position: absolute; white-space: pre;">Analysis has the highest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic accuracy for a non-invasive CAD test and has demonstrated a high <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">level of concordance to invasive FFR, as seen in our PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials. Our product can measure the FFR value and determine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whether a lesion is clinically significant &#8211; a &#8220;clinically significant lesion&#8221; means <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an FFR value of 0.80 or below. Because FFR values <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.37pt; position: absolute; text-decoration: none; white-space: pre;">are the guideline directed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">measure to determine <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.99pt; position: absolute; white-space: pre;">the need for invasive revascularization, this data offers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a more clinically accurate, non-invasive basis for determining the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interventional treatment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.43pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current AHA and ACC guidelines support CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.24pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 358.66pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.01pt; position: absolute; white-space: pre;">Analysis as a more efficient care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway. The guidelines designate CCTA as a Class 1, Level A test for CAD in certain patients with stable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or acute chest pain and no known CAD, with our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.6pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 353.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.37pt; position: absolute; white-space: pre;">Analysis given a Class 2a, Level B <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition to help physicians guide patient treatment decisions. This CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.84pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.82pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 481.24pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.59pt; position: absolute; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway enables physicians to identify lesions that require revascularization&#160;in less than two hours, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines recommend patients with positive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.32pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.3pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 334.72pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.07pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 382.29pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.09pt; position: absolute; white-space: pre;">findings be sent directly to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiac catheterization lab for possible treatment. Comparatively, AHA and ACC guidelines provide stress-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based testing a Class 1, Level B recommendation, suggesting patients with suspected CAD and positive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress-based test findings first initiate guideline directed medical therapy. Only if symptoms are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resolved by medical therapy, which can last weeks or months, are patients then sent to the cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">catheterization lab.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 400pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 156.15pt; width: 388.8pt;" src="business10d.jpg" alt="business10d.jpg"></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 569.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 10&#58; AHA and ACC chest pain guideline<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 274.74pt; position: absolute; text-decoration: none; white-space: pre;">s<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 589.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.18pt; position: absolute; white-space: pre;">Analysis is indicated for patients with stenosis levels between 40% and 90% in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vessel because a physician&#8217;s review of a CCTA alone may not appropriately identify the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment in these cases. For example, in the figure below, two patients with &#62;70% stenosis based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA alone would likely be referred for invasive coronary angiography (&#8220;ICA&#8221;). However, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 511.17pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 530.5899999999999pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis reveals that while Patient A has an FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 286.37pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.03pt; position: absolute; white-space: pre;"> value &#62;0.80&#8212;indicating no need for intervention&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">121<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patient B has an FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 167.5pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.16pt; position: absolute; white-space: pre;"> value &#60;0.80 and should be referred for revascularization. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.42pt; position: absolute; text-decoration: none; white-space: pre;">As of March 31, 2025, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis represented 99% of our total revenue.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 163.5pt; width: 388.8pt;" src="business11f.jpg" alt="business11f.jpg"></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 280.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Figure 11<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 114.22pt; position: absolute; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 119.75999999999999pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 164.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 184.16pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT&#160; <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 196.42000000000002pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 233.64pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 235.44pt; position: absolute; white-space: pre;">Significantly Improves CCTA &#8211; anatomy from CCTA + Physiology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 292.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 94.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 139.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 159.16pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 169.62pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 206.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 208.64pt; position: absolute; white-space: pre;">better informs clinical decision<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 341.95pt; position: absolute; text-decoration: none; white-space: pre;">s<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">122<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.92000000000002pt; position: absolute; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.67pt; position: absolute; white-space: pre;"> Plaque Analysis transforms coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 167.94pt; left: 426pt; position: absolute; top: 70pt; width: 115.2pt; z-index: 2;"><div><div><div style="position: absolute;"><img style="height: 167.94pt; width: 115.2pt;" src="picture4.jpg" alt="picture4.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque assessment from a time-consuming and variable manual process, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which is seldom clinically used, into a rapid, automated, and highly precise AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driven solution. The Heartflow Plaque Analysis automatically provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive 3D assessment of a patient&#8217;s coronary plaque, including a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">characterization of plaque types and quantification of plaque volumes at every <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">point in the major coronary arteries. The Heartflow Plaque Analysis has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">validated against the reference standard of invasive IVUS and shown to have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a 95% agreement with IVUS in quantifying total coronary plaque volume in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our REVEALPLAQUE study. Moreover, o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.41pt; position: absolute; text-decoration: none; white-space: pre;">ur current findings from the DECIDE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">registry show the Heartflow Plaque Analysis led to medical management <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">change in over half of patients beyond CCTA alone<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.8pt; position: absolute; white-space: pre;">. Because coronary plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume is a strong predictor of a patient&#8217;s risk of having a heart attack <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regardless of ASCVD risk score, coronary artery calcium (&#8220;CAC&#8221;) score, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stenosis, this data offers incremental predictive power over risk factors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stenosis alone and can aid the physician in optimizing medical management. Furthermore, only quantified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque analysis based on CCTA can assess non-calcified plaque, which has a higher risk for causing a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">heart attack as compared to calcified plaque. In contrast, while CAC scores also use a CT scan to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measure plaque, they estimate CAD risk based solely on calcified plaque. We believe that our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.97pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis is applicable to the approximately 60% of CCTA patients identified as having 1% to 69% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stenosis and adds significant value over review of CCTA alone, which is unable to precisely quantify or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">characterize the type or volume of plaque that would impact a physician&#8217;s treatment plan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.32pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis guides medical man<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 295.18pt; position: absolute; text-decoration: none; white-space: pre;">agement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 364pt; width: 612pt;"><div style="left: 111.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 173.37pt; width: 388.8pt;" src="business13d.jpg" alt="business13d.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 550.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 12&#58; Plaque is critical to guide medical management, regardless of FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 414.14pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 422.8pt; position: absolute; white-space: pre;"> results<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to its comprehensive plaque assessment capabilities, Heartflow Plaque Analysis incorporates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a nomogram derived from an extensive international cohort of over 11,000 patients. This nomogram <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stratifies coronary atherosclerotic plaque volumes by age and sex, providing physicians with a valuable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reference to contextualize individual patient data against population-based benchmarks. By leveraging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this tool, clinicians can more precisely assess a patient's CAD risk, facilitating personalized treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategies. This integration of large-scale data enhances the actionable insights delivered by Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis, supporting more informed clinical decision-making.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">Plaque Analysis was cleared by the FDA in October 2022. We began our limited market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">education efforts in the second half of 2023, and we expect to broaden our market education efforts as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 686.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">payor<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.01pt; position: absolute; white-space: pre;"> coverage for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.09pt; position: absolute; white-space: pre;">Plaque Analysis increases. We also anticipate our Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.37pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis to be included in updated cardiac imaging guidelines by radiology benefit manager EviCore by <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">123<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Evernorth, which provides coverage guidelines to leading commercial health insurers, effective October 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Heartflow PCI Planner<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.36pt; position: absolute; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.9pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner, which we</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.85pt; position: absolute; white-space: pre;"> expect to launch in 2026,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.73pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> will enable pre-PCI </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">assessment of coronary anatomy, lesion-specific physiology and plaque localization through an </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">interactive 3D model, combined in a single interface. The tool will provide interventional cardiologists with </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">advanced visualization and clinical insights to help answer critical questions for revascularization </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">strategies, such as which lesions to treat, how to treat them, the complexity of PCI, the need for calcium </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">modification, what ancillary tool to use and how to optimize stent quantity, size and placement. We expect </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow PCI Planner to offer procedural efficiency through advanced preparation, improved patient care </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">by ensuring optimal treatment at the right time and increased clinician confidence with detailed pre-</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">procedure knowledge. We plan to provide Heartflow PCI Planner to accounts as an integrated feature to </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">enhance procedural efficiency, not as a stand-alone product.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key benefits of our Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the unique features of our technology allow us to offer superior clinical utility and economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to our customers and the broader healthcare system. The key benefits offered by our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform include&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.01pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow products have been clinically validated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provide a more accurate non-invasive assessment of blood flow, plaque characterization and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">volume compared to traditional non-invasive tests, parameters that have been established to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">highly clinically relevant. Our prospective, core-lab adjudicated NXT trial demonstrated that Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is able to accurately calculate lesion-specific FFR values with a high level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">concordance to the invasive reference standard of FFR. In addition, our retrospective, core-lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adjudicated PACIFIC trial demonstrated that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 369.14pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.49pt; position: absolute; text-decoration: none; white-space: pre;">Analysis offered superior diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accuracy relative to CCTA alone as well as SPECT and PET. Individually and collectively, these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">studies support the differentiated level of precision that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 398.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.96pt; position: absolute; text-decoration: none; white-space: pre;">Analysis offers relative to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other non-invasive tests as well as its clinical reliability. Similarly, our prospective REVEALPLAQUE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study validated our Heartflow Plaque Analysis relative to the invasive reference standard of IVUS, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrating 95% agreement for overall plaque volume and excellent agreement in identifying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">plaque volume and sub-types at the lesion level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments and personalized care&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 422.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.95pt; position: absolute; text-decoration: none; white-space: pre;">Analysis has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinically demonstrated in multiple studies to positively impact physician decisions on intervention and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient management. The ADVANCE prospective registry which included over 5,000 patients globally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">showed that in 67% of cases physicians changed their patient management plans, predominantly with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">respect to revascularization, based on review of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 368.26pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.61pt; position: absolute; text-decoration: none; white-space: pre;">Analysis relative to CCTA alone. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Similarly, our DECODE study, which included 100 patients, demonstrated that in 66% of cases <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians changed preventative medical therapy plans based on a review of Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis relative to CCTA alone. Further supporting the value of our Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">product, among patients with a CAC score of 0, physicians revised their management plan to a more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">aggressive therapy approach in nearly 50% of cases after reviewing our Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">report. In 63% of cases in the DECODE study, physicians increased the dosage of the patient&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">medication, indicating that patients were being under-treated based on conventional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">testing methods that fail to both quantify and characterize plaque volumes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 319.28pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.63pt; position: absolute; text-decoration: none; white-space: pre;">Analysis has been clinically demonstrated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reduce rates of false positive CAD diagnoses relative to other non-invasive tests and more accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identify the patients that actually need an invasive procedure. Our PRECISE prospective randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">controlled trial which enrolled over 2,100 patients and compared Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 440.5pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.85pt; position: absolute; text-decoration: none; white-space: pre;">Analysis with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">standard of care, demonstrated that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 332.7pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.05pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was 78% more likely to identify <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients in need of revascularization and showed a 69% reduction in false positives, or unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ICA tests. It also showed 2x the yield of ICA leading to a revascularization procedure such as a<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.24pt; position: absolute; text-decoration: none; white-space: pre;"> PCI or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CABG.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.08pt; position: absolute; text-decoration: none; white-space: pre;"> These are economically important procedures for our customers which, when done in place of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">124<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a diagnostic only catheterization, result in more efficient use of valuable cardiac catheterization lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">facilities and staff time. As a result, our calculations based on the PRECISE trial indicate that net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">average cardiac catheterization lab revenue increase<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.47pt; position: absolute; text-decoration: none; white-space: pre;">d 20%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.36pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow RoadMap Analysis offers significant workflow benefits, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improving workflow efficiency by reducing CCTA interpretation times. Our SMART-CT study <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated that the use of our Heartflow RoadMap Analysis reduced read time by approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">25%. In addition to reducing read times, our Heartflow RoadMap Analysis enhances consistency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">across a radiology program resulting in a more than 40% increase in inter-reader agreement. Given <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the intense demands on radiologist time resulting from an increasing number of images to review on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">daily basis, we believe this added efficiency and consistency strengthens the competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">differentiation of our platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 298.7pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.03pt; position: absolute; text-decoration: none; white-space: pre;"> Once the patient is diagnosed with clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">significant CAD and referred to the catheterization lab for an intervention, our Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provides information that is useful to interventional cardiologists in planning for the most efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">treatment based on individual anatomy and disease s<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.12pt; position: absolute; text-decoration: none; white-space: pre;">tate.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.55pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform enables early, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">detailed pre-operative planning, allowing physicians to triage patients to the most appropriate site of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">service&#8212;whether a hospital-based catheterization lab or an outpatient interventional center. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying the complexity and severity of disease in advance, our technology ensures that high-risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients receive care in fully equipped facilities, while lower-risk cases can be efficiently managed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outpatient settings, reducing strain on hospital resources. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.52pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow&#8217;s 3D model provides a precise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">preview of the anatomy corresponding to specific views used in invasive catheterizations. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.74pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.72pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis provide quantitative and visual insights on lesion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">severity, plaque burden and type, and hemodynamic significance, which enable more precise pre-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">selection of interventional tools. This allows catheterization labs to be better prepared with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">necessary guidewires, catheters, and adjunctive devices before the procedure, thereby reducing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">inefficiencies. With growing demand for complex structural heart procedures&#8212;such as transcatheter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">aortic valve replacemen<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.56pt; position: absolute; text-decoration: none; white-space: pre;">t, left atrial appendage c<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.2pt; position: absolute; text-decoration: none; white-space: pre;">losure, and transcatheter mitral interventions&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">catheterization lab capacity is increasingly a constraint for hospitals. By reducing unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic angiograms and increasing the efficiency of PCI planning, we believe the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform frees up catheterization lab time for these higher-acuity, resource-intensive procedures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276pt; position: absolute; text-decoration: none; white-space: pre;"> By leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. A fundamental challenge with traditional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stress-based testing is the lack of a definitive diagnosis, which often results in a cascade of follow-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests. Stress tests frequently produce inconclusive or false-positive results, requiring additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">imaging studies such as cardiac catheterization to confirm or rule out disease. This layered testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approach prolongs the diagnostic journey, delays appropriate treatment, and adds unnecessary costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and inconvenience for patients. The Heartflow Platform offers an entirely digital and non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">experience that better serves both patients and providers. The CCTA + Heartflow Pathway provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fulsome array of insights with only a single patient exam. All results can then be viewed and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">distributed digitally to all of the patient&#8217;s care providers. In addition, our platform offers the flexibility to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">add new visualizations, insights and updates as the technology evolves, and physicians can receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the benefits of these updates conveniently through the same software platform. For example, when <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis and Heartflow Plaque Analysis were introduced, our accounts were able <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to access these technologies through the same connection infrastructure and platform that they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">utilized for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 202.70999999999998pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.06pt; position: absolute; text-decoration: none; white-space: pre;">Analysis without the need to buy new equipment or establish new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">connections. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">125<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our production process<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our production process involves a sophisticated and highly refined system that combines advanced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">machine learning algorithms with &#8220;human-in-the loop&#8221; quality control process, where learnings are fed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">back into our algorithms to improve their performance and efficiency. After the CCTA test is complete, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s images are securely transferred to our cloud-based system through our established software that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrates directly into the account&#8217;s infrastructure. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When the images arrive, we leverage multiple machine learning algorithms which have been trained from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a database of millions of annotated CCTA images to precisely segment CCTA data and extract patient-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific 3D anatomy, which includes the coronary tree, myocardium and other anatomic features. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality of CT images and the anatomy extracted by our algorithms is inspected through propriety software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that guides quality-oriented production analysts through each step to review and potentially correct the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">segmentation, as needed. Our machine learning algorithms then utilize any analyst inputs to generate a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">final 3D model of the coronary vessels. Our algorithms then compute stenosis, plaque volumes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque characteristics as well as blood flow simulation with computational fluid dynamics over the entire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary tree. The simulated blood flow and pressures allow calculation of quantitative <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.21pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.19pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 520.61pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis values at every point on the coronary tree. Once complete, our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.38pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.36pt; position: absolute; white-space: pre;">RoadMap Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.75pt; position: absolute; white-space: pre;">Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.17pt; position: absolute; white-space: pre;">Plaque Analysis are securely delivered directly to the physician in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">multiple formats&#58; an interactive web experience where they can explore the data in detail, PDF <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summaries, and direct delivery into the electronic medical record. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The corrections and changes from the analyst quality inspection step are stored in a database as labels <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for training our algorithms. New and improved versions of our algorithms using the latest machine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">learning methodologies are trained with incrementally more labels and released over time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporated into our platform. The core algorithms for the 3D coronary anatomic model and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.08pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis are now on their 3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 221.75pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">rd<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.52pt; position: absolute; white-space: pre;"> generation with improvements over time. This iterative approach of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combining improved algorithms with human quality control processes continues to enhance the accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and efficiency of our technology. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have also invested significantly in automating our production process through improved algorithm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance, visualization, and internal workflow enhancements, which have materially reduced our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analyst processing times from 69 minutes in 2021 to 26 minutes in the fourth quarter of 2024, significantly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enhancing our margin profile.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Our data security<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform relies on industry-leading security controls, including encryption at rest and in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transit, multi-factor and single-sign on authentication, granular authorization and a secure development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lifecycle. We have designed the Heartflow Platform to de-identify data for processing, ensuring the most <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identifiable sensitive data (including PHI) remains segregated, encrypted, and within source regions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limiting privacy and security risk. Our commitment to information security is demonstrated by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HITRUST, ISO 27001, and SOC 2 Type II certifications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our clinical results and economic evidence<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most studied AI-enabled test for CAD. The accuracy, clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utility and economic benefits of our Heartflow Platform have been evaluated in over 100 clinical studies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and more than 130,000 patients, including our PRECISE and FORECAST trials, each a large randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">controlled trial, with results published in over 600 peer-reviewed clinical publications. Collectively, this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extensive body of clinical evidence has supported regulatory approvals for our products, established <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broad payor coverage and society guideline inclusion for our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.44pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 405.86pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.52pt; position: absolute; white-space: pre;"> Analysis, and is driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rapid commercial adoption of our portfolio of products. We have sponsored 50 of the 100 clinical studies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and are continuing to invest in evidence that highlights the clinical utility and economic benefits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis to support expansion of payor coverage and commercial adoption. In the future <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">126<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may also invest in clinical studies of the Heartflow Platform to expand indications to broader <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">populations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our clinical programs have been focused on (i) validating the accuracy and reproducibility of our product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offerings relative to invasive reference standards and non-invasive alternatives, (ii) establishing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">differentiated clinical utility of our products relative to non-invasive alternatives, and (iii) demonstrating the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits associated with our products including reduced costs for payors and improved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency for providers. Our studies, including the PRECISE, NXT and PACIFIC trials, have consistently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated that the Heartflow Platform is more accurate than traditional non-invasive tests and highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concordant to invasive testing, reduces unnecessary invasive testing, and enables physicians to optimize <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment and ultimately provide more efficient care. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.35pt; position: absolute; text-decoration: none; white-space: pre;">The &#8220;p-values&#8221; noted below indicate the measure of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the study&#8217;s &#8220;statistical significance,&#8221; which refers to the likelihood that a result or relationship is caused by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">something other than random chance or error. The &#8220;p-value&#8221;&#160; indicates the probability value that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">results observed in a study were due to chance alone. A p-value of &#60; 0.05 is generally considered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">statistically significant, meaning that the probability of the results occurring by chance alone is less than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">five percent. The lower the p-value, the less likely that the results observed were random.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">None of the studies discussed below that collected adverse event data related to the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reported adverse events related to the Heartflow Platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 160.25pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 168.91pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;">Accuracy and reproducibility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197pt; position: absolute; white-space: pre;">&#58; Numerous foundational clinical trials in cardiology, including the FAME 1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and FAME 2 RCTs have demonstrated that FFR values are the most accurate predictors of the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention in patients with CAD. Key clinical studies that have supported the accuracy and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reproducibility of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.54000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.51999999999998pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.6pt; position: absolute; white-space: pre;"> Analysis relative to invasive FFR testing and non-invasive alternatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">NXT (2014)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.98pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.97pt; position: absolute; text-decoration: none; white-space: pre;">-sponsored<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.99pt; position: absolute; text-decoration: none; white-space: pre;"> NXT trial was the was the basis for de novo 510(k) FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clearance of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.62pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.28pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis. It was a prospective, blinded, core-lab adjudicated trial in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which CCTA was performed prior to non-emergent <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.77pt; position: absolute; text-decoration: none; white-space: pre;">ICA<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.87pt; position: absolute; text-decoration: none; white-space: pre;"> in stable patients with suspected CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis values based on the CCTA were compared to invasive FFR values. The trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">also compared the efficacy of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 286.97pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.63pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis relative to CCTA alone for predicting FFR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">values. NXT studied 254 patients who were scheduled to undergo clinically indicated ICA and who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">had CCTA performed within 60 days before ICA or who agreed to undergo CCTA within 60 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">before ICA and studied 484 vessels at 10 centers in Europe, the United Kingdom, Japan, Korea, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Australia. The results showed that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 307.5pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.15999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis is highly accurate compared to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reference standard of invasive FFR, with a per vessel accuracy of 86% compared with 65% for CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">alone (p &#60; 0.001). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PACIFIC (2019)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> The PACIFIC trial was an investigator-initiated, prospective study funded by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Company to evaluate in a head-to-head manner the diagnostic performance of several non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests commonly used to identify functionally significant CAD. At a single site in the Netherlands, a total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of 208 patients with suspected stable CAD underwent CCTA, SPECT and PET, and then used ICA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with invasive FFR as the reference standard. The Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 375.26pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.92pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was not initially included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the PACIFIC study, but the investigators subsequently undertook a retrospective PACIFIC FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 517.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.27pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sub-study to evaluate the diagnostic performances of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 391.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.26pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis compared to CCTA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">SPECT, and PET. Using invasive FFR as the reference standard, the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 460.95pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.61pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated the highest diagnostic performance for vessel-specific ischemia of all tested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">noninvasive tests, with an AUC (Area Under the Curve) of 0.94 compared with PET (0.87), CTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(0.83), and SPECT (0.70) (p &#60; 0.001 for all).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;">Differentiated utility, improved clinical and economic outcomes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.59pt; position: absolute; white-space: pre;">&#58; Numerous studies have demonstrated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that use of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.42pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.4pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 185.82pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.48000000000002pt; position: absolute; white-space: pre;"> Analysis favorably impacts clinical management, supporting physicians in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making more informed and better patient-specific decisions about intervention which drives more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">127<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use of resources. Key company-sponsored clinical studies that demonstrated the impact of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis on clinical decision-making, outcomes and provider and payor economics include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCE (2018)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored ADVANCE prospective registry studied 5,083 patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at 38 centers across the United States, United Kingdom, Europe, and Japan whose CCTA showed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD, in order to determine whether the incremental addition of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 434.33pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.99pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis resulted in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">change in patient management.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.78pt; position: absolute; text-decoration: none; white-space: pre;">Results at 90 days showed that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 438.82pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.48pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis findings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">drove a change in management plan for 67% of patients and that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 444.38pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.04pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#62;0.80 did not have any reported major adverse cardiovascular events compared to those with values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">0.80 or below who experienced higher rates of major adverse cardiovascular events (p &#60; 0.01) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">despite overwhelmingly non-invasive patient management. Additionally, CCTA-based stenosis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">severity was determined to be a poor predictor of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 373.8pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.46pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis values, demonstrating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that CCTA alone was not as effective for clinical decision-making. A review of outcomes at one year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">showed that physician management decisions were safe and durable and that deferral of an invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedure based on Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 246.09pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.75pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was safe and appropriate, as it was highly unlikely to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">result in a later revascularization or adverse clinical event.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PRECISE (2023)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.85pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored PRECISE trial was a prospective randomized controlled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study conducted at 65 centers across the United States, Canada, the United Kingdom, and Europe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which compared decision-making and outcomes based on a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 460.04pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.7pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway with the &#8220;usual care&#8221; pathway which involved alternative non-invasive or invasive testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">methods chosen by the clinician, such as <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.43pt; position: absolute; white-space: pre;">exercise electrocardiogram, stress echocardiogram, stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">nuclear myocardial perfusion imaging (single-photon emission CT or positron emission tomography), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">stress cardiovascular magnetic resonance imaging, or catheterization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.66pt; position: absolute; text-decoration: none; white-space: pre;">. The study included 2,103 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">participants without known CAD or prior testing and had a median follow up of 11.8 months. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study found that, compared with the &#8220;usual care&#8221; pathways, CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 456.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.73pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">78% more likely to identify patients in need of revascularization (p &#60; 0.001), and resulted in a 69% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reduction in diagnostic-only ICA. The net effect of this pathway was 2x the yield of ICA leading to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revascularization procedure, from 30.5% of cases to 71.9% of cases. As a result, our internal analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">based on the PRECISE data demonstrated a 20% increase in net revenue for the cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">catheterization lab, on average. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PLATFORM (2015)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.5pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored PLATFORM trial was a prospective controlled study of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sequential cohorts that enrolled 584 patients across 11 centers in the United Kingdom and Europe. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The study assessed the clinical and economic impacts of using a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 481.09pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.44pt; position: absolute; text-decoration: none; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway to select patients with stable, new onset chest pain for ICA. The study compared outcomes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">between cohorts with a &#8220;usual care&#8221; invasive pathway to a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 450.53pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway. The study found that the CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 344.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.71pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis pathway reduced the rate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary ICA by 83% from 73% to 12% (p &#60; 0.0001) and showed a 23% reduction in costs at 90 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">days and a 32% reduction (p &#60; 0.0001) in costs at one year based primarily on the avoidance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary invasive procedures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our clinical portfolio includes 10 studies and over 25 peer-reviewed publications specific to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.74pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. These studies and publications, which include large, multi-center, international trials, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document the performance, accuracy and clinical utility of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.6pt; position: absolute; white-space: pre;">Plaque Analysis as well as its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive impact on the physician&#8217;s ability to assess risk and manage outcomes. By providing more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate and detailed information on plaque types and volumes than can be achieved with traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests or risk measures, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.18pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.15999999999997pt; position: absolute; white-space: pre;">Plaque Analysis supports more appropriate, precise medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.89pt; position: absolute; text-decoration: none; white-space: pre;">Key studies that support the clinical benefits of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.16pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.14pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">REVEALPLAQUE (2024)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.15pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored REVEALPLAQUE study demonstrated the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accuracy of Heartflow Plaque Analysis relative to IVUS, the accepted reference standard for coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">plaque measurement and characterization. REVEALPLAQUE was a prospective, blinded, core-lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adjudicated trial that enrolled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.54pt; position: absolute; text-decoration: none; white-space: pre;">237 patients<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.99pt; position: absolute; text-decoration: none; white-space: pre;">, with 432 lesions, in the United States and Japan and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">128<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared coronary plaque quantification and characterization between Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and IVUS. The study showed that Heartflow&#8217;s Plaque Analysis results for total plaque volume, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">calcified plaque, and non-calcified plaque were strongly correlated with IVUS measurements, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">achieving 95% agreement with IVUS.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">DECODE (2024)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.75pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored DECODE study evaluated the impact of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis on clinical decision-making using data from 100 patients who underwent CCTA. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each case, three cardiologists with expertise in reading CCTA and preventive therapies aligned on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management plan based on patient demographics, clinical history, and the CCTA alone. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cardiologists were then provided with Heartflow Plaque Analysis for the same patients and asked to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determine a management plan. The results showed that the use of Heartflow Plaque Analysis led to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in treatment plans for 66% of patients, including 63% of patients who had medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management up-titrated. The likelihood of changing the management plan increased with higher CAC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">scores and was more pronounced in patients with significant coronary stenosis&#59; however, even 50% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of patients with a CAC score of 0 had a revised management plan with Heartflow Plaque Analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCEPLAQUE (2024)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 212.72pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.05pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.64pt; position: absolute; text-decoration: none; white-space: pre;">The ADVANCEPLAQUE<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.16999999999996pt; position: absolute; text-decoration: none; white-space: pre;"> study is a retrospective analysis of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCE trial after 1-year follow up (see above for more information related to our Company-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sponsored ADVANCE trial). In a multi-variate analysis of the data, high total plaque volume as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identified by Heartflow Plaque Analysis was shown to be an independent predictor for the risk of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adverse clinical cardiac events. In addition, the risk of an adverse cardiac event was shown to be 2x <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">higher in patients where Heartflow Plaque Analysis showed a higher total plaque burden compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">those with a lower plaque burden.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">EMERALD 2 (2024)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.41pt; position: absolute; text-decoration: none; white-space: pre;">&#58; The EMERALD 2 study, funded by the Company, enrolled 351 patients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">presented with acute coronary syndrome, including specifically-identified culprit plaque rupture, within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">3 years following a CCTA across the United States, Canada, Denmark, Italy, Hungary, Belgium, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Australia, Japan and South Korea. The study sought to investigate the additive value of AI&#8211;enabled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantitative coronary plaque analysis together with hemodynamic&#160;analysis as predictors of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent plaque rupture. The study showed that adding the CCTA-derived, AI-enabled measures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">derived from FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 167.74pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.4pt; position: absolute; text-decoration: none; white-space: pre;"> and Plaque Analyses predicted plaque rupture more accurately the reference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">model of CCTA alone (p &#60; 0.001).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">DECIDE<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.75pt; position: absolute; text-decoration: none; white-space: pre;">&#58; Based on the success of our DECODE study, which supported CMS coverage for Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis, we initiated in <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.41pt; position: absolute; text-decoration: none; white-space: pre;">March 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.2pt; position: absolute; text-decoration: none; white-space: pre;"> the DECIDE registry, a prospective real world analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">measuring the impact of Heartflow Plaque Analysis on changes in treatment decisions compared to CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">alone or alternative non-invasive tests. In contrast with DECODE in which physicians retrospectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">identified revised patient management plans, physicians in our DECIDE registry will use Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis information to implement real world patient management changes, with medical management <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">changes being defined to include a treatment modification, such as initiating, discontinuing or changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">dosage for a preventative or anti-ischemic therapy, additional laboratory testing, a referral for a specialist, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">or undergoing stress testing or ICA between 90 and 180 days post-CCTA. The study&#8217;s primary endpoint is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">change in medical management following Heartflow Plaque Analysis, performed <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.53pt; position: absolute; white-space: pre;">90 days after the CCTA<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 530.64pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and made available to the clinician already treating the patient<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.87pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 351.41pt; position: absolute; text-decoration: none; white-space: pre;">compared to the initial medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">management plan determined by the clinician based on the CCTA alone, and the secondary endpoint will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">examine changes in key outcomes including death, heart attack, revascularization, cardiovascular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">medication changes and cardiovascular hospitalizations at both 90-days and one-year follow-up. DECIDE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">was initiated in March 2024 and we expect to enroll approximately 20,000 patients across over 30 sites in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the United States. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.63pt; position: absolute; text-decoration: none; white-space: pre;">As of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.39pt; position: absolute; text-decoration: none; white-space: pre;">&#160;March 31<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.83pt; position: absolute; text-decoration: none; white-space: pre;">, 2025, we have enrolled over 10,000<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 385.28pt; position: absolute; text-decoration: none; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.05pt; position: absolute; text-decoration: none; white-space: pre;">patients. Our current findings from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the DECIDE registry show the Heartflow Plaque Analysis led to medical management change in over half <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of patients beyond CCTA alone, demonstrating a high clinical utility in guiding individualized management <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of patients. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.64pt; position: absolute; text-decoration: none; white-space: pre;">We believe that the outcomes of the DECIDE registry will support expanded commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">payor coverage and continued adoption of Heartflow Plaque Analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">129<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Company sponsored or funded clinical studies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The table below summarizes the results of additional clinical studies of the Heartflow Platform that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have sponsored or funded to date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 124pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 249pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Koo et al. (2011)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12.75pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">American <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">College of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cardiology<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12.75pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">DISCOVER-FLOW study<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Bon-Kwon Koo, James K. Min, Bjarne L. N&#248;rgaard, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Seoul National University Hospital<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 103<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; Prospective, multicenter trial sponsored by the Company, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">aimed at evaluating the diagnostic performance of non-invasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">fractional flow reserve derived from CCTA in assessing the functional <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significance of coronary artery disease. The study involved patients <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">with suspected CAD who underwent CCTA and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.47pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 248.45pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 266.90999999999997pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 275.13pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 137.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, with results compared to invasive FFR as the reference <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">standard.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.13pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 213.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 231.57pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 239.79pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 180.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated high diagnostic accuracy in identifying functionally <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 192.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significant coronary stenosis, with improved diagnostic discrimination (p <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 203.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#60; 0.001) compared to CCTA alone. These findings support the potential <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.169999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 58.150000000000006pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 76.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 84.83pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis as a reliable non-invasive method for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 226.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assessing coronary artery disease, offering a promising alternative to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 238.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">invasive FFR for guiding clinical decision-making.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 305.25pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261.75pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Morris et al. (2024)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 261.75pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cardiovascular <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Tomography<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 261.75pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">SMART-CT 2.0<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Michael F. Morris, Mahesh Chandrasekhar, Harish Gudi, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Banner University Medical Center, Phoenix<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 120<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; The Company-sponsored SMART-CT 2.0 study (also <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">referred to as the SMART-CT study) was designed to evaluate the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">effectiveness of an AI-informed coronary stenosis quantification tool, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">known as AI-CSQ, in assisting the interpretation of CCTA. This tool, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">aims to reduce the time required for CCTA interpretation, while <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 137.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">maintaining or enhancing the accuracy and confidence of the readers. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 148.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The study involved 120 CCTAs from patients at 2 sites with stable chest <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 160.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">pain or symptoms of CAD. These were analyzed by six readers of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 171.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">varying experience levels, including cardiologists and radiologists, to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 182.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">determine the impact of AI-CSQ on interpretation time, diagnostic <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 194.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, and inter-reader variability.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 213.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that the use of AI-CSQ significantly <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 225.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">decreased the overall time required for CCTA interpretation by 25.8%, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 236.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">regardless of the reader's experience level (p &#60; 0.001). It also improved <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 247.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">inter-reader agreement and boosted reader confidence in diagnosing <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 259.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">coronary artery disease. These findings underscore the potential of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 270.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">advanced AI tools like AI-CSQ to enhance the efficiency and reliability <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 282.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of CCTA interpretation in clinical practice, addressing challenges such <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 293.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">as time-consuming post-processing and variability in reader accuracy.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">130<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 318pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Curzen et al. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(2021)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12.75pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">European Heart <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12.75pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">FORECAST<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Nick Curzen, Zoe Nicholas, Beth Stuart, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Multiple centers across the United Kingdom<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 1,400<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; The FORECAST (Fractional Flow Reserve Derived from <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed Tomography Coronary Angiography in the Assessment and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Management of Stable Chest Pain) study, funded by the Company, was <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">a prospective, randomized controlled trial across 11 sites, designed to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assess the clinical and economic impact of using CCTA combined with <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 137.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis in the management of patients presenting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">with stable chest pain. The study compared this approach to standard <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">care pathways that did not include <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 193.74pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 212.2pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 220.42pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, aiming to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 172.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">determine its effectiveness in reducing unnecessary invasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 184.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">procedures and improving patient outcomes.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 203.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that the integration of CCTA with <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis into the diagnostic pathway for stable chest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 226.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">pain resulted in a significant reduction in the need for ICA and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 238.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary procedures, without an increase in adverse patient <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 249.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">outcomes. It found that random assignment to the study arm using <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 261.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">CCTA and our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.71pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 109.69pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 128.15pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 136.37pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was associated with a 22% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 273.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">reduction in the need for ICA, a 52% reduction in the frequency of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 284.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary ICA, 40% fewer layered non-invasive tests, and no <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 295.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">increase in adverse patient outcomes or in costs (in the United <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 307.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Kingdom).<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">131<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 434.25pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Min et al. (2012)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12.75pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">American <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Medical <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Association<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12.75pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">DeFACTO study<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; James K. Min, Jonathon Leipsic, Michael J. Pencina, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Multiple international centers (United States, Belgium, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 52.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Canada, Latvia and South Korea)<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 72.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 252<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; Multicenter diagnostic performance study, sponsored by <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the Company, involving 252 stable patients with suspected or known <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">CAD from 17 centers in 5 countries who underwent CT, ICA, FFR, and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis between October 2010 and October 2011. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 137.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed tomography, ICA, FFR, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 212pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 230.46pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 238.68pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">interpreted in blinded fashion by independent core laboratories. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 161.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accuracy of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.85pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 99.83pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 118.28999999999999pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 126.50999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis plus CT for diagnosis of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 173.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">ischemia was compared with an invasive FFR reference standard. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Ischemia was defined by an FFR or <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.54999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 199.53pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 217.99pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 226.21pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis of 0.80 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 196.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or less, while anatomically obstructive CAD was defined by a stenosis <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 208.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of 50% or larger on CT and ICA. The primary study outcome assessed <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 219.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">whether <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.03pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 84.00999999999999pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 102.47pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 110.69pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis plus CT could improve the per-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 231.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">patient diagnostic accuracy such that the lower boundary of the 1-sided <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 242.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">95% confidence interval of this estimate exceeded 70%.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 262.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study did not meet its primary goal for per-patient <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 273.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic accuracy, as it resulted in diagnostic accuracy of 73%, with a <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 285.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">lower bound of the 95% CI of 67%. However, the use of noninvasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis combined with CT in stable patients with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 308.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">suspected or known CAD showed improved diagnostic accuracy and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 319.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">discrimination compared to CT alone for identifying hemodynamically <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 331.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significant CAD, using invasive FFR as the reference standard. This <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">suggests that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.71pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 106.69pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 125.14999999999999pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 133.37pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis could enhance the noninvasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 354.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assessment of CAD by providing physiologic insights that CT alone <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 366.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cannot offer, potentially reducing unnecessary invasive procedures. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 377.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Following the completion of the DeFACTO study, we substantially <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 388.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">redesigned our technology, which improved product performance. The <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 400.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">results of this improvement were validated in the NXT study, which <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 411.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">resulted in a per vessel 86% accuracy and was the central evidence for <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 423.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the initial De Novo 510(k).<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other clinical studies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following summarizes the results of additional clinical studies that were not supported, sponsored, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funded by the Company. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">SCOT-HEART (2015)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.5pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.26999999999998pt; position: absolute; white-space: pre;">SCOT-HEART was a foundational open-label, multi-center, parallel group <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">randomized controlled trial that compared the standard of care against the standard of care with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">CCTA. The study registered 4,146 patients across 12 sites in Scotland. Enrollment was open to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients aged 18&#8211;75 years who had been referred by a primary-care physician to a dedicated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">cardiology chest pain clinic with suspected stable angina due to coronary heart disease. The study <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">highlighted the clinical superiority of CCTA over traditional stress-based NITs, finding a significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">41% reduction in the rate of death or non-fatal heart attacks after five years in p<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.46pt; position: absolute; text-decoration: none; white-space: pre;">atients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underwent CCTA evaluations. The study also demonstrated that patients in the CCTA group had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">higher rates of preventative therapies throughout follow-up&#58; antiplatelet therapy use fell from 48% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(baseline) to 41% (at 1 year) in the standard of care group (p &#60; 0.001), whereas it increased from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">49% (baseline) to 52% (at 1 year) in those in the CCTA group (p &#61; 0.017). Statin use increased in <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">132<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">both groups, from 43% to 50% (at 1 year) in the standard of care group and from 44% to 59% (at 1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">year) in the CCTA group (p &#60; 0.001 for both groups), but this was greater in those assigned to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA group (p &#60; 0.001).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FAME 1 (2009)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.64pt; position: absolute; text-decoration: none; white-space: pre;"> T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.32999999999998pt; position: absolute; white-space: pre;">he foundational FAME 1, a prospective randomized controlled trial, enrolled 1,005 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients with multi-vessel CAD across 20 sites in the United States and Europe. The study, along with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">FAME 2, showed that deferring intervention is superior when blood flow, as measured by FFR, was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">greater than 0.80 but that when FFR was below this same level, intervention was superior to optimal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">medical therapy. In FAME 1, patients diagnosed with CAD by ICA and planned ICA had rates of major <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">adverse cardiovascular events that were lower with deferral of FFR negative lesions than with angio-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">guided PCI of all lesions independent of FFR (18.3% vs. 13.2%) (p &#61; 0.02). In addition, 78% of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients in the angiography group were free from angina at 1 year, as compared with 81% of patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">in the FFR group (p &#61; 0.20).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FAME 2 (2014)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.64pt; position: absolute; text-decoration: none; white-space: pre;"> T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.32999999999998pt; position: absolute; white-space: pre;">he foundational FAME 2, a prospective randomized controlled trial, enrolled 1,220 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients across 28 sites in Europe and North America. The enrolled patients were appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">candidates for PCI in stable condition who had angiographically assessed one-, two-, or three-vessel <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">CAD suitable for PCI. The study demonstrated that patients diagnosed with CAD by ICA and with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">invasively-measured positive FFR had rates of major adverse cardiovascular events that were lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">with PCI and medical management than with medical management alone (8.1% vs. 19.5%) (p &#60; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">0.001)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.34pt; position: absolute; text-decoration: none; white-space: pre;">. This reduction was driven by a lower rate of urgent revascularization in the PCI group (4.0% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">vs. 16.3%) (p &#60; 0.001), with no significant between-group differences in the rates of death and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">myocardial infarction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sales and marketing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We believe the Heartflow Platform adds significant value across all the subspecialties that impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">cardiovascular care including referring cardiologists, imaging physicians, and interventionalists. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">structured our sales force to efficiently call on these key physician stakeholders, with a primary focus on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the imaging physicians who are instrumental in new account adoption and the referring physicians who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">are critical to driving volume growth at accounts in our installed base. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We market and sell our Heartflow Platform in United States through a direct sales organization. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025, our U.S. commercial team included 44 TSMs focused on opening new accounts, 55 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TAMs who are focused on broadening referring physician awareness of the CCTA + Heartflow pathway <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and driving increased volumes at accounts in our installed base, and our customer success organization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that supports seamless onboarding, implementation and ongoing utilization at our accounts. We support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our direct commercial efforts with a marketing team that generates demand for the CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway and highlights clearly defined value propositions for the various stakeholders across our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer base including cardiologists, radiologists and interventional cardiologists.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our TSMs engage with physicians to communicate the value proposition of the Heartflow Platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leveraging our large base of clinical evidence to highlight its clinical and economic benefits as well as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lack of any new capital equipment purchase to drive new account adoption. Our TSMs have substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience selling into cardiology and radiology practices as well as engaging with broad stakeholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">establish new diagnostic and therapeutic solutions, employing an enterprise sales strategy. Our TAMs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utilize our extensive clinical compendium to educate and train physicians on the benefits of our platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">133<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ultimately driving more referrals to our accounts. Our TAMs have strong backgrounds in establishing new, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disruptive therapies and growing a cardiology referral base. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 172.32pt; width: 468pt;" src="business15b.jpg" alt="business15b.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 289.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 13&#58; Overview of Heartflow call points<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 309.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our software is simple, intuitive and does not require case coverage by our sales reps, which affords our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 321.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial organization a differentiated level of efficiency relative to most other medical device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 333.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology companies. We intend to drive further adoption of our Heartflow Platform by leveraging our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 345.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing and highly efficient cohort of TSMs and TAMs to continue opening new accounts and driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 357.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume growth. We expect to selectively add additional TSMs to grow our geographic presence where we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 369.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">see areas of opportunity and modestly grow our team of TAMs to continue to drive awareness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 381.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits of our technology and broaden our referring physician population as our installed base grows. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that all accounts with a CCTA program would benefit from adopting the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that as of December 31, 2023, there were approximately 2,700 hospitals and outpatient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facilities in the United States that perform CCTA, and this target account base has grown at a 10% CAGR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 2018 to 2023 as accounts increasingly recognize the benefits of a guideline directed CCTA program, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our analyses using Clarivate&#8217;s ProcedureFinder data repository. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also have small, direct commercial teams in the United Kingdom and Japan. We may continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our commercial activities outside the United States in areas where we see potential opportunity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and supportive reimbursement dynamics. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 513.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have invested significantly in research and development efforts over more than a decade to establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 547.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the first and most widely adopted AI-enabled non-invasive test for CAD that is authorized for marketing in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States. We have built sophisticated AI-based algorithms and established an intuitive, easy to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use web and mobile customer interface, developed secure data transfer software, a scalable cloud <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">database, and quality review software, all while facilitating operational scalability. Our highly skilled and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">focused research and development (&#8220;R&#38;D&#8221;) team has been pioneering AI-based coronary imaging for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over a decade and remains uniquely positioned to continuously advance our Heartflow Platform. Our R&#38;D <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">team is comprised of PhD research scientists with expertise in AI-based algorithms and medical imaging, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alongside software engineers skilled in cloud architecture, AI algorithms, machine and deep learning and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3D visualization, as well as product managers and designers who ensure optimal customer experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and design. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are continuing to invest in research and development efforts with the goal of driving improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform and expanding its applicability to additional disease states and patient populations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 699.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our near to medium term research and development priorities include&#58; (i) continuing to train and improve <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">134<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our AI algorithms to drive greater quality and efficiency and reduce manual involvement&#59; (ii) enhancing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product features for both <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.64pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.62pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 248.04pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.7pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.36pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.34pt; position: absolute; white-space: pre;">Plaque Analysis&#59; (iii) developing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional workflow enhancements for our customers&#59; and (iv) expanding indications for our platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including asymptomatic risk prediction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reimbursement <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ability of our customers to obtain third-party payor coverage and payment for our Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products for their patients is important to our business. Demand for our existing and new products is, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will continue to be, affected by the extent to which government healthcare programs, such as Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Medicaid, and private health insurers, reimburse our customers for the use of our products with their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients in the countries where we do business. We have successfully engaged with third-party payors in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">major markets throughout the world to obtain coverage, coding, and payment rates for our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Nonetheless, not all third-party payors reimburse our customers for our products in all situations. Third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party payor reimbursement for the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 289.7pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.36pt; position: absolute; white-space: pre;"> Analysis is broad&#59; however, Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is our second commercial product, and we continue to work to expand coverage and payment for its use. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if we develop or acquire a promising new product that has been cleared for commercial distribution <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the FDA, demand for the product may be limited unless our customers are reimbursed at favorable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rates by private health insurers and government healthcare programs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.49pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a Category I CPT code, 75580, effective as of January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1, 2024, and third-party payors have established coverage policies for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 447.5pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.16pt; position: absolute; white-space: pre;"> Analysis that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">apply to approximately 99% of covered lives in the United States. A new Category I CPT code was also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recently established to describe our Heartflow Plaque Analysis, which will take effect in January 2026. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Plaque Analysis is generally covered by Medicare, with five of the seven MACs issuing final <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">LCDs that determined this analysis is medically necessary for certain Medicare patients in these MACs' <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions, and the remaining MACs providing coverage on a case-by-case basis. In July 2025, CMS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proposed to establish a national payment rate for the Category I CPT code that will describe our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis when performed in the physician office setting. If finalized in the final Physician <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Fee Schedule rule expected to be published in the fourth quarter of 2025, a national Medicare payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate for our Heartflow Plaque Analysis will take effect on January 1, 2026.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, our customers purchase Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 339.68pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.34pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reports generated by our products for their patients. These customers then submit a claim to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable third-party payor for reimbursement. To the extent that coverage is denied on such claims, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the reimbursement paid does not exceed the customer&#8217;s cost for our products, demand for our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be reduced or our charges for our products will have to be materially reduced. Internationally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare reimbursement systems vary significantly. In some countries, our customers, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hospitals, are constrained by fixed global budgets, regardless of the volume or nature of patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment. Other countries require application for, and approval of, government or third-party payor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement. Without both favorable coverage determinations by, and the financial support of, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government and private third-party payors, the market for our products would be adversely affected. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot be sure that third-party payors will maintain the current level of coverage and payment to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers for use of our existing products. Adverse coverage determinations, or reductions in the amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of reimbursement, could harm our business by discouraging customers&#8217; ordering of, and reducing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prices they are willing to pay for, our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">It is our intent to complete additional clinical studies and analyses, as needed, to obtain and continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand coverage and payment at favorable rates for our products in countries or regions where it makes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic sense to do so. Nonetheless, coverage and payment for our products can differ from payor to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payor. Furthermore, as a result of their influence over the healthcare system, third-party payors have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implemented, and are continuing to implement, cost-cutting measures such as seeking discounts, price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reductions or other incentives from medical products manufacturers, and imposing limitations on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage and payment for medical technologies and procedures. These trends could compel us to reduce <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">135<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prices for our products and could cause a decrease in the size of the market or a potential increase in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition that could negatively affect our business, financial condition and results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to uncertainties surrounding insurance coverage policies, our Heartflow Platform, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes the separately billable services, Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 317.5pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.15999999999997pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis, is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to periodic changes to reimbursement levels by government payors and private health insurers. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For example, CMS adopts changes to reimbursement policies during the annual Medicare rulemaking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">process, which includes updates to Medicare payment levels to hospitals under the Medicare Hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Outpatient Prospective Payment System (&#8220;OPPS&#8221;), and updates to Medicare payment levels to physician <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offices, independent diagnostic testing facilities, and freestanding imaging centers under the Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Physician Fee Schedule (&#8220;MPFS&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Updates to payments under OPPS, which are in the form of Ambulatory Payment Classifications (&#8220;APC&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are made annually and primarily driven by the geometric mean cost (&#8220;GMC&#8221;) of the service, which is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculated based on hospital cost reports submitted to CMS and hospital claims submitted during the prior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calendar year before the rule&#8217;s publication. If the reported GMCs for these services decline, whether due <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to miscoding, erroneous claims denials, use of alternative revenue codes, underreporting costs by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hospitals, a reduction in the cost of the service, or a change in payment policy by CMS, CMS may assign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such service to a lower APC, resulting in a materially lower reimbursement rate for at least the next <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calendar year.&#160; We may not become aware of our hospital customers reporting a lower GMC, or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reason for any such reduction, early enough to prevent an impact to the GMC for the applicable period or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any potential payment classification change that CMS could make as a result of a decrease in the GMC. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Once hospitals submit their claims and CMS calculates the GMC for each procedure, our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remedy any such issues may be limited by CMS rules and regulations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow&#8217;s FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 143.44pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.1pt; position: absolute; white-space: pre;"> and Heartflow Plaque Analysis are also subject to reimbursement changes under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MPFS, which determines payment rates to physician offices, independent diagnostic testing facilities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">freestanding imaging centers. Like OPPS, CMS evaluates and updates payments rates on the MPFS on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an annual basis, and changes to the conversion factor, relative value units (&#8220;RVUs&#8221;), practice expense <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocations or procedure code valuations can affect the reimbursement available for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 506.75pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 515.4100000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis. For example, services that convert from Category III CPT codes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to Category I CPT code status are subject to review and re-survey by the American Medical Association <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Relative Value Scale Update Committee, which may recommend an updated physician work value or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice expense calculation in the form of updated RVUs. This initial review and any subsequent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resurvey can impact Medicare payment rates established in the annual MPFS. We believe the American <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medical Association may resurvey the CPT codes describing our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 423.96pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.62pt; position: absolute; white-space: pre;"> Analysis as early as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2027 and our Heartflow Plaque Analysis as early as 2029. Additionally, the American Medical Association <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and CMS continue to evolve the CPT coding structure and payment calculation for AI-enabled healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services.&#160; Changes to existing codes or coding policies, or our ability to obtain new codes and establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate values, may impact future reimbursement for the Heartflow Platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to risks associated with coding and government reimbursement, our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 487.47pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.13pt; position: absolute; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Heartflow Plaque Analysis products face reimbursement uncertainty from commercial payors, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as UnitedHealthcare, Aetna, Cigna, Anthem, and regional Blue Cross Blue Shield plans. Commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors routinely reassess their medical policies, coverage criteria, and payment rates, and may choose to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deny coverage, impose restrictive utilization management protocols (such as prior authorization), or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce or bundle payment amounts based on internal cost-effectiveness assessments or evolving clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines. Even if CMS maintains favorable Medicare reimbursement, commercial payors may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">independently determine whether Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 286.97pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.32pt; position: absolute; white-space: pre;">Analysis or Heartflow Plaque Analysis meets their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plans&#8217; medical necessity standards, which can vary among commercial payors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The overall escalating cost of medical products and services being paid for by the government and private <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health insurance has led to, and may continue to lead to, increased pressures on the healthcare and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical device industries to reduce the costs of products and services. Third-party payors are developing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increasingly sophisticated methods of controlling healthcare costs through prospective reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">136<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and capitation programs, group purchasing, redesign of benefits, and exploration of more cost-effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods of delivering healthcare. In the United States, some insured individuals enroll in managed care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs, which monitor and often require pre-approval for the services that a member will receive. Some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managed care programs pay their providers on a per capita (patient) basis, which puts the providers at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial risk for the services provided to their patients by paying these providers a predetermined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment per member per month and, consequently, may limit the willingness of these providers to use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Competition<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We consider our primary competition to be traditional non-invasive tests for CAD including primarily stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tests such as SPECT, stress echocardiography and PET. The primary providers of imaging systems that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perform these tests include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V. and Canon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medical Systems Corporation. These companies also manufacture CT scanners and therefore have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vested interest in growing the CCTA market in addition to protecting their share of the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market. These are large, multi-national, commercial organizations with significant resources and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distribution capabilities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also face competition from companies that have developed or are developing AI-based platforms that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leverage CCTA to diagnose CAD, including earlier-stage companies such as Cleerly, Inc., Elucid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bioimaging Inc. and Keya Medical Technology Co., Ltd. We may also face competition from companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing AI-based platforms, even if they are not currently in the CAD market. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the primary competitive factors in our market include&#58; (i) the accuracy, reliability, and utility of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the test as demonstrated by the strength and quality of clinical data directly utilizing the test and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting it&#59; (ii) speed and efficiency of achieving a definitive diagnosis at scale&#59; (iii) per patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economics including reimbursement rates and relative costs&#59; (iv) availability and ease of use including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integration within hospital systems and clinical workflows as well as customer support&#59; and (v) effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing and physician education efforts as well as ability to impact physician mindshare and historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice patterns<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.88pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Intellectual<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 134.64pt; position: absolute; text-decoration: none; white-space: pre;"> property<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our success depends in part on our ability to obtain, maintain and defend our patent and other proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights for the Heartflow Platform, the validity and enforceability of our patents, our ability to operate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without infringing the valid and enforceable patents and proprietary rights of third parties and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continued confidentiality of our know-how and trade secrets. We are actively involved in research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development and therefore seek to protect the investments we have made into the development of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform and our proprietary technology by relying on a combination of patents, trademarks, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secrets, and licenses, as well as through internal compartmentalization processes, confidentiality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements and proprietary information agreements with suppliers, employees, consultants and others <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who may have or gain access to our proprietary information. We seek patent protection in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States and key markets internationally for the Heartflow Platform, and any other inventions to which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have rights, where available and appropriate. We also rely upon trademarks to build and maintain the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrity and identity of our brand, and we seek to protect the confidentiality of trade secrets that may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">important to the development of our business, especially where we do not believe patent protection is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate or obtainable. We license from third parties certain patent rights and proprietary know-how <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we believe to be useful to our business. We have non-exclusively licensed some patents in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent portfolio to a small number of licensees in a limited field of use that is outside of CCTA, and we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that those licensees' product offerings covered by our patent portfolio are complementary to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product offerings.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patent portfolio, described more fully below, includes claims directed to the Heartflow Platform and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery, as embodied in various systems, computer programs, computer implemented methods and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related methods of use. These claims are directed to various aspects of deriving anatomical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physiological information from image data for the Heartflow Platform, aspects of the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">137<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">user interface, machine learning methods for generation of the 3D models used for our FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 476.37pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.72pt; position: absolute; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Plaque Analysis products, and methods of deriving blood flow, anatomy, plaque and organ tissue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information from the image data. A number of our issued patents also cover indications other than CAD, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as peripheral artery disease, stroke, or aneurysms as well as technical applications related to image <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">data analysis and processing, and platform-related PHI and data transfer methodologies and a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued patents cover alternative methods such as deriving FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 350.85pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.51pt; position: absolute; white-space: pre;"> using purely machine learning methods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or from other imaging modalities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, our owned and licensed patent portfolio includes approximately five hundred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and eighty-six (586) issued patents and one hundred and three (103) pending patent applications globally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of which nine (9) are allowed. In the U.S. this includes three hundred and nine (309) issued U.S. patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and fifty-six (56) pending non-provisional U.S. patent applications (of which three (3) are allowed). In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign jurisdictions our owned and licensed patent portfolio includes two-hundred and eighty (280) issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign patents and forty-seven (47) pending foreign patent applications (of which five (5) are allowed). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The two-hundred and eighty (280) issued foreign patents include one or more issued patents in Europe, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Japan, Korea, China, Australia, Canada, India, Hong Kong, and Israel. We also filed twenty-three foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utility models between 2011 and 2014, having ten-year terms, all of which have expired. The forty-seven <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(47) pending foreign patent applications include one or more pending applications in jurisdictions such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Europe, Canada, China, and Japan. We own all of our issued patents except for 7 issued U.S. patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and 8 issued foreign patents, for which we have exclusive licenses. All of the issued U.S. patents in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">portfolio are utility patents. Assuming payment of all appropriate maintenance, renewal, annuity or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental fees, as applicable, our owned and licensed issued U.S. patents expire between 2018 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2041. If issued, our last to expire pending patent application (without accounting for potentially applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent term adjustments or extensions) is expected to expire in 2045. One of our U.S. patents expired in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018 and we do not expect any additional expirations in the near-term. The next expiration of a Heartflow-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensed patent is expected to be in 2028. The next expiration of a Heartflow-owned patent is expected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be in 2031. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patents and applications generally fall into three broad categories&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.40999999999997pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 328.83000000000004pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.18pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, including claims directed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">segmentation, determining blood flow characteristics using artificial intelligence and&#47;or fluid dynamics, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and visualization generation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow Plaque Analysis, including claims directed to plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and vessel visualization and characterization&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow RoadMap Analysis, including claims directed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">image quality and annotation, segmentation, and vascular tree generation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The term of individual patents depends upon the legal term of the patents in the countries in which they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are obtained. In most countries in which we file or intend to file, including the United States, the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term is 20 years from the earliest date of filing a non-provisional patent application. Additionally, a U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisional patent application expires twelve months from its filing date, and its subject matter can only be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claimed in an issued patent if, among other things, we timely file a non-provisional patent application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making a valid priority claim to that provisional patent application before it expires. In the United States, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is terminally disclaimed over an earlier filed patent. The coverage sought in a patent application can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">denied or significantly reduced either before or after the patent is issued. We cannot be sure that patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be granted with respect to any current pending patent application or with respect to any patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications filed by us in the future, nor can we be certain that any current pending or published patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application will be granted with the current claims or that any current or future patents will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercially useful in protecting the Heartflow Platform and our proprietary technology. In addition, any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents that we may hold, whether owned or licensed, may be challenged, circumvented or invalidated by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">138<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The success of our business strategy also depends in part on our continued ability to protect our brand. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We own registered trademarks for the Heartflow Platform. We also own and maintain registration for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of domain names. As of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.09pt; position: absolute; text-decoration: none; white-space: pre;"> December 31, 2024,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.41999999999996pt; position: absolute; white-space: pre;"> we have registered the trademarks &#8220;HEARTFLOW&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">word mark and logo with the USPTO. Although we own registered trademarks and domain names in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States and certain other countries, and have filed trademark applications and secured domain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">name registrations in the United States and in certain other countries, we do not have assurance that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademark portfolio will be adequate to secure or protect all necessary trademarks that we use. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform also implements software modules licensed to us by third-party authors under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;open source&#8221; licenses. The use of open source software may entail greater risks than the use of third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party commercial software. Please see &#8220;Risk factors&#8212;Risks related to our intellectual property&#8221; for more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">description of these risks. We have established a review process for screening requests from our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development organizations for the use of such software that is designed to help us mitigate risks related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the quality of any open source software implemented in our technology platform. We also review any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open source software used to support our software development, but not directly incorporated into the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, as part of our general quality management processes. While these review processes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">help us mitigate risks associated with the quality of the open source software incorporated into or used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing the Heartflow Platform, we cannot be sure that all open source software is submitted for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval prior to use in connection with the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also rely on trade secrets, including know-how, unpatented technology and other proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, to strengthen our competitive position. We seek to protect trade secrets and confidential and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unpatented know-how, in part, by entering into non-disclosure and confidentiality agreements with parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who have access to such knowledge, such as our employees, collaborators, manufacturers, consultants, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors and other third parties. We also seek to enter into confidentiality and invention or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assignment agreements with our employees and consultants that obligate them to maintain confidentiality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and assign their inventions to us. We also seek to preserve the integrity and confidentiality of our data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and trade secrets by maintaining the physical security of our premises and physical and electronic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security of our information technology systems.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to stop third parties from making, using, selling, offering to sell or importing the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform depends on the extent to which we have rights under valid and enforceable patents, trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets or other intellectual property and proprietary rights that cover these activities. We pursue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property protection to the extent we believe it would advance our business objectives. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notwithstanding these efforts, there can be no assurance that we will adequately protect our intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property or provide any competitive advantage. For more information regarding risks relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property, see &#8220;Risk factors&#8212;Risks related to our intellectual property.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Government regulation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United States regulation of medical devices<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are medical devices subject to extensive and ongoing regulation by the FDA, CMS, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Department of Health and Human Services Office of Inspector General (&#8220;OIG&#8221;) and regulatory bodies in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States and other countries. Regulations govern virtually every critical aspect of a medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device company&#8217;s business operations, including research activities, product development and testing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing and production, contracting, reimbursement, product messaging, medical communications, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales, marketing and advertising. In the United States, the Federal Food, Drug and Cosmetic Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;FDCA&#8221;) and the implementing regulations of the FDA govern product design and development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preclinical and clinical testing, premarket clearance or approval, product manufacturing, product labeling, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product storage, advertising and promotion, product sales and distribution, import, export and post market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical surveillance. Our business is subject to federal, state, local, and foreign regulations, such as ISO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">13485&#58;2016, ISO 14971&#58;2019, FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;) contained in 21 CFR Part 820, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the EU&#8217;s Medical Devices Directive 93&#47;42&#47;EEC and its replacement, Regulation (EU) 2017&#47;745. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform consists of three main analyses&#59; Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 366.32pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.67pt; position: absolute; white-space: pre;">Analysis, Heartflow Roadmap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, and Heartflow Plaque Analysis. All three are authorized for clinical use in the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">139<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain, Israel, Saudi Arabia, and the United Arab Emirates. Only the FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 399.65pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.31pt; position: absolute; white-space: pre;"> Analyses is authorized for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical use in the European Economic Area, United Kingdom, Australia, Canada, and Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FDA premarket clearance and approval requirements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless an exemption applies, each medical device commercially distributed in the United States requires <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">either FDA clearance of a 510(k) premarket notification, grant of a de novo classification request, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval of a premarket approval (&#8220;PMA&#8221;) application. Our Heartflow Platform is regulated in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States by the FDA as a Class II medical device. The FDA classifies medical devices into one of three <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classes. Devices deemed to pose low to moderate risk are designated as either Class I or II. Class I <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices are subject to general controls such as establishment registration and device listing, labeling, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adherence to current good manufacturing practices outlined in the QSR, maintenance and investigation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product complaint records, and adverse event reporting, but are usually exempt from premarket <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification requirements. Class II devices are subject to the same general controls and may be subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">special controls such as performance standards, post-market surveillance, particularized labeling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements and&#47;or clinical testing prior to clearance. Manufacturers of Class II devices, absent an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exemption, are required to submit to the FDA a premarket notification prior to commercial distribution. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Devices are designated as Class III, which requires approval of a PMA application, if they are deemed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the FDA to pose the greatest risk. These high-risk devices include life sustaining or life supporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices, certain implantable devices, and other devices that are intended for a use that is of substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">importance in preventing impairment of human health or that present a potential unreasonable risk of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">illness or injury. The PMA approval process is more comprehensive than the 510(k) clearance process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and typically takes several years to complete.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">510(k) clearance marketing pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A 510(k) notification requires the sponsor to demonstrate that a medical device is substantially equivalent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to another marketed device, termed a &#8220;predicate device,&#8221; that is legally marketed in the United States and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for which a PMA was not required. A device is substantially equivalent to a predicate device if it has the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same intended use and technological characteristics as the predicate, or has the same intended use but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different technological characteristics that do not raise new questions of safety and effectiveness, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information submitted to the FDA demonstrates that the device is at least as safe and effective as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicate device.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA agrees that the device is substantially equivalent to a predicate device currently on the market, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it will grant 510(k) clearance to commercially market the device. If there is no viable predicate device for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new device because, for example, of a new intended use, the device is automatically designated as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Class III device. Unless the De Novo pathway is available for the new device, the device sponsor must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fulfill more rigorous PMA requirements. The PMA process requires that the manufacturer demonstrate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that the device is safe and effective for its intended uses, which generally requires the submission of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extensive data, including results from pre-clinical studies and human clinical trials. A PMA must also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contain a full description of the device and its components, the methods, facilities, and controls used for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing, and proposed labeling. The PMA process is burdensome, and in practice, the FDA&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review of a PMA application may take up to several years following initial submission. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After a device receives 510(k) clearance, any modification that could significantly affect its safety or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectiveness, or that would constitute a new or major change in its intended use, requires a new 510(k) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance, or depending on the modification, could require the filing of a de novo classification request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a PMA application, which would require the submission to the FDA of clinical trial data, among other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information. We are required to determine, for each modification to our cleared products, whether to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">submit a new 510(k) notification for the modification, based on the nature of the modification. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine a new 510(k) submission is not required, the decision and justification are documented in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;letter to file.&#8221; If the FDA disagrees with our determination, the FDA can require us to cease marketing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recall the modified device until 510(k) clearance, grant of a de novo classification request or approval of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PMA is obtained. We have made, and we plan to continue to make, minor product enhancements to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cleared products that we believe do not require new 510(k) clearances and that we document in letters to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">140<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file. We also intend to make product enhancements from time to time that we expect may require new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) clearances.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">De novo classification process<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A manufacturer can request a risk-based classification determination for a novel device in accordance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the &#8220;de novo&#8221; process. Medical device types that the FDA has not previously classified as Class I, II, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or III are automatically classified into Class III regardless of the level of risk they pose. The Food and Drug <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administration Modernization Act of 1997 established a route to market for low-to-moderate risk medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices that are automatically placed into Class III due to the absence of a predicate device, called the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the de novo classification procedure. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedure allows a manufacturer whose novel device is automatically classified into Class III to request <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">down-classification of its medical device into Class I or Class II on the basis that the device presents low <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or moderate risk, rather than requiring the submission and approval of a PMA application. Pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Food and Drug Administration Safety and Innovation Act (&#8220;FDASIA&#8221;), manufacturers may request de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classification directly without first submitting a 510(k) pre-market notification to the FDA and receiving a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not-substantially-equivalent determination. De novo classification requests, like PMA applications and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) notifications, are subject to the payment of user fees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the FDASIA, the FDA is required to reach a decision within 120 days following receipt of the de <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">novo request, although the process may take significantly longer. If the manufacturer seeks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reclassification into Class II, the manufacturer must include a draft proposal for special controls that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. If the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FDA grants the de novo request, the device may be legally marketed in the United States. However, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FDA may reject the request if the FDA identifies a legally marketed predicate device that would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate for a 510(k) notification, determines that the device is not low-to-moderate risk, or determines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that General Controls would be inadequate to control the risks and&#47;or special controls cannot be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developed. After a device receives de novo classification, any modification that could significantly affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its safety or efficacy, or that would constitute a major change or modification in its intended use, will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require a new 510(k) clearance or, depending on the modification, another de novo request or even PMA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We obtained initial marketing authorization for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 341.73pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.39pt; position: absolute; white-space: pre;"> Analysis through the FDA&#8217;s &#8220;de novo&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classification process, supported by clinical data from our NXT clinical trial. Through this process, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed that special controls provide reasonable assurance of the safety and effectiveness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis and therefore it can be classified as a Class II device. We received a de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorization on November 26, 2014 for version 1.4 of the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 394.7pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.36pt; position: absolute; white-space: pre;"> Analysis. We received the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) clearance for version 2.x of the FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 261.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.6pt; position: absolute; white-space: pre;"> product in January 2015, and 510(k) clearance for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification to the intended use language in August 2016. Additional clearances were received for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategic architecture scope change in December 2018, which is the device we refer to as Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform. The Heartflow Platform version 2.0, which added the PCI Planner function, received FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance in August 2019. The Heartflow Platform version 3.0 received FDA clearance in January 2021, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the newest product generation, Heartflow Platform version 3.18, adding Roadmap and Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">functions, received FDA clearance in October 2022. The <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.88pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow Platform version 4.0, with improved </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque detection, received its clearance in July 2025.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Medical device clinical trials<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clinical trials are sometimes required to support 510(k) or de novo submissions. All clinical investigations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of devices to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigational device exemption (&#8220;IDE&#8221;) regulations which govern investigational device labeling, prohibit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promotion of the investigational device, and specify an array of recordkeeping, reporting and monitoring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibilities of study sponsors and study investigators. If the device presents a &#8220;significant risk&#8221; to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">human health, as defined by the FDA, the FDA requires the device sponsor to submit an IDE application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the FDA, which must become effective prior to commencing human clinical trials. If the device under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluation does not present a significant risk to human health, then the device sponsor is not required to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">141<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">submit an IDE application to the FDA before initiating human clinical trials, but must still comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">abbreviated IDE requirements when conducting such trials. A significant risk device is one that presents a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential for serious risk to the health, safety or welfare of a patient and either is implanted, used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disease or otherwise preventing impairment of human health, or presents a potential for serious risk to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient in some other way. An IDE application must be supported by appropriate data, such as animal and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scientifically sound. The IDE will automatically become effective 30 days after receipt by the FDA unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the FDA notifies the company that the investigation may not begin. If the FDA determines that there are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial to proceed under a conditional approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regardless of the degree of risk presented by the medical device, clinical studies must be approved by, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and conducted under the oversight of, an Institutional Review Board (&#8220;IRB&#8221;) for each clinical site. The IRB <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is responsible for the initial and continuing review of the clinical study, and may pose additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements for the conduct of the study. If an IDE application is approved by the FDA and one or more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IRBs, human clinical trials may begin at a specific number of investigational sites with a specific number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of patients, as approved by the FDA. If the device presents a non-significant risk to the patient, a sponsor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IDE to become effective and, if it does become effective, the FDA may or may not determine that the data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derived from the trials support the safety and effectiveness of the device or warrant the continuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical trials.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ensuring IRB review, adverse event reporting, record keeping and prohibitions on the promotion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigational devices or on making safety or effectiveness claims for them. The clinical investigators in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the clinical study are also subject to FDA&#8217;s regulations and must obtain patient informed consent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rigorously follow the investigational plan and study protocol, control the disposition of the investigational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device, and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategic business decisions or a belief that the risks to study subjects may outweigh the anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Expedited development and review programs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following passage of the 21st Century Cures Act, the FDA implemented the Breakthrough Devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Program, which is a voluntary program offered to manufacturers of certain medical devices and device-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">led combination products that may provide for more effective treatment or diagnosis of life-threatening or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">irreversibly debilitating diseases or conditions. The goal of the program is to provide patients and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers with more timely access to qualifying devices by expediting their development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment and review, while preserving the statutory standards for PMA approval, 510(k) clearance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">de novo classification. The program is available for medical devices that meet certain eligibility criteria, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including that the device provides more effective treatment or diagnosis of a life-threatening or irreversibly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debilitating disease or condition, and that&#58; (i) the device represents a breakthrough technology, (ii) no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved or cleared alternatives exist, (iii) the device offers significant advantages over existing approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or cleared alternatives, or (iv) the availability of the device is in the best interest of patients. Breakthrough <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Device Designation provides certain benefits to device developers, including more interactive and timely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">communications with FDA staff&#59; use of post-market data collection, when scientifically appropriate, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facilitate expedited and efficient development and review of the device&#59; opportunities for more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and flexible clinical study design&#59; and prioritized review of premarket submissions. When reviewing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Breakthrough Device Designation requests, the FDA may require a combination of literature or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">142<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preliminary bench, animal or clinical data to demonstrate a reasonable likelihood of clinical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technological success. Receiving a Breakthrough Device Designation from the FDA does not guarantee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that the FDA will grant marketing authorization for the device.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Post-market regulation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After a device is approved or cleared and placed in commercial distribution, numerous FDA regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements apply. These include, but are not limited to, requirements to&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">register establishments and list devices with the FDA&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maintain a quality system that is compliant with the QSR, which governs design, development, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">manufacture of devices&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">establish various specifications and controls for incoming components and finished devices&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that devices are designed to meet user needs&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">verify that finished devices are manufactured to the appropriate controls and that they meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">specifications&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that devices are assigned and labeled with a Unique Device Identifier (&#8220;UDI&#8221;) and that certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">UDI information is provided to FDA&#8217;s Global Unique Identification Database (&#8220;GUDID&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that labeling and advertising and promotional activities are consistent with cleared&#47;approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">uses, adequately substantiated, and truthful and not misleading&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">analyze quality data to identify and correct quality problems&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">submit notifications or applications for clearance or approval of product modifications that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">significantly affect safety or effectiveness or that would constitute a major change in intended use&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">review, evaluate and investigate complaints and report adverse events to the FDA when a device may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">have caused or contributed to a death or serious injury or malfunctioned in a way that would be likely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to cause or contribute to a death or serious injury if the malfunction were to recur&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">report to FDA corrections and removals undertaken to reduce a risk to health posed by the device or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to remedy a violation of the FDCA that may present a risk to health. In addition, FDA may order a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">mandatory recall if there is a reasonable probability that the device would cause serious adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">health consequences or death&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">comply with any post-approval restrictions or conditions, including requirements to conduct post-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">market surveillance studies to establish continued safety data&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conduct clinical studies in accordance with good clinical practices and applicable regulations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including requirements for clinical trial registration and results reporting on ClinicalTrials.gov.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Manufacturing processes for medical devices are required to comply with the applicable portions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">QSR, which cover the methods and the facilities and controls for the design, manufacture, testing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production processes and controls, quality assurance, labeling, packaging, distribution, installation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">servicing of finished devices intended for human use. The QSR also requires, among other things, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintenance of a device master file, device history file, device history record and complaint files. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer, we are subject to periodic scheduled or unscheduled inspections by the FDA. Failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain compliance with the QSR requirements could result in the shutdown of, or restrictions on, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing operations and the recall or seizure of marketed products. In February 2024, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued the Quality Management System Regulation Final Rule (&#8220;QMSR&#8221;) to amend the QSR, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporating by reference the international standard for medical device quality management systems, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ISO 13485&#58;2016. The rule becomes effective on February 2, 2026. Until then, manufacturers are required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to comply with the QSR. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">143<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The FDA polices these requirements by inspection, review of required reports or submissions, and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, and the agency has broad enforcement powers to address any violations. The FDA may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct announced or unannounced facility inspections to determine compliance with the QSR and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations, and these inspections may include our manufacturing facilities. Failure to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable regulatory requirements can result in enforcement action by the FDA or other regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities, which may result in sanctions and related consequences, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">untitled letters or warning letters or it has come to our attention letters&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">injunctions or consent decrees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fines or civil penalties&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recall, detention, or seizure of our product&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">operating restrictions, partial suspension, or total shutdown of production&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA&#8217;s refusal of or delay in granting 510(k) clearance or premarket approval of new or modified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">withdrawal of 510(k) clearances or PMA approvals&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA&#8217;s refusal to grant export certificates&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">criminal prosecution&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unanticipated expenditures to address or defend such actions&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reputational harm resulting from such actions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other regulatory authorities overseeing the implementation and adherence of applicable state, federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and analogous foreign regulatory authorities may also conduct unannounced inspections. Such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inspections may result in similar administrative, civil and criminal penalties. The discovery of previously <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unknown problems with marketed medical devices, including unanticipated adverse events or adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events of increasing severity or frequency, whether resulting from the use of the device within the scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device, including the removal of the product from the market or voluntary or mandatory device recalls.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">International regulation &#8212; European Union, United Kingdom, Japan and Canada<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to market and sell our product outside of the United States, we must comply with numerous and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">varying regulatory requirements of other countries and jurisdictions regarding quality, safety, and efficacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and governing, among other things, clinical trials, marketing authorization, commercial sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distribution of our product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although many of the regulatory issues we face in the United States are similar to the issues in other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">geographies, the approval or certification process varies between countries and jurisdictions and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involve additional testing and additional administrative review periods. The time required to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval or certification in other countries and jurisdictions might differ from and be longer than that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to obtain clearance from the FDA. Regulatory approval or certification in one country or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction does not ensure regulatory approval or certification in another, but a failure or delay in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtaining regulatory approval or certification in one country or jurisdiction may negatively impact the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory process in others.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">European Union<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The primary regulatory environment in Europe is that of the European Union, which includes most of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">major countries in Europe. The law regarding medical devices is harmonized in the European Union. Until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a few years ago, medical devices were governed by the Medical Devices Directive 93&#47;42&#47;EEC (&#8220;MDD&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">144<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Active Implantable Medical Devices Directive 90&#47;385&#47;EEC (&#8220;AIMD&#8221;), implemented by the member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">states of the European Union into their national law. However, on May 26, 2021,the Medical Devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation (EU) 2017&#47;745 (&#8220;MDR&#8221;) entered into application, repealing and replacing the MDD and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AIMD. As a Regulation, the MDR is directly applicable in all member states of the European Union and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not require further implementation into national law. The MDR and its associated guidance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documents and harmonized standards govern, among other things, device design and development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preclinical and clinical or performance testing, premarket conformity assessment, registration and listing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing, labeling, storage, claims, sales and distribution, export and import and post-market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, vigilance, and market surveillance. The MDR is based on very similar general system as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDD, but adds obligations on manufacturers and distributors of medical devices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Since May 26, 2021, medical devices placed on the European Union market must conform to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements set out by the MDR. Medical devices must comply with the General Safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Performance Requirements (&#8220;GSPRs&#8221;) set out in Annex I of the MDR. Compliance with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements is a prerequisite to be able to affix the CE mark to devices, without which they cannot be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed or sold in the European Union. To demonstrate compliance with the GSPRs provided in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDR and obtain the right to affix the CE mark, medical devices manufacturers must undergo a conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure. The conformity assessment procedure varies depending on the class of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, but most cases involve an assessment by a Notified Body. Depending on the relevant conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure, this assessment may consist of a review of the technical file submitted by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer, an audit of the quality system of the manufacturer, and testing of the product of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer. Even though a Notified Body is a private organization in one of the member states of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">European Union, all Notified Bodies in the European Union are designated and accredited by a national <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government of the European Union based on stringent criteria. Only such accredited Notified Bodies may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">give a CE Certificate of Conformity following successful completion of a conformity assessment procedure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted in relation to the medical device and its manufacturer and their conformity with the GSPRs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CE Certificate of Conformity confirms the conformity of the device to the GSPRs and allows the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicant to affix the CE mark on the assessed medical device and to commercialize it in the European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Union after having prepared and signed a related European Union Declaration of Conformity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a general rule, demonstration of conformity of medical devices and their manufacturers with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">GSPRs must be based, among other things, on the evaluation of clinical data supporting the safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance of the products during normal conditions of use. Specifically, a manufacturer must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrate that the device achieves its intended performance during normal conditions of use and that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against the benefits of its intended performance, and that any claims made about the performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safety of the device (e.g., product labeling and instructions for use) are supported by suitable evidence. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This assessment must be based on clinical data, which can be obtained from (i) clinical studies conducted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the devices being assessed, (ii) scientific literature from similar devices whose equivalence with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessed device can be demonstrated or (iii) both clinical studies and scientific literature. The conduct of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical studies in the European Union is governed by detailed regulatory obligations. These may include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the requirement of prior authorization by the Competent Authorities of the country in which the study takes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">place and the requirement to obtain a positive opinion from a competent Ethics Committee. This process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can be expensive and time-consuming. After a device is placed on the market in the European Union, it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remains subject to significant regulatory requirements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The MDR also establishes transitional provisions, amended by Regulation (EU) 2023&#47;607, permitting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain devices that have been CE marked in accordance with the MDD or the AIMD to continue to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">placed on the European Union market under strict conditions and for a specific period of time depending <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the risk classification of the device and the date of issuance of any related CE Certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conformity. Accordingly, CE Certificates of Conformity issued by Notified Bodies in accordance with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDD or the AIMD from May 25, 2017, and which remained valid on May 26, 2021 and have not since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been withdrawn will, with certain exceptions, remain valid until December 31, 2027 for Class III and Class <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IIb implantable medical devices and until December 31, 2028 for other Class IIb, Class IIa and Class I <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices with a measuring function or which are sterile. Class I medical devices, for which the conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">145<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure in accordance with the MDD or the AIMD did not require the involvement of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notified Body but will require the involvement of a Notified Body in accordance with the MDR and for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which an European Union Declaration of Conformity was issued in accordance with the MDD or the AIMD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to May 26, 2021, can continue to be placed on the European Union market until December 31, 2028. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Manufacturers of medical devices may only benefit from the above extended transitional provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deadlines if the following conditions are fulfilled&#58; (i) the devices continue to comply with the requirements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the MDD or AIMD, as applicable, (ii) there are no significant changes in the design and intended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purpose, (iii) the devices do not present an unacceptable risk to the health or safety of patients, users or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other persons, or to other aspects of the protection of public health, (iv) the manufacturer implements a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality management system by May 26, 2024 which complies with the requirements of the MDR, (v) by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">May 26, 2024 an application is lodged with a Notified Body for conduct of the conformity assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the devices covered by the CE Certificate of Conformity, or the devices intended to substitute for such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices, in accordance with the MDR and a related written agreement is signed with the Notified Body by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">September 26, 2024, and (vi) from May 26, 2021, compliance with the MDR relating to post-market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, market surveillance, vigilance, registration of economic operators and of devices is ensured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in place of the corresponding requirements in the MDD or AIMD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, CE Certificates of Conformity issued by Notified Bodies in accordance with the MDD or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AIMD from May 25, 2017, which were valid on May 26, 2021 and have not been withdraw since but which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expired before March 20, 2023, will only continue to be valid in accordance with the extended transitional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deadlines above if either (i) the manufacturer signed a written agreement with a Notified Body for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conformity assessment of the device covered by the expired CE Certificate of Conformity, or the device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intended to substitute that device, in accordance with the MDR before the date of expiry of the CE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certificate of Conformity, or (ii) a competent authority of an European Union Member State has granted a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derogation from the application conformity assessment procedure in accordance with Article 59(1) or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Article 97(1) of the MDR.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On July 26, 2011, our Notified Body at the time, TUV Nord, issued a CE Certificate of Conformity for, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thus allowed us to affix the CE mark, version 1.0 of the Heartflow Platform (July 26, 2011). The CE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certificate of Conformity was subsequently reviewed for version 2.x of the Heartflow Platform and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confirmed in March of 2017. Our current version, version 3.x is also CE marked under the MDD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(November 20, 2019). We currently rely on the transitional provisions of the MDR to continue to place <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">version 3.x of the Heartflow Platform on the market in the European Union.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, TUV Nord assessed the conformity of our quality management system (&#8220;QMS&#8221;) with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">industry standard, EN ISO 13485, and TUV Nord issued the certificate confirming that we meet all EN ISO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">13485 requirements. Based on the EN ISO certificate, TUV Nord also issued a certificate under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDSAP (Medical Device Single Audit Program), stating that the requirements of EN ISO 13485&#58;2016 for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality management systems are met in Australia, Canada, USA and Japan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the second half of 2024, we changed Notified Bodies from TUV Nord to BSI by an agreement between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TUV Nord, BSI and us. BSI has taken over Notified Body responsibilities concerning all MDD&#47;MDR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements. BSI has also taken over our QMS certifications. After this transfer, all certificates issued by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TUV Nord remain valid and in effect. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The advertising and promotion of medical devices in the European Union is subject to the national laws of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the individual European Union Member States that implemented the MDD, the AIMD and that apply the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDR, Directive 2006&#47;114&#47;EC concerning misleading and comparative advertising, and Directive 2005&#47;29&#47;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">EC on unfair commercial practices, as well as other national legislation of individual European Union <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Member States governing the advertising and promotion of medical devices. European Union Member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States&#8217; national legislation may also restrict or impose limitations on our ability to advertise our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directly to the general public. In addition, voluntary European Union and national industry Codes of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conduct provide guidelines on the advertising and promotion of our products to the general public and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may impose limitations on our promotional activities with healthcare professionals.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">146<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, other countries, such as Switzerland, have voluntarily adopted laws and regulations relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical devices that mirror those of the European Union. Medical devices certified by a Notified Body and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked in the European Union may be placed on Swiss market.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The United Kingdom left the European Union in January of 2020 and the transitional period ended on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2020. In light of the fact that the CE Marking process is set out in European Union law, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which no longer applies in the United Kingdom, the United Kingdom has devised a new route to market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">culminating in a UKCA Mark to replace the CE Mark. Northern Ireland will, however, continue to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covered by the regulations governing CE Marks. The United Kingdom Medicines and Healthcare products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulatory Agency (&#8220;MHRA&#8221;) has established transitional provision to recognize the acceptance of certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked medical devices on the Great Britain market until June 30, 2030, at the latest, depending on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the type of device and its classification. Accordingly, medical devices which, for example, meet all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of the European Union MDD and have a valid CE Certificate of Conformity and European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Union Declaration of conformity issued under the MDD prior to May 26, 2021, may be placed on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market until the sooner of expiry of the CE Certificate of Conformity or June 30, 2028. Medical devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which meet all requirements of the European Union MDR may be placed on the market until June 30, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2030. Manufacturers of medical devices located outside the United Kingdom, including manufacturers of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked medical devices, need to appoint a United Kingdom Responsible Person before the devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be placed on the United Kingdom market. The United Kingdom government plans on introducing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new legislation governing medical devices which will be delivered though secondary legislation. The first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">piece of legislation was laid in 2024 and updates post-market surveillance requirements. Additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instruments will follow in 2025 and 2026 to introduce new pre-market requirements including international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reliance, and further enhancements to the regulations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We applied for marketing authorization with the PMDA in Japan in February 2015, which was approved in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 2016. As a result, we are able to commercially market the product in Japan. Our initial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">SHONIN application is still current and includes a minor change notification.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Canada<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow received our initial Canadian Medical Device License in August 2015. This remains current and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">updated frequently with amendments for every minor software release. As well, Canada recognizes the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Mobile application as a separate device identified within our Heartflow device family and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires amendments for Mobile updates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other regulations &#8212; federal and state fraud and abuse, data privacy and security and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">transparency laws<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to FDA restrictions on marketing and promotion of medical devices, there are numerous U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal and state laws, regulations, and guidance documents pertaining to healthcare compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protections against fraud and abuse, including anti-kickback laws, payment transparency laws, patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inducement laws, and false claims laws, and, in some states, prohibitions against the corporate practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of medicine and the unlicensed practice of medicine (collectively, fraud and abuse laws and regulations). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our relationships with physicians, hospitals and other healthcare providers and referral sources for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products are subject to scrutiny under these laws. Violations of these laws may be punishable by criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and civil sanctions, including, in some instances, imprisonment and exclusion from participation in federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and state healthcare programs, including the Medicare, Medicaid and Veterans Administration health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs. Because of the breadth and far-reaching nature of these laws, we may be required to alter or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discontinue one or more of our business practices to be in compliance with these laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These healthcare fraud and abuse laws and regulations are complex, and even minor departures from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">what is expressly permitted under the laws and regulations can potentially give rise to claims that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statute or regulation has been violated in a manner that could result in serious criminal or civil <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">147<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consequences. Several of the more significant healthcare fraud and abuse laws and regulations that may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our business or ability to operate are summarized below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The federal Anti-Kickback Statute is a criminal law that prohibits, among other things, knowingly and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully offering, paying, soliciting, or receiving any remuneration in cash or in-kind (including any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">kickback or bribe, but also common forms of remuneration, such as service or consulting fees, service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees, meals, travel expenses, discounts, or rebates), directly or indirectly, overtly or covertly, to induce or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in return for purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although there are a number of statutory exceptions and regulatory safe harbors protecting some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common activities, the exceptions and safe harbors are drawn narrowly. Practices that involve <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration that may be alleged to be intended to induce prescribing, uses, purchases, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recommendations of prescriptions, uses, or purchases of our products may be subject to scrutiny if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis based on a review of all relevant facts and circumstances. Several courts have interpreted the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to induce referrals of (or purchases, uses, or recommendations of prescriptions, uses, or purchases) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal healthcare program covered business, the Anti-Kickback Statute has been implicated and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potentially violated.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, the Anti-Kickback Statute was amended by the ACA. Specifically, as noted above, under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Anti-Kickback Statute, the government must prove that a defendant acted &#8220;knowingly&#8221; to prove a violation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ACA added a provision that clarifies that with respect to violations of the Anti-Kickback Statute, &#8220;a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person need not have actual knowledge&#8221; of the Statute or specific intent to commit a violation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Statute. This change effectively overturns case law interpretations that set a higher standard under which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecutors had to prove the specific intent to violate the law. In addition, the ACA codified case law that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim including items or services resulting from a violation of the federal Anti-Kickback Statute may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constitute a false or fraudulent claim for purpose of the federal civil False Claims Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The federal civil U.S. False Claims Act prohibits, among other things, any person or entity from knowingly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government or knowingly making, using or causing to be made or used a false record or statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand&#8221; for money or property presented to the United States government. The civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also applies to false submissions that cause the government to not receive a benefit to which it is entitled, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as a discounted sales price for products covered by federal healthcare programs. Intent to deceive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is not required to establish liability under the civil False Claims Act. In addition, the civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes a whistleblower provision that allows private citizens to bring claims on behalf of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States government alleging violations of the law. Whistleblowers may be entitled to up to as much as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thirty percent (30%) of the government&#8217;s financial recovery resulting from such claims. This incentivizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential whistleblowers to file complaints in federal court, which complaints are relied upon heavily by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government to investigate and prosecute allegations of violations of both the civil False Claims Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Many medical device, pharmaceutical, biotech and other healthcare companies have been investigated or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecuted under these healthcare fraud and abuse laws and regulations. Investigations, prosecutions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(and settlements) relate to a wide range of activities, including among other things, improper clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">studies, provision of consulting fees to physicians for services that were not commercially reasonable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providing free product to customers to induce them to do business with the manufacturer, providing high <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value meals to customers to induce them to do business with the manufacturer, or providing non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliant discounts or rebates to customers, with the expectation that the customers would bill federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs for the product or the medical services that involve the product. Other companies have been <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">148<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigated or prosecuted for causing false claims to be submitted by, among other things, marketing of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products for unapproved, and thus noncovered, uses, or for promotion of uses inconsistent with approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">labeling (&#8220;off label&#8221; promotion).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The United States government may further prosecute conduct constituting a false claim under the criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">False Claims Act. The criminal False Claims Act prohibits the making or presenting of a claim to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government knowing such claim to be false, fictitious, or fraudulent and, unlike the civil False Claims Act, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires proof of intent to submit a false claim.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to the Anti-Kickback Statute and the civil and criminal False Claims Acts, the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal government has the authority to seek civil monetary penalties, assessments and exclusions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against an individual or entity based on a wide variety of prohibited conduct. For example, the Civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Monetary Penalties Law authorizes the imposition of substantial civil money penalties against an entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that engages in activities including&#58; (i) knowingly presenting or causing to be presented, a claim for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services not provided as claimed or which is otherwise false or fraudulent in any way&#59; (ii) knowingly giving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or causing to be given false or misleading information reasonably expected to influence the decision to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discharge a patient&#59; (iii) offering or giving remuneration to any beneficiary of a federal healthcare program <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely to influence the receipt of reimbursable items or services&#59; (iv) arranging for reimbursable services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an entity which is excluded from participation from a federal healthcare program&#59; (v) knowingly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully soliciting or receiving remuneration for a referral of a federal healthcare program beneficiary&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(vi) using a payment intended for a federal healthcare program beneficiary for another use.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are other federal anti-fraud laws, including the Health Information Portability and Accountability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act&#8217;s fraud provisions, that prohibit, among other actions, knowingly and willfully executing, or attempting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to execute, a scheme to defraud any healthcare benefit program, including private payors, knowingly and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material fact or making any materially false, fictitious or fraudulent statement in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery of or payment for healthcare benefits, items or services.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Finally, many states and foreign countries have similar healthcare fraud and abuse statutes or regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that may be broader in scope and may apply regardless of payor, in addition to items and services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursed under Medicaid and other state programs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Violations any of these laws or any other governmental regulations that may apply to us may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusion of devices from government-funded healthcare programs, such as Medicare and Medicaid or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable foreign programs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Physician Payment Sunshine Act<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Transparency laws regarding payments or other transfers of value provided to certain licensed healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">professionals and teaching hospitals may also impact our business practices. The federal Physician <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payment Sunshine Act requires most medical device manufacturers, including Heartflow, to track and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">report annually to the Secretary of the United States Department of Health and Human Services (&#8220;HHS&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial arrangements, payments, and other transfers of value made by that entity to physicians (defined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to include doctors, dentists, optometrists, podiatrists, and chiropractors), other healthcare providers (such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as physician assistants and nurse practitioners) and teaching hospitals, as well as ownership and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment interests held by such physicians and their immediate family members. The payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information is made publicly available in a searchable format on the CMS Open Payments website. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similar laws have been enacted or are under consideration in several states and foreign jurisdictions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including states such as Massachusetts and Vermont, and countries like France, which has adopted the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loi Bertrand, or French Sunshine Act, which became effective in 2013. We will need to dedicate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant resources to establish and maintain systems and processes in order to comply with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations. Failure to comply with these federal reporting requirements can result in significant civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">monetary penalties. In addition, information reported to HHS, since it is publicly reported, can potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">149<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be used by a whistleblower to bring claims under the civil False Claims Act alleging that certain payments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or transfers of value gave rise to kickbacks or false claims.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Foreign Corrupt Practices Act<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) prohibits any U.S. individual or business from promising, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, paying, providing or authorizing the provision of money or anything else of value, directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, to any foreign official, political party candidate or certain other persons (including health care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">professionals of state-funded hospitals) for the purpose of influencing any act or decision of the foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity in order to assist the individual or business in obtaining, retaining or directing business. The FCPA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also obligates companies whose securities are listed in the United States to comply with accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions requiring them to maintain books and records that accurately and fairly reflect all transactions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the corporation, including international subsidiaries, and to devise and maintain an adequate system of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal accounting controls for domestic and international operations. Activities that violate the FCPA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">even if they occur wholly outside the United States, can result in criminal and civil fines, imprisonment, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disgorgement, oversight, and debarment from government contracts. In addition, several other domestic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and international anti-corruption or anti-bribery laws within and outside the United States apply to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Privacy, security and breach notification<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other federal and state laws and regulations restrict or otherwise impact our business practices. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws include, without limitation, data privacy, security and breach notification authorities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA, as amended by HITECH, requires health plans, certain healthcare providers and healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearinghouses, referred to as &#8220;Covered Entities,&#8221; to protect the privacy and security of certain types of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health information, referred to as protected health information (&#8220;PHI&#8221;). HIPAA also imposes various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements on &#8220;Business Associates&#8221; &#8212; entities performing services for, or on behalf of, a Covered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Entity that has access to the Covered Entity&#8217;s PHI in connection with providing those services as well as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their covered subcontractors. Three key sets of federal regulations implementing HIPAA &#8212; the Privacy, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Breach Notification and Omnibus Rules (collectively, &#8220;HIPAA Rules&#8221;) set forth a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards that Covered Entities and Business Associates must meet with respect to protecting the privacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and security of PHI. HIPAA also regulates standardization of data content, codes and formats used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare transactions and standardization of identifiers for health plans and providers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our customers are Covered Entities under HIPAA, and, in some cases, Heartflow may be considered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Associate to such Covered Entities when they pay Heartflow for certain services that involve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sharing of PHI with Heartflow. When Heartflow bills payors directly for the services, Heartflow is acting as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a Covered Entity. Whether acting as a Business Associate, covered subcontractor, or a Covered Entity, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow has obligations to comply with HIPAA and the HIPAA Rules, and either contractual obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to its Covered Entity Customers or statutory and contractual obligations to ensure that any sub-Business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Associates comply. This requires risk assessments and a wide range of compliance policies, procedures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and practices to safeguard.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Penalties for violations of HIPAA regulations include civil and criminal penalties. Our failure to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA could result in significant criminal and civil penalties and other damages which could adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our results of operations, financial position or cashflows. We have developed and implemented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">processes designed to comply with HIPAA and are continuing to assess the need for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safeguards, policies, procedures, and programing and to develop them where necessary. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements under HIPAA may change periodically and could have an effect on our business operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if compliance becomes substantially more costly than under current requirements. Additionally, a breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of unsecured PHI, such as by employee error or an attack by an outsider, could have an adverse effect on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business in terms of potential penalties and corrective action required, in addition to reputational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">damage.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">150<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to HIPAA and other federal privacy regulations, there are a number of state laws governing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy, confidentiality and security of health information that apply to our business. Most states also have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities governing breach notification. New laws governing privacy, security, and breach notification <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be adopted in the future as well. We have undertaken measures to comply with health information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy requirements to which we know we are subject. However, we can provide no assurance that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are or will always remain in compliance with diverse and changing privacy, security, and breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification requirements in all of the jurisdictions in which we do business. Failure to comply with privacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security or breach notification requirements could result in civil or criminal penalties, which could have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on our business. Our failure to adequately protect personal or health related information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could have an adverse effect on our business. A wide variety of provincial, state, national and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international laws and regulations apply to the creation, collection, use, retention, protection, disclosure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer, and other processing of personal information, including protected health information. These data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection and privacy and security related laws and regulations are evolving and being tested in courts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may result in ever increasing regulatory and public scrutiny and escalating levels of enforcement and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sanctions. Our failure to comply with applicable laws and regulations, or to protect such data, could result <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in enforcement action against us, including fines, imprisonment of company officials and public censure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims for damages by end customers and other affected individuals, damage to our reputation and loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of goodwill (both in relation to existing end customers and potential end customers), any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have an adverse effect on our operations, financial performance, and business. Evolving and changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">definitions of personal data and personal information, within the European Union, the United States and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere, especially relating to classification of IP addresses, machine identification, location data, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other information, may limit or inhibit our ability to operate or expand our business. Even the perception of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy concerns, whether or not valid, may harm our reputation and inhibit adoption of our product by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current and future end customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare reform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current and future U.S. legislative proposals to further reform healthcare or reduce healthcare costs may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in low, or even no, reimbursement for our product, or for the procedures associated with the use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our product, or limit coverage of our product. The cost containment measures that payors and providers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are instituting and the effect of any healthcare reform initiative implemented in the future could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly reduce our revenues from the sale of our product. Alternatively, the shift away from fee-for-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service agreements to capitated payment models supports the value of our product, as they are intended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to reduce longitudinal resource utilization, which can be cost saving for both payors and providers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ACA was enacted in March 2010. As a U.S.-based company with anticipated sales in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, these healthcare reform laws will materially impact our business. Certain provisions of the ACA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are still set to become effective in future years and the administrative agencies responsible for issuing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations that implement some aspects of the laws have yet to do so.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There have been numerous legal challenges and Congressional actions and amendments to certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aspects of the ACA. For example, on August 16, 2022, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">signed into law, which, among other things, extends enhanced subsidies for individuals purchasing health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance coverage in ACA marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maximum out-of-pocket cost and creating a new manufacturer discount program. Additionally, on July 4, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, the annual reconciliation bill, the &#8220;One Big Beautiful Bill Act,&#8221; or OBBBA, was signed into law which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is expected to reduce Medicaid spending and enrollment by implementing work requirements for some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beneficiaries, capping state-directed payments, reducing federal funding, and limiting provider taxes used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to fund the program. OBBBA also narrows access to ACA marketplace exchange enrollment and declines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to extend the ACA enhanced advanced premium tax credits, set to expire in 2025, which, among other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions in the law, are anticipated to reduce the number of Americans with health insurance. Further, it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is unclear whether there will be additional attempts to repeal the ACA outright or further pare back its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidies and enrollment periods.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">151<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The uncertain fate of the ACA notwithstanding, we expect that the ACA, as well as other healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reform measures that may be adopted in the future, particularly in light of the recent changes in the White <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">House and Congress, may result in more rigorous coverage criteria and in additional downward pressure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the price that we may receive for our products. Any reduction in payments from Medicare or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government programs may result in a similar reduction in payments from private payors. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation of cost containment measures or other healthcare reforms may prevent us from being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to generate additional revenue or attain profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Employees and human capital resources<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, we had 699 full-time employees globally. We believe the success of our business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will depend, in part, on our ability to attract and retain qualified personnel, in particular highly skilled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology personnel. Our employees are not subject to a collective bargaining agreement, and we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that we have good relations with our employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our human capital resources objectives include attracting and retaining top talent, investing in our talent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with leadership development and job-related technical training, and increasing diverse representation in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our employee base through inclusivity initiatives that build on our culture of inclusion and belonging. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal purposes of our equity incentive plans are to attract, retain and motivate employees, consultants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and directors through the granting of stock-based compensation awards and cash-based performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bonus awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Facilities<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our corporate headquarters and research and development facilities are located in Mountain View, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">California, where we lease approximately 61,500 square feet of office space under a lease agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that expires in August 2030. We also lease and occupy approximately 26,400 square feet in Austin, Texas <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily for additional production personnel under a lease agreement that expires in December 2026. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not own any real property. We believe that these facilities are adequate for the foreseeable future.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Legal proceedings<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have become, and we may become in the future, involved in various legal proceedings arising from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the normal course of business activities. We are not presently a party to any litigation the outcome of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which, we believe, if determined adversely to us, would individually or taken together, materially and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our business, financial condition, or results of operations. However, we may from time to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time be involved in various claims and legal proceedings of a nature we believe are normal and incidental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a business such as ours. These matters may include employment, contract, intellectual property, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product liability and other general claims. Regardless of outcome, litigation can have an adverse impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on us because of defense and settlement costs, diversion of management resources and other factors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 539.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Corporate information<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We were incorporated under the laws of the State of Delaware in 2007. On March 1, 2021, we completed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an internal reorganization in which a newly formed parent holding company was put in place. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previous holders of our common stock and preferred securities became holders of common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred securities of HeartFlow Holding, Inc. The equity incentive plan, outstanding equity awards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants and certain other equity-related agreements of HeartFlow, Inc. were assumed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. Our operations and business activities remained at HeartFlow, Inc., and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly-owned non-U.S. subsidiaries of HeartFlow, Inc. remained in place. On&#160;July 17, 2025, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated HeartFlow Holding, Inc. into HeartFlow, Inc. and the previous holders of HeartFlow Holding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc. common stock and preferred securities became holders of our common stock and preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities and the equity incentive plan, outstanding equity awards, outstanding warrants and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other equity-related agreements of HeartFlow Holding, Inc. were assumed by us. In connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidation, we changed our name to Heartflow, Inc. Our principal executive offices are located at 331 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">E. Evelyn Avenue, Mountain View, California 94041, and our telephone number is (650) 241-1221. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">152<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporate website address is www.heartflow.com. Information contained on, or accessible through, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">website shall not be deemed incorporated into and is not a part of this prospectus or the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement of which it forms a part. We have included our website in this prospectus solely as an inactive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">textual reference.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">153<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1233" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth information regarding our executive officers and directors, including their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ages as of June 30, 2025&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 139.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 212.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 219.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 212.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 212.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.51pt; position: absolute; text-decoration: none; white-space: pre;">Age<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 0pt; width: 219.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Position(s)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Executive officers and employee director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 91.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.08pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 27pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">53<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 27pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">President, Chief Executive Officer and Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 79.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 79.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.53pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 41.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 41.25pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Financial Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 129.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 129.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.55pt; position: absolute; text-decoration: none; white-space: pre;">................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 55.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">64<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 55.5pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Medical Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Non-employee directors<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 84pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">76<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 84pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director and Chair of the Board of Directors<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 94.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 94.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.52pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 98.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">72<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 98.25pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 112.5pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 81.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 82.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.03pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 112.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">59<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 112.5pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126.75pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 117.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 118.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 118.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 119.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 119.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.39999999999999pt; position: absolute; text-decoration: none; white-space: pre;">....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 126.75pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 126.75pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 101.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 102.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.08pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 141pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">66<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 141pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 155.25pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 94.78999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.99pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 155.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">66<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 155.25pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 169.5pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 84.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.46pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 169.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">80<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 169.5pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 183.75pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 183.75pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">67<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 183.75pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 198pt; width: 212.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 212.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 132.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.12pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 215.25pt; position: absolute; top: 198pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">61<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 198pt; width: 219.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 219.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 359.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our audit committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 376.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our compensation committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 393.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our nominating and corporate governance committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 410.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Dr. Downing, Mr. Smith and Dr. Taylor have each resigned from our board of directors in connection with the trading of our common <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 419.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock on the Nasdaq Global Select Market.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 436.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive officers and employee director<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.79000000000002pt; position: absolute; white-space: pre;"> has served as our Chief Executive Officer and as a member of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors since March 2022, and as our President since January 2022, and he served as our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diabetes portfolios of Medtronic plc (&#8220;Medtronic&#8221;), a global medical technology company, most recently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serving as a President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">branded consumer foods, from January 2004 until March 2008. He received a B.A. in Psychology and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">History from Duke University and an M.B.A. from Northwestern University&#8217;s Kellogg School of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Management. We believe that Mr. Farquhar&#8217;s extensive experience in the medical sector qualifies Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Farquhar to serve on our board of directors and his role as our Chief Executive Officer provides a vital link <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">between our board of directors and our management team.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.09pt; position: absolute; white-space: pre;"> has served as our Chief Financial Officer since June 2023. He joined the Company in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until July 2021 in various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leadership roles spanning global marketing, regulatory and clinical affairs and business development. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University of Pennsylvania&#8217;s The Wharton School. He is also a CFA charter holder. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">154<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.55pt; position: absolute; white-space: pre;"> has served as our Chief Medical Officer since March 2012. Prior to joining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company, Dr. Rogers was the Chief Scientific Officer and Global Head of Research and Development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at Cordis Corporation (&#8220;Cordis&#8221;), a medical device company that was formerly part of the Johnson &#38; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Johnson family of companies, from July 2006 until February 2012, where he was responsible for leading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments and research in cardiovascular devices. Prior to Cordis, Dr. Rogers was an Associate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Technology from July 1994 until July 2006, and a director of the Cardiac Catheterization and Experimental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular Interventional Laboratories at Brigham and Women&#8217;s Hospital in Massachusetts from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">October 2000 until June 2006, where he was responsible for clinical care, education and research. Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rogers served as a Principal Investigator for numerous interventional cardiology device, diagnostic, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pharmacology trials, is the author of numerous publications in the area of coronary artery and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiovascular diseases, and was the recipient of research grant awards from the National Institute of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Health and American Heart Association. Dr. Rogers previously served on the boards of directors of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corindus Vascular Robotics, Inc. (formerly NYSE&#58; CVRS) from 2016 until 2019, where he was a member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the Audit Committee, and InspireMD, Inc. (Nasdaq&#58; NSPR) from 2013 until 2022, where he was a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">member of the Research and Development Committee. He received an A.B. in English from Harvard <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">College and an M.D. from Harvard Medical School.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Non-employee directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.55pt; position: absolute; white-space: pre;"> has served as Chair of our board of directors from June 2017 to May 2019 and since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020, and also as a member of our board of directors since September 2014. Mr. Weldon is the former <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chairman of the board and Chief Executive Officer of Johnson &#38; Johnson (NYSE&#58; JNJ), a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developer and manufacturer of healthcare products, having served in those positions from 2002 until his <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retirement in 2012. Mr. Weldon previously served in a variety of senior executive positions during his 41-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year career with Johnson &#38; Johnson until his appointment as Chairman of the board and Chief Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Officer. Mr. Weldon has served on the board of directors of Fairfax Financial Holdings Limited since April <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020. Mr. Weldon previously served as a director of CVS Health Corporation (NYSE&#58; CVS) until his <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retirement from that board in May 2023, Exxon Mobil Corporation (NYSE&#58; XOM) until his retirement from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that board in May 2021, JPMorgan Chase &#38; Co. (NYSE&#58; JPM) until his retirement from that board in May <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2019, and The Chubb Corporation until its acquisition by ACE Limited in January 2016. He is a member of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">various not-for-profit organizations and is also a member of the Board of Trustees for Quinnipiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University. Mr. Weldon received his B.A. in Biology from Quinnipiac University. We believe that Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Weldon&#8217;s knowledge of the healthcare industry and his experience as chief executive officer and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">chairman of the board at Johnson &#38; Johnson and on the boards of other publicly traded companies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which have exposed him to reporting and governance requirements, qualify him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26999999999998pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since January 2022. Mr. Barabe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as the Chief Financial Officer and Executive Vice President at Affymetrix Inc. (acquired by Thermo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Fisher Scientific, Inc.), a provider of life science productions and molecular diagnostic products, from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2010 until his retirement in June 2013. Prior to that, Mr. Barabe served as Senior Vice President and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chief Financial Officer of Human Genome Sciences, Inc., a biopharmaceutical company, from July 2006 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until March 2010. From 2004 until 2006, he served as Chief Financial Officer of Regent Medical Limited, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.K.-based, privately held surgical supply company, and with Novartis AG, a pharmaceutical company, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 1982 until August 2004 in a succession of senior executive positions in finance and general <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management, most recently as the Chief Financial Officer of Sandoz GmbH, the generic pharmaceutical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiary of Novartis AG. Prior to that, Mr. Barabe served as the President of the Specialty Lens <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Franchise and Group Vice President and Chief Financial Officer of CIBA Vision Corporation, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contact lenses and lens care product manufacturer, until 2003. Mr. Barabe has served on the board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors of Cartesian Therapeutics, Inc. (Nasdaq&#58; RNAC) since 2016 and previously served on the board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors of Veeva Systems Inc. (NYSE&#58; VEEV) from September 2015 until June 2021, ArQule, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 2001 until January 2020, and Opexa Therapeutics, Inc. from 2014 until 2017. Mr. Barabe also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currently serves on the board of directors of Vigilant Biosciences, Inc., a private company. Mr. Barabe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received a B.B.A. in General Business, Finance from the University of Massachusetts at Amherst and an <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">155<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from the University of Chicago. We believe that Mr. Barabe&#8217;s extensive finance experience, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">his service on the board of directors of several other publicly traded companies, qualifies Mr. Barabe to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.14pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since November 2020. She has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as a Special Advisor to Brighton Park Capital, L.P., an investment firm specializing in software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information services and technology-enabled services, since June 2020, and previously served as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chief Technology and People Officer at Forescout Technologies Inc. (&#8220;Forescout&#8221;), a network security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">software company, from June 2017 until January 2021. Prior to joining Forescout, Ms. Cullivan served as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Executive Vice President, Business Operations and Chief Information Officer of FireEye, Inc., an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enterprise cybersecurity company, from January 2013 until May 2017, and as a Senior Vice President at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">McAfee Corp., a global computer security software company, from April 2008 until October 2011. Earlier in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">her career, Ms. Cullivan held executive roles at Autodesk, Inc., EMC Corporation, and Oracle Corporation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Ms. Cullivan has served on the board of directors of Axon Enterprise, Inc. (Nasdaq&#58; AXON) since 2017, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">where she has been a member of the Audit Committee since July 2017, Chair of the Enterprise Risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Committee since March 2022, and a member of the of the Nominating and Governance Committee since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">July 2024. She has also served on the boards of directors of Cobalt Labs Inc. (dba Cobalt.io) since 2022, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">where she is a member of the Compensation Committee, and OPSWAT Inc. since 2021. Ms. Cullivan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously served on the boards of Astra Space Inc. (Nasdaq&#58; ASTR), where she was a member of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Audit Committee from February 2023 to July 2024, SADA, where she was a member of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compensation Committee from May 2021 to December 2024, and AaDya Security Inc. (dba Judy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security) from March 2021 to August 2024. Ms. Cullivan received a B.S. in Finance from Santa Clara <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University. We believe that Ms. Cullivan&#8217;s extensive experience in the technology sector, including her <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past roles at leading technology, cybersecurity and digital infrastructure companies, qualifies Ms. Cullivan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.2pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since March 2023. Since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018, Dr. Downing has worked at Bain Capital, a private investment firm, currently serving as a Managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Director on the Bain Capital Life Sciences team. Prior to joining Bain Capital, Dr. Downing was a Resident <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Physician at the Brigham and Women&#8217;s Hospital in Boston from 2015 until 2018. Dr. Downing is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">author of over 40 peer-reviewed scientific articles. Prior to his medical career, Dr. Downing was a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consultant at McKinsey and Company, a global management consulting firm, where he worked with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clients in the pharmaceutical, hospital and financial services industries. Dr. Downing has served as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">member of the board of directors and the Nominating and Corporate Governance Committee of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">NewAmsterdam Pharma Company N.V. (Nasdaq&#58; NAMS) since November 2022. Dr. Downing received <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an A.B. in Chemistry from Harvard College and an M.D. from Yale University School of Medicine. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that Dr. Downing&#8217;s extensive investment and financial experience, particularly in the medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sector, as well as his medical background qualifies Dr. Downing to serve on our board of directors. Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Downing resigned from our board of directors in connection with the commencement of trading of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock on the Nasdaq Global Select Market. Dr. Downing&#8217;s resignation is not due to any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disagreement with us or any matters relating to our operations, policies or practices.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.94pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since December 2011. Since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2007, Mr. Lightcap has served as a Senior Managing Director at HealthCor Partners Management, L.P. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;HealthCor Partners&#8221;), a venture capital investment manager focused on late-stage venture and early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial stage healthcare companies. Since 2019, Mr. Lightcap also serves as a Senior Managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Director at Healthcare Venture Partners, LLC, a venture capital investment manager focused on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments in technology driven companies in the diagnostic, therapeutic and medtech sectors. From <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1997 until 2006, Mr. Lightcap served as a Senior Managing Director at JLL Partners, a leading middle-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market private equity firm. Prior to JLL Partners, from 1993 until 1997, Mr. Lightcap served as a Managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Director in the mergers and acquisitions group at Merrill Lynch &#38; Co., Inc. (&#8220;Merrill Lynch&#8221;), a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial services company. Prior to joining Merrill Lynch, Mr. Lightcap was a Senior Vice President in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">mergers and acquisitions group at Kidder, Peabody &#38; Co., an investment banking company, and briefly at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Salomon Brothers, a global financial institution. Mr. Lightcap currently serves on the board of directors of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Careview Communications, Inc. (OTC&#58; CRVW), KellBenx, Inc. and Paige.AI, Inc. Mr. Lightcap also <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">156<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously served on the board of directors of a number of HealthCor Partners&#8217; portfolio companies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including Corindus Vascular Robotics Inc. (March 2008 to October 2019), Practice Partners in Healthcare, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">LLC (September 2007 to April 2019), Paradigm Spine, LLC (April 2008 to March 2019) and RTI Surgical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holdings, Inc. which became Surgalign Holdings, Inc. (March 2019 to September 2021). Mr. Lightcap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received a B.E. in Mechanical Engineering from the State University of New York at Stony Brook and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from the University of Chicago. We believe that Mr. Lightcap&#8217;s extensive experience in the medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sector, including his service on the boards of directors of multiple healthcare companies, qualifies Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Lightcap to serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.59pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since November 2021. Dr. Riley <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has served as the President of the State University of New York Downstate Health Sciences University <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since April 2017, where he is also a Tenured Professor of Internal Medicine and Health Policy and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Management. From 2013 until 2017, Dr. Riley was an Adjunct Professor of Healthcare Management at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Owen Graduate School of Management, Vanderbilt University and a Clinical Professor of Medicine at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vanderbilt University School of Medicine. From 2007 until 2013, Dr. Riley served as President and Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Executive Officer of Meharry Medical College, and from 2003 until 2006, served as Vice President and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vice Dean of Health Affairs and Governmental Relations at Baylor College of Medicine. Dr. Riley has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served on the board of directors of Compass Pathways, plc (Nasdaq&#58; CMPS) since 2021 and HCA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Healthcare, Inc. (NYSE&#58; HCA) since 2012, where he also serves as the chair of the patient safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality committee and as a member of the audit and compliance committee and nominating and corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governance committee. Dr. Riley previously served as a director of Vertex Pharmaceuticals Inc. (Nasdaq&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">VTRX) from 2010 until 2015, Pinnacle Financial Partners, Inc. from 2007 until 2013, and the Federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Reserve Bank of Atlanta, Nashville Branch Bank Board from January 2013 to June 2013. He is President <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Emeritus of the American College of Physicians and an elected member of the National Academy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicine. Dr. Riley is also a commissioner of the Medicare Payment Advisory Commission, chair of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board of Trustees and of The New York Academy of Medicine since 2019. Dr. Riley received a B.A. in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Anthropology from Yale University, an M.P.H. in Health Systems Management from the Tulane University <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">School of Public Health and Topical Medicine, an M.D. from the Morehouse School of Medicine, and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from Rice University&#8217;s Jesse H. Jones Graduate School of Business. We believe that Dr. Riley&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience as a practicing physician and his leadership, executive management and patient care skills at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other leading medical and educational institutions, as well as his prior public company board service, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualify him to serve on our board of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.12pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since September 2011. From 1997 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until April 2020, Mr. Smith was the President and Chief Executive Officer and then Chairman of Intuitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Surgical, Inc., a developer and manufacturer of surgical robotic products designed to improve clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outcomes of patients. From 1978 until 1997, Mr. Smith was Senior Executive Vice President of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hillenbrand Industries, a manufacturer and provider of products and services for the health care and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funeral services industries. During his tenure at Hillenbrand Industries, he was a member of the executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">committee, the office of the president and the board of directors. Mr. Smith has also held positions at The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Boston Consulting Group, a management consulting firm, and International Business Machines Corp, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology and consulting company. Mr. Smith served as chairman of the board of Tandem Diabetes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Care, Inc. (Nasdaq&#58; TNDM), from 2013 until 2015. Mr. Smith received a B.S.E.E. from Utah State <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University and an M.B.A. from Harvard Business School. We believe that Mr. Smith&#8217;s extensive medical, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and directorship experience in the medical sector qualifies him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors. Mr. Smith resigned from our board of directors in connection with the commencement of trading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock on the Nasdaq Global Select Market. Mr. Smith&#8217;s resignation is not due to any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disagreement with us or any matters relating to our operations, policies or practices.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.54000000000002pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since August 2010. Since 2005, he <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has served as a General Partner of U.S. Venture Partners, a venture capital firm. From 2001 until 2004, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Tansey served as the Chief Executive Officer and President of Epicor Medical, a medical device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. Prior to Epicor Medical, Mr. Tansey was Chief Executive Officer and President of Heartport, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc., a medical device company, which is now part of the Johnson &#38; Johnson family of companies. Prior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to that, he was with the cardiovascular division at Baxter Edwards, a medical technology company, for <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">157<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nearly ten years, holding various sales and marketing positions. Mr. Tansey currently serves on the board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors and as a member of the organization and compensation committee of Inspire Medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Systems, Inc. (NYSE&#58; INSP) and previously served on the board of directors of Intersect ENT, Inc. from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2006 until 2017. He also serves on the board of directors for a number of U.S. Venture Partners&#8217; portfolio <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of private companies, including Cagent Vascular Inc., HighLife Medical Inc., Luminopia, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MicroTransponder Inc., Neochord, Inc., Neuros Medical, Inc., ShiraTronics, Inc. and Shoulder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Innovations. Mr. Tansey received a B.S. and an M.B.A. from the Notre Dame De Namur University. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that Mr. Tansey&#8217;s extensive experience as a venture capital investor and as a member of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">boards of directors of multiple companies in the medical sector qualify him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Charles A. Taylor, Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.23000000000002pt; position: absolute; white-space: pre;"> is one of our founders, and has served as a member of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since July 2007. He is currently the W.A. &#8220;Tex&#8221; Moncrief, Jr., Chair in Computational Medicine, and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Professor in the Department of Internal Medicine and the Oden Institute for Computational Engineering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Sciences at the University of Texas at Austin. Dr. Taylor served as the Chief Technology Officer from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">April 2010 to February 2022 and then Chief Scientific Officer of the Company from February 2022 through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 2023. Prior to joining the Company, Dr. Taylor was an Associate Professor in the Department <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of Bioengineering and Surgery at Stanford University from July 1997 until August 2010, where he held <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">courtesy faculty appointments in the Departments of Mechanical Engineering and Radiology. He received <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a B.S. in Mechanical Engineering, M.S. in Mechanical Engineering and M.S. in Mathematics from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rensselaer Polytechnic Institute and a Ph.D. in Mechanical Engineering from Stanford University. Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taylor has published over 450 publications in scientific journals and conference papers related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiovascular bioengineering and patient-specific modeling of blood flow in the cardiovascular system <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and is also an inventor on more than 300 issued patents worldwide. In 2024, Dr. Taylor was inducted into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the U.S. National Academy of Engineering. We believe that Dr. Taylor&#8217;s extensive knowledge of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company as its founder, Chief Technology Officer and Chief Scientific Officer, experience as an inventor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and knowledge of our industry qualifies him to serve on our board of directors. Dr. Taylor resigned from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our board of directors in connection with the commencement of trading of our common stock on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Nasdaq Global Select Market. Dr. Taylor&#8217;s resignation is not due to any disagreement with us or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">matters relating to our operations, policies or practices.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Family relationships <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are no family relationships among any of our executive officers or directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Board composition and election of directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our business and affairs are managed under the direction of our board of directors. Our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currently consists of seven members&#58; Mr. Barabe, Ms. Cullivan, Mr. Farquhar, Mr. Lightcap, Dr. Riley, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Tansey and Mr. Weldon. Under our amended and restated voting agreement (&#8220;Voting Agreement&#8221;), which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would terminate at the completion of this offering, the stockholders who are party to the Voting Agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have agreed to vote their respective shares to elect&#58; (i) one director designated by BCLS Fund III <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investments, LP, currently Nicholas Downing, (ii) two directors designated by the holders of our Series A, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series B-1, Series B-2, Series C, Series D and Series E redeemable convertible preferred stock, currently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Casey M. Tansey and Jeffrey C. Lightcap, (iii) our Chief Executive Officer, John C.M. Farquhar, (iv) one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">director designated by our founders, currently Charles A. Taylor, and (v) Timothy C. Barabe, Julie A. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cullivan, Wayne J. Riley, Lonnie M. Smith and William C. Weldon, as directors designated by the majority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the foregoing directors. In connection with this offering, the Voting Agreement will terminate. As a result, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following this offering there will be no contractual obligations regarding the election of our directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After this offering, the authorized number of directors may be changed by resolution of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to the terms of our amended and restated certificate of incorporation that will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective upon the completion of this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">158<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Director independence<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our common stock has been approved for listing on&#160;the Nasdaq Global Select Market. Under the listing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rules of&#160;the Nasdaq Global Select Market&#160;(&#8220;Listing Rules&#8221;), independent directors must comprise a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">majority of a listed company&#8217;s board of directors within a specified period following completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering. In addition, the Listing Rules require that, subject to specified exceptions, each member of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">listed company&#8217;s audit, compensation, and nominating and corporate governance committees be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">independent. Under these rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the company&#8217;s board of directors, that person does not have a relationship that would interfere with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of independent judgment in carrying out the responsibilities of a director. Under the Listing Rules, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain types of relationships generally occurring within the last three years will automatically disqualify a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">director as independent, such as if the director is one of our employees, is in receipt of direct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation from us in excess of $120,000 in a twelve-month period, or is engaged, directly or indirectly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in certain business dealings with us in excess of specified thresholds. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has determined that none of Mr. Barabe, Ms. Cullivan, Mr. Lightcap, Dr. Riley, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Tansey or Mr. Weldon has a relationship that would interfere with the exercise of independent judgment in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carrying out the responsibilities of a director, and that each of such individuals are &#8220;independent directors&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in accordance with the Listing Rules. In making these determinations, our board of directors reviewed and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussed information provided by the directors and us with regard to each director&#8217;s business and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personal activities and relationships as they may relate to us and our management. Mr. Farquhar is not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered independent by virtue of his position as our Chief Executive Officer, and Dr. Taylor is not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered independent by virtue of his former employment with us within the last three years.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Classified board of directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In accordance with our amended and restated certificate of incorporation, which will be effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.74pt; position: absolute; text-decoration: none; white-space: pre;">upon <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.75pt; position: absolute; white-space: pre;">the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, our board of directors will be divided into three classes with staggered three-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year terms. At each annual general meeting of stockholders, the successors to directors whose terms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">then expire will be elected to serve from the time of election and qualification until the third annual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meeting following election. Our directors will be divided among the three classes as follows&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class I directors will be John C.M. Farquhar and Julie A. Cullivan, and their terms will expire at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the first annual meeting of stockholders following effectiveness of the amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class II directors will be Jeffrey C. Lightcap, Casey M. Tansey and Timothy C. Barabe, and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">terms will expire at the second annual meeting of stockholders following effectiveness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amended and restated certificate of incorporation&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 528.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class III directors will be William C. Weldon and Wayne Riley, M.D., and their terms will expire at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the third annual meeting of stockholders following effectiveness of the amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; white-space: pre;"> division of our board of directors into three classes with staggered three-year terms may delay or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent a change of our management or a change in control.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Leadership structure of the board<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 627.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our corporate governance guidelines to be in place upon the commencement of trading of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock on the Nasdaq Global Select Market will provide our board of directors with flexibility to combine or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">separate the positions of Chair of the board of directors and Chief Executive Officer and to implement a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lead independent director in accordance with its determination regarding which structure would be in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">best interests of our company.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Weldon currently serves as our Chair of the board of directors and Mr. Farquhar serves as our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Executive Officer. Our board of directors has concluded that our current leadership structure is <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">159<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate at this time. However, our board of directors will continue to periodically review our leadership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">structure and may make such changes in the future as it deems appropriate.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Board committees<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has established an audit committee, a compensation committee, and a nominating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and corporate governance committee. Our board of directors may establish other committees to facilitate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the management of our business. The composition and functions of each committee are described below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Members serve on these committees until their resignation or until otherwise determined by our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors. Our board of directors has adopted a written charter for each committee that satisfies the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and Listing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rules, which we will post on our website at www.heartflow.com upon the completion of this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Audit committee<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audit committee oversees our corporate accounting and financial reporting process and the quality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and integrity of our financial statements, the qualifications and performance of our independent registered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public accounting firm, our internal audit function and our risk management program. Among other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">matters, the audit committee&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our independent registered public accounting firm, and has sole responsibility for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">appointment, compensation, retention and oversight of the work of our independent registered public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accounting firm&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluates the independent registered public accounting firm&#8217;s qualifications, independence, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves the scope of the annual audit and pre-approves all audit and non-audit fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and services to be performed by our independent registered public accounting firm&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews with management and our independent registered public accounting firm the results of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual audit and the review of our interim financial statements, and reviews our financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and our management&#8217;s discussion and analysis of financial condition and results of operations to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">included in our annual and quarterly reports to be filed with the SEC&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our internal audit function&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our risk management program and reviews risks related to major financial risk exposures, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">information security, regulatory compliance, and the steps our management has taken to monitor and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">control these risks and exposures&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">establishes procedures for the receipt, retention, and treatment of any complaints received by us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">regarding accounting, internal accounting controls, or auditing matters&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves all related person transactions&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews the audit committee charter and the audit committee&#8217;s performance on an annual basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audit committee consists of Timothy C. Barabe, Julie A. Cullivan and Wayne Riley, M.D. Our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors has determined that all members are independent under the Listing Rules and Rule 10A-3(b)(1) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the Exchange Act. The chair of our audit committee is Mr. Barabe. Our board of directors has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined that Mr. Barabe&#160;is an &#8220;audit committee financial expert&#8221; as such term is currently defined in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Item 407(d)(5) of Regulation S-K. Our board of directors has also determined that each member of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">audit committee can read and understand fundamental financial statements as required by the Listing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rules. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">160<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Compensation committee&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our compensation committee oversees our compensation policies, plans and benefit programs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particularly as they apply to our executive officers. Among other matters, the compensation committee&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves corporate goals and objectives relevant to compensation of our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Executive Officer, evaluates the performance of the Chief Executive Officer in light of those goals and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">objectives and approves the compensation of Chief Executive Officer based on such evaluations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves the compensation of our other executive officers&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and makes recommendations to our board of directors regarding non-employee director <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compensation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves or makes recommendations to our board of directors regarding the issuance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock options and other equity awards under our performance incentive plans&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">engages in risk assessments of our compensation programs&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews the compensation committee charter and the compensation committee&#8217;s performance on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our compensation committee consists of Jeffrey C. Lightcap, Wayne Riley, M.D. and Casey M. Tansey. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has determined that all members are independent under the Listing Rules. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">chair of our compensation committee is&#160;Dr. Riley.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Nominating and corporate governance committee&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our nominating and corporate governance committee oversees the nomination process for our directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and policies relating to our corporate governance. Among other matters, the nominating and corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governance committee&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifies individuals qualified to be members of our board of directors, including candidates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recommended by stockholders, consistent with criteria approved by our board of directors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluates and makes recommendations to our board of directors of candidates for membership on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors and on each of the board&#8217;s committees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">develops and reviews the adequacy of our corporate governance guidelines and code of business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conduct and ethics and recommends and proposed changes to our board of directors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees the process of evaluating the performance of our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees management succession planning&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assists our board of directors on corporate governance matters and board of directors performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">matters, including recommendations regarding the size, structure and composition of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and its committees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our nominating and corporate governance committee consists of Jeffrey C. Lightcap, Casey M. Tansey, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and William C. Weldon. Our board of directors has determined that all members are independent under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Listing Rules. The chair of our nominating and corporate governance committee is&#160;Mr. Weldon.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Compensation committee interlocks and insider participation&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">None of the members of our compensation committee (Jeffrey C. Lightcap, Wayne Riley, M.D. and Casey <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M. Tansey) is or has been during the past fiscal year one of our employees or has been at any time one of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our officers, and none of such individuals has any relationship requiring disclosure under SEC rules <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 699.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable to related person transactions. None of our executive officers currently serves, or has served <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">161<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">during the last fiscal year, as a member of the board of directors or compensation committee (or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board committee performing equivalent functions) of any entity that has one or more executive officers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serving as a member of our board of directors or on our compensation committee.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Code of business conduct and ethics&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, our board of directors has adopted a written code of business conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and ethics to be effective upon the commencement of trading of our common stock on the Nasdaq Global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Select Market, which applies to all of our directors, executive officers, and employees, including our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal executive officer, principal financial officer, and principal accounting officer or controller, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">persons performing similar functions. The full text of our code of business conduct and ethics will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">posted on our website at www.heartflow.com upon the completion of this offering. The nominating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporate governance committee of our board of directors will be responsible for overseeing our code of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business conduct and ethics. We intend to disclose any future amendments to or waivers of our code of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business conduct and ethics applicable to our directors and officers, including our principal executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officer, principal financial officer, principal accounting officer or controller, or persons performing similar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">functions to the extent required by applicable rules of the SEC or the Nasdaq Global Select Market, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our website at the address identified above. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations on liability and indemnification matters&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation, which will become effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.3pt; position: absolute; text-decoration: none; white-space: pre;">upon <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 462.31pt; position: absolute; white-space: pre;">the completion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering, limit our directors&#8217; and officers&#8217; liability to us and our stockholders for monetary damages for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">breach of fiduciary duty as a director or officer to the fullest extent permitted under the General <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;). Such provision will not eliminate or limit the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability of&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholders&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any act or omission not in good faith or that involves intentional misconduct or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a knowing violation of law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director for an unlawful payment of dividends or redemption of shares&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any transaction from which the director or officer derived an improper personal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">benefit&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an officer in any action by or in the right of the corporation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These limitations of liability do not apply to liabilities arising under federal securities laws and do not affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the availability of equitable remedies such as injunctive relief or rescission. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As permitted by the DGCL, our amended and restated certificate of incorporation will provide that we will, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in certain situations, indemnify our directors and officers and may indemnify other employees and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitations, to payment of expenses (including attorneys&#8217; fees) in advance of the final disposition of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeding. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we have entered, and intend to continue to enter, into separate indemnification agreements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with our directors and officers. These indemnification agreements, among other things, require us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement amounts incurred by a director or officer in any action or proceeding arising out of their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services as a director or officer, or any other company or enterprise to which the person provides services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at our request. We also maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and officers are insured against liability for actions taken in their capacities as directors and officers. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">162<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that these provisions in our amended and restated certificate of incorporation and these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification agreements are necessary to attract and retain qualified persons as directors and officers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers, or control persons, we have been advised that, in the opinion of the SEC, such indemnification is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against public policy as expressed in the Securities Act and is therefore unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">163<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1258" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive and director compensation<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This section discusses the material components of the executive compensation program for our executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers who are named in the &#8220;Summary Compensation Table&#8221; below. In 2024, our &#8220;named executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers,&#8221; comprised of our principal executive officer and the two most highly compensated executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers (other than our principal executive officer) and their positions with the Company, were as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar, President and Chief Executive Officer&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese, Chief Financial Officer&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.05pt; position: absolute; text-decoration: none; white-space: pre;">, Chief Medical Officer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we are not required to include a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements applicable to emerging growth companies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 summary compensation table<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 289.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> sets forth information concerning the compensation of our named executive officers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the year ended December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 321.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 123pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 45pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 44.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 50.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 66.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 66.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 54pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name and principal <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">position<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 126pt; position: absolute; top: 0pt; width: 45pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 45pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.37pt; position: absolute; text-decoration: none; white-space: pre;">Salary<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 45pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 31.39pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 0pt; width: 44.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 44.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">Bonus<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 44.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 34.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 221.25pt; position: absolute; top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.66pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.63pt; position: absolute; text-decoration: none; white-space: pre;">awards<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 40.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 274.5pt; position: absolute; top: 0pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.19pt; position: absolute; text-decoration: none; white-space: pre;">Non-equity <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.17pt; position: absolute; text-decoration: none; white-space: pre;">incentive plan <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 56.989999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 344.25pt; position: absolute; top: 0pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.66pt; position: absolute; text-decoration: none; white-space: pre;">All other <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 66.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 56.989999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 414pt; position: absolute; top: 0pt; width: 54pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 54pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.42pt; position: absolute; text-decoration: none; white-space: pre;">Total ($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.26pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 84.21pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 126pt; position: absolute; top: 45pt; width: 45pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 45pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 6.13pt;"></font></font><font style="left: 8.76pt; position: absolute;">590,480<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 45pt; width: 44.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 44.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 31.509999999999998pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 221.25pt; position: absolute; top: 45pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 3.88pt;"></font></font><font style="left: 6.51pt; position: absolute;">1,030,400<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 274.5pt; position: absolute; top: 45pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 27.88pt;"></font></font><font style="left: 30.509999999999998pt; position: absolute;">654,369<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 344.25pt; position: absolute; top: 45pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 37.88pt;"></font></font><font style="left: 40.510000000000005pt; position: absolute;">5,200<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 414pt; position: absolute; top: 45pt; width: 54pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 54pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 7.63pt;"></font></font><font style="left: 10.26pt; position: absolute;">2,280,449<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 23.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.54pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">President and Chief <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.34pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Executive Officer<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.76pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 70.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 72.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 72.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 72.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 72.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 72.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 126pt; position: absolute; top: 82.5pt; width: 45pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 45pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 6.13pt;"></font></font><font style="left: 8.76pt; position: absolute;">400,548<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 82.5pt; width: 44.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 44.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 31.509999999999998pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 221.25pt; position: absolute; top: 82.5pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 3.88pt;"></font></font><font style="left: 6.51pt; position: absolute;">1,067,295<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 274.5pt; position: absolute; top: 82.5pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 27.88pt;"></font></font><font style="left: 30.509999999999998pt; position: absolute;">222,338<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 344.25pt; position: absolute; top: 82.5pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 37.88pt;"></font></font><font style="left: 40.510000000000005pt; position: absolute;">5,200<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 414pt; position: absolute; top: 82.5pt; width: 54pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 54pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 7.63pt;"></font></font><font style="left: 10.26pt; position: absolute;">1,695,381<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.84pt; width: 123pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Financial Officer<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.76pt; width: 123pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 116.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 117.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 117.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 117.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 126pt; position: absolute; top: 114pt; width: 45pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 45pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 6.13pt;"></font></font><font style="left: 8.76pt; position: absolute;">535,600<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 174pt; position: absolute; top: 114pt; width: 44.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 44.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 5.38pt;"></font></font><font style="left: 8.01pt; position: absolute;">230,000<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 221.25pt; position: absolute; top: 114pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 274.5pt; position: absolute; top: 114pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 27.88pt;"></font></font><font style="left: 30.509999999999998pt; position: absolute;">294,580<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 344.25pt; position: absolute; top: 114pt; width: 66.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 66.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 37.88pt;"></font></font><font style="left: 40.510000000000005pt; position: absolute;">5,200<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 414pt; position: absolute; top: 114pt; width: 54pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 54pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 7.63pt;"></font></font><font style="left: 10.26pt; position: absolute;">1,065,380<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 129.75pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.84pt; width: 123pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Medical Officer<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 475.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amount represents a $57,500 bonus paid at the end of each quarter to Dr. Rogers during 2024.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 492.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts reflect the grant date fair value of stock options granted during 2024 computed in accordance with ASC Topic 718, rather than <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 501.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the amounts paid to or realized by the named individual. See Note&#160;14&#160;of the consolidated financial statements elsewhere included in <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 510.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this prospectus for a discussion of valuation assumptions made in determining the grant date fair value and compensation expense of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 519.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our stock options.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 536.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts represent annual bonuses earned by each named executive officer in 2024 which were paid by us after certification of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 545.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance achievement in early 2025. See &#8220;2024 Bonuses&#8221; below.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 562.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts disclosed reflect Company contributions to our 401(k) plan.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 579.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Narrative to the summary compensation table<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each of our Named Executive Officers will participate in our senior leadership severance policy, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in &#8220;Senior leadership severance policy&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Elements of compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 653.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 salaries<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2024, the named executive officers received an annual base salary to compensate them for services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 685.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rendered to the company. The base salary payable to each named executive officer is intended to provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">164<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For fiscal year 2024, Mr. Farquhar&#8217;s annual base salary was $594,881&#160;effective as of&#160;March 3, 2024&#160;(and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it was $572,000&#160;prior),&#160;Mr. Verghese&#8217;s base salary was $404,250&#160;effective as of&#160;March 3, 2024&#160;(and it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was $385,000&#160;prior) and&#160;Dr. Rogers&#8217;s base salary was $535,600&#160;effective as of&#160;February 7, 2021. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 bonuses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2024, Mr. Farquhar, Mr. Verghese and&#160;Dr. Rogers&#160;were eligible to earn annual cash bonuses targeted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at 100%, 50% and 50%, respectively, of their annual base salaries. Pursuant to our annual cash bonus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">program, each named executive officer was eligible to earn his annual cash bonus based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attainment of pre-established annual company objectives. These pre-established objectives include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue, with a target of $120.1 million (weighted 40%), gross margin, with a target of 70.1% (weighted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">20%), interactive product validation (weighted 20%), asymptomatic strategy (weighted 10%) and patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">care (weighted 10%). The actual achieved bonus amount was paid in 2025 based on achievement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such objectives.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Equity compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each of our named executive officers currently holds outstanding stock option awards granted pursuant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s 2009 Equity Incentive Plan as described in more detail in the section titled &#8220;&#8212;Outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity awards at year end&#8221; below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, we intend to adopt the 2025 Plan (as defined below) in order to facilitate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the grant of cash and equity incentives to directors, employees (including our named executive officers) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and consultants of our company and certain of our subsidiaries (if any) and to enable us to obtain and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retain the services of these individuals, which is essential to our long-term success. We expect that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Plan will be effective upon the commencement of trading of the Company&#8217;s common stock on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Nasdaq Global Select Market. For additional information about the 2025 Plan, please see the section <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">titled &#8220;&#8212;2025 performance incentive plan&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other elements of compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Retirement plans <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We maintain a 401(k) retirement savings plan for our employees, including our named executive officers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">401(k) plan on the same terms as other full-time employees. We anticipate that, following the completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of this offering, our named executive officers will continue to participate in this 401(k) plan on the same <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terms as other full-time employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Employee benefits and perquisites <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">All of our full-time employees, including our named executive officers, are eligible to participate in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health and welfare plans, including&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">medical, dental, and vision benefits&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">medical and dependent care flexible spending accounts&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">short-term and long-term disability insurance&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">life insurance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that the employee benefits described above are necessary and appropriate to provide a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitive compensation package to our named executive officers. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No tax gross-ups<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not make gross-up payments to cover our named executive officers&#8217; personal income taxes that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may pertain to any of the compensation or perquisites paid or provided by the Company.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">165<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding equity awards at fiscal year-end<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> summarizes the number of shares of common stock underlying outstanding equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incentive plan awards for each named executive officer as of December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 126.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 466.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 131.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 14.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 57.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 57pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 131.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 80.81pt; width: 131.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="2"><div style="left: 134.25pt; position: absolute; top: 0pt; width: 75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 80.81pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.41pt; position: absolute; text-decoration: none; white-space: pre;">Grant date<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 212.25pt; position: absolute; top: 0pt; width: 254.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 254.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 189.17pt; position: absolute; text-decoration: none; white-space: pre;">Option awards<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 78pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.64pt; position: absolute; text-decoration: none; white-space: pre;">securities <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.86pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.67pt; position: absolute; text-decoration: none; white-space: pre;">underlying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">unexercised <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.68pt; position: absolute; text-decoration: none; white-space: pre;">options - <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.63pt; position: absolute; text-decoration: none; white-space: pre;">exercisable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">(#)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.64pt; position: absolute; text-decoration: none; white-space: pre;">securities <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.86pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.67pt; position: absolute; text-decoration: none; white-space: pre;">underlying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">unexercised <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.68pt; position: absolute; text-decoration: none; white-space: pre;">options -<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.65pt; position: absolute; text-decoration: none; white-space: pre;">unexercisable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">(#)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 12.75pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.16pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.12pt; position: absolute; text-decoration: none; white-space: pre;">exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.15pt; position: absolute; text-decoration: none; white-space: pre;">price ($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 12.75pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.41pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.41pt; position: absolute; text-decoration: none; white-space: pre;">expiration <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.89pt; position: absolute; text-decoration: none; white-space: pre;">date<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 90.75pt; width: 131.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 131.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 83.53pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 90.75pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">8&#47;24&#47;2021<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195pt; position: absolute; top: 90.75pt; width: 14.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 4.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">57,070<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.78pt; position: absolute; text-decoration: none; white-space: pre;">11,422<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 90.75pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 90.75pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">8&#47;24&#47;2031<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 103.5pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2022<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195pt; position: absolute; top: 103.5pt; width: 14.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 4.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">70,633<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">32,106<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 103.5pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 103.5pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2032<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 116.25pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">468,380<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">1,534,951<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 116.25pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">2.22<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 116.25pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 129pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.12pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.12pt; position: absolute; text-decoration: none; white-space: pre;">3,996<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">187,784<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 129pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">9.58<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 129pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.37pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2034<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 131.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 131.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 70.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 72.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 72.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 72.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 72.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 72.25pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 141.75pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2022<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195pt; position: absolute; top: 141.75pt; width: 14.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 4.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.12pt; position: absolute; text-decoration: none; white-space: pre;">7,849<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 141.75pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 141.75pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2032<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 154.5pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">77,413<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 154.5pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">2.22<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 154.5pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 167.25pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.12pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 167.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 167.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 31.44pt; position: absolute; text-decoration: none; white-space: pre;">111,633<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 167.25pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">2.22<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 167.25pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.37pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2033<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 180pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 13.12pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 180pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 180pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">197,573<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 180pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">9.58<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 180pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 9.37pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2034<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 192.75pt; width: 131.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 131.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 116.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 117.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 117.25pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 192.75pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.12pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;9&#47;2016<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 192.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">39,709<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 192.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 192.75pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 192.75pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 19.37pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;9&#47;2026<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 205.5pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">2&#47;28&#47;2020<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 205.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">43,785<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 205.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 205.5pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 205.5pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">2&#47;28&#47;2030<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 218.25pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;22&#47;2020<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.12pt; position: absolute; text-decoration: none; white-space: pre;">2,231<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 218.25pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 218.25pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;22&#47;2030<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 231pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;12&#47;2021<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.12pt; position: absolute; text-decoration: none; white-space: pre;">3,395<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 231pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.62pt; position: absolute; text-decoration: none; white-space: pre;">194<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 231pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">8.33<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 231pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;12&#47;2031<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 243.75pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195pt; position: absolute; top: 243.75pt; width: 14.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: normal; left: 4.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 40.12pt; position: absolute; text-decoration: none; white-space: pre;">6,849<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 53.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 243.75pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">2.22<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 243.75pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 134.25pt; position: absolute; top: 256.5pt; width: 60.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 18.12pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 212.25pt; position: absolute; top: 256.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.12pt; position: absolute; text-decoration: none; white-space: pre;">77,698<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 280.5pt; position: absolute; top: 256.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">158,136<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348.75pt; position: absolute; top: 256.5pt; width: 57.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.88pt;"></font></font><font style="left: 36.510000000000005pt; position: absolute;">2.22<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 256.5pt; width: 57pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 57pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.37pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 403.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts disclosed in this column reflect the number of options granted to our named executive officers that were subject to time-based <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 412.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">vesting and have vested.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 429.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unless otherwise noted, the stock option vests and becomes exercisable as to 1&#47;48th of the total number of shares underlying the stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 438.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">option monthly following the vesting commencement date, subject to the applicable named executive officer&#8217;s continued service through <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 447.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the applicable vesting date.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 464.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 102.92pt; position: absolute; text-decoration: none; white-space: pre;"> stock option vests and becomes exercisable as to 1&#47;4th of the total number of shares underlying the stock option on the first <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 473.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">anniversary of the vesting commencement date and 1&#47;48th monthly thereafter, subject to the applicable named executive officer&#8217;s <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 482.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continued service through the applicable vesting date.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 499.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The stock option fully vests and becomes exercisable on the first anniversary of the vesting commencement date, subject to Dr. Rogers&#8217; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 508.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continued service through the applicable vesting date.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 525.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Senior leadership severance policy<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we have adopted a senior leadership severance policy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Severance Policy&#8221;) covering each of our named executive officers, which sets forth the benefits <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable to participants upon qualifying terminations of employment. Under the Severance Policy, upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">termination without &#8220;cause&#8221; or a resignation for &#8220;good reason&#8221; (as such terms are defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Severance Policy) (a &#8220;Qualifying Termination&#8221;), provided that the participant executes and does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revoke a general release of claims in favor of the Company and adheres to any restrictive covenants with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company to which he or she is bound, the participant will be entitled to receive a certain number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months of base salary continuation based on his or her position at the Company (twelve (12) months for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Farquhar, nine (9) months for other C-level participants, and six (6) months for senior vice president-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">level participants) (the &#8220;Severance Period&#8221;), with payment commencing on or within ten (10) days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following the sixtieth (60<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 178.64pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">th<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.05pt; position: absolute; white-space: pre;">) day following the participant&#8217;s termination date. In addition, if the participant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company will pay or reimburse the participant for his or her COBRA premiums during the Severance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Period.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">166<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon a Qualifying Termination occurring within three (3) months prior to or twelve (12) months following a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;change in control&#8221; (as such term is defined in the Severance Policy), provided the participant executes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and does not revoke a general release of claims in favor of the Company and adheres to any restrictive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covenants with the Company to which he or she is bound, the participant will be entitled to receive a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain number of months of base salary continuation based on his or her position at the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(eighteen (18) months for Mr. Farquhar, twelve (12) months for other C-level participants, and nine (9) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months for senior vice president-level participants) (the &#8220;CIC Severance Period&#8221;) plus the participant&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">target bonus for the year of termination, with payment commencing on or within ten (10) days following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the sixtieth (60<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.98000000000002pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">th<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.39pt; position: absolute; white-space: pre;">) day following the participant&#8217;s termination date. In addition, all of the participant&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding equity awards, to the extent unvested, will become fully vested and exercisable as of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participant&#8217;s termination date, and if the participant elects continuation coverage under COBRA, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company will pay or reimburse the participant for his or her COBRA premiums during the CIC Severance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Severance Policy also contains a net-better Section 4999 cutback provision, which provides that, if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments to a participant are subject to an excise tax under Section 4999 of the Code, then such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments would be reduced by the amount needed to avoid triggering such tax, provided that such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction leaves the participant in a better after-tax position than if such payments had not been reduced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(taking into account the effect of the excise tax).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 non-employee director compensation table <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have paid certain of our non-employee directors, Mr. Weldon, Mr. Barabe, Mr. Riley, Mr. Smith, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taylor and Ms. Cullivan, cash fees as set forth in the table below for their service on our board. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also reimbursed our directors for expenses associated with attending meetings of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and committees of our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Taylor, one of the Company&#8217;s founders, served as our Chief Technology Officer from April 2010 to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">February 2022 and as our Chief Scientific Officer from February 2022 through December 2023. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with his termination of employment, we entered into a separation agreement with Mr. Taylor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an employment termination date of December 1, 2023, which provided for certain benefits in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consideration for his execution of a general release of claims and adherence to the protective covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set forth therein. Those benefits include (i) severance payments equal to $658,341.76, payable 50% on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effective date of the agreement and 50% on June 1, 2024, (ii) payment of COBRA benefits for 12 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months, (iii) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.41pt; position: absolute; text-decoration: none; white-space: pre;">i<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.63pt; position: absolute; text-decoration: none; white-space: pre;">f the Company paid bonuses with respect to the 2023 fiscal year<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.93pt; position: absolute; white-space: pre;">, payment of Mr. Taylor&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">target bonus for such year, payable 50% in April 2024 and 50% in June 2024 and (iv) acceleration of 25% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of his then-unvested options.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In addition to his service on the board, since December 2023, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.41pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Mr. Taylor has served as a consultant to us </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and was paid cash fees of $3,178 in 2024 in consideration of his consulting services.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">167<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.88pt; position: absolute; text-decoration: none; white-space: pre;"> table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> sets forth information regarding the compensation of our non-employee directors for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fiscal year ended December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 190.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 190.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">Fees earned <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.63pt; position: absolute; text-decoration: none; white-space: pre;">or<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.66pt; position: absolute; text-decoration: none; white-space: pre;">paid in cash <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 51.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.66pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 31.63pt; position: absolute; text-decoration: none; white-space: pre;">awards<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.66pt; position: absolute; text-decoration: none; white-space: pre;">All other <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.14pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 41.15pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 51.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 85.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.25pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 45pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 87.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.66pt; position: absolute; text-decoration: none; white-space: pre;">........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 59.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.17999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 73.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 110.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 110.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 110.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.28pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 87.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 102pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 116.25pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 95.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 95.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.33pt; position: absolute; text-decoration: none; white-space: pre;">.....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 116.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 130.5pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.33pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 130.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 144.75pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 79.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.27pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 125.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.25pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 159pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.06pt; position: absolute; text-decoration: none; white-space: pre;">571,082<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 59.19pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">611,082<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 285.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The aggregate number of stock option awards (whether exercisable or unexercisable) held as of December 31, 2024, by Mr. Weldon, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 294.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Barabe, Ms. Cullivan, Dr. Downing, Mr. Lightcap, Mr. Riley, Mr. Smith, Mr. Tansey and Mr. Taylor was&#160;520,730, 100,730, 87,188, 0, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 303.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">0,&#160;185,000, 135,000, 0&#160;and 460,301, respectively.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 320.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">This amount includes&#58; (i) $329,171 in severance payme<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 274.13pt; position: absolute; text-decoration: none; white-space: pre;">nts&#59; (ii) $40,015 in COBRA payments&#59; (iii) $198,718 a<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 450.3pt; position: absolute; text-decoration: none; white-space: pre;">s a target bonus for 2023&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 329.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and (iv) $3,178 in consulting fees.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we approved and implemented a compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">program for our non-employee directors that consists of annual retainer fees and long-term equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 390.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Director compensation policy</font><font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we have adopted a director compensation policy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covering our non-employee directors (the &#8220;Director Compensation Policy&#8221;), which sets out a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation program for our non-employee directors consisting of annual retainer fees and long-term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity awards. The Director Compensation Policy became effective upon the commencement of trading of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s common stock on the Nasdaq Global Select Market.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under our Director Compensation Policy, each non-employee director is entitled to receive the following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash compensation while serving on our Board&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 512.65pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 399.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 399.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash Compensation<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Cash Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 101.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 101.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 101.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.97pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">50,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Chairperson Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 132.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">45,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Audit Committee Chairperson Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 207.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 208.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 209.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 209.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.44pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Compensation Committee Chairperson Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 249.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 251.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 251.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 251.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 251.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.91pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Nominating and Corporate Governance Committee Chairperson Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 359.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 361.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 361.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 361.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 361.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;">..............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Audit Committee Member Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 189.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 190.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 191.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 191.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 191.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.91pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Compensation Committee Member Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 232.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 232.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.12pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 98.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,500<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 112.5pt; width: 399.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 399.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Annual Nominating and Corporate Governance Committee Member Retainer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 342.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 342.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.12pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 112.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 655.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">All annual retainers will be paid on a quarterly basis following the end of each calendar quarter in arrears, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and will be pro-rated if a non-employee director serves for only a portion of the calendar quarter. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">168<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, under the Director Compensation Policy, non-employee directors are entitled to receive the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following equity-based compensation while serving on our Board&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">New directors&#58; Each new non-employee director appointed or elected to our Board (or any non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">employee director serving on the Board prior to the offering who did not receive compensation for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">such services prior to such date) is entitled to receive a new director equity award valued at $500,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the form of nonqualified stock options as of the director&#8217;s first date of service or the IPO, as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">case may be. Subject to the non-employee director&#8217;s continued service through the applicable vesting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">date, 1&#47;3 of the new director equity award will vest on the first anniversary of the grant date and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">remaining 2&#47;3 of the new director equity award will vest in 24 substantially equal monthly installments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">thereafter.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Continuing directors&#58; On the date of the offering and on the date of each annual meeting of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Company&#8217;s stockholders thereafter, each continuing non-employee director is entitled to receive an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual equity award valued at $250,000 in the form of nonqualified stock options. Subject to the non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">employee director&#8217;s continued service through the applicable vesting date, the annual equity award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will vest on the earlier of the first anniversary of the date of grant and the Company&#8217;s annual meeting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of stockholders in the year following the year in which the annual equity award was granted.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 288pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">2025 performance incentive plan</font><font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we have adopted the Heartflow, Inc. 2025 Performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Incentive Plan (the &#8220;2025 Plan&#8221;), which became effective upon the commencement of trading of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock on the Nasdaq Global Select Market. The principal terms of the 2025 Plan are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summarized below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purpose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The purpose of the 2025 Plan is to promote the success of the Company by providing an additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">means for us to attract, motivate, retain and reward selected employees and other eligible persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through the grant of awards. Equity-based awards are also intended to further align the interests of award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recipients and our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Administration<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Board of Directors or one or more committees appointed by our Board of Directors will administer the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Plan. Our Board of Directors has delegated general administrative authority for the 2025 Plan to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compensation Committee and has also formed an Equity Awards Committee that is authorized to grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards under the 2025 Plan to participants who are not executive officers of the Company. The Board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Directors or a committee thereof (within its delegated authority) may delegate different levels of authority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to different committees or persons with administrative and grant authority under the 2025 Plan. (The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate acting body, be it the Board of Directors or a committee or other person within its delegated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authority is referred to in this proposal as the &#8220;Administrator&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Administrator has broad authority under the 2025 Plan, including, without limitation, the authority&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to select eligible participants and determine the type(s) of award(s) that they are to receive&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to grant awards and determine the terms and conditions of awards, including the price (if any) to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">paid for the shares or the award and, in the case of share-based awards, the number of shares to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offered or awarded&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to determine any applicable vesting and exercise conditions for awards (including any applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance and&#47;or time-based vesting or exercisability conditions) and the extent to which such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conditions have been satisfied, or determine that no delayed vesting or exercise is required, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determine the circumstances in which any performance-based goals (or the applicable measure of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance) will be adjusted and the nature and impact of any such adjustment, to establish the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">events (if any) on which exercisability or vesting may accelerate (including specified terminations of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">169<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">employment or service or other circumstances), and to accelerate or extend the vesting or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercisability or extend the term of any or all outstanding awards (subject in the case of options and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock appreciation rights to the maximum term of the award)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to cancel, modify, or waive the Company&#8217;s rights with respect to, or modify, discontinue, suspend, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">terminate any or all outstanding awards, subject to any required consents&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subject to the other provisions of the 2025 Plan, to make certain adjustments to an outstanding award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and to authorize the conversion, succession or substitution of an award&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to determine the method of payment of any purchase price for an award or shares of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock delivered under the 2025 Plan, as well as any tax-related items with respect to an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">award, which may be in the form of cash, check, or electronic funds transfer, by the delivery of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">already-owned shares of the Company&#8217;s common stock or by a reduction of the number of shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deliverable pursuant to the award, by services rendered by the recipient of the award, by notice and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">third party payment or cashless exercise on such terms as the Administrator may authorize, or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other form permitted by law&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to modify the terms and conditions of any award, establish sub-plans and agreements and determine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">different terms and conditions that the Administrator deems necessary or advisable to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">laws in the countries where the Company or one of its subsidiaries operates or where one or more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">eligible participants reside or provide services&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to approve the form of any award agreements used under the 2025 Plan&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to construe and interpret the 2025 Plan, make rules for the administration of the 2025 Plan, and make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">all other determinations for the administration of the 2025 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Availability of repricing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Administrator may (1) amend an outstanding stock option or stock appreciation right to reduce the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price or base price of the award, (2) cancel, exchange, or surrender an outstanding stock option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(3) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an option or stock appreciation right with an exercise or base price that is less than the exercise or base <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price of the original award.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Eligibility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Persons eligible to receive awards under the 2025 Plan include officers or employees of the Company or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of its subsidiaries, directors of the Company, and certain consultants and advisors to the Company or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of its subsidiaries.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate share limit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The maximum number of shares of the Company&#8217;s common stock that may be issued or transferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to awards under the 2025 Plan equals the sum of the following (such total number of shares, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Share Limit&#8221;)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an aggregate number of shares of the Company&#8217;s common stock equal to ten percent (10%) of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">total number of fully diluted shares of the Company&#8217;s common stock outstanding (including, without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">limitation, any outstanding warrants) as of the date of commencement of trading of the shares of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Company&#8217;s common stock on the Nasdaq Global Select Market (the &#8220;Initial Trading Date&#8221;), plus<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the number of shares available for additional award grant purposes under the 2009 Plan as of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Initial Trading Date and determined immediately prior to the termination of the authority to grant new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">awards under that plan as of the Initial Trading Date, plus<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">170<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the number of any shares subject to stock options granted under the 2009 Plan and outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Initial Trading Date which expire, or for any reason are cancelled or terminated, after the date of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Initial Trading Date without being exercised (which, for purposes of clarity, will become available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">for award grants under the 2025 Plan on a one-for-one basis).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the Share Limit will automatically increase, if on the last day of the Company&#8217;s fiscal year, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Share Limit has not increased during such fiscal year pursuant to any Board-approved increase(s) by an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate amount equal to or greater than five percent (5%) of the total number of fully diluted shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s common stock outstanding (including, without limitation, any outstanding warrants) on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">first day of such fiscal year (the &#8220;Minimum Annual Increase&#8221;), then in an amount equal to the difference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">between the Minimum Annual Increase and the aggregate amount by which the Share Limit increased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to any Board-approved increase(s) during such fiscal year, effective as of the last day of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fiscal year.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As noted above, no additional awards will be granted under the 2009 Plan if stockholders approve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Plan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Additional share limits<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following other limits are also contained in the 2025 Plan. These limits are in addition to, and not in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lieu of, the Share Limit for the plan described above.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The maximum number of shares that may be delivered pursuant to options qualified as incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock options granted under the plan is 2,000,000 shares. (For clarity, any shares issued in respect of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">incentive stock options granted under the plan will also count against the overall Share Limit above.)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The maximum number of shares subject to awards that are granted under the 2025 Plan during any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">one calendar year to any person who, on the grant date of the award, is a Non-Employee Director <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shall not exceed the number of shares that produce a grant date fair value for the award that, when <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">combined with (i) the grant date fair value of any other awards granted under the 2025 Plan during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that same calendar year to that individual in his or her capacity as a Non-Employee Director and (ii) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the dollar amount of all other cash compensation payable by the Company to such Non-Employee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Director for his or her services in such capacity during that same calendar year (regardless of whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deferred and excluding any interest or earnings on any portion of such amount that may be deferred), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">is $750,000, provided that this limit is $1,000,000 as to any new Non-Employee Director for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">calendar year in which the non-employee director is first elected or appointed to the Board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Directors. For purposes of this limit, the &#34;grant date fair value&#34; of an award means the value of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">award on the date of grant of the award determined using the equity award valuation principles <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applied in the Company&#8217;s financial reporting. This limit does not apply to, and will be determined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">without taking into account, any award granted to an individual who, on the grant date of the award, is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an officer or employee of the Company or one of its subsidiaries. This limit applies on an individual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">basis and not on an aggregate basis to all Non-Employee Directors as a group.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Share-limit counting rules&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Share Limit of the 2025 Plan is subject to the following rules&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Shares that are subject to or underlie awards which expire or for any reason are cancelled or terminated, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are forfeited, fail to vest, or for any other reason are not paid or delivered under the 2025 Plan will not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">counted against the Share Limit and will again be available for subsequent awards under the 2025 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Except as described below, to the extent that shares are delivered pursuant to the exercise of a stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appreciation right granted under the 2025 Plan, the number of underlying shares which are actually <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued in payment of the award shall be counted against the Share Limit. (For purposes of clarity, if a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock appreciation right relates to 100,000 shares and is exercised at a time when the payment due to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participant is 15,000 shares, 15,000 shares shall be charged against the Share Limit with respect to such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise.)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">171<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Shares that are exchanged by a participant or withheld by the Company to pay the exercise price of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock option or stock appreciation right granted under the 2025 Plan, as well as any shares exchanged or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">withheld to satisfy the tax withholding obligations related to any stock option, stock appreciation right or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other award will not be counted against the Share Limit and will again be available for subsequent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards under the 2025 Plan. Shares that are exchanged by a participant or withheld by the Company as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">full or partial payment in connection with any award granted under the 2025 Plan will not be counted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against the Share Limit and will again be available for subsequent awards under the 2025 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, shares that are exchanged by a participant or withheld by the Company after the Initial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Trading Date as full or partial payment in connection with any award granted under the 2009 Plan, as well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as any shares exchanged by a participant or withheld by the Company after the Initial Trading Date to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">satisfy the tax withholding obligations related to any award granted under the 2009 Plan, shall be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available for new awards under the 2025 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To the extent that an award is settled in cash or a form other than shares, the shares that would have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been delivered had there been no such cash or other settlement will not be counted against the Share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Limit and will again be available for subsequent awards under the 2025 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the event that shares are delivered in respect of a dividend equivalent right, the actual number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares delivered with respect to the award shall be counted against the Share Limit. (For purposes of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clarity, if 1,000 dividend equivalent rights are granted and outstanding when the Company pays a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dividend, and 50 shares are delivered in payment of those rights with respect to that dividend, 50 shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shall be counted against the Share Limit.) Except as otherwise provided by the Administrator, shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivered in respect of dividend equivalent rights shall not count against any individual award limit under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2025 Plan other than the aggregate Share Limit.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the 2025 Plan generally provides that shares issued in connection with awards that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted by or become obligations of the Company through the assumption of awards (or in substitution for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards) in connection with an acquisition of another company will not count against the shares available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for issuance under the 2025 Plan. The Company may not increase the applicable share limits of the 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan by repurchasing shares of common stock on the market (by using cash received through the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of stock options or otherwise). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Types of awards&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Plan authorizes stock options, stock appreciation rights, and other forms of awards granted or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">denominated in the Company&#8217;s common stock or units of the Company&#8217;s common stock, as well as cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bonus awards. The 2025 Plan retains flexibility to offer competitive incentives and to tailor benefits to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific needs and circumstances. Any award may be structured to be paid or settled in cash.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A stock option is the right to purchase shares of the Company&#8217;s common stock at a future date at a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specified price per share (the &#8220;exercise price&#8221;). The per share exercise price of an option generally may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not be less than the fair market value of a share of the Company&#8217;s common stock on the date of grant. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The maximum term of an option is ten years from the date of grant. An option may either be an incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock option or a nonqualified stock option. Incentive stock options may only be granted to employees of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company or a subsidiary.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A stock appreciation right is the right to receive payment of an amount equal to the excess of the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market value of share of the Company&#8217;s common stock on the date of exercise of the stock appreciation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">right over the base price of the stock appreciation right. The base price will be established by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator at the time of grant of the stock appreciation right and generally may not be less than the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair market value of a share of the Company&#8217;s common stock on the date of grant. Stock appreciation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights may be granted in connection with other awards or independently. The maximum term of a stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appreciation right is ten years from the date of grant. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The other types of awards that may be granted under the 2025 Plan include, without limitation, stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bonuses, restricted stock, performance stock, restricted stock units, stock units or phantom stock (which <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">172<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are contractual rights to receive shares of stock, or cash based on the fair market value of a share of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock), dividend equivalents which represent the right to receive a payment based on the dividends paid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on a share of stock over a stated period of time, or similar rights to purchase or acquire shares, and cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards.&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any awards under the 2025 Plan (including awards of stock options and stock appreciation rights) may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fully-vested at grant or may be subject to time- and&#47;or performance-based vesting requirements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividend equivalents&#59; d<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 184.12pt; position: absolute; text-decoration: none; white-space: pre;">eferrals&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Administrator may provide for the deferred payment of awards, and may determine the other terms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable to deferrals. The Administrator may provide that awards under the 2025 Plan (other than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options or stock appreciation rights), and&#47;or deferrals, earn dividends or dividend equivalents based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the amount of dividends paid on outstanding shares of Common Stock, provided that any dividends and&#47;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or dividend equivalents as to the portion of an award that is subject to unsatisfied vesting requirements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be subject to termination and forfeiture to the same extent as the corresponding portion of the award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to which they relate in the event the applicable vesting requirements are not satisfied (or, in the case of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted stock or similar award where the dividend must be paid as a matter of law, the dividend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment will be subject to forfeiture or repayment, as the case may be, if the related vesting conditions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are not satisfied).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Assumption and termination of awards&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If an event occurs in which the Company does not survive (or does not survive as a public company in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respect of its common stock), including, without limitation, a dissolution, merger, combination, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidation, conversion, exchange of securities, or other reorganization, or a sale of all or substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of the business, stock or assets of the Company, awards then-outstanding under the 2025 Plan will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically become fully vested pursuant to the provisions of the 2025 Plan so long as such awards are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumed, substituted for or otherwise continued. However, if awards then-outstanding under the 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan are to be terminated in such circumstances (without being assumed or substituted for), such awards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would generally become fully vested (with any performance goals applicable to the award being deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">met at the &#8220;target&#8221; performance level), subject to any exceptions that the Administrator may provide for in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an applicable award agreement. The Administrator also has the discretion to establish other change in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control provisions with respect to awards granted under the 2025 Plan. For example, the Administrator <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could provide for the acceleration of vesting or payment of an award in connection with a corporate event <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or in connection with a termination of the award holder&#8217;s employment. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Transfer restrictions&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to certain exceptions contained in Section 5.6 of the 2025 Plan, awards under the 2025 Plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally are not transferable by the recipient other than by will or the laws of descent and distribution <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and are generally exercisable, during the recipient&#8217;s lifetime, only by the recipient. Any amounts payable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or shares issuable pursuant to an award generally will be paid only to the recipient or the recipient&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beneficiary or representative. The Administrator has discretion, however, to establish written conditions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and procedures for the transfer of awards to other persons or entities, provided that such transfers comply <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with applicable federal and state securities laws and are not made for value (other than nominal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consideration, settlement of marital property rights, or for interests in an entity in which more than 50% of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the voting securities are held by the award recipient or by the recipient&#8217;s family members).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Adjustments&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As is customary in incentive plans of this nature, each share limit and the number and kind of shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available under the 2025 Plan and any outstanding awards, as well as the exercise or purchase prices of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards, and performance targets under certain types of performance-based awards, are subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjustment in the event of certain reorganizations, mergers, combinations, recapitalizations, stock splits, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock dividends, or other similar events that change the number or kind of shares outstanding, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extraordinary dividends or distributions of property to the stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">173<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No limit on other authority&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Except as expressly provided with respect to the termination of the authority to grant new awards under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2009 Plan if stockholders approve the 2025 Plan, the 2025 Plan does not limit the authority of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board of Directors or any committee to grant awards or authorize any other compensation, with or without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reference to the Company&#8217;s common stock, under any other plan or authority.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Termination of or changes to the 2025 plan&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Board of Directors may amend or terminate the 2025 Plan at any time and in any manner. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stockholder approval for an amendment will be required only to the extent then required by applicable law <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or deemed necessary or advisable by the Board of Directors. Unless terminated earlier by the Board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Directors and subject to any extension that may be approved by stockholders, the authority to grant new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards under the 2025 Plan will terminate at the close of business on the day before the tenth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">anniversary of the effective date of the 2025 Plan. Outstanding awards, as well as the Administrator&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authority with respect thereto, generally will continue following the expiration or termination of the plan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Generally speaking, outstanding awards may be amended by the Administrator (except for a repricing), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but the consent of the award holder is required if the amendment (or any plan amendment) materially and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affects the holder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amended and restated 2009 equity incentive plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following summarizes the material terms of our Amended and Restated 2009 Equity Incentive Plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;2009 Plan&#8221;), under which we have previously made periodic grants of equity and equity-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards to our named executive officers and other key employees. Upon the commencement of trading of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s common stock on the Nasdaq Global Select Market, the 2025 Plan became effective and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no more grants may be made under the 2009 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan was adopted by the board of directors of Heartflow, Inc. in 2009 and was amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restated effective March 1, 2021 in connection with a reorganization of Heartflow, Inc. in which the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan and all outstanding award agreements thereunder were assigned to and assumed by HeartFlow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holding, Inc. As of March 31, 2025, a total of&#160;8,583,703&#160;shares of common stock were then subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding awards granted under the 2009 Plan, and an additional&#160;193,596&#160;shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">were then available for new award grants under the 2009 Plan. With respect to the stock options then-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding on this date, the weighted-average exercise price of such options was $4.98&#160;per share, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the weighted-average remaining term of these options was&#160;7.77&#160;years.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purpose<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The purpose of the 2009 Plan is to attract and retain the best available personnel for positions of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial responsibility, to provide additional incentive to employees, directors and consultants, and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promote the success of our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Administration<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan is administered by our board of directors (the &#8220;Board&#8221;) or a committee thereof (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Administrator&#8221;). The Administrator has the discretion to (i) determine the fair market value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, (ii) select the employees, directors and consultants to whom awards may be granted under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2009 Plan, (iii) determine the number of shares of our common stock to be covered by each award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted under the 2009 Plan, (iv) approve forms of award agreements for use under the 2009 Plan, (v) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine the terms and conditions of any award granted under the 2009 Plan, (vi) institute and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine the terms and conditions of an award exchange, (vii) construe and interpret the terms of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2009 Plan and awards granted thereunder, (viii) prescribe, amend and rescind rules and regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relating to the 2009 Plan, (ix) modify or amend outstanding awards granted under the 2009 Plan, subject <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to certain restrictions set forth in the 2009 Plan, (x) determine procedures for recipients to satisfy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">withholding tax obligations, (xi) authorize any person to execute on our behalf any instrument required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect the grant of an award previously granted by the Administrator, (xii) allow a recipient to defer the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">174<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receipt of the payment of cash or the delivery of shares that otherwise would be due to such recipient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under an award, (xiii) establish additional rules to accommodate the rules or laws of applicable non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions and afford recipients who are foreign nationals or are employed outside the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">favorable treatment under such rules or laws, and (xiv) make all other determinations deemed necessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or advisable for administering the 2009 Plan. All decisions, or actions taken, by the plan administrator or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the administration of the 2009 Plan shall be final, conclusive and binding on all persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">having an interest in the 2009 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Eligibility<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our employees and consultants, employees and consultants of our parents or subsidiaries (if any), and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-employee members of our Board are eligible to receive awards under the 2009 Plan, provided that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only employees may be granted awards intended as incentive stock options.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.22pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> As of December 31, 2024, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">approximately&#160;606&#160;of our and our subsidiaries&#8217; officers and employees (including all of our named </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">executive officers), and each of the nine non-employee members of our Board, were considered eligible </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">under the 2009 Plan. In addition, approximately 13&#160;individual consultants and advisors engaged by us </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and our subsidiaries were then considered eligible under the 2009 Plan.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Share reserve<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, a total of&#160;10,543,521&#160;shares of our common stock had been authorized for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance under the 2009 Plan,&#160;8,583,703&#160;shares were subject to stock options then-outstanding under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2009 Plan,&#160;no&#160;shares were subject to restricted stock and restricted stock unit awards then-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding under the 2009 Plan, and&#160;193,596&#160;shares were available for issuance under the 2009 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Types of awards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan authorizes the grant of stock options, stock appreciation rights, restricted stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted stock units. Awards granted under the 2009 Plan are generally not transferable by the recipient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than by will or the laws of descent and distribution and are generally exercisable, during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recipient&#8217;s lifetime, only by the recipient. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock Options<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.2pt; position: absolute; text-decoration: none; white-space: pre;">. A stock option is the right to purchase shares of our common stock at a future date at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a specified price per share (the &#8220;exercise price&#8221;). The per share exercise price of an option generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may not be less than the fair market value of a share of our common stock on the date of grant. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maximum term of an option is ten years from the date of grant. An option may either be an incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock option or a non-qualified stock option. Incentive stock option benefits are taxed differently from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">nonqualified stock options, are subject to more restrictive terms, and are limited in amount by the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Internal Revenue Code and the 2009 Plan. Incentive stock options may only be granted to our and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our subsidiaries&#8217; employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock Appreciation Rights<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;">. A stock appreciation right is the right to receive payment of an amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">equal to the excess of the fair market value of share of our common stock on the date of exercise of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the stock appreciation right over the base price of the stock appreciation right. The base price will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">established by the Administrator at the time of grant of the stock appreciation right and generally may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">not be less than the fair market value of a share of our common stock on the date of grant. Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">appreciation rights may be granted in connection with other awards or independently. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restricted Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.75pt; position: absolute; text-decoration: none; white-space: pre;">. A share of restricted stock is granted subject to vesting, transfer restrictions and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other restrictions as determined by the Administrator, or is a share issued pursuant to the early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise of a stock option. Recipients of restricted stock, unlike recipients of stock options and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restricted stock units, have voting rights and the right to receive dividends, if any, prior to the time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restrictions lapse with respect to such shares, however, extraordinary dividends will generally be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">placed in escrow, and will not be released until restrictions are removed or expire.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restricted Stock Units<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.29000000000002pt; position: absolute; text-decoration: none; white-space: pre;">. A restricted stock unit is a bookkeeping entry representing an amount equal to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the fair market value of a share that is granted subject to vesting, transfer restrictions and other <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">175<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restrictions as determined by the Administrator. Unlike restricted stock, shares underlying restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock units will not be issued until the restricted stock units have vested, and recipients of restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock units generally have no voting or dividend rights prior such conditions being satisfied.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Adjustments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As is customary in incentive plans of this nature, the share limit, the number and kind of shares available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the 2009 Plan, any outstanding awards as well as the exercise or purchase prices of awards, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance targets under certain types of performance-based awards, are subject to adjustment in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event of certain reorganizations, mergers, combinations, recapitalizations, stock splits, stock dividends, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other similar events that change the number or kind of shares outstanding, and extraordinary dividends or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributions of property to the stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Assumption and termination of awards<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If an event occurs that results in a change in control of us or in which we otherwise do not survive (or do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not survive as a public company in respect of our common stock), including, without limitation, a merger, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combination, consolidation, conversion, exchange of securities, or other reorganization, or a sale of all or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantially all of our business, stock or assets, awards then-outstanding under the 2009 Plan will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically become fully vested pursuant to the provisions of the 2009 Plan so long as such awards are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumed or substituted. However, if awards then-outstanding under the 2009 Plan are to be terminated in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such circumstances (without being assumed or substituted), such awards would generally become fully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vested (with any performance goals applicable to the award being deemed met at the &#8220;target&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance level and all other terms and conditions met), subject to any exceptions that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator may provide for in an applicable award agreement. The Administrator also has the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discretion to establish other change in control provisions with respect to awards granted under the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan. If we are wound up pursuant to a dissolution or liquidation, awards then-outstanding under the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan will terminate immediately prior to such event.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No limit on other authority<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan does not limit the authority of the Board or any committee thereof to grant awards or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorize any other compensation, with or without reference to our common stock, under any other plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or authority.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Termination of or changes to the 2009 plan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Board may amend or terminate the 2009 Plan at any time and in any manner. Stockholder approval <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for an amendment will be required only to the extent then required by applicable law or deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary or advisable by the Board. Unless terminated earlier by the Board, the authority to grant new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards under the 2009 Plan will terminate on March 21, 2031. Outstanding awards, as well as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator&#8217;s authority with respect thereto, generally will continue following the expiration or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">termination of the 2009 Plan. Generally speaking, outstanding awards may be amended by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator (except for a repricing), but the consent of the award holder is required if the amendment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or any plan amendment) impair the rights of the holder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 employee stock purchase plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we have adopted the Heartflow, Inc. 2025 Employee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective upon the commencement of trading of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock on the Nasdaq Global Select Market. The principal terms of the ESPP are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summarized below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purpose<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The purpose of the ESPP is to provide eligible employees with an opportunity to purchase shares of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock at a favorable price and upon favorable terms in consideration of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participating employees&#8217; continued services. The ESPP is intended to provide an additional incentive to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">176<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participating eligible employees to remain in the Company&#8217;s employ and to advance the best interests of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company and those of the Company&#8217;s stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Operation of the ESPP<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">It is currently expected that the ESPP will operate in successive periods referred to as &#8220;Offering Periods.&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ESPP administrator may change the duration of Offering Periods from time to time in advance of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable Offering Period, provided that no Offering Period may be shorter than three months or longer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than 27 months. The ESPP administrator may also provide that an Offering Period will consist of multiple <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;purchase periods,&#8221; with a purchase of shares under the ESPP to occur at the end of each such purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period. However, only one Offering Period may be in effect at any one time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On the first day of each Offering Period (referred to as the &#8220;Grant Date&#8221;), each eligible employee who has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">timely filed a valid election to participate in the ESPP for that Offering Period will be granted an option to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase shares of the Company&#8217;s common stock (each, a &#8220;Purchase Option&#8221;). A participant must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">designate in the election the percentage of the participant&#8217;s compensation to be withheld from his or her <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pay during that Offering Period for the purchase of stock under the ESPP. The participant&#8217;s contributions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the ESPP will be credited to a bookkeeping account in his or her name. A participant generally may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elect to terminate, but may not otherwise increase or decrease, his or her contributions to the ESPP <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">during an Offering Period. Amounts contributed to the ESPP constitute general corporate assets of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company and may be used for any corporate purpose.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each Purchase Option granted under the ESPP will automatically be exercised on the last day of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Offering Period with respect to which it was granted, or the last day of each purchase period for an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Offering Period that consists of multiple purchase periods (each such date on which ESPP Purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Options are exercised is referred to as an &#8220;Purchase Date&#8221;). The number of shares acquired by a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participant upon exercise of his or her Purchase Option will be determined by dividing the participant&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ESPP account balance as of the Purchase Date by the &#8220;Purchase Price&#8221; (as such term is defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ESPP) for the applicable period. The determination of the Purchase Price for each Offering Period (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each purchase period within an Offering Period) will be established by the ESPP administrator in advance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the applicable period, except that in no event may the Purchase Price be lower than the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.48pt; position: absolute; text-decoration: underline; white-space: pre;">lesser<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.15pt; position: absolute; white-space: pre;"> of (i) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">85% of the fair market value of a share of the Company&#8217;s common stock on the applicable Grant Date, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(ii) 85% of the fair market value of a share of the Company&#8217;s common stock on the applicable Purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Date. A participant&#8217;s ESPP account will be reduced upon exercise of his or her Purchase Option by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount used to pay the Purchase Price for the shares acquired by the participant. No interest will be paid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to any participant or credited to any account under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Eligibility<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Only certain employees will be eligible to participate in the ESPP. To participate in an Offering Period, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Grant Date of that period an individual must&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be employed by the Company or one of its subsidiaries that has been designated as a participating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsidiary&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be customarily employed for more than 20 hours per week&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be customarily employed for more than five months per calendar year.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limits on authorized shares&#59; limits on contributions<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The maximum number of shares of the Company&#8217;s common stock initially available for delivery under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan will be an aggregate number of shares equal to one and a half percent (1.5%) of the total number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fully diluted shares of the Company&#8217;s common stock outstanding (including, without limitation, any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants) as of the date of commencement of trading of the shares of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock on the Nasdaq Global Select Market. In addition, this share limit will automatically increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the first trading day in January of each of the calendar years during the term of the ESPP, with the first <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">177<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such increase to occur in January 2026, by an amount equal to the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.76pt; position: absolute; text-decoration: underline; white-space: pre;">lesser<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.43pt; position: absolute; white-space: pre;"> of (A) one percent of the total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of shares of the Company&#8217;s common stock issued and outstanding on December 31 of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately preceding calendar year or (B) such number of shares of the Company&#8217;s common stock as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be established by the Board of Directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Participation in the ESPP is also subject to the following limits&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">A participant cannot contribute more than 15% of his or her compensation to the purchase of stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">under the ESPP in any one payroll period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">A participant cannot purchase more than 50,000 shares of the Company&#8217;s common stock under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ESPP in any one Offering Period (subject to adjustment by the ESPP administrator for any Offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Period that is longer or shorter than six months).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">A participant cannot purchase more than $25,000 of stock (valued at the start of the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Offering Period and without giving effect to any discount reflected in the purchase price for the stock) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">under the ESPP in any one calendar year.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">A participant will not be granted a Purchase Option under the ESPP if it would cause the participant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">own stock and&#47;or hold outstanding options to purchase stock representing 5% or more of the total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">combined voting power or value of all classes of stock of the Company or one of its subsidiaries or to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the extent it would exceed certain other limits under the U.S. Internal Revenue Code (the &#8220;Code&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have the flexibility to change the 15%-contribution and the individual-share limit referred to above <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from time to time without stockholder approval. However, we cannot increase the aggregate-share limit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the ESPP, other than to reflect stock splits and similar adjustments as described below, without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholder approval. The $25,000 and the 5% ownership limitations referred to above are required under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Code.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Antidilution adjustments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As is customary in stock incentive plans of this nature, the number and kind of shares available under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ESPP, as well as ESPP purchase prices and share limits, are subject to adjustment in the case of certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporate events. These events include reorganizations, mergers, combinations, consolidations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recapitalizations, reclassifications, stock splits, stock dividends, asset sales or other similar unusual or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extraordinary corporate events, or extraordinary dividends or distributions of property to our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Termination of participation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A participant&#8217;s election to participate in the ESPP will generally continue in effect for all Offering Periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until the participant files a new election that takes effect or the participant ceases to participate in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ESPP. A participant&#8217;s participation in the ESPP generally will terminate if, prior to the applicable Purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Date, the participant ceases to be employed by the Company or one of its participating subsidiaries or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participant is no longer scheduled to work more than 20 hours per week or five months per calendar year.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If a participant&#8217;s ESPP participation terminates during an Offering Period for any of the reasons discussed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the preceding paragraph, the participant will no longer be permitted to make contributions to the ESPP <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for that Offering Period and, subject to limited exceptions, the participant&#8217;s Purchase Option for that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Offering Period will automatically terminate and his or her ESPP account balance will be paid to him or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">her in cash without interest. However, a participant&#8217;s termination from participation will not have any effect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon his or her ability to participate in any succeeding Offering Period, provided that the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eligibility and participation requirements are again then met.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Transfer restrictions<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A participant&#8217;s rights with respect to Purchase Options or the purchase of shares under the ESPP, as well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as contributions credited to his or her ESPP account, may not be assigned, transferred, pledged or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise disposed of in any way except by will or the laws of descent and distribution.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">178<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Administration<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ESPP is administered by the Board of Directors or by a committee appointed by the Board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Directors. The Board of Directors has appointed the Compensation Committee of the Board of Directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as the administrator of the ESPP. The administrator has full power and discretion to adopt, amend or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rescind any rules and regulations for carrying out the ESPP and to construe and interpret the ESPP. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Decisions of the ESPP administrator with respect to the ESPP are final and binding on all persons.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No limit on other plans<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ESPP does not limit the ability of the Board of Directors or any committee of the Board of Directors to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grant awards or authorize any other compensation, with or without reference to the Company&#8217;s common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, under any other plan or authority.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amendments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Board of Directors generally may amend or terminate the ESPP at any time and in any manner, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that the then-existing rights of participants are not materially and adversely affected thereby. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stockholder approval for an amendment to the ESPP will only be required to the extent necessary to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meet the requirement of Section 423 of the Code or to the extent otherwise required by law or applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">listing rules. The ESPP administrator also may, from time to time, without stockholder approval, designate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those subsidiaries of the Company whose employees may participate in the ESPP and make certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other administrative changes as authorized by the plan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Termination&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No new Offering Periods will commence under the ESPP on or after the tenth anniversary of the effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of the ESPP, unless the Board of Directors terminates the ESPP earlier. The ESPP will also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate earlier if all of the shares authorized under the ESPP have been purchased. If an event occurs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in which the Company does not survive (or does not survive as a public company in respect of its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock), subject to any provision made by the Board of Directors for the assumption or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continuation of the Purchase Options then outstanding under the ESPP, the Offering Period then in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">progress will be shortened and the outstanding Purchase Options will automatically be exercised on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date established by the ESPP administrator that is not more than 10 days before the closing of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">179<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1286" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Certain relationships and related-party transactions<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following includes a summary of transactions since January 1, 2022 and any currently proposed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions to which we were or are expected to be a participant in which (i) the amount involved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceeded or will exceed $120,000, and (ii) any of our directors, executive officers, or holders of more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">5% of our capital stock, or any affiliate or member of the immediate family of the foregoing persons, had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or will have a direct or indirect material interest, other than compensation and other arrangements that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described under the section titled &#8220;Executive and director compensation.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 convertible promissory notes financing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 209.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, we entered into note purchase agreements with various investors, pursuant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 221.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to which we issued an aggregate of $98.3 million&#160;in principal amount of subordinated convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 233.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promissory notes (the &#8220;2025 Convertible Notes&#8221;) to investors, including related parties, with original <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maturity dates of 48 months from the initial issuance of the notes. Pursuant to the January 2025 note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase agreement, (i) the first closing occurred on January 24, 2025, at which time we issued $44.6 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million in principal amount of the 2025 Convertible Notes and (ii) the second closing occurred on January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025, at which time we issued $3.7 million in principal amount of the 2025 Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the March 2025 note purchase agreement, the closing occurred on March 26, 2025, at which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time we issued $50.0 million in principal amount of the 2025 Convertible Notes. The aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount outstanding under the 2025 Convertible Notes will be automatically converted upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering into shares of our common stock without interest.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following related parties, or their respective affiliates, participated in the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 107.92pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="position: absolute; top: 381.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 384.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 384.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 139.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.56pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 35.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">23,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.44pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 49.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">6,595,648.51<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 81.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 89.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 89.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 89.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.61pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,078,516.75<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 94.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 94.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.52pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 78pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 84.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.46pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 92.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">1,822,713.44<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.97pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 106.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">1,460,234.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">U.S. Venture Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.36pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 139.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.5pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 120.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">811,558.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 135pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 135pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">250,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 149.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 91.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.94pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 149.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">144,650.88<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 553.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 570.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited, as nominee for entities affiliated with Hayfin HeartFlow UK Limited, owns more than 5% of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 579.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding capital. See &#8220;Principal stockholders,&#8221; note 3, for additional details. Hayfin HeartFlow UK Limited is an entity affiliated with <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 588.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Services, LLP, which is the administrative agent under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 605.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP owns more than 5% of our outstanding capital. Dr. Nicholas Downing, M.D. is a former member of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 614.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors and is a managing director of Bain Capital Life Sciences.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 631.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of $1,929,687.95 in principal amount of the 2025 Convertible Notes purchased by Capricorn Healthcare &#38; Special <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 640.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opportunities II, LP, $57,996.00 in principal amount of the 2025 Convertible Notes purchased by The Skoll Foundation, $52,169.37 in <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 649.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">principal amount of the 2025 Convertible Notes purchased by Capricorn Healthcare &#38; Special Opportunities II-A, LP, and $38,663.43 in <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 658.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">principal amount of the 2025 Convertible Notes purchased by The Skoll Fund. Capricorn Entities own more than 5% of our outstanding <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 667.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 684.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Timothy C. Barabe is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 701.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a former member of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 710.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">180<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 98pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of $786,399.92 in principal amount of the 2025 Convertible Notes purchased by U.S. Venture Partners X, L.P. and $25,158.30 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 107pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in principal amount of the 2025 Convertible Notes purchased by USVP X Affiliates, L.P. U.S. Venture Partners Funds own more than 5% <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our outstanding capital. Mr. Casey M. Tansey is a member of our board of directors and is a controlling member of U.S. Venture <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 125pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Partners Funds.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Casey M. Tansey is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 159pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Vikram Verghese is our Chief Financial Officer.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amendment No. 1 to 2024 Credit Agreement and related matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 24, 2025, in connection with the issuance of the 2025 Convertible Notes, we entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendment No. 1 to the 2024 Credit Agreement, pursuant to which our lender, Hayfin, converted $23.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million of outstanding indebtedness under the 2024 Term Loan to 2025 Convertible Notes (the &#8220;2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan Conversion&#8221;) under the same terms as the other purchasers of the 2025 Convertible Notes, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described above. As a result, Hayfin became a holder of 5% or more of our capital stock. For more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information about the 2024 Credit Agreement, as amended, see &#8220;Management&#8217;s discussion and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of financial condition and results of operations&#8212;Liquidity and capital resources&#8212;Hayfin credit agreement&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Note 8 to our consolidated financial statements included elsewhere in this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the prior credit agreement with Hayfin that was refinanced by the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement, we issued warrants to purchase an aggregate of 185,407 shares of common stock to Hayfin. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of the Series F redeemable convertible preferred stock financing referred to below, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">antidilution adjustments of these warrants resulted in the issuance to Hayfin in March 2023 of additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants to purchase an aggregate of 1,462,260 shares of our common stock. The warrants have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price of $0.03 per share of common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Series F and Series F-1 redeemable convertible preferred stock financing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, we entered into a Series F and Series F-1 redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase agreement with various investors, pursuant to which we issued an aggregate of 61,344,029 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of Series F redeemable convertible preferred stock at a cash purchase price of $2.8505 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for gross proceeds of $174.9 million in multiple closings and 21,465,064 shares of Series&#160;F-1 redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock at a purchase price of $1.9098 per share for gross proceeds of $41.0 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Series F and Series F-1 redeemable convertible preferred stock financing&#8221;). The Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock was issued upon conversion of the indebtedness under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding subordinated convertible promissory notes issued by the Company from September 30, 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to December 16, 2022, in the aggregate principal amount of $40.0 million.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">181<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The table below sets forth the number of shares of our Series F and Series F-1 redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock purchased by our executive officers, directors, holders of more than 5% of our capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock at the time of the transaction, and their affiliated entities or immediate family members. Each share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of Series F and Series F-1 redeemable convertible preferred stock in the table below will convert into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock at the then effective conversion rate per share for such share immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 152pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 248.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 248.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.64pt; position: absolute; text-decoration: none; white-space: pre;">redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.66pt; position: absolute; text-decoration: none; white-space: pre;">convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.15pt; position: absolute; text-decoration: none; white-space: pre;">preferred <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">stock (#)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.64pt; position: absolute; text-decoration: none; white-space: pre;">Series F-1 <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.64pt; position: absolute; text-decoration: none; white-space: pre;">redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.66pt; position: absolute; text-decoration: none; white-space: pre;">convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.15pt; position: absolute; text-decoration: none; white-space: pre;">preferred <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">stock (#)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 59.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 70.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 148.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.09pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">35,081,564<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 56.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">99,999,998.18<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Lonnie and Cheryl Smith Family Trust<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 189.24pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 197.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 197.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 197.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 197.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 198.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 198.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.04999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,068,125<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 70.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,408,505.15<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 140.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.46pt; position: absolute; text-decoration: none; white-space: pre;">..........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,508,156<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,689,375<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 84.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,136,167.06<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,905,025<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,321,383<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 99pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">13,654,851.50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.64pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 92.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 93.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 93.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 93.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.08pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,169,444<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 113.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">11,885,000.12<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">U.S. Venture Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.36pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 140.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; text-decoration: none; white-space: pre;">..........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,508,156<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 127.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">9,999,998.68<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 81.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 89.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 90.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 90.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 90.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.52pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,013,904<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 141.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">8,591,133.35<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Schiehallion Fund Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 137.06pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 148.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 150.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 150.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.44pt; position: absolute; text-decoration: none; white-space: pre;">......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,490,791<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 156pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">7,099,999.75<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(11)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 95.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 95.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.58pt; position: absolute; text-decoration: none; white-space: pre;">............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">73,469<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">80,898<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 170.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">363,922.46<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 344.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221;<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 361.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The consideration for the Series F-1 redeemable convertible preferred stock was funded through the conversion of outstanding <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 370.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subordinated convertible promissory notes.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 387.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP owns more than 5% of our outstanding capital. Dr. Nicholas Downing, M.D. is a former member of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 396.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors and is a managing director of Bain Capital Life Sciences.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 413.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a former member of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 422.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 439.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited, as nominee for entities affiliated with Hayfin HeartFlow UK Limited, owns more than 5% of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 448.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding capital. See &#8220;Principal stockholders,&#8221; note 3, for additional details. Hayfin HeartFlow UK Limited is an entity affiliated with <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 457.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Services, LLP, which is the administrative agent under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 474.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 483.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 500.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 3,176,720 shares of Series F redeemable convertible preferred stock held by Hadley Harbor Master Investors (Cayman) II <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 509.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">LP and 992,724 shares of Series F redeemable convertible preferred stock held by Texas Hidalgo CoInvestment Fund, L.P.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 526.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 3,399,403 shares of Series F redeemable convertible preferred stock held by U.S. Venture Partners X, L.P. and 108,753 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 535.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of Series F redeemable convertible preferred stock held by USVP X Affiliates, L.P. U.S. Venture Partners Funds own more than <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 544.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 561.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 1,402,222 shares of Series F redeemable convertible preferred stock held by Capricorn Healthcare &#38; Special Opportunities <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 570.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">II, LP, 37,909 shares of Series F redeemable convertible preferred stock held by Capricorn Healthcare &#38; Special Opportunities II-A, LP, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 579.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">12,729 shares of Series F redeemable convertible preferred stock held by Carthage, LP, 1,142,851 shares of Series F redeemable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 588.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock held by Pacific Sequoia Holdings, LLC, 223,661 shares of Series F redeemable convertible preferred stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 597.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by The Skoll Foundation, and 194,532 shares of Series F redeemable convertible preferred stock held by The Skoll Fund. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 606.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities own more than 5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 623.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Schiehallion Fund Limited and Baillie Gifford Funds affiliated with The Schiehallion Fund Limited own more than 5% of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 632.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 649.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(11)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. William C. Weldon is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 666.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2022 convertible promissory notes financing <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In September 2022, we entered into a note purchase agreement with various investors, pursuant to which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we issued an aggregate of $40.0 million in principal amount of subordinated convertible promissory notes <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">182<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;2022 Convertible Notes&#8221;) to investors with original maturity dates of 48 months from the dates of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance. The 2022 Convertible Notes automatically converted into shares of Series F-1 convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock on March 2, 2023. For more information, see the subsection titled &#8220;&#8212;Series F and Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock financing.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following related parties, or their respective affiliates, participated in the 2022 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 107.92pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="position: absolute; top: 160pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 384.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 384.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Lonnie and Cheryl Smith Family Trust<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 189.24pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 197.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 198.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 198.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 199.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 199.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 199.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.4pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 35.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 139.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.56pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 49.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">5,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.97pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,458,284.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 78pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">150,501.65<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 260.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 277.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a former member of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 286.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 303.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited, as nominee for entities affiliated with Hayfin HeartFlow UK Limited, owns more than 5% of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 312.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding capital. See &#8220;Principal stockholders,&#8221; note 3, for additional details. Hayfin HeartFlow UK Limited is an entity affiliated with <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 321.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Services, LLP, which is the administrative agent under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 338.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 347.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 364.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. William C. Weldon is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 381.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Investors&#8217; rights agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated investors&#8217; rights agreement, as amended, dated March 2, 2023 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 415.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Investors&#8217; Rights Agreement&#8221;), with the purchasers of our outstanding redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, including the following directors, holders of more than 5% of our capital stock and entities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with which certain of our directors are affiliated&#58; BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow UK Limited (an entity affiliated with Hayfin Services, LLP, which is the administrative agent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under our 2024 Credit Agreement), HealthCor Partners Funds, Wellington Entities, U.S. Venture Partners <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Funds, Capricorn Entities, Baillie Gifford Funds, William C. Weldon and Charles A. Taylor, Jr., Ph.D. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 487.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following the completion of this offering, the holders of&#160;a<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.75pt; position: absolute; text-decoration: none; white-space: pre;">pproximately 55.8&#160;million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.74pt; position: absolute; white-space: pre;"> shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, which includes all shares of our common stock issuable upon the conversion of our outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, are entitled to rights with respect to the registration of their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares under the Securities Act. For a more detailed description of these registration rights, see the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section titled &#8220;Shares eligible for future sale&#8212;Registration rights.&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 555.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated voting agreement, as amended, with certain holders of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock and redeemable convertible preferred stock, including the following directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officers, holders of more than 5% of our capital stock, and entities with which certain of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors are affiliated&#58; BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin HeartFlow UK Limited (an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity affiliated with Hayfin Services, LLP, which is the administrative agent under our 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement), HealthCor Partners Funds, Wellington Entities, U.S. Venture Partners Funds, Capricorn <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Entities, Baillie Gifford Funds, William C. Weldon and Charles A. Taylor, Jr., Ph.D. Pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended and restated voting agreement, BCLS Fund III Investments, LP has the right to designate one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">member to be elected to our board of directors, which designee is currently Nicholas Downing. Upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, the amended and restated voting agreement will terminate. Members <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously elected to our board of directors pursuant to this agreement will continue to serve as directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until they resign, are removed or their successors are duly elected by holders of our common stock. The <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">183<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition of our board of directors after this offering is described in more detail in the section title <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Management&#8212;Board composition.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Right of first refusal and co-sale agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated right of first refusal and co-sale agreement with certain holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock and redeemable convertible preferred stock, including the following directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of more than 5% of our capital stock, and entities with which certain of our directors are affiliated&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin HeartFlow UK Limited (an entity affiliated with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin Services, LLP, which is the administrative agent under our 2024 Credit Agreement), HealthCor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Partners Funds, Wellington Entities, U.S. Venture Partners Funds, Capricorn Entities, Baillie Gifford <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Funds, William C. Weldon and Charles A. Taylor, Jr., Ph.D. This agreement provides for rights of first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">refusal and co-sale relating to the shares of our common stock and convertible securities, other than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F and Series F-1 redeemable convertible preferred stock and the common stock issuable upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conversion of such preferred stock, held by certain parties to the agreement. Upon the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, the amended and restated right of first refusal and co-sale agreement will terminate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management rights letters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the issuance of our Series F and Series F-1 convertible preferred stock, we entered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into management rights letters with certain purchasers of our redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including holders of more than 5% of our capital stock, Wellington Entities, U.S. Venture Partners X, L.P. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Baillie Gifford Funds, pursuant to which such entities were granted certain management rights, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including the right to consult with and advise our management on significant business issues, review our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating plans, examine our books and records and inspect our facilities. These management rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">letters and the rights granted to the parties thereto will terminate upon completion of this offering. Certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our obligations under the management rights letters will remain in effect after the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, including certain tax reporting and financial disclosures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Letter agreement with Bain Capital Life Science<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with our Series F redeemable convertible preferred stock financing, we entered into a letter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with BCLS Fund III Investments, LP (the &#8220;BCLS Letter Agreement&#8221;), which holds more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">5% of our outstanding capital stock. Pursuant to the BCLS Letter Agreement, BCLS Fund III Investments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">LP was granted the right to designate a board observer in a nonvoting capacity, which right will terminate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon the completion of this offering. Certain of our obligations under the BCLS Letter Agreement will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 487.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remain in effect after the completion of this offering,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.77pt; position: absolute; text-decoration: none; white-space: pre;"> including our obligation to obtain the consent of Bain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 499.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Capital prior to making certain public disclosures about Bain Capital or certain of its affiliates and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 511.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">pro rata lock-up release rights of Bain Capital which provide that, in the event we or the managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 523.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">underwriter waive or terminate the lock-up restrictions contained in the Investors&#8217; Rights Agreement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 535.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certain lock-up agreements (including certain lock-up agreements for this offering), then such restrictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 547.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable to Bain Capital under the Investors&#8217; Rights Agreement or any lock-up agreement will be waived <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 559.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">or terminated, as applicable, to the same extent and with respect to the same percentage of securities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 579.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Letter agreement with Capricorn Entities<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with our Series F redeemable convertible preferred stock financing, we entered into a letter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the Capricorn Entities (the &#8220;Capricorn Letter Agreement&#8221;), which collectively hold more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than 5% of our outstanding capital stock. Pursuant to the Capricorn Letter Agreement, the Capricorn <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Entities were granted the right to designate a board observer in a nonvoting capacity. The Capricorn <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Letter Agreement will terminate by its terms in connection with the completion of this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Capricorn Entities will not have any continuing rights following this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">184<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023 Taylor Trust repurchase<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 29, 2023, we entered into a common stock repurchase agreement in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F and Series F-1 redeemable convertible preferred stock financing, pursuant to which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repurchased 102,739 shares of common stock from the Taylor Family Revocable Trust, a family trust held <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by Charles A. Taylor, Jr., Ph.D., one of our directors, at $8.3235 per share for an aggregate purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price of $855,150.00.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 184.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Michael Smith, a relative of Mr. Lonnie M. Smith, one of our directors, has been one of our non-executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 196.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">employees since 2014. His overall cash compensation for each of 2022, 2023 and 2024 did not exceed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$300,000. He did not receive any equity compensation in 2024, and has received an aggregate of less <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">than 17,123 incentive stock options during his employment with us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 240.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive officer and director compensation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Please see the section titled &#8220;Executive and director compensation&#8221; for information regarding the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 275.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">compensation of our directors and executive officers and the new severance plan we intend to enter into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 287.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">prior to this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Indemnification agreements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have entered into indemnification agreements with certain of our current directors and executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers and intend to enter into new indemnification agreements with each of our current directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officers before the completion of this offering. Our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation and our amended and restated bylaws will provide that we will indemnify our directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers to the fullest extent permitted by applicable law. Further, we have purchased a policy of directors&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and officer&#8217; liability insurance that insures our directors and officers against the cost of defense, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement or payment of a judgment under certain circumstances. See the section titled &#8220;Management&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Limitations on liability and indemnification matters.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Policies and procedures for related-party transactions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has adopted a written related-party transaction policy, to be effective upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commencement of trading of our common stock on the Nasdaq Global Select Market, which sets forth the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policies and procedures for the review and approval or ratification of related-party transactions. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policy will cover, with certain exceptions set forth in Item 404 of Regulation S-K, any transaction, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arrangement, or relationship, or any series of similar transactions, arrangements, or relationships, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which we were or are to be a participant, where the amount involved exceeds $120,000 and a related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person had or will have a direct or indirect material interest, including without limitation purchases of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">goods or services by or from the related person or entities in which the related person has a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest, indebtedness, guarantees of indebtedness, and employment by us of a related person. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reviewing and approving any such transactions, our audit committee is tasked to consider all relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facts and circumstances, including but not limited to whether the transaction is on terms comparable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those that could be obtained in an arm&#8217;s length transaction with an unrelated third party and the extent of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the related person&#8217;s interest in the transaction. All of the transactions described in this section occurred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to the adoption of this policy.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">185<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1309" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Principal stockholders<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth, as of June 30, 2025, information regarding beneficial ownership of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital stock by&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 139.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 151.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each of our named executive officers&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each of our directors&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">all of our executive officers and directors as a group.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 231.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The percentage ownership information under the column titled &#8220;Beneficial ownership prior to this offering&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 243.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is based on 64,086,637&#160;shares of our common stock outstanding as of&#160;June 30, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 255.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#160;51,226,348&#160;shares of our common stock resulting from the<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.53pt; position: absolute; text-decoration: none; white-space: pre;"> Preferred Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 444.72pt; position: absolute; white-space: pre;"> Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and&#160;6,470,743<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.91pt; position: absolute; text-decoration: none; white-space: pre;">&#160;shares of our common stock resulting from the conversion of the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 279.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(based on the initial public offering price of $19.00 per share)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.68pt; position: absolute; white-space: pre;">, in each case as if such conversion had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">occurred as of&#160;June 30, 2025. The ownership information under the column titled &#8220;Beneficial ownership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 303.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after this offering&#8221; assumes the foregoing and the issuance of 16,666,667&#160;shares of common stock in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 315.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering and assumes no exercise of the underwriters&#8217; option to purchase additional shares. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 327.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the following table does not reflect any shares of common stock that may be purchased in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 347.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have determined beneficial ownership according to the rules and regulations of the SEC, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally means that a person has beneficial ownership of a security if they or it possesses sole or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shared voting or investment power of that security. In addition, shares of common stock issuable upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of stock options or warrants that are currently exercisable or exercisable within 60 days of&#160;June <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">30, 2025 are included in the following table. These shares are deemed to be outstanding and beneficially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owned by the person holding those options or warrants for the purpose of computing the percentage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership of that person, but they are not treated as outstanding for the purpose of computing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">percentage ownership of any other person. The information contained in the following table does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessarily indicate beneficial ownership for any other purpose. Unless otherwise indicated, the persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or entities identified in this table have sole voting and investment power with respect to all shares shown <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as beneficially owned by them, subject to applicable community property laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">186<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise noted below, the address for each beneficial owner listed in the table below is c&#47;o <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow, Inc., 331 E. Evelyn Avenue, Mountain View, California 94041.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 216pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 219pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.44pt; position: absolute; text-decoration: none; white-space: pre;">Beneficial ownership <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 34.48pt; position: absolute; text-decoration: none; white-space: pre;">prior to this offering<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 345pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.44pt; position: absolute; text-decoration: none; white-space: pre;">Beneficial ownership <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.46pt; position: absolute; text-decoration: none; white-space: pre;">after this offering<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 216pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 216pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name of beneficial owner<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 24pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.42pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.38pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.4pt; position: absolute; text-decoration: none; white-space: pre;">beneficially <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.9pt; position: absolute; text-decoration: none; white-space: pre;">owned<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 24pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.9pt; position: absolute; text-decoration: none; white-space: pre;">Percentage <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.92pt; position: absolute; text-decoration: none; white-space: pre;">of beneficial <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.41pt; position: absolute; text-decoration: none; white-space: pre;">ownership<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 24pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.42pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.38pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.4pt; position: absolute; text-decoration: none; white-space: pre;">beneficially <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.9pt; position: absolute; text-decoration: none; white-space: pre;">owned<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 24pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.9pt; position: absolute; text-decoration: none; white-space: pre;">Percentage <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.92pt; position: absolute; text-decoration: none; white-space: pre;">of beneficial <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.41pt; position: absolute; text-decoration: none; white-space: pre;">ownership<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">5% and greater stockholders&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 83.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 148.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 148.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.31pt; position: absolute; text-decoration: none; white-space: pre;">..........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 83.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.35pt; position: absolute; text-decoration: none; white-space: pre;">12,448,158<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 83.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">19.4<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 83.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.35pt; position: absolute; text-decoration: none; white-space: pre;">12,448,158<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 83.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">15.4<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 97.5pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HealthCor Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 118.72pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 126.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 127.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 128.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 128.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.22pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 97.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">6,697,556<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 97.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">10.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 97.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">6,697,556<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 97.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">8.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111.75pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Entities affiliated with Hayfin Services, LLP <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 193.84pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 201.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 202.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.22pt; position: absolute; text-decoration: none; white-space: pre;">....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 111.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">5,283,265<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 111.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">8.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 111.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">5,283,265<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 111.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">6.4<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.64pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 92.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 93.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.3pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 126pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">4,414,491<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 126pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">6.9<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 126pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">4,414,491<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 126pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">5.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.52pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 85.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 85.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 85.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.75pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 140.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,922,837<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 140.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">6.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 140.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,922,837<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 140.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">4.9<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 154.5pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">FMR LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 45.39pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 53.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 53.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.370000000000005pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,289,465<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">5.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,289,465<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 154.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">4.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168.75pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 83.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 83.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.33pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,498,383<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">5.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,498,383<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 168.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">4.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 183pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Named executive officers and directors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 192.54999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 197.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 100.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.74pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 197.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">1,430,094<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 197.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">2.2<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 197.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">1,430,094<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 197.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">1.7<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 211.5pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 86.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 87.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 87.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 88.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.21pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 211.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">205,949<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 211.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 211.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">205,949<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 211.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 225.75pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 128.68pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 140.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.81pt; position: absolute; text-decoration: none; white-space: pre;">.............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 225.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">360,215<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 225.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 225.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">360,215<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 225.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 240pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(11)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 95.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 95.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.81pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 240pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">290,948<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 240pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 240pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">290,948<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 240pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 254.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(12)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 97.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 98.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 98.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.27pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 254.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">171,002<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 254.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 254.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.24pt; position: absolute; text-decoration: none; white-space: pre;">171,002<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 254.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 268.5pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(13)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 84.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 85.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 85.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 85.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.77pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 268.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; text-decoration: none; white-space: pre;">46,340<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 268.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 268.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; text-decoration: none; white-space: pre;">46,340<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 268.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 282.75pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(14)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 120.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 120.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.86999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 282.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.37pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 282.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.37pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 282.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.37pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 282.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.37pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 297pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 93.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 94.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 95.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 95.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">6,697,556<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">10.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">6,697,556<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">8.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 311.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.25pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(15)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 95.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.86999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 311.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; text-decoration: none; white-space: pre;">40,131<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 311.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 311.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; text-decoration: none; white-space: pre;">40,131<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 311.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.36pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 325.5pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 83.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 83.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.33pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 325.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,498,383<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 325.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">5.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 325.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,498,383<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 325.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">4.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 339.75pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(16)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 90.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.86pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 339.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,187,509<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 339.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">5.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 339.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.91pt; position: absolute; text-decoration: none; white-space: pre;">3,187,509<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 339.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">3.9<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 354pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(17)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 135.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 135.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 135.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.85999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 354pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.65pt; position: absolute; text-decoration: none; white-space: pre;">1,110,535<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 354pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">1.7<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 354pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.65pt; position: absolute; text-decoration: none; white-space: pre;">1,110,535<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 354pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 33.14pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 33.14pt; position: absolute;">1.4<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 368.25pt; width: 216pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">All current directors and executive officers as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 216pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">group (12 persons)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 87.08999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(18)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 98.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 99.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 100.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.66pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 368.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.35pt; position: absolute; text-decoration: none; white-space: pre;">17,038,662<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 368.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">25.9<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 368.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.35pt; position: absolute; text-decoration: none; white-space: pre;">12,429,744<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 368.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 27.58pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 27.58pt; position: absolute;">15.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 506.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Indicates beneficial ownership of less than 1% of the total outstanding common stock.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 523.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 118.74pt; position: absolute; text-decoration: none; white-space: pre;"> of&#160;(A) 12,014,234 shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 532.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directly by BCLS Fund III Investments, LP and (B)&#160;433,924&#160;shares of common stock issuable upon conversion of the 2025 Convertible <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 541.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Notes purchased by BCLS Fund III Investments, LP. Bain Capital Life Sciences Investors, LLC (&#34;BCLSI&#34;) is the manager of Bain Capital <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 550.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Life Sciences III General Partner, LLC, which is the general partner of Bain Capital Life Sciences Fund III, L.P., which is the managing <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 559.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of BCLS Fund III Investments GP, LLC, which is the general partner of BCLS Fund III Investments, LP. As a result, BCLSI may <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 568.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments, LP. Voting and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 577.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">investment decisions with respect to the securities held by BCLS Fund III Investments, LP are made by the partners of BCLSI, of whom <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 586.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">there are three or more and none of whom individually has the power to direct such decisions. The principal address for BCLS Fund III <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 595.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investments, LP is 200 Clarendon Street, Boston, Massachusetts 02116. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 612.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock expected to be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 621.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by the following entities, collectively referred to as &#8220;HealthCor Partners Funds&#8221;&#58; (i)&#160;4,519,474 shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 630.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of our redeemable convertible preferred stock held by HCPCIV 1, LLC&#59; (ii)&#160;1,248,939&#160;shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 639.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of our redeemable convertible preferred stock held by HealthCor Partners Fund, L.P&#59; and (iii)&#160;833,075&#160;shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 648.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by HealthCor Partners Fund II, L.P. and (B) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 657.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">96,068&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by HCPCIV 1, LLC. Mr. Lightcap, a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 666.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors, is a controlling member of each of the HealthCor Partners Funds. Mr. Lightcap disclaims beneficial <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 675.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ownership of these shares except to the extent of his pecuniary interest therein. Collectively, together with Mr. Lightcap, Arthur Cohen <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 684.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and Joseph Healey form the investment committee on behalf of HealthCor Partners Management, LP,&#160; the investment manager for the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 693.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Healthcor&#160; Partners Funds, and have sole discretion for voting and disposal of HealthCor Partners Funds&#8217; shares. The address for the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 702.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HealthCor Partners Funds is 186 Seven Farms Drive, Suite F-371, Daniel Island, South Carolina 29492. <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">187<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#58; (A)(i) 2,122,442 shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Heartflow UK Limited as nominee for the following beneficial owners&#58; (a) Hayfin Healthcare Opportunities Invest LP and (b)(I) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Special Opportunities Fund III SCSp, (II) Hayfin Hostplus LP, (III) Hayfin Chief LP, (IV) SunHay LP, (V) Hayfin Big Cypress LP, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(VI) Hayfin Hamilton LP, (VII) Hayfin Opal 2020 (A) LP, and (VIII) Hayfin Opal 2020 (B) LP (collectively, the &#8220;Hayfin Special <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opportunities Preferred Stock Beneficial Owners&#8221; and, together with Hayfin Healthcare Opportunities Invest LP, the &#8220;Hayfin Preferred <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 117pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock Beneficial Owners, and each, a &#8220;Hayfin Preferred Stock Beneficial Owner&#8221;)&#59; and (ii) 1,647,667 shares of our common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subject to warrants exercisable by Hayfin Tourmaline Luxco S.a r.l. and held as nominee for the following beneficial owners&#58; (a) Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 135pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare Opportunities Invest LP and (b)(I) Hayfin Special Opportunities Fund II LP, (II) Hayfin Special Opportunities Fund III SCSp,&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(III) Hayfin Hostplus LP, (IV) Hayfin Chief LP, (V) SunHay LP, (VI) Hayfin Big Cypress LP, (VII) Hayfin Opal 2020 (A) LP and (VIII) Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 153pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opal 2020 (B) LP (collectively, the &#8220;Hayfin Special Opportunities Warrant Beneficial Owners&#8221; and, together with Hayfin Healthcare <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opportunities Invest LP, the &#8220;Hayfin Warrants Beneficial Owners&#8221;, and each, a &#8220;Hayfin Warrants Beneficial Owner&#8221;)&#59; and (B) 1,513,156 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 171pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by Hayfin HeartFlow UK Limited and held <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">as nominee for the following beneficial owners&#58; (a) Hayfin AUS AIV LP, acting through the Hostplus Series, (b) Hayfin Special <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 189pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opportunities Fund III AIV LP, (c) Hayfin AUS AIV LP, acting through the AUS SOF III Series, (d) Hayfin Chief LP, (d) Hayfin Big Cypress <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">LP, (e) Hayfin Opal 2020 (A) LP, and (f) Hayfin Opal 2020 (B) LP (collectively, the &#8220;Hayfin 2025 Convertible Notes Beneficial Owners,&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 207pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and each, a &#8220;Hayfin 2025 Convertible Notes Beneficial Owner&#8221;). <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Each Hayfin Preferred Stock Beneficial Owner has shared voting power and shared dispositive power with respect to our common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 233pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of the redeemable convertible preferred stock in proportion to its pro rata beneficial interest in the redeemable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock. Each Hayfin Warrants Beneficial Owner has shared voting power and shared dispositive power with respect <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 251pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to our common stock issuable upon exercise of the warrants in proportion to its pro rata beneficial interest in the warrants.&#160; Each Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes Beneficial Owner has shared voting power and shared dispositive power with respect to our common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 269pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of the 2025 Convertible Notes in proportion to its pro rata beneficial interest in the 2025 Convertible Notes.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Each Hayfin Preferred Stock Beneficial Owner, each Hayfin Warrants Beneficial Owner and each Hayfin 2025 Convertible Notes <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 295pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Beneficial Owner is structured as a limited partnership acting by its general partner, which in each case is ultimately a private limited <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">company. The general partners of Hayfin Healthcare Opportunities Invest LP, Hayfin Special Opportunities Fund III SCSp, Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 313pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hostplus LP, Hayfin Chief LP, SunHay LP, Hayfin Big Cypress LP and Hayfin Hamilton LP are Hayfin HF GP LLC acting through Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare Opportunities Fund GP S.&#224; r.l., Hayfin SOF III GP S.&#224; r.l., Hayfin Hostplus GP Limited, Hayfin Chief GP Limited, SunHay GP <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 331pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Limited, Hayfin Big Cypress GP Limited and Hayfin Hamilton GP Limited, respectively. The general partner of Hayfin Opal 2020 (A) LP <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and Hayfin Opal 2020 (B) LP is Hayfin Opal 2020 GP Limited.&#160; The general partner of Hayfin Special Opportunities Fund II LP is Hayfin <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 349pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">SOF II GP LP acting through Hayfin SOF II GP Limited.&#160; The general partner of Hayfin AUS AIV LP, acting through the Hostplus Series, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and Hayfin AUS AIV LP, acting through the AUS SOF III Series, is Hayfin AUS AIV GP LLC acting through Hayfin SOF III AIV GP S.&#224;.r.l.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 367pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The general partner of Hayfin Special Opportunities Fund III AIV LP is Hayfin SOF III AIV GP LLC acting through Hayfin SOF III AIV GP <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">S.&#224;.r.l.&#160; Each such private limited company may be deemed to share voting and investment power over the Heartflow securities held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 385pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the limited partnership for which it acts as general partner.&#160; The number of board members of each such private limited company ranges <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">from three to five (other than for Hayfin Hostplus GP Limited, SunHay GP Limited and Hayfin Big Cypress GP Limited, for which the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 403pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">number of board members is two). In all cases decision-making on the exercise of voting and investment power with respect to the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow securities held by the limited partnership requires a majority of the board members of its general partner present at a quorate <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 421pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">meeting, at least two board members are required to form a quorum, and no single board member has the power to direct such <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">decisions.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 447pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The principal address for Hayfin Heartflow UK Limited, Hayfin Services, LLP and their affiliates is 65 Davies Street, London W1K 5JL.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The registered office for Hayfin Tourmaline Luxco S.&#224;.r.l is 15 Boulevard F.W. Raiffeisen, L-2411 Luxembourg. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 473pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i) 3,388,522 shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hadley Harbor Master Investors (Cayman) II LP and (ii) 1,025,969 shares of our common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 491pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock held by Texas Hidalgo Co-Investment Fund, L.P. (each a &#8220;Wellington Entity&#8221; and, collectively, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the &#8220;Wellington Entities&#8221;). Wellington Management Company LLP, a registered investment adviser under the Investment Advisers Act of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 509pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1940, as amended, is the investment adviser to each Wellington Entity, and Wellington Alternative Investments LLC is general partner <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to each Wellington Entity. Wellington Management Investment, Inc. is the managing member of Wellington Alternative Investments LLC. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 527pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Management Company LLP is an indirect subsidiary of Wellington Management Group LLP. Wellington Management Group <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">LLP and Wellington Management Company LLP may be deemed beneficial owners with shared voting and investment power over the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 545pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares held by each Wellington Entity. Wellington Management Group LLP is a Massachusetts limited liability partnership, privately held <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by 181 partners (as of June 30, 2025). There are no external entities with any ownership interest in Wellington Management Group LLP. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 563pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Individual percentages of ownership are confidential. However, no single partner owns or has the right to vote more than 5% of the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Management Group LLP&#8217;s capital. Additional information about Wellington Management Company LLP is available in its <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 581pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Form ADV filed with the SEC. The address of all entities referenced in this footnote is 280 Congress Street, Boston, Massachusetts <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">02210.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 607pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">following entities, collectively referred to as the &#8220;Capricorn Funds&#8221;&#58; (i)&#160;857,457 shares of common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 625pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock held by Capricorn Healthcare and Special Opportunities, LP&#59; (ii) 1,058,496 shares of common <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 634pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock issuable upon conversion of our redeemable convertible preferred stock held by Capricorn Healthcare &#38; Special Opportunities II, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 643pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">LP&#59; (iii)&#160;28,616 shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by Capricorn <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare &#38; Special Opportunities II-A, LP&#59; (iv)&#160;71,238 shares of common stock issuable upon conversion of our redeemable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 661pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock held by Capricorn S.A. SICAV&#8201;&#8212;&#8201;SIF&#8201;&#8212;&#8201;Global Non-Marketable Strategies Sub-Fund&#59; (v) 31,526 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 670pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by Carthage, LP&#59; (vi)&#160;41,641 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 679pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO CIG, LP&#59; (vii)&#160;50,870 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO SFP, LP&#59; (viii)&#160;76,067&#160;shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 697pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO TSF, LP&#59; (ix) 1,162,999&#160;shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 706pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by Pacific Sequoia Holdings, LLC&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">188<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(x)&#160;216,570&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by The Skoll <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Foundation&#59; and (xi)&#160;190,614&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Skoll Fund and (B) (i) 126,953&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Healthcare &#38; Special Opportunities II, LP, (ii) 3,815&#160;shares of common stock issuable upon conversion of the 2025 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes purchased by The Skoll Foundation, (iii) 3,432&#160;shares of common stock issuable upon conversion of the 2025 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 117pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes purchased by Capricorn Healthcare &#38; Special Opportunities II-A, L.P., and (iv) 2,543&#160;shares of common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of the 2025 Convertible Notes purchased by The Skoll Fund. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 143pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners, LLC, is the general partner of Capricorn Healthcare and Special Opportunities, LP, CHSO CIG, LP, CHSO SFP, LP, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and CHSO TSF, LP. CHSO Partners, LLC has sole investment and voting authority over the shares held by these funds. Voting and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 161pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">dispositive decisions on behalf of CHSO Partners LLC are made by the separate decisions of Barry Uphoff, the Principal Manager of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners LLC and a majority of the CIG Managers of CHSO Partners. Messrs. Eric Techel and Ion Yadigaroglu are the CIG <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 179pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Managers of CHSO Partners LLC. Messrs. Uphoff, Techel and Yadigaroglu may be deemed to have shared voting and investment <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">control with respect to the shares held by the funds managed by CHSO Partners LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 205pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners II, LLC, is the general partner of Capricorn Healthcare &#38; Special Opportunities II, LP and Capricorn Healthcare &#38; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Special Opportunities II-A, LP. CHSO Partners II, LLC has sole investment and voting authority over the shares held by these funds. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 223pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Voting and dispositive decisions on behalf of CHSO Partners II, LLC are made by the separate decisions of Barry Uphoff, the Principal <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Manager of CHSO Partners II, LLC and one designated representative of Capricorn Investment Group, LLC. Mr. Uphoff and Capricorn <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 241pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investment Group may be deemed to have shared voting and investment control with respect to the shares held by the funds managed <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by CHSO Partners II, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 267pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Investment Group, LLC is the general partner of Carthage, LP and the investment manager of Pacific Sequoia Holdings, LLC, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Skoll Foundation and The Skoll Fund.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 293pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The address for each of the Capricorn Funds is c&#47;o Capricorn Investment Group LLC, 250 University Avenue, Palo Alto, California <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">94301. CHSO Partners, LLC and CHSO Partners II, LLC&#8217;s address is 2020 K Street NW, STE 720, Washington, DC 20006.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 319pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of shares of common stock issuable upon conversion of the 2025 Convertible Notes.&#160; These shares are owned by funds and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accounts managed by direct or indirect subsidiaries of FMR LLC, all of which shares are beneficially owned, or may be deemed to be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 337pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates and other companies. Abigail P. Johnson is a Director, the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 355pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#8217; voting agreement under <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 373pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Accordingly, through their ownership of voting common shares and the execution of the shareholders&#8217; voting agreement, members of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 391pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The business address of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 417pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) (i)&#160;2,763,056 shares of our common stock issuable upon conversion of our redeemable convertible preferred stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expected to be held by Lonnie M. Smith HeartFlow IV Grantor Retained Annuity Trust u&#47;a June 24, 2023, (ii)&#160;417,208&#160;shares of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 435pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by Lonnie M. Smith HeartFlow GRAT III, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(iii)&#160;139,879&#160;shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by McKram <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 453pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investment Capital II LLC, (iv)&#160;34,246 shares of our common stock held directly by Mr. Smith and (v)&#160;24,079&#160;shares of our common <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock subject to options exercisable by Mr. Smith within 60 days of&#160;June 30, 2025 and (B) 119,915&#160;shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 471pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of the 2025 Convertible Notes purchased by Lonnie M. Smith. Mr. Smith has voting and investment power over the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares held by McKram Investment Capital II LLC. Mr. Smith resigned from our board of directors in connection with the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 489pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">commencement of trading of our common stock on the Nasdaq Global Select Market.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i) 373,380 shares of our common stock and (ii) 1,056,714 shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 515pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of&#160;June 30, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A)&#160;(i) 114,815 shares of our common stock and&#160;(ii) 81,618 shares of our common stock subject to options exercisable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 541pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">within 60 days of&#160;June 30, 2025 and (B) 9,516&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purchased by Vikram Verghese.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 567pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 214,675 shares of our common stock subject to options exercisable within 60 days of June 30, 2025, and includes (ii) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">119,528 shares of our common stock expected to be held by family trusts established by Dr. Rogers for the benefit of certain members <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 585pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of his family and (iii) 26,012 shares of our common stock expected to be held by a trust beneficially owned by his wife. Dr. Rogers may <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be deemed to beneficially own such shares.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 611pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(11)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i)&#160;56,256&#160;shares of our common stock, (ii) 136,306&#160;shares of our common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock and (iii) 98,386 shares of our common stock subject to options exercisable within 60 days <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 629pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;June 30, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 646pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(12)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A)&#160;(i) 36,779 shares of our common stock and (ii) 2,645&#160;shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 655pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of&#160;June 30, 2025 and (B) 131,578&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by Timothy C. Barabe.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 681pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(13)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 44,413 shares of our common stock and (ii) 1,927 shares of our common stock subject to options exercisable within 60 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">days of&#160;June 30, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">189<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(14)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Does not include shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by BCLS <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Fund III Investments, LP or our 2025 Convertible Notes purchased by BCLS Fund III Investments, LP. Dr. Downing is a managing <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">director of Bain Capital Life Sciences. Dr. Downing resigned from our board of directors in connection with the commencement of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">trading of our common stock on the Nasdaq Global Select Market.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(15)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 40,131 shares of our common stock subject to options exercisable within 60 days of&#160;June 30, 2025. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 133pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(16)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock expected to be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by the following entities, collectively referred to as the &#8220;U.S. Venture Partners Funds&#8221;&#58; (i) 3,021,023 shares of common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 151pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of our redeemable convertible preferred stock held by U.S. Venture Partners X, L.P. and (ii) 96,648 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by USVP X Affiliates, L.P., (B) (i) 51,736 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 169pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by U.S. Venture Partners X, L.P. and (ii) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1,655 shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by USVP X Affiliates, L.P. Presidio <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 187pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Management Group X, L.L.C. (&#8220;PMG X&#8221;) is the general partner of the U.S. Venture Partners Funds, and (C) 16,447 shares of common <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock issuable upon conversion of the 2025 Convertible Notes purchased by Casey M. Tansey. Casey Tansey, a member of our Board <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 205pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of Directors, is a managing member of PMG X and shares voting and investment power over the shares held by U.S. Venture Partners <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">X, L.P. and USVP X Affiliates, L.P., but disclaims beneficial ownership except to the extent of his pecuniary interests therein. The <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 223pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">address for the U.S. Venture Partners Funds is 1460 El Camino Real, Suite 100, Menlo Park, California 94025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(17)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 136,986 shares of our common stock and (ii) 157,628 shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 249pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of June 30, 2025, and includes&#160;(iii) 775,779&#160;shares expected to be held by various family trusts established by Dr. Taylor and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(iv) 40,142 shares expected to be held by various family members. Dr. Taylor may be deemed to beneficially own such shares.&#160;205,479 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 267pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares expected to be held by Dr. Taylor and his trust have been pledged to Section Capital Partners, LP. Dr. Taylor resigned from our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors in connection with the commencement of trading of our common stock on the Nasdaq Global Select Market.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 293pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(18)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Includes the shares described in footnotes 2 and 7 through 17 above for beneficial ownership prior to this offering and, since Mr. Smith, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Dr. Downing and Dr. Taylor have each resigned from our board of directors, excludes the shares described in footnotes 7, 14, and 17, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 311pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">respectively, for beneficial ownership after this offering<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 269.65pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">190<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1337" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Description of capital stock<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following descriptions are summaries of our capital stock and the material terms of our amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restated certificate of incorporation, which will become effective upon the completion of this offering, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our amended and restated bylaws, which will become effective <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 351.41pt; position: absolute; text-decoration: none; white-space: pre;">upon the effectiveness of the amended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and restated certificate of incorporation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 244.75pt; position: absolute; white-space: pre;">. Because the following descriptions are only summaries, they do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not contain all of the information that may be important to you. Reference is made to the more detailed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions of, and the descriptions are qualified in their entirety by reference to, these documents, copies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of which are filed with the SEC as exhibits to the registration statement of which this prospectus is a part, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and applicable law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">General<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 233.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering and the filing of our amended and restated certificate of incorporation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our authorized capital stock will consist of&#160;300,000,000 shares of capital stock, par value $0.001 per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share, of which&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 277.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">250,000,000&#160;shares are designated as common stock&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 297.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">50,000,000 shares are designated as preferred stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As of June 30, 2025, there would have been 64,086,637 shares of common stock outstanding, held of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">record by&#160;577 stockholders, assuming the<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 257pt; position: absolute; text-decoration: none; white-space: pre;"> Preferred S<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.86pt; position: absolute; text-decoration: none; white-space: pre;">tock Conversion immediately prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">completion of this offering into 51,226,348 shares of common stock and the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Conversion upon the completion of this offering i<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.68pt; position: absolute; text-decoration: none; white-space: pre;">nto&#160;6,470,743&#160;shares of common stock, based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">initial public offering price of $19.00&#160;per share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.46000000000004pt; position: absolute; white-space: pre;">. On&#160;July 31, 2025, we consummated a 1.0-for-2.92&#160;reverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock split of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 397.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holders of our common stock are entitled to one vote per share on all matters submitted to a vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will not provide for cumulative voting for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">election of directors. Subject to the rights of the holders of one or more series of preferred stock, director <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">candidates standing for election will be elected by a plurality of the votes cast by our stockholders present <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in person or represented by proxy at the meeting and entitled to vote thereon. Our amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certificate of incorporation will retain a classified board of directors, divided into three classes with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">staggered three-year terms. Only one class of directors will be elected at each annual meeting of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders, with the other classes continuing for the remainder of their respective terms. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividend rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to preferences that may be applicable to any preferred stock, the holders of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be entitled to receive ratably, on a per share basis, any dividends declared by our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">out of assets legally available.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to preferences that may be applicable to any preferred stock, in the event of any voluntary or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involuntary liquidation, dissolution or winding up, after payment or provision for payment of our debts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other liabilities, the holders of shares of our common stock will be entitled to receive, ratably in proportion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the number of shares held by the holder, all our remaining assets available for distribution to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">191<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No preemptive or similar rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of our common stock will not be entitled to preemptive, subscription or conversion rights. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There will be no redemption or sinking fund provisions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Preferred stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Immediately prior to the completion of this offering, all outstanding shares of our redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock will be converted into shares of our common stock. Our amended and restated certificate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of incorporation will authorize&#160;50,000,000&#160;shares of preferred stock and will provide that preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be issued from time to time in one or more series. Our board of directors will be authorized to fix the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">voting rights, if any, designations, powers, preferences, the relative, participating, optional, special and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">series. These rights, powers and preferences could include dividend rights, conversion rights, voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights, terms of redemption, liquidation preferences, sinking fund terms, and the number of shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constituting, or the designation of, such series, any or all of which may be greater than the rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. Our board of directors will be able to, without stockholder approval, issue shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock with voting and other rights that could adversely affect the voting power and other rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders of the common stock and could have anti-takeover effects. The ability of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to issue shares of preferred stock without stockholder approval could have the effect of delaying, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferring or preventing a change of control or the removal of existing management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock options<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As of&#160;March 31, 2025, we had outstanding&#160;8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.53pt; position: absolute; text-decoration: none; white-space: pre;">,583,703&#160;shares of our common stock issuable upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">exercise of outstanding stock options<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.88pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.42pt; position: absolute; text-decoration: none; white-space: pre;">with a weighted-average exercise price of $4.98&#160;per share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.08pt; position: absolute; text-decoration: none; white-space: pre;">, a<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.18pt; position: absolute; text-decoration: none; white-space: pre;">nd <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">5,326,194&#160;shares were unvested, with a weighted average exercise price of $4.63&#160;per share. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.2pt; position: absolute; text-decoration: none; white-space: pre;">For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">additional information regarding the terms of our equity incentive plans, see the section titled &#8220;Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and director compensation&#8212;2025 Performance incentive plan&#8221; and &#8220;Executive and director compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;Amended and restated 2009 equity incentive plan.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 424.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Warrants<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025, we had outstanding warrants to purchase an aggregate of 1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.41pt; position: absolute; text-decoration: none; white-space: pre;">,647,667 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.08pt; position: absolute; white-space: pre;">shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, with an exercise price of $0.03 per share, issuable upon the exercise of such outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants. The warrants will terminate on the ten-year anniversary of the issuance date, however, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants will automatically net exercise immediately prior to termination if the fair market value of one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share of common stock exceeds the then current exercise price per share of common stock. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with certain change of control transactions, which include SPAC combinations, mergers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidations and the sale or lease of substantially all of the assets of the Company, the warrants will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also automatically net exercise if the fair market value of one share of common stock exceeds the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current exercise price per share of common stock. The warrants do not automatically net exercise in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with an initial public offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 575.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Registration rights<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering and subject to the lock-up agreements entered into in connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering and federal securities laws, holders of shares of our common stock that will be issued upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the conversion of our redeemable convertible preferred stock in connection with this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holder of shares of our common stock issuable or issued upon exercise of certain outstanding warrants to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase shares of our common stock will initially be entitled to certain registration rights under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act. These securities are referred to as registrable securities. The holders of these registrable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities possess registration rights pursuant to the terms of the Investors&#8217; Rights Agreement and are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in additional detail below. The registration of shares of our common stock pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of the registration rights described below would enable the holders to trade the registered shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without restriction under the Securities Act when the applicable registration statement is declared <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">192<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective. We will pay the registration expenses, other than underwriting discounts, selling commissions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock transfer taxes, and fees and disbursements in excess of $100,000 to one counsel for the holders, of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the securities registered pursuant to the demand, Form S-3 and piggyback registrations described below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conditions and limitations, to limit the number of securities the holders may include. The demand, Form <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">S-3 and piggyback registration rights described below will terminate upon the earliest to occur of (i) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Liquidation Event (as defined in our amended and restated certificate of incorporation) where the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders receive cash and&#47;or publicly traded securities or the holders receive reasonably comparable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration rights, (ii) with respect to each holder, such time after the completion of this offering after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which Rule 144 of the Securities Act (&#8220;Rule 144&#8221;) or another similar exemption under the Securities Act is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available for the sale of all of such holder&#8217;s shares without limitation, during a three-month period without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration and such holder holds less than 1% of the outstanding capital stock of the company or (iii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date three years after the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Demand registration rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, holders of up to&#160;approximately 55.8 million shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, which includes all shares of our common stock issued upon conversion of our redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock and the holder of warrants to purchase up to an aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;1,647,667&#160;shares of our common stock, will be entitled to certain demand registration rights. Beginning <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">six months after the effectiveness of the registration statement of which this prospectus is a part, holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holding, collectively, at least a majority of the registrable securities held by the holders of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued upon conversion of our redeemable convertible preferred stock then outstanding may, on not more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than two occasions, request that we register at least 40% of the registrable securities held by the holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of common stock issued upon conversion of our redeemable convertible preferred stock then outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on a Form S-1 registration statement, subject to certain specified exceptions. If we determine that it would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be seriously detrimental to us and our stockholders to effect such a demand registration, we have the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">right to defer such registration, not more than twice in any 12-month period, for a period of up to 120 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days. In addition, we will not be required to effect a demand registration during the period beginning 60 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days prior to our good faith estimate of the date of the filing of and ending on a date 180 days following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effectiveness of a registration statement relating to a registration initiated by us or if registration on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Form S-3 is available.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Form S-3 registration rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, holders of up to&#160;approximately&#160;55.8&#160;million shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, which includes all shares of our common stock issued upon conversion of our redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock and the holder of warrants to purchase up to an aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;1,647,667&#160;shares of our common stock, will be entitled to certain Form S-3 registration rights. At any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time when the company is qualified to file a Form S-3 registration statement, holders holding, collectively, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at least 30% of the registrable securities then outstanding may request that we register registrable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities having an anticipated aggregate offering price of at least $10.0 million, net of underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discounts and certain other expenses. These holders may make an unlimited number of requests for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration on Form S-3&#59; however, we will not be required to effect a registration on Form S-3 if we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effected two such registrations pursuant to such requests within the 12-month period preceding the date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the request. In addition, if we determine that it would be seriously detrimental to us and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders to effect such a registration, we have the right to defer such registration, not more than twice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in any 12-month period, for a period of up to 120 days. Lastly, we will not be required to effect a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration on Form S-3 during the period beginning 30 days prior to our good faith estimate of the date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the filing of and ending on a date 90 days following the effectiveness of a registration statement relating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a registration initiated by us. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">193<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Piggyback registration rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the Investors&#8217; Rights Agreement, if we register any of our securities either for our own account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or for the account of other security holders, other than through this offering, holders of up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to&#160;approximately&#160;55.6&#160;million shares of our common stock, which includes all shares of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued upon conversion of our redeemable convertible preferred stock and the holder of warrants to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase up to an aggregate of&#160;1,647,667&#160;shares of our common stock, will be entitled to customary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;piggyback&#8221; registration rights allowing them to include their securities in such registration, subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specified conditions, limitations and exceptions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Anti-takeover effects of provisions of the proposed amended and restated <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation and bylaws and applicable law<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will contain provisions that could have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effect of delaying, deferring or discouraging another party from acquiring control of us. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions and certain provisions of Delaware law, which are summarized below, could discourage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">takeovers, coercive or otherwise, and as a consequence, they might also inhibit temporary fluctuations in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the market price of our common stock that often result from actual or rumored hostile takeover attempts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These provisions are also designed, in part, to encourage persons seeking to acquire control of us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negotiate first with our board of directors. It is also possible that these provisions might have the effect of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing changes in our management and could make it more difficult to accomplish transactions that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders might otherwise deem to be in their best interests.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Classified board of directors<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will provide that our board of directors be classified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into three classes of directors, with each class serving a staggered three-year term. As a result, in most <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, a person can gain control of our board of directors only by successfully engaging in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proxy contest at two or more annual meetings of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Authorized but unissued shares<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our authorized but unissued common stock and preferred stock will be available for future issuances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without stockholder approval and could be utilized for a variety of corporate purposes, including future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but unissued and unreserved common stock and preferred stock could render more difficult or discourage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Written consent&#59; special meeting of stockholders<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that stockholder action may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not be taken by written consent, which forces stockholder action to be taken at an annual or special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meeting of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that, subject to the rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any holders of preferred stock, special meetings of our stockholders, for any purpose or purposes, may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be called only by (i) the chair of the board, (ii) the chief executive officer or (iii) the secretary at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">direction of our board of directors pursuant to a resolution adopted by a majority of our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Advance notice requirements for stockholder proposals and director nominations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated bylaws will provide that stockholders seeking to bring business before the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annual meeting of our stockholders or to nominate candidates for election as directors at the annual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meeting of our stockholders or, in certain instances as provided in our bylaws, a special meeting of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders must provide timely notice of their intent in writing. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To give timely notice, the notice must be delivered to the secretary at our principal executive offices not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">later than the close of business on the 90th day nor earlier than the 120th day prior to the first anniversary <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">194<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the preceding year&#8217;s annual meeting. However, if the date of the annual meeting is more than 30 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">before or more than 70 days after such anniversary date, the notice must be delivered not earlier than the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">120th day prior to such annual meeting and not later than the close of business on the later of the 90th <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">day prior to such annual meeting or the tenth day following the day on which public announcement of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of the annual meeting is first made or sent by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated bylaws will also specify certain informational and other requirements as to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">form and content of the notice. These provisions, if not satisfied on a timely basis or at all, may preclude <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stockholders from bringing business or director nominations before the meeting of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Election and removal of directors<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will contain provisions that establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific procedures for appointing and removing members of the board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the amended and restated certificate of incorporation, our directors may be removed from office, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but only for cause, which requires approval by the holders of at least sixty-six and two-thirds percent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(66-2&#47;3%) of the voting power of all then-outstanding shares of capital stock entitled to vote generally in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the election of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vacancies and newly created directorships on our board of directors may be filled only by a majority vote <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the directors then in office, even if less than a quorum, or by a sole remaining director (and not by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders). Any new director shall hold office for the remainder of the full term of the class of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to which the new directorship was added or in which the vacancy occurred and until his or her successor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disqualification or removal. The treatment of vacancies has the effect of making it more difficult for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders to change the composition of the board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No cumulative voting<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a corporation&#8217;s certificate of incorporation provides otherwise. Our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation will not authorize cumulative voting rights for our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The absence of cumulative voting makes it more difficult for a minority stockholder to gain a seat on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors to influence a decision by our board of directors, including regarding any potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">merger, tender offer or other potential takeover transaction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amendments to our certificate of incorporation and bylaws<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that the affirmative vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all then-outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of capital stock entitled to vote generally in the election of directors is required to amend certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions of our certificate of incorporation, including provisions relating to the size of the board, removal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors, special meetings, actions by written consent and cumulative voting. The affirmative vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all of the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding shares of capital stock entitled to vote generally in the election of directors will be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amend or repeal our bylaws, although our bylaws may be amended by a simple majority vote of our board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Delaware anti-takeover statute <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">195<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a business combination with an interested stockholder for a period of three years following the date the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person became an interested stockholder unless&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prior to the date of the transaction, our board of directors approved either the business combination or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the transaction that resulted in the stockholder becoming an interested stockholder&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon completion of the transaction that resulted in the stockholder becoming an interested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding at the time the transaction commenced, excluding for purposes of determining the voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (A) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares owned by persons who are directors and also officers and (B) shares owned by employee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock plans in which employee participants do not have the right to determine confidentially whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares held subject to the plan will be tendered in a tender or exchange offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at or subsequent to the date of the transaction, the business combination is approved by our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and authorized at an annual or special meeting of stockholders, and not by written consent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by the affirmative vote of at least sixty-six and two-thirds percent (66-2&#47;3%) of the outstanding voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock that is not owned by the interested stockholder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Generally, a business combination includes a merger, asset or stock sale, or other transaction resulting in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a financial benefit to the interested stockholder. Subject to certain exceptions, an &#8220;interested stockholder&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is a person who, together with affiliates and associates, owns or, within three years prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination of interested stockholder status, owned 15% or more of our outstanding voting stock. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision is expected to have an anti-takeover effect with respect to transactions our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not approve in advance. Moreover, Section 203 may discourage attempts that might result in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">premium over the market price for the shares of our common stock held by stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Choice of forum <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will generally designate, unless we otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consent in writing, the Court of Chancery (or, if such court does not have subject matter jurisdiction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thereof, the federal district court of the State of Delaware) as the sole and exclusive forum for (i) any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fiduciary duty owed by any current or former director, officer, employee or agent to us or our stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or any claim for aiding and abetting any such alleged breach, (iii) any action asserting a claim arising <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or bylaws or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware or (iv) any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that the federal district courts of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States will be the exclusive forum for the resolution of any complaint asserting a cause of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action arising under the Securities Act. Further, our amended and restated certificate of incorporation will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide that the foregoing choice of forum provisions will not apply to suits brought to enforce any liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or duty created by the Exchange Act, or any other claim for which the federal courts of the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have exclusive jurisdiction. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that any person or entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notice of and consented to the foregoing provisions of the amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation. Although our amended and restated certificate of incorporation will contain the choice of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forum provision described above, it is possible that a court could find that such a provision is inapplicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for a particular claim or action or that such provision is unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This choice of forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have waived our compliance with federal securities laws and the rules and regulations thereunder. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">196<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the enforceability of similar choice of forum provisions in other companies' certificates of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation has been challenged in legal proceedings, and it is possible that a court could find these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">types of provisions to be inapplicable or unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations on liability and indemnification<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For a discussion of liability and indemnification, see the section titled &#8220;Management&#8212;Limitations on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability and indemnification matters.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Transfer agent and registrar<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The transfer agent and registrar for our common stock is Fidelity Stock Transfer Solutions LLC. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer agent&#8217;s address is&#160;245 Summer Street, Boston, MA 02210.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Nasdaq listing <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our common stock has been approved for listing on the Nasdaq Global Select Market&#160;under the symbol <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;HTFL.&#8221;&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">197<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1360" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Shares eligible for future sale<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock, and a liquid trading market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our common stock may not develop or be sustained after this offering. Future sales of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, including shares issued upon the Preferred Stock Conversion, the Convertible Notes Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the exercise of outstanding options or warrants, in the public market after the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, or the perception that those sales may occur, could adversely affect the prevailing market price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our common stock from time to time or impair our ability to raise equity capital in the future. Although <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock has been approved for listing on&#160;the Nasdaq Global Select Market, we cannot assure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">you that there will be an active public market for our common stock. As described below, only a limited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of shares of our common stock will be available for sale in the public market for a period of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">several months after the completion of this offering due to contractual and legal restrictions on resale <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described below. Future sales of our common stock in the public market either before or after restrictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lapse, or the perception that those sales may occur, could adversely affect the prevailing market price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock at such time and our ability to raise equity capital at a time and price we deem <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sale of restricted shares<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on the number of shares of our common stock outstanding as of March 31, 2025, upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering and assuming (i) the Preferred Stock Conversion, (ii) the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion, (iii) no exercise of the underwriters&#8217; option to purchase additional shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock and (iv) no exercise of outstanding options or warrants, we will have outstanding an aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;80,616,619&#160;shares of common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Of these shares, all of the 16,666,667 shares of common stock to be sold in this offering will be freely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tradable in the public market without restriction or further registration under the Securities Act, unless the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares are held by any of our &#8220;affiliates&#8221; as such term is defined in Rule 144 or subject to lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements. All remaining shares of common stock held by existing stockholders will be &#8220;restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities,&#8221; as such term is defined in Rule 144. These restricted securities were issued and sold by us in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">private transactions and are eligible for public sale only if registered under the Securities Act or if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualify for an exemption from registration under the Securities Act, including the exemptions provided by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rule 144 or Rule 701 of the Securities Act (&#8220;Rule 701&#8221;), which rules are summarized below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of the lock-up agreements and market standoff arrangements referred to below and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions of Rule 144 and Rule 701, based on the number of shares of our common stock outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(calculated as of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> March 31, 2025 on the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.31pt; position: absolute; white-space: pre;">basis of the assumptions described above and assuming no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of the underwriters&#8217; option to purchase additional shares, if any, and no exercise of outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options), the shares of our common stock (excluding the shares sold in this offering) that will be available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for sale in the public market are as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 557.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 84.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 380.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 84.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Approximate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">number of shares<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 87.75pt; position: absolute; top: 0pt; width: 380.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 380.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">First date available for sale into public market<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 36pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 84.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">64 million&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 87.75pt; position: absolute; top: 24pt; width: 380.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">181 days after the date of this prospectus, upon expiration of the lock-up agreements or <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">market standoff arrangements referred to below, subject in some cases to applicable <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">volume, manner of sale and other limitations under Rule 144 and Rule 701.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may issue shares of common stock from time to time as consideration for future acquisitions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments, or other corporate purposes. In the event that any such acquisition, investment, or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction is significant, the number of shares of common stock that we may issue may in turn be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant. We may also grant registration rights covering those shares of common stock issued in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with any such acquisition and investment.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">198<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the shares of common stock reserved for future issuance under the 2025 Plan will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up agreements, a registration statement under the Securities Act, or an exemption from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration, including Rule 144 and Rule 701.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 144<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under Rule 144, as currently in effect, once we have been subject to the public company reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of the Exchange Act for at least 90 days, and we are current in our Exchange Act reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at the time of sale, a person (or persons whose shares are required to be aggregated) who is not deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have been one of our &#8220;affiliates&#8221; for purposes of Rule 144 at any time during the 90 days preceding a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months, including the holding period of any prior owner other than one of our &#8220;affiliates,&#8221; is entitled to sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those shares in the public market (subject to the lock-up agreement or market standoff arrangements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to below, if applicable) without complying with the manner of sale, volume limitations, or notice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions of Rule 144, but subject to compliance with the public information requirements of Rule 144. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such a person has&#160;beneficially owned the shares proposed to be sold for at least one year, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holding period of any prior owner other than &#8220;affiliates,&#8221; then such person is entitled to sell such shares in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the public market without complying with any of the requirements of Rule 144 (subject to the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement referred to below, if applicable).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Rule 144, as currently in effect, once we have been subject to the public company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting requirements of the Exchange Act for at least 90 days, our &#8220;affiliates,&#8221; as defined in Rule 144, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who have beneficially owned the shares proposed to be sold for at least six months, are entitled to sell in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the public market, upon expiration of any applicable lock-up agreements and within any three-month <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period, a number of those shares of our common stock that does not exceed the greater of&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1% of the number of shares of common stock then outstanding, which will equal approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">806,166 shares of common stock immediately upon the completion of this offering (calculated as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 on the basis of the assumptions described above and assuming no exercise of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underwriters&#8217; option to purchase additional shares and no exercise of outstanding options or warrants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to March 31, 2025)&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the average weekly trading volume of our common stock on the&#160;Nasdaq Global Select Market during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Such sales under Rule 144 by our &#8220;affiliates&#8221; or persons selling shares on behalf of our &#8220;affiliates&#8221; are also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to certain manner of sale provisions, notice requirements, and requirements related to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">availability of current public information about us. Notwithstanding the availability of Rule 144, the holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of substantially all of our restricted securities have entered into lock-up agreements as referenced above, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and their restricted securities will become eligible for sale (subject to the above limitations under Rule <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">144) upon the expiration of the restrictions set forth in those agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 701<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Rule 701 as currently in effect, any of our employees, directors, officers, consultants, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors who acquired common stock from us in connection with a written compensatory stock or option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan or other written agreement in compliance with Rule 701 before the effective date of the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement of which this prospectus is a part (to the extent such common stock is not subject to a lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement) and who are not our &#8220;affiliates&#8221; as defined in Rule 144 during the immediately preceding 90 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days, is entitled to rely on Rule 701 to resell such shares beginning 90 days after the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus in reliance on Rule 144, but without complying with the notice, manner of sale, public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information requirements, or volume limitation provisions of Rule 144. Persons who are our &#8220;affiliates&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may resell those shares beginning 90 days after the date of this prospectus without compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">minimum holding period requirements under Rule 144 (subject to the terms of the lock-up agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to below, if applicable).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">199<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Lock-up agreements and market standoff arrangements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, we, our directors, our executive officers, and the holders of substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of our common stock, stock options, and other securities convertible into or exercisable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchangeable for our common stock, have entered into lock-up agreements with the underwriters or are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to market standoff arrangements, and have agreed, with respect to the lock-up agreements, that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the prior written consent of J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Sandler &#38; Co. on behalf of the underwriters, subject to certain exceptions more fully described under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section titled &#8220;Underwriting&#8221;, we and they will not, among other things, sell or otherwise transfer or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dispose of any of our securities during the period from the date of this prospectus continuing through the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date 180 days after the date of this prospectus. See the section titled &#8220;Underwriting&#8221; for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to the restrictions contained in the lock-up agreements described above, we have entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with certain securityholders, including the Investors&#8217; Rights Agreement, our standard form of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option agreement and warrants that contain market standoff provisions or incorporate market standoff <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions from our equity incentive plan imposing restrictions on the ability of such securityholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offer, sell, or transfer our equity securities for a period of 180 days following the date of this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following the lock-up periods set forth in the agreements described above, and assuming that J.P. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co. do not release any parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from these agreements, all of the shares of our common stock that are restricted securities or are held by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our affiliates as of the date of this prospectus will be eligible for sale in the public market in compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with Rule 144 under the Securities Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Registration rights<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, the holders of&#160;approximately 55.8 million shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock will be entitled to rights with respect to the registration of their shares under the Securities Act, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the lock-up agreements and market standoff arrangements described under &#8220;&#8212;Lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements and market standoff arrangements&#8221; above. Registration of these shares under the Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act would result in the shares becoming freely tradable without restriction under the Securities Act, except <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for shares purchased by affiliates, immediately upon the effectiveness of the relevant filed registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement, subject to the terms of the lock-up agreements and market standoff arrangements described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above. Any sales of securities by these stockholders could have a material adverse effect on the trading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Equity incentive plans<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to file with the SEC a registration statement on Form S-8 under the Securities Act to register <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our shares issued or reserved for issuance under our equity incentive plans. Such registration statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is expected to be filed and become effective as soon as practicable after the completion of this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, shares registered under such registration statement will be available for sale in the open <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market following its effective date, subject to Rule 144 volume limitations, vesting restrictions, and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreements described above, if applicable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 599.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 10b5-1 trading plans<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following the completion of this offering, certain of our officers, directors, and significant stockholders may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adopt written plans, known as Rule 10b5-1 trading plans, in which they will contract with a broker to buy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or sell shares of our common stock on a periodic basis to diversify their assets and investments. Under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these Rule 10b5-1 trading plans, a broker may execute trades pursuant to parameters established by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officer, director, or stockholder when entering into the plan, without further direction from such officer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">director, or stockholder. Such sales would not commence until the expiration of the applicable lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements entered into by such officer, director, or stockholder in connection with this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">200<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1408" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Material U.S. federal income tax consequences to non-U.S. <font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">holders<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holders (as defined below) of the purchase, ownership, and disposition of our common stock issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated thereunder, judicial decisions, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each case in effect as of the date hereof. These authorities may change or be subject to differing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpretations. Any such change or differing interpretation may be applied retroactively in a manner that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the matters discussed below. There can be no assurance the IRS or a court will not take a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contrary position to that discussed below regarding the tax consequences of the purchase, ownership, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and disposition of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This discussion is limited to Non-U.S. Holders that hold our common stock as a &#8220;capital asset&#8221; within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">address all U.S. federal income tax consequences relevant to a Non-U.S. Holder&#8217;s particular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, including the impact of the Medicare contribution tax on net investment income and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to special rules, including, without limitation&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U.S. expatriates and former citizens or long-term residents of the United States&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">part of a conversion transaction or other integrated investment&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">banks, insurance companies, and other financial institutions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">brokers, dealers, or traders in securities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accumulate earnings to avoid U.S. federal income tax&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purposes (and investors therein)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tax-exempt organizations or governmental organizations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons deemed to sell our common stock under the constructive sale provisions of the Code&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons who hold or receive our common stock pursuant to the exercise of any employee stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">option or otherwise as compensation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tax-qualified retirement plans&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;qualified foreign pension funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">interests of which are held by qualified foreign pension funds.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment of a partner in the partnership will depend on the status of the partner, the activities of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal income tax consequences to them.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">201<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">APPLICABLE INCOME TAX TREATY.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Definition of a Non-U.S. Holder<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of our common stock that is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">neither a &#8220;U.S. person&#8221; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an individual who is a citizen or resident of the United States&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a corporation created or organized under the laws of the United States, any state thereof or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">District of Columbia&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an estate, the income of which is subject to U.S. federal income tax regardless of its source&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a trust that (i) is subject to the primary supervision of a U.S. court and all substantial decisions of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which are subject to the control of one or more &#8220;United States persons&#8221; (within the meaning of Section <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">7701(a)(30) of the Code), or (ii) has a valid election in effect to be treated as a United States person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">for U.S. federal income tax purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Distributions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As described in the section titled &#8220;Dividend policy,&#8221; we do not anticipate paying any cash dividends in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future. However, if we do make distributions of cash or property on our common stock, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current or accumulated earnings and profits, as determined under U.S. federal income tax principles. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax basis in its common stock, but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not below zero. Any excess will be treated as capital gain and will be treated as described under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsection titled &#8220;&#8212;Sale or other taxable disposition&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to the discussion below regarding effectively connected income, dividends paid to a Non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their entitlement to benefits under any applicable tax treaties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade or business within the United States (and, if required by an applicable income tax treaty, the Non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Holder maintains a permanent establishment in the United States to which such dividends are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a trade or business within the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">202<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consult their tax advisors regarding any applicable tax treaties that may provide for different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sale or other taxable disposition<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition of our common stock unless&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">permanent establishment in the United States to which such gain is attributable)&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">more during the taxable year of the disposition and certain other requirements are met&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our common stock constitutes a U.S. real property interest (&#8220;USRPI&#8221;) by reason of our status as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U.S. real property holding corporation (&#8220;USRPHC&#8221;) for U.S. federal income tax purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income basis at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax treaty) on such effectively connected gain, as adjusted for certain items.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal income tax at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale or other taxable disposition of our common stock, which may be offset by certain U.S. source capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such losses.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With respect to the third bullet point above, we believe we currently are not, and do not anticipate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">becoming, a USRPHC. Because the determination of whether we are a USRPHC depends, however, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and our other business assets, there can be no assurance we currently are not a USRPHC or will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax if our common stock is &#8220;regularly traded,&#8221; as defined by applicable Treasury Regulations, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an established securities market, and such Non-U.S. Holder owned, actually and constructively, 5% or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">less of our common stock throughout the shorter of the five-year period ending on the date of the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition or the Non-U.S. Holder&#8217;s holding period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Information reporting and backup withholding<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payments of dividends on our common stock will not be subject to backup withholding, provided the Non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Holder certifies its non-U.S. status, such as by furnishing a valid IRS Form W-8BEN, W-8BEN-E, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of the sale or other taxable disposition of our common stock within the United States or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted through certain U.S.-related brokers generally will not be subject to backup withholding or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information reporting if the applicable withholding agent receives the certification described above or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Non-U.S. Holder otherwise establishes an exemption. Proceeds of a disposition of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted through a non-U.S. office of a non-U.S. broker that does not have certain enumerated <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">203<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships with the United States generally will not be subject to backup withholding or information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Copies of information returns that are filed with the IRS may also be made available under the provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resides or is established.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided the required information is timely furnished to the IRS.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Additional withholding tax on payments made to foreign accounts<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to as the Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;)) on certain types of payments made to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds from the sale or other disposition of, our common stock paid to a &#8220;foreign financial institution&#8221; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a &#8220;non-financial foreign entity&#8221; (each as defined in the Code), unless (i) the foreign financial institution <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">undertakes certain diligence and reporting obligations, (ii) the non-financial foreign entity either certifies it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not have any &#8220;substantial United States owners&#8221; (as defined in the Code) or furnishes identifying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information regarding each substantial United States owner, or (iii) the foreign financial institution or non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial institution and is subject to the diligence and reporting requirements in (i) above, it must enter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into an agreement with the U.S. Department of the Treasury requiring, among other things, that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">undertake to identify accounts held by certain &#8220;specified United States persons&#8221; or &#8220;United States owned <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign entities&#8221; (each as defined in the Code), annually report certain information about such accounts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the United States governing FATCA may be subject to different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under applicable Treasury Regulations and administrative guidance, withholding under FATCA generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applies to payments of dividends on our common stock. While withholding under FATCA would have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applied also to payments of gross proceeds from the sale or other disposition of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beginning on January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">final Treasury Regulations are issued.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective investors should consult their tax advisors regarding the potential application of withholding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under FATCA to their investment in our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">204<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1434" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Underwriting<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are offering the shares of common stock described in this prospectus through a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters. J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co. are acting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as joint book-running managers of the offering and as representatives of the underwriters. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into an underwriting agreement with the underwriters. Subject to the terms and conditions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the cover page of this prospectus, the number of shares of common stock listed next to its name in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following table&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 211.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 390.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 74.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 390.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 390.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 0pt; width: 74.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.63pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan Securities LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 117.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 117.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 117.85pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 24pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 29.4pt; position: absolute; text-decoration: none; white-space: pre;">5,666,667<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley &#38; Co. LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 115.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 115.57pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 38.25pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 29.4pt; position: absolute; text-decoration: none; white-space: pre;">4,833,333<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler &#38; Co.<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 87.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 52.5pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 29.4pt; position: absolute; text-decoration: none; white-space: pre;">3,166,667<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel, Nicolaus &#38; Company, Incorporated<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 176.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 176.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 177.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 177.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 177.04pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 66.75pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 29.4pt; position: absolute; text-decoration: none; white-space: pre;">1,500,000<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 103.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 105.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 105.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 105.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 105.89999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 81pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 29.4pt; position: absolute; text-decoration: none; white-space: pre;">1,500,000<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 22.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 22.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 23.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 23.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 23.11pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................................................<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 95.25pt; width: 74.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.85pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 24.12pt; position: absolute; text-decoration: none; white-space: pre;">16,666,667<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 336.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters are committed to purchase all the shares of common stock offered by us if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase commitments of non-defaulting underwriters may also be increased or the offering may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminated.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters propose to offer the shares of common stock directly to the public at the initial public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering price set forth on the cover page of this prospectus and to certain dealers at that price less a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concession not in excess of $0.798&#160;per share. After the initial offering of the shares to the public, if all of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the shares of common stock are not sold at the initial public offering price, the underwriters may change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the offering price and the other selling terms. Sales of any shares made outside of the United States may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be made by affiliates of the underwriters.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters have an option to buy up to&#160;2,500,000 additional shares of common stock from us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cover sales of shares by the underwriters which exceed the number of shares specified in the table <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares. If any shares are purchased with this option to purchase additional shares, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters will purchase shares in approximately the same proportion as shown in the table above. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any additional shares of common stock are purchased, the underwriters will offer the additional shares on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the same terms as those on which the shares are being offered.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriting fee is equal to the public offering price per share of common stock less the amount paid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the underwriters to us per share of common stock. The underwriting fee is $1.33&#160;per share. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following table shows the per share and total underwriting discounts and commissions to be paid to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters assuming both no exercise and full exercise of the underwriters&#8217; option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 632.7pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 312pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 315pt; position: absolute; top: 0pt; width: 75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.98pt; position: absolute; text-decoration: none; white-space: pre;">Without option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.42pt; position: absolute; text-decoration: none; white-space: pre;">to purchase <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.92pt; position: absolute; text-decoration: none; white-space: pre;">additional <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.88pt; position: absolute; text-decoration: none; white-space: pre;">shares exercise<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393pt; position: absolute; top: 0pt; width: 75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.97pt; position: absolute; text-decoration: none; white-space: pre;">With full option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.42pt; position: absolute; text-decoration: none; white-space: pre;">to purchase <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.92pt; position: absolute; text-decoration: none; white-space: pre;">additional <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.88pt; position: absolute; text-decoration: none; white-space: pre;">shares exercise<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 312pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 312pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Per Share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 47.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 49.150000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 315pt; position: absolute; top: 45pt; width: 75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 43.28pt;"></font></font><font style="left: 51.470000000000006pt; position: absolute;">1.33<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393pt; position: absolute; top: 45pt; width: 75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 43.28pt;"></font></font><font style="left: 51.470000000000006pt; position: absolute;">1.33<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 312pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 312pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 24.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 24.259999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 24.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 24.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 24.33pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 315pt; position: absolute; top: 59.25pt; width: 75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.37pt; width: 75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 16.79pt; position: absolute; text-decoration: none; white-space: pre;">$22,166,667<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393pt; position: absolute; top: 59.25pt; width: 75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 12.71pt;"></font></font><font style="left: 20.9pt; position: absolute;">25,491,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">205<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that the total expenses of this offering, including registration, filing and listing fees, printing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be approximately $5.5 million. We have agreed to reimburse the underwriters for expenses relating to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance of this offering with the Financial Industry Regulatory Authority, Inc. in an amount up to $40,000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A prospectus in electronic format may be made available on the web sites maintained by one or more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocate a number of shares to underwriters and selling group members for sale to their online brokerage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">account holders. Internet distributions will be allocated by the representatives to underwriters and selling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">group members that may make Internet distributions on the same basis as other allocations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have agreed that we will not, subject to certain exceptions, (i) offer, pledge, sell, contract to sell, sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any option or contract to purchase, purchase any option or contract to sell, grant any option, right or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrant to purchase, hedge, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file with, the SEC a registration statement under the Securities Act relating to, any shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock or any securities convertible into or exercisable or exchangeable for any shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, or (ii) enter into any swap, hedging, or other agreement that transfers, in whole or in part, any of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic consequences of ownership of any shares of common stock or any such other securities, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publicly disclose the intention to undertake any of the foregoing (regardless of whether any of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions are to be settled by the delivery of shares of common stock or such other securities, in cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or otherwise), in each case without the prior written consent of J.P. Morgan Securities LLC, Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stanley &#38; Co. LLC and Piper Sandler &#38; Co. for a period of 180 days after the date of this prospectus, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than the shares of our common stock to be sold in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The restrictions on our actions, as described above, do not apply to certain transactions, including (i) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance of shares of common stock or securities convertible into or exercisable for shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock pursuant to the conversion or exchange of convertible or exchangeable securities or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of warrants or options (including net exercise) or the settlement of RSUs (including net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement), in each case outstanding on the date of the underwriting agreement and described in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus&#59; (ii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for shares of our common stock (whether upon the exercise of stock options or otherwise) to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan in effect as of the closing date of this offering and described in this prospectus, provided that such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recipients enter into a lock-up agreement with the underwriters&#59; (iii) the issuance of up to 5% of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding shares of our common stock, or securities convertible into, exercisable for, or which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise exchangeable for, our common stock, immediately following the closing date of this offering, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the underwriters&#59; or (iv) the filing of any registration statement on Form S-8 relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities granted or to be granted pursuant to any plan in effect on the date of the underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement and described in this prospectus or any assumed benefit plan pursuant to an acquisition or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar strategic transaction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our directors and executive officers, and holders of substantially all of our common stock, stock options, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and other securities convertible into or exercisable or exchangeable for our common stock (such persons, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the &#8220;lock-up parties&#8221;) are subject to market standoff arrangements or have entered into lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">up party, with limited exceptions, for a period of 180 days after the date of this prospectus (such period, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the &#8220;restricted period&#8221;), may not and may not cause any of their direct or indirect affiliates to, without the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior written consent of J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchangeable for our common stock (including without limitation, our common stock or such other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities which may be deemed to be beneficially owned by the lock-up party in accordance with the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">206<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrant) (collectively with our common stock, the &#8220;lock-up securities&#8221;), (ii) enter into any hedging, swap or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other agreement or transaction that transfers, in whole or in part, any of the economic consequences of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership of the lock-up securities, whether any such transaction described in clause (i) or (ii) above is to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be settled by delivery of the lock-up securities, in cash or otherwise, (iii) make any demand for or exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any right with respect to the registration of any lock-up securities, or (iv) publicly disclose the intention to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do any of the foregoing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Such persons or entities have further acknowledged that these undertakings preclude them from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engaging in any hedging or other transactions or arrangements (including, without limitation, any short <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or any other derivative transaction or instrument, however described or defined) designed or intended, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up party or any other person) of any economic consequences of ownership, in whole or in part, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The restrictions described in the immediately preceding paragraph and contained in the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements between the underwriters and the lock-up parties do not apply, subject in certain cases to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">various conditions, to certain transactions, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(a) transfers of lock-up securities&#58; (i) as a bona fide gift or gifts or charitable contribution, or for bona fide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estate planning purposes, (ii) by will or intestacy or any other testamentary document, (iii) to any member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the lock-up party&#8217;s immediate family or to any trust for the direct or indirect benefit of the lock-up party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or the immediate family of the lock-up party, or if the lock-up party is a trust, to a trustor, trustee or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beneficiary of the trust or to the estate of a trustor, trustee or beneficiary of such trust (for purposes of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreement, &#8220;immediate family&#8221; means any relationship by blood, current or former marriage, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">domestic partnership or adoption, not more remote than first cousin), (iv) to a corporation, partnership, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limited liability company, investment fund or other entity (A) of which the lock-up party and&#47;or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediate family of the lock-up party are the legal and beneficial owner of all of the outstanding equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities or similar interests, or (B) controlled by, or under common control with, the lock-up party or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediate family of the lock-up party, (v) to a nominee or custodian of a person or entity to whom a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disposition or transfer would be permissible under clauses (i) through (iv) above, (vi) in the case of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partnership, limited liability company, trust or other business entity that is an affiliate of the lock-up party, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or to any investment fund or other entity controlling, controlled by, managing or managed by or under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common control or common investment management with the lock-up party or its affiliates or (B) as part <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a disposition, transfer or distribution to limited partners, members or shareholders of the lock-up party&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(vii) by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decree or separation agreement, (viii) to us upon death or disability of the lock-up party, or, if the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party is an employee of ours upon death, disability or termination of employment, in each case, of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee, (ix) as part of a sale or transfer of lock-up securities acquired (A) from the underwriters in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering or (B) in open market transactions after the completion of this offering, (x) to us in connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock (including, in each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or exercise of such restricted stock units, options, warrants or rights, provided that any such shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock received upon such exercise, vesting or settlement shall be subject to the terms of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreement, and provided further that any such restricted stock units, options, warrants or rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are held by the lock-up party pursuant to an agreement or equity awards granted under a stock incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan or other equity award plan, each such agreement or plan which is described herein, or (xi) pursuant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the Board of Directors and made to all holders of our capital stock involving a Change of Control (for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purposes hereof, &#8220;Change of Control&#8221; means the transfer (whether by tender offer, merger, consolidation <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">207<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or other similar transaction), in one transaction or a series of related transactions, to a person or group of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affiliated persons, of shares of capital stock if, after such transfer, such person or group of affiliated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">persons would hold more than 50% of our outstanding voting securities (or the surviving entity))&#59; provided <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up party&#8217;s lock-up securities shall remain subject to the restrictions in the immediately preceding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">paragraph&#59; provided that (X) in the case of any transfer or distribution under (i), (ii), (iii), (iv), (v), (vi) and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(vii) above, such transfer shall not involve a disposition for value and each donee, distributee or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transferee shall sign and deliver a lock-up agreement, (Y) in the case of any transfer or distribution under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(ii), (iii), (iv), (v), (vi) and (ix) above no public disclosure or filing shall be made voluntarily during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted period, and (Z) in the case of any transfer or distribution under (i), (vii), (viii) and (x) no public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure or filing shall be made voluntarily during the restricted period, and to the extent a filing under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beneficial ownership of shares of common stock be legally required during the restricted period, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">filing, report or announcement shall clearly indicate the circumstances described in (i), (vii), (viii) or (x) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, including that the securities remain subject to the terms of the lock-up agreement&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(b) exercise of the options, settlement of RSUs or other equity awards, or the exercise of warrants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted pursuant to plans described in this prospectus, provided that any lock-up securities received upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such exercise, vesting or settlement be subject to restrictions similar to those in the immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preceding paragraph&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(c) the conversion of outstanding preferred stock, warrants to acquire preferred stock, or convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities into shares of our common stock or warrants to acquire shares of our common stock, provided <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that any common stock or warrant received upon such conversion would be subject to restrictions similar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to those in the immediately preceding paragraph&#59; and (d) the establishment by lock-up parties of trading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plans under Rule 10b5-1 under the Exchange Act, provided that (1) such plans do not provide for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer of lock-up securities during the restricted period and (2) any required public announcement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">filing under the Exchange Act made by any person regarding the establishment of such plan during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted period shall include a statement that the lock-up party is not permitted to transfer, sell or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise dispose of lock-up securities under such plan during the restricted period in contravention of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreement and no public filing, report or announcement by any party shall be made voluntarily in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with such trading plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co., in their sole discretion, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may release the securities subject to any of the lock-up agreements with the underwriters described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, in whole or in part at any time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our common stock has been approved for listing on the Nasdaq Global Select Market under the symbol <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;HTFL.&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making bids for, purchasing and selling shares of common stock in the open market for the purpose of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing or retarding a decline in the market price of the common stock while this offering is in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">progress. These stabilizing transactions may include making short sales of common stock, which involves <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the sale by the underwriters of a greater number of shares of common stock than they are required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase in this offering, and purchasing shares of common stock on the open market to cover positions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">created by short sales. Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater than the underwriters&#8217; option to purchase additional shares referred to above, or may be &#8220;naked&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shorts, which are short positions in excess of that amount.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters may close out any covered short position either by exercising their option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares, in whole or in part, or by purchasing shares in the open market. In making this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination, the underwriters will consider, among other things, the price of shares available for <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">208<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase in the open market compared to the price at which the underwriters may purchase shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through the option to purchase additional shares. A naked short position is more likely to be created if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters are concerned that there may be downward pressure on the price of the common stock in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the open market that could adversely affect investors who purchase in this offering. To the extent that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters create a naked short position, they will purchase shares in the open market to cover the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters have advised us that, pursuant to Regulation M of the Securities Act, they may also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including the imposition of penalty bids. This means that if the representatives of the underwriters <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase common stock in the open market in stabilizing transactions or to cover short sales, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives can require the underwriters that sold those shares as part of this offering to repay the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting discount received by them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These activities may have the effect of raising or maintaining the market price of the common stock or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing or retarding a decline in the market price of the common stock, and, as a result, the price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the common stock may be higher than the price that otherwise might exist in the open market. If the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters commence these activities, they may discontinue them at any time. The underwriters may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carry out these transactions on the Nasdaq Global Select Market, in the over-the-counter market or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock. The initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price was determined by negotiations between us and the representatives of the underwriters. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determining the initial public offering price, we and the representatives of the underwriters considered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of factors including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the information set forth in this prospectus and otherwise available to the representatives&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our prospects and the history and prospects for the industry in which we compete&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an assessment of our management&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our prospects for future earnings&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the general condition of the securities markets at the time of this offering&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the recent market prices of, and demand for, publicly traded common stock of generally comparable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">companies&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other factors deemed relevant by the underwriters and us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Neither we nor the underwriters can assure investors that an active trading market will develop for shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock, or that the shares will trade in the public market at or above the initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other relationships<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide from time to time in the future certain commercial banking, financial advisory, investment banking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and other services for us and such affiliates in the ordinary course of their business, for which they have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received and may continue to receive customary fees and commissions. In addition, from time to time, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain of the underwriters and their affiliates may effect transactions for their own account or the account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity securities or loans, and may do so in the future.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">209<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling restrictions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other than in the United States, no action has been taken by us or the underwriters that would permit a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may this prospectus or any other offering material or advertisements in connection with the offer and sale <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any such securities be distributed or published in any jurisdiction, except under circumstances that will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possession this prospectus comes are advised to inform themselves about and to observe any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions relating to the offering and the distribution of this prospectus. This prospectus does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction in which such an offer or a solicitation is unlawful. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the European Economic Area<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In relation to each Member State of the European Economic Area (each a &#8220;Relevant State&#8221;), no shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publication of a prospectus in relation to the shares which has been approved by the competent authority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in that Relevant State or, where appropriate, approved in another Relevant State and notified to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offers of shares may be made to the public in that Relevant State at any time under the following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exemptions under the Prospectus Regulation&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Regulation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Prospectus Regulation), subject to obtaining the prior consent of the underwriters&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Article 1(4) of the Prospectus Regulation,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of shares shall require us or any underwriter to publish a prospectus pursuant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Regulation. and each person who initially acquires any shares or to whom any offer is made <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to us that it is a &#8220;qualified investor&#8221; within the meaning of Article 2(e) of the Prospectus Regulation. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">case of any shares being offered to a financial intermediary as that term is used in the Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation, each such financial intermediary will be deemed to have represented, acknowledged and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed that the shares acquired by it in the offer have not been acquired on a non-discretionary basis on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may give rise to an offer of any shares to the public other than their offer or resale in a Relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">State to qualified investors as so defined or in circumstances in which the prior consent of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters have been obtained to each such proposed offer or resale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to shares in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Relevant State means the communication in any form and by any means of sufficient information on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscribe for any shares, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the United Kingdom<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to the publication of a prospectus in relation to the shares which (i) has been approved by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Conduct Authority or (ii) is to be treated as if it had been approved by the Financial Conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Authority in accordance with the transitional provisions in Article 74 (transitional provisions) of the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">210<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Amendment etc (EU Exit) Regulations 2019&#47;1234, except that the shares may be offered to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the public in the United Kingdom at any time&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Regulation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the UK Prospectus Regulation), subject to obtaining the prior consent of underwriters for any such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Section 86 of the FSMA,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of the shares shall require the Issuer or any Manager to publish a prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Regulation. For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relation to the shares in the United Kingdom means the communication in any form and by any means of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decide to purchase or subscribe for any shares and the expression &#8220;UK Prospectus Regulation&#8221; means <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation (EU) 2017&#47;1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act 2018.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any offer subsequently made may only be directed at persons who are &#8220;qualified investors&#8221; (as defined in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Prospectus Regulation) (i) who have professional experience in matters relating to investments falling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended (the &#8220;Order&#8221;) and&#47;or (ii) who are high net worth companies (or persons to whom it may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise be lawfully communicated) falling within Article 49(2)(a) to (d) of the Order (all such persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">together being referred to as &#8220;relevant persons&#8221;) or otherwise in circumstances which have not resulted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services and Markets Act 2000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any person in the United Kingdom that is not a relevant person should not act or rely on the information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included in this document or use it as basis for taking any action. In the United Kingdom, any investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or investment activity that this document relates to may be made or taken exclusively by relevant persons.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Canada<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of applicable securities laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for rescission or damages if this prospectus (including any amendment thereto) contains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">province or territory for particulars of these rights or consult with a legal advisor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriter conflicts of interest in connection with this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">211<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Switzerland<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus does not constitute an offer to the public or a solicitation to purchase or invest in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares. No shares have been offered or will be offered to the public in Switzerland, except that offers of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares may be made to the public in Switzerland at any time under the following exemptions under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Swiss Financial Services Act (&#8220;FinSA&#8221;)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any person which is a professional client as defined under the FinSA&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 500 persons (other than professional clients as defined under the FinSA), subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining the prior consent of the representatives of the underwriters for any such offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Article 36 FinSA in connection with Article 44 of the Swiss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Financial Services Ordinance,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of shares shall require the Company or any investment bank to publish a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus pursuant to Article 35 FinSA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be listed or admitted to trading on a trading venue in Switzerland.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Neither this document nor any other offering or marketing material relating to the shares constitutes a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus as such term is understood pursuant to the FinSA and neither this document nor any other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering or marketing material relating to the shares may be publicly distributed or otherwise made publicly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available in Switzerland.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the Dubai International Financial Centre<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This document relates to an Exempt Offer in accordance with the Markets Law, DIFC Law No. 1 of 2012, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as amended. This document is intended for distribution only to persons of a type specified in the Markets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Law, DIFC Law No. 1 of 2012, as amended. It must not be delivered to, or relied on by, any other person. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Dubai Financial Services Authority (DFSA) has no responsibility for reviewing or verifying any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nor taken steps to verify the information set forth herein and has no responsibility for this document. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities to which this document relates may be illiquid and&#47;or subject to restrictions on their resale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective purchasers of the securities offered should conduct their own due diligence on the securities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If you do not understand the contents of this document you should consult an authorized financial advisor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In relation to its use in the DIFC, this document is strictly private and confidential and is being distributed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a limited number of investors and must not be provided to any person other than the original recipient, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may not be reproduced or used for any other purpose. The interests in the securities may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered or sold directly or indirectly to the public in the DIFC.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the United Arab Emirates<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been, and are not being, publicly offered, sold, promoted or advertised in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities and Commodities Authority, Financial Services Regulatory Authority (FSRA) or the Dubai <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services Authority (DFSA).&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">212<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Australia <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Act 2001 (Cth) (the &#8220;Corporations Act&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">has not been, and will not be, lodged with the Australian Securities and Investments Commission <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(&#8220;ASIC&#8221;), as a disclosure document for the purposes of the Corporations Act and does not purport to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">include the information required of a disclosure document for the purposes of the Corporations Act&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may only be provided in Australia to select investors who are able to demonstrate that they fall within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">one or more of the categories of investors, available under section 708 of the Corporations Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(&#8220;Exempt Investors&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares may not be directly or indirectly offered for subscription or purchased or sold, and no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invitations to subscribe for or buy the shares may be issued, and no draft or definitive offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">memorandum, advertisement or other offering material relating to any shares may be distributed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application for the shares, you represent and warrant to us that you are an Exempt Investor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As any offer of shares of our common stock under this prospectus will be made without disclosure in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities for resale in Australia <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock you undertake to us that you will not, for a period of 12 months from the date of issue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the shares, offer, transfer, assign or otherwise alienate those shares of our common stock to investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in Australia except in circumstances where disclosure to investors is not required under Chapter 6D.2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Japan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Instruments and Exchange Act. Accordingly, none of the shares nor any interest therein may be offered or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sold, directly or indirectly, in Japan or to, or for the benefit of, any &#8220;resident&#8221; of Japan (which term as used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">herein means any person resident in Japan, including any corporation or other entity organized under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations and ministerial guidelines of Japan in effect at the relevant time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Hong Kong<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 591.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document, other than (a) to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(Cap. 571 of the Laws of Hong Kong) (the &#8220;SFO&#8221;) of Hong Kong and any rules made thereunder&#59; or (b) in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 627.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong) (the &#8220;CO&#8221;) or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document relating to the shares has been or may be issued or has been or may be in the possession of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">213<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">SFO and any rules made thereunder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Singapore<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, no shares have been or will be offered or sold and no shares have been or will be made the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject of an invitation for subscription or purchase, and no prospectus or any other document or material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the offer or sale, or invitation for subscription or purchase, of the shares, has been or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be circulated or distributed, whether directly or indirectly, to any person in Singapore other than (i) to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 of Singapore, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to Section 274 of the SFA, (ii) to a relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision of the SFA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Singapore SFA Product Classification &#8212; In connection with Section 309B of the SFA and the CMP <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulations 2018, unless otherwise specified before an offer of shares of our common stock, we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined, and hereby notify all relevant persons (as defined in Section 309A(1) of the SFA), that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock are &#8216;&#8216;prescribed capital markets products&#8217;&#8217; (as defined in the CMP Regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12&#58; Notice on the Sale of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investment Products and MAS Notice FAA-N16&#58; Notice on Recommendations on Investment Products).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Bermuda<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Shares may be offered or sold in Bermuda only in compliance with the provisions of the Investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Act of 2003 of Bermuda which regulates the sale of securities in Bermuda. Additionally, non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bermudian persons (including companies) may not carry on or engage in any trade or business in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bermuda unless such persons are permitted to do so under applicable Bermuda legislation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 424.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Saudi Arabia<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">permitted under the Rules on the Offer of Securities and Continuing Obligations Regulations as issued by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the board of the Saudi Arabian Capital Market Authority (&#8220;CMA&#8221;) pursuant to resolution number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3-123-2017 dated 27 December 2017, as amended (the &#8220;CMA Regulations&#8221;). The CMA does not make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any representation as to the accuracy or completeness of this document and expressly disclaims any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective purchasers of the securities offered hereby should conduct their own due diligence on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accuracy of the information relating to the securities. If you do not understand the contents of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document, you should consult an authorised financial adviser.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the British Virgin Islands<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares are not being, and may not be offered to the public or to any person in the British Virgin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Islands for purchase or subscription by or on behalf of us. The shares may be offered to companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporated under the BVI Business Companies Act, 2004 (British Virgin Islands), &#8220;BVI Companies&#8221;), but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only where the offer will be made to, and received by, the relevant BVI Company entirely outside of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">British Virgin Islands.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in China<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus will not be circulated or distributed in the PRC and the shares will not be offered or sold, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and will not be offered or sold to any person for re-offering or resale directly or indirectly to any residents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the PRC (for such purposes, not including the Hong Kong and Macau Special Administrative Regions <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">214<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or Taiwan), except pursuant to any applicable laws and regulations of the PRC. Neither this prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nor any advertisement or other offering material may be distributed or published in the PRC, except under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances that will result in compliance with applicable laws and regulations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Korea<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered under the Financial Investments Services and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Capital Markets Act of Korea and the decrees and regulations thereunder (the &#8220;FSCMA&#8221;), and the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been and will be offered in Korea as a private placement under the FSCMA. None of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be offered, sold or delivered directly or indirectly, or offered or sold to any person for re-offering or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and regulations of Korea, including the FSCMA and the Foreign Exchange Transaction Law of Korea and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the decrees and regulations thereunder (the &#8220;FETL&#8221;). Furthermore, the purchaser of the shares shall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comply with all applicable regulatory requirements (including but not limited to requirements under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FETL) in connection with the purchase of the shares. By the purchase of the shares, the relevant holder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the shares pursuant to the applicable laws and regulations of Korea.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Malaysia<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No prospectus or other offering material or document in connection with the offer and sale of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has been or will be registered with the Securities Commission of Malaysia (&#8220;Commission&#8221;) for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Commission&#8217;s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus and any other document or material in connection with the offer or sale, or invitation for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, to persons in Malaysia other than (i) a closed end fund approved by the Commission&#59; (ii) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holder of a Capital Markets Services Licence&#59; (iii) a person who acquires the shares, as principal, if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offer is on terms that the shares may only be acquired at a consideration of not less than RM250,000 (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its equivalent in foreign currencies) for each transaction&#59; (iv) an individual whose total net personal assets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or total net joint assets with his or her spouse exceeds RM3 million (or its equivalent in foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currencies), excluding the value of the primary residence of the individual&#59; (v) an individual who has a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preceding twelve months&#59; (vi) an individual who, jointly with his or her spouse, has a gross annual income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve months&#59; (vii) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporation with total net assets exceeding RM10 million (or its equivalent in a foreign currencies) based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the last audited accounts&#59; (viii) a partnership with total net assets exceeding RM10 million (or its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalent in foreign currencies)&#59; (ix) a bank licensee or insurance licensee as defined in the Labuan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services and Securities Act 2010&#59; (x) an Islamic bank licensee or takaful licensee as defined in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Labuan Financial Services and Securities Act 2010&#59; and (xi) any other person as may be specified by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Commission&#59; provided that, in the each of the preceding categories (i) to (xi), the distribution of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares is made by a holder of a Capital Markets Services License who carries on the business of dealing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not constitute and may not be used for the purpose of public offering or an issue, offer for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a prospectus with the Commission under the Capital Markets and Services Act 2007.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Taiwan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered with the Financial Supervisory Commission of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorised to offer, sell, give <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 703.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advice regarding or otherwise intermediate the offering and sale of the shares in Taiwan.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">215<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in South Africa<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Due to restrictions under the securities laws of South Africa, no &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 355.79pt; position: absolute; white-space: pre;">offer to the public<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.43pt; position: absolute; white-space: pre;">&#8221; (as such term is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined in the South African Companies Act, No. 71 of 2008 (as amended or re-enacted) (the &#8220;South <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">African Companies Act&#8221;) is being made in connection with the issue of the shares in South Africa. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, this document does not, nor is it intended to, constitute a &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 384.5pt; position: absolute; white-space: pre;">registered prospectus<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.62pt; position: absolute; white-space: pre;">&#8221; (as that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term is defined in the South African Companies Act) prepared and registered under the South African <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Companies Act and has not been approved by, and&#47;or filed with, the South African Companies and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Intellectual Property Commission or any other regulatory authority in South Africa. The shares are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered, and the offer shall not be transferred, sold, renounced or delivered, in South Africa or to a person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an address in South Africa, unless one or other of the following exemptions stipulated in section 96 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(1) applies&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 222.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 94.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 386.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 94.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 94.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 96 (1) (a)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 0pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the offer, transfer, sale, renunciation or delivery is to&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 19.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(i) persons whose ordinary business, or part of whose ordinary business, is to deal in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">securities, as principal or agent&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 51pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(ii) the South African Public Investment Corporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 70.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(iii) persons or entities regulated by the Reserve Bank of South Africa&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 90pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(iv) authorised financial service providers under South African law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 109.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(v) financial institutions recognised as such under South African law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 129pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(vi) a wholly-owned subsidiary of any person or entity contemplated in (c), (d) or (e), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acting as agent in the capacity of an authorised portfolio manager for a pension fund, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or as manager for a collective investment scheme (in each case duly registered as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">such under South African law)&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 184.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(vii) any combination of the person in (i) to (vi)&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204pt; width: 94.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 94.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 96 (1) (b) <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 204pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the total contemplated acquisition cost of the securities, for any single addressee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">may be promulgated by notice in the Government Gazette of South Africa pursuant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">section 96(2)(a) of the South African Companies Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 489.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information made available in this prospectus should not be considered as &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 406.43pt; position: absolute; white-space: pre;">advice<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.33pt; position: absolute; white-space: pre;">&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">South African Financial Advisory and Intermediary Services Act, 2002. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 521.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Israel<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Israeli Securities Law, and has not been filed with or approved by the Israel Securities Authority. In Israel, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus is being distributed only to, and is directed only at, and any offer of the shares is directed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only at, (i) a limited number of persons in accordance with the Israeli Securities Law and (ii) investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity in excess of NIS 50 million and &#8220;qualified individuals,&#8221; each as defined in the Addendum (as it may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be amended from time to time), or, collectively referred to as qualified investors (in each case, purchasing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for their own account or, where permitted under the Addendum, for the accounts of their clients who are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors listed in the Addendum). Qualified investors are required to submit written confirmation that they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fall within the scope of the Addendum, are aware of the meaning of same and agree to it.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">216<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1505" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Legal matters<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">O&#8217;Melveny &#38; Myers LLP. King &#38; Spalding LLP is acting as regulatory counsel to us in connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering and will pass upon certain legal matters. Certain legal matters in connection with this offering will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be passed upon for the underwriters by Cooley LLP, San Francisco, California.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1531" style="position: absolute; top: 163.2pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Experts<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The financial statements as of December 31, 2024 and 2023 and for the years then ended included in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus have been so included in reliance on the report of PricewaterhouseCoopers LLP, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">independent registered public accounting firm, given on the authority of said firm as experts in auditing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and accounting.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1578" style="position: absolute; top: 254.4pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Where you can find additional information<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 289.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have filed with the SEC a registration statement on Form S-1, including exhibits and schedules, under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Securities Act, with respect to the shares of common stock being offered by this prospectus. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 313.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, which constitutes part of the registration statement, does not contain all of the information in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the registration statement and its exhibits. For further information with respect to us and the common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contained in this prospectus as to the contents of any contract or any other document referred to are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summary in nature and not necessarily complete, and in each instance, we refer you to the copy of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract or other document filed as an exhibit to the registration statement. Each of these statements is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualified in all respects by reference to the full text of such contract or other document.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You may read our SEC filings, including the registration statement of which this prospectus forms a part, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over the Internet at the SEC&#8217;s website at www.sec.gov. Upon the completion of this offering, we will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements, and other information with the SEC. These reports, proxy statements, and other information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be available for review at the SEC&#8217;s website referred to above. We also maintain a website at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">www.heartflow.com, at which, following the completion of this offering, you may access these materials <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SEC. Information contained on or accessible through our website is not a part of this prospectus or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the registration statement of which it forms a part, and the inclusion of our website address in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus is an inactive textual reference only. You should not consider the contents of our website in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making an investment decision with respect to our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-1<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_77" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 151.75pt; position: absolute; text-decoration: none; white-space: pre;">I<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 155.08pt; position: absolute; text-decoration: none; white-space: pre;">NDEX TO CONSOLIDATED FINANCIAL STATEMENTS<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 113.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 194.93pt; position: absolute; text-decoration: none; white-space: pre;">Years Ended December 31, 2023 and 2024, and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 125.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 168.32pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended March 31, 2024 and 2025 (unaudited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.34999999999997pt; position: absolute; text-decoration: none; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 137.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 428.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.63pt; position: absolute; text-decoration: none; white-space: pre;">Page<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_113">Report of Independent Registered Public Accounting Firm</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 257.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 257.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 258.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.08pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_113">F-2</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 428.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Financial Statements&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_461">Consolidated Balance Sheets</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 147.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 147.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.91pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_461">F-3</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_447">Consolidated Statements of Operations and Comprehensive Loss</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 305.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 305.46999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 305.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.59pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 55.5pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_447">F-4</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; </a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">Deficit</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 42.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 43.050000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.06pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 69.75pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">F-5</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_418">Consolidated Statements of Cash Flows</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 192.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 192.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 193.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 193.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.06pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 96pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_418">F-7</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 110.25pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_129">Notes to Consolidated Financial Statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 209.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 210.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 210.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 210.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 210.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.49pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 110.25pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_129">F-8</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_113" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To the Board of Directors and Stockholders of Heartflow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 127.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Opinion on the Financial Statements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 147.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have audited the accompanying consolidated balance sheets of HeartFlow Holding, Inc. and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 159.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, and the related consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss, of redeemable convertible preferred stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders&#8217; deficit and of cash flows for the years then ended, including the related notes (collectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 195.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 207.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements present fairly, in all material respects, the financial position of the Company as of December <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 219.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 231.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conformity with accounting principles generally accepted in the United States of America.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Basis for Opinion<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These consolidated<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 158.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.45pt; position: absolute; white-space: pre;">financial statements are the responsibility of the Company&#8217;s management. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(United States) (PCAOB) and are required to be independent with respect to the Company in accordance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the U.S. federal securities laws and the applicable rules and regulations of the Securities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Exchange Commission and the PCAOB.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We conducted our audits of these consolidated<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 279.59000000000003pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.36pt; position: absolute; white-space: pre;">financial statements in accordance with the standards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about whether the consolidated financial statements are free of material misstatement, whether due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">error or fraud.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audits included performing procedures to assess the risks of material misstatement of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 128.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.9pt; position: absolute; white-space: pre;">financial statements, whether due to error or fraud, and performing procedures that respond <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures in the consolidated<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 208.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.89pt; position: absolute; white-space: pre;">financial statements. Our audits also included evaluating the accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principles used and significant estimates made by management, as well as evaluating the overall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presentation of the consolidated<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 213.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.44pt; position: absolute; white-space: pre;">financial statements. We believe that our audits provide a reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis for our opinion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#47;s&#47; PricewaterhouseCoopers LLP<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">San Jose, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">March 26, 2025, except for the effects of the reverse stock split discussed in Note 1 to the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 555.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial statements, as to which the date is August 1, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have served as the Company&#8217;s auditor since 2009, which includes periods before the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">became subject to SEC reporting requirements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 729pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_461" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 222.02pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Balance Sheets<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 105.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 181.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 133.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 40.77pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.2pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.74pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.88pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Current assets&#58;<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 60pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 111.53pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 60pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">122,767<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 60pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 37.42pt; position: absolute;">51,367<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 60pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">109,786<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 32.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 72pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 4.01pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts receivable, net of allowance for credit losses of $1,058, <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.61pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">$814 and $742 at December 31, 2023 and 2024, and March 31, 2025 <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 23.21pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited), respectively<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 101.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 103.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.44pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 72pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 23.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">20,546<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 72pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 23.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">24,639<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 72pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 23.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">28,312<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 104.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash, current<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 98.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 99.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 99.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 99.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 99.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.58pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 104.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 51.21pt;"></font></font><font style="left: 53.84pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 104.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">150<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 104.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 51.21pt;"></font></font><font style="left: 53.84pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 116.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses and other current assets<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 166.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 167.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 167.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 167.56pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">5,134<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">6,132<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">6,541<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 128.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total current assets<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.47pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">148,447<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">82,288<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">144,639<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 103.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 103.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.61pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">9,921<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">8,920<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">8,655<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 152.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease right-of-use assets<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 126.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 127.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 127.56pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">20,961<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">18,805<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">18,642<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 164.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash, non-current<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 103.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.56pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">4,467<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">4,325<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">4,475<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 176.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current assets<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 90.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 91.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 91.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 91.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 91.58pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">1,255<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">4,366<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">8,030<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 188.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total assets<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 68.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 69.55pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">185,051<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">118,704<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 188.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">184,441<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 205.5pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.15pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities, redeemable convertible preferred stock and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders' deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 227.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Current liabilities&#58;<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 239.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts payable<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 77.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 78.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 79.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 79.44pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 41.86pt; position: absolute;">2,887<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 41.86pt; position: absolute;">2,870<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 41.86pt; position: absolute;">1,972<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 251.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued expenses and other current liabilities<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 176.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 177.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 177.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 177.46pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">24,790<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">25,319<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">35,983<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 263.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, current<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 132.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 133.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 133.42000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 133.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 133.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 133.55pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 263.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">5,138<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 263.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">5,416<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 263.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">5,453<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 275.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total current liabilities<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 103.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 103.56pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 275.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">32,815<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 275.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">33,605<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 275.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">43,408<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 287.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Convertible notes<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 65.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 65.55pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 287.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 51.21pt;"></font></font><font style="left: 53.84pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 287.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 51.21pt;"></font></font><font style="left: 53.84pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 287.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">65,824<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 299.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Term loan<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 37.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 39.440000000000005pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 299.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">134,008<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 299.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">136,431<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 299.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">113,831<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 311.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 111.56pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 311.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.23pt;"></font></font><font style="left: 41.86pt; position: absolute;">4,440<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 311.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">20,835<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 311.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">22,441<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 323.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 65.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 65.5pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 323.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">903<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 323.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 51.21pt;"></font></font><font style="left: 53.84pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 323.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">40,945<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 335.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, non-current <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 139.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.56pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 335.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">21,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 335.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">18,537<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 335.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">18,173<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 347.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current liabilities<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 98.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 99.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 99.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 99.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 99.49pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 347.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">429<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 347.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">214<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 347.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">248<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 359.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total liabilities<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 75.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 77.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 77.47pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 359.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">194,049<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 359.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">209,622<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 359.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">304,870<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 371.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Commitments and contingencies (Note 7)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 383.25pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.81pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock issuable in series, $0.001 par <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.41pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">value&#59; 122,231,454 shares authorized, issued and outstanding as of <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 22.01pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 72.78pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, and March 31, 2025 (unaudited)&#59; <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 31.61pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">aggregate liquidation value of $951,917 as of <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 164.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 234.37pt; position: absolute; text-decoration: none; white-space: pre;"> and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 41.21pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024, and March 31, 2025 (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 139.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 139.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 139.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 383.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 383.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 383.25pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 433.5pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; deficit&#58;<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 445.5pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.81pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock, $0.001 par value&#59; 210,000,000, 210,300,000 and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 12.41pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">210,300,000 shares authorized as of <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 134.5pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 204.65pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.01pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 (unaudited), respectively&#59; 4,940,925, 6,122,048 and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 31.61pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">6,252,861 shares issued and outstanding as of <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 170.47pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 240.62pt; position: absolute; text-decoration: none; white-space: pre;"> and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 41.21pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024, and March 31, 2025 (unaudited), respectively<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 185.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 185.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 185.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 185.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 445.5pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 54.77pt;"></font></font><font style="left: 57.400000000000006pt; position: absolute;">5<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 445.5pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 54.77pt;"></font></font><font style="left: 57.400000000000006pt; position: absolute;">6<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 445.5pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 41.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 54.77pt;"></font></font><font style="left: 57.400000000000006pt; position: absolute;">6<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 495.75pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Additional paid-in capital<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 89.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 89.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 89.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 89.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 89.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 495.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 34.79pt;"></font></font><font style="left: 37.42pt; position: absolute;">97,465<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 495.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">112,241<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 495.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 30.35pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">115,311<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 507.75pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated other comprehensive loss<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 142.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 143.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 143.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 143.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 143.49pt; position: absolute; text-decoration: none; white-space: pre;">............................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 507.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 43.23pt;"></font></font><font style="left: 45.86pt; position: absolute;">(501)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 507.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 43.23pt;"></font></font><font style="left: 45.86pt; position: absolute;">(772)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 507.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 36.57pt;"></font></font><font style="left: 39.2pt; position: absolute;">(1,008)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 519.75pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 71.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 73.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 73.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 73.47pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 519.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 27.69pt;"></font></font><font style="left: 30.32pt; position: absolute;">(874,533)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 519.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 27.69pt;"></font></font><font style="left: 30.32pt; position: absolute;">(970,959)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 519.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 21.03pt;"></font></font><font style="left: 23.66pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 531.75pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; deficit<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 115.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 115.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 115.58pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 531.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 27.69pt;"></font></font><font style="left: 30.32pt; position: absolute;">(777,564)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 531.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 27.69pt;"></font></font><font style="left: 30.32pt; position: absolute;">(859,484)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 531.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 27.69pt;"></font></font><font style="left: 30.32pt; position: absolute;">(888,995)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 543.75pt; width: 266.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total liabilities, redeemable convertible preferred stock and <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders&#8217; deficit<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 96.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 97.49pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 543.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">185,051<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 543.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">118,704<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 543.75pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 25.91pt;"></font></font><font style="left: 32.980000000000004pt; position: absolute;">184,441<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 715.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-4<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_447" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 118.73pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Operations and Comprehensive Loss<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 105.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 181.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 133.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.3pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 38.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 39.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 39.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 39.970000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 39.99pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">87,174<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">125,808<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">26,843<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">37,205<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 62.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 66.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 67.03pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">29,123<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">31,359<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">7,420<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">9,264<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 49.120000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">58,051<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">94,449<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">19,423<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">27,941<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 100.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 112.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 113.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 114.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 114.21pt; position: absolute; text-decoration: none; white-space: pre;">....................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">35,854<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">43,517<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">9,443<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">13,924<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 140.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 141.25pt; position: absolute; text-decoration: none; white-space: pre;">........................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">95,111<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">112,154<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">26,038<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">31,519<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 102.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 103.08pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">130,965<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">155,671<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">35,481<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">45,443<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.31pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(72,914)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(61,222)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(16,058)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(17,502)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 151.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest income<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 64.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 64.81pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,457<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,066<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">1,512<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">543<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 164.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 69.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 69.36pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(24,694)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(22,768)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(6,243)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(5,093)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 177pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of convertible note<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 158.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 159.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 159.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 159.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(5,120)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 189.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of common stock warrant <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 30.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 30.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 30.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 30.99pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(2,320)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(16,395)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 53.88pt;"></font></font><font style="left: 56.510000000000005pt; position: absolute;">1<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(1,606)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 213.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of derivative liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 163.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 163.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 213.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,158<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 213.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(222)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 213.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">(61)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 213.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(9,045)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 226.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 116.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 226.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.62pt; position: absolute; text-decoration: none; white-space: pre;">325<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 226.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">168<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 226.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(155)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 226.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">358<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 239.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision for income taxes<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 156.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 157pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 157.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,108)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,373)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(21,004)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 239.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(32,345)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 252pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(Provision for) benefit from income taxes<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 164.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 165.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 165.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 165.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 165.93pt; position: absolute; text-decoration: none; white-space: pre;">.............<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(547)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">(53)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.88pt;"></font></font><font style="left: 51.510000000000005pt; position: absolute;">72<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 264.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 35.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 35.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 35.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 264.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 264.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 264.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(20,932)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 264.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(32,345)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 277.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 108.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 109.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 109.75pt; position: absolute; text-decoration: none; white-space: pre;">......................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(1,239)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 301.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 158.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 159.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 159.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 159.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 159.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 301.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(26,794)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 301.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 301.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 301.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 325.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 182.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 183.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 183.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 183.93pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 18.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(123,688)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(20,932)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(32,345)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 338.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive loss&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 351pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 35.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 35.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 35.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 351pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 351pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 351pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(20,932)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 351pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(32,345)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 363.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other comprehensive loss&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 376.5pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation gain (loss)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 158.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 159.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 159.25pt; position: absolute; text-decoration: none; white-space: pre;">................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 376.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(504)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 376.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(271)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 376.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 53.88pt;"></font></font><font style="left: 56.510000000000005pt; position: absolute;">1<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 376.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(236)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 389.25pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total comprehensive loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 103.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 104.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 105.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 105.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.21pt; position: absolute; text-decoration: none; white-space: pre;">........................................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 389.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,159)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 389.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,697)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 389.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(20,931)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 389.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(32,581)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 417.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to common <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders, basic and diluted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 125.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 125.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 417.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(25.32)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 417.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(17.98)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 417.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 41.02pt; position: absolute;">(4.23)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 417.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 41.02pt; position: absolute;">(5.25)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 35.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 441.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.66pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to compute net <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.46pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">loss per share attributable to common <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.26pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders, basic and diluted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 125.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 125.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 441.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 18.88pt;"></font></font><font style="left: 21.509999999999998pt; position: absolute;">4,885,231<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 441.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 18.88pt;"></font></font><font style="left: 21.509999999999998pt; position: absolute;">5,363,435<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 441.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 18.88pt;"></font></font><font style="left: 21.509999999999998pt; position: absolute;">4,943,430<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 441.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 18.88pt;"></font></font><font style="left: 21.509999999999998pt; position: absolute;">6,164,617<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 626.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 612pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 792pt;"><div style="left: 0pt; position: absolute; top: 540pt;"><div style="width: 666pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.5pt; position: absolute; text-decoration: none; white-space: pre;">F-5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 666pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 792pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_432" style="position: absolute; top: 63pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 63pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 307.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 82.2pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 125.11pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96.6pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 271.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 516.75pt; position: absolute; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 108.6pt; width: 792pt;"><div style="font-size: 0pt; left: 63pt; position: absolute; top: 0pt; width: 666pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 157.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 54.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 29.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 157.5pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 10.65pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.89pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable Convertible <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.75pt; position: absolute; text-decoration: none; white-space: pre;">Preferred Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 286.5pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.2pt; position: absolute; text-decoration: none; white-space: pre;">Common Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 412.5pt; position: absolute; top: 0pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.85pt; position: absolute; text-decoration: none; white-space: pre;">Additional <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.06pt; position: absolute; text-decoration: none; white-space: pre;">Paid-In <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.06pt; position: absolute; text-decoration: none; white-space: pre;">Capital<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 470.25pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.45pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.79pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.22pt; position: absolute; text-decoration: none; white-space: pre;">Other <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8pt; position: absolute; text-decoration: none; white-space: pre;">Income (Loss)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 543pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.92pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.79pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 606pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.46pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.59pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.79pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.68pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.91pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.68pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.91pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at January 1, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 104.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 106.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 106.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;">........................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 14pt;"></font></font><font style="left: 16.63pt; position: absolute;">39,422,361<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 20.66pt;"></font></font><font style="left: 27.73pt; position: absolute;">538,423<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">4,943,764<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 45.08pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">5<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 41.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 19.85pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">58,436<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 41.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 54.83pt;"></font></font><font style="left: 61.900000000000006pt; position: absolute;">3<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(752,084)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(693,640)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 53.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 102.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 102.81pt; position: absolute; text-decoration: none; white-space: pre;">..........................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 29.54pt;"></font></font><font style="left: 32.17pt; position: absolute;">99,900<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 53.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 35.39pt;"></font></font><font style="left: 38.02pt; position: absolute;">589<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 53.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.64pt;"></font></font><font style="left: 43.27pt; position: absolute;">589<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 41.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.41pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of Series F redeemable <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.01pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock at $2.8505 <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.61pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">per share, net of issuance costs of <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.21pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">$5,904<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 39.050000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 40.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 40.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 40.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 40.71pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 14pt;"></font></font><font style="left: 16.63pt; position: absolute;">61,344,029<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 25.1pt;"></font></font><font style="left: 27.73pt; position: absolute;">168,957<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 75pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 75pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 41.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 116.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.41pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of Series F-1 redeemable <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.01pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock at $1.9098 <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.61pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">per share upon conversion of <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.21pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible notes and accrued interest<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 150.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 150.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 150.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 14pt;"></font></font><font style="left: 16.63pt; position: absolute;">21,465,064<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 29.54pt;"></font></font><font style="left: 32.17pt; position: absolute;">61,186<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 116.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 116.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 116.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 157.5pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.15pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 153.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 154.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 154.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 154.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 154.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 157.5pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 24.29pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">26,794<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 157.5pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(26,794)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 157.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 179.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Repurchase of common stock<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 120.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 120.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 120.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 120.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 120.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.83pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(102,739)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 179.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 32.73pt;"></font></font><font style="left: 35.36pt; position: absolute;">(228)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 179.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 179.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 37.98pt;"></font></font><font style="left: 40.61pt; position: absolute;">(228)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 191.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 143.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 144.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 144.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 144.74pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 191.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 24.29pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">11,874<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 191.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 191.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 29.54pt;"></font></font><font style="left: 32.17pt; position: absolute;">11,874<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 203.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 130.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 130.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 130.8pt; position: absolute; text-decoration: none; white-space: pre;">............<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 203.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 203.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 47.73pt;"></font></font><font style="left: 50.36pt; position: absolute;">(504)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 203.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 37.98pt;"></font></font><font style="left: 40.61pt; position: absolute;">(504)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 215.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 44.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 44.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.75pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 215.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 215.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(95,655)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(95,655)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 227.25pt; width: 157.5pt;"><div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 44.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 116.72999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 118.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.69pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 9.56pt;"></font></font><font style="left: 12.190000000000001pt; position: absolute;">122,231,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 25.1pt;"></font></font><font style="left: 27.73pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">4,940,925<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 49.52pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">5<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 227.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 24.29pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">97,465<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 227.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 47.73pt;"></font></font><font style="left: 50.36pt; position: absolute;">(501)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(874,533)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 227.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(777,564)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 239.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 102.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 102.81pt; position: absolute; text-decoration: none; white-space: pre;">..........................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">1,181,123<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 49.52pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">1<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 239.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 28.73pt;"></font></font><font style="left: 31.36pt; position: absolute;">4,563<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 239.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 33.98pt;"></font></font><font style="left: 36.61pt; position: absolute;">4,564<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 143.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 144.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 144.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 144.74pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 261pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 24.29pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">10,213<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 261pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 261pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 29.54pt;"></font></font><font style="left: 32.17pt; position: absolute;">10,213<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 273pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 130.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 130.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 130.8pt; position: absolute; text-decoration: none; white-space: pre;">............<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 273pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 273pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 47.73pt;"></font></font><font style="left: 50.36pt; position: absolute;">(271)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 273pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 37.98pt;"></font></font><font style="left: 40.61pt; position: absolute;">(271)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 285pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 44.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 44.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 44.75pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 285pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 285pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(96,426)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 285pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(96,426)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 297pt; width: 157.5pt;"><div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 44.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 116.72999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 118.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.69pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 9.56pt;"></font></font><font style="left: 12.190000000000001pt; position: absolute;">122,231,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 25.1pt;"></font></font><font style="left: 27.73pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">6,122,048<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 49.52pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">6<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 297pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 19.85pt;"></font></font><font style="left: 22.48pt; position: absolute;">112,241<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 297pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 47.73pt;"></font></font><font style="left: 50.36pt; position: absolute;">(772)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(970,959)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 297pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(859,484)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 309pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 144.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 144.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 144.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 144.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 144.87pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 25.1pt;"></font></font><font style="left: 27.73pt; position: absolute;">130,813<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 309pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 35.39pt;"></font></font><font style="left: 38.02pt; position: absolute;">578<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 309pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 309pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.64pt;"></font></font><font style="left: 43.27pt; position: absolute;">578<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 330.75pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.470000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.71pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 330.75pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 28.73pt;"></font></font><font style="left: 31.36pt; position: absolute;">2,492<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 330.75pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 330.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 33.98pt;"></font></font><font style="left: 36.61pt; position: absolute;">2,492<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 352.5pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.470000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.71pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 352.5pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 352.5pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 47.73pt;"></font></font><font style="left: 50.36pt; position: absolute;">(236)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 352.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 37.98pt;"></font></font><font style="left: 40.61pt; position: absolute;">(236)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 374.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 86.81pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 374.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 374.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(32,345)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 374.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(32,345)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 386.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at March 31, 2025 (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 147.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 149.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 150.75pt; position: absolute; text-decoration: none; white-space: pre;">..<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 9.56pt;"></font></font><font style="left: 12.190000000000001pt; position: absolute;">122,231,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 20.66pt;"></font></font><font style="left: 27.73pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">6,252,861<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 45.08pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">6<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 386.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 15.41pt;"></font></font><font style="left: 22.48pt; position: absolute;">115,311<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 386.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 36.63pt;"></font></font><font style="left: 43.7pt; position: absolute;">(1,008)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 11.34pt;"></font></font><font style="left: 18.41pt; position: absolute;">(1,003,304)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 386.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(888,995)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 612pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 792pt;"><div style="left: 0pt; position: absolute; top: 540pt;"><div style="width: 666pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.5pt; position: absolute; text-decoration: none; white-space: pre;">F-6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 666pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 792pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div style="position: absolute; top: 63pt; width: 792pt;"><div style="font-size: 0pt; left: 63pt; position: absolute; top: 0pt; width: 666pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 157.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 54.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 29.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 157.5pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 10.65pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.89pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable Convertible <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 31.75pt; position: absolute; text-decoration: none; white-space: pre;">Preferred Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 286.5pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 32.2pt; position: absolute; text-decoration: none; white-space: pre;">Common Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 412.5pt; position: absolute; top: 0pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.85pt; position: absolute; text-decoration: none; white-space: pre;">Additional <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.06pt; position: absolute; text-decoration: none; white-space: pre;">Paid-In <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.06pt; position: absolute; text-decoration: none; white-space: pre;">Capital<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 470.25pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.45pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.79pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 24.22pt; position: absolute; text-decoration: none; white-space: pre;">Other <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.91pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 7.8pt; position: absolute; text-decoration: none; white-space: pre;">Income (Loss)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 543pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 4.92pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.79pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 606pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.46pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.59pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.79pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.68pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.91pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.68pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 14.91pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 157.5pt;"><div><div style="font-size: 12pt; line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 44.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 116.72999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 118.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 120.69pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 9.56pt;"></font></font><font style="left: 12.190000000000001pt; position: absolute;">122,231,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 20.66pt;"></font></font><font style="left: 27.73pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">4,940,925<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 45.08pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">5<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 41.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 19.85pt;"></font></font><font style="left: 26.919999999999998pt; position: absolute;">97,465<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 41.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 43.29pt;"></font></font><font style="left: 50.36pt; position: absolute;">(501)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(874,533)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 22.44pt;"></font></font><font style="left: 25.07pt; position: absolute;">(777,564)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 53.25pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 144.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 144.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 144.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 144.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 144.87pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 29.54pt;"></font></font><font style="left: 32.17pt; position: absolute;">10,561<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 53.25pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 39.83pt;"></font></font><font style="left: 42.46pt; position: absolute;">77<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 53.25pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 53.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.08pt;"></font></font><font style="left: 47.71pt; position: absolute;">77<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.470000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.71pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 75pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 28.73pt;"></font></font><font style="left: 31.36pt; position: absolute;">2,723<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 75pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 33.98pt;"></font></font><font style="left: 36.61pt; position: absolute;">2,723<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 21.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.11pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation gain <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.71pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 55.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.470000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 56.71pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 96.75pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 96.75pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 59.27pt;"></font></font><font style="left: 61.900000000000006pt; position: absolute;">1<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 96.75pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 49.52pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">1<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 118.5pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 86.81pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 45.96pt;"></font></font><font style="left: 48.59pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 118.5pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 40.71pt;"></font></font><font style="left: 43.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 118.5pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 55.71pt;"></font></font><font style="left: 58.34pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(20,932)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 118.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 26.88pt;"></font></font><font style="left: 29.509999999999998pt; position: absolute;">(20,932)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 130.5pt; width: 157.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 2.96pt; width: 157.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at March 31, 2024 (unaudited)<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 147.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 149.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.82pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 150.75pt; position: absolute; text-decoration: none; white-space: pre;">..<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 157.5pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 9.56pt;"></font></font><font style="left: 12.190000000000001pt; position: absolute;">122,231,454<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 220.5pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 20.66pt;"></font></font><font style="left: 27.73pt; position: absolute;">768,566<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.82pt; width: 18.44pt;"></font></font><font style="left: 21.07pt; position: absolute;">4,951,486<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 349.5pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 45.08pt;"></font></font><font style="left: 52.150000000000006pt; position: absolute;">5<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 412.5pt; position: absolute; top: 130.5pt; width: 54.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 54.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 15.41pt;"></font></font><font style="left: 22.48pt; position: absolute;">100,265<font style="display: inline-block; height: 5.82pt; width: 2.66pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 470.25pt; position: absolute; top: 130.5pt; width: 69.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 43.29pt;"></font></font><font style="left: 50.36pt; position: absolute;">(500)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 543pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(895,465)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 606pt; position: absolute; top: 130.5pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.82pt; width: 18pt;"></font></font><font style="left: 25.07pt; position: absolute;">(795,695)<font style="display: inline-block; height: 5.82pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 221.5pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 220.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 774pt;"><div style="width: 567pt;"><div style="line-height: 7.28pt; position: absolute; top: 4.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-7<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 567pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_418" style="position: absolute; top: 44.93pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 44.93pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 64.13pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 191.71pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Cash <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 386.29pt; position: absolute; text-decoration: none; white-space: pre;">Flows<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 78.53pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 271.59pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 90.53pt; width: 612pt;"><div style="font-size: 0pt; left: 30pt; position: absolute; top: 0pt; width: 552pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 336pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 336pt; position: absolute; top: 0pt; width: 106.5pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 106.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 34.02pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 106.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 30.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 445.5pt; position: absolute; top: 0pt; width: 106.5pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.79pt; width: 106.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.68pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 106.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 36.15pt; position: absolute; text-decoration: none; white-space: pre;"> March&#160;31,<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 20.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.09pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 20.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.09pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 20.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.09pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 20.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 18.09pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 445.5pt; position: absolute; top: 31.5pt; width: 106.5pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 106.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 34.22pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from operating activities&#58;<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 28.759999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 28.779999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 54pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 18.43pt;"></font></font><font style="left: 24.95pt; position: absolute;">(95,655)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 54pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 18.43pt;"></font></font><font style="left: 24.95pt; position: absolute;">(96,426)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 54pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 18.43pt;"></font></font><font style="left: 24.95pt; position: absolute;">(20,932)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 54pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 18.43pt;"></font></font><font style="left: 24.95pt; position: absolute;">(32,345)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Adjustments to reconcile net loss to net cash used in operating activities&#58;<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 76.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Depreciation and amortization<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 107.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 107.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 107.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 76.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">4,744<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 76.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">5,358<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 76.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,192<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 76.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,372<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 127.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 127.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 128.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 128.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 128.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 128.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 128.52pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 87.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">11,874<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 87.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">10,213<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 87.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,723<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 87.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,492<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Amortization of debt discount and debt issuance costs<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 181.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 182.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 182.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 182.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 182.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 182.78pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 99pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,777<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 99pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,609<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 99pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">719<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 99pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">998<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 110.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Amortization of right-of-use asset<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 117.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 117.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 117.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 118.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 118.05pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 110.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,889<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 110.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,735<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 110.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">669<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 110.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">724<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 121.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of convertible note<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 137.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 137.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 137.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 137.24pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 121.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">5,120<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 121.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 121.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 121.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 132.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of common stock warrant liability<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 179.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 180.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 181pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 132.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,320<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 132.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">16,395<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 132.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.82pt;"></font></font><font style="left: 42.45pt; position: absolute;">(1)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 132.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,606<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 144pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of derivative liability<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 140.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 140.74pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 144pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(4,158)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 144pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">222<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 144pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 38.26pt;"></font></font><font style="left: 40.89pt; position: absolute;">61<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 144pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">9,045<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 155.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Paid-in-kind interest<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 76.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 77.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 77.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 77.74pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 155.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">144<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 155.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 155.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 155.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 166.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Non-cash interest charges<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 97.05pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 166.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">865<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 166.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,016<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 166.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">217<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 166.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">545<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 177.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in allowance for credit losses<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 130.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 131.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 131.97pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 177.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,190<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 177.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(244)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 177.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.82pt;"></font></font><font style="left: 42.45pt; position: absolute;">(1)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 177.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 35.93pt;"></font></font><font style="left: 38.56pt; position: absolute;">(72)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 189pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Changes in assets and liabilities&#58;<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 116.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 116.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 116.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 116.36pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 200.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts receivable, net<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 102.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 103.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 104pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 200.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(9,350)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 200.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(3,849)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 200.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,455<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 200.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(3,601)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 211.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses and other current assets<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 159.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 160.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 160.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 160.12pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 211.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(357)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 211.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(998)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 211.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(722)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 211.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(409)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 222.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current assets<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 103.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 104.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 104.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 104.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 222.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(402)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 222.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(2,698)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 222.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(334)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 222.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(341)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 234pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts payable<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 81.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 83pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 234pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(623)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 234pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(327)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 234pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(401)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 234pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,627)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 245.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued expenses and other current liabilities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 167.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 168.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 168.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 168.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 168.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 245.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">3,759<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 245.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">426<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 245.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(6,030)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 245.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">9,301<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 256.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 104.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 105.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 105.74pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 256.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,761)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 256.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(3,218)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 256.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(748)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 256.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(888)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 267.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current liabilities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 110.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 110.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 110.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 111.05pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 267.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">190<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 267.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(215)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 267.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 267.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 38.26pt;"></font></font><font style="left: 40.89pt; position: absolute;">34<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 279pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 150.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 151.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 151.3pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 279pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(76,434)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 279pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(69,001)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 279pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(22,133)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 279pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(13,166)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 290.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from investing activities<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 301.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Purchase of property and equipment<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 127.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 128.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 128.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 128.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 128.55pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 301.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(6,105)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 301.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(4,357)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 301.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,749)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 301.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,101)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 312.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 151.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 151.34pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 312.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(6,105)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 312.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(4,357)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 312.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,749)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 312.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(1,101)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 324pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from financing activities<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 335.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds from issuance of Series F redeemable convertible preferred shares, net of issuance costs<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 322.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 322.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 322.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 322.84pt; position: absolute; text-decoration: none; white-space: pre;">......<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 335.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 23.39pt; position: absolute;">168,957<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 335.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 335.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 335.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 346.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds from convertible notes offering, net of issuance costs<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 209.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 210.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 210.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 210.72pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 346.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 346.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 346.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 346.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">73,860<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 357.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds from exercise of stock options<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 138.92000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 139.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 139.08pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 357.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">589<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 357.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">4,564<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 357.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 38.26pt;"></font></font><font style="left: 40.89pt; position: absolute;">77<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 357.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 34.37pt;"></font></font><font style="left: 37pt; position: absolute;">578<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 369pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Payments of exit, prepayment penalty and lender fees<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 181.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 182.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 182.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 182.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 182.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 182.78pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 369pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 369pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 26.21pt;"></font></font><font style="left: 28.84pt; position: absolute;">(2,327)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 369pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 369pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(518)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 380.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Payments of deferred offering costs<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 124.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 125.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 125.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 125.11pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 380.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 380.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 380.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 380.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(998)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 391.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Repurchase of common stock<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 107.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 107.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 107.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 107.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 107.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 391.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(228)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 391.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 391.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 391.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 39.04pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 402.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 165.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 165.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 165.34pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 402.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 23.39pt; position: absolute;">169,318<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 402.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 28.54pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,237<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 402.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 38.26pt;"></font></font><font style="left: 40.89pt; position: absolute;">77<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 402.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">72,922<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 414pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Effect of foreign exchange rates<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 101.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 102.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 102.27pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 414pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(504)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 414pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(271)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 414pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 42.15pt;"></font></font><font style="left: 44.78pt; position: absolute;">1<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 414pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 34.67pt; position: absolute;">(236)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 425.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net increase (decrease) in cash, cash equivalents and restricted cash<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 230.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 231.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 231.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 231.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 231.74pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 425.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">86,275<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 425.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(71,392)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 425.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(23,804)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 425.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">58,419<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 436.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance, beginning of period<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 103.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 103.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 104.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 104.05pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 436.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">40,959<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 436.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 23.39pt; position: absolute;">127,234<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 436.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 23.39pt; position: absolute;">127,234<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 436.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">55,842<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 447.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance, end of period<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 84.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 84.86pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 447.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 16.87pt;"></font></font><font style="left: 23.39pt; position: absolute;">127,234<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 447.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">55,842<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 447.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 16.87pt;"></font></font><font style="left: 23.39pt; position: absolute;">103,430<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 447.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 16.87pt;"></font></font><font style="left: 23.39pt; position: absolute;">114,261<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 459pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Supplemental disclosure of cash flow information&#58;<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 470.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash paid (refunded) for taxes<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 109.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 109.36pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 470.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">405<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 470.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 38.56pt; position: absolute;">(72)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 470.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 32.04pt;"></font></font><font style="left: 38.56pt; position: absolute;">(72)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 470.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 481.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash paid for interest<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 81.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 81.36pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 481.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">20,800<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 481.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">19,163<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 481.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">5,308<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 481.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">3,439<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 492.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Supplemental disclosure of non-cash investing and financing activities&#58;<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 504pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Purchases of property and equipment included in accounts payable<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 223.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 223.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 223.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 223.12pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 504pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">808<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 504pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 504pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 504pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 38.26pt;"></font></font><font style="left: 44.78pt; position: absolute;">6<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 515.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition of derivative liability in connection with debt refinancing<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 229.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 229.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 229.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 230.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 230.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 515.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 515.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,125<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 515.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 515.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 526.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Right-of-use asset obtained in exchange for lease obligation<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 200.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 201.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 201.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 201.97pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 526.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 526.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">579<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 526.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 526.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">561<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 537.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Conversion of term loan principal to convertible notes<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 179.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 180.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 180.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 180.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 180.97pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 537.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 537.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 537.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 537.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">23,000<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 549pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of convertible notes to certain employees in lieu of cash compensation<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 261.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 263.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 263.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 263.21000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 263.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 263.24pt; position: absolute; text-decoration: none; white-space: pre;">........................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 549pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 549pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 549pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 549pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,353<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 560.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Reclassification of term loan debt discount to convertible notes debt discount<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 251.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 252.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 252.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 252.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 252.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 560.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 560.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 560.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 560.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">239<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 20.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 571.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.75pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Unpaid deferred offering costs included in accounts payable and accrued expenses and other current <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">liabilities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.12pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 571.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 571.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 30.48pt;"></font></font><font style="left: 37pt; position: absolute;">413<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 571.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 571.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">2,325<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 20.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 591.75pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.75pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Unpaid convertible notes issuance costs included in accounts payable and accrued expenses and <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 12.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">other current liabilities<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 82.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 83.08pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 591.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 591.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 591.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 591.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 12.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,114<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 612pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Reduction in right-of-use asset and lease obligation due to amendment in lease terms<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 279.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 280.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 280.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 280.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 280.74pt; position: absolute; text-decoration: none; white-space: pre;">..............................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 612pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 31.169999999999998pt; position: absolute;">1,776<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 612pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 612pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 612pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 623.25pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of redeemable convertible preferred stock<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 256.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 623.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">26,794<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 623.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 623.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 623.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 634.5pt; width: 336pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 336pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Conversion of convertible note into Series F-1 redeemable convertible preferred stock<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 279.71999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 280.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 280.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 280.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 280.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 280.77pt; position: absolute; text-decoration: none; white-space: pre;">..............................<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 634.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">61,186<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 390.75pt; position: absolute; top: 634.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 445.5pt; position: absolute; top: 634.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 500.25pt; position: absolute; top: 634.5pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 35.15pt;"></font></font><font style="left: 41.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 752.28pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-8<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_129" style="position: absolute; top: 90pt;"></div><div style="line-height: 0.72pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 306pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 0.72pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_161" style="position: absolute; top: 91.2pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1. Business Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 113.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Description of Business<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 133.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in July 2007 as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 145.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. On March 1, 2021, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 157.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company completed an internal reorganization in which a newly formed parent holding company, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 169.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc., was established. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 189.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company is a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.87pt; position: absolute; text-decoration: none; white-space: pre;">commercial-stage<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.76pt; position: absolute; white-space: pre;"> medical technology company that has pioneered the use of software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 201.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 213.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s novel HeartFlow Platform uses AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.08000000000004pt; position: absolute; white-space: pre;">and advanced computational fluid dynamics to create a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 225.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personalized 3D model of a patient&#8217;s heart based off a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 237.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;). This results in actionable data on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 249.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.11pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The Company&#8217;s HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 271.02pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.37pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis and Plaque Analysis software assists physicians </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 261.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">in diagnosing, managing and delivering precision care to patients with CAD.</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.42pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.01pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">The Company was awarded </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Conformit&#233; Europ&#233;ene Mark (&#8220;CE Mark&#8221;) for its HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 350.2pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.55pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis in July 2011. Th</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.16pt; position: absolute; text-decoration: none; white-space: pre;">e Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 285.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">received clearance from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in November 2014 for its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 297.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.73000000000002pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis and in October 2022 for its Plaque Analysis</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.15pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s United States (&#8220;U.S.&#8221;) headquarters is located in Mountain View, California, and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company also has offices in Santa Rosa, California, Austin, Texas, and Tokyo, Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company had the following wholly-owned subsidiaries as of March 31, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.86pt; position: absolute; text-decoration: none; white-space: pre;">2025&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 369.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 231pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 234pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 231pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 231pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 89.52pt; position: absolute; text-decoration: none; white-space: pre;">Entity Name<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 0pt; width: 234pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 64.07pt; position: absolute; text-decoration: none; white-space: pre;">Country of Incorporation<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 231pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 231pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 69.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 70.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 70.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.72pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 12.75pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 231pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 231pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Japan G.K.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 102.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 102.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 103.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.14999999999999pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 27pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 231pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 231pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow U.K. Ltd<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 87.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 88.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 88.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.25pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 41.25pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 231pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 231pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Technology U.K. Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 158.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 159.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 160.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 160.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 160.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 160.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.66pt; position: absolute; text-decoration: none; white-space: pre;">...........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 55.5pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 455.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Effective July 2024, HeartFlow International Sarl, a wholly-owned subsidiary in Switzerland, was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dissolved.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has incurred operating losses and negative cash flows from operations since its inception <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and has an accumulated deficit of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.65pt; position: absolute; text-decoration: none; white-space: pre;">$874.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.22pt; position: absolute; white-space: pre;"> million, $971.0 million and $1.0 billion as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.73pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 537.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and 2024 and March 31, 2025 (unaudited), respectively. The Company expects to incur losses for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future. Historically, the Company&#8217;s activities have been financed through sales of shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, common stock and convertible promissory notes, borrowings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under term loans and revenue received from customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">As of December 31, 2024 and March 31, 2025 (unaudited), the Company had $51.4 million and $109.8 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in cash and cash equivalents, respectively. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Based on the Company&#8217;s current operating plan as of June 20, 2025, the date these interim financial </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">statements (unaudited) were available to be issued, the Company believes that the expected cash </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">generated from revenue transactions with customers and its existing cash and cash equivalents will be </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">sufficient to fund the Company&#8217;s planned operating expenses and capital expenditure requirements for at </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">least the next 12 months from the date these interim consolidated financial statements (unaudited) were </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.35pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">available to be issued.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-9<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, the Company may experience lower than expected cash generated from operating activities or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater than expected capital expenditures, cost of revenue, or operating expenses, and may need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">raise additional capital to fund operations, further research and development activities, or acquire, invest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in, or license other businesses, assets, or technologies. The Company&#8217;s future capital needs will depend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon many factors, including the market acceptance of the Company&#8217;s products, the cost and pace of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing new products, and the costs of supporting sales growth.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Should the Company obtain additional equity or debt financing to satisfy its liquidity needs, the issuance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of additional debt or equity securities could be dilutive to existing stockholders. Furthermore, any new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities could have rights that are senior to existing stockholders and could contain covenants that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would restrict operations. There can be no assurance that the Company will generate sufficient future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash flows from operations or that financing will be available on terms commercially acceptable to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company or at all.&#160; If the Company is unable to obtain future funding, the Company would curtail <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses by reducing some of its research and development programs and commercialization efforts in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">order to maintain liquidity, if necessary.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reverse Stock Split<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">July 31, 2025</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.55pt; position: absolute; white-space: pre;">, the Company&#8217;s Board of Directors approved an amendment to the Company's <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended and restated certificate of incorporation to immediately effect a reverse stock split of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the Company&#8217;s outstanding common stock at a ratio of 1.0-for-2.92 (the &#8220;Reverse Stock Split&#8221;). The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of authorized shares and par value per share were not adjusted as a result of the Reverse Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Split. All references to shares, options to purchase common stock, share amounts, per share amount, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related information contained in the consolidated financial statements have been retrospectively adjusted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to reflect the effect of the Reverse Stock Split for all periods presented. The shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underlying outstanding stock options and other equity instruments were proportionately reduced and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respective exercise prices, if applicable, were proportionately increased in accordance with the terms of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the agreements governing such securities. In addition, the conversion ratios for each series of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s redeemable convertible preferred stock, which will automatically convert into shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock upon the closing of the Company&#8217;s initial public offering (the &#8220;IPO&#8221;) of common stock, were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proportionally adjusted.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_403" style="position: absolute; top: 458pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 458pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2. Summary of Significant Accounting Policies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Basis of Presentation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The accompanying consolidated financial statements include the accounts of the Company as well as its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly owned subsidiaries and have been prepared in accordance with accounting principles generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accepted in the United States of America (&#8220;U.S. GAAP&#8221;). All significant intercompany balances and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions have been eliminated in consolidation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reclassification of Prior Period Presentation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain prior year amounts have been reclassified for consistency with the current year presentation.&#160; A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reclassification was made to the Consolidated Statements of Cash Flows for the year ended December <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2023 to identify non-cash interest charges of $865,000. This change in classification does not affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously reported cash flows from operating activities in the Consolidated Statements of Cash Flows <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and had no effect on the reported results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Unaudited Interim Financial Information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The accompanying consolidated balance sheet as of March 31, 2025, the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and comprehensive loss and cash flows for the three months ended March 31, 2024 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025, and the consolidated statements of redeemable convertible preferred stock and stockholders&#8217; deficit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of March 31, 2024 and 2025, are unaudited. The financial data and other information disclosed in <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-10<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these notes to the consolidated financial statements related to March 31, 2025, and the three months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended March 31, 2024 and 2025, are also unaudited. The unaudited interim consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements have been prepared on the same basis as the annual consolidated financial statements and, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to a fair statement of the Company&#8217;s financial position as of March 31, 2025, and the results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its operations and cash flows for the three months ended March 31, 2024 and 2025. These interim <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial results are not necessarily indicative of results expected for the full fiscal year or for any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsequent interim period.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 189.78pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Use of Estimates<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The preparation of financial statements in conformity with U.S. GAAP requires management to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates and assumptions that affect the amounts reported in the financial statements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accompanying notes. Management used significant judgement when making estimates in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination of the fair value of its common stock and stock options, deferred income tax valuation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allowance, capitalized internal-use software, depreciation of property and equipment, allowance for credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">losses, revenue recognition, valuation of operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities, and the fair value of convertible debt, warrants to purchase common stock and embedded <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivatives. Management evaluates its estimates and assumptions on an ongoing basis using historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience and other factors and adjusts those estimates and assumptions as facts and circumstances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dictate. Actual results could materially differ from those estimates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Segment <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.97pt; position: absolute; text-decoration: none; white-space: pre;">Information<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company operates and manages its business as one reportable and operating segment, which is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business of non-invasive coronary artery disease detection solutions. The Company&#8217;s Chief Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Officer, who is the Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews financial information, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue and net loss, presented on a consolidated basis for purposes of making operating decisions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocating resources and evaluating financial performance. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company's measure of segment profit or loss is consolidated net loss, which is used by the CODM to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measure actual results versus expectations, set performance metrics, and develop the annual budget to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieve the Company&#8217;s long-term objectives. Significant segment expenses within consolidated net loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes cost of revenue, research and development, and selling, general and administrative expenses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which are each separately presented on the Company&#8217;s consolidated statements of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive loss. Other expense items that are presented on the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations include interest income, interest expense, changes in fair value of warrant liability, other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income, net, and provision for income taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table is representative of the significant expense categories regularly provided to the CODM <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">when managing the Company&#8217;s single reporting segment and includes a reconciliation to the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">net loss shown in the consolidated statements of operations and comprehensive loss for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.02pt; position: absolute; text-decoration: none; white-space: pre;">and for the three months ended March 31, 2024 and 2025 (unaudited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 513.15pt; position: absolute; text-decoration: none; white-space: pre;">) (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.09pt; position: absolute; text-decoration: none; white-space: pre;">F-11<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.3pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.86pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">26,843<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">37,205<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Less<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.75pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.68pt; position: absolute; text-decoration: none; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 85.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 85.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 85.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.36pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,420<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,264<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 148.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.24pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">22,330<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">25,983<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,897<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,328<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Regulatory and clinical<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 127.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 127.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.81pt; position: absolute; text-decoration: none; white-space: pre;">...........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">13,524<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">17,534<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,546<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,596<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 135pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 161.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Sales<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 51.629999999999995pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 52.209999999999994pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 52.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 52.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 52.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.769999999999996pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 161.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">53,374<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 161.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">66,895<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 161.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,554<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 161.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">16,953<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 175.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Marketing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 70.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 71.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 72.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 72.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 72.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 72.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72.66pt; position: absolute; text-decoration: none; white-space: pre;">.................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 175.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,949<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 175.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">14,470<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 175.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,901<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 175.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,682<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 189.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">General and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 146.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 147.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 147.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.67000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.71pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,788<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">30,789<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,583<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 189.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,884<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.71pt; position: absolute; text-decoration: none; white-space: pre;">.......................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(16,058)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(17,502)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 218.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 141.28pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 149.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.26999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(22,194)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(35,151)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,946)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 218.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(14,843)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 232.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">(Provision for) benefit from income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 194.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 195.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 195.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 195.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 246.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Segment net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.33pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 246.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 246.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 246.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 246.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 359pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net represents the consolidated amounts for interest income, interest expense, change in fair value of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 377pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible note, change in fair value of common stock warrant liability, change in fair value of derivative liability and other income <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(expense), net as shown on the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company derives revenue and has long-lived assets primarily in the United States of America. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 415pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue by geography is further described in Note 3.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cash, Cash Equivalents and Restricted Cash<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company considers all highly liquid investments that are readily convertible to known amounts of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash and purchased with an original maturity of three months or less to be cash equivalents. Cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents consist primarily of amounts invested in money market accounts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides a reconciliation of cash, cash equivalents and restricted cash within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated balance sheets to the total shown in the consolidated statements of cash flows (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 543pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 123.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.53pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">122,767<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">51,367<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">109,786<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 72.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,467<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,475<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,475<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total cash, cash equivalents and restricted cash<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 214.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">127,234<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">55,842<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">114,261<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2023 and 2024 and March 31, 2025 (unaudited), restricted cash represents deposits <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">held as security in connection with the Company&#8217;s facility lease agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Fair Value of Financial Instruments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is an exit price, representing the amount that would be received to sell an asset or paid to transfer a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-12<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability in an orderly transaction between market participants. As such, fair value is a market-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measurement that should be determined based on assumptions that market participants would use in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing an asset or a liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">priority to valuations based upon unadjusted quoted prices in active markets for identical assets or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that are significant to the valuation (Level 3 measurements). The accounting guidance establishes three <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">levels of the fair value hierarchy as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 1 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Observable inputs, such as quoted prices in active markets for identical assets or liabilities&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 2 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Observable inputs other than Level 1 prices, such as quoted prices for similar assets or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corroborated by observable market data for substantially the full term of the assets or liabilities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 3 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Unobservable inputs that are supported by little or no market activity and that are significant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair value of the assets or liabilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular input to the fair value measurement in its entirety requires management to make judgments and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considers factors specific to the asset or liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), the carrying amounts of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s financial instruments, including cash equivalents, accounts receivable, accounts payable and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accrued liabilities approximate fair value due to their relatively short maturities and market interest rates, if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable. Management believes that the Company&#8217;s Term Loan and 2025 Convertible Notes bear <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest at the prevailing market rates for instruments with similar characteristics&#59; accordingly, the carrying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of these instruments approximate its fair value. Fair value accounting is<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.04pt; position: absolute; text-decoration: none; white-space: pre;"> applied to the 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes, common stock warrant liability and derivative liability. No convertible notes or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">derivative liability were outstanding as of December 31, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Concentration of Credit Risk and Significant Customers<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents, restricted cash and accounts receivable. The Company maintains bank deposits in federally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insured financial institutions and these deposits may at times exceed federally insured limits. To date, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company has not experienced any losses on its cash deposits. The Company currently has full control of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its cash and cash equivalents balance. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 10, 2023, Silicon Valley Bank (&#8220;SVB&#8221;) was closed by the California Department of Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receiver. On March 13, 2023, the FDIC announced that it had transferred all insured and uninsured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deposits and substantially all assets of SVB to a newly created, full-service FDIC-operated &#8220;bridge bank&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">called Silicon Valley Bridge Bank, N.A. (&#8220;SVBB&#8221;), where depositors would have full access to their money <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately. On March 27, 2023, First Citizens BancShares, Inc. (&#8220;First Citizens Bank&#8221;) acquired SVBB <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the FDIC and operated SVBB as Silicon Valley Bank, a division of First Citizens Bank. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully transferred all funds to another financial institution and did not incur any losses on its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deposits as a result of SVB&#8217;s closure.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No single customer represented more than 10% of the Company&#8217;s revenue during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 or for the three months ended March 31, 2024 and 2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-13<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No single customer represented more than 10% of the Company&#8217;s accounts receivable as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Accounts Receivable<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company performs ongoing credit evaluations of its customers&#8217; financial conditions and generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extends credit to customers without requiring collateral. Accounts receivable are recorded at the amounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">billed less estimated allowances for credit losses for any potential uncollectible amounts. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continually monitors customer payments and maintains an allowance for estimated losses resulting from a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer&#8217;s inability to make required payments. The Company considers factors such as historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience, credit quality, age of the accounts receivable balances, geographic related risks and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic conditions that may affect a customer&#8217;s ability to pay. Accounts receivable are written-off and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">charged against an allowance for credit losses when the Company has exhausted collection efforts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.43pt; position: absolute; text-decoration: none; white-space: pre;">success<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.55pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Property and Equipment<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Property and equipment are stated at cost less accumulated depreciation or amortization. Depreciation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and amortization is computed using the straight-line method over the estimated useful lives of assets, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which generally ranges from two to five years. Leasehold improvements are amortized over the lesser of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their useful life or the remaining life of the lease. Upon sale or retirement of assets, the cost and related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in results from operations in the period realized. Maintenance and repairs are expensed as incurred.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Impairment of Long-Lived Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company reviews its long-lived assets, including property and equipment, for impairment at least <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annually and whenever events or changes in circumstances indicate that the carrying amount of an asset <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impairment, the Company uses an estimate of the related undiscounted future cash flows over the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remaining useful life of the long-lived assets in measuring whether they are recoverable. If the carrying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the asset exceeds the estimated undiscounted future cash flows, a loss is recorded as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">excess of the asset&#8217;s carrying value over its fair value. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.41999999999996pt; position: absolute; text-decoration: none; white-space: pre;">No<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.2pt; position: absolute; white-space: pre;"> assets were determined to be impaired during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.45pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.24pt; position: absolute; white-space: pre;"> and 2024 or for the three months ended March 31, 2024 and 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Deferred Offering Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalizes certain legal, accounting and other third-party fees that are directly associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with in-process equity financings as deferred offering costs until such financings are consummated. After <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consummation of the equity financing, these costs are recorded as a reduction of the proceeds from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, either as a reduction of the carrying value of preferred stock or in stockholders&#8217; deficit as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction of additional paid-in capital generated as a result of the offering. Should the in-process equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing be abandoned, the deferred offering costs would be expensed immediately as a charge to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating expenses in the consolidated statements of operations and comprehensive loss. No deferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering costs were capitalized as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.89pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.68pt; position: absolute; white-space: pre;">. As of December 31, 2024 and March 31, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited), deferred offering costs of $413,000 and $3.3 million, respectively, were capitalized within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other non-current assets in the consolidated balance sheets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Internal-Use Software<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalizes certain costs related to internal-use software during the application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development stage. Costs related to planning and post implementation activities are expensed as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred. Capitalized internal-use software is amortized on a straight-line basis over the estimated useful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">life, which is generally two years, after the product is deployed and ready for use. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-14<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or changes in circumstances occur that could impact the recoverability of these assets. Capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal-use software costs are classified as a component of property and equipment, net.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Leases<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">At the inception of a contractual arrangement, the Company determines whether the contract contains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease by assessing whether there is an identified asset and whether the contract conveys the right to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control the use of the identified asset in exchange for consideration over a period of time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">An <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.99pt; position: absolute; text-decoration: none; white-space: pre;">ROU<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.2pt; position: absolute; white-space: pre;"> asset and corresponding lease liability are recorded on the consolidated balance sheets based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the present value of lease payments over the lease term. An ROU asset represents the right to control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the use of an identified asset over the lease term and a lease liability represents the obligation to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease payments arising from the lease. Leases with an initial term of 12 months or less are not recorded <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the consolidated balance sheets. The Company uses its incremental borrowing rate to determine the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">present value of lease payments, as the discount rate implicit in the lease is not readily available. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease terms used to calculate the ROU asset and related lease liabilities include options to extend or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate the lease when it is reasonably certain that the Company will exercise that option. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company elected to account for contracts that contain lease and non-lease components as a single lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">component. For the years ended December 31, 2023 and 2024 and the three months ended March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 (unaudited), the Company&#8217;s only leases were for its facilities, which are classified as operating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leases with lease expense recognized on a straight-line basis over the lease term. Variable lease costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which primarily consist of common area maintenance, taxes, and utility charges are expensed as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred. The Company does not have any finance leases.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Term Loan is accounted for at amortized cost. Original debt issuance costs are deferred and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">presented as a reduction to the carrying value of the Term Loan. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.89pt; position: absolute; white-space: pre;">Debt discount and debt issuance costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are amortized using the effective interest method and recorded in interest expense within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated statements of operations and comprehensive loss. Refer to Note 8 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2022 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company issued convertible notes from September 2022 to December 2022 (the &#8220;2022 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes&#8221;) to certain investors (the &#8220;2022 Convertible Note Investors&#8221;), which were all converted to Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock in March 2023. Refer to Notes 9 and 10 for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information. The 2022 Convertible Notes contained embedded features that provided the 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Note Investors with multiple settlement alternatives. Rather than accounting for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embedded features that qualified as derivatives separately, the Company elected to account for the 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes at fair value each reporting period. Debt issuance costs were expensed as incurred. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Until their conversion in March 2023, the Company recognized the changes in fair value (including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest) as change in fair value of convertible note within the consolidated statements of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company issued convertible notes in January 2025 and March 2025 (the &#8220;2025 Convertible Notes&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to various investors and certain employees (the &#8220;Requisite Holders&#8221;), which are accounted for at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortized cost. D<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.75pt; position: absolute; text-decoration: none; white-space: pre;">ebt issuance costs are deferred and presented as a reduction to the carrying value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the 2025 Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 198.47pt; position: absolute; white-space: pre;">The Company determined that certain features of the 2025 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes contain embedded derivatives that provide the Requisite Holders with multiple settlement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alternatives and the embedded features that qualified as derivatives were accounted for separately. Debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount and debt issuance costs are amortized using the effective interest method and recorded to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest expense within the consolidated statements of operations and comprehensive loss. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recognized the changes in fair value of the derivative liability as change in fair value of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-15<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability within the consolidated statements of operations and comprehensive loss. Refer to Note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">9 and Note 13 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common Stock Warrants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s warrants to purchase common stock that were issued in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.13pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not meet the equity indexation criteria and are classified as a liability. The warrants are recorded at fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value upon issuance and are subject to remeasurement to fair value at each balance sheet date, with any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in fair value recognized as change in fair value of common stock warrant within the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss. Refer to Note 12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Embedded Derivatives<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to its refinancing in June 2024, the Term Loan contained certain prepayment features, default put <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option and default interest adjustment features that were determined to be embedded derivatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requiring bifurcation and separate accounting as a single compound derivative, as discussed in Note 13. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The impact of bifurcation of the embedded derivative on the date of issuance was reflected as a debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount. The fair value of the derivative liability related to the Company&#8217;s Term Loan, as discussed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Note 8, was estimated using a scenario-based analysis comparing the probability-weighted present value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the Term Loan payoff at maturity with and without the bifurcated features. This method isolates the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the embedded derivative by measuring the difference in the host contract&#8217;s value with and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the isolated features. The resulting cash flows are discounted at the Company&#8217;s borrowing rate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as adjusted for fluctuations in the market interest rate from the inception of the Company&#8217;s comparative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">borrowings to the reporting date, to measure the fair value of the embedded derivative. Until its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derecognition in June 2024, t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.34pt; position: absolute; text-decoration: none; white-space: pre;">he derivative liability was remeasured to fair value at each reporting period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and the related change was reflected as change in fair value of derivative liability on the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The 2025 Convertible Notes contain certain settlement features and default put options that were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">determined to be embedded derivatives requiring bifurcation and separate accounting as a single <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">compound derivative, as discussed in Note 13. The impact of bifurcation of the embedded derivatives on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the date of issuance during the three months ended March 31, 2025 (unaudited) was reflected as a debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">discount. The fair value of the derivative liability related to the Company&#8217;s 2025 Convertible Notes, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">discussed in Note 9, were estimated using a scenario-based analysis comparing the probability-weighted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">present value of the 2025 Convertible Notes with and without the bifurcated features. This method <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">isolates the value of the embedded derivatives by measuring the difference in the host contract&#8217;s value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">with and without the isolated features. To measure the fair value of the embedded derivatives, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">resulting cash flows were discounted using appropriate discount rates that reflect the overall implied risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of the instruments based on their purchase prices and adjusted for fluctuations in the market and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Company interest rates when necessary. The derivative liability was remeasured to fair value at March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 (unaudited) and the related change was reflected as change in fair value of derivative liability on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consolidated statements of operations and comprehensive loss for the three months ended March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable Convertible Preferred Stock<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company records redeemable convertible preferred stock at fair value on the dates of issuance, net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#8217; deficit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because the preferred shares are contingently redeemable upon the occurrence of an event that is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outside of the Company&#8217;s control. The Company has elected not to adjust the carrying values of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock to the liquidation preferences of such shares because it is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertain whether or when an event would occur that would obligate the Company to pay the liquidation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferences to holders of shares of redeemable convertible preferred stock. Subsequent adjustments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the carrying values to the liquidation preferences will be made only when it becomes probable that such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liquidation event will occur. The redemption value of each series of redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-16<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock is equal to their respective original issue price plus accrued but unpaid dividends on Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred shares and all declared but unpaid dividends (if any) for other series of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred shares. In connection with the Series F redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock financing, the cumulative dividends payable to holders of Series&#160;C redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share depending on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of issuance, with an aggregate total of $88.5 million as of December 31, 2023 and 2024 and March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025 (unaudited). Refer to Note 10 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Revenue <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.43pt; position: absolute; text-decoration: none; white-space: pre;">Recognition<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Compa<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.22pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ny sells its </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.07999999999998pt; position: absolute; white-space: pre;">HeartFlow Platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.59000000000003pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> to medical providers in the United States and in select </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">international markets. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.13pt; position: absolute; white-space: pre;">The Company determines revenue recognition through the following steps&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Identification of the contract, or contracts, with a customer&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Identification of the performance obligations in the contract&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Determination of the transaction price&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Allocation of the transaction price to the performance obligations in the contract&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Recognition of revenue when, or as, the Company satisfies a performance obligation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company identified a single performance obligation, which is comprised of a highly interdependent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bundle of goods or services that are not distinct on their own but are as a group and consists of providing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation services and the requested analysis, including an image file and related licenses and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support. Revenue recognition commences only after completion of installation, implementation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">training for new customer accounts. The Company&#8217;s service consists of providing a visualization of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s coronary arteries and enables physicians to create more effective treatment plans. This service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is normally billable upon delivery of the analysis to the physician. Payment terms are generally net 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Substantially all of the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.95999999999998pt; position: absolute; white-space: pre;">Company&#8217;s revenue is from usage-driven fees and generated on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> a &#8220;pay-per-click&#8221; </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">basis </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.11pt; position: absolute; white-space: pre;">each time a physician <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.99pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">orders the Company&#8217;s HeartFlow </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.67pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 365.09pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.75pt; position: absolute; white-space: pre;"> Analysis and Plaque Analysis. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company also derives revenue from <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.33pt; position: absolute; text-decoration: none; white-space: pre;">subscription fees from customers accessing the Company&#8217;s hosted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">software service during the subscription period. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.64pt; position: absolute; white-space: pre;">During the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.31pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.1pt; position: absolute; white-space: pre;"> and 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and three months ended March 31, 2024 and 2025 (unaudited), 98.1%, 98.8%, 97.6% and 98.9% of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue was from usage-driven fees, respectively, and the remainder was from subscription fees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue is recognized when control of these services is transferred to the customer, at an amount that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflects the consideration the Company expects to be entitled to receive in exchange for those services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company recognizes usage-driven fee revenue <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">upon delivery of the requested analysis to the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">physician, which is when </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.20999999999998pt; position: absolute; white-space: pre;">control of these services is transferred to the customer. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognizes revenue on a straight-line basis over the contract term for subscriptions where the customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pays a fixed amount upfront for unlimited analyses. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.28999999999996pt; position: absolute; text-decoration: none; white-space: pre;">Contracts with customers typically include a fixed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">amount of consideration and are generally cancellable with <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.78pt; position: absolute; text-decoration: none; white-space: pre;">30 days&#8217;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.64pt; position: absolute; text-decoration: none; white-space: pre;"> written notice<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.28pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The transaction price consists of fixed consideration and variable consideration related to utilization and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume rebates for reimbursement claims from government and commercial payers which are known and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determinable based on the number of analyses delivered within each quarterly period. The transaction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price (inclusive of both fixed consideration and variable consideration that is not constrained) is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized as revenue when control transfers. The Company uses a portfolio approach to estimate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">variable consideration using the expected value method. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Unbilled Receivables<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unbilled receivables generally represent revenue in which the Company has satisfied its performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligation prior to invoicing. The Company records unbilled receivables within accounts receivable, net on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the consolidated balance sheets, based on the Company&#8217;s unconditional right to payment at the end of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the applicable period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costs associated with product revenue include a flat rate commission per analysis and new customer site <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commissions as well as implementation and onboarding costs. The Company capitalizes new customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">site commissions and certain implementation and onboarding costs that are considered to be incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the acquisition of new customer contracts.&#160; Capitalized implementation and onboarding costs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortized over an estimated period of benefit of two years and capitalized new site commission costs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortized over an estimated period of benefit of three years. The estimated period of benefit is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined by evaluating average customer life, the nature of the related benefit, and the specific facts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and circumstances of its arrangements. The Company evaluates these assumptions at least annually and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">periodically reviews whether events or changes in circumstances have occurred that could impact the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period of benefit.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company expenses flat rate commissions when incurred as commensurate with its usage-driven fee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue recognition and amortizes capitalized new customer site commissions to selling, general and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative expense in the consolidated statements of operations and comprehensive loss. During the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year ended December 31, 2023, new site commission costs were not capitalized as the amount was not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material. The Company amortizes capitalized implementation and onboarding costs to cost of revenue in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the consolidated statements of operations and comprehensive loss. Short-term capitalized contract costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are included in prepaid expenses and other current assets and the long-term portion is included in <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.99pt; position: absolute; text-decoration: none; white-space: pre;">other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">non-current assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.78pt; position: absolute; white-space: pre;"> in the consolidated balance sheets.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Remaining Performance Obligations<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue allocated to remaining performance obligations represents the transaction price allocated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance obligations that are unsatisfied, or partially unsatisfied. It includes contract liabilities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amounts that will be invoiced and recognized as revenue in future periods and does not include contracts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">where the customer is not committed. The customer is not considered committed when they are able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate for convenience without payment of a substantive penalty under the contract. Additionally, as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practical expedient, the Company has not disclosed the value of unsatisfied performance obligations for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contracts with an original expected length of one year or less.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company records contract liabilities when billings or payments are received in advance of revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition from subscription services. The contract liabilities balance is reduced as the revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition criteria are met, generally within 12 months. Once services are available to customers, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company records amounts due in accounts receivable, net and contract liabilities within accrued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses and other current liabilities on the consolidated balance sheets. To the extent the Company bills <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers in advance of the billing period commencement date, the accounts receivable and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corresponding contract liabilities amount are netted to zero on the consolidated balance sheets, unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such amounts have been paid as of the balance sheet date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cost of Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue includes, but is not limited to, personnel and related expenses, stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation costs, third-party hosting fees, amortization of capitalized internal-use software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of contract fulfillment costs as well as royalties associated with technology licenses used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the delivery of the Company&#8217;s HeartFlow Platform and allocated overhead, including rent, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-18<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equipment, depreciation, technology services and utilities, related to the Company&#8217;s production team. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">role of the production team is to support the Company&#8217;s patient case volume revenue by performing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined quality-related activities on CCTA scans submitted by its customers for analysis. The production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">team also supports activities in the Company&#8217;s clinical trials and research and development, which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocated as research and development expense.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and Development<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costs related to research, design, development, clinical studies, regulatory activities, and medical affairs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are charged to research and development and are expensed as incurred. These costs include, but are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limited to, personnel and related expenses, clinical trials, stock-based compensation costs, third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consulting costs, the portion of the costs incurred by the production team to support clinical trials and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development efforts, and allocated overhead, including rent, equipment, depreciation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Clinical Trials <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accrues and expenses costs for its clinical trial activities performed by third parties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including clinical research organizations and other service providers, based upon estimates of the work <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completed over the life of the individual study in accordance with associated agreements. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determines these estimates through discussion with internal personnel and outside service providers as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to progress or stage of completion of trials or services pursuant to contracts with clinical research <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">organizations and other service providers and the agreed-upon fee to be paid for such services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Advertising Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company expenses advertising costs as incurred. Advertising costs includes design and production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, including website development, testimonial videos, written media campaigns and other items. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Advertising costs of $778,000, $1,538,000, $327,000 and $384,000 was expensed during the years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2023 and 2024, and three months ended March 31, 2024 and 2025 (unaudited), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-Based Compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accounts for share-based payments at fair value. The grant date fair value of options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted is measured using the Black-Scholes option pricing model. Option awards vest based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">satisfaction of a service requirement and stock-based compensation expense is recorded on a straight-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">line basis over the applicable service period, which is generally four years. For performance-based stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options, the Company will assess the probability of performance conditions being achieved in each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting period. The amount of stock-based compensation expense recognized in any one period related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to performance-based stock options can vary based on the achievement or anticipated achievement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the performance conditions. Forfeitures are recognized in the period in which the forfeiture occurs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Income Taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accounts for income taxes under the asset and liability method. Under this method, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferred tax assets and liabilities are determined based on the temporary differences between the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which the differences are expected to reverse. As a result of the history of net operating losses, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company has provided for a full valuation allowance against the deferred tax assets for assets that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not more-likely-than-not to be realized.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company applies a comprehensive model for the recognition, measurement, presentation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure in the consolidated financial statements of any uncertain tax positions that have been taken or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected to be taken on a tax return using a two-step approach. The first step is to evaluate the tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position taken or expected to be taken in a tax return by determining if the weight of available evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indicates that it is more likely than not that the tax position will be sustained upon examination by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant taxing authorities, based on the technical merits of the position. For tax positions that are more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely than not to be sustained upon audit, the second step is to measure the tax benefit in the financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements as the largest benefit that has a greater than 50% likelihood of being sustained upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement. Significant judgment is required to evaluate uncertain tax positions. Changes in facts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances could have a material impact on the Company&#8217;s effective tax rate and results of operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">component of provision for income taxes in the consolidated statements of operations and comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive Loss<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Comprehensive loss is comprised of net loss and foreign currency translation gains and losses. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Foreign Currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The functional currency of the Company&#8217;s f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.78pt; position: absolute; text-decoration: none; white-space: pre;">oreign subsidiaries is the local currency except for<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.87pt; position: absolute; white-space: pre;"> HeartFlow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">International Sarl, which was the U.S. Dollar. For all non-functional currency balances, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasurement of such balances to the functional currency results in either a foreign exchange <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction gain or loss, which is recorded within other income, net within the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and comprehensive loss. The Company recognized foreign exchange transaction losses of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$172<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;">,000, $269,000, $137,000 and $357,000 during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.84pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 467.63pt; position: absolute; white-space: pre;"> and 2024, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">three months ended March 31, 2024 and 2025 (unaudited), respectively. During the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024, and three months ended March 31, 2024 and 2025 (unaudited), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recognized $504,000, $271,000, $(1,000) and $236,000 of foreign currency translation (gain) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loss, respectively, in the statements of comprehensive loss related to foreign subsidiaries which have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">local functional currencies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net Loss Per Share Attributable to Common Stockholders<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Basic net loss per common share is calculated by dividing the net loss attributable to common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders by the weighted-average&#160;number of shares of common stock outstanding during the period, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the net loss attributable to common stockholders by the weighted-average number of shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share calculation, the redeemable convertible preferred stock, common stock warrants and stock options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are considered to be potentially dilutive securities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Basic and diluted net loss attributable to common stockholders per share is presented in conformity with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the two-class&#160;method required for participating securities as the redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and common stock subject to repurchase are considered participating securities. The Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participating securities do not have a contractual obligation to share in the Company&#8217;s losses. As such, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the net loss is attributed entirely to common stockholders. Diluted net loss per share is the same as basic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net loss per share because the effects of potentially dilutive items were anti-dilutive given the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net loss position during the years ended December 31, 2023 and 2024 and three months ended March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2024 and 2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recent Accounting Pronouncements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board (&#8220;FASB&#8221;) or other standard setting bodies and adopted by the Company as of the specified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complying with new or revised accounting standards, which means that when a standard is issued or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revised and it has different application dates for public and nonpublic companies, the Company will adopt <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-20<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the new or revised standard at the time nonpublic companies adopt the new or revised standard and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do so until such time that the Company either i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period or ii)&#160;no longer qualifies as an emerging growth company. The Company may choose to early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adopt any new or revised accounting standards whenever such early adoption is permitted for nonpublic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recently Adopted Accounting Pronouncements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In August 2020, the FASB issued Account Standards Update (&#8220;ASU&#8221;) 2020-06, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 421.36pt; position: absolute; white-space: pre;">Debt-Debt with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Equity (Subtopic 815-40)&#58; Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Equity<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.77pt; position: absolute; white-space: pre;">. The amendment simplifies the accounting for certain financial instruments with characteristics of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. The new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard requires entities to provide expanded disclosures about the terms and features of convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instruments, how the instruments have been reported in the entity&#8217;s financial statements, and information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about events, conditions, and circumstances that can affect how to assess the amount or timing of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity&#8217;s future cash flows related to those instruments. On January 1, 2024, the Company adopted ASU <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020-06, which had an immaterial impact on its financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In November 2023, the FASB issued ASU 2023-07, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Segment Reporting (Topic 280)&#58; Improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Reportable Segment Disclosures<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.11pt; position: absolute; white-space: pre;">. The amendment expands segment disclosures by requiring disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of significant segment expenses that are regularly provided to the chief operating decision maker <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;CODM&#8221;), the amount and description of other segment items, permits companies to disclose more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one measure of segment profit or loss, and requires all annual segment disclosures to be included in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interim periods. The amendments do not change how an entity identifies its operating segments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregates those operating segments, or applies quantitative thresholds to determine its reportable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">segments. During the year ended December 31, 2024, the Company adopted ASU 2023-07, which had a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure only impact on its financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recent Accounting Pronouncements Not Yet Adopted<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In December 2023, the FASB issued ASU 2023-09, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Income Taxes (Topic 740)&#58; Improvements to Income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Tax Disclosures<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.1pt; position: absolute; white-space: pre;">, which requires enhanced income tax disclosures, including specific categories and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disaggregation of information in the effective tax rate reconciliation, disaggregated information related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income taxes paid, income or loss from continuing operations before income tax expense or benefit, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax expense or benefit from continuing operations. This guidance is effective for annual periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beginning after December 15, 2024. The adoption of ASU 2023-09 is expected to have a disclosure only <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact on the Company&#8217;s financial statements for the year ended December 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In November 2024, the FASB issued ASU 2024-03, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Income Statement &#8211; Reporting Comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40)&#58; Disaggregation of Income Statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.9pt; position: absolute; white-space: pre;">, which requires more detailed disclosures about specified categories of expenses (including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee compensation, depreciation, and amortization) included in certain expense captions presented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the face of the income statement. This ASU is effective for fiscal years beginning after December 15, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2026, and for interim periods within fiscal years beginning after December 15, 2027, with early adoption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">permitted. The amendments may be applied either (i) prospectively to financial statements issued for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting periods after the effective date of this ASU or (ii) retrospectively to all prior periods presented in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the financial statements. The Company is currently evaluating the impact of this pronouncement on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures in its consolidated financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-21<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_388" style="position: absolute; top: 90pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">3. Revenue and Contract Balances<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Disaggregation of Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes total revenue from customers by geographic region (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 152.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 225pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 58.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 58.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 58.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 58.5pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 225pt; position: absolute; top: 0pt; width: 120pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 120pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.26pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 120pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.76pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 348pt; position: absolute; top: 0pt; width: 120pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 120pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.55pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 120pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 39.26pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 24pt; width: 58.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.25pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 24pt; width: 58.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.25pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 24pt; width: 58.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.25pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 24pt; width: 58.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.25pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 348pt; position: absolute; top: 36.75pt; width: 120pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 120pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.54pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 225pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.66pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 49.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">77,725<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 49.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 10.1pt;"></font></font><font style="left: 18.29pt; position: absolute;">115,036<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 49.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">24,394<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 49.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">34,298<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 225pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 74.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.77pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 63.75pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">4,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 63.75pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">5,185<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 63.75pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">1,210<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 63.75pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">1,452<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 225pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.869999999999997pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 78pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">4,003<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 78pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">4,297<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 78pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 35.11pt;"></font></font><font style="left: 37.74pt; position: absolute;">979<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 78pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">1,194<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 225pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Rest of Europe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 69.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 69.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 69.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 69.83pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 92.25pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 35.11pt;"></font></font><font style="left: 37.74pt; position: absolute;">954<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 92.25pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.78pt;"></font></font><font style="left: 29.41pt; position: absolute;">1,290<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 92.25pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 35.11pt;"></font></font><font style="left: 37.74pt; position: absolute;">260<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 92.25pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 35.11pt;"></font></font><font style="left: 37.74pt; position: absolute;">261<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 225pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 64.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 64.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225pt; position: absolute; top: 106.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 286.5pt; position: absolute; top: 106.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 10.1pt;"></font></font><font style="left: 18.29pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 348pt; position: absolute; top: 106.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">26,843<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 409.5pt; position: absolute; top: 106.5pt; width: 58.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 58.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.66pt;"></font></font><font style="left: 23.849999999999998pt; position: absolute;">37,205<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 289.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenues by geography are determined based on the region of the Company's contracting entity, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be different than the region of the customer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 321.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Balances<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unbilled receivables included within accounts receivable on the consolidated balance sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 353.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited) was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.58pt; position: absolute; text-decoration: none; white-space: pre;">$342<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.82pt; position: absolute; white-space: pre;">,000, $574,000 and $861,000, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides the breakdown of capitalized contract costs on the consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sheets (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 417.15pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.16pt; position: absolute; text-decoration: none; white-space: pre;">Three Months <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.89pt; position: absolute; text-decoration: none; white-space: pre;">Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 60.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.53pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,077<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,941<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,154<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs capitalized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 116.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 117.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 118.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 118.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,081<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,952<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,064<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 89.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs amortized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 113.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 113.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 113.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 113.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,217)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(3,739)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,307)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 103.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.11pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,941<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,154<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,911<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 550.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides the breakdown of contract liabilities included within accrued expenses and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other current liabilities on the consolidated balance sheets (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 582.9pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.16pt; position: absolute; text-decoration: none; white-space: pre;">Three Months <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.89pt; position: absolute; text-decoration: none; white-space: pre;">Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 60.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.53pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">118<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">498<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 60.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">182<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract liabilities added<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 111.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 112.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 113.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 113.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 113.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 113.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">470<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 89.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract liabilities recognized as revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 184.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 185.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 185.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 185.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 185.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 185.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 186.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(90)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(316)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(27)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 103.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.11pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">498<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">182<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 103.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">155<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-22<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_373" style="position: absolute; top: 90pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">4. Fair Value Measurement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes the Company&#8217;s financial assets and liabilities measured at fair value on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recurring basis by level within the fair value hierarchy (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 144.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 94.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 1<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 2<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 3<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Money market funds included in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.81pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 80.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.690000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.18pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.33pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,343<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,343<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 297.65pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 94.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 1<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 2<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 3<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Money market funds included in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.81pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 80.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.690000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.18pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 436.65pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 77.3pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 (unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 1<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 2<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 3<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Money market funds included in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.81pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 80.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.690000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.18pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">22,441<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">22,441<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.33pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,945<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,945<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">63,386<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">63,386<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-23<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; white-space: pre;"> following tables present a reconciliation of the Company&#8217;s financial liabilities measured at fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.43pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.22pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited) using significant unobservable inputs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(Level 3), and the change in fair value (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 134pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2022 <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.9pt; position: absolute; text-decoration: none; white-space: pre;">Convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.14pt; position: absolute; text-decoration: none; white-space: pre;">Notes<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 147.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 147.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 147.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.43pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">56,066<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.53pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition of convertible notes upon conversion into redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 25.959999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 27.119999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 27.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 27.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.47pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,186)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 90pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 90pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 254.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2022 Convertible Notes, which are not regularly traded, are classified as Level 3, since their values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot be determined by using readily observable inputs or measures, such as market prices (see Note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">9). The fair value of the 2022 Convertible Notes was estimated as the sum of its components (conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features and the debt component) as of the issuance dates and as of the subsequent balance sheet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dates. To value each of the conversion features, a &#8220;with and without&#8221; methodology was employed. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt component was valued using a discounted cash flow method that measured the net present value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the principal and interest payments to be received by the holders of the 2022 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(excluding the conversion features) through the estimated maturity date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 358.25pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.14pt; position: absolute; text-decoration: none; white-space: pre;">Common <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.38pt; position: absolute; text-decoration: none; white-space: pre;">Stock <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Warrant <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Liability<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 147.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 147.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 147.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.43pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.53pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,320<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.53pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">16,395<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 116.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 144.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 145.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 145.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">......................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,606<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 130.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of March 31, 2025 (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 196.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 197.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 197.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">22,441<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 519pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In determining the fair value of the common stock warrant liability, the Company used the Black-Scholes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option pricing model to estimate the fair value using unobservable inputs including the expected term, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected volatility, risk-free interest rate and dividend yield (see Note 12).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 563pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.64pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.13pt; position: absolute; text-decoration: none; white-space: pre;">Derivative <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Liability<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 147.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 147.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 147.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.43pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,061<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.53pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,158)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.53pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">222<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition in connection with debt refinancing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 220.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 221.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 222.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 222.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 222.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 222.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.43pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 92.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,125)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-24<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In determining the fair value of the term loan derivative liability, a two-step valuation approach was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">employed, which included a probability-weighted scenario valuation method, the Black-Scholes-Merton <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">method, and the option pricing method, using unobservable inputs (see Note 13), which are classified as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Level 3 within the fair value hierarchy, and then comparing the instrument&#8217;s value with and without the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">derivative features to estimate their combined fair value. The debt instrument is carried at amortized cost, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">which approximates its fair value.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 170pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 360pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 108pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 0pt; width: 108pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 108pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 108pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.27pt; position: absolute; text-decoration: none; white-space: pre;">Derivative Liability<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 108pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.54pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 360pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 147.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 147.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.19pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 35.25pt; width: 108pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 108pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 85.73pt;"></font></font><font style="left: 93.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 360pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Recognition in connection with convertible notes offering (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 305.21999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 306.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 306.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 307.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 307.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 307.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.18pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 49.5pt; width: 108pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 108pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 70.72pt;"></font></font><font style="left: 73.35pt; position: absolute;">31,900<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 360pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 144.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.87pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 63.75pt; width: 108pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 108pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 76.28pt;"></font></font><font style="left: 78.91pt; position: absolute;">9,045<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 360pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of March 31, 2025 (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 196.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 197.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 197.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 197.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 197.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 78pt; width: 108pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 108pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 65.16pt;"></font></font><font style="left: 73.35pt; position: absolute;">40,945<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 278.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In determining the fair value of the convertible notes derivative liability, a two-step valuation approach was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employed, which included a probability-weighted scenario valuation method, the Monte Carlo Simulation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">method, and the option pricing method, using unobservable inputs (see Note 13), which are classified as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 3 within the fair value hierarchy, and then comparing the instrument&#8217;s value with and without the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative features to estimate their combined fair value. The debt instrument is carried at amortized cost, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which approximates its fair value.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_358" style="position: absolute; top: 358.25pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 358.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">5. Balance Sheet Components<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Allowance for Credit Losses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table presents a reconciliation of the allowance for credit losses (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 420.65pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 225.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 105pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 225.75pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 0pt; width: 105pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 105pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.05pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 105pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 31.76pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 294pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 24pt; width: 105pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 105pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.5pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 36.75pt; width: 105pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 105pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.04pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 137.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">212<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 294pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,058<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 49.5pt; width: 105pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 105pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 76.05pt;"></font></font><font style="left: 84.24pt; position: absolute;">814<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Additions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 44.900000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 45.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 45.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 45.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.46pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 294pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 63.75pt; width: 105pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 105pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 88.29pt;"></font></font><font style="left: 90.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Write-offs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 45.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 45.300000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 45.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 45.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 45.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(344)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 294pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(244)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 78pt; width: 105pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 105pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 83.84pt;"></font></font><font style="left: 86.47pt; position: absolute;">(72)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 112.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 92.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,058<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 294pt; position: absolute; top: 92.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">814<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 363pt; position: absolute; top: 92.25pt; width: 105pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 105pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 76.05pt;"></font></font><font style="left: 84.24pt; position: absolute;">742<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-25<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid Expenses and Other Current Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prepaid expenses and other current assets are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 130pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.53pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,583<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,017<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,633<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs, current<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 103.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 103.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 103.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 103.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 103.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,953<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,453<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,453<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 28.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 28.529999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">598<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">662<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">455<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total prepaid expenses and other current assets <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 218.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 219.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 220.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 220.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 220.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 220.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.91pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,134<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,132<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,541<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Property and equipment consisted of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 282pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment at cost&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computer equipment and software<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 155.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,842<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,489<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,489<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Furniture, fixtures and equipment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 149.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 150.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.96pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,095<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,233<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,233<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capitalized internal-use software<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 147.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 148.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 148.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.53pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,535<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">52,606<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">53,542<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Leasehold improvements<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 114.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 115.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 115.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 115.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.96pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,057<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,057<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,079<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Construction in progress<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.11pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">57<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">27<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">176<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Total property and equipment <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 146.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 148.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 148.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 148.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.46pt; position: absolute; text-decoration: none; white-space: pre;">..............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,586<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,412<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">61,519<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; Accumulated depreciation and amortization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 220.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 220.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 221.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 221.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.06pt; position: absolute; text-decoration: none; white-space: pre;">.................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(50,665)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(51,492)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(52,864)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 152.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 131.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 132.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 133.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 133.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.43pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,921<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,920<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,655<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 464.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalized certain internal-use software costs totaling <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.95pt; position: absolute; text-decoration: none; white-space: pre;">$4.6<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.4pt; position: absolute; white-space: pre;"> million, $4.1 million, $796,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and $936,000, including stock-based compensation of $408,000, $393,000, $77,000 and $6,000 related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to internal-use software development efforts, during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.78pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.57pt; position: absolute; white-space: pre;"> and 2024, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">three months ended March 31, 2024 and 2025 (unaudited), respectively. Amortization of capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 512.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal-use software totaled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.31pt; position: absolute; text-decoration: none; white-space: pre;">$3.2<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.76pt; position: absolute; white-space: pre;"> million, $3.7 million, $733,000 and $1.0 million for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 524.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024, and three months ended March 31, 2024 and 2025 (unaudited), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Depreciation and amortization expense related to property and equipment, excluding capitalized internal-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 568.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use software, was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.75pt; position: absolute; text-decoration: none; white-space: pre;">$1.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.2pt; position: absolute; white-space: pre;"> million, $1.7 million, $471,000 and $370,000 for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.18pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 580.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;"> and 2024, and three months ended March 31, 2024 and 2025 (unaudited), respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Non-Current Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other non-current assets are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 640.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 85.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.11pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">988<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,701<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,458<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred offering costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 103.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">413<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,323<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-26<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 28.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 28.529999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">267<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">252<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">249<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 14.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total other non-current assets <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 138.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.53pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,255<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,366<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,030<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 134.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Accrued Expenses and Other Current Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accrued expenses and other current liabilities are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 174.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued payroll and related expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 169.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 170.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 170.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 170.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 170.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 171.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,228<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,206<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,758<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Customer contract and rebate liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 175.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 175.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 176.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.06pt; position: absolute; text-decoration: none; white-space: pre;">...................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,109<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,421<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued royalty<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 72.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,604<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">736<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,149<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued professional fees<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 117.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 118.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 118.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 118.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.53pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,672<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,597<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued clinical trial expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 136.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 138.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.43pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,148<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,215<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 28.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 28.529999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,513<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,695<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total accrued expenses and other current liabilities <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 229.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231pt; position: absolute; text-decoration: none; white-space: pre;">.............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">24,790<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">25,319<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,983<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_343" style="position: absolute; top: 328.5pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 328.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">6. Leases<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company leases office space in Mountain View, California, Santa Rosa, California, Austin, Texas, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Tokyo, Japan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Mountain View, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In August 2021, the Company entered into a facility lease agreement with MV Campus Owner, LLC. (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Landlord&#8221;), for approximately 61,000 rentable square feet in Mountain View, California through August <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 426.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2030. T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.7pt; position: absolute; text-decoration: none; white-space: pre;">he Company received a tenant improvement allowance <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: absolute; text-decoration: none; white-space: pre;">of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.7pt; position: absolute; text-decoration: none; white-space: pre;"> $1.8 million, in which the remaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 438.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">unused amount of $1.4 million was credited against rent expense <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.54pt; position: absolute; white-space: pre;">during the year ended December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023. In connection with the lease, the Company established a standby letter of credit for the benefit of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 462.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the landlord in the amount of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.42pt; position: absolute; text-decoration: none; white-space: pre;">$4.3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.87pt; position: absolute; white-space: pre;"> million in August 2021, which is classified as non-current restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 474.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash on the consolidated balance sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.78pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.57pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Santa Rosa, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In October 2024, the Company entered into an agreement to sublease approximately 4,000 rentable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">square feet of office space in Santa Rosa, California for 29 months commencing on November 1, 2024. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with this sublease, the Company paid a security deposit of $8,000 and recorded an ROU <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">asset and lease liability of $169,000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Austin, Texas<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 602.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In January 2023, the Company amended its facility lease agreement in Austin, Texas, which provides for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 614.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 26,000 square feet of space, to extend the lease term which expired in November 2023 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 626.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">with a five-year renewal option to December 2025 with no renewal option<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.19pt; position: absolute; white-space: pre;">. In connection with the lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amendment, the Company recorded a reduction of $1.8 million in ROU asset and lease liability from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasurement that previously included the renewal option during the year ended December 31, 2023. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 2025, the Company amended the lease for its Austin, Texas facility to extend the lease term an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional 12 months through December 2026 and recorded an ROU asset and lease liability of $561,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 686.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the lease extension. A security deposit of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.51pt; position: absolute; text-decoration: none; white-space: pre;">$150<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.75pt; position: absolute; white-space: pre;">,000 was recorded as non-current <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-27<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted cash as of December 31, 2023 and March 31, 2025 (unaudited) and as current restricted cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.76pt; position: absolute; text-decoration: none; white-space: pre;">on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.88pt; position: absolute; white-space: pre;"> the consolidated balance sheets related to this lease.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Tokyo, Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has one non-cancellable operating lease for its facility in Tokyo, Japan which was set to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expire in November 2024. In April 2024, the Company entered into an agreement to extend the lease for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional three years through November 2027. In connection with the new lease agreement, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recorded an ROU asset and lease liability of $420,000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Operating lease cost consisted of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 218pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 201pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 201pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 337.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 337.5pt; position: absolute; top: 25.5pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 95.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 95.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 95.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.74pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,906<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,900<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,222<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,251<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Variable lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 86.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 87.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 88.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 88.19pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,597<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">378<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">363<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 72.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 72.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 73.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.21pt; position: absolute; text-decoration: none; white-space: pre;">..................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,026<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,497<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,600<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,614<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 315pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cash paid for amounts included in the measurement of operating lease liabilities during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 327pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024, and the three months ended March 31, 2024 and 2025 (unaudited) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$4.1 million, $5.2 million, $1.3 million and $1.4 million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes the maturities of the aggregate lease payments under the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating lease liabilities as of December 31, 2024 and March 31, 2025 (unaudited) (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 391pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 466.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 333pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.38pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 333pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating Leases&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.33pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,647<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,243<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2026<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.33pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,109<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,797<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2027<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.33pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,177<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,185<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2028<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.33pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,155<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,155<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2029<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 25.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.33pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,309<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,309<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Thereafter<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,645<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,645<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total minimum lease payments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 139.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 140.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 140.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">30,042<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,334<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; Amount of lease payments representing interest<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 252.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 254.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 254.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 254.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 255.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 255.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.15pt; position: absolute; text-decoration: none; white-space: pre;">..............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,089<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,708<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 152.25pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Present value of future minimum lease payments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 219.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 219.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 220.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 220.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 220.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 220.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.28pt; position: absolute; text-decoration: none; white-space: pre;">............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">23,953<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">23,626<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 166.5pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; current portion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 105.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 106.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 107.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 107.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 107.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 166.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,416<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 166.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,453<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180.75pt; width: 333pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 333pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, net of current portion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 211.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 212.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 212.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.75pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 333pt; position: absolute; top: 180.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,537<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 401.25pt; position: absolute; top: 180.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,173<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-28<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes additional information related to the Company&#8217;s operating leases (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands, except weighted-average data)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Right-of-use assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 88.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 89.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 90.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 90.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 90.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.91pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">20,961<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">18,805<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,642<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average remaining lease term (years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 214.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 215.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 215.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 215.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.94pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">6.5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">5.5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">5.2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average discount rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 144.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 145.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 145.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.94pt; position: absolute; text-decoration: none; white-space: pre;">...............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">9.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">9.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.07pt; position: absolute; text-decoration: none; white-space: pre;">9.2 %<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_328" style="position: absolute; top: 219pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 219pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">7. Commitments and Contingencies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 241.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Royalty Commitments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 261.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has entered into various exclusive technology licensing agreements and other software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 273.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensing agreements. The terms of the agreements require the Company to make annual royalty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 285.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments in fixed amounts as well as certain milestone and revenue-based payments. The revenue-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 297.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based royalty percentage is in the low single digits, subject to reductions and offsets in certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 309.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances with a minimum royalty commitment of $50,000&#160;annually. Future minimum royalty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 321.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commitments due under the terms of these exclusive agreements as of December 31, 2024 and March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 333.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025 (unaudited) are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 353.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.38pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Minimum Royalty Commitments&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2026<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2027<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2028<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2029<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Thereafter<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 48.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.31pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total minimum royalty commitments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 161.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 161.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.84pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">300<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">250<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 507.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company incurred royalty expense of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.32pt; position: absolute; text-decoration: none; white-space: pre;">$2.1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.77pt; position: absolute; white-space: pre;"> million, $1.5 million, $336,000 and $414,000 for the years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.57pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.36pt; position: absolute; white-space: pre;"> and 2024, and three months ended March 31, 2024 and 2025 (unaudited), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purchase Commitments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Open purchase commitments consist of agreements to purchase of goods and services entered into in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the ordinary course of business. These amounts were not recorded as liabilities on the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">balance sheets as of December 31, 2024 as the Company had not yet received the related goods or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services. As of December 31, 2024 and March 31, 2025 (unaudited), the Company had estimated open <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase commitments for goods and services of $5.2 million and $4.3 million over the next four and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">three years, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contingencies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company is not involved in any pending legal proceedings that it believes could have a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on its financial condition, results of operations or cash flows. The Company may pursue or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be subject to litigation and other legal actions from time to time arising in the ordinary course of business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including intellectual property, products liability, breach of contract, commercial, employment, and other <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-29<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar claims which could have an adverse impact on its reputation, business and financial condition and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">divert the attention of its management from the operation of its business. The Company accrues a liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for such matters when it is probable that future expenditures will be made, and such expenditures can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasonably estimated. There were no contingent liabilities requiring accrual or disclosures as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024 and March 31, 2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Indemnifications<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company provides general indemnifications to management and the members of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors (the &#8220;Board of Directors&#8221;) when they act, in good faith, in the best interest of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company. The Company is unable to develop an estimate of the maximum potential amount of future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments that could potentially result from any hypothetical future claim, but expects the risk of having to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">make any payments under these general business indemnifications to be remote. The Company also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintains insurance coverage that would generally enable the Company to recover a portion of any future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amounts paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_313" style="position: absolute; top: 270pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">8. <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 85.33pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Initial Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 19, 2021, the Company entered into a Credit Agreement with Hayfin Services, LLP (&#8220;Hayfin&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for total borrowings of up to $70.0 million (the &#8220;Initial Term Loan&#8221;). The Company received net cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of $68.1 million, after deducting $1.3 million of lender fees as a discount to the debt, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$629,000 of debt issuance costs. The Company also issued a warrant to the lender to purchase a total of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">108,154 shares of its common stock. The fair value of the warrant was $4.3 million as of the issuance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date, which was accounted for as a debt discount. Refer to Note 12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">New Money Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 17, 2022, the Company entered into Amendment No. 1 to the Credit Agreement with Hayfin for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional $50.0 million term loan (the &#8220;New Money Term Loan&#8221;), collectively with the Initial Term Loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Term Loan&#8221;). Additionally, certain terms of the Initial Term Loan were amended. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received net cash proceeds of $49.2 million, after deducting $820,000 of lender fees as a discount to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt. The Company also issued an additional warrant to the lender to purchase a total of 77,253 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. The fair value of the warrant was $3.5 million&#160;as of the issuance date, which was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounted for as a debt discount. Refer to Note&#160;12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Amendments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company entered into Amendments No. 2 and No. 3 to the Credit Agreement in September 2022 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 2022, respectively, which enabled the Company to issue Subordinated Convertible Promissory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes and to increase the aggregate principal of the Subordinated Convertible Promissory Notes that can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be issued to $42.0 million (see Note 9). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the first quarter of 2023, the Company entered into three amendments to the Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin. In March 2023, the Company entered into Amendment No. 4 and Waiver to Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin to temporarily waive various covenant requirements that had not been met through the waiver date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and to enable the Company to amend certain terms of the Credit Agreement. Under Amendment No. 4, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part of the Series F redeemable convertible preferred stock financing closing (see Note 10), the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued to Hayfin 1,462,260 warrants for shares of common stock for no consideration and committed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell 921,018 and 1,201,423 shares of Series F-1 and Series F redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively. These shares were issued to Hayfin Heartflow UK Limited upon Convertible Note conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and upon the initial closing of Series F redeemable convertible preferred stock with the same terms as all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other investors. In March 2023, the Company entered into Amendment No. 5 to the Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin, which required the Company&#8217;s securities at JPMorgan Chase Bank to become a &#8220;Controlled <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-30<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Account&#8221;, as defined by the Credit Agreement. Also in March 2023, the Company entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendment No. 6 to the Credit Agreement with Hayfin, which permitted the reacquisition of 102,739 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock from an employee&#47;founder of the Company. In connection with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amendments, the Company paid $94,000 in lender fees, which were recorded as a debt discount. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendments No. 4 through No. 6 were accounted for as debt modifications for accounting purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, the Company entered into a Credit Agreement and Guaranty (the &#8220;2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement&#8221;) with Hayfin for a $138.1 million term loan (the &#8220;2024 Term Loan&#8221;) to refinance its outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loan obligations under the 2021 Credit Agreement, as amended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.34pt; position: absolute; text-decoration: none; white-space: pre;">(the &#8220;2021 Credit Agreement&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.1pt; position: absolute; white-space: pre;">. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, in connection with the 2024 Term Loan, the Company entered into several other adjoining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with Hayfin. The 2024 Term Loan extended the maturity date from January 19, 2026 to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">June&#160;14, 2028. The 2024 Credit Agreement was accounted for as a debt modification for accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 24, 2025, in connection with the issuance of the 2025 Convertible Notes, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into Amendment No.1 to the 2024 Credit Agreement, in which Hayfin converted $23.0 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal under the 2024 Term Loan to 2025 Convertible Notes under the same terms as the other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasers of the 2025 Convertible Notes. The principal balance outstanding under the 2024 Term Loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as amended, is $115.1 million as of March 31, 2025 (unaudited). The amendment was accounted for as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt modification for accounting purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prepayment Terms and Other Fees<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any prepayment or repayment of the principal balance are subject to an exit fee. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.98pt; position: absolute; text-decoration: none; white-space: pre;">The Company is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">accreting the exit fee over the loan term using the effective interest method. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.83pt; position: absolute; white-space: pre;">Under the 2024 Term Loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company has the option to prepay the 2024 Term Loan subject to a prepayment fee of 1.5% for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepayments after the second anniversary but on or prior to the third anniversary of the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and a prepayment fee of 3% for prepayments thereafter. The Company must repay the loan in full <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately upon the occurrence of a change in control. In addition, immediately upon the consummation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of an IPO or SPAC, as defined in the terms of the 2024 Credit Agreement, the Company shall repay the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan in an amount equal to the lesser of (i) the net cash proceeds of such IPO or SPAC in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">excess of $150.0 million and (ii) $35.0 million. In connection with Amendment No.1 to the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in January 2025, the amount immediately payable upon the consummation of an IPO or SPAC, as defined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the terms of the 2024 Credit Agreement, was amended where repayment of the 2024 Term Loan will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at an amount equal to the lesser of (i) the net cash proceeds of such IPO or SPAC in excess of $150.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and (ii) $50.0 million (or $55.0 million if the underwriters exercise any portion of their option to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase additional shares).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, concurrently with entering the 2024 Credit Agreement, the Company signed a fee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">letter agreement with Hayfin under which the Company agreed to pay $9.2 million in fees to Hayfin, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of a 3% exit fee and 3% early prepayment fee due under the 2021 Credit Agreement in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount of $8.3 million payable in sixteen equal quarterly installments of approximately $518,000 through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2028, agent fees of $150,000, due in annual installments of $30,000 through March 31, 2028 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and an upfront fee of $721,000. The Company paid the $721,000 upfront fee and $30,000 agent fee upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the closing of the 2024 Term Loan. The exit fee and early prepayment fee must be repaid in full <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately upon the occurrence of a financing event, including, but not limited to, any IPO, SPAC, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance of convertible notes or equity. The exit fee and early prepayment fee remaining under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">original terms of the 2024 Term Loan, which were immediately due and payable upon issuance of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes was amended in January 2025 to be immediately due and payable upon the next <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">occurrence of a financing event <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.66pt; position: absolute; text-decoration: none; white-space: pre;">as described above.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Initial Term Loan had an interest rate equal to the sum of the applicable margin of 6.0% plus the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">higher of SOFR and 1.0%, and the New Money Term Loan had an interest rate equal to the sum of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable margin of 15.25% plus the higher of the adjusted term for such interest period and 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest payments are due quarterly. The Company may elect to pay the quarterly interest in-kind (&#8220;PIK&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">through the last interest period ending before the second anniversary of the original Credit Agreement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">However, if the Company elects to pay interest in-kind after the first anniversary, the applicable margin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increases by 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">With respect to the New Money Term Loan, the Company may elect to pay PIK Interest, provided that, (i) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">prior to December 31, 2023, a minimum of 3% per annum shall be payable in cash and (ii) on or after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023, a minimum of 6% per annum shall be payable in cash. During the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$144<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.57pt; position: absolute; text-decoration: none; white-space: pre;">,000 of interest was paid-in-kind and was added to the outstanding principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">balance of the Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan bears interest at a floating per annum rate in an amount equal to the sum of (i) 7.0% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or 6.0% if the alternative base rate (&#8220;ABR&#8221;) is in effect) plus (ii) the greater of (x) the forward-looking term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate based on SOFR for a respective tenor (or the alternative base rate, if applicable), and (y) 2.0%. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ABR equals to the sum of (i) 6.0% plus (ii) the greater of (1) the Wall Street Journal Prime Rate, plus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">0.5%, (2) the Federal Reserve Bank of New York rate plus 0.5% or (3) CBA Term SOFR for one month <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tenor plus 1.0%. The Company has the option to pay interest in-kind at the rate equal to the cash interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate plus 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Debt Issuance Costs and Debt Discount<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt issuance costs include third-party costs incurred in connection with the original Credit Agreement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt discount includes fees paid to the lender, warrants issued to the lender and the embedded derivative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability as described below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the refinancing of the 2021 Credit Agreement with the 2024 Term Loan (the &#8220;2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Refinancing&#8221;), certain prepayment features of the Term Loan, default put option and default interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjustment features were determined to be embedded derivatives requiring bifurcation and separate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounting for at fair value as a single compound derivative. The fair value of the derivative liability was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.1 million, as of the issuance date in January 2021, and is remeasured to fair value at each reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period. In connection with the 2024 Term Loan Refinancing, the associated current fair value of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability of $1.1 million was remeasured at the date of refinancing and was derecognized and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded as a debt discount to the 2024 Term Loan. Refer to Note 13 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In connection with the conversion of $23.0 million of principal under the 2024 Term Loan to 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes under Amendment No.1 to the 2024 Credit Agreement in January 2025, $239,000 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">pro-rata debt discount under the 2024 Term Loan was reclassified as a debt discount under the 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The debt issuance costs and debt discount are classified as an offset to the Term Loan on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated balance sheets, and is accreted over the loan term using the effective interest method.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; text-decoration: none; white-space: pre;">, the effective interest rate of the Initial Term Loan and the New Money Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Loan was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.56pt; position: absolute; text-decoration: none; white-space: pre;">16.1%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.9pt; position: absolute; text-decoration: none; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.12pt; position: absolute; text-decoration: none; white-space: pre;">26.8%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.45999999999998pt; position: absolute; text-decoration: none; white-space: pre;">, respectively. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.03pt; position: absolute; white-space: pre;">As of December 31, 2024 and March 31, 2025 (unaudited), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective interest rate of the 2024 Term Loan was 16.0% and 15.2%, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Collateral and Covenants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan is collateralized by substantially all of the Company&#8217;s assets. The 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement contains certain customary representations and warranties, covenants, events of default, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">termination provisions and affirmative and negative covenants, including, among others, covenants that <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-32<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limit or restrict the Company&#8217;s (and its subsidiaries) ability to incur additional indebtedness, grant liens, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">merge or consolidate, make acquisitions, pay dividends or other distributions or repurchase equity, make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments, dispose of assets and enter into certain transactions with affiliates, in each case subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain exceptions. Events of default include, among others, non-payment of principal, interest or fees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">violation of covenants, inaccuracy of representations and warranties, bankruptcy and insolvency events, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material judgments, cross-defaults to material contracts and events constituting a change of control. Upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the occurrence of an event of default, the interest rate applicable to the 2024 Term Loan shall increase by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3.0% per annum and the outstanding principal balance, along with any accrued interest, shall become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable. The Company is subject to financial covenants which requires the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company to maintain a $25.0 million minimum liquidity balance in cash and cash equivalents at all times <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and minimum net sales for twelve consecutive month periods ending on the last day of a fiscal quarter, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which is not tested as long as the Company maintains minimum liquidity of at least $60.0 million and there <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has been no decline in net sales for two-consecutive fiscal quarters at the end of such fiscal quarter. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">minimum twelve months trailing net sales covenant increases each quarter and is $70.0 million for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarter ended March 31, 2024 up to a minimum net sales amount of $110.0 million for the quarter ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">June 30, 2025 and each quarter thereafter. In connection with Amendment No.1 to the 2024 Term Loan in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 2025, the minimum liquidity cash balance covenant under the 2024 Term Loan was reduced to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$15.0 million from the previous $25.0 million. Other non-financial covenants are outlined in the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Credit Agreement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024 and March 31, 2025 (unaudited), the Company was in compliance with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan covenants.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Debt Components<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The components of the Term Loan are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 398pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 266.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.16pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Principal value of Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 128.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 128.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 128.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.62pt; position: absolute; text-decoration: none; white-space: pre;">......................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">120,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">138,137<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,137<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">PIK interest added to principal<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 135.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 136.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,118<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accreted exit fee<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 77.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 78.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 78.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 78.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 78.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.49pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,819<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">567<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">770<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt discount<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 65.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 65.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.91pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(5,664)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,095)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,910)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt issuance costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 92.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 93.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 93.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 93.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 93.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.49pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(265)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(178)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(166)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 266.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 266.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 76.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 78.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 78.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 78.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 78.41pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">134,008<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">136,431<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">113,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 537.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The 2024 Term Loan was classified as long-term on the consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.81pt; position: absolute; white-space: pre;">sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.46pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 549.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited).&#160; As of December 31, 2023, the estimated fair value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Term Loan was $132.4 million. As of December 31, 2024 and March 31, 2025 (unaudited), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company believes the fair value of the 2024 Term Loan approximates its carrying value due to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relatively close proximity of the 2024 Term Loan Refinancing and amendment to the balance sheet date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_298" style="position: absolute; top: 605.75pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 605.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">9. Convertible Notes<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">2022 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the period from September 2022 through December 2022, the Company issued convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promissory notes to the 2022 Convertible Note Investors, with an aggregate principal amount of $40.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million. The 2022 Convertible Notes bore interest at a rate of 8% per annum, compounded monthly. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate principal amount and interest accrued on the 2022 Convertible Notes was due September&#160;30, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2026, and could not be prepaid by the Company without the consent of a majority of the 2022 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Note Investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-33<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The principal and accrued interest on the 2022 Convertible Notes was subject to automatic conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon a Qualified Financing (defined as a transaction or series of transactions in which the Company sells <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of its capital stock for cash proceeds of at least $100 million, including the 2022 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes) at a conversion price equal to 67% of the price per share paid by the investors purchasing such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital stock in such Qualified Financing. Upon a Non-Qualified Financing, whereby the cash proceeds <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are less than $100&#160;million, upon the written consent of a majority of the 2022 Convertible Note Investors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2022 Convertible Notes shall convert on the same terms as a Qualified Financing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2022 Convertible Notes were also subject to repayment upon a Change of Control. A Change of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Control is defined as a sale of all or substantially all of the Company&#8217;s assets, a merger or business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combination with a change in more than 50% of the voting interest, or after a person or group, directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, owns more than 35% of the capital stock of the Company after the Company becomes publicly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traded.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Company completed a Qualified Financing and all of the 2022 Convertible Notes, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including principal and interest, were converted into 21,465,064 shares of Series F-1 redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock and the Company derecognized the 2022 Convertible Notes from its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated balance sheets. The Company remeasured the fair value of the 2022 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 298pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately before the conversion and recognized a loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.1pt; position: absolute; text-decoration: none; white-space: pre;">$5.1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.55pt; position: absolute; white-space: pre;"> million from the change in fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within the consolidated statements of operations and comprehensive loss for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, the Company issued convertible promissory notes to Requisite Holders in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the aggregate amount of $98.3 million,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.54pt; position: absolute; text-decoration: none; white-space: pre;"> which was comprised of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.18pt; position: absolute; white-space: pre;">$74.0 million in aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount of notes issued for cash consideration, $1.3 million in aggregate principal amount of notes issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in lieu of cash compensation to certain employees and $23.0 million in aggregate principal amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notes issued from the conversion of principal under the 2024 Term Loan. Net cash proceeds was $72.7 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million after deducting $1.2 million of debt issuance costs, of which $1.1 million was unpaid as of March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025 (unaudited).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes are due and payable in full 48 months from the issue date. Upon completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of an IPO transaction, the 2025 Convertible Notes shall automatically convert into shares of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock at the IPO price per share at the lower of a 20% discount and a valuation cap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of $2.0 billion on a pre-money basis. In the event the Company completes a sale of shares of preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, the Requisite Holders may elect to convert the outstanding 2025 Convertible Notes into shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such series of preferred stock at the same terms. Further, upon a change of control transaction, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Requisite Holders may elect to convert the outstanding 2025 Convertible Notes into shares of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock at the lower of a 20% discount to the implied price per share of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the change of control transaction and a valuation cap of $2.0 billion on a pre-money basis, or receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment of all principal and any accrued but unpaid PIK interest.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes do not accrue interest for one year following the date of issuance. Following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the one-year anniversary of the issue date and for the remainder of the term, the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest will accrue on an annual basis at the rate of 7.0% per annum (PIK Interest). All PIK Interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accrued and payable will be paid by capitalizing such interest on an annual basis and adding it to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding principal amount of the 2025 Convertible Notes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes contain embedded derivative features, including conversion upon a change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in control and automatic conversion upon completion of a qualified IPO, that were required to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bifurcated and accounted for separately as a single derivative instrument. The issuance date estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair values of the derivative liability was $11.1 million and $20.8 million in January and March 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited), respectively, which was accounted for as a debt discount. See Note 13 for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information. The debt issuance costs and debt discount are classified as an offset to the 2025 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-34<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes on the consolidated balance sheets, and are accreted over the loan term using the effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest method.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of March 31, 2025 (unaudited), the aggregate principal balance due under the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was $98.3 million and was classified as long-term on the consolidated balance sheets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The components of the 2025 Convertible Notes are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 174pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 393.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 74.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 0pt; width: 74.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 74.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.38pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 12.75pt; width: 74.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.12pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 25.5pt; width: 74.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 74.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.66pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 393.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 393.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Principal value of Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 160.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 161.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 38.25pt; width: 74.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 31.41pt;"></font></font><font style="left: 39.6pt; position: absolute;">98,315<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 393.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 393.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt discount<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 65.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 65.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 65.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 65.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.91pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 52.5pt; width: 74.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.64pt;"></font></font><font style="left: 36.27pt; position: absolute;">(31,279)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 393.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 393.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt issuance costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 92.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 93.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 93.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 93.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 93.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.49pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 66.75pt; width: 74.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.2pt;"></font></font><font style="left: 41.830000000000005pt; position: absolute;">(1,212)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 393.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 393.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.11pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 81pt; width: 74.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 31.41pt;"></font></font><font style="left: 39.6pt; position: absolute;">65,824<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_283" style="position: absolute; top: 285.25pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 285.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">10. Redeemable Convertible Preferred Stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Company issued 61,344,029 shares of Series F redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock to existing and new investors at a price per share of $2.8505 for an aggregate cash consideration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$174.9 million, net of $5.9 million&#160;issuance costs. Contemporaneously with the issuance of the Series F <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 343.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, the Company converted all of the outstanding Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 355.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued by the Company from September 30, 2022 to December 16, 2022, in the aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 367.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount of $40.0 million plus accrued, unpaid interest of $994,000&#160;into 21,465,064 shares of Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 379.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock at a price per share of $1.9098, which represents a discount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">33% from the cash purchase price per share. Additionally, in connection with the Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock financing, the cumulative dividends payable to holders of Series C redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 415.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depending on the time of issuance, with an aggregate total of $88.5 million.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance of the Series F redeemable convertible preferred stock triggered the anti-dilution protection <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision for Series B-1, Series B-2, Series C, Series D and Series E stockholders. As a result, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recorded a $26.8 million deemed dividend in the amount equal to the change in fair value of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">abovementioned series of convertible preferred stock before and after the anti-dilution adjustment. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the Series B-1, Series B-2, Series C, Series D and Series E redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock was determined using a &#8220;with-and-without&#8221; model under which the equity value of the Company was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocated using a hybrid method, whereby the enterprise value in the IPO scenario is allocated to each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">class of shares using the fully-diluted shares outstanding and whereby the enterprise value in the non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IPO scenario is allocated using an option-pricing model to reflect the full distribution of possible non-IPO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outcomes, both before and after the anti-dilution adjustment. The following table summarizes information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about the significant Level 3 unobservable inputs used to estimate the fair value of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock at the modification date&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 599.65pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.13pt; position: absolute; text-decoration: none; white-space: pre;">March 2, 2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 99.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 99.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.94pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">4.8<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">88.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected term (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 111.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 112.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 112.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.52pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">2.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 108.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.89999999999999pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-35<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Redeemable convertible preferred stock consists of the following as of December 31, 2023 and 2024 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2025 (unaudited) (in thousands, except share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 172.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 72.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 83.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 172.5pt; position: absolute; top: 0pt; width: 295.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 295.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.58pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024 and March 31, 2025 (unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 35.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 172.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 12.75pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 72.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.9pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 72.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.38pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 72.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.9pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 12.75pt; width: 83.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 83.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.15pt; position: absolute; text-decoration: none; white-space: pre;">Number of<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 83.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.14pt; position: absolute; text-decoration: none; white-space: pre;">Shares Issued <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 83.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.92pt; position: absolute; text-decoration: none; white-space: pre;">and Outstanding<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.14pt; position: absolute; text-decoration: none; white-space: pre;">Carrying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.63pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.41pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.63pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series A<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 39.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 39.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 48pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">4,082,965<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 48pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.16pt; position: absolute; text-decoration: none; white-space: pre;">4,082,965<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 48pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 62.25pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series B-1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.830000000000005pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 62.25pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">1,954,846<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 62.25pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.16pt; position: absolute; text-decoration: none; white-space: pre;">1,954,846<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,940<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,940<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 76.5pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series B-2<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.830000000000005pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 76.5pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">2,848,263<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 76.5pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.16pt; position: absolute; text-decoration: none; white-space: pre;">2,848,263<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 90.75pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series C<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 42.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.25pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 90.75pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.84pt; position: absolute; text-decoration: none; white-space: pre;">11,343,434<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 90.75pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.34pt; position: absolute; text-decoration: none; white-space: pre;">11,343,434<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">104,378<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">193,167<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 105pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series D<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 42.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.25pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 105pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">7,151,873<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 105pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.16pt; position: absolute; text-decoration: none; white-space: pre;">7,151,873<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">110,756<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">110,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 119.25pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series E<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 40.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 41.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 42.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 42.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.190000000000005pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 119.25pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.1pt; position: absolute; text-decoration: none; white-space: pre;">12,040,980<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 119.25pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 30.6pt; position: absolute; text-decoration: none; white-space: pre;">12,040,980<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">304,197<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">305,018<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 133.5pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 39.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 133.5pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.1pt; position: absolute; text-decoration: none; white-space: pre;">61,344,029<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 133.5pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 30.6pt; position: absolute; text-decoration: none; white-space: pre;">61,344,029<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">168,957<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">262,295<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 147.75pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F-1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 48.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.300000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 49.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.760000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.77pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 147.75pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.1pt; position: absolute; text-decoration: none; white-space: pre;">21,465,064<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 147.75pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 30.6pt; position: absolute; text-decoration: none; white-space: pre;">21,465,064<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">61,186<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">61,491<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 162pt; width: 172.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 172.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 26.509999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 27.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 27.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 27.279999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.3pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 172.5pt; position: absolute; top: 162pt; width: 72.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.54pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 248.25pt; position: absolute; top: 162pt; width: 83.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 83.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.04pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">951,917<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 314.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The significant rights and obligations of the Company&#8217;s redeemable convertible preferred stock are as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividends<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 378.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock are entitled, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.09000000000003pt; position: absolute; text-decoration: none; white-space: pre;">on a pro rata, pari passu basis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.52pt; position: absolute; white-space: pre;">, when and if declared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the Board of Directors, to non-cumulative dividends out of the Company's assets legally available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">therefore at the rate of $0.030, $0.284, $0.284, $0.7384, $1.24, $2.0265, $0.2281 and $0.1528 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">per annum, respectively. No distributions will be made with respect to the common stock until all declared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but unpaid dividends on redeemable convertible preferred stock have been paid or set aside for payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the convertible preferred stockholders. Except with respect to the rights of the holders of Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock upon a liquidation event, the right to receive dividends on shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 462.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of redeemable convertible preferred stock are non-cumulative, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.76pt; position: absolute; text-decoration: none; white-space: pre;">and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.44pt; position: absolute; text-decoration: none; white-space: pre;"> no right to such dividends accrues to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 474.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">holders of redeemable convertible preferred stock by reason of the fact that dividends on such shares are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 486.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">not declared or paid in any years<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217pt; position: absolute; text-decoration: none; white-space: pre;">. At <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.19pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.98pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.99pt; position: absolute; text-decoration: none; white-space: pre;">no<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 528.11pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 498.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">dividends had been declared or paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Dividends are payable to preferred stockholders in the order of&#58; first, the Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, then the Series E redeemable convertible preferred stock, then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Series D redeemable convertible preferred stock, then the Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, then the Series B-1 and B-2 redeemable convertible preferred stock, and then finally, the Series A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock. After payment of the full amount of any dividends described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, any additional dividends shall be distributed among all holders of common stock and all holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock on an as-converted basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of Series C redeemable convertible preferred stock are the only preferred stockholders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entitled to cumulative dividends upon a liquidation event. In connection with the Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock financing, the cumulative dividends payable to holders of Series C redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depending on the time of issuance, with an aggregate total of $88.5 million, provided, however, that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company shall be under no obligation to pay such Series C preferred accruing dividends until a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liquidation event&#59; provided further, that a holder of shares of Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock shall automatically forfeit any then accrued but unpaid Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accruing dividends with respect to such shares upon conversion of such shares into shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-36<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.64pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), the total accumulated, but not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">yet declared or paid, dividends of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.43pt; position: absolute; text-decoration: none; white-space: pre;">$88.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 246.44pt; position: absolute; white-space: pre;"> million related to the Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock was not recorded in the consolidated financial statements as an accrued dividend as such an event <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was not considered probable to occur.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders of Series F, Series F-1, Series E, Series D, Series C, Series B-1, Series B-2 and Series A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock are entitled to liquidation preferences in the amount of $4.2758, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.8647, $25.3317, $15.50, $9.23, $3.55, $3.55, and $0.50 per share, respectively, for each outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share plus all declared but unpaid dividends, if the shares are not converted to common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payment of liquidation rights to preferred stockholders are in the order of&#58; first, the Series F and Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock, then the Series E redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">then the Series D redeemable convertible preferred stock, then the Series C redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, then the Series B-1 and B-2 redeemable convertible preferred stock, and then finally, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series A redeemable convertible preferred stock. The remaining assets, if any, shall be distributed to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If upon the liquidation, dissolution or winding up of the Company, the assets of the Company legally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available for distribution to the holders of the Series F, Series F-1, Series E, Series D, Series C, Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">B-1, Series B-2 and Series A redeemable convertible preferred stock are insufficient to permit the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment to such holders of the full liquidation preferences to which they are entitled, then the holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s common stock will receive nothing in respect of their equity holdings in the Company. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon such an event, the assets of the Company legally available for distribution shall satisfy the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respective liquidation preferences of the preferred stockholders with equal pro rata priority in the same <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferential order as described above.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Conversion Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each share of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock shall automatically be converted into fully-paid, nonassessable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock at the then effective conversion rate per share for such share prior to the closing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a firm commitment underwritten IPO pursuant to an effective registration statement filed under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act of 1933, as amended, or SPAC transaction covering the offer and sale of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, provided that (i) the aggregate gross proceeds to the Company are not less than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$100,000,000 and (ii)&#160;the per share price of the shares sold in the public offering shall be no less than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$4.9884 per share or $5.7010 per share (subject to adjustment from time to time for Recapitalizations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as otherwise set forth elsewhere herein) so long as a certain investor holds at least 11,693,855 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F redeemable convertible preferred stock (a &#8216;&#8216;Qualified Public Offering&#8217;&#8217;) shall automatically be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">converted into fully-paid, nonassessable shares of common stock at the then effective conversion rate for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such share upon the written consent of the holders of a majority of the Series F and F-1 redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock (voting as a single class and on an as-converted basis). The conversion rates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">per share for previously issued preferred stock were amended as a result of the Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock financing from the original conversion rates per share for Series B-1, Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">B-2, Series C, Series D and Series E redeemable convertible preferred stock. Upon a Qualified Public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Offering, shares of each series of the outstanding redeemable convertible preferred stock are convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into the number of shares of common stock determined by dividing the original issue price for the relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">series of redeemable convertible preferred stock by the conversion price for such series. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), shares of Series A, Series B-1, Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">B-2, Series C, Series D, Series E, Series F and Series F-1 outstanding redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock are convertible into shares of common stock on a 0.342466&#58;1, 0.403088&#58;1, 0.403088&#58;1, 0.576386&#58;1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">0.646673&#58;1, 0.695098&#58;1, 0.342466&#58;1, and 0.342466&#58;1 basis, as adjusted for the reverse common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-37<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">split, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holder of each share of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F-1 redeemable convertible preferred stock is entitled to one vote for each share of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into which it could be converted.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_268" style="position: absolute; top: 174pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">11. Common Stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the Company&#8217;s Amended and Restated Certificate of Incorporation, the Company is authorized to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issue 210,300,000 shares of $0.001 par value common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Common stock reserved for issuance, on an as-converted basis, consisted of the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 248.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 180.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 180.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 180.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">51,226,348<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options to purchase common stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 159.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 159.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 160.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 160.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 160.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.28pt; position: absolute; text-decoration: none; white-space: pre;">..............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,268,314<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,537,203<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">7,905,811<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,583,703<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 111.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 112.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.64999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 26.509999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 27.669999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.75pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">61,142,329<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">61,411,218<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">60,779,826<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">61,457,718<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_253" style="position: absolute; top: 362.65pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 362.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">12. Common Stock Warrant Liability<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 19, 2021, in connection with entering into the Credit Agreement, the Company issued Hayfin&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a warrant to purchase 108,154 shares of common stock at an exercise price of $0.03 per share. On <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 17, 2022, upon amendment to the Credit Agreement, the Company issued Hayfin a warrant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase 77,253 shares of common stock at an exercise price of $0.03 per share. On March 3, 2023, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon Amendment No. 4 to the Credit Agreement and as a result of antidilution adjustment provisions in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the Series F redeemable convertible preferred stock financing, the Company issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin a warrant to purchase 1,462,260 shares of common stock at an exercise price of $0.03 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 469.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(collectively, the &#8220;Warrants&#8221;). As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.8pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.59000000000003pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants remained outstanding.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Warrants have a net exercise provision under which their holders may, in lieu of payment of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price in cash, surrender the warrant and receive a net amount of shares based on the fair market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the Company&#8217;s stock at the time of exercise of the Warrants after deduction of the aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price. The Warrants contain provisions for adjustment of the exercise price and number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares issuable upon the exercise of the Warrants, if upon the issuance of next round securities, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Warrants are then currently exercisable and the next round price is less than $25.3317 per share (as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjusted for any stock splits, recapitalizations, and the like). In such case, the number of exercise shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shall be increased to equal the quotient obtained by dividing (a) $8.0 million by (b) the next round price. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Warrants also have customary antidilution protection provisions. The Warrants will terminate on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ten-year anniversary of the issuance date, however, the Warrants will automatically net exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately prior to termination if the fair market value of one share of common stock exceeds the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current exercise price per share of common stock. In connection with certain change of control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions, which include SPAC combinations, mergers, consolidations and the sale or lease of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantially all of the assets of the Company, the Warrants will also automatically net exercise if the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market value of one share of common stock exceeds the then current exercise price per share of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. The Warrants do not automatically net exercise in connection with an initial public offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The aggregate fair value of the Warrants issued in connection with the initial Credit Agreement and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended Credit Agreement was $4.3 million and $3.5 million, respectively, at issuance and was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized as a debt discount and recorded as a warrant liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The warrant liabilities were remeasured to fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.04pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.83pt; position: absolute; white-space: pre;"> and 2024 and March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 and 2025 (unaudited), resulting in a (gain) loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.99pt; position: absolute; text-decoration: none; white-space: pre;">$2.3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.44pt; position: absolute; white-space: pre;">&#160;million, $16.4 million, $(1,000) and $1.6 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million, respectively, within the consolidated statements of operations and comprehensive loss. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the common stock warrant liability was determined using the Black-Scholes option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing model based on the following weighted average assumptions&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 210pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.3pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 52.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 52.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 52.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 25.3pt;"></font></font><font style="left: 33.49pt; position: absolute;">12.68<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 25.3pt;"></font></font><font style="left: 33.49pt; position: absolute;">13.64<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercise price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 65.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 67.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 67.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 67.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 67.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 67.64999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.03<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.03<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.03<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.03<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contractual term (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 120.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 122.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.69pt; position: absolute; text-decoration: none; white-space: pre;">.............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.73pt; position: absolute; text-decoration: none; white-space: pre;">7.6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">6.6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">7.3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">6.3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 82.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.86pt; position: absolute; text-decoration: none; white-space: pre;">.............................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">84.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">72.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">79.4<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">71.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 178.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 179.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 179.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 180.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.21pt; position: absolute; text-decoration: none; white-space: pre;">......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">3.88<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">4.44<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">4.20<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">4.04<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 65.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 65.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 65.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.33pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_238" style="position: absolute; top: 364pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">13. Derivative Liability<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the 2024 Term Loan Refinancing in June 2024, the Term Loan contained certain prepayment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features, default put option and default interest adjustment features that were determined to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embedded derivatives requiring bifurcation and separate accounting as a single compound derivative, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussed in Note 8. The fair value of the derivative liability was recorded at the issuance date as debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discounts and reductions to the carrying value of long-term debt on the consolidated balance sheets. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability is remeasured to fair value at each reporting period and the related changes in fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value are recorded on the consolidated statements of operations and comprehensive loss. Through the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of the 2024 Term Loan Refinancing in June 2024, t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.35pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">he Company continued to adjust the derivative </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">liability for changes in fair value of the Term Loan.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Estimating fair values of the derivative liability requires the development of significant and subjective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates that may, and are likely to, change over the duration of the instrument with related changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal and external market factors. Since the derivative financial instrument is initially and subsequently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carried at fair value, the Company&#8217;s income will reflect the volatility in these estimate and assumption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The derivative liability was remeasured to fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.82pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.61pt; position: absolute; white-space: pre;"> and June 14, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulting in a gain of $4.2 million and a loss of $222,000, respectively, within the consolidated statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of operations and comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.57pt; position: absolute; text-decoration: none; white-space: pre;">loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.35pt; position: absolute; white-space: pre;">. In connection with the 2024 Term Loan Refinancing on June 14, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, the associated current fair value of the derivative liability of $1.1 million as remeasured at the date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of refinancing was derecognized and recorded as a debt discount to the 2024 Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the derivative liability was estimated using a scenario-based analysis comparing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability-weighted present value of the Term Loan payoff at maturity with and without the bifurcated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features. The Company used both the Black-Scholes-Merton and option pricing method to estimate the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the derivative liability because it believes these techniques are reflective of all significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumption types and ranges of assumption inputs that market participants would likely consider in <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-39<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions involving compound embedded derivatives. The option pricing method was employed as part <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a back-solve analysis to the Company&#8217;s Series F Preferred round of financing. The Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions used in determining the fair value of the derivative liability is as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 134pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.38pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">June 14,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 47.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 48.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 49.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.160000000000004pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">17.7<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">18.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of business combination or IPO (with feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 252pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 253.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 253.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 254.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 254.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 254.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.16pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">70.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">80.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of business combination or IPO (with feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 253.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 253.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 253.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 254.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 254.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 254.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.26999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of Default<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.69pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">5.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of Default<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.8pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability to incur new debt<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 128.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 128.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 129.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.27pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date to incur new debt<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 129.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 129.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.37pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.61pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.61pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.69pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date (without feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 125.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 126.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.74pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1&#47;19&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1&#47;19&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.44pt; position: absolute; white-space: pre;"> &#8212; Discount rate that reconciles the total fair value of the Warrants and 2021 Credit Agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the transaction value. Debt yield reflects a change in the credit benchmark for a &#8220;CCC&#8221; rated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes were determined to contain certain settlement features and conversion put <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options which require bifurcation and separate accounting as a single compound embedded derivative, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussed in Note 9. The fair value of the derivative liability was recorded at the issuance dates as a debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount and reduction to the carrying value of the 2025 Convertible Notes on the consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sheets. The derivative liability is remeasured to fair value at each reporting period and the related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in fair value are recorded on the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the derivative liability was estimated using a scenario-based analysis comparing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability-weighted present value of the 2025 Convertible Notes with and without the bifurcated features. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company used the Monte Carlo Simulation method to estimate the fair value of the derivative liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because it believes this technique is reflective of all significant assumption types and ranges of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumption inputs that market participants would likely consider in transactions involving compound <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embedded derivatives. The option pricing method was employed as part of a back-solve analysis for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scenarios in which the Company was expected to raise another financing round. The Company also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employed a waterfall analysis that allocated certain exit proceeds to its outstanding share classes for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scenarios in which the Company was assumed to exit via change of control or initial public offering. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s assumptions used in determining the issuance date fair value of the derivative liability is as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.88pt; position: absolute; text-decoration: none; white-space: pre;">January 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.88pt; position: absolute; text-decoration: none; white-space: pre;">March 26,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 47.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 48.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 49.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.160000000000004pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">7.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">7.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of IPO<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 80.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 81.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.74pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">60.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">75.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of IPO<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.72pt; position: absolute; text-decoration: none; white-space: pre;">5&#47;5&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.72pt; position: absolute; text-decoration: none; white-space: pre;">5&#47;9&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.69pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">20.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 98.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1&#47;31&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 98.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;26&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 112.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Discount rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 61.510000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 61.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.84pt; position: absolute; text-decoration: none; white-space: pre;">............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 112.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">31.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 112.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">63.7<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 232.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance date estimated fair values of the derivative liability was $11.1 million (unaudited) and $20.8 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million (unaudited) in January and March 2025, respectively, which were recorded as debt discounts. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 2025 derivative liability was remeasured to fair value as of March 31, 2025 (unaudited) using the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 26, 2025 assumptions, resulting in a loss of $9.0 million within the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and comprehensive loss. The aggregate fair value of the derivative liability as of March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 (unaudited) was $40.9 million.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_223" style="position: absolute; top: 312.75pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 312.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">14. Equity Incentive Plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2009, the Company adopted its 2009 Equity Incentive Plan (the &#8220;Plan&#8221;) which provides for the grant of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 347.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock options to the Company&#8217;s employees, members of the Board of Directors and consultants. Options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted under the Plan may be either incentive stock options (&#8220;ISOs&#8221;) or nonqualified stock options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSOs&#8221;). ISOs may be granted only to employees. NSOs, Stock Appreciation Rights, Restricted Stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Restricted Stock Units may be granted to employees, members of the Board of Directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consultants. As of December 31, 2024 and March 31, 2025 (unaudited), the Company reserved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">10,543,521 shares for issuance under the Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Options under the Plan have a term of ten years from the grant date. The option exercise price will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined by the Board of Directors, but will be no less than 100% of the fair market value per share on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the date of grant. In addition, in the case of an ISO granted to an employee who owns stock representing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than 10% of the voting power of all classes of stock of the Company, the per share exercise price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be no less than 110% of the fair market value per share on the date of grant. Through December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 and March 31, 2025 (unaudited), options granted generally vest over (i) four years with 25% vesting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the first anniversary of the issuance date and 1&#47;48th per month thereafter or (ii) vesting monthly in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equal installments over four years.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.99pt; position: absolute; white-space: pre;"> option activity under the Company&#8217;s 2009 Equity Incentive Plan is set forth below (in thousands, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">except share and per share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 156pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.02pt; position: absolute; text-decoration: none; white-space: pre;">Available for <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.01pt; position: absolute; text-decoration: none; white-space: pre;">Grant<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.52pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.02pt; position: absolute; text-decoration: none; white-space: pre;">Options<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.76pt; position: absolute; text-decoration: none; white-space: pre;">Awards <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.5pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.02pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.03pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.52pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.77pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.51pt; position: absolute; text-decoration: none; white-space: pre;">Intrinsic<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at December 31, 2022<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.84pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">4,312,292<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">3,225,122<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">28.52<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">6.17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">3,561<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 50.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 50.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.84pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">16,018,730<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options granted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 2.63pt; position: absolute;">(16,881,199)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">5,780,871<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">2.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options exercised<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.31pt; position: absolute; text-decoration: none; white-space: pre;">............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.39pt;"></font></font><font style="left: 22.02pt; position: absolute;">(99,900)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">5.89<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options canceled<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.78pt; position: absolute; text-decoration: none; white-space: pre;">.............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,863,212<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 13.83pt;"></font></font><font style="left: 16.46pt; position: absolute;">(637,772)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">21.45<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 156pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 143.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 143.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 143.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;">....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">5,313,035<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,268,321<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.13<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">8.19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.17pt;"></font></font><font style="left: 50.36pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 50.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 50.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.84pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 37.73pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options granted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(6,533,982)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">2,237,514<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">6.46<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options exercised<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.31pt; position: absolute; text-decoration: none; white-space: pre;">............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(1,181,123)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">3.87<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 184.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options canceled<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.78pt; position: absolute; text-decoration: none; white-space: pre;">.............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">2,300,439<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 13.83pt;"></font></font><font style="left: 16.46pt; position: absolute;">(787,502)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.79<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 198.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.84pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,079,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,537,210<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">7.96<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">68,256<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 213pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and exercisable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 100.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.74pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">2,886,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">5.86<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">6.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">19,989<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 239.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and expected to vest, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 100.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.74pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,537,210<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">7.96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">68,256<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 403.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 156pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.02pt; position: absolute; text-decoration: none; white-space: pre;">Available for <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.01pt; position: absolute; text-decoration: none; white-space: pre;">Grant<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.52pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.02pt; position: absolute; text-decoration: none; white-space: pre;">Options<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.76pt; position: absolute; text-decoration: none; white-space: pre;">Awards <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.5pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.02pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.03pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.52pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.77pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.51pt; position: absolute; text-decoration: none; white-space: pre;">Intrinsic<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.84pt; position: absolute; text-decoration: none; white-space: pre;">.....<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,079,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,537,210<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">7.96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">68,256<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authorized (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 103.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 104.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 105.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 37.73pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options granted (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 127.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 128.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.25pt; position: absolute; text-decoration: none; white-space: pre;">..........<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 13.83pt;"></font></font><font style="left: 16.46pt; position: absolute;">(796,801)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">272,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">12.67<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options exercised (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 137.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 138pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; text-decoration: none; white-space: pre;">......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 13.83pt;"></font></font><font style="left: 16.46pt; position: absolute;">(130,813)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.42<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options canceled (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 133.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 133.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;">........<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">279,047<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.39pt;"></font></font><font style="left: 22.02pt; position: absolute;">(95,525)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.21<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at March 31, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 62.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 62.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 63.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 63.220000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 63.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.27pt; position: absolute; text-decoration: none; white-space: pre;">....................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">561,738<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,583,703<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.98<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">7.77<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">74,619<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and exercisable, March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">31, 2025 (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 103.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 105.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.69pt; position: absolute; text-decoration: none; white-space: pre;">...................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 153.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">3,257,512<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 153.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">5.54<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 153.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">6.27<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 153.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">26,657<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and expected to vest, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">March 31, 2025 (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 134.42000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 135.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 135.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.74pt; position: absolute; text-decoration: none; white-space: pre;">.......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 180pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,583,703<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 180pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">4.98<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 180pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">7.77<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 180pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">74,619<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 625.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The weighted-average grant date fair value of options granted during the years ended December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 637.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023 and 2024 and three months ended March 31, 2025 (unaudited) was $1.26, $3.59 and $7.10 per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 649.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">share, respectively. There were no options granted during the three months ended March 31, 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 661.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited). The total grant date fair value of options vested was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.53pt; position: absolute; text-decoration: none; white-space: pre;">$3.2 million, $2.0 million, $477,000 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 673.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$811,000 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.72pt; position: absolute; text-decoration: none; white-space: pre;">during the years ended December 31, 2023 and 2024 and three months ended March 31, 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 685.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and 2025 (unaudited), respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-42<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes information about stock options outstanding as of December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 110pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 126.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 126.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Range of<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercise Prices<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.16pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.64pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.14pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercisable<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.22 - $2.22<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,523,524<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">8.38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,227,106<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.72 - $2.72<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">837,855<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,313<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$5.08 - $5.08<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">159,745<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.70<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.08<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,640<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.08<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$8.32 - $8.32<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,792,026<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">4.99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">8.32<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,553,500<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">8.32<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$9.58 - $9.58<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,162,762<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,978<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$12.26 - $12.26<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,136<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">0.60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.26<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,136<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.26<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$12.38 - $12.38<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">1.41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.38<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.38<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$27.97 - $27.97<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">3.86<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">27.97<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">27.97<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.22 - $27.97<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 67.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 68.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 68.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 68.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.94pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,537,210<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">7.96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,886,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.86<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 310.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes information about stock options outstanding as of March 31, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 342.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 126.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 126.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Range of<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercise Prices<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.16pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.64pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.14pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercisable<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.22 - $2.22<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,420,470<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">8.18<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,492,291<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.72 - $2.72<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">790,324<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.00<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">101,456<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.72<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$5.08 - $5.08<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">156,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">8.61<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.08<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,389<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.08<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$8.32 - $8.32<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,720,271<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">4.71<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">8.32<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,549,980<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">8.32<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$9.58 - $9.58<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,161,674<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">49,545<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$12.26 - $12.26<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,136<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">0.36<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.26<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,136<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.26<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$12.38 - $12.38<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">1.16<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.38<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.38<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$12.67 - $12.67<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">272,831<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.90<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.67<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">553<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">12.67<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$27.97 - $27.97<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 72.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.99pt; position: absolute; text-decoration: none; white-space: pre;">....................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">3.61<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">27.97<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">27.97<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 184.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.22 - $27.97<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 67.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 68.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 68.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 68.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.94pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 184.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,583,703<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 184.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">7.77<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 184.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.98<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 184.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,257,512<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 184.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">5.54<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 557.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock options and the fair value of the Company&#8217;s common stock for stock options that were in-the-money <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at each reporting period. The aggregate intrinsic value of stock options exercised for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 593.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 and three months ended March 31, 2024 and 2025 (unaudited) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 605.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.12pt; position: absolute; white-space: pre;">,000, $1.7 million, $1,000 and $1.1 million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-43<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-Based Compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company estimated the fair value of stock options using the Black-Scholes option-pricing model <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on the following assumptions&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 142pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 171.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 78.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 171.75pt; position: absolute; top: 0pt; width: 142.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 142.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.51pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 142.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 317.25pt; position: absolute; top: 0pt; width: 150.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 150.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.92pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 150.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 54.63pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171.75pt; position: absolute; top: 24pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.87pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 244.5pt; position: absolute; top: 24pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.87pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 317.25pt; position: absolute; top: 24pt; width: 69pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 69pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.5pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 389.25pt; position: absolute; top: 24pt; width: 78.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 78.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.37pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 317.25pt; position: absolute; top: 39.75pt; width: 150.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 150.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 50.91pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 171.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 171.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected life (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 104.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 106.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.41pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171.75pt; position: absolute; top: 52.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.23pt; position: absolute; text-decoration: none; white-space: pre;">6.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 244.5pt; position: absolute; top: 52.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.23pt; position: absolute; text-decoration: none; white-space: pre;">6.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 317.25pt; position: absolute; top: 52.5pt; width: 69pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 49.71pt; position: absolute; text-decoration: none; white-space: pre;"> n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 389.25pt; position: absolute; top: 52.5pt; width: 78.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 78.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.23pt; position: absolute; text-decoration: none; white-space: pre;">6.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 171.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 171.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 83.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 83.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.99pt; position: absolute; text-decoration: none; white-space: pre;">..................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171.75pt; position: absolute; top: 66.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 8.99pt; position: absolute; text-decoration: none; white-space: pre;">54.7%-55.7%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 244.5pt; position: absolute; top: 66.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 8.99pt; position: absolute; text-decoration: none; white-space: pre;">53.7%-55.0%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 317.25pt; position: absolute; top: 66.75pt; width: 69pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.36pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 389.25pt; position: absolute; top: 66.75pt; width: 78.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 78.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 17.99pt; position: absolute; text-decoration: none; white-space: pre;">55.0%-55.4%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 171.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 171.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 98.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.03pt; position: absolute; text-decoration: none; white-space: pre;">............................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171.75pt; position: absolute; top: 81pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 42.89pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 42.89pt; position: absolute;">4.2<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 244.5pt; position: absolute; top: 81pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.11pt; position: absolute; text-decoration: none; white-space: pre;">3.5%-4.5%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 317.25pt; position: absolute; top: 81pt; width: 69pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.36pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 389.25pt; position: absolute; top: 81pt; width: 78.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 78.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 51.89pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.89pt; position: absolute;">4.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 69.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 171.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 171.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.46pt; position: absolute; text-decoration: none; white-space: pre;">.........................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171.75pt; position: absolute; top: 95.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 51.22pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.22pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 244.5pt; position: absolute; top: 95.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 51.22pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.22pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 317.25pt; position: absolute; top: 95.25pt; width: 69pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.36pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 389.25pt; position: absolute; top: 95.25pt; width: 78.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 78.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 60.22pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 60.22pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 69.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 267.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The significant assumptions used in these calculations are summarized as follows&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 287.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Fair value of common stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.19pt; position: absolute; white-space: pre;">. Because there has been no public market for the Company&#8217;s common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 299.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair value of common stock shares underlying stock options has historically been determined by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board of Directors at the time of option grant by considering independent valuation performed by third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 323.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party valuation firm as well as a number of objective and subjective factors, including valuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable companies, sales of convertible preferred stock to unrelated third parties, operating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 347.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial performance, the lack of liquidity of capital stock and general and industry specific economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outlook, among other factors. The fair value of common stock was determined in accordance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable elements of the American Institute of Certified Public Accountants Practice Aid, Valuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Privately-Held-Company Equity Securities Issued as Compensation. In 2023, the Company considered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the stay private scenario and IPO exit scenario. In the stay private scenario, three market methodologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">were employed including (i) a market indexing valuation analysis based on the Series F Preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing round, (ii) a guideline public company analysis based on the Company&#8217;s historical and forecast <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating metrics, and (iii) a guideline transaction analysis based on the Company&#8217;s historical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forecast operating metrics. In the IPO exit scenario, the total equity value was estimated based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected timing, offering size and pre-money valuation. A hybrid method was used to allocate equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to common stock under the stay private and IPO scenarios.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected term<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.43pt; position: absolute; white-space: pre;">. The expected term of stock options represents the weighted-average period the stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options are expected to remain outstanding. The Company does not have sufficient historical exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and post-vesting termination activity to provide accurate data for estimating the expected term of options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the vesting term and the original contractual term of the option. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.98000000000002pt; position: absolute; white-space: pre;">. As the Company is not publicly traded, the expected volatility for the Company&#8217;s stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options was determined by using an average of historical volatilities of selected industry peers deemed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be comparable to the Company&#8217;s business corresponding to the expected term of the awards. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.51999999999998pt; position: absolute; white-space: pre;">. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the awards. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.01pt; position: absolute; white-space: pre;">. The expected dividend rate is zero as the Company currently has no history or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expectation of declaring dividends on its common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company also issues stock options with vesting based upon completion of performance goals. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value for these performance-based awards is recognized over the period during which the goals are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 699.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be achieved. Stock-based compensation expense recognized at fair value includes the impact of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-44<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated probability that the goals would be achieved, which is assessed prior to the requisite service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period for the specific goals.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Total stock-based compensation expense is as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 142pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.3pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.17999999999999pt; position: absolute; text-decoration: none; white-space: pre;">................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">307<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">82<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">57<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.88pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 132.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.87pt; position: absolute; text-decoration: none; white-space: pre;">.........................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,339<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,151<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">517<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 155.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 157.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 157.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 157.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 157.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 157.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.65pt; position: absolute; text-decoration: none; white-space: pre;">...............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,722<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,755<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,124<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,888<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stock-based compensation expense <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 188.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 189.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 190.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.22pt; position: absolute; text-decoration: none; white-space: pre;">..<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">12,501<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,213<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,723<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 259.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Includes stock-based compensation expense of $627,000 during the year ended December 31, 2023 related to a repurchase of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 268.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common shares from one employee, as described below.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 285.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;"> and 2024 and March 31, 2025 (unaudited), total unrecognized stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 297.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation costs related to unvested stock options was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.53pt; position: absolute; text-decoration: none; white-space: pre;">$20.7<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.54pt; position: absolute; white-space: pre;"> million, $16.5 million and $15.7 million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 309.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively, which is expected to be recognized over a remaining weighted-average period of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.03pt; position: absolute; text-decoration: none; white-space: pre;">3.22<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.48pt; position: absolute; white-space: pre;"> years,&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 321.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2.79 years and 2.65 years, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January 2023, the fair value of the Company&#8217;s common stock declined from $41.67 to $2.22 per share, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prompting the Company to reduce the exercise price of certain stock options to $2.22, effective July&#160;10, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023. No other changes to the stock options&#8217; terms were made. The Company calculated the incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value by calculating the fair value of the award immediately before and immediately after the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification. The fair value of the award immediately before the repricing is based on assumptions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(including volatility, expected term and risk free interest rate) that reflect the facts and circumstances on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the modification date and therefore, differ from the fair value calculated on the grant date. The average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional compensation per award from the modification was $0.09 and the aggregate incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expense was $649,000, of which $340,000 was immediately recognized on the modification date and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remaining amount is recognized over the options&#8217; remaining requisite service period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Board of Directors approved a repurchase of 102,739 common shares from an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee of the Company at a purchase price of $8.32 per share for total consideration of $855,000. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the repurchased common shares was $228,000, and the difference between the repurchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price and fair value of the common shares of $627,000 was recorded as stock-based compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expense within research and development expense in the consolidated statements of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive loss during the year ended December 31, 2023.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_207" style="position: absolute; top: 549.5pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 549.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">15. Employee Retirement Plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has a qualified retirement plan under section 401(k) of the Internal Revenue Code (&#8220;IRC&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under which participants may contribute up to 100% of their eligible compensation, subject to maximum <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferral limits specified by the IRC. The Company may make matching contributions of up to 4.0% of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee&#8217;s eligible compensation, subject to conditions specified by the IRC. During the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 619.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024, and three months ended March 31, 2024 and 2025, the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 631.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">matching contributions totaled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.54pt; position: absolute; text-decoration: none; white-space: pre;">$1.4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.99pt; position: absolute; white-space: pre;"> million, $1.5 million, $356,000 and $688,000, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-45<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_193" style="position: absolute; top: 90pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">16. Net Loss Per Share Attributable to Common Stockholders<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth the computation of basic and diluted net loss per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stockholders (in thousands, except share and per share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 144.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.3pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Numerator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 177.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 177.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 177.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 177.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 177.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.71pt; position: absolute; text-decoration: none; white-space: pre;">.......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,239)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 107.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 177.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 177.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 177.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 177.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 177.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.71pt; position: absolute; text-decoration: none; white-space: pre;">.......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 107.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(26,794)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 107.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 107.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 107.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 133.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 62.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 62.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 62.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 62.75pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(123,688)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,932)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(32,345)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Denominator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 174pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to compute <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">net loss per share, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 162.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 162.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 162.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.85999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.............<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,885,231<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">5,363,435<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,943,430<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 174pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">6,164,673<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 200.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 139.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 140.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.28pt; position: absolute; text-decoration: none; white-space: pre;">......................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 200.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 32.83pt; position: absolute;">(25.32)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 200.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 32.83pt; position: absolute;">(17.98)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 200.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(4.23)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 200.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(5.25)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 386.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following outstanding shares of potentially dilutive securities were excluded from the computation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diluted net loss per share attributable to common stockholders for the period presented because including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">them would have been antidilutive&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 430.9pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.01pt; position: absolute; text-decoration: none; white-space: pre;">March&#160;31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.29pt; position: absolute; text-decoration: none; white-space: pre;">(unaudited)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 180.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 180.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 180.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">......<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding options to purchase common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 25.959999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 27.119999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 27.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 27.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 27.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 27.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 27.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.709999999999997pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,268,314<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,537,203<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">7,905,811<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,583,703<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 111.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 112.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 112.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.64999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 81.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 81.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,647,667<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 96pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">132,147,435<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 96pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">132,416,324<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">131,784,932<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">132,462,824<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_178" style="position: absolute; top: 557.15pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 557.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">17. Income <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 137.32pt; position: absolute; text-decoration: none; white-space: pre;">Taxes<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.55pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The components of net loss before income taxes are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 599.55pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 63.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 64.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.21pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,634)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,422)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">International<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 57.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 58.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 59.080000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 59.160000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 59.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">526<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">49<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss before income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 131.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.84pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 683.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">For the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.20999999999998pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, the Company did <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.33pt; position: absolute; text-decoration: none; white-space: pre;">not<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.22pt; position: absolute; text-decoration: none; white-space: pre;"> record any federal or state <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 695.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">provision for income tax expense. For the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.86pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.65pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 707.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">recorded an income tax provision of $547,000 and $53,000, respectively, from international jurisdictions.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-46<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table presents a reconciliation of the statutory federal rate and the Company&#8217;s effective tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">rate (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Tax at federal statutory rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 123.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 124.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 124.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.31pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,003)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,027)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">State taxes, net of federal benefit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 149.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 149.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.37pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,032)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,247)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in valuation allowance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.26999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,418<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">16,563<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 123.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 123.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 124.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 124.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 124.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.27pt; position: absolute; text-decoration: none; white-space: pre;">...................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,722<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,706<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value remeasurement<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 119.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.36999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,075<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,482<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">R&#38;D credits<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 55.940000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 56.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(391)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(281)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 122.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign rate differential<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 105.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 106.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 106.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.72pt; position: absolute; text-decoration: none; white-space: pre;">..........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(50)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">41<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 136.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 28.779999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 29.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 29.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 29.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 29.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.22pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(192)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">816<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 150.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 119.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.69pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">53<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 303pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Significant components of the net deferred tax assets for federal and state income taxes are as follows (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 315pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 335pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.01pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax assets&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net operating loss carryforwards<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 158.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 159.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 159.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 159.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 159.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;">.....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">142,089<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">143,066<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development credits<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 169.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 169.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 169.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,586<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 136.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 136.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.72pt; position: absolute; text-decoration: none; white-space: pre;">..............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,316<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,611<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest limitation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.72pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,551<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,964<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accruals and reserves<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 113.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 114.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 114.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.3pt; position: absolute; text-decoration: none; white-space: pre;">.......................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,493<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,502<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 122.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Fixed asset and intangible asset basis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 183.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 184.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 184.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 184.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;">...........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,250<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 136.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 125.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.77pt; position: absolute; text-decoration: none; white-space: pre;">..................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,791<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,955<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 150.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 174 research and development capitalization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 249.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 249.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 249.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;">.................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">12,432<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,675<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 165pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total deferred tax assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">184,508<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 165pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">201,499<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 195pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax liabilities&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 209.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Capitalized implementation costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 160.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 161.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 161.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 161.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 209.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(756)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 209.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,556)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 223.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease right-of-use assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 170.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 171.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 171.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 171.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.72pt; position: absolute; text-decoration: none; white-space: pre;">................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 223.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(5,346)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 223.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,653)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 237.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 39.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 40.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 41.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 41.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.660000000000004pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 237.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 237.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(66)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 252pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total deferred tax liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 120.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 121.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.74pt; position: absolute; text-decoration: none; white-space: pre;">....................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,102)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 252pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,275)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 266.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax assets, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 108.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 109.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.31pt; position: absolute; text-decoration: none; white-space: pre;">.........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 266.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">178,406<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 266.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">195,224<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 280.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Valuation allowance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 90.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.78pt; position: absolute; text-decoration: none; white-space: pre;">................................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(178,406)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(195,224)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 645.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As the Company has incurred annual net operating losses since inception, a full valuation allowance is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided against U.S. net deferred tax assets due to uncertainties regarding the Company&#8217;s ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">realize these assets. The valuation allowance increased by $20.4 million and $16.8 million for the years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 681.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.57pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.36pt; position: absolute; white-space: pre;"> and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-47<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, the Company had net operating loss carryforwards of approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.61pt; position: absolute; text-decoration: none; white-space: pre;">$542.9<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.1800000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million&#160;and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: absolute; text-decoration: none; white-space: pre;">$435.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.12pt; position: absolute; white-space: pre;"> million available to reduce future taxable income, if any, for federal and state income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax purposes, respectively. Of these amounts, $355.9 million of federal net operating losses are carried <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward indefinitely, and $187.0 million are limited to 80% of future taxable income. The remaining federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net operating losses will expire starting in 2030. Utilization of net operating loss carryforwards may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to an annual limitation in certain situations where changes occur in the stock ownership of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. In the event the Company has undergone or undergoes a change in ownership, utilization of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the carryforwards could be limited.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company also had federal and California research and development credit carryforwards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137pt; position: absolute; text-decoration: none; white-space: pre;">$9.4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.45pt; position: absolute; white-space: pre;"> million and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.77pt; position: absolute; text-decoration: none; white-space: pre;">$7.0<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.22pt; position: absolute; white-space: pre;"> million, respectively, as of December 31, 2024. The federal credits <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will expire starting in 2030, if not utilized. The California credits have no expiration date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Deferred income taxes have not been provided for undistributed earnings of the Company&#8217;s consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign subsidiaries because of the Company&#8217;s intent to reinvest such earnings indefinitely in active <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign operations. The Company believes that future domestic cash generation will be sufficient to meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future domestic cash needs. The Company has not recorded a deferred tax liability on the undistributed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">earnings of non-U.S. subsidiaries. The foreign withholding taxes would not have a material impact on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s financial position and results of operation. As of December 31, 2023 and 2024, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">had $0.6 million and $1.1 million, respectively, in unremitted earnings that were indefinitely reinvested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to its consolidated foreign subsidiaries.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s gross unrecognized tax benefits as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.7pt; position: absolute; white-space: pre;"> and 2024 was $8.2 million and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$8.6 million, respectively, all of which would affect the Company&#8217;s income tax expense if recognized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">before consideration of the Company&#8217;s valuation allowance. The Company does not expect its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest and penalties accrued on any unrecognized tax benefits as a component of provision for income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table summarizes the activity related to unrecognized tax benefits as follows (in thousands)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.81pt; position: absolute; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 442pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 138.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 139.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.22pt; position: absolute; text-decoration: none; white-space: pre;">.............................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,371<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Increase related to current year tax positions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 199.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 200.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 201.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 201.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 201.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.69pt; position: absolute; text-decoration: none; white-space: pre;">....................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">817<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">558<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Changes related to prior year tax positions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 190.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 191.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 191.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.74pt; position: absolute; text-decoration: none; white-space: pre;">........................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(149)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; text-decoration: none; white-space: pre;">........................................................................................<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,597<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 540.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company files income tax returns in the U.S. federal jurisdiction, various state and certain foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions. In the normal course of business, the Company is subject to examination by their respective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">taxing authorities. The Company has been selected for audit by the Internal Revenue Service for its 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax year. The examination is at its early stages. However, no tax adjustments are anticipated. The statute <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of limitations remains effectively open for the U.S. federal and state tax jurisdictions for all tax years from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2010 through 2024. Tax years outside the normal statute of limitations remain open to examination by tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities due to tax attributes generated in earlier years which have been carried forward and may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">examined and adjusted in subsequent years when utilized.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Three Months Ended March 31, 2024 and 2025 (unaudited)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company had an effective tax rate of 0% for both the three months ended March 31, 2024 and 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(unaudited). The Company continues to incur operating losses.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the three months ended March 31, 2024 and 2025 (unaudited), the Company has evaluated all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available evidence, both positive and negative, including historical levels of income, expectations and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-48<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">risks associated with estimates of future taxable income and has determined that it is more likely than not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that its net deferred tax assets will not be realized. Due to uncertainties surrounding the realization of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferred tax assets, the Company continues to maintain a full valuation allowance against its net deferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax assets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_144" style="position: absolute; top: 146pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">18. Subsequent <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 163.98000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Events<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has reviewed and evaluated subsequent events as of December 31, 2024 through March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">26, 2025, the date that the consolidated financial statements were available to be issued.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, the Company issued convertible promissory notes to various investors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 232.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain employees (the &#8220;Requisite Holders&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.53pt; position: absolute; text-decoration: none; white-space: pre;">in the aggregate amount of $98.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.85pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.62pt; position: absolute; text-decoration: none; white-space: pre;"> which was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 244.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">comprised of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.99pt; position: absolute; text-decoration: none; white-space: pre;">$75.3 million in aggregate principal amount of notes issued for cash consideration, $1.3 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 256.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">million in aggregate principal amount of notes issued in lieu of cash compensation to certain employees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 268.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and $23.0 million in aggregate principal amount of notes issued in the 2024 Term Loan Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 280.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(collectively, the &#8220;2025 Convertible Notes&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.56pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.91999999999996pt; position: absolute; white-space: pre;">The 2025 Convertible Notes are due and payable in full 48 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months from the issue date. Upon completion of an IPO transaction, the 2025 Convertible Notes shall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically convert into shares of the Company&#8217;s common stock at the IPO price per share at the lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a 20% discount and a valuation cap of $2.0 billion on a pre-money basis. In the event the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completes a sale of shares of preferred stock, the Requisite Holders may elect to convert the outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes into shares of such series of preferred stock at the same terms. Further, upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change of control transaction, the Requisite Holders may elect to convert the outstanding 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes into shares of the Company&#8217;s common stock at the lower of a 20% discount to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implied price per share of common stock in the change of control transaction and a valuation cap of $2.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">billion on a pre-money basis, or receive payment of all principal and any accrued but unpaid PIK interest. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes do not accrue interest for one year following the date of issuance. Following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the one-year anniversary of the issue date and for the remainder of the term, the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest will accrue on an annual basis at the rate of 7.0% per annum (PIK Interest). All PIK Interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accrued and payable will be paid by capitalizing such interest on an annual basis and adding it to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding principal amount of the 2025 Convertible Notes. The Company is currently analyzing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate accounting treatment and financial statement impact related to the 2025 Convertible Notes on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its consolidated financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Amendment to 2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 24, 2025, in connection with the issuance of the 2025 Convertible Notes, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into Amendment No.1 to the 2024 Credit Agreement, in which its lender, Hayfin, converted $23.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million of principal under the 2024 Term Loan to 2025 Convertible Notes under the same terms as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other purchasers of the 2025 Convertible Notes. The principal balance outstanding under the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan, as amended, is $115.1 million. The minimum liquidity cash balance covenant under the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan was reduced to $15.0 million from the previous $25.0 million. In addition, the amount immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable upon the consummation of an IPO or SPAC, as defined in the terms of the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement, was amended where repayment of the 2024 Term Loan will be at an amount equal to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lesser of (i) the net cash proceeds of such IPO or SPAC in excess of $150.0 million and (ii) $50.0 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or $55.0 million if the underwriters exercise any portion of their option to purchase additional shares). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The exit fee and prepayment fee remaining under the original terms of the 2024 Term Loan, which were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable upon issuance of the 2025 Convertible Notes was also amended to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable upon the next occurrence of a financing event as described in Note 8.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-49<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 33.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 60.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Facility Lease Amendment<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 12, 2025, the Company amended the lease for its Austin, Texas facility to extend the lease term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional 12 months through December 31, 2026. The monthly lease payments are approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$57,000 per month during the one-year extension period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Grant of Option Awards<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subsequent to December 31, 2024, the Company granted options for 272,831 shares of common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to service-based vesting conditions, with an exercise price of $12.68 per share to employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_2482" style="position: absolute; top: 206pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">19. Subsequent Events (unaudited)<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For the interim consolidated financial statements as of March 31, 2025, and for the three months then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended, the Company has evaluated events through June 20, 2025, which is the date the unaudited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interim consolidated financial statements were available to be issued and through August 8, 2025, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is the date the consolidated financial statements were available to be reissued.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Authorized Shares Increase</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">In May 2025, the Company&#8217;s stockholders and Board of Directors approved an additional 1,000,000 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">shares of common stock to be authorized for issuance under the 2009 Equity Incentive Plan.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Grant of Option Awards</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Subsequent to March 31, 2025, the Company granted options for 212,888 shares of common stock, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">subject to service-based vesting conditions, with an exercise price of $13.64 per share to employees.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Facility Lease<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On July 2, 2025, the Company entered into a facility lease agreement for approximately 8,100 rentable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">square feet of office space in San Francisco, California for 39 months through November 30, 2028, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the option to extend for one additional three-year period. In connection with the lease, the Company paid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a security deposit of $90,000. The average monthly lease payments are approximately $40,000 per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">month during the lease term.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consolidation of HeartFlow Holding, Inc. With and Into HeartFlow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On July 17, 2025, the Company&#8217;s stockholders and Board of Directors approved the consolidation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. with and into HeartFlow, Inc., with HeartFlow, Inc. continuing as the surviving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. The previous holders of HeartFlow Holding, Inc.&#8217;s common stock and preferred securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">became holders of HeartFlow, Inc.&#8217;s common stock and preferred securities, and the equity incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan, outstanding equity awards, outstanding warrants and certain other equity-related agreements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. were assumed by HeartFlow, Inc. In connection with this consolidation, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company changed its name to Heartflow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amended and Restated Certificate of Incorporation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In July 2025, the Company's Board of Directors approved that immediately prior to the consummation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company's IPO, the Company will file an amended and restated certificate of incorporation that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorizes 250,000,000 shares of common stock, $0.001 par value per share, and 50,000,000 shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, $0.001 par value per share.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2009 Equity Incentive Plan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In July 2025, the Company's Board of Directors approved the termination of the 2009 Equity Incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan effective immediately prior to consummation of the Company's IPO.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 13.5pt; width: 612pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_688">Table of Contents</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_706" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 13.1pt; position: absolute; top: 179.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 229.44pt; position: absolute; text-decoration: none; white-space: pre;">16,666,667 shares<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 287.2pt; width: 612pt;"><div style="left: 140.4pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 57.28pt; width: 331.2pt;" src="heartflowlogo.jpg" alt="heartflowlogo.jpg"></div></div></div><div style="line-height: 13.1pt; position: absolute; top: 409.48pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 241.01pt; position: absolute; text-decoration: none; white-space: pre;">Common stock<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="line-height: 13.1pt; position: absolute; top: 491.08pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: normal; font-weight: bold; left: 257pt; position: absolute; text-decoration: none; white-space: pre;">Prospectus<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 592.68pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 96pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 125.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 108.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 96pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 96pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 165pt; position: absolute; top: 0pt; width: 125.25pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 125.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 3.1pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 359.25pt; position: absolute; top: 0pt; width: 108.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 3.04pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 625.93pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 42pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 282.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 143.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 42pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 42pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324.75pt; position: absolute; top: 0pt; width: 143.25pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 143.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 3.15pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 701.18pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">August 7, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>business10d.jpg
<TEXT>
begin 644 business10d.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" &[!$\# 1$  A$! Q$!_\0
M'@ !  $% 0$! 0            (! P8'" 4$"0K_Q  < 0$  P$! 0$!
M         0(#! 4&!PC_V@ , P$  A #$    ?W\
M
M      @ D  @$@    02   @$P"00 2@ D     @ D
M                !2M8Q:5HJ4 2"!1(I 5B!20K$B,5K:4*BT"@*K4 *H %
M44"0B!2Y"L!60I$A $"DV":A 5K(6@$"M;"EI%8J* 2)I$B:!%(I(3J7
M                     !#X-7/GU>&,>B)+A;4%J!:DEB9+H@W"9$)OMGY;
MBU1]1Z%!-Q1856)1<56)I-A2;BD7F7HI<)YQ,NYTN)N5I<3=I69<I69<K$R=
M,[J+V:<)Q$X7J4D7:1.%R*W"YG69=RK<)PF7:9W"Y5,N4SF7<J7"YG$TW*Q,
M^BF?T52                        !&E=*_29\R_8X;Z^'Z\C\R20$@$2+
M@ 2";@ ,PI7#[WN !($B02O=G02))  D2 0!(D !$2) ( J7$  5)P!  N0
M"(%P"( %R[[89'1<                        1:K'Y_\ ZKR=._E78L)
M!!)"!-R0""0N  S P\N   D2 I3S._T?3X^&1(  D2  1*;2 $5)DB20 *E+
M3<K  J3  !<  !<  !<!ZI[X                       $-4^OCI?U:[6^
M4Z  M7S^GOY=_9?U3:GQOR6I?L/K\U\CQ<=]'T_9\_AZ0_*_S3&?3]')O)X#
MG1>X #,##RX  "1("+\I?JGZ9Z?#RR/HIG]^5/1QY?0QIZ&'/Z..?H8\WWXY
M?=R\OVX9?9S8:._0?N?JKGZG+S:E^G^HRS@\WVN/BP[UO6WW\%\-ZWG<N/\
MJ>CC??VXSW=^/=/7].KI;\Y_/20*DP  7   7   7 7C+@
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MFX #,##RX  "1(""0D202 )$@ "1(  D2  *DP@D"I,  %P  %P  %P$S,0
M                      $:.^AIB^5<Q\/8!,Z>^^^UHMG_ ,I\U[_+Q6;V
M+X9]#]!JOZOZ;;'Q/QN9^7Y5S*D97N3"\ #,##RX  "1(  D2  )%HO@ D2
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MG.U\YPCCKMQZ%FO7'/L!4TT;H !4F  "X@D "X  "X"9F(
M       !Y)RN<O'ZFHU!]#3%\JYCX>P  ""1!-P  %P &8&'EP'.AQ<?H4<#
MGJG=)HD[& )$@ #7Y4V&!!#7%IK:-;)TM6NX.FOU<?5Z6W/XZ<WFFY<[@5.<
M#I( %28 0G1%+D9KZ*63FBS1<S@E,JDP3<F!,S$
M Y7.IBA-&COH:8OE7,?#V()02   N02  N02 S P\N$3\A#]?#\HCVCY#,C]
M(36)LX$B0 !KXD;# B")3>4$P@F$)3,JT7N@!4YM.E0 5)@"',V,ZXO.Q^K+
MYLK>9%?4T0A9YMOG[<-N5WQV,=(4Z/OMAU1IEGF&Q,S,0
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M^5C?=:/5I/MTIH:G5F]\?!TS\:=LLOR[ YNOY]L=S5I>KJ)F8@
M           &@3?P"-'?0TQ?*N8^#OYD6YZWRS/'3R+92O-DW?R[>1U8912R
MMN9FFQ]>?7S;VU/0QID&NFH:Y>_I'1]=%9S P\N&E3G,Z"/A-I%PPHV.?E\?
MJT?*>4>0>,:],&.TS7Q(V'6?SMWC3^5\1W=F88<N]/3L3S;8#ZN.^=N'F3SN
MS?.?3HW?'/KTQNFGB,/T$Z.?I'CZ^;4]*GRGCGCGCGE'(I^CY>1AO'V:&]?@
MUECINE;0](Z.MGJ;'I7RUC9[4Y^GIE]WG>GBWJ^5^AG/I]V6R4S,0
M              #0)OX!&COH:8OE7,?#UU5R]?W>QYN&\&]W6*9/+VSPGB]'
MI#T_)R_DZRO-L[[[KS:0TZ,YKCC6=O-VGB?FU_3WOX<GPU5OF!AY<!^<AO(Y
MT.F29QB?H.<4'Z= D2  -?$C8<"R<D6E-I354M")4F5K2FB)5-"JLN;3I4 %
M28 $0M-RLZTFN1Q.A[6W3.5VS'\[9/6=;[M[Y5+*S<M F9B
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M.60Y5R?/3Z*5Q3>>[,E8GGTZ% !4F  "X  "X  "X"9F(
M //.43IDR4   &@3?P"-'?0TQ?*N8^'LACD6UAMG8RUS+7+(JUNUMD"P%PQE
M5G,M)QSDZL&]7R,VPUV=3H S P\N&K<MM?:XXKU8UYNC9<TVK2?GEYQ]B/?3
M]Q(D  >,? 98:LSU^/JP\G*_G7K\]+^52^5Z\]:W\>M/#WU]MCXF>N15I=U=
M&9S6)UJ;- !4F  "X  "X  "X"9F(                /YZ#NDX#/WN,\
M - F_@$:/^@IBU:YCX.P "(3( %P  0N3!(&8&'EPYJSTQ"'B>CY^Q>3NY:N
MZ;RG2&]/#PI=ZN?IR>KI+DF4I  $CP3WB0!(D!!(2)  'S'RGK@ J3  !<
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MKD\\VL  !!(      $$@      $$@                $$@ $!$I ()
M              #F0Y5/U% .:CC4_5\  '/9T(
M                                       #XC\&#],3L,U>?@T?OP9Z
M  #0)OX %DP0QXL@     J3  !F1AY(   J3   *DP  "I,   J3   !<
M!<   !<   !<   !<   !<   !<)GHGN%P  U<<<'Z,'/IJL[6   - F_@ :
M[,; @F"0@D  !4F$$H)#,C#R0  !4F"P7P 5)@  %28  !4F   "X   "X
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MNNZ^CFU=7?%N:?4Z,O;Z*^;Y_3YNV>;='/\ GWYOH]$^QY'?/#W$9D8>2
M*DP  "I,   J3   *DP   7    7    7    7    7    7    7  9H1SC
MGBFN+]7+N.-?%H^JD>_=]T-2YVR3HY\BSWT7M'7.=@!H$W\ 6S38@M"MUZ*6
M31!.B:*V(1"]E*5E.2+)()#,C#R0  !4F   5)@  %28  !4F   "X   "X
M  "X   "X   "X   "X   "X #- KSGR]/Y[]'-KGTJ9]P]&?4X^?=>K)9;M
MPG#=^77FFW2,3^F7/( T";^ +9IL       J3""0!F1AY(   J3   *DP  "
MI,   J3   !<   !<   !<   !<   !<K/ ^>N2>CQ;,YM\,RT]+HR]*LW$:
MDT;9RG)<=/AFFMM,\<WCN['56+@ ,T!2J%JHE$8!$9_:24U%:6K*5I &@3?P
M!;--@      %28  ,R,/)   ',1U"   5)@  %28  !4F   "X   "X   "X
M   "X   "Y6>+XODG5S:RRVU-E?HCIROHC$_!+*<YR3'37>D?3KC6\=BXZJQ
M< !FA;SC\I8G95]<?QC1/?AVAY]N!?8X>L_/[_GSSQCLRR>O9D'!IM+V/,ZU
M\_LE8- F_@"V:;   $PK*2 26,U;)@  S(P\D :Y,E,A!_.(?T?@  %28  !
M4F   5)@   N    N    N    N   "D8Q.NM=,L/C78NO/]&,ZKB=@-/NMA
MAK;(&>(3&<IQ[/?U[4V'MAF..UP &:%O&.#[:XKT<_L\O5AW;Q]E</3GFW)P
M+?KW[CGK;7'W+;[(XY]+T,-_<FDM+#0)OX MFFP  #Q<K\Z=&.[(MG.<KD,7
MR.J,IQF<@ !F1AY( _(4[".N#"#^?(_H'-@@  J3   *DP!!)!*I, ""0%P
M  %P   %P   %P   5:%I?G#KQR[#HTMV\79?)T^-BUEO7G32_7\9\MWOMFV
M/Q8]'H6Q^_+;=6W)T%AT7  9H $(E*A6"2"0  '/QT" 6S38  !Q!COZ'3RZ
M1YNW!^C@AK/CS/Z,^/Z&,?0^+T_YW;,  &9&'D@#\CS>9OX_ T_: Q<[]  !
M4F   5)@03=%$D5K,S63!"+)!6A:X*W;8J:(J2DE<%93*M$RM!*%R"0  %P
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M(Y$/U8/N--@  (U5S=/W>IY^&\?3=M%(GR[8\Q\O7V'ZOF[CXNR8  ,R,/)
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M:3]%,YI!( S(P\D #B4U ?IR5)@  %28  !4F   5)@   N    N   !%Q(
M  N    N(XZRWQK?E\S+?8>_+S)OIV#Q[?/MAR7'3C,8="5WRNF//>[<6_-W
M;R=2%P &:          %LTV  :\X^CCKU>'7L[[CSRAGKB=HW5FYT[-MI\O/
MH[;7=F/+TAU1MWCZ  ,R,/)  \ P$VZ5)@  %28  !4F   5)@   N    N
M   N    N    N"*K7\.:^Q6GRUWQ;;#-\KTFZ:W:QCND9%2Z81)%P &:
M       %LTV  ?%2^B=<?;C3*S&XCR]F=TIB6.WU%C;'R(;>ED-+@ 9D8>2"
M4 F *DP  "I,   J3   *DP   7    7    7    7    7 )<TY]O"?5YV=
M>=W:L]KR=\^=V:&IU??W^7F4=/0],^U\91H!< !F@         !;--@  !(1
M"8)03!-8F8F  ,R,/)(P2FV&[8;=OEZ&&Z1&/IR0^4^)'KI %28  !4F   5
M)@   N    N    N    N    N "AI:%*3TLB)362L:VEI9B6 7  9H
M     6S38      !4F  #,C#R41H'#7C?6]CN\WP<>GU\>G(._S\[\KMYLZY
MV%E3JGTN'J7SNLD"I,   J3   *DP   7    7    7    7    7    7
M  7  9H          6S38      !4F  #,C#R0I=?)-T519-:DQ2R\  5)@
M %28  !4F   "X   "X   "X   "X   "X   "X   "X #-           :A
M/E      !4F  #,C#R0  !4F   5)@  %28  !4F   "X   "X   "X   "X
M   "X   "X   "X 7C+@          8N8 4      *DP  9D8>2   *DP  "
MI,   J3   *DP   7    7    7    7    7    7    7 #(3TP
M   #QC'"(     !(  'NGAE0  "I4   J2   !(   J2   !<       )$@
M  2   !(   $P   2)'HGV
M
M
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MQM,@@S\O1.S:Y9=N?/A3842Y&XI-CI(0*R.-[RU6+]NNNENC40L+[KM]IV3
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MK&Y4^*%\/E/8])#*]</)8U)GTWD:/S4K<22+"Q;CP67X\.RW_7QK=YG[9)\
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M&KB*6,;$6KIU8T1/L5X=>]?U-O\ KX+/GPIL*F>H=2+&MW:GQ']AN\S]LD^
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MTQ\&TS4GST1\%4[P:/2)CX*IW@T^D3",DTVI6JH\]'7"*)2[>QS:VB\:M<?
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M:0K@[[]Y6PYHJ68JZ57J\G2./_\ N/\ _\0 91$  0(#! ,'"PT+"@0% P4
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M7C,6U<I7C,6E<H^,Q:5RCXS%3M,5.T_E6S>.-TQKQ:8](YHW3NG<WH:3W&M
M2TW9$UIIYM04J:?F$(>;25(L\%A)#: 1Q$M8U36'*N&RI=IH=E3[&.MMCK:*
MG5C\O\ZAV?C&<44VZMO5AYXF) LMLNC-8KZ1@>D'Q;""?Z6RJEJAL[:&GCR@
M)4HT2DJ.P D^:+*JV;)KLH:^*%)4GC I_6!'I_HK*J6K*K/*H:>/+\S-SK*G
M=,Z,9 K6>EB<N*'D*5GL //X8W93:IK=%.S*S4VRW^ZRI32/X$I_FG@EH_K4
MC1LC-:4GI:1E4E4P^NP !4\)0&7AZ.>%]3#<O(!K1VF-V;4GIQU .\MZ*<2P
MXM*5I2X^"$)K6O7+%00:")[<%IIK= UN99>3,/J6G>ZF["KUM7#*R4ULA+=5
MJKD K9"^IMN8;=&B'MVS+6FQ0;T$F2VITFA9WS6["PHA&)2I2NQ!-(D=P.AD
M:8GM&;HM-HT.XPME$JJX5-I?+M,472A@:I.&5:&A! W<]33<WN69?9.ZQ+VE
M66VG9?1PD'$7R7.$#?E2DC@U-G.-SG4QF-TNYZ9T\O2"9-;07O&54V"=(J;0
M5+2TJO8)2;5$J-$JY)AZ7<"WRI-X4N6 @\#UM137S1H_0>F]+K?7(,)<WNT7
MEL6TIZTW9MKM'4BTFO3#C=A12ZV4N))&LX@X\T!+CF#C@2C5E^(I6IK!>O7G
M#.Y9O2.YW04TK3.C93?$N[5F9F S,@MS4RD+L%M=67$@6%854E8[#'[Q9?\
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MM9T\A_$W$N6QR^"DBG0(T4A+S4@J9KUT3-*YJLULX:L*'G$,%H(LS%;Z\4$
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ML22Q(%L#%,H73+GD%^I7TUK!-HD[23X_S.W*_P!XM$_XM'QQNC_MN=_:N?\
MYK_&9=6]I]B:.4LEQ"^>]%!39X(>:.]9AI.;SS3J>:PY>8[?##S]MZ^!L50A
M*QGDFS@=7@PU91)"X.G&Z6!-)9NC6MJ@QPB0_!I?1=>$63,6D_KDYYVN;'Q0
M\;4VD@U#9K:Y-<:4B9<H_+/:E6AYJ0I'6YEG6ZMDC]U5<(6L7VE#RTRH9_=2
M+5(><!E5 9\&\IYH'YS;E%)3N@T259;^83X5K"$?QJ3&Z:J=-SH_3.?ZB_QD
MHO I.T@HYZ8G[& Y4O*V !7M<*" /P?*V1BXO+7480VJVTIVMJU@E%*4H:&+
M171L<&G9;==*:H*?9,K?8\JF'@AQ-MIL:V\?&8M6G4JYO0(SM*[9Q/W8%3P=
MOKGQ?G/(3#LE/L38H5R[S+[(R!4TM+@&'.D1U1I1G[J)TQ)I(T=I=B7>E%@5
M;=(93>659CAU6;6/#V80;VZL6,(#:BP$LN *&8_]!U))ZX@5<1@E-: UVGSQ
MN8TE)Z<T8C<GIY8;LE9T+-+*;$L^ZJVJ6412TEUTFQ>*-2LMH4E09C3&AM+[
MG)E<O.M*4U4V5A-I!;/%4E:00I-#G7 X&APBX%[>I<(2<:?^A.CMW[\E+HT7
MIZ2;W0:(QL2\TLMO-J-<6IQ*''4@6E"BT+X)L(6VWP0J=W SBRG>&D-$M*XK
M:+B9:!UFUPY@TK4D8&G@C>_4][ZS?P>]]#&]^IYWVF_@]_Z&-[]3SOK->\'_
M *+HC>W4\[ZS?P>_]#T1<=3SOO-_![WT,7'4\[[S?P>]]#%QU/.^TW\'O?0Q
M<=3SOM-_![WT,7'4\[[S?P>]]#&]^IYWWG/@]WZ&-[=3WOO.?![O/^@C>W4]
M[[SGP>[S_H(WMU/>^TY\'N?0QO;J>]]ISX/<^AC>_4\[[S?P>[S_ *"-[]3S
MOO-_![O/^@C>W4][[SGP>[]!%QU/.^LY[P=^BZ(5+]3JB#]V9RUV2CHUVSS6
M<*^,P6]S_P!\*4[Y<.@[7];N5!VS<#V"EJU?U3E376R:Q<=3SOM-^\'/HHWO
MU/.^\Y[P<^AC>W4[[\3GP>[]'&]NIYWWG?>#GT<;VZGG?>=]X.?1QO;J>=]Y
MWW@Y]'&]>I[WWGO>"OF1O7J>]]Y[W@KYD;VZGG?B=^#U_1QO;J>=^)[X/5]'
M&]NIYWXGO@]7T<;VZGG?B=^#U_1QO7J>]]Y[W@KYD;VZGO?B>]X'Z.-Z]3WO
MO/>\%?1QO;J>]]I[W@KYD;VZGO?:>]X*^9&]>I[WWGO>"OF1O7J?]]9SWBOZ
M*-Z]3_OK.>\5?1QO7<!WTG/>)^9&]=P'?6=]XGZ*-Z[@N^LW[R5]'&]MP7?6
M;]Y+^9&]MP7?2;]Y*^9&]MP7?2<]Y'YD;UW!]\YOWDKYL;UW!]])SWDKYD;W
MW"=])KWFKYD;WW"=\YGWFKYL7&XKOG,^\U_,BXW%]\YGWFOYL7.X[OA,>]5_
M1Q=;CN^$Q[U5]'%SN/[OF/>ROF1<[CN[ICWJOYD7.X[NY_WLOYL7.X_NY_WL
MOYL7&Y+NM[R"_HXN-R?=;_D%?,BZW,=UN^07\R+O<QW4[Y!?/[2+K<UW6YY!
MSZ.+O<UW4YY%SZ.+K<YW4YY!SYL7>YSNASR*_DBQN>[I7Y%SYL6=S_="_)*B
MQH/NI7DG/DBSH3NE?DE19T9W2KR*ODBSHWNE7D5?)%G1O=*O)'GBSH[NE7DC
MSQ20[:?<+^2*2';#[E469':?<J^2+,CM/B5\D?@FWTQ^"[?,8ZW]JQP/M6*Q
M7\J\*UCX.:,+?#%3J5D!S1]LX^V<8[//&.SSQCLC'9&.R,=D8[(QV1CLC'9&
M/V,8_8QCLC'9&.R,=GG@6CCE[7 ^> I?%LV1MJ#YHQC&,=L8[8QVQCMC';&.
MV,=L8[8Q^PC'[",=OF^WV\,8[1XOM]O#&/V$8_81CMC&,=D8[//'VSC[9Q3^
M3P>B/!Z(\'HCP>B*CF\45'V$55R?/%5;//&.V,=L55M\PBJMOF$</E?PB.%R
MO,(^V0C[9".'L'CBJ]GGC'9YXQV>>*JY/GBJN3YX_=\\?N^>+*/M_O%E&V,?
ML(Q^P_E_?/N8_?/N8PC".#'!C';&.WS?_>W\>7_H)9MJB9>N:) J20*:R3A3
MPPVE@HH]676K&Y-379PO/"4/A:T5LI12HP)(.4+4&^&%VG,J6<ZX>"D*26DG
M@ K%"H6N):].$*3>@)'7+O%L<0-ZU8]E6%]=4WV*Z&JACQ>81;19MNX]BE.N
MN6J%)6W@[Q*53MVQ+($ZVX_B42WKE.PKQ>FOFA"ZFIQ2KL1F:>B/6WT..\%"
M:YZZB@PSBS1Q)=X) 417)0IMRA?]4;>U*417]ZD/BZ;:KV8K%*A3FRS:'APA
MPV5.*Y 3=_O9UA3' EP>*+1!VUQ@XK6H\9-*#\CCA)L;(;5ODF6Y./BQBU:E
MG7^U%*?&;,+ZVVMSD6?XXL8.J[4$D\UKTP<+K]):\%/36 *J0.7:_AK Q2V1
MV94/<F+5>L>RQ9KUCV80E,*5%W&7YAI-DQ.H+A0I)X04DCI!!'GA4Q:F&$Z1
M:]9"4J=3KMBB,$[,-1YXE&$#26D64O7J98-*43P<'$6D]-.:)!)G9O3*UKJU
M+%C"S0*KZ/!#*A-Z6TN5(JU+A@-\*E*IQ(Y67@Z(*;S1FD!:M*0IDRJ.*?7.
MN +[*HSQUTB0LN3PL49:+2OP0BI6H-YVSC6O"UC5#"K33BG."]?@":SM"\I2
M[R%!A7PQI!%B;4A8H@MIX>=Y5 U=C&A%EJ2TY0AM;-A+5$@E2: DD <(\+,X
MG63$N+$C*3*> M2G"9WCWO"K0M^QV,N<Q.*;F1HV:NR\I*7A-XW=M50&E6=@
M37BZZ'5%TJ<T?,MAR_+0J,+!E!B:5S5:RQ@N*.YB2?/&+ZTF@"1@\!@E-$CP
M 1IE5V=%I[8/DAMI*-T*9)?K#[*E6?;(:KT\;+S9XR-7F=*LK)WP7@)<[$I5
MB.FF==1YXF?ZM*('&36IVPHVWU+'%0 %#I%/R.."FWMAM.]B9GE8>/" *2[K
M';2%>(VH4+UI3?*L?PQ;I>#M@2!S6?36#C<_HK5!LM>FL T4A7(M?Q0,$M@=
M@5'W1BS3K_LL6J=?]F,)5"DQ>1G^312EGDTBU5I9UBL(XJ3M$)R2.3:\\4M4
M-8)KA -,(&!K! =\&R$KM5YOM\48*J-E(*J"HUX=']&G&'6B2#L-?%"#UP/$
M @4Q(SH*8G9#E;\S0- K.FOIV_80RNC.D ,#-75*8<6 @WJ#D$A073LJ[871
M<HAASUEM14W9PQ*K1K9Y]42SQWTE]RE^VE26ME"FST9>>&DEI2K6(M%5.DD^
MF'7+WG_[1(++"GWNWBA3JRLY98T'BAE-RER6S;<5:YD\*T:#5X/CB:47%RM@
MT$N%!D# &U2U:'98@'A:Q6+RZ8F4##?0 F*<V":;/!#2 )'[F*R;5:3X56XG
M%;[7)\J4P ^W1#C]G2DOI,>OMMK04ZN$FF66)QZ<8EDE G7<=\S*BL"IH%:R
M$\4<$#54TQ)X("UDZ%DFP09Q*W2NFRULH,*8TI&'7:<8A-K\X3P:JVV1\4*5
M9FF&.Q>M5V"@VQ9 3-&TE-Q8L@X%05R<JV>R%,CT18-XA '"<!-G6:)M9=&>
MR& 5HPQQ/F)&&T_)C"<7%; <=@Z3JSAT%*D\_P!L-HAXE*4X'A9>VZ-L.K6R
MEFR@]=4$ULGPY#L=9U8Q,MJEGF6R*7V.K%-,#0;<<,QKA?6UY8K&6-3T:_MC
M$HQ?LZ557^HJEL,,;\T\%,%<]*4Q%/Z+*+58KUFQ]LXS8NXQ2I"=@-?%"<$(
M5VRUYHJ<!GS;(6FP01X]D*-N +,<51Y)RBE$GE'*$BE#X^;_ '@DK)YLO;0I
M-76%C,VK7@@"DRMP<44\=/E@HMJ7R\*04T<<5V;02.FU!<50-)]?3GLH<>C*
M#2F'&/'_ #B>350//GK'R>"%!2Y+2# ]<4J7,IM-E:"[CLI7/7JVMO-G=!HN
M<JD,;W?2JUP0"F52S15<!5:2:JP//$@L2[TNM0#@O)@F5)*;JT54-Y6RH*X^
M7!P%8827&M.(O"I;LPU=UPJ RD6*[02%G;8R@*:8:EF7J*=:0XF]!J 5)-!4
M5M@JZ;).VL,*4RK0[KY3=RN_ 6T\*YOPH(*JVK9)X02:D:\XFDE<G8!K289>
MLA(J;M]+E0=6":4IKQU")IPN:1E9BU;X#H22:A%4)H"#6EFEG@TH.8TAHV)G
M13A*2AC?-_P>+> A 4:D.<U +.7/&C5!EC=(TM2;;[DB9=-<56% K*:\8:Z"
MI 3B!@?QWG_,U1HE1V GS0@EK1S4^.$J978<3^JY9%#T'5"V VN>2,4,)95:
M[7>)!/36M(0W::F'F<1+V+?[^5-L*>*&'GG^,TIM*O\ -593E$Q^"+?!XLL&
M2ZK9?@6.FM8="T-3+A'"E V7D; ]2QXZQ9L22YPX%-F]9SI:-$FUYX;9HVXX
MDWJ4I!=!X-FT*ISSB4:,T<#=J<"U-)SMAL$JILRUT^*&G+TS"4IL(DE)1-JS
MH7%64>,[(>I*S#\LH\!JYOE9W9=H44Y5HF%-*2_I)M6"I'>]X*ZGP"CS'[4@
ML]=N.6FUXA:A0_"+KE__ !_H*!1A1LBO@\<%5"JT<</L(. %!EKKE:U\^<)-
MT7QQ6W%(<)-,5 6?'388P-%6;6H&"G #$P5!*:ZOE@ZJYIR\,*-% 8U77'90
M5@8<U?MG^=1Q!&T&$@'1[,JH<"665-(R-5+M'Q0X_P +2"58JG1+@KY : \=
M0(#I::>;E^,[9L^#C5K\<)9#C"V'LE*;4C',MJM*KC$ZZF;,P*5$X&.!E=;U
MIC7LK5/!"WP\W- @DSP:25Y!K>^&6NM*0%I1*N2YX+;MFJLZ%)P-#GC"'%%I
MV7=ZXX\!U_BT"<N",\,(E7-[8%-ZIL*#2CDD+XV>?Q0TU=*F%)-M,ZI*YI-*
M6BV:H\7-G#R$S3[[V" ]<6?T8EZ4%.RK2G-"EVYC2;I%#I,2HQ_\JFS4>""]
MUZ_[6+/C%F%'K]]R?_E_/<4&T'&R:&AI7&&6Q+Z,DID?UR>;O7)DDF@O5I0D
M-ULI";"P3V50<-;A,U/2,EZV)I+SBW,$A&]V[RM*THJE*],:6*'M%2VE0@-H
M=4ILI3P;*FGPPNM,.&"A0.OA;(TLL:-G6TM)ML5E&RP?_,(:X941:%F\J=FT
M'+3*-[NMHK@)EENQS+=0G$ZZ5Q%*:H0@-F8"DI5*%HE+BJ!;:@DEH@$VN&;-
M0 *U(4"(D4JF@T,6W9D/DUM&Q=@E%;022:"FPD86L#! .Y^5F7N,7G$Y653%
MAU(4.#6R&B>"2JJAJ&0F#>S2PSV#;*GOT8+8(!VZQYXN%KFM&(219G4S)2HX
M4#"3>8$ZJ5.7FB>6!+K+!/6'FT3.76[2A2G%M$IX5*X;8TFRA!;NAUPMH4XU
MQ0V5(0:!5>$5)(6:"F.9-J@(4,,1K\'R?TX%N%&Q"<7%*U$?% ];6G63_+2R
M*16R:_FBK$FSD*5BH,RTV/7U!10G: *G#HBEZ]*-*%I;][=TUW8-KFPA:"TT
MVXHVT.E0I^H:0&;5EP"JG0;E.O@YP@59FW<W-'TM\][6D*2VUHV0G757:G[S
MG -H@#IRK44QP.=%WS<L];1=ANQ56?KAX--M<(*46%)=Q7+6+[_-];](CAAP
MH<]ALVU#)-YQ*TVU$. AQZ4]D8NRZC4B\Q15>7"AE*ESLVR<'9)"#=:EA::U
MM980E&^FVGADB\LMC-=,_% 4Y,IEWZ9WEA%,5A.=.@0YZU)N<5,V7 E?*NSC
MT>&%M=;3J;/%'*IGCT_S[-7'@1;20G#9G#8*4"6*KV4;/6T'-NIJ4!1J:5&%
M,N?"!2_<=3F $L)%1O=)'#QIPPL#&M,<>B8M3>C9V0M52ZXTN75E<*;55?!I
MURWSTVXQ>VWQ,O ./)0A-59<! 0#9R52G-TQ-(WV\ JM4N(?*SK4E8<ILS%,
M/%JB<LOJ4I1*%DUPR)SXHPH%;=NR&75IF9&<=ZZY+)?1@ V%!P6=0-*#F^6,
M%2#FCG,@[>,*[F"W MR@[.\H,\O!"G*3:W&TV1,M-H=%:A=T@(&/8[=6S5"%
MV)J0F$)2$R;<T@IH*N[X;4W:4<#P <.B@,.,@RTU+H/#G74NVN26_P#L?-EC
M#S^^$IPHZA(2M[.]LA* 0DX)LI33# Y]*>#Q11.L_P!.M=A5D9Z@,_%G#*;X
M&U@:$T/,*Y0P*RP<U$J%K4:';'_,!/8FN.K+;'/JVZO' QRQZ,8><HXD;32'
MFZ-@Y?FC:N;:3[+9IX(2V6])2VF#ZS*H<0M&V]3=C#70\T,.W,YHEY(M(D1.
M7O\ [D&SXJPI03+RJ ;2[QY12=A77T1HYVDQ/3B_6I9*4R*3M<39=(',=HB4
M31K32"?Z[=%FOM22KQ5I"F;>CI23< 4M-;*N5845'F%=0IAM,+?)EIBWPP]8
M#+>6]RUAGV5LC7E#EG[E"N.D9I:#-T.-EI8NL<AP=G-"L&=*H7B9TR12K6BX
MH3SZL:0A:75:?[7-)D+I?9*N:6Z:Q2E(2\E+DZXD=;FD-IMZT%M-GI-HQ(+W
MLJ6?4:F13,)4V?9+])2GW/\ VB3=0RYH1XBN]1/!Q%,%7P4$UU85'BZ(M!:=
M'2EFT994VI3>5J^J4FUJLY\\+723E98JMN)+EMVE+0M$@4IA9!IGCZ?R$T0S
MIB7?7BAL*"M@M)H*C*+!7.)KZZA#Y4X.* M!LX##*$DC<UHQBO7$OS%LZ^$_
MA6F./^T6?P;23>MH2Y2,BBT4\4Z[0.K*&B+F<8*KNB6[#%*ZL>N>?S1HI 2_
M*ME-VA:7JK/"$R0%<YL6>>E<LHTK4,+*:@M/M@4.84\,]HC2I!F0D9,LLD4V
MK:37S_D5*0Z$K7@INMGGK"5%96E0HDT\%(4BH=IV138\&<*X1('-:^*.+=^T
MKX*PE-DNX9V:<T=M/:[-.>U\D97?/7';_M "2;RM+O\ AM<VNL%"4T7MU<GY
M:QQ?WLN:D'KE3E7S4BU8'"P0YQ3MIS=,8H.(X;G%'1"Q>(0YVLGTPOKJFSV+
M8],6JU3E3)45M6E4I3)/QUBO8:U_%%<;&M$$UBW44@@X(Y7Q8QQ^'R8(M!>K
M$>#_ '@JNRL=&&R*9;=?/%KBTR56[]KMKT\\ U*.>MOFV16G3J_$.;5LU00"
M\ZYE0)L[,H)MK:<.#HM43S?[0Y90VV]G>$@)&LUH:;:>:"A;+[,KFXZ"IM>K
M*T1LA0X=Q[(=71C@82W:)1[(=6K#S0E*ICK;8JZCCJRH.B%J2%< VEIP6=5?
M1$LVMQ*Q2P4\0;:\8XZOME"JRI9]D2Y;LGE$9\W!AT5NUJ!*E!1!&NSJH,Z>
M:+HG1\I-JQ3-%P)2/8[HT/36.?7M_(BT5:M\OUS413+G\4-+L,6JU0Y@XOLA
MC089P4=;<EABE92I Y=#:-.33SPI5;:<[02%';085A*K+&]]G'!S.L<+.)9V
MZMMCC+R3R.A43:+: G,6@5>!51#RRXM*SK2 3ML@ 8_D5FKYGE)P3(7=K_,A
MP)<1)I1@J<#M/\H1+<()!SE[RWSURB51;4#W656/\LXTAZREU=>(B@>IJ)XE
M/#LAY)2TQ7UPUO\ H]C\T&R+FU@AZM^KD$>M]-3%%%2T*P7+E(>':PX>M^Z$
M.LEO2)DQ[*BT!R[*;7F\\2;1F)F08)K?;XK[:[K0<U*0FBEJ*_6V5*0\=A42
MEOSPI"F:)/&;]>V +Q;QZ(G3=2U\!:4E;8+?("U@5KSC&)YD-3%R#:2E#94O
M*P5H!R\T.IN@TT!4.I6HD8\45APW>A6)L4*G5$5!%/7"D9'/#P0INC+BDBKL
MO=;]1E=WM+LUYZZH4FCSB4&TTQ=;\7R+SUL4UU.R%(_#)E.I@-GW8A+?X9+)
MU/I<_@$-HJA9V%7I,,IJM7A]$3BKF4EIC:NR?WEV86W=SLW+:D(85[M%KXX6
M@I*$(Q6^"61RPWBL\U!#:$S"0Z.(Y:NCRBWQZ[*4UYP@E:V6P>$[>7'MKNMO
MT:X31333P%$3%X!L26L#XZ0RR5N2+??*^L'9O?.% *2M?(-#X"1^(JQ;#FPB
MUXX3US2;+H]:N701JM6,//TPBTG1FBS@9N65-A0-#<I=<-#KM5&S$8C:(<<0
MU+:'9SF)8S!=<UNWIJ.BSJA1"=(2P/K"$N7KW.M!LX<QB759?895Q6BZ7'L:
MJ"ZE.%*899Z\*XQ+66IR9=<5=MN8(32M<"-4"IEG9=Q%VA3B5)?!J31=K(8P
M_,A2IDC@*"&T2N'&!396?]_CC@2[.B6D]<$IOF\4=9?).O96F,%=AW1H0D%$
MHB:!5A7KX-!X*X;(;HSHR1E4FTI"YA2D]KMKJ.FOY$&8B;>++I6YPJK:2@#+
MA$)-:=,:58:E7EW9L(*&R@:JJ2"<#SF$A:6&2D6E<*VK6JIPPS%.: @H>:DA
MC-3 4IL:E! M*X66 AELS*UJLWA6%V<;-FZ!M=.4,H_X=*S5;TOK>2K"A1=F
M@^,1+.VQ-KH2EIU+:V\[=;'BLVZG'*)UBX6S*CUI*;0&RVFU2UK^+\BL-N#?
M)ES99F[.^!^IEG"G&U;V3+\%V3MW:MMOCYP%V%I<UN!05X12&EAMN7;[W7A0
M=N^,_%#:<23C4UQ\,+7#AMH0CDFOGK!)O=(.5/X5O<IZ6@ ?0*^*''K4[+Z1
M[.60I 'ZZ;$2S@EWFYJO"8O;/^:#7TPL'>,P!@IUQ#@.O@.6H*QO9[:[=#W$
M3J0_+)EM2E(4Z?V:@I/HB=7OB83,ZUI2ET##B)LI\?\ W@OV74MI4&F@A8LD
M6JVTTS.(AYJ\T0SHM"2T6W JV3:! =O->..6= ,@(4\/^+#5I1$HE)[494 $
M\]JS#?%>Y3A;O/TMWQ>BS"54G'W/8YH-A2-EVF@@N?AC+GL<J%@)U\,0AR\0
MOG)])B54&5*KK!&/AB:3?2,O(^R%:EJ>V6%VQAX(WP'%ET^N/("%/_LDV1A"
M5%+NCUU/X()@*SQ#NW;C0],-N6&7&^5:IS5KE$E259E"XDO+EA,V'<J7M?EA
MLG[EZ/;6N]L+F5*0."46EDC$8Q*/4;5D5-5$@#V(7@]YJ]-8PO%6>+F[SDX^
MG\1 S^U(K2S]JQZV#X+/QP>N5YJ6?CBM8YX2JBD.?K ^B%'@(;YR3XZPH6Z&
MF7G@:P>;P1E!/Y$^QB;;O&JM<(AUI0Z$K!73+5SQI9MS22+Y1L60S=C75% >
M?5#+K2'$ONJNE,ME-BEH+*D61JHF)5RW*J<>1<S,E>;V76I<#Y->C"-'N6-[
MU5=;W2Z%Z[R\39\'QZXE"#).RA3=72U*1C6MLX]$28N!.MD55,N@MN<G!L5I
M^YC$PJK,K+$U=8"JO]MM8^"SD.C\BYE12;([(0JB[-D62*T.W;"<2W7VT%)X
M6T<?GV>*+44M1ECM_P!HRP[7_P#*+-E8/8:QTY10J4.3C7XHKA9U)P\<4[#D
M_'C%:@J.NE>:F48DE.M7Q90IH/BRO%T9*K3*%.$M"WCJ RRP@(M&Q7$5*N?7
M"58(73 U#?-3 ^/GBG"4[[(:64^GS13A)<]DQM)Z8]:/3%+6,5JZI'L?8CTX
MQ9LN,LCUI=L@;*5.?3 %33MG_P 84,*_;9 *B@-H-E*:VAG6L,I"+24"A<XN
MNE,^B +LIIFW7^*%\#+]WVU<_%^(M+M[ZI_RUC?/-;XG3X(4C^K4_P"8MF7I
ML1QJ[,=L)-I+JE>P%"2.=Q5GP^"L.IN''6>R9LFFLV]@SP@IRIK\\$\((UG5
MK\42[=I4VV?80DCFJ*Q*"];FW<[OB<^VSMIKI$F+Q#.O?%YO?GL<>O1SP*WD
MSLEU)#YU55Q;)U\],H>X("L@:4.J$:SD$\8ZA6M*[*\\4.S\A./7$O;.39I:
M/MS3PP&;MF9F.9!"M>.Q.<4O&&CV#M37]0Q;4M=LX:D#;3 X0ZG@D'!#M*J[
M99.5.QIE#BB!9I0.4JWK%G+'GAPV IS,*LBYRIJXWGAS@E3=<5V<.3X=<*3B
M!E77R?\ >%$T'/A^KX>> FR\:^QTK^]%"W,?;9^:,BB[F-(N*];FKJB-MB$/
M4GI17L+*'D*3K%YK'/4:P1#B+:YMS4IQE21E=T4":[:Q,JM:6:GAQ6TKO!J>
M*TFF&JR3A\0B6LB8T6Z3P$F:+^Q&9;KMK!=KI67G3E*WH(U.!8LIK79SU,5M
M;[<3FX $CIKZ(T=26;D63E)IFJU[(S 5QMM">#7*-&*WNF39.;*IHN5_3%13
M3QP>$V]*Y$*JD[:JJ:G73GC2/79*5EDIMJ;5BH<$GAUQIL&0.&&$*IO33; 5
M>&:WE=CBGK5"JFRFO;%Z+"4TQ"0/$(5C^09Y >;+*_6;2"TH;4J!.'3MA#I?
MG$2SF+RV5W;G840UK PR &,):_X!H=0-77GIH*VBR]3$:L(6@7\R>PT<ENU[
M:]3YZ<U8<I:T=-$7DJ[?WC.6*>*K4K XTI#J"5Z/G";3#H?O%Y7EG! LZK&7
M/G$^BFCY=2<"IWU[61><G5LB>; TC+H% %-5)K6UUL>**U?8%,PYARJ5]$)0
M"W+&N:EU/*X7FI"S^$3],+!8LJY%:5_6M9<T3K02\V0*<'+M> \=KS?FC6BV
MW.SQJG[<T%K%Q_V0THB <T]O]<Y[.71"TXI:]P=FWIA;MV G4HV:\HG#P8^.
M-[T4^R>,T$%WVEL51TU@+NRS7B\*T=1V030%65:011])RY>K5A3_ +0LW;Q=
MUN>MIUX#'"$HO+MQ1L!RUP,[=GGU8Q:K19%BT2%*Y=,!P=44_(2T7D-*N?UJ
M4!UXBF><(-W0:L2!J%=@U0OKI//2O/T[>:'5V5MKU2]0!JZX*'"'5=:;:&4O
M4C_,Q,+5;2!JV:O%%"34D\U37XX>%7 =GR0\:M@#5LZ8M>>E>?IBV3G_ $)-
M!2$\'$Q;,9_F/F\K8$FG32&5=8T97C*,S>UU <6O3$Q6YG;(M*2]+$-]KZX*
MT.L$9TZ(F"G?6Z!7&2IO1Q2Y3UNC5% #,UK0V:1-\*3;3V-4W)_>%O[&)YFW
M)SZ>SDER>]::PXI)=//YXGBAR97:XB42^]5@9FRF\P&SGZ12'FTF<F;?]82A
M&\SV)JCKF7!RVPY_49+E(M5\HX3KUUV?]G,7'#JHGHR_(=;$4MX^&./'K>44
MM)43S5\>$4J5 ZJ5^*$B%&D<;&.-A%!%!_0N&CB1MB8HA"-1-(=9L@=$(CGU
M10Q\4:JZMNK^2A&8_,%8QPSUPI5 =BJ77M:<:% %20< -?HKMA2S0$YKP4.C
M*NV%=< 9.3>+7I,+7>A->SSY[.V+*U@&O%[+;X(X6KUI->%K/QP#66IR,O":
MP,6RK6?RN:*?E O"7%N]F.U'L>#FJT<(GDWK3SBSPT.,[T=RODVDV^!V-!48
M[*PXZ3]UCV=B4$A[D7_QYPRL)9=2,K/7#M-/B.R&24Z*FDTJ;2+MW6X+>.&J
MSYX84E,O,C!2;+=B9UN5'"%C--GB^>&+2932P'KBER^]^9-KKGC'BAVSO'22
M$8!6];CI!%Y36.@U\$3JE&60$>N@M7/Z06DWM=E!MSC2#K:GA8 N@VV&*=BJ
MP+RNW&N?_H"INI Y.($+-X4K5QF\DZODBIXVO(^B FSP!EV//MK'%X&KLQJY
MHME(IV79#5S<T4L@CE\;P1JNSV?&\&4*%K@G(9^UV0HE8J<QG^DV4V4\_P#^
M\?\ _\0 <1   @(! @,"!083$ L-" ,! P0"!08!$P 2%!4C!Q$B,C,@)#9#
ME:(0%B$P,30U0$)24U1C<7:4TM7P)4%08&)R<X&"DI.TM=/4Y$11876#D<+#
MQ.+C%R95='>$A:.DML71U@@W161EEJ:R@(:AL?_:  @! 0 &/P+_ /EI,IRP
M"*&G-,A9QA"&G]N4I>*,>)Z,9963Y-?%+1'4]G]%&/D]FB;Y_BR^@\?O=?%[
M)M?<3(?Q3Q[)M?<3(?Q3Q[)M?<3(?Q3Q[)M?<3(?Q3Q[)M?<3(?Q3Q[)M?<3
M(?Q3Q[)M?<7(?Q3Q[)M?<7(?Q3Q[)I>XN0_BGCV3:^XN0_BGCV3:^XN0_BGC
MV3:^XN0_BGCV3:^XF0?BKCV3Z^XF0?BKCV3Z^XF0_BKCV3Z^XF0_BKCV3:^X
MN0_BKCV3:^XN0_BKCV32]Q<A_%/'PZ=J?[VO^$>AL/\ A#LOY3Z7KOE_N/E;
M[+Z'O./9-+W%R#\5<>R:7N+D'XJX]DTO<3(/Q5Q[)I>XF0?BKCV32]Q,@_%7
M'LFE[B9!^*N/9-+W%R#\5<>R:7N+D'XJX]DTO<7(/Q5Q[)I>XN0?BKCV32]Q
M<@_%7'LFE[BY!^*N/9++W$R#\5<>R67N)D'XJX]DLO<2_P#Q7Q[)9>XF0?BO
MCV2R]Q;_ /%?'LDG[BW_ .*^/9)+W&O?Q;Q[(Y>XU[^+>/9%+W'O/Q;Q[()>
MX]Y^+>/9#+W(N_Q=Q[()>Y%W^+N/F_K[DW?XNX^;^ON5<_B_CYO:^Y=S^+^/
MF[+W+N/Z!Q\W9>Y5Q_0./FYK[F6_]!X^;>ON9;_T#CYM:^YMM_0>/FS+W-M?
MZ%Q\V-?<^T_H?'S8U]SK3^A<?-?7W/M/Z'Q\UM?O"R_HG'S5U^\++^B<?-37
M[QL?Z)Q\2TU^\;#^B<?-+_L=A_1N/FEK]Y/_ -&X^:6OWF]_1N/FAK]YN_T;
MCYH:_>CW]'X^7]?O1W^C\?+VOWLY_1^/E[_LS?\ ,\?+NOWLW_,\?+FOWNU_
M,\?+?_9V?YKCY:_ZAG^:X^6=?X!G^:X^6?\ J3_S7'RQ_P!2;^:X]/\ ]4;\
M#CTW_5F_ X]+_P!63\#CTOO"?@<>DU_>$_!X\_WLOP>/.][+\'CSM/\ _GZ*
M@)(!+&UL6-$:2F6UCU5F]/Q>*$>;S BYXD:/KZ(<H_$(4@A$':>$BQ)9%UGO
MKXLF8B^.U/E=T.8@SY[!H</2G8)].+UR'O>(!KZRO2&/3Q0@LH .FGT?T$/I
M_G3\OKG]('Q>/'^B6NNOYWQ=>+CPAM^(R_4L4>(1ERS@K3HD*LP^O](:T:ZC
M<GZ46F\'T)/G;\OKGXXZ$).<E>Q%1N/++398FFH_ ?-.'E^M759[@]T7?;7I
M1D$+YZY.://XN;D\?E<OTW+])\]<G]OY'Z)90\'7E,IC]P<$O*^(<=>Q,7F:
M\_I.7Y'&,+<F@]84==,L-/SCL+"88_=[Q2^J.XT6(5E0S.<Q-?% 80QYI2E^
MXCQ.RHL$=L:.,B<CQK$";#, RG&90)3@0D_-[KDW."Y3ND6KU8DZR!H]^J8/
M+S+3C#SS\\H[6WZ7=A]4X[:7P%XF/<FK&CDK)6#LE(QYI,QK^3GY.3R^[W1;
M7MO%5<8GCI,C3?"T5G65B"NG7ZK2A#:+$T"<\^?J!EV_1=-[;N#X3-#$.FI6
M#%":WC< /H"08S_L6:HSS\OE'^[X1I95\VQEBL2U?B>0A5 &V8KB(6/2DA/Z
M?O&5OH/JG']OA6=BQT\7705ZNNT<NXVWS; .Y@3DY^67>$VA?5B_&/R^N?CF
M7)_"WE%QN6Z+/44=5UJT.;%\?#LF)U$.1B&SSDA]3(+Z?CV"^$+_ .W?ZUQ[
M!/"%_P#;O]:X]@_A T_78]XO]+X]AF<Z?;H?%_I''L2S33[=)XO](X]C&6Z?
M;J/%_I''L>RC3[=5XO\ /<?,/(=/UU;XO\]Q\R;K3]<CXO\ /<?,^TT_7*>+
M_+X^57=/UP/%_E\>B-I]N'B^ CH6U<97>HKT\42:B$DK%9ZB@O$2X8#YYC@P
M7UPQNE\KTHQ=UQ152.A-8V1W=6-!61*C4VBB,S"5E9+0(VF$DY;A"5XR-;:_
M==SN\,P)JWH=$]FB>#CO:10E7)*.T*RF$!W%1PY>E8<AUY1<G5][N\8M*R85
M?K['&9M"&)9F%@"5?6IGYCNE=8&Y(\)RW/6RVV3D]+Q4LV4ZQ@&0ILLIKIJ,
M@G5F#7SLQ@88DZQUX=F$X%/TR/>P'W7>[0L2+*"WCO:9BP<Y8$\4& UJ[<8K
M]_Y$-XLO2;O=>V\45QKT?+;@@ZQ-"E>LY5BTD D$+LT-AUCNXU*<YMK_ "L+
M;#TI/EOA!Z<EYS97@6<U-2ZKZD^BD+>@,G)S_0$'NB]$7CT+$_V(7CX^9=O/
M]C2\?^7Q['LFG^LJO'_GN/8CFL_V.D\?^D<>P7P@R_NZ8[X]/XUQXNP,CIMJ
M@:^+>UO01GZ_1U[OO9\^OE?(_4S^>H?KH_HEF7W-V_\ $3<4?]YZS^)B]5D"
MZ?-JQJC(D80TYID&(HBL"C'Z.9 B+#]UQ2FZ]00D*H 'M9F&/IS*!C$^[&<_
M(\J,I_9.;=^CXN7Z"M934$^&<QD6 OJV)$ZTF&H16F3G"/S^<G>^MY_4^%;;
MK5>S0U893TW!:<NT&,)K2%S^FYX[&Q]4[KB-I7(&KDV1-:A78 !>>L82F'=V
M@S)#D)./=$W.]%P,I)1@,3MD2<I:^+2(X2C.4I?N.,Y;)B^0V\\K-J.OL$:L
MYTE5:Z<NS8\T(>>N6(^JV_SQ?5>*QLD])-KP[/?T\?EZ,J=SS3^DFP':/_A>
M*QN65EFD]E=:&NKM:P&FE2PQ,G3L18ZGG9Z3EEY!(#W>;Y ^"@N;Z>0L$8U+
M!HB0TM0BV@PZ7;"9CG\N,I[GV;['ZO\ +ZY^.7+>[N:VU@)[EV^38V*JLJ]K
MGYR;WS.ZCG[KTNUM=WND^.KV<Q^-U59I,)N<OD <(N5@>US[<]R:J_>$'N^1
M]D+PUNK$UDV[I8$+!QX+ W8@@G$RK 6AG0GL0V_69%NZF3ZH7C1!,.RKWO-'
MG(69)L2G(Y&#FF0YC,3E*93L$(4I9[QB\58@+<HZ98B5=&12ST"M,$5YCESS
M[[N11AZXW>.H5 ?FB.8%QL//MJH@+R[H$%66B 0#/EC#D3&,6W 8O1#VN F5
M SS+#.%70UE8M"469C"!5E5V6B+K+<D(;0%QC$+DXK$H"86'3@Z:M(H\XLRN
M#;@O,'5!.,\PDA 6[ A"[NR,WIAB+P!)0>VNO#D%#FE/Q1_52E,DYS^JS(3=
M+ZJ%GS0VX5IDM1^5S[DV0L<WZSD%\]:?;C^B68_<Y;_Q(W%'_>>L_B8?5ZO,
M40.HF3GGLG<5 0G-S\TEUCC!/R_2]WWOMW TU5@KJ!ALB6"*, 0']+$4.[Y.
M.LE0+[O-S;<#.#5YO^)0,-3D_4;>UQHL,<!@@/9B$<>2$!\O)M1C#S(<GU/@
M^/II;-2U$XS+:-N2UG%N/*Q'J)M=7#<A]3)P"MK5XJI+1Y0 CK*>D8SE.4O*
MG,A)S).4IE(0A2EYN'>RE.D[1:DZW&)VBP(U+SBQB8Y!A_8U]L7F?4_C/Y?7
M/Z0=/MQ_1+,?N<M_XD;BC_O/6?Q,/J<CQ_H.G^%_5?3K.JW>JWO_ )?I1[.W
M^R%XJ<2Z#<[40*]VAU7)L;4'I[?2]*3>^5?/ZD7G>B[O@0[&TKT2,:^( W'5
ME9F^A[J)9CY_.CZ/CGYH\FNG-I/Q_$Y?IN;Z3CQA*(ND=?%KJ.<9Z:?O./2B
M\[D\^/I/I?U_%K7+']<TY A<W-(P%SEC.4=J7/WT.04O1\9(VK2:=D8^*TTB
MZ6R%$SKE8.!-B*< $F$!(>W[A-KR.Y^IUUUJMHIUX9$Z?0N_M\A)"Y=WD'S^
M;]3XE 9A3G#SX0G'6<?UT?H.):Z3AKI#SI1E'72'Z[C<W!\GU3FCR>=R^=Q]
MOXNFNGJ?R^N?G7D\?EZZ>/ET^+KR_3?./CU\?BT^3KXO'QXXZZ:Z:_%TE'7Q
MZ:_/6GVX_HEF/W.6_P#$C<4?]YZS^)A]3G<:7(R8],)E9'(- ;_41G'R8RB8
MR_)M\LOW_&,@N+V>0,3JG20;(D-+40>FMH[.T$S'/Y493Y_LO&;3Z3#GFE[5
M@1X99!PK:J(9%@I)& .<:Z>SR^(T/+\F/C)Z/BFJ'WF;N#V1]GUP:=EA%9KD
MES"K&V[>M@:%= TN0NVO]0V2]WP@F.LK:+1N@8U:KJ=V;:Q(QU/,16.91+E8
M[J/M7F0B3=\OC)[)T,F&4,MN1I^,Y] K[L8Q.6((3'#>)#R"$(,I=J,.,[08
MK%IAK6D@UX)3/IL 85;BQ$7?<\X$XS]\"4=+ ),JJPFAN:DT0@F*<5(QY_,Y
MX1^R<!8JRS@R-& 9&!+O0!-;;3<HRAWD)[$I=Y[5Z7C$;W%_$&ZF_5Q696.3
M4UOHV&4CB8\OD-!B?+N_KMKVS:XSG%0:Z0EF.M6S30\KXI[QB-=:ZQ_N^,IR
M<GU,7'^Y3K/<E+,U]-(RU\1=<=F/2[F3]?Y.LRD'[;+B,(Z::1CI&,=-/D:1
MAYL?4_E]<_.A33^) ,"%EK_:C"//+A9HWQ67@C</K]D9C VU^L7A+IQ?8H?.
M1Z_Q]VPG&Q7AKKYA('Z=V,8_2=ZH3]E-/ZI\]:?;C^B"V,^$-)7';MPXU:6X
M5(6>(9:8L>Z%3V#/EUEV2<9_[U[4G7_\&M70?77P,Q^YRW_B1N*/^\]9_$P^
MIL;=-3:L+;4>M@??9GO[/F]T8Q !_P";C'PKD!5>:W1 195O?:TVP3W>8?3P
M-T\_3E[P@RE\KC1VWIPLM1T\6IX%95(2,(QA'=DF9?>VX1AM=1N;7 :9FJ5[
M.6E&:JP=)*Q6)#F[U<JTQS#/RI=X,G>\Y-WA6P2K8A>4"4(6>H<F74;/D%DQ
M*9R=3,GUPQNE^R\.=F*]-V@X:P<[XY]YLOI2=\<G)N<OHQ[0OL7 <CE6B[:!
MKS0=',XIZRV.GYBB"88#3V.[]<#+PTM7*1 !YL[K0]2'8T,RQ&,6"3ZF9//Y
M8]V/NOL7#ZU=6+K+6DN9];QD*N?NMGEZ<TR#A#D[O;&(0N-+-"E )R,^<4YD
M9/ !/IEQ,F( ,_V,?=>U<5]RZE$UE5?*+&I3PU#Y7-Z*!AKF\ORQ=0,FU[5Q
MIDG0P[:BOTNCVZ?QZ!Y>7EZ??Z?GY/(W-O=VO;?5?E]<^IG=Y/: JT(2B*,R
M:%*=EB?F@44# C#)_L:XR]U"93;01E+P4?@;\'9&ZP9)"GDV5ZP41G+S)]./
MKDE^<?I.3M-IKRX;M>/T7&Z3-\$H])?%Z8:(&)P_4^7BME#_ +23C=CD.!95
MII\71;5==69/U,OS'H!Q^^> T_AGPBRPUL^O*"ZK!%L:)GD]+*,('9)R#_\
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MJC 43G:,N2-8*O+4@(X8#'D[O]BEY!E;X\/]Q.Q%4]!FMH:-F9,EB)(G8]=
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M6P><ZCM IH=0&:Z.T04">B],+TG'@7TQ [C&-Z8;G$*8KO7]1JG B<(Q_-.
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M4^[(,3]47UI8JC-M%:XR?[GKG^3F>,8^YZE_DY?X&04*12SLL8G7BMAS 6$
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MO%GB2MHL2^J0KG;3YX^/E9W?)%/G[XZ_3EZM<?>J\G?;6YPX"GNZBU-7EV+
M599)NE1/"7)L.B6.0BQN>$_(8VB^1QCV,IMJV[E\_;5TYU;Z#4*ERJKI6116
M<0G(0,R CR"'M[N[ZK3[<?T.RW[A\!_EOPB^HS'[G+?^)&XH_P"\]9_$P_ R
MZFJP=396F/6R"2VZ &^TRF8(A;K4QKPW)RCWA""%Q78'D7@U^%JK#BVM 7*O
MASHK;;(M3= NQV+7QZCUQ.$.[@R3:Y_2DXPJJL<&&.>*V2K=AEK^>Y!:4C0Z
MJ/K1G',95R8?1VK'-#R+&H6JT.4XNE:$08N-AE(.G@WI\CN<]I&NK5GJ2_NT
M%ENR^BW^L""N>8L[ 1"+;7EP[WAW&S89"^T;R8[X<M=SS(%<6A3MV<K*4K#$
M:S)JER=PG#NQ 22Z4K4P-FL.[+NY\PU5C)C^5,5UNA> L%==@R-:K7SK&ZR<
M^T(')XBG$Q#=6V@SW3"+M;ECD-=DD,%JJ2D7HL>>+34F5ZVP;+US=DA7LN_F
M9W\1+E(P,;11"AL]SN\/XEDD8F!2W3T,?MH$6VK:C9EU(CQ4"TPQ7S&<K$.C
M8V]KG&(.Z(>[\&XI,<1[2MV&J<RZ?4II[L5+9-LOKAPZR\-L I$[PGT'&38A
M=^#\.!28K535EHQF53?@=L$+%-R-<452$9TX,07GNN=[M?42<#>M\ ^%M!?'
M+"H=8N\[O<RLWVK2,5FP4XIY-95B='L1ENSL4NO:[C946V]WBX#EXXJ HL4;
M\'N#NZ-*N39J&7'Y2NY"5.4BQB*]E+[#&T7:7GZ+C":NQP80YXK9*MV&6V&?
M9!:4C(ZJ/K1G&L95R471VK$Y0\BQJ%JM#E.+I6A%&+BTQR^JQK02O;=RMM O
MJM+W"=O8MV,2Q7AZ\2FONQ&4;@Q;O/W.[QX1S:^!6@SI/++2!*;([F^Q56=2
M#L\2>Z)=J#MN.$#=^4:Q$6NY[KO=LO&.T=Z]I8VU;6B7=;B4I])%CSSVHE-
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MH10^B9#WI<+@2N*[.]Q2MOM+3*,@JZ#6PDS'D[.2L.RAT]GD?FD*F3L%7:-
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M-^>W.VKXH\OZKJ]J>GZWC!-&N;<Z2VE#F\[IYY!;S5_:Z60MO[%R?&,M^X?
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M_P#F^/F!AGNL_P#S?'S PSW6?_F^/8_AGNL__-\>Q_#/=:P_F^/8_AGNL_\
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M3O99"J"M#8+U+16P/HG2LG.7IT[!)U4=A7G)S1)MN+*]U.!>,MRO'"CNS8E
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M-\XI[OK[2"FY&<!]+XQ[A/@Y;]P^ _RWX1?4:_:U^,-6=FV%"O1"1AMQF<1
M &$>>192GPA6K63JQ;>7)3L6M)<5*%P3Z"-8[8)+*,S)S1VA[FZ3G[K<XNU:
MT\S&QZT)36L9 *+0#\!!9D*,C0'O0Y"B)N#W1>7ZAFUNGU:VN4%(K#;4XP%
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M 6OR.: U)E)&/TY/AA%N_5>6'U/BBQI/QZMY3DZB^@8Z^G71$8NW[HEK.*+
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MQK7D8F/J""?5+M*;U>7IN]S)&MR'LVNS/&Z>C94)2@8U28H55D*]]22SU:.
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M+1KG%V^PHWQK@9(4GK>4%$UT5>EW9_+7>B+X6$C6LL?QG+[NIT8C.I ^>VJ
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M'2=B!Z.L%EDZ['$J[GL.]'TS[0O(V1=X1H: Q=0*T4RMQ*UJ4[O$J[+;NC0
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M69T41 (T #Y@=S,0G! N "?N(]5)H.@)HJIWX_\ E[RCI>$OV. CWFTX&W)
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M'":7Z:>1=8.@^$ZP([&/8 P0\9( EL;8.#4X(%&=D\E+%!R$,12]KRTM?$1
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M'#&@L83^S3(4'MSH A!["YR&$)XUME(7,#I@'=^!H#0$_P#DN/MT Z!">@-
M: G_ ,F0OKD8Z!">@- : G_R<I(%@V/#8B""Q#'6'0(3T!H#0$^]["*0YY+=
M03.WCG;JD;BL3JR22222222222 6=)99999>61Y=D-"0       =#3111111
M08<YSG.=C]VC]VC]VC]VC]VC]VC]WI$@A"$(0A?H%_0+^@7] OZ!?T"_H%_0
M=J\YSG.<!&,8QC&+&,8QC&9SG.<YS:UK6M:U:, X8J( /_ZAW__:  P# 0 "
M  ,    0
M                                  20  2     (   2) )(20
M20                                   ;PDDD M+VDS[2_7-M)$;3OM
M2O\ TV]M+TFRY&K2$@,I$                          IRMY!4?(Y/OEV
M][,V@,]H+6O@3;+0QAJ[76EL@!OB@5@                        "=?MB
M3LFTD@&420!2 'TVTDK9 )/]O_221$FR4@&P&R5@
M    3V0 "VT T      ! GA     "VT00"$( !
M             IP $NK#I2P     ! "Z#2@QQ^T<.LS/*B!
M                      -  1^@Q7L$     !  UD"B@D' N(D@F>B!
M      (                        ;P &">,B@      ! $!"    "&&0
M   0!          (                        ;P P]_%_@>     !  !
M  (          !          (                        ;P 6\UXJC4
M    !  !     6 4$$4 ( !          (                        ;P
M %'LZ8?0    !() !  !( %VCY=P   !   "      (
M     )!;P   @0"      ))( !   ( T;F58P   !  0&TF"VVD(
M              )(;P0@   D $@  !(!( !  !  VPD$0P ( !  A\S,G6=B
M(                        ;G,BAPD&P+26 ((!)(!  !  D  $@  ( !
M M_[ @6_P(                        ;VDT/@]2^-N& ) ! )(!!! @@T
M\X0@6( !( F[Q"S/4 (                        ;S*V^L0,%-@@ (!)(
M! ( ! #+T96&"$X))( ?-L) 4C$(                        ;U5"I*BN
M&_8" !!(!(!  ! F4 F4DT$( !  "CF77"$@(
M ;R:I?>G0RA02 !)( (!  ! "       ( !   2T5&86 (
M          ;FVW:DBF,B&0      !  !  @ "    ( !   $VF 6" (
M                   ;P/;$T0NW:@  DP%  !  !(-L+$-!]   !
M   (                !       ;PDT>P IE*P  (/C&'A  ! & ;/J@@
M !          (                !!(     =4 $P    $0  .X+@O5
M @ $      !          (                )       :P
M QPVQ              !                            (      -B0
M          !  !              !          (                (((
M  ( &\@      "  0  1  !            $"320 $D@   !(
M     (!(   ( !_,T"6R0 !6HGG+"&MA/U(LO::(L C*W(6X'AMM"PG0T
M                ( !    ,RP    -TB4   +&T]OBR=/VV4OUK;20 /[&\
MDP/-@                    (  !(   @      "       "
M      "  "4 $                     (   (
M                                         (        (      (
M         (   (                                 (  !
M&P$  @("$      !  (   (           "                        !
M (     )$*2DFR0-0P@     !   ) )) ! !(#-?4D@DH!( (!)) ))!!)!
M     (  A!(      &\HO$*6G(VT     !  (   (     "!WUM@D@
M           !   -T6&LD0    %2\,!![<?T@        (   (
M "                      /+&Z/S0     &&B@""8D2         (   (
M                         $       !P\KM6         @  ("
M   (   (                        B19,)_(D   .//B;@
M(       (   (   (                        CH/R[40D  #*7GM.8
M     "2$ (     !     (   (                       6+N5#%)CB
M)ED'JMPP      #V K<     )!(   (   ( $$   @     @ @        %@
M[.RDPK    "A$$         ZO=]H     ))!   (   ( TRV"4 6T&D @2V0
MP        :KV?&R           !(    &3XDX     )!!!!  ((!! &?A]9R
M0?W3!3"A43(  !(( U/PW#[D           ((    ^/S-8     !)    (
M ( " M]U];+ +5:V]\D     !  DP"&V                  8MDKH
M!     (   ( &&&"PV2@T$RRP40@       /Q5^W;V                LT
M"!EBV    !     (   (               "        7M#1V%@P
M       >C!]DV0     (    (   (                        &2P4"8@
M0               (A-9A3@   $P     (   (
M   +/!!00                 B20R8    P6PX<P (   (
M            $XBR4@                     (    ^:I[*" (   (
M                        $                       (    &B2FTP
M(   (                                                    (
M         (   (
M      (           (   (                                 (
M        !      (   ))))    ))))    !)))(   !)))(       !))))
M)))((
M
M
M                                 /_$ "X1 0 " 0,# P,$ P$! 0$
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M=J<+# 4888$^3-"B<>HP] \ZEM W,34B<@,Q<.D$Q.9[IR2G 86*:U'.CH(
MD"("6%R3$D (3<1 HNS*PL*=M9&*<)827 LY98"1*J,P;<1B-S-QDU(G:$8*
MPC.;2&)*;-%)TBL:"B&I&1(17*L"354)5.0B.R1,GN H)W'=*VYT,@\@^?\
MT7\G<>QGC!K>6D05BV1B9J.^]:S/99(@ZSCI[=5/W6UF"%"]4TU,O4XCA>)V
MT"@@HS"6,9AWC>,:R;&<HC,Q,1UU)N+)8L9.2;QC7Q!]8U#L<L-F>J-XG6Z;
MX-Y8GB>NN>SLG$\3M.@68)C,7'>,>NA$41#*6'?CUT(X1[(_Y">J>HA5HJ&8
MF'KTT3]B#B)6HK88!:!W@10@J:P ]"*F8.LM'L2$0F@FZ$&R2+P4C",N0A.3
M)B7$Z5PD*YB9L66!B'EK3;@V7$1,$A2-B>+!@#@"))@"%"0,E;:F@ DG!71
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M@T0H0FPB)4.%F<$N9SJ=X8MJ6IM(=]35#/K#S01ONG(#M$8<,I%0"*G)@30
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MRV5@E,1>B;_;R 1%A**!B$ 6'V!(32"B;2"0P%$YSI@SB&,Q(W6AI5X&=@1
M$IF\-.1I9'@BM#&R=0A19L R;<B*FPB\SB9(;-@J[?2L^*VVN'_.0D#*8(J)
M7:K,8TUQ2,EF(DK+G ][E8&",*0&7(FXDYC&D*BTTTL3@I\:4$3"PJ7L-OII
M$Y4SL3B9B)T"S L6P+!R\8=$B1#,(QWC'^ES1GC6R[&78[NVN>F>G?7'7'7M
MS^W:=N=OTS1GC]>.N.O;G69BXST[\>NCN=K^FNF_'Z??'^+GIGI.)XG_ #Q-
M<UYUED+"S)8JW+%/TTF7G<@$#-2"(\ED,L>L0):42H0@+<$HS$1OB T0[MIF
MF%]M9$0F51D2 LD#*18UH=4=)H1P0,J(5YB1#20R7%""H7"[PE)JM!0YQB'4
ME4*3.!?"RT*[HI\I*UBC$0) AE=X3V.\!%N"B] 6A%(S>P!!2VY#8(WD&5J4
MV2)I)S#>C  5 S=0Q-2 186TYRC&:@:V3?2N;=*/=AIAYMX@!D)E3PQIV1%K
M!C!Q,9_P;SOSOJ"(@CB*\:@X_P#03)&9KOI^".$$!()#$.98*<:M:($ U@BP
MQ$P@7H2H,\-5Q*!3"BZFX)I2,>#<37D(7(ZHT](FBJ$1(-K:2IBEA1 L$$)(
M+A8WI72#)9,&K1PK)4;]=+HK,. I-##C_2%H<IIG\"V&BYK+Z=-##6%LDE#=
MW^VB2'>2ZD=EBO7IJ\6(/%&^Z/8]ZCE2,<),[1OSZZ832I6.J>D1O9.^=#")
MB!%B=T%VRUTGTT4$1*R2Y3#.\CZ3ZZB,Q,^LG#O'R=,F,6KT9ZS<_P!WJ540
M"FU! S,JDP^FD8$8JRBXCL=XYB+UC;1FQ"N<YV-0!&9T.Y?1CUCI.HE1BRQL
M7G;"7.D64(#D$I.T/3CO-;0KXCB!8D)QATF!*3<S4R;YOMWT)M$9ZW@>VT^F
M^F)%A,JQN=I+GZ:&#B#JQAOH8&F#Q2\'$:"6VL,UMMM<_P :B>.32:AB3QG.
MF($"R03&R6<D')=:3:9((8C DC:'[5J:,H>3+GU[FLPN$N\-1B&9@VO.F(IJ
M*LXM'O'&^A.'1\>G)_G@64EYWTVBVE#N;4Y*XTB2209%S+.\9W\SJ"52I;B"
M9923$3P=A$1)LI1#!+B2#$[;:0^0W:IR;!"8$W:T$FB1Y1 P;2,>UZ.TPPF&
MA#!.& W6W1:@9&6W$W!%;LQJ$N9@"3+H+0F)C4 M(+(TD#,*JM\RD:OU&,H9
M&*+F9 Q/>M"EB &4YO(1Y;$Z#=OY+ HV0Q"C 66KP[;;3_I!L* P%HR*Y"*]
M=HJ1DRA19(9$N^VFSN))0" %!(+BX-M H!9"LTB0E50BUF<:)*ARDL5!V,83
MZ9"5VH/2$90 L<&Y.D 0C*-L)U& C'IJH,4#:G(9)6;V_P!)C1#VIAPX)C&/
MQ-RR F!8B$IA%$IEJ$#BQ,'#+?:Y>8];T",1,YN0W[=;+='G+NZI+1 8E<5.
MDNY;=A3W(#A<5.@X.D=T:S#1$YN.-*D@G(E@HPF$3G;G52.I+2,^CSC4$)2[
MB 6;:8!4+80O1,-A<4511J"G&9-+G(&"&6%,!,4A[31:4.W")81G!%WG6=-%
M*,CQ.(.8V,FI[S7G3%#7'I/C1B9BF)B^B*,9[U.KU "N7V-Y9G:&*%%<(B9(
M&"@F\]:U-M5WBBQR&_%:;%F&%A$,5$R[<:!#,%.$2)R(_G2QD.\5L,",-Z?;
MCZJQY[_WJ&41T.5,\\?C4K2S&RP& H0ED!FIU",3A$ I*0))8>4ZCZ!5&2@8
M-I"I%$K!I%@V., 70!WGIIL<!C@#9,+#"X1WTX&"VH%-D[Y_G32G"_YVQ[.A
M*4%=0Y1M)G&@\E6BE(FU2*J1--*PQFTA2'3+ I,EZ Y8C!P3DMDB5LZ@4440
MHQW"*E 5!@;[0DV($V+GT$5N^<>&I$D-B28:$,6@P-7*# F1)04IU/YD=<8\
MF26+-MU!H70DZB6*,H!2&2)3&I>E$@DH&L1, 0)%65%3D+(RLPJ>9)E0Y8QM
M_HU@7@7QH!)+(F>2);/,.-4U"/$2*L(S*7&_0J$@*1 XB9"6)6K'00$0)3D7
MEE2!A: 5#49)2AH)0E*$H 7+ILS0H9*,S))2LEH6Z!0O2D)$$DFC$J,^P[,2
M2 J,*A1$A2%,$YW_ -'$T9:/752G"RCN,%<8AU1>H40A DMBLQ773H))(EW$
MD>!ZM=(# ) !!NAVSYFMC23I%,#&U!A+HY1SF8Z/26(XF?7&I\&QG!@^FRW?
M4:&"B1D8[*>]YU-I6JJ*I)N653+<LSJ&!*:9PK+26"N4G(BC"H1$@@&96)WC
MKG<DT0G-Q,$^<Z:Q/IF:%B(A)7%S>H%@#!, ,&Y!L@EA5NBE-J%K@A^-HT!&
MBA*!B931.ZXTK4E>LHIR&R=I%T<"(AJ2 0@A6$22QO*0*]+:1%65E667?G2[
ME)6P2%MV\:6Y*2YFD-^K^-#: )&P0T;:$LSU1?R7\=.T-OAI_'0[:$;29E"B
M2,EQ.^C+5DDJO*Y@#<QYT@22013"+%2JU4 ;C25@#8I4D]20EE ,8B?)Q81)
MS,(C!E(20-B3,)@V%ZF)3UF-1%<5_P"!9N8D>^(CB/>+ZLK\$E)"[)N=N'20
M.X'.49.7@E[=&S:2.@F#M)YC?5$1 V$UXP9XT2HAC9.>Y-Z$XX!-F173C;4.
MH:M\RKC$9T!3:RBV[GW.AH4*LN(QN;G?&HC'DJ<;0==7$%'\\]?]&7B^UZ<,
M<:&RD@S),P$#.\Y=2N&6%)9EFURNG="6#"!"[B4E)58MW"*J1$&<4D%1#+,C
M2<]]F3"<! (F9(C#1.W*$P\\BZ,XA!V(["6P&JLR39,@U%75K*J 9A $E:Q*
MJI7:6OIUO6"6CG;S_H^:B,)-U/5.\3UU)IN>%KSTF*T3-( Q DF-L]8U)N7Q
M+).E[^+TN@HZ.#Z\<F@(<R"[(9&/7Z<ZR,0##E=V6GO^1H61)NY*\L%&:=M1
M&((CU@K.W'XTF=D9'U,=YJ+[UJ5.1,HJ!7:G'?OH*VH@PP/!L(Q6-3#Y)<=)
MEZ7R;<Z)(6("E4C/JR_Q<GL!F>5FIB6]MYG4V*"3<52<X/-8T 46&C9B?-7#
M/6],V<_6,0\*QF+S02(A*+(EK='^>@VU#L"!R>6S;I.H),N+N90?7X:&3!CU
M^Z-*,,]R1NO2?I>A K!P3M7O];TIC3'/.X3];FH=!:L]9)<])Z\;Z9;EA(,V
M@KH>-$L(7\+*1VQ)SH\N.Y;288C!#WT[8,&Z:0AV05 :F;YO_/C4:^?/(">0
M$293)D&MDLF:&H4Y;V8IZ.P57F!*FZ$DEAOLL27$FZ5(8DTF)?73";)P(2C%
M8/Q:T-0 9FP;B7#-7I5R9TAZ J=^<[3>D+K#:P2#B;B:QR:49D9L%,@9$)+4
M0-:!8H#<.Z28;8F$EWG=C$183D,5SH*#(@] I>@&-XU8$DL@22ID.8AGMK,Q
M<9Z3B>)_T#8D3.W/31WL2%),9O%3QVU.2XXWR*>@A96<7I":6(6@I#&U/KI$
M6N!Y#,RWSJFX)P(D]!],QJ3/@5VE+V75G-:2W5DO6WI?JQOV\K3BYVC?Y9J3
MB30>5B?7OT721 0$* R8XV.IH6&5%5&#]Y_K4# 2)>_+K\.31@['^FWG<P[G
M[BJ*."M0! @XV\8UO.YAW-;1MQMHJ8J<Q4]]%*E+E*7NF=<=)CI.8XG?]-YW
MYW\ZWG?G?S^SIMQK,3<8Z=M<]<]>_.LB-CDV>YK:-N-O&D&T%Y32J0LA@;/&
M/_ V(9AC0ALLU@%L2"1D2RY659D9%RB"2"-&:R2D*"C9*$3*+'8'ZZH68V25
M<,D<%+*3G3@  .)EJ5$42I6X82DU86;L ,695#6,%E:L<BR7I+&<Q>.I#<'H
M1S%(8KLE')B2EFO(L"  @8DDF@5T&\<0 2P#=$KL#>=#15J13=HA++ LJLRZ
M0 29(1!R$APR50@:M-A=*,R*/=8W3 *)#I"=HJLQZ1Z_Z R;7H3,!,6*&AEB
M+G&@"/R+,V@A!(@-P <:#>$D7!&2@AA48*F73<F8F9)0,B*B+@&Y@2A30(AQ
MWL^53)UE!*S)O!D5G602:=Q1;@7(.,S1V+=,> M,S$RP%@+H=M&41@\ FH("
MB3GNLZ!)"9[D&8SFX<=9D[2(&FHN&LXGQK?E.'O.X'KG_D(&G#3VU*5]R2E(
M+M+QQ.F*Y@(Y53O>?$=76(D!M@&9[()]-$.<=# L)P+-NN[&FFQD(E*2)=CO
M'.C32L240.XAS$Z)K@D@DD9&,S_<:1" D@ BS 3!4?TZD4*!5(J&&\^C:-*W
M&8*U4-2FV%W]-*I9',Q49YI6C:=(P^*IN@.7*9;== H2C/JX_K;1"0@KX8GO
MZ>O^AF*6C1AQ9)=E9WC3(8B" @IF8*E2<=>= *9!;@ 6YY-0"@+NRUI93NGK
MI4E#O.+B5+E@C(F:TTD#B <YYQ-SUU.#/.[G+,Q=&KXL1DP.=HCM!ZZ*L&2@
M22Q)6,&V-%QI2ZB1K$!TT@@@%:BLSB8STT!BNT_G_"I"PQUQU,)J#$)O$53V
M]\8-?"_SKQCUSYY_7!-1/WXUDBYC[<_\#]L=/T $MJ/2[M9^\*5 F""@%=@L
M"%RSJD-'07U.%,)"@@I#)<(9F0:>!1#$]]1D2_:  BCD$,PUV$6*_ T$;%$1
MW7&E79M6%]:WD $0G3A-V,*R,I!EH&\6<#B!%=G$SG>68-91F25G,SF[]<?Z
M-YO-3QQN&HH-ACEH?S_.K?3Z2>BS&K?(]K^O.A4!L)X@A;=N=!2*4;412G<W
MUCCT?$Y\:0YOTY>QMI2A8U7GKSR:$(6MUXZ\\&NM['XUUO8_'^!H7@=&5J)M
M,1.[@K'7.HA 0R!P%8@03;HXTRER@7>&/KXT@ A8%"V8&)]-0B(MP;O8R^FE
M")0G$[]N=9^R)WQ,3G04!D+L1:,9B+QHM M9@+6,P%L;\: *@9!$-KC%\_\
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M&BN RA(25@4%2R)48X!<L-E:A(I0%$5BP0E/2952$JR8B5+W'ZHLTK$.(*(
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MSA(@$P( -0$A*==A)>Y\2DHBJX-13C2*5\EC@,Q4]-5K@/ S(PA@2[Y%X\&
ME0A+'6&0"Y(&)*W)!L!Q"V]8SIRQB6/^"4(TPAM',S3/:NFB6 "23AEQ&(WQ
MZZ56$LH/#P,TWJ"1#%+JDP7^/PR6RE,Y\[ZA5W%K,/K=XZZ!8$ #<2,FJ23Y
M>I1,QND3!3CMN=S4P@Q9^TMB.DYZND0KH,UE9.O4TBAF^WIUTC&T3OS^QPL0
M3..O;0BMXV6AO(3M.I$5ZV)-A5,$(#B$8=6C!"D@*!"G*H)K1FD)2HG20,-
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MS)*,7@FLDLJ-T(@M$9,Q0)6FY92*)@:F@$ 2ZF$G,>Z2H*-"($ #&B@DN19
MHC$T@1-H.L,;")P148C+>)=M,:%'/C\>?V"M\;]M+6B>DB0A"D**1SH'(4)
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M^\826,LY +DT3,>^F@Q6>*RE2,3,8.@H!%=,,W^IO^-3<6$EV3 F(F^*ZA
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M/!]*;]!S4L->:EAKS4L->:5CX*VDDK8(-C;RSF[4?Y2:5MVNL_Z1UHZ7AQ(
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MKS4L->;,E2Q59/;+T"@AMG#EG-VH_P"-6\B@7T(<[]#A0#.H.;6]6@3%!F
M+$[)G>V;!L"3%!98%3#ZCUEPG1Q($J1/.N=FR00 $S )7>XLS8BN@EHE#C@U
M7-).YP (B"4&*O#X7WC<H3APQ)!T^2NG X36<(X,@R'^-<@,P$B!> DH^U[0
MN$P>:-,9.SO;&%N&" TP+Q,2OT'%%$*2WKJ<IOT'-*;]!S,3U XBU;90*3$-
M0))8W+2PUYJ6&O-*Q\%9D<)#=H3JOEG-VH_X58L46M01H'ABG#T#R*?21[*P
M-!U_C-#/BR)=%< !N (L&!4RYG=#. 38%W<LAB4#PI(+\'(!*@QU_,=HOT:%
M^AP4GL!<9EC291:&$KMG+@;!1&!O'KXVB6A#,>82\L,4^8@UA)D3BG"I;DD&
M0T,1BBR@)*20 L( QQ$!HDPT(TDS"8I=3%; 4)"*P(CW'27@C@   [*' 2GE
M6X8"]@35&N:%GS99/!DA.QAR<A+"@&,/S+$(";5H!3&6EY$=B4WZ#FV%%)>C
M8M@4*3[J@>0;<L_ 09*03<'7QJ^:2)3J7 W(]KKU+N9/"Q*"%EB*-"J020!"
M\)]Q*D&@#$@H]LV@X$DA*#72TP1*).#_ )]-,:0"3_;%='T&XW:GR2L?!3%8
M0APVKRY)S=J/^#6$\OX_ZJ(4A FZ503:!V;NC'Y\+O[,U/Z5%<B>42@96P#"
M'^OR*V"N^S?R>!.<&+AM8P#C$ QZ18$D>R>1B@R.01KM#D))##@LEG*+F3^>
MCFR:2-H,  )1K0B 0K(+AR(5%Y?%''>2QE-^@YB1[EAE&C);)\9YPHYC$T,D
M"9ZB=FDN@D5Q$Q*"6A $ @;!(^9(2JT@$!"&#P%"4-D%E,M..*+/-35+50)X
M$6-88"& H08*"%:86%R!*@D((6%0(L#R96/@KZ+"&W.?+.;M1_P:P\!,#Q*C
M5PTPB 2 !4/&RAS3"B39:TA5_L\BMP-R+A<[6IMW T?ZO%# ?HI4$GWZ&LEA
M'!0_-DFXL2$F^PUP["_K# A)QL!":\> R#?"P\0!:%/6\-0 ;>",R[A^".C,
M%72)V#C*;]!U'Y&EAKS4L->:5CX/,ZG-VHY7,]MQRGI#!<$%\(O6MM/_ "2T
MD<"(DL) #H#(:2. *;$X2%>#0QRBUW@;*.<UV5Z8ADO0<@"8J)#$$2E+IP>.
M!-VK9$;UQDZ64%8H2L@N#W<(H%R@:G!<&"#@U F0+@8DX (5ADD$9K%TPJC"
M-'#ZJ?PX,"V D&$X;^PMC\B@1R,  NU%?2\;!3V,.R'1=4D<BJ N-AWDO %>
M$ *@[(F,J %M@0=D.(;I8K(&+=(J"0+[ :<8X'$Z-%R1 *<I*S##NJR&R+*$
M7.]\&]W.0]\:*2R?.( $E$D B9B<!,.,>YE%ID! $8D!+&@4<\,AE-^@0)C>
M,,U0C&J$:8&3R!!)#4A1A,*QCHQ00!<"EZUEY)TL!=O9+A*;]!U'Y&EAKS4L
M->:5CX/,ZG-VHY1$.3E^8(&D@(@M."02?*>-83%#MX)4^6_/Z8P@04$/AI3[
M'/M9G28>1%X#@5TFX7#9"1G3.D<U/(K#CB*;NAP  6%":0#V*%5P6B,:QVQB
M8%1J2*ED@)B& 4!'9P5,(L#X%@$1)3>D@46E2N4OX4N5:/,@*+!EE(@"*T*0
M;^PM \BCQCA7D<&2RY@@2 G -)(0! H38VRF0ZI<1DH6K8@HJ^B?,D<HCT@
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MO%^2L&(*)EZ+ ;"&M=!)"0YNF&'#HC=)R[$+HR+(:ZE#I2!RG)*E4":5A"K
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MI>N4,87" @ORPOL<SF7-5D8R4'"#&P=;9#6+D%C&+1H+6D"^?XR9.6&%,2C
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M$?S>[L6*D,/T$827%C<H_>[!4Q#39!+>,&)(@"-RRR.2T8ADV_@H/P3Q"
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M)4+4L>'B1!GS"1D%38.R;"2.0445&&D<()APG =D6 @A>"+B#^ 18M%02"F
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MA3)?B( @A #!(*(FH@ CB81"-M+@(7KM76F@>UVZ[;!W#.APIEK-]E_^+@>
M(%(;"")/K1TJ%E/\K';IT+Y>G5"(PPP.]51"NQ&!C,WJA;/_ (\"1WIDR/+:
MJ( E)%H.0*VVMT*8XA(05QL:*V'K)\&(T&D0(%02F+9P=P3CH5ZP=.-S&;L=
M'. 0S&$3E=%7JM "L(?5>;IL]L(8H:VQPK"0-R Y!$13D;6H5R.<C$E.;M1T
M*EAKRF8P:6="G%RF$4 5#\[O$C&8EUH.PL1X2L?!Z$YNU'0G-VHZ$K'P?Y3"
M,C]"G,,$V3@% ]%)4J#)/$1'^4B*!0(PD.#P'\)$D :"] 86K5I!*@2+A9L
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,4@4#7-!F/G_ZA__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>business11f.jpg
<TEXT>
begin 644 business11f.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %@ T4# 2(  A$! Q$!_\0
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M2"09!\Q!/-5M:^#?@'Q)I]Y8ZMX)\.ZE97M]_:=U;W6E021SW> /M#J4PTN
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M5;&Z1PWIM:(']*K:[^VM\&?#.I2V&I^,&M+N(!FC;2;XC!Z$$0D'\#0!PO\
MP]&_9B_Z*9_Y0-4_^1J/^'HW[,7_ $4S_P H&J?_ "-7JF@?M2?#'Q1IHO\
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MZ-^S%_T4S_R@:I_\C4?\/1OV8O\ HIG_ )0-4_\ D:OJJB@#Y5_X>C?LQ?\
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M9_Y0-4_^1J^JJ* /E7_AZ-^S%_T4S_R@:I_\C4?\/1OV8O\ HIG_ )0-4_\
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M=%D^[>9_[9/_ /$U83Q-ILGW;G/_ &S;_"M2B@"DNL6;#(FS_P !/^%%7:*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X _P""
ML]KJ&N:)\--%AN3%ILUS?WEQ"2=KRQ+ L3'W FEQ_O5^?=C\.[B-3"=0\I0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*3..3P*6OG_]O;7M6\/?LE_$&71+B2UU&ZM8;!9HB0R1SW$<,N".A\MW&>V:
M /)OC#_P4R^%]KJNN>#?#'@_7?C*MO#+%K"Z'8B;3UA (E#.P/F)C=DA2A&?
MF(KQCX(_LR_!7X]#4=<_9W^/'C?X81S#S]3\)V.HO#-9YZ@Q[T?9T&XO(O&
MW8?:W['GP5\._ S]GWP?HF@64<$MUI\%_J-UM'FW=U+&KR2.W4\MM4'[JA0.
ME>;_ !Z_X)I_";XW^)O^$DM4O_ 6OS$K?7?A=TMTO4;(<21%2NY@3EP 3GYM
MU 'S!X'^(W[.O['/Q.NF\ V7BW]HSXKNL@U+7K0B^>RB _?-%(%VDX !9=YQ
MD&0#*G[C_9K_ &POAS^U/I]X?"%_<6VLZ>H:_P!!U6'R+VU&=NXJ"59<\;D8
M@$@'!.*Z/X%_LX_#W]G'PR-%\!^';?28V ^TWK#S+N[;^]-,WS/ST&=HS\H
MXKY?_:@^&=I\,/VVO@/\4O",7]E:SXDU?^Q->2V&R.]A=X8M\BCAFV3L"3U\
MN,]5S0!]UT444 %%%137,5N,RRI&/]M@* ):*RY_%6BVN?.U>PA_ZZ7*+_,U
MG3_$SP?:_P"N\5Z'#_UTU&%?YM0!TM%<!KGQJ\"II=Y':_$;PGIU^T+K;W%U
MJEO)'%(5(5F3S5W '!*[AG&,CK7"? 7]JS0OBAXBNO NMZCH5K\1]/B\R6UT
M74H[RPU.( _Z392JQW(<$M$W[R/D," &(![U1110 4444 ?E7_P7._YHG_W&
M_P#VPK\JZ_5O_@N59RS6?P:N5&8X6UA7]MWV''_H-?E)0!HZ-%I;RR-JMQ<Q
M0JN5CM8PSR'TR2 H]^?I74Z7XA@U2;[';V5Q'&L9 ,EQOX'3=P!T]JX6O:/@
MQ\$=6\5ZEYX=+6U6+?/<RMMB@C/4L?7VH H^&?"FI^)M:@L=,M7NY"P :,9"
MY[G'8>]>^WNI:=\#O!-QX>L-0CO?$^HC9,\'.S=QCCZU3D^)7A#X4PS:+X4A
M:]F4!;G6(1F24]PF3POO7B&N:C_:VM7%\L91II=Y'4]>H/\ A0!['KFBZGX?
M\)V'AF:8QK+%]MNV5\>86Y ..N*\1U*;RVE1T8!#\N1UYZ_2NUGN-5U_3888
MEEB(4+YLDC'<OT-16_P]DE53=R?,O.]>=Q]* ..L8RUP5=]ZRJ,D_=!_*NW^
M)$T2^!;'PY' +W[*OGM.,G9D9VCO1-\/45CMNV2/&#\O(P?YT/X+OK-E:"\5
MMPR.2OT]<4 =+_P2]79^WA\-1M*8.I_*>H_XE=W7[^5^*_[ GA>YC_;6^'6I
M7UN#=1'41]H0@9!TVZ7##OUK]J* "BD9@H))P/4U2GUS3K7/G:A:Q?\ 7295
M_F: +U%8,_C[PQ:_Z[Q'I,/_ %TOHE_FU9T_Q@\!VN?.\;>'(O\ KIJUNO\
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ML54A6(Q?$W[6'@'PE\/M*\8ZC-J4>E7VLCP^84L':ZM;[<ZM#+ /G#*T;*0
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MOIV_%M+\4UZA_7W'J%%(.0#C%+4@%%%% !1110 4444 %%%% !7D7[5^@_\
M"2_ GQ!IVW?YKVQQ]+B,_P!*]"\7^-_#GP^T9M7\4Z_I?AK25=8VO]8O([2
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MLWOWQ7R19ZQ/J2)<2OOD)VGY>?PQ7NOP \57)U&6R>XE>&&/Y(<X"DGG_(-
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ME!W7HUNDUHTGJFG\PHHHIG8%%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %%%% !61XD\1#PW;VL[:?>W\4MPL,AL8O,,"E6)E<9^XH7G&3R
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M_P!R/8'_ -GJO)\$_CZWW?VD]O\ W(FGG_V>@#Z(HKYOD^!O[0K?=_:<V?\
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M)O6 >?*LBHV^<29V\CYFW<'_ ,,[_M._]'<_^8UTO_XY1_PSO^T[_P!'<_\
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M_'*/^&=_VG?^CN?_ #&NE_\ QR@#ZJHKY5_X9W_:=_Z.Y_\ ,:Z7_P#'*/\
MAG?]IW_H[G_S&NE__'* /JJBOE7_ (9W_:=_Z.Y_\QKI?_QRC_AG?]IW_H[G
M_P QKI?_ ,<H ^JJ*^5?^&=_VG?^CN?_ #&NE_\ QRC_ (9W_:=_Z.Y_\QKI
M?_QR@#ZJHKY5_P"&=_VG?^CN?_,:Z7_\<H_X9W_:=_Z.Y_\ ,:Z7_P#'* /J
MJBOE7_AG?]IW_H[G_P QKI?_ ,<H_P"&=_VG?^CN?_,:Z7_\<H ^JJ*^5?\
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M6=__ '+=J/\ V:@#U.BO-(_ GQ%7[WQ1W_\ <OVP_P#9JL1^"O'J_>^)&_\
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M&.\\I(9(F2-GQA %92$(Z9R>O:OJ.O@[]F)5C^-GAL!R03=85NW^C2]*^\:
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MA;:M8V][97$=U9W$:RPSPL&21&&592.H(.<U8K\Y::=F?5;ZH****0PHHHH
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M\>V&%2/E]^E;=KX?GT?X5IJ#R (\N]^1TKRFXNH=6U"6:;<(R,)WH [+P_\
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MA=>>#-)F329Y_%&M:Q82QQ06\D,Q>"&VFEE:5A& H8(!N)+#&#T'P%CBU/\
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M!52.0#7L%3'W:,*;W5O_ $F*_--_/NVRY:U936S_ ,V_R=O^&"BBBD 4444
M%%%% !1110 4444 ?E7_ ,%SO^:)_P#<;_\ ;"ORKK]5/^"YW_-$_P#N-_\
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MUE/FC&*V1Y&!BIU:^(MK*5OE#W?SN_F%%%%9'KA1110 4444 %%%% !1110
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M &I7WA10!\)0_LT_$E<G_A&]A_V;ZVY_\BU8O/V</B:UFT=KH2).1C?+=V[
M?AYE?<M4KS6+/3[ZPL[B=8KF^=H[:,@YD95+L!]%!//I0!\N_L[_ +,/B[P?
M\1++QAXIOK>U^PI*L5DNR2:9GC>,EBIVHH#DC!))'.._U?110 4444 %%%%
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M0+>PA2-8$M_D,!C(,31X^Z4*J1Z%17@G[77BOPQXH^#K6VFZS9:IK7]I6_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>business13d.jpg
<TEXT>
begin 644 business13d.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %W TD# 2(  A$! Q$!_\0
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M^&_^27WKNA-I*_3_ (?_ "?W>3/8****D84444 %%%% !1110 4444 %%%%
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M8JP*Y(89'#H65A@JQ'-.SM?^M4G^33^:[@]'9_UJU^::^3['1T444@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SGX7?"#_ (5M
MXP^)&N_VM_:/_"8ZRFK_ &?[-Y7V3;;Q0^7NWMYG^JW;L+][&.,TGP>^#_\
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M%'_# O\ U<;^T!_X7/\ ]HKZJHH ^5?^&!?^KC?V@/\ PN?_ +11_P ,"_\
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M_P"%S_\ :*^JJ* /E7_A@7_JXW]H#_PN?_M%'_# O_5QO[0'_A<__:*^JJ*
M/E7_ (8%_P"KC?V@/_"Y_P#M%'_# O\ U<;^T!_X7/\ ]HKZJHH ^5?^&!?^
MKC?V@/\ PN?_ +11_P ,"_\ 5QO[0'_A<_\ VBOJJB@#Y5_X8%_ZN-_: _\
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M&_M ?^%S_P#:*^JJ* /E7_A@7_JXW]H#_P +G_[11_PP+_U<;^T!_P"%S_\
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M!^7_ ,U&^(#?[VN9_P#:=>JT4 >91_ [R_\ FH'CIO\ >UK/_LE6(_@UY?\
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MF8*D:*"69B>   23[4 4/%GBW2/ WA^\UO7;Z/3M+M%W2W$N<#)P  .6))
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M \]5.=Q7</F]ZJ6DA1;>Z_K^M?F%%%%24%%%% !1110 4444 %%%% !1110
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MSF-%K,<%B:?QIRB_.$HMR^Z48._RZGK]%%%8'TP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !4-Y9P:A:RVUU!'<VTRE)(9D#HZGJ"#P1[&IJ\R
M^,_Q</@"&PT;2;9M2\6ZT3#IUG$ 2#T\P@]@?7C@Y( - '*?LK1_V;#XWTB
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2*1HED'OU _X$: /;Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,^35O+_Y<KQO
M]V+/]:KR>(O+_P"89J3?[MOG^M;%% & _B[9_P P76&_W;7/]:KR>.O+_P"9
M?UUO]VRS_P"S5T]% '(/\1=G_,L>(V_W=/S_ .S57D^*'E_\REXI;_=TW/\
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MU;E^T!_X0W_V^C_AOK_JW+]H#_PAO_M]?55% 'RK_P -]?\ 5N7[0'_A#?\
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M +?7U510!\J_\-]?]6Y?M ?^$-_]OH_X;Z_ZMR_: _\ "&_^WU]544 ?*O\
MPWU_U;E^T!_X0W_V^C_AOK_JW+]H#_PAO_M]?55% 'RK_P -]?\ 5N7[0'_A
M#?\ V^C_ (;Z_P"K<OV@/_"&_P#M]?55% 'RK_PWU_U;E^T!_P"$-_\ ;Z/^
M&^O^K<OV@/\ PAO_ +?7U510!\J_\-]?]6Y?M ?^$-_]OH_X;Z_ZMR_: _\
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M)6Z(!CH3D\  YKH*8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF/6M7QIX#USP3K4VD^)-)O-(U& X>UNH61OJ,CD>A&0>QK%M;=VDRPV(OW5
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MC)X$L1\1)/&4ES=3ZD=,72H;>1U-O;Q>:9':-=NX/(VS<2Q!$4> ,'/F-O\
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M1/E3(S_9YW6228LR',Q9<[CQEC\M=)XN^!^B^,[Z^NKR\OX9+OPQ=>%7$#H
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MQU'1>#GYB!7DUE\=_'GQ44_\*_\ "<D6FR#,>KWB8B(!^\LDFU&SZ*'KT:.
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M4T@2^0;RW>$28R 2.,CNN>H[C(KP./PVOPMUJ7XF^&;/^SH=0NS:^+=!B8-
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MCN.A]Q5^F(***X3XS?%S2O@OX*GU_4U:XD+"&TLXV >XF()"@]A@$D]@#U.
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M;8:A*M&4)N.KC%OF_%*_]6N>Q6R'%48.=T[;I/7\C[HHI.O(I:_,SYP****
M"BBB@ HIKML4G:6]EZUDWGB%K3.-)U*?_KC$I_\ 9J -BBN,O/B1-:9QX/\
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M7KI_\DOO$W:+F]DK_G_DSW:BBBI&%%%% !1110 4444 %%%% !1110 4444
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M=+>1IE)G?,3"+.T'>I)KW:'XC>$[GQC-X2A\4:++XKAB\^30DU"$WR1\'>T
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MAUXXTJ30O%6GP+!!NYBNHD7"LC=&!"\,.#@@X/%>[TD 4444P"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XKXC^!M4\9-I
MG]E^(+K0T1W@OUAD?;<6<BXD0*" )>%VR=4RV.N#UNGV%OI=C;V5G"EM:6\:
MQ10QC"HBC 4#T %6*K)J%O)?26:2A[F-0\D:Y.P'IN/0$]@>3@XZ5U2KU:E*
M-%_#&_3OW[_/8Z)5JE2G&F]H_KW_ .">/:;^S=8V/Q\U#Q]_:>O-:36%NL5N
MWBW5F_TI+B>5P\)G\HV^)$VPG,8(;$:YYI_&SPAXL^*WQ*\/^']$>QTK1=#L
MIM5O+[Q!H=QJ&GW=Q.KVT4"K'<VX=TC:X=OG.W?&2N2"/9)_$FD6MG/=S:I9
M0VEO*8)IY+A%2.0'!1F)P&SQ@\TFL^*-&\.K"VK:M8Z6LV?*-Y<I"'QC.W<1
MG&1T]:X[)Q47LNGK_P /?Y+H9<SYI27Q.WX67Y*S]6]SXF\;:5XQUSPW\-/A
M]J'A2/QGXA\/MJUA=:7K.@0WMEJ5K:F&*"_6TO;ZUBD!22%ED^U,R,[J%D.]
MDY7Q5X;M/B5I7AOPWX>\,WWC+PWX?\&+IVH1ZOHNGWU_HY2YN+=YH%N=0M8K
M:X4V\RK/ UT#Y2_+M53)]V>*O ?@GXN:/:1^)/#N@>--*1O/MEU6R@OX V,;
MT#JRYQD9%5=>^"GP\\51Z2FM> O#.L)I""/3EO\ 1[><62@@A80Z'RQP.%QT
M%:<SW?Q7N_6S5[?/;\4)-15H[6T\O>3M^%K_ (,^9F\!7GQ&T7XV^,?!FEW4
MFOZQI6G?\(KKU]:.EU);RZ7;B7[.SE"KN 58JRG< "PQQSNB_#/=X%^(5L-,
MUBU\(W=KID<^D^%/AK=>'K1)HKHO),-/O+F62\.PKYXCBVS1J%#2,,#[MCC6
M&-4151%&U548  Z "LF[\9>'[#6X=&NM<TVVUB8 Q:?-=QK</GIMC)W'\!1=
M<WN_U;^KZ6UU)6D4GT_X'^7W:'Q=;^"C??"ZZM-1T">PT>V\:+>VFJ:/X-N6
MTBY;[)@7-QH,S-(MOYI*L(OE\U1,"O+#>^'_ ,,[SQC;?##1-:\(2Z9X=DTS
MQ7IMS%#97,%HMO.\2PNL,V7M4E7+1P.<H/E7A17V''J%M->3VL=S#)=0!6E@
M5P7C#9VEEZ@'!QGK@U8H;YDT^O\ \CR_U:R\BU)Q:DMU_FW^O]:GPQJ7@;XI
M_$CP#XAO[[3KRR\0^&+?3O"$0O=/>7^TK6"\CDU2ZBA$D;317,21#:KJ9!$R
MA@6KV/\ 9)\+W7AN'Q>T,;67AZZN;>2PTVU\%W/A33[=Q&5F-M8W5Q),@8A2
MY*1J6RRAMS-7T"TT<<B(SJKOD*I."V!DX]:?3YG9I]?UU?ROK;HVS)Q6ENG^
M5E^%E?K8^ OA=X?\56&G^$=.AC^(&I>(-*\<7-__ ,(CKGA:2ST"UMY-2N-]
MT+XV46XK!,TR;KF4%R,(> OJOPG_ &?M1\62?$)?%>O>+--\.77CS4K\>$V@
MM;:QOXA<+)%*7-M]I:-V56^6<(VWIC(/U/63HOB[0O$EQ=0:1K6G:I/:MMN(
M[*ZCF:$^CA2=I^M3%\KOUL_QY/RY5O???:SDN9:]T_\ TO3_ ,G>UOS/'/VB
MO ^O^-/BA\%?[$OM;T2.SU>_ENM<T.UAF>P0Z?,JLQGAFA4.Q"9=#G=@8.#7
MEE_\/_&4?A[Q!X1TFQU8_$V+QM+>:/\ $&\LO+257MHY&U">18_)(%NQM&2-
M0K,@4*N#M^M8/&7A^ZUV31(=<TV768QE].CNXVN%^L8.X?E5MM;TY;>\G:_M
M1!9,RW4AF7; 0 2'.?E(!!.?6ET^7ZI_IZ?.S*ZKR_RDOU_I7..^!-M:V/PG
M\/6EKHE[X=-K 8+C3M15O/CN%8B8N[ >:6D#MYHXDW;P3NKOJQ-)\;^'=>O!
M:Z9K^EZC=$%A#:7D<KX'4[58G%:E]?6VFVLEU>7$5I;1C<\T[A$0>I8\"KE)
MRDY/J1%<JLB>BD!R,CD4M04%%%% !1110 4444 %%%% !1110 4444 %%%%
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M7>ZDX&3@9[UUND^&](T&:]FTS2[+3IKZ19;J2UMTB:X=46-6D*@;B$1%!.2
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MKS7$DKOY@9T))96R"<>I?L\W&F3>)OCK8:B]HRW'CJX1[2Z9")%-C9C!5OO
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M **** "BJZZA:M>M9BYA-VJ>8;<./,"YQNV]<9[U8IM-;CLUN%%%%(04444
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ML@@;2!MV\'FMCPK^SIH-CX>\/0>(Y+CQ#KNEV1LI-4^U3P-<1%R_DR!''F1
MM@+)NX'UKUY8S*J>&I3LO.*A%N]GO=ZI;-2UN[P;29Z,L3EU.A3E9>BC%ZVZ
MWW2V?-K=WBVKGG^D_&?QOXS\-_!9K'4K+2-1\7-?0W]Q]B$R#R48AU0D8/RD
MXSC)YR.*A\:>)O&GC'2OC'9?\));66D^$]-?3WLGL(RVH,;0M+-(V0T9;G9L
M(49Y#8KVW2?@[X0T.'PO#8Z1Y$?AEIGTE?M,S?9C*")#RYWY#'[^<9XQ57Q/
M\"_!'C'6K[5=6T07%Y?P?9KS9<S1)<H 0OF(CA690>&(R.,$8%<\,XRNGB.>
MG1Y8J[7N0;3]JY+=_P#/NT=_=>W<RAF>7TZZG"ERQ5[>[%N_M7);O^2T;WT>
MW<\7^'<GE?$SX)OM+;?A\QVCJ<+%4/@#XT?%#Q-)X8\5RVF/#>MZHMG);7D^
MFVUE'"TC1[8&,HN&F4K]UL[B&PHXQ[Z_PG\*2'PRQTA1)X;1(]*E6>59+=%"
M@)N#9=?E7(<D''.:J6'P1\$:7XF77[708XM12=KF,>=*8(IF^]*D!;RD<_WE
M4'D\\FJGG>755)U*/-)QLN:*=O>J/3WE:_-'WMU;9[A+-L#4C+VE+FDU97BG
M;6;T]Y6OS1?-NK;/<\HU/XI^./#?Q(N!XCOY]&T!M;6RL9+?3(KO29[9F"HL
MLZ9FBN"3CYB%!/2C4OBGXX\-_$BX'B._GT;0&UM;*PDM],BN])GMF8*BRSIF
M:*X)./F(4$]*]5G^!_@NY\0/K$FD,;F2[%_);B[G%J]R"")FMP_E&3(!W%<Y
M&>M$_P #_!=SX@?6)-(8W,EV+^2W%W.+5[D$$3-;A_*,F0#N*YR,]:RCFF4Z
M<U'[-G:$=]-5=NSWO)\S[)$?VAEKWI?9L[0COW6KL^\G=]DC-^.WC[5O!.D^
M&[30WAM=2\0:W;:.E_<Q^9':"3<6DVDX9L*0 >,FO'?BMXH\8'PG\7/ VI>(
MUU%M#T>'4%U=;&.*6Y@E1@]O*J853G!#*!QVKZ7\6>$='\<:++I.N6*7]A(5
M8QL2I5E.5=64AE8'D,I!'K7/:?\ !/P;IGAG6=!BT@OI^M+LU%IKJ:2>Z&,8
M>=G,AP.!\W Z8KERS,\#@J4/:4KSC)/X8O[47?F;NK13CRVL[WN89?F&#PE.
M#G3O.+3^&+VE%WNW?X4X\NVM[W,KPYX?;PQ^S_)8--#/MT29PUO:);( T+,!
ML3C(!QGJ<9/6O*OV;? <\?PS\.:W/X)\%6]M_9$DD>N6REM69C&P#-FW !.2
M"1(>#WKZ6;1K.313I+0YT]K?[*8=S?ZO;MVYSGIQG.:J^'_">E>%O#-IX>TN
MU^RZ/:P?9H;?S'?;'C&W<Q+'KU)S7/#.7##UZ=O>J34F]E:TK[-:Z[6:.>GF
MCIX>K3^U.?,^FEG?9K77:UCYM_9"\"W$G@7P9K<G@KP4;,1RR#7<$ZOD/( W
M_'OC.>/]9]W\J\9M](?4/AGJ8O/ -AIND2>)G6;XE"6![JR'VT9_=!?.P#\F
M=P'S>E?>W@_PAI'@/PY9:#H5I]ATFS4K!;^8\FP%BQ^9R6/)/4UD1_"/PE%X
M)U+PBND*?#VHR2RW5DT\K"1I'WN=Y;<"6YX(QVQ7T-/BJG#&U\3*#:G.+6KN
MHJ4W?X[<WO*R=X-[JQ[M/B.$<56KR@[3G%K5W44YN_Q6YO>5D[P?5%C6/B9X
M2\,ZU9Z)JOB73+'5KD+Y-I<W2)*^[A3@GN>GK3-%^*_@WQ%KQT32_$^E:AJZ
MEU-C;W2/,"F=PV@YXP<_2O*+[P/K_A75/'&D6?@6+QAI_B:Y@EM+R\N8C;0Q
MK#%%Y5UYCB4JGEE@5#$Y]:[OP3X/U#1OBUXZU>YLDAT[4+;38[2="N)&BBD6
M4 9+#!8=>N>]?/UL#@*="515&Y<MU[T=7[FG*KM6YGH]?=>O;PJN$P=.BYJ=
MWRIKWHZN\5MJU;F>CU]U_+$O/%'BW6/CUJ_AFPUN'3-!TK3;/4Y818I--/ND
M</$K$C:&"X)P2,\8/->;> /C1\4/$TGACQ7+:8\-ZWJBV<EM>3Z;;64<+2-'
MM@8RBX:92OW6SN(;"CC'TE;>#](L_%5[XDAM-FM7MM':3W7F.=\2$E%VD[1@
ML>0,\US]A\$?!&E^)EU^UT&.+44G:YC'G2F"*9OO2I 6\I'/]Y5!Y//)KIH9
MIEU.G*$\.F^6*3<$]5%J6THOWI6:E=M6VU.FEF."A3E"5%/W8I7BMU%J6S35
MY6:EJU;;4\HU/XI^./#?Q(N!XCOY]&T!M;6RL9+?3(KO29[9F"HLLZ9FBN"3
MCYB%!/2KVI?&#Q/:>%_CE>K=Q"X\*7;Q:63 F(U$2L PQ\W)[UZ//\#_  7<
M^('UB32&-S)=B_DMQ=SBU>Y!!$S6X?RC)D [BN<C/6J_B3]G_P !>+M6U74=
M6T$75QJJ!+U1=3QQ3D !7:-7"[P ,/C<,<&MXYED\I0=2BU91O:$=U*+>G-U
M2DFW+6^UM#:./RN4X.I2T2C>T8]))O2_573;;O?:QY3H-QJ7B+X^:A<Q7_V+
M5+SX=6<WVP0J^R1I=Q;8>#R3Q63\,-;^(FF_LO\ A;4_#^I-K=]>W:J\;1PM
M=P6OFR"40>:VV:4D @/[C!Q7T*?A;X7_ +>T;6AI2KJNCVPL[.Z26176 *5$
M;8;]XH!/#[N>>O-94?P'\"PZ)<Z1!H2V^GSW:WPA@N9D\B=<XD@(?,)&3_J]
MHY/J:U>>8*4(TY4[I.F[.$6O<4DU\2=FFFM5LUL[N_[6PDH1A*%TO9[Q37N*
M46MT[.Z:U75>;H_ GQU<^,]$U:.^U6YU*_TV]-M*NHZ;]@O8/E5@D\8 0OSG
M<@"D'I7IM8'@_P "Z)X#L[BVT:T: 7,IGN)IIY)YIY" -\DDC,[G  R2>E;]
M?(X^K0K8F=3#JT'LFDOP6BU['S6,J4JM><Z"M%[;+\%H%%%%<!QA1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>business15b.jpg
<TEXT>
begin 644 business15b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$Y.C$P.C4Y  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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MBIG!F%1<DSBIG%"M#^OYN^_)<&JL@                  "@UZ9X?2
M                4F$F1EU         *37Q=3+@  !@R  8,@ &#(
M 48SK?N^1LKH^+-9              Y;+ :&/1DR,  %!9B^  &K3A YQ/2$
MYU.D2QFACT9,@..3L4_0               @YN.7#F0Z?-7G:A:30QZ,F0''
M)V*?H                      48SJOO^3M7SW%JL             !Y=GF
M::0/Z #QT.U#19Z,GDT=MG%QU(<J'5!T(>2Y[MG%9ZPGAT=%G')W$>:AI$]B
M3B$[H.YS=0              !2>))[:'@@;G-!G31Y[FD3V).(3N@[G-U
M                   %$M#>LYN^?)\&NL@             ><ANDY"+6<?F
M^#JPYU.:#8QST=OG/AOD]/3Q_.LS51ZTGCB8:?.70]*#D$Z'/($[]._3=H
M            !!XH'M6>*1L Y7.J3K\Y!.ASR!._3OTW:
M       42UQWG*V/TG$KSD                 "#GLXK/00VJ  :J,5-_@
M %)Q:=HE8              !!S0;:,^   *3BT[1*P
M   "C#57H.9M7SO#KL
M     &#(                        48QH7U?-WUY'AU[
M       $0A@57D                        "F<03C-5@
M          *,-;]WR=E='Q9K(                   $8?G..<??]ETGX/K
M@                        .<?<]CT+X;K_P!YFJL@
M       48SJOO^3M7SW%JL                    QBG&. ON/I>_\ XAYP
M                        #@C[5W_=WQ;I/WUZJKR
M      !1+0WK.;OGR?!KK(                   #&*<8X"^X^E[_\ B'G
M                        ."/M7?\ =WQ;I/WUZJKR
M       !1+7'><K8_2<2O.0                   *81EP']O\ 1=^?#O.S
M2J@                      $84RX*^V=]W=\8Z?]]>BNL@
M           48:J]!S-J^=X==@                   *9Q@7:[^&OM7HO0
MKX1Y>\<;%5Y                       C$_CKOS3_0WHN[_C'4; Z/A?I6
M0                       *,8T+ZOG;Z\CPJ]@                   "
MG#2/K^=YJ_IGU/L1^.?$W")JK(                      $8Q^4;/)C]9>
MO['^-]+U)\QZ>K8                        _-G7/;\C8_1\:O:
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M&ISD@[ +.889X<X&U 80;F-A%E.D#A<P8ZS,#+T<V'29SL?L>I1E@
M  !K8S,UZ?*8T7HQ(N9D1R2>B!Q>;O,<*#,#Z#-CG\V$6 I-RE^
M     *35!]I\A^1^9AQ83:YP">IYS4; .?#<!49";5.3C:A]Y\9:C>P
M        *329<S!2_&<FN399A)\9CILLYZ.PS6Q;#$S-"\ER,W.;S:YCI^IM
M(^H      # ,@&      #(        ""6#+!D     &#(!@      R
M   #!D                          !1+5_IMGG7^E.1I'Z%NM_*MBF:*A
M1DV%RJ%4LF6:ADLS"RHS;-2HS"S)<J@8P&<   3G-TXD= _,.M]&/S3Y;.^F
MXE6:   B<8_S+\\_T?R>9?K6^Q<^F<PM5PI.2V:+*A4*C.99A94*,LW&;E1F
M%F2V ,AG   #.?VB=F>2XW?7YS\STW\OZK]*PR9  &(9M$U;)K\@
M         &99_7.+M6NYIG.='>UKP<_H1MQ+U.YFC8S4*E1L9J%F:<[(SME1
MLA9F%RJELC.PIC+.QFF-JK-A1F,VQF0  !-1B&;V3XK@>^W\Z_G&RO.<0  "
MP<W/@S_03=H/ZIL5L8M62V<PV&R5QFJ6PHMFRRX7"C93FBV*9V,TQ;-LVS1<
M-C&9   #(2_7AX]BOPUX/O;X%YRO)D !!C"[-.R9&3(
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M #)@ #\&-,L[/+\ &3&/FK3]S=924GZ   !DU?SC?U0\-/<1"X73G9-5V?\
M .SWI\EY>K_<Z*N'NPCT.ONCX!S>&_O^G])SE?358>SO%.PSMOQ&R[:JT9])
M;-\-6.>C?ERV]/E&?HW[,CZ?/+WUG?A7H6:='LV9XK5I#W^VGD9WC\^QI[VG
M(LO.SN[P.K2GON1O;YUHY2^\]AI'Z3RBX7"B]F>)U_T;_P Q_"SE5D!&$3/A
M%^^?,\S?;NOA<*I7*XQLGK]GI_\ D_L\(YVSZ]=6+M)U1[?&R/%;<*]*W?\
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M9C&8K8FXHJY6666667"X6S7NU_-OJ>I_G/%G.0!!C\W8)V@
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M;;\EOTE[3.T_-7K?TBG;G;GBMVA?I$[C^>[['V3D']%Z)NE65#)L+8V>[?\
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M%,U2NE<XN-53NN%LVNRS)99L*8V>Z_\ -WE]2?.$T $&/S=@G:
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M6_G#WFW_ "W.X]^J=SZ!?"O-U5?FQ^A/2^@?POSW[\!89V
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M84;"V+9RQ7NA_-WUU=>AU+ZGE=\?$?.JOS3_ $-Z/L3Y1U&S?&\.PXW
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M6667&;C.8SLC-3BXS3%LV6Q;-EE,4S99LA4+A4++++A7N9_.;[_U#\[](SD
M08_-V"=H                    !DU?SQ?U#_G-';]?&;A1;-EEE%%EFPJ%
MEPNE4KA9:K9N&39&*C-QFS846466666669A<+ALA6RO$=Y_0_P#S9_2<U-6+
M AB)>&?[Q_%'-_V?YB73FV:*+++++++*+A=*X7*X64JF;+A<8J,W.;A<+++*
M*-A19991<+A<+I7[F_SE_0O4'SSU#.0!!C\W8)V@
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M,Q68SL-D*+*E19999<*IS4+EMA149V,T64S=.;A<XNG-3.Z,9O\ T_9>[?\
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M   %!@0' P ! @@6%1<@4!,4,#8W$!$Q0!(A.& R-$AP&$$E)S/_V@ ( 0$
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M>1)D3,^'-ECY2!,D5S22Q$MESNZ&EINL;2S8H\:=-@R9DR80S\&=EQQHDV9
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M:=V^ D DA(+/Y;;_ $U<'Y%]LIK\<6/6\%Y@UE8!7D2VVUOMM^SZWG'8XCI
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M3:.E3#8C83"YX<V@H ,L$*TK7 [/^RFT5WJ,V$(;"Q]SL*C&@PWU0 SV[O\
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MAN!N=LW<,QQXURP6MQ6N<\4+B:;"3]J#SZ_Z(1'4MN-OBUPSKEE_%->:$!Q
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MS47\)"!(?&4/S4;\)=SZ/^,H?FHOX2$#1_QE#\U%_"6HD/C*'YJ-P_Z7KBA
MT?\ &4/S47\)"7T?\90_-1?PD(&C_C*'YJ+^$M1(?&4/S4;\)"!(?&4/S4;\
M):B0^,H?FHW#_I>N*$#1_P 90_-1?PEJ9#XRA^:C?A^N*$'1_P 90_-1OPUJ
M9#XQA^:C?AH09#XRA^:C?A+4R'QC#/\ ^N,/_K0EY#X>SZ$;\)"!H\9S[/H1
MOPT(6COAT/Z$?\-:C1QRGF?0C?AH2\A\.9]"-^&M1)#O9]GT(WX:;#EOAT/Z
M$;\-:J7.4]#^A&_#0@0/AT/Z$;\-:B!\.9]"-^&A @?#V?0C?AKN>7^'L^A&
MX?\ 30@2_P /9]"-^&M1+_#V?1C?A(0('P]GT(W#_I+42]/_ %K'?Y8WX:$&
M!\*9Y(WX:$*#X,Q#)W4B_AH0V_IH?_R_AHL:!770^CW7\-7+66EIXT4L6NAP
M>(Q/^8J0E8390/8X0ZMHXC$T(Q)V\:GJH*!19'19>29NYQ^2?2CHW1>!,RW'
M93%/T9HPTMFF]!_U4M(RL%[7PIECGUP -/25IJ%*OEA> )@# C/L]>C-0ZAQ
M#\7;",J>]@V]"*GW?GLQ^M?Z4'*]!ZN0<KD'*Y!RNXH.5Z#E<@Y7(.0>@]7H
M.5X0<%5!RN0<@\(/'K_HKP@]7H.5R#D'H/XJ]!Z#T'\5>@Y2KSW1!IMB,'55
M0XQEW0WL.-1Z^O2G1(>E(+0XVQ6-KGB.!IF/44)45IA/+;CAAWQ]?OS5QQ-2
M0,L=JT? =/1@U[BT#$DDX4Z\_7+%3DXR3A=QP#6AJYPIGZ]6SH)O>YQQJTKE
MM$_IF(S<UOH"#E<@Y7(.5W%!RO0<@Y!RN0<KT'*Y!R#T'JZJ#E<@Y7A!RN0<
M@^B#T'H/5Z#E>@]!R#U>@]!Z$17\4'*X5;TA2CO<(7!I_:*T?I1\H^E:M>##
M-=@=T^HQWK2,C#$-LY"B W"I:#EMPQ'01F%>\\ZX]'KV($NPN/E/V*1@PY.'
MW7%?<:&VIR)&!S-3Y>&*G9Q\V\W5M& Q]<?7>F8.H,J>]@V]"*T@[\]F/UKO
M2@]7H.5W%!RN0<KT'*Y!R#D'*]!RNXH.5]$'J]!RO0<KT'(.0<KT'H/0>KT'
M*Y!RN0<KR@Y7H.5R#U)1 )F$#X3V@=-52VUSLJ9;E#BOAOO8ZE6T1N>XN<<U
MPZU#CNA$ZLVNX(ASG7O.*&;AZT7+D_T[%/R1Z @Y7(.5Z#E<@]!R#E>@Y7(.
M5R#E>@Y7H/0>@Y7(/5R#E>@Y7(/0B(/0>@Y7E!RO0<@]!ZO0>KT'*[%GS@I*
MAEX7%A_;-/2L!B<:>G8M?&ML+C9N\G\%6E./I1:<PGQHKV-87&C:85W#9ZU3
MN>*-]2H9IS#WV?O8-O0BM)._/YG]:[TH.5W%!R#@M;1!]R$>W!7>%5!ZN0<K
MZ(15?3G(1:HN"#E<@Y5KZ4(E$(E2A$HM;=F@Y!R#E<@Y7H.5W%!RO0>@]!ZO
M0<KD'*Y!RD#6>DQ_^1#]*=X76AD.@>U;X?6N79IIV+\T>@(.5R#U=Q0B46NR
MZ4Y]6IK^:@Y7(.5]$V*K@@Y7(.5W%!RO0<A1W!:P-PK5%XH"#M3HF 3'-<WG
M&BO8,BJW'')-B@8+ "[J0<KD'JY!RO38GKP5<,]OJ4'*Y!RN0<KN<S'P@M'G
M\V@_,/[7MV9]7O8-O0BM)O\ S^9_6O\ 2@Y7<4'(.335V:BP8D*"R+JWACW4
M:XM=:[H<10TPK10I:)%:Z(QCWA@JXM:YP:-I<16@&\HOH;5>KB@]0&.C%UH<
MX-;>ZT$T:-IH,!Q."?@5 :Z*;6@N.X DUZL:I[#")#P6D;' M(\JUB#E<@Y!
MZ::FE4YCFP]9:;:@74PJ=A=ECL3.=2G1OQ46%$@TO8YAW.:6G'@4'*]!ZN0<
M@X[,4'*[BKJ9X*Y!]5>KB,\$'U0>KT'*[B@Y:,/Y_*?KX?[2=X76AD.@>U'A
M="Y?NIIV+OM;Z @Y7H.5RA!T1P8T%SC@&@5))W 8UX*)!=#(;$:6/NI8\%KJ
MY$6G&M>"B0HL&&USV/8'#FE[7-#AO:2!7J37YH.5Z#U+PHD9S@QKW6M+C:TF
MC1F309<5$YCN/KB@_!!RN0=3[U=A]JN*J:5H:;]B#BG/.%#C50-'Q8S;@Q[L
M <&N*B0GPG4>"VFQPIZ5$AQ+&O+'ACA1KBUUKN@Y'J4M*19MI9#8YUN)+033
MI(RVJ+)QI;&(U[1LN! [5!K%<(;02[8!B2<@!TKV-BAMQAQ!_E/W(ES'%A.6
MQ!RN0<KD'53+GUH"0T5-!4 <3L'2BZU"+7!!U%<@Y7H.0=SF?."T:?S:#\T_
MM'V[,^KWL&WH16DW?TE-?K7^E!RN0<M9;SO%QZD;:"8KBYOI4/4SNAM':/CA
M@O@-BP"0 3'!(:V[Y8YN)I4@G):/9"T9+:3T8V"TN?HZ/,S$4T.J<1;;M[S/
M"F+B#WJ@2$E*R0TCI2(Z)#B13"@0V\VK</="ZAZA11- 2;](Z-9#+G26D&PH
M@B9.AMB/M(IM+>W#!0="2<YI&/(Z/B.<R2#W1W$#W5L,Y,:34$Y8G/'#9I/0
M$NZ3?%AP72D:#WU\0.OA95!HT UV?<N3 8R!ID.>'N&C8X:VE>;S<:XXJ6D)
M :&A:0CDW&9U-*]]S6G,][GM#MF"T?)2LAI*"V&329D.[&EU*@&X$=Z03S<"
M*43)27TG,3\Q&)ARLJ7.<*ASHE#D#04KCC3 ;"G:)DIYDI-20=#EVS4.!&8X
MW8'^\#L*C>*8'I4](Z/$^R5DRY_N^HB/. ;C0BF;B-IP'!0M$Z-B3431>L?K
M&N<6QJ8,<W"CFTYU-IYO1M431^CYF7GX4NY[IR08]]QP;&#"!EX!+CO<I+04
M%DM)MC0'F-,LAQW/#P&PFNZ0;SMIAFOR>@PIJ:BQWZR6EF7NL< Z+E;#I7FD
MC,XTXJ._1\70#HTL"R")UL)T-V)8X,?_ 'E.<.-!]IY/R[9J;(']E+$S.^HA
MXTZ\NM<H3&F))DX>861-2"&5KX3*TZ\3N"EM$R@D(42.7Q=>R^+'9_PY.8+
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MND'33F11"BPW2VH+(9KSZDD.';P7Y+2$)TI BZ;U472$*%%9"$K?_; $ FN
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MJ(<I-6%Q9=<T FT<<,!UD@!0-#!T)\W/3AEY"(]T.6B-@WN>?!- 00*;W9X
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ML)L41/[ 9X8_Q0 82U[Z1.^&T?<@]OAQ>?X/-\BYKQ[I$JZN I3T*'&UM8)
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M!8P!<?;@^](13C_, ?"*Y7_R=:%Y6M=%;";*Z1:*"=8W'?1S,+_*-@X+3/\
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M#;,/<:1Y4J/WG':&V8>XTCRI4?O..T-LP]QI'E2H_><)L&V8]5%D>5:BG_\
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M%:UDS*E?D@_5Z3"FR132)/,-FJI?IY[?2O7TJN(%(@4J(M/AQ&8L+3HW+0"
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MG-OP>5KRCES\<QYZLW?!Y6O*.7/QS'GJS;\'E:\H9;_&\>>K-OP>5KRAEO\
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MF_\ I@-2IQ3ATW\."G3I486)+[KC4;6$5DG35MD"[K= 1J+:&J(I:!34J)?
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M2LED7"*AMHJ7XIPOTWX75?"OA6^)4QB!%<E2G6V660)QQQTQ!L!!-1&9GS!
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M2V1>101+KODC/%I055MUQGB;2P<VYNI&8J' S$$-V%F'>(RW&%T':>Z#1R1
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M5!H'4D+=H=8M%OD(2%.:9YQS/F*L0\KK5LLK1H<K,U#<C26J@,W4*5&.8A*
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M !B"ASU'4%Y^3ZS(K6T-U(JI"K.74@TZ63C:"](W,L23=@X3@Z%=#4I %_\
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M17.C)TYVF1@]L6<97F5]VB9?%&04&SN]U!Q&*)P&O04J=;S2R01WD"%Y;-P
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M:=6-!8:F=&R:Z0)P2D5CTE4^.=BV3WV2X/TBFRGJ9+I52(+Q373$>2/&B0#
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M/0:\WN'H<@MTGUG?C60++"#JH\Z'-KWB'-@S8R$:,PED"D1WH\1C1RB,%[2
M.1&*,VT5B8K<]O.36&(J)D4M0R@C F&@#5-,(MR2XER2@VV[>V<10*Q&L='<
M-NWQ78OCH'@JZT;D&IB;LB08KU+(F2B\F[DF25[BE5K!"8J[<<(8[1B9]#=X
MI:>$2YA$B[R,0CXDCW2).$QRM1QH4I@90FZFZGB1JJB*O%1B=I>-R%]*PL6)
M9-A$@JZOW7$AQG@)+F_I$;^D$YI^2Q@@;I:X:_4<(N[>Z8F,8<=U@_%^@>7O
M:Q4B%0LF<LY!)'^EX0E!W>9VRV8S>^FUV_K#,Q>9(2 =QH\VKM.FZI];817+
MMG0&\#>:\+Y$8S-X:J"072NO3Q35-O9-N+*LK8D"5;(!T;O%\0+0)-(!YY+A
MFD,8TAT4ST4ZE<WR%1/J.$7=O=,3&,..ZP?B_0/+WM8J1"H63.6<@DC_ $O"
M$H.[S.V6S&;WTVNW];\C,?)770I,X;P5JM GL?1&.58?FBN=YQKQKR(,*Z!C
M>K'%(4Q?_<KF+:*&>/:,M MR,Q12ALE3=)E8\"G>HW-15D*O3L$URDW]+F'"
M4O\ [E/G_M3_ '^CB]%;54:! CS6,I)0933DLHJM=K.<2.5P'MTC\'H->;W#
M1CD%ND^MF:U!X08P\7M.@CE$0CWRF=9:Q]9D=Y+':8 W\F>',KOKI#M8D,,X
MDFV#7*([WC:C2Q)TC6BL\5=KBL8C?1Y:_!PB_"G/ZZ9&4V2NNA29XW@K5:!/
M8^U!N7HN8B.=YQI!KR(,*Z!C>K7%(8Q?K9VN_MD3Y4R7ZZ57[9HGR5<<-_R?
MKIF+:*$>-:#M MR,Q1RALE3=)U&\*G>HG,15D.7IV":JDWU:YAPE)];.UW]L
MB?*F2_72J_;-$^2KCAO^3]<_G\_]OHXO16]5&@0(\QC*64&4PY+*(K7:CG$U
M5<![=(_!Z#7F]P]#D%ND^MG:[^V3_P#5<D^NE7^V:)\E7'#?\GZZ9&8^2NNA
M29PW@K5:!/8^B,<JP_-%<[SC7C7D085T#&]6.*0IB_6NLAVM@"%(MSNC5PS:
MD205FVCFH]&JP:-4PFZBJ-FX48]>LC6KVR6=K*'#A1\A1Y9!572U%MLD:UK4
M1%(0KG^2P0T(1[W,8%JN<B<1;"&9IX<T I,8S.:-*$[$(-Z(J-<FIKD\'(CD
M]#FHY%^N7VN*^51V ; (<LCQRO#S1PS,JKCP<TS&/1%\'L?I:PHEUC<YCN?!
M<=#8 +<18C9<B"S4I @YC9S(_3M(_F4;E"I-]K"C(YF@C%^NF8MHH9X]HRT"
MW(S%%*&R5-TG<QX%.]1N:BK(5>G8)KE)OZ7,.$I?K62NE^;E"U%KIJ,U/ARM
M/)'^"\W!+RTG#S3<9[5S"M$1EE$RA)<>I@6##W"N*3E>3A;Q(Z1S+I4Z$'+*
M9\_R"C#+*)FT4^IHHT<3 @CB8  1-08A"$U&#&,;>36,&Q$:QC41K43DB(GA
M]<N7#K;%(ISUMK-CK/IHB/5(]F]SPQY( -\GIRND$8GHZ,QW[2L =4 :PLW]
M;E%MS+;6#W;KF[C]YT,)7>4HT)R)()_Z5(3<7R!@:/ZY?/Y_[?1Q>BMJF- @
M1YC&4DH,IAR6416NU'.)KE<![>0_!Z#7F]P]#D%ND_\ =O8YCW5WUW>>N#W?
MUW=N[U\X$+5U?1V&C9W]WETA=>C3Y//6VBE]HO93;X1C.0FC1H62BR"'D,09
M98D-'?*CQZ^"\(5 O4+YQTG8&5PHQW"5J<T7P=Z%3Q\E?%.3D7[/@O-4^#PY
M\&Q+V*7S:\5*.V3+W!9['BG<=!+5C/S\9C6NU*Q'J?DTCNE0"-.[Y_/]_DOT
M5CDV0RNCJJP6X<B-W"D>]R#CQHPD5'&E2CO&  D]L0B:E8/61K<NF]B>7QNS
MUZM*F3LL8Y9O=S]&U8K1OKX[$C%1Z*.0MLD!Z.9HGJUR<5F0TDE)E5;Q!S84
MA$TJX9/2U['>6,P7HX)Q/Y/"9CQD36B_G=H':![%MGV"WEG3=T]^;O>?=J5O
MTSU_=+.AW>\/<NAE[>Q[H37J;CF2]+T7L@HZNXZ+?ZGI.\H0I?3=1M W]G>V
M]_8#NZ->R+GH3*L#Q'LGD9E(Q3HG2YD?+XM6K@S(D:0PRQ)5&7;\Y)V-#)4E
M7;:/\$)X7""K9U!?XW-2NR+';+2Z56RE4S&<C,:-IPO?&D!U.$ S#1BL)'&F
MVI/G\_W^,HHY&*7U/$QXD0<2_L0M'59#U+'/(2H)_AA@5OEN8I41'-0^P;S/
MYV+X[<2S M,PEDA401Q#G;)DA?&8]"E$-XX_C+#R<;2GI\I/?^?S_>_O_+(N
M,=BT[)*_$+NRIK&QA9C%&_G7R) ]UL N/[RDD!CJ=D4+Y"HY4"A7N\K@62T3
M9(!]2:!/@S&M;+KK&.T3S1#;;GB?YHX3"*-W(@2C72-^L(BW%?C%WETD<F(!
M*;'PH>Q(V05!O.@^3EV8Z+K,YHWJUOE.T#UE&-[AO"YXVO41.6L:N1%4;]*N
M;K8O@[2Y6J[GR<_TI]#\_G\^7%IB79KV?W':984#G"R&9!L14]36R&J5'1FV
M18,]ACL((P=+VQFD*(K(CY;QOT7%.^IM<6RW'%8V]QBZ8C)<74[1OQB)I63&
M:3D(CGAC&$]X]R.@SQREXPKLW[EZKV8U]K/[Y[QV.[N[(DZ1M=W] 3J]_HM&
MOO"+M[G/2_3H?VC8EW-W?[ +"N@]X=X]5WMU_7^=Z3H(O0;?1^UZF9KW/;MT
M<WT5C&QQ<GD7M^"A! 2V;3JTTB-(.,B'= L&D57@:+;40V^=UN.QK%:^BQ+M
M([.+;LZE943IL=FEMXE_ FS=Q@FQ3&BPH/3$(<H )I25I(>,L@<>.;?;\_?]
M_P"!>?O>GWN,>%!Q.^R9+RZCU4DM*!I648"^WM+)7N1!P@^E2/V0(C7(^2)R
ML1_SY?/[B>'O>VXL[RS(X-=4095E.*QA"N'%AA><[VC$BD>K1L5=+455XKLD
MHCOD5-J)YH9B +&>]@S$CNU .UA!\BA(WDYOCRY^C^_J:'7TDK)<CR:P)5X[
M11946NZN1'AGL)9IEE.78@0(<..0DB3MR2-5PVLCOUN<P>'9GACL3MK"O/:4
M4B%>"R:GM@0M#9X.O#7UA($^+K:_II$11E#K*P_M6O\ G_L]_P#C^BDWZ0.]
M##F5%?$KDE=$LR7<6T.JCB23T\O;Y$F(1?I<G-!JWEX\^/'Y^C^?[7VO?7\^
MJK15EED>2Y"4T>@QJF:!9\]X&L=(DG/**")75<)"#6?93"MCQ!O1Z[B\F+1P
M^T3L\D8A!R2TC4E7>5^35N4UP;>8B]%#N>EC5YZSK'M4$:0,,V,0ZM85XQJ0
MK/N?/['\_IXL<DZ)+(L1\"/$K>KZ)9\VSL(M;$C-D]/+42O/+8JN2*=6L:YV
MVO+FF&8DR DN3E;+^08R3-I:F%10!222E#TQNL21*DQX3&J6'RW%)J+HVGUD
MNOH_9';7>1U&,U-1WBVI;*G6Y2-'JGNAS]D8!A(<CEC/3;8]S]#&N>RBQS/,
M!3$O90^3%Q^S@93#RB#(LH44LXU?-V*ZL/7E+%"Y\,KF'%)>CQIH<->?S_W?
MZO'BN6GI.^W2;>##L&]Y1JWNRJ.YZ3;GG)8_K>@:C7=W@1),K7R"O-J\?/\
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M^*J3\6<(YV0M(G[$E53Z%^WM0!$_@O;]OA.\X59: \-3&#)!D?N##(83??\
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MVS"P983I !55;&4"R@[S![++.6E7)C-DRC/5\=AVP/,D"QB&U:RDJ$D=5&(
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M<U&8]F]M!$27;T]&E=1UB=+'DVEA5LFI$C*]QT@UL9C3O>5R2' C@1F@YG"
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MN1DE*0\F253'([KXS44CW.5W-&-:Q.:(B,8UK?!G$'_L")_YVPXPK[$6P_\
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M:M?_ --XP#X?T$^1IG'S^%?H\?\ MV_RY9_1B_=_T?J/9!_GJW_YFC\=EO\
MU_(/_'C_  #]LU-_Y:QXKDCA(90XS@,@J#:KE& *TRF,Y$1?-B9S<1W@UC.;
MW.1K5XL>S_%IKY>64V!CC3JI84X+QRX^MT6.,YHXX4E; L)0@Z649!J8;C,$
MKB-82+FW:;VIX-D-5-G@EX]36,R) <B'<YBP(4?'[%P3/5RQYHI)V'%.&<A@
MCCZ'N[9+;&*K+Z^KL\=N0]1E5G5V*6$B!06^\2N[MIZGDR/U2"D%*DEKS+MB
M(UP#-XG?MMM/D^HX[/\ M:KA<Y&)7D2+9(WFPA(J3!V->CG(K?,-DBF1'>*(
MJV34=Y//CM'[9IPB,2RGDI*,1D;JCQ7=-(>SFBZ%)#KX]3#YB1S7<SL1WE+S
MSK'NTW+<XP%KYDB746V+RCUT:U 2?*)'+,VJRUDE!+BF&>"1(^R)63 22MD:
M&/).PN3VDY66G@RWR,RR*XA'JS1CU?1-ZR,;':VXYO*584$)98BN6/O:%B"?
MI[9/\[E7_P WQ?N^/I:J^E/1S3DO$;_L;[/+U.+Z>7I3X4]_C LIOU-"HHU+
M <:=TT@[6,:Z\C&>C ,(<_3DDB=)$ 92L$[DT1%5&.QN\IY/5U5KE%1,KY>U
M(!OQC4]YH)LRF!D!YI^M.%I?*\O3[5.R^YK8[Y8<;J:*59B$S<(&OFX_%"LY
M4;Y;H\4PP#-H1VT,RG)I (KVS:*HEFDY)=TL.H;C[ZR>(E>=Z1$DN-(6*E>H
MX34<^*^/,/O%:P86N1A'BP2MN@&B6!<Q'9%A'32:(.R!DDN*$@U\H).F(,A0
M/1A0&>416(]BM8O[0L2_\-%Q1W&*N(&R8TD8DX04,2MA2LDL R9K$<U[&/:B
MM"P[V.V'G0K>1&,<WK)7:1VB9IVC3Z=LE]))M+J;#KI[6M?9]3'.#IQ5< ;I
M#C'E39"R&#<6/J8]6#LX,,;SRI5!GH8X6(KGF,X]NC!#:WQ<][N0FM\7.U,1
MC6\^.T3"$GK[)QT&>77=W2S>3JM:( $E)+:#HW<C+M;'4;[?;()1JKVY=+EU
M!K^''MLC?,I8PQF/:0DIZSJX8P%Y,.IHZE8H7>[-51IY3DXL<TP#-LG[/LMC
M,EG@8I+-*D%:<"_2\"'+ABZX3)Z-8\,WOJ>.*XW.3H2,\;<BEY*DVPNIF,Y4
M.'(-'Y3[2O$*0Z#*>Q-/4.(+F,,G98^0(3#HAS/<4T' FV#O95$D7=B2L6'.
M1'072VGZEDU ]!I^F6"4;I.]K:Y5!MHA%^?IYK[_ *%Y(B>CP^K]363IE?)T
M.'U$&46&?;=R5S-X!!DTNTIS:BKS5$\/#P+*ER#2I)W:S2)!7E.5W)$5SRE>
MI'N5$1-;EY^' 8MC;V<^-'5K@ F3YD@ G,;H8X(9!7C'I9YM%&Q.3=3=2:N2
MJ&KN[:M$YRN<*!8S88W.=XKS9'D,;S_QN7#I,Z3(ER">WD22D.9_V7$,]2N7
MWD7GRY\O?Y<1XT^TL9L:(B)$CS)TF4"*B,:Q-@9S/:%-"-&W0Q$1C>7/QY*L
MBLG3*\ZIRWH$L\4NGPYIN1W-?I5415;S1O-$7THG#5M+6QLE'[DMC,DS-'^0
MLDA?)Y^V\4^#CNCO6R[JY_W,ZZ5W?XD4WZ1W%C)R-YY45OME5>?PK)J[";72
M'C43S099X9G"5R/4:EC$&YP5>UI%8BJSR6JJ<VHJ$D'*4T@KWD*<KU*4I7JY
MSBE(]SGN<]RJO-7([4KO'B+(FW5O+/!?N0C2K&9(+#)J8_7$*60YT=^L3'ZQ
M*U%T"Y>Y<-D6EA-L3HQ M/82S2RL&U5<P;22'F>C&O>KT&US?*>OCY?%+9V\
MR?>#IY\:6&+93),QN@9@&($*27&VMW98U=#=+5:)>7FN7 +^?E5S2REB"C&K
MG5,F4K6!5^A!NCPY<<3G;CE51RS"5RJ5&CYEW*6@H627U5$U$2?-YH>848$B
MBT-?YW:8%JJXIM#SE([S36":\O4UL^97R=#A]1!E'AGVW<M0]Z.09-+]*<V\
MU151/#PYH25+D&E23.UFD2".,<K_  340I'.*151$34]?>X'(CE( X2-*$X7
MN&4)1KK841&*UPR,<B.:]JHK51%][ALFTL)ME(:Q!,//EFEF8-JN<@VDD%(]
M&-<1ST&US?*<O)?+XB-NK:SG1X[]#5FS),U8P'J-ING;)))1CE8SFYK!N1=L
M:(U58B+9T&"6%C;3[53ZI,L,H2@))$D8LHI)$*N'S!&8FRR''UJ\;%>J\E=Q
M\_N_!]OP\?A\>$B"R*^%%:/:2,.WGMCH+T:-E).WIY?K-/#9L*9*AS!J]S94
M8YH\IFXUS2JV0)["-W&.<U^DFI[%</\ 7\$ESY4B=*+RWI,PQ)4@FE&C;N&.
MXIGZ6M:C.;_):B-][CHF9%>,AZ-KI66T](J#3PT;*'0:,_Q>7#)D&7*A2Q:U
M'*BF-'DCW&N870<)&$;N,<YK^3]3V*X?Z_A;"5.F2)ZN8]9IY133%>)$8-ZR
MB/(?6-K&[2[B:41K?>XCE/D5X<D0B%BD-;3B$C%1%;NQW.D/41M+E34-6N3G
MR3P5>$MGV]HMHQ.3;/KY2ST;M*+2V9U'4M1H5<)R:^;Q+HY>5QWD>?-/8H09
M>N+*,6=NATM"3K'E=(W![8]I^[S$B-_8\)(M+";92&L033SY1Y94$BN<UC2'
M(5R#:YSN3.?)'*YWZ[Z+$OVS4/RI%X^[]'D?VZKY"J_H_G_N\/>7[' 0V=M9
MV (_B ,V=(EB!Y.CS 3F<P?@U&<F-1$9R\?ACP)=K92H,9!]-#D3Y)X<?;8H
MQ;,8Q7A$T0U48]MB>9<YJ.Y.5%[I[ULNZO2E;UTGH$7=WEY0M[ID7>\ZB.;[
MHNI/:\'@0[2RB09:/ZJ%&G2@1)&X/;)O@$]HC:A^012L76Q$Y>'/@A*NSGUC
MRMT%?7S94-[VM]"$=%(S<1OMVM5OFUU<UXEZ;ZZ9U_-;!&V<_E-YMV5ZO0?E
M(YB1 KN<^:+I<BM5>$P3)Y4Z@4!GF;8P(SI )*I*=*$IFQ1R3/>CGJR0-P$8
M5 M>(K7N:,=U78K:V636=TU6H^3"/7P8KD \+2D9)!&<C!#(XCMIL@TMS1"5
MPQ\GL[H[ULNZO_9G7R>[_=-]/I'>Z;FIO/>(6\C*A5U:=3NZ>];+NK_V;ULE
M*_W93\VPM](ONZJ7W+W5=SGP>!$M+&) EZNJA1ITH,21N,VR;\89!BD:A>0[
M=8[6U&_K>:\)@N3RIU X!GR&V,&*0X97TV^4%QVQV23/)S=H.(@$:1H6N ?4
MJ,'=UV*VMCDUG=,5J/DPI%?"BOV'A&1XY,:.[2QI%=YED@TMZ!$X@1(A1_Q?
M\?'X?!W)4\/%41?! ALK:SL Q_&.&;/DRA \$9YD9C/:'R6HWDQB>3R3G\/S
M_C^Q\/V..Z>];-*KQ5*SK9/=_-3;WA"W>F14-YY-35\X[4GM>#P(=K8Q(,O5
MU4.-.E1XDC=9M$WP">P1M3/((I6^4S3RYHBHH<CR"TL!9'!/+2-6CCR21-IP
MD$(OTM <S>5"2&INSV#Y>+PMY(J3[M6/$$SFCA1R*FL$,#=(&N7Q1'/1$,1.
M:M:8I48[T\U#675O6B<NIPX%E-AL<Y?2JLCR&,5?#VRIRX=*F29$N2_V\B29
MYS/7EX*XA'.>Y?LZD7[/ N]+6RL^GU['>$Z5-V4)IUH%9)BH+7H37HY->B#3
MGYOA15=U;5HG+J<.OL9L)CE^RV/(8Q?MJG!),HYY,DB\R2)!7G*1WO.<4CG/
M<O[I%^SP+O6ULK/8W$!WA.DSD"A>6X@NI,5!Z]*:]')KT0?_ *KCNWORY[NV
MMCH.\Y_0[/+EM]+O;*B5JKJ9H5B^CES5. !L+2QGABHJ1A39TB4*,FE&*@&'
M(]HO(:UOF=OP1K?UO N];6RLNGU;'>$V3/V-S3N(#J3%1BOT,U:.37\A_P#J
MN 5\JTL9,"+HZ:%(FRCPXVVQ1CZ>.4BA"HQN<--MJ<F.Y(O)5Y_1X_\ Z6^7
M+/Z,7[O^C]0^?S\?1[WI]/$.PN,>HK6?7Z%@3K.IKILN!H(AV+#D2XYCQ50_
MG6;9$\ZC'-\M&\15R#'J2]6"KWPEN:J#9=(XNA2+%=/ 58SGJ(>XX6A7;8E<
MJ*C>:0+VGJ[J"A&&2';U\.RB;PT<T1NEEA*+6UKG,"_EK%J)MIH5W X((P P
M0@;%#""(8XHXS![+(P0,9M#$,+6C:%K$9HTBT>'A*D4..4-)(G?IV13T]=6E
MEZ7/>G4EAQ1/,UKWO*S<7FU[G<^.ON<0QBVG\T^G;.AJITOR=*)],2HI"<VH
M,:-\Y^M]'!*PD**2M+'=#+7NC!=#)$*Q1$BDB.9L. \;E8H58X#F*K7MY<.A
M4--54<)YG2'0Z>OB5L53O:QCS*&$$ 7%>P0VN(X>XJ,:U7:6MX+6W-; MJX^
MC?@6<,$Z$;:(THMZ-*$4#]LK&$;K9X.:BHNKEPE?1U-;2P$>0J0JF#%K8C2F
M\2/Z:*(,=KW.\IQ$9J?^O\>7 Q9!0TMX,*JHA7%7"LQBU:551-G"*@]2MU^2
MSEX>GX4A4E56U$-%U)$JH,2OB(Y?2[9A!")%=[SM*+_C>\LVXK<?I*ZWL=WO
M"V@5,&+93ED$0YEFS8\=LJ4II#6G*I'N0Q40RNYHG'LC[@I?9 C$&E]W7"[W
M:/8V-MMFH%GH/8Y@:C3<G"=H5/*X;$OZ6INXC";K8MQ7PK*.PO)$W$!+"8+2
MM1&^6G-SN34Y>2O$2BG8U03:6 HW0J>73UQZN&H&/&!T6 6.6(!1C*5C"#8)
MS1$5B>#W<PPXT<$:'&".+'BQPC!'#&$S:$ 4<:-&,(Q(U@@C'R&/R/>X[XAX
MCC,2WUN+WK&H:H%EN.]+^M'!23K=[[U+J7AL*_I:J\AL,DED.X@1+.,R2UKV
M-.T,P4@0S(PI6H3DTFDCVHJ->Y%6CE5-9)I.G#$[G/7Q2U2Q(VCIXSJ\@W1$
MCAVA=.)0*./H&O\ @TX;45]97P*D8RA960X46+7,&=Q''$V%'&V,T9E(]3#8
M)&E<\BZ?*XG18.&XM"BV871[&/$QZHC!GQU5%<":(,0;90'*B+M2=2>')4YJ
MG ZVEK*^HKQ*10P*J'&KX8G%>\A7#C1!A$+>>YQ7Z476Y7._7\3Y[,5QIDVU
M!*B6DUM%6,E6,6<O*:">=L5"3(LOVT@,E[Q%1$W&KRYHL&@IJNCA/(Z0^'3U
MT6LC..]K6O+T\0(V;Q6L:PA%:KWL8-%\EK>%M9.&8I(M%+O]XEQZH+/WM2N4
MG5K%WMW6NI'.>CO'T\(B(B(B(B(G)$1&^A$Y+Y*)Z.2+Z/UO!KJNQG'X%S(0
MJ2+:%2UT6S,AU:IVEGBCLD%0BL:KMPJ\W-:Y6JK45/G]CP\/!=*(G/[?UUQ+
M]LU#\J1?J&1?;JOD.K^MN/\ ^EOERS^C%^[_ */U]#"@1BRY<A^V". :E(1_
MP-:GCZ/%7>AB>6O@B\'GRZ0C8\9NN2L:97SRQV(G-[S1X4LYQ,$U%<<KV#:-
MJ*YZ:T8G'\7[W+[O^[DOZ[\[Y_<_CXLID./NQJD#9,Y^X$>P I=AB[97-,;F
M5S6Z8^IRZN:-Y(JI7RY@-N/;1W2X!-P#]\#2*%Q-(B/(+SK7)H.C'^'HX^?S
M_>5O+T\^2*BQ;@@--?//(C1C[@5W3Q=.^W:1^^/1J3RBC8TGI'S3\^+6UX=^
M;,*T$8.L0MPKO0W<.Y@6?;(]J>]SU*G!0&324!7B*WFB\B#=I>G-JN:O)4T\
MVD<U=/D^'')J*J_!RY\?/Q_X?5\2_;-0_*D7ZAD7VZKY#J_J$6O@BWYDTXXT
M8.M@]PQG(QC-97-$W6JZ>9'-;X^G@Y7T>ML9CWF9&LJ>9(:P?MEZ:'9&DO4?
M@FD8G>CDK>/GR^WX^/-?!5Y(B>U5R<W)^<8%='ZDP(DF<5FX$6F+$'NR"<SD
M$UVAGCH:Y2/]#&/7R>(]R2/RK)<HT./)W0.UR0,:0H]II5.FEKVKK<)HU]JC
MW.143Y_/_7P>Y8#G6QI8H)Y.X)NW).QQ1CVGOWUU-1ZZT%M>3R5VI6HO_#[/
M/T?:_.&$::B&(P0V\VMU/(Y&-;S?R:FI5T\U5$\?%>)-98"V)L0JBD!W!EVR
M)X\MP+WA?X*GB-WAZ')S_.Y.16K[Z+[W_'C_ (_S*B_Q^CA9U54O+#1ZC24>
M3"@1R/9X/9'-/-$&;;<BM<HU<B:57GS3A8%Q"-!E(U"(PNE4(-SG(TP2C<\1
MQ.<Q[6&$Y['Z/;?G_/[?SY?;7DG->%J.@_1%L#O3I^JA>$'I4F]1N[R@_2_(
MFWN/,NG2B([C_=_Q<G^2Y=2<_'WN(U;7!WYLPB"CAUB'N/7FO+<.\06>"+XD
M(U/>]LJ(I!D32\;W#(G-%Y/8JHY.;?)7DOZYODKS\E7)X_G?/YIR7WU\$]*\
M1[E\?362Y)84>1N@7<D1V->4>RA%DLVVN3SA&H(G/S:_G(JHO)WM7<O;?=^Q
M]1Q[_2WR[9_1B_=_T?HW/<O)K45SE^!$3FJ\O2NGT^'P<_>Y\0KZBE==56+"
M%AR]B3%WF#*^.YW3RP1I(O.A(WD<+7.TZV<QN:YW'@J+\/+WOH^7-.:>]SY^
M_P#!]OE[R\_:^_S2YKJ^7U$S'IHZZX#L21]'-+$!,&+<.$0SZHAP$W([C#\K
M0Y[3-*B_G_/^;GZ?@Y.5?:HU7*B<7$2NE=1(H+'NFW'LR1])/2+'F=/N&"(1
M^4>4%^Y&><7EZ=Q'M<Q#7&16D2HK *UI)<PB,;N/]H(+?=#R"<EVP 1QR<G;
M;'*G+AM32W[26CV*4%?.KK>EF2F-:KR/@1[ROKC3MH35*3I=W0Q-;M.GQ^:_
MP?*5=*<N2<_%WW/SOFGV/3R<G[Z?Q\N(F-DE:;J=72K6+#Z>2N] @GC1I4C>
M:'IF[99@&[1#L,_7J8S2URM-.II?6Q8]A/JS%V)$?1/K)1(<\&B2(+W[,@3F
M;S&[!>6L)"C5%3Y_S<_3\')RK[5&JY43BXB5TKJ)%!8]TVX]F2/I)Z18\SI]
MPP1"/RCR@OW(SSB\O3N(]KF)^<RPNI?10R38-<PVQ)D<YEG*%!@AVXL>25-^
M480MS0@Q:MPI&#:Y>/G]SWUY>_X*JKXZN>E4X\51.?@G->7-?@^WX?WQV@VT
M/4VUATD./$,-VB0"-83D#8&"OMAD8%K-)F><;Z&>+N(DVCW76B.>P(PB=(62
MI6N:\#HR(YTAI6KRT*U45^GEY3'\9!,EXT>YL8QQL'"*<E'15RO4[I9K.9U,
M#;<)R,&"!U<?FC3)[W'9[N5HHD3*#/':4\:X6UAC?%F-CDZ2TC2S$>$XR#)H
M2<9\<B/&A$Y+Q/BQZ>575&+0+ZSLOT3/(G7XJQS=D+WO:X-:I2>'TNBNZ<BH
MTBF:LKCM!)543J([:B"CPBL9-A%-'6V X;E6?O212F.\EZ,*Z,9KM21X[D52
M]F\$6J$N15\N3;R6/,9Y.DERU>\;9#R! 7IHZB&@Q=/K1KBB>C=#K2CJL==1
MR1UT^936C;:QEG,6M$IMNQCRB/BJV8QCW.)&:%(SEU#:5B:DQ%/1^CN1)[Z<
MN;87/T?!S5>7P\T3F[DBP,5FX\6W*C*X=O>OM9L22DBQ#'*1U;$BE;"8*(PZ
M;0Y03$.3FPCN;D*[*Y,FN]E,FER(%*"$X\Z,"+!D!=,%;V#:I\:2KC-0<08T
M, #).YS4Q%&-V T+J6-6U<Z#429E,QCQ3 EM%7K(\^P\W9RBO0(WL=(D(4 "
ML;Y".5K\C$D.NMKV-;K%J*&TNS4L<M?N'UFCR.KANG3FO8T*QNL&C6<R/W/0
ML*%[&)U<:1622/A6TB4KJF8RKL^K2MD#D:;*NDL&@8\F9U#M+B:'-,-%X>>#
M6AJ8[D8C(0#S)(Q\FHCE0TXQSN4B^6Y-SDQ?#2GA]7Q+]LU#\JQ?J&1_;JOD
M.K^H8M_V[6_^9'^_Q96U9E*7%W!L+ZR#C4>LFU\F9+:Z8I:YME/44!^A7NW7
M,4CI(!EVQ^7N,R"TD8Z6]G-,-P(KI;ZF@@]0IBR3V%EU4/P$NAL:%UP%<W=Y
MJ_TMP8 P-I0Y0.:ZRA0K0=U'BK5$>Z2M=8H::UZ28[45C2'F)%.JL<CT1S%O
MA5&.%I2AQG(NDD,MI<[J0)!>UZ60YJE:AG(F\TD)0C&_S10D&]IAT]P,.FRE
M7]G!/)4I_*BQXD5X1[*OVF;>X]548];EY)K?S8BP<5FX\2W,C:\=O>$M9L22
MDFQ!'*]U=#BD2$P41#MVF2@'(4G-'KS\\N:4N[OI7YQ6!$9?)W!= =X7N\$\
MI1/8I4&O+7SYN1%56X\RPH/9'97=7&O)9SV<ZNCPHDPA61X4(4 HE4B#$YY3
MRNI:PG-6#5O,*'@\I4ZI]CA,KJJM#*R=9C="ZV-3;S&J7><_>:\@4<<@!<VL
M:5[5'"E QB%0%L\I%5245LV4>?!8$4A7U\NT-*L(3 D&@9722FH1[^6XCE4;
M<QJC!A<J[4S'*:RN3U4":?6)C@&ME*R0UX1.<\ EEL60]=M7M:Q5XHS2\1DU
M9G-(ZSI9$V4:DF;:LVCU%M'F%E%"1I4>8;9BH S6#1[V$>BV<<%4&')CEC]3
M/9)F$-/UUT-6;H#2"1@;*>2SIP!5Z>)%>[QX3[?S]'S^#QY<0Z@;E2IJ*.GC
MU(4<C@)&)  9YAHWR'/*17[I?23;T\]+4XI:Z:,[Z:#.,&LF]$0JC)*<Q9,0
M$O1YY&Z4(D)ID57M:WT(JH>F;B7=,-:^22#;S\D:/)M\$<A@S96/OL7,VY!!
MM0T1M2/9 JN>]GM$K[ZTH2W%C,NK.L:B6DZ#'008L=["'0#G\W <]7 $%L9Q
M7$YF,[0P9,>%94)+VQO:D%W-G+;2X"08TYQAABUH8WF5.(0]PDB:.8SJ/%!;
M:[0C1)0'R8+<-')CL*4H"(Z)C33PWD6,YOE,>UCW,:_9>NKS;VZDXJ;VVJ/9
M#/R"58"BQ3S9E?!@0ZL@P%(3N\HY,B1),]=#=W8:'QTZD:ANSNXJ DBUN2-;
M/' ,=TE\"4!31IL7J2HPQPC>QJ@)(;J5JJWPT>-[E=W ==:,B)1P*KJY,&/U
M)&$EFFS31',D.:P2(P P$9K*CD5R-YJF+Y!6"2@AW%PM!:Q'RSS(\"2(@G=;
M&/*59"QB13.(492$Z=[-+"O:KUXS2&##1078Q3V!H%Y:K.LMR1$>-@3RXDYQ
M:<A;?W2 Z/!"@'$1X-Y$U)C]L=CH\F9DTZOL9['%*YM>$$151D9SE!J"TI">
M;"UY'JB:G)X-NI-?C'44D:,1U1E>.7Q+TW4 ;S$^_AOGO9$CG:WZ=>VOBN@O
M1W)2HQ7MPA@\=B!)*C7J1"MG6I.['AMQI(>!KI:C/UK]1G)+:5C%=RCHC$5.
M/G\UY>_S1.7/DB<OJ&/?;MOERS^C%^[_ */T<G_,&_\ ANXPBPQN4&);/L:.
MO 60$1P*RSS;H3A.PH3^9.$[PE()J2!#>XD=[3-9QAM/99HE_!SKV25LD?L=
MIZMM#8UU+(MXMC0]*$TA0H^/T[H5W,N'O9[K((1$?QVI9#/R:UN8%+FG:*^3
M3D@X_''/EUQ1236SI,*K!,9/E- ]'1@R 58MSS=<SP;Q6Y9%L,TN[29W;9EP
MB-V07S,4+73R@6175N0CQOO,A8=>=Q:^[+>2X4Z3&1_2OCR&C9;XM1Y4''*.
M!BF-7A7+15]M8=5,LK8)A0GRQ,&+KV11CF2)?7)'''1*^(V2<LN/VDU663]^
M%2UX<WQT[P18J^Q0\0C+&$Q8X0I)[FLX!QH<^[)<R=$0Q7.(-$PRAM+BZKK6
M_P <EYS=6^.X,3*;B'!GV:,I,<KJBMI+.)"'#CR&#L;>SKY;B."(8W,DS7/3
MM6.8EZX^)4Q+#$\NOL*F8I,M&FK)$AR2:>UJ(E9(FTTZ.\)2Q( 8<D3XA#PA
MN=Y_!,FLLOBVP<AR7%Z.XQ@=!71*<4;)GCC;M;8,86[ZVO(1I=\]@Z'-*W4D
M"(WE$;+>+,K6*-.S^OLU$.LQQ[5K$RR2BX]JD5)'=$Y1N)UKB=]-*9=-GI0:
M#[;;4VFU3"[J!!QRN((,<0NOHJ4@(QC :&00/>EB\YWR#D.\3G@$5B;>U1Y1
M>9FW*H4B\I*S)J1]!45T.,"_G!@=3CDJOCALF=UR90=H5K(L^N"Q4,X)U<3B
M\Q*FRD>/4,'$:"W>1E+6V5H*7.L+B,_NQ\X!(K72&11I)D60K (&QT'#@L*<
MLL/:0VSLJ6PO<%O<AH8-];L#1U<](%;"L*ZQOA1-F%!0:SV,L.E8 +AQD<QH
M'/>]<"%[.K/-@Y5>QZ*W#*P1]+CS.\(\MS+'&<A#158B]/*CB&V)*MKHDV&]
MQ$8C1J1.V'_^X?\ '[%\?]_T<O1H1$:GZWEY/&%5MH-IJZFPF^R2F"<>L2Y
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M58OU#(OMU7R)6_0CCQ@ED2#/:,  C>4I2O5&L8,8_+>]7*G)J(O-?#EP2/*
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M<32YR(YJ*J)[9/0K&6E985KR)S&V?"D0U(B>^QL@8W.1/?7@4>,$DB0<C1!
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MMK<W7(]'/'R=]%B?[9J'Y5B_4,B^W5?(E;]#C'_;==[R+_Z2SX?FOH]_CO\
M0@8+:NRFU>;O;H'T\6J<=T>Z;XIJ=85T;I%_]5+$!G+Q7CL[6OCBB,L)=[75
M47D@QQ8K+6+6U87\M:,V8HXV^NGV^OE\'#L.!/ON_$(6N9;OZ!*9]N!'<Q)
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M+A[()*3R.52"?MN1RM9$OLF-;$=;RY<:JKJ5\,!=JN>@I<V;*FQI01INJ@Q
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M@L9\>TER9<%^3AMVMR+?INI8 K(4>>DT,<0XYAJ[>7$<LQVA@Y*VOPY<*O\
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M1%_O]?M_6S$_VRT7RI%X^?P?1Y#]NL^1J[ZV?/X.*#[=M\N6?T8OW?\ 1_\
MY:Q/]LM%\J1>/G\'T>0_;K/D:O\ K9\_@XQ_[=M\N67T8OW?]'ZW28R^F-(,
M!?\ _"11_P"MB_6S%6-]*9!4E_<QYH3O_D#=]0MG?_60UIT^Y7QX_P#^7^MN
M.M=^N9.*G^3(M)QF?R2)]&/]U_-];K8>VK8U@7O2([]:X<Q5(9&?8%*WP_:&
MWZU_/Y_9X[R>Q5BT48DE2+[3K)#71H@U_P 9463(3_,?4*C(Q,51E$^JF.1$
MY->%7R82K\+B,),:KO>: :?6R/"BC4TF4<4>.)OMB&,]&#8G^4Y43[7/BLJ
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M]6DK[*W) O-=GKPC2:?<RZ+^^NRJJ(LZ-AR$X(!<;YDA)5M9?'5(9@7,D_\
M$JQ--MC!^-=B.FX^*-TZG.0L;+_R&>[8"R"EU4)7F&XG3@<$ZEK@/PY.Z:3X
M_K-H%)T$=(2.";T@1.:O: $5I:J\))[4.Y+WOJ,)( *5949 "W$Q:/J_+DAS
M.VW\;67Y,T><IS,ENZ2 *4@]\Z"SN+;EX%$4G*#518L$4@X*_5:K16\/MW.=
MW]*!9 KOX"@$;N ZCL*:!)Q)6B6UN&_"@6(Z8#XU+:T&-X9LQ#JAAZHP78JH
M.@@8.F(ZD[6]97CP-(F9*[0;IQU&%!0N(^G^$&RYO;3'6+-.RA7),U*@R7K
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M2QN46% $M"I :K1EE,WW^PE4'4%-.^T_YQ.O>N9U.#9:@O+*_BA!\:(+E&]
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M&G%[0S$J:V:^?R[WM>\]=+\I^\DQWTZPR.,K'<6M$5^:->W30()!^ 6(,+8
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M"B KISVBLK8%NQJN@5*)8EOA.D62TGQ'BZ>5ESK,T<!F)=$I.AN#GP9,T9Q
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M.IZ;JTL16BLDQN*HAD"(%BUE+1C2S(MVM]#HH"J84RYN'^<,/^[\";_FD?\
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M(LV$2AM"$$2M0:-*PYFN#,Y-CF(C1]6,W!"R'<F\,OLZ-4 ].ZL[NQ&-RRN
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M"200022"00 0"0       222"22"2 ""0 2  0"0 0#S^?S^?S^?S^?S^?Q
M              "0"22 "02""0 0        "" 00" 0 2"2" 2"0"020(L+
MTL+TL:N.NN.NO!               20"20 2"00""0"           0 2"0
M02022  ""02 52.%2.%2.LJ.LJ.L\@                   20
M            0          "    (  (  (        ?              ""
M0        2"2                "2  "2                       "3
M             """ 00" 0"2 ""                "0" ""
M            !5@               02"0 """0 " 0                0
M"0" 0                      !>                  "20  0    "
M             "0    "                      "0
M                                (                        !_
M                    L                         ">
M             _                     4@
M "*@                       "3                    !>@
M                #/@                       !5@
M    !>@                        #/@                       !>
M                   #"3@                      !R @
M            "0                    "@-@
M _!@                        [                     7@
M                )_@                       "?@
M     ^A@                       U.@                        ?@
M               2   !)"" ""0               0   2"   "0
M       20  0  00"020           2" 20 2                  ""2
M 0  20                02"""022  020          2"202   " 0
M            "2 00 222               "0" "" 2202020      !( )
M)))))(         0A      ( ))))))(         !
M         "EQ8N$T"04&ZT/6N;6VVT7/@  !TH-0-;H:G*P4/6;[6VVVTII
M  A@222222222222222222"#!LX#?-=PB/)@-%$)W$DDE&8@   JLW$]G+@E
M;$I%ID7$DDD$P)   G@                  @ER A$DBU_\ D&D$$@@($A@
M -O@!9!A$DBQ\\;D$ P@DELD!@ /&@ #P                     %@4D$$
M'C ?8D$F@@@@LL!CW9@ 8[6DD  ?#<<_@BB5M$DAA@!R@ 1
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MP?+.*&I;KZ\49L?N< !,   ( *"):)! ))(( )   (6#1 ,B11^@-_N<:)@
M"033IP &2#"3? 8*>7<9L>9A<(20")*: !,                     (622
M#3123N9=[J0JB)*2001IP 'T  03Y=>*^KM GJ4T$JB"0.H !,   (   !
M! (! (!)   (0"402#3*/Y3Z]GB.200:"0-H ("240?S#ZYTOC3:[+$O[G"
M0P !,  ! )8(8))  (8  83(  (>)86000-Y9@S1? F0022::/H $B886<C%
M!@^AK@9'RY<\:(+3J !,   !)0)())  ((!( )   (>2819 &20@4#@T #1:
M4" +5R 'X088*0V0"#3W0R&;32$ 20"H !,                     (>22
M2:!*40" 9":02214"  5]!7H220*(06000!31000+%J02;[T/L
M           (0+2"  *#22"2&,"822237*4&RYC?6"""*)+ "246"12031#S
M6ZVYB                     (9ENE4T"ERF'8*02',FFEOH3,HX,["PVF"
MD_%LC*22X,WENQPTGMWV))))))))))))))))))))!(:43* L"2" ;!206"28
M:8 0?T3Z%" !"_  "0821 &20+080$ \U&^                     (700
M"$BX4  2"+324020)303N(Y$* "5S4&"222: %40 282:#.TMT
M           (0"%@N241<&(R03!!"&6628.4$#0 7\>22O $"0R<N! 02""
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M#(%@D]8-.;-PK<[P$DU3R +H" ##37$%@A75/<!Q?(46>)0 !,      (
M           (00 ""0+20!#G" R6R0*"0"8* $T""0223"2"MU0$"@"R1!("
M'  !,                     (83L""20;1"$EQV00"   :9;* *V3B2"20
M"!"&6;H" "020# &B !,                     (6 #%N20" *#0"3B)L0
M200"_( $, +*." ""032"!#G600 "";(  $                     (2 "
M!$!\"(" 380@F.9822&$R '$D #&#L"(202!"$APW60" ="  -
M           )1RQ)9&# D_DDFE*&]UB*^J8   F;O6TF'ANLTDDVA5KOBJTA
M3H  *&                    6)=Q__ -)IAM'0%$RT1Y%Y4ZG   "QZ?\
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M1L$<B:2(X\O:YW72/>< 2<*IYKU\->F6"13L#;?7C7;M@&$I"B:TVS,\<O7
M&,EHX2_>)ZO'.-13;0%R=O3CXR4H:,A-JNO%_'A$ D%7<N/;7B>.<6P[ W))
M$^7I6+!0IQ5]FVW\U@#&2T<)?O$]7CG&HIMH"Y.WIQ\9*4-&0FU77B_CPB 2
M"KN7'MKQ/'.+8=@;DDB?+TK%@H4XJ^S;;^:P!C):.$OWB>KQSC44VT!<G;TX
M^,E*&C(3:KKQ?QX1*($1(!#"&1I@J50(4<GQ9D):&)6)@0QJ8+,-&M'QQV__
M !02)D)+/L>M3A; 02D 95EE-Q'-01)#F?*/IVU_^**.XAU[^T3Y9-.D@D1
M6!N81:C/FPERB9U4^//A]/\ \3!0-H\[T=?#G'K]"!"$&"DB(Y9B=Y*%>DB4
MIN=ZZ_\ XH A*(2A,=_^R=L8&PKR0$DB9>#IHI@Q4>^(?]UQVO\ _%"RH@(0
M9-Q=9!VBEF1#5U1L.T08%V!+!$"H+WS//;_\4[!2 ;7!YOIMDK#$E<U4"$DP
MP1"\*$#$""!IJ7:+'9Y?'_RCG6G<^T<^-9N$ZR>$/AU_F01%(.LE>^Y\H_\
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M_P#V3MC V%>2 DD3+P=-%,&*CWQ#_NN.U_\ E0 -2K]/^8B1)XV5BI>EG@.
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M%Z;@DE))DL)J5;=( #ND\;L3 C(.MQ"S:G?@&%79OB(Y#TG<3>0ST:#T/SK
M$@Z;)72!Q,S]/^.,DH@]_ 19'3[I%)IN%OIC,JB9=M'3V\?-;OZ\O@S?(6
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M,UUR<,B<Z*DNH>D-W@GPD?#&>,3J2$K=_G48<WC%S< :\O6<EEMP<SQVE\,
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M+::2(1R1H3?4^-U?\Y0:2)'-5,QXHG=\9-*Q BFT.B'24NRX$& 9'P$0JU2
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M1\2+,$I)]2H0YF#2DJ9DT1L[-Z86E)9.\74UJN(O#4"B20,C**"0F5@!6%2
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M]>'IG',][(*[7UZX$VSY/S&&F]5'YUD:=S?Q'0ZX_;XYH>!\?Z%TZ/D_ ^N
MB;&GJ_''AE1O?>GI?'G@P&VO+MKWP")=!4:?&+C!@9EWX=M<8S"YYC7O'E@P
M&VO+MKWQD!/2NGM<>^!K?M!1TO$)"T=OYBI"J3RL&N'I@G,G2^W;MK(B7R+[
M0S'MD2M@+MN8W7SAPW70DZ6P>5X.I@O]\GUPHUT5/>$R $H>H?S"-33*BE5V
MO*HM)N#TC*)>=%O2YCVR-5N(OKKC(Z%OBR_&/Y@#F)MJ;\8R<VAYPIVC"M-Q
M;<L1V_Y@9[M3;\F1BJ>6-^48;?3F]^$?S(5?2=WUXJ<.9T?.JU[X%T>[^L&
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M[U/?#C4UV[/3N<& H,$.NJT><?\ ,EIF-/@=]W.)"$=:%0=Y77SB#6J\H8'
M0()BWY^6=I#'8>]UW\L%&>697E$^OGG;_P 1[_-Y!?J0U\.7S<)?2KP&_P G
M?>)@@S%1)1=>]-SG /C[2Q&!:W'B>>L& VUY=M>^)3I3,4B)J3K@XQ&"$AQ?
M&],\]<!DM' 0I,%94D56.\1M4HM+ILFA+3,I*PSB@]5!*A(E]&8T8U*#S0,B
M4W.JUMHP""%+!H@VD0E<*M&49PB3N)#UY1FN3K=-RR73I\9EZ:8PP[/'I<Q[
M9-4"5MGI1?MZ8R$MP,NOW>$!>2*D:-Z]L'#.SJ._GFY-J.UIZ9.;S&NFKF,J
MWF==/68R-,WS516N.N"Q*XJ?:ICRG) 3"N5]M>^1\OKPR),U\5:K7OFBW$WK
MKQ<9L#>)F=*UG=>O]9 +Q5R]8CSC!F[+&Y?A'OAG>6HGVYC -O75V[9%2?69
M=N(]\A0UX>\NX\//)!!XX\]Y]^F&"#*_6WJ/%873\]'U[XP# +Z]'U[S@2/7
M[8_+$4@IA[3S>N(-:KRAD$) YCL\?+Z9+3,:? [[N<F,65?@>L\^)UR2*#[E
M=^]82CZ$=]69VD,=A[W7?RR/0=2_USG"Q<<&CKK]X1B4.I4ZTGP\//$<./%*
M=]5[QSD(1:N.8LCBM7@36XM[5+$9(N_,75_I@71[_P QP)3,=CB; KUQP)E/
M%,;+OK40'.1^60%#:RUQ&S<2K";9A#0O*A%&8 \@DJP$L $+(.!,R3>YEP4
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M)&EG&%47$NF!$@)8*RP TNBL1PWZ1@F2JIC1\133*V"ETB8(S \1OF+42)9
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M(_F KK74OTK!()F>+I\8_F$3AVB8[:PV^G-[\(_F HVZYM],$@Z\72]X_F4
M'O&H\XZ_O KEKK7;7ODT F7%%2W$QSZX@521F+O*@)"(JE,&C'>R+ P0$#MP
MI!2P";4LV0*CQ8+PT&)(D25% ,(PX_E>!"2&DB*$23##]:+@&Q* :%:G#>#4
M$:8*@1"1&$98?5*A"R"6CP&,0I7B@ 4$D+SP39B()K.I;24!"8F\28<PQJ@@
M@L"Q048B:F%>"4= 0"!*)7>NSJPD43&1&!.3/'R-.Q,BQM-M5CGL& 00P@RV
M(CLC FS3+7:9O".Q7A\P%K2- A!;+HE$8 8HV=25"" %:5(C"2*BNFDJ2$M!
MI7(&.3%2&"5"*661-.-E+9MB"5B#!(EOIBS\;<JT0&$R$;,LZ"'))DV9 2 K
MN"?:66U1\+PJ>K6&WTYO?A'\R%7TG=]>*G#F='SJM>^!='N_K!@-M>7;7OA&
M+Z5'M,>^',Z/G5:]\^E_K!W,=K9*[5\XF.@S#;L8XKB^V'V'HL//9\HP^3_9
MO\7R?_-TQFIX_ASGR?Q]^F*5\$]&,Z=G\.??OW^Q[U]]?\>4O7X[\\3S_GRG
MT_*?X\OOS[>?^$I[C\?Y>8^^O^.?)_'WZ8?OY\_O37^/OW[S_P#+Y'XS9\7Y
MQ2V6+CZ.M;QU[G'I<Q[8+ECRG\8D$:Y:]8CVQJ6'?KY17XQ2M=ZMKM7Q@PB/
MC?IB[W'%4^G\P2"\BD8Y"#[U.2C 124X9)'50,G:7%(BJ?(5;S6GA[XX%)I-
M1@RQJ=\=\ ^M"6P;&>'-ROC@-)H*#26JORUK(D)U=.%_O7Y[D$)"8CCI$G?#
M*I=(#2]Q[WK)3W>> .^=^U3@U !@"0!9L&HNGRR4I@@+#'!$"^FB\3)8;I"0
M;C8U*RLW!@JR )3($2)=1VWWQS"9%*%:3(+RIA%HS6C,A E"P43R^YA0Q 4S
M'6S8+K4WO P*$A"RDM<&BIB.J"T&JI0A754E=(Y(*:(P1NQJ>&_?"J;1,BBS
M-'45XSBEG&@3JA'72?+C"M'5FC "[DXKUXR4HC) @0EL=K+R> #*030E&:!$
M.]W. (BFC 62>#4\]L$"5I@!W >P]"-8B*B$V]S4\<<$#BB&@?Q7-_I\<7>X
MXJGT_F&NGE^8Q=3'>F6NU?&%8B>=\QO6+(:*\^VO?!4:-<4>F/N9N)Z%<1D)
MF>"(N.J)QU<_WG)X/S_H=GC^'-=E>V0V88/9_7%*UWJVNU?&#"(^-^F+O<<5
M3Z?S#73R_,8NICO3+7:OC$"O.S<>&+N9[40UVOXR57TFM=>+C'W,W$]"N(P*
MB--)X-B(GXGP5)1Q:#[L44\7> U#@"%-+&K6FI\6240"6J&ED3<34]IQ4B2!
MHAZBI-).FNF(Y*4@CM0H.&:VMX,JE%!0$A[<0F")U J;ZS,QWN:KKJ14-#4(
MMU/]R&-"FR$@DZJI6B>R84A"=8N0K8U =3P<$'4Q*(L&(0U.SB8<2!KI%#X1
M&(Y[G=ATC0!L01,63KKUR8D0&;6SQ:V1<P\8LH#8BKN2$,[&CJCM:;#L3B*D
M,@1P.\C*(8(4T</2^;<0"L-)2(\!^;G( Y*0)DC9V>7<.(JB,TDT"?EUS+6&
M@10AJNDJO'6I2,% A,)DTI(I>$NR^<!@W(C=:8VRM(8KB)PL&)%#+"&DD[SV
MZ3BZF.],M=J^,*Q$\[YC>L60T5Y]M>^"HT:XH],[\]^A7$87W/;7X]L2N"NE
M]M>^30(DXL_6*P=.*L.\?W!Z:(CKY:Q2_P!I^&'R?[-_B^3_ ,SY'XS9\7YR
M-IKQ_#KW,.9T?.JU[Y]+_6#N8[6R5VKYPE%5X]>8C!:WWNBNU_.!-L^3\Q@[
MU/%V>G]Q,2E/_>F *H>"3I='MDMRE2+?M&'8<LO'0LB_/#FAXU%=-:P@CEW1
MQ>O; V55._:*QAI3N21B3M=WD;NUE8WXU?CA-\E?IK^8"N6B;WZ5D,6L\73X
MQA&YA\)?6,%-USN%KB,A4,1'7CRK\9=,L>+;7;WP"UO>W]92$JURUVU[X1AF
MZFK\)B?/!677,W.JL]\)43ZO'E@0#:^/IJ_'$H2#KC7G%Q[Y'10[205P%_G
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M%LSU?B<&.HXF9KTP4=9N=5Z8K!,1Q5GC']P7''<_6--[X*[7,>V$N8\I^#(
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M+RK@0++M;5XJ-@U*X]XXQ1O.A)"(R[PEMD7QO;P_^*0"<2R0D# 6TSUI-/\
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M &>=2;G?[/.I-SO]GG4FYW^SSJ3<[_9YU)N=_L\ZDW._V>=2;G?[/.I-SO\
M9YU)N=_L\ZDW._V>?_'(98^BAE#K_<+RRVA=8*J0#JS;)5L((:(8:3%/ 0'1
MT5]&&*C!#:,B4'0P/")8"0MB*R$Q2]TD6,")+ERV7OFN>Z<>_$\J/EO:^E:K
MV_FZ_P SW3L>11M/^6W \J=+O^&QKMM1KGX?OX\JYOSYZ]!Z5W!M'H_&(HFV
M?0CGMMH;12^EWZ#CRZ4&^Z;:/$OQ7^:'XXGD;4%\IMOP/*MGLO8>5=K=['E6
MB;B#;A],L>"^G'R9>OM^(GTD>Q^^>RZW?>1[Z?0]%\]^?X#!@P8,&#"7,DRV
M!^<L6DG>DST+C,@8"29+EY)*(! DA6%H%;,%0%1NA0#M&="Z@*)"6&%5 A-G
M#CPD_@)'",YZF*9!X^#HF#T;#<6H304'3%B"*FFP(0<)88"4NJ(#)@  ),,"
M'$=Q@XY"<,6J+5Z!^>)Y4!CQHO0/>*-:#B?UHKIU$\)X.VCQW<4?#R:<=C70
MH[OT]IY5_E"^9CQ7-]O>U=V]K'IX'QXNFL]BW!M4>/%;M8\JWO"+;V8X-J[6
M[V/*NUN]CRK8[KAL>5'PA;<MCR-JT3<0;</IECP7TX^3+U]OQT[X]=Z6^._'
MV#QX]%\]^?X#!@P8,&# ;EL# .]EDY8S9I0Z#4&2"1:8D;0/2G069I&36@AU
M,H"!>9C%#<= DR6N)-\+#? (;*6+RP&A05B(];^503.L1X?P8G7V?ZA WV^*
MYO1^* X?S](& !@F32=D=T=JR^;:Q&II#UE%K>"!D7(S@C%]TY5%$IQ@B9;3
M'-Z&1<=Z_/I)4OT^4^LUL?'8CK#>NAY''+X]'BIU0\+L#SM>V9*(+P/7X*;V
MMOI^J(&Z+:IQO';Y78#VYJ#]?E4'Z_*H/U^50?K\J(UGVYIAT'0.W?-$&9=N
M:(%R-G"\[^'<5WR?-(,,XR8;:/1\W-=?L?/H[42S'QX<'[J- %-_)F>L1Q%#
MMLU./GT:YF>,:3@L[/-MJOO\^O\ O67JZ^='\QUS?.LU;M\J6+GX^TUT>O\
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M6&0!@(*IRSP6;41AMKH2-G'2@6+7&%9R"4)2S.^\Q 7!-R!<DQY+V*4!9HF
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M3U[\_%S01UAPYGQYS_%V;9]T^F%\ ,Q&Z$+ FC03%=("@F4:ZD,H$B4C)F*
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MQY7K7&F;7XWI=AG_ !K Z'X^[$Z^S_7=FV?? 8(J"9@G>"?.D'(.MR;[_:@
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M>^/NS>'Y/H+[3I]V)U]G^ZF9O3W/K!B+;5!L5@LLR6+.YL\_2#8Q'AMTH (
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M.S4YHX2 D\#,CLXH>(UX02.%E-L32,,1(+$;=MZ4OQ^$2VMNC62^&B%ELT@
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M%+BQ$K(UEV. I)U-AYG0@O9L@,1<:&<Y<(2IED%.+*:.,1%3,66.J[AC5O4
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M@(@"%F1 @14$*35D!B? ["=AB(B3$WVJ28DG;7R_@DF))VF_E3:[8W;4H"D
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M+X!6 THTPG!AD(?&80=F!U6B++\FGNL.J\:&YU=#0H%)&=H'SH22#[_*)6>
MC!N961 F4BR K5J[)[0N;&M*RN+7'7[Z,"Y4>FUB*#XAQ=#E2R+KSFX#S$FI
ME<LQJ!(5!$K=035*V\ ^$!BHY(Q7;DB"UGL&%DS0G"8%?%'3!4:3&2@G2S@
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M!L;XUW_C,='N?1-^1[?=B=?9_KHA2=[NWH#B.5O+!V49P>+>U*&: X?S_P
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MD%J$@HTA$%-6A5V5Y85S(7R(&31)NKI8?+EL_9;6S#9SSTN@<R&'.X[AT9L
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MG$+8A)+L2V()LHQ@WHWHQ@$2RXO2^:4.U=^&9\%E%-*OT\Z<W4"*J \09_S
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M/Z?)J3<^S^GR:DW[TF_W'O:I-_OU/_E42I#*8)$"@"(00;#I3$1+C9<>;'G
M'AF,_5$7&C43HN*B! S*##H%-03.=<;Y3Y,S2JY]KW5@^_A4.CR-/D4\T]*V
M4^R[&D<$_(TZJWO%)YGI_52S,76\[*.!X.LN6I)+E.9+;0TVE^ZT_.D[R7_Z
M TA@MA$=XHPV%Q$*.J[\4%K<'HH])YI31OGWSZ*_LMYDNP=RW6+U=&KTUWR%
M0?)\CI_7!\.X>?*OL7UGZV_$N5*E2I4J5*E0UEUL$BX@"B8$X9I1(EXJK:E.
M 8<(L<B1M$-VD\JIJ#2--;-GN"2K'!6</^:6_P"_@A821?)^=:EIH-E':C*G
M0U%O.X4%%0:&AK<7A":ZQ@1NB)$J#O;8F%8&P<# 4#(2B_J%I^EH%8F;$GZ>
M.UG1(D\4_65;2O$T?7K67P2WUU* ;N;1^LO:N#\;X5OO]]V[YTH6;Y7I/S_=
M?#/.3'R_5";[)Z0'GQ1/=N/?2\OU3'8>?90\_P!T>U'UWECFG8[Y ]Z_V6\R
M5<!T#VHP9^/W4-7IKOD*@^3Y'3^N#X=A[Z_]8^Y_(J5*E2I4J5*E2I4O\JSZ
M8]:5PSBP<F"$P6:% 7I.5Y($%5D*L!3=!&[O.)("!93HBL$(! J!%A(#-F3E
MC\($5@!NX(%EG!:H6&V*Z/.$) 22C:GE:&0@CEE:8O;::F6BWD(/1?,]&*<R
MES*7,I<RES*7,I<RES*7,I<RES*7,I<RES*7,I<RES*7,I<RES*7,I<RES*7
M,I<RES*7,I<RES*7,I<RES*7,I<RES*7,I$TRAHP/G[K:6:*%YNF.]V_D,K)
M<I=6)#M1 $FZ6D%O$T3K'$:G8U+("V5 50.QN0$@9>V ^136@WED\H1X_=1:
M"W6\>#Q:H=9>$>WWQA$A=?-STQZ15R[1M?<_Y23JG1:/'QZ[Q]+\U!(OY/ZH
M"\&W!\TA+&6CC-[4'_AYW?L43JSX1V^+Z<\?8ZS(1.L^_3?TJ1,S:,?VL,Y9
M^,E='[9OXS.7O^/M^OL=>Y'+Y]?WZ&U1U^K^_0_#P>]6.@E@$!M!8%@0W2D=
M_P I&B*"0$ EC)A:'B2GX*&Z!>(H0#DH3.?Z%.OE=F('3K&$1,&[U:@W2[RY
MH-5G$?JHW5\8]HJ.4\9]Y^^-8:.=_:HARY*/_/']U-V[C$-L;9^WJ>'DSY3)
M2DS.B-[7'Z- Q85WR:Z$;^A0(U7FR+7U6-?MZ49/;L\?;]?8ZUX^WZ^QUD0B
M8O-2)F;1C^UCX_O\<<OGU_?H;5'7ZO[]#\$3_P!3VJ(_ZOO4F]&*Q!:/-UC=
M-3!K&R&K+"O%KP:KM'(O"0Q$P@L6D5[S@\8]'YO2;&8+0D S@7RWT )F( $A
MD,2O$E^<Z?Y/&1R<9V=0K09-K "K,J)Z8B)-4G#I<IAR @ (PM7 ,K\,(V3S
MGPJYNCG'C3C$\6^:+-Q*PVSM:D$AH DG/[HSB>+_ !3C(YO\]T0B8O-2)F;1
MC^UAC+'SAI6Y,QZ8/_' H%0%U8)HFN&KP5BQO=9I.@_O(-"%$X,7!LX>"R)B
M1H-F7"0Z7_G=D+:"9U 9+/1XFAG@H &* VA@X";>P)8MP? N)LN:_@A&R><^
M%7-T<X\:>L7SYVJ8;D>I\C[%"..S$Z_#V N*49/;O8XF_EF[]UK3/A\_=_\
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MJ\XMO/QV(.>M0)%LZ;\Q%&Z)7B1_[Q[XI B#K%CQO:D@H$BS)F\$V=?"_AI
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M:R)S:9]ZA(&&)AV^]:@3,WC']_ @YH!S9BHUZ_!7N/CNN/'V_A$X@H@9#UC
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M/]E6;+%;G3>"4.C5GXPC\>GW(@5V>(!+A]P=2993&"9<2WZY,)PHHC5"@-\
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M 7:2FZC9K'J]_P#F<CJ>]:?1903'$O*O&S#H\P_;VIQK]W+$9ZM:9\/G[O\
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M%(7 5!0-?U3[V["XB'4E//BUC.U+VG0C!@@@"2%5P"2B7"CC$\6^:12P/$I
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M%L! =Y%,FVCV1$-86@02 *QN5TSJ1@**S><]U!P+7K%Z@%-*&PL#X'^=NO\
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M+"BK$@0@3/:BLNU*232!VE1E![UX&]'^JSW/RW<*2''$IP_/I+:HW[*QYZS
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M'),,^-<7J_NB"QKSS1G,1K1C7R3?I:U.,ZXO;.^?MZ8B[ V\Z4R6"+W;6ZM
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KT98NG#G8M=T2@1!;P(Q9\18UBA.H@LEB:QF2 O-Q0CD( "( 1;IT>S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>business1a.jpg
<TEXT>
begin 644 business1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &2 X4# 2(  A$! Q$!_\0
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M_#T;]F+_ **9_P"4#5/_ )&H ^JJ*^5_^'H?[,?7_A9J_P#@BU/_ .1J0_\
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MS0!]0T5\K?\ #T3]F3_HI?\ Y0-4_P#D:E;_ (*A_LR+C/Q,_+0=3/\ [;4
M?5%%?*O_  ]&_9C_ .BF?^4#5/\ Y&H_X>C?LQ_]%,_\H&J?_(U 'U517RK_
M ,/1OV8_^BF?^4#5/_D:C_AZ-^S'_P!%,_\ *!JG_P C4 ?55%?*O_#T;]F/
M_HIG_E U3_Y&H_X>C?LQ_P#13/\ R@:I_P#(U 'U517RK_P]&_9C_P"BF?\
ME U3_P"1J/\ AZ-^S'_T4S_R@:I_\C4 ?55%?*O_  ]&_9C_ .BF?^4#5/\
MY&H_X>C?LQ_]%,_\H&J?_(U 'U517RN/^"H7[,AZ?$O_ ,H.I_\ R-2-_P %
M1/V8U.#\3/\ R@ZG_P#(U 'U317RJ?\ @J-^S$./^%F_^4'4_P#Y&H_X>C?L
MQ?\ 13/_ "@:I_\ (U 'U517RK_P]&_9B_Z*9_Y0-4_^1J/^'HW[,7_13?\
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M:I_\C4?\/1OV8_\ HIG_ )0-4_\ D:@#ZJHKY5_X>C?LQ_\ 13/_ "@:I_\
M(U'_  ]&_9C_ .BF?^4#5/\ Y&H ^JJ*^5?^'HW[,?\ T4S_ ,H&J?\ R-1_
MP]&_9C_Z*9_Y0-4_^1J /JJBOE;_ (>B_LQ_]%+/_@@U3_Y&H/\ P5$_9D'7
MXE^__( U3_Y&H ^F=0NY;>950@#;GI[U6_M*X_O#_OFN8\!_%+PQ\:/!FE>,
MO!NI_P!L>&]263[)>_9Y8/,\N9XG^255<8>-QRHSC(X(-;M %K^TKC^\/^^:
M/[2N/[P_[YJK10!:_M*X_O#_ +YH_M*X_O#_ +YJK10!:_M*X_O#_OFC^TKC
M^\/^^:JT4 6O[2N/[P_[YH_M*X_O#_OFJM% %K^TKC^\/^^:/[2N/[P_[YJK
M10!Q7Q:_:*\(? _3X+KQ?K:V+W.?LUG!"9KFXQU\N)?F;&>U8WPZ_:U\ ?%/
M2=8O] UR21M(MWN[VQNK1H+N*%!DOY+?,17F?[2WP1\>7_Q7\'_%WX?6EAK^
ML>'8&MI- U0[4G3<S;HF/ ?YB.2,8!SVKC=!^(O@KXG>*?'UWXB^'=Y\/_C=
M9>&;Q)XKRY=Q<6ODN"492(Y.O4IGT8XXZ5"+H2FM9)2?I;;3JN[3T,'*7MXP
MVBW%>M[7UZ-;)/?YG?V/_!27X.7SQ8U;6X8'?8;N?0ID@3G&6DQ@ >M=]\2_
MVMO 7PH\,^'O$&M:Q-<Z1KY(TZZTFS:[6? !XV?6OBS]G/\ :$M-'_9/'PZB
M^''C#QAJEV;R"(VNC^;I<K2RN5S.6(&W/.5X(K'^)G@/Q5\$_@G^S=I&J:<U
M]XGLO$;W::0EPJL9&E1TM_,.54DX&>0"QZUZ$\)3C6]GJES)7ONG>]EY:?>>
M?#%5)4^??W9/;:VVOF?:?PY_;=^'OQ4\86/AG0)M=;5;S=Y0O-#FMXOE!)R[
M# X'>NE\2?M5?#/P?XD;0-9\?:)I^KHP22UEG7=&QZ!O0_6N#@^-_P 5M8\)
M^,IO$WPCOOA[!8:-<7=MJ-QKL%\LDRJ<)LC4$'OGVK@_V-O@CX+\;?LI:?<:
M[H.GZMJ7B9+R74=3O+:.:Y>1II%W>8P+ J ".>HSW-<DJ4$I3:LHVV:=V[VU
MV7PO\#JC5E>,;ZROT:M:U_7XE^/8^A_''[1?@/X:-IZ^*/&>D:(=0B,]I]JF
M"B>,8RR^HY'YUB:/^V%\)O$&K6FF:=\1M!O-0NY!#!;Q7 +R.>B@>IK,\*_L
M[^#?!OPKM?#5]96?C:WT>"9+&]\0V=O>3P1L,^6KE. #Z5XW_P $[/A[X4U;
MX"6.LWWA?1;W6(=5N_+U&YTZ&2Y3;*P7;(REACM@\4H4Z,E-W;4;?--NWY:C
MG4K1Y%9)RO\ )I7/L\ZE< X+#/\ NT?VE<?WA_WS56BN(["U_:5Q_>'_ 'S1
M_:5Q_>'_ 'S56B@"U_:5Q_>'_?-<#\9/VA/#?P%\.6NN>,+NZMM/N;E;2)K.
MS:X<R%68#:O.,*>:[2OC_P#X*970LOA+X/N&2218?%%K(4B7<[8CE.%'<\<"
MM:454JP@]FTOO=C.I)PI3FMU&3^Y-GJO@']NGX7?$;Q-;:!IVN7FGZG=$+;1
MZUILEDL[$X"HS\,WM3?B%^W5\-?ACXWU+PEK=[K)US3MOVB&QT:6X5=RAAAE
MZ\,*^>/CIXSU3]L1O!?A?P7\-O%FF7NGZC!=W'B#Q-I8L%LX@1G8Q8E@<<A3
MGVJ"S\<>,_ /[>'Q6N?!G@*Y^(=_)I]K%/:6^IQ6+1((H3YA:0$'D8P/6N^.
M'A*235M).UUTY;._1.[6O:YPRQ$XQ;3O\.MGU;37G;?0^D?#O[=GPEU_39[^
M7Q4?#]M%,L ;Q!9O8F1RI;"!Q\W .<=*U;7]M#X/7MU#;0?$SP_+/,ZQQQK<
M#+,QP /<DU=\+V\OQF\&P7_Q/^%]AHFK0S2K'H^N&VU8PJ.!(LFS:-P[ 9XK
MYS_8'^''A'7M#^)%SJ?A30M2N+/QC=Q6LUYID$SP(H0JL;,A* 'D 8 K*-.D
MW/F37*KZ-/JEO\S5U*J4.6SYG;5-=&]OD?;HU.=@"'!!Y'RTO]I7']X?]\U5
M]J*X#M+7]I7']X?]\T?VE<?WA_WS56B@"U_:5Q_>'_?-']I7']X?]\U5HH M
M?VE<?WA_WS7$?%3X]^%?@KH\6I>+];CTV*8E;>!8S)/<,!DK'&.6/L*ZVOF[
M]JCX&>,_&'C'P-\2/ <=CJNN^$))&&B:ID0W:.!G:W0/Q@9QU!R-O-TU&4XQ
MF[)[O^O/3\2)N2A)P5WT1Z-\)OVL? 7QJN+NT\,:W(VI6L;32:;J%HUK=>6.
MKB-^2OO7G[_\%(/A!'=SP'4M>/V>9H)95T&9HT8'!RPX 'KZ5RWPU^)GA3XF
M_'-?^$]^&EWX ^-MAILPM9+BZ>2.X@V'?L="J.=N>&5L#@,:\2_9+_:(T_X7
M_#GQ]X9N/ OB[Q?<ZAXAO)(TT;2#=6+[T1!'+)NPIRO(*G (/>N]4(^\U%Z1
M32NM?>MH^UO+>Z.+V[LDY+65KV>FE]5_P=M3[/\ &G[7WP\\"_#_ $;QM>Z\
M]]X;UB?[-9W>E6K76^3:6*D+R" #UK!\#_MV_#CXB>+M+\-Z--X@.J:E-Y%N
M+K09X8MV"?F=AA1QU-?#GQ#^&WBKX2_LQ^"SKND-9:GJ/CPZI::%YJAH49'*
M1DCY5)X'M@5]T^ ?C1\5_%&I7EKXJ^#-]X%TN*PGN%U:X\06]ZOF(F43RT4'
MGUSQBG4H4J<)37O6;ZI;)/YO5K3MYBC6J3G&&UTGLWO*2^2LD]>_D=?XX_:<
M^'?PUUH:1XG\;Z/H^IX#-:W$P#H#T+#L/K5OQ9^T+X&\"Z+I>L:]XRTC3-*U
M3_CQO)YE$=Q@9.P]^*^:/V%?AWX9^(7PV\8>*O%&AZ?XBUW7/$-[%>76IVR7
M$GEKMQ&"X)4#<>F.WH*]E^%W[,O@GX>>"Y?"\UM;^,=&BNY;RSM_$%K;W@L2
M^2R1;D^4?K7/4ITZ/NS;NK/UNM4O3OU-X5)U?>@M+M?=I?YVVZ>9<M_VT?@[
M=7$-O#\3/#TDTSK''&MP,LQ. !]2:]>359I$5U=2K ,#CJ#R#7Q'^PO\-_"&
MN2?%B34O">A:C)8^,KN*T>[TR"5K=%8;5C+(=BCL%P!7VFJA5"@84#  Z"E7
MA"FTH7V3^])CHSG4NY6W:^YM?H6_[2N/[P_[YH_M*X_O#_OFJM%<ITEK^TKC
M^\/^^:/[2N/[P_[YJK10!Y]\:OVFO"7[/]KI5QXQN[VW34Y6AM18V#7+,P&2
M"%Z5A_"_]M#X;_%SQ(F@:'K=Q;:S*,P6>KV#V4D_KY8?[WX5X;_P4-UQ/#/B
M?X)ZO+;W5W'8^(EN&M[&+S)Y HSMC3(W,<<#/-97C[7M8_:Z^-7PQN?"7P_\
M3^&[7PSJ)O-1\0>)=.%A(L?RD1KDEF'RGH3][H*]##T(5(1E+JVF[Z)+KYGG
MXBO*G.48]$FE;=N^A[5XJ_X* _"WP=XKU;PYJ%[KCZKI<YM[I+30YID1QZ,O
M4<]:U-%_;F^$NK:3%J-QXPB\/PS.R11:_;M92R;3@LJ.,E<\9KYA^$'Q&\>>
M _VEOCPW@CX9W7Q#-UJL?VD6VKPV'V7 .W/F*=V<GITQ7UK<Z':_%;X;'7?B
M#\.-,T[Q&NGW&=.UB*WU*:RPK$*LQ3'^U\N.M9SA3IT85)+>*;U757VW-(5)
MU*TJ:>S:V?1VWV':-^V!\)_$6KV>EZ;\1M!O=1O)5@M[:&<%Y)&.%4#U)KU?
M^TKC^\/^^:^-/^">/P]\*:I\![+6;WPOHMYK$.L71BU&XTZ&2YCVLI7;(5+#
M';!XK[!I8FG"C/DC?0NA4G4CS2M_PS:+7]I7']X?]\T?VE<?WA_WS56BN0Z3
MHZ*** /G?]I)O!%OXRT-_$W@#PQXKNY;(XNM<LTEF\I9@!#&Y1L?-*S?,0O)
M]:S4\-_LXM?"T_X5AX9^U_;!9F/_ (1ZV+AB,[\;<[>#_M<?=K&_:R^/OPF^
M''Q0T/PSXZU_6-&UC4-)W"&Q@_<7%I+,XVR2D%5^>!AV//O7@\W[6W[.>G7Q
MMI?$GBIH9ITD9OL!V.L>651(!D'!P'!R?QI@>\_9/V>+R\@:S^&'@]]/Q(9Y
MY-$MRZA55P555.0R.'!R..H!XK<T?PK^SEKVM:7I,7PR\,1:C?Y5(+K0+9'B
M;) 5P5R"VTD8SQZ5\^:#^U?^S1<1M8GQ#KT M$('FV?DA(S&-L?"_-A4'/4G
M)]JO6?[<_P"SCI_CB/Q%;ZMX@BE+"=UDTQO+ER2%8,RY7&3P.H(H ^N/^&6O
M@VRY_P"%6>#O_!';?_$5^9'_  6-^&7A'X:ZU\,(O"GAC2/#:75O?M.-)LH[
M82E7AV[@@&<;C^=?8VF_\%5O@-J%Y#9IJVI)<23-;JLEBX^8#@DD< ] 3WK\
M_?\ @I_^U1X(_:9\0>"1X-DO)#X?2]M[W[7;F(!W>/&W/WA^[;D4(#X=W'UH
MW'UHHJ@#<?6C<?6BB@ W'UHW'UHHH DAA>X?8@W-UQ2K,8\ 9R/?%(A:)@02
MIZY'%-=2K9QUYI@>A? ?POHOC7XF:;HVN216^GW*R9DE=D4%5+@$@C&0I'XU
MR/BIK-O$6HG3HS!8&YD\B/<6VQ[CM&3UXQ6;',89-\;,C#HRG!ILC[ZSY/?Y
M[[H!NX^M&X^M%%6 ;CZT;CZT44 &X^M&X^M%% !N/K1N/K110 ;CZT;CZT44
M >FZ+X)'BWPE,="TB;4M5CAA+):PR32[P3N 51CD8_*OL_\ X)OZAX=T7P'X
MEM]=\":'KUZM^TCR:W K32! BF& %2=_S$X([5RW_!,+7(M(\3:W(Q*.1A6S
MW(KZA_X)5>%[/5)/BWKEV%NI[;Q'/:P1L XC5R'=@"."2HY'O7ET,=&MBJV%
M2^"WXFTJ3C",WU/H:23X$>?# /AWI$MU/*T<,/\ 85OOD0#(E4$?-&>@(R?;
M&33Q'\"+?0] O[[P'X9LYM71'%C_ &7:O-;[@#^] 'R@;E'KR.*ZR3]GC27D
MM_,U?4Y/)FC*[F7=Y$9S%"K8RH0LV&')#,#G-6[SX#Z#/'H0CFDM[G2XQ";I
M8T,MQ& ,"0D<GY5^;KQ7I&)PK7/[/:S6D?\ PA/A[%Q*T/F-HENJQE< [L@'
MAB$X!^;BJ[7'P+DMX[J/X=Z+!:;4D>XNO#\*1[63S-H.W[X4HVTXX<>^.TM_
MV;/#]G=0307M\L:R2/*CE',F\AFY8':3(-^1W)]:O7'P%TR9I(AK&J0V)\MX
M[-)5\M)EB6/S<$'<2J+P>,EO6@#R'XA6_P $-:\ ^(M/TOP/H5IJ]SH-U=6Y
M;2+=&C80NR@D<AR 6&,C SFOP+=N>..:_H?\<_ 32/ _PY\7:M:WMU//'H=Y
MYJ2*I663R7 <<94 $@*IQ@#TK^>!UQ@YZT(!NX^M&X^M%%4 ;CZT;CZT44 &
MX^M2PIY@D);&U=V",YID4?FR*FY4S_$QP*DAMVDD*J0?7FFE<"_I=TUBKR(%
M!8%2W<@]1]*]0_9G\$>'/B-\3QHOB4BWTV6UFN/-,NQ(S&OF')[@A2,>]>9?
M8## 5F+PS9!5"O4>M4X9IK.0O$\D4F"-R-MX/!'XBE6IN5-Q3L!)KC0MJ5V;
M9%CM_/D\M%/ 7<< 'T Q6?N/K3Y6W=L4RDM%8 W'UHW'UHHI@&X^M&X^M%%
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M ([2_P##U#X&?W_$_P#X*5_^.UE_JMG?_0)/_P !9K[>G_,CZ^HKY _X>I?
MO^_XG_\ !2O_ ,=I?^'J'P,_YZ>)O_!2O_QVC_5;._\ H$G_ . L?MJ?\R/K
MZO$?VKO@+J_[0'A'P]I&CZG8Z7/INLP:G))?^9M=$5@578I.[YAUXXKR[_AZ
MC\#/[_B?_P %*_\ QVE_X>H? S^_XG_\%*__ !VG#AK/*<XSCA)W337N]B)U
M*4X2A*6C33]&K,^O82Z6\4;N6V*%Z\<#%?*?B+]G'XPZ+^T)XO\ B5\._%WA
M#2EU^&*W-OKEI/.ZQHB Y"IM!W)G(/2L[_AZA\#/[_B?_P %*_\ QVC_ (>H
M? O_ )Z>)O\ P4K_ /':JGPWGE*7.L).]FOA[[BG4HU(<CEII^&Q[W\(=+^*
M.G:=JB?$_7?#FN7DCK]B?P[9R6Z1I@[A(' R2<8Q[US/[,'P+U;X%:3XRM-6
MU*QU)]<U^XU>%K'?B..0* C;U'S#;VR/>O*O^'J/P,_O^)S_ -PE?_CM'_#U
M#X&?W_$__@I7_P".U7^K>>WE;!S5U9VCZ/\ 07-1LKRO9WW^7ZGU]17R#_P]
M0^!G]_Q/_P""I/\ X[1_P]0^!G]_Q/\ ^"E?_CM8_P"JV>?] D__  %FOMJ?
M\R/KZBOD'_AZA\#/[_B?_P %*_\ QVNM^%7_  4 ^$_QD\<6/A/PZVO'5[T.
M8OM>G+''\JECEA(<< ]JSJ<-YQ1A*I4PLU&.K;B]$'MJ;VD?2-%?)>K_ /!3
M[X):)JU[IUR_B7[3:3O;R[-*4C<C%3@^;TR*J?\ #U+X&?W_ !/_ ."E?_CM
M:+A?.VKK"3_\!8>VI_S'U_7B7QR^ >N^//%NA^-_!'C"7PEXST6-X83<*TMC
M<H0<)-&#TY/(!.#7EO\ P]2^!G]_Q/\ ^"E/_CM'_#U+X%_W_$__ (*5_P#C
MM7'AC/824HX2=U_=9,JM*47%R5F=;\/OV:_&]W\7H?B;\5/&&E^(/$EC8R6&
MG6>A6CP6D*NI4L=P#9YSC%=-^R?\"=9_9\\'^(]'U?5;+4IM4UN?5(WT_P P
M(B2(BA6WJ#N^0]..:\L_X>H_ S^_XG_\%*__ !VC_AZE\#/[_B?_ ,%*_P#Q
MVM7P[GS3C]4G9JWP]+W_ #U,E[!-/FUO??RM^1Z/^UU\ ?$/[0'A7PW8>&]7
MTS1]0TC55U(3:JLC1MM1@!A%))R1UH\%>&?VC[?Q3IK^+_&?@#4O# DQJ%II
MNE3QW$L6""J,R@ ].M><?\/4O@7_ '_$_P#X*5_^.T?\/4?@9_?\3_\ @I7_
M ..TH\-Y[&')]3DUKO&^_P#PPYRI3GS\]G:VCZ)M_JS5A_9J^+/PGUKQ##\'
M/'6A:1X6UZ\>^FT[Q!9/-)92O]\PLH/Z^@]*]=_9^^"L?P-\ G0VU>YU_4[F
M9[N_U*Z8DS3-UV@DX4= *\-_X>H_ S^_XG_\%*__ !VE_P"'J'P,_O\ B?\
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M.-HFW-MW<$5]&Z/^R.GC+36%O;K+O7&43CD>M?@N(^D3++:_L\9@(M7[M/\
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MOBB.R\Z^1E&YV(4"C^*NV^'6CPZA=B66/<1(!GTK]FS7V,<+*M77NT_>_P#
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MC%K^MN!,+6P658BC7CRR4GI\CPL5)2J)H_I(HHHK^7#V3\7/^"U?_)SOA/\
M[$^V_P#2V]K\^F^\:_07_@M7_P G.^$_^Q/MO_2V]K\^F^\:H HHHI@%%%%
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M-F=TB;4///6E+8DY^BG,F#3:Y[%!1110 4444 %?;?[#]Q]F\#>*';;@1/\
M>.,_*:^+]+LX;Z]BBN+D6<#'#3%"^T>N!R:[O2->BTGP#JG]G:D^GZFDR1@0
MW,B/-'CYOE! (/N#4R=1+]V[,\O,L$L?1]B^Z?W'[9_\$VV#?L+_  Y(X_>Z
MI_Z=+RNL_:D^#6F?';X8OX8OM>A\.WQN4N--O9Y%51<+]T;6(W \C YYXKC?
M^"9[;OV#/AF?5M2_].=W7I_QP^!OASX^>$4T'Q"+B'[/.MU9WUDX2XM)EZ.C
M$'GDCZ$].M.+Y9IWV:U6^^YZ7+[CCY->NEK/U/G+5/B=XT^&VO\ A/PQ^T9X
M$\->*_#ES>+:Z7XJM8$F\NX& LDD;@JK'Y3\H!'K7+^!?A3=Q_M\^/HE\=>*
M0^EZ<-6,ZWOSW:ET(M9CCYH!N&%_V5KURR_8SU37O$VA7_Q'^+&M_$/2M!F6
MXTW2+BQBM(XW4\&1E9C)P!U /'6NJ\4?LRS:C\?8/BEX?\:7GAF\FMEL]6TV
M*S2>+4(00=A8L/+S@9(!/ QBO0]K".L7[S4TVEIJERNW>^]EV//=&4HN+B^5
M.+2;5]'JD^UMKO>^QXE^R;K?Q!\5^"M4^*?B;XB:QJVF^'YM1CB\.LY\JXV[
M@#,W5\'&T'I7@=E^T]XUU[PW-X]A\=?$.3X@&[::U\-Z?I3R>'# )/\ 4D ;
M6.W/S8SVZ\U^@?[/WP!MO@7\.;_PA+JW_"26MY>7%U)++:" %96)*%=[9 SC
M.>?2O/=(_8UUCP?=R:7X/^,/B;PK\/YKDW,GA>S@C8H2VYEBN2=T:DXX"GIS
MG.:U5>C[:3TM96T^<NCW]/+1$RHU72BM;W=]=_Y>O3U7?='F/QB^)GC34O'&
MC:CXLU?QQX%^&U]H<%S97W@V)E*7[ ;Q<E?GV*<_*>.E:GCGQM\3)OV>/ ^H
M>'_&UWXXTB6_D37_ !5X.M!'J'V('Y=B')$@Y5B.21^->Q^./V>O$VH>,+OQ
M'X+^)^J^%+G4+-;'4+2]M1J5M.JC D6-W4(_J1P?2L6Q_8XM?"WPZ\,Z#X1\
M;ZWX:UW0+R6_@UR'#">:0YD\ZW#!'0]E)X]36*J4N5;*S6EK]7O^&J>O;0U]
MG5YGJWIO>WV4M.VO2SL];E/]D7Q:OB#5O$UMIOQ2U#QSX?A6-X-)\36[KK6F
M,>OG2.<NIYZ],#IW^EZ\;^#7[/4OPY\;>(O&_B#Q/+XN\9:[$EO<W_V-+.%(
ME((18E9N<@98DGBO9*YZ\HRDG%]%]_W*_K8VH1E&+4EU_KJ[>ES\D?\ @KM_
MR<AX9_[%&U_]++ROB.OMS_@KM_R<AX9_[%&U_P#2R\KXC'6O[!X3_P"2?PW^
M#_,\?$?Q6<_H]^VF^((K@#=Y<N<>O-?97['_ (C72?C(6\O#7;Q3!L_='I7Q
M; AFU<(!G=+C]:^HO@+?)I/Q5M&D?R2L,>-W&<')K^;.(Z,\9P!G=&>L858M
M>O,D_P #])X+M+B+#TOYXSC\G!G[ ?'+6(%^%<SS%2S0D#\J_$7QD?M.M>.&
M4_*TP-?I!\>OBM]L^'JVR7B;53 ^;MBOS0EOEFC\27\KKY4[D#_:.<5^??1T
M]OFN?8S,:\>5>QY7\E&-V>SQ1EL\FX7I4:K]ZI7NEY*+_P SRG3LPZLI/\+Y
MKV^W\03^'?%&A:]"=HGC564<=.*\4M\3:HQ7INKU#Q7NCT'0B ?W87+>G-?T
MWD>4T<?PUF^"JQYJ<F[?*[7XI'YIA,=4R_-,+BZ3M*+3_P S]4OA3\5+O7O
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M6+HMQY,B29^:-P175?%JQ>R\57T90JWF,#GZFN&L9/\ 2-AZ=*_UJR[%QIK
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MI5(VN*^RQ$N6%[7U2'3BI-IGWQ^RUK@\2>%]2TF4^8H =>>>?2O3_"=F=/\
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M-O[3_(TQ?\5(_I(HHHK^9CV#\7/^"U?_ "<[X3_[$^V_]+;VOSZ;[QK]!?\
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MGR1KM73U'_ S_A7#[?\ .:-I_P FNSZU5E9-F'L*78W]:\62:QPT(B'H&)K
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M'(X)]#61,NW.>HKK?%(7[6XPT?<+C!9?4UR<S;EK.8B&BBBLB@HHHH ****
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M=%>Y\SQ!PKD>,R^KCN&JC<J6LX-W?*MY+TZF-=:;HT=F^RQA$BX!^7N:\O\
M$,*V_B6Y6-1'!M!5%Z"O1]:0#3H]1B;?$Z@NH]37F^L74=YJ\LD0^7:.M?V1
MFU"$J5*2E9\ZM]VI^%83FN^Q4/7%4[S5(K&<QO&S$#/!JZ.M<[K^6U$@<\"O
MSOC+-L7DV6K$X)VFYI:I/OT9[&'IJI/ED7/^$BM\_P"KD(I\>N13-M6&0FF:
M/H+W3*-N6<\"O1/#?PKN;R893:./NCFODL'F7$3PZQV88J%&CU<HQ7YD8K$8
M+"*]1V^9S%A8S:BH,4#FI;C1[JUYEMW45]E_"/X-Z19Z/%)?*)'(^Z0.*T?$
M7P;TK5+CRK;;$/4*#7YO5\?\EPN92P4J<ITH.WM5;6V[4>Q\!4XHA&K[E.\+
MVN?#?D@=1C/J<"LZ[U2*S;8T;,?[R]*^XI/V4UN;!FCF4N?N@Q\5\[?%GX'7
M_A/5)H'C!49(P.#]*^ORKQ4R?BYRP.18M0Q'V8U(I<W=*[W^=^Q]+A<THU)J
M->G*">UTU?TN>.?\)##_ ,\F_.C_ (2*#O$XJCJ&D26K$!:SI%,;8?K7SV-X
MSXHRZJZ.(DDU_=C_ )'U\<-1DKI'1P:]!-(J"-P6.!FOJ+_@GR/^,K/"G^Y<
M_P#HEJ^0+#'VR+']X5]?_P#!/?\ Y.K\)_[EQ_Z):OMLCS['9[D685,=)-QB
MTK)+[+[')6I1ISBHGB7Q*_Y*+XI_["MU_P"CFKE[I9/*)BQN4%CGT S73_$C
MGXB>*/\ L*W7_HYJYJ:UENT\N$D$\''I7Z3F5+&5LKG3R_\ BN/N^MCBC;GU
M*^GW@N>W-7[BU?R]RYZ5H:'X1,'[ZZ/E0CKZGZ5W-KI<M]:[++26N84 &\K7
MIY9A:F&RM?VY44)[7;22?SL:TZ-?&5G#!4W-KLK_ )'E$4DL;X89!-:L;H5&
M17;-X33<=^E7 E[JHX%0-H-HJD36EQ;_ .UBO6RFG0PEXPQ49I[*Z?ZEUL%C
M8W<\/-6_NO\ R.0DVL.!4'V=FY XKJI/#,&_,5TI3T;K6I8V.FVL8!(=^Y-?
M0U,'3Q'O5/P/(=9QNDM4<;!ILC#(7(K>TS1X)(B)X?FQUR:Z1=-M;B,O$.1Z
M&JNQH$<!<#UKLIQHTX\E-6.25:4SB=8MDMIRB=*SEZXK1UABUPQ/7-9W\5?/
M9C[N)T\CT:6L%<7^%OTKBI%+32#&?F/\Z[7(VFJ.BZ%]NO\ 8J>8[O@#ZFOQ
M'CW**F:_55&2C&/,Y-[)*WZ'IX:I&DI29@V^ER38RNW\*M?V&RD+W/X5]U?#
M7]EWPOI/@VRU?Q6TAN+S#I;Q8)"$<&NIN?V1?A_K$"W6DWDENK?ZP3MT^E?R
MQ+Q$X$R^K/"U*=:IRNWM$ERNV]O>/5IX+/,3AECL/@JDJ3V:2=[]4KWL?GI9
M>%Y+B4*!N).,"KFH>#7LV*O&ZL!WSZ5^A^A^ ?AA\,V2&"P.K7R\-/(H8#Z5
MO:IX#^'?Q M5FFM!:.P_A4"O/?BWPWAZRA')YO#O[3?O^J6Q[<N#^+_8+%_5
M+1?1NTONM^%S\N9M%GC8@# ]ZJ26\L/+#BOT2US]D_X>WJD6.NFTG//[T!N?
M2O)/B+^QSX@T%6O]*,&LZ;G[UN1N ^E>]@^*N!L\J>SH8B6&G+955:/SDM$>
M'B*.:9;'VF8X.I2C_,XOE^]71\@X.:7&VNU\0?#N_P!*OIH9K>2%T)RK*1BN
M7O-->TSDYKZ#$\/XS#T7B86G2_FBU*+^:N12Q5*LKPE<DT/F^3Z&O3/AC_R4
MCPM_V%+;_P!&+7F6AC_3D^E>G?#'_DI'A;_L*6W_ *,6OW+P[_Y$E7_$_P C
MAQ?\5'](]%%%?S*>P?BY_P %J_\ DYWPG_V)]M_Z6WM?GTWWC7Z"_P#!:O\
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MU2XMX[B5W :8C!QT'M7*W#?O#CCVJ*C)17;K10W6BL2@HHHH **** "E5BK
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M7-,[TN[L.M3<+ /6F,W-.8[1CO4=9E!1112 _?+_ ()F_P#)A7PR_P![4O\
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M_P!M"YTR8);JURH&3)(^,_H:^5EX<\>XV<:*P+NNZY5\V[(_5UXZ8_$.%/\
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M4^J8O"XF.CC.+_$_;O\ 9I\2+-\,[0LZ@A>=QKX*_P""A>L)J&O311H0&N
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MSW'WC'9*R2OY61_2.!\#\IP_[_.\5*HH]&^57^5CW/PW<6EY9K:Z7$+6VC&
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M)?%&HV]G,1EH/,+/^0!KB_B!^UWX4\&Z1-9^"-SWN2$E-ME1[G<17RE\5/B
M_B;7KBZ+R[V'65LD^]>6:GJ#S0G*X.?O=S7]49/X/9=@L!2S3B.K.I5<>9TM
M%%>3O<_/\PXOS_B=J>)KRI0?V(M_<W?4Z;XE?%K7OB!J$MUK&JS7]T7)&XX1
M1Z*.U>>,S.V6.6)YI2X;ZU)';R3+N"\"OHZE26,Y</@Z2A3C\,(*T4N]EI?N
M]V>=2IPH1LBSHO\ R$(_I7IWPQ_Y*1X6_P"PI;?^C%KS/1U*ZA&#UQ7IOPQ_
MY*1X7_["EM_Z,6OW[P[3CDM9/^9_D>?C/XJ/Z1Z***_F8]@_%S_@M6?^,G/"
M8_ZD^V_]+;VOBKP7KUS8Z+XGTU&V65]9C[1@9)".&&/QK[5_X+5?\G.^$_\
ML3[;_P!+;VO@O3]1-C'=A8PWVB%HCST!(YZ^U &QJ'C:]:U^QZ?MTZQC)VK
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M.M.NM-6ST^WN1<1R/,3^[C/*_6LR1BQ^;K[U/)[SDV VBBBF,**** "BBB@
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MM'_WU7Q_$&78C-Z3PU.K34/\1WX7V>%BH4TSG]/7-Y%]:^O/^"?''[57A/\
MW+C_ -$M7S)%I]H'W1%"Z\\-7TW_ ,$^/F_:L\)X_N7'_HEJ\W*LBJY'D..A
M4G&7-&6L7=:1:+JU55J1/$?B3_R43Q3_ -A6Z_\ 1S5SE='\20?^%B>*?^PK
M=?\ HYJYS!K]7HW]E'T1QO<,T445OH(,TNZDP:,4UY &:7=Z\TE&#2W 7</2
MC</2DVFC!I_(!<^U)1@T8-+T *-QHI=IH0!N/K1N-&TT;">U#N ;C1N-+Y38
MSC]:/*;T_6G:3 3=29-+L;THV'TI>\ ;C1N]1FE\IO2CRF]*I1EV 0?2NG^&
M(_XN1X6/_44MO_1BUS1B8=JZ7X8_\E)\+?\ 83MO_1BUA75J4E;I^@UNC^DB
MBBBOX*/IS\D_^"LQM[G]I31+.?P_%K0;P=:2EAA9H@+Z\^ZV1QC/'/TKX%UK
M18;2WAU)-"O].LY 8XVF@!1Y!GC+$\_,N>,]QBOO;_@K5'HJ_M,Z'<:AJ]WI
M-W%X*A,)M1S)F\O1M_,]/2OAM-+AUB\N=-U7Q+<'3+7][;[IMR^85[#U.,>V
M*H"6SL+.TU/Q);WF@/;7+3J88X889/L@)9DX9L8XYQ@<=<<51C\0:#I5E>VV
MH:&+N:^CEDM;GR(XGA5F^7Y5)!SANO3/%<_K>L7FG1:6;;5+@R- LSH9,F-_
MF7KWROY USEY?7%]-YEQ,TTF NYCDX P!5: =R_C728$$EKI=N)8)HY8%FL(
MF4X7YE<G[P(^7ITYZUPMU+Y\CR[%3S&+;44 #)R0 .@J+S&X^8\=*0L6ZG-(
M!**** "BBB@ IQ&T9QCTIM6!,]PL4+994R%'U]* );2\*;]^6++L&WBM6RFB
MNY$COIY(QD*<>E9(MS']^-@!S@K@U=DBM5M#,I9921A2/U^F<5K%NUA'4PZ+
MI$)BGLTDN#&^?+D.58<]\=:Y_P 1:0WFO=Q(WE,<MA<!:@T_5)+$[Q)E5).T
M]R1CFO8O"UK9^*/"^RZECMHX\K(%3YL,>"/IZ54EH)'@;#:Q%)6QXHT*7PWK
MUYITOS- V%8C&Y2,J?RQ6/6!04444 %%%% !1110 4444 ?67[#OB!=%U?4-
MS;"?FQ^%=9\$?V]/BI\$-#UKPGX3TS3;[0K75;FY::2T,]P))G../,&1E>PK
MQW]F>[C@O[\LVP^60#VSBN,TRQTW4[O6&_MZ32+];AW"[MB2(#QSZ[J\NCA9
M4\95KN-E*WX'U^9+#K*<(Z;3GK<^Q_\ A[%\<9-<%I#;Z PG)CBC?3@I21AE
M 3YV#U'<5NZ1_P %6OC((]1>[T72+G[.Q1/+M%4 A5(#?ONN2>GJ*^#-4ADM
MTTAKC6Y&>ZD4S,'#+%AE!<$>@"_]\FM>.S;1XYHK#Q)<1(EQ-)"8Y1_I"@9#
M#T//.:]70^0/MK3?^"K7QCO+6TU1=%TZXT@W*12NEDJY.T[HP3+P<C@D=*SM
M)_X*R?&^VO(1K>E:!%82>9!YT%CF59#N\MMIF XV'() (R<]*^"_%.I7.EZK
M=6%EJUQ<V054#>9PPX8C XX;-95SXBU.\C>.>^GE1W+LK.2"Q !/U^4?E1H!
M]=^//^"J7QI^(GA'7?"VJ+X<.E:M:RV5P;?3V23RW4J=I\PX.#[U\;2A1C:,
M"F4I8GJ<T@$HHHH *<BANIQ[^GUI%I\D?ER!0P<8SE:.H$ZVA%R8QAMI^\K9
M_*NBT4VL;1J[3$ALY0X.,UGV2Q0V)NTE$4\'"KW8FI[#Q$H:+[3 K*G.Y1SF
MMTN5$W/4](O= D0>:KF-CN!D(W8Y&#^.*X^;P_<3WTZ6\7GPLQ)\H_*>>IK&
MC\J^62=)Q"H;_5Y^;'K]*ZWP[XPOK>-H+=F,0CS(<=5JA''>)=%:$/,L915;
M:5P<Y_PKEY$*DU].^"[K3_%FDG38+-8[U7.YY%['K7C_ (_\ S^'YE8(,L6W
M 'WJ7&Y2. HH/4T5SC"BBBF 4444 %%%%  O45]A?L7^)$T;PYXAC9]A:WE&
M?3*FOCY?O"OH;]G6\2WT36\MY?[A^??::\S,<-+%T'3BKZH^JX95%X_]^TH\
MLM_0_7+_ ()M_P#)B_PX/_375/\ TZ7=?1E?./\ P38;=^PG\-C_ ---3_\
M3G=U]'5WI65F?,U+<\K=PHHHIF84444 %%%% !1110!^2/\ P5V_Y.0\,_\
M8HVO_I9>5\0J,FOM[_@KM_R<AX9_[%&U_P#2R\KX@7K7]F<(_P#(APG^%'S]
M?^+(NV.DW%])B"-G)XSVK6N/",]M'NENX$('*]Q6EX;OC:^')<<,)#\V.>@K
M N+J\US4(K.W#23.=H_QK[7'ULOR?+Y8['2Y8+7>U_N.7#T\1C,0L/AU>3=D
MB'[#&K%6NH_J*KO'$K$+*)3Z+S7O?PU_99NO$*I)>+-.[#)!'RBO?/"/[&]A
M;S(9;>)2/[Z U_(V?_2+R++Y3I8/#7:V;D_R/VNAX9U\/%3S?&0HO^6W-+\+
MH^$H]$OYEW1:9<R)_>"&HC8.DZ1W"/:%CC]ZI'XU^PO@3]CW1+S3UWK#T_N"
MN)^.G[!%A/X=N;C3T25U!8%$&Y?I7QN6>/6<RE''8W+T\(W\236G?XOT.2KD
M/"=:3PN$Q\U56B<H^ZWZJ-T?E;K5C)H,@\]=\;#<K+T8>M8I\16_]UZ](\5^
M$KS1+[4/#>K(1-"S?9IG[X_AYKQBZB:WN)$9<%3CI7[WQ)QEBJ6%PV:Y'-2P
MM9:-K52[/Y'YW/+:N"Q%3!8V/+5@]5^3^9O_ /"10?\ /-OSK2;#*K 8##-<
M1G##ZUVJ_P#'O#_NBN_@;B+'Y]4Q$,:T^11:LDNKN<>)HQII.(Y>E9.I6;W%
M^"@.VM059BL6N%9UQA:^]SK*Z>;8=4*KLE)/[CEA4]D^9F=;Z>"-I!9O8UH6
MOAFXN)!Y<#Y^M;WA?27N+V-%B\QBWI7V#\%?@OI[:3<:OK]NL5I'C 90<]Z_
M+..N*\CX RZ.(Q-)3J.RC!;OOT_$X'BL5B,53P.!I\]6>B7<^4M#^$.LZUM6
M" R%AG"J?YUT,G[+?C*YM_-AT:25,>M?:EOXK\/Z*Q30="1@GRB1P,']*R-6
M^)FNS2$1.EG%VC05_+N.\<.*L7+FP>74:='ISQ<G;UYO\O0_9,I\)>*L<_:8
MZM"BGT^)_/5'P!XH^"NOZ 6%WIT]NZG!!4XKB;[P_<V.0X.X=:_3.S^(M_)&
M8M2M+75;?O'/$I_I7.>-?@+X5^+FBW6IZ!;1:3JL<3/)9J %=L9X]*TR_P 2
M,JQE:-+B/ ?5U/3VM)MQ3[N+O^!R\0\$<1<+T7BZL8UJ,=W#=>;B]?N/S9^;
M)!!R/>DW5V_C'P=)H.H7$$T>R2-B,8]#TKBI5*OM(P17W>;9+7REPFY<U.:O
M&2ZI[/YH^/H8B&(@JD'HS1T'YKX<_P )KZR_X)Z_\G5^%/\ <N?_ $2U?)F@
M_P#']_P&OK3_ ()[_P#)U?A/_<N/_1+U^Q\*_P#)(XI^53_TEG!BOXR1XC\2
MO^2B>)_^PI=?^C6I?">D)K%X8F0, I:D^)'/Q$\4_P#84NO_ $<U7_A[(8M0
MD(_YYM7[]E.VWV3RJW-;W=S2OO ;*V8HUSZ5AWWA>YMSCR,G_9%>CK>2+R"6
MXJU:PW5\P6"U\US[=:]WZRZ:O4C&WF84<-BZTE&G%ML\B;PO?.NY;9R/85+8
M^$;Z209MF ]6%?2&A_!GQ!K44<NW[.K?P@5O-^SOK>X@S-^5?G>-X_X4R_$<
MF(Q5.,UTNW^2/N*/!?$%:',J-D^[7^9\Z6?@L*H\R$,W?BLO7/"\EJQD2WPF
M<<5]*2_L_>(8\D.<9[BN4\2_#K6O"B[[VW\ZVZ%\=*]++>-\@S2JJ6#Q5.I)
M]$]?Q.'%\(Y[@:;JU*.BWLTSYV:TV_>7'UH6.)>JYKI?&E@+2Z$T2G9(.!Z'
MTIVF?#G4M2LQ.TD2%QE8B<-73Q-QGD7"-&%7,-'/96OL?'SKPIP4ZDK)G-;8
MCT05'-&JQGC%6KS2[C2;V2WN%(9>,$8JO<?ZHU]+EV:8//,J6881)PDM'8VA
M)2:<7=%#M5;)R?FQ5ANE5))"KG S7P.95524)/1'?!$N6"GYC^=20Z/=:M*J
M6HFW9P=N:73[&XU"2-(8S+(QVJJ]37VG^S-\ QX?T^;Q'XIM(_L^T- DA#9/
M?BOQ_CSC;+^$<J>)QB<JDK<E.]G+7>ZU2-(4\17KPPF#ASU9NR7YOT1\DV'P
M=\4ZD&>VL+Z95ZM@XK&UGP;JVDR213)<1S1_>#Y&*_2#5?BE%ITY@L-/MH81
MPJK"H_/BLJZ\4>&/$D1B\0>%K2X$GRO<)$%;![]*_ES!^,N/J3;Q66+V+_DG
M-37G>4FK_(_6ZGA7Q;3H+$0]G-O[&S^]NQ^:DEC?*?\ 7/\ ]]&JD]Q<6_!G
MD)^M?=OCG]D_0/&EK+?^!]06.89/V&8A?P'K7R;\1?A+K7@G4)+35K*:UF0X
M^9, _0]Z_5<JXAR?BO#RCD&(J+$I7=.I-J2]-E+Y'YQ7AB<OQ/U7,J+I5.S6
M_H]F>>_;IO\ GJ__ 'V:3[9,W_+9_P#OHTV>W:WD*L.:C]J\&IBL=1FZ=6I)
M-:-79U6B]D:FD7$DEX@>1F&/[QKTGX8_\E(\+?\ 84MO_1BUYCHO_(0C^E>G
M?#'_ )*1X6_["EM_Z,6OZ'\/ZU2MDU:523;YGOKT/*Q22J)(_I(HHHK^83V#
M\C/^"LVN>&-$_:H\,-XGT*;7K.3P?:KY,,XA,?\ IM[\RMSS[<#WKX"UWQ1X
M:O-066Q\-16D%O*A2(NW[Q V2) 6/)''%?9O_!:HD?M.^$\<?\4?;?\ I;>U
M^?9)W'FJ [*;Q/HMU?-/+HP6%EBC,"OA0JL2Q!]3P/I6'KVH6-^UN+#38K"*
M*,*Q5F+2-W9LD_I626)ZDFDR3UI@%%%% !1110 445WGPWL_#MUH?BPZ[:B:
MX6R L)C+M\B8G[^T$%NG3FDW8#BK=(I-WF%@=IV[>[=J[S]GNW2Y^.W@"&<1
MF-M;M PE0.F/-7JN#D>V#FN-U+39M*O'@FVEL @Q$,K*>A!%5;6\N+&[BNK:
M:2VN8F#QS1N5=&'(((Y!I]+@?;NL:IIWB:PTBROO$FC^/9-:U+4] .JV.C"Q
M^PM) /(@*M!$S'S K!MO'(S7SG\=%C\/>*-'\+P010S^%]+M]-NP$7YKOF2X
M#$?>(DD*<_W:\VAUS4885BCO[E(EN!=*BRL%$PZ2 9^]_M=:62\FO[Z2[O9Y
M+FXF=I)9I6+.[$Y+,3R23WJD!JZ'I<.K.$9)?M+$G QMS]/2OH#X0?#::ZTZ
MXOY9%>2!E_T3( <=\>]>*:1-86,<<J2R*Q/+*:^C?@9-+>:9?318\B0A078;
MN^#6XK'"?M#?"?6;RX_X2:VTUEMC'\\<6&$<8Z<CJ?7ZU\Z,,?\ UZ_2GQ-'
M_:'A&WC#+?W$K^4S.VX(J\[![G!XKXA^/'PQNOAIXL\N:W2VM-13[9:JD@8!
M2>5]L'U[5E)#/,Z***S **** "BBB@ HHHH ]R_9UA::34-@'W>21D#BN,T;
M0;W4+S66M=(.JC[1Y)D7!,66.<+GJ0#C) XKVC]B[0QK%YJ>%+LHP ![9S7A
MNH>+M<\*>+-5&FZG<V.V]F.(FP,[B,D=#7T6.DG@:"MKU/$PN+]MC:]"_P %
MOQ+.IZ"%N/LRZ7<6\MPQ2%-T3ALID'=NZ_*#QQ@FJ.L^%[N\ODCL=*FMUAAA
MBEA)4R!B@.Y@/[W7)QZ5A7'B/5+B;S)-0N'D\SSMQD.0^,;OK@8J5?%NLB82
M?VI=>:&W^89FSNV[<YSUQQ]*^=/;*VLZ3<:+=?9KN)H+A1EHF()7V..AJA4U
MY>37T[S7$KS2N<L[L26/K4- !112K0 E36MN;JZAA4J#(X0;FVCD]SVJ.I4\
MV%EGCW(4;(<<;3VIZ =#X^\!WOP_U@:?>20W!*+(L]N2T; @$@$@9QGKTK%M
M[&2:U><+N53@@=?K4UWK]]JQF^W7#W<D\@E>6=B[%L8SD]\5V?@_2(]0LYH4
MMV^V.@$6%R&/.X'\*NG'N!Y\79L#L*DMX))& 52S,<!5&23Z"M#4-+EL;J>%
MH2FUR.1C&.U>E_#/X?R7%I:>+I8_.TW3[B9YX0N<M'&KQKCON9@*QKU8T8WF
MSLP>#J8RK[*FK[M_(\_@\&Z^^GW%]'HFI/:6[,DUW';.8XR#A@S 8&#QR15K
M3([V+_1$M[J.ZC43.%C8D1XSDCTZ<],&OKGX0^*+>W\-_"^+4_$WB33-;U";
M6FBTBS4BQOI6GD^6Z);.&;Y3\IXQ[UP?B;4FM_@A+\005CO];TFV\(LRCGSH
M)3YV/^V,<0/^]6M.6EV<DXJ,G%=!?@OJ6FR>)K&2ZM6CO0T311-PL[ \Y'O7
M2?'+2;?5+&&YM[9%69G,J[,%&!/RYKPGP?J5GJ7B/1HXYKFW$;*LLL9)8#J?
MPKZ'^)NH6EGX7TR/SOMTH@XD)"D#K\WO6Q*/BS5K$VFH3Q*O"-^54*[#Q7;F
M?5I[A$783DF/I^/O7)2C:W3%92C88RBBBLP"BBB@ HHHH !UKZ ^ UK)=>&=
M8V)D^6__ *#7S_7UQ^R)H!UCPSK3X4B.*0G</137O9-*,<0W/LSP\XQ;P6&]
MK%V=TOO/T_\ ^":_'["7PU'H^IC_ ,J=W7T=7SG_ ,$W!M_87^'(_P"FNJ?^
MG2[KN?VD?CQ:?L\_#>7Q/<:=)J]Q).EI:622",2ROTW-@X &2?I7ARO4J62U
M;_%L]F+7)S/9*_W*YZG17RRO[07QJ^'/B#PZ_P 3?AUH\GAG7IU@BNO"$EQ<
M7%@6Z&X5MP/!'3 Z\UZ'X>_:8T3Q!\?_ !#\,!!:V[Z59K<IJ[:G$8[IRR@P
MI'@?.-QXW$_*>*MT)]-=]GVW^[_AC+V\+7>FVZ[Z+[_^'/8Z*HPZ]I=U-#%#
MJEC-+-N\J..YC9I-OWMH!R<=\=*:WB+2(]473&U;3UU-NEBUW&)S_P!L]V[]
M*PLS>YH451U37=,T-8VU/4[+35D.U#>W*0ACZ#<1DU/<:A:6EF;N>[MX+0+N
M-Q+*J1!3T.XG&/?-+S'Y$]%5=-U6QUFU%SIU]:ZA;,<">TF65#_P)215JC86
M^Q^2/_!7;_DY#PS_ -BC:_\ I9>5\0K7V]_P5V_Y.0\,_P#8HVO_ *67E?$*
M_>K^S.$5?(<(O[J/ K_Q9'4^&]2@ET^33'3$LA+K(?H.*]'_ &8O G_"6^.)
M(Y$#-'*J#C/>O$-'N"OBFT0GY<BOMG_@G?X?CU'QY?W$@ROVK R/2OR'QLSV
M57@NM&D[2C65/UL?><"26!S>>-:O[.E.?HTK)_>S]"O!_P ']*\)^%XI9U0,
MJ98]*\.^)_QKT3P5>2Q[X\(<<,*]H_:@\<#P+\.YBCB(E,!OPK\:?'WCNX\;
M:Y?W^IWDD.EQR$(J,09*_BS(?#1<89V\LP=H0P\;U:C>B>CDV^EKGT>3XBCA
M\%4XBSV4JG/)QA!.SE):OY'Z9_!_]M#0FOEM99E9"=N-P-?6WA_QKH_BZR$E
MK<QRQR#E21T(]*_GCTO7-)^U*+.[N;&X5ODD5^/J:^A/A5^U3XI^&VIVMM?W
M9>W8@1SJQ(8=.>:_6,Q\-\]X.P,L7D=>&.PD?B4=>7IYO]#C:R'B:O[/#Q>#
MKO92=X2^>G+^I]*?M]?L^P322ZUHT 2=&\Y'4=\Y(K\VO&.AF^BDU6$!'0[+
MF$=4?H3]*_7V/QZOQD\'1F?:[-$.WM7P3^T;\(Y/ ^M76L62 Q2-^_A_A93U
M-?+^%7&V"5:OPIFZ<,-6D^36_LYNR4O-+KJ?19MP[C<?ED:LU_MF&5I+^>"[
M=VNG=>A\?,OS>G-=I'_Q[0_[HJ'Q1X4%O%%J%D2UK-S_ +K=Q4R$_9XL]=HK
M^SN",CQ60YAC,/B5TCRM;25WJF?B.(JQK0C*(5IV=T(;610NXEA695JUO#;R
M?<#C.<&OUVH[*[/-G'FC9*YZG\&=,N]:\36<$,0#/,H&X5]Q^.+A/#?A:STE
M\">0[F X[5\V?LE^(-.N/&EM'+:Q-)(N%<C[K>U>]_%'2[J;Q,BS2&3/3Z5_
MFAXZ9G7Q_&:P>(AR0H05O[R:3O\ >?J/@[E.'QV?5LQQ#Y94;)+U3N97A;X?
MZCXB5I8;A;>VQEI6S@5J-H/A709#!J6MQW%V/O*AZ5S_ .T9XJF\!_"[2[&T
MF:UDN -[0G!Z=Z^$=2^(FI"_E8W<NYFSDL37G<%>'.-XWRV>:XG,%AL.IN$4
MXMMM6UW6FI[O%?B=Q!B,RKX'))QIPI2<>9I2;:OY61^C-KX-\,>(0?[-U4Q2
MYP <&M_PE\-+SPSJ+3B\C> <NWJ/2OSD\-_%S6=)D62&ZE4^JN?\:]N\&_M6
MZPRQ6MU<-<C(!WG! KU>(O SBO+\,ZF6XB.*H]E\7RB]7\F?(0\5.)\+A:F'
MS."KIJUU:/Z"_M3_  ^L8]:N+RR79Y@+D=LY_P#KU\CZMIPCWMT(ZU]H?%#Q
M)'XGT?SXTW!USS7R-XJCVW-T@&!N-?OWAFZN:<$SPN80YIX=N"OO9):/M8_'
M^&\?4Q'/%JRN[+R.:T$9OC_NU]9_\$]_^3J_"?\ N7'_ *):ODW0%(O6]E_K
M7UE_P3W_ .3JO"G^[<_^B7K]'X7BX\(XI-=*O_I+/L\2_P!\CQ'XD#_BXGBG
M_L*77_HUJM^ LG4#C_GFU5?B3_R43Q3_ -A2Z_\ 1K5/X'OH=-O))IL;/+;K
M7[SE-]E_*>76;BKH],T:%9;U(F7.[BOJOX+_  ?35/LDRVX:5RI4$<5\FZ;J
M"RM#?6S+A<,:_2+]D*XBU2WLY& )\M37\S_2$S3,\LR2C# U'#VTU!OU/V/@
MK'TJ67XG$\MZE)7/3O#?P3@TZP62Y1<\$J!TJIJVBZ+:W0B!4$'VKU7XF:L^
M@^&I9X<!BF,_A7YZ_$K]H230]?> R&1AR3D^M?Y_T?#S,.(,UGE63P=6K%<T
MY._KW/HLGQE?,*4\?C\0H0O;7S/M_P /?"W2M7MUFRKJWM7.?%3]FFRUC1[D
MVR+)E,&$KU'M7D?P/_:<BNH8HS<K(H*AUSRO(K[/\.ZY:^)M+BNX'6574&OH
M,JX5I9?7EEN.HRPN.IZIWEK;JKNS[GE9AB,VR>NL3"KSTI;/=->9^(?QZ^%-
MUX-U:>Q,;(@<R6S,.I'5:\(\8:?<1K;>(;269(I2J2?,?W$P[?C7[,_M@_ 6
MP\3>'Y-2M[<"=<N"H'RMV/2ORA\::2_AVXO[>>%EM+HF"\A ^XW:0#UK^OLK
MS6MQ_DM\0KYCE^E2%K^UIRZQ7=I75E\6G4_.^(,'"C4AFN"7[JJ[-=G;6+]=
MX]]CDKWQU#XRTJS6YMF76[<D37 ^Y)&  OXUBW/^K-:EUX)B\-VD5W#J4-^L
MY*[%7#+QG)K+N?\ 4X-?T;X91PU/A.V%ORJ4]'I9WV^1\735%?[O\)GMTJ.*
M+S+A1@G)Z"I#WJ7P["]SJL"+RQD '/O4YMC*>%495%T;_P# 5=G?\,)2['UI
M^S%\#=(U/39?$FM6LAM[8[UW' )':O7?%7Q.61!INF6HM[*,[1@U+X4T0^%_
M@C9VL(DC:X'F.TC=37*>$_#]SXBUR*VC3C.YF[=>]?Y-\09Q/B/.,7F>.J<T
M8SERIO1*^EC^G?"3AO+</E#XAQJ4JDKRYGIRQZ+>Q531M3U68S16S2YYX!K4
MA6[T]=MWICF,<%MIK>^)/QP\/_"]5TBQN;=[V$!965=V#W%>:Q_MG*EP8IK.
M&^M\\B11C'M7IY#E/%F84_K.4Y=.<'LU%NZT_NV)Q_CEE]/&RPM'!SJ4XNSD
MM-NW<]4\!^ [7X@:@8-(OVT_4.RL<<U:^(7@-KN>3P5\0[%9#,N+/5L8*MC@
MY[UC>!?%&B_$)6U_P-=OIOB"U^>2R8X![\>HK0^)7QFUSXB:/;V.OPP1WUJP
M =4(?CWKUZD\)BJ<X8BF\+CZ.M[.,E)>7](^PC/!>(E#EHN-;"RTDGI4I2MH
MUU/@KXY?"&?X;^)+K2YWWF)OW<FTCS%ZAJ\>DC,3[3U%?H'^UEH)U?X2^&M<
M>%9+J _9FE(^<@CC)KX'UB Q7LGRX%?NN69K+BSAJCG=9+V\)NE4:^TXK23]
M3^4Y8:>6XW$9;4ES.E)QOW2V8NB_\?\ ']*].^&/_)2/"W_84MO_ $8M>9:)
M@WR?2O3?AC_R4CPM_P!A2V_]&+7]">'2_P"$2J_[S_(\_&?Q4?TD4445_,QZ
MY^+G_!:O_DYWPG_V)]M_Z6WM?GTWWC7Z"_\ !:O_ ).=\)_]B?;?^EM[7Y]-
M]XU0!1113 **** "BBMGPE9Z9?\ B/3(-9NVL-*DF1;JZ5-YCCS\S!>YQ0!C
MKUJ62-HPA(P&&1QBM#Q,UC_PD&J'2V)T[[5(;5F7:3#O.PX[?+CBLG)H0$OF
M,V,G..E>B>"_A!K/CUF;2].EOP1@1P$;]WL.]<=X>O+6SNHWN(?/7/*]C7N7
MAWX@Q^&YM/U+P^6TI(Y1)"JD<$?>/L1UK51$<GXD_9_U*Q2>2P+;K=<W%G<(
M4FA8#E37EMYI]QI\I6>&2%N@W XK[0\-?$.+Q;XLEU;6M=3R+O,;W=TQ"ESU
MS^52^+OA78_%'F.^TV(PGS);I&7;M'0*HY'%/E&?/'P-\!WWB;QC90BS$\D@
MQ#:S YE)'&T=Z^OI(?!_P/M3X?U!X9?$%TF^6&*08@8_PD]L#M7F&CV]O\'=
M<D\2KK3W]O8E&CNT.QL#C8F*\+^-7BS4?$WC*?7CY_V2^<RP23-\Q4^P/%6!
M]AZ/\1O!6B^&YWGN5,BR%UC1@-W7@5\M_M#_ !4/Q0NH!(D1^P@1PF)-N%&>
MOZ5YC=>(KF\LEAW$!!@8XY]:T?A=X5;QQ\2/#NCRR%8+R]B2>5V("0@[I6/L
M$#'\*F6PKG(7UG-8S>5/#)!)C.V12IP1D'!HCA\R/Y5R54EL#/'K7VW\6M$\
M/>,-6E^)=M;Z5\5EBTG[&EG9Q7R6DTT-TL&&4K#,3'!)%]W S@Y857'@OPK\
M/'U_P]H7@VQU34-1T'7=U]?37$DT8258TAC"NB*4!;+%6.5!. &SSL9\245]
M$_M0?#GP_P"#O#7AR[TG2+#2;S[=>Z9=KI8N_)=H/+'+7/,DBDLK2(%0D<*!
MR?G:F 4444 %%%6]-%O]K@-TCR6P<&5(V"L5SS@G@''K0!]4_L+Z]:Z+JVM"
MZO(+1#"6!GD5 3T[FOF7QE,)_%6KR*VX-=RMD=#\YK;TOQ)ID/AK7;"6%EEN
M-HLB(4=U4,3@OD$'WP<XKC),]^O>I]^^LKKH>90P,*&)JXE/6=OP&[C1DT45
M1Z84444 %/A4,W)P/IFF4Z/.>!GVI =M\38_"2W^DIX->>:P33(!=RW"%7-W
M@^;^&3Q7'*TC(44MY;'.WMFFQECD;B%[UJ:7(N63RUE8]#5TXZ",Z-0LB^:&
M"9YP*^D_@?K_ (2\(:QI<M_J$-X+M/+=9?D$6>,DUY1:PV>MZ.NG/:[-1@5B
MA5>6[\^IKH+/P'<:A\+8KX6WEWMM(Z(P&&/?!_*MEH,[;XY?#>,ZM?W^F-#/
M9EP\+VSAU(;ITJ+PC\4K;X5_!B2T1DGUV\NIO)A9<[ ,#S&'ID<#OBN+T7XL
MWDNEV.@S62,J,$9DSND([G/1J[G4O@K>^+XV>2#R[E8]R"W&9.1D;@>WK7)B
M<+3Q45"ILG<]3+\QK9;.52ANTU]YX5)XNUE;VTN_[3N?M%G*TUO)YAS"[,78
MKZ$L2:HW6N:A<:>FG27DTFGK,UPEJSDQK*P 9PO0$@#FMCQI\/\ 7? &H1V>
MMV+V32+OB=A\DJ^H-7_AS\,=1^(>N)I]H@!."3GC%=/*E:QY3?,=9\&]#.H*
M$41-() RJ?\ 68[GZ5ZQ\4]'N=/T&V6[1W52 JJOS#TS[5Z)\!_@6/"/B^_A
MU9+>VTV")<7%S(0RD#+!<#DUR'Q<D^W:E>R:?^]LH;MV#/UV @  >E6,^=->
MN';29XW@"/(PW;5QM]*\\O5VR[0=V.,UW&OW$C:A=0M(9(F<E=QY]JSM-\*M
M=+)=R%1:1?>W\9/M2EJ*YQ]%:^L6/^D/-%%M@/3'2LBL&K %%%%2,****8!7
MV-^QIKUAI?@OQ(+J]M[27RGVB=PNX%#TS7R-I+6D=Y"U]$\MKN^=8V"L1[$U
MTT?B/3F\#ZAILL>W4&F5H&C@3.Q>,&3/N<@+SZT<TXZP=F>9F&!AF%'V,W97
M3^X_<7_@FVV[]A7X;GUDU/\ ].=W75?M33_"^X^',>B?%>\?3]!UBZ2UM[I(
MI6,5QR4<.B,(R,9W/A?6N/\ ^"9IS^P7\,L_WM2_].=W7O/C#P7H7Q T"YT3
MQ'I5KK.E7 'F6MW&'0X.0<'N#R#VJ5I)-]_ZMY]CTK6BTNW]7_4^-]>UKQ_^
MQ;XD\#I;?$9_B+X \07BZ?!HVI*/MD$1QM:)U)W@ CYB><=!53P5\(/ \?[?
MWQ"LV\.V:QZ?I']L:?$Q<>5=ET+3H-W+99L]1R>*^@/ ?[&'P@^&_B>+Q!HW
MA7.J0MO@DO[N6Z6!LY#1K(Q"'W%='XP_9S\ >.OB)I7CK5M&=_%&F[1!?6]U
M)"6VG*B15(#XR<;L]:[Y5X]&[M23=K/5:;/6SZ[ZG!["5FK*UXM*]U=.[W6E
MUI;_ #/E#]B3X9Z4OPB\1_$^."[U#QMI=SJD6FR23LZ0#YAM2/H,]Z\#\!^!
M_&WQ.^#MWXITCX<VNJ^*Y+][D_$JY\8P6MW;3B7.QH)'78O;:Q&<Y'! K]1?
MA?\ "7PQ\&_#<NA>%;*6RTR6XDNGBGN'G)D<Y8[G)."3TK@-7_8K^#>N>,SX
MHN_!\9U%I?/DACN)$M)9,DEG@!\MB2<G(Y-;+%Q]M*>MGRV\K:OJMWY^MR)8
M67LHQ6Z<F_.^VZ>WIZ'SW\0OAUXE\6?%*+Q!JOA_1/C#+;>'+>VU7P8=<CBO
M-&EP-]PB!MK$]B#SGCM6;>:)I'Q8_9_^&>G> -<EN+:UUFX(\%>.-8$%QJ[(
M?GM!(,;PA!P.1@BOJWXB?LN?#OXFZS#J^JZ3<6>J1VXM#>:1>RV4DD(&!&YB
M(W*!P >E2ZQ^S#\--:^'^F>#)O#,,&A:6YEL5M9&AFMI"<F1)5(8,3R6SD]Z
MRCB(\JOT:>GJWZ/?32_F:?5Y<S\TUK_A2]?6SMY'D/[(TGAK1_BIXY\/VOA/
M6OAQXKBMH9]0\)S7R7.EQKD 2VQ7.#D\\C.[IZ?6->?_  K^!/@WX-G4)?#6
MGRQWVHD&\U"]N7N;J?'0-*Y+$#TSBO0*YJ]15))KLOZW?YF]&G*FFGW_ *[?
MD?DC_P %=O\ DY#PS_V*-K_Z67E?$*]:^WO^"NW_ "<AX9_[%&U_]++ROB =
M17]B<(_\B+"?X4>-B/XLBC#=?8_%5G*1D*R\5]U_\$\?$*:=XYU"$LJAKH2!
M3Z&O@K4&VZY"?=37T_\ LO\ B0>$?BM&A.%N%CDYX]*_G7Q,PTL;PGG48J[H
MXF,E^OZ'Z#P;!5LUCA7_ ,O:4X_A?]#[_P#V]KB6\\ R!,D>43Q7Y >)XV?P
MW#Y88[)G$A'8YZ&OV5^.#0?$+X>IL4-)Y7/Y5^4/Q \-3>"=<U&PO(2VF74F
MX-C[ISU%?DO@?Q!@\9C,SRW%55"6+BTI/N['KYAE>)J<*X6M2@V\-.7.O)]3
MQ >H.&S7HFCM)=>#9_M9)D21?(R.<^U5X_#>@PRM.;N62/J$QS]*](^&?@>^
M^)>KVB"W%GI=NP"JH^]S^M?T=1P\/#? XG,LZQ$;3@U&$97Y^EWTZZ=CXO*L
MNQ/$F,IX/!1>Z;E_*EK<^R?V5GOH?"-J+DLRF%3S]*YS]J[6M-CT>]2958[-
MI'O7L6DZ3:?#?P>N)54K$.O'0=*^#?CSX_N/B!XMDT>V??$CYE=3TK^ ."<C
MQ/&'%<?J<?BDMO5/\#^I,?F6&RZCB<XJ/W8QY(_WI6LOU9YWH\9N_#=^D@W0
MJ=Z9_A.?\*YP+M4#M5KQ%XKBTVW_ +*L?]3&<._=SW_"JB?ZE&_O#-?ZX8?,
M,'6J++\//GG0BE)K[OT/XR<9MRK25E)Z!_%36^]3NO-#_>Z<5TXF*E3LQP=G
M<]]_9#O(K;XB:>)0&#.5 /\ >/2OJ[XH7%SI_BR(EMY7#$=>*^9OV/\ PB-2
M\=6MQ(AQ"IFW9P 1TKZ4\7ZFJ^-)Y;CE&BVY<<5_G!XP4L-C_$66'4[-0BI7
MV7NIG[?X,1E+'X^JE>*Y?OLS@?VM=,;7/ASHNJQ%IE;$;[>BG'>O@74K5VO#
ME3G.*_2W1[?3/%VAZEX5U6=8[2=MT4K'[IZC%>+>(/V-KNXUR>2RN[.XM&;*
MNTV"?UKWO#7C7A_),HK<-<05G2<*LIQERN46FDK:)N^FVQ\'QED6*X:SW$25
M&4J-:3G%I-ZR>JT]#Y1TVQ>9=B*Q/?@UUWA?P?=W.HP,L3L=X^X,U]F?#W]E
MG0/"UN+K79()@N"5WY6NNEUSPQX;N##H?AZW*Q\>8L0/([U]IF_T@\!3YL#P
MW@I5[)I3E[J]4E=_B>5E/"/$O%"D\%A_9P[U/=_"USB-(^#LU_X2$=P#"1'_
M !+WQFOCSXO>$7\.:[=1,,88J?\ &OTP\%^+$\5V=Q&\:@@'@+C&.U? ?[3<
MK2>,M3&S:/.(QZ5\)X%<0YGC>(L;EF)E^[J0E)QZ<V]UYZZ^1\UFG"&(X(S.
MEA*M7FE43<NU[]#Y]T5?+U&0'^[_ %KZL_X)Z_\ )U?A3_<N?_1+5\KZ;&RZ
ME(2,#%?5'_!/7_DZOPI_N7/_ *):OZWR:E['AG&0M;^+^3/0KN]5'B7Q*_Y*
M-XH_["EU_P"C6K&63R[<?[1Q6S\2/^2C>*/^PI=?^C6K& #6X!_O<?E7ZS1K
MU,+A*E:DKR4-/N.*>^IWGP[G::WNHF;Y0N:_1/\ 8M\41VMMIVYN!B,\_6OS
M;^'=PT=\\&,*Z<U]:_LR^,GTF\FLF?#I)E.:_(/';),1GO!U2IAU^\I.%1?]
MN[GWW LX5,97R^;TJQ:7J?H5\=M> \*LD3CYD)Z^U?DQ\1-0">*-8NY290DA
M(SVK[T\8>-)]9T4HS[B(R,9KX7^(&D36OB&XF:/?%,=Q7'>OP3Z-LZF(S+,<
M9C%:I-12^5[GU_$N2U\%P_'#4TW[UV8/A_Q+/I#1:C82M;M(RLR@\'!SC]*_
M37]DWXI2:II5I!<3YCF4,,GH<"OS/TG0Y]6ECA6/RHP1G ]3BOMWX#6G_"-:
M59 M@QCO7U_TCW@<+EF&S"CIBJ=1.+6_+;5/R.#A# XO%Y7B,-C=86]V^Z=S
M[1^*4UO=>$;R,E>1QFOR$^/VBVP\9W\ &Z*Z^^H&.?6OT)^(_P 5@-!:W+KM
M5?F8M[5^;_Q,\0+XF\<7D\9_<PDC(/6OA?H_8K%9YQ/C,YA#EI>SC%^;3T^:
M%FV#_LOANK3Q?Q3E[OR/"]<T.71;C!=GB)^7)K'N?]6:[;Q[.DBQA1_%US[5
MQ%QS&:_T>I4X4\#)0@HWUT[]S\5I2<K7*+#Y&IOA^X73]025F8(K[FQUIQ/R
MD57VA&SC_P"O7Y3F^$CB'3DU=)-/T>C_  /0BE*+A+9GZ-?L^^/M-^(?@I='
MO9?,DB7 60_,OO78^)S8?#/POJEYISPO>/$55F8#'6OS@\%^/]0\'7R75M<2
M*R'Y0K$?G[5]%:+\4/\ A9VDO;7UBL\\4>-R2D$YK_./C[PDQW#>.GF=!\V
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M-]XU0!1113 **** "E#L.A-)4MO((FRR*X(Q\U #H[AUA:+/[ICN*^]1/C/
MQ2\=JLV%C/?M*EO \[QQM*P1<[4499C[ 572P$=MM+!7/!&<UIV\<\ENSG<(
MTZ-NQQ_6H(=%OIULFCL;AUO9#%:LL9Q.X(&U3W(++P/[PJO?+-;RM#*LD;Q$
MQM'(-I4@X(QZU<9"/4?"D^EW.GH/M=K:1HH6XCDD.Y\_Q >HKLM/;X<^&M*B
MO=1\03:I=O-N:R@=AP.Q[ 5\Y_2GOV/?-5<9WGQ,^*%QXUF2VME%EI-ME(+>
M/@%<\$^II?A6OA;4]4\KQI<W2Z5;IN40$DY]/85P/7BMWPOIIU)[F .4/E%A
MCOBDMR;G5?%?6/"%UKT=OX+L)(M,B0#S)OO2-W-<G8WEUI+-=174EO<X**T3
ME74,"&&?<$C\:S88)IKD11;GDSM^4'-=WX?^%VKZI-$#:RF63!!D0[<8[UH!
MC>#_ !!XHTW4K2/P_JVHZ=/&[&$V<[1E&<!6(P>"0 #[5%J6H>*O".LO;7=Y
MJ&FZA"DD7S2LKA)03(!S]UP3GUS7UE\)_@?I/P_T]O$'BBXC@N5!,%NP^9R!
MD''IFO*_VI?$5E\0-8@U>"-?[1M8_*F:, *T(X3CU7^M8RB4>*^)/B!XF\8P
MQ0Z[KVHZO%$0T:7MR\H4A0H(#'CY0!]!6!1168!1110 49-%% "^8Q_B/I24
M44 %%%% !114L:%E7"Y/TS_GO1H!%4]E</:SB2/!8=B,@CZ4Q,QR!N,@Y -6
M'9I96EPJDG)P./PQ3BK@6H[=);% J8F#<L!PP-=)X;M56996@_>1LN"O0FLC
M2@\;"3;O20;=JUZCX+T5(-0AU#R"\2HK-;^N![UT+06YZ'\)?#_A5[R:\\01
M/"+CF"[C;_43'[H8=U/<5<:.6WUZ[TV*Y0Z1;W7F7'E(&RI_B []:=X3\+R:
MU-+-81M/8R2!KFSQ\R9Z(/\ &M:ZAU3PCJ5S';:;)8V]RY@C2XBW%0>/O$=C
M0,JZ[\$?"/Q(F%QHUT=.NK-2S21J$\XCD,!V/O7*>#])\7_#GQC#/=W4EQ',
MV0\CEB%Z#<,\C%;K>'_$%I(L<THMH%#I)<H_E<D\9'I6LRW#:0+W0XY-2U+2
MT7[5*6\S=@X^4>E 'KOQ=^&\/Q8T?3KR\TU-2O+"W7?]E4DJA Q@_P!!65^S
M?\+--T/QQ=SZLHT6SLX2?LZPLSR@<Y]<U>\ ?$34[R1-4\20MI%E#&)'O!*(
MU?;G("^O2O _BY^UU)-XE1O!"3:=%"S":\:;=+<G/)(["@'8^K_&G[2%E?S&
MVF\+7(T%&>W^UE/)5QT!R>>,9KPWQYI>AZTMW)H5]'.&!D<.QW -VXZ5\[_$
MC]H+Q-\239Q:C>[HH@%6-!M';)('&:;#XH>QTJ&5)3''(,2%&YXIBN2^)_!H
MM\3W"J610J!6R7.> /6N7\77EQI:-ITL$UE<0CRYK.92CH>."#R#QGGUKT7X
M016OC#XF^')-4U);72;!VU*ZDD!9(8(%,K,0,E@-O0 DYXKW77O!.D^,/%7_
M  G=CIEE\3YO$YT>VGFDM;A8]CM+!>S)&P1U;=#&NXCY2_(YJ&R3XH74I;G2
MYHA&\XC ^=5R(P>,GZ].:Q)+23:\HC^4?>]!7W!HOAG0[6PU'P/X=\(Z'?0W
MFEV,DVI7*2F:\WZGL+-(K'8NQ5^ZIQR>X%>5_M/>'=*\,3>%[NPT^VTX:EIT
MS2K9V4MI#,\<[H&6.7Y\;5 W'&< XYJ-QGS2U)4DR%6)]ZCJ&K,H****0"JQ
M7H<4;V]3244 ?OE_P3-_Y,*^&7^]J7_ISNZ^DZ^;/^"9O_)A7PR_WM2_].=W
M7TG4 %%%% !1110 4444 %%%% 'Y(_\ !7;_ ).0\,_]BC:_^EEY7Q"O6OM[
M_@KM_P G(>&?^Q1M?_2R\KX@%?V9PCID.$?]U'SU?^+(IOICWFLPLHW#BO0X
M];/AGQKI=ZK%1&J(WM47@_2[?[&VHS'+(Y"K[XZUF^)]MW,S;LGUKTL;P7AL
M=D^886GOB?>?J:Y?FU7+\QH8NEO2::/T!^'_ ,8H=;\-I!+=@*5XR:X?XF^#
MM)\3+(S/$^_L>M?&OA?XCZQX3_=H6G@SQR<BN_A_:'D\M1+:R,P'/!K_ #0Q
MGAAGN28Z4L+1D]=XIG]DY+Q=PQB4\2ZZHN7Q0DM/3S.@C^!^E6^J+(I5HP<E
M:]Y^'L&D>#85D)150<"OEVX^/S8)2S;=[YK'U+XV:WJ49CMX?*##&[/(KT:G
M!/%G$#CAJM&;Z:IGH8GBK@W+\/.%"O&*ENH+<^@?VBOVA%FL7L-/FW3L-BHI
MZ>]?+FK71\/Z"TS%O[0OAO:3/(4U4M8Y[J\-W>R-/*6W$L?>NAU:QL/$D,:R
MS"WE"XR?NXK^V/#GPIGP7D-:5))8NK%J_P#+=;?>?RIQ=Q<L^Q-.C2AR8:G\
M,?U?FSQV9B\A8YR3WKLD!^SQ9_NBH]<^'UUIL)N$/F6Y.%D3D4]6/DQKZ#%;
M<$Y!F.0XS%PS"%G)1L^CLW?4^4Q-:%:$7!@,UVGAGPK_ &A8"XDC_P!8_P F
M1G('6N,!K1M?$5_8QI'#.RQQ\JN>!7ZEBG55-^Q:4N[U/'Q%.K4ARTG9GU1\
M$=6L_ VI"ZN)T@Q@88XR*^E8M6\,?%%2J75O]LVX!B(_*OS*;QEJ4S#?<?A7
MHWPF^+R^%?$%K<SRG8K ,!Q7\5^('@KC,X^L\0X?&NIB[7Y%"W-:RM'6^B\C
M#(LQSSA'$/&X&K>[3E'H[:?D?5]KX?2W\1W>E3H28V.&'!-/UKPY!I(+FXFA
M;J/G-;/]H:?\58[76O#NJV\=Z5&^&1PK\#G-1W6@V=G,K^*O$-I;KU$9E'(K
M^;L+FV%P^"> S#"R>)C=.+C[UUY63/[JP/'^1XK"4L=5Q].%XKFBY)24K:JS
M_P CBFU&]GA,8=WA)QNS6_IWB3^R]*%C:PK+,Z[<E,GFN]\/^*_AY'MLK*\M
M;B0_*#P173V?A>S^UK?11V\EOC<&"BOCL/Q+B,CJ5+8=TW):<RL_E<YJ?B+D
M&9RJ4\/*,N3724;OY'+>'=*/@KP;>ZFR,]RZ%@&XK\^_C7X@GUGQ1=-,H#/(
M7./K7TU^U)\1M1L9'M;343!;A#F-#@=:^*=4OYM4O'EGE\QV/4FO["^C[PCB
M*4*_%.*DFZR<8K5-:IWUTMZ7/XZS[/JG%N>U,UEI3A>$4_*6Y3$*B7>*^D?^
M">O'[5GA3_<N?_1+5\^S:8UO8I<&16#-MV@U] _\$^?^3K/"G^Y<_P#HEJ_K
M;,Z2HY/BDOY)O[TSGYU4FFCQ/XE?\E%\4?\ 84NO_1K5'X;T7^W)C!NV@#<3
M4GQ*_P"2B^*/^PK=?^CFK7^%^GR:EK3P1\,T3'\J^TRN<80<I[*/Z"5&IB*B
MI4E>3>AT^C^'[/0<LI+2D8R:[OX77[6.NF:/<!GK4\/PUN)E#/NJ]I6A'0YB
M&8K@UXF:YE@<RP-?#0J*<I1:LF?HF0\.8W+,7#&5TU8]XB\1B2R4D]1SFO/_
M !9>64\P\R%"<GG%<EJWCJ6QAV C&,=:XR^\53WDQVNQ%?BG"?AE4R_%/&N7
M*GM:Z/U+.N+<+3I>RFTV>G>'[[3()@YB4$,.WO7K5G\4-,TG3MYE557MTKY&
M6^O68D2,@)]:SM>\2+I,0:\NWD?'$(/\Z]_B3PCRWB>LJF/K2:Z[[?IZGQM+
MQ$H8.BZ4*7.^FQ[+\4/CG<>)5EM]/!BMNAF)KP#7?&D4)>&V_>2G[[^M4K>X
MU?QE/Y$0:QLN[ =:J>,O"=AX;M8U2[>:Y./SK;*^).$N"Z]#AO)*;J2;LU"\
MK?XF?D.=<25\\Q488N?I%=#*OM2-_@D]ZSKC_5FEA7Y!27/^K-?TK.I[3 N=
MK71Y45:5BC4^H0PI%$8CEROS5!TJ:W2&28!V)'I7YKBM817<ZMG?L,L=)NM2
M;;;QM(W3:HR:]6^'?@G5])D6XN;>YMX>I;!7\*L?#_5M-T56EG=()0!M^7D^
M]7_%'Q:N)&"17+"!<@>]?S%Q5FO$>?XO$<.91@;4WI*I-.S2UW:Y4F?(8_&8
MS%S>%H4_=[LMZAX#M_$5P=MT<L>5FYYKU#X:_LX16*VMY>(9F#;U1 ,$5Y-X
M%^-&EV6H(=1L8YU#<D9!/O7T3:_M3>$(+.%(G:W(&-K  CZ5_/\ Q3#Q(R[
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MTT*=23W((8G5\L*Z[X8_\E(\+_\ 84MO_1BUS!]B:Z7X8_\ )2O"W_83MO\
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MN_#>O217B,BABB2JO[J53TP>U=+H5]/I=DVG6UP&C<[9(I!V].?2OT[^.7P
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M]\O^"9O_ "85\,O][4O_ $YW=?2=?-G_  3-_P"3"OAE_O:E_P"G.[KZ3K,
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M0_G?)L8Y\]&H[R@[/S&^'3S,/85]5?\ !/7_ ).J\*?[ES_Z):OE3PU]Z?\
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M8/I5GP;H\OCGQK")ANBC<,?PY'\JJ>"H1=6NI1?QF/@=S7:_L\R1Q>,+BVD
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MOY+/=/Q<_P""U?\ R<[X3_[$^V_]+;VOSZ;[QK]!O^"U7_)SGA/_ +$^V_\
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M[F."\A7Y(R%*/GKCTJ2\\?HL-K;-,)-K%I(3%@O]3WKYET?Q9,T8_>[9T/\
M""N*L-\3Y[>XC1IVF96(._YB/H:7*%SZ#C\<2S>(II/[/9V"C[,MNK;Q^5>K
MZ7IWBO6O#3ZA?66I/'G]U&UL[Y'N2.GTKY7\%_$>ZCUZ*YMKK;<Y $:DCGUK
M[A\ _%_Q'XAT.WLPMU=76/\ 5HVU&^N.*-@N>0ZYX<UC3]%D,\CV]N?W@$ML
M?E&?<"O'[74;>[U*X26:>:&(,PDMTPA]BM?:GQ&634-%=O%IBM[%(MLD=J@9
MP/3/K[U\"?$;7[?P_JUY9Z/YEM;.S!8S+R$]?K3T$<%\0/$%O)JL@;SF!/\
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M+X3_ !U\-+&;"_OS&D@QAUP.E>A^&=2\2?#[7G\0>#'COM.F/F.@.<CKBO\
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M]N(K_P <\3^)'_)1/%(_ZBMU_P"C6KB]:4R0*H'.[%=I\2O^2C>*?^PK=?\
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M@9"0<C-=/K"B\DE?H&8D"N:FC\MR.U?WCQ'E/]CX3"9=AXVI48J*?=K=_/\
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M7J_PIN++4+:20&1[E'R&A.''XU\:6'CF\T^Q%K'%$4!SN.X']#71Z#\=-?\
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M.,8/J .<?6O,B<FBI<P-?6_$FH>(K@27]TUPR\*#@*OTQ60>IHHJ+@%%%%(
MHHH&>W6@ HI>:W+/P;KU] DUMH][/$X7;)';NRG()'('L:'9 ?NK_P $S?\
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M_P!%GD_\)C_[LH_X<;P?]%GD_P#"8_\ NRG<#\HZ*_5S_AQO!_T6>3_PF/\
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M_#C>#_HL\G_A,?\ W91_PXW@_P"BSR?^$Q_]V47 _*.BOU<_X<;P?]%GD_\
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M^(<81T2LM/P,)4*<G=H_/7_AS5X$_P"B@>(O_ >#_P")H_X<U^!/^B@>(O\
MP'M__B:_0JBNK_73B#_H*?W1_P B?J]+^4_/7_AS7X$_Z*!XB_\  >W_ /B:
M/^'-?@3_ *'_ ,1?^ ]O_P#$U^A5%/\ UTX@_P"@I_='_(/J]+^4_/7_ (<U
M^!/^B@>(O_ >W_\ B:/^'-?@3_H?_$7_ (#P?_$U^A5%+_73B#_H*?W1_P A
M_5Z7\I^>O_#FOP)_T/\ XB_\!X/_ (FC_AS7X$_Z'_Q%_P" \'_Q-?H513_U
MUX@_Z"G]T?\ (7U>E_*?GK_PYK\"?]% \1?^ ]O_ /$T?\.:_ G?X@>(S_V[
MV_\ \37Z%44O]=.(/^@J7W1_R#ZO2_E/ST_X<U> _P#H?_$7_@/!_P#$T?\
M#FKP'_T/_B+_ ,!X/_B:_0NBC_73B#_H*?W1_P A_5Z7\I^>G_#FKP'_ -#_
M .(O_ >#_P")I?\ AS7X$_Z*!XB_\!X/_B:_0JBC_73B#_H*?W1_R#ZO2_E/
MSU_X<U>!/^B@>(O_  '@_P#B:3_AS5X$_P"B@>(O_ >#_P")K]"Z*/\ 73B#
M_H*?W1_R#ZO2_E/ST_X<U>!/^B@>(O\ P'@_^)H_X<T^ _\ HH'B+_P'M_\
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M  'M_P#XFOT*HH_UTX@_Z"G]T?\ (/J]+^4_/7_AS7X#_P"A_P#$7_@/;_\
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MT%/[H_Y!]7I?RGYZ?\.:O ?_ $/_ (B_\!X/_B:/^'-7@/\ Z'_Q%_X#P?\
MQ-?H711_KIQ!_P!!3^Z/^0?5Z7\I^>G_  YJ\!_]#_XB_P# >#_XFM#P_P#\
M$@_!'A[7M.U6+Q[XADELKB.Y5&@@PQ1@P!^7IQ7WW12EQEG\E9XI_='_ "#Z
MO2_E"BBBOBSH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>business2b.jpg
<TEXT>
begin 644 business2b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$X.C,U.C$Y  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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MK2!*0]B1*HHR**\I"5+?*T@32XP$767H5!'%WFP)F E"F(DE#8,W2+P.0
M                         "D/G&8-+A+6(T\RO*PCBA)DCCT(@B2%(0PP
M7"9X,KEF&G!I\2QD@HS(1N&9B(<Z%<1)7EU'TY+Z.0
M          :(F@A>I('B3AT(HH#W*L\#S(TMPUP,8EK&/RJK-T6KOVME[L9+
M:]7O:?:F+5OR.G>>G3FRK3N ;0$,="K+B+.+G,]'T&.P
M            /SIFCYF RN7 91+K*<Y*TL0M(AS I:Q;A&E:0Q8DQY=;9R_]
M1Z6U/G<&RGDM*;W,FF7LMS!UJPGR?F5\1O>9Q(HF22+4*PG"US[.G8
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M_+GTFYBWO9K?^=:'A9=Q=Q?1V,.&)S#)^^HY
M    !^? U<)(B"O)4]R/.Q(D&=2WRXR8*L@29F/''>C])L>WMMWS^4\?'=6#
M+7R5%/MC,:]9\OSR_17H\>>!Y]G_ #?F5VI6Y*Q;MDS#'QXEI&*C]^QR
M                        #X*FL9;1T)(KCT!7$:210'D4Y2E(2YP>IWF*
M#UN]2>UWK%\%H6%Y_2O"V7<_VFY&^LSZ/_'.996YCO;Z)U[YV[W/X7G8;\SK
M8JM6JK;N8)+9/W\G(     . $                    $\@^#1JJ1)1DL>Q
MW."N.Q2E:49'E049+D,3Q!E%2(S9FQ_:[MP]K9R]%=S?':UE^<T_GG+'M+05
MYR1-)KW73L'TF:W>/AMKY]S[+P4Q;-O!'[^H<@    XAX1,$M2)X22
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MV6^JF_[J^OL80]?T:[%79;P7+E-7!VM?F0 X+?K> KE
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MZ)C5ND!C1$RB\D?&N:Z_GT\B?FQ+=Z)BC))0IWU6]CXQL>$%OKL8H-ZT@GE
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MD$7(?1@V.,,'S7.Y)%^'J85,]&?S38PR8I(LZ@'[^SD    X+?K> KE
M                 $_.+\D=Z:    S 9"(,H2E*LH#D\B?*,KS;DWU,4'S\
M,*ERGH7<4)2&2S94U:,(%I&/2B /W]G(   !P6_6\!7*
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M3A3$*=3W/(ES(Y]'#R/FJ;#&1#3DA#P*0B#H0Y>H+I-WS4<U4+<*<_?T<@
M  '0BHM31(                    JB45[6C\@9H  #D]C/QEHQ*6P39U*0
MH"L+_-VC/YIB:TFX9B$MTLLLT]2&![%>3QF0R::H&(RSR@/W]G(     ""0
M                  " "?R!&@  .Y[EWEJ%$"^C(YT(8N\^@QF4U&-5#/QL
M@:HDV89,:GN09=A0'H7R;1& #')C(LDZG[]SD
M     'Y C0  'H< ZG!R9F)DC3*9]!RXS0TP 1IN<9@-=2E,4EJ$44A7E6>Y
M6&0B#*TBBRC"9^_ Y                            !^0(T    !V/0RP
M7:9?-^SDP(:>%J'D7B9;+5+!+3+F(([E2>)V(\F"E)<D"Y3&!^W\Y
M                     !^0(T    !ZE\F6#9 W1,;&%")-:BVSJ747R1YC
M@Y+G)PDR2( \"I(XCRB*$\B4/VO'(                            /R#
M'S\  !R=S,I?QN ;F&H9IN6@=R/*PABYBK+P)(FSW*PKSL<%"5!(%.0AY$81
M1^RHY                            !^04^?QP  ":-G#9,W)-!S6TMDN
MP@3U!T,@&3 5Y5%4<'L>A;Q6%*31X'4HBX"-/UNG8
M         'Y!SY^'!V!U ,C&W1OB:PFEYP>1T/,Z$B9*+T*PI"Y"//0B2Z3J
M4AW(XK"I/0@R5(D_78<@                            _((?/X'H=SP!
M4&?#?XV</ER8D+@.Q'E&767^7020($ECN3!:A<94%039%D(59$GL=R&/UT'(
M                            /R('SR  !D$V5/I40)\NB%*XJCJ2I?Q>
MQ&$B29%DZ9>+C+8)LO4%M%CEEE&19U*(\S];)R
M      #\H1\P3@  R:;4GT\-)328CRY2%,B%\E><'L3!4E2;8&9SR*$CB0+;
M(,J2WS$AC JR-* _6T<@                            _*\?*4X /0J3
M-1OR;1'S!+1*8\#R,SDL21X$B=C(AL@9^+2.I81=!=A9),FL):I)ECD0=2TC
M]<IR                            #\PQ\ARD .Q<YGL^GIC0^>A$E83I
M>AD8H"1/8E"\C=4N4]B$)HH"O/(@2--=SR+*)(NPLPM4_58<@
M                 _-<?(TL@Z@]3+YN.;]GS4,!'H31>)D4KR,+@+@)TSP9
M_*PH"3*TBSL4AU+8-?"O+.+&+V,DG8_0^<@
M   _-Z?,TUX. 3IL\?1,M<^?I!%XEX$N>I)$L7893,BF1"\B1*4IR7/,CSJ2
M!;Q"%CEG&/#/!;!C _36<@                            _-D:(&N9"%
M>91-O#9D^=Y9IDHN,O\ *0C"H.YM@;3EA$09 *D[GH48.YT*LCSW.A'%CF42
M%,/'Z SD                            'YFS2<\B".Q5F[!=)\YBX#,A
M?Q%D4=BK*(W%-@BV36\S 9<*TB2-*XH"H.A0$P1I)D*3)KH8,/U''(
M                      /SB&BI0$"6X2AM(;F&@Y9!>A?Q#GJ>17DR;0&:
MST,!E495+@/$I"0/ \"N*8IRO)HCR#,*&LI^J4Y
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MY2^CQ/<E3*!MH7V="A,6EVE\'D5IYE&4))'8HBUC5$EC+A^@$Y
M                  !^:\T].22!;A&%CGH3AO\ EG&FQ,E^E,3Y$&3#= D"
MD,DE$6>7,=R>(DH":* A2?+5-1C9$PP?I,.0
M    ?FK-/R;/(C#R*X@"R2G-]B4/GP7<7X5A(G)=1N2669',M$4510% ="L!
MZGH41P6(6 2YKL?J*.0                            ?G3-3"3(PI#Q.
MY&&.B5/H&8#-3B^R_P IB?+;+B-JRTR^S/8*TZ$">YW.#V.A[E&<GB8,/ _1
M"=@                            ?GN-/R6(X]"**4HRRC(1M0:4%87.=
MBD/8H"]S8LN4H#/QV!U(XD22(XI2J)DH2/),CB&/MP<@
M            _/8:ME4=2WSDAB *$V6+<-0C)QD8ARB*TJ3/1/&;"_SJ=BA/
M$]SV.#R*8KB4(T\RG(0Q<?H3.0                            ?G3-,C
M8(^PY\P35,H"%/$V()LTH,AF0B0+=(TE3:0M0VG+F*8A#W.#H>92%PD"2Q4D
M>4YR=#!)^AXY                            !^>0TS,LGWG,J'RK/F@4
M1;I7&X1C4U(,LDH>A&'B707F;G%PG<CSQ*LHRL)8H"$.2X2&.3D\BR3[O'8
M                           'R6/DD<&>#;H@C0DL4C2W3(IMR:G&/2Z3
M)Y:A2%49#-[B6*<Z%$>I[D621+$4>A!$J>A2EOE]'V#.P
M             +2/SBF(#P/8\B5+7*8LTHS/ALT:,%LF4"E)$HC(YO$29)D2
M4I %XD>3A*$"2Q8I<)"DR8Y/JF;#'(                            .#
M'!\>S3@M\HRN(4ARB(XM@SH95-,B^"^2++6)TS0;-&23@%N%>3)*E(6J>),D
MR1!F<V],XG8                             _\0 ,Q   @(" 00! P(%
M! (# 0   @,!!  %!@<1$A,4""%0("(0%2,P-Q87,3(D)SA 03/_V@ ( 0$
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M)UU^QG$*"P?57W1R>EY5-O68BP,EW>1SDR3,[>!P1%,!$"UGKR[9ATYWS?\
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MJEZ>(Z4=2*75+B/!NO?'.><T_M\.VW7:QU5__?[-#/J;MMK]=M;R$E$K=IM
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MG6;>=%>1<VZJ=.Z?1>YTYW.RY%P/]=#/JC_SK_&O<;6E>],LJ7"D)NE L<S
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MR!,A1"8@?//7 Q)S$Q=24*B RSV>5B!7C;C '9[*)RIY6+&J3\17YOZ@ /\
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MNMW'L9_K2N_O"UQ_&OZTKO[=7;M#C@'@Q6N_MUO8_C)=UG%:[^W6NT.-@?\
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M_#U\'Y=V\KKU^7N=.=B>5KYA?U^GP>MK$\_*+&_(>O#B= 5Z^+E>^OX-R.)
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M7T]_O8:E#6<'ZH;T $T!DBH1W:&N]#"B% %&9V>:-BR4)%)P4[+L"&S[*)'
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M7!*K;&W,04"!-*9"N[Z5Z5%OF,B"$6$?44D$CY\]O[N^6R+3!B^,B0%3/,!
MK$3)@LLZ<RU@*S_J#(;>W(XC*6Y %^DR,-0.W[Q'Z'-A\,PN4#V3%A,(!#$<
MG1]_%PB2'(ZH,>47C'#=0\5*.C8W>D2%,MF;A^1DA+:(^1U)8]8V/!<Q%%6W
M!YC8Q :LA5WG1]X.\"TW6*!&; 2$#'60$%&25( $#!@C#U@RC0[M J4P&B@P
M@ $I@H%#]X 6*T  @[$+EEG0I&!!+#:0- ![HA0XYQQ#  $\A&-#H0T.SW&H
MT@Q>[.&ND%W!X[9A)8T%" "($4>LU,X5;:P*$W%7+^$DI;/V>HE9:&RE4OU7
MU6J]T'G>_M=O[MLA, !P A=,C!DNL(<QTTTGN3.^\60E6T9PL[PP ;!?GI!&
MA)1>;+%_3!AUQS=E^)E&-@?K+>1S^L-;$&R68I-!BS< @)2T&#&V[G\F'"02
M >SY@W3($=OT0PB#9_6>\S'PC))2VO-@&(RW %4[",EH/D4W:HMLYI90,230
M 0@:J#(C54AO9CC2K(  YJ[^V+HJVF=8\>?!L9[0Y"0I&M"P.A"V;PH3H*#\
MV$P,QTG"TP^6OH_-0+*%" M@IEA'C.GW"91*&(693NU#TEXVWY@=07COO!(!
M>M8K:,,AE>#+99I21T*W$_?S_=], >$?,RI_J7@58!/XEG@-?]@1X.\>62;K
MN(;>7U@!@"(X(>HYF"*T"@6+ ^;PF@HD>GY@S>UWA0A[]1&9UK(H" D/17$2
MO35ZP@D$L(#6UF!AV>_Z@E$BWED*N4T8;'3IH=SGJ-3"\-'MK"ZMX$"@)@["
M:@OC$A4L (H19$Z2(A"VB#\PX&D10O!@2J D?R<0BW<#HT)HXA*-(8S T 0%
MA5M>$MBB-P0IH#$/ZPH$ G'VHV-%OB!$# C7'^3KLZQ,)99Z=H<DDC\OQ*-9
M3;>JE10>8/.YQ_=BD 7D.X_4<!?3]P*!PK2"40N.]M'IDFE#6"*QQ2BLJ,4M
MCS'@/9^H*I'D:U"H3LP'818P](-%C'E0_<SU;CUBZPA&WB**$KQ"* H?1<.'
M0! UQK%0!#(\$0 1RO% /6Z X?4.9!+ #%)N2]]#D\3V$ P!EO&D*"&"3>@0
M,D0*=@1*V@9P4LJ-,YT# >XK6$&FIVX [SD< S8M5Z/\0K*&0!K(TVY]H**J
M;LXB4:F$@&C 'EP?EQ>AA:.E4>=6/B9Q$+*@CRA?![-;SSST_NZ.+$F/P<0"
M?T,/&[*]Y0+$6^8CK W"'F\(4!*@.@K5'"" 4"(HS3W^XMCBLW04S23$!Z0@
M""2:9$?W" F4:N61L<;S)E_N:_+#O8/,:F(L5H3^&(7F1LGWGM"98J&8*K @
M"J&R<!C@^T(/E<S<DI!*\^:J8[O6\$PRB0NHX';,#25*"P'?M" S>KZ]OFR$
M*A2Z_J $MG7P044:%O[QC.HV6/24("-8Z0-CD*;$!"FO&PBE+J ;=4:=![+?
MJ#Z']V>8D%ZV/'*@40,,#P0F'<@BP2]'!\N"WY<![AT@8D@A^X!3Y!'@9\,Q
MI&+AQPRY3LH'6"--EG]0XA(&G&BA!ESJ?AAI+?Z0P:M#B?<QY40!I$D^\+%>
M PF[MN?J&Y BC9W](*IAQI[A%:&Z+YWX2Y>EC<WG*C;GGTY@#20]C@YQ[0PT
M>^YB!JFU5 W+X !J)[*"F+L3(PJ5);?N%:T5>"#  89[=(9.ZK&XA$52[:<Q
M=)"(7G2&BHN]-8?0%_2!_=T'^APCO!K;C,NSJUO431F5!5J3[0>^5F!I<^T)
M5-4>GI  L']PMIA!S3UI]NGW".>W?TB9>@_,QD <OU-6';^XH4Z=(3#-8:5T
M,)X'MU34&@'(3L,"A,#X/-(4L!J4]D*/6",<'M"/JS+))V#S'^4QUQ::',B1
M8D.B0]($6& @-6V@L 12&H('" EBP] J#.M2!G5UAW50*% !(UFAHLE>E0O9
M9YV@@D[![HC@Y>QU<8*R6LN5MP?W:X$Z>7Z4#S2L@_&9BH$M^7H^"+C%&_*A
MT;4:4O;M''4$S@CI;S9D!""& QQ";!VHRRWFDL+7]P(S69+8+V,U-;VC9G,_
MY#'-FZ*^"Z"'8)$=2](@=P"O<G3] L1P*+XJ$ FT]C-J":VO[]H)).=1EN^8
M2>F[( ]1\JH)J, &B,H!$ZYKB ?$C0A$H*2H40+I1TT)@ *#<B9B]\!+L("7
M"EP9\+?J_:9.@,N@,89@>F*B&#X=!AQL#6#!B3K?!A6 "*CW@V=S@_NR@_.Z
M'U%DRY_4*6 &7 ?!N9LJ$>=]^HK'QS+_ %WA3A=_N TD%3#;7T8H[*KVAD@%
M:_46(PQ0.41/7]UTELR64-(PX&\#C(L[VF'$!8W%#.D7!BQ:APP62"PRZC!#
M9ZT5DL/7M"0+U,#\%>\IT##Z.F?01/K&H:*R]@D<6PT)8OP&L20H4LG(P%IP
M N6&,%-N5!U#&XFSPSR 7%US!:L# >&H'3A'"T1IL4_:&@& \Z0P]]X[)OM?
M$,XFR%;7QN+?5%OHF".7VC'T",1(P;'??B"AD1'$8Y@_]GY_CC\O\1^7^(_+
M_$?E_B/R_P 1^7^(_+_$?E_B/R_Q'Y?XC\O\1^7^(_+_ !'Y?XC\O\1^7^(_
M+_$?E_B/R_Q'Y?XC\O\ $?E_B/R_Q'Y?XC\O\1^7^(_+_$?E_B/R_P 1^7^(
M_+_$?E_B/R_Q'Y?XC\O\1^7^(_+_ !'Y?XC\O\1^7^(_+_'_ !8?XHB(B&($
M (U?FGO',:PR&5B4 Y$P(UK"$R;YBR C,&R*' 03!-6E$!SZP6]5!"G7]P*I
M08W1BG9F58'<-E@6G-PLQOL^X??34MI=! V]V!!6MS0V6U]607A@.@:,#PP!
MG47.7H?LDL-F0D!DB>9A$&<<$>I.I3^(D**CW@N3<PF/5J+TVFT"$\ [[OOO
M#E2,OZY]E G#.Q9$%H@ 203B #M!/ B6J-"102(*)%B!*9,$]B,EE#!4!IF&
MA4""#2S@D?1W"9]5!FOK!YZ#_P!*KAMJ<Z3JPEP;T"A(<!P/L+^IDHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH =WAH&$J/PL".*ZQ.!W&H/(_@ 9/
M^_P0J2(@A<#:&4 SB+ML>8A:U6#,@,#?$#Z"$&<&!8(O"L7CK!8%2@L<0C"(
MD]K]XZ2>$:B))"KU^H=AD#1W8QM#$6FH$RHRQ::O:$DH107WS 8]M)9NZ>V8
M,<ZQO8P<(@AEV@,%0,_72$2+6GI#,V..!?0%PF2<BGGX^##KVV:'J 56""#M
MB6TXMAV.H+.(@B*4)<G,VHH KM(L(IFMLGY[F@W*$0 E8E=? 44F/6W N$ P
M74:@^O*:-%&O_3$@+C/[K0&G7K\SU[_U@,7Z&HXP\'$M) /]=I>$OLF>]%ZQ
M9USDX&O^1H&OW#UL+\4:9 >AEM!5#$CRX+IP@9OSK,NN"2&:[3W".T4(:CCU
M@D("!W_4($0)._>!EZ\<RB)HP0RH5U]89>:@#K P1 [':U%8/](?4$090!_$
M%=M/H(?=MSK#40R5UC2!'6-;>\,SNNW&\"$*/MZF ]'65D$F:HD:;@B$)&*-
M4O("(ZL^4 A@!@J JX 1'D21%4Z(Y--&0A% AHP9E>-!@2"6<TFH'&"\] 9F
ME\^U7V?,)C_[( M1GN!W(>G/]=YZE0YTQ)[P\:PH?A+QO#,MR,S2R;F9E2F\
MRM6X"RQI4WHFRA5$;Q%V5(P>0H!:[IXHZZ _J"F*\_4*ACY<:R=WF&>Q&C!<
MHAH!00PBUF*32Q$<:!UCDJ /M8AP0?*A-21KL0?>%7"'VG/,YXM[3485]R?4
MOJ 3;:FH.80!*.04)(H<P$=M>D( :POB&C@)$#3BC15 :ZZ?O\(\Y@(8\\Q;
MIU DX,P !58IBX"@$3CF.)8$!Q8%A8 (<'AS***M@M1 &&47TFQ"8_.5G3W\
M_,?_ "?Z\_U\S'O^HA@;MX@P+ZQW)MMZS+"_GW@/LF8&LS='SB<C=?\ 9;,0
MON#0#-7E&*1C7YB#5P0 @KS:-;,#^(1FIU_R4 +YON$"^P$U"-HXUA0!T YH
MH=*T/76&!Y_<?)N]U#!75>5+N!G5SPFR7X1-3&:X)OKQ!1>[A,7AN&4UO"">
MT YP@R#IZ?44^1SOMVN')$W'6+SM"VNW[PC?C#!+7,?=R5X03P)!U4J ^,P*
M-62&(L! <,T 7Q5801PS"ER T>&($^1P*1](2W];26$7=X432_CL=8X##_7F
M)AT_"3\<%V= "LM[C:-O<(7$[Q#(%MV_<>"30;ZB%D@[Q,J2BJ5Z_!A4!VGE
M0F,N \$!D*Z5IZF R!P/UM++FSEPWQP8[:YYAK&4O8]8:, '/:/GE6]*8#).
M)).\NLVAW@&'$Q^H)>\F!)"]6,=((A)*KRX T=R?V0!#M;UF\B,-0W $6]OS
M N&S# 9'$"B3N7AA.P;VZPFG7W8@UG[@\]!_(@A$ C8X,(B(!QAH+W:!Q?M%
M#[Q'3_K8!(;0GNU008QO3),*,*A4U1PH*BDD58# )QT]$,5<#&P'!A/T]H?Z
M\Q,.GX22,/VD6>![S+;=(PFRL^XB?73/ZE577XC8@( 1QTWE7 P!8MP@]!9T
M])>L6P;@<,-8^1L_$.76>;2MP!F$&%'<&_U QQ1]?-Y@]/\ )JDP??\ $#'"
MNXH!^%;0^2<@=?U X 1S;A38 ?,$O"P?U/07T,.<)=LXZ1B]$HQP.0+A$88?
M2+\P^A1. ^:P;$![P73!;0O IM;1A62,$S]P>>@_DAQ2VL7A-I%[*M>J+J=K
M/J$/\O3Y<AQO,K2B31D0Q D @.Q45P7%/!\H#@R;A(A11;$A(!8&H6$8^7-;
MBMV*GQ@+C(V'BW_X]B4":!P SP*&2T+$ [X(!(8(&"161QE)L.?0)-$H#.!>
MUE#)F"C6IG *L=&-FT<$#LX!U&"A0$[BR3"&F_ .H4 39!=@W+ SRF:9LD5&
MB% TQTTQ6418R"D*)+@+H-.,%OC'1L5@!/9D: Z'4+"#1B>=W18$]^EEFA7)
M <9TF7P"QD0TK.:8V+3J4T""B 2"" 20-$00#1I>$( O?Z60BAHZ)S:.?_/S
MS[T 9("9>Q.<,'L",    96O =F_!$/")5I_^(F'3\)68(4$</1[)?A\ZP80
M1X[=XE$9AA!5I\3=@%#H@T3\&%)BJ,'S0^_S%B+E9,:O 74/FQ<!C_#68HHF
M,#!_D</8]YK2A=GP09R08\_V%J(%&G-#ET^8'OYV-2P"!.NQ(A0-6/J#8L3]
MQ!HM(XZ3&G"X4@PI:GJ>T78#9>+U7>>K"Y]8K"OG,#,D<K]_J"1"$08=#3U1
MZ0HS^\B' *R63-/$$''X4#7F?N#ST'_@Q!K\?'J".Z,"D"$$   M@V=C:K/;
M-&(-'CP%B!)/0DF]$6+IL #389H%;MA8+A[)/ A'*U6N?]&4W74ISIH19=/D
M1W(-?\AF>+4 *,(FCRPRL6QR%,B9Z$Q:$:TY99#5(!DD&# KA%)B=$%M#!"
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M4-XX6;2$V$AYX;V#Y4PE+.@BE2MC3@0](AA!S_OU! B0 T-(:#BJ*]5"76P
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MWSPT1QA_J.5!N.%D5#>/J &"1YVS!./4XA=9#!V8T&O6)'@"R>&_6&%34,/
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M^)2NH@"J7^X*>H\CB$(A5U#5D?GSW_NQ&6$K3^&C?R(-;@L#D2_P*ZWX4#2
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MZWMS-@+_ !&_*?J$ $N\PU-$\=/W 2L'&@%]HU%*9M3 S6^(" $ ;'?G;,!
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M@QRRW"QT?]X4 +1VYH!2#(UF(1JU>."0(Z!.'O !!'1?B-DWHX#*]L_/U*7
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M6'*'J/\ D?0 :03B(!HK40N 2E%I:\O'?10PHFDU(Z#F'*!$,&=X$S9%K_R
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M2                               2 2 02" 22 "" "0"2
M                    2""  " 20(2YEX000""
M        0"""0" 2 3K0'$@2"2 0                             0
M"022"(<3"JD.2"00                             2""0"0  2O&P!MQ
M2 "0                             "02"0"""269L 9E0 02
M                      "02 20  3Y@022[B2 0
M           "2" 0   9QT0(&^022"                             "
M0220 2""CZ@ 6!   "0                             "    "" 01X&
MZP SR2"                             0"2"    0 VLG,,".0 0
M " @                   P"2 ""200 "%2!;E *MBH     2&0DDDDDDDD
MDDDDDDDDDDDF:"2 "00"" ""  20"6KZP    !P@
M#@" 02"0 202 "00 >! B,A0 ">                      ;02  " 00 "
M"2 20 "2FM*$  3                      ">0022"22  2"0"0200)8J0
M(K&8                      3@2"0 22 0"000"    " ":=%3
M              "<2"22 0"   ""  0 020 &284AI   022 0 R$$$ $
M   3P" 0"0 2""0"   0"02   "8J9H@"2Q>MLPY#2PP"P2B   "<""202"2
M "2  " "0220   3"](H #\[.T)2]FIX3>F'&D  3B20"0022" 022""2" "
M     3#M "<&FL/ZA"G!> 4G(T  ">"2"2""0"""0    "0 0    "8(, 6$
M0H00$@4.&&V 4JD  3@0"2"2  "0   "222 "     3
M     "<  "20"20 0"222  " 0    "8                      3@  0"
M"00"02220  0 "     3                      "<   2 " 0 2"220"
M000    "(                      3@  "2   00222"  "2"     3
M                   ",  "20" 2"2  "022  0     6D
M       &/   """"2  20"""2020      6@                   "!0
M 0 2 "020 22"""20      $                    $$  "00 0" "0" 0
M"2"2 0                               "00" "002"200 020
M                            ""2 "0"0 0"  20
M           "    020 0"202"  0
M2  "0"022" "0 """0                               02 202""02
M""""02""                             2"2""2202""020 020
M                         "  2 0""02 0222" " 0
M                  00020"2"20"2 02
M   0 2220 2"" 02"000 2                             2  "00" "
M222 " "2                               "  22202" 20""000"00
M                             0 "" 22"""0"02""0
M                 ""0022200022 2 2"""
M     "20 2 2200" 02 2 0"                              22  0"
M22200  0" 2""                              "" 0220 """ 0  "2
M"0                             2"0 222"" 2" ""2200
M                   02""2 2""" 00 ""0"20
M       "" " 00 20  ""00  02                             0  2
M00"  20 2 "2" "                             "0    2 20"22 "0
M0 "0                               "" 0""    "0"02020
M                      022"2  ""   002  ""
M           "" " 2  "  2002  "                              0
M"""200   0 00" "                               2 "" ""000" "
M202"220                             2"0 222"22" " 0"20"
M                        """20 """ 0 2"0"
M            " 2200220 0 0 0022"
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M!VXZ#VPH0! 8",81"W:BH. #*$L()9.3[T7 *)0A3(!P+_@-%IHF@ *4J+L
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ME22!"8,04H20"$BVAHD$ LF92Q&!>&2)N' U'&8S&&CO[,D0%P-L/&P?"FE
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M[?\ ._@/7U G"DC.WOOE(,>9#1Q%PP<Q!N34,0,0$L(!70S[XJB:"2@.D-D
MO),$,W8)%) PLOTL! .2X Z(1<LV860E"91("13#E!8*"0UU']$%^TDQB&'[
M+0NZ, ! F+SQM/L/::4/5?#HB8$$6W*"$6F2Q$?.2%C LI]I^*(8L60TQ<Z:
M404R0KY8YE=# 4.@98)Y:=MJAB<";P7 &#QPUH72&X6.XB.39IA3 L7.:[]Z
M(!LI@BIC.QQ=^&C)@J@9 \@;O86Y#=@!""@,M),@B]JR2+EYNZQ3)(DSG1*&
M>[G(9FF!9.%I3O@9\3=@BV+8OWPS<1"BF$!8ALYBXTSUY(P@BR J4&O%A&+9
M(D+&4JDE QQ]M0<VL1<,D.;A<PI#P/(<A-R@M\_E\M=*))B283@$X6"YR/=L
M(D).'D'N_$TX"2>.H&^=W!R 61):@DA-1[@Y31,$!-O$W)*S0S FTX42-*53
ME:/Y7][^ ]?4K_%U'\%4$(%L%/3?E (8F6_DH*XTHB9"D2]#W+^/Z(-.0%QJ
M80 F&29M@LGQC)PD93"CW^-:4PKCO@J&1T(!928^_P S/(GZ-(M& 8 O*R^T
MN)$EM(Q%YOAHZ!F\"XL>&-2*<"\>PO8RX6%(,W/V/S\AV9RAZY9[*AVCC]&K
MD8UZ:2,B<<J8$\G+Z==1T#VR4*A!N(-^/D\),NK(SW?VU:AL  S?B2;SCV=!
M8!*-_;1SJSQ'MY>'6M^TJQM:A#!\FQ^5=F9+8!E+7/J.",@I@2:*4X[Y<<,Z
M !:AK9[N!328,>P'WY-Z%:A'X4B.Z"YD]4?:<*(0 \,LSR]^==3Z%;N?][^
M]?4K_%U'\',9B=,=YTC%WEI/S]4 '%)_T!$U+IAMPK?M IPV%E0";4NV-(+\
MH$34N@G'$8>^.70.U 1&RPNN?\H"4M_5!$C8M+5YT%B'S5#.Z&5\^C^Z!L$P
MR6/G6U! 0[OY"I6W\9<ZXOC]I<_C]T$:4$@'X_:(E%V+MES_ &E1I #D#U5!
M9+%VT5*<1[?M 18_'[;2U%H)^/VDS-WB6LV300$.^EH5 (TD*RQ;XT$F<E;]
M]\Z($M_&+>)M=T")N72EZ+Y?][^ ]?4K_%U'I]_ >OJ5_BZCT^_@/7U*_P 7
M4>GW\!Z^I7^+J/3[^#[]2O\ %U'IYR!IWV>6?J0,P1<E#GXJ!&(!G&* &)7(
MFEY%+R*7D4O(I>12\BEY%+R*7D4O(I>12\BEY%+R*7D4O(I>12\BEY%+R*7D
M4O(I>12\BEY%+R*7D4O(I>12\BEY%+R*7D4O(I>12\BEY%+R*7D4O(I>11 P
M+Y$?PNTR;!K)]:(3.\_S+U,%']6^8-  5UP'U6R.U;([5LCM6R.U;([5LCM6
MR.U;([5LCM6R.U;([5LCM6R.U;([5LCM6R.U;([5LCM6R.U;([5LCM6R.U;(
M[5LCM6R.U;([5LCM6R.U;([5LCM6R.U;([5LCM6R.U;([5LCM6R.U;([5LCM
M6R.U;([5LCM61]'Z%$NDYGH$ AIZJ 666,E;GZ47@5R=+P* .)?(#_\ /!__
MQ  M$0$  0,# P,#!0$  P     !$0 A,4%QH5%AX8&1P5"Q\! @,&#1\4!P
ML/_:  @! @$!/Q#_ -JLM%G26C6.E)M)H%V#!;HTD1RV!02=F2@J0B<C&*O6
M8UQ5] CZ+D(&,VF:@'10,"9&KV"6:/I$/(8:(#U>JB\P3D9%HPL$V7'>I840
MR!+,H+D[_P!9OVIXIZ:3_HJY%=!H( !(K +KK4X&!P+BASL)RW*!@J5_8$C8
MR-FEI#,#KKM(EQ$:Z4IWB'C%8>HS)>-J!LY,0A3 "P"FT44=7DM+'L$SI%FB
MS2(NL20JM<G5_J\1JP>H)):34SV#M?W=_4H$!R,0A&@FJ!J]8/\ 5\VF%@ !
MZ-2JO$N\K2BKW^*AQQ&1&Z5"2N7)"YJ1@W*%L;I!#8/BI$)2"] L2[+'K00R
MU21L2T)DDR12[ "V%@$%46>CH6ET45(4WSAW_P HX:6XQJ[HZ_U7MZ'6=/7Q
M2Y<->G1;\UP58_;]E&HXK* NM3QA,2Y8S$*S! >M,DPKLO6V/7OT?V*-$ OJ
M8BE'5F'I;W:Z^E1ZB#(9<(@18'IEJV?\G$!-DC L]>JE'LIG9,?:#?\ JH2C
M&CJ&3UI#L%1.: &LB;7>M&L(T"<Z+Q,^BA0C ESM)E!J]J",H&X[K^;?L<9[
MRPR=*$HV$2]>KNE+I1<!"-0E*<"7-+UJ*/B5/J7J/5H8&16M;3U_JH@DXD_/
M:F*3+7$A/SVZX:<-EZC >U1_ X.(]D=^W'6HXVK1-RS2)FB=2[F>\^D_U5"F
MZ'H.L=O^7I@AP:+ BXO3RT0X.'$+HR"^9^]$$O80V'JL1ZT!D"2CTMM9S;]B
M1 D)Z@P3I/6@/@A8P),_YUH"+C.6>AQ;KSU?J=#*98]QNQ26S!;LXDEC&&_;
MI_5-+J')4#$/L6K]O?UDHM:$Y(WD6DG 9H@0#A2L$ F5K!'%)BD**Y@]75KS
M^Q$WH%.WV]Z03!"Q$(M!#$3?[5*6/: C$B$%AF+6H)$T9) @@GK3;7- W5T.
M'&KWZSZ_U0@1,I-S#3)>-A&XI(C-B'EO04!1;6U"0# H3"B2[7N][Q0"$^+0
MQ(0L1(DEZS'2I#:9[>*%E+8A::A*:W;4V6!PC<CVSB6NRK*7H!UVFI3*4I5W
M$ ]8#K:Q[;K 9P[',"NAUC^XRQ=670E@56E1Q68I9H6'$DD]:5$DJ62$1^_%
M05U /0(E-XC3-# <BQB>UX_J@8)FFA -1;SM?UBG D1225LZ!#HTYS*0%NBX
M,'>PI@6-SC#<D3H6WM5X1UYI+,D,R1\.5*5=V)6/5YHR/KE@F<N!*B(S2A6B
M8VR,XXQ3HZ4A,&:6D%=3: :%XI;)R:-P0I/6Z\T5ON8- 6@-V9I);F'JYB#+
MTO0QE=# 9,=+,V-:8<K8'([N$ZPQ&(H% )1;JN@RDDO..G]3 OB&@H0T8_.U
M7:=6]<S,+$=HB'2L<A>YMW2=97!0]%"R""!>1$C]ZZM$#%E"%V@4L-!-">DR
M1I%-HF:X_5"$MB.U)A0A3<9)4V09F7,THD): "_@6PM0[?8EL88+/KFEAS+8
M339C=M!>EAX(3B?^X^9)Z(V<$'!LD1U*#-UA!&H%S 01TI$9(/$N)FM8)K:*
MG;LVJ= :G<MWJP$P9<8:+,1-K/PU@2 2$<Z,3^21-3-0668Z_G>?Y%"8F\5L
MY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5L
MY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5L
MY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5LY\5(
MB(M.?'T&$RV$V3$=M:@PP2!2=(0+?6?]IG5B%-D+DTO!V:$UPD$ &0W=E<:3
M25J,>TP63!890B*GR=(,C"";K(K7&*)PA*P $F4P7$#),9?R8F_P_3LW;Y/H
M(4LPR7[3<I%<(+"Z>\=Z#0'.$6'K*.FM$L;4E9U;8SQ:G7E "0R)D#K)%'%(
MQB,!$++!AM1&N2EX*-F0F5>&@?FA8SJ0B<53C!!B*0XJ1(*'4Q.U0L$<DAZ8
M-_3JTV6 L28M>^^-LT*%HND^V8_?B;_#].4IB;14B(BTY\?1%6.)=)'",DV6
MU'9DR =^]_&$:=9 !,R8@7,0DZZT8*R<0,6ZF(R LB/>+$27EJ7V@$\I]9TE
M4(9C!:"+]A,(&=8.&LVDR[L%E9Z01]+T@YIX^_;W_=B;_#]/S=OD^B)/N-K8
MIL(&+JJF]Y;FV.(E06PL,'1CXMJ4W0!P,$EYMF/RU*+E)-D]\-IG7>E<$J,(
MCDU.09&KIEO*APL$IKQ9QF2EU>D\TX4+1XGID)[M2 5B03WQ<9>' J:A/9<H
M0  9946L=\XI21[#,G63UM0MFQX5EZ6;WV_3$W^'Z?F[?)]*24A;,0Q>T2VM
M,30)+).H6NA/9F%XH@0PD.4%*S<%6E(J@_:*O ;<,U+0(PP-%\KH5* #ST%*
MT2,)I$-*\ !0@]H9>_:-OTQ-_A^GYNWR?2@HDZHRCDG\O?2F1"]<LNLLO^:9
MH!#,)LN41B)]>\4 MAJC><6R+2;8U%M=1AB,M<C-:U4[.JUY*F\""% 77'&[
M7XP03@0>*KB<(C6H*-)D<T6 8U@R'6!9S:,B.M*Q,.103TEC2^:)2P%+H>TX
MGUJ8$CU^GW+TJWH)906[H=OI>;M\GTZ^C'6PVZ7QN7I["HC7<1]DP3B*1-Q%
MBI" F80(MI"VE#.E!1@G2(22(*I7D_5ZF6 @-X#('!$H<YDZ15!FI-)-"ICA
M"A#-R_N4+%.#&SV?^6G6UZ4R%DQU[Q//[@-7D/>>-%M)0+5]S;H;[$L33;C[
M?D5A,FQU]]L3GI>DB^CK"??\?>MWY?S=.U)$='\O=C]@6E;=KQI>_7U;T KQ
MU>V\>[:FWBD@'K^;<S_X^;M\GT],Q QF/O1"%H61?N]#M&]0C)@@E9,=[$Q?
MI3$2*$M!.!@@I(DV8D(<@"!$@2:(E(6P2\6L=C,'I"Q!"H%"X$K8O5Q2*P$I
ML%:(:E"T]TZ'[9ZG7F=XB6P%Z@A2?:V>/=GK-OT+$IK!B',YX82:+OK.[\2Z
MZ4W7_G&G?OUS5G1(G:?]^Y=F\5D S-^8]+Z1?.2G0U#%R+KK&FO:LP$>MO7?
MKGM:*2.CW/SMZZ?H(D/OVF7WVF=88">OK&W?D8Z+>,Y6=R=.[I6[I%NF',8L
MV).E;N/- %NOQXVF;8A(B^?3\^V>E1:?;WU^ WTHA0BVU_77OJ#I%@DQ.DS[
M;=:"=_3XQMWZEJ2XMZ>?S-;N/-;N/-;N/-0)F;QCS03KZ9?:9]A[U;7\_,^G
M?^'-V^3ZEB;_  _HJ1,QF&1O!Z4-QD" C)FLHD7%,+2<D),<!RW@7O$O["^L
M9JQWSD/1UG:E7/Z.AZXN?A%\NN #)K2,];7B7'YM,["P/Q,Z..UIUF/TG77\
MOOT[T8]'72??\=*V:YCYZ?A-XK"2_;[][/4.:*+)%OD_8T+,7_VF=69O^?$2
M=*M[^9_R,7]!K(^<>O\ FN*,]NW;I;]V)O\ #1,,8U]/\D][:U,S(=?M/5-,
M=("43^#-V^3ZEB;_  _I#$B):Z0];48K"FY(>C^?>@W059%K=(W_ (A3#^?G
MSU:6?V+.?T%,4(>MHZ5LY\5LY\5LY\4SP1WGLG3O2S=J7'Y_SMB:Q1!G-HS6
MSGQ6SGQ6SGQ6SGQ6SGQ4"(B\Y\4*8_/S3I4OMK8>F<_PYNWR?4L3?X?I^;M\
MGU+$W^'Z?F[?)]2Q-_A^GYNWR?4L3?X?I^;M\GU+$W^'Z?F[?)]2$(F+S6[C
MS4"9F\8\_3!*)BTU(F9M&//U00B8O-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N
M/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N
M/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N/-;N
M/-;N/-;N/-;N/-;N/-;N/-2)F;1CS_\ 0B__Q  J$ $!  (" @(! P0# 0$
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M+,>!69HV###<^*!3W6'&E3'Z]<3VRP$F] XQ%N/#>-U$2(/86]%U,[KR* 1
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MKV!T\V!I6N#-=%AB7.7K@F4D4+"5)[.^]O$O-$*L$N-VF/)YY'(R9XC=?O\
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M27$$.P46X!3K+@26FBQ\8\]X+P5G!B,PW%RY<_.^!#"B;54A*&03RYXP0::
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MP,V\" &XP>KF=]<"T1A:F6Q#K*U,QQG!UK.\&&5&45U"/&;"& .P;8?H<>2
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MZ[G7$!8^+#?C+Q#'0#!<3><SUG@"@N("FV6.=YA-2Z=8ID]1A&*YLI_H"#%
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MN13>'9R)YB("(+Y4C'&%$=D=0P"R-K\?\1A]"_HG^>4 N+7M'+]7^W&P\OZ
M_P".-<G7Y#^DWW]<:Q"F#P_+=]?'$1!G(N2'?R]_]*LQDKA*W =P=' $,>W-
M>6I/M9GYY8*1!M74,:[;UT<%&)<*I*3,_7Q^A)T1%ES$U'?^L.U0%HPN*./I
MW_@JJ(8&,04"R*'WXXC$&S;8R,'&6]QO/.$2!'YGD[/'C#TE+,/Y-.:&<S1Y
MX2):![9\=%_+[Y7L+1DN4$<J&;YQP"S,@J83NCMI-9N.88.!ARPM?I-WN]<!
M2"FC*#BC[[NYR64J5HTU]M\XSP/QZ)?\0.[O_'(%@H(ES'#O?O'$<<1,D^2L
M#YIGR(W0RL53"QB_>IW>%&S[-"N2&)WK6." @( 9()<?Q[QP@4 M&'%/*=O%
M.EVF<Q[NYYN./RW(BG2&$N<S!<3BA(14?#,#\7[QQ.L9"I34WC>XZ"9O"[BW
M36C#R>O\<RN:QG.Z9CC":GUR71I+GN31AO,@HBTZR^,:M^IGFV\@MVP3VBT[
MS]KL;*=,E4EV/\(1:Q5D#Z*^<Y"_' (!P;J_I@.#-FA:ZCU[_P \ AU&]S,Y
MB4S9=AX.1 I "-!G94 %!"A:<$L[!756P$*!I5.TJKB8L+3\!M]JZZ[YC;;5
M%FA*".$ C=VN!M:9!"C*Y 8ICG1L&G8"(U"#0H,F3',F!?>?VE_%Y13&,X?Q
MA!^_7-'X?VYK\OW_ -N['R?O_0='E%@N*9D\(#S%QS8*93A+DDSF?1R&<*/8
M*.IBL[_/+JHH\ /-#)^_SP79#(4V?Z3X<FCBQ&Z@8;,SUC.G/?#\&()MB8 4
MR]O^^'Q40P*T[S[XQRR%W@17;<A^G4X+)D!BW8;]#F_N<<LF@%E$&[2R(8TD
MR8JRY1:&]&CS[SP9]*7?^&.KKB (4J]@YZ]DO#29H(1PZ/)E#.\<07<&+5IT
MP8\OOFC)7!F^RG2FOVR7X]'Q*>4\_P"/'"!+0?;-][_4T<61TUQ4$,LNW&+Z
MXL*2 O19M?!G\1VIS#7((%+^,^;WB08 4D>JO3.OU).!F56SO,1&:8^O?%R*
ME [6R:4^';..8)$.J:A_D>]SF0(0XHX,HUZ0FN 60AM&SU_/KA,*/%)-XWZW
M,==\5EB@;F8,A=A[OJ<DP5VZ5,AMBXNF\O(Q*@)VFWLWCUQ>RT$&2SQK._E^
M!T@;9(XQ?9\9XN B)"J4)3M3[/.F9R) @W9A^;ZG%E9JYN\]/QP:KY%^CS3\
M?U 2@Q$>P$<.K/,=A'%#HP<$K3(Q!@,$Y)[Q?('6=CAT9!9L;Y%7D(BE<58I
M,EI'/+>4#@ZH<5O4/F!!* *@&U&M.';AC)>K.:/P_MS7Y?O_ +=V/D_?^@Z
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M"7?G>,&M\L:TBK! \>-8#\\82E"22JC>^S6?3P\(_/KU^9N_U-_7['FGX_\
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MMN$'%#27)[7K23O?D@@T16J T.Q_R\71^4 O8Z#+3=^> P7M0 ,ST3=BS@Y
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MLQP.#XL)".V8]8_;BBN(1@V#/MUS-^W18*S5]3K#>LCIFD%4& 8[==3N\*Q
MA[+(8?%]UX:H.JWRM>"^KV:P&R66X,FCY9 Q<$HE+6$HJ(QJ3-Q)E,SP4).J
MFD,_7L!G1+0D%@B1UB;K"F#M4?-CF]8>[@\N&">W+AT'C'Z]<ID%%R?;\M>_
MJ8D*&DN)$GPW]./'%Z<7&-FQ6PA-<0=1LR?<WY#]//!P"11KAQ*>,O7%(<TH
MDP()CL^9AIQF^91 '#EK=IKO@DJ.F%>@^VL[MQPK!9#R=!CM,%_T@B4;<?(#
MO/S_ $-_7['FGX_^8#<2'E")(VC)Q4O:6I7(I:4@!)GG8 U^(?8I^M[DL:,9
M99<_C_OQY_M/TOPK^YCWQ0R]M!(552![KF8F>/8DV@!%9E3<B[-<.@$)H8+P
M8'&5M-?\^ZA $+5WU KSKT\E<(ZR.>YC"[OKC!N!*AH.!;3HTO5Y3 ,,PF"6
MDM8&(HPXPK(8TA? N'.Y<<ZCX*P?A3JSZT<B2Y$#)[3/;+X\<O # .ESZQKY
MSCF"\7&'R)X,?/[YXAD!DPV.\^L)\<?(HR%#%8AMG>,UZ'<2O01N1'=Z^-<8
M0E 0.'(2-*93.,CS1( L4;'KY"3-,4)=41':%#PXSUSI%!@ Z5Y:O4[MXM$C
M$+ P0;?*'CQ+*4K3:!5G#O8]3(N< "XH0\'8<ZB9H$LUCUY [?YKB0@TRS83
MP9R<PRU6G?;<9/'YY/&455D3P8-9SU=<-!0;$R_7A?<\:XK\E,MPFN]XS)C6
M>.^E!;TC1,[/YM 1T(8N6+O)/>^+90T"8A&&D^/G?*S%1D)8F2[MZUGE0)2F
MRUZ$/_>!PHFLD_5\3S]9Y(IN"7Z>:?C_ .@]1 %#PBR?YSQI!W;BN=L+Z3%-
MJ;L/3-GB]/HY_(.?Y!S_ "#G^0<_R#G^0<_R#G^0<_R#G^0<_P @Y_D'/\@Y
M_D'/\@Y_D'/\@Y_D'/\ (.?Y!S_(.?Y!S_(.?Y!S_(.?Y!S_ "#G^0<_R#G^
M0<_R#G^0<_R#G^0<_P @Y_D'/\@Y_D'/\@Y_D'(FC)-[?7G^>/90(QVC45B3
M?"V\$$*"$^,YZI*+2YY,K?CT?]O?P=?\N]P3-F)YX0K23VH//G]\X>0F4"U;
M3P2&[;AJ:5QA:AJ-19-9V9/&MN8!I'9HN-F:) 4J8'V#MH/D,)Q$ #T57!,>
MUMN,IGK %SG+CPOC].!/YCO+VYOK_/$(, W8(GH%_><^!Q<X4*3VF)ZIKB.)
MXP&B8_"U,T!&E)?T.*"IOFL,1KP$ .!D#S#[?!,\%T$GB89=BZZYE4H(8!=4
MIGSAWH6>:@IDC[+F6WQCPMQ!V 2'H^C[L(L?0-2N!I#R97ZF>$PWE9&OCWXF
M<[J[HH)I/#'XC]YXR22<H3(9Q/TO^7,S0#<(L^R7\<G<7D9!&XZLQ3@NI"0-
M@]V-A([\\>LC"M SJ?>]8]\F!$+&RVAOO]O&IGQFD0J7'A5G0>.'V-& -$WG
M6?1CAV@#02@,E06--O42;3!35@23%W?7Y'BL._;K P^_^C_#^SS3\?\ X [E
MX#!7XSKU^/3PO2!0I=,>!V-/SP^/%SRP1!F5^>)RJO;U8Y\]IQ?3-_CP!HMP
M6YV)^H<H].%5-HQ9JF_6;RZ]E:#!"+GW/C@8RA("04W7M/\ IX&]"M-=98IC
M7P\%N;C$:K@EF+>66+I QJV._P 9QWP;@PQE!^ _&#-PG:0IBV-JG3YSCDUM
MQ4JF9P_&!UY/:@5!H)70!-;;U.%"'Q$A"%,Q:R:;"C]*=PD:I55\;QO *4R.
M"QA[^/ODV0N3VCK,^F8<<=EBK0B"XF7QN_N\"W"PHHDS7KU_CE\9C$NV2X_;
MZ7@4Q2<+21,CGQ?ORCY+N44$Z#'DF/.."W#8#1R%Q3_KW1H7>U% BNO.?C/&
MR#(@-#AS7$Z%<<?)AH5P(N1A\.\99Q;AE C0B;BYM^/G@' D06RO5^\><^$"
MP8RT-X(POPMFLO, * 5V.'!K=&YUG/!*>$/T?W_O=^R?J/\ C@ #0MMR8SB]
M^>;0OP'ZQKYSCUCCS+;$,=-;G\-WZYD>D9BY_P ?/(M09<<_,0_4?\<P2X;@
MX*Y@Z#+;DSRU4HEN$TF=S\?'"2R&0P:F#WFZN-\?B'8 0VC \9N[B</HOH0!
MYA+^3[I#L.]L*NX@V.28H\QNK 'L(S%QJ.WB T*I5RT7Y?QY>!%/%I7.FM9U
MU7BUG,EY#I9OIV[XXA,LT4@)GC3&Q4F;S<#-Q+&,J?K\\-#/B;WN^R;N=\N:
M]4[Z\]4CY=SB45I@6 OZJ-F]CO@Y$.!QB/XGQ9]0J$44V^W<MGYW@X_08*[I
MCT6._P!. :VRS;<?7Z\CWJD\9&X,/9E[ZX$(*]4C8IJ3N#)GA29 *$#H@-*)
M?O' QM*4 =BV96F FWQ4TM#0Z9][<8)ZU/%+:&KKR>A O1 9B$4NBTP.HBSQ
M,@GJH"1+BJI#<-9X.7SO&M:/_P"$[@$Q.\&M?Z/\< ,Q14S<8+UO3Q,)=UB8
M&TRNH9?RZBT/IO.0&#KN]!Q[6( X?1$<R)XS1'1L% $U5S-@YUTN$!'(D&CY
M87J9O$/(1:$B<HG<D+YQE 5%2D*3M-1,RWQCFPFS!T*&WC#XV9O"0HD4]IT9
MZ\?G8=9:4&*VUP&COQRI:,C)Y;?/WXWQ$AJ/D"T'2'?#F2,YE!,$/+F^<9X"
M&AU0W)/AOUO7"681+AI#;?X\;X:)3,%$]"!EWUK/-E8=C.(R^LY#6>)1,1(E
M;!SZOXS=<OM] '.YF]!X9Y\4A!%&<TS6M[+OB7@HH*J$&+H6^_CF ,8#) F6
MTLG N(=Y"7HST85\]\'>PF3*CUX,_7OB@DJB<SI%T&6ADVO!A0%56 -Q(K@=
MQ-<!&8D":!V8J4N2EO"@$F,FXXQ<:L,9#^]E,>*K\_\ PX^'D.P9293?KR],
MXR9 BH9!WG%),9SYZ0:(5>"QYSM^9W2C312"LO LMQE1 V$#1M)5#'7EQ#L>
M-I!BM$,U[XX/GB=GM&LUSXSBMO8(6=IL5'[\R% K&2PGW<?O.*@DV& 15MSW
MC&WLC<>  50G5Q7OK6:<^):!,<;NC]>-R@,L<C&?3+O]#A* I!DO8![Q-]]<
M2BT 0L0L)2ORWDT'<U"I%@X>?KOAVDI 5*A1W 3O9YXE/C*H<#-T\F)Y[G&N
M;PH(HS*K(?\ 7 A.L,T&T"UF/>9I#Z<%,AT&YUE\'CA\KHM*'0NAZZSNF6&\
M:2II236+7.L<&]T%B-F#?!_G?"O@@Y*#G.S-M\?/ EI 2HB20U,^)9V<$@5R
MA_HQ(;NX1MX-%QT(^$<D][ZWCEX8'(&A)4[3-WA\\!%;:KOID_;^7^]Z+*]P
M_GWLXM5\_P#("3JEXS,R,'+==0[U^>45<;,JX/9KUCYY:DJ5;#*3%3/F=<%#
M)$@;91VLAKQQPC9@A(J 2C(Y#J:^8D2.LS )DF88+,J;,I'#E[F4)IF^(YMD
MV4:'09OO&N8!1*9UTK<M]=WEQ4$8^]SKZ]>>-3AG+/!^2_R<Q2^!59&>V-3T
M=U+00#*1#<O=GZXR+&$18,=V#O!XO@$6H"YCT7*^<'L3''9BL24'?:YDGSK>
M0C'@#%*ZR&AG?!9 6JE(]'ZE?$=\M@%94AIB9RFLXGSP(!U).B4@>3N=<CC*
M$[=^793O_/%%&5Q$W<%W)CM\\H*U1040,(CV_C.^1P/8I04TWCR_7*)K*J$.
MQ S?GZQQM5(E4R8-"N7?Z\) ++132",(X4QDPG8R$C# 8(:-]?XS.(@ MGO=
MX\>?#R+FAV988-2F2W 2T%K<8'R9I+Z_*Z_O9BLNGP ZGW?G#QJM'^D99C@+
MKY_JH.YQ&4#!<RSDT,<]\)!S(6[4*=[/U2\7<T'1?O -7L^"(^@8$@:6F^[0
MPV V.ZYDID4NIBMQ$XAG"Z]D6.RNW#O@@+V% ,0;Y3/U)IX=B"' NF]7/6O?
M#M:$B@7& 7Q/#OBC&,B'!^&,8F=N>*58FGAG:2E3_'!;XR.)1Z[[J\,"U6"@
MT-<&<DZWWP(8#Q6>:*]F#!BR*FFL 2LFG&!WKLU"!)L$>AESY\W].#$$ #:I
MB#ZPEU).%(&U1X0O?0=WQS+JK%AIW,>6GOE"PI@@T&^2:/UWQ9$Z1F"P/V8[
MW23DVID;$OS/'?6_!8V44M19KP-\P[G%<^8-R#G T/@N/JI4M+.T,MSG,=S>
M.*,4N;.ZW+UCS^W$P2BH"G5T/KJ>^'%"B9D NQ>L^9PX6B$72.8/>IOP\906
MF!#"SSTM]Z>+K-:;\V?6FK->/[TIF.Q/$\C<WP<-Y?6_NZ_H(90.J]^/7[<(
M42^+UY]<1%'?] *"R]_*'(K34%K[;)_CYX530"*!S;]SRSGI-P6%G=!SJW%6
M3%H>D2H:#%T7TIX+,O.L6%(N2L%N%-?.3'""O )X>=3N_)&R'455&/K'G_'"
M!R&ZF+BS_P XY"'.DI3N(1^\<+J& \ 8S2_CZX@]P"9$4&^,RF3[W4P1&O*6
MEK-]Z.5*3&*-Y^#"/G#QRPI8ICU&4RYQ\9O-IQ.V8#:]5T_)V/2$1!:SV)?/
M7?*&(2BJ3/H]?S;.EDS"PFQ.W'ZO)644.X+O$'KKAF1T%F\X*=>/?CD0RU#,
M1/RWQUYXY)Y:B9A:R-XQ;OC]#8#X$P4;GZF?'(^"FE9'."28Z;N<(!&5,1,G
M<&'\\<02JA>@4'%/)E<<4MM);*9E8R96_G@LQ3"C5HY5<2DE]YY'K')H($?Y
M_O*] &2RV&3=(Y[HZI:^%4_ 'YR_S/\ >@%#!Y82:WYS^?S_ $L0(3?9IB3Q
M?\=</,E[],UU\?R\96:ZX?MUYSKD]0 RJO<SK'S\<Z%QN 5V59XU<O()5%81
M+8$))"VNLFT+80D&1B)+H+CC?\; $X2N/>LR:X6Q0R^0+7POFRV\*!&GE\8O
M=G4GOA"I!AHSJW#N4ZYAZBTRP3P\Z_\ >=YF5)@H.1U[_P#.3X&-2.3/3Y)<
MY;Y'+78H.1)5WMGH.[R;06D!PSI-X-_MPP0,T91 S!<+B?> YBR&"[X201S-
MWZXD!<S8M<N<8\/F\R5X-(&^76>M7OC 'D*JU$R?C?%[;-![JL)/G9QT[2#"
M,,];SC%QP&8A,TPFNVZR\%A8ER^^\3%OC'(ZY+61<8(,N5^/1 IY2X8A&]%B
M_OO'!0*JI-)UO/E88//**)A3L3]7X/CC:ZL%(@ED;X\EXP3@ 663'79<?XY:
M\BF%1P2^/G.(:X(T"(GNV^E_-X(8$P@4AN;Y376\\PH]0/<R!UE_O;C(9<?:
M.XHUZY,7V'YO^O\ D&BFUFFE0:$PXMU>.!*L"C,E;\._.(IK12)Y;9K_  CO
M@C66!2>%U-XSOC?!I6>>H6WJ6B]G,J8Z!$-J.;IP>./+:TSHO^I/?G'#,KM9
M3JZ+A\\4.%PBJY\.-^]]PXC'FY6*>7@?K&9QV"-,#$I:')XP]8 2@@$"JU#$
M8=X_(395?":12Z2X]E>0.!+ E!?>M4\VB<!(U72YIC9NYR\Q18 J(R:@E?UY
MNN +D*4%L=8].>7Y/8$*;!$LV^>N*PS)$Z38OC=Z3/&!!4R*;"&,E(\]<4@%
M6X@@NP3,R[JXXW 44&$I%_R^]\I8%#"T809WB>?!R#^99"]85C>7YY?C(ED>
MF,()Y\\*N7BTS=1TPMK\9XHHVQ\.MF]Z+. % B.U)A6<,;_ODJ,E LF]$=?O
MC'%J15J6):N++X;M>3R1<-BADK%SZD[4_8)\[?IKWO&O[VBQV9F6=L8P0QG?
M&:FHE3I+C^>/^"2>R\10WU[_ !_.N.O%#22;7W=?F<M8G*P*BP7(--K<3@,Q
M8DV.2V+LRPI%<9542["&3"";X#%20^"=RIU[ZO)7)3!64SG&!\S[X80"5 QD
M:Z_<[QQ4!%$Y* [^&OG7"?;0R#F?3!O,\9X3,*.-$GG./9QC6H2\FS.&R%U>
MN+>W3):D;#M@XN,\R^%BL$2"A4<:Q77#(R441?.19G_WF89B"D S(( WN^IF
M\0WHA &@8C1.D:747D%S,$R.#D+E >/;G!8RF$^@O5QV2G(3JPXJ+(ZQ^MY*
M($H5 1*!VZG0\F(5U%%]5)-W_IYL<DQ%+"1^YCQWQ!R!#(*,-BL=3(Y<<F>1
M. :P5<N[X^>:5J#BL+8CC#UW\\9C10= );%<R;KJAPT4U48 \1:QG@WP'5:-
M$CWEQ%/)KOE0F-PN(Y!K%9C5O246"KH]OGQN/F&.$*7H+I3!D6R?=SKA"SU]
M"'?U_>[23@NPEO4<2;[T\* Y[/O/_?X_KY_ER<4(ZX1WOT1^_P!^ 9T"7M0U
M/"\N:A!PF[:1+N^3NAV""74[C0N/.3OB.H"08R/BNC\Y)YJ\, X9N?##6^"
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MSG/K6<]:XV38T4$OA&-P=3Q;1YR.DWAOXXAB! ; (B3 K=_-7 +@O%(%7O\
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M&E87L0(Y:3)TY^>7\2(":K7Z-9YHN$1;/6V?7?T-Q&1#$K+WG/[CV*$4M 7
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L 5.H5/0*/1WPYGAM(85F!ZU'F(:S"(I%@WQ\"*E*G&5@%0"H,?(A7^^$_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>business3e.jpg
<TEXT>
begin 644 business3e.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" '[!$$# 1$  A$! Q$!_\0
M'@ !  (!!0$!              8'!0$" P0("0K_Q  = 0$  P$! 0$! 0
M         0(#! 4&!P@)_]H # ,!  (0 Q    '[^
M
M
M
M        !&B=8!(@D!!)!( !!,(E(   ()@E!(!!(
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MYOABO7]'>+3YF=W/]#^;;WMIER1J                    ,$5L;0
M                30F@ $1#D]"(^6^.\!]/@]F<G1YNY]*H]'GD6=_J?S3\
MJ[8_8?E[_@]Z?#.8O ^3IC"+8HSWH>59=[?5KP?7^*GTODTQXOJ6YZ?G1?R?
M3]#^UY-#<O?:_GZ5YZ_!],_%]/Y7^GQ>YY[,;T>'!_"^@\/^UY'K_P _N\E=
MN%]\.]7^OYOJCQ_3\G>AQ_H=YM=5@                    *Y,"      (
MMT-,^3.R75K7*Z75S4LO)"22I2>O9V+2H7HBRI)(     #F+<-P B!LI.DQI
M,$;HG281(U%HZN=]VF?-$:QKMFNZTZ4KOK;;,:&Z72M;L13D.M6=^CGK;10G
M<;8G6(VIZEZ=N+*-;EG(DD                    "LC$      'S]RVD_7
MR4WG>^JW\H]O+#/.]7ZL=?#X27@-LKEXNF%]N'MGDWI73DJ#7>4='%9_@^C4
M'J<W)EU[.C.1YY0G>GTRY- 2     +=.<  02&AJ$$@() A$I @D@D! )
M @D()                      "M3$@     %'8;4)W\DKXNB3]>&:RBO(Z
M[$Z>:,<G16>^-F<TQOKCU9D\HVK!*:W7IC7W#KD/3I9'-TU)NL++EK6SW1!G
M<     "V3G                                           *U,:
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M3-U57&F<)?IG8&5P  !9QS       PA7Q"3A       )(6"3 W@
M                @1C0  !>?(O[;^EW[^9_&]?HM\I/[-_>)CXGD>LOQCX+
MPC_0GW'HC\U^5C'K]/L_^?OA;1^4\N.^CK9GRG"K7RUGTYSHPKJ,K%\_O\N^
M[P733/L^3VS'T.?RSAOV>O*HN:WJJTY*M<WAM1/;SRO*]3VIZLMEZBY^E,
M 62<P     ,<5@0@T         ,X6D2H                         @IC
MP  (CRI^R_IWS^_J+]VL/XWYSZ/_ ,L_S[-_)\WY7_U[^]^W?Y\_++Q_/_EO
M&?[U]_#_ '.K)^9Q8OLSR7!S^Y_Y\^,S/!RZ9Z53O7,YL_K'!2N5SM&]=9GE
M2D=\9WSWCVZ>5MB\K8_;*65M7<3/],^2MLG2ZT   6(<P    ! RK#K
M      $W+7.T                        0DZ   "&EO 7](_NWJG\=_-K
M ^<^<^4G]D?TGZ3_ "_X/V+^%_E7A#^B?U>M/J_1^EG\J?CM$??>SYF_3OJ)
M!CR2/Q.#WE_._P +7N=XSM7SAK2;HQF'3D^KA] <G;Y+OE+K1(8I&YF\HFU\
MBU@     + .4    X"I"$@            RA<YG0
M   0\Z(   56U*4M]W]CXD_H;]DUQY/17Y?\#YR_4_M=V>%D_)_,^VOP/\ZK
M'ZKOKGZCV9KX'E>@/SCYVF\KPJT87HRETTA>/3GM,.[R[0[KKRY1F4=>]9A,
MWSC*U@     )R<H   .D4L1T             '8+G)2
M      10Z8      @D     02          )F<@  !U2CS @
M  Y2ZB4@                      C!U0                       2TY
M   <12A%P               =@O,SH                     !'CK
M                   DQR   JLKL                &5+Y.T
M            #"'                        #/F\  BQ2)H
M       3LMT                     &).N;#J@
M'.<P,X;@ <!0AB0                 :EWDH                     ,8
M14BQM                     !G"8&:-P *\*J   0B4P6( 1*8
M   &>+X-P                    (H0(   5-(4+220@$E"P    $!G9M56
M0   0M96  !(BQ#< <!Y].@  !G?SALS5:\"G86BQ=NV,PQV
M%TDO                    !69@P  "K\MJGZ>/U136AXWO#3C[&.\$M$[1
MI68!=8$0B4P202 $(Y-\Q@\_=F?HS.R(()  0\F:U]9XW6J2 !R%P'( 0@IX
M   +_+XL:,:LZ%RQ;%X]OO+?R^WS]"0           $J+N
M      !5IB0  #9RZ?)#>LH]#SZ=Y??OJ/-HWT.?U3Y?=Y/[?-]$\'IU/T5N
MKI\_(\/KT3;.:,ZF[.?T+$S3S[QV<_%O;M;O/;-R]J>9U?/7WN'/\VLVRI>W
M5S^:^+T.AOS9JV6?;;^;MK;O\GV-EOZRP$@  7 =@ I BP   M#.>O>.:EME
MHY%=5BI8           #4]"&3   -$:I() T!J    @E#0U$@     *P,0
M (K2K7'='-(>?IC71A,,M>SE."VYL=GMVXOV.G'?P:R'IIA%J^MG;];[H@FF
MK7L2K%6RLVN]?ZY=BEMG/KFNSF\S8Z7;1KLVHEM-*[TYO0V>I!(  %O'8!TS
MSJ;0   #Y[:,ABK7IZ/>#S+3PZP            !:Q80  -$<5838C6(Y4Z2
MXX:3"MB.:P:)&D-):S4;:-$ZBT<DV     %9&(     $$@      $$@@D
M    !;AV 0TID    &&BNMV[+3AWY\YGL             )>72   51])]!E
M.+&'>SVSOPO)DW'R\^<07V?4@'N>YAN[;T?^=_#Z:WY*QNBJ9ZU[\M<^"=.6
M(I#ZKZ6\?D_F8GW=F'[^^T?GOGM0    "LC$
MMP[ *L*Z     @D              !WCT4  :0'EW]+_ $B@?O/M*9^R^DYO
MF_*M#RO,K/[3Z2[_ (?Y2N/?]>T_GO$['!S5-]1]!7_N^YZV_+OS7';;UE]+
M[\AX^;S9]U]KZ0^!^&P';WYSEXO-OV7UOH3Y3YKZ6?SY^#[D     5D8@
M                    %NG."DR)@                    'HD[X!HG'Z7
M[U*1#O[^W3.,^CW0SU?2[U'8YL+)\+Q:G^A]R7\7!T].GM9X=?33)<G)OS;+
MVZ^VM:?0>]:'S?SV^M>GII!O;]:7>5Y]K_/^!U+6[E:Z@   %9&( $$@
M                !;IS@\_F'                     +X,[$:1$!]/U>&
M\\4Q./,X,I3/42T..D:23?6,TMJ_1WOW\,M:N&UH]W]NL92;AYM(A#6T\DP3
MQ5BL_7]G-Y89#/&3\7(D  !6IB1"L:=%,]/G^I\>F*SG%UK?33&2<]>4EQU[
M".GK'=RL                !;)S@\Z'2                     +KA*2&
M=G;D<Z2#DX]=(5GEM8 >'?U_]<PW?U>8?M?K?3_PGQFW?H\P_8_6WOX'S\T\
M7RLYY?FUO]=]5P5YN[58'SOAU][ON^C/@?A/0GP?Q'-:PVTCCM&D6K?VO7L/
MRO*[E*@  5J8D1;Q%$4MUT\O1U>G,//ICNYX%R=OKSEUJKT^..</L=_7SYYV
M\?U@\[N                 MDYP>;#B         !REAG$<9QG'#C..7$<9
MQG&<9QG$<9Q&PX@ "YX2TK[U/3L3S/,U@D  /GA^Y?MU]_&?%UA]#[MN?*?,
M<TZ4[]5]%;_RGS/0UVX]-=-=,%KJT9CDPSG%QYSCXK@^5^;Y; 03H;9FOO4]
M.P?'\K?>0 !6IB0(;-(8QOM;2T:R9RTAG*S9,;XD    )A2RT DH7*%@
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M6=N.W4KOI/;]6OXN_E?Z;?RW_.O):=9            #;,UGZ?J65Y7C\DW
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MS:\\2S[[-U\WN9]M,7SDL,5MPS3GZ?230               "T3G!715@
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M4Q\QV_G ^K\3Z4^1U5MKOVM^;Z>UR]#Y=    &V9K+TO4LOS/)WIU  ( 8T
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M?YW7'\M\N    1MI'C;/>W^WEB/G=?A3OY?JDKD^?IJ';E@W+UYWMXO3672
M  !MF:X]'T;&\SS-\R  (&8U"'@]MFM.:B*,%S]\F[?/L?JRYO+]B.=WDP:G
M99%;>=KUMS3/T/YMZ:ZLNW$[+4J;?6^.1$]\().MB4I)^7TZ^]3QI[Q]<E6H
M9GG>;7/;8XK2/4W12]^/4D      "R#F !2Q$        6>5@  #(DT*Z
M$$NZ6<3>'EW]/_1?D=_9W]8T+^I?IVEVM:^O_P %_&?LG_#O\:V#YGF@ ! :
M5:2332+ C6)UAK>4ML5)4+1JG2S<D #29B?7VRCBX.69  $".@"O,=:/[.7K
M\O5.M\^&M>>^>:P]"N.C@YZ:V3;>D.?//=%>?#.6:UQ>6F(THUFP>?2N-\^W
M%IM%-F'7@^SAB/-M;]XIVFBB9[91M%O:7L[$       +&.8 &!*'-H
M,T9PA(  !997IU@ ()8PYD=U(SLS:TTRC;Y^_P!$?N_RR_KK^IX9]1[OWO\
M\X?X'O'X#X>9\'   A!SN4179,<47K-0]6/+AK#4V]KA-9G,YZ]N8Z]9B&.L
MDZ^&3Y[^4.C;UA3E[F>I( VS-<>CZ5B^7Y?):0 !!CH"81.$]'NR/)R=K"B:
MJSLTG6&TY$*2F"4APG,<<PF>2M"_6BO9FZT,R\E>"KGM92-EF\T@M&L2
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M\I4TM:;YODF<>MS1?R?2D67/6OL^/ZWXNNQL^@    "PCF  .L4(8L
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M%1Y:8;IC.XUC=E@<W5U]^:63>$Z+=X]-NG/!>O6<88V;G=,D$@    3\Y0
M"%%.F@    )@8\CX    +'(,=$$1STPO1S0W'>[=L.[GK+RYC>  <=(CG;U2
M?EY@     @D       -$PGM[)IQ<6\  $,.@)=#JZL/OT2?S.#RS6TEZ.:O:
MWFG-UX;JXH3UUNKS+4-T;8^DR&>?'VO?//:KO9YIEYG1FMZ93BVB'3C%L;Q_
MIB28U[,VM?#IHO3D[NN]<6IZ2P0/F1/U,9(S]<<W0K(     $].4   $#*D-
M    "S2LT:5LTJSLO1%RB)6LK4GM2L,K(  $K+G.8  &R(A_?VS/AXP    !
MLRBAKQ?4D3NM&E;:V     :&"WZ,WS\V^9  $,.D$$@ ()!!(         A$
MI$(E(     "=G*    0LJ X@   6>5A6?#]XLA$M,K%L5>MAXVB.DU):MMS&
M2A8E)L4A9C@ 3<MPY0  #CB,%U=<AYN4    #2K\W?-T_-[Z7S_VO^!MY!Z'
ML/%5EXM5)(    T(;V]TPX?/WS8  0PZ0                       )V<H
M    (^4X8H  &;,T0J)\"1IE=HE6>47FT>M7T)6*7TGM1';E8\Y>C<=N9-DE
M8 Y"T"Q    #CBL3[N^8<7$     A4U7Y0/3M^H'P>GY,=O+ZVVQNC7F]N<G
M9K9OBP   &AA=]LOSY<DP  (<=019-#0S1HM165X5!%D9FK2BLHJ2D$0DM*A
M(           3<Y0    #KE8$!-@ +$(,=06AD7>?[7ZE<N^FZ-:93'0LFI(
ML$B1W2VC.@    XX8?HWSG/@D    !LSC\=?J:_KW\BOR7VG&L_,5K?8GK\S
MU9P]^ZUP   -"*=?5*.+CY+6  $..H*/*%.NB.EZ-Z/+[O'U].])O>N%B;%Y
MM()KGYNVR]#Y[QK1D^6V<Z,]M-,2B,*SV&.3TH5EKC>METX[           "
M;G*      80K4AQM!9Q6( $SYIB:WM24X:2KT.#T7R=9( D!<1E#<     :5
MB,=O7*.3E     0XJQ\$NI][^:/'.6_H[7#Y&K?6#?DLS'HUFX   &AA]]LO
MACN  !$3HBKQE7M[MJTIU\=53IF^2,]V<4 Q[/>6-O*]*8?U.*4\/94V[VAQ
M]/EWMXLUS7@_7T>ON7D\IY=''T5]37Y*=Y.J4>CR>^O-ZVD$@         ";
MG*       8H@I$R4E<@ ++059RL02[!+2<$I-P     !I6,1OMF,<D@ $$D
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M">(W&IH<2.5/$<IL.*EJ'Z\K^PN@ELP>?^J?0M*ZFZ)X3F 02!,3>
M                :0ZFENY2H              ZEK=JE=9  "/&,  %S*$R
MD           L9%P"2E5]$5   ',2X                        X3D-P
M            .,W&X   ZI&#8                      "0&4
M               !L-QJ            #::&\    ZA@CJ&@
M        .<S)E
M
M                               #_\0 .1   0,$ 0(#!P0! P0" P
M!0,$!@ ! @<1%" ($# 2$Q46,D!0%S$S-"0A-S@8(D%@(R8V@)#_V@ ( 0$
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MS[L9N+M7!MO:_H,RKAK35^W=V>L6A%O-M!I*6)#" =Y4?EK^/M74S*/I(AL
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M0<.^*)K4:F"230]4\("2@TU2?= (*AP4*PE"=H"=YP79]_?!*E(\UGS[/;%
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M?&"%6VE)4>)H?IAIA]Q*LE+0GKV-DV5T*B-.R"D("@E5M.ROA"0"$FE1]/A
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M4IWA<:'TA:4Y1BW1G!,21T,G<-PX82WCCKJ7V]LMZT-*3< M5N>2P#:"21V
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M+<4VEQQD7/O%.U5S"3E[HHFYV8;S=HD*3I9<*9<.^D)%;93@FI7RSWA7G"T
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MGG#B4RJ6&R1M9F[9->E09U_>H?"F\*@0VM6T>8>%KC=OF^=U=#05H13CF(F
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MHG1L5X@@?H:65#C\8F[_ #BRLQA37_U9#RD-_P#\=))S\*P^Y5I#@X.6EO\
MO+=8FE;)6(\/)PP1EZXB;7>SA7_W(=/^"NOCV^'$OL5'1Q(R+R)Y2SZNS22.
M_2%N%S"7<1'Z',;$\UE3Q:YY4^Q,3U$J7*CX^70TI1'_ !4A0STXQ.&R6DI;
M](G-%?L*S]W;$\GR=2Z>@$U]F?M/MX5@)VC*%>E:HD<105%>7C$FORB30_\
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MZ5)7M 4TIU0,P:]^7\=0K^NC4=\8B)HJ07@@;B*6E!%E-TBW+/C_  I&@Y_
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M^QCZM?[$)ZAY?Y_;^?WZ9U@;VD)-XN' [AY\#E_&%;@)X>B.TZY_1W0#[>$
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M7G<:\,HK;BTX[J'DM)1V6MVUK#R*XCABO]R$QM3P<VR=W]FVOC$F_P"3O,+
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M60R X".%. T' ?K?[<>']?5K\,,\X!NR/]9*?1KIH><)-=XY$<.?XNL 4_\
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M81:6U9>PI$2#VE[1:U)(U.J[IL4RXSD,J"81A^!?)2H*)95JE25.+</M#DI
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MK'O'_3"DE2AHI%I=Q&OMQ-Q82!NH\;V^KOP$;ZR1;=GW^/A@$U)V?9O/D/\
MK][8-(,Z05'7U8GQ&]/AI_7<(-MFK-0F@I7.'G*N2=2>$O?;%18BD*%P0[Y.
M7:I!EX4R\#B!:;=@EY@\FMZ/4L2F1L=D2D6T]W'!4X8)Z%=67$P^\@BRIJ-6
MHO8XR^($+E#$93M%3=#E7&\A<ZRQE2PRN-S3MI?4V(1J6Z)DI=D=)"=^'LQF
M3)A'W>2D!8_:15]N%NHA>C<!% ?/+< GVOG):@"?C2,0C0,2A*A6(A!*U$RV
M,DS%N,^[$-=4>%+J$,XE+:#N[0$B9GPE5ZY&7=#0U'2"#"YT+0L@522)-WFF
M4U=TB)2T,[1[X;4Z92274HE+2I=.G\,1+0@XQ_9'R4"A@Q$C99B4C9^PJEA?
MY)%PZ8D35$ E4KAL$31*5E3!&F,O:&TZ1C_PS;"DC]=,\..[/)(3,AVB^M$N
M-W:-->.'V=I%(AQJ&DN*/ZS6TQ5M(-,5YK;@2H>*Z<9C#RCF&4]E]NL'@W2D
M3\9DC"A/+XQ_0P.SG_>!Q5(/J]\L0C(6U.5:BF>UG(BWH:XE)Q0G7WRE[O[:
M!LI=ZZDRB])C27*6F&E)J,6J\5(ZZ:2,AV=,0Z7-XLG9LS)+=[&\Z;RN;F8/
M=+!6TI)0PG9.D$*<.]5KP-L$_P"K(?+N#1=J/>LSP-W+H7+T23L:]\"1F3,'
MQXX6\RN#99BD[6(82M+K\_G*K(M]'#!=^+H>"BR'66E+,-8#8S55>6L[:X;B
M0'%;=)<7*E"QNRM(6&##J"5*B%AQLK"PD;IL01,C64OW\,/.[7,8:,39+*:?
M4$A/V7Q'?E3ZW$VTEXC3WXVC28=2(E&W7$R$4J9%11\R;>C;3#"G$OMN1:MN
MF"[ MOI6-T:$[MN/JPT]LXB+B4V^,0!%)_2! *4#NI[M<;&AKJNK:' M@<&Y
MKJ5XS[\// 11>])M"9_JMT8$DPCC'Z123+P55B)=+KT.XA>R$(D@(.\55)EJ
M<3"H>+;0G9*C"BM9N#LS/3A/$,[U9YMPFS0(/+>$M,.JVCB9?FZB?V_[:&1:
ME_Q8T:EP]+!$[I$QSTPHA4@#,^S"-Y]3'$B<_ 3PDS"_2_=@MUTN@R'%GP[\
M$S36!35HC6<OJPI24LIX*/#7CSP4KVJ!HE7?/AASR1<9Y2D?''S>R3Z<YX3(
M.!"C+6KC*8M?OPA%#;RU"4CNWGJ??A-E()[/#Z.$]EV?:,I=^*:['S< SOZ.
M%)"D-.+$U3-1TXVM@DES9K,T$;HTE(3UPX"N'</,I]QP-UM:^*J?=;^V1*4N
M32BM/*> I]3A*44MRT)%\),YUM;,_K8,M%SEPL<;<,FBJ8/T3CR';*22?$8[
M_?\ B=KOQ3A)FD_7A(FK$Z=M]&7OQILR?/J]V)UXG1^.3O+/GII$O'!,GE^D
MD"WB,+); 6+J5J.6!<A [*KGZ\!7#"K_ -J];:GESQT=^#OI1T@'7<MRIY4,
M9;RB$([I;2DJ!YH"AS.,X^!_IOE;)S&(RUPPJ4UJV2VUE  XH2K:'2P2A1.'
MF7$S7$J4A39["DTFUN[7&1=&^D72A6QR2 <B)2ND )]:UR;2>.\H3X3P_P#
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M\NR/_HE@_!ST*/\ W<R[U0S(_P#MX5\%_04_]V<LOK^20_\ ^+"O@F^#Y?\
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M')*H;DMI;4O!2AC,72F(>#0WBB'34-!-(![L+82S#1B$F;C&P4E7.L@K]W+
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M(=$1&0D2TB#8BTH9<3#I4G:;9!*&E.)=;70$)GT2^%$Q/28MYMF+Z(&(V$'
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M4+35QP[,0[NTE+>/AKQQ!@)RK+EJ_P!L$7/_ '15+ZL0@_U5ECIUBUQ(5/\
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MA:!0GPQ!QD5E^8M9AEZY*96ER7);<E)-^2DS]VAQG>;YIG<6O,8]147Y!9L
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M$>K:((M[<0JJ8:!GK"*BS?CM23?$.Z$0;Z=>MJU.HH5PUE_0=XR(M*<QK/\
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M\]M5 "DZ"GZ.'U2BU(;NVR&^L'T-J!1^MRMIA:0F(B&Y[T/LB\O@G:71;O\
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M1Z=#FS5X2. -H7E>9"A%:?0V@FGVX=-+>UU!(J'KD/WX=%"TM:E0!G^DM/\
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M=^(]U#3JW'B1)20E(!O.03*GA=)F+$7GQ.^M^(2XD0T0R6S".SJ#@5\]I,6
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M7T</\\N,D++,Y9^7/\XP-CF*+XL2^EC_ )^,$%/$X9^*4?OE/\\?X8? Z?\
M^7-_^0'QICS?^LE;_P#1!<&=>.-51:'.8Y9<D!Q_K?\ ;Q>.Y*7!%J<AL"B/
M,HA-9RYH<I&I3GR++<_I\A";>UXK9/Q0[.SMZ=R]E'MC++ZFQ7<T9\PU?3],
MWI;96_\ A;7B;D^C<5;V\8R3IV!FY.;U>;:F3D]67[G!J/2Q\2/YQ.W LQS
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M85-G:5XUMH_J$-4ZATUFA;I;.YD*CP_4ZA%/EE<=TUQ%]^O.I8>)75@NJ%
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M,8[<YS\6,<<L.W"X\^ACZ^?QDOO#$@Y<LHY[<<;D>S$L>8D/J2_R_>Z7Y_\
M#]\<?;Y4%GT8Y\?./ES^+_4^7[QX)'XOBG'ZT/J\1*//;">.W&?O;+[XX_-]
MMZ'MB\T1?T?6)_9\9^\G3$SX1<^'G/S2?_\ 3[VY^QVRS&/Z6>SCVD?V\>TC
M^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD
M?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>T
MC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCV
MD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>TC^WCVD?V\>A.,OZ,9\_V<
M?:RG+S1CC,I9_!B/$RY\T?5''\$(^K_V_K_>;&99\47H%_I^K/\ 7_S?>S/'
M('L_!DG^7CMEG.<Y^7.?O;V$[9P_I^/'&)1\^)8[<9QQC[6*L,^D3TB?H?-C
M_:3_ (?O/"6?,.7H%Q_1+YW]G][.2.?2)YOS1^?]\-G/JS]7^B7&/M,SEGLC
M'$I2S^#$>"FEV^G+MQC/R1^9']SX"P49-:;%/8+U5S< I;0]'4V#')RJNVT
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M!],:HU18!FT&:E24M'<#I*_41 =17ML$>6*AL]686Z06ZUI$Y-5+4[F@N_\
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MX;4]P:D5*F0!1*,B3*]*3OC[D8<@I#\/=+N\GA?8N]*#0=/8TNF@:EG(?2X
MT!@["XDUY&./WUS@E]T;2OIP\7A!]E8M09Q2+<JVP*KUBOH\\A%V3D7GM_2D
M&0HN(E"09A3\\2"G&<)_HSA]B65F ,8CGEED!1%C"7U9<D_0G]Y!_HQ_A^R?
M/X3$S_>G][!_U9$Q_?E+_%]C8S; IVK+.:ZL:-E;),630YQ5Z4#7AN-0GXPT
M^PF[M9QD>1]O"@7W,6+HEPC:>Z>*W5G@.,"L; Y2@'?GS$VX9S ?-RXSV8^
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MC(3]89>,2C9V,91SVQS%QG&<2^M'T^/].W'_ ,IO?]?Q_P#G-J#_ .6;'_\
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M-U7XTCW/[?#FP;:DIW?XG=W0[O>'^H=!S]9X/&K._P#H.]_=3J[W8=Y]+O\
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M"%&/UI%F'DC]JTW+_P!<+ELH_P#9A$JIV?\ &7+^]_/<\&ZFX#=2S86/*P
M 06A%PT(UW*O.<9$K^7HRS)+>R4,M[Q>WX OY\?PP^UM+NE1"\ZE",L08+&
M CYN21Y1G,>] ?HCZ<9!%]/\GP@A/35S97S2!+1NEI"TS1:Q )^GZQMVSM*E
M"<"'\,2Z[)7VB\^TH7;+M48J5+%O*_I#:@2ZFQ5H^I1"4(9*I1L/$=N.<O\
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MHA7%NFF0D]N$8PW"$*7@-54K=(@O)B80;IS\DF3F<8ENM3(Q/<.P4GB%^?\
MB>#NG2?P-MJ3SM2"]O5M.ON3)NF:>TX&Q'2-38-XC6XE[Y+XQ=SBNC<!>EFH
M:ZVN)77=[1%5<VY"WXL4=C7'YQAE(8MPGA<Y-KVG&:=GOMM?K1V(&7M5ZJL;
M9!Z MD359=V%PS<5DQPYO#3>$+TS^%[Y+N^Y8J#>:?K8618#NKM=]JRB?J^O
M=N%K$=NXUU48L%88>*4I80_%BX=K6875FG896D8-YJS5E]D)%"[RAZ\MY=V)
MZEI<_*P)RJ(JUN0 7=W5A;3,:I<L".FP=YQVPL;BS=-"/(*3MK;-.V;FW#PQ
M=0R7:%#9#M!XO%F4)3#J2R3MK>'5N0ZJP1C6P4/&<#[@=N%2CX:^T(NSXPO$
M+NZH380E-;64N?48^K<AU\N@6JO1G _.M[Q47'[SZ7U-WVQ"EX::?5?_ )02
MC7V2BE]=H5UJN$$TU^]JROL5J^P.N">V)AQ8I1<D/%\,6TM=KK$!9*U(Z2)A
M..0@:K6E.:ZK:D#]&[T\Y%Z1AP92J[Q]DHMPO%_."4<^Z@_4WD2D*<3Y.[EJ
MKTA&F088="N)?;7VA>AN^U(7A=Q5-]AE11VN5):WMW<]-6O""%BN7A;6+HPI
M<BXAB4&/:'R>%[0O%;5C6L5P4L6 U3"FHM1)6R"KA(R*@I=IVJUQ"N)RB'T'
M7=!M+ %M;2PA"7K:U8::2L91"N/F[,<\ISE*<I^).9)RD0I"$*4I9S*8I3$^
M$C^CC[?E\V"Q\XY_@E]7]"?$H3QF,X9[)1S\GP@Q8^,DXPQ^O+DX65AYHQQS
MYQ^",?"%_C^"&:'QCEV]GX8_.C^YP%\/GQRXQ/\ V<_4E_9SER?K_D_M,/5)
M,)Y+:U:5A<R5B]C3U2XU 5A=]).!%S=W \3WP,JHN?=<$4(RBXU.@C<,WLM/
M:ETRI[JJ^J!AYW2]QT#C=B*O51(H9I-4K?OA.LZ4JL(-A%Q3PO6+ (JR%D6[
M,.ID5^R($3C->LVH%'<K^CTY%?4%WMK(%$5FM4#]TE5X&8,XS": RB)'XICG
M'GC*/^TA+[.'#8\V/.".?EE^-_ZO[= A$BD?Z1R*[^ $D%<7,') %+'T(3)V
M]HN?Y,''@@\L<AOY\7O"2TI]2?9RI$F(])N>]MW<\^_M^VY/#[?B^O\  3_/
MC^&/V36KT69*+Y'O]*"3$QP*2(M^48>H$?-N%G]$*!.&*Y DHT-9*$;1\,NS
MO)N<8&C3JEA]".$A3M3C]KSPK_\ PKL.9"L-9%5![UJD9)KE9E#T!++R=.LF
M'_X040A<6UHMIU#W2IZBM=/AIXV,<H@E77/=4FF[ TUNI F'=;;Z?:*T(,Q*
M"WB"X\H"ET.EMK'15(C="L:91RJK&I62KYH5S:3-C=L)'3Z*+#9.\B[J#@"[
M2O%E6VK6GYWU??QJ<6^ GJM.9K85-5?6%\VNS:NS25ID;/IR[EOM-/P4%NJ]
M;M"L[Y-]7IEZ=VR7LA#[U3P,296(.1$LT/O 'H[FV-D6[[+='[7A>OFM>75K
M'3-7J9N-+0M3%W6_$WO^7.<@$O37*3N]AXK7T0>JVR\('[Q99A95:MV'%937
M=Q,%.Y'G7M+.-37.DJ:XG++WY:]*KX)_%\,O%=IY>%E9V%I7)VZLJM KR>*E
MQJ:T;%AV'O=94<X[A2$)[*<-G<,3:XQ4*OFFT1AI1<Q*NV7JGW$XSFTG67S*
M(Z.V:7VF-U>N>:*+IC[PO>Q-I1(8;:"UE9.4M;=&KY"I;*V0ZOJ$U&^?<Y_>
M3HQ,$6$JUTT]DI?"W5$EQ6@1V9K!>FLFT) K+EBJWNM%7L<^YSC@NP074#5Z
MH09E#NA'QBG5?-)HC+2BYB5=LO5/N)QG-M.LOF41T=LTOM,;J]<\T473'WA>
M]B[2U)-P<1DTS974J_NXLSDZ1]!:3D;/JNGA ?4;?=_0E*7>W>K%M[7%'!-:
M\76U- TJ&RLJ@Z"%F996;C"J\F??&^-43# B$'TK0@SZ-MKBBTGIUO3];"QT
MY>7C3UW26-WG$JI^G3$!<26HM-[,"=YR(4A"%]C#PN-*-2L-':=G:ZSU#I&Y
MU#<A:<TR&.GPW7\J5_\ +]!R L6JT0Q#8MR;74S%NM&'N%H& :T\G[B-Y;6"
MA_*$K4M9T?2#35C-=-A<.L+(<[%UK=7$XQJ!!47)M&%O;6Z8EW*F>()B44+C
M3IHYJKY':#,3ZZ\WG25\R3D5<JY'FO%#O!+LDXTP'5*5$!75D[:,::O&>5UI
MD=;5LVN_86O?#M?>@Y%XIMD3K:P2K3@-DK(?:Z/NK5"G#I77S_048T\N=\57
M4)OOTY[9@T^C=A:JI>*--97H&F8"W7_:\)OV"%&"CL-7HZ81H>0Y]2-*O/\
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M"66,F[8;>1SY^3D[.?<[1_Q^'\);^3W1-3W&3O>RT_@]7,]IJ.RDLV5/W@:
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MI]+1QKG>H=,:EU(P*PNDYU6E#N] DRPDVNCWM9CE8#&UU6%3^U'GCR"6[H9
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MB%W!B]3@9@SB01H1*(D,]L)CG'GC*,OJ$AQ*>>;LA&4LXC&4\^A]6,/3G/\
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M<[JZ]+ CTCH;?QEA4&N#FZ1#%!*4=_;+;*XDAS>%'ZM7!4$[$HB^) :I7\8
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M%CW7[5D_\$@MJR?BN-^ES!]4W[(+L+7Q?\HR$=<#+M)NX?81!]H !@L9C_K
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M:)HFB:)HFB:)HFB;?ES@X3B#T;!O0.@P]3X";HV!W@/_  ?E_*?#@\1D
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M (+'Y@" $HP VWW 6\*0Z 0!(_Z3.DL'!Y7PD=,4(-J2+I'),B_YL\\R3;-
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M9%+'PC *^Q4C6;9C-NC5<+)%W<+O@%&$JL,<* O+5_,T%#7*D7]@;B6]:H,
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MQ-0L$U.IM"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBFU9.*_#-U!/T_$^?\
M"O>GR=.0W:B@@:QU;F_#%S7O0V?.D[/RVDJ,@%>>$(;].HZOEI9[7^ (,6\\
M@ -U+Y0)"?L0[C<'@$4(MG"PE)7!8C #+]0RMT3JN#)/ )[:P\964= "@HV
MVE\6,MLPD%8 1PP'G+T:^ZWVJH!R*B"X=A =ATB8 $%,\]#PT (@0?8@IOP=
MKQPN8 A4*\-!X DBD@DS#BR^?<@0$,BD;8G#)+ =!HL\&8F>D<>0CXS,"IL4
MT3=$MYQ+B9/>=3][.IP"%*66*!A3I9A4-<J7@P+76XVW#H*0A&/C#K<,G$@
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M$($H0 <,^*'1?EFK@!R0KI%E64@6,862"YECH:(PKK"2()AE-DQDU15='_D
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M(P"$DW0[A+(XU[L$2!Q[0O*W%:+Z?DA/(H 5(L/8X>]PPJ(@A!P\$[7[3NY
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M&HT F;B.OL1^XN)CP,(!2[R8 RLXSA+%K9K0SPACEH%;^A^;A%J\\&836-$
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MD(G_ )1C^RDUD^68)\>A"L G!R>U<Z NCIZ^0 3A#E',*QR+[#3U;HXKX[D
M@ >JC:<U/:>D*YU[90JU;%9$D,$%&AH=75[LIT>A\0)D,0M09F?K\.$0(WI@
M7LXI#:AL2((3!!V85S"8-C"1T"M;LGM@CX)N A17IF6 IB2LV(!9?8AF[?\
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MH0:"$?"\"D,@"?\ HL+_V@ , P$  @ #    $
M
M
M
M     8D" $$  $4    B$ $
M            %[OBN!WOI(-AT9I4/&8!H                      (
M                 )  $.Y.4(D^/<63+#C(5/*_9Z
M  !(        " @$          !  #2'^R25BG'D14$>L.T37B
M                  ._DTVR&^& "0     !  !+B#BK[C)V:WS_ +\Y:G[$
M                            Q&6VY%/E L!L     "  ! 0$ ( H @@!
M(    @(                             !Q7"V=\NJY7A      0
M                                      0     ,EA$H,(LE( I(
M  "          "2""                                   ()! A EI
M)MD %)-    0        00    0                                %
M(ROK E MGF) "(LL@          00       00
M         ?-#R.!([::]ILTI$
M               !_P"^HI]J TX:ZB)@6=8   @     $           $
M                      DDDE^G[/IW(M>YO"KUTDDDDD@
M                               DDDE7>$C*DU^/+?2=NDDDDDD
M               @                       $DDDDDD\LTDDTLDDFDDDD
MDDD@   $@              $@                      $DDDDDDDDDDDD
MDDDDDDDDDDDD   $                $                       @
M                    $                    $
M                                @
M              @DDDDDDDDDDDDDDDDDDDDD@$  D                  $
M                      $                       @ $   :
M        D                         99" 2     ;0    0   $ $@
M#:^0             @                        $B"0?[3# 0;>"9 1;3
M   @     (1=A            $                         F$$%/.Q?;
MI/\ SV"E$0         0X>"            !   !00!(    0L@
M M18M=[:P&3+X2II""    !(    3 4             (  !>]E,UP %]?&@
M           $   @   $ @         (    !3(                 !RS0
M04VP]S\5                                     $
M (   !?4_;TUCN4>L                             !
M            %XM<"S1S$((>S?P      B                     (!
M                   "QMLA&!_I.3 *+$AD    !4NG!60
M   !                       -L_.  (?!&,P$^ Y(     *JER>F0
M            (!          )) )(!(()  !DX@  #&F;BDY# ")Y@    _T
M"RQ0    $P"20       !           !) E*5_'X$0#)W0  #HT$J!=7&0
M#J    $?D?E $DV(WV-8 $ A$ @  (!          ( 'A""U AMVE)+B  !
M*!"1<!@ !,(   FIUUTB(2C?X.?OZ!*.G9<0 ! (         ! $BGHPN'T7
M(2^'@            #$  !""PBM^]2H, H"QW:EC&XQ@  (!         ! !
M"DM'FB ->G"K0   ,M;      !+@  ($$?K0FA0    @          ! (
M        !  :3T4!W0\0D   $H-< (    "    ))!^DB([)))))))))))))
M)))(            !( #('3R#GF0?P   DEJ5A0   !'X      $ $@@
M             (        !   (  *M@F.N:Q8   ";PMGP    *K  !))))
M/))))+)))+))))))))))           (  )   $"MJDB#$    /7-4J@   !
M-H  (##V6SGTF 4V^ 6VB         !        !   !   %*,NL$8    #B
M.Z6H    )P  !""H6_:LZIB5P.^LBB       (                  $%#J
MJQ    !'+TT"_P X  #0  " /CX#H:-_KBV8Y8C        0 "0
M  2  -3@PYY\@ !(Q*_O-Q:2$ "<    %L,K]%-,]6DQH(@/!D     "
M             !#, <9R<  10/L7*5I:(  *P   ,SEG51O+V$>IL>REJ^\
M    0                !*$  !0[@  ($S#HLJ$!  ":@  ! &G.^2'4Z1O
M)KNZY.)D        2      0       \HB  94    "D@ !     .M  "!G"
MCHO,<:J7'_4;0X$$     0         "     0 8BB   .@     (
M!4   0,Y/3[2BAWS^-H.S=4H     "         "%$MD @   "   !
M ]T      >D   !A(! (         - H      0    "    0_@K) @0  0
M  =@    #OX+$    !C@                          "     "   2"/X
M%RDP "    #8     *^_ ,    <X  "!,HE!$D@I!ML@
M "  "0-&7E(@ 0     8H     ,N5D    !B   0 7QXPBYY!CO4
M          "2 0  LWD  "     "D     +/F4D    <    !5$18K]UQ7IR
M)@                  ""  ($D "0      :H  ())4U.I@!  #ND    LN
M)!$(H%MDE@$(                   02  "0       #6*_AC1"#F^&0LJ@
M2@   !^7=::AFP&E28@DNWPQ@@                           :P-08..
MD\ROX=$8"8    /Q58P89.$>N^>U?GL[(D
M  .#-9)$$E)D'G7 @1@   !A  AV(]HLM@!A)]1*$4=WD
M          !0'?QQ.U?JH<;, ",     .G*H4#[E?D7S/I[._G!;S@
M                   0              "@     &!$@62>*]1X]8#V;4B@
MH,                         "               0      !@
M   E  ,@                            2              0   "
M                                                           0
M     "                     2
M
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MVBV"0#$ ^BF,$XE"0D%0R=^<*@1:%74M",FKX4HVHM,XYOA",>F847&0F<G
M. M[.]](EGVF)R"*;Z#!<]>#S?/$0H,"_'KN^OM>23;6QVS6JFQDEQ20RC;X
M"CK>\[RAT,+S>8KJ&-B7&-":7O2C9775AJA%LW9B!11^],D*G[ >&-,,VH>/
MS]!,UGB)P)T!TN_>\I^_$S:53%-3VILX(HG#E5(+.0EV0&A)30Q1@;4"J#$V
MV,"P*BRE2VDB 5=*"W9X#8Q6@O1 : H"F1PX')$@*<"-"K@VRJ'*("D1&P&J
MJ(D>53@\R%:*%M$$!)$.BAD5(L&0P0K:424(R:3"SY3[?3;_ /0 UY_;QA/N
M><YYI407(V,1""X:K'(Z6E,+*@#54RFD &%G!FQOH!;E2HB)#E610B72 0RK
MHI+8%*^0H^?TP8X+4/,ER6H0F %')A$*,F*Q#MI2A2PG$*5S(TA5"(BEA' X
MC(RP,4@(R'@7'5K,&D"B%K!AID<UPVVU+MH19.(TIJ\/?,:JT(M0LN( "PE,
MM#0V%*#*%XB\E5!2H5X1D !) J@RN26:6A,'? D"I*N%4".!G>06,N7'**-H
MM+T;]+GN\,R+&2K 9="#M7"V\$- 8U)&D441.:F8@DK)@-%*6UBB.E;50(<
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MC@9!A2H=- 'UG>^+ (3E *QEJ[3._3-/$R$4<:?69Y1!,R2L,@]RIC\WBMR
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M!D,I-DR[9VF2V6T;A&L=U.#?"R] .)$()@<+3D]$U$QK\W!9W\.";3!P'+@
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M8F\PV*KJ <),%PMTG@!(H8%4C;!*,5Y'HO@.7L;/5@G S!P@!RQ(A!)E"7@
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MD0*DBR^SJZ^O%DQ+/0)!-T$T5+FT^'<NVZZQ_P!&?[/=[\]_?@JHH^1C]SD
M);$5%NK8_'UXW5!FRX:!\FL7'(P )1&,MT&+2R7ODH!<5A2:N0Q:4PYWP%05
M!BT-#;9U=<KC+@GH=AX'N;X! $2D $[1@3VDO%4BBF1KXJ9?5US0&!9T7<=E
M[XHT"-*"_??]LJ_]>?%U9QC(^?V_&F#7Z_ZY3)O_ ,^TY3!K_P ^TY3)O]?]
M?TNUQ/YUP\,W^=_XG#(>$?T'B14C&<&=-PCT]\1V/R/'\E_;G\:_;G\$_;G\
M$_;D]_<?ZY'P_9Y'P_9_HIY/N<IY_G\'[<CXY3R?B8A48<->/TW\<89%[7Q
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M-%W3.F"2]M,B%4B63N>.+EB(X1>37A_-LL9]J,"]A(+6S 7'% %40,Q+8$Q
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M5<_3_9QZ"*YRGZ;\N?7/I)9W_/?CW> E()4<$<^B[G'%/JILF/\ KC60B+A
MZ&0 []<4#%&$#/QAR=[-ZYNRAZ=WWN[NN%$#V#3ZR]?77* @W,YO&P_CVSD!
M-[5UCE(8^KUQ946 [>@2_5# 4T6 ':&\HN<PMF\=<-:GKQZ_Y?ESN\9,_3?!
M(J3!.1P(A%4H:T03FKA3R_&=/W+_ %MC-S'SRE41D?<QA7!\<3B(4H)",*T6
M_3'?$5DDU8"X*L@FH;\\28FU2S<:\*/VX-LI%<BJ(>JEL<YO&V5X!0U /@5"
M<SIMH!RB^6F?$YB^,/ 1A=?+_MQ;11&(%5)T3,\XQQC'EC!,JDB=A1;[XN#Y
M:+XTP(1*$]<@9IW07,Q@@7Q>&DZS0;G-1D:[QK 5W4QRPLP( ?;GQA:]88Y\
MNM?[TO!_87/O[<BJ<;P@:=(U9X<!6 #P8I!@AJ].;GDB(&8P-L8PQP-/-XA4
MPE7. S].4WR=-949PZNN73L=<?H?,WG?:7LAK4<A\JB99TWC4G8.A5F.0 #6
M;(' T5=GHYSM-W,Y L(^4,]@X!A8'#R/':(O;E2@@S(>.4-J(P"9$;I@O @&
M:0Z,"82U^E.9>W$R7;,8<L[YD#F\K2AP4.C^]X=X"S)/8DWVSN<HN@HYK'?L
M^=<61943U(B>0^-]O:' ;R[1#S,0V,EP:I--O$@;N  9GV.(2M^8"@N<&(>O
MH><V3T;;[YET^>"81;!+RQSNW'CUP489"@9++.\X/]\,R]M<WM]WO@J_4_[S
MY_P2#L'YY T3AC6/C'X!-PG0)!;8AJ(F.^%MAN# ,!-R10%0WAB)%05!)@8-
M $6.>>B1$8<$8SQV][SQF*TFT#K?KK%Q>.10 U!?N NCR_F\H!,=&KN]XXT,
M_&-Y?>.#N _&M^\W\N8LE\GK(F'-/&N%'&T:DR(G1-K"-X4I:7&$"D+U6-P9
MP+-Q M(E 74H.HC'F2E %Q*U88A4,LZX2*P(JK EB[UG,RNQ7 $(0$P"W''H
ML/"%6;DQF8<_D/GF8 KP[9YQ].$>:BZ84,9!C<$)QVUB0,3)T'?GZ_V5!\NN
M6E=+TA;UDS6^>M<D_7@Y3Q/K> CZRW'S/7$+DZ[W]_'][%]'W _-KF(OHSAV
MW:A D!(0&T2PUOP?'YK_ &MD<GCK[<<[S-7,XHBL%WHG7CC811/<4;EHGL4R
M%1%!H7A M++D^P\&0@XP:Y)F1F?H\''*.).?G8]]\,\4LQVNKG=^TYERJ(]
M'J^'_A^4JU*P M!+2BK9CD\UJT&H5<PPU/>.9"K(HMN P,S72YX*V.#J,9D9
M<,)EO!6+AWC$7+#K/(>.0MF33V?7\3%F+N8OSY^O.[WY[^^_Q,"&!V&!^33S
MS[W[^>=WMV]OUY#QS<N9KU\<AJ8\<ZG7CK[?A#<SYYIIA\]\[O?GO[\T0P>.
MOMR!HGX]3KQU]N&-8^,?I_A\];Z^>N.55X@76AG7GXX (&5!L#2Q^,ONWB&!
MJ%&LBL($RCHE C00 8"*5)"GB2V+F#Y8&+IV&SJ3!*#EQZWZ_-V_;@N0Z%,N
M[^G,L,^9OOK_ %S*7#UZP^_'VX<(6Z,[KBWMX>(7&IWVC=T  M5 P4"B18[*
M&N!.8!6U )?A!%=6SS-A5*@W0]-DNUD5\N18$C'+B+%PM*UZ0S/M\\NB-K7(
M5NOB]<UR*CXF+F:XS.:"F^L1(N:AE.%0OUEJ"_SU\_V" "@K@9:_34^_,O4*
MD(1$*("Q<L7!>)2BJ'='W'X$$Q>.B0,K8LL"5(@N,I+IUA1TY86 7,J ZTY+
M:D"D7111$V(U3" [,HCIOQ^%-7/C^W@MDS>,,\Q1*HA=2-10F!'Q\!S,9UT_
MG\=S7]L4/*/RY(PH&5 &,*&@H=@AI4&NT7"[1BF\/KGS,"@("+TE!TWISM[&
ML77E/TS>(N  PMG]GQJWOA/?A $K>,A/_,YP'!E] %6V,^W"[:TB,F[ 0:8=
MAP+P%@H#NB@:##E-K"M .7T9X==\^=]__ H.P?G/XX/1W,?.N:@.%PH,BJ"B
MK9C@O?C)F0*E4(@-MXEP] (!1J3!]:9\<=P4Z*#<SK3UX+C;X7[^-^\\#%,"
M4NBM[S3DB"E#& SPH="H13EZ6RX#(132JX-:#8/D,D)!.1605$XMUY&BH8.L
MA6<C9+^!C'K21<@O"<7!7>"8S3%\;+S-Q4R_/[9^GO@.#ZACR@"RC@ :;&$A
M;K577JI[BS/$ 7O][[]=YZX9!\_V!B)!$1' YFA)(0<%%AH4);#)T[RJ%H2/
M*.CF%&83-WE,<CT.0I-*JL)+%P3[(N T%:&X&AKRF)30LJ*+#;&*)5X!L:2J
M9FLP$<(548K+I51"0X A BI=/)A!0(WC:0!& $1$X:CU@MC,B1J:/*?VI'8%
M!L4OU:^O#5LRTE,6+H1J@O@64$MT'6'7_3K^[HA@\=?;G4Z\=?;7.IUXZ^W.
MIUXZ^W-:QPQDP^3'--,/GOCG#D\.?UX80P>#!]C'_P ,L%\%XT  +5EIG'1^
M;7("(;1QAIIQ4,[,\*Y29$43A!#.#2@ %. (D 4&$ 6$X8AA0;08Z1@\)AV<
M%HPA.C<A:X\ZX3!L#V"9,:P"WK&N8:#;I%V()CL#F(\1BBV!8@ DLXC\&L--
M(=I5<P=5 +60N#['CD$&O)\_O=C_ *%$($/6<[]:_P#>.)D8ELA17PG(KVH1
MS1!:K?LS9_ 05U]^YYN_]^S 'C^M*)Y)R "%A=*J&<7J]ZPQYB(&4Z*(*>QW
M^[R HLA<IY:R9#74XF -RX+!)D@Z*&F9.1DL:=@?H,MB+CR0W&%]*]K<):;O
M@0*(8E]!2D-R*C"X(.P4<@8D1%J@%9DK<BC/<@!4LBTDENV'0$%,B,AK#G^U
M0XQ)+H:1>-%<Q 4 C9!)HL<"IR 0Q>OK=]>,_P!JFKGQS=F9OU\\,Y,AM,_@
MXWCYQ^O#.L_&?TY2RE\7/VYTO1MZ/EY[Z\\\^M^OGQ]>>/>O?QY^GXF<&4V&
M?PIYY'PXWZYY];]?/.YV;.SE//X=7KSU]]?C2RE\=_;D?&]>^;LS-^OGQ^#C
M+@=+C_+&,&#P8_#%+F>>];X%4@=,"I<@+D#)S5MXC. JE4"8 7E.DY<:B"U0
M*@L7+CC8*W.P'R-S T;>$:;'$XQ4+,(("4M,OD,57J*L3A)<D7*  #FVER27
M!&/03D-S/GCFD;*>#<?,\8^.2VD2PK:*@ 58.8M_MBV+EE#K&_B9'WP'EC_$
MI^B<6[ 6^:/E,]>.\<K!91HN%G% <@2G+H HY9HHQX=254--K:9D%9@-"A!3
MPCP2[AQ*H0$4907C=V% R6'0 %,P<0PA $#,,RPAD'HY,>45#4G+E5K#-7*_
MVG$2!'2Y,?77%=^7ENJ:4 (%4+@C[.KG]/W-:?[+@-MI]+?YX-<*N-[X:"];
MR=/Y<GT)%! &%>!BGUX9F(M-VS%R3<#@)4H$06R3(S''>N(09K1%X*KDQ4/-
M[XE$IPJZF&N'/ZZP'KVSN%0FLCW)67AE&IM+3._G&\OKC.*8]AEIZWQ= 4]A
M6-X'U>^ ,4Q>D)GR7U,\?<'@7R'U<./'"G?;V^)<XN8X]<92(CL+ ]1<ZOAF
M7$E%OGLG>2Z,'Y  5@+WB_MY^G+N!GYT_3)CSFWDM<&/E/%]I,?GSXA"]@#Z
MW'[O&\VBN<:GT;='Y\!BX1!\Z+\Y7B)\93O3!WAGNYXH.% Z@GK3_P"O.PY+
M=-VYP_[K\U1QTZ89O'V\\BQ&#Y>BGUQ].*L,T1C&QG7?Z[Y"R@K]LY^<?G\\
MR!K)@=RQW[;^W)4K)@)X^GK_ "Z+<>*7_P \<>XYZ._6^:F7Z3$SA5OUIJJ/
M",!" 89ZB$$0AP4<.N70 %91*#'&>,YL%DD3P'/6X\(1A.>H^4QT+KQCAA62
MP]LPOAM=YUOF7+MW\]\4-\6"J) T$ 9KN@SNUZ3-8W-1B&$1G]ITSQRAY,X3
MWB][?RV<AV0 M6(2X.'1,$P!HB2>)%P=ZP(^DZ>16R8W0@I13 4,)&+BS%MB
MK=RX8N%8U+Q\0N49;%K;N94[(1%G;S9 J!@(0&6(4\50HN8L3N!A8M.P*SH0
MNJRVQC0R:5<;>D$D@$!%8K6Q\L#^TO'O!\TXJK[P $WN 2Z*\(FC#C%[G\]_
MV%@O@O,O<I?T'_K>>G?!>A\A%IV0VX26D7AVDB*PG(<RK0ME3A@I/"HS:J4T
MQE)DXS ^E,DF@^P8:F&@!C4M$94@ %PSR)H"5R))(8HA!1."O:XH",&"!F&J
MHF"@'=410C14<*C&(S@T219$T0I5DR&H"D32*0W-+DT[L#+L.)C8%S'A4A"+
M?/CA*A229+%*MPI!C0D6,L(>$:YS3' D6I 67 M"#NNPI1\;%0Q@F08I8F8D
MBJTKHXB-B% 98+H<DN5CCF#DD*$1!)+I:%58*KM^7 ,+_P!3<^4PPAWP#CMS
M8.,WCN!!RE$7"3"FX@1UE=(EQE-@F&5!& !&IP-1A(\I=5]G?,42!,*L@@+<
M4]!P8!)JC)M& !S[BD0/C23="=0D9<JD)D3(HU0!D"*9P!:M$@_"JF1$.PS#
MY$\<MV5'&I)(RB;!#;C/&BW*Z0DQ<29V]CQ2]LOJY_EY<5W<_%_S'OOSRS/C
M/%<WL$F$S3#(N,W/7$&)Y<#0E/(F0=A*-$+A$S,%:FLX@VL598#LN#LT;PX[
MQ.PDSWM_0_?@TMY:Q<S)Y?I.-VL:1H$S&%%;*"Q/%)E#!1&F*A3^W(W%F0;C
M)==>/J3/'#AJ;+7<S@?,S>8&JJNMZL-!@TW#YX":\K(+EEA3&/&^^.!+C-/C
MM/WQZY%ES_OR_P"_Q8:TR,D//3/IKUG@&!G!GM^^> ('+\Q^E]_KR AUC4UG
MT_+^?,"/7[9_\]<$$+*OCZ_M_5.0I%#:4I]>6!(@XYPL:I @J%>+/@D;8"1O
M7;_J_P!@QK'QC@0!P.5%VDF"QE'7*+QJR=B90\]3XY-E@ C&#XB59UQ%5NC7
M2-MPI;B\JTK!I(OD181-NWB=T\Y0!5JP,JL]!Q5H E$[81T=VS' N)Z_?&#H
MP_?;PHY1F0<L8BMCC.=')2!"+G)#/&NOM.2JR0N8JA\,9J8WM:A6X:%@&-KD
MV^,<C\-RV!F81>UH9(U:X+,#CTD-(,S'QQ)L(SK(T %@51U]>*V'0 *V@$*T
M^)T<1_8$<W,RVLZZ'#0G%F:4&ICON_[\"'-0QMFGUZ+\<%S)],X7[>?'P@.=
M0+I,&#MK+]CD8<SJ5H>S<-_7B$)%-(RJ>7+ZWYBJ2XL(Y0U'#0D<F3C;I6W*
MPP7+[O7VX0D2L*I6.B 5%[N+PE3$4$PQ -90+L@":V+0#)((TB#,[QZHW4>0
M+6% V:#UR!U/I/\ *HA40\HA]^?8/N-5JNJEX9LS-S,I2S6,YZX(V(S<1GSX
M^OX$ITN?CO\ +A!/6J0R,7VK/K/*ZM/8 <U%[,LCA9'AI^KME -@R8B7S>7;
MX\,V8T69=>"X9YR:G2@W1]PK7 ="I%I:)JM]LZXA\=#"EVLL1BC;(3P#M<CP
M@S43 _U,!7!%+"H"G *FY:>>181M0%6;AN':7@K(2QTB.EX.$._MQ3(R3R@5
M)LIDLO7"!E! Z@0_""M$G%%["7*U72L*4,CK&CV: +J0:Y(R6,<2PB-AV",3
M O3"SA[T8!*I$)E><D.!+>14B*J NJ9".%)F^N50"K8 JS<-L[FN^4 1&$(H
MXBZ&XB[QRQ,@6L"G-P57V&;>9<1*B4.-%*J5"%."UH!WI@:%NIC6AN9\Y6"B
MN8@4L^9>YP"K  C5M"(NF#,6Y4D? 5HHZ]G#1\']-X]X/FDY,Z(*&[9Q0$K:
MFW!@$CX",RYM]8,^/[-J-/:;VZQQ!OW?^K\:^O"U 18RA2XE!-F4#+FZ$D&8
MKHVEP2GY<<)7 ,M"NE=Y,_+'#"#?B?GL\\M?H5(PTU%#>/J\Z]&_1';K/OSB
M<1PTT9@])UCZ_J8>(B6M=_GXU\<Z20=N[J]X_P"^3+@LK@,YRZNL[Y(51'UV
MP/WZUB<T&U7W;2WWY\?,ZBLF0"$LN#1>':"8]8R>=ZOOC2'3#Y/Z8/GKH846
M2GSD&._]^3AJP^#3B\93_P!XEC(J 4!DIE(9T8O B9'-%N ARTZS^G,;[%P*
M]E[\>=3? (PI%QC"C>>M7Z\3AHF!<&T8I<65<<KM-]F%V]>KMUPU8"2RMRDW
M[/RX3SVBHKOQ";_\GWY>35-DR9W\<5\<"-+(N]]6>;[).R"2RRI-Z_?R<;E<
M>>I?TXX!<#I<#-QTSUSWUYX"H%8L,L,K#,#+P$95!!$8@**.'.'_ "!LX< K
M0>X6OF"&-W7B5^_*G-<\>-64N /I2<X$\CXJT(ZXWX[1*&5LP&,0A@Y)CQC[
M?@8UCXQROE_E_P!OW?Q..T7!+9"&B;5<1HQ'A!*>6 )J\%FB",<JG6<J]GP4
M7(\(Y.C52-2A_6".47#*(%5HL?SYM%!T1I" @C<-C!4O"VHS<!"#<@$P2$1X
M)1$(,"@D: )<L0X"7Z[40 Y:!  6#C(65U)$-4J EO!,(9L*2(0;(Q:$5#A+
MLB8IB36V 0T<R1(IM1TMBT2*&04#QEWIG@4%L6@,8F08!@-5K$&)F[,FO;B<
M"(!+0 L3 $ !(<1X2]&0@ )D2\K +3841@<"U&5N"41X+LB5<J!$%X$EI.:R
M#&"L"<1S$&)I+P! %9&E($!$VNS67$:$U8G:L#H?S7^J!$H"GDN3B@-3I("H
MB@!;B(%'$UF;]'&O.;\?V"4NJ7XO')" Z!;\94PXK)92"4LJ2 P, "& J>VA
M%0C$ J55  "+!DBC>QE^N>;>=WR\:IBZP=3''0H#S*913T=K=(. &!I! >#*
M!EA3&#3DM2>4SZ8[NN9<F5\8C'KF9#TYX,'DK1 AMD-:V\-R;E4A@2X8)JZL
M+D^2 9"0$S1-UNN#D[F0%ADR.@IYX*B\-SFZ"A@^F,G$#DQ$!C8793O?%>E4
M"$54&<O@ZHU;O$F&9)7<GU_+F.<> MC?/U_7B7 B+*P%RJH+@;K 4!8PB XI
MB0([(Y4ABD0M!E  PQ(\<DU\,"4Q%#)$*$)DPD[D;.& HH H"^'N;*990<,"
M4<M7L\( @0 YJWS)D1>,>-F0@KL.]$OTY"0NM!I+]*MB;NN4$P%Y@9V(0+,:
MXC$ >0RR_'O/>.3RGORS+W/YUQZD4QUCGS\?S8)R9@PY76%UIUG!R)@MSP5,
MLP#<[865(W]R^VV@G&5FYN\">4$576P#!6;<=&$!QJHA,0ENWUO^0:;-UGR%
MG_1PN6*@WL%/LFWKRTC6(R01 KV_.?U!7-9-*JO)6WS^O]3DAT1!#1-4WUY5
MQ@T!0J2>4]H=G4[X#7IDLU=--&)]E.7CQ ]D20!U%C^JN!?'(6%R!8(ED20I
ME]\+%D*%M"CQ3 7S]GC #BERQ7Y81P3Z-O"0L64GE<$\:!?.ZJ 1H5X-5IJ6
M>7E # H\C:**#4OLO(HHIE,@LFYD,?4BG$&"""8!#:8B.3%0YBSD)T0Z8[\=
M_9!*P V59#?HXOZ$4\V#<+,;X]8E#+81F9.HAJ<3JL-N,WB9C$R3#9V;0, 9
M0XRM!T(D(W,:+K=G)991L$9Z 4W0VQM#B$2>(5W,_&<)V='- : ;A 0/. EF
M3NR?S^??^J\97 :K2%Y.(\M.B5!8;)%QE"46"2NTSWUW[_L,C6';X.W@:&!7
M)0V]^_/7UX'$#84-R,^8G"74()K"BZUAS9P@,Q'!!JIJ(/OWQ9JLG-'MZ3+N
M$XA)R0"4,!"CE 5JU7EBT:(F2+K';T<2)<'*SAT-4%QET(W0$$"ZG::E\PIC
M@[D#3LH/;]+CKA;7M0S*7KDJGE'@;T #4V+KA-7K'J+ 6KLSDET7;"T#C?J(
M*(9>6A8^1G B4PV'!Q--A+/KS&/L;3JX&#13'EXV=BL(0QGX?^X\A_<#B#O,
M%ZSO7(759RFE37(S1=/?(,X'("E86FI+W7/*0H$!MK[)70P?H$!8LBU7(WI+
M_OB%.2VX":"0>DO:BV6DD =,"-B-O=X%$N"MEA5SC"LKIYJ@@LR,34A!S'O?
M'+()%#*<X@ AB94+P7=H5>X*[PB@-BW-96E.X*DVQ"8?4YW#Q&Q_)'"W DW*
MG28J93XPEU46>,,^4W_M> :+%4F :,BB>*.WDO@&,'; 3*K<56[;Q(  M ,T
M\$S:D;W3@FHON<B?ATHWK?%JOE7[O^.R9-FOGKB!38!VT73K(T]\:6?B8J!J
M*8$H!,!XV*$Q;H=UH^,!S-TZ1\7>#F]<<J^5_L$2 (,CNN<>?.?I(23D#U$A
M"6D ,51_7#QO?OD#1/PA;"ZLS/%Y"C"FGLNY\\AC!C6-?'C\8:F/'XF-8^/[
M<9,E*>KGA#'&/,W2DH!P8E  %'RF7+I#Z=?&.&B:Z_KQWKOXXD:!##P3]^L_
M/4"4 D6 AXDXN"S'#NP/U>H;W( K5G#$\P&Z@'2RL?"!S[LE0YG45P[PZX"#
M0*F'=)F4)*?+S/P=&"5/D@A<KYO%%&9@J,%!)!5"&")Q;UZIOAR\SYX_@QE"
M*1G>1,GEZ> @+O35 2Q09DV8G$^@,P7@*D%;XYB5LZ#!2XR6@;F>.2V"FQ0Q
ML3XSPQND\0X&>6Y/O7A)!6R&<VF_'TTTYAR83[;9QW;F==<&^(E= 6HV,WYF
MG,,=1$%2.$(0IB'@ZB-+O>@S5N"^8/,"G3CBBY;F&+L-U<@#ZB@;PEB[DQ5D
MY2G$@$VNYFWYXK/E#I+@BM@DH'*F0J$(Q59*FNYKA4@'%ZB]BHZP.^)L1P@!
M0*IND+5P%0XR&$&>2.F\-_\ <&9@-,"M!043WLD7D,@L(5K?("_^<, $ =*4
MA@UZ'_4"K1#A5Y*S(=9\<9)@3)!4-=_SPRR%QTL;FM=?EP7"*,PZ0?T]\AX,
M:]?X+8ID-O1\NCGOIT^?Z?79L\?UU,C$R.XG<[G%9D6$5> +#Q>]\&/6"(A"
M$ )+,X^>:.=!VW\IOB_3?-/%G\]7.RYX[>_[ D,< %\]NW&7#X*<F(*8V*8;
M8 5+4 _\X5@W$^;Q"5F3A/0G5=J@$2L0OJP^RJ:?IUO^QCO7?QWP,8=</>6<
M.7Q[QP\L U!#,N@$9$(*:"0Q-*4X2"D595Z!YV&8H,=L]1/6N%X+EL3H:C')
MOWQR;%N+$-S11 )+?&!) .J>?#*N+KAA1 ,(3I%68@+0@W&"6R$3>:Q<[<\5
MJA<!@& $$,!4T#AI"J!( J9# /6_F\";?/;@-FN&T!D*< T<".B\"T$<^O@5
M-$, $'= E\CMQ2&MAH2(=&#Z\.>8@Z.PM"^P O@.@C,,+R8?YOWSQR@F@3"2
MQ !#(.3-KQ,12N;J(L6*S4YABH!& 9""3LRMWGF;,<P@51FAEI[7@NTHM(+9
MT!=WK4XY8<<6=\@$8X@NB%F-'4+)I8CY;TX:^:P147)3039J9Q-(A@L!0 C
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MNFF+@:[-IN-^V/PSI<_KG_7[<WMA=F(BK^I>1MQQZ\&"3EA!@J%(NVH<B><
MT"*TX,)$<N] MIED%M5*BA!44I$  Q"B ':K)H-9Y@2B8>#MD8C2-,2F2!L
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MQ=;+TD)QFXD@A[RPX@E4TZ$H0,+30+QS2*1V #^C#W_E2S79J4S@?8S9V_\
M(@[+R&ICQ_5.!68K\&-&ORO]T4TI\*<DZ",.T^Q#*5X@H%83-$@H6!BW? !
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MZG7CK[< " !X,'^5Z<?+@!^:DZ_W_P ]WH8-3P9IUUO$_O",,G_?>.(]$_\
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MQH6)4-@-N16Y )<("3551:H#,MXS3&=@^S');AG- <%HB>%C(9B-0T *Q@]
M"VWD<#A9D"4! @"UW?.8!0@IBPFI-C?%<R^1$H2OQR:LRA(LY<0(P!@QCC\(
MW:(!JH"*EX(J2+C0"Q?%:D8QUPAY=6MZ0/(ME"P!:8&-):^$N@ "DA&)H$2E
M(!JY"91R*,GCS620A3#MBPQ,<K;FYZ6HPB@ D/3:A(0[ "" .#ESB$6/=D-E
M5H7FJ5HC65L8*Y):!R+="4%TA04,B"#RB/BT,<BB(%$R$0K8QLF,DA"VDH41
M%5[FK9+"6HA@KXA& )&BA-*ITA*WB8?F+F&" 0A**@E!) ,0-Z&0'!5!3(5D
MF1+(#10& I0'E4Y%(T (J2"2NGD#,S)UD!V,8.0D+6*>\815TY4%"4"HSANS
M=<V9(P7 /$PQ$-15$8?$AQ>#>WR_;/V^J3^\1LF?'?VYW._'?VXB;)\XYI!P
MNCM^#CC>+JXO$0J0=+@^^N4\\<;Q\XY&#&.GI^'OGOHV^/PC9&^.^&9,W4[F
MYQ$RD/+CCC>+JXO(RS'GK[ZYU>C;T<]=^.&;,S<Z^?'_ !14!]/KPB$,!@\W
MQ_&?KQH(.$Z0KB8J3.2*P2XS284>*444Z,8Y$8$SJW&#(FHJCYW"-) @S.R$
M5L"'!! 0J'#:44-8IXLI$4$0P!8L@%#0<(=@B(2[$!L,AWK-D=)&0;++*P0,
MX]YMP!"9W#W,W@CZJLFM&SDP,JL1\Y=>*0K86*=-G%)S#2@Z5$ GFJ"HEYRI
MT4(-XU*4H% YAH#<AD!NTNB"1<BJ P/0$&3(E0 -XGB%X" ,U[(T6)+@%$IJ
MQQRQ!EG(5%4*@12CUAO47CO(+D!2Y%%(2-.>&PZDCH&1%A7KF-*4C@I9H%$E
M84S+%4J(:ZP#($)5 J'& 5 5"18 [.*$*Z2L W.)D4'@087"D@\(0:%G+0CP
M813;0(I#(G8X,Q@/S9.H5?7$0J6+@U&?<>S1OA2PM!@5H[(F6Z)Y.9P("W"J
M9[@/BMD>"7FDU%Y9 !Z(/ 4'(#+*:<B!3L!2'#!Y:\V[1V)+A*2'K<E+$B%%
M"(!0<9Z62%DI(,;"D@\%KQ7%P";R@0@G('%325;*"(D1$B0J/HFLLDD(8"QQ
M<A8A"R"@O3LOK^\_&^N-I*/A*MUUY[SV\AY];UG]TIDCLSR-$C.Q)V&S%#Z]
M10186I!&%TWUGTA((:Y2T(S*?X[X@/S(JX6%&:X:U@XS:B*E1(5$[R3.=<+2
M;A,#<?I1-^^*+EV19G]0SOSHY@@Q"]":#?L&OVR*"HN4-4-ZS)IZSQV!;"ZM
M=3)^SR7 4MPZA&>G&,>.5O!<D:46%,GH>++9H/"Q9\3-QF<4J V8792S&>&+
MBR>7;/>2^[<\;20Y/4&'QZ]?& $%+\1-NET2_3CTB'2Z51?(?3B@RC9*)>FK
MX'?V78Q[B?.>O9N8_P"$E!?]SRE Q<7Y9P#HT4UVV/9/N,/,L3-$C=F&LXS'
MLYDE?"RY0C@WV=.0:I60A9V!5%TDM1^10 8%6'$RNM(;>^)VB18&QFFS/7W=
M@P-#MC.&"XB_DQRMR2#P#O4C\=>!%,*JDQ,U"=7^?CB%!'!WUE_0ZQXX*0^!
MJN&PYP TGP'*VI(C"%1I V:,G?&D58<P8]B#>]LIN\-P$BXQF0=A#$#7IXAA
M&<>$@QY8]C.#4VB%HNH'S=PSYG,(48%>S9YRGB:Z.!;Q=@'ND:NC'NWF5;JX
M&XECK-.F),<IF)AI%R%4IBO)(4 U$R!W#NN^$L3@5 U@Q090<IX7#$PZ(D*!
MM,F@WFR<# [8#,TLTJ_K&G ',+6F&3./G)69,3"V04C/(!K\4/CEKFZ+J"4^
MJ/KC"HFKMC!RX6-]8PZ$@*890<L^1S]_/-X $#^5Q<>?MP*$903.?@UY'9CO
M%)+="Q$%\@U+=GDBY,QH5)!NH"W'Z"TEJ)&2P#2&1;3O5-CV4Q),49OP;AZG
M%3E@4PTH#,J$ZIG@KL.1!P<U^^(XCR@'>A+IN;SGOU/[U9F69GGUP#(]@L$D
MQ8H8IC&%AEVG*T0,^X0NV(;PW#(7+%(X"BJD!$ARLH#NLLW9<*O'KY(8I,H@
MM<M/.S\K+IH).P1# 4P>' B^#CJ?3!D1)!QQ!ZAA0E1!E9%<LS@786!RVDJZ
ME:)P@(1"(42%%*=HH\*)I^$(EDB)8DA O*,5'JC* 6 W$2.M@64+(3M9)@[E
M2)R3 PH!T1:5T.VN#W#8)00H6B_'T)AS]F66#HZ'A)5XUX&(GL98 )E<R/
M!TL4C4PF1F'O.<2A9EH>A,1&&E]/#&%14SAS*$N>R P\M)D6!-,V0Q_Z7+6!
M8\*749G\/OCA3PO_  T'8/S_ %P8I4T^+N>+^$+87SWQ!V7YY#QK7K\ #0'Q
MC\(:F/'X0=EYZZ\?C!V7D#0'$'8/S^$/'Y/\[]\@: _OE3)LR?)KE&!"I)PH
M(R IV@[.&'')<I<IHJW.[G"#05<4HI*11"K5%5E+)(2!H&E,9/I>,05F 7++
MA?5_P<"&6T05!(J<JM5NWCJZ)S#AU-+*3UGB%I^%H4Y/%<Z+E5X>.RG)-!D"
M8N9\\,*F;$0VA48N6D  Q1<=Q0LE9K"R.'B)\-F" Y1PH!+FY]\4RGE:0:G>
MM!@37(,8XB0U*$RN,$AB!1JV8&(=0YQP+WR3BDV\G1QMD,Q/'"5' @,?H$N"
M&O',"7PK%6C"BU^VN"9/(0R-V[TX7'E612J@!G 03WYAQ,.?=L=V/6L+WOA/
M &()<DH?.+\GMRKY7_N-/)R/CE'#,]LOC=I/.NN&\RMMRW6Y<>^(!!&1A]M/
M^G(KX!,,UM-__/G@5& "<&075]W[:Y (M(=6LQZL,[;Q^PRP.A*\M2ZX+= R
M[8MTMKY]F7!MJ,7TZ/7F>M<N*!W!SAB^?/\ ' G54X4[X2G>?%."ALHMN8Q?
M'\\,00FDV.I-C6L:SQ*(+.L05+L2;FIK@-A5/DC;YKKP\##)+2R/3HAXWGSD
M]\;O?>,YD]<C3AL!^WC.OM-\?EC!<,$C^?YX0RX(*449N][GG@@PS>0G\];<
M/[C/V*=F"UG7?WX=#M!G>?6^=SOQW]N;89?'?.EZ-O1\_P#;24NKGXX&Q#([
MIFSW]/7"CZB#@PSG+ZN^, V6.5]QQG?CYY)BGL(&XX#&N9(\4(8WX\.=9^IS
M(,D-Y'N$";1OC7+F<+KM/%WK\*^7G@Z-'CX\<AA(=&M?:<3+5F>_\\RPJFV\
M*>_'GE>O;/4'5OCUR(.7'<K#WZ_^>TQ8H4EIM*._MO5X/$.TOB?;QC-X:5^&
M_/I\]\K;<OT_#J=>.OMQRUR^7?.IUXZ^W#H/)#J]8UR+S*&U(+-ZEQ\8VP?\
M2'63NZU^@%T0LP,[NA\??@-"U/#,%W;ACZZY-8U@/BWK]^!=/M]C>/'_ &CS
MZWZNKX^O(^'[<H(*"Z+E^#AD HP.5/0%:_'#8 I4M$G&4%6 PXY80+@16=RT
M0#CC:!;F(HBD88B-*)P._P 4,7$3$0*!3AQQ1OPP6)4#.+="QQII$@:= 76%
M.T4'B@*8$JX"ZKHO7G\.YWX[Y&6,\QGWY@KCY^7@('<P7?H_U_8D=*HX=*X^
M_7U\. +;.R*,T?N[U-/$%#Y" *@JB4970O&N%*0I$"@@R9LR(W7%&H ,Y%D5
M;CX?T9FY&QC,6YTZ.YXXI%%:K+\7?$0!-@1=X'+C.#AD1G8,A\NCZ\[<#8Y6
M;U==^. I0HZ3(S>3&.#@3DH*?),%]S@&HJDCBD1R9CMKUPQJ>A3B6J78S/QI
M!AQ@H$$P1_.N@O%6"P@,4:;+F3:ZH<NF1![I3OQ[,?\ :+,^,_;B#S'(-$FO
MAX7OK@LPUHM$# &'JP?*(- I#EJ4(;.6+<0&YH:9"5!*#.@F^I,A("P#A2@)
MFAN56D:0E\WQ<Q389@6 5.(!+&4O4>A1+D<.&5^Q44/ZC"O!BH#"<)@3[$I$
M/@Z+3R$(SF2@(' $IT(2F #Q#9+&#G3&Q<0H:=-17X9=&4#H2].LS.>6 7 "
M/.+ZSG7 $AD!0>\[/CZSBDUK[*RKIV.TQG1[B&8!B*59"P#4<<VCERQ&HQ**
M, \XX0402A,L(KJNW?OF1:$FIF0J!,BS6TY'B70$&P4(+L2-[O!!;XRL@%($
M  !HH%D7&0OU$&9"CYZY/8%501<,H,I7&=\C;0+<*"%G9$F7C?-^RZRR*96F
MK]'A2*B[*DU1,BS&'N2B->D4)T%*QR6]<14+\5NA=!?.\><5@0**+C%0HI)Z
M>"Z*$L@M5N]'.;2;XZRV'FYSC/@_3XXQ4\M/&&7ZG[?]G9&Y(T\G?*A_2ALT
M5H#2FT4AU5'M)1*S4T=@M*@)R."L5(6H47A]7,$1BI(*0A+>43-:"!V-0TMB
MJHKH./U&#>(J#%P7DRY44G)OU 5B'&20[.MH%0, 9\T*EJ,.6KP8"S0, ,"R
M<$30$*@6\CDNY.I,'8H-\[RD[L$<U@AX)#11W*&(%#EZLO+N8E#)D;8 D&%!
M@LAE.RM#SP0:"9ZZ5[GKM^N^20T BH@!VH*"9B]+6&JH+"\JL-')5')F\E!6
M-]XZG!4=#E: '?(0+Y\@3SQ9I1&RB'R<&F_J\"L#CZ(1%Q!(M!,SAHH$:D,
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MM&G#B@2J56*H6(6VI^04XLGL4.%R65!0#A^]#D\"8,T3BFK#X90@CMH%5AG
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M1(HT3.0Q97)E@("P!28&X 80(-D-]S3GD)(3QU^*H-LJ@]*40<.PG>.7'*@
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MPR98PYUP 0 =@H/R?CLF;/X\\T7$O\^/ZZ?I7[:^=?KQW'7?ZO0^?RSPS?\
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M\P[R</3\8X@(H>Z3?GY[\\"ZA+A:6XZ#?Z\HJHH=$AY6X[SZ?GB12)BLP[E
ML3.^O:@)TYAEN_(.-8\9X1Z^1/+WP#53Q?G[\RK%WW2>;\^?OP]%J4PXA!21
M7?)5<YCV%,Q' U-)A>& +<&=7W.K_P OSIV>,F?IQ(-57$(.*8U'XW;!W?0+
M+)WUF^/']<N'3A^O' IC$TG?HS]YR&E@@D%*BM[/MRFFFY,K7MW9D&,<JW4:
M$E@"$35)YY@<-.P&&%,.A,8>66I6GHT4+TH6MSP9(41TZ1ID<$P^.= &J_,Y
M?'3ZWMB"V>@AH P_QQH,SRMM0*3ED#&ZN$-2V\.U<;LSO[<63:@BNUH?<=_/
M$:"!:;&&B(82%GC8<?4F!J1X!C;GSQB8IFD(EP./GN9>0E$'DD!GI+@Q^PV'
M0$56N,I@=F3-X*.A2HM*-ICSR4)*&;D"W:/C-%T'Y4$I"4M7+RJN+QHE5855
M7 5%%0\V<8+EF.UK/6/_ +TP 2I* B= ADR!-\&C *!^ F.X0IYXRK $[10@
M91.7_/$G4R:7((\VL"KGD-7RM161@@L9VOEX&M&1JY<34F]EGSS$@56 C7H+
M*9SQDTE*@099!ZRAYXV6 44W$)<86SC!I(F<R;<Q#ZGR<:H5,14%AKB1!SQD
M44 %L8I3SG-SGDW%#[(+S*I^>^87:/J4WFE7QK.BR8Q=)!KO1^>V<E:H9L0/
M"6?^]C'%(*7 4@7/T??"F$+"M68&XW/\<4#. "^9/Y_8XJ;SW^O]C0=@_/ #
M0'QCCI94,><:+Q[UN@-394P,F13D^*+OM+C##;@J!YDO/%7"LPD3U!3"Y22]
MDU?X'CU+#KR5+\S/#%,>2R?7'CYZG-?BZ>2Z,*2TH(8\&0$H\JL$4!#$T"AF
M.(G-Q#LS L6B'/"VU!H% &:Z5N <+0-!T-J"AU&"S#Q0R(KF0E2Q%@QGJXO$
M'8:FN320#HYEBJ7Z8>+PD/#S,?+6*;<;_)2H^.0"8-S;//)F(S'9_O\ OCC$
MB[.\?O\ KQ8+G:Y_]QRA=D<?KLQ^=X%PQJYU?>N&A(%UN@"212*!0GD8,INL
M&+WF1+C\F#L'Z<V1R>.OMR'@^W#2-H/NS@)6&-@TP:L94?0XVH$LP#(QD<SS
M%';)J1$H8(E08K@H94.7&4:VVXK5#!D*]8D"A9BT)KGY$_\ G!52,K2 JW+A
MU. %022H?(W(C"1>//-J#$Z,S!N5F3BDE!J\,E*NLV9!P!PZ.$6 H#"LCO)7
M!-GT>Y\[YZZ=GGD&4UKU\>/IQR1R>')]N;$<CLZ?DY7SZ^GCG7DWT?IK\:T:
MVJ[+N/5[G.IUXZ^W.IUXZ^WX=WOSW]^&&F'R8?O^%?/-8-%A\[^_?/'K7J[G
MS_1U.O'7V_ Q)B:G5W.=WOSW]_[/KA$$HE,9-8%Z'H>#F7.AD$A>MG"ZA3)V
M<$)1<;C5+ILIAY7+7B%=M,>A-X@:"14"-6 -&X>N./V-,SL^+J&M?A3R??\
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M!717%>CB PE$(B6BS)FS7]P^&/3X]_3A+K6W9,K)13ZS/"8QM2KU5 $P(7/
M"E$D+2HJ+"B;U?MR- 8P"I\2YSKN\<J^?Q52*H:%I]N=3KQU]N2# ^-7A%@
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M$$, 9JX[> KB%-U0F<.S/..+D*H7(&IHFX_'7!V;55E")?+$UO@M,F$ P%/
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M-@I$2>'WA(H+4%>J'>@%0 ,)Q4Y !3H*UJ.)@.&_T9^5L?)^_%=;B(!3>2&
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M8A(Z1I4Q@*93,]B\H 0,FFHH4D57*M.U+G"0"8!:0 Z.N./;Y)"0A4:%(L@
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MA<&,I=NDS-\42;FA1T>82Q??&OH(#Y30):FL==O,&]@9PC=]79Q&JJ&0J4[
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MR\7"9MRP:FB,'<QQEH; JRB$$F6[( >,/CB?) K#X#,S>[TQRK2*0D?HZ%_
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MHF@4D5@ HO+@SVF+FC(I**4C#@&6];C@$HHH1 H)!)TTH"%]@@"/&.$\(EF
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M*@U[?+H77(,3]?N@)&T,9[.LR:+OBTT!!R94BA,)6JR.R&;0'A&Q0JBH2A@
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MW@FN]#)*9+IJYL"H%J>$0T29H7W)[P+Y5DQ7.F5?EUPVAL82@:^HVX.;H?+
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M5T9=H8P<#Q-O+_MVJ9S.I72S[))-NN-;##5@805'5"BKW2V2!/I"\!L0$SY
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MF5>C21F 0U[*K:DJ"UK')M&4-*1T*"^;W.,I5MVP_P!]XB!5J:!"!I"18**
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ML,73%,8#:EHJ\V0[H'%]+/C0%YNZ=?@H^#:SAES@\]=:"=:OXSR6[JDS4?\
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M39I3"\8$R-:DN?)O)\?J%ZP(&:D=2>LB .2<D<C9M,01I]A"PI<HY ,WD6>
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M2;JN!!>0F()$E8D"P^!VOEMG\,QODAO[>69?2PZB8S[2:V95V 3M!F8 9'O
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M(5HEBCNROPS(!( SX5MA@0F+^R:]3'PA;Q38E:)!'K6!(ZBD!JXJVUC01N[
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MXZ"+#5QE$7K*Y@@W8P$D9R.=&7=RGIS&B(ZDM-Q]I^PBXS% ?TI D[!*!*T
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M7/Z+C( %PR$RHG!I82QZF%FI^V"J$I;[,E,$V4"Z,E"VS.$122T')%38&8.
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MTF(G5PO/8V\JAA&*-,YNNT2%O),V)G" J9^2^@6CX0PME[,MF!QU<V3XNFJ
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9V>G7^+U)?<_AQ-0W>?T8+^?A>?\ X6__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>business4f.jpg
<TEXT>
begin 644 business4f.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %A OH# 2(  A$! Q$!_\0
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M0[D <DX!X%>/?M\?MZ?!_P#:'^!MOX1\$ZU?7VMMK=E="&XTV:!?+1SN.YU
M[CBG3_>-16[DH_?RZ_\ DS^[<J2Y=]N6_P">GX?B?JK17SU\>/VKO^%/>)/#
MO@;POX2D\?\ Q"U>Q;4(-%&JV^EP0VJ$!I9KJ<[4R0P48)8J1QQ4?PO_ &PX
M/B/\/?B!J?\ P@^L6_C;P,/+U?P7ITL>I7+S&,O&EM+!E9U<@@, /NGCU6EI
M26RO^#L_7733KH0M>6^[M^*NO3377H?1-%?)?AO]K[XA:3\1_AIX?^)?PQT_
MPI9?$!V@TYK#6VNKS3Y@@=8KR!H4V,00#@\$'/0BHO _[8WQ%^*WQ!\=>%?!
M?PCCU;_A$O$5QH]]JL^MQP6R0QEE1_G4,TKE3\B@A0"2W0%V>WK^#2?W77WC
MZ7Z:?C>WW\K^X^N:*_.W]FS]HS]I+Q-J7QH!\$67BXZ/X@N[?R;[Q+'"NCR)
MG_0XOW?[R->?WG? XKY\^#^CZWXA_87^._Q'U_PT9]1U[2YX9?&USKLMS<W[
M)>(?L[6K';$J')#CD_I6<I.,7+HHJ7WK1?\ !^ZY?+[RCU<^7\=7_P #[[6=
MOV5HKY2UC]I3_A0OP#^!ND:/X=D\8>.?%^F:=INAZ&ERMLLKBVBWR22D'9&N
MY<G!^\.@R1:\"_M;>+[[QOXR^&OC/X>6_AGXHZ1H<FO:5I]MJOVJQUB *<!)
MA&"AW_*05/0GMBMJL53E.-[J+?\ Y+J[>BULC&C)U80G:W,D_P#P+1?CI<^H
MZ*^+O%G_  44&C_LJ^!OBOH_@S^V]<\37<UG_P (U'>E3;M LSW),@C)(C6$
MG[G1ATKU#_AJM=:^)'P7\+>&=%BUB+X@:/+K]S>&Z*_V99)$CJ^T*=Y9F*#)
M7D4<DN9PZIV^=F_R3=]M"KI14GLTW]SM]]]+;GT#1114#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OCCQ!J/[5/
MPH\=>,K2#P1IOQ^\#:U=M-HXFU>TTN;2X6R?L\J2(!(HR!GYL[<EN<#['HI6
MUN5?2Q^>'A']@GX@1_LB_&CPE?+HFA^+_'VK+K5GH%A-FPTW9,DJ6P<# SM*
MY4%0 O)K<^,GPV^/7Q@^"?PRAU;X<) _A?6XX_$/@&T\2P;/$.GQ1QHLGGAE
MCVL0_P"Y<Y /.2*^\Z*J^OE[O_DMK?@K.][^NI.MDF_YO_)]_P#-6LTSX2^!
MO[-'C/PG^TUXR\:)\*=%^&O@_6/ SZ79:7HE]:R)%=F5"(Y1&5S*57<SA2G0
M;VQFN?TG]E/XIVW_  2WU#X12>%]OQ#EN&D31_[0M3E3J*S9\[S?*_U8+??]
MNO%?H;11+WH.GTLE]TG+\Y/Y%0DX3C46Z=_P4?R1\0?$+X(_%CX:_%[X3?&'
MX?\ @VW\<ZKI/A"+PMKWA:75X;"0 )P\<[Y3AV.2,_<& 021SNC_ +._[0&M
M>(/VG_$%Y8V/@OQ-X^TG3TT.\TO55DA66.,AX%D4B1&5,1F5D0%B67BOT!HH
MFW4YK]>9>BD[NWS[W^XFG^[48QZ<OSY;6O\ ))/OZGYE:-^R3\0+_4/@+J&G
M_ /1_ =YX4\1Z?=>)-7_ +9L[C4]0$9!GNG=6R\>Y2VTNTA9N$P,GZ4^ /P8
M\8^"?VOOV@?&VM:/]B\,>*FTXZ/??:H9/M7E1%9/D5RZ8/\ ?5<]LU]0T5I[
M1W;[\W_DW+?_ -)5OF9\BMR^G_DK;7YZGP1X*^#_ ,>_@'K7Q?\  /@SP'H_
MB;PCXXU6]UC3O%]_KD=M'IOVB/:T<MMM,LK+A0 -H)&=V"<>[_L/?"GQ'\)?
MV4?!_@GQIIG]D:_9Q74=Y9?:(IO+\RYE<?/$S(<JX/#'K7T!16:_ANF];J*^
M44TE]S-)>])3VLV_F]S\YM'^!_[1/P;^#?C7]GKPM\/=(\4^%->FOHM,\=R>
M((K6.QM+K(83VK*9'=06^[QEN-V*[SXO?LD^+['X??LN^$/"%@/$4/P^\1Z?
M=ZQ=K<0VX2"+:99@LKJ6&[<0JY;VK[=HJHS<7&6[3B[]^3X;_KU82]YOL^;_
M ,G^(X;XY?#-/C-\'_&'@>2[^P#7M-FL5NMN[RF=2%<CN V#BOEKX6Z#^UAH
MGAWX=?"J+PWH/@+0O"KVMMJ?CZ#5;;44U6P@4*88+-XS)&[K@%G Y7@KW^WJ
M*F#Y)-][:=-+V_-^3ZA+WH\OK^._Y+TZ'P7\1?V=/B'K7[47Q USQ#\+-*^,
MOAC7[:"+PQ?:_J\*V'AS;'MD5[:7<PRW.8D8G:.?F;'##]CSXN1_L2?"/X?C
MPF#XLT'QTNL:AIXU&T ALQ-<-YOF>;L;AT.U6+<].#7Z6T44W[.*BNG+_P"2
MNZ_X+W?KJ.;]IS7ZW_&+B_P?HF?)/[:G[,VO_%#QY\./B1X9\+:%\0KWP>US
M%>^"O$3QQVVKVTJ_=5Y5:,2*PXWC;D@Y^7!M_LB_!WQKX9^('C#QMXG^'/@W
MX0Z3J=M%9Z5X,\-V.G/<VBJ09'GOK6!#('*A@F]@-W12!7U7113_ ':LO/Y7
MW^_SO;I84_WF_E^&W]*U]GH%%%%( HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#Y6_;F^"?C3XQ:K\%)O"&C?VO'X=\96VJZHWVJ"#[/:H1ND_>NN[&/NK
MEO:KO_!0WX-^,/CG^S_'X:\$:1_;>M#6[*[-K]IAM_W4;,7;=*Z+QD<9SZ5]
M.44X^ZDETDI?-<OX>ZOQ'?6_ER_+7_-GQ=^U3^R_XDU[XZ>$_C!X<^'OAWXO
MII^C-HFJ^!?$DUO"MPNYFBF@DN$:)74R,26[+QG-<YI?[,GQENO@#\9QI6B>
M$_A-XL\7M;_V%X7\)VMC:-IUK$VY[>:^M88S*\@9U#,S!<G! 8@?>E%3;W90
M[W^5WS/\>]]--AQ?*XR[6^=E9?AVMWW/S@\)_LJ>-I_B=\ ?$VF? 71_AG9^
M%=35_$%Q#J]G<ZC='RE#W$[JV9$W*=HW2.2[$JO?WW]C7X+^,OA3X_\ CYJ7
MBG1_[+LO%'C";5-(E^U0S?:;9FD(DQ&[%/O#Y7"GGI7U%16G,]?._P"+BW_Z
M2OQ\K9<JLEVM^',E_P"EO\/G\>? GX2_%?X)_'+XM:7+X2L=9^'OCO6;W7HO
M%%OJT4<EB[QL4@>V;YV+,57*\#!).*YCX-_LG_$*V_X)Q^)O@]KFG6_A[QMJ
M0OO)MKJ[BFB!>821[I(6=0& QP3C/(K[JHK+E3INF^L5'Y+;Y]/^";<SY_:=
M>9R^;W^77_@'P7XB^!/QK\1_#WX&^-H?!>FZ;\3_ (2W+6J^%YM9B>'6;)8H
MXB\=PN4B>01 A7/R[CD\8/<?!7X4?$[XD?M33_';XH>$;/X="R\/_P!@:1X8
MBU6/4KCF1F>:66-0F/F; '/S#@8R?KRBMN=\SD];W?SDK2?SU\KMV2,5!*"@
MMDDODG=+Y/YZ:MGP1\#OV-?&WA?]J3Q4/$NFQGX,Z7-K-_X6+7$+[Y]36))D
M$:N74)&)%&]5ZG&=U:_[!7[+OQ%^$OQ \2ZU\3+1$30M-3PGX1F^TPS-+I:W
M,LQD_=NVW=F,88*V!@CBON"BIA)TU%+I'E_/7ULVO1LJ?[QR;ZN_ZV]&TFUW
M04445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:U@83KYWE^9)*Y./E",J*HX$CY/-33LN52[N_IO][LH^2;]74[--Q[?CHO\
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MV(I\.W2:BT7VSPOJ^GVVCK;QS-#/=ZM(C6L\<C1!6\I5*&10OF8-?1$?P?\
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MC=$Q..H."*]'KG/ O@#1OASH\NG:+#.L4]Q)>7$]Y=2W5Q<3N<O))+*S.['
M&2>  !@ "NCHE;IY?\'\3.-^OG]U]/P"BBBI*"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HKB/%'QN^'_@F^:RUWQGH>EWJ_>M;B^C$J_5,[A^(K$_X
M:D^$G_10M!_\"UKT:>6XZK%3IT)M/JHM_H=,<+7FN:--M>C/4J*\M_X:D^$G
M_10M!_\  M:/^&I/A)_T4+0?_ M:T_LG,/\ H'G_ . R_P BOJ>)_P"?<ON9
MZE17EO\ PU)\)/\ HH6@_P#@6M'_  U)\)/^BA:#_P"!:T?V3F'_ $#S_P#
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MN7W,]2HKRW_AJ3X2?]%"T'_P+6C_ (:D^$G_ $4+0?\ P+6C^R<P_P"@>?\
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MO_#4GPD_Z*%H/_@6M'_#4GPD_P"BA:#_ .!:T?V3F'_0//\ \!E_D'U/$_\
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ME7,U?^5I/3:]FNM_J*&(6+I.G-WLFUY6UMZ-=.Y^QU%%%?/'(%%%% !1110
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M[<P1$%_<;6%<1XRU ^)O$FI75U<_9]/MG*F3/N<*/KUK+T75+?2;R+4]&O\
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M:V:ZNY)##"GW(TW$[57)PHX':OHKP5X^T'2;>-GEB''J*T_%7QB\,M:-_I,
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M2;NWJWYGJT.M+_;5^N[_ )>9!_X^:U;RW74(\8SQ7FLFH?9_$FHAC@?:I/\
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M?\TC^?>/,^_M7'QR^F_W<-7YLY"^UH33.2>]?8G_  2LO%NOCU>A3G;",_\
M?FXKXEGLY(58R+@=:^R?^"2TD<GQ^U/8<XA7/_?BYK\]P;?M97_DJ?\ I$CY
M[+*<8UDX]$_R9^Q-%%%>&>X%%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ]>#@GRI]M/R/,Q/%6>9HG3YMSTL1VVEVSAW6,;<5Y)XZU:PMB[1W"LWIFN
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M;#:G3IM^?IMZ>_2J'@7XE^)OAIJPU'PSK5WH]UG):W?Y6_WE/#?B*^G? _\
MP4&\9:U"- \8ZY-IEK=*83XATRW1I[4D8$AC8$. <9VX.,XKDE_:-%VARU%Y
MZ->MM'\C9_6Z;LK27GH_G8\KTG]BGXSZMY3+X*N+6*3_ ):7ES!"%^H9\C\J
MW/%O[-]A\ 88;OXE6FO:M=,@ECM-$LF33F8C(1[Y\ ^X121V-1_&KQ7\:?AK
MK%K;:UXWU/4=(OT^TZ9K%C<D6M_#P0Z,N,'!&5/(R.Q!/2>"?B]XU^*GA>R<
M>);NWUSP[']ENA?H\VG:MI[MGRYX\%#,I)'S >8AQG*\[4EC>=.LX<O6R=_Q
M-Z4<3*:4K6?:]S@M'\277Q&UY->UR&'3_"GA^(_8],M4V6MOCE41.Y[ENI.,
M]:\U\>^+)O&GB.YU&0;(FPD,.?\ 5QCA5KU[QEH?_"0>#?$MGX9>QM9-$<7N
MH:':JP?[.Q+/+%DG*1L5!&20#D\"OG[OC-=4(N4O:2^1]=F7)@H++J3NUK-]
MY=O2.WJ=Q\)2L/B:6XV;G@LYY$SV(4C/ZUQ4S>9ELY)-=QX B&EZ+XBUISA8
M;4VT7N[D#]./SKA&QR!TJU\<F<^*]S 8:#W?/+Y-I+_TEC:***U/#"BBB@ H
MHHH ]$^"?Q*UGP#XIM[>PU&6UTW4KJW2_MT *W"JY*!N.Q8GBL?XL1RP_$;Q
M$LT1@E:]E=HV&"NYMW]:R?"5Y;:?XHTBZO&*6D-Y#+,ZKDA%<%B!WXS75_M
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M NWN%%%% @HHHH **** "BBB@ HHHH **** "OW'_P""0_\ R;#/_P!A1O\
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M4^HR/Q&PN8UUA<73Y)2VOLR&2PN]/D%S K0/USCY6^M;EK?+XHTR:WD7;=Q
M\&I]%U)+K2[BTF()V'83W&*Y[3;O^S=9@GSA9#Y;?T_S[UWXS#U.(*&*PV-I
M)8BCM)?:1IQUPOAL=@98[#PM4CJFNO4\I\<6<UG<RJPQ@D5Y9JDA>3'O7O/Q
MCTN:.\EEB7,<@W+CW%>'_8));M0PY+5_.M>+C)Q9^(Y744J2FST+PKX=-UXF
MO9&7.;N3_P!#-?1.C6=MIM@"0H(%><^']/2RU2Z8@ F>0_\ CQJ]XL\526%N
MRHV..U=5*T(W9\MF,IXVORQ(O''BB)9&C5^^,5G> ?#ZZE?/?3?+!%\[,:\U
MEUJ36-4"NQ.6]:]PL[$VGAW3+"!3YEXV7QU8#@#\Z]7)\%_:N.AAV[1>[[):
MM_)'KX/*ZF)Q%'+Z.DJKMZ+J_N.A\$^7K?CB"]G7_1(V#+D=%7I^9KVSQ-\<
M-.\.XM+-F=E7!6,=/K7,P^ #X3\ 7%\R8N?*+LV.^*\>T;34UR^N'NW+Q0]5
M_O'&23755ROAWQ$QM;-<3.3P>!2I1C'[7G\]6?U5BL5A.#<FC>-X4TDO-GMN
MB_M"PS7 2?S(E8_>."/T->I6:Z9XZTYBVR3<O>ODG6/#L'V7[7I@V,G6,< ^
MQKL?@_\ $6;2[I+225O*<X3=_">ZU\GQ9X7Y77RIYYPBY1E2UE!O7U0<-\4X
M7B.DY4?=DMT1?%CP ?!>I+?:>-D>_( _A/I]#7F?Q T>/7M'AU6!.9%^? Z-
M7U!\3+,^)_#,S* 7*;A]>HKY\T)5N$O])E& ^7C5O7T_/^=?2\+9C7XNX1=3
M&/FQ6$?*WU<//T/A?$O)X^PAFU&/O0?O><6> /HX;<&7G-?9_P#P27L?L/[0
M-^,8W0C_ -$7-?,^L:#):7DJ[. WI7U=_P $M[=K?]H2XW<;H./^_%Q7G8.-
MJLO\%3_TB1^/X#$>TJ)7W/UWHHHKPCZ0**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#Y6_X*8?\ )J'B3Z2?^DL]?@!7[_?\%,/^34/$?_;3_P!)
M9Z_ &O3K_P"Z4/\ M[\T 4445Y@!1110 4444 %%%% !1110 4444 %7=)TN
M35M1MK2+_63R+&/Q.*I#K78_#6U$>OC4YF$=G8 RRN<<<' _G^51*7*FSNP-
M%8C$TZ4MFU?TZ_@0^/KYEU:32XVVV6GGR(HEZ @#)/N3FN4J[K%[_:.IW=T1
MS-*TGYDFJ5$5:*0L96^L8B=3HV[>G1?):!74Z=XJMM,^'.L:'#%*-1U2^MY)
MY\#9]FB5R(QSG)D<,>,?(O-<M15G$=-\.OB%J_PP\66'B#19S%=6K@M&6/ES
MIGYHY "-R,."*P]4O5U+5+R[2WCM%N)GE%O""$C#,3M7/89P/I56B@ HHHH
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M_4L765/B6=5/:K?\3^2L55=/-YU4]%5O?_MX]0_9Q\</I,S6WF8Y#J,]C_\
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M(HYAI7B:5U'$<JRX_G_*O2O&WQ"L]2\/K:V[AY)$V\=O7->4ZI.(->N3)QN
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M>KA8N>%KQBM5ROY)V?YHX^BBBK/*"BBB@ HHHH **** "BBB@ HHHH ****
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M)H?&+R2WEQE\UW7@;7I-%NDY^7H<U]#?\.R?C"&R-$N!_P!MM/\ _DRK,?\
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M_)A[1>?W,^3_  ]XWFA"PRO@#CK76MJT%U"'W\FOH/\ X=(_&$'(L;C\]/\
M_DZKD7_!*;XSPJ%%G<X_WM/_ /DZMXY=B$K.5/\ \&TO_DSR*V#ISES05ODS
MPG2=6C10 _ZUU6FZY\P D/YUZQ;_ /!+GXU6^,6-P?\ @6G_ /R;6G;_ /!-
M/XVV[AO[,N#C_II8?_)M;1P%=?:I_P#@VE_\F>16RR4ME^#.7T.^2ZLPC/\
M-VR:MW%U!I\9DGD50/>NYM_^"?WQTM@ FDSC'_36P_\ DVH]8_X)\_'75X?+
M;3+A!C&1+8'_ -O:[8T*\(<BG3_\&TO_ ),\;^Q<3S6V3/ O%WQ8MK0R)#.
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M%/?WMFVM-+I)O6Y[L())1BK11KT445X)T!1110 4444 %%%% !1110 4444
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M ,&TO_DP]HO/[F?#]%?<'_#H_P"-/_0,D_[_ %A_\F4?\.C_ (T_] R3_O\
M6'_R91_9.(_FI_\ @VE_\F'M%Y_<SX?HK[@_X='_ !I_Z!DG_?ZP_P#DRE7_
M ()'?&C<-VFR 9Y(EL#_ .WE+^R<1_-3_P#!M+_Y,/:+S^YGP]17W/\ \.B_
MC!_SY7'YZ?\ _)U'_#HOXP?\^5Q^>G__ "=1_9.(_FI_^#:7_P F'M%Y_<SX
M8HK[G_X=%_&#_GRN/ST__P"3JMZ=_P $?_BW>3!9=MDNY<M=M:*I!//,=S(1
M@?[)_&E_96(6\J?_ (-I?_)A[1>?W,^&M%T>Z\0:I;:?91F6YN&VHO;U)/H
M 23V -?T._L-_""Y^"_[.WA[2+]&CU&[47LZR+M< QI'$&7^%O*CBW+V;=U.
M2?(/V3_^"9/A7X%ZA!KWB>:W\0ZW$0\=LH,D",#E6=V"F3!P0H1%R 2&(!'V
M[55Y4<+AWA:4N>4FG)K;3:*[ZZM[72MM=BO)\S"BBBO%- HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ>2Q+"V(3N41NQ;=M Y-?:=*VE_Z>VO]=M^BF_O-?UNPHHHJ2@HHHH ****
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MWGXQC;C,MOB1XY^)GP[\:VJ?$3S=;N?!VH7NI^'=),$FH^'-114,=L@CLAY
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M\C$<[>2,C/.0//%_:&T1_''Q0\+C3M0^V?#_ $VWU._FPGEW$<T#S*L7S9W
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M>Y]Z?YBC^(=,]>WK5#0?$&F^*-,CU'2;V'4+&1F5+BW<,I*L589]B"/PH T
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M5)-R6][K96>Z]/3Y"]I*[DM+_H[_ )KT/D&\_8MU>&XMK2WN](U32['X1R>
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M$EANP1\K@REE!R<]+XL^#>IM;^"(]?\ A[<_%2PT_P -1Z7'I]UJUK--I>I
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M?LKQZ+XJ\*ZL?$326VEW-U=:C8I:!4U-FNY[JRWG>=OV>2YD(Z[C@\8Q6WX
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M:/3N]K]+O[-SU3P;\9O"_COQCXB\,:5>^9JVAR>7<1L5Q)C;N:/#$E59@A)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ7\<_L]CQGJGB74/[:BMKG4ET>6S$]B+B*WN-/EDEC:6,NOG1NT@#)E#@'#
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M+9$6<R'.<<_0-%;3J3J2YY/7?\;_ )_U8<_WB:EJGI\K<OY+]=SY*^$W[/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
AHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>business5d.jpg
<TEXT>
begin 644 business5d.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" &S!' # 1$  A$! Q$!_\0
M'@ !   & P$               ,$!08'" $""0K_Q  < 0$  @,! 0$
M         @,!! 4&!PC_V@ , P$  A #$    ??P
M              X.F722%.R#8Z9="'-T.DW!QFS@'(P['.*^^$6MW.\$3"-"
MOO%%BY
M   ."$0[D&:%*R')"FAR=).LG7+IEPLXR'. [Q=E??#M!$BB5HI$A7&@BUHD
M7<                                                        X(
M4D&Q LLA2036BC;TJV-+)><[P[.O,9VIS%G&4C#.I=VGFO5Z5!W^?L'1M4!5
MWILN2S%D4T7BOTPC7O5!'RB11JZYBM$@[X,@
M                             !P02#>@S09V2]B%G'C_ *VWZ>VZ_ES1
M?3NIQK9ALY9E93JM[&$*I&[4V(UMO6*_7O2Z&,JZ;NT.K;-]-H;>GLSK;-JQ
MC[=3Q%Q*/6C0KC5HT$:MW
M               ."%)!L2UED.:6M0K$',K$HV?/^[3W+ELXBLJM'9A7]>_I
MOQM36NRANZF2];<TSS7GZ$\;9TZGH[>6;J\#*<WZ=U@W4;P$>%L2"8A7&K1Z
MZYBM$@[@
M ADO>@309V2UB%:@30<V0;HP)3E;K).W$G=*5NE+VSA2=)F(]L2B8A,0Q,48
MFM=/58FZJYBM&@C0Q&J1H5S$$>NN8K1JD:+D
M                            '0@S2UUD&Q+6(-B!99+V(,[):Y3Y9\4^
M-M>@'H^9I1M[&X6OLVWO:^+>=;D[I,/T0LK4T]NNCMXTYE]4W.?2^?LQ=3.Y
M>[K9+HE-03%*/!&I1XIBFN-!,UUQJT:(
M                       #@@S2]B!;9+6(-B7M0)V2UJ4NLI^UBU*=SQ2I
MT\F[4H'<5CD[F%MCEY;NVL)<J_ LM/;CHZUR:/1I6Y3@O7UMM(;&K7"VO5_U
M?+VHTMNHZB>HKF*D>M,5(U=<U6C5US-2/6[
M                           AY0;+):Q+V):Y G9+VI:>92^RF;F*5MV4
MK;E3=N5.V9R.S.0ME+WX@SS#SGIG$;&=/O/0W#[%=4IE4*,SVK55==5-.%5T
MX532Q/4US,,3%"9KKC5IF"9J1ZJXT0
M                    '!!DE[K):Q+6(%R7LLEK4I99975WL:]_I4O;G3=N
MRG;4Y#9G([$Y6^4M>@2=).F<Q,(U>)BG$W1"<H3^O54=54]2NI:D+XXNGDCA
M<F=Q7,ZZ9A7&K3="/6F:JX\'8
M               '4E[DM99+V):ZR6L2UF)5GQ_^O^^\0.#RK;\_S>N0'!QG
M/7)D& 9 =HXYQGE@<G.$]U=WU-]AW??'Y3XJO<W1F4IFNN8I3-29K1ZJXT0
M                                                 @R0+4M;9+32
M]MDK<E99U'^A>F^2CQ?!M'RVAUQ   <9<G   .<  !W9G-R_Z5?MGM?5CY-X
MV:A&:JKF*DS0F8)FFN+%V
M          !P09)6^R7LQ+6V2UF9:]*S>4?USUWS/?!?%<1P  !V.<N).<.D
M0     ]H?L_K?H8^>>>G*JYFE,5US5"9KKF:DQ4[
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MV.$(QPG+F!BF%21JN4OE#SFE2EJ@QDK9M]<./SMF?(>:\G/KO7^;/\^^=XB
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M(3!IZH'F(:IFNY]&OU'4R]R]GY;/!R8   #G&<NZ?U'%>W\TE949>)HD#$P
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MX."$="4*N=2,8F,1F^YI:::F*"K'TR]J.8*<?(_S)L   .\97[1[7'^SX@
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MCFIL["4;$=$F               #!D&#( 8!G!G@Y8,\'(
M             8,L&0                %%)DJ):8!P< ' !P#2<UW/5XY.
MH!P#@ X !P#@X!P#R/-N#;<'4'4Y!U !P#@X !P#Y^#WL*T =0#@X .  < Z
MG(.#@&!SS0/:4X !P< X !P< ' !P#@P<>91[2@'4 X .H !P =3DZEHGB2>
M\9P #@'!P"&:6GI\      21K.;2@         &LAL@38         ,!&?0
M         #J:KFU0          !JF;6          &J9M8    "@EF&40
M   8/,X          &&3,P         !C4R4           #!YG
M   P>9P          ,'&<0            8V,D@         &/#(8
M  !9Q>(           ,;&20          #&QDD          QL9)
M  !PQRR!;I<6#( !@R      % *_C#.0      .#D %)*L!@RX8,\@
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M5&V%LYE5M6S..SJ:ZU;63K=7#D;9S,ZA/6R5H761N42U5^7=F%7TZ\YVWF0
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M'/,LI1[I   &.D<<2=,9EY8G,.8YMMBXF$96M9&Z:YVO*NZ,YXB[I<G,\@
M"1@FI5]HV2L<Q;(1(DG&$IB<Y*N@YG6,51<V<(14S(   X.L,:71MU^Z-=-T
M(7W#:M7<LS//D9=U=W6V%W.UJW=JW8;CC<7<YFEEW1:L;N7YGNT]SM6WO*7(
M!Q'$K3/S%VJI6N=X7:O$=B6J9"LIM./0H6.5-3W:/3FS>OI7-YW;O+M\>U-3
ML4'HU>KG-MBYR        P#(     ,.,N0<,<L@  ,&1@R   !PQ:W/O\O\
MO1VWU=?"VI9:W:TISD;E$LQD;;HOS7VL%ZT;:Z=6T^AC<25X   ##S:TYRW6
MTKCU]K",-[,&[Q+%HZ>4X:EJ3E8<=C:UJ:J[-^:-*C&-^=I*J]IFR    .F(
M8?KLI]U=HPE.K;W4RUL;BINH$X52"B2S3R[*\:X;J_:,7LE><XWE5B+F8 ZQ
MQQ'.NTHWRE8ME=PPG48I&RN]H64IBQ$H4\7:A%@L><ZLQ=.(9,A+O.8
M                      @0S@#*]+*]<LYV:CC7^J[*<J*G;B3JNH4'?9JR
M?5*]LR    &'J)3.SKT*%O3-LS*BL8LIV:JS'-N)6_*-12IL<71F-[07K*P
M    !@&<,99<##G(PQED&#+@Y    .#G!D P9&#(
M          #!D##&>,X,\@      ,,99  P9X.6#(
M
M
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M=E$"US<!L],[@Q>N[D222V=L6LK56W0ERC/=L$TTKL+2XMU-N P,# ]G# Q
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M\HNGY 2BIHWK>Y*$]7P&R'+)'U!JUX"=+H-D:NM23H98*3,UTGM\)GX]L_\
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M71UA"C--]GU.0JEB'X8/U3&..6+CV[/")^&>)W_ ABQ9Y5]LZ;+CDKZR43V
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MFYC*\%G=MX=@4.)K6)22/ORUQ3M>O/"&'V]XC_PD#<H<_-@&XAX9)'C'\P8
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MT%-54U56+H-5AC1D%&0ZW_\ K#__Q !;$0 ! @,$! <)"@D*!@(" P ! @,
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M+HQR.T1<N.J'YP4\7SB$@CCG7!3=XGG04W&'4>;2AYS%ZK+39UUK W8[M<*
M&*N+L*L/72"@J1\J BZBZ>5%"AJFKSH4BC0U5R5D3S#,QRD7CR]ISB[5-?SE
M8K -/[>CE)V8]<3=$B1LO\Y-)=6X-EP*4G'^(S$6(2E3<N<5R[B@NN=%*-VM
M<<1#WB^$%I4Y#>BILQOP\1+M%YW)^@0C/(TU0XX6WY1AT4,Q6ZO ZJC*N_?@
M8=7<==D<U)N[*XX]NF)<AV:>ECAHDA1J*4 !)]75&E6C23LNGQ*32^=O)Y)W
M[HMQX35AR<RM5X*70W>(<'VZ9;X<4J65)RQ!NSB!HE^;1->FM#GCAS0\$Z?N
M4XE";TP_YN%Y N[\M6,.3BTM7U(TC%Z[?R/*H#=S]$3W&=L<7KX<OW/)NX*S
M&O(UK\GH=%]\RZ?&O-"JD5"-^>6KGAA\3#ZG!XO18*2<AF,S@8/]OI.7TUQ!
MPNF]Z#6%S'=%MOS=T@,%*6EZKJDA/)RR&..,(;[BM[Y%H!-"!A5%55-, <::
MN2(6B];%JH.?BN-J.*M<6A5,G)H;3IN67%8"[0BF>W=Z1"J=UV4IM1>\82M)
M!3< 2Z->^G3G#GC.$<XJG$"&.:O&&>Z@B3!1;=J.4%$M"[O)TF[/FKA2&EI5
M9\P)BNFO&B-7+-*THDX'&F.6Z'Y94UP=EPWXQ2"I1EJ7;H#H76\?FPI7=]E2
MDY2XY9V"$' JK@<]GJ-8D*S;DU:)Q$T"-!7/0U3@K57,4SU1-J0)9IQ%4OWB
M!*4*AR_.. KKV5K3")X?CMB71<*E>-3G<XCGV")Y#7=KO=-6>*+DTGC7S<\Q
M.6H$^F)/2K#[<TDJ8)&B."2=>K&@.536F<<V6K^W027,X"$-ZX ;\_J,4;\_
MJ@* \LCH@7?._P L522#?J1D:8CF-,(JFM;W&.9IB>FD<7S_ /+%&_.RRXF7
M5'$K6_CMNX^F.+4F_B<S=Q,74>=_E@)2,E4&R[A$S=>8T:5T&L!-*Z]7;KAA
MH,LW+]*;HXGG?Y?X0;N97B,C=Q'-!(5FJO.*QQ=O5!2WY_5!2WY_5!0A>1A5
M6O[;E0Y**UV:X8L>:FA>N+37*J2*^F!P:M3] G=XQ'WH'!JU?T"?\1'VP.#E
MI?JZ?\1,#@Y:7ZNG_$3'X.6E^@3^^(_!VTOU=/\ B)^V.\%H_JZ?\1,=X+2_
M5T_OIC\';2_5T_XB(_!VTOU9/^(B/P?M+]73_B)C\'[2_5T_XB8_!ZTT/7.Y
MTT^>F.\%IJ>N=SII_>)V<\?@Y:?Z!/\ B)^V/P<M/]73_B)C\';2_0)_?3'X
M.VE^@3^^F#P:M7] G_$3]L?@S:FM@?XB?MB8L.:EA4(4OY@*O57*+I"KK@*5
M#400?1_;4"Z]6&D*?F;J17&):1L:PI06G:B1,SBZZ*2J0J\,,Q6B14$JNX84
MJ2 9KAM:SBRW)EN4EJFXTAMM1NG(%;B%$D;>+6N6H?A-;?ZX?\-K[D?A/;?Z
MZK_#:^Y'X4V[^N']QK[D?A3;OZX?W&ON1^%-N_KA_<:^Y'X56[^MG]QK[L?A
M3;OZX?W&ON1^%-N_KA_<:^Y'X56[^N*_<:^Y'X56]^N*_<:^Y'X56[^N*_<:
M^YOC\*K=_7%?N-?<C\*K=_7#^XU]R/PJMW]</[C7W(_"JWOUL_N-?<C\*K=_
M7%?N-?<WQ^%-N_KA_<:^Y'X4V[^N']QK[D?A3;OZX?W&ON1^%-N_KA_PVON1
M*\-;9ECQW4.IQO)6RT0NHPK1 (_9(KE"'K%X4"FA39MHT)%5%:7E '!*J 98
MTIAB0"!6)B4=E9V9EIBH&%3M K=(V5'\82HJ4 <D5T9V[?[9UJOHC@O)AQ]U
M]=+C0*RI5 D74J5C>^;GJI6L6Q:+MJ3RYTBY4W;@)NI2GB  5ID*JP O5-!!
MNA-.43Y6S=TQCLC'9%=W7%?D]<5^3UQ7=UQ4^;UQ4^;UQ7Y/7%?D]<5^3UQ7
MY/7%?D]<5^3UQ7=UQ7Y/7%?D]<5^3UQ7Y/7%=W7!N9HK>V;(9>=0M"D\=Q"D
MJ2K*[=4#'" HM:SI2UF4A"U)NS%-J/%G:;I4*IW'C0JC:"C7AHS];^UXR@9>
M[Y8BQC=L6VMNC&.O%.V#F>?WBM()4=7N&GOLFL]X)H5P2N@&P<16'2:\\.>5
M_:\90,O=3RA%F*I8UL[TI]4'W@J2G%1RVF)KA!)26"G*TKR*'+G('H)C\/+.
M*[M%4K2N1]1'7%F6E*6DWI&E7AUI.-*@$X'4:T/."![Y)'_@4V/^J?JMP<SV
MU?UCGC!IE&7(3UP+WEX>^^GJC'?U0*CRJ]$5/F5Z:1=4.:#>\E5W;A6" 8P3
M "O.ZH%?*XW5[G&CT]7OP!3FOH@T5@OH]VBLTG" 0Y@DU(SU>^<;5VSBJ]G;
M&*K[=/;T1Q^W3''[=,!#BLG;BMM*_P (45 W F\Y^DR!]D#!!Z(E32S+1^;_
M *1!\*EZ)^TFI)LWB*ZDZS3;L'KU;8M2VIB><H%+":Y)40G9ES:\]\3E2CC*
M57G,=S5;.V.!]J)LQZX\LAMPA)J20-BJ5U'/ T254!,!Q"TI6TL+"A44]F.,
M+?;:Q>6EL;5%*?14PQ,RLVN^V\VI(SN+2K+YN4&@<-S+WF3/_#7A_P!17U&H
M\L=M4"]6A=N;KM>N%!U&JH.NOLCCQ1<57L[8Q5>SMC''[=/OA4E&"C0G5G "
MO*/NBZ-RCK/V0 1QE+KT>#2*=NW-[F/@='@BOE815!UQ0(Y, 9E67A6-83MH
MJO5T;(/'>7@E(UW:\HTJ:##*J@2([FX(V74S+IM10I>2-(QB.52Z<J[2>>F9
MM?@4O!O@^L;S.OX_YH[[\#/B\OZ<_P#>COOP,^+R_IS_ -Z._' OXO+^G/[_
M )7;"._' OXO+^G/[_E=L([\<#/BZOZ=,?>COQP,^+J_ITQ]Z$VEP//]'5_3
MG_M@3G X_P!'E_37_O0J<X&I'_UY?TY_[T*M/@<G^CR_IS_VPJV>!@_H\OZ<
M_P#>A-L<##_1Y?TY_P"]'?C@7\7E_3G_ +T=^.!?Q>7].?\ O1WYX&9?@PI.
M_O@^?]4(M'@6YG8BFJZ^['S2NN@.J)G@K)3S2IFP)T/) *M"NB%:^*":8BE,
M1O*A#S3K;BF'&R%H-U5XW2"-N&!@I*<HEY5<PL)0"349#+$4KL]@Q@6)85F)
M#MO6BA3F8ET)44JPP%]-%;]6/%QIBNV^"""4C@\IYL8:;NYY-[?<O89;(%N\
M##_1U?TY_P"] MK@6?Z.K^G/_>COOP,^+KGTU_[T=]>!WQ<=^F3&_P"5VPCO
MGP-^+CGTV8^V.^O P?T>7].?^V.^_ SXO+^G/_>COOP,^+R_ITQ]Z._' OXO
M+^G/_>COQP+^+R_IS^_Y7;".^_ SXO+^G3'WH[[\#/B\OZ=,?>COOP,^+R_I
MTQ]Z.^_ SXO+^G3'WH[[\#/B\OZ=,?>COOP,^+RQ_P#W7\/\T=[^#%L)/<4U
MW$_3B,+"W$UWJ6:Y8#C ## Y&U+*F++6.ZFBTV<4/#C(< -*I(KN)!XPJ,*'
MW$I*R$H%XG  19_!67EFM/;LSW @IOI9Y;B@<17.[AY)34:Z&H@3W =A9;-E
M+FZ8:;NEYN\1KH"!CKIZH[Z<"_B\OZ<_O^5'?3@7\7E_3G_O1WTX&?%U?TY_
M[T=].!GQ=7].?^]'?3@7\7E_3G]_RH[Z<"_B\OZ<_P#>COIP,^+J_IS_ -Z.
M^G SXNK^G/\ WH[Z<#/BZOZ<_P#>COIP,^+J_IS_ -Z.^O SXO*^FO\ VQWU
MX&?%Y?TU_P"V.^O SXO+^FO_ &QWWX&?%Y7TQ[[8[\<#/BZ?ICOVQWYX&_%Q
M>O\ YMS[?1'=' NT/Q?N=VREJY+O'?17( T*CTT&'E YVIP?F[.0'I>93.R"
MP5(6V$*-W]FJCUX"/(57:/7$L?\ AL_\W_2(/A//"7:6LX!*?]O3%K3JYMY6
M.%8;;:I7")Q&D-!JB\+P0(GTEE(4@W3SQ(\*+6D $,/+<2,DJ5Q1K- K 8XG
M;$W;=IVKC,.%NNP_9")JU+,"9B7=7H12\03MVQP9ME%LR25IIITT2X,L=1IE
MQL<!D0: "Z/>9,_\.>W.*^JW">6D\_JBR; G+41W4\L2LF,5.KNCBIU\:G-Z
M=E(+O N0\20NUGA4+NWF4I(IA>)3>K2H4D$<K$ QW[X&_%M?TM?WH[]<#/BV
MY]-<^_'??@;\6W/ICGWX[[<#?BV[],=W_+COKP-^+COTUW[\=]>!OQ<=^FN_
M?COKP,^+COTU[_V1WUX&?%QWZ:]_[([Z\#/BX[]->_\ 9'?7@9\7'?IKW_LC
MOMP,^+COTU[_ -D=]>!GQ<=^FO?^R.^O SXN._37O_9'?7@9\7'?IKW_ +([
MZ\#/BX[]->_]D=]>!GQ<=^FO?^R#/\"'E! LAV5O8:;NEUPHKKN%9K=KJ!YC
MKGN"\M-LF9L*:[O; *BS=+;B+HJ0*T*CKNW:D4N@DBJ@4$I5Q2,"#[DE9KEH
MS"4,-EUT[[H0-95JH!CU#C$"#85@68RERTIT34[RE2 !;&7)TJ22:&I"A=KL
MCOMP, N_@\KZ:]JPSK7HRCOOP,^+R_IK_P!L=]^!GQ>7].F/O1WWX&?%Y?TY
M_P"]'?O@9\75?3G_ +T=^^!GQ>7].?\ O0+:X&?%Y7TY_P"] MC@7\7E_3G_
M +T=^.!GQ=7].F/O1WYX&?%U?TY_[T)MG@8K^CJ_IS_WH3:/ LC_ .NK^G/_
M 'H[X\#!_1U?TY_[T*M;@8/Z.K^G/_>COMP,^+R_IK_VQWVX&?%Y?TU_[T"U
M>!:<)FP%XY*$Z_Z@J.X>"MIXR$]WKK@$*2M_7EQR#CEF!E%I62]9CGC15)J4
M.)XR'$^<#B.@T4*@D8PHWAQ?!L^1-ISK4FWRW%"NY(XRCC08)!5F"<AB1'".
MV4R+*>#LE3N>731:T"AJKC'C#'E5KCCC7$Q6N9KS^$((JH4VCV1)225I&&J!
M9>.$.V0J)NRU)$3,N40UJ[;?!L^=<D5)F&U*O(-0F\;I%<<,LHME+5KV4UP@
ME0G24I/!-*BA#;=<L<*8 5U\D1JO9E=*>R$/,\'+ [H5=-I6FCB XD)0?)J,
M 4X[Z9Y4F)AZ;<O+*C4DXDGUPL)N 5A"FVQ08DQ(2C[ZP4I)!.R&K&#0!(&6
M,:!M I=3Z!"I)"AD/0(F[.Q)AQ*FX!K[RF@5I[QT:L2E)(*2G++'.+'M'\)+
M-=L>;H9A@7I)2L^+51QYL#N,.I4A;DNL4(*D>@FN7KC@Y)MR,C,6T^ >Y .Y
M@L8+4HD*50BANGDD5NJ"M8!BUK7>GW<U4KM-(PT>.!_F)RK%@VVN1<T;GC&7
M>(M#G'3=5Q"JA!Q2GTA-VF13;EDHE9EVA\2_=6DZJGCJI3G]D-*+4E->;=(&
M_BT\/A&ZK1IID:DTW  5])],%3:\"<8=6D\DP\58TA [GJ3$X_IC!A-<^VN.
M#2FK1DIRS9TA 6@J84O)*FP5J-3D"D<8[@?)%."5N-V9P@%G%5V6>4I"U:JB
MMPXY<:E::JC7%?)\DXUY\8*;IH>3X<GQI293YRO4E%8LB1[MG694\ENJE?6^
MVNX&.$=LK>=-DR:J6?+YE'%O$#&\10T"@:4P\KS:$A7(Q*=?\3_,1E%F6F_(
MOA:%%)!%<3=4*U*5#+M48Y<)))F=EY:W&.3.5[H2G)"T$(K1. JH&\<BJA&)
MQ-2MMM.VG-LB8=3P8L9O0T[YS.+PXM4[!7' ).'/768>7W:[W0I2KXQ54G,]
M/@.>Z#%8T?;L8T?;L8EFQJAB3<<5@,##=DM(%2(MEEIK(4C31IH+M8=<(JI)
M(NXBAIE'!BVF^$4DJQ9Y5V9;2KN!2L5<6JG,Z5P&LY&E16'FBTNXX*!*E)(V
M$$YTSKZ/!X)@MVCIP!>:9>-3O04CU]L8>7686M[C*<<=OJYE*IX9,-B\1SB+
M+;5=%:Y#5 3164.7=D6DL)BT#A#.)]/@\E;3'EK"J>L[HX,J4FR[8E:U8>2F
M@V* 52@^=G2&P.Z$M$\IU-S]Z.'#JS;")<G\G:06T@X<=H%6Z M(36F,2LFY
M.*P"J<QI'X/K:=3?/08LQN7DVA5(4:0M\JA+6DQKUP&J"'VJX=$6G(!":TU0
ME%">VWWG%D:0\9+V"D[*183W<MH(4T<Z@*^<*&+:0A%I.I33R">=2!7TFIZ8
MM1Q3?!VR)9OBA>G+]/*X]4QXO/9 &EP'\Q/%SBH!!&WKBT2J>L&RZ&CH#@).
MQLE ]( I"7 N0<;IBD+!WT \.?DTSC*DGE4)&VNSF//A@3$_9CTN^I.*<>;M
M_M"992<28?>0ULB8?TD4S@PS%I+<EY)4Q*FXH7$H(PY1NJA_@BZUP=D[;:5>
MFDH#[I1GQU IH=>!%2, 33>>!W"QFT)9,E-D(G$ -C2<6_3!)&0OY C,X''C
M4YR"-5"/#D30.H.U?U$&.#J] S/VA3C-I5=KM*%)&_,XPN\;Q'E*54Z\_9"4
MZ,\7DG/WNAV10[#%#L/H\#**B+/6MS@Q;#"R3HRQH/D\>IH-66.JNW&+.;2N
M<:O8U<1OR(S&\[_3E'">9+MJ$G$K0A(3J%U ',,(4!HZMYIY?3E[M3#GNU@&
M$O0',.WV0RO18Q9EJ,HH%4COI)JV>F+;F91RMW$G9C'<JCDE7H.^#*D9@CHY
MX=;NPO7S18#UVW91;9N*:60*8<O ^F+?12T9M) "*-*(&%"4 DX4&)I7:<37
MP>#ZKKKW]TOZL/&H=_O%?6,#P@*Q9\O7&F.<6;.S95HUIH =@U1,6M+L\1SE
M>V$3[,RG2).0BT9CN@E R3$Z7%E%SR;T,:1L)#FHJKT^".6D[ ?48X-JHQ.C
M</\ 5#7Y2U_?)_\ )'"DWK:>.9T;6/\ VHE)-4U1 &OVQ94F).3"5)%:;!6+
M6?#T\ DD8ZB8EGUL$;(T_="KHUPFS5A%_&E*PN\5TQSI 9- 8M==$'FAQ?'/
M/X+395JCN<TRA3)&J"FD#DQ(_"H^<GZPBVL;16?[K_QIBV%5LFRA\ES^:OJ_
MX#(;:O\ _D,.FDLG?I:[\![O";A=)<'DH;>94[,G%+2%&I&J\JBL== .F$_R
MJ56C3V),2[66F+I4*;;NA'UHE.']@S*PWIUM5UNM$#F%V^1VQAB;DWTI<E5I
M?*Z*%U8I0ZP*ZM>NH*2*@B"ES2E1V5/HR[==3%O2;3\HN84!>;R(V$TH.GC>
MF)KQ(,33I63!))AM!A#&D&,2LBD*Q.N#P3[]66[+LUO.A%R@S4E::]%V\:[0
M(L2S.X+&E[,FA4RS096%<:]JQKGQ:5&6K'7;G @.K+MFK2ROE702G'/BJ]04
M<-9,+LKA]*)")::=*4Y7G4J%-E5+I#_##AC8,PEN>EN[ !=+:DH:J*9E:0E1
M-#4*O>D9RG\J%B:$*M5AR1=IBBI>%?GIN^BAZ3%A\-;%MXW)%]2"J]<TB;FE
MI6H1QE5ILPYM48YCW98\=[G_ -*8LM5)2T1\C_1"N4KG/K][DI5#RL=9$2O!
MU%!4;\ML.<&T'4!T0[P?N)Y/5$U9EPY1-,%!\"R57;$M4;;D69A.,G_J>V+5
M6%6@KB5P'U(2KE\2$F"*PX:0X:GP4P# =@/4@S1\X^F$3%2*XXZ\89MA+0 *
M4Y;!$Y:(?. '1A"]<.Y'FBQR!:K']Y[8MT_C[N]#7_C3X-B*HM[YB_JF":I=
M^>KZWAC"+&HJ@I$O+%,[=*1=I[(G++;F9TI.P[=D-6>]*$H)-*Q.5E:J-36)
M6RIVUTN&5J*$=9WQ:-D35DK6)DUI=UC7S>"FEX<Q]1BP%41-#:4^V$&DPS_?
M)^O'",UMIS84-?4$6 PGNI((J(F5@*#:<J4ZHG+,6U/!>)%:PZZE*DIZ(LN7
MO3*.<1.-(:E4T'DTCN(7Z[3#B+B<HMP428IQSX &(&\1*250*#,0[+A&J'F0
M(>%*P,CVUQ)?")^</7%J&LZH_P!W]5,6DJMGV:-FE_FKI_X))#Y3^'_<5$R:
M,MCY_J$"": FM,,XFQ*6IPK:!2)H-J3?"A5 *!CAQN(0D$URQK@*F8LVSYF7
MT+DHPM-*7=&D4YB!Q?V:1.\ ;$F$FXP999R*%*4!T$U_S0]8=O<&G--9TRMQ
ME*M2;PI2I20JNJN8HJAI41*\/'E%MJ98"%N417C(HH&A)"KU[JI%L<)95#;<
MF<=,FM=5<^G5F8?5W16'I:Z3")7'*"V$#9"7M0BQ++=G5)-#0D5PPI%B2Z9-
MV7;:%;M.G:8M)N[,.K6*7Z4 &[M6!>SB\LZ\.B+1LFS;3%V<EFW4TR5RA3S5
MIHM(UT!'-$U_)]P:G&RWW%0'4EQ=1NXQ5[3%L_R835F.]W6 \X-&J\&$5"@1
ME@%<;G&.> C@_P .9J6*;-X0!27&R&C,*%%I-;OC4TJ36E58+S)ODPA:7$)6
MA04E0"@I)J"#[DJ>.[SGZJ8L]5)>?W@#_*(5RE<Y]?O1QBP[.6\4KQU&& I(
M V 1QC#M%"D34G>,6VP&MT#W;/5=LFTAM*/4(L_\H:VWO;A$]9UI.3ZBELD4
M&7S8[UVD+_BE>B'&U-\H%)W@B J)C*,SX.45.R*'9!)&>$=,-)BEZ.3"M</9
M'FBS#2U&/[SVQ;1K..?,:^HGP;/--+S>PP]CI>?V^"54A2MD>.6H7LHL688E
MT<?.G7"+66"3=QRO4QH*TQI77UF)*?0ZNJJ5VQ/,MJ3?33*)\J<5HP*XTVZX
MLM+5D2"YERB5%-:=$6I.*M.=<>43<J:5/@JBR54/2(1\./[Q/UA]L6VO\> &
M=$>H1P?EBVBNLCI@MN!=:5B97<3QO3#$HW-+)KC$BD2BQ75#D\EQL"NJ$*JJ
M)NEV+:#I"JC" **-?=EI%ZU'I9IE=P@JV1,R#TE.%+BPL@)RILW1814H44F)
MN02]CE$W9R@"=0B;30D;(')[;8E_A!SB)\UF2=R(M!59.6 U _S6OXC+"OZ7
MZQB>-'Y8;=-]6$F'D!8(U$$4RK4=7/$E*L6#PM*)E9N6G7N!U7DJ">,E>>U3
M>JIHL428Y(HG%*@#S>X0#@0"-XK%L<%9&TU!^@0\G$7105Z,NOV0[P:M!WQ3
MB:MHY"JI4=V(J=4.61/,CCH(%-F8$.,E)HM!KS0$H9\GJA]H3')2=V<6+P:?
MF%A3R"$@YD81(R+4@TE#:1EB2!4FGJV 9;SC%E(/=\N4"H<*KO0#4'UXQ;8>
M1//(<216[CD,$C+5X*A=WQ:?!==NVU;+Y3HVZ2^CU%2@V:E- !B4DFM*5 XQ
MC@E;CEFNIX/6@5I7?4B56LDUXW)-=1PN[R:\J\F@XJ1G3'IQ]4,'\9(^?]41
M**I*OC?]D*Y1YS[W8IG;B='R:#9E >?".B.^3[:CC#%HI=^'-(>M&1;!NXJQ
MIG#MDJMMI*5 C/+97"+<LA=BS(:Y0YO2#MVY>[**I)3:=X]D2)NS:5'(&OHA
MKA/9LJFZM *J4QSZQ!X66;B=$G'=_"+<M!$XNK8 %=0 ]4*P3#N7;9&L>Z<X
M.<(5C"'0,(SU1:0UB')BK@Q,2+E]L<T TA.,'*)C(\WVQ(&DVQ_>?ZHM#%\_
MW:/J^#)F@<YO884:Z7G]O@O*I""3T_QCQZ%"]ET1989< OG&$2K#B/)&&V'4
MJEUFX=>J&)A2I12EJQ UF&)IM4VJ]3BFN,6M;2YT]S-*H@8'HA6'B4\K6?!\
MF)!5%#G$ W7*_P#4_P!<=R]VVF,">1ZH993)@9"@'JB:MEEC9Z1$_;@<20GJ
MBS;5<#@XVN O272-@]4$E*1C"%T5G$W,T3S1:UH-.)(PK2'*J5495]W@LACO
MNE#[EP 'ZM8G&V7[6F0THK *=NKM6+.#;:0,!U1=*M<3J$]SK.&1B=7686.>
M!D>VN&.6.<>V)DU=K\V)E56F4[+W\U0?Q27YW!_F,6B?QF4WEWU)@>Y_*!8+
MML6-?DZHM*0(?EUIY5+X+J-7*0*UQI<IA>)C@=PE[^20EW:(GV$A#Z58$J2;
MND"3M(XX& )32B2 GW $Z\]D$DZL.804A6!$.67(NFJVD5W"GU:#U0Y8$@L<
MC'MJ AK@_(-D$HJ1T=7\8"6@ &TW0!00D$G6:G4(LR118['?&;Y+J29-*N6%
M4HK#,9Y4RQYK74W.V5(3B@!,J+P6H:P%&[CLH*[CAX-VO&.0]G:O7'BR5%";
MI5RCMIVZHX:<'.[I7OC()NS\F+[=VMY=*<0#6J@NI&O #5' FWU6]9.E=J)R
M4.BF@JH42%$(7B/*&&O%*E'.&?RK]D_4A@T8=WK'K$',\Y]Z)-[BQ9"IZX+F
M5-VJ&5S3B36L&5F5KK376$R6FIF(9LN1;II\3TYQ)-H;=2E H(X=NI[[A!ID
M>L#[/=;5=9F$C64].4,?"@[CZHF@7)E*;NR)^3T,LE03C%#2I@<>'>WHC6/=
M.<'.)=N]"I50%2E7H,# Q:0XO084->NL6*Y7 PLT.$-'MZ8,3&1YOMB4!$VS
M@>7L^5$X:O'YB/5X(-&S\Y/U3#F/@NF$&D)4IS!L5B2#C%"X"(+S5W!>K;#T
MX$' UA,PJ9305I3FB>062<2*P@:X5K\%<2ZJ$?.'K@JN8GSO]46,PF5E>[E4
MQ%<8MJV]+4)-.8PN:6O&I])B_ <IE'!ZT=-*Z(Y[X6O1HI#3B7#GUQ/K"$9Z
MC$XN^L\Y@FJ:0H( @K1MB3TJ9@.8C?%C(+CU\C/7T;8F+,5I+R:[<(G)B8ET
M!*0<(F[0<<9*5880]@Z2=9/N#.%FJDG=[8=55-W97^:MJ&BILKT8XQ/_  DC
M\YWV0/<NFA4<C%L6*;(FN_=CM^.K>=:2.*1C>P%.*4U!V;1A$O\ RA6,%):M
M,+E'<C5#BT5IYR02*G "Z0,*JSI)VC(VBV'91]MU! (NJ%17($5J#N/HA->?
MJ@I6,D^"0":;,XX,63IWG)U[\BD@%NJ.1-VJ1Z1JSU[[=MA=J3%4FC:"4(0G
M4 ;N VFF--5(M5KN?@[8R5CCOF873<%X>D*'AY@)\ZL6*EJSN$=JV;Q4=TA#
MJ4TI4MTR V7Z]$)PG.@PXL(6BIPKCU0IT5--I]<:2-,(2JOAJQ4(X.,Z5H?-
MB280D$.4&><:-"#Q*&&T ?[0M.,/V@B19<>=4$D).)PW1:,ZNT[0==<KBHGY
MHQHFNX4KMQ/NMK%VFVOJ$,X*4=RCU0J84VZ%=LHFK0TS03$U/-2G&<=PYH1;
M4C,93 33/"'N$%DWN(^5#(T0HY?QAJU)"9%)>8XVPH/MA#6E-1C"I8QW,8[F
M,21,H^%+3I!7*)BW)1; 0;-O*I2\%=>43CP2Y@* G+GU0]+]U-B%6$D8Q+V:
MEK*-'V[&-'V[&"R3"92]Z(9DPV<NJ%<E/-_J/@K-&C\\>I4#'P#!QS]RS'A*
MS"0YB"8$DU:$NDM4!H(G;&?E]9(W1+V:MX\8'T1+V:EA&K*.$*[JR!MAE^N$
M5!'@G;"%46GYZ?7"Q>HGY7MARV2B2$H#JIA$PN^<3!("8H8H8L6>[EF C5U1
M-VSXRZ.V$"UEM*UQ,VJI].>J*525& [QR(>6O;#(4MQ&.:TCTD0_9;4O)H>
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MS2L=L#B)C5$SGVVQ4Q4^ZX:)$6[,:&SR:TXIA4RE2U?./K,)=3"5B$O1IZ$
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MR$UY84*'<:X ;@, .,0=^(J^A;X8%:3,L*)?XUX [22=H-*4%.?,RZ=2X5$
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M/_V9_P#0A>C5N_8B?_LK_P"A$[8UKRR"X_)3;"$X%3LJ\AO'[8H">:IA3?\
M&$U\$$0?#!%8([)_E2F! [ $)H<1UP@.A1PO)41=&T5BS]'[%T1L=&D6F3';
M<V\D+L[1Y2U,K6 0I+LT4@*!/%5J704H23K07%ZIJT^&'2*8;$O8NHL>ST<5
M$@U+R[EQL8( =6BIH *7;HYJ1\\O2_[*J_L[/Z$?/*TO^RROQ#/Z$?/*TO\
MLLK\0S^A'SR],/LNK\0S^A'SR],/LNK\0S^A'SR],/LNO\0S^C'SS-,OLTK\
M0S^C'SS-,_LTK\0S^C'SS-,_LTK\0S^C'SS-,_LTK\0S^A'SS-,_LTK\0S^A
M'SS-,_LTO\0S^A'SS-,_LTK\0S^C'SS-,_LTK\0S^C'SR],/LNO\0S^C'SR]
M,/LNK\0S^C'SR],/LNK\0S^A'SRM+_LLK\0S^A'SRM+_ ++*_$,_H1\\O2_[
M*J_L[/Z$6?PMZ8R"P\Y.-3#6UAR6ER",J%5V]CS$1+_,YPF-J$C*L:/Z3W5K
M$LG]R6DL56LJNAMMM2@"5*2$N&M5!U*;IGI2:L^:=DIIE34RPXXV\VL"K:D'
MFXJDD4(4#0@U!I%V\F^?5#@3T'#P0<H,*$'*#E!_E.(&78$ 0F!=O% P*A4Q
MP;6;+SFD F[3%;-LAEVT7:UN7I< 2P<6"* 3"T.@&H4&KJDE!,:8:2SVDULS
M-H33I<072VED<5M#;1U;:4@8<A()H!553A6":*P%!L\ML5/<Q4]R(HKN?#%%
M=SX8HKN?#%%;O#%!W7EC%!W7EC%!W7EC%!W7EC%!W7EC%!W7EC%!W7EC%!W7
MEC%%;O#%%=SX8HKN?#%%=SX8XW<^*,=WBBF:D\D9$Q9\_,2$PV\T^II2'$+O
M(SXB@K8:XY&-.4RMMV#HYIK*T3,VHT]*6LV!2C\IQ6%TI]<0V[>4N\;B&PD)
M-XD !*;N(QQ[_P ?9,'+L'^4X@0,X$"! SC0(4T3X13M$A95#S%R=J/SPOEK
M]LKQGTCJK%4CUG?5%"K$1AZ\X\WILKZ)P:\;'56@SJZ^LK>'$W$WU _:J5%,
M!"H.<*A4&#G_ "G3L@0,X&4"!"!&@HIHCPC?>5E?"SL+Y:_;*\9](;8=?4$R
M[:EDY74DXQ9.@&D=JT4W+$)/=4&'7C#? ;;CLN76U4-VM#3\\6_HS.:-S!8M
M!)!J0GBT"CCMY]W1AZ;9X_T:K_"#'OH7@!"]L&%0KL'.#_X5R!1(K"=96I(I
MNB]15U(Z<S#E48H07"<^,!XXX_-''YHX_-''YHX_-''YHX_-&/-'&YC'&W#O
MQQMP[\<;<._&/-&,4A05A=7=YBFOAC)-5TYZ8P%)3A3BGO02&Z!(@T.)A2TH
MIQ3X3'%K?":D\^,8]C'FCC1C&/-&,<:.-O'>CC;QWHQYHQYHQYHQ@7]L$*_/
M%;R*MJQWYY<T)4I2:*!/VV773LJ4&R"36]@ (NH"OYQ=?!X(X_-''YHX_-''
MYHX_-''YHX_-''YHX_-''YHQYHXW-";W- KS0D_:P#]K"105 Q@5";UV^>YJ
M!3OPCE1H3])_"+]Y65\+/0OEK]LKQGSV=*F-'-'W[>F4RY2I+((JO+IH8T?T
M1L2QFTT#:EA(J5)!->OGBSPB\ PA(2-R0(7:>J=2@9"G1'"QHPUI)8PG)9*>
MW&@5@) O8=&.0_7#TN]+*6EQI7$44U((R)&6<2TG.3F$LRZZKN4-+5X0*1,6
M=:$B*S4B\R=A6A2>O*$FAO'K])L[^#5S[_8\<+Y(A8KA2\-NSPQ45I>I393X
MX)^U@G[6#>YH56./S1C''YHX_-''YHX_-''YHX_-''YHX_-''YHX_-%U)5CB
MM.7- 4%DXY;^R35%;EXC9EX8%74<=%.:N<<>!>CC;A'&W"**BBN:*'?&,<?F
MCC\T<?FC&,>:.-N$8\T8\T8*VQB/77N:@_/!44IO'/\ 7"KRF[S1QYZ8]_SM
M[BUC1?1"UM*';LLBXPF\7YMXZJ58"1>(4X11;ETBC2:JQ!-$DJ"['X,]'#]'
M3K^DSH2$NLMK<D&4NINE=W5$.C$*2/17$@$[:*'S0\%%[CZ"3"4]UYO6CCU:
MZ/-_@F]@\Q[NVC\M'F_P3>P>8]W;1^6CS?X)O8/,>[MH_+1YO\$WL'F/=VT?
MEH\W^";V#S'N[:/RT>;_  3>P>9]W;1^6@V]P3#_ &(F/=ZT?EH-O\$_L(F?
M=VT?EH&D?!0?]AYGW<M'Y:$V[P3G_8>9]W;1^6CS;X*/8/,^[MH_+1YN<$_L
M'F/=VT?EH\WN"?V#S'N[:/RT>;W!/[!YGW=M'Y:/-[@L3EH#,/\ /\T%HH_]
MZ!:7!1,BBM%INSKU15%KS;^KKZZCLR 2*U H1O$3O!M9-K2QM#06V1;"T(*Y
MBR9A*69Q*0#532U:I#],!=#:<0KT52J(AYO4/N23S:FWFRI+K*T*0IM230I4
M%4((4DA23BE23D8J*55LK%GR$Q;#[4M+-..O.N!MIML54I77@E(Y2UJ(2A(*
MU$)289X/=&]'F _IG;M9\!*_,>S[I)!%X-.S0!%5MW2;NINDJ2E:\%E4YP3H
MP1H<^^L85\VI]%[G]6PWX&%6EP4I_P!B)GW=M'Y:%6UP4I_V(F/=RT/EH5I#
MP3#_ &(F/=VT/EH.D_!,/]B'_=VT/EH^:7@E]A+_ +NVA\M'S1\$WL(F/=VT
M/EH^:/@F]A$Q[N6C\M'S1\$_L(F/=RT?EH^:'@G]A$Q[N6C\M'S0\$_L(F?=
MRT?EH^:#@G]A$Q[NVA\M'S0<$_L(F/=VT/EH^:#@G]A$Q[NVA\M'S0<$_L(F
M/=VT/EH^:#@G]A$Q[NVA\M"+=X)E8?,1,8X?O[:.W^NAO1?0'29+K=@6JJP[
M7^L63-J4_*K6:74]LJHX-8J@JIQ=%'!M0H@V_8%KZ/3JK/M&5+2@3<=O!3;J
M-CC*QQ5H4,J*J#Q5I0NHCQPE)4H)2*D[(LG@V88DA;6F=J"PI)3:5LRH0ER=
M<20K-./:YY"KJDNK()2M+2@1!G>"B1:N^8$Q;+@XJ9DVG.RRG*'%2FVEMH!.
M=$I2G<(\W^"?V#S'N[:/RT>;_!-[!YCW=M'Y:/-_@F]@\Q[NVC\M'F_P3>P>
M8]W;1^6CS?X)O8/,>[MH_+1YO\$WL'F/=VT?EH\W^";V#S'N[:/RT>;_  3>
MP>8]W;1^6CS?X)O8/,>[MH_+1YO\$WL'F/=VT?EH\W^"?V#S'N[:/RT?-!P3
M^PB9]WK1^7CYHN";V#S/N[:/R\?-'P3^PB9]W;1^6CYI>"OV"3'N]:/R\#2?
M@L]@DU[O6AU_ZQ"7>"VW'TL-,S>BJ#D]VU,3][>A0>4\0DJ-2H)2:CE@YZ2Z
M#SUA,BT)5]JU[#=5Z%:<L*)HNA3KVDJ46*K46T*OJ;60-8M#BD-J1RQ&A7TG
M\(GWE97PD["^6OVRO&?/2$DJ>F&Y= ))(R$:,62Q9DB@!%';HJNGQPI]I2P
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M]<)T?M)'JLL37+'?"-'K89XO:%V]MUJ>J%V/-RG'=ESU&OBAYS4S%#A_E!G
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MYX]:?+?V0Y6*T@*K!-(T55^S%F_?"??B.%G'3^WC]M9W^%2/G>"97[8)_P#
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MO5VGOF*)[KQP GNHH(H(H(H(XOE6.+Y5[.&^,-\3$Q>P$<^_SUT'. W!;$%
M7"%:C*.VE1VT8[;,"<5Y&.WE^7^<=N*CMY4=NJ\O\X[>7O$=OK\O\_CCM]S+
M ^6^OQ0Y,%><!V[ G5###P_G&?E6%N5[(%"8;FW&3G'FB\JF/C_/!M)SR'ZX
M%I.;*>77'FO.9BE>J+-TOM6SEE;.K!^V23XE)CYXVD?\>U^*_P#DCYXVDG\<
MU^+_ /RCYY.DG\:U^+_^2/GDZ2?QK7XO_P"2/GE:3#_66NC5?_G2/GFZ3_\
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MAS[^KO0XYKIUY_'Z&0@(! ]$"TT-001Q><&'' X6)HJO//(7>!H*<I/K4I2
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MZ96W4KA7992GPY4.HS'*,Q((X5/?.)56B=A0C-SK>$S)G=;;TV7'6G'?5?\
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MCL80;(\1$E)53PK<38?S*5N)K^@['B'<[N*TH_#5PO?V9O+ 4@ISLIN+>2
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MX[$X1<H+HAT&<_$V?8F\R->IJY\_)_@E4_\ ![=3RC2!5R-5+^44)+*IR3K
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MT-3)QY.?#?8W6GV(<-DLCLE_,N_I$+;8]-0'?W%B&%>FGR'A3<VY'<9W^"1
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M42$DRJ*CTD(5[KS)/\%J?_@]NI3_ "ZI7Y[3[)]CZ'4$9 1>J#AF\X(<2GI
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M]ZVDSS*N^P@B)F)=]AW+8P)<FHQV_" O]JV.<=WKV^S9Z2?19'.N/B6!T%1
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MZ@0Z!2VL'M?:$@@K&T]!O1-P"+D^5Z/9;3OX+4_^JC6NS_&$W\V:\S&V-J_
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M-5QX4[:V2&UE5Q5PWK@B</$5@"-S$CB$2<ZEE,R(K*8]J/3U3W; '^M86\,
M;S&7KE:?/0UP>CLM"G:0@$ _5M&F26 /@)E\<HX&+V<.(?=6=H,EQS8'U;*D
M/DI'H9Q#SFZ6?C8S]B<<U=+VGL6FD?2=5<Y'E%$R_P""SCCA-M-LIF>D.%D
M! 3S=/H62!="(PC0<$RO2&2P<(.YB"?*/=RWM#G)<'IMJ/1J=&1N+#5MCD>2
M4\[N>0Z1!W;AYK20>I[:MM+N$C?4 R9_'T[9VP$([ "Q$:%,$RL\B/#X&0;$
M:J7-F5>:T*9J$ABL@A5"W\#IY>+_ ,].T('24'IPAI9DX#<,3,1\MS(7VT#\
MWJ<^MU1+N+^..SGD%^3:@JBX92J6."X</7:?;35<7U9(F6T3' >F3IV*2\B\
MJ6+:*O<VWX\]A<#F7ICWQLSDWIJN$.'CL'P^_M&DIS2HC)K[8' 7Y/F1H,=T
MF6\S:3'&LNKFD\<=@2[C@$GW=/E>P>J.V:&.2HD24V(]K 0SF%IY[\P39"H2
M=KE[0JDP^#:+'<<%MU"R..960D#F#H'R0GV.V@U$;>5Q,HY)#"8D?1[,;?=V
M9HTHR8DP19>?P](F/$;SK&J')YX^9IOD[!1ZDS(D@ZKBNR8R8I&++D:+*9MY
M]0\QNMM]B[+V:Q5R7.C/QUU%99:RG*-PQXAV<],V3X1[)I-6AM7?C2Z=19E3
MD!-DF0H_-; 0-IK@["PYE=],Y71LT;)F!QU;-HA7>#@%G$A][:D5,\PN/I')
MY%0DY;-DD>XUQ*U0FLEE?;K,IAL^^.7L1>)PVJDH!('&&*E"E 28(DB/%/-D
M\1S,+GN[743_ $;_ -X?M?A=WU8_Q6W]KMVW8<^.*_DV7'[&/>LJ;L>=5LN.
M;<F*)Y%N'@PWBHK@MLNV2<BH6 ZQ89??V7.9GY2DMMV[=O\ 7MY2;UY[)AS(
MG;MOXLVZS/!AJ9D7'R;,N@VG@F2+N7P;-JR&\2'$D_6M2)T<U)*7IMOY?3!,
M<CK7CA8KS06&VY.5O.B;L[(#DXO'M_T6CKSIK;_>GYE:7_-87Z1K%J?ZU#OO
M^C(/T)"%<%%45%%<%11[:69NI>.9'AWUIB9;L7CG=*HL\?[C5&1V0PXN2[(Z
MVYD>9U7%DM.U*$]39(WFAD<%L'',D2%G @ER).B7GD-$AT>4V20R]JXKR2K2
MJ_3:@Q,TG)L6HTC(Z@NQM0!FL2\^I'DP:LP\0-=DZ!ZS7)MN.JM-/5HU5C,U
MBB.8XEULG9R:8=]GAN"[ >]EC.6O'>&JOG%I=UJ0Y--YM!Q=J#V8(,4<W=OY
M'<,.4U-/"SCQ[S<,G"^R99OH#K;;SC;;PH+P 9 #PCS"Z(]/W5JC[144_!I%
MKN>M/GK_ &9OS/L67-:H,^K1!7#OY"/_ !>;NLJ.*64!QP1<,;))CDHHAH)!
MF)<<_=#;NK=USV0\A--JF.=W=B/D]DM(I=*1#JL2G-U2I8Y082.\X;,3,7J\
MC2=TF_36HQV4'HKH%TNCN7QA(+9S%4!.X2V<L!04QQ[268FOB22:D8RR$]RL
MPXPYX[67RR%SVT[5WPXNQRP+MHXS,9RE:[$O.1;30:6[CF[HX;.:W*9O*'_#
M;J3GF0D61>C##-BG[G1^E:^7\EKP?HF7:[?\2T_\U"U.BXX;76H^*)VVV6))
ME^K:[=+N8U-CW@G,PX>UQ7=%Z-*F/AM#^T,FW(>>Y+3V=SSKI&=EJ-Y:K52I
M;.6&KJH4]'I9M9VBY$-0#<V=W2Y32X^6M O)0"@TZ3UN&'4*2+1-5-]\)[P$
M3H@&SO!H''<:<U'77?\ FUFJU6..F4DA>=!PB19,AEHSA11\/C%KD_4@MGW8
MYLW$@JF;-GZ-HS<<A8.,D>4_H"+0O%):9>$G1#D\C8$,=UOL6K[9:--IL-[0
ME&R\)ZXFPRYJ^>(I1]#4#3,2[))\#U2V5YEMY"'+E7F\G+V.PO-TW965:%2-
MD>04LQAF+(&FR?L?F29YKAA6F8X%ABH9&))D0C[D+91^RJKPB@]T1%W 6R-/
M. ,=<J(!$B*X'2+[8=MSCB)@(GJH.DF?HB1=W[7V7V*S*.9-8*:4R%4&0%-O
M<9(^N$60&34SQ\NFU_!@]4\S(R!.&N94$>?@'BM/T#;:,@>;$C/2Q(Q,QY7N
M/I<F]1SDN.U-430#*JTEDD5<%+/*C/$(>'P2/P+79^S6O^T-5^=NQ_+BC_F-
M6L7V+&V2[BW6DSV<-=Q&Q0N\V3[(.E^&/X=GW!7'*)/+A[40'9QG?PK%9[KT
MEAD/U;2$3H@N5=W@#9P\N*YLV/C<>4?M=D/*FY,WK]P=F);*>>(N\2%.(^$.
M'\JVA5FWA898%(CK(\O,SCD&&.?DS/./9.2TF@-Y[V5D):;+#)WD8+*\"-AZ
MJ7IQ\79'+*#("(1VO%Z1_P"Q:9,P0Y,<7-D8X<[A9>(N/N&_U[&9X(+A;Q3<
MIEXWB6YMPI@(_P#GRK$O=$F"I:D B]DCR,V__.3,B_!M-WKM-)'&*:;US1O/
MD3^ZD-^[M&FM="2R)HB+C@7=#]K/,W[CS.IY_P H-WE_''8_(+\FU*95K$46
MH8%Q)TZC,.S)EO\ .;C!;_ _V+9!W VF5$\QHN<.8M]@#'A;=%Y"[[9M'9F2
MB"@M2Y#2)S<F?&-G7G%X& U"'NEX@ 6O+<,A#W=GI+G$^Y*VLD]F/6#+Y#>K
MI^XL&?\ RI]D645>Z>(/PV\WX=ICOJLB028+X;N>TBG.;B!"-@NV&<3 A&VB
MYPN-KN+M'DZ)#:GR=+D*@FC(?#<L:9W+N7NP<X;$Q)0<Z)F P7LS9]%T?_/<
M'8')@JW$Q%19),-8>GQ>)G'[;9NBQ*2T]&-V&IRG!'=LSX/"4=H/))OVHSM,
M=.!%3E\PN+':X,A>E<'!]KL&[#5>S"*=H0+AM,DY\F-Y*XJ*J]RR60B^U@+M
MI3;J<M.ILZLEFYUV_;,W]7E:M=7^+?\ 7.VOGNYZJJ_E63O*G,ML.UVELO$O
M?LJXIO''FMPKVUWVQ[VY;)EPYBQWVPR#AAO54MSKTL1[R66R?T*N'-;/VL-U
MF7N?(0JG?Z5DZ61.+A'?9R.R*,D28YTZ?'XUC4S)7"WH1[^4M=UZ#HM5!W/&
MF(/35P<^J1#[WW]ID?!.3D. J=_BM'#?D5S'W67S*PO?B1?TG6+0E[U!OK^C
M(/T-AF+CKJXFF2+AD45S:F;N<G3QMG=G0WJP3<*EU)UL-*>\U#AY!<+('&'!
MIO...:NH6CV+L=A'>2]$4Y_YAM HL1P7)=2K^I?%6%$]BFLPPD0:'*(.@<9O
M2<=;_P"% _\ 0JG[7/\ R*3:@+WID]?[,/F>O9<4Y[1P[3T5X?><?F]JVJUA
MCA@HJFY1L@N(@@*XH*<V:V?#2C8X$\7-TNY'NSMBVR)N>JNIG<]QX'N,+5"5
M(<1N!2XDJ7+/'#DHC1O.E[P2LY?*J,Z=2OU5YM8>15Q)BDM"<"B01+U"/!CB
MXT'JKSCOIEJC1)>7;*<Z3K**O&Y!DD>SNCX89Q*/]I]DL8-APHN&8MUFP,4*
M%!4'I2JFYQS-G:8^V&.H[[$%I]04<L5M-BA+AN<%DL\M\?$UQ%O[3:M_YX,&
M(*>R/52&'Y&:UW8)CD*)0Z>!-KQ*A UDMC_T6ZE*KVI%Z,/@Z):^*?\ NO7_
M -%2[4%OP*33T_LK-F::4B.RU2F2E*3P.GRDDM$<N0^ \@E;;HU6NK/!3;Q)
M]B8,H&P+/E:=.#(R YZ:#?96N2U=*SM%<BTHZ/*5Y^9%<??"0Z_(TGBE1)6R
M^=G(;PCLO)NM-M9VGFG&7-*QG&G ]&SN$U'<=8:=3P1=EZ;C?<]D;@]E]*M)
M<J4"[L.[UW::\_$A4YYI\V7 8R2)DB7)"-(DU&08M..R--S5["RU%Y.POK*C
MO8:?G9#)'<QB!\7!T&^)MW3M J0N"W&F +$K*)*D:1&:!F0P0ARF1P :D->Q
M/>QV!@)JO0WAQ(C F 9D'TN$SZ'#8'W7VA!M!4<'F\#R9_\ $5FXT9W/#98<
M>?,4S@\V @SI%Z7TW1U;+AS8EAY-J6W_ ,.K=2EYO%9:!D?S@[*VA$A$Z)%A
MS*(#P\7L9YK8:PQ91<Z.(1L/\/$0Y U&7W/4^Q.NEV5KL5AB1I1&\G"#3K!-
M I=UER&Y]M<<;:]5>=:M3([+PE&I""P.5M]AU7-7:9;[K3P-_3!NZC79?.NA
M9]GU-TD%>^WTQ+R' RG[NRRJ>^L=]6W&=1!:/DSZ0Y7@<;L^R)DLL9C)/)DP
M1&S(\H@[GX]3U/3[BUWFL=[E>CECWBC%  ?R1M=O_P"<_I^J?.W:_EK2%_L-
M6L7V+*OKVJ3Q_P"3[$SBJ^&^#SOY8M^XM'<=Q\\@,=2PQY0VC!H2]L-HV_=V
MJCY]&,LHTQ\(. ?P\EI#WAKCCY=LZKSKSX"O='8U7<.D2)[T,MN)5P!<N5>W
MT[1:/5*<PU)%IM&]2.)]/I.C(\/.)6 8,TDX-5II5U<![GIVD'IZPN+N<9X_
M!Z0]D"R#N0Y--)YAPN9<DI[:&O+R.M>\L#S X1I0D;0XDJ,N!V5KWY:C7EVQ
M7?AO3=N3B_V;<W_G+_M6HP8]*(XN7Q0E23*U9!?5X:K[6;$P"_O;3*:6.:%*
M>)I%]1,N(??YO?\ F=3_ -:_M 7\>=B\E?R;4T'4BZ0+.5$-,7?I^2?1\NT5
M0;9!AQT@, 0D7 Q, *Q?9LB>O;F[6&%CP5=82V=/)(O\&:T]/4'8Y_8X63+\
M#-:' 7_*WQE/%XK(YVF"]QFD>[#U.Q@./%I[N\0%T;78@,DN,:I-O2<O@@UM
M(B?N(GX=OLKBN_>MLR9AW8+@OEVY4/L$G33B[FQPG,I AYV74YD<#C$B\"P2
M*U&.3%9'.P#"D!OS'A'SF1=PPV?GAUSQ/9+2Y4K#B=)B!';3(U&B@63A'NS<
M#TQSE;:F1,&A+#%.ZM@**FH18[O(M';1>B38I[X+!=Z-CB_/E,J(^%4JB],E
MNE_S4H[?NW_4["#*818]+>I&4>8Q"*;(EY&U?D':Z_\ %W^N>M>\47'--CN\
MV'TS'![\7FT[)S]ZPHG<YL;;\-W?2W\V%L/"3M6Z6Y4WX^%;=S^M9/&W+E[5
ML$PP\;P;8=]+?_;OVP+#A[7;L@[URKN).9+.BFY6EW^NW8W /-J9A'#M6 #+
MG/BQ[UJ4\R;BS'*A*SICN00\6U1,$X-H<Q[W2L <RZN;+[D_,JB]^+'_ $M6
M+1U_T#?/]'0?H:/"G[J36<S>/^31SZ)^6Y_T)93)5(B7,2JN*JO?7S.N<@$<
MBW>ARJ\^!)B!E3FLT)H_$D50X,?[=:I)-CLUNEUTL:Y2J@I*S/4W"=5\7174
MC30,R<:F-\JTY:+(NS*-ZF5* S.2'(=;>F4A]TG0?I<IP.DY'-K.V:\;C+K?
M.O*N?0*HOK3_ ,BD6HJ^#)J*_P!C'S=UJ.>/2=<:7W;1V'UTQMZUD\Q&6T7(
MA8NGV@;S=*S++:8 *M@*)X(6<<QXU%4#_%:NW<I$.),N]2:?*2_$R>1(P$.>
MT\SLL<@Y3:LFJYR?@':ZLP#)MEEH8>9Y27 MJ.((AG[CC!MJP5N(NS3H2$R+
MR*2!*CF1F45WQ,_]58=,U4R/)IX<:'FR$T0^'GY.WS+1)3'S02!S/-"N)[1)
M+)FS?YN'I?9=(-72LQ38QN,JS'$676S(#U&1X2(@Z>H?9=3LMKIW;D.:LNK7
MLIL5X"$44VXSO%FR=QG=:LSWVXL<%];(/1_"MG7[">N1VZEP>HNWDQ]W3H_^
M&U[D[]V:]^BY=J2G>IL'\U9M697??BQ4^TL:WY<CS. E Q7,!>,'<EXCG8[;
M P\)OHR\ZZV*$NF;+^BZT1]CSMGFM>+?@4OK?"'U]IGQLP^\$K!G+*"D.8D3
M' ?"M-BO/'+AO1R?)&TV>5%>AD!QY4<7N3DGH%(;=C^FM$;6JUR3K1PXTAN6
MH;T,LL/$>#*7+'I_:]5UWIV\^RH[!I_D[:[4_P"]9Y,-3V1QJSQP&=F3.T9Z
MAD:S60+1=8(3U'&6'-4?3'>5 /4[)(CF)PI($]'(5Q4.'.31>.WFM=6)FYH4
MR60IVBDS##_N_F8HJXBN*+WK-,";C3TM-HEY%P56SR;.PZ7L>7:-/V8/4VK(
MYFS*ZVV9$B[U<T@!W-X^N).>[M!(][JQ,"+MJV#KP1\WV@1;]J /,U?^&5,@
M7UAC-</X;MKH[L!*MMX+W\\^'F$O'M=U/XW_ $[4_G;N^M?&E+_8ZIYF=>B/
M&7DAQE^3:MGO)TD<D<W.3+H/6,0QSQQ<?:1.VY#?-X1]X)-^[M6G!7LC[,<?
M7*2_M/Y$>P[^+(**@J*XN90L'#FXN8LR]T=BXLF8!Q(LJ9!X+$M<>':W7G$8
M*:1,-&V!  E$['GZ1:KGB!;:2EL&&&&&T9T7.6?*/!J6,Z55I,5MY<=$GFIT
M="S>E">FX >QZFE9L-5'"),=8$PSEXHY[0I;T%L9\ G-G>;,H^.L.0M4 -ML
M]0/5&W;%'Z#S:ZT<204Y0!Z.;NP<['[RWCH.) J8*'<='P+*?@H2K:(&/"S0
MG%3?W3TJ2%J^7<B \_A<B _EVE'C@V\3P^MQEP_AY?,N'ZU^J$OX^Q^07Y-H
M"(+(,B4SE2:$S^G))Y1\.S+^NC++)MD28<9B!9NB%FI +B#S3;HDG;0QS6W]
MK?9QHEPQ,5''MC9<!WIIDBIV\A6KL;<:"PVN3OY&#_PV!]SLC;VNOKYQ-DA\
M0,A?@6D*N"(!BJ;^?H':2..\9\@155Z.BULW#[@K)S8-IC@B\1E;!F,.3GS$
M1>/X]A:/34U7>+>_#H>/8WW4R-CN4N%$Z(<.:P-O'AD4D)L723AX#:S-=CS^
MF<I94#>F.XBY[=L5+<OX=C=W<.94Q\(/_P"-FU7FU1P3W06E5E\.&,<Y]K-V
MRU39:+WY<E[NR$9KGEOLH(KY71'Q,F:UVD_T?_KG;7K]=RGJB_\ ,&;<_K>9
MOW]I,>U;,O-SX6YDPQQ2P_\ 1;O<7>LN0>WA]FRIQ;TW)A;M)V\RVW9S5-ZH
MB;K9<<JKVAYTME7'(:V5=^0DRKO[D[<V+A*2IE3FMF3>@IN]>U!FR=3KA(.1
M(T27THR>[CWEJE,-.F^[AY.:Q"'1;;%%W]UQ>94%[\9K]+5NS:]Z@7S_ $=!
M^A1&2Z+C[>?R<Z9OP;21'HLBTTF'BM#F3WZEYI()*B.#E-$540AS"64O"'.(
M_P X_0ZLO\.3\32+4I?!?J*_V,?,_P"NWK=NU%>YD&>SO\LLGZUF2\)H5MV_
M,%L$Q4EP2VFUAS(I'VS,NZLPG:%=0O<Y;7EJH%@-/IDA(V_#SP8Y!+WY#:?+
M9)5O%U3JM!H[!.;WWW*W,>AM9?#/8<WM5JE089$ 4>ELHT\/ :N1G63U^#H&
MX8ZGN[8.G'DZ8ZH.2&,YKP]UD-O/:9)@QH85.HMC*D3U E=C$;09MD$S<CQN
MY[&WJ].P5![.Z<)ER:\\YO,Y4G.RUF(^[R$ZY[BWV$PMU+8 ()1&94B8B(FY
MX8SNMKE]Q%]JR6\HW/>AP?JVC!VM7,ON!,_R[=39Y>[DWD7^P1[7K]>[=<3_
M .F2K4I=;+C38:Y<.;D L\YCFVBJ3CS=\0((P_W5M(I+.JG.R)B;J?:@Y2VF
MNOGS$)"C)(K>4LF8L^G:MF]48FN]+;C4\G5%ATV7L\EUIH>3]//LGIN2U+BX
M[YUY(J*F/.W&@3WOR\MA -Y%S)8$:%9,E-R&6]A'.YTF@[,;9]VYR7L5AS.R
M9#SN8FHZJZN/#GUR'L>3N_\ _3V5MZ;)%Z3)$WF8D<M7A C#5ER.QY'#:TVF
MX[KKKO'V+TTBD&^2DF8FPRM!F#@::'LF<.+V*SF?#EW25H$Y@;9:T>'Q.+3]
MQ8TE(YD;04AB2%@D,N6:R^(X9$Y;M_SV!XBP%E=54QWGDZ+0>V'ELJDX19B(
ME4E)<7"Z1>7YG$9%@F&)*2V.HC#DE3V7VX[LX6'5BMR'ASBP4C)D W ]+M3(
M604UI\J:CG=J(>=O>9_R+7$@(R@Z=;&64A>FYM,^&R(_:]G+W]KOIZ]6_3E2
M^=N_ZU[J8O\ 8ZGYAKZJ8L^_X_U;''<0<)(/-9?6,<EI]->[-3Y#S9M%OSM^
M%]L#*Y97"PY2JN(F7>BMQF(81R]X[J>[LY(WY&RRJ6/.YE#A&PO&G B\W%CT
MO'M&I#)+D/BDY?4\W1_!M-AU>I.QG("MQV832-(## , >KF>!SCD&1=C]1]C
MLV^W7CC ++? @M@N4!R"68#;X^CZ79N0S>*J.B&5-E<.*L51 NCP,:GXRT=H
M'G4/I (D[AX&;*!\=L#('P7<*CN=3W-D:=/. [DQYT\FQU>+J2:8*:YO-$1R
MJ:6;E2TO\IISGIK?98O&ZSZE9)($V0OLDHFVO ?"9\/O2LT>_?"99^U@_)/\
MLK5>2G2ERA$/7$,_Q0V?5,<X9C5>WFS6$NTX#9I[L<UKD>+?:B+^/L7DK:GL
MPR$!#;,=V]<\R2?2L22V<<=V8AQ2T$TPY("97[262QN+]BV._#M6 7LQ:C6*
M+S[K5;'TUG'W@G;RC<P+#TL,_#]L,A]Y:8>. -IE!,11=,.D[ELXWQH*#(J.
MH67(:2<C(\7L9D5DW8X)NWEOX;"N*:TI<C#+0[T'-TB*PZV!2"XG3+,J-CE\
MOIVBTV+CL<4Q1W#F><S<16F..,APO.*F).[Q\'+DT\]M<D0<RXH/>X0MLT^<
MW&D TVKP*+N#>L.<1(O#R$-@;;JT/#'$LQ$F/A=,+(K-0@'E7%//32?EZ=GF
M7G(J/ONMBHMRV#PCAQ](#],.T83Q-EG4(<I-9-3*?%T_2[7<3O0/]<[:\W/Q
MG!YOX&S;MKWDMFW)CVEMOW(F_=SYK<^Y.;M63^FV;>F_%+<_/SVQW\^_"R9,
M=WK6P[:672+*YCWK YCB?,0^-83<1,H\Y#OMCORJN"$G-81:Z(#D1%7=;9<N
M?,ZVB"G;XNC:.#W)[+ 9BQV4[6<<G -C>(]^#BKF\([2G"WJ3I6XR4=VY<,4
MQ\:TOF7&.WO[7U8K=E\6@7O_ $=$^A/UA_#D5THJ+W;N4L<OX/'Y5G'G%4C=
M-3-5[9$68E_I^C5E?'FI^(I5H"^"537^QA\Y \5]LT]P0':&7A,-K^#YNTGS
MJJBRGD](K:1]D!S*6_>K8%PE[S)92%>D.7'W-I]$I9LMR*C+B 9OD2(L<)3)
M.B) #G&X Z=KJ09D)E];I[/4J?F4D2-.AM;-'?$0/3,^5=<:U/ M>10YG:6Y
MAAXPYK1E[3T..2^OR06#+O5]X1-%3!$; L^7R-!HK292C@4Z5@"]^/&'1:_#
MU;;(P7*.KE>(>X;/N<WAN6H[0HBA=FYKCQCX#LPGLOX$NS/KCF]^1G9@O;!3
M^J.UP ''"&_7&E+#AU#@,YQ&UZ/Y.UO]&2+;$$R0+;#$44; RP#SJSPVH;KN
M*OO4Y9:J:[S=DD]+XO?6<4%UI,QTI4N4:8&^X?'[QO-R3=F7CS!IIE(&LH(X
M/<CXE@<<@Q3=9$09>)AI7VT#HZ3N34#[7:Y=/<>U3*;6)2KA@IMLM0V6B+Q\
MCI61UL@5YZ4.U*BXFRP;1[.UF[C:#:D..M^(Q8# E$P7$23M%8,YD6F.0.YP
M;\&S6TLZP,,ML,HV>DK;>J;Q>7J9G??^U6/308S(@1JCAD>1L!#-[(9N'Z7X
M]F68H&##01XK0N=,R-T-5TO;#(G+5",S/&,5,8IL-J"Y3R?8>)FG0P(MKY1L
M#SYM74;LHN,P74QWX1VD3WP!9N*Q#!V0\I( 9F@QR"9EQ/:;?0$O3+:$N-I.
M89LH&PZF7,8<)1GW&^F)6[H?ZVQ*#Y;D)4$EY^'QPL_36IX!2#EB^]!(V$,Y
M'(\0YPVC)R33CK;;FEJLAK=C:M3T)!Y*.]@B(/1.8?%:YX& @@OT$0RI@BCM
MA\7_ )]-M04_C;]-5'YVA_RJIB_V2H^9!9[>;55/++(/X 6C!OX1%5P3=F.S
MU2A[T-7 E**#D5ON72R>IF6G[L+237LT:?(3?[,,81+-[D;4F*TA')J*"H[N
MQL]-UWRW#+\"S(=VK6)=^RO&F*9^''+T0([35J$9D\3S-/$F5T,XAPB[V2RI
M=]JIR $LI)&-]6F_*= ],/MCEH,RMWHF-'$E,ONT^-*==%\0+Z5ENF>GH.'R
M;NGJ^VVTD;!D 3#,VUG-6^F/$'JGVVV DXVO:<)G%5+Q1 +8LNHZJIB.HCH?
MEVV69'%&37*F)8@8VER:=F6DU34-6&T')39F7.)"/<,2#_JG3MD;WYS)IK^M
MR?XK-1FTZ.55]<@'I?@_AV=U.'50</?6:7'-I9@7UN[']:US?%OA1E_'V+R%
M_P"JT,X[R"A+*P;+^%/6TI&9LN<2[@[2H#PBFB6J!#VQ/I?AVR<R)VK:\EP6
M0+< DN]SR1LRP6\!7%"<3'!NSDD'5':1<06R7@7/8*FRCQO:V@4%AK.JB&LR
M+XD'J@:3G8_#M.U:54!;<CDJ&K!*G /1$0]4M7&Y&HQLX0VF=021=-EH#='*
M?CNY[-BB<BWE17"3(B^-QV\[IYUC (%+),T=GH<+7AO^UVV<(XOHJ$CQNCG=
M>S](B*P/4R8<"2]RS+#QYV',A<0CGY3^K<M*AR>!R/(<$P3B%2 O(Z'IEGZI
M(%%CTQK55LN9^0?!$B]#IN/_ (H#L\3I:A"\X_(+'%#E.EGR^0W;G7_JMN=,
M4P[1%;AD/>Y=)/U[49M93^4JK3T4=4L%$YC(92M=].]"_P!>[:\'-Q+#P^XV
M;8<_;MO[6_+;H\Z8;[(N[?;+Z]N+ARKA]FW$MOL\_?L&..[F5>W85Q1.^-N#
MF*RHJ+Q+[PK O%OW&/>L)MEP9<RKS89+*:JF(]SW[-F8\#)B\I$G F0NZLW#
M;-O9(;+:EI+B!O>,/L=G6@QP)"043FS9;&A]-"7-]GS'E[\?_P ;K=G5[UW[
MV_F$/Z%16T5<":?<).;>9)_^9?1ZTOLTQ/[-2[1U\%*FO]C^<COINTW+4B1C
MCJPF2Q]SYB(G.2X)9G+Q+'YT3MY^R_X[,R62P-$P$N9#]C*QIW3:<3:KO K0
M&?5'R-=WJ(_[5II=\FV!]KC<!?CR=M50\)C2_"R6IIX[T899^R7  69:#B(M
M113OEET1_O;1XK>"NML@RR&'.0#QNY?QEDSJI'E)TR7GS=.W5;O!TPI[M/N_
M'<[G+#%YEW+]SM6:'P6FT_!M :83-(=F,@R/C'G B+Q&P(G'?8@.W4[9;3L1
MUQ27#>9'#9S.%X[AYCM>5/\ 0%83_P"GR;3QQRIFCHI=X=EC6B4>'>Z@QS;I
ML>&A29#31-DRP 9A:>.-QMF%FXS=8@U$HX-LI+9EQ7=JR-!RO \YQVY]W?3S
M+O4W'Z1HKCZCCS.3)A_J1QMES+E)151QW*0='YVCQO\ A%5I[2_UX9OR;5V6
M+WTQ4JA@3;[28:,IZ,(Y#!ON&FNQN.\D8>J:36!EFR[DX\_X6=RV<,F(]IU1
MP7/G\/D[<33.)YE1P#)5\/BR/_WC=NDGX5NU_3YD5G#C2'%+*F7?M+YO#T/$
M(;7883_)9]!87>2XN _&,B\3C=*U"3O=<_TQ4?G:+ZUYZ<O]FJ-L.^N%F0[R
M-BGN,G^S9(YN.9T02RHI(F7I^[.Q(#8*A(X.FYEP7.)AE+L=JG%!2RN:+P#C
M@O+.LL^_;?:=;]Q:E..]BI].BIE7MN&T?#^%8P1>T2)Y.6PEFWF6X<!Z.:TV
M%V\-ZX;LV4+=;Z916X<9M234AN-)'RGP:N0.4/HCV1MKE;&4^?++77B1M2:T
M_&S!RG)YO5+;"<XI+*\;#L@MH1QD^CT^4_&6S=;X;XX8IINOM+[W(YW%L#"0
MT;:8OQ'./3XO2B[OVRP'YXR"N&8TWMEY5EB2C%Z(\&D31#G Q.R52FH1T,W2
M/*A8G%>>SGE(? SEV3Q[=B(MPX"BV%1C"7?$LW1L-/>0HTA\A !+H&9CPVNE
MXMZZ.OX^Q>2O_5:"BBB[YGV?IR3;I95PQ3,G-;>0FRZF15%<</!L3Q]A9'5-
M>_XMM0W%T@7A3'<@^"(V#45$:!,,.V?E61<RAEW *IS61I1SDWSDB[K9>UAO
MLA3Z1 DFFY'G8XZJ</<NY-2PNT>/2R:T<0BU%C51,A9RRR Y3^LU;3(;S=/C
M-1V6S%J& L(!9C O+L[@^+.DA*;A<R9.ZL[2Y,60]2FT<,JB2:2LN!GROQW<
M^?IB-AT9+K$R1$BE(:EM.M-&]LK)B['D&&F>H&75;U.2= [-PH#A*#!.$]AT
M)52>+(UE\,(X?EG;C7,9$1F7?,^(B\W"S=2+3&-394=4U!(]1_5 Q$>-OL8<
MIJ>E<%J"G>A_ZUVU8\98N_\ YJS;MYN;&W/]FWV$M]CM6]=5W+8QXD[:8<UN
M+B4DY^]8MR;^U9,=R=]?$MAP[EQ1>W;#GW]OM6QPWETN]9 QZ7;2V@F;'Q5W
M>5; <V0=RX>%:L5Z4R7%$(VN^C89^*R31,]60Z2&F/X0V)<2SDN02\KS<W?8
M<_3M;M+7P;O7K_,8?T*CMJN*A%4E]83),OT>N+_G,M/[-2[)XK-57^P^9_\
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MSY2SD2;T3Q;-Q<<<G*%O][; 44E[R)C8R<<+:54=%H,JHB=T3I_J6;7OL/\
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MXK33VG# /ZVRA#9:Q'<+CI": /A9<C;?VO3TK/G)F$^))@;9D)@X7@FUV/\
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MS;[CK[9,.WA(,AC!IV? R@N<TNIM\EI:C,-W;-18K<9@ ;::$0 &Q0  0'(
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ME1V;/);(S?&/3VM1IQIIR<#WI=KUMWI%^\D>D2:8L"L*S3J<\V[,"7M5,=<
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MT")+-^5(>BR3F;8\\X'G>2C330BRUD>;==<@R)-TID>3(AQ7I,?KC24T'W6
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M^E:9CY\@IGV>.+;#7:;: &F^21/WMU8)+$2.R[*O50,[K+#;3AC\P-U7B$C
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MF'=Z[#MT*_$GS9D--BG.4%Z54Z3(8ILW:I48J.6E#F-06I2.!FEQ5QMU)G:
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MIK4*3WK: A/7(S\K'*J0CAC\UG"0=0K,Y:WM41-?:M%9MG)91E7HXD6WH'A
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M2GPDY?>UZ'0T7">D=+$\P"]XY:TT4%J86NJQ3X Y#\I@SQ/$XG#,$0XM>M
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M-$%Z,[%6$W[&\Y./)RPS\);%;H,$A9\O%;C,"*)V F!H#Z*0/"@)P%H"XA!
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MW9("HCBR##'L,@*G[KW'0GF<9](47]>''YH=.[Z^)!_IPT?AG5*;E#%LXRV
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M2G)SI+H&(:7UP 0QH5C5YFA96(=,U[[^<;LZ*M]2R[DP@1+A'UY915/<NPV
MW)SC*5QC4:O!]P]1/GP'.F:E0/KRK +ZI=+(P;>MF=OT%#DZ &1],BUE/0+\
M +,I/W^UB<+M]">(X3AEBX>TBL-N6=WB+PP;7<><\)ID%_Z1EG9P+98[>1-J
M9MS[^-;7T%.[!;5O*=CDT 12W1!(G)H1P6.66!5# .!@_O2E!N=LD[!^YSUT
MQY2H'$@0"FN_#R@8[=!M:^LD'<UB%I@A8I5\%('TS#.""8/H"T18(2AP:,E!
M2( \GJ"71L>>N4#^E.10\*ZS&4Q!*I$%%F0#R1_A"?& 2?\ <U&62 = @*=
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M0OQJYKHU(2AZN[C(B9.J!/& <=8<R2K4#NMH*TNI%4V$!KH)H1,?TK"2+ZN
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M X<H(O." 6 3X"R3+I'=*,1HSX-9%2C * 9%3@<B&$432(;8M3T/!=MZM#5
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M6M M0S25$)T";0T,(;\HT4- $(Z+/2F6[D,5;?*D]F4K9B[:$#X^C"V23$
M*4@3#?!+I&T44P&%0&]*D'(K$=VC02DR <&D!0!QA0.;3-2!">)C9* )"16
M K0$_,-55K;"4+HWP7XHW<GO^Y$*"LZP/P?GN[^>6+_K913<#"X&M\P2\PB;
M;J(A.*+7 2VED!Z!5*J\RHRR14ROV!4 ).5QRNA%,L%>O#4@6UI8('7C/*S4
M[FP[1+&G4BS!4/J'UQ:-'4 /  ZH^$$&UK$6-ELHBN@?YD(RX^X0*P=8W8!N
MBFB@%F/HK##,[2,V#(\Z(.#%.@7V00 F$],J_DF 0A4BHT;!<*38BOB8'3FJ
M%Z1^-,FG# [A$!MKP5&\3H)W,1 YA=FQA!<C*4NFXSJ0GE=JT0#1P62 "01
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M%F5!^X9$P> %UG)"U5V6:F$I1OM!! ,Y,AU1$^"<,X7)) PJ9!(*A4%MG1!
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MLV"4180B8W]D4A9QH%T4)#EB]A-, ]QY 8@F#L(/00XV4"OTMDIG[(0O$#P
M!((0B#0I+ "JVAY)UNI2B*<%!-ZP.Y%@@N>(>0+9=0YM!LR@Z0#Y F'XP(&
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M86@M&%(3PO\ ^L2?_]H # ,!  (  P   !
M          +20 " 0"8 ;0
M                    0"*) 3 ;9!+#98
M                              "8;X#7GQ82)FY3!
M                                         !(0E@R0AZ.Z&%S;(
M                                                   ":!1(YM[*
MNOZ>88;#
M  "("8JDO"7?'?76;"!
M            #;23;#UD(M/D2YQ3#30
M                        8)1*/UE9-<O(%;* 38
M                                   "10T[.,WDANY@J.1(
M                                             :;*1.:<@%G(;IA+
M>313                                                    !01Y
M#"_S2[22[UM4:9 0
M      " +!W7)MOO_P#_ "V[7H!D!H
M                    -@D/,  D@    D@ #0,,
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MSKAP   #^%:%;P:<!OAME6Q0X8 )[IP #O@)1#1;A)F*"B?7J"B24#%8)!(
M(!) (D>   $G>*    ,](!& HIW9L(1V\1(RA8 96P (AXB!366B(]KU!:^;
M83KY.B9( )!))   "(    TP)    &!9)8("GP2RT6I4N=M01/MM0 &3N 1!
M?TY G%7@'3(P*I1(/))!()) ) (H8   %'1     MG(#(J0KB1\!AVH-+38Y
M@#J@ $KZ!62/FD##<6P7$$AIC%N=<  )!!  (!"X  !"-0     &.!  ,UOU
MT1+>L/I.2ET '50 *(Q((8=:_P!QJU&>R@WMQN^A8"22"00 "0+,   04
M    N " .QY\Q(7Y.='G"EF009= ("="0J)!2H18Y\S3AY(3-5$5" 0 0" 2
M"0D    H      !72"#]"7BXX/QY>.'P8,0"9   Y"F"T4Q!<XSOVN#,I;N+
M5:^ 0 00202  D   3       !L"!!13>&&T0#L%9Q?BUW 44 #4"42VB4$A
M(MI=& 2T/%H'5'00" 2"2"23]   "H@     #[DP%%)B#JI,3'4NEETB-=@D
M #0^ RAYC5(D_$!_A82NWB'D0 "0"200"  1    ,      #ZTVQ#0*V6Q'&
MS4X[8M H:-L !!?8$!]Z0S\&>0+SC)LUU:SP"" ""0 0 *     0      #@
M*,C8LI<R;&6?F#,N[&2[EL  R3EPP<6WP=HD2&K+U26/GAZ 0 0" "00 1
M         #=B!Y!"Q7*GB]*.-*'*F#!+<  UU=L3TD7!FZE( \E3643$A00"
M  "2 "030           !4B0J74E3*R,F,)!ZB$L2KUT !YV/C"F*,-9LK5*
MDP%P7#=\""0"20 2" 200          2"*:01Z>ZJJ+#N%K7F%T!$(8 #4&X
MLNVTV(D2.2MM';<@0D^ 0 220"2                 RKI^HNY]( !$[VDT
M0%N."@                @$ !(B$0                           $(
M                 "20 22"0" 22020"0 2 00"22222  2" "222    "2
M0 02   "0 20"" "   " 2 0"22       "0          "
M         0           "          "     "                  0
M                    "           "          "
M                   0                                  "
M      4 !  !       !@      "  0!"P       !*!$         "
M   % "   $   !(1X<MS:S02D"^'U; ]?YD   "#.&R10     X8%BK:6(@
M #$617QS&D   "D 3W[A(   !M]WW')I,W2P+[![#5Y:_P#@  #D\+78,
M  [1>4L?Q[    4T^Y:<-]    ;Y;8WGB    !6<_P"(5].)HQ(.*8F5Z-8V
M  !4FDE. $    "\U$Z;0H2   -?JLE*7G4   (EX2,0@T   (_8!TM\#)[8
MP+,=;\-:R'$   #^Q3\,T    NCZ4(H" 0   ?RJ^'-EF    (R0Y8V1B
M!#+I \=G?&X  #$- QG3I         D      H!0   @0   !8B1;/M
M.L3Y!G5P    "_!32M4:A0 #=%H?8%_*P
M)!JTM/     *J-?C4<@      D4)@4 A    !$ $"
M            $ 58       4  1"
M
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MAGNIF&$@Q*!M)U0@20!8VP4LDF@ <-5L) E@())/2FB2UY ' 1LSP,[,:5,
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M=RH>0HEDEPD8C0&V%6+1(7&3KYZ>Y'"H))F0;*K1NFE@0,P H&0E@ I:H#0
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MH,8J^FH@H#BQ?18<><=]*6&P,GF.<9O=DO4/'WZ/EJ'A^S^'R?ZQ'WZ_>O\
M,?9-'>?O33+-PSFG[X:A^NKIT^PQ'^'5TZ?;@[66U&&8OIX]-],[$/(:;KQX
M1^) C?:259DSLN^@VM%R$CB]V_#>)D6V8N2I=_BNN8%T (2DL;J].\8WP:3.
M338$ZVB]/#4LC Q6'IZK\NO,\O3/'KY1R/+]='RU?/T>GV>\ N!8[?;CU\K-
MGTZ_?'O'A[?G[/>(>/OT?+4/#]G\/DZ\'TZ]?L]X\/;\_9[Q#U\CKT^QWU#U
M\N_3['?4/7R[]/L=]0]?+OT^QWU#U/#O^'R[ZAV&;B3OQV]-603)8"VP&28]
M<O&G!# V'+F*<=Y5B?Y2@-)L&3J1CU[5HY3<$)$X4'QN/'6/^4/#Z=?QZ$[Z
MI[ACZP^F\ZB[.I\.K'<UTN=SX:2B9YX^L/D:&5),]/K#Y&L&"TR,3$)@5WLA
MU*238$ 9CHF8>G.KA+&?>4?O30@&!4QC8D*?C63W??\ LIS56Q 1'ZVWTRR)
M4P&2Y6BJE80(9&;0D@Q#$@!2J+3>G=$'+K/C5,7SH=)R9WMIYQXZD<14"6:I
M$23H.!H("V0"(+(1"YC&A(OV8Q;1E)X;J=.EQ$2$1"I IA";#304B0;<$*#)
MY37A_P 1N58;,;&\?YI]+Y:$RG+#NS&&_-V;WIQ8XD1S&77IX[P^/L^U^733
M;X_/[\CC3=3?<^'5CN:;J;[GPZL=S2VLWX^L,=C4/#Z=?QZ=_P#EG1)($ (3
M;;#A[;Q1I#(PE,!RGVL7O_,!!D5(QF+;[>3P:!D0&&!2XC?INS777A]O\:AZ
M^G7I]COJ'KY=^GV.^I=?3[L^O34NOIM/Y>O37@^G7K]GO%M@[,_'%^'$_P W
MSZ]_WY]=*C GK)&_X]N=2I$)Y=>O7UXQ"[N_'X?\SJ^'TZ]>GV&+X?L]>GV&
M(":.>/0G;STT&M@P[TXQT6HO0+JV)5;8N>KYO=U'1@M$DBPBKAWF:_JI"4/,
MXJOSI) !$MIL .):8H@ !,!P'4C+)( 2324@M+9#D87$UCKMR)SNMWYZ\-?6
M>?EZ&O4OJ\NGJ7U>73U[UO1/H<:OB['G?+T.-)TXY).<>,/+?6*FWEM^Z]]
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M>O\ CY:LVOS?AY>?@)'1^JXVT3&;DGO%F44P,PFEE.6Y4"*F9@0$81I#%8>
M,W%+,!!;U,2(22:AE,SBW3D%C0-R^.<L]LZR>[[_ -F!D%F"5 $.Z2XB+L-!
M"@0W@"@-@  Z5>A-@<JF^^>=%A!>8)]Z=300$S!!"<.+VW[1MJ2H0U8=G)#O
M[:*UZ,,JR)!E $I7+IJR+""^C &$@@V T5RJCT090U9)U"-M)6A#J(;$"1<@
MI(O^$)G(N-V^").LZ3N:APPHCO,5I&/TD@E0-HP2*(0K,^5UC-,T)(922C2,
MDT*8N>OE\]3?0^U\W39U?5_'R?%\\Q[3K/+7K_J?,GNZ]?\ 4^9/=U]OYGW>
MNOMO/Y>O77VWG\O7KK[;S^7KUUZCZ\^Z?'7VWG\O7KK[;S^7KUU]MY_+UZZ^
MV\_EZ]=$UY[\>?=Z]=#^X)K0"X D1)1J3142?!@,@1)A<M$A15M B4Y#SB_X
ML1=(@)%(WELL2*139 H@E(T@0@$DB2!426U0IPAE64EE%!U]:^[?/7UCGY^A
MQI,[VS=U/?7$&O#?G\6-^3G6?K;_ #SE7J<Z1W[<&3L+G/4W--"=[-.8N4SV
M(.=)OL1;_+T--O4]?Y>AQI")<X6,^#\>LB9-_NWG2:M^ ?Z\=.V>P(SF_=X&
MOO7/S?-TO1*XY&8\[[ZP-)L!,PJ,&T\R7I4$8 @JDE*"J&)13(*ZI;2(=@ K
M@0$B[5U80TV"Q[<Q,QHP;5_0^*@D2=B))X3!)<#0@'/$:$V<C)*2BJNDKE+,
M\SS.H# ']4$SX5/,ZBN#[WX<:I(L5KDZ^?;&AZSM',_2/'4U@8\;S'X\8U81
M<SMNIX_J+UF)(F>M?A_S8V(Y(>A_1,2WC;0_45 "$YBF3AO'0K*0P(IC!4IH
M"20"8A%0%2J0(BIWF/AB2\#A:@@FQH"A--2^?I&$JP"8A[$&YHB$;),>48\,
MZF.<C/-3>9*\YT.$$]"AQB.-HNJ:<8,@S2Y]N=#BDB,T5&<\U/3L@0UGN7L>
M/.VA0&):(V>/#C$[:81$A3&TQPE0_<;4^WS''_"8MN+CF-0R"Y*%Y1:#$ CH
M9=<(9"3DTN14!M@?,Z2.('!2B##F8A0% 2$EZI<E"@ADBNF@T%F :(-MO9 &
M&Y5RQEXGG/.NW_@$0/E2/G/B1TVTN2H?2PU1 (C>3U!R A8(3T!30(%*(U(.
M'#A$\WM%US,ZF;YOS_L?$2P&",+H4O,HK3Z,"SSO':CK[NAD"I(G+<.;[NDH
ME<[8&0OWS9JX<RW>98FXC]]JB5AP+$F,[_K3@X4(\(OQSXZB(+AFW:F^H[IF
M"F;'(61 R:$"31-H&@!*AW@A9H$0!L@ 9',)EYTH9THF^XE^'/6+_NH',031
M#@=..^C&K-(+ HW8&XP@F-.L:BX7T-):2 )@:$,J Y,L2-#)WQTG1,$YB^_]
MH.#[/Y?-U!P?9_+YNH.#[/Y?-U!P?9_+YNH.#[/Y?-_B#@^S^7S=0<'V?R^;
MJ#@^S^7S=0<'V?R^;H1"%>#,HOC<[F)9U#NN1C@A$(1).4(CJ;84P@(@3W(&
M0LZ@^$0F<* N\L,;U8.B\(6.IH6$%^BBH8M*]TA:"R[0S1C$_P!'%3;MY?O^
M1DBGC/Q&-!=X7:^WWOHD#&=+R1D=(SDRE@S;,]IYT5G4!@J.3ZW/&A&:2R*R
MYF>L](\=#!(,P1AY.V]:ICPKO&W;UZ:^J[].WKTT81NG/%].V\3/34D+*:LA
M,/)H340QG"4IP0*H06D9(4 BA(9MIHD-U_1C.9(4K$T,71%%"G2=3-R6 &?&
MUQIB6,2QVFO[(8WWXQIE@] 6+C;GYTJ-:3#:3ITTI+225(]/QG.K(=AD):OK
MYQM+HA$#-QW<QY1GG@Q!AG!GTV]=-FC-/"6O;32G'\Q-<UYZ)A618T ,CA6)
MMTDX\560*18!;*;@Q!Y!P# 1Z0!6=HW-)_DH&U*6V;R]72P "W$7P>,\S?,Z
MOR: C68R5ZP>XE,%%0,X<C8WSXZ Z#D)N(&AW9?'NH)"2H4E7OVCRTHD=V8&
MT\]\^?*0*;Q*'+S\.VIE)E)!RQQUN]1]"98YLP[OK.T:$323TVZH^--*<+_6
M'A\OY"%RK,A4#OF9QJCA@2D3R=";G)G1'A*%$VF-W1YDLM)0JP5+6-U0V=W0
M@D7@I+6^)TB4@/\ 2F+KUK;417%>7_?.@L$\W9V7:1N,@3B[(22)+@A55B^>
MNBB1U$SQ,DBV"D";:5\'%KJ%3AEV\-8_L;P!&!@$$K<L-)$@(6V,,1,+1)I&
MD1A%##H*T%MG+U<SUU-"2)@X0^YW8T,H2YEDQ*';M\Y7*;S'7->%=]!E8<YC
MP- 4P@DG)+/I?ESIK+> .1H!EMCVT\$OR@% S&*!*\&C8U/92BB4RK'->@H@
MX,ADK"ABQQ1_>?FY:0*2NY$[+IP@F 2D@ F#"<#8FIS)D(QE4N[42X)ET$G(
MOO</BNTDJLZS_P 9.="83V%U_@.V=M?[C\:AX?+P]ZUC-?QQ;;1 XK]FTZ0S
ME9<+-\&];&(GB3"23)++)"RMD;0T1SD(2$U4I$)6!2F1ID0D00K(PDCEWU*J
M#B=V4@GQQ<>>BP['\*4OH:<K++_G[]?Y'@<=/R7K?*Q)[7'MKT(&MNE9@WU(
M"<R>:Z5$B9I)OQK.E@UJ6)B^3QY\M%)9IP'S\M^352%3*RUB:G!QOH+*A%(:
MF9L[1Z:DMTRCUG;TZ:B,,^>![:3$MDP]K]=*[*>0B!5 P69YXTY@ZC!>@%D\
MVB700 8 /+^DI&%#C:>L//;0-RECV6/'/?6!V/;^KACAU<O=VG*Z>@($5-A7
MCC/CK&4! 4H-C8Z:0(P1LD GRMXZ\Z@!L0G@?KWZ:'NL(VE?"MW?5%2!9B)9
M-ZKE^-!D%JHN3Q/V^RRKRS_02QN"[D[G#%ZL#(P]H='/7MI@KDA=R1CYCC3H
M+DTK0J6]S_= L+&0SDYXB^AWT-F)JX@LRD\;U$Y=">"%"(@P,C4>><:G$P,W
MM>?3XC01(E 00Q1@/OKHXXX%["_8\35,5"HL4QS%P],Z<P:1N^9F:VXK1$@
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M<MQ,[OAT,ZD8BID"]94Z^GAI$&W,[R?B#3&"Q#31Z?KPE2AZKV9JXZ<8B]'
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MRWVO5[<8VW>^GW/;^<WA[&FRO['[?/2PW3KC.\7H 02]#\?:HU I!>*./#2
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MVGMZ9\XT0&7(VN*=?6<ZP,W%XN/*-("@9@W$*(K$=NFLP,< DDD.)QY:$$9
M30V03",TD,1%I$I"B8E))D#:'"Y;EIH!*$B%MBOCC4]>&$W E)B*2.*IF2DA
M.]'/Q[Z=%=1-KGP5S]I8$APE<N#Q<NVGR1)&L,F6T9OG.H5:6( 205T8,]=0
MG;8JD!>>^+OM>>2^&R[>#P#104LYS;Z5_*IF.,<??UH%L\SOGOS_  T,</MK
MT'SU@]$^_P"_]9.Y'D1^>EA,!N[OMZ),,*$=8+8PO;PU.$A=GEL_'E_,G)]G
M\/DZDY^_1\M(F1.^LCN:CC\$%*?AC)CRD^"@QV6(';]XTEF*@USXSSYUI*Z
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MQJ-0X/'U\-SC&G$,*A[SI$%['\0\??H_P$P&>OYU)._I'KJ43LF9B*WV_>@
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M[:/<7-Y_'#YZ.LY=MMYK/'AH<A!VO>9_-Z $1"P[3?:310 2( 3C)EOB?P8
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M$I$F!(!<KE+UCJ3O"1;-3W5-0^BU%E <DH8&+"4=/9;(5W9 @6K5$M&4$/E
M@402I2\79HRXAV9E."JH8,F@!=0@!%F:B@H@"H"5HE-&#>!J"VED"Y)@H[U
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MUHA3,21!DAEPM6$ S:S3BKN:4LXLBA<\5J 0D)F7,UG8@&E(S(H0X9'=<.C
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MK$LLFF0&1<3.\",J0""L2[TMI)-OB@$*E@LDF&D0$3"/"C(,+4\ A%1":!Q
MEA4(%F@U+^6$!-D-BY%MS8GF84Q,!0.T!#FDE60<4@H0!- V18[L0S!(0 ;$
M>7_! WV]M&^(#! 2H@:0;B3&2I>69$-JP0-$" R4:&EDP"(9,066<$FB6D&
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MD #$0-38V%J O.BG)F&:W*B$R( RTHX&J63PC8R4RB1#4H= %O*D RT'"3!
MO)G(3-B@)9!4U8S)Y 4_S?T_^S,*Q,3.^CBY>8.B S"B 0I@@F78"82":0*(
MG9%@'<JB#!)A2")"H0L$D6P"8H;)*K&*0@L!19E9A85*-+A7\B!T!2$ <E-/
MK#L42$"VD8Q49)=6:"<<@0I5DP&)9971%%4!1,9:7"B"J@E7=BL2IFDD7S6#
M0.;)D(J(,@0D1#,@D#0$UM49,4B#REMK'_(3P=S0K"P#,);P+$H1*V%T21S*
M\!22:@8D].(N0 A"!)C9G7DT=N4P51L0P2R&B; 0*R0PDRDO [Z6-98E&Q2(
MEH2(808-$<986U Q4@PN40H)5@.HHB+T1*T5L U- $5D&:@E9M"8@*1&$0:E
M#0JA*0! :I!"2SHP3'=,8!)1R99"8=0@3) 2$X0"HBQ0 03M%QL$!7 DW3*+
M,K.DYS,B) #81D)",C/_ ($$S!/.^H').H.-02,68=SL[?S!$01QMY?]>39R
M<]^?X@Q%<:;(;.&SRT 4$'!_6#C2#D'N3_$&8OG_ .Z 4$'!_,'&H."\]?X@
ME8)<N[&)[:YZYZQB>W_>"Z+S6>_/]6R&QR./+0 0 ' 5Y?S!P5CI_P#TF__$
M "T1 0 " 0,"!@(# 0$! 0$!  $1(3$ 05%A<8&1H;'!\-'A$" P\4!@4("0
M_]H " $" 0$_$/\ X;P!JRK3PCUU#;;[:'O73?[YZZ7JZZ7J_G7=Z?O7=Z?O
M72]3\ZZ7J?G7=Z?O7=Z?O7=Z?O7=Z?O72]3\ZZ7J?G7VG]Z8[)U&?SKI>^NE
MZOY_A#G6"^S]^_*]KZ.?OE_]M"X-&#T/EZ^WM*<&WWYT(SGC:/769G@-]_+5
MCR<[>'703KZ'I^=*"6 Y4CSG7VC]ZZ7J_G0+@F,Q>NQIV_7AKM^O#7:T\IGA
MJ/+Z?C4>7T_&I9BN9/SK-;6;*G$UOIM\9'#',?\ =):%PWT[ZJ0J7!N\P;Z@
MLQ[?G4EF=SG27%>VD2G_ .S'O73?[YZ\1Z';2#+4>N="<:4ATSC'X9KWTPJ"
M$)!%SE)!N2TE"&>!)/8E3$(&$U2BI@F0"EL:C( R'1*%H<4NU+W 1!:UA$$P
MLE (*)MBQBI8U@M#<-Q3+#"9T3,: V@5 8K((3@8P"J*U1/AE;::+#5)A6$N
M":$&Q4(@5J61D:2:X\Y0P,0D%P@4@Q5R JLF! 9!&#0 N.4JBD@N) ,RBQRT
MDI'VH<!98R6V9)! T(ZLI"<;*3)F]%RS&"@A0$D2$DDDB"@8$#PE  910#.2
M&AD,9B 7 @5C*R<V1H::,%8"A"2)!-*H138H,R3&.G?45F[?WC^ )/9XT\]=
MS[OI$8=!\'_["%P:#Y:@MS[?O4F=O74F*#IJ#F(09RE?AXCQ3N'C%P+,FP,0
M2+- %*%4?%LA=Z"A"X8CRVS0F8$RD#+F&:%@1X1,9H$28$PZI4$2 D!*,K)*
M0K2T04%@(DT)O&2%#+DT09-V18"R4%2!@:DU.46%+B!0@@  *#6'&<( H,@0
M2&'I)-"","FBI,H1 ! JZ)(HV2D-90E,2F<P0,B^+H\J7R<K.AG@H6H<C(*F
M;1"R3,3]"3'"$A#A(ET;59&!#)M030 SMH1I1-4Y6P$$U A")CBS]FH!BI)$
MP*U4!E0"TH  "P(A#&D )"8!)1+"$0BGAWU)9G<Y^_>H!)XF@^#I!R:_0\>T
MXTB,/_UYN>*._P!]]>(]#MI!EJ/7.I+QX9U!;GV_>@27P-!" 6W+$U^,3X:+
M@A!"$DT2F6&A 0&1J-S 8U!-C 9I!$J '1*A(1BQ)!+/@*(:5_&$0+YO\!"N
M$D-2 B!2@$DQ,*J*E5B 04#=.(A2DD RP:!UPBDLEH)6-)+%:#F5+F2"F(@R
M02$B@A3)D0 !1"4KH8B.3)D$U@(M0I"1 O-E)")H0P1$%9,H63!%W,$.P%(5
M@0$M*#07@*)A(VD1S"(PX#3(KBBJABC7)"860ETL/2@!*!229&:1IDS % M'
M8=%U+G>DDI=2 $DPE"ALAA*09"@@*DBB[@AG<00@V<QT9GKUUX!TEO'/7UU)
MC)ZZ#X.DD3G3SUW/N^DAAV_^N\1BL!J"W/M^]29V]=6+B-?C''W[TDMQM^?O
M_91LGR\TO\&FC-;4=9W]](1F&6(+(XBO34+T#*3PS7 0=-")P1$& @V8;+)I
M]8'2DPB,HJB"-;S$^BA@D*RPSO._-1J-LL3OEKO"&>%C1DI*0PACG%-&-](N
M8F0\U*1T-2Z%+8')9&^*\-)1$KD(%L3(41(<:9EJ05N2,8FQ.F>NE2=L ;MD
MU/7Q(T<02(\6ZD<OS>F+!0@+#0#)*@<YR7+@,& E)E5,_532!30"J)"_$N9G
M/)N1K#Z16\-^]ZA!;X>.T\Z*%\]YG4%F-SC[]Z22A>@;P^_\"!U,:,D\>WWY
M_P#K E@WT]Q?.W;4EN/?/EJ3H&L%?7KG0F.'?]:,.FQSU?OIJ2W&QS]^]7:&
M+^[_ /-;$UOTG?PZ&VJ90D H!56J0:3YTQ2.Q+%#1FN"@E=+$28%.,6"!A3F
M6-3),V@J5*I&)6!JFFD(C00.(HX<@H2 !IE"K$A:T.EA %H'$"11(0DX8$H*
MQ A1ZNH2@ 2590G%5&3 B0)Q3D$HJA$DZ#GQC8*A6P #!I8TC $<",(,,XD"
M $K+,W)(!()X5LV+0M%@N8"#D0# &%B%60(5%(N )!0B* R[VQ&235(*!"9D
M4-!4R-4P[!G, ILS&I 0#O!QG;DISH9LGAU)9G<^[]]>(Q>$U!9C<X^_>E"\
M3J"RSV_.D62Y]-269W.=&YYI[_?;_P"KDZ3['U]-046^^NVMLP9="G&_B5I%
M[N@;B/?M]K7>''/E9&IFZ'XG01S-<1GB[>_.D+A8*R)!0I*BXFM.V<7A%(9D
M P+@ H^#H06PJ(0*R*)?T0@BE4,";"26&,:',]>MB,2$8.0$T#[0 D!Q@B)$
ML!&(4E2$XD24!;(YB]F[Z&($FBH$9%Q%Z01$!>@R*2"$(Q"W4C-L,4$"RES-
MVB 1WB-! ,PK!*G =5NI!F#&J6MM#&FC[4:&-P =8DSHEH#-I4(&'!N9AG$'
MC,5  DD4106)-1AQV 9X@%3)S)"+*YGR>>CZ;NI^OSS5\^/?4F1.%'4EF??]
MZ*%/$YG7@'5"\SJ#J.H+,>WYU@OL_?OS_P#4B6-2.*W\O/0F.'?]:,)!1\SI
M@B+?OWQU!;GV_>A!9WWY^-,D#DW(R87O/V5 (\%)J=V>+ZY'24RZV&,5'V;U
MU3%R?]KSTR),3@"\96R>)KMIH!2=SZ2O.TW<:<DA,0)E-*?LZ% @4 ,[$ 6X
MCUTEZMSVS%H>G&C2A+EDBB6=BNW30"  J! GI,'_ '4LWN?.S=>,WH, B4HI
M9@2$QD);VTPE*G!7LK3BSIQH< ,93,,"09(A4HJ1VNU+8I%%C)LD .Z=J#FB
MDK>[YZ8$<,< DA:A5T8FZCE":I/G%$^YR;1;[]IWL^Y:G37US:=.AWZ:0PR!
MBR?;?I=;:GJ5BJ.),&_ZT&.%P"'I;6H[-J3C[]Z,]S;O&^A(_<7J2FGV^G\&
M3J:V>/Q_]3B]_@ULM[OWZZ"6-%,13G.C4\ZC%7M]Y?L:QJ/5S!OBL:% )3 G
MG$3YUYZ%.!+2$>2!8@'?;,2HC?$DS?O6@9'&0ZSEC/.9U5D+NZIN9V]>8O<M
M01!V3IO^-&R,?NBOQ/30XS#QK]]ZXUN&8CYJIC2>B]#-+[TUTWT<_CY/B)PG
MT9<GEKZ-]T^6I:^OUZ'RU.J D-O R-Q&[>A@<UB;DB9OD]]0NA$<Q>?#/;6S
M:FN_V3^+-1F'J),;-;'/GI"PU[]:)IS#O/.F8;,?\0N_VL&::W [(YG%8SI5
M6PE2@NHX06Q;I!0@8"RG$0/AC15!T[X"M_#1!; 1)-W$;\:#X.ICJ?4^\:2%
MXG\_C^!)'_U(R^!]\M&">?;1R^'WT_@P;Q;SOC[^F,AN&JZ/W\::8&1WD*L+
M$HM,$L;ZCE%)!I&D"@'Z32D9.N:,<0%PB'0YM"(7/\2T>"_IAP[B?5-OON](
M^R??Y>D?1/O\O2-&OMOU;YZ^\_5OGI2)6,2G'WW[0ME8Y3[CCGM'].(D<6GR
M^MU/I!/2<9YVT GJ)^*"Y7"K28B+">["<[%&KFGJ-E%!!B5J)*.F!U) "I8&
M 1*1#)?+.C(FXSQ>?71WXI[???7@C9T=_O7IK-X>YH^1GX^=&YYI[_?;_P"G
M-SQ1W^^^CYF?CX_@0!]G6 V-#/6#WT(.RP2A$&$A4@@>=%3@R#0(U9U) TK*
M5%/8DV0<B*@S.3=5B2U01YC8]=,K1OM/AXGGKZA]W//7T#K^'RUU'DZ_A\G7
M4>3K^'R==2>"L^T/DZJM8=CX=#SZFN-N=CX=#S[:Z[?8^'0\^IKKM]CX=#SZ
MFNNWV/AT//J:Z[?8^'0\^IKKM]CX=#SZFNNWV.S;H>?77<]87U]'74>3K^'R
M==1Y.OX?)UU'DZ_A\G4_\/PU.^)NQ0W<:$189$;H6BPQ/#MET,"3,%%"*,(!
M9)4I-' *$@H40JR9'C0(U:E99EWGX=OX22'?1J>/GZ:S?=S^,3O\/_T^+W^#
M1N>/OYU@UB]_@T:GGX^NA9W]KT2+!,-Q<1H84B+9(<X&"6\IB3^NJ7G[]7SU
M+R_9_+YNI>7[/Y?-U+R_9_+YN@%!0G POC)J;7G!\KQ//76V6#$Q')??NZ8X
M.@*\W$E?;==OZ2\_?J^>I>7[/Y?-U+R_9_+YNI>7[/Y?-_F7$UQ_$H(E O)+
M' &>#9&B#8S(=V/3VT8:P/N:S?=C67A\NMGC\:Q._P .LWW8_P#S9'#/_CDB
M9(YV_B3D_B28DGB;\O\ S2*@BF2;.Y_K\WSHP3S[:Q>/LZQ>/NZN 6\&<NL?
M'X--:\$<]] K/AMG[/VO\-4848Y_&GJ4 L'*"'&^C&U$9HMX$$-DDAW='9%)
M(R$H"%CM$1DT<BH*D() E;$$!5*2=0\/E_G(?5]=>NC3PK.]RZI;I\:R7;G;
M'.MGC\:V>/Q_&;P]M9/=]_\ 2004%P3;V/Z*&4.__I;$YT"=Q,$U=Y>'-D;.
M@8I+ &(=F,P^TZ0"P55$$YZ%EM[%7I%-*DF.9I68,U6)O<";C,=)WB&^CJ./
MU/X?)U]*U]*U]*U]*U'_ &-Y^^6BMP?%_6JQ?)MJ=1.@F5IS'Z)J./J^[/EJ
M.)Z_=GRU!+992I(Z1$56[XFB%DP%FS$=WI[(QH0L@1V"1>-G00EC,V7=L 9K
M)M%&C4&9@)8)ESZ'2+RAB,8"5B-C@I>/+3L@G"68B:DY8_>D AJ5E1*S8W@-
MV=>'L^U'V.\P\??H^6OM>@6(^ST^P>,<SUZ]/L=Y[_J>GV.\QT^O7I]COJ.C
MR>O3['?4:B-1''U?=GRU''U=?P^3J./JZ_A\G2<3UZ\]G/&N ?B)X[>G?28A
M FQL;Y\?+3C[9&PD; 9-R.MSK<@! .)-GDN#;;&L?PI(52Q()\5W$Y*TAI0*
M;9A+),(VQ+Z(%-C&VOI6OI6OI6OI6OI6OI6OI6OI6OI6HX^K[L^6@O'=GJ;^
M.A+*YJ*^Q^M4D^[&WII2);L,G**UJ^UP%??^ZF#C,+&Q4S!&W6-]#?%! B;1
MD;N<XG08#3'DH:$1?\Q^/[ZF(*"8ZW*4<UD\]1& T02J 26&,UDA@TNT@@A*
M*'*6" 5 ,$\1&*@> *S7C.G5Q&+A58F(GF<]9TQ ,<I"V25F14) ,6[1*9S"
MDHA3O,4:>>+"7($\#M,41L:F5HP9%X*"D7$9=M(("6!:EF+? YIF'2RKRS_@
M%[%XKC1LXQYLZ990I@19LECR#QU%&@$6X\XGDOQIQ@?<BRS'AIRI\B1H089;
M;_:?3F=4LI,^M_?+K+_PK\:CI]>OX?+7TK7TK7TK7TK7TK7TK7TK7TK7TK1)
M#=VU?8%%ER1A89J[Z5DR(-6&-G<F7.#@G^&A>-$X5PE"F_EEWN<3C9:E6#5[
M&ZX[PQQ@[U^9URQ]G@K]=]3^\_=GRU]R]?P^3KL?9_#Y>?N/G\/EYALPWVY\
M'06N?#OQ]K71[-?2M#$F'21Y_?GUT$+0>(GUHWGP\YQF'CU_.EE2>+J./J^[
M/EJ./JZ_A\G17"06P1'&+WYF=$S$A8 <3<2])YL9RT!*%P.[TW]-,@! T18D
M(4G.,;V$P3F">^_\M"\:)1$LUUAB/FGPJ-1,/@)2$A3)XW0 "YZ'1<^,H'5.
M@ B7H!S.&#B8*VF<&LGY;,3/;F\Z^C<_CZ]-?1N?Q]>FOHW/X^O37T;G\?7I
MH1S=IHO\?7II:+GS+VZXWG:,:,R;VX!%<9GCKI)&0??^,8U;R8CQN.OQDT^?
M8ZOP]32$S3\WP]3G3?U_4^)Y.IZ@]#/Q/)TI )V0/ )_S1!X58019)M.D(,+
M;W-CD"98UH2U6;^O$EJ\ *PH@A!D'<!8W44B)S.I6>ATLF4#8#V P@WF +P8
MP P#2815E *L60<!:8F312=QCF7MXVV:TQ$(9G?P/FXT'8._C_$G?.FXD^_O
MU)^7UFPO\NZ]K_';_ \G7UKGX'DZ^V\_CZ]-<6_ZOXSXZ?.\]7\9\=?;>?Q]
M>FDNO,6\\=GKHV1M"T8#M@68P[D++RT  K!%;2V],U-U2P?0)-38R$&;A2&2
M21[:2"X "JK!)QUQH]?D$8&"\Q.:96Q&!Q8L$*",PE:(;EB^:_?'KKZ-S^/K
MTU]&Y_'UZ:^C<_CZ]-?1N?Q]>FOHW/X^O37T;G\?7IKZ-S^/KTUZCZWX^O37
MT;G\?7IKPW'C1[?7IH':[8+_  ]=0,V;^+\&>W306.U#SQW^3J".K$'G+C;S
MF(T-)(EG9EE=3LFE1B+#:4+$)<@J- .8 F0+EE9#TV" W=N<3',,Z\0Q\O\
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MJL_E)*(E9B)$ D!7*'' 111;DM#.EYS(&-)!QF)" XT20!EC5B4**4"ZG1.
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M$4"<L[>/Y;U*5::87;SOXE<Z@04SF+R=SXU>02C4=>.DUO.-.&)Z,5ZSZ:]
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M"+2*<1VOOJ#)K,JF']0;7TTR$YQYFO>>VF+Q]W^L(PX+OFZK-;Z,K$_'B?\
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MW.C#R)QFF_;IVYA1$U$Q9"][^=/.C)DZ4\_9=;W@.Y?!VU(DY\?6N,&V0TV
M+4L%V/K?IHLD!NA%.?+MMI,4$LI9,YQ<1_S0.8@;A@DV9PSVWU%H+!*V\.<<
M.9T,&7<PD_LHXWU'A);2=UY\JT  C$G69C;S\]]%O&5/BOX1->S^I>KIS_Y"
MR.Y[Z81JV&=\$]9]M'-N:%IV4<TCX'\EJK+;""0&-YFUY[Z B(4R-U8+9)(B
MY64(ZL2P05((2>;=XD%WT?*XRC89$#%8F1!+0D0!B(:C9'*3%8X9T4++MD#H
M&[?.FE=L2.(XNN= 4(&$B_GK&F915A2]&3N:05N,%Q+""))W@@;86$42(!@[
M)$D 0L8P$),!;-&9#+ HH*[M*+-E$C#0[R//^[2MSDIML]/L7I31)HL/93DA
MML=--#AW%"EWC%WTQJO1B](T,440@*04-Y&0"11A(D4X4MZ4\/KC[FDH',_@
M/GPTZ,^1,%RBDNQ6Y-7_ &L(/:^L(3N,%0R])9 N8D7H&F]GSV-%)EEO,O->
M=\ZER5BZE#][:1%[9O<YU#*,!Q6?7.H2S0@E?3M+4GKH(8D"NX5-1Q9L$Z;5
MY70LEN3=YTRW=3S\ ]/U7DJ\[XUT7[OZ]=2&*.%\)Q&]7L:OXF-LL\2_K2 X
M? $M K&8XCPAT9%A(PVK:89CYTS&JBBD]5%/6O$3&54F\*C>/SX2&H2IB,,/
M3K3C2+QOQ][^G749R9WQZL4^1H4%,D,5T,1QMJVLIRQAX>W?RUG+@B[Y)YV\
MM2RI4YBR4H;QX1Y$0)@B<-#&VT:29!FFAS^O72') M^:M5X^NDV22V7H<1X:
MF10SF"8EWS03Y:*#E&3[&:N])(L1!->!3OY:9?*>?X_[:JNXR:9\^WW9UUO0
M_&A4=_7?C0T0MW4SX>'&A60D79WV:]LF-'!8HG.7;?CIQ6C6A" ,[[?<<&HY
M0* 1ORS>GHA+.6+M_P"]=]*":#:.&(2Z=!!9-=Y&^V_3P9X0MA9D9R[?]U%A
M")VQGXU+ D[-1/;;4)D?)_ID=VINY_@^H'CUT>_UK0.A71E4B\\\,)D30/0L
M[0Q9&)XH>-(5PSV\\1,<1CF*DQU=$A7O\ZM7B4QR?>G&CXY>^Y,?\J>=(.\A
MM%NWV(T5QQG<A,^7$2Z; +/%^W;42BG9'Y^Q-Z2$(/OQWGQF"A(2<C\QSI@H
M0)V%!?!7V-3"(0S5L.TR?O0@#E@1RKR3^R,Z!A2)#?GQMZ?K/ F<27._+H!$
M81U_YH]3W/X13*K*M59ZYO\ R&1W/?47I>I]>>JXQYOI;\_;LO/N?XAIM%YN
MI<$7QU[Q9DQ&!C(B4FV[OIHI.;A)FS<MJ=D8NXTJ;5HHLHI8DEU S6AP*J!.
M10EA,;,MS'#@)@H)0HB$94$"!,:9&:8&4L)!0QA"0C+&,($L,UAW]-(+.1RE
M^>DQ(@K!,B)1&D235NT53K1!X?9#0UN8- DT4+1!1!(;[P Y(-&QY'4B-00N
M9S+&34RJ='#6NW]@2;B\GGK/ZX*J"R!92AF8E*=IDI!!-3AAB7;KTDTRV;>&
ML-^>NH#UKOT6[7-;SSY&EK(A4G8F7/2?'KI0I#3&'4/#Y?U0",U=1"+.&)FS
M1#")$:\<5@V]:T,0% G06:=IKCW-2W3&"3?KZZ3?08\M%L"8^-.?PZGM!)6T
M;>?$&CQ/A'JNB,=.WYCTUWB1UB=\W1VJKT@!R,>X?G1HB;N$Y,U/6?/4]8H&
MXZ,QS'GH0:<$2 0E%%*;09&JL4S"H0LF8"1""$PIHYT7W  4(V>1QJZ8BE"$
MF0F!)I@JW.BLN),KTO\ %NT:=S+$Q>?/+YNIYMZ^,_E\W5N67Z^FH<)6&>[M
MX\]]0[O(VC/R^D1I8,"<SDE.QN?K)(7K[]/(QN:OA,UE<C%/VS53(&=J]?C3
M%@M:[37SJ6(SNO$SV^[:8&X87,!7JYB=.? V_O\ LZ*?<W^U_P!7(KOU^8W[
M=- (W5=L<'M^M7EQ#.>L;</7-Z 4)FPQ._CB/74,2%S#$7TV]N6='4)=P-Q]
M^Y(5 ":BN=OSIB+0V)SDYVU<B$9NN#SCC]NHA*U#G@G>G\Z,K)9NF[UY"N^H
MUU;W4?5_YJ7N%(4@A4X]=+&2C&_)QO\ %YT2*3$U+.[^M 1&^(.V/7SU/" $
MX/P[AQ$XTA6,7X7B(X[8TNBQ%8G'AKSSX8\N-#Z'T$-!@6:_7A'MH1U4\U^/
M;4=[#R8$Z2GQ;NJ?M^]3,$?77^=\E[G#.=*M*Z#==N_'CJ5DYK%]N+T+3T;E
MK&VDA.?%QS73@XT8 56 VK$>SI.YWWZ,?K4<'9,.2,MXGVT-@27M3*>Y]\2-
MXRB9DE.W?PT1$H"YP*?>SQJ()P*.6,W?)V=(X$LR0FR>KW_#I::SX9['&.>V
ML_L[#@IW]M),U%GK;;&B+;"$=5BN8]\:C.TD-\_Z[S.B@./_ !F3N>^L$_\
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M%F(TRDQR33WSTUPJ(8<TKY=^SK[CE_Q *H0+?34B#0H 2R9;,A PM0LZD
M@3EUB595EM<\:;5Y_P!&@6$SQ.$8V^9YTDYA!#O&.>#U=M*5Y3^18TW:GQ_6
MNSU_6LWA[&LWA[&MOC\:$S#<)'$CZ5[Z )CJF;;C.TWY1G528D3I</OOI3[
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MCW0*6)%S2SZL/A-:09,(%K!G$W$1-==%/Y-IVK,?.A8<HQ7MDQWTLJ\J^O\
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MK$,_GOIE=$"$K<XC?OMG5V;4M;<-*G;9M_Y2D#8:NK-@XTX#R>PO'3ECE_\
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M/UJ7:,,1?-?\\]M/D.%RE3M=UTT A8 ]XN_#MM'*E.T; ]Z#Y]-"Z$3<WO\
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M <@"165H&X("FX@!-&%T)<N@99L)%K&((I=&XK\FJMH;5)LIH3((T3G)$70
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MJKIY 9+")@DR5E&XB!A3?H!3108+2L6[:-02A@#22-E#:2F)U 0K9"8%;0!
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MB:!1TV2KT5C !C(P39H2MNI-.Q#20>%D-"M1 DBK',FX!+FMC4V&9'G(0W"
MQ 4*P?X1BLY\':XA9KWK4(M<T:5D&R,GAX"*C+@)&=F)$*A8"1NF$*.",PA#
M>+-"=%H"BBC)F"@4 &J3381"#F)J%".=-6&4D#6I*S9 6 T)HA(JRBXZ 4C7
M-%%@C33-?:%K*DAIVX=!RE(I!"$B[HE*!F:(+>:(;*=LB"L*P$ 0$RA)$ $9
M00"([B7!/0,LFL8;!HL  *)0H$"LHA+%29R4BQJ"#!BE$JK!%D ::BL A !)
M@( X \O\)CR\ I8CM2AAZFI6*699P,FR[$22XE"XQ!;$@ 2,V;%I)041( 23
MK 0@;D-1Q4E2KC0H '(0BWBJ(L,*BEPB2)A6E;,HA#>534&($@*)0!@PDG4E
M 2M"7&@OBP-"0E 09,TJA&N4F,1!8 H6+29] I22LH (; C(4K2UH(TW."$L
ML#D1OH38UQ(4! B1PP0$0"6ERB"%X;!79 "R70F"<Q??_!3UI/A/W^Q.D(DP
M"LE ]Y_/?0*.4JNQ&:[^Y632!&<4"4%W/"><Z$/2PDEG5@0>H$N](&T1 HB4
MK<R7)Z-%2LU2!(?),,.%PFHHA$D;:A99!BH@MAH#U58=T).,A=2756L G(@4
MA<LC'3KHLAH2B0TK,(RQ.-"4813 &:3=,P.V:T*>:"LHPQ+-G@,7ILQ"F00K
M9*I*3G!C1H B64+4!+1G98R0Z H+"23-J#,@=K8TG(,)<')D@J$3;-!)"XL4
MW/;*")223$PN@@A<Y,'EYWC&J-"((W&%6&)C?_H 10X;7^=  $\W$6KYUC10
M''\#E80G0:3NQY8Z)$V3EDD&0'L;7@Z:008($02S++%J8>-0A,0X2:,XDM6\
M)?0J01% H!QC,BHUDS&B)B2V65'E"SC;.D3&Y58DE&7>\8[;HT$H25N,U).>
MT.B&V4 A#F"B0K;R&@LYA<!&JE@$S 1"C0"I5 B&_+L[S-Q!$T).PF4@D2G5
M\Y#H:@I$EBQ5 S,$C!D*AQ';P$:A99++!G@(.J"'"39B<0)2+8D(309-($.K
M)<TS'2-MAV%%D=XL^]^-#Y*DC%T#U!GQC&C!.8)_PH+L"QA(<@QOO,9U$.DN
M8S,F6R[B-IHT0.1 \2=39\>VAP*.=XS[J'YO5CL(SXL;6\]:TD4E$5AF E1&
M(F3LYK3< =:V-$=$.^_4 HXXE(CQ3%[3.@BAE1-@H6.H GDU!RTR#+$@8@B"
M0YAO4()"^>6CIOWC5 MD3DLD5X$Z" ."/\7#4UCGIJX C<32;Z,NVQY.H*"$
ME,YME6@X-IX-!/00D*4AG*B*.=C5 1"0BH,5B %WFM02$AEHF)N8G<\JYTC#
M8E,A'+-K6U3M+3 "V<41L1AV276<!02PD1 28%ASF+-.S9%3,#:V,Q+')6^B
MN+'D8QFOO2)8&4UL-K9(+]-1)&8B8$$WF 87D#IIF3!,#7!X)D,UEWTD@ 60
MS6-4DF2V7;0W9N*R P<NS8XF-1  $1B*D\)%FI?'_&0>;?3\X,;Z.(RJ/":E
M[9ZWI6TD(TKA#$@D,LS!.D"%66$@84VA1#)("S<%PB)J&D,3)2>^D@P ;I1H
M4MY;HDIT'W$PDI#(L(ANDI EZE2C"B<3(P7#=T:1A $$E$00 E0LJ2G(" &4
M! D,0"I<X+*50'2<WDR(;P)#$S6^G$PP(IP4AH$FQ5DDD1S@)#O%,%&!5MT)
M-686*J3?$,X'Q ,C);*O@9MU51F4PSD$'AI\'_&:F2L^-#%<%SA32@E2DB,-
MA[CZQS(" <#;<+FUR_G2EP"$D9/!G4DW"VZ4"9& D@3G9MZR0HSIE&$(!$\/
M#GK'2(TV!E"4!UZJD;WY-%'A&5K=N$IGI">&# -#D#9!!8B1!31C$+(6WDY,
MG:8VT"40)="U<(*J4P\:6TS)F2 :[PPRHWOD($P(2K*1EG$2GM.D)L11%9X[
M0429P?YF"T0X((D')'/31S$U*+C0Z4HNC)%A5%TR"463<-B)8)(,UQD&4 4
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MVQCP_P H./ZP9B^?X@F8)YB_/4$1!'&W^L'!_,'&N>N>L8GM_A 3 $YZ]_\
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M+"98B*&Q6:4U,A1@4P# @JA*RVI"4M4PL4DR2 HF!:3>SF@@@Y&YI2D(%(A
M:\9"6THD/$XG!8L()3.88$R$ TJ)FQ;3C!R$D8P@S"Z>E61C)!"$ *0J0@@!
MC6*(R&@%,$(D,K1X6JV^) @<$-2LCHV<EZ16A*%0E!(N9)<?&(F208 U$46H
MT4#"30;,Z4,;M-Y8N*1 NYK*12PJ"= H#C_2#C4$K!+EW8Q/;2"0@G"2>O\
M !@#M7\8(*.-O+4!@#^.N_.H."L5C^8."L=/\>FW'\09B^=89*>=]02L$N6+
M>[EU!B*X_E!(03AL_O!Q_P#M==^=02L$N7=C$]OZ08@CB-% %!@,$Y@UM&SD
MV?\ :#,7SK,3<3'2<QQ.\:09D&<R9C$_S 8(T5BNVMUW<N[&)=X_K!F+Y_\
MXD__Q  L$  ! P(%! ,! 0$! 0$!   ! !$A,4%187&!\)&AL<'1X?$0(#!
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MZ?7W"X7!L08YW<S=V+5\8<N@QDSL6IYQY;A8BQ!GG;A<&Q!CG=B+B1I?F?\
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M  #(#@+@&P $(WVO"D#T<'&@C<21EM3T:*5*-F#U\1T?>$1.:8#,_0N8Q/\
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M=RM&HSZ1C56*#F\]TQ!3N97]Q6@@9O.GZG(1<WN"Q(0FF3^L]E0GGS=O1E<
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M'9%T@P/$%V,,!0Q["9-FQB" B 94AV  0) ;*C$L9D1#AG 1!%01JF)H"?\
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M%;C@V3Q#0>V\@')9:HRA D1F&_'() 56=C)9I^$<(<!Q))+8 N,*%CRF'_+
M+$P3J,-ZC8V L%@Z$R] 9V#"\P$?LC$RY1P7[C7]S,ZA &[^F=>9V#G/7*[>
MUB">6>_5="?:(E^LRB<#4X/- BIT!>A)P)'\8=P @@ N0"7!"+G/UYUT?J<7
M9@"V5R^ ILBE8D<";5)@L&(?0@8_:!K$&G"P$1R+"Y(N%HCK,TZS.L#1%.39
MFN<8FF>&X4,E-\H!+X@P\!:0HY<SBJ  G B23?SPMED"WD=7&X/^0 Q'!>.^
M?M/'R\.P=YN'-V,EW->J34[Z%[+@28-O);96 MZZ?IK= CK8/17M<,@(! D"
M0H<W(4YN_P !Y-8W0JM=:F"\\G<ZY\![%2SBYEV[E:._TO0*9\SFRR =-,.=
MUR%L9K?7)6EJX]N]6EEPDGRTMH]L0SDD7>N&F*X3WW(PC58 JUMQARH_9%3F
MRK.%G3DILR6^V*L;2"8>5Q8* .(6.?[E98$M8'6Z(!UQFO*&H<K[+$"_71>@
M=&YTMX9<WB6%>#.?\PRX#[WRK-_2ZDYZZ2JSI["/GKOS"MD2XPW-J:]F8NA;
M(?2\)R2%C:=: /XGUM%EF299A9GK50"+G;)Q!)I18YHY6! 22D)=F0X3D UZ
M!6( N.!RE$!I1<@W:RCDYP/T%41?B._Q_*6_DJDZ^@LW3!HY="X,1(D[@"<
M1:FNS2:_C;+5IW@)@+A,X+MWZ%NB@$P#U/FH) 44HL> 2I); :CLSGVR(-EH
MY"_"%S*'6ZH9 !.YC]*/7-= X:(5B8VHO..5/;C4?&R]8/3OD[RF*P<13I^J
MI'/-UH"0;'C+XJC%W.2@5T JS$Y#?#WV6X&0(>3.>B=")ZO5*W!5<AM0!D[.
MEN_KE]7=5'$Z 3<XGNR@6'S$ & U^WE.31!C ;UI@H!6?IUWT7 -.0VB>RZ\
MS\_-'9=!5<T9@77<3G4"WAL9/ /KM&.=AU*[-QLW0-B=VS?VN%70_79EP &(
MWPP"<A,C<TVPZL%W(Y[9J;RJ HJZ ^S"0KHECD(N>IWK=%R-OTO*85YH]BN!
M5^,W3!;!:_!'2/;?S(_D_')TP46-HXO*&A0%U&\) 4D E53>^P '9AV,$A!G
MQT@ZEJ!3=J@@Q X+R<-4S- !![=?Y(W>F(P.4AKX40_$'!1R!&7Q@$'%@"%N
MJ1&,H!/ZS++2,W$2P]",.OR#'NW'9>17D_JQ!SH(OC^"J)AK;6HY 1<TSA!(
M"**_<"%T, -7!<V>4* I0%<02 3$? #X*P% $&8<@2X_Q"$SD.\A@\G*S;VA
MJ^O_ !% G: ,10DCW4'C?$B$TABL'A$@(,5D#8'J]E28"[Z ";#G/RKF<'_$
MT+5LI8^-1LYP-:,A29NTWC$BI[LO0., 6N.-4!*U-][>F+JH(&#$WQO@OJB(
M);S3VAO!6K0TQ,&;&*==5V] Q@288$DEW4_AAN;K9!Z&^A0'&Q,C$]%H1T-A
M7M1_> %F],G]_&S-5;STT6M >FM@*2=5PZ+TM2N8"DAA^.@\[+@*WMC4G8JA
M.\.@_<&%&5@/2]GKS%>0^W#=20!ZM['29LJB]CA&+][_  !XP59L#"<!#3FC
MX[_+*H9NRQEEBODOGA7K"<!P[SY?#!<KIO7@-I0%B(,'//=;AG94_!KBJKD/
MD_T08R9G#T\X\LX7SM\MB,++<'^.T]]]5 8!V2+_  ZQ!YF.U*BR@@]DL^\G
M*8"% $G:5]$<$Q'*T.QV*0&?!YZUK(E-)'W9I@G )#  VD?24DQ(\V/W#M$@
M=>.&_3)4:?041R\U@Y5Z,2:V&'WXUI9OZ_L]S@RAF#=X68"PK3K^%:4%.* T
M#\?@#!20$ 8+,F%A(X^O1X36H)<V-D08,L<6TG*M5V!FYB1;O(+'IU<4A]NN
M8"%//'1M@F$ -0!GQRM'?Z6?Z_:;J'33@XR C82B-/RU6%^6A)G@-V0! 50B
M1%O9(C4$IK<\CX<U<F8'X-=5-'Q2#0'S_/\ 0X;WB/2 ,0!AA--LW9?(LVK7
M'2%Z$^6PCXE2%BW+1#KZ#_/?RMP,?[-;-MY,$-EB#XXTI@*ECQYT."DE-90Z
M5Z2JG9RTSY@KC-&5XZME*R3@@&)L74@1+:'7@3F;\O<S2,Z+\)9(@1Z.#3N,
MSILP[E>7+I.3W*I$\?W)073S\P5N&1XI'*A."ZZZ74Z_R+-  :,NK(6BHQ!,
M^.C<LU"1SHH [/H=42"H!J)Q " F 9%&M)Y07 W;B)7D$DL+F!+=$'M:4XL7
M." 'U+#N>J=Y<D-###&_709&@94\$-NX,80'H[(HDB S&F+4$BY\@$7VT; Q
M<!<TEVR<A 2A/P6!9>@82X(".N$:&,29$"Q$27= +3A(S<Y8M/:$$*]%V]A+
M$0HP"A"?P9HG$<N !(!:(V@J@D09  O\1%DKDP)R.5Y%GM $D V"M9Q55>&
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M_1,)WU5B"093QG97 E_T7C/Y+Y$ZSW.V3=_X[,;[B]/N$1(F>M$'L@X_)O\
M(:X&NPCD_6FRJFV[_P X6 N28YWS!TO^>EPAA_*6JG)Z[4O&=]60(\'Q- F>
M4U!R"H'>=,-@>)%83'WZZI& %B\T5>@-H(/J&&2T!(TH/;I4@L.;VC)\\[Z@
M8]/K[A;@?R!#O_-'?Z3N"<;:UA$X3#!8FKB&<[P@%2$N 'BM&72#-1PZH;U<
M A)/2U=4T<?(4SY,'?@J"6=OLK>!B+^45N23\SCVRV*CD)Y&;JH$#O5GB\F2
MB @4%X]1: 0OU.6:S /G8_@QE< E1XH4@UR(AQ6>;%RX"2F!*:C!7(K"4"!2
M;H#M)(8\76(-*R@IXSBJ3!90/O%5RA%L=QSLAHWET?A 0-S5-V&'Q.(9^A=P
M9I;\PU;8D\'JOG10#F0\Q<&\+N7Q?H-XT,\)&?,>%L21$T\I70'N]3MA9.SF
M>OYC>U%0  Z =ZS\K@)1V>G>%*9K(Z '&E=EP'9A-[9C#K,G-\_5N\+A\;DJ
M;P-$\6((@%G8D/<M<U1.@<:-!: '2L&5068T?AO>*W0^$"-E8!L.PE??I<M_
M XC+0# !8(( #4M63,Q&9%<=L^N,JHZGS_*1 <B%!T"[,P.,LBBU[A9F4"!J
MMHC#GJ %) !E6FD] @6&$"$"=J\%0' 2) (=_0-D"21!0 ESF7''R8P\2N>L
MQ6,41HS%BS.WO^G8_P!9W(()09!@P :HO9174?Q[ &[%@S!)A\"9+()4DU !
MC1]B"()8""CBF8D+?S+M? 0+W<_X<D@$EGQ1$$AG"&-P2S$#F::"&R<X8N!I
ML1=D/! <W<D]:[K! ;6R(),FJ)1J X 4P'EI>Q62;'['+W[(QJHO;4:HD:*,
M50X@L<@&P)_T:&R@Z*!&).!!A0Q.%&MU5V;J_'LG $5CP 6.:)9.!*!W38YZ
MPY^73D<CUOMF<K9 )RR!\ L)*SABI?L8Z;8ARRVDR15_YRA"N&%\&_ Q1":L
MFC/MYW*_=G'/*3@B#4DVQ"SBFMTP(&L-NOK9PRX"3@P]D,T"K*@/C&SV<%-@
M!F&_5T].N8Q]+](4EB^B=*%]LHK8-A/2%V)"UL5(MZ_ I@;^PL :2B..%,2B
M$L%@?6&D=%N"VR 8OP.G!#\MB8!6P/(03,9:5B@,7A>ZT8J],(8WEFM@84\6
MP>?NI("&0U?4T9ZLM"(T*"]?E&&[EK;_ ">+\,76)6N_VX4DZ7N#/6GH+P6W
MF/A:@8]/KZE7)KD^L/U;! L4T+E01@R.#-<3 \Q<(B2 4==2%PF*D^V*XC $
MIM]*SHX"470SX4"H+0[$[K6 -C2-TJ74@,P3=.H?!>464<N]6F96!G7XW'BP
M3Y^GTFX'M\K/[GY3$&ECA]>-**4\ZJYJ7Z*QT2S4[JV!U4@LR\#O]O1M0^CN
MWRQ^W*!/V+T+9M2ZZ"^\5^%$$3\SA;%UP%!U.FVZ(*]Z07SE9E4#K!L+6]_
M=?03Q/*OUX 6CT!L:NOT%E 2&2Z%U 310Q6-S<)R&A+ #-3C[$U2$&LC7E"Z
M(#9.0#GP[U5BQ@4(YIK;5^D]E"IS'BFP0P!!>Q^/X4 B&.&'A;4^J/A$2KW+
M^O#NB2?GP[S5$O@Q]5N")$7[XLL6:D,=P:,RJ44B*^W+(%R2AK%MT#U>M_V\
M)@JYU-ICUK*DG3+6._D)P8%K/G-?;R3)R*WX$[#XE-I\IP1#UP$\9;@\#'Q=
MUH02E@C&>,+B*:Q0!G#S6NWM?3FBL+O-RVK$U"KL5O92/?F,0X,3N#TP6Q\
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M.@!NB9*<\;QFOL&DK QRI))",/:5Z499#S0.=X'^0D"&%K@M&R78WKB?QE<
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M-*J[@ZE@V?WK(J8R@0$UEGU+,&6@*V3,Z@#49"*FP_<BP<1; !@^K%>+Y6H
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M0>'-5 &\\46(\+J#R1 72U2"QAF H.U-1IB4A#]CE10%@U\7-5AD0Q@?'A4
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M54*'>[&PW7R2BFA-V>J\@)DQA6 B2U,>V3#J[( >+;H7_=BB0# (S(,/KIP
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M$?H<[JI:?,G2LG!5-Z;_ 'PQ@'9XQ:NE5([B@M$^=V78''X/VZC^MXF)L'@
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MO8:WH<,.JD,=9Z40VRP(S24&0#TT%12LGK6HW7'.*&#+O).'<@3=QM>\E_\
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MLPSAEU";DMIY!E4(9 6 G'[ZZ@]XFG7ZYIP ->!+%YZ+0.*'ON@3FS4>.57
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M/'=.#QUO55$J&63^+3(AI- ?DRN$]L"GV:O0""GY!R5@;&;0#LPH=')]=)Y
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M4=[T9R '"$3>D<32M0J# #U'2Q?_ +?HM;QTHFJ*,M@+"@>LJX*ID)\4SM1
M5W?-K\?1<$[\;NN8LX<NBL2:CZ H?A06Z(:Q2(KU$L%A"IS,'G=T"^WWQ^C7
M38>/V/OJN(<A!OA,GYTR7@FLU,QJN@E40<GVB>7@%IQGY=9 _"L%L'')?YYK
M[44D @. J-AU,D4X:WN1\UX"QB-F\=KJIN""9<&:[)] 2R@<+ &"]&D3.:P\
M$;B]H@!+(8:+K\D"46!QC\K7-'FE;65XDIX?X# #@H4('"TYR(-0#'W#O.,N
MBD$_(CCK*H2-91298GTC1P^XD4/P !,="!SSA?(HLPI+D*:N]"OD:YV[EMF7
M"-C16/A.C6D(+;OU)HH#!1?XWP(5#,!$U<ZYU5H66&<,9_8/0.-UC"F)=@0T
M(/Y"D9 PS0U@QU3,KZT,36R9.@^+_ Q;_)B-!\M^D!ELO&**0&812Q!#@>("
M*J% L4 44_EJ()ZAG=ZGZU1*>WPP&81I=<,P![4Y"]UH!04"UM ?),SA)%J*
MMJVBNQ1SE%EP P;=#3!8DWX=*>50 -B"O-9BY'"1-O-O"S(ZC7W_  ."\HLF
M+Y"^,FC&#P=#)O$7*CJ5[4Z]5P@HB;&,2]5P@:7'+V%4@(/2+A[#)!+=X=@U
M+:XJ66\;EZRW+*>C26Y@ I!W7&T'G112_P L+C%\97H&7MS%W6X(+7$:;&NB
M[ 4+5WQD8K$3E("_00!1VHQVY8XVR",4U,;OX6496 W%ZIH*UQX<OB42:GD.
M7ZL0*VH7Q"?YJ0$%@.I@!-P8,U\'39.<F"@SI.?P)#3"^MLG#F%3++,@*30-
MDL<,H/, N-:(DLPP N+2MD%,3/6\!ILM%&<BWZ(JV?8YATXY74-7.=%<G[V/
M..VH"<G.5RL-V4I<\^/W.>"SCKP^? _<K?VU>63ANEN1]XX,RZ$['YJ-&LX7
M267D_>)1ALZO/%U5CYR#J;>58$^WZ1MBO)#*>C5L@J$JS.>?"5T*$8^5,E@"
MM39U;LS(^ !<)+FA ES 0SD/_7*0^)8N6S$@.X (>[.C-CC1(I$EP(FO$,S9
MU.MCL&G<'_BY9G+8606SR<^T$>#6#8A %1C^QO'A.L8C_M>8EH5! /4>A#)D
MS7R_:MN9R6Q7DG3SNZ<'FWO7F*>E>]AZ?X5"13UZXOX3F]X "UPH.96)LAQ9
MVKI3NNX&9+ENKE-#E_!$X1//A'>UL/A51)*]C!<8])FXSQ=7)3ZURI3$*0\A
M?H-=C558RI+^A?M R+U<K=MMX G> <](D8)EB<%J4,B?')#KNS+_ !^!D &,
M #"Y/Z$\8.#&"!BTYU"?^G6O8"T )','O39O %2(!9;T%,M7)C)$G98:E,O=
MJ/$) "@*83X%MV&: #GDE6.?)9@1DH^@IGDSH!$)8'G0ZK8%=*(T>:(-70F"
M.\RZ@,HP&KZ=8D\JQ]_=&69:\UD&R '@.:@1=U^MQ.[A2%>(/6G95)88;:=)
M&:D'&8&!.GTGA ;B)S8=6^".9(ST7&JL7X]TTY=A\6&F/^:_]C ED&BC<O=K
MK16&X 8?)*N@O6Y;J5)2.@07[D.Z<3I34-Q,E>0 6'#R*!!3[U$3A4TKL:T!
MDRX#=J-1,F58G;UGIE4G_P!5<U.WM<9FE/-$X8 Y>+;KN#395(?E=?9>*8/;
MV&:Y32H@5J4R0;\+BCP^"8'1F-R_+*YF2W7 9T%.C)BDQ=WNU\'"D[C,N\^"
MLC4_&',ZGV\3C/2CW3D1?-N;WG('@/S K@+/[UP=."P?2M>;H@@)"0S_ *57
M"(#3S&[^,4P:P ]!QUT6JH8?GP98G2<^#VQOFMP<E'J*1@MD<P$4;/FKJY&!
M+!Q:Y%[$"RT.SY*!M:=, (# 6(.!1.$SL0,0O<D,!+$B&5 80(!FX 6P#NH!
M.U04J*" UL.&40.QEW$.0 ?"R#'Z_M-YLI9@!@#1CNM$OP>SY"L#K<[?GDK4
M;I6ZASP+X <K[8/U6)>I$TMEN67*MSA]I[%8$S(Y:6TQ>%=DG^-7[WJKGXXK
M\5H@OOM3ZNZZD$>?1<*IN'(G[TC@DA;[HOY?*Z\A@P\;J0#?$_/GA<*]?ID>
MV0$,#9=8K1\$\IB@V0P!)K9V <PY1#XPAQQ!< !)P\P* !U!!!(V,H?:Z 12
M!L@O0U@T.#@5]!%_A.N./_$QF(;(UF,8%35.@=B?^Q#^,LP!%W6!"6M9?D#[
MUM?=2.][X5%I5@?VU.U%F1YB6Q[+,/C!OP9>5%Y"B B"AB<$ 'EXG![Z.?FJ
M($^2BKS!9DWD)*3Z$G<O*4?9O0RL%6:FJ)MCX6(;$>S/)=@Y[E_GJK$/<N\J
M,:POD$4+]NJ$!> \>NQ*[Y<S6@.Z.,*<Q6 5L82* #RK@7N@Q\-I=!;I5JT5
MO'R:0H(R0 U;<A#,4W@BUP7"<6<D<CX!C6CW;)8DM,6"B[Y4IC$(JNOM8$BN
M0/&>SXF$P-2QU!>VTL3]D1D!:NJ^B+T"H:K3$ N :!YQBBSWO@/9+"Z@B:X0
MHJITV*YF8CPZY74T+V"&@!\H9X4Y=C[:\-5H3V:C8Q<4NA,!@%PGP+$1L)[)
M'Q"0362.#S.RJ*4I 3&0,T  <OW A!PB !\W"V2O-V#+?'_+$ML1H^7V74D^
MW3UR'B@"Q'8 ??=>R(&&>9+H5"$2C8:)@/4*I;G16;H(6EQ@Z,Q7X!X:CYQN
MB!S9-Z/=7!!<*F6V<(X&S)PQGQ9+X:3CVFRD!!D9B5Y1I ? T_:9A8,J!O\
M?*H3%6%T2C'-. ,"2!?FURM860A$D,[(NP6BW=T]$TP3PVB)_"<AJ^BD%"AB
MY.&D#">S>U0%%P'/O1%+VW1;\EMT #QN;,^!_;+4+?WZVR9<APA7X4%OY#W
M''5B"">YD2:]$0.YR!N45 &=<WG9UHV2W.@;=:)GB7.58903BSREL+,M24L4
M>]X1*#6]@34ZH8W0.*=HTKZ():AAS%,6+@[$[Q]P!?$'I(8!CI36DI0A"6"G
M1'-99([=H L.U*H.LD8 ]HHO:!8K]$7E5KIS@,^V6@5?.OIU2RG/G):B(![_
M *"F7E:GUQ,<].58GF"WKTP6X MHWB_=T0:.9\'VKD_PTC+AM*L +W=5C.2!
M*)O=JC:%\A8:W6V2).R+(K16?4V(/!U1\/'?$/8O%I89!0?@SIPSQU\;$6G2
M^/*<H#R:27DSP& J,[R7;2'RL#8PP'K"RH[$3&OPL2.3.[7(N735QB^ X9]8
MF\G55BE]0](Z=#_Z'?PXZV"]Q5RN5X5_.#966*+7\:=;XJ1Q_.B\EFM'SU4@
MG2'8%1]U,:B;9C.X))$ *+E-1$5S08NBWC/XZZ@?,WWUQ' 88;DZ;U5P40#.
MWIY/V0D!0I]-%N X3"S]F!G"W)&.Q?*NF96)#2;$3OIA;*8XO6F_M.T+V!M&
MT+1\*A75!]&NL^%P'YLV]-5!.J8_7!DT].XR X\9D+!"X<4X+A@-I:11?(,R
M@!OE=5K6LZ5\Z)B<Z='WN*IV(Q^2"U\L:@Q"4%ZC+S_"&D!D.-D!EA^IK3M0
M**!50!QS[+ EI@7,A@K<JH<<]E<L@!V B'Z0TY'*]TC5$<9L"=QOQU!&NO0\
M\*$&\F&E^WL0J \87C3FJN12XO:KTLM3 ]-X%>!<!I'\KR& >BM,$=HP_%@8
MTABTS?7?_+#2@P(&OF8PJQ-@LP$\Q[S/TN8,8^CJLB>%FGD8(@-&#R'LY^>H
M9*IEUQ@EME3%N\+I!2%#3+! O0#EAQ65D40Z3ZY3G,)&HZ9?M5C$;(>$8JX-
MZWV7,UL13K.K4Z*X,;A*7:+T78WR@%_</70'A5"+B!< +$<-ZHIMJ4L"DT.4
MZ U%4K@!_->@/+#S"Z/>ZI6** P';W36 )U9CA!9$GA9_$24J-4P.WTK>]FF
MH6!,@O>_NZV!4B=OD;JIGQ:T!EP&M/%U$ DJ1AO&: J&6=P^]I*<++MI*<IT
M#D]2L23#[Q\UN%(BE(UO6]X1)R83N._1A"PH(20&MG&RG;T[I-(['=B; +B2
MSW18SKZ@R-$"D,.R9"0(-1J0=Y)Q,@;62D"60CY57@EB" B0R^&O -",O!.,
M(B)2T9BR <#'!N"R--OK \@Q'(0)"XQ,)JB2MO<?@QK;[;H!A73LL6]@B'XW
MR;YE50U/U/TZXGRWZ:XKA<]CE+57@DN/6A9SV70EM[JG$;+0FMZYTU[X$^2;
M@PJB?1UXU<KC*F$Y,(@^[M:L!I)1!FK/SA$+A/>>O7!=B0B'2,?:W "O?7/R
M9*>.X?&Q%PJ$];XP]ZRZ2EL+'S@*['A)-L,VZC @Q EA$B$GZGSF8SUO_0,G
MJL-<X@]K0 4LIS99-QM1B@"@9>P$0/2YB286))9A,\?RN%D_6;)@=N6S?'C[
M*"5/5H#YSHL25N !?7I7LN%94$?HI, RWXN,609;.B40</)=ZD@6 L5E%("5
M!'SO]E9G%%F[/RW,'.6N,KN+6)(!4FQ/!-9P 9=20IJ#PC)U653^!S3$D?G1
MA.F>X%5-^.77/= \'CS][*;Q28K";"_300)2,NH:NV:JG(KV!QU<$\P;HWLO
M -IE1XN=ENZC\.,MI6@++GYK5JN!@@L"]+@0"F!6 <?3A[IR >1/QRO,.#"A
M\K4$U N9TS7Z3&!5!*X!$FI7"/L+,J^(BB8D,<MS$5E:JA-\&&JX1^WWA*8,
MZS'Q]5NLB?77KR$"<RUM_"P(W'K,]I<8($<0@: 6_51)D;OV'U_BJ'%"0<0"
M';-F$ FHJ@V+!J2)+! (OK&IRN$LWI2-67"*C.SF[AZ.NP(F3$\T:5-06.XX
M;K(GY@$/+#Y5I#BA1&46U98#S&CIC-<$T"@$%N"&O(Q^N$EJ9 ]D@'NY>@'1
M KR?WH'HN@#$4/=A/1VV X4#9[C==0,D@46H5P(["6*3YTO1'$WP7*-#(0(&
M./E1G,BPN8-A>H"U@!NV8A&40PV!.)AP=I$R1\GI &5DL=>O!ZBY=B!C90IC
MG6D*[=:0]4>/)L3UN+/];O"8&MD&X,#D@2.VWTE;$):POMI.$A,2PPYFX%:6
M6H 4VW,VA@P]\6KM\JP=;.7+TO0%*GZR[]5P#@D9Z[,L056(?@(ZJ7R;MG,&
M- DN<09('.VVF P)EDDC6D"*<0PM!$0LB1HL !(IYI<G!%2,.Z 8%]&V]%)"
M,8@K@PC\0Q![SA(#,1$!,I\0F 1F%(_FGJME/.EY$'P$E* A.(#6@^"I*$8^
M%_M!S)3OGD+<E6R;'DKH!K^<>R8*AI9D(DDN@;M GPO(]MSJR#//-_P]"[#5
MP<'QQTS*R!W,&K?+NB#WJ^F.5]%Q/;.5SJJ$[1PKE-NLPN";O\K<"//.ZZ E
MCST-G7 .1>^I6%$TJ:R7CDH5:(HHJE["/H2HB-?0#0/CZ:$B772N#7N09P!Q
M1H=#(@[8>*$T"A;^'+&09Q!!_P"8#(9#!/(N9"L$3$-LG60#B1""7!_28P @
MBAC8L=@(5\@W ;EN<$J&9&?,,++])K8!OBN 9P\3G;59T46U*Q/XI^:H.1 =
MV0) .XN+H@ECH<[W#$RP!19G//=$&.)JZO  B9<,6,=A9"ZX"0&1ES(/CP"!
M2C;_ #N# -@.K0J@!+FYXG9>R EF52B$@2+S:U^ HQ\5L\N%]$O'CZT49/B^
MLM77"T2!K/5DPUX^@RI.0I/\$5@%+/%Z!:7R1%R.F0T8S-3.& 3DUUZ"<_Z=
M=@" ]R774 )4&3#'5,2''[+:P]4Q).276]G7@"D!?I]RL@<)/91YBBDHXW5B
MFK>:_%N,L0D=6\4RUFC/+;F@_#DN%]KOLWG%T8RV[OPK5O6]=.B^D^8M3N%)
MN->/;XN"B>CO4L]IQ5?F?%+2 VS$1O(#<!!2T+ 7L &C6/\ D$ 5)9W)?AV0
M4JQ B"8SUF-!(8N&37$AF K@'81U("#*2YBNLM>S% .\04,HL0H%Y9/ =2(K
M,)GC1Q+%PG2',.6"&ES)(9@\(3TJ<E@U1J?*"V'8#$O"RNN 3F;T.#6%(KWH
MG["P<8W@+:[2@CX'"]P.P]+X2S".-C9"U52)"C3M)W9T*42+=(+B!!=B0;EF
M@$0?D(GI*NN"G_=.L 4<^+D@,+(?2""H%Y%Y;. #((#9QF86EM6WZ);>!^$.
M@SPH]0X" S*;<!V21WW3$8A $ H)^^71>(<7EL&.,(@&+D">9Y%-2(""MQ "
MT!Y$)>$.;P8V/$ @MF-EO>I49QN^8HC2E0@,_-6PNGR!:DF3ZVMF$9,&<)8V
M0+2PHQ)*!1^7BB;[Y38?=-H(V,8$:6M./A>IZ&\)U;R!=0=)R0"U;AY,S-7Y
M/O+H ?Q2-)L! ^JCO1.F[/IHF#% S,S*,7G"0P"#(D $R7<DDL3F  S19,*\
M((,2EB"*3VP2H6 9N2XD'=@/&LXP))P:2EGF:---7=VF1Q?$$@AB7+(I5%"$
MJ0P0T4 $@0@9!V(  =@-2 3<FL(4%X'\,00;*)$QI@%F  8 9("21J%$^P4<
M #:?/%B@5";H7S=J4 E<YXE_<RVK(SXA&5IH$Y,#>AYBJ*?1"8E.US=9%#=P
MP\EL#B:&\L/*#9=]')KDR_/L>-,ME3-RMK;JX&E'0=T&/8%2K].).H)AT7"S
M#JVU5P->N#YQ;&R_5'U!CSFJ=8=+8F.,LU$P"9QF*Q4P'ABY)_I@0EG[QXD(
M&$K?G %$ D. )?\ EK5JU:M6K5JU:M6K5JU:M6K5CI_#.I<HTR!(BDGA-$##
M=8, Y<%R'\J5 Z&#\8Y"IA': 0V3Z(JROS(KE?;Y5K^S><6G\/<U%$<D&[:@
M'G8#Y=U).+M<^-G=D=79;&HD",?#%T'=RX1H A1*BE"+8F9LZDY+.M6[8N.+
M2G6_*^(+(&@3P<@)PR-0L(0&8R02:4<GC4)O@8S0\#BJ*V-I<@H2SFU'0-%$
MRN@(V#O>AJ4$)$D'"?)A\X+LKAS.?!P-;(,5V>^8/QMNNK=#V\>@HKEZ IWE
MU 4"\:H4F)Y?^E@AM#:22B:"SDPS%NDX2"0BBO8WF.48<'HM<TA6E YL:4E5
M%4L"!FG>-U25:GX_G\<W!QB8$/"I2,)Z[K.=%3(R%U NY,B.X[H$!EUN0]/A
M98J1GOUV\HC6;3JO\5 &[56]WZFQ7H-88\3@4 H]+ 8,N^$3PNW@6?!M0X*K
M5ZM[@KS.+ZP;I+[@Q0%P@1L-#->XM_MAAS@'3_;##G .B88#GX.G_D88#_3#
M#^D U .O\88#HF& _C# =/\ YYC_ %,I[S$V5,AN"%8V.I-AI#_V;=OL>Q($
M'1PY:R$1YU S#ZF5X*3=G&D196?_ ,V%@LR.QNWVRE"A12__ /\ P8RGZ"H4
M'@7X(/C$*Q$_\R"("AC>*"RC?#@M:#.20>/'CU"@5.G3M\6*#)J$Q T3*P_8
M6+A!'Z&0I@>47)_\QX\#6%R. :-,3[UZ\V1(LF3!PX,!<$B0FN9$$&H7W^$B
M",:)]?\ SG#QSVLQ:+F,Z<W;E>G3I1^?$26&(ZJ)VP2I>-QDEF-_\O%EH2$K
MZ32I&:J@@0(;BQ:%""! FZ-$(KB]IT-CS.E@08]*7L\0(/\ YQ0D0,]^_OVZ
M6+"?Y$R0Q(V.!Z 2F3E7>DXB7_:%H2H=]$\@?S*($ "88&>(E;.<8K _\H+$
M.@,='";D1 =" A1K1P,: '_RQT= P6 .@HRZD/\ T"* $Q'G@3GGB,([H'M@
M: =_YP^&!/*P( R?^9:HZMK')%H\0XU_S$V\Y+97!^U@&5?SE@. 7_<A2O#M
MW9AMQR/_ # Q0AS=.?\ YO,BG\UEOO\ ^@9N6;FK;F;?^@9N6;FK;F;?^8$
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M AP%G8NSN',,^*(( N+,6<5$5=S,?*)&#DF6)!:N4,PEI+AD2)!B0X.]@<@
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M1JSET2@YR7EG'>N>85?Q7H0%-;9Y "G\>QQ$1C!K,&:(2Z H ?V$+E^/]"C
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M(OPD;4O76A)J0R#(\:&^!,PD(S$ E:KQQ&@#Y:U?/80 ;TW\H\NP; !NI$B
M14E\4*]1]E C;-]:3F:A)%A+([NLXT?C$IBU;BZ[BO97X7,*5*E0P+1X]G0K
M,D9SR?O?^)-([^45<E#T<@0$0%ZY?8Y=%U &@M\+1.$D1://\<*$3?HFDE&
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M*!F.)-5E_9/ 4F+5(/>1T!$3;-=BY#+).J>"S4W]%1 +M.+O[TH4*#0?X<
M<Y;]NC3071="0"0"(AS,69-T1\T4I.<)+?$6-;47MF:W.*"!&XOTR1\@Q92"
M9=F9UPTN*67);'16"]0Y5L]+^<(9Y=2A,:Z^7#1K<.Q 1#-A%/@8 B'F#!(!
M[8_-J4 :@. 2-.A\1<:1+%-D.< Q7D>(H#(R "YBE6M5$C]^K]#[I0M=8\M8
M&&OT=\5P+1HV;%L:" D #48%B/<SD-K(PE@A  P__ 88#HF&%*9?QA@.@3#
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? !AA2F288#H$PP'3_NPP_P L,!_6& Z?QAA__$O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>business6e.jpg
<TEXT>
begin 644 business6e.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %D Q<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUOI_C[]I3Q7\*4\/RV=MI*S)8>(FN@\6IW%N(?M<*1[!M,1N$!.YLX/3%-^
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M\9S@45)6HU*BW5TO_ 8O\V^_H."YJM.#V=K_ /@5OR_X<QOA1^VGXM\3>,/
M.D?$#X,W7P\T[Q[&S^'-7A\1VNK1W1$'GXDCC5'B!3;@L,Y;! YKZNK\^?AW
M^S[XC_9^UW]GKQS)<_$'XC6TUNNFZOHGB9IM4'A9I[,8GM80@-HL;KY3%@=J
M-M)%>O?"?XO?%WXE:'X1^()U;P39>#O%US+;6OAZ[MY+>]L(R95A=;AIB+F;
M,:EH1&F06"D8S734C%-QAT;7XZ+U:ZK3TLSGIR;BI2ZI/\[M>2[/7[T?5%>
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M\/-5EAT_7;U]5FO/#=SJ6H:$JRSFVDCL -Q+;E4.R,%4YQR*T=-Q33>M[?\
MDTH_^VW^9"?-JMK?^V*?ZV]3[ ^+'[27AKX:_#?2/&M@\/C#1=3U6STJ"XT6
M\BEB9KB01JXD!*LH)&<&O0E\:>'VT[4-0&NZ:;#3I&AO;H7D?E6LBXW)(V["
M,,C(;!&:_.<_"'Q]?? CXKK;^"_$CSQ_%>U\16VG7.E"UN[RQC:W:2:"W0*C
M9 8[8^I!'4$5O_%[PKJ>I?M"+\--(TV\M?!_QRFTSQ-J$%Q&8)K!;,A]126(
M_,C2QI;J0?XBP-*$>:T>LFOE>,):^2]^[_NV]"3Y7)](K[[2DM/-^[IY_?\
M=5]\4O!>FZYIVBWGB_0;36-24/9:?/J<*7%TI (,49;<X((Y4'K532_B(]WX
M^\5:!>:=!I^GZ';6]S_:KZI;OYPD5F8- K>9"%V_>D #9R*^)/VB/AOK&A?%
MKQU?>!_"?B.^US6[O3Y&\-ZOX4&KZ!X@\I8U22.^C4&P,87G?*N"G"X(-=MX
MT^%FK>*?B?\ M.KK?@WQ'J6A>(/"FB6L*:.GDR7SI%+YL=I-(!')(A(^7)[
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M*\>_LM_ N+X13_"'QAXA\?\ A\W-GHMQIFDM/HVJ!YI&@G:[1@D2?,"X<JP
M]375448R<8[K9;WU?WV5MK7NVM$<]-N48R>SM?I;3\$WWO:VNZ/H./\ :A\.
M:EX_^%/AW2+6XU6T^(NF76JZ;JL;!(XX88EE^=&&[+!@,=CG-<Y\?_VG/&7P
MO^+7A;X>^!/A5_PLS7M<TRXU18_^$BATGRHX7"MS-&RMU!^\#[&N9\7^&?'&
MN?M7_LV>(M:\/2^=8Z)K UV[TFVEET^PN9;>/$;38(4%LJNXC=CBL?\ :7^
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MEIR2B[(PA)RBI/J%%%%26%%%% !1110 4444 %%%% !1110 45P'QL^)=_\
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M[=@W,H4$;@:=M+_UK_6O;J"U=EY_A_7SZ'K]%<KXM^)WAWP3X4M/$FJ7DO\
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M'JE<7HWP:\%>'_B%JGCJP\.V</B_4X_)NM88,\[Q\?(&8G8O X7 .*S=#_:
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MBD,NQCA=LF"FX;C]"44;QY>EK?U_GN5S.]^O_#K]3P?1?V89-'\ _P#"-?\
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M_NYIM9UW[/?:);Z)?6[W:S&Z6W=GMKAYI$:;SXVD=@X<!BV6#8&/5:*.9O\
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M=L[98F%'W,-%6_F:3;^^]O*VO=L]/7]I#XG2 M_PGOB9$&<EKE/E_P#'*/\
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M)_CY_P!#I<_]]O\ _%5\O44?VQC/YE_X##_Y$/KU?NON7^1]0_\ #R?X^?\
M0Z7/_?;_ /Q5'_#R?X^?]#I<_P#?;_\ Q5?+U%']L8S^9?\ @,/_ )$/KU?N
MON7^1]0_\/)_CY_T.ES_ -]O_P#%4?\ #R?X^?\ 0Z7/_?;_ /Q5?+U%']L8
MS^9?^ P_^1#Z]7[K[E_D?4/_  \G^/G_ $.ES_WV_P#\51_P\G^/G_0Z7/\
MWV__ ,57R]11_;&,_F7_ (##_P"1#Z]7[K[E_D?4/_#R?X^?]#I<_P#?;_\
MQ5'_  \G^/G_ $.ES_WV_P#\57R]11_;&,_F7_@,/_D0^O5^Z^Y?Y'U#_P /
M)_CY_P!#I<_]]O\ _%4?\/)_CY_T.ES_ -]O_P#%5\O44?VQC/YE_P" P_\
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M\CZA_P"'D_Q\_P"ATN?^^W_^*H_X>3_'S_H=+G_OM_\ XJOEZBC^V,9_,O\
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M-/!*^)[XW%W\NGVY!;_;.>E=6%P]3%U8T::U9E5JQHP<Y[(9X%^%NJ>-)ED
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MJ7$?\0<>A%2_M!>,M=T?6O!7Q+TBZGO?!LUQ&]YI['?'&^>OL 1726MJ^H7
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M>W-%I5YI+OR7L+UQ@^H$F]1^6*\Z\1_\$Z89@TGAWQ?)$?X;?5+4/^<B$?\
MH%?9MCIDFP<5KVVEMW%4(_+[Q9^Q#\4_"ZO)%IEGK=NO_+73;M2?^^)-C'\
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M Z_6NH\@QJ.X^M%)W'UH$?H]\)[YI/AQX5Q$PD32[6-6]?W2]*Z>WU".1U"
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MIWA?POI$[ZB(2]W?743)# &8_,#_ !'O7U5X>^+?PY_97\-MX:\#^'[CQ?\
M$J2$///.4%M;3D<RRR=<;CG Y.*\)^-G[;7B#Q%Y^B>$K4Z7 0(3=QQI&PB
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M^R?#X8K<ZW(!D$ $-Y>>  06P22JC)XGX]?M2>(OC1'%HEM!#X9\"V+!=/\
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M+<T/YDOC5_R4K5/^N=M_Z3QUQ%=Q\:O^2E:K_P!<[;_TGCKAZ];./^1EB?\
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M<1-:E?[WF;L8^O/M6,<QPKDX3GRR726C_'?Y'7'&49-J4N5KH]'_ ,'Y'@5
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M'X1,HP!+JOS>^(^*X:M8+64C#'05*G0@OY;OUDV_RLOD%%%%:GDA1110 5]
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MY&Y#TSCQG!)-=7H/Q.U_P_XNN?$:W?V_4KN*:"[-^/.2ZCEC*2)*"?F!!_,
M]JUO@'\-6^+7Q8T'PZV4LIIO.O9 <>7;(-TASV)48'NPK2,5%61P8G$5,76E
M7JN\I?U_PPOC[1;WP;X3\,:)J%JUG=7=N-79&(R8YA^Z)QT^4=#S7GE>B?M
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MY"9'(!8J#CG&<5POAKP'XE\90:E/H.@:GK,&FP-=7TUA:23):0@%C)*R@A%
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MZA<-/=7$MS,QRTDSEV/U)J).Y25CZKM_VDO!?P[M;3PYX%TMKBTEN$^TZA)
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M'>OG*@ HHHH Z0^.+G_A72^$?(C6U75#JGVA20Y<Q>7M(Z$8Y'ID^M<W110
M4444 %?4?_!-==W[6'A<>ZG_ ,CQ5\N5]4?\$SEW?M:>&1[9_*6*M:3M-,3V
M/Z ****R&%?+'[=4QM]!T*0.(QYCH7/8'&:^IZ^3O^"@UF]UX$T@1NR$7'.T
MX)'7%5$#XVA^SM?*55<QKN&Q0 _N:+/6!-FY>W9V1]J%^I&<8_\ UUC:7#)'
M&@-RQ^;@YP4]JN21R*A)+31AMZE,AHV]_6I T->C;5M,NQ8E/M++AD8<@9KY
M?\::5=1:Y$)DV.AR1G!Z]O05[9X@\90>%89KHW7GRF/#1J22#GCZ5X)XN\;2
MZSJ_G3Q+'EL(K')Y]QWH Q+J9[6\V+&?.;E5'(QZYSBO3?AQXQM-/NH[+5/E
MT^XB-E<;FR%W=&].#7E4EP6\[[5YO(YW=1SU/M7>_#O0=)M?#]UXIUFV-_I]
MK+B.UWCYYOX20>PQ0!E^//!MUX4\27EBR-]F!S#=%B5E!Y# ?2N%OM#>S7=)
M-))O&?NX'X?_ *Z[KQMXNO=2U"YO)[Q/M%RJGRVY-JF/E"CZ8Z5R-UK$C+%%
M*PD((S)'G;^M %;24"L%"9:7H<YX SU]?6O<=)C@\<?!75M,SY<^GNM\/*//
M PP'O_\ 7KPRZE>U<!&7 X!3CH1D_K^5>A?"WQ<OAG4M]Y$DFE3*870_*9(V
M&* -'X-PFTUV2VF0(S(2N\#/W>@/;CFOK_\ 9OTFWU[7+V2XCP3;X@4?>7)Y
MQV_&OE?5/#5IX'\3Z1<:-=27FFZLLDL*2)AHQ_#N'IQ7U)^S'J1MO'2QQ*+C
M[5%A2XYQC.UOKB@#Z?T718='LWBA=BL2K&"W5B1DD^O:OR ^+^Z/XR>/!$-L
M@UJ]7RV/  G<9ZU^N-CK(6\N+%YY!?X<K&QR&0YX7MD#BOR2^-$2M\;?&QWL
MH;7+W:C==AG<@&@#T'Q_J4L?AOP= ;;?:2Z,%?J$SGU[<UZ=\++>&Z\":>8B
M$=%">7&"=W//S5Y-X\F27X=^!UG4Q,UHX0*?EX?&#@UZQ\,?,T7X4V6R+='Y
MI01L?O9/8=Z +<\<UKJ,T$JF$1YQ]H.U\'K@]Z@U"V>%;>0@M(!N0J^/I@_6
MHM3N MY:*R20'EE+\E1WS[4EU,C2&6,DM&H\D8Y<9QT/:@#7T?Q-K&A,HLK@
MHW&V/>WS-[BNSUGXP>);KPR+9AF69CF3)#8[AL'ZUY=+?'R8TB'VNZ1C--$6
M! 7&.3^&<"F:QK<UG802L6,4CC&"><]\>@H ]E^$WQ&N/#,,]A?3(=-F?S(9
MF&?()ZCKT/-?<7[.UQ%>:7K-S"5:*::-E91P1L(S7Y8Z?JIOKC9<^9%%&094
M7 7/4#ZU^DG[#MX=0^#<%R23YDK@$G/W99%_I51V8'T11114@?E;_P %K%Q9
M>#F];I1_Y#EK\J:_5W_@M>F-'\$MZWA'_D)Z_**JEN 4445(!1110 4444 %
M?2'Q&4Z+^Q#\)K6"4JFK:SJ-_<1@XW.DDD2D^N%5:\ \.^'=2\7:]8:+H]E+
MJ&J7\RV]M:P+N>21C@ "OI7]M"+1_ /A?X7?"K3;Z._O?">GS'4I(3E/M$Q1
MV/ME_-8 \[67UJTM&P/EFBBBH **** "BBB@ HHHH **** "BBB@#^FKX#Q^
M7\)?#J^D4G_HUZ[ZN*^#$?E_#'05_P"F3?\ HQJ[6KGK)L05^ O_  4Z79^U
MQXD'_3)3_P"1)*_?JOP+_P""HJ[/VN_$0_Z=XC_X\]"^%C/DNBBBH **** "
MBBB@!5ZUO^*F\NUT6V.28[,.2?\ :)-8"]:Z#Q4K7%OHUY_RSDLUC''0H2"*
MA[H]"A_N]:WE]U_\['/44&BK//"BBB@ HHHH **** "BBB@ HHHH ZOX2KN^
M*G@P>NM60_\ (Z5_3%X'79X+\/KZ:?;C_P AK7\T'P?7=\6O!(]=<L1_Y,)7
M],GA%=GA315]+*$?^0UJ_LV$:U-D_P!6WT-.IK_<;Z5 S^;3]K-?+_:,\=KZ
M7^/_ "&M>4V=W-8W45Q;R-%-$P='4X((Z&O7/VOU\O\ :7^(*^FHD?\ CBUX
M]52^)L1OR^(--U#+7^B1>>>LUC*8"Q]2N&7\E%8%%%(84444@"BBB@ HHHH
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M*G? ZZ^+G[-]_?Z7:O=ZOX=E7588H\[G2,,)0  =Q\IY6QW*BOPDIL HHHI
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MR?K7[UP?L3_ VV8M'\--$4G)/[INXP>]0_\ ##?P'W[_ /A6.A[O7RV_^*H
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M3W/AF]E73]7MW^U:5J>S<;:X4$ D=T()5E[@YZ@$>[44 ?S+?&?X#^./V?\
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M?[.__1*=#_[YD_\ BZ/^'??[._\ T2G0_P#OF3_XN@#^=RBOZ(_^'??[._\
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M ,.^_P!G?_HE.A_]\R?_ !=6+']@G]GO3KI+B+X3^'7D3D">W,R?BKDJ?Q%
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MC1XJL/%7C#Q9'%XDM?AU#;7GA2/5OM=JFE),L+J+GRQ/]H6Y%^/L^\0A O\
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MNMHH Y+_ (3'7/\ H1-:_P# JP_^2:/^$QUS_H1-:_\  JP_^2:ZVB@#DO\
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M=PO8&[DEC\D$9W+'$7Y&V5<9/;:5KFH:'I\%AI_P[U:TLX%VQPQ7%@%4=?\
MGY]<DGN3FNXHH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMH
MH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$
M36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DF
MC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O
M_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMH
MH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$
M36O_  *L/_DFC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DF
MC_A,=<_Z$36O_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DFC_A,=<_Z$36O
M_ JP_P#DFNMHH Y+_A,=<_Z$36O_  *L/_DFLZ^\1?$+4MD>C>$--TP,[*]U
MX@U8 Q+CAUAMTE\TY_A,D?0_-TSWU% '$^$/AS-I>I)KWB;69/%7BG846]D@
M%O;6:M]Z.TMP6$*'N69Y6& \CA5QVU%% !1110 4444 %%%% !1110 4444
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M#\SX!.T<X&:[&GJ*X4444AA1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>business7e.jpg
<TEXT>
begin 644 business7e.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" 'H!&8# 1$  A$! Q$!_\0
M'@ !   & P$               $$!08'" (#"0K_Q  < 0$  @,! 0$
M         0(#! 4&!PC_V@ , P$  A #$    ??P
M                                        '72L9F,A"0    A6(D*6
MC>.=I
M     "'2KH]]>]I3=C9Y0Y)    '$DLK<SY1XN]>5K\[@
M                                             1BKM=#!?K]W9;YU
MYJITS<Y4>78O O&B2)&]*63U+W$01)Y,NC/U/UV^'R;QO.P
M                                               (89[V_;?9V-B/
M$\:T[S3E:65Q>ZZIN%#*=>E#)FD7<5-DX3.BGU/U.]GRKR?*;
M                                      <:U02          &'.[OX^
M]#K9T\;QN*>:($(A9R1S  %H[:9].OIWL-Z_DW YR
M                             @CIMDQUVNA*6           8H[6WC_O
MZF6?+<?K +BT->Z^;J5!,\ ,@(CMIGTZ^E^FWK^3<GG,@
M                                B1R7^:3]">^T.\KS+@\_K6AD6&BL
MIDRHVKS.M;B=\QTS-#QP     (S/"7*L"I$WE9Y]5U/H&\;S-T_!>6JZ.!QC
M+4(GO(DU,Z)?5]S>[Y-I1D
M         !A/O=7XL>U%L>-X\QCM)5M2TU(ER?FO YS'6*VZ92$2      @D
M.X[Y77DI[&?9O8^_/Q7Q]38.^:5V-KNB0()T2^KSO=\GJD
M                                 !A/T'3^)_;Q6?Y31   $9CE*"41
MQB0   !W7CJK-51<=XX0 ":^SGV;U'NW\.\]>D4G]A,'8 <317ZMBWJ^3VY6
MN                                               ",*>@W_B<W<-
MH^2UP  !6>I@V*^O^1JN[K:K_#?=T_1N!=!<!C< '>9!O6TZ3/Y*Y;R4H59X
M$00K/KY]G[7OU\4X=1KDYVL02 F-'?JNEO;\GW8VD
M                            #"?H-OXG-W%:7DL(  YRJ&[BWU_5_P B
MR%[O@WAZ#G:B_FGZC@/Y'Z[-G6\=0?/Y[P\;WK*Z?7UVOFZT@ !)"XY=1.RC
M=(TCUE^[UA]H^&;<^9ZOKM^3?K.1]7-V38#B:&_4-+?3Y;NK
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MF?2C\T?2>7!\EL]YGZQDJ*QFQ'G_ /0=;?\ ^=[7*X
M                            :MFJAZGF%._B^)G>BU/)9@ !=6_K7AU>
M=FGZ)P]E?TM\MKG4Q8T\7V<;>&[T/SMZ'*>[\R\T_+_H2KWT=M=7QNF&;WN2
MDVL6V "?*_D2I6U)"(D:Y/;/[%I?0)\;V[=C)CCS?!M[Z?P<N\3NY.YW<Y7F
M"//?W>MZ#^"VN5@
M&F)LR4HR4C#_ &Z?$ONULOR^8 =E)7C/'J/,V_J=>X?6\7+WU;S'#'2CZ&_4
MOD_KL6>,WL_='Y9H=R/L$KDQ;%\[S]T\WI:L>DWI"  $P5DD2F C9[T?5.=[
MY?&>IBWY]>J>^T[TZ,8,Z/&V;T.]S6@>>/L]7T.\3LQO(
M                              PN7R7> C%W7Q_$KM,?>>RQ! J-8V"W
M?"8?OZBT-+IP(6<\LPQKZQQ?E?.6O3TW5A]MC3;\/&)VHP8=5=O+"@    <L
MD>T_T+H^[OP*UW^HYT[U?/XCWN)G/G^QN'%L<IF!YU^KU?1/R>SRF0
M                                      !K^;   QYTJ?$CMQC3A9)\
MV#,;&>Z>,U2MZJD3L@ "M5MLCCY%D8/K50W/ Z]S@%>*"  7SDQ9WS8Z/"D'
M14$6]PO;XO9KY[T9?;\U*VP7GK^C[%XI$#SD]'B]&_-98V
M                               #7\V  !9&_C^)#,Q3RL@ VTU?'8'O
MZ6P\^X  .=9NN];DT?H-L[O@.2MI)$  "NVB[<U8841(1L^@#U6'V?\ '9,<
MV\QE2WJ^=44@0/-SM8O2/B98R
M          &OYL  (6GMU^([/&(.=< 9-U]#*^ES]6^KWP !$YQ;(VK[O&VY
MX*O0RN6&6*  7I:F:L^"G1:AD8!%O>OT&/UX\SM1)Q'!/:<"8*FCS5Z=?2GE
M7C8 @D        @  D@F"0! C"!&1!(""0   ""0  () " 2"          2
M@B*0-?S8  %O[-/B)RL,Z-P!V2V9X7)UB[G6  $2=IM[,8/2ZM[/CN,R   +
MIM3*^? BU! (3;Z%>GC]?>'M3(  "/,W;KZ8Z=XR ZJ.J]Z-TL\!)(  "%9
M " 2 $SKTK&EJ]E[ $==:R\Y:+TMCD<;Q'%*\)(L(R@E$",Q!,51"MDD@@0H
MK_.U.Z92"'52..2:)TMGC)6R9         XQ2MZ&K-8IC8EK^;   HV:OQ%7
M81UK "-XVA\UI-?<UB]9/560!RE<^#N2[%0,W(X@   K,UN;)3A+@(",S]#.
M]'JKR\O:  2,L0RQA=Z%8"P$6GN[/D3]T]UU>;T4.^R)$Z")VG,ZC5FS'<KF
M*V2!$UBSY]5XJD +ASQ]!FK'K?\ &O$1 1:._M^/?WOW=+\MH:8\+>R1\\[^
MJGU[R>,\]\:6CA,$W13'Z:8%;F*=*6K>X=:=<-UH?GB..:Y,[%8L>UQ(1$^2
MLMD^UN>V?P/Y_$"'1$?/)^C/H7GIQ]#BE2          3N%Z/I_2S^<_GM4U
ML:[7\V  !3KU^(B[!>&P Y9(2S=I3B?;4>@ <ZN^NS=%>W:&7SO":@  ",H0
M 6#E5]!^[7TBTK=@  E7S::I( :7_5/1^?OB.1GSA:=1*D=YT$R=)S.LUY-'
MBH%7+T*V4\M8\H3'@ .9OO\ :?6?7_\ %_*<X@#6GWG8\2.;K;(?,9V>Z&#7
M2T>4W-^CX;[G@<&9>7*W@0/==DNZKA2:OY7J65YKH:=^RY'G!Z3FJI@V69/3
MXZD7#93,=L=?9O0_2#\=\_SK4"F;.;X\/N/:FOBWEK>B>XMX        [2I0
M12XOHGH?JK\G&;/,<CLFVOYL  "3E\0]F!Z  !-FS90RE%DE@ O>F2U%Y6^#
MB       ?4)G>NF!V      TE^M]SPA^<\?,7*Q[F&3";.!12S"GE<,0EN&*
MS#!5C/1P+>-530PHX!&S>W[-Z'[#/C'G^40!K1[KH^/G*U:WXJLCYGL37>ZO
M1O\ F/,:<^%,O,LF]! ]O62ZJJI2>_Y'ZWN]AR_+K7C3WW'"Y2XEVLFYAL/$
M['^-[-%XVS5/U1J^['R3D<XJ"*7L9?CE^Q]2V?DGGP         $$*_]#ZGU
MA^5R9O\ +\[G,Z_FP  .@^)6['=$N4TM( $2>,L&+RD@KMZRR:528H@D
M "?L^GRSUMQNP     &DOUCH^/OS_3QEQ\61#<,I!5"\"=*P<# QI<9U-DS6
M8QL94)\U)-*#$@!&6]OV;I_89\9YO*("&L_O-CQUY*8\UKVK$Q\C]@LCM>.O
M/J^/\U#$3'2B![9LEREJ1.'_ "OTG:7M>0\GLN+6_=X51B]..U.7HRY:XGK=
MF.!BS/Z;@27>]=]&6OX?G$ 4O9R_'+]CS6S\CY@JD*WC=-D"A2$3D0A*9'&
M  0"2"*7!]#Z7UB>4G-_E]:-IU_-@  <3Y"338% *& 517(MMFVFMV8.O5</
M7K4;$A6U:Q:F0^9QN6[YNI>H\W8G;W,7<WT%A\G:A4    *^?6^;^'(
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MUJ85\IQ-XT2G9$V<SI.12SD31+' GB1A,T< =I&C8_K/J2YN:YM"T;-?S8
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MD-42T"?-MS#9OZ>B!Y<&MY6S:(HY)F6"X#*DMT-QN+I(@'"(^=3KXO-G%4
M        *MU<[Z<N9L3N(LU_-@  ==(ZKWD,V;A(          ##_<V\>=MF
M7QFE4RY\<XER+'8-E=&E;O:539-\?:7=3);!@_)CRQ3+J_\ 5^OO;\FXR9 0
MLFS!TH [ 0.!$(X)[SB=Y02GROV%A%ADH#D=A<\-W29@ $,=68<EV'(XEADD
M56KF48ZX73=3C(%64C#-UMQ!-^E..)$[)B:3L'"K5 !19F:-2[5X
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MDUB1 )Z\9=SZL3BKZ'_8?8^VGQ3S>?S6LKT+*,!2[S<R6M?U7#O9\GRQM(
M' YH4E=@G2RXAZ6G9F*]G3:5OI;%XMO'>.TOM:UG:N[T=+4].=',714<K6
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M2=/?CYGNQL   XJ*6(1/&U4HUE*%99)XUI:5,]U9</;B1R2A"Z-(YVL
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M:[Z[I>\?R/>Q49T  (H\^_=ZWH-X/9C,@
M    <:+#B+R2R5M"%X3'>2D3WRZHBPTWW%IJ*RMYY$(CO1"T]D)>'<=*>Z([
M"-K  664 RF8NZN/XY^GAQIY?:GCII;-'/O2^ABKVAFK_.M9_8PX6WZL;*V2
M+3K&2]7;ROAR7YK;59P9-"NSRKHZ.EGFU-7\-[2U\_ YE;+_ (GT'\YM9,NW
M6_-OKO*3[EY[SP^@\>C6CW0^D:7NM\UWJ"=!=X .2//3VFMZ&>)V8VD
M                           ()  $$@          #'W1Q_&;MQC[AY1R
MAF.JCG&JR:Y<N:#!W6Q"Y\B!D74VLSQ-S\_9J4VTRZ6E5=_0R-LX,+:6>S\.
M;@<RO%:F=F_#=+V@_/GI=5/IG*\J?M?!Q+FQT?''O9[[6]N_![/68J+X+J .
M1YV>NU_17Q^=:0
M +*W<?QFYV,N7D%R45ZRWK+=,O8;6+C6YLU%TY'!&1N;LYFPYKUTMVV9G5?O
M<>SKX^ZU)>'36_ YD\7G52K5K.++5\N.6F+$I>CVCZ!O5ZWM#Y39F082+R+Y
M)(J)YS>DUO1OS.PM(
M    0M?;Q_&5EMBC1L+CQK?.%U>*N64 0(HRACS9OU]BJSEE]7+K]U.7C2:
M(5/(N.]>1THXDD@ A+Z"N[7U[\WGF #'I8)EHN@\W^YB](?/Y8Y
M                                       %"SU^23;IC76CI)PQR*
M!;F'-((O;'FV;U]B9BUMZF7 /7YMCS4 5B[+EZS,Q:T.DM=  (^A/H5]<>3G
M[R( !R1YJ]3%Z4\G-&P
M      "EY'R:9UC:U,)$A:LJ3MK;1&K5$J+5)IF+)P,D8]C/=<U:P6H][:X;
M.C9,XB0JJ62,B:5LI=+6P#@V+8.  $OI WH]$]";H"+09+BR8)R%:IDJIYM;
MSTPT"0                                               $E+Y#LS
M"<4I<+.PW$UEK=I32@0Z:V'" R338S[3/-8YY7MJ9FT;>G$2!>&HROR-JRO2
M:$E;+:I1<8 )?1_G>KFN[ KR7YHF"G&-34/,]'<",@
M                             )68^/S+@P#7+;Z>C%9*JY*]QU8[4D$"
MXYKP*KAW,^X\E59)R\ZKY>=:<0R K%6M2OJT2N:D(@1+DR.@H-$(>U&1O#5R
M  !=)OM5,@                                               $(=
M:/F,S]+SQCFQB+6QVZ2L9*S!*8[4H N?-BY%RZ^YF+6V>R]IG'.!M_G4#+@8
MY"Z&ODN?>W:5I\V@QEHYR+KR.DMBBI0^KK(WFQ.0   D
M                                ! MTP*=(   .1.WB!RI/>1B_,DYH
M0OC!DESII*$) 1( O4S(30
M                $$P2$ D J2A,",$B8$80$Q$")2(1,)1$$@   @D
M                                             +!U\NJ.]H["8+92
MC-PAW36=*57)0<V*WL6?).3#SI,E"I3;&DTFIB^+3.XIEIM8<LBQ$C:.2LY2
MU%M%A:VU@[H:=FZ^:][4R@Q9BIFY6CKB2$NZ9ZJ1"T]B*B<YL
M                                      $-:]#H:?\ H?/8?YW1QTM5
M-WGT_F]RO['-WVU\FE/3YN-]?TN7</(Q5OY-D>3FU=Z=+FTZ;79*8"6P=FQ>
MF/-VM/.C@M+3SUO;U[[MB]2.9N:-[6ID'G]NA=OAZJ<W>Q?M:'LDR^.E=F.#
M9V(V>)JEO[^RG(Z&,NGY_'6CV=U\O/PNO[3:\\[6
M                              03'!,(8E5RPGMDB4PB2$NN)[)B,(20
M$4P0$A%*$",Q")3$3H3R.R(21*8ZT]D1@&:9]QY.60
M                                 !QK!'*U@               K"29
M
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M:;'VP"*"\@]@X=J[+&Q8XHT:$4\NVSR[;/+ML[.B!"PS-BT;%D7YV@14<9J
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M[.1W^EFFY#3'E$N*A"D4%BT#%D$DRG:,BX+1CQ13(H9=NBDFDU;J%!!,SCU
M[ SDP^97E"E9MYUXB"LR3D00*X.(/"E68II.4(7PBR$3X()@7Q' %$6Z1%C-
M&236;UV'+13& H.["97(*O\ 2S^_>=.]:R6T-1P$#JVVZ>J=,U>SUU.4.7@-
M@V^R*T6Y6^S3UEKU@7=.*BX:6:$J5I]!4JJ+'L<77YJO=FL:U=;)<-?,HM>7
M;5ZPM-(;2A;A#2-KUZZK%OU=5>FZQU[5K<XFE*7:?A\SU\^?ZSE:U?S1D+%-
MH.(O>EI.R7B'CNDQ43J%U;+[LZ+-2)M@VLNR-CZ"TE4XVK[EB4WBK)M=(QE*
MPUHF(*2I@!M:5IDXI1AJ/_V'@HZUUQF:J6Q71^XV:--@M05]S7Z+[MU$YZ*(
M8I] #D 5RE.51B0H5RXFB$F,FPE6I@##"'+;+&5@@=P*Z@ (@0@8<G,9R I)
MQC98TAL&#1V+JXX_7AS$G3":5]G9W3\2Q*Q;1?%JA"KY9JK3H9CK34Z-7F]H
M%YJ$4P ?@8J@\G.)OJU,L1-QR$3F73B,<35N2L,/3HZ6F:A+1I'D5C9( 3CS
M^">]0)W>N9[5BC-E+F,*V:<CV;*NM98Y]:WR"9/5&R7C"UHK\[>$@T3'19ID
M&Y)&48JQC5P"U2AE\L-1IL1&:_U*2,MCO]-:42==\NCQ#!:L^"J2)"F;L@P6
M[$!3(F<RR+=,B:#4Y022%<&J/$P<!41:%3PY2 6+8)/<4KK4A)F&;1KCR#<0
M69I)$*4!,H0A,0324-$-4$+#1$P"FO89H^%=U.081\@RE6?X;#4\7'2<'5V$
M!(_WUEHU6N"H?E[MND\2F" \QAX9_$/<(?0R>-5GD<=._2*99"]23@ISG74
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M?'';6$3;MTH$R"K>K@ A'@[HR<;\0( .6%[MH_8O]]:Y)6&K.H83I5+%T_\
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M$4]AF\EPP1BL5\IRF/'X)XWBGX/,L++D3%ARE\GXY_)\@?F/#B?R_*7E[O\
M#>'B8(<QP2YDP3YU00 4/+\VN2QY]CPX<L7W;1^Q?[[8GV'JH>36ZQDEL("/
M*9)MA(I)8AH-$PHI BEA@X@LB5,SA)+D*D@46ST')\'\M+?J_9.$\1@\'D=G
MXF HX80-A,./ $/]2G+Q$2@!R\0$!'%4_I&*@V.N9)9M)I.$B2;HA U)')'<
MS[[SLA<5U7!<*82"<YE#=W8U)SR_LEB\\?/GYYT7";55F).8B9A)8V!VSL%
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M'L?^'>V=T95Y[>R!0)2&@?8Z)XB%\BW,%;5@25(==- B1T1);"K%,5,2"@Z
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MAYAC;_TXZZ\O^'CT=C^%'79E[P[_ +#'\/I6.NO+WAX\PQ_#Z5\G7;E[P_\
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M73<4J59HZLD 5OOIC?2M$1-9'R9/(4U,,HILM)_W-V5>0\=;HZS<DMMKS*G
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MPE(ZI=2:58:M.IJ"3;;*@*:2!?=7:3C$LX52LJ<539<S.VPJAZ:(=^A0\O\
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M)%PK"TK0ZAPS&< T!(&B,D;I&Y"6F67)1+A<39!-+L;\(*[2UJI2THJIQDF
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M1.HMRSP34;Z7LK!^WHI)I07HLZZ8<<3Z"J9DR-[91P >%O!>5"X0LH<EV&U
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MGYJ8I<+1-!<KA#3C_(0'"E#5G6E*N(W0Z@)F,I2Z:*:;3+EM6G?)"E4..)I
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M>?=MAQ\)J2WW?U1T\) Q$<_Q+ESODJ  X;K>4\QP;I9V]Q:8>N-*5(5]4J;
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M+D&QG+D&K-68%@9=/(-(<PL?>VV+_AC1?Q8GS*FPU^%E.?.45]=3#=*X/)^
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M1"9G/X\[/#66LZ2PZ>::N,((JY].CQLG&/"*B"\5G&YDVU8@_P"[/^!R\/\
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MEHF"-_,PL=J6E)F<W"1]K6%W-5QM5FN_>PFI%8WG-O'KM60!S&XYCO%E*J\
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M>XL"?!:?#)D@H"7>ZG6!/:Z-]K$@%8FM7";-6]>TRI)*AD\,SP7M5E)EK*5
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MS<S5FT,;BSC)00-,SKT3\/(6,!EG\JC8"=$F-ZQF$O\ @-S7?_Q'_\0 =A
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MR-;B'K]0_53U<"1R'S-OJ$3SBD'5'A*[AX1' EO4C,%S%=9W,2X.4>/[4U\
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MM0_)?J\=J'X6OF8[4/R7S,=J/X6OF8[4?PM?,QVH_A:^9BCK(Y7B&9>O#_\
M7-1M^1;CAZUG#G[-O#AHY<KGH#Y:K&DV!@[:8\)!UV7 /S_=D_Z5MH4_*E_%
MZO?<IWZ6@>=J8^S!EI^0/&VB>QM9M"G_ &O,\[3:L!6;K+CN&X+0O.(T+[9.
MBT)FWQ.-"3"\XWS3IIFF*G+9>21"VB%K:>GO>/$K:;Y;_1/J]'_HOX!,42+Z
MJ-R))?T[G!\A/,@R9 :C$>7'>>!!!Q3;9= R&T^ ^$>H?-N="XK2NQ'79%0@
M4N+'DK$;0VWXE.)F=, 0F@##]0JK$*>ZYSOH4Y\3_*-7"2(U]NZQ&73<9%@G
MY$:*TRZ_I ])LUU#47-USG3/LVM-IKSH/N:>3:(2"]RM&0.M'IGY)VX??TZ>
MB/:.3;B:]FBUHW$5[=YN=HZXYVKIX<"RG"3B]HV-BM^XX\?5+/PL?5+7PL?5
M+7PL?5+7PL4-V/IN >_9+=:BV5FI!_;P/,LY9<N;Q?,P9C%CB;A9NF+F2G9P
M"1<'B87(&>GDXRZ+?<>/A.995?5YTD3^QA>;:SY<N=++^QCL6OZTOF875  ]
MBQR__P 'F=V?['=9VC3\J7\7J]]RG?I:!YV<GLQ7T_)EC;E/8VPVE_3,SSW<
M]GWJZ+VQL2+J>IJ4Z;,:-K_W>X&_X!IL>4G# !3V2(K4Q7-FG!:!^#3Y$[9^
M2@CJ[Y0H:O2J>9>$S48+4I=/UJ6S'7VS4_@=(Q4DLS1$7+BU  ?[>'$::!S3
M5$5=YRNONMLO-N_J%\ \<$6[D(N&4*\(=8NWQV:_#+Y^.S7^L+'9K_6%CLU_
MK"QL\#:9#],LDSS_ ..ZD>$^Y_ =VK_I<VD3\J7GN(D3[JY8R6H0D7U464PB
MI\O'IC!_&V/GX],8/XVQ\_'IC!_&V/GX],8/XVQ\_'IC!_&V/GX],8/XVQ\_
M'IC!_&V/GX],8/XVQ\_'IC!_&V/GX],8/XVQ\_'IC!_&V/GX],8/XVQ\_'IC
M!_&V/GX],8/XVQ\_'IC!_&V/GX],8/XVQ\_'IC!_&F/GX],8/XTQ\_'IC!_&
MF/GX],8/XTQ\_'IC!_&F/GXR8EQGB3I1IYHU3^8#\^JF0@B=*D2(GX<>F,'\
M;8^?CTR@_C;'S\>F,#\;8^?CTR@_C3'S\>F,'\;9^?CTQ@?C;/S\>F,'\:8^
M?CTQ@_C3'S\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C3'S\>F,'\;8^?CT
MQ@_C3'S\>F,#\:8^?CTQ@?C3'S\>F,'\:8^?CTQ@_C3'S\>F,'\:8^?CTQ@_
MC3'S\>F,'\;8^?CTQ@_C;'S\((3X9$70@2F25?YK\9Y^>Y51/NX42J$(23I1
M9+**GR\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C
M;'S\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S
M\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S\>F
M,'\;8^?CTQ@_C;'S\>F,'\;8^?CTQ@_C;'S\(HJA(O+F*YIYRO?<IWZ6@>=E
M)[+#R?DRQM\GL;:;4)_VW.\]]">UN^Q"I\IZ;LW7X3(RUIF^6%4*?+A7M'(A
M2W&P?YMS4:>O<Z,/1]D-JXE=JS4>5+&C/TZ729\QJ&UK.C3]4I#$J3HB;F[Z
MK;KEAZ.KC)<T5.14\]"4N@9+2I]V]+?E8DWDNJCSR&6>2J1*2'\+B_#_  6J
M"(I6V\JDF7$)9\/N<7&V)+XQ&XJXY&@3-,ER(DSQV+?X2QV+?X2QV3?X2QV3
M?X2QLR[4ZM2:<X7?;-N94(L54LK=5]N?;\"USW^$_P#XLV9Z/_KZE_M6/KMV
M9^/:7^U8^NW9GX]I?[5CZ[=F?CVE_M6/KMV9^/:7^U8^NW9GX]I?[5A-':?9
MEU<^4?HAI(9#XWU5B14ZMM!1'$;;<6+ I58A52J5!X.HQ$I\,W'^,R!MR0YI
MQ8MVI+=:9YS%:VEV@A][JIW0=JZMMHM/5"$X4*JZ.Z-.B?+<Y8[+;O1MUN-)
MCMNM-.HXWYV?5J@YIPZ=%>E231,R1IALC*T?#,D&UL$Y3-1;3E7!U:OSYE.V
M;=-Q*1LW!?)EMR+<6D_4+/JE[RW/+TMV:YIWBII]&?U?/_7X]+W/N)-GK_\
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MDFZV#P>MN(&JWZB^>K" I#KRJ4R:HJIP=\8SAC[DD:RQ&AZ2QP8!F,.:\B"
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MWQ-XI47I=CQ)&H?ME[]XN_ \S1CA>Y:X=JD(<(#>7$9^8)@N1"N:+[&-5YH
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M.C"G(@LPV CM)\ $QL]786W'=.C0GJM4Y%62F[9,08VR;!4&3'CN[,178NO
M*;+TH4O=DG&Y%E2-1&VG%="GTO?JC4^]T./#[Y5:5OM4F[LTC6]5&78WO,V1
M;J2G]-O4=(RR3'=:FUNM]TK9:DR]I8*1X5!J\K9VA;5TXZ2P$HI8G!-*O'X3
MAN/Q)":;9N,ZB.]'<1E[-;&;4UW9W8>3M"T]3=D*-+K\Z'$>H\:!%N&_KN.%
M?J3)+2O6/N:KKV*/M[)V/VAV.V;V/V9KT.F,[4--4_:"M56NQ]U=$J-'?D.1
MHD=@?\I=S=<(-+->RV1VPKFQTZF=T*(Y4)#S]2D[14^;&?&I5"-')VBR)K41
MOZ7:6D#M.R=:('\E4]3&Q]4W;;:/)H=1J#\+:G8>"-:G[-R)$,&;YFSVY5&1
M5H%1#T.]N\%W=;,W76F77,^YMM56MCJK+C;.=T?:F7,+9[8[O=M!5:-6*6<&
M%M55=D:8&\1:E491&Y46]V:>RTW7FM5S'_"9E#LAM1$=VJ+9EZ@T^72)*U"I
MMLT]MHMR:B[RW,-NU-5B&Y(=BJ>C+TWFW&F^XQ(C;+?2:C[+;1QYLAFA_2VF
M2.]L4*>Q-="+NT-_4U4B-OFV[JWZ7+GCNL4=O9:K&U4>[K%J,"G!19RI.H95
M?9XWYT**$7T32]%J0;LR.VY$TQ?S=YMS$2J)LS]((_<J.$%12C?2=JJ=_K1B
MC-W7<PJ/>XW.8U-YW0_:,;'PSV7KU(I;&V7=-=[_ %,V'^B':;9PIE3>[R#1
MJ?4*=4@I<&LLF7TT<H\J*XT+?.MLN:N.Z]27]G=J7ZM5NZ:_4(4"?1?IW5(#
MM<V;D%/&GTF*$-X'0:DR'7*-'[U\$C0YEO&RO=$HM.C,.]S.J,2C@Q 9A)(V
M>JX#1ZU3FA#3;$C!Z,^TW[;%#%*2HI].ZV4K:BODJ<2UC:.0=4EB7V8^N,/_
M -W\_+'V9U._O&/8]C[..CU>7'V$Z17U<*%J\O)DO1[G +8B.$EV:8:C5)A'
MXH\FJVF;[8GX/EX1Z&8&.8J.:9&GNQ\ \9Y)R+FJ>JF%Z!Y,N+U<'$8/T2XA
M<@]*#;UL7+GQ=9?5NQZO1_;QE;UE\+Q<6"JK:G(.70.%$.'U"'U;<1%9S$]<
M5$D7E2SC+$*O0S236=FXKA/%T&;;+5DY@_+L$9'P\<OJ+CV;5S1/8Q+S]0A3
M\D'G?<U_9%?]>G8YS>N7Q*A/9_,RF\<YWV_H]I-HVOS-5;QODJ+MC/>?D!#I
M],I.V&W+L^IU!T'3:AQ&F=HVFP,P:><=D2'8\6,TT_+EOM,MNN8J^W=4"3%V
MHVAC-Q3I+6T5>K<"BTIJS=Z=(J-6G29>T%4066-\J4G*"TZR#5#I\%ALW9>T
M8^S$:3_6X^!$@=S:(E&U<@ZWA>/A>)N]1N%O+);KN$?=XSR3B0E/,1ZUN"T]
M/-2;S11Y#+R<.JR(\:DA#PJ:>-BU<TLM R#Q?<X9JM-=1'HACD)+F#[=O$TZ
M/B682*W')DWBMJ#3R"H6AQBTT7A@YVGO,;417H:SJ#10M!Y>-UAQT3MTA\/J
M\[A0<'G&F"=9-4XP<9'J\?MF/_QPVJF.5N7+R7E[GQ\-M.FJ9JWF)<O-W>#X
M@6#ZYC9NI!)1-G:><,*LW'7G]&2)W/M->'IAVN._=&EG4HS8%*)EY!1]&;;]
M5JSFW@;#G-/FL!=ER#D*IZH^-YDNM.*(.RY#HR'R7D9AP1ZOD!UG'?>>UX@;
M/6, W/K\=G7< D=DB]/ [A\OBQ2ZF(*R<=T8IFW:.I'TC,1+Q],Q^7AL&6'#
MS46A::ZZE=P#^M<\O&^53688;0BW<4)37R;C#@T\,G"CW7EJ&Y)2QI&PX.+Q
MS<QDAQPO"TS904!&PL.T3LU,05/3Y*Y34 !+(U;N>XB''.;S[R?.:_,R6\<Y
MWVY?:]H]HFOS-4;Q(JE0;VN=:9T6QCTW:S;V3.ER)#P1XL.%$A5_4>E293K3
M#0=GF?/.-,:K@.=TFL-U"EUI^F=ZJ5LXFTVT%=&D4MTS=,:]5:I5:D=:JCEX
MZL2.ZWLW3W&@=AQ94UMNJX?^\._FRP^!N"RFC'6XT)4ST@X> '',+Z.C]&:*
MC4S)?)[#4#^K\/'_ ...2IM9\/\ DTK+J^XQS<D'BNRM%IU.&T^+C#W/P\<-
M0OXLE]"/ID-I\7P[6\>F/J#DNZ/^^QQO(TF?(1 2Y_ QFW,!XL\K!9?!?=<8
M:>,SG-M+PYB3#Z]<>+J!ZW@F]Y;1O(E200/V+P]6T <<#VOL\<M0B^Z0)B^$
M%P_4OB%J>\PJ9H62Y7#T+Y6"()FH:*-K>[NA>/!=Q&?!I\7P/,!0<0U),R&T
MD5LO%+Q_Z/!ZA.)DXV&8+D("8O'JNV,27++VA;YMOP\ 025>(B;$FVS?0V[G
M;+BUJ4VV8-ASCNFYV7MOKKC+,AQP&WV6@D.*P026WF#>)UK1/@W<Q%MWG'>V
M#&>_L<O2*H[FG#[C"D,QEW+H%N[/Y>$13$$5.4E0E%.$^M8&I@;7FW+ER6Q'
M4L\HKP;_ "?B8-'7Q800<(24"-#<#JM<'MF*<S'G,5 #XM6.$II$<-AVYHAD
ML1G+V_M>JU[2Z[C9?K<E"IB=8LOJ5KP;\(3BNB8K<)HHNHB_>I02(Y>_:7"$
M]$2N4P,D-VF,:-8BM\7.E30YBI-APZG>[1E<7,TYW$>H4V4U,A20U&)#!7@:
M7$!#Y!MF)-NMGSK3HFT\@.@N7\'%D,U_:7O# K;^T=/V-WJ"FS\*KR'GI)/M
MDW3@J[D4)4F1,:ITBINP6I3O(UI-MLM[35*(]+=?VKK#=:GA()HFF)#5+@TL
M6HFFPV8L:,!IS)\WG-4CYS+(/-Z/\<I+VTM(:JZT22Y,IS,A^8D1N0YI7'(@
MM2&X=0^IVE;"H1Y+;:CFTB9X]CS\D?9FP/SZ8+HY2++X6.7U?4PJ\BY]&$]G
MV<![.76]C!99+FG+C5CR'&%S%5$"Y#]T/AX3>(;#ZY97"1!G9@VFFFXZ%=Q"
MI*J8-U\R,RZ5)>5;_"Q=R)_WW83DZ5Y5RZ<>+ZF$%S+B$E'),6IU'$S2WU/)
MQ&1$)P$/-,_4\;&UNS%2E-,PYC9$P;G55PQ>C2&OZ0"^1B3''CC.%>PZB9(;
M9^$..3/DZ<357VXD^#PX_P#/"+?F7JA:O)[[S9/DUG9-?]>G>=KP^S&:_O<?
M#@+J9$7(HIU.(^'!6ID;?&TO%G<&.7,CTLB)!(<BPB6]/JCRJHW=8;^<P>2%
MP\J.9<5OBVX==X<A73+)>F\?[>%A@HN(Z3C6JJ9Y<75N\#&XP=&^29*AO'R-
MM@-A%AG8&B6N;054'#J\QAXG0NM -5TO !OBYO#[AEQ$T3+(^J;QC8/ZSS-%
MWP.5I5]3R<4H)0MNLO/.,F+B<EVZO:0E?Y=N!V/F*50V1KC^ZPS<.^13W>,Q
MAEZY8W;S3GM08D4:2>J-'D/0]0O#@F)[N)?>PN;]YB.^.6[SBJ#L,AZ#BC*L
M:^1@(R%8.1&Z?L-AXOEXI6S,)Y]FG3)!.SPU2L-D+-4G?OEOR, 1"D2BT47(
MM+%;@:24#7%*+WES;7VTPQ'I-/B.N,LJ*M.D))K/'P$7D!9A%!AF3.MYYVX<
MVR/CX>/UO#KTZ81LF5C,<%*P+/&O]LPK !H (D*N  @@>'AQG41ZTK%1T"3*
MP>%W_=S$,%)'K:S!)'K2%;;CX?<83SC_ -Y<_L%B0VZ[HAH1><L(\N8#P0P?
MTR3(4S#T(_F?D^1C^?IQZ:.+RBB>@'4\'B+M_6\<S+5XKQ2U6":YOCXNO[GF
M_+QS<V07%EQ1,EMMZQ<?CV^VXY)\I45.4MR'D\;AWK&3KQ,CGR$C6K\F_%S$
MTI!W9:>[DUP^-<>,W9Y,ES>8[H1^ZX@/UOA^^X,-ZR9%,PD$R63A<'#;V@>%
M@R"<!F-UK:,/I?XMI6?G/,/0E/N&EM@'%$$7J77%KN>5ZUX'F-J#A&9#SH$U
M9IEXHE>Y>&%WEY&>=;&\GFFD!LVG3)TA,'''N,6F^;:]>PT;59AO.$;8O-;V
MZUIB;H!JB9TKC!L")QWUW@/1:=YK#S,>8CS#99,NI-AFDKT&])X2 --GT4+4
M?4<]N#LGN:PC_?!AE^UQ3AOS1O0@([1:=9@N1WM0!'UQKK_TN T)C4E"A./F
M^U4&# ) -/&+&D;#<@^,0;[-IW5/[U@U?JK,,Q7(1>4CU!MZPZ+#EG'ZVY_^
MEC49J[,E\3R*,*DUS?'SK3KS''X/-Z;77^UX>!R2K338N:3@AKZC@=4>#VSV
MS%(9@5 :FR=ID^,5^+8\<5[58M>YP]/VSLG<;.)[%'@)_JS?FP*K#32H&V54
M9H^T$-%,8T':26+O>7:".W8K;+E8EBWL_5NRW^7+HLKMFGEE?^LWQ_Y7"_.X
M-$\$LL_?8R\7D^PN/8RY?NXY/8Y,TPN?)PYHB8#+^?/'\V6%7AY$Y<\7'R<O
M53U<+E[&:*JXY?4Y<)=]Q,9+T)RIB,62!RV<B>/@.KP*5Q+R87= NEE<.L29
M:=_6MQ2P)\F-^J,=AV0B]36? +B+WV%CJ:2MT!AY)"#RV.X(Q\'I'V1Q-)$R
MS?/D\[4?)J6RB_ZY/\[6A]F.U_>6,2!+)%&0]DI\O4(^KA7!$K%NS<'H6_P<
M*_E:.67"7RL7K<@I<N2+GEXO%X&/"&ZX0Y;U4O"*W#R)R-H.1!Q)85O$5V'@
M#-U=6T0RY$("\*S$N/SBB]"E-$\RA61G.#Q.H&*E&"0 /I(D-:A6FI\Z?.ZI
MX))CQ/&"\)$6:6^3Y'F!8*E:0JN7B^5B*89LF+PF+HW(K>[<8$5GY+%->CQJ
MG593=2CO"(1WS3@ON$2 -,/O;>*Q'BR7HR26&VI;399*#AB8.M.CX!MW$W[;
MC9B#&-3W.E.B]R$B \]*O(1^3AQHLLY#%H*J^$!7V_ _L8VM[H-8:CSWA8D0
MZ!3I5J(^YQLCN_CGZX[AM7157'"5YT2NR1QXKR$B\1OL\&U,5&I+B"C JM\?
MWMX<!X6QAYYJ86J@)R@%_A#P=3'$\VEA7KQ9JG#QC;X!X1T#5QMXL@?#C1?%
M&WP#P0<Z!KR+8!+?9B&U8Z/TQBG:X&617'</4]SYU_[R?]@L20><)D-UAJIB
M&JJ<P'@WX^KR3JY$L1W+P^'@/W/P\*@FI@A9(Y;EF/C6XY)\CP<O0?3P\7K_
M (^.9D..+?ED;.ES?'Q==SR<<$F827#UX[2+IV]:W7<L.^SVW'U5.RR'EW1K
M-/'_ ,JQDZZ;8Y\A"U?P^YO;QFQ)=>.[*TF-)+?&NOQF[+= \AS%(]X^'=QZ
M_K?#@@W@T83J/Z!*JEP=9J__ 'LPI!*(B1.1LF"3,KO&O\3G/,+1>ED]PVBX
MRT@>5<0/_P#R_ \QK3-PC(>>$PL0'/)*_C#^C:P>]&(9&V*$4QB*@MFT]<[:
M]SCW&+3?-]E?AHFY\9YPB$76UJK#2-B3H!JB6AQ@V'..\VT[P:3+3N#:AR-2
M.+K:,N]\8<C7;.*\;I<R',Z;XM1]1SM6GNR:P!+5 12$5<;NS4"M ]+J:9G?
M<WVFEU'O7.;4H]09D\A*(@[8:<T9!<)L>/:WIMN.]?!Z[HL"(\PZM5@'KEX)
M$US;D;P>TU=*_P"UX%\28=FE*)I885ZG)9'M/GR(V&^T,![/5YH^>TGN:Q*;
M)\QCM[PC#C:#(4W [(;@TVS#[8WS6*(W F%.9(KB=*.450>.*]JL6F;E^G[9
MZ[B@I[%*A?F \VIO>'#ET"H,+F26RJ=M%2I\0^'VN5':/WO_ *T?'_E,3\[A
MU$R[5Q/N<6$S]7EY/(QT]!<ON<+XF?)CU>CU?4PG3R)_,N+@\'E0?9QRKER8
MNY.'I7U,9]*%RIE[G'V/L];WV/\ X\N.3/D7E)4P@JHYCRJBITXS[01]0O (
M,/9@F9+FB>3A@ R:R>974SZBZH6EB8W,FI,>*C0R)[,CRYH+1X\/&O(8\B<F
M)B\G*^XO)T=;SM9\F;LLO^MU'SM6'V66_P"\M8J8FX/U5*M;/I0M<\:1."UI
M^"BWB8^+;BP"S0A);>%%!N[J\&-)%"W*UPB4>5P^KAK=W41&[<D;7-=0^MBS
MCN=',[N7WQ68U[G&GCY$)M,\W \<?$<Q,>9BC&B1X<@Y3B)F;A6^7J8FR2]<
MDO$)&.7%<?@X!$%4='K%=FACX%N!#V>G#J-KF9*+3@JI(:"?ZO#Q2WW(]-IZ
M;W/D G1'9$^:]VY;AR)LELPKX*\20YLRI$T"" V:]H!J&=_.8F5.I$#DRI/;
MQ+4.C4/P6O7+&[\0.!0MBO F?JVNAQ8:,;DL+,5&[/4\'&S% DH"39#KE2:N
M'+1;M Q$A /7,:TPE"\R1!%H0"V[K8CD ZA]%PB6?O<1ZC-JS>^'II$@/B2,
M<?5:(@\/JX8WAH=>PB,17PC&PAN\,,/ #9-BBB1B:DG$'5(1P;K/"7-ED3Y9
M<?&1"/:89 UN/?8YJ1D2FOE>X\Z]]Z<_LEB6#Y. WND%5)H1,[MU#P3-O">B
M9EEI79Q&D74\&T=ZZF%1LR-N[)'"&PU'QK;_ /YF.WJ'2.2DPQXO%=S_ (^.
M8<D&5P\CK32)IV];@-SCZN$L6?UASO%CJV\7A]>^W^BQR%4?YQBY^'Y?N<<\
M3PAGR*V(JMOOSQZ'=E&YGT.M- %OC<!N<>.?=F"?#F+;+1IY?7-O"B;LE(W@
MNBRT;_OFM=MO\I@?1TM45!NR@"F16W__ $KCX^;P2 I$"$2"2IDJC=PD0WN6
M8%0UM?/G+M+2M\GUSS&]/4ORYX30<D+[45_&'WS"[X:@FJVER/, K;9B]<Z+
M3QMZW&+7KGAX;T*@X;M[8O"XL-H$ W0 G6B"HN7[NQ<YIN-M:MFDSAX(;]\8
M701A[>F'==LXKQNW6!S.F^+3?.>-ALCJ<L75 2=9&.PJ YI<38N[]Q\=S=^G
MV5G-8NAU%V4:B2Z;C+3"APG:-VNY?QVM\WX^"69.?C&BC9I Q(1P;>L5\J-8
M=_K>%*-/?=DH7*V^+##3C?'U2!]SCZO-N:?A\[[:^+INZ(BYHFT@F2N>M7>1
MC9\*9)E2F"/,W)<<8II(W.3JM"(/R;P;]:<YK5]J:Q14]BG1$_)#YM>^Y3OT
MM _]0+2"6H5JL#VM,H45)\IGU>?N>89 [>+0U=;+E1O'UE]T#XAB_O3'UE=T
M'XAB_O3'UE=T#XAB_O3'UE=T#XAB_O3'UE=T#XAB_O3'UE=T#XAB_O3'UE=T
M#XAB_O3'UE=T#XAB_O3'UE=T#XAB_O3'UE=T#XAB_O3'#L3MZONJ(P/]FH'C
MZR-N_B9G]NQ]9&W?Q,S^VX9C5FD[3;-MR#L;G5FEBS"U.&T"<9DR'@SN5=18
M^BVV*N/.M)AF3&>;?CR&P>9?9,3;=:<&X7&W 6TP,"0@,.0DY47SKH_;X_\
M:P[[*NN?VCPEJ)["HN.CI7-<L>QET9X]E<LL)TYHO*B8Y/43"=/0283/U?!3
MHP'0/*6:8]4O8QE<*<O0G*N.#A4D\+%AYBJ]!IB0QRV/)DG6ZV Y><(<E'B5
M+<166D5#D38[(V^,;X!\#$B,Z\LE]R!!%"3U.&PA^3APW.!48(E7+IX<&:^&
M1&OOB\[M%Y+^RR_ZY4O.U(?9:;_/M8GH"7?3&8AD=MB>BGN''0@@EI9ME:@6
M>XP;[-PVKQ%ZJ^]\/".MJ&H)D2IF2+[[&7(1HF99(.1^Y]_AQLTR-QHAU"&[
M+AZV%874/E(T(;41SQ?>8RFLJ<.>)1Y1-)RH+W!P7X-J-QQI ZS+A)P*R]QM
M"7!U\6&H@.D2YF/+[IKQ\ =Z(1.\*+TKXI>0&'@7DR'//A54'QKO'OQ59[CC
MF\UY"@,1W!Y3$![42O\ *PT"9I&CL#PK=SCAEX(]GX?R,,LAE>Z-B$"YYN7=
M5TNSQ20NU+H;Q.F*W@CFOQ<6*5&%;&5E-D\N1)S;/&5U@>3A]W45ZG4]\8H"
M+A+IQV2LMPT .#D "2H'(BCXN-Y>T]=!(6FLKTU#( &X?'PQO,<;XSMS)NH*
MJGVWR,"ZZX*HJ\(JZ*(MGA%@V3R74*\45<W4L'A'W& -G59,4XUL)<Q\(BX,
M, :*;K;C.3V72W=U;O=^=<^]G_9Q,!\G0;W*GJI,@)G=N86\)FWX?VS';3\N
M'BW=@E7AXN'7\?[9X>/5RSZ?"MQR'5.D<LQB]6WB+K^/CT,4J^_UX6D2RT_$
M\/J8X J/6Y;RBYVVG\N^W^BQR!4K<ASS*+FGC>![G'/ZUF?)HVJOR\>ABF*Y
M=Z^+"!;[SP\)KE/0\AST185.KQ=?WNE@T4I0QLN T%LW[N#K#>VWX_KGB8/T
M3,Y"*ST&URC:%MWH[@X[O;<)=FB>JHIFN$S)S1]54 ;_ (-__P W';3,\^1-
MW:R7WV]<&%N4[,RM41$EZW#<-[>#W]6T%76T0G$?509M>N)IIE^->=^EVCF&
M="4R;U[:/B]$F UIFZ%SK1!7''.;8N<L<[5T.U:PZ,!8Y14+T*NM,36'<))V
MRR>/F0W[=VVM/2YHS^^X:O?B#<!:R"CJZ;V@9B(_3_C#>K6_6N:,W?M6'29?
MAN.(+R)IZ[2IZ%DFTZ-]5DWGKC';TW(WAG[7@U?<C \A.(R*!,?O;M#2)TN^
ML:PW./5;;;YK@^]8<)F4T? X3+3D2>BJYQVM.N]_.#4X.<;;=\/FL2D-7MV3
M6W7=^7E]:[;UC\KC9L*4]->C$[F9366F'4D;G)U1$67W&S8;]:<YIUWVIK%+
M3V(,=/R8^;7ON4[]+0/\?VAJS"(K]-HM4GLHO0KL.$^^TGW+FTQ3*[&A!4JY
MM,Z[4ZW/>-L)3P2)#QMIO#W'D#=IZ?9.R2?=1&MX50 AHSBN*;@FTLF$-@B7
M"Y=K6'J?8Y>MA#?C;LYF:$T1-&26F0BMP%9QA:?OL=5/_ACJI^!,=5/P)CJI
M^!,=5/P)CJI^!,9-QA<'+._4 .7BX;;/<_"^Q@-.G7W(=R;PP-BCU/=ZF&OI
M6F1**.>BX_-<HW%U./3XNICH3\"8Z$_^&)5.J<-F;#EM$T^P\ D)B2=*>*8+
MQMN!DXTX(N-Y$B8VDV=>D.RF=E-JJK1H#KO7W%D@TA_K=<[/6D<TO!\ZX/VU
ME?E8>]D7G$^4>/5Z<\<N?L+EC)43V<79]/+;A/5SS7&7)RK['1CI3DY$SQGX
MOL8#)>7/H7'_ ,4Y,&XEMZ)PW)C57D5"R)M, X0H&2=;U+CQQ$H_]W!AVWC'
M+(<_4LQ1WB8U=RG-OJWER+HD!W%\'#+1ESTQ\7C1>6QMGP<''0A4G$RZ>)!N
M /,%&EU57P10KT][YS:KR5V87_6JIYV:/LMA^=#%8/-0^F-0(55.!2WQ[P<.
MN/ -UA"J-="N'U2$L#P6.N(/(2#G=;X6%%5;>N4C(AY,A\DO PZQHE*T4$E5
M;<K;>L)!X>'6F64U'!YJY<U0O!N\?#;[QBZR;O.W<FF5W5M/$:L52&,R;*:]
M 4L.HV/@RB+WO9XEZKZ"#AD^U<F6B)]5@;_:^ST\<YR/):G#T6GXPX%,A[(2
MY$Z+QO+A]]@,UX%X54D)<VPXR]QBAS(0ZE!E1!BL,Y9;M( >=)WQ#<[3$9F.
MJI<(JZ\5I\5MXC;XE_KF(VJ8\V6L ER@^\!<(V^[Q1"/,'W8$XY0-KR(X<H+
M1]K#^CQDI#PP)SMIH2:=C!\7M>)\QZX66)3R7-H2@YSI\7EGAIE@9"F9"B(*
M=I=X/N\19CS!GN_$;9J/]5;X]]N&ZG4U.,S?JM163R33NO'5X^I9B]56P.J@
M#R'XPB(> W@W.4+BRN)HE5! >L)X<><-!#2(M1-4#,?%\@,+$:N[W,4QQX$1
M24%>"9&"XK_#L(O.N>X+_NQ/%]';.]]-[%10[MU"WK@Y@[-[SR*RY6LKO!N\
MSJ5#P>EZ+R</%ZQQ\>.920A7>O$TJ:=OD WQ]7'"Q+3EY;I32\-O_-6_#Q]3
M3,O866U_:W7_ 'LQSR.J.?)80HORPQS"2M3/I>)I0M]X'7QSH3+N'/2=8R\K
MKA@K]ZW;+AM5K70K?"X-,^.["V;U?X.HC67@=:SWV.7H]7+IQPW(GJ7+FN.!
M'[^'KD*IY74#''=[U<EPO3]C'0_JVEGDK5FIX/@=3'^]N"U5=LRX%;$56[RA
M,\+8KBAER*8BBW6^*!^/@;U,07KD*":I[D;V_P Y@=$W3\?4:%I?>V&Y@]Y1
MY1L<LT5%%UO6KK_ ]MQLN--WQ(ZOE=OVAJ[QN$G5MT>;T/:O7<0$]B*RGR4\
MVO?<IWZ6@?X_MG_)>O\ Z*EXV4)4);:0TN0BIKTGT"'6PA9U(.&RQIN8UG[W
M3^7AU;Z@2:+F:&,SJG;V5X=?AYKUWBQ>CM>%"-PD01GYH35@=4POL<U>:]:_
MJN;U-[JH(X'4.2Z!A<-O5,+P/\IC/?*H.2DO#/?MXK^2WWWR P#2&X: F2$Z
M5YK[HO"\Q1S5,TRS%<E3W..M4B]548,B#JV?[>(REWY.W>$16B=4^*V[>!#K
M_:O<X!U&Z\:M$V-I*_R\)\1 9\=GKOO,::1I;26D6H^P30K80C;Q>'\U?,7[
MBX[IO_2!6?SJ^=(?MC:_*Q)3[?(_.GCU.G'W.3-<>JJJGJ8MZ.3+/"?8]7"=
M/$N6/9]E?*POJY)FBY8\)45<T++HQR6IRY<N.'B3H7!(=W$OX"P'*N1(5R=&
M181P533$;L_[6"7IO3)!3IQ+J3PMV-!EF]PIX_"6)\YY5M4G 8'/.QD2X1'_
M '\/"+RJ@%DXOL#X/R_,0A51)%S147)4P1FMQ$N9+[*^SYNV?DM[,+_K55\[
M)'V1'\X.*P"7"#55J0$:+T%OCUW#C2)C5!5Y6\N5,6.AI(JDH&XA9H/@VEAX
M!*U%MS<4N3R1##JJES;NIU>3,<((H/ G(67 !7=9W&5A+SK:HX29"ODXHE1#
M3MT1BN.Y\C9!>/P^'&F*7\SUDY2-SP?<8L,40TX;W%R-2#Q?'#"E>09:8K;T
MAHV&7N\/21>8APF0'5DOEH,,CX/$?_[N(FR5%-RH,C(UGZ@:$C&\6_Y(/AL\
M?7PR")>8LBC1>RY[47^_@89E[X+)M$3N[Y$#K9!Q\?EW^N8V<&1(0WW*3*XD
M(O E 'P\5\P>(7F:+.3-Y13B.P+1OQ(IKRM"\TKCMJH2&?E>7AEY25=%VX6T
M3DNZX_[N8>"7$;CE;O&L\-^H0<!%??ZW@A"=&=T^6UL^"WQ1L/":0L '$.F5
MQHGAW8UBTV@4!%" B1%'QN/J=73PZP\A9.@2*X1\J7B'A7X,P<>=?*.X'.H*
M<R;L8_ Z_&(^=+W*_P#=BH))!PV^]M+X63$#NW,+2N,',+S%0ZHY<^Q<A\=Q
M=AU.K\O!:(N"SGP@X0F:#Y1@#?YO'U'-\'IEBJIP\7@<?'CT.R^!7BN;CHGS
M=I\/4Z_5^!C@I[P<6?%,(UMM,"'J>/SGO,<E.>MR'A6>7R>8QSS;AAF.0MG8
M2<7N,>AF) .7=9UX333\6WX..>C22-$;3-M\43RBZGKF"4VI&ZJG"VVX.NA6
M^,8:>#T&Y@EGFTKAM*B>,+M@?F_'QQ9Y>K:O+C@NM]@US7'#O:.9<EVDH7?,
MQQW6^K8HHOR\%E=Y/+T>ZX,9%%53MRO%\D2ZWK6V>/SF!WA!LLD*NIJZ2N:!
M[I=H^B+->W5T_6L#JFVW.$7+@;CSWX[CG'I6EO49QD.RU=1MWP]'UIK#:0-U
M-M8#R/.*U5&I'?#2>TB:$WW(X<_I>N.M:0?;.:>WS15HDRBZ /HZWU[2D7Q7
M-8V^'FVW/'YW (R<0JGO;BNN.PY@,;K:=HM" .<;G-.<YI.M.WM<[B4I-F<8
MM9(PLJ09.>M%Q\Y9]\\C&R7>EJ:S&5_(PG.M.NK(W"9JD.B' PYZTVYJN_;<
M14]AAO\ [O-KWW*=^EH'^/[9_P EJ_\ HF7C9%R0:@/>=LLQN\$T$O[0X9D!
MJ(#[3;@HXI =IC<-X> >.DOAECI+X98Z2^&6.DOAECI+X98Z2^&6"<)2M 5)
M>(N@<;JRXX1ZFG=Q("EID]P<=YAS3K>HWS6JT;6.D_AECI+X98Z3^&6.D_AE
MA>4NCU5)<=TW_I K'YPO.F'W%3WI9XGQ7FB2/(>=E4][(K'X;SI&-I>.W=N[
MOVT/O6.CU.3'(JIR<N/YN1,(J^J..3V<TY,9^5T)ZF/9Y<T3'(G0I<BX7D3+
M/E]C%O#;XRXR3ES7E]C"KX2];+H]U@0S2U>6[U$PC**N0\I*A<EN+&T(]0A!
MH1Y<RQ#!05)4]X0,E7)4O&\A^5C09,[$!LTN7Q_!+&CT"V-Q)[)%YZJ[6U1A
MZ*.U+U.[U,/@39G2J7O#H5&PP["H/32W0_76HP2FN9D-.N><<'V1_P"[BQ6V
MY(O(S)ENU%C-"1IZ+,=-YHA+P].XH[OVUD\:SC3:&0MZ19Y*'NL,,F5^IR<J
M$:G[DL'&S+/V2<^#CLN !$1<Z_@\18E<)BA%G:/3[HCLP <A<8J1)QV"!=7$
MZB:BI($BFT\7%RSL'B:$>SOP^R.I>R1-<XEF3@=;CPNH8(2)=< \J%XH^/A<
M[E4^!!7X=W])Q8JT".6D^"-S?NMLWW%;X8?:\, [SF=J-*I$EEA<5OD.>UXA
M1#3-O7S>1>3-P+^M?X&%47 59#JDTHC9HM@-_"/AGC9G+(;J5,+E7(%;"8'"
M'!U\;6O6*V8PHZ(?1F.J& ?L-2>8Y-0\FM2WP"PO&TBMJ/(@\AC[K 6 \'6R
M%4S2T_*#KA@@9>D")%F0MG8'!Q_V\ AWFA)8*N+T#;X7:.'J>V89@@VZRCH"
M+HW='AW7=IU_6\-0IHMI,CVAK.&*(_'\'W[>)+PAZ%CB# N*EU\AT@,QN^U@
M/._?@\]&KQ,N+3:S3H[ R42YINH0+V78I%X!Z&[R&M3M;W-'LW=+_%Z3+C,F
ML.A)(J-2DVEI,-G%DQH[1%V>O(E.BVTWVKK0/N_Y,[AL/% 47\'FU[[E._2T
M#SW*N28ZX_AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?
MAQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?AQV@?
MAQV@?AQMBB.#F6RU?RY?_9,O&QPH]87>L4S2*4M$Y2ZXAU,$*SCX554LI+I)
MUO#L-R\.3UO3=P6\/$2= 6P)09]<KO7/ M]KZIXSU!Z,^7DQ(%I\Q;$N"T<T
M0;?<88]'3<R4$5-PY%X?"X.#$<B7,R:!2SY%S4?,/+/JEE:-Z]7P0\/W'JX$
M]Y<R55'TH?14'AX?'O\ MG9=?"*KSS@(3:.7TF4CO$7C![D^S;<T[PPJA?R>
M.TZU^>!O#*QE-%(R0K!N\'!9S:EZF7TK\DC\3#BS'7GE2RTWF-W/P[N:LX?!
MQW3?Y?UC\X7GEB5>GQYT=5N0'PS4"]L:='G&7/MC3C;GV<>D[GV/IG5.3_7<
M9=Z'?C2I_M6/2AWD_P#:E4_:L>E+W)_[3J?[5CTH=^,JG^U87Z4O?&E3_:L>
ME#OQI4_VK"_2AWE_]J5/]JQZ4/?&E3_:L>E#WQI4_P!JPMM*>^,ZG^U8S2DN
MYY9>FE3_ &K%G>IZWV.^=3_:L*CM$>-"3)?IO61_LSL-28VS[@.L'J-$57K+
MJ(7LV/3G P&_T]]Y&US >^51:!%]PS*;#&K)H+SCF0IGWYK8<@^XJ.">>V5?
M-P^4E^B':5,_@UC'UI._]8]I_P!\8^M)W_K'M/\ OC'UHO+_ /Y%M1^^,?6>
MY_UCVJ_?>&JE"V*AN2F%16N^<ZL5>."YH5VY5:HS89G>(Z;AQE<;Z6UQD*(F
M7)R)EY[=:U3H\YD5S;U$('65+KZ#[)-2&;[1STW./!)WI>R+I1:I4U__ #6
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MM_ ''2W\ <=+?P!QTM_ ''2W\ <=+?P!QTM_ ''2W\ <=+?P!QTM_ ''2W\
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M$>IS3B Z&^=YJ94]TY=ZT]-RS:S:/9Z=NLZ)L^]4*74&!:>L*T#8?;%X'6'
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MTFHS([[LRF/PF9/TQ8$'=*/(:;C/+9JR6NNG=Q:DU"G1XW=1:B,T=Z/O,B1
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M<</@MYSFNOAUZBU)JHZ8D0PY+.ZR#\EIT#<CF?WS=<&R\!M/,F33K3@D!MN
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M@P?9,'&7V'767&SY'.OEAJ3'-'6'VP>9<'JFV8W 0^9W8?L=U/:!/RI?QCJ
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M\WXQ=<@#$[3ZK(QD<55\(&HP$)>_NQL\XYF>=4D*F2$8<'@^[ZN'ALS%N!,
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MN5JN[0DV$VJ[05'OA*:A1W778E*@V,1V(M.B:IHTPVUJ<(*\ZZXFI_\ 8?\
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M[=NP*5*X#P%Z",Y$J G]@.O[LKPU*^95-K3F+O8UV8.OOZSA6:J4^T_V3#4
M1;F60+[>*AZ1R#5D?)L0+'W6D3OLJ-_L:?S]Q_;!_-3&]HY$0WX?H'[:=JW^
M8K$Y=ZG?7I*TZ!]BQI3CX$8E:4/LO'DLXO*0A!H0 2I!$%A1)ERB+W?V55@
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MT&AGH'-8#RVYOF3%:,7R\W1'PMY8UU\1H;&.+R#GIS6',^>'7^B)/^9 ] 7
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MV"DPAJ D""?0,)"VD^-2#]3NG&NH)UG*5\TGOFP#.60*-L],'8V2[5;9.OR
M.1Y79=;9.3@T2U9;5^7 ^A<V23DP-]^4/6_].R7!L>?*,+NIU#6\\C;H<3.(
M$!N[,)PO07%[L=[HACRY#DW*61_>TJ=L\'J<CN90Z[!GGZKB&6%P/%/F&/+0
M)FX;7.\?3*G/1&4[;O:%98H*\2ZVK'J;S7=E&(8VQ"5VF>CI #^! ODDGB;G
M/X>YK:G5N>S:C%P87(-84,BRK!@#XV>L+$I->H+"G#C<%T0/HL6J#. L.(02
M5@0CSP4>E"&"'-9)H((,!!^Z=-J3$16"Q2"20Z#)L0]E2B#^Q,V.#R?30A]
M?;A2Y3X4EL)$@GY"B:'[#/0"94"!P"&%(B1!P@#%^ !T ;DM&(,@B93X81J
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MU1D6 KD*EFAT_$1U@0,_?#9PRH$!%"!@F0)\"#(G!"@!=L-UM!U/!"+" FS
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M'8',-Q'8=<L0*B/&()!,"M"U[SKD,(VP2/2FJ#7U !BG/E"D0PPB5D =5D-
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M!H69/M0)X;4(;MB.HGW_ .J&)8(6B"$MC: ST6*WOZ*S^OP%V+]/I+ 7C/\
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M1AH19]M5$%_EOB0+ZV0E4"K]1L$U(6VH#I#9T P%!/6 0#S[@DP(3[C)972
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M<O9U5 0M"6'A!DLRUUE80Q[,"9D-Z-.4#DR[$%1PA;AE(3!9X!S\5%E :O\
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M_-2P?_F?_]H # ,!  (  P   !
M                           "TFVVVVTFD
M                                     !)MDDDDD]P@
M                                                $<W00"""Q4
M                                                          !,
M&"!  0#U                                                 #DD
MDDDDDDDDDE'+_M))(O(
M       5"3;;;23;;;;:8Q!0;726[@
M                 $-9MXU)B_\ _P#_ /\ 4VJB)D$AX
M                                 %4=$C<'H     $P&49T@ 7
M                                            V0   K-0    @()
M_FD '#                                                ,H   3
M$>0B  $S\,A[H( *(
M     L  $E=PN]/    @D]=+ &H
M               $8   -8#!&PD &@$PV9S@:
M                        $@*  "7R7EOZ   $DLG*)ZC4
M                                    %0  6A,QWF9$  D@<]__ &/H
M                                              ! 1@ -\Z%!MLSD
M  ( (K ;1E                                                "<
M)(_'.&=\R2    %6$JP(D
M         !  .$@!(P@*  $C;:^VZ!-
M                    < -V   2)8  !9WLG6" )@
M                              DP N0  (?5(  'Z?\ .RP2&X (
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M-Z3$G4N -           2]@  &T$  0$2NQ      $D      K@$ D@DD $
M "("\#H,@ #(A$&JKX S(2$ @0    ">8   $@@ R^N=&"W     D@     &
M8@$$D@@$@   $ 2HHP!  D*5 Y*Y %1 4 @ 4D @@20H   F  "S)F]H((
M " @      V@ @@@$@  @ #X HD. : $#0 "DR@ 3 "V @4$$B@ 0U   "/1
M,M:4@7WAC'_FI@M<V   "P @@   @ $ $F $I@ $9DAL M/-1  '&R D"D@&
M$DS'H@  5Y@8[-UW?+["?0UV@#G(@ !?0   D$$D @ WP@J D"5@0K(.BH4@
MD" @ $B6D!+;P@2    CZW %Y!G_ ..(TILU5PQ<0 #ZH!)) ! !(  MY)PA
M$6(E?007W L) )((!!(@ )P8)@2H  !U"YJ0=O)YVE82_=]OO@40 $)!((!
M !))(!& 6 ()H@ SM,@H$, "A(%H)(()(K6A<A    4 (   ID#(  0@ " @
MD  !<)  !(!!)(  IP#!(()ZFRV)!4!,P$8  ,((! )>;?B (
M    \    @  $ %I!   )((!( $\ (D   #)W%P8@%< #K))! ! !))!0SX
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MDDDDDDD;2*V0M!K      "QXWXP0      4'PY*K[!:;X      <(7M(0
M    !._Y6_WWWV_^_P#O_N*   (@     "F44L,@      /O0>UWC;@M
M  !>L0E%X       ,#%C  D,A%C@C #DN038"J    %!IMF/WRD     &_+;
M:4Y=M05      S8[S!C8      "J1O*G@YXLK/2 *EC:0  $@   *UT'*FWM
MC@     6'F 3T##<0(      1@A6@+C      525K&5U<$R:UDB:DM2  1N
M  0BD V)D@>=      U?R@XF![1     "H5?U*3AM*T, 2  - +)( 3LY$ 0
M 3:9B0  $(   59$#8435#@       N3H%N8'     !75?1&;ZAP<H "0 2*
MG)T "H%XP"  U-HR " P     !  @H ((          (!4      #-5%[#WI
M+XPI<@"""DQ8$W#N ^< 0#SP500  >
M   *IV6/?^!>UAU@ "0'(/E?(*63$J"")?OM"0 !A
M              (  $           !D! ?!" V=/801;#TV"  "(
M                                        = ;80  ZCPCB !X/NP"2
M %                                                *, 00  -(4
M !: :8>  ""
M -"0   QY $ #(2  )"2"0T
M           #S(TE^Z#TF !<_0  4 0J8
M                      9'I01 !4\8 B'*222#-V!"
M                                "TA " #;IOL \*"0"#))):
M                                          #?4020 $Y:%-F[P200
M0                                                    "(22220
MT%(-MEJ2"0
M     !$!( (6H""4E J!    (
M               "/,/RB%<X6J9DQ->==LQL
M                         !/<[/[M)S*4%O$0XPL)TQ
M                                    !&0&Z7WUW\?VA<Z&#7$>0
M                                                 :
M      (@
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M_14?Z*C_ $5'^BH_T5'^BH_T5'^BH_T5'^BH_P!%1_HJ/]%<II*KYMCK4C"
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MEBW#OM4A+V0"(NX(OKB]1@L- J%F !%2(PD0B;)ARUX(M A=92:V:@6*<L1
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MT.N(U<JPR3BI7&,Z[LJ?)=$;<#!>03:$(=QC1HLBW =6)(*K@S>5:N?=?3B
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MI*"(4@:I80 O=O$$L%) $LI* $H D@ (,,E(:F?E"Q"%A":J EA+ TI<?2H
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M5Y+.; 0R9 !A!!AXB2?0+5!,P3O%^_V O;Q_4[?^CQY*^]E?:C9S)[OW]MV
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MB!EK?&,-PPMH&'":5;2W*$)(,$+-Y"+NI84C(E""0APRP)<Q:\Q4F;%(RR,
M3.DA>]XBIEA-K@)UFR8M-Y+&6E:1G!$39#8;1(#DLT06*6",D)!29DS^2IV$
M178"2*KW+RER_P!SAZ-1Y/7C=ZT0L(V[:_\ HS-8>L$*+@[_ &_]77[4D,6T
MZ%S;]U/1(!,-V<3X;4Y&"63B1+FD?.U,6T(ELB6N]?\ :%\# $%@X+957.<S
M=:Z DO$QQ!M_?UFV2^MIU=#I5T\+.;Z6RQ\V]FZ]6IB^U^U$I8.18)7=BV[Q
M.A"<#"]U-O;2BS "'4F_%_:G#'<LY_ON#4!@#T^N?E:S[=['R_U5E=<FO_ N
M&-JFCD3;DVZ[HYJ419,;YSYB:,IJ#$D)-NE"#=*4L%#;&:7 #W)^F#U^%?B^
M*N (CCP'WK0N]M1+3TGW_A!!O:4J["?2>SM1ZP@IA#4$!81)99II!;@2@8T$
ML(D##"0H:80R!%09,"Q)$*;S:G5X6AP91*A*E *F #8,."QD B0 =4$#V0M"
M+,JA$* 0R*(($2*A0Q(L$&R9&H7,QF1;)J; $00(M2(;NB2]3+')?)"A36H:
M:$:0T&\**R6C@*I0PP" ,P+2&%$-!.YCT!$7$!JTR<DW90H,I3 K+&9F)@:!
M,$P@F1#$(9F"UU1( RB<"V@LR;;'F"!L5!+K3% L%DY0$LT\2W A+DI$$D\[
M[$N,"E1$)8&P,86#A/9L@$31)A"-Y.A0O FU%[P3'S*@B%*L$8!BN U4.C@U
ME#2R95V.";P!&2)(Q:+PDF"V!NB,HZA2A4IL#@8BZ$D2!27G@#90;8PR4"%8
M<00JM"E27 A(@A1<!7=D([#;?A894,&#BRA(,O)"S=AD+_F$9+Z "$M23D U
M@1(Y"(2X6!PV,DQ TF%HF :F3LF1(@%/%$27@N" "\R#"K6S)9!,'*&PPFM%
M2(B,+DDP(-D)BX$#*FRDMHB)7C W-9:G6 0",@MA "&[+=12&2<0G4S$J),)
M-$V#*"5]R(D1&M$4M0V2ER.S?OC.U8^QP]&A(%UC#/0S7E\_^C./]OZ(K Z'
MQ]GL3YK^7[)B^U^U*B($X[:>+-)C ,#B4OK!FCN!F;+@C$G&>NUE:6@ N>%C
MS- G(CB_7]NW"M*1ELYNC2_D]!'K$Q4E D:%VW!-8WUB\%V#5#O3]29D-@ED
M)VCKF](SF10YE1BM8UVU[4$\% 8*R!)C,3ZE28D"+6]9TU> H4 9R-XO7YBD
M%A<>EI<8X]M_LS\KV5YO\_9@\;5#B_X5$D^3NFW#4-8'6(ZD2Q9]J=[>.)R?
M-'1C3-N4:?'UO$7Z7R$5^#X:L2$[5L4SSI&VM6^E\/\ #%QG&G6H@P-S1B\^
MD0<Z5DDJ17 !I&H)(Z;(J&$-R) 1M?3?:T:N )%G Y2",,.M\S<I0!9$@#87
M+(W<R@(DX7*&"@69&0$F(,HED1X;]'^FCH%Q=P1D6M9)P&+M(Q@:.RDR/JQE
MMM:@B&X(HHPQ"VF2'6(WR0I"$$:MK1.N8]RB3-R6'.;-IMB-L7H[5E20E!>
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M,BC00L20C>Z2,N02PL&'5X>GM16 $&MDI86("XP@S-!E&36,9(0NCVM"+"4
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M$@ , MQ*3:%DD+G!U 3N="VW,1<F )F*"'($298!,S(78'JW5'Y"@ AL C@
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M>KU*R-&UT8FAUC7^#!Z/Q18E9FWM.:/!Q_X-N0W-G':H-L8X^L&8OO\ 0 F
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M%0-4MU 0MMD"40#=8,7&%,9T,"22Y)-CHO,EIJ29*4"R2):X&X!)XHG%(@]
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MU\"9JG1&;XS>@ @ # $!Z%-D7&S<[-:SJD+JA@G8VJ!$!E*"99ATG6,ZTA*
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M'UM-2I()Q<4DMQ#L*65(J;J(I8R86"Q,V"'BD#1F<(%"2!)M ,J90BBSLQ6
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M029U+$"'SB]'@1YQ_P!&W;!I/Z_?F8P3K>,IK\Z5-QL21?A%+,%M;3B4,S!
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MLCA>1ANN_:*5EA;T<VH3!"BL[YX9)]+NE6#6T^C-HUFS,:A69T@WO):W?^$
MH?+?9U>/[IB+."<?W0I,:YIFRDL90ESIT^_F\'M4_EOUW\10CA^T>"!@ VB;
M2CE*;)4*E, @.!58(@BW2/\ S&2=Z5PVNGAO/.:2RTA)<0J4 H"X0IH<?N?J
MV%VHAQ.^3<A;[))F&KBI"%  2DQ%LQ1>!2";=8(CU-=IH&: 1( N++ZPB8<%
ME*< 20 ="ZPV=:2#-$"P@(05(#I>8S1F[!&+W+:9OGVBK^=5LS'M;M]9=WN_
M2QW7S^8B:8#"NI'A3F"<$X.B)+':GA,]:,7-2_\ <W)M,668+!2,ZCB7>HP9
M8'2('6VVY-)N'R?=[M0;?/B]_H9)WI!+=B+C44MC86+3:;[3- 04A"2FDB9P
M=:,TJLA;3A*EQ)V:^=W?80F\Y?@[S20Y3\N\IDX%^M:#$OS_ .7!Z/XK TEM
MIVH& 01((R""2.S1F$H! P@@+LV,XHC3_<*=X(Z<??(=R*YZQ?U*25^8^Z7=
M[TWS?K?[OG:E=,Y+!N!$8U=:16(QK.$;WQG&O_@,G4J 7 6-K.#3^N/YH(TL
M3:Y"F^:*9PNN(W0_\X%MB!.V]OEZO9B/2<-])FV9KYC=^R)E[;ZL,7UDHV1M
M)O%W&^_I0DM1:4O2;8SI5I2/+% 2$6T*/B,-)D&8+@?B&G3EO$,Y2Y.+:\\U
M 6"PUB\:\8_VKH=%S/\ E^V?ML=D\?B9BE,P?J!Y4#"(H%$5\/+KC27FT(F$
M;!)?3B=Z/C0FR)1@2;K.UB<S08<HCB^3@ZZTW5W7[)HY,PZQ>-/QOT-)6W0G
M)<9$./PT@M*-(B$$SA--NE0DK:J$<ZD$'YT7X+=]@JLS"EK=HS_3J3KM&=.I
MWO\ ^;!Z/XK)U?H8%[@\_P ]:.U)W^^H1:L-Q_@AV>S4.WSX/TAV^?![5#L_
M)]GLT"X*X@ZP_+4.717\-(C"0T7Q?I]8=OXX^.2AA>7O:SUSWS_-9I+X9+^I
M63KFUZ__ )S\'YK.XQQ_<5\QN_5P]&O=WPZ<5AZ,AHWJ6Q;I;\4!< 5T$/A:
M;&:<:70OF?+O1$(0!O9TOGSXFC%L?(^]8*P%[$T3[R #:-T!TWO^"&X)J"&
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M8WSIJWI2C@F7!S:7OZ\UF[W^@?BOA-_X&PNPT0+B6[+N!.V;2>* 0&6Q(0M
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M'.@CPY2H&)9A1(4H0V(1AP1 5H M%)S#5*(XI$MYA* 0$BTQOAC&!A,-3>Y
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M>>NN_EWI>.FNWDV^U3O)^W[?-7J23E(SK?G.E9/5_/V)CO>UTH1$R=<ZNO\
M/J]/W6CU_5,K+/;YL]FC<6DQO)M.9[.*DO._7]-07G;K^VH[,[>7OX-JFW[.
M??P;4B;GRN?@DI):@-FUPO?$1%N](C1(YE%+-2 1SZ,K]?\ X#86)@QOQ0DT
MKLB6@4NX)+BS1Q6J)0G+C*Q\E6)C&)< R%E4@!"J&0LT[R@!HGAFYT%AV8#G
MN>I?YMUGYAO\].L_,-_GIUGX#\SX[_ ?F?'?X#\SX[R7S<F_M\O!-BT5L#-^
M,9YZTL"$HR;HR/J!->H@3-O59,IOU[-%\0#FMO#98<Q)'>I#J- &P.F4M2P9
M!(89$N":08$(5"4,#%R0G.&>^;Q]7#&U7\Q(C,95G.*<0SCUW.C#Y/\ S%D=
MDISU [ 5 )B>ZD;/SM]EUHN9&'Y^)M0DB2]F[R6DS1@G8_\ -P^6HHS+ 6&>
M+G;U^UGJ?0]WZHGS.=F5C(YM@XM_X8-CY/N]VH-CM\W?M&P*S#$WM.,>*GF$
M\:PF.\5+9F4#J':U?(X_^"K'P/<I=0N2+ZMSTSZ?6_'?7M^K\1=A9_I/\U;3
MK4^.DACE<;>NUW1!-K_G)(V,X@Z_8,WM,7(>8OMZ,5/)_N._R:!F1Q;K.I=N
MSI)T^FI^0J !:<>-7RS6-H)!H9^R4L6Y;#+;\07\Q3L1C*SNQ=7>G+&[_P"9
MRQO3$D"%.9-&\+MK]L>6!NP8KS:\ZYI>2LR:MWGV_P#/$:Z8\MM[4^," I;!
MYLYN8/M>R8SZ9FLV@S1<+$)+$_U_YS*T5O)&]2RP7'0EA?H'/--,.3&V8F93
M2HMZ_(??)O\ ^K*G1?EI!:ISZ O!.7ZKG]?67CL>U2\=CV^DFY;-\?5E/JF_
MZ+\SU^WYS<WMW^CYO\GKG'V/+Q(J,0P3&Z#UQ%!)L9F2!>CWG'_GDFT8]:&5
M9<!J0)&RS<)$.&?LF:$ C,.WT78EC2@7V7EAS?S?>-*+ ;?^8D)Z:8BWF^C%
M A9'8S93KFT&BV<_:86+L8_N*4QF0NLJ(QF^&>D5'^BH_P!%1_HJ/]%1_HJ/
M]%1_HJ/]%1_HJ/\ 14?Z*C_14?Z*C_14?Z*C_14?Z*C_ $5'^BH_T5'^BH_T
M5&;)P&N)Q5T(!9.&K.W:K\MP'+)!/Y3$]9HMW?'G[FPNU$P G#19!J*B\Z,P
MT5%!!2@DEDOGUZ)0"176$F^HQO%];\5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\
M5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\
M5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\5\XW]OGBOG&_M\\
M5\XW]OGBOG&_M\\43$Q3Z%_;YI4[W<J,#.BVW6Y)1_/-2@0JU$!%(<!:]@81
MLD,B@78APG$DZ"%F3%Q&.'.49)*:V91$4=,73CG%J*)_,G R($P2:QQ21 @
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M/UG_ ":8R(PQ@!-MIMSO0),RIA9)Z;)VJ420I8NR#:-&_&M$E0;I-T:&')(
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M -E29#^5P]&C]E ,L&!I LR6/2AY07 B3"6A0AR#F(8&XP%VADA((E64;3$
M25QV-X$ 0D*26K%N#DN26 $@%8A*K$$MV D(9(A -PNQHQJV3,:B.Z]R D5
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M1O?-%P\[B4DBPMB]RQ>I2P)>8 1GK .Y4'2(ELC,2&02L(PQ3(H#$01(K%T
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M_@Q62%!#"R05$"*.H1_>Q@@,2+&H"4(8B!8Z(&]WH==2H  %P9,*++B]O+4
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M4$*%V8&F6$!RB!,! =I-4 1L 72!)=*'3P9!"@N6P"NBRDT^0S0@R>&4(E9
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MIW0C-C26,W<3#071(4" P8@L91&RRR0("2Y)D0MF0E"'K#%XE8$Y92X@Z,#
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M?KMBBP19;2,](!''"D+FDP J\=LFA  2%85$XE@NLR(8ZE!7E5#E* R, @V
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M#"   7D03 8P0)%X1H+!8P_%N&>CDI")( &X%$DD)PQID)E$)T 4TD"S,3&
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M@YM0V:;)J9!18%"E&KD=]PL,894=K#2D0 PI'*X;$UF:EBLD)8I-;0LX20L
MAA BA+WNV'ZAD@.\>/@=*&$^/:0!$L$":+!)5(BSH78B[P@0"/9KYH9(S2@*
ME$9XME;,2M6_G-LXX%(Z)\C$D'^K T;5NO,,$B3@EL'RX 4+1KD1UTC@S YU
MD1$A0H\?I<N7+ 3$O$Z6\32:TA<C)7B&W6 /D$T0!XL9P!A&[ -HM !@#D"
MYID!2X$BOBSQX<J05@NWYL/ ^*5#\0[?]H%A_P#1=_MH_:J^O4$NW/\ 07"N
MPJ?HW3<6@N0H.()H1:3*=5SM2 0"02 !%&"1E^Q>!P(:6=CSQO<%S51I#E%4
M710@%WD 6SD] 38 4L>FH:< WR2U8E>G:2D92!QJM50!##0G]@E-80U-)6#
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M:F7N.AU8"CDGH^XZ'5M.]*X\3WR"W]=>Y[Y!;NO_ 'V.0K=U_P"^QR%;NO\
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M%09H+"0"*)YD6,W#^F9D0&\'L,FLB8W*0/BR9=; +$ TVY8T0Z6+G @$+3!
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MFD;!@2D&-'P!ID8R5..8F]$^N?S"FP4S (! N(FSQHZD,8(@,*BB();(Y?\
M@+D&K8]#K7D^?]8 5C>7>->R?+.B&BR"W5K]5F23E^\-:U(QOG9P3K$C>VD&
MX[916B5N=SXYT*679]-,+400WO&2_M&G8(;SKA=TP8C^0PO:KJ171)[FH!HC
M+X^<NCKC"'L1%M8JP,?BQOMK6R]F5N7'3@2Y?Y:9]JD?G)S/7LZR3) $'#C\
MJD9 ETRXS@1A3XLQD Y(0P(@-!%@( ?H3!6?\5%4@'XQ^ *VW)^38K*F+X 5
MXO?\KY)0,%/KEC6P<J$#1]<0(L.9OJ:052E8BX:G2"<DDPJ65WLRUF*X @+
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MF)5,+HP- 1O1LH*2&5%&T^59&L"# -.S<LOZ,<20^[H>/Z!R!E&\,,+H5OP
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M #-'#!9XC-I"0@H#T1&".T!(2$@X$ID1H4>?]# )RK<]]ZP!\Y!GYO68;]O
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M!Y;-XTR .,8MSGS1QH@-LR:Y(3*%;-HI/D6 *KP2NF$H>:WW)^C#K^H/5(%
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MA]1)= 2YZD? >*@:$Z))DGTCY)9 &E-7'<B\$'W',] H#,HX:0TS<M%$)DY
M23$0TJ0U$="3G=FSN$FY&3E!4OC"I!<:74_E@#2\,$$ZMAQRQ2PD7!ZUM4QY
M509,1DM4.=6[[D(/#%A$)^Y:X+N .!A+!1C,=<[=?V!DN^IO(5"&R?<UW!W]
M::P*8>-X6.?,8SSL1R0;.?&B2B,MPP.@FD3 0^T?!Q ?2ODZ9UL%.^'::!-X
M-?:TJ0;.1EOW3*4F@K985"4C@@WNVA(];")['&L0%QMPO3XIEEIYM]?$UFO&
M  (2R#%B@.'<#,::'X>&I.3E%]XT&AN7F_*W>E"PV[4#T$N9 295)A58(R;@
MV!/"<9-.X:)'M[X?A&':7T-/A/#T$Z*YRSJ \O$/P8I\HJ*59=94 3R$DF4T
MAR[9G,H5S$?%8DY4#R/JI$>].$>5.-=PJ+C#R\'C6<.KOT?C7(+F86;<*U6(
M@+^2:R!(!^&<4=9K@"6(-@^==XD&!<0<0Z:$FC39,6&DD*YN!Z;T&T82SXK,
M'ZQA:HCPG08@\[EOMYT@ %G!@=I-8 -0RU?.U:H3$YVIN_XF8>AFOB[>NH'8
MV%"D/UJS%C0!5I7>:9.(N[%^*_@M1$3Z8YX  -J&M/:N9,.GE;+CKD1",$98
M>S6Q9/P:L0L,LWBI_9C.%*?!!^U=0BLVC%G6H X)6A!Z[5Z=,#S\>.88;&%8
M@XX6\:N7=H7,/J5\D8$(C\)=;+V%A-)<*@FG%1NN.-N)*0O-=R^M,G'C#;1&
M#&9);7*4$:[G2I!5HH6173K:DF[2A\FVDSA 0#L3WL*.(2F&=<;S#096\ $$
M  WL:D-#GH!8,P2@17B:!N\5NAG",&,<:021<6HHS>JLBO18&H9J9*8C,#!Q
MW%0.3VVPM$OGO4DA$L6<*.+%G74A@98FPSP(@8@[T(T6G.JP(3& 0H6@EH8
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M$L(YW&Y4"+@DP'-YD>*( 2!VDW&>57A*@X!A)1>FR!D8+:J,.D($=_ :EC7
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M R#_ !$LL="*2';QAJW[[T7MECNMCA0<D.X9EN.%?T.:2Y<KKY!KSF<OBN%
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M4D8E6PF C5@#Q4%0S3Q8:7YC5T%SW:%XB+I!AE,"*#N"\C.@0S$7=) YG/\
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MO'3"OD@*IA: -E8D L7EIBLJP)Z( [O.1MA7]0A)6/5(#U(8  IC*I^"RD(
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M!)Q "9"!!@K&#1P"0(@0$FX B)@,!P(R,@!)@<BPE@T]DU9RIN,-1"X0@#H
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M8E$PYX]?QL*8]<]/T$%3*GT<T=$S&NI.>_S1EFI90SV)PW-&43H#J\@!!(4
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M3&DFIQT@WG *(G?P)#P,#(PUS9'.X!YG# 2K:7$166<L1P("]DP)F$RU0!^
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D(, Z)G=\ZU0!9*5\9RX=H_ZI#1P'(OV#?2B%@[,GL!_^9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ffrctanalysis2a.jpg
<TEXT>
begin 644 ffrctanalysis2a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #W +P# 2(  A$! Q$!_\0
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MPT; L823N_UGS5[I114]$NR2^Y6!OFE*7=M_>[A1110(**** "BBB@ HHHH
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M!\M7@\I4*G?NS@DU]3T53?,[^OXM/]%^IFHI1Y5_6C7ZGRG\!?A'JWA?XF>
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M^)G_ $0[5_\ P?Z=_P#':]DHH^OX;_H#A]]7_P"6!]8I?\^(_?/_ .2/&_\
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MKQ:U&IAZDJ-56E%V:[-'!.$J<G"2LT>)?M:WDES\/-%\)Q23P?\ "9>(=/\
M#LDUL</'#-)NE/T,<;J>O#>E>S6-C;Z78V]G9P1VUI;QK###$H5(T4 *J@=
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MO>'(U+2*.+FW:0 HWNI;<#]1WXXSP?\ \% O$.ELUCXE\/V^J7-O\DI!:RN
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M[EQM2\O8G,88\*,[-H).!DY^AJMI^L^"-)T^Y\3^-?$-QJE]IL!NB-;7RTA
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M@"BBB@ HHHH **** "BBB@ HHHH X7R_^+X>9_U+NW_R9KNJX_R_^+O>9_U
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5X3F:[<8DN&#8]%'"C\JOT44 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>heartflowlogo.jpg
<TEXT>
begin 644 heartflowlogo.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X0]N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(U.C R.C T(#$U.C T.C(P  $
M : #  $    !          @   $$  $      0   0$$  $    L     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !4#@        @ "  ( /_8_^  $$I&248
M 0$   $  0  _]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=
M&AP<("0N)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8
M#0T8,B$<(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R_\  $0@ + $  P$B  (1 0,1 ?_$ !\   $% 0$! 0$!
M           ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $
M$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ
M-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(
MB8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8
MV=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$        !
M @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,08205$'
M87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#
M1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66
MEYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7F
MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ [OQ[X]FTBX.DZ25%V #-.1GR
M\]% ]?Y?RY"W\&^,=<B%Y-YQ!&Y&N[CYF^@))'XXJ;P?:1ZW\0!<7:J?WDER
MR.,[FY('X$Y_"O;:[ZDEA[0BM>K"AB+J\3PZT\0>*O ^I)!J*SO$V";>X?>K
M+_L-SC\/QKV'1=:LM>TV.^L90\;<,I^\C=U8=C4>OZ!9>(M->SO$]XY /FC;
MU'^>:\=BEUKX;>)&1AOB?&Y?^6=Q'GJ/0_R/ZQ:.(6FDOS-I3C45WHS7\5^-
M-;U;6Y-$T9+BW19#$%C4K-*PZGU4?TZUG_\ "!^,T3[:%?[1UVBZ'F_GG'ZU
MZIHD^BZX1K^GQQM<21^4\F,.N/X6]^GX8[8K;J'6Y/=C&QO#&.FE&G%'D/A7
MQ]J.DZDND^(6E>'<(S)-Q)"?]HGDCUSS7KP.1D=*\I^+VG01S:?J**%GEW12
M8_B P0?PR1^5=YX0NY+WPCI<\Q)D, 4D]\<9_2E5BG%5%I<6)Y)QC5BK7W1M
M445XKX]\;>(M(^,^A:'8:F\.FW+V@F@$:$-OE*MR1D9''!KG.,]JHHKSCXU>
M)-7\+^#;>^T6]:TN6O4C9U16RI5B1A@1V% 'H]%<U\/]2O-8\ Z-J-_,9[NX
MMP\LA &XY/.!Q72,RJ,LP ]S0 M% ((R#D44 %%(75?O,!GU-&0.XH 6BDR!
MW%!8*,D@#U)H 6BLGQ/K+>'O#&I:ND*S-9V[3")FVA\#.,]JQ/AMXWD\>>')
MM5FLDLV2Y: 1K(7R JG.2!_>H [&DW#.,C/I7.>/]8N= \!ZSJ=DP2Z@MR8F
M(SM8D '\,YKFO#WPI\.FUTW6KPWT^N,D=S+?F]E$C2$ GH<8[=.E 'I-%><:
M9_R<#K?_ &!(O_0UKT>@ HHS10 4444 %%%% 'C>M6=WX.\:"_A0-&96FA)'
MRLK9W+^&2/R->IZ+K5IKNGI=VC\'AT/WD;T-/U;2;76;![2[3<C?=8=4/J/>
MO+6AU3P)KH9#NC;H<82=/3V/ZBN]<N)@EM-?B>5.<L%/F>M-_@>P5EZ_H%EX
MBTU[.\3CK'(/O1MZBI='UBUUJQ6ZM6X/#H?O(?0U?KB]Z$NS1Z<91G'FCJF>
M&0MK7PX\1E3EX6/S+_RSN(_4>A_D?U]$B^)GAE[99)+J6)R,F)H&+ ^F0"/U
MK=UVQTJ]TUUUA(C:IR7D.W8?4'M7%Q?#;PU=R+]FUB:0-R%2:-B1[8%=CJ4J
MRYJB:?D0W*+LM3C_ !#K%YX_\36]M8P.(@?+MXVZ@'[SMCI[^@%>V:;8QZ;I
MEK8Q?<MXEC!]<#&:HZ%X8TKP["4L+?$C##S.=SO]3_08%;%85JL96C!62-N9
MN*3"OFKXRZA'I'QLTC4I49X[..UN&1>K!)68@>_%?2M?.GQ157_:"\-HZAE9
M[$$$9!'G&L!'1?\ #2.@?] 34_SC_P :XGXH?%S2_'?AF'2[+3KRWDCNEG+S
M%<$!6&.#_M5]*?V5IW_/A:_]^5_PKR?]H.RM+?P#:O!:PQ-_:"#<D84XV/Z4
M 7M*\5+X,_9^TS61&))H[-4@0CAI&8A<^PZGV!KD/"_PSUGXG6*^)O&'B"]6
M&[RT%O%C.T' 89^55ZX 7WS5KQ'IMQJ'[,6CO;HSFT2*X<*,_("P)^@W9_"J
M?PU\$Z!XR\,V\D7B[7;>_A79<64-XJ^4>Q5<9VD=/_K4 1ZSIWB'X&:M8:EI
M^KS:CX?N9O+DMIN/?:1G&=N2&&.G(]?0_BE\1/\ A%_ ]M>Z5(OV[55 LV8
M[%*AC)@]< C\6%8&J?!WPK]JM-.U3QEK3SW,F+>WN+R-B[ $\ KZ9Y_#O6-\
M>?"TFF^#_"S6C22V6D(;)G?EL%4",<<?\LR#[D4 5O#7P7U/QKI=OXB\2^)+
MD27T?GQ1@>:^UL%6+,<#(YP!Z<UROQ*\/^*O \%EHU]K4VH:.[M+9S<KM8##
M+R25ZCC)'?UKZ,\!>)+#Q+X/TR[LYHBZVZ)/"C<Q2!0&4CKP>GM7D/[1/B;3
M;T:9H-K.D]U;2M/<>6P(BRN I]SG./IZT 3_ !FEDB^%?@YHY'1BL62K8/\
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MQY:;P<AB 23R.F<>N:].U/3;/6--N-.U"!9[2X0I+&W1@?Y?7M5NB@#Q2_\
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M<E)'0B!865H@!^D  @ $ !4  P ;86-S<$U31E0
M             /;6  $     TRUL8VUS
M                                   -9&5S8P   2    ! 8W!R=
M 6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@    48EA9
M6@   >P    49UA96@   @     4<E120P   A0    @9U120P   A0    @
M8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD9    GP
M   D;6QU8P         !    #&5N55,    D    ' !' $D 30!0 "  8@!U
M &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE;E53
M&@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(        /;6
M  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[H?___:(
M  /<  # ;EA96B        !OH   ./4   .06%E:(        "2?   /A
MML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8  /*G   -
M60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@  )F<   ]<
M;6QU8P         !    #&5N55,    (    ' !' $D 30!0;6QU8P
M   !    #&5N55,    (    ' !S %( 1P!"_]L 0P ! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\( $0@$N!M) P$1  (1
M 0,1 ?_$ !X  0 " P$! 0$!           !"@(("0<&!00#_\0 ' $! 0$
M @,!              $"!@<#! 4(_]H # ,!  (0 Q    'OX
M       #\GR;\0^O]3Q7ZOU?(_I?2\Q^A]#S[W?=^,]KVOF_/['Y7E\WY^O)
M_I'['B\?Z_B\7U_K>O\ ;^GZGI'H^AZI\_YWL7R_E^X?)^/Z;Z'H9
M                                  'GGM_3\-^GR7QSZ7(?*??^YYM[
MOV/A_:^E\C['O?A^7V_Q_+Y_\J_MQG]?Q>O]'X?3^T];Y_WWJ_*],]'XWK?S
M_A>T_-XY[C\OC?[GC\
M
M
M
M
M
M                                ^1]GSZJ<C^]JSR/[VM7WON>&_6^M
M_+=A=&DT4H*EF7*6"%A9EE2_8^KZNQGP_A;/_ X[M5Q[C>P7QOA_[0
M                              ,3POZG)-4/O<XUD^YS36[[/+_@/=^J
M        /Z,8]J^9QS97XO#]H_A<)VM^#P?[GUOG@
M
M
M
M
M
M                                                  >?>[[.DW+>
M2:4<LY+K/R#[G\VMQ-1;*RLRSFH6E-)HT 5+,UE$$6Q+,LJNHE^X]3T]Q^,<
M4W:XIQ#:SCO&_P"J0                                 ?Y&LGV^9:1
M\G['TTY)V'YM[WV            !_MG.Q?QN([J<9ZZW=XSUQZ=Z7QP
M
M
M
M
M
M
M /YM-/.4?>Y\<WY5J/R;[_\ A=RUB0U*S*MAJ%E96<V94+2KMFF@"I<IJ8@A
M869J1=8KZ%Z/I;Y</X5T'X9P?U7Y_P X
M   >>>W]/G_RWM+03EG:7F'N_=@C2*              _P!<S:;X'".@G$^J
MMTN-==_WYP
M
M
M
M
M
M              /Q?+KG]S?DO-OGG+?*OH>^65+#4K*FH(:E9E742Q;*RN6=
M(0M*;310"IK*68@A8:F60U_M&Y?%^)],>!]>[&?$^&
M           /#?J<AYH\U[?T=Y1V3_#OS&BIK*)RBHTB@             /1
M?1^1T:X;U'T+XCU3]-X?4
M
M
M
M
M
M                       'YN[SRYUR/F1V%ROX+W?<A32:9TE+*EA9:R:A
M86%EJ1-1;"RLRS-3"%IHTFB@%364LQ!"PUE*4NW/&^,=5.O.MM@?C?%
M                      'C/TON\K^>=T:4\E[%_P [H I2FBIK*)B"-(H
M            ?6^KZ/2OA?3G1WAO4?[?C\
M
M
M
M
M
M                                   &E_+/L<E^S>7>2?3]V&BRT6&C
M14TSI+*E+#4KDU"PL+*RIJ)8ME9FLI4(6FC2:* 69J99B#%364O^AO=Q#AG5
MSKKK;T#T_3                         'R/L>YRRYYW)SUYCVG_)ORH33
M-* "E-%-3+.4D5%10            'HWH?(ZN\"Z-WJXOUIF
M
M
M
M
M
M                                               >8_0\_'WM/EFG
M_*?L0U*PU#6*FBRT:A314TSI+*E+#4KDU"PL++4AK%2RN4U,K(+31M*4 U,L
MYLD&-U,OTWK^OU8Z\ZWZ%\*X1_M                        @T5Y5V'R0
M[$[O^)]KZ0-%*$)IFE !2FBFIEG*2*QI0            VC^!PGL3UW^?_9/
MG?!
M
M
M
M
M
M T"YO]CD=VARCYWS^5*FC134-%AK%3134M0IHK.TJ65*6&I:E2PL++4REQM+
M*Y34RL@M-&TI0#4RSFR08M;1<?X[V<ZNZK]2^?\ /
M   'POM>_P ;^R>]-.>2\]!HI04I2A*E9I0 4IHIJ99RDBL:4
M/U_#X.K' NC>CG#NI/\ 4
M
M
M
M
M
M                 ^8]C7&_M?DVDW+_ *ZU:4TS4TE-&H66H6&L5-%EHU"F
MDTFDJ:D*:A<FI6%A8:R5*7&TLM92S*R"Z72:2E -3+.;)]-X/7[']8=6[L<4
MXJ                     -3N0\PXN=F]\_!^U],JZ2@&BE!2E*$K-2E !3
M1319S<H&-12@          -M^.\#[0];?G?[CUOG@
M
M
M
M
M
M                                   >)?8]CAWW'R?R#ZOM%3:4TI:5
M-)4TFBFBFH:Q6&BFI6&C14TFDJ:D*:A<FI6%Q4UDI8EBZ&34RS*R"Z72:2E!
M2SFY'2/@G ^L'777/]68                   ,#F1SKM;E?V!W#_CKR%0A
MD4T4 T4H*4I0E9J:  *:*:+.;E QJ*4         !Z1Z'R.WO6/YMV+^1Q0
M
M
M
M
M
M                                                    #4/E7N\3
MNW^2_.>?R%A9"E3;.EJEI4TE32:*:-%AK%8:*:EHL-%32:9IJ0L-2U*RL+BU
M*RI8:B5634RSFH"Z-&DI04NW'&>,]L^J.J?I?!X0                 !^7
MOR<9NS>[]&>6=A2N30*:*ADA=)2@&BE!2F@$K-30 !31HJ69<H&-12@
M   /U?%X>S/6WYXWBXSUP
M
M
M
M
M
M             !H+SCZ''/MG[O\ +O:5*SJ&I:@D*5G9HJEI4TFF::*:AHIK
M%8:*:EHL-&DJ:9T60T4U*E+BU*RI8:A2Y+,LYJ%I32:- >\_&^-W8Z@ZC^_]
M/U                 !\MY_9X<=K=]:O_?Y;#4+"ER:E04T5#)"Z*E!2E*"
ME- ,U*F@ #1314N4LQ!%1H        /],NLO7_1'2?AO40
M
M
M
M
M
M                                     './L#W^1O:?V,;HILT5*S4W
M"FI 5-)I-+5+325-,TT:*:A8:A8:-%-2L-&DJ:9T60U"RU*EA8:E9E6Q-1;*
MRLS4Y(6E-I37KOS/E]X^GNH?4/G^B                /B_9]SA%VWWYX!]
MCDA311#4+"ER:E0:*5#)!I:E!2E*"FB@,U-)0 #1314N4LQ!&D4       !U
M!X)TKU/X-TJ
M
M
M
M
M
M !SC[ ][D9VG]2+H&BFH:EHT5*SJ)J6H60%32:32U2TTE33--&BFBXM0U"FB
MRU#132:9TE+(:A9:E34+"RLRKJ)8ME96<V94+2F_5/F_/[V=.=0>H?/]$
M            ?B^7R\$NW>_-=OM<D-&C12FBB&H6%+DU*@T4K)"#12@I30!3
M10A*FDH !HIHJ:RB<HJ-(H      #I[P7I;JGP7I0
M
M
M
M
M
M                              #0#G7M<;^VOI0T:-%*#131HT:*E9U$
MU+10"II-E*I::33-3131J%-0L-0IJ5-0T4TFF=)2RI8:E94U"PLK*IJ%BV5F
M69J80M]4^=Z'>SIOJ/U#Y_H@             #_*N)?:G=>E'*N<)60*:-E*
M4T4L+"PIK)94I2E9(2K4I04IH IHH0E324 %*4T5-91,01I%      =7^O\
MHOICPOI\
M
M
M
M
M                                                        #3WE
MOEX<=T?0_FUMG64T#1HT4H-%-&C1HK-3431J5 *FDVE6M#14TS4T:*:A34+#
M4-%EHIJ&BIIG265*6&I7)J%A865E4U"Q;*RUEFH]4^;\_O7TYU)ZC\_T@
M          .4_879_,7GW:$K(:2I60*:-E*:*4L+"PLM2LJ4I4J$)5I4H*:*
M :*4(325* "E-%-3+.4D5%10    RR[/=;?G??#BW68
M
M
M
M
M
M                              '@_P!S7 7O7W?P?/8:-&HFISI-2&C1
MHT"E*:-&RE9J:B:-%D!I-)HI6AHK.DJ:-%-%AJ&H6&BRT:+#14TSI*65*:++
M186%EJ0UBI97*:]4^;\_O;TUU+ZA\_T@            -"^7\VXR=G]Q1E&M
MKJ+J5D-)4K(&C1HI312EA<5++4K*E*5*A"4JZ0"FB@&BE"$TS2@ I3134RSE
M)%8TH   ?H^+Q=Y.JOS!LW\7AX
M
M
M
M
M
M            'R/MJ^/?7L>4_3U#4M2LK#1J&ISM-3*4IHT:!2FBFC94J5-1
M-E+(#2:37]F9^GXY_/K7YGDW_GK3.DJ:-%AJ6H6&L5-%-2U"FBL[2I94I8:E
MJ5+"PLM3*7&TOJWS?0[V],]3^H_/](           #6'[W(N#_;W=OYWD\J:
MC-2B-;B[FTLAI*E9 T:-%*:*4L+BT65E94I32/\ 7./U_#X/Z<Y_/WYORO)[
M0!HI04I2A":9I0 4IHIJ99RF(TQI0  ^\]/Y=@_J+\J>B^I\H
M
M
M
M
M
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MKR/"[*"E*4)4K-* "FBFBSFS$D5C2@!L]\'A?>GJK\P_TS(
M
M
M
M
M
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M>8XW104I2A*S4I0 4T4T6<W*!C44H=3>!=)=0^$=,
M
M
M
M
M
M                          >0?7S7B_0/A_&\EE31HIHJ:34RS-0T:EK)
M84IM-1-3-3*4T:_UEW/XAZO23KWY^S''?7          ^=\^]"N:_9YM=@<@
M\K^C[::*:*:AK%8:*:EHL-%32:2IJ0IHU*RL+BUZK\WT>]W3/5?J/S_3
M     _CU>%';O<&J7(N2S+*EBZB65EHUBT60K-B5*MBZ7:ZD*5FI4>B^E\[H
M]PGK?H!P[K[ZWU_5          \6^E]SF]S7M;0OEO9/YOD\Y2@I30"5FIH
M IHIHLYN4#&O[<^.P+U)^5???E<9
M
M
M
M
M
M            P."O>_J:K<IQ#4S26<ZE31HIHJ:34RS-0T:R:E84T:B:F;2[
M=\5\'6'J[T/=?B^(           #^/3G_P X^WRT[(Y'\-[GL,TT4T:A36*P
MT4U+18:-)4TS34AHIJ5+ZI\[T>]O3'5WJ/S_ $P       !_E7'3L_L[0+F/
M-H(6%F:D+#4+*RT:Q:+(E2Q*E6XW<ZT:D^I];U>G_ .L.B?"^O/U?'XP
M       /,?>^KRLY[W'HERSL?&Z*4H*4T E9J:  -%*:2S+E&P'R.*6 ^IOR
MQ_5,@
M
M
M
M
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M@ &BFBI>O77G0?1;A_5
M
M
M
M
M
M  'X?GS7/_1'RO._HYQ:AJ&BPU"PT:F6<Z2RT4T:*:2IK*:2PUNKP[/9#J/U
M_KO4@               U&Y1]'C!VWRGX?W?.:2II*FC134+#4-0IHLM%AHT
MFDK.BR&O5/G>EWNZ9ZQ]1^=Z@        _QKCIVAV;H!S/F94N4U,00L+,U(
MNL52RLM0W"ED^G]?U^QG6/4F[G%>'               #\7R>;D;V+W5S[Y?
MV<4H*4T 4T4(2II*  :+]=ZWHV,^F_R7]?X/2
M
M
M
M
M
M                   ',/L[T.5W:7SH:Q:+#4-0U#18:A8:-3+.=3*:-%-%
M-?ZYUU>ZLG2_KCQY                 \X]_P W#WN+E>O'W??4M-)IFIHI
MHL-&H6&H4U*FC4*:33.DI?5OG>EWMZ9ZS]1^=Z@        _RKCEVAV9H#S/
MF@!4UE+,00L+,U(:QM2RLM^S_*^1W(ZFZ:]?^;\L                #0+E
MW8W'SLCO'\_7F6I2@I30!310A*FDH +TKX3U!UEX#TB
M
M
M
M
M
M                        !\M[6*X_Z,^#\M[2%@A<5AHU"PU#4-%AJ&H4
MU,K.IFI4U^AX]=K.FKNQPP                 !^)YKQ*[?Y3I_RGZA2J71
M4TS4T4U#134+#4-%-2IJ&BIIG7JOS?2[W=,]:^H_.]0        ?Y5QS[0[*
MT YIS--% *FLI9B"+8FLI2EV8^#Q_N5U+T[]9Z_K@                 :H
M\@Y?P^[4_07SWF]M"5:5*"FB@&BE"$TE2C]CQ^O8XZ:_)OH'J?-
M
M
M
M
M
M                                ',3L[Y?+3M+Y<-0U"PU"P0N*PT:A
MJ%AJ&C4+#4*:G-_2\6^Y727EVZXGH                  #\_=XE]P<FTSY
M;]-*FRE:&BIIFIHT4U"FH:A8:++4-2L-%]4^9ZG>_I?K;U'YWJ@       #_
M "KCGVAV1H!S3F)HTFB@%F:F68@Q79CX/P.[O4/3O[?B\8
M    &N/VN3<(.VOT3\Y['N)4(2E72 4T4 T4H0FF;TLX3U!UDX#TF
M
M
M
M                                  /%31Y-1$UR/&4\T/RS _2/33VI
M=E#;^7>1?6Z      'ETFMUH   ^FC;R@
M
M            /R_+FN1^C>,?#^]C%84U#4-0U"PL$+BL-&H:AK%31J%_VSKM
MWTI[6ZG#/(                   !^?MQ*[@Y+IIRWZ8-)I-%6J-%9TE31H
ML-2L-0UBIHLM&H7U3YOJ=[^ENN?4?G>J        /\JXY=H=D: \SY@%IHVE
M* :F7U?YGS; 73/3'VWJ^J                   !J]][E?"/MK]#?F>3V"
MFD(0E*: *:* :*4?2^OZ=D;I7\F?2^'U@
M
M
M
M           !X/)R&LY9)JC8@     9UM[+U-7KI->UT    !R?2KFP   -K
MEN?-@
M                                            :(<\^9QM[DX_#1J&
MBXK"PT:AJ&H6%@Q6%AHU#4-8M=;^IO<Z2]<>P                    !^?
MMQ*[AY)IIRSZ<+(#2:31I2C16=)4T:*:AHL-8J:++7JGS?4[W=+=>>H_.]4
M       ?Y5QR[1['T YKS"9606FC:4OT_K^MW]Z8Z<]L^5\L
M        #1CE?/N*W:'?$6RI2FD(0E724 T4H!HO7CKGHKHQPWJT
M
M
M
M                              :Y2< +.5=S_'         _1.KK7?E=
MA5    Y/I5S8   &URW/FP
M
M ."/?G$];N2>G#1J&H4U#1<%-0T6&H:A86#%8:AK>/@_M]K>E_H
M             ?G[<2NX>1::<M^E$T65!2II-%6K2II*FDIHT6&BPUBT7U3Y
MOJ=[^ENOO4?G>L        /\JXX]I=C<_N:\NR:F696077]6)W1ZAZGVUXWQ
MX                     #D=V+W%S=YOVD65E94I32$,BKI* :*4>X_)XY8
M?Z=_+P
M
M
M                                           _@DX-6<(6?Q0
M     ?NUWTF^Z$?UV@  <GTJYL   #:Y;GS8
M
M               \<^SZU>G]#\*Q6&L6H:A34-0T:A87%34-%AJ&H7%?4?E^
M6PM^?/L_2^MH                      ?G[<2NX^0::<M^@FHSJ6H4LA2I
MM*:4M*FDJ:313134-8KZI\WU>]W2W /4?G>L        /\JXY=I=B<_N:\NA
MH9-3+,O8'J_K?H?PGAX                      _-WNOSW%^C/!_K\BQ:A
M2RN30*:*A#(IHH!HM@KI_P#,.PWQ^-
M
M
M
M      #S&2JO<Z$H            +$\WW%M   Y/I5S8   &URW/FP
M
M                                !S"[0X_S$[0X\6"%AJ&L6H:A34-0
MT:A87%34-&H7NOT7]O;'B?L@                      #\_;B5W']_33EW
MOE2IIG1HL+(4K.RFE+2II*FDT4T:+ZG\WUN]G2W O4?G>L        /\JXX]
MI=AZ <UY:6&H7H_P/A?77K/K\                       :_?8Y!7X[B_1
M?\^O(4UBL*65R:!314,D+I*4=)N$=3]:NONEP
M
M
M
M            /()*B=SJ\@            _J+K,WL3:  !R?2KFP   -KEN?
M-@
M                                        "OK^AN#>*_:]2%Q6%+!#
M6*FL6H:A3<+#1J%A<5W7X5]'M?TI]H                        ?G[<2N
MX_N::<N]XV4TA-,ZAJ6H)"E9V:*I:5-)IFFBPUZI\WUN]G2W!/4?G>N
M   /\JXX]I=@\_N:\ME=P>+\>[D]0=9?TR                        <@
M.R.X>=W-.RRE-"&H6%+DU*@T4J&2%UZC\_X]C[I;\LR
M           #C1)Q N0      !9_:W74                     #G/)7!N
M0      !WO:ZSJ
M
M                                       /C8I^W&HZ
M =3&K4#0   Y/I5S8   &URW/FP
M
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MW[4                     #ENE5M@       61YOM+:
M
M
M          *M\SRCN0     !^E;Z0?1R?-KYQ7YL@   %Q*;W:M   ')]*N;
M    VN6Y\V
M                                                !S^[#X_R0[>X
M=$T;BZ-8M%2XK"PT((:Q:AJ%AJ&M\N!_6['=-_?
M     _@VXD]Q_8TTY=[AHIJ&I:-%2QG2:EJ%D!4TFC15+325G7J?S?7[V=*\
M(]1^=X        !_E7QWM>?[;U/                          .3G8?:_
M-+G/9I31HT4IHI86%A2Y-2H-%ZQ]=]+]+>#]6
M     #A$E?!@       6\6]^U                      Y;I5;8
M%D>;[2V@
M
M                                <N9*K-P    !]&=0IKI9;NM+[V?U
M4!_+'@IIU9SY3F GD* #>QJX T   !R?2KFP   -KEN?-@
M
M                        <8^Z^$:6\W^%%1*FHFC<79<6BI<5AJ%$+BL-
M3-V#?SWS#V[XGL@                         #\_;B5W']?33EWN%!HIH
MT:-%2LZB:EJ%D!4TFRE4M->I_+]?O9TIPOU'YW@
M              \V][Z%<+N[]'_RZ\K(%-&RE*:*6%A84UDLKMYQOA'=3J?\
M_                            #A$E?!@       6\6]^U
M           Y;I5;8       %D>;[2V@
M
M                                                       #\**5
MMQX$@   '^M=FYKOK->KT    !^='+]."%SJF@M93?3JT   #D^E7-@   ;7
M+<^;
M                                           KJ?I#K#S[Z/K)J%C5
MQI*FHFC<7<-0J6%A8:A1LIQGZ7>3H7EP                           _
M/VXE=R?4TTY;[AHI0:*:-&C16:FHFC4J 5-)M*M:>I_,\'>SI3AOJ/S?
M                               !P\[7[LTRY3S0TE2L@4T;*4T4I86%
MA?JO7]2S)T9^5O\ 6                            .$25\&       !;
MQ;W[4                     #ENE5M@       61YOM+:
M
M
M           ..:5GV    /IRTNWTN4      #\Z3AW7)%FYTW_2    <GTJY
ML   #:Y;GS8
M                                                 \_^CZU=7](]
M4LZBZ+#2:A8U<:2IJ)LU%W%L326%A>O/3_*M_>O_ +(
M          'Y^W$KN3Z>FG+?9-&C1H%*:*:-E*S4U$T:+(#2:31?5/G>OWKZ
M4X?ZC\WP                                  #2GE/,>(G:W=D74K(:
M2I60-&C12FBE+"V+NE?S-['\WXP                           '")*^#
M        MXM[]J                     !RW2JVP       +(\WVEM
M
M
M                    %,MC4=   !_26P)OI':        /C8^RH    <GT
MJYL   #:Y;GS8
M                                                   U+Y?\/B7W
MEUN:BV&DU#1J&DL6Q;C2:B5-FXNHNO\ 3.K'/YMY_P#;>CY@
M               !^?MQ)[E^CIIRWVIE*4T;*"E-%-&RI4J:B;*60&DUZG\S
MP=[.E>(>H_-\(                                 'XGE\M:'O3]&_D
M;\T:W%W-I9#25*R!HT:*4T7MCU;T5N_Q7@H
M  '")*^#        MXM[]J                     !RW2JVP       +(\
MWVEM
M
M KA)XY(      !8'79FT                 #5)*8#    '<1JQ0T
M        .3Z5<V   !M<MSYL
M
M  <Z.RN(<L>VN"1-1-1-&HNH5-0T:AI+%UC44FHSHUL!Q[Z??'H#G8
M                       _/VXE=S>]IER_V&=S-3*4ILT4%*:-&C14J:34
M34K"R#U/YOA[V=)\3]1^;X0                                 .$G;
MG=>I?(^5QFI5L747<VRI2I6:@&C1HO43@/5/4S@/50
M         '")*^#        MXM[]J                     !RW2JVP
M    +(\WVEM
M
M        I4L:TH      !<*>3>(                  X1LU[V0  !Z$MW*
M:^XM              ')]*N;    VN6Y\V
M
M            .2'</7^A78/$U1::B:C-AHU%U$T6&C4-)8NL:BNB_6O*.K/4
MW+                              /S]SB5W-[NF?+_,:3<34S4RE-&C1
M04IHT:-%2II-)J%+ZI\WU^]G2?%?4?F^$
M      <P^>]B\J^P^SY"LV)4JV+J+M=9!2I6:@I=Y>)\%[5]7])@
M                   <(DKX,       "WBWOVH
M'+=*K;        LCS?:6T
M
M                 "E2QK2@      %PIY-X@                 "I8SSF
M9   ';EJQFT              !R?2KFP   -KEN?-@
M
M                   #B3WMU?JIR[C\36,I51::B:C-AI=0U$T:A34-)>RG
M2_.MV.#_ '                              !^?MQ*[F]K33E_FA2FTU
M$U,U,I31HT4%*:-&C14J:9T:]3^;X.]G2?%?4?F^(
M             #4SD?)>$G;O=1K%HLA6;$J5;%TNUU(4K-2[+?"XQWZZ?Z"
M                           X1)7P8       %O%O?M0
M        .6Z56V       !9'F^TMH
M
M                         %*EC6E       +A3R;Q
M  %&2X\ND   %P6;WGM               Y/I5S8   &URW/FP
M
M                           !P,_0_4/B7W?DE+#>,L2EBEIJ,ZB:AI;#
M431J&N_OYZ[+]N^'[X                              'Y^YQ([G]G3/
MEWER:E2PIN)J9M+,I31HT4%-%-&C1I":]3^7XN]G2?%_4?F^(
M                     >=>[[M;7O/OZ%E9:-XJ61*EB5*MQNYUHU(7U3YO
MRK'G2/YS                            X1)7P8       %O%O?M0
M                 .6Z56V       !9'F^TMH
M
M                                  %*EC6E       +A3R;Q
M           \SBB_?&   /HR]K/)^I0              ')]*N;    VN6Y\
MV
M                                       *[_Z4Z2^!^AZF+12E-0UC
M+$T(I;#3.HFH:6INR9^9>W/W/!L                               ?G
M[G$GN?SZ9\NV:-2U*PLM0U$TFYS94IHV4H*:-%-E->I_+\/>SI'C7J/S?$
M                             !@E8GOS]!_E>3S+J)865EHWBI9$J6)I
M"V+MK?[_ (/7LY=#?F@                           #A$E?!@
M6\6]^U                      Y;I5;8       %D>;[2V@
M
M                                             4J6-:4       N%
M/)O$                 #3]*:;    W$6Y0V               .3Z5<V
M !M<MSYL
M                                              5N_P!/]#_C^;PI
MJ&H:Q:*4IK%J)8FA%+J)4U]#ZWM61?S-VZ
M      /S]SB/W1Y=,^7ZRFDL-2U+4K"FC432;G-E2FC92@T4U#4M>I_,\7>S
MI#CGJ/S?$                               !7%[Q[R\J^A].%F:D76*
MI966H;A2R)4L9T%U:'Z#_,W],@                           X1)7P8
M      %O%O?M0                     .6Z56V       !9'F^TMH
M
M                                                   %*EC6E
M    +A3R;Q                  Y[25'+@   =.&K6C0
MY/I5S8   &URW/FP
M                                                     !6H_4OY
MX_RUI-'D2IN%Q:AHI2FL6HEB:$5Z9\OZ%AG\X=N
M            ?G[G$?NG>F?,*FIEF:34++<K*EAHTFXFIS94ILT4H-%->I?,
M\?>WI#CWJ/S?&                               *]W=7<_@7V/NS$$+
M#4RR&L;4LM2U#4*61*FK-71'YN^E\'A                           '"
M)*^#        MXM[]J                     !RW2JVP       +(\WVEM
M
M                                                         I4L
M:TH      !<*>3>(                 ',9*IC    [#-69F@
M    !R?2KFP   -KEN?-@
M                                                          "M
M/^I_SC$U#6-T;-L[-)J%Q:AHI34+#437K?QOIV"/SKVT
M                 /S]N(_=+3/F T5-3+.=&H:EJ5E2PT;349U,LJ:-&BE!
MKU/YF.]G2'P/4?F^,                              "OSW1W'KK]S[I
M4UE+,01;$UE*4N*ER:-0U"ELQ=#_ )S^N]?UP
M   !PB2O@P       +>+>_:@                     <MTJML       "R
M/-]I;0
M
M  *5+&M*       7"GDWB                 !RW2JVP   .R+5EMH
M          <GTJYL   #:Y;GS8
M
M    K4?J;\VKJ+4L34-8W1M-FV=&H7%N%*4UZW\;ZM@7\Z=N@
M                      ?G^2<1^Z)IGS"%-&BIJ<ZF4U#4M2LJ:+#<34YT
MFI#1HT:'J?S/'WLZ0^'ZC\WQ@                             "OSW3W
M%KK]O[I0#4RS+,08VIK*4L6Q*7)HU9@Z(_._UWK>N
M        .$25\&       !;Q;W[4                     #ENE5M@
M   61YOM+:
M
M      !2I8UI0      "X4\F\0                 .6Z56V   !V1:LMM
M              #D^E7-@   ;7+<^;
M
M        %;']3?FS^>Y34-+8M342XM1='D3::31K%J&H7T/YOOV'?S;W.
M                               /S_).(_='CTSYA"FC1314U.=3*:AJ
M6I65AHT:B:G.YE!HT:]3^9X^]G2'Q/4?FX
M    KQ]V]Q>%_8^N:-I2@&IEG-D@QNIEF4L6Q+9VZ$_/'[7B\8
M                 X1)7P8       %O%O?M0                     .6
MZ56V       !9'F^TMH
M
M               %*EC6E       +A3R;Q                  Y;I5;8
M '9%JRVT               .3Z5<V   !M<MSYL
M
M                 5R?T_\ F_\ !]GU2PU$VEAI;%J:B:Q6+LV;9VE-?J>'
MV+)'YA[S                                   _/\DXC=U>+3+F&)EF
M:-%-%-%9W,LS18:EK)H&H:-,[34R@UZG\S/>SI#XWJ/S<
M              "MKWQW1YS[WT&06FC:4H!J99S9(,6I7^C,M#] ?GD
M                      #A$E?!@       6\6]^U
M    Y;I5;8       %D>;[2V@
M
M                     4J6-:4       N%/)O$                 #EN
ME5M@   =D6K+;0               Y/I5S8   &URW/FP
M
M                      !7R_2OYT\Y^G\V&@4L-1-IJ%6Q=)8FL5B[-IM-
MV,?S+WO]7ZGG                                   _/\DXC=U>#3'F
M7C2S-3-3*:*:-%32:F69J%-RN30-0TFXFIFIE]3^;CO9T?\ )]1^;@
M                      ?R:M8']!]X?R;WDU,LRL@NETFDI04LRSFR?6>O
MZMF'H;H4                           #A$E?!@       6\6]^U
M                 Y;I5;8       %D>;[2V@
M
M                                  4J6-:4       N%/)O$
M          #ENE5M@   =D6K+;0               Y/I5S8   &URW/FP
M
M                                   !PC_1/YZ\'Y%QV9Y$\B:AH%+#
M<32:AJ*6LZQ:A8OD[N?GONO8#CGVP
M   !^?Y)Q'[K]73+F/CA8:364J:F4T:*:*FDLS4S4*;EK)2PII-Q->J?,QWM
MZ.^7ZC\W(                           'D/T_>KE]Z]Q%A8:&34RS*R"
MZ-&DI04OM'R?DV*.D>DP                           .$25\&
M!;Q;W[4                     #ENE5M@       61YOM+:
M
M                                             !2I8UI0      "X
M4\F\0                 .6Z56V   !V1:LMM               #D^E7-@
M   ;7+<^;
M                                               '&+O?HC4GFO"(
M;*GDF;9\D-&@4L-Q-)J&HHTEZV]-=L[U]?<T
M            _/\ ).)'=?J:9<Q\)8:Q4U,TEG.I4T:*:*FDU,LS4-2U+4K"
MFC7J?R\][>COG>H_,R                           -*^6<AX@]N=EXM2
MLJEBZA965F6<U 71I-%+M9QSCG>3I[J(                           #
MA$E?!@       6\6]^U                      Y;I5;8       %D>;[2
MV@                  #^9/*8\@/BCXPQ!]!7VD>IK["?04
M                    !_&>11Y&?(6?%P!]8?9K[(GK:_U4
M                          /EH\C/,:^33Y:/6*W04          4J6-:
M4       N%/)O$                 #ENE5M@   =D6K+;0
M   Y/I5S8   &URW/FP
M                                                        !RO[
MBZ;Y^]E]8)J&C4-&IFV?(FX;*4%AN)I-0N]O7O/.M73?:H
M                      _/\DXD=U^CIGS'P0T:+BU#19FDLYU+131314TF
MIEF:-&I:E2^I_,G>SHWT?4?F9                           Y.]D\VYG
M<_YG*RN*PU*RI8FHM+DLRSFH6E-= >%<.[']7]:
M       <(DKX,       "WBWOVH                     '+=*K;
M  LCS?:6T                #YF-';-($T_-5DU\/QD    _P!:]DEV<7<
MW47?&/8K0                           /AXT732&S40U93P*S\^    /
MVUV2-MY=VUW^-K+<P    #0B3FF@      &YB]5[0    *[DR      !UP:V
MSH     8&L,FB9IK9J<:W)Y98@ =+&K8#0          I4L:TH      !<*>
M3>(                 '+=*K;    [(M66V@              !R?2KFP
M -KEN?-@
M                                             #0CLCK3E-W/TDFH
M:C.BPT:AHU,VSY$\D-%*#4->K?&^UW__ #AWX
M             !^?Y)Q*[K^=IIS'P8M0U#136*PT69I-3FRT4T4T:2IK+.BP
MU+4M>J?,G>SHWTO4?F0                          5^.Z^SM<_N_6-0L
MM2I86&I695L-0LK*SFS*CK)UOU[TLX'PD
M#A$E?!@       6\6]^U                      Y;I5;8       %D>;[
M2V@              #R:.6=G,E-"F?PP        #*ML9KIJ=4Y=L;0
M                   /"TY6',EG1]/X         #W=>I*]=)K;B@   .'2
M5V&       .O"V=&P    *";Q@      6I&^I"@   ?XQH>G*>SF:GB:
M#I8U; :   '%J2MQ<                      6I&^I"@  #4).8R     :
MM'*YD   ;CKTO4         =.5V]4    #D^E7-@   ;7+<^;
M        ^0C3*S4--6#7H\43RD^,K\N0?Z5]"OI1ZSE[W;LH;7KN=+LG9_JH
M             Y<IJ>@   [7+Z0H                    'GDG-^M=4^@-
MVI=[*_W4                    #2^3FS8  !_:=GIOS?EG$>(7Z$_-B;-K
MI-0U&=%AHU#1J9Y&=IY(:*4=_?S?^AO5_C_4
M             _/\DXE]U_,TSYCZY36+4-0T6&H6&C4RLZRE-&BFBFDU,LS2
M:A?5?F7O;T;ZGJ/S(                         /A/<\]:SO[MC_&;2EE
M2PU*RIJ%A9695U$L6RLKW5Z=ZIV]XSQ\                           #
MA$E?!@       6\6]^U                      Y;I5;8       %D>;[2
MV@             ?XQSK3C!<\VT_@            !N,O9QKK1+]%0
M               '\4<T$XOV<];G_&           !%;UR]SVNEQ_JH  X=)
M788       Z\+9T;     H)O&      !:D;ZD*  !\[''E.)MSK:@     '2
MQJV T   .+4E;BX                      M2-]2%   '(9FL8R
M            !9S:Z\M     <GTJYL   #:Y;GS8                 T]D
MYDV<YDTSK^"0       #U->@R]*5Z5GWZ@           <D$K!,   "R3-]H
M[0                   ,#B SP L^4D &W2V>IK;BT
M   51F>9C(  '2=JV*U\U[7J5V?U)^2?\M9*SLV:7:6&HSHU"FH:-3/(SY$W
M#73?J?M3H[U?V0                                     /S_).)O=?
MRM-.8^MBL-&H6&H:AHL-0L-&IEG.DU*FBFBFDU,LYUZI\R][>C?6]1^8
M                     YX<ZY'QZ[2YP4TFF=)2RI8:E<FH6%A965346V4^
MA.E?0/2]8                           #A$E?!@       6\6]^U
M                  Y;I5;8       %D>;[2V@            ?X)RSC@K<
MZH(              !ZVO<=>TDOTUH                   '\4<FDX+W.M
MJ              #==;&<UO%: !PZ2NPP      !UX6SHV    !03>,
M "U(WU(4 #^=.0!7_9\:0      #I8U; :   '%J2MQ<
M      6I&^I"@  #D,S6,9                    LYM=>6@    .3Z5<V
M  !M<MSYL               #RXX^IR#9UB0           ?N+TP7LBO0H_U
M4          ?*R4<M8^*@  #=9;BS8                   %>]GA&R  !]
MVMOUK;10                  !Y-)1^UC\V   +4C?4A1P1_27Y<\A^YQZ%
MQJ**SLV:7:6)J)HU#4*:-SG?K?Q?O=]OS?\ H;)0
M                !^?Y)Q.[K^5IKS'U8(7%8:-0U"PU#18:AJ%-3FS-3-%-
M%-&BIKU7Y5[W=&>'U'Y@                        5^^[>P=;_O\ U9:+
M#1HJ:9TEE2EAJ5R:A86%]0^=Z5D3HCIX
M<(DKX,       "WBWOVH                     '+=*K;        LCS?:
M6T            :)25Q=9TZD                 ]R6Q UU77,
M         &@<E<.YU+0               #_ %KLM-6(IKZ^@.'25V&
M  .O"V=&P    *";Q@      6I&^I"@#71*Q":*L@       =+&K8#0   XM
M25N+@                     "U(WU(4   <AF:QC(
M  %G-KKRT    !R?2KFP   -KEN?-@              >"2<*;.0MS\]
M          &UB]VYKJPO]M          5F&>/3(  "KIN=[/V@
M        :1R4\=8Q@   ;B+<C:_U4                  #B))7.N   /2U
MO$37[-HY.=U=$:+=B]6KI-)87&HHK.S9M=)8FHFC4-0T7MKT!^@-G^)<K
M                                   _/\F>)_=?R=-^8^KBL+!"XK#1
MJ&H:Q4T:A8:A34YU,LS13131KU/Y=[W]%8]2^8
M &OWV_>KW]X]APN*FBRT:+#16=)I+*E+#4K+6]?#N,=I^J.NP
M                !PB2O@P       +>+>_:@                     <M
MTJML       "R/-]I;0          !\')75LX]W.,                  #
MH\U9CE]KM                 ^'DKG6<?KG&                 !LRMJ:
M;VMH<.DKL,       =>%LZ-@    4$WC       M2-]2% YC25@[GXA
M   !TL:M@-   #BU)6XN                      +4C?4A0  !R&9K&,@
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M:A86#%86&C4-0UBT4U"PU"IJ9J99FBFC7J?R]=[^BL^I?,H
M         '%+MSE^CG,/N&C4+#6*FBFI:A316=I4LJ4O9?JOK_?SA?&0
M                       !PB2O@P       +>+>_:@
M     <MTJML       "R/-]I;0          -&$JYL^#(
M    !Z0MG>:Z6V@               :8I5D9U\0                  #[!
M;3$UTDMX=)788       Z\+9T;     H)O&      !:D;ZD*.+*5O[C_ !@
M       #I8U; :   '%J2MQ<                      6I&^I"@  #D,S6
M,9                    LYM=>6@    .3Z5<V   !M<MSYL
M  <L9*WMSY&@                 BNJDU9#E]6M        '^24J6=;D
M]R6[?-_UT                 !Y_)1SN/GP    =?FK-S0
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M#                    /T2SY-^,U788       Z\+9T;     H)O&
M !:D;ZD+Q=2MK<(         '2QJV T   .+4E;BX
M   M2-]2%   '(9FL8R                   !9S:Z\M     <GTJYL   #
M:Y;GS8            ^+*UC/)ID                   >KK9X:Z.J
M   .#25^&   !;D;Z$*                 !QD2M<P    !]B7CF_K5
M              KEL\1V0  -N5N9M@ <2OT'^9-<.5\*BV#%%J6&L5AI=,ZA
M86+(M32;-FO>^-\J[G_G;]&_[30
M     _@WGBEW7\/3?F7HXJ:AHL-0U"XJ,5AJ&BPUBU#1HL-8J:364J:]4^5K
MO?T5OU+YF@                    !PF[GY;J1RGZA4TE32:*:*:AK%8:*:
ME34-%V*^#\RP5TCUJ                            !PB2O@P       +
M>+>_:@                     <MTJML       "R/-]I;0        !_,5
MS4XG,                       =B6K*Z_V*             .$<S7OUE
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M185-0N+4-&DL+!&K FD\G5OIGO+?7K?LL
M           #^#R9XI]U_!TXYCZ,+"XJ:AHL-PL+BL$+#4-&H:Q6&C18:A8:
M37JOR==\.BO-ZE\O0                    TAYC]+B;V]RM*:4M*FDJ:31
M31HL-8K#134M=9>L^'=+NO\ BX                            '")*^#
M        MXM[]J                     !RW2JVP       +(\WVEM
M     _C2L:G)%D                       #K0U9XFO[*            '
M F3@3<                              #KPMG1L    "@F\8      %B
M9O@NS\"@          Z6-6P&@  !Q:DK<7                      %J1O
MJ0H   \I37-0    - $KZ,   #W-;2[8         V,3U90    .3Z5<V
M!M<MSYL           :%R51[GS]      !E6U\N]R[?R[/'NR^FGUM#^2//C
MQVS7PU0328T.L\]D       ZT-6;E_64       5(V>=[(  'UJWD)KZ^T
M              #5F*7.O&@     = %MV-@                #F1)5*N
M /UB\+/)ZC0 'QWO?/K]_IS\?_Q^3Q000IHU"XU%A4U#6*Q:FTL-08ZG[OK>
M[WA_.'Z>]2^/]D                                      #^#>>*G=
MG']..8_/AHU"PN*FH:-0U"XM000L-0T:Q:A8:-%Q:A?5?E;[X=$>SZE\O0
M                 ^#]WR5XN]^7?$>YYBE9V:*I:5-)IFFBFH:*:Q7_ %EL
MB=!]:>E>AZX                            '")*^#        MXM[]J
M                    !RW2JVP       +(\WVEM        '^,5EKGD$R
M                       !V7:LJM            </I*ZEP
M                   !UX6SHV    !03>,      #[%?CD           Z6
M-6P&@  !Q:DK<7                      %J1OJ0H         Y;I5;8
M &RRW5FP              !R?2KFP   -KEN?-@          <Y)*I]Q\\
M    ;EKUU:ZA1[5:      /X#163E'9R@L^'D      Z9S5J!?V;0      .
M3DE7:X   %GB;ZZ6@                5WV>&;(     '^I=E;V"4
M          "JDSS 9   ZA-6JF@  .._>_YMU'YOUN;-008A31J%Q(L6IK%8
M:BZ32:A?>>-\K[A?GK])?I>+S
M    ?P>3/%7NOCFG',?G&X6&C4+"XM%AHU#4+BU!!#6*FC6+4+#937J?RM][
M^B/;]2^7H                  ?SV<*.Z>2ZG<F^C"EE05-)I-+5+325-,T
MT:+#6W'&/D]V>FN#@                            #A$E?!@       6
M\6]^U                      Y;I5;8       %D>;[2V@       "OHSP
M>9                          L/S?<VT          #E_)58UC_*
M                          .O"V=&P    *";Q@
M=+&K8#0   XM25N+@                     "U(WU(4         <MTJML
M   #99;JS8               Y/I5S8   &URW/FP         !H!)4PN/P0
M    !72^:[PS6[E         #XV3CO7"MGR%     !T]:M0K_<H      ^:D
MHYW/PB   =!5MSM@               #\Z*0=QY @      [[M=]6@
M         !Y=%'J^/\D   M?-]+E   UCY?P;B]^@?RS"Q-1-&S4$&*E*:BW
M%(HJ;Q6%BZ36[/7O9O7+I+OB5
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M         !K')3AN?C4                               '7A;.C8
M %!-XP                  .EC5L!H   <6I*W%P
M  !:D;ZD*         .6Z56V   !LLMU9L               <GTJYL   #:
MY;GS8         &J$E/G6?B)     -N5LCS6]EH           ^2CA SPUL_
M)0    #LVU91:       K2,\;F0  /\ :KN.=^ZV@               <TTJ
M?L       ;!K=CF_]J                XGLUPV0  /7EN^3?Z5   ?YIPF
M_2/Y%\@^_P 6-PU#6,J:-FH(,0T4WB19 MB:AJ%Z.]5=S]+NI>XP
M                              !_!Y,\6.Z^,:<\Q^9#4-8J:-0L-PIK
M$AHU"FH:AK%8((:Q:-0L->I_+\O>[H?W_4?E[                 YS<_\
M?Y$=J?96FC1HJ5G2:-% *FDTFEJEIKUCY7KV+^AN"?TY
M             #A$E?!@       6\6]^U                      Y;I5;
M8       %D>;[2V@      #5^2F[<_*H        !E6\DUU%7H=&U-O]0
M/'HT'3F=9S)3Y-         /7;;G>=>J6@        ?CQ3IN-04
M  'MJ[FKLN>T2^C5_:?F)YBOB::PFFEGE,@              Z\+9T;
MH)O&                  !TL:M@-   #DPG!!D     #7ZS\J       /<U
M^C       +'TUT8M         '+=*K;    V66ZLV               .3Z5
M<V   !M<MSYL         >:Q3?N-?4    '])WEFN]:_IV@            :
MCR5<[G5=     +*4WV:M      &CJ4]6   !8,:[P-                55
MV>7;(  ']Y_    "WG-[\V@               4V&-.D   [DM6(V@   -*N
MP.K>3'>'YJ*#1N&H:QE39HU!B0&C4-0L618:B7I5U+W;T?ZJ[@
M                             '\'DSQ9[JXMIWS+Y>*PU#4-8M%-8J;A
M36*PIJ&H4UBU"P0N*PT:]3^7Y.]?0_T_4OE[                YZ\\]WCY
MVO\ 6PM!HIHT:-%9J:B:-2H!4TFRE[ ]6<9Z'\$^*
M          !PB2O@P       +>+>_:@                     <MTJML
M     "R/-]I;0      /S)*=EFG+(        _0KKO-=PY=HK0      /B(X
M_,\,;/&4        '5-JTRT        !P#9X'L@         #;9>MTO3A=D+
M0   !@:IIS'3D>FM2             =>%LZ-@    4$WC
M_9K827VU?O#[)/X#SA?!TV;EM3W0          I4L:TH      !<*>3>(
M              '+=*K;    V66ZLV               .3Z5<V   !M<MSY
ML        # JBL\T&0   !Z MIZ:Z'6@             #Y22L59RS9    '
M[9<3;V^4     # I8LZR,@  ;-+=2;               'F$E'G6/R(   L/
M3=>;6/\ *   .O+5G-H               :F24QK@  !5T3.]J+0   /Y=8X
M._I;\=>7_9XVFX66@;-0U#6,J;-&H,2 T:AJ"*BSI3U+W?T?ZI[A
M                               '\'DSQ:[KXMIWS'Y0A<5AJ&H:Q:-0
ML-&H4UBL*:AJ&H6&H6"%Q7T;YWE[H]&_4]X^%Y0             !BG,7LCW
M>5G9GT(:-&C0*4IHT:-%9J:B:-%D!KT?YWAL9]"<,_6\<
M               X1)7P8       %O%O?M0                     .6Z5
M6V       !9'F^TMH      '":9KV7(        W\:LI2[/6@        ?+I
MPBDX5ZS^9        BK:&=]';0       -:$IA,_CH         -_FN^LN_-
MH       _P 8YRIP)LTI9            Z\+9T;     H)O&
M!^L=#FND:[Y1M%;^B              "E2QK2@      %PIY-X@
M        <MTJML   #99;JS8               Y/I5S8   &URW/FP
M   ..$E:*X    'LJVX&MIU               '\Q7,9XGL@   #:NZN2YU^
MY0     '"5FO:R   +B4\F[5               <36:XK(  'IJWA)JIO9SV
M9   ^M6\=-?8V@              5UF>'C(  &ZJW%VP    --N>]7\D.\_R
M_A;#14V4T#9N&L5B:31LL&)"E-0U!THZF[MZ/=5=Q
M                    #^#R9XN=U\3T[YC\O%2C%86&X7%J&C4+#1J&BXK"
MPT:AJ&H6%@_=\&^QG3WTMX^#^V             /GO.XX]N^YHYS3VISM+,T
M4IHT:!2FBFC92LU-1-RL+V*ZIXYT'X+\H
M   <(DKX,       #;M?0                      #RPU70       61YO
MM+:      /"TI6L_,H       /[2PI-]Q*_W4          :8R57KGP)
M   !LZMSZ:_1M       %45GF:R        !Z_;9%FNI"@        #_ "3D
M@5S6?.4           Z\+9T;     H)O&           !ZRO;J7L2UZA0
M             I4L:TH      !<*>3>(                 '+=*K;    V
M66ZLV               .3Z5<V   !M<MSYL        >-24LKGX5    /6+
M;?N=;+V@               # K=L\6F0   !WZ:[Y-      >)24BKC^4
M[0-63&@              *:#.H3(  ';1JQPUR?2KFP   +.$WU\M
M       'YL4@=8\CD   LHM]FU     _RLX@_HO\@^%\DX4;Q7&V&C2:-%!L
MW#6*QG1HV7$@A2F^D_4W=W1WJKN(
M       ?P>3/%SNOB6GO,?DPL-8J48K#4-0N+4-&H6&C4-%Q6%AHU#4-0L+O
M9P7W.M_4OT?L/3V           !JUR;7&SMWVO)OJ^20U#4-,[F:F4I39HH*
M4T:-&BI4U[;\;U[#/1'%?ZL@                             !PB2O@P
M                                      !9'F^TMH      K#L\BV0
M     !].6H9OI):           !Y3)4TLTT9       %FF;[!V@      :42
M4ZM80        .@S5H^:]7H          #Q*2K!<Z/H          .O"V=&P
M    *";Q@          ?WG<::[SK]A:                 *5+&M*
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M?'=K>,>F                              !PB2O@P
M                       !9'F^TMH     &L\4M[X_XP      #]LMCS?0
MJT            #X*2H99J&R      !L2MU:;_MH      50F.:"
M#KJU9EFOTJ            _ BKQ<\N60         .O"V=&P    *";Q@
M      #V];3K6\"@                 "E2QK2@      %PIY-X@
M          <MTJML   #99;JS8               Y/I5S8   &URW/FP
M    -0)*:^L?Y0   !9U;Z[J                  /B)*;=SK<@   '71JS
MPT     !RGDJUW    M3S?46T             "N*SQ-9   W-6X^V!6Z9XL
M,@  ?Z5=BF]AE              JO,\M&0  .KK5H]H      <L.Y_SEHSV3
MTM!!"&I:-8KA=%-)N%E2FS>*Q-1*;-%Q.DW4W>'1SJKN4
M                        ?P>3/%[NOAVGW,?CQ=Q;$J:A<5A2P0L-0UBU
M#4*:AJ&C4+"XJ:AHL->E_,\W1GKKW]].!^Y]AZ>P       ->.03G-V%-&>;
MW^'>BII-3+,U#1J6LE+"FDW$U,U,I31HT4%+O5PKT^TW4'Q0
M                  !PB2O@P
M   !9'F^TMH     %9AGCTR      !%6?L[ZWV@             >*R4W+GR
M!       +5K?3]0     -:Y*5FL?Y0       !UL:L[M?T@            '
MYL58KGF$R         .O"V=&P    *";Q@         ;0K;B:]I4
M          "E2QK2@      %PIY-X@                 <MTJML   #99;
MJS8               Y/I5S8   &URW/FP       *IS/,1D   #JHU:8:
M                 &E$E/76/Y(   ']A=0GDV0H     ?/E'2X\^D   Z:-
M6N&@            !^.4>6/,4   LHM]FU T\DIK7    [XM=^V@
M    !YK%'C6/Q)   +;$WT4M      'S_L^EPM_2/XR\]^M\ L-000AJ6C6*
MX713::*#1LWBL2Q-&S?27J;O#HWU5W*
M          /X/)GB_P!V<+T]YA\4W#:ZQM2IJ%Q6%+!"PU#6+4-0IJ&H:-0L
M+BIJ&C7Z/CWMMQ+VMR>&^WM5Q7V?3?F>0    ?Q;FO/(,:C\MQI+S2>'?:DY
MU*FC1314TFIEF:AHUDU*PIHU$U,VEF4IHT:^Z]+%B+H/X/VGJ9
M                     '")*^#
M      %D>;[2V@    #S(H_WQ_@0      !V$:LT-               <]$J
M0L8       Z(-6W&@     *[S/#1D       #>^:MRK^Q:             !
M\Y)4 N=-4         Z\+9T;     H)O&         /?UN%S?L5
M          "E2QK2@      %PIY-X@                 <MTJML   #99;
MJS8               Y/I5S8   &URW/FP      !K')2TUC_*   !Z MU.;
M]9H                   "N(SQ.9    [0M62V@     *V#/&)D  #],O#3
MR>IT            !R[2JNP  !]);>*SO[Z@!328U 0  #WU;L[7]"@
M       <6DK<,   >XK=PF_ZZ       UPY9P/C)^@?R+_/K&-A34+!BA2RT
M:P:QM*;312E-F\5B:B:Z3=3=Y]&NJNYP
M          !_!Y,\8.[.$:>\S^*S8FC<-KJ%AI+"XK#0@AK%8:AJ&H4W"PT:
MA87%34-&H:^_^?Y?<OA^;UCY/F^\]#7[G@W_ *1_'N_)>WGS?Z,\<^QGPK[F
M?Q_-36*PT69J96=2T4T4T5-)K*5-&C4M2L++4-1-)N<V5E>Y/3'R]QN)>L
M                             !PB2O@P
M              !9'F^TMH     XC)7,8       ]A6ZC-_=4
M    *R;/']D      ?[U=VSOV^T    #^2*0=QXT@       ](6YVU[2H
M           &O,E,NX^-        !UX6SHV    !03>,        #Z$N*3>V
M]H                   %*EC6E       +A3R;Q                  Y;
MI5;8   &RRW5FP              !R?2KFP   -KEN?-@      "N(SQ.9
M  L5-]PE                    'GJ4F6?.T   'UZWB)O[6@    !I3)3I
MN   !8\:[8-             5/F>:C(  '6IJT$T !Q52MZP   +=4WT"M
M           IR,:7(  !WC;L$J       !S@[9Z"YY=K=!+K"3 Q%&H6#% :
MEN%Q:QM*;B:E2FC<-0UTEZD[UZ,]5=T
M          #^#>>,/=G!]/N9?%C2)4L39N+HUBT5+BL+#0@AK%J%AJ&H:-0L
M-&H6%Q:+#1J&H7%J""&L5-&L6H:AHL-0L-%F:9U,LM%-&BFDJ:RFDL-2U+4K
M"FC4371OK[UNN_5/H@                               #A$E?!@
M                                  "R/-]I;0    !3>8TT0      "
MS&WV)4               #QR*35Q\V@      L8-=O&@    -#)*@UP
M  !9S;Z\J               !Q62MXP        .O"V=&P    *";Q@
M   6+&^X"@                   "E2QK2@      %PIY-X@
M      <MTJML   #99;JS8               Y/I5S8   &URW/FP      /
MQ9*.ESYP@   ]C6[/-_14                    !P69K^,@   69V^PJ@
M    4MV-6T   W'6Y*V            /((I WQ_P   %NR;Z 6@ ><Q1XOC_
M     #KDU9Z:            &J\E+K6)@  95=:SO9"T       #^>XXY]^?
MD_6GE_6^--:A<;,(QL*:A8,4!J6X7%K&U=,Z-%*:-]).I.]^C'57=0
M                                 _@WGC%W;P;3_F'Q(6+8TB5-1-&X
MNRXM%2XK"PT(7%8:AJ%AJ&C4+#<*7%8:-0IJ&H:Q6""&L6BPU#4-0T6&H6&C
M4RLZRE-&BFBFDU,LYT:A9;E979+CN>]W1GH_H8
M          #A$E?!@                                      "R/-]
MI;0    / I*2&L(      'O2W7YO].@               !6]9XJL@     #
M?QJW@T    !7;9X;L@      #<I;C;7^Z@               ?PI3%N=6Y
M      .O"V=&P    *";Q@       #:=;FDU^C:                    *
M5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M      #D^E7-@   ;7+<^;       YFR51;@   "PBUW;:
M       'G$4?]>/YJ   !T,:MP-      <,IFO!<@  15T+/DVKH
M   #AHS7>9   V(6Z]-_[4  *MS/*1D  #ZM;QTU]G:           !7A9X8
ML@  ;X-6_&@        /EO<^=Q1_0_X]\O\ L\9A,4QIK4+BF!C8:+"XD(66
MC4-8VXJ:39H%Z1]2=]=&>JN[
M   !_!O'&/NW@NG_ #'X4-)J%C5BHE3431N+LN+18EA8:A1"XK#4-0UBIHUB
MIN%-8D-&H:A36+4+!"XK#1J%AJ&H:+#4+#1J99SI-2IHIHT5-3+.=&O2?G+!
M/0_K>@>A                                 .$25\&
M                          +(\WVEM     XNI6U8       L*-=V&@
M              -6XI;Z\:      /TR]3/)]A0    IF,:C(       +7<WT
MQM                 Y1)5P8        Z\+9T;     H)O&        +3\W
MU-M                     I4L:TH      !<*>3>(
M'+=*K;    V66ZLV               .3Z5<V   !M<MSYL      "LDSR 9
M   'Z=7@\^3U:@                     *Q3/(AD   ?H%YJ;]"M     '
MCD4@KX_XP  #N>U8=:            I<L:LH  !8':[RM   <\4J0L   "S4
MWV"4           ?P12'N/&D   LV-]@%         'EWV..<5_T-^._D_>^
M5#4+"8ICHNH7!,3&PIJ%Q(0LM&H:PMA32;+TDZD[[Z,=5=V@
M                          #^#>.,G=G ]/\ F7P8:+#2:A8U<:2IJ)LU
M%W#4*EA86&H40N*PU#4-8M%-8M&H4UBL*:AJ&H6&H6"%Q6&C4-0L-0T:A8:A
M34YLS4S13131HOTWJZ[[=$^/WCX<
M '")*^#                                       %D>;[2V@    55
MV>7;(      _UJ[[GR>U4                 *:#.H3(      ML3?12T
M #SV2BW<?X@      &Q:W66OZ%                 _-BD=<>+(       .
MO"V=&P    *";Q@       >]+=EF_P"V@                    *5+&M*
M      7"GDWB                 !RW2JVP   -EENK-@
M#D^E7-@   ;7+<^;      &!1\8\90   =+FK7S0
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M1<5A34-0T:Q6%@A<5AHU#4-8J:-0L-0IJ<ZF69HIK]7Q:[M='W:7C
M                           #A$E?!@
M            "R/-]I;0    *-['D:      #=%;C;8
M%?EG@RR      ._<UWQN@   .>$E2*X       '?UKO>T
M  !7DF>%UR       .O"V=&P    *";Q@       =[6N_P"T
M         *5+&M*       7"GDWB                 !RW2JVP   -EENK
M-@              #D^E7-@   ;7+<^;      &L\4J[XP   +-S?7Y0
M                 !^=%&:X\]0   =J6K(;0     '+*2K!<   "VLWT64
M         "M:SQE9   Z/M6S6@   .!;/ =D  #*KK^=[%V@          5:
M&>53(  '7=JSJT          !KSRG@G'WOK\D_C>QZ<+"14-0L&*08ZJW%<4
MP(L-&L2%ADLM&\5QMZ1]2=_]&.J>\
M        !_#Y,<9NZ^O]/N9<>-1;#2:AHU#26+8MQI-1*FS<74742I86&L5*
M,5AJ&H7%J&C4+#1J&BXK"PT:AJ&H6%@Q6%AHU#4-8M%-0U"PJ:F:_3\6NXO2
M?EV^XEH                                  <(DKX,
M                          61YOM+:    /#XI!WQ@      =UVK"K0
M               '.B2I5<      #IXU:P:    X<)7:8       %SV;VOM
M                 TH2G4P       .O"V=&P    *";Q@       7,)Y-O*
M                     %*EC6E       +A3R;Q                  Y;
MI5;8   &RRW5FP              !R?2KFP   -KEN?-@     #D/)6+N
M J\+/)[.                       56F>7#(   W/6XZV     !^')1VN?
M.$   ZQM6B6@         !\Y%'6X^ 0  "U$WU*4   #P62DIK'^$   =[&K
M #0          \\BCKKQ_@0  !;S;WY4           :[\IX'R [Z_)'X_L^
MF7&6""*AJ%@Q2*QM6XKA<XD!HUB00A9:-](>I/T!T6ZJ[Q
M                         '\FL\>NZ.O]*><\9C.H:-1=0J:AHU#26+K&
MHI-1G1HW%U%U$J6%AK%2C%8:AJ%Q:AHU#4*:AHN"FH:+#4-0L+!BL-0T6&H:
MQ:-%AK]OP:[C=(^UMIQ38                                  '")*^
M#                                       %D>;[2V@   #G"E3%@
M    "U2WU#4                 #R:2C9<      #9);K38   %9=GCVR
M    ![(MXAL                  ?RQ1@UCSR0      #KPMG1L    "@F\
M8       ]:6\:U_JH                     I4L:TH      !<*>3>(
M              '+=*K;    V66ZLV               .3Z5<V   !M<MSY
ML      5S&>(S(   V)6[&V                       .)#-<ID   ?NVW
MOIO]$      K=L\5V0  /IK;R&=?;6@         <HDJX,   >HK>#;_ &
M   5)&>=S(  'O2W:6_Z0         #C+)6MN   -AUNOS?^U
M :\\HX'R"[Z_)'XOL>EC2V%B6%Q14-0L&*8U%JW%<$PL*4UB0D!KI%U)^@NB
MW57>8                                       _P ;.5/;?!>>W9'#
MS4349L-&HNHFBPT:AI+%UC44FHSHV;BV&H5-08M0I8(6&H:Q:AJ%-0U#1J%A
M<5-0T6&H:A<5&*PU#18:Q:^V]+R=SNC_ 'MC^.>0
M               <(DKX,
M61YOM+:    .*"5PF       -H5^M@                  :9:D0     !^
ME5\Z>3^P   %1)G0!D      #J,MJ9L                  "I<SSD9
M   Z\+9T;     H)O&       .GS5JYH                     "E2QK2@
M      %PIY-X@                 <MTJML   #99;JS8
M Y/I5S8   &URW/FP     !4E9YVL@  #JLU:6:
M  &AR5!&    +K4WLE:     !II%-Z^,   6:IOL%:         !4F9YV,@
M =O&K&#0    '*5*MK    MQS?0FT         "G@SI$R  !W_:[VM
M       :\\IX'R$[X_(_X_G]3&S&L;8HU$L)B*AJ&L4A,:BU=8I@86%+#4+"
M=(>I/T%T6ZJ[T                                        Y^]B<3Y
M3]N<!_DWE::B:C-AI=0U$T:A34-)K&V*BU+&=&X;74+"IJ%Q6%+!"PU#6+4-
M0IJ&H:-0L+BIJ&C4-0L+BL$+#7MWQ//W(Z/^GZS\K8
M                 '")*^#        ZK->YP                     !K
M37,QD       61YOM+:    *ZC/#YD
M   "[]/)[=0   I4,:U(      !WY:[YM                   5Y6>%K(
M     '7A;.C8    %!-XP      !WV;[[*                     !2I8U
MI0      "X4\F\0                 .6Z56V   !LLMU9L
M   <GTJYL   #:Y;GS8      I/L:YH   ._37?)H
M    ><11:OC    MI-]&E      %,%C5%   -^&K>C0         \-2D=<?S
M0  (JY_G>UUH    'X,E'BY\X0  #K4U:":         &L4E+#6$  #_ &J[
M;GR>\T             ->>4<"Y"]\_D;\?S^F6&L;,:QTA2Q+"XHMQ4N)"8U
M%K6L),3"PIJ%Z0]2?H/HIU5WF
M    !K9R?XW&WNSK;X#W_4+%+349U$U#2V&HFC4-0II-8VQ46LV)HW#;6L53
M26%Q6%+!#6*FL6H:A3<+#1J%A<5-0T:AJ%Q7>#A'N]C.G?I?O^#0
M                            X1)7P8       %O%O?M0
M         .6Z56V       !9'F^TMH    J]L\EV0
M              +D$WN9:   *)EQ\-(      !:&F^LUH
M   ''"2M%<       =>%LZ-@    4$WC       %HR;ZP6@
M        4J6-:4       N%/)O$                 #ENE5M@   ;++=6;
M               ')]*N;    VN6Y\V      *&;'SZ   "T"WUK4
M                "B8Q\,@   LTM]@U      '#U*ZK   '^E79\^38&@
M      .#;-?=D  #=5;B[8     %<%GBBR  !].MXZ;^WH        "O8SPF
M9   Z$M6XV@             !KURG@7(?OC\C?C>?TL0I8:QLPTBC42P8D$6
MPIK%(3"EK6L),#$5T@ZD_0G13JKO4
M        #XOWO6Y%=R==ZC<RX[$L2EBEL-,ZB:AI;#431J&H:*FL;8TB5+$V
M:-Q=8VII+BL+#0@AK%J%AJ&H:-0L-&H6%Q:+]!Z_EZU]2_7W[X#[H
M                              X1)7P8       %O%O?M0
M           .6Z56V       !9'F^TMH    J9,\X&0
M                +;K?0]0  !0;N/YY       +=TWO]:
M    !S22J P      !UX6SHV    !03>,       6_V][5
M        I4L:TH      !<*>3>(                 '+=*K;    V66ZLV
M               .3Z5<V   !M<MSYL     #XJ*)%\8   %NAOH(H
M                 %*]C6-   !85:[KM      #R62C[K'Y\   =_FN]S0
M       _R2E2SK<@  %E=OLJH     &H<E,^X   %F6;[#V@       #^.2D
M9<^)(  !:%F^L]H              &O7*> \A^^/R+^1Y_4@@Q"FH,*QTBH5
M-08D$6PL+!"84UJ%Q3 Z/]2_H/HGU5WL
M           !":1<\XQRM[;Z^^/]WU\6HEB:$4NHE3434-+J&HE-0U#2:A8M
MC2)4U$T;BZ-8M%2XK"PT((:Q:AJ%AJ&C4+#<+MCQ/W^P'3_VO4OE^4
M                               #A$E?!@       6\6]^U
M             Y;I5;8       %D>;[2V@   "HDQH @
M                 %JF;ZAV@  ?*Q0]OC       %R6>3<>@
M       -%9*?MP      !UX6SHV    !03>,       73V]G5
M           I4L:TH      !<*>3>(                 '+=*K;    V66
MZLV               .3Z5<V   !M<MSYL     #Q:*/E\8   %R:>3<:@
M                     *>S&CB   #N^U8-:       JBL\S60  -CUNL-?
MZJ       !H@E0)@  #Z=;Q<W]U0      ILL:<H  !O4U<":        '.J
M2I1<   ?=+>-FOI;0              !KURG@/(GOC\A_C>?TC1J"#$*:Q,:
MQTBH5-0N)"1;#4+"0F%-:A>CO4OZ#Z(=5=Z@
M               #Y+W/7YB]J\$T.[!XA_/J&L6HFHE$6K8FDL34-+J&HEAH
MU#2:A8U8J)4U$T;B[+BT5+BL-0HA<5AJ&H:Q7T[YGL]6NJ/O;K\)^A(
M                                 .$25\&       !;Q;W[4
M              #ENE5M@       61YOM+:    *AS&@B
M                   6D&^KB@  ?)11 OC       %T*>3:J@
M        -,HIP7Q@      =>%LZ-@    4$WC       %X*>3VJ@
M             *5+&M*       7"GDWB                 !RW2JVP   -
MEENK-@              #D^E7-@   ;7+<^;      \!2DBP   !=,>3:
M                      J/L\\V0  !VZ:L9-       <ODJJ,   "X+-[S
MV@       5E&>/S(  '7)JSTT      !Q<9K;,@  95=6GDV4        *N;
M/)]D  #LBU9;:                &OG*> <BN]_R'^+['I00T4U!B0%-8F.
MF-14-)K%(6+(6&H6$Q3'3H[U+^ANA_5?>H
M              'CGVOF\QNU>!Z?<TXSA1J%AJ)J)1%+J)I-8RFEUBTFH:+#
M2:A8U<:2IJ)HW%W%L326%A8:A1"_9^E['2?K3[W0KKSZ_P"KXM
M                             #A$E?!@       6\6]^U
M           Y;I5;8       %D>;[2V@   "H<QH(@
M               %I!OJXH  'R440+XP      !<WGDVUH
M    #26*=M\8      '7A;.C8    %!-XP      !>:GD]2H
M         "E2QK2@      %PIY-X@                 <MTJML   #99;J
MS8               Y/I5S8   &URW/FP     / 4I(L    796]AU
M                  J3L\ZV0  !VI:LAM       ?CE'ECS%   .R;5EEH
M      ?))1Q8^.   +>4WOU:      !Y[)1VUCYZ   .\;=@E0      !\'%
M'.X^;0  "X;-[OV@                :^<HX!R+[V_(/X_L>E%N-L$-%-08
MD!J%@QTQJ*-1+B014+#4+"=&NI_T)T.ZK[V
M                'B?W?E\[NRN%:6\XXM^=Y<%-0U"QG4*(U2Q-)K&:*NL6
MF=1=%AI-0L:N-)4U$V:B[BV)I+"^J?*]SHAUS]W?;@/V/V_!L
M                             <(DKX,       "WBWOVH
M          '+=*K;        LCS?:6T    5'F.>B
M               6KF^GR@  ?E%"AXP      !</F]W;0
M   .?R5%&       .O"V=&P    *";Q@      "\^\GIH
M      !2I8UI0      "X4\F\0                 .6Z56V   !LLMU9L
M              <GTJYL   #:Y;GS8     '@TE(RX    N=O)MB
M                5%&.?R   #N3-6([H       5QV>);(  'WRWCF_H
M    #D2E8E@  #8U;K37^J@      "KLSR<9   ]T6[;-_UT      !QPDK1
M7   &SRW2V\P                 :^<HX!R-[V_('XWL>B6%QUJ"%A318,2
M%+"PN&I%14-)<5A(J&H7HSU-^A>AO5G>H
M              'Q7O>KHYSWB>D'/>*>+?<^4:!J&H7'.BJBTL32:QFC46PT
MFH:-0TEBV+<:342IO]+Q>;;GB/V=\. _;VOXC]/_ 'E
M                        '")*^#        MXM[]J
M     !RW2JVP       +(\WVEM    %4]GF&R
M          !;JF^@5H   H7W'X<@      %KV;Z7V@
M<J9*M-P      !UX6SHV    !03>,       7GWD]-
M    *5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M           #D^E7-@   ;7+<^;      \HBC5?&   !</F]W;0
M              *:C&GR   #OXUWP:       &H$4TKXP  !::F^J5H
M %0UG05D  "P:UW?:        Y\25&K@   6WIOH=:      !3Z9T89   L-
M-]TE                  &OO*.O^1W>WY _']CTL2 L+CK4&*E*:Q((#4+%
M85%1;"Q+"P19T8ZF_0_0SJSO8
M       #Q/[OR]0.:<9U-YAQWP/D/Q_\-"EAJ)K&4JHM+$U$U$T:BZB4U#1J
M&DOU/J^QM-Q7[&WG#?L[=\/^Q]-ZOE
M             X1)7P8       %O%O?M0                     .6Z56V
M       !9'F^TMH    K2,\;F0                                 +
MD;R;D@   H[W'C<@      %DAKM(T                  !PP9KQ,@
M =>%LZ-@    4$WC       %Y]Y/30                     "E2QK2@
M    %PIY-X@                 <MTJML   #99;JS8               Y
M/I5S8   &URW/FP     /RY*%>L?YP   +74WTRM
M    I#L>%H   +&TWVVM        IF,:C(  !TF:MC-      #7E*3MQ_G
M _K+O$\GM-        ?SI2=9U]0  #K&U:):      &M92IOCQ@  ?V%WN>3
MV6@                  -?>4=?<CN]_Q]^1Y_3+"XD!8NL;8,5*:+B00I87
M&L:QI;"Q+!T7ZF_0W0OJWO<
M      #YGVO!KGR;XFOG(_C^%\@^1XS]OYOFOU/1_P -2&HFL92JBTU$U&;#
M7[O@]GU_XWT/;/A?3]^X]]/8OC?U?</@^_\ [R@
M                      #A$E?!@       6\6]^U
M    Y;I5;8       %D>;[2V@   #@:SP%9       ^U7]R
M             +E37N-H   IJL:>H      !VG:LBM
M 5D&>03(      '7A;.C8    %!-XP      !>?>3TT
M     I4L:TH      !<*>3>(                 '+=*K;    V66ZLV
M            .3Z5<V   !M<MSYL      47V/,T   %DEOM&H
M             _/BAG?'^>   "TM-]5K0       .)*5R6   /[R\#/)ZY0
M    ' )."#   '2=JV*T        !P1F> -R  !](MXR;^\H     "OLG!Q@
M  #I*U;':                    U^Y1U]R0[V_'GY'G]/&V%+BL$!8NL;<
M2%*:+B00I8:QLQK&HM-=%^I?T-T)ZM[W
M                  _@\F//?I>I\+[_ *GQ_O>M^#Y_%_'O,&4?J>+S_3>K
MY?L_1]KT/YWN?:>CYP
M    !PB2O@P       +>+>_:@                     <MTJML       "
MR/-]I;0   !R2DK 7       %BAKN(T
M *J+/,%D      #=VZN'S0                  %,9C4Q       .O"V=&P
M    *";Q@      "\^\GIH                     !2I8UI0      "X4\
MF\0                 .6Z56V   !LLMU9L               <GTJYL
M#:Y;GS8      IN,:;(   .VK5C=H                       :V12FOC
M   N&3>\%H       'ED4>=>/\R   +%LWV_M     '\Z4E;GP60  "U3-]0
M[0        /"XI(:\?\ -   %EV;['V@    #^8I)L>$(  !:A;ZEJ
M              -?^4=?<D>]?QU^1Y_3C5Q6%A2XK! 6+K&W$A2FH6""%+#6
M-F-8Z=%NI?T1T)ZM[X
M                                                         '")
M*^#        MXM[]J                     !RW2JVP       +(\WVEM
M   &F4E."X       Z6M6OV@                             !7B9X8,
M@      ?J5>FSY/LJ                  \RDHS7'^(      !UX6SHV
M !03>,       7GWD]-                      *5+&M*       7"GDWB
M                 !RW2JVP   -EENK-@              #D^E7-@   ;7
M+<^;      %6UGE*R   -^&K>C0                       Y=,U6&0
M+T$\GIE        "J@SS"9   V[6YBV     .?$E1JX   ]66[_-_KT
M    *E3/.AD  #>5;@[8     Y[25'+@  #TI;P\U^W:
M    !K_RCKWDCWM^-OR?-ZAN&HMQJ%A86%@@+C=1;B0IHL+!"P%AK&SHIU1^
MB.@_5O?
M                                              '")*^#
MMXM[]J                     !RW2JVP       +(\WVEM    'S<41[X_
MSP      ?4+>;F_J:                              Y%I6'8
M%JAOJ(H                 ').2K_<       #KPMG1L    "@F\8
M O/O)Z:                      4J6-:4       N%/)O$
M     #ENE5M@   ;++=6;               ')]*N;    VN6Y\V      .#
MLS7UN0  !]A;>KSO]&@                      *[K/#5D   >Q+>*;
M      YE252+@   7-'DVX     *O;/)=D  #N*U8G:          Y7259+@
M  !5U7.]E[0    *OS/)1D  #M:U8_:                      U_Y1U[R
M1[W_ !G^3['I,Z39N+K&V#%2PU"0L!K&W&V"%-%A8,0I>B75'Z(Z#=7=\@
M
M                                   #A$E?!@       6\6]^U
M                 Y;I5;8       %D>;[2V@    4W&--D       M"S?6
M>T                             #562E[<       #J8U:@:
M          J:L\W60      !UX6SHV    !03>,       7GWD]-
M              *5+&M*       7"GDWB                 !RW2JVP
M-EENK-@              #D^E7-@   ;7+<^;      '.N2I/<    7"9O>.
MT                      "FZSIJR   .ES5KYH        #\M*/S/E"
M=P6K%;0    ^%BCE?'\T  !5T2;VH4         #\.2CU<^:(  !W<:L(-
M  #XJ*.-\?RP  !<IF]P[0                     !K_RCKODEWO\ C+\C
MV?2-,U-)LW%UC;!BIJ"%Q :QMQM@A31J"#$Z)=4?HGH-U=WT
M
M                         !PB2O@P       +>+>_:@
M       <MTJML       "R/-]I;0    *ZC/#YD      #=]JX:T
M                     !_+%%VX\_0      #]:KNN=^PV@
M    :_24GKC^4       '7A;.C8    %!-XP      !>?>3TT
M           I4L:TH      !<*>3>(                 '+=*K;    V66
MZLV               .3Z5<V   !M<MSYL      ?#Q18OC_ (@   =X6K!;
M0                      \=*/5\?\ E    L+S7=6Z         %=)GB R
M  !ZZMW^;_0H   #CBE:%@  #=QJX@T          !7'9XEL@  >VK=SFO[+
M0   ./B5EF   -MVKFK0                       U_P"4==\DN^/Q;^1[
M'I&S1IG2:31N+K&V(QM-0L&(6%BW&V"&BFH.B/5'Z*Z"=7=\@
M
M                         #A$E?!@       6\6]^U
M       Y;I5;8       %D>;[2V@    <ZTJ3L       "W%-]"K0
M                      *I#/,ID       =RVK$+0                %
M;%GC"R       !UX6SHV    !03>,       7GWD]-
M    *5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M           #D^E7-@   ;7+<^;       IYLZ/L@  #8U;K37^J@
M              <44K@L    7'IO<ZT         :F24QK@   6R)OI):
M!3U8T=0  "R]-]CK0          -2BF/?',   6UYOHK:   !4%8T-0  "QG
M-]N;0                       / .4==<DN]_Q9^1[/H0T;-&RLU-ILWC;
M"XU"FH6#$+"QK6)!#1>B'5'Z*Z"=7=]@
M
M        <(DKX,       "WBWOVH                     '+=*K;
M   LCS?:6T    #\62C7<_ H      !MTMR.;_OH
M         <:$K5,       #Z5;JDU[G:               !K=)2ZUC\F
M     .O"V=&P    *";Q@      "\^\GIH                     !2I8U
MI0      "X4\F\0                 .6Z56V   !LLMU9L
M   <GTJYL   #:Y;GS8      '!Z9KZ7(   %O2;WXM
M     IJ,:?(   /8%O"-?T*         !388TZ0  #JLU:6:   &LA2NOC0
M /JUO%S7VUH           IP,:9(  !U>:M'-   #7>*3U\>   /U2\)/)ZG
M0                        \ Y3USR2[W_ !5^3Y_2$74*;-FBLZ32;-8W
M46XD*:A<2 L+%N-L+T/ZH_1?03J[OP
M
M      <(DKX,       "WBWOVH                     '+=*K;
M LCS?:6T     5D6>0+(       L'M]W5
M  'CI1]>/^<       '3MJUBT               /\DJ3)SQ9        '7A
M;.C8    %!-XP      !>?>3TT                      I4L:TH
M!<*>3>(                 '+=*K;    V66ZLV               .3Z5<
MV   !M<MSYL      #6B2E5K"   !U":M5-                     #1*2
MH!<    =H6K);0          XJ25OK@  #Z O'3R??4  !7J3A0P  !UX:LZ
M-            <8DK8,   ?1%XJ;] M   X!)P08   Z?M6K6@
M              !X!RGKCDCWQ^)?R//Z4SR3="&H4V;-)I*SH\AK&V+<2&BP
MN) 6%QUKH?U1^C.@75W?@
M                                                        '")*
M^#        MXM[]J                     !RW2JVP       +(\WVEM
M   &A\E0.X       'Z1;HF]\K0                ,#\B3]JT
M "HNQS[0       "S/-]A;0              .)*5R6         .O"V=&P
M   *";Q@      "\^\GIH                     !2I8UI0      "X4\F
M\0                 .6Z56V   !LLMU9L               <GTJYL   #
M:Y;GS8       ITL:4H   /]:N;YWMA:                    !4Q9YPL@
M   7#'DW@          !YF4=[X_QX   LN-]D%  '\*4B&?&$   M]S>^-H
M          'P$4=M>/YN   +*LWV7M  '^"4F6? $   M=S?3&T
M                #P'E'7/)/OC\2?C^Q\_%34O),TJ&H:-&S25-,[-PU%L+
MC4-%A<2 O0WJG]'= >K^_0
M                                                        !PB2
MO@P       +>+>_:@                     <MTJML       "R/-]I;0
M   !@4RV-2D       'IJV_VMH%                _P2N0GB!:CE_JM
M       ')>2KW<        ?OK;M:W@4             #GQ)4LUG\V0
M   #KPMG1L    "@F\8       O/O)Z:                      4J6-:4
M       N%/)O$                 #ENE5M@   ;++=6;
M ')]*N;    VN6Y\V       ./B5EF    .D[5L5H
M <_TJ)7$P   -L5N=M@          "JTSRX9   WK:N M  #F_)4SN   -E%
MNIM?ZJ            *OK/)5D  #=UJX>T  - )*B5P  !ZY;=^SO]*@
M                     !X%RCKCDGWQ^(OR/8]&&H,0W,W-T6%AHV;*FDTS
MHW#474&-L*7$A>AG57Z.Z ]7=_
M:?\ .. ?TYWM'P_FWZGA\P
M                    '")*^#        MXM[]J
M !RW2JVP       +(\WVEM      Y(25@K@       #V%;;<UMA:
M      !\[)61LY1LCMPU8T:          'X<4A[CR=        /1EMQ36XEH
M            &D$E22Y^-0         =>%LZ-@    4$WC       %Y]Y/30
M                     "E2QK2@      %PIY-X@                 <M
MTJML   #99;JS8               Y/I5S8   &URW/FP      !\W%(S6/*
MI    +6DWTXM                   'X\4U;C55    +,LWV'M
M  '-:2IY<   95==SY-C:  JQL\KV0  +";?=E0            .?\E1.X
M 5=/SO9VT "L2SR)9   [CM6)6@                          !X#RGK;
MDIWS^'OQ_/Z,S9N%A<0\DS4W186&C9LJ:9J;-PU&M8D+"EZ%]4_H_?\ ZO[^
M                                 U%YOP'CQWK^=/Y]Y_:];W-H^'\Z
MVPX5SS:3AW./N/G_ $0        /D?<]7Z[T_:
M                         '")*^#        MXM[]J
M      !RW2JVP       +(\WVEM      _/*6[&M:        ?=VV@LZZ7V@
M             :YR59[G3= !8[;[8J          .$#-?)D        ??K:J
MFN@=H           '-&2K;<?)@         '7A;.C8    %!-XP      !>?
M>3TT                      I4L:TH      !<*>3>(
M  '+=*K;    V66ZLV               .3Z5<V   !M<MSYL       #A(S
M7N9    ]B6YQ->I6@                  5]$X/,    >W6W8<[_=H
M      ?G12#N/($   [XM=^V@!YO)1WN/PP  ?W5=ZF_9%             _
MQBE!<:\(  !W8:L*- #Y"2CC<_((  (JZ'G>U5H
M      '@7*.MN2W?'X>_&]KY^,J:ELW!B0IY)FY4N-IHV;*FF=)LW"Q=8U"]
M"^J/T?O]UA^@                                -;^5\.XM]_?FC\SS
M>"+"IK%<IY/9_@<FV2XGS/8?B_+O>N-\J]+^1];-0   !_G9X[]SXNL7+>):
MJ\RXAT"ZS[+VKX?RP
M    <(DKX,       "WBWOVH                     '+=*K;        L
MCS?:6T      <N)*K5P        ,SM(U81E^TM            _BCC'<U[4^
M.0 #^DM53?3FT         #X>2DMK'FD        #^^N_N=]TJ_N4
M  #\>. USPIN?\H          '7A;.C8    %!-XP      !>?>3TT
M                I4L:TH      !<*>3>(                 '+=*K;
M  V66ZLV               .3Z5<V   !M<MSYL       #Y"2D_<^1(   !
MT6:ME+_8H                 '.R2I?<?S    %EAOLHH            KN
M,\-F0  -@UNQS?\ M0'%E*W+   '2Y;7S8             '!=FOVR  ![.M
MW=K^Y0.1"5BF   -TUN,M@                            >!<HZVY*]\
M_AK\GS^E%N-)8FI;-PN*0TFYNYE6XJ;-&S25G2;-Q=0O0CJK]'[_ '5_Z!
M                             \3^_P :XE?H7\O?.>UZ134+C46%36+4
M+%U]#ZGO^N?#Y#Z=\?[?WGSOJ_5^E[WZ?B\Y?Y[/F?<]'X/Z/S_*OL_&\8^]
M\+YKVO3_ *<>7L3T9WSN!PCFH
M            '")*^#        MXM[]J                     !RW2JVP
M       +(\WVEM      &!4A9YZ,@        >RKWS:Z^R_KT         !_
MDG-2*_%SJ4@   ^G6WA-;JV@         <1V:Y;(         W(6QJUO>H
M      '.>2NA<ZM(           .O"V=&P    *";Q@      "\^\GIH
M                 !2I8UI0      "X4\F\0                 .6Z56V
M   !LLMU9L               <GTJYL   #:Y;GS8        X^)668    '
M;!JQXT                 -6I*?5SYZ@   &URW+F_T             :KR
M4NM8F   +?#>^B@4W&--D   M7S?3VT             #Q"2D9<?R@  %L]O
MHZH%1!G0)D  "R<WV>4                             >!\HZUY+]\_A
MO\7V?G)J6H7&HE34MF\2%A4W-W*EQ:-&S1IFII-F^A'57Z1W\ZP_00
M                       'F7UOB<0_T/\ EGXCZ/RX(,5*4UBL5"+4WBL+
M%TFDU!%N-%32;-_[9\O7OH_OC<_@?/0
M                  !PB2O@P       +>+>_:@
M<MTJML       "R/-]I;0      -=9*8]S\J@         ]JM[)R]<)??[0
M      /+).4YQFUG5>0    #UBVXC-;!J         /RY*:-SJJ@
M BN@TUVT7I OZ8     !^!)S$.)UFCS(            Z\+9T;     H)O&
M      +S[R>F@                     %*EC6E       +A3R;Q
M           Y;I5;8   &RRW5FP              !R?2KFP   -KEN?-@
M     #^=*@C.BR    #O:WW_ %                &N<E0W6?$9    /]:M
M\3>]Z@            "G(QI<@  '81JS0T-3(IBZ\<P  /65N_M?J*
M        *F3/.!D  #JLU:6:'@,E):X_R  !^_5XK/D]#H
M               #P/E'6W)OO;\._C>U\S"S&DU+4+B0J;ELUB00TGDR:+%L
M-&C9HTS4WT(ZI_2N_G6'Z#                             ^,][YO$7]
M$?E3R[[7'\94T;-008AHIK%8L@6Q-0U#46II-0N-D6_Z9\G6WI+OO=_K[L0
M                                               #A$E?!@
M 6\6]^U                      Y;I5;8       %D>;[2V@      #C5)
M6HN          !E6W\O1-=YEVZE]SL_U4   >/QJ39I&G/E-&+/XH      &
MSZW!IOT>@        !I!)3\N?Y4          'I=O2>7?U=S%V0CZ&@ /D8U
ME33$Y]V<Y$^(0             =>%LZ-@    4$WC       %Y]Y/30
M                "E2QK2@      %PIY-X@                 <MTJML
M  #99;JS8               Y/I5S8   &URW/FP        -9I*:ES\N@
M  [:-6+9?Z[0              -0Y*FESXT@    [8-6/&@
M.+[-;-D  #[=;R$U]+;729X@,@  =RFK$30              '+5*KK   '[
M]7BL^3T.N!R<!&   .K35I)H                              #P3D_6
MW)OO?\-_D>QZ$5A<X:D$S2:QU8B%3<MFL2%A3R9318MAHT;-EZ$=3_I??SJ_
M]"@                           ?@>SZG%']"?E3Q#D?#S1N&X7&5-FC4
M&) :-0U%018:B:A8:BZ366==7>E^^-[>NNRP
M                        !PB2O@P       +>+>_:@
M      <MTJML       "R/-]I;0       *N3/*!D            ?16^XQZ
MA7U\OZ9^<?)IYF>)'R"         #?9JVS-?NT         *_"<&F
M     !_K7I2^@'^\?R'FM? )C                Z\+9T;     H)O&
M   +S[R>F@                     %*EC6E       +A3R;Q
M        Y;I5;8   &RRW5FP              !R?2KFP   -KEN?-@
M   #CJE9U@    #I U: E],M              Y5I659^10    ;9K<5FOI+
M0             /.HHZWQ_A   %HQOJ7%'^Y\H0  *NEYWM#:
M   !^-%'NX\P0  "R@WV7*4#.NZ   6UYOHK:
M        /!>3];<GN]OP[^-[/SAB19A<X:D+,VFL:BHFIFC<-0L$-3-RV(MA
MHV;Z$]3_ *9W[ZO_ $,                          !^=Y/#QI[^_+.M7
M+^OTW"RT#9N%AK&5-FRP8D!HU#45"11J)J)KJ=TYWQOYUIVD
M                                     !PB2O@P       +>+>_:@
M                   <MTJML       "R/-]I;0       /EXJ#W.F;(
M                       '6)JT)-?[4        !_!)4=N=!$
M                      '7A;.C8    %!-XP      !>?>3TT
M             I4L:TH      !<*>3>(                 '+=*K;    V
M66ZLV               .3Z5<V   !M<MSYL         "LXSQV9     ]FM
MLLYUTMM            'G4E=.SD'<S     ]!MN,YULE:              !
M5E9Y6L@  =&FNS*U3&   -XUN$M@               5SF>(C(  &ZJV)9JH
M+<   >X+=PFO[+0                               /!N3];<H>]/P_^
M/[/S\+G&R"#&S#4QN869LN*XTFIFC<-00L-3-RVJ&H7H3U/^G-^^K_T2
M                     !_A<<B^]/S+J'SOJN%PMAHJ;*:!LW#6*Q-)HV6#
M$A2FH:@QLZ>=0=[=#.K^V@
M           !PB2O@P       +>+>_:@                     <MTJML
M      "R/-]I;0       !Y*E/QG7!                           +"S
M?=90        !Y;)3MN==T                               Z\+9T;
M    H)O&       +S[R>F@                     %*EC6E       +A3R
M;Q                  Y;I5;8   &RRW5FP              !R?2KFP
M-KEN?-@         ?C25+[GGX@    $5TPFK"LNU%H          _(CCLG ?
M6?*Y     /UZMH9WT%M               '.&2IC<   ?U5NQ-:.L@  696^
MPZ@               :HR4P-8F   K>V:T29   [PM6"V@
M                  /!N3]:\H^]/P]^1['HPN-F%SC9!!C9AJ8W,+,V7"U$
M-3-FX:A,0W,\DM*Z#]4?I[?OJ[]%                         0G+3N;\
MZZ*=E=*0A9:-XKC;#1I-E*#9N&L5C.C9HN)!"EZ3]3=X]'>JNX@
M                                         .$25\&       !;Q;W[
M4                     #ENE5M@       61YOM+:        !X3)45N=<
MT                          ]'6X'-;16@         :VR5 [GR%
M                         !UX6SHV    !03>,       7GWD]-
M                *5+&M*       7"GDWB                 !RW2JVP
M  -EENK-@              #D^E7-@   ;7+<^;          'Q*5(F=)D
M   '^U=.)KM0UO\ I_NH       'ET<AK.*3/A2     #^NK2<WU.4
M         #^%*1#/C"      #ZY;Q<U]G:                *=#&E2
M  #*KJT\FR@                                 /!^3=:\I>\_P_P#D
M>Q\Z+<;8MP9QU,4@@QLPUG&R&IFDUCIB)J9LW#4&(;EOH3U/^G]^NK_T6
M                     .<W:W1'.3MK\^E-8D$(:EHUBUC4-&DT:*4V:AK%
M8SHV:+T4ZK[LZ6=2]T@
M         #A$E?!@       6\6]^U                      Y;I5;8
M    %D>;[2V@        #QB2I;<ZF(                        !]^MMV
M:W0M           U-2I&SY"@                     'H"^U+JJR
M.O"V=&P    *";Q@      "\^\GIH                     !2I8UI0
M   "X4\F\0                 .6Z56V   !LLMU9L               <G
MTJYL   #:Y;GS8          'P<5,KC1Q      ![LO3Y>C,N\A]W:    /\
MDUIEY^V<SK.>TS^4      ?IU:$F^JJ@                5YDX6,
M#L U9L:                 XTR5J;@      ;V+< ;
M                 'A')NM.4_>?X?\ Q_/Z,)%F-L6PN&LX60D&)%F&LX46
M9I-8:1!J9LW"PN)T)ZG_ %%OWU?^C@                      !HSV/T[R
MZ[G_ #5AK.$86%+#4$$(66S6*X7132;*4ILWBL3703J_NKIUU!WC*@
M                                            #A$E?!@       6\
M6]^U                      Y;I5;8       %D>;[2V@         ?#15
MQN.;2                        >Q%LR;V^M            UN2I8SKN@
M                   'TY;8F^%EG--D      =>%LZ-@    4$WC
M%Y]Y/30                     "E2QK2@      %PIY-X@
M     <MTJML   #99;JS8               Y/I5S8   &URW/FP
M  !\M)5SLYD,@      #_6MB)=GE]T/5#ZE?ZS\:/@+/'S7<U73X!
M!]NMJ":Z*V@                #6*2EAK"      +@4WO5:
M    !\(E'1GYE      +-+?8-0
M/".3=:<J.\_PY^3Y_1AJ%Q3&R+8MA<-9QLQ9A<3'6<+,;$U+4+"PL34MFH7H
M1U/^H]^>K_T<                      -).P^H>6O='YE_SN,:BU=8I@86
M%+#4$$(:EHUBN%T4VFBE+OAUIW1U*Z:[\R4
M                          #A$E?!@       6\6]^U
M        Y;I5;8       %D>;[2V@         #^63@Y9P-9_B
M            !N&MK&:]XM             \MDJQ)H%<@
M    ?9K:]FM_+:G[/--D      =>%LZ-@    4$WC       %Y]Y/30
M                "E2QK2@      %PIY-X@                 <MTJML
M  #99;JS8               Y/I5S8   &URW/FP           /YC@(SP<N
M?\H                    V:6U<UM(H                  IX,Z1,@
M #9E;J#>8                 *P;/(]D     ?5K>.FOL[0
M                      !X3R;K7E5WC^'/Q_8^=%&H;@Q3&R+8MQ7'6<+F
M$A<3'6<+,:2RW"XU$J:EOH1U/^I-^.K_ -(                     #2;L
M/I_EOW/^9/\ /4A36*0F-1:UK"3 QL*:A8,4*66X7%K&U:F]X.N.X>K'2OZ(
M_P!%                                                    '")*
M^#        MXM[]J                     !RW2JVP       +(\WVEM
M         &D,E8ZYUB0                    #*NT$U8H7Z)0
M    /X). ]G"1/Y4                  'N*VNVMP%%3]GFFR      .O"V
M=&P    *";Q@      "\^\GIH                     !2I8UI0      "
MX4\F\0                 .6Z56V   !LLMU9L               <GTJYL
M   #:Y;GS8            '.]*Q;/BZ                  !77W.K'R_8V
M@                  <:I*U%P     +#3?=)0                 -!9*A
MMP     .NC5GAH                                    >$\FZTY5]X
M_AS\GV/0Q2"*-PUB0F-D6Q=8V868V0SBL&.LX7.-J:F:BW&HEZ$=3_J;?GJ[
M])@                   #2?L/I[EWW/^8_\Z@Q((MA86"$PIK46XR8&-A3
M4+!B@-2W"[G]?=O]9.D?TA_K-
M                  <(DKX,       "WBWOVH                     '
M+=*K;        LCS?:6T           #\*.&=SPFN?E8
M   &Q"V4VNB*@               :0R5G+G51                 !T8:L^
MR^KV@5/V>:;(      Z\+9T;     H)O&       +S[R>F@
M        %*EC6E       +A3R;Q                  Y;I5;8   &RRW5F
MP              !R?2KFP   -KEN?-@            #S^*\]SQRN?\(
M              V#6R/-=(K0                   /@8HYWQ_.@    _0J
M[[GR>OT                 !_DE*5G7)     +>#>_B@
M                     >$\FZSY6=X_AK\CV?12I<;((HW#6)"8V1;%UC9A
M9C<P8D5A<XW.-J:EJ%Z#]3_J???J[])@                  #2KL+I[E]W
M+^8_\=8QTBH5-0N*01;"PU"8IC36HMQDP,;"FH6#%-P^!=M];>C?TS_1-@
M                                                  #A$E?!@
M    6\6]^U                      Y;I5;8       %D>;[2V@
M     >-2<&K./5GX4@                 ]!7NNO;27Z"T
M   #\N3BZ<%;GS-               !Z MAEKL;+_M0 J?L\TV0     !UX6
MSHV    !03>,       7GWD]-                      *5+&M*
M7"GDWB                 !RW2JVP   -EENK-@              #D^E7-
M@   ;7+<^;              &G4E>FSG;<S               'H"]TVNVT?
M1V@                    5E6>/K(    ZIM6F6@                  .
M'J5U6    !M0MSZ;_P!J                                     'A?
M)>M.5W>/X9_']CT,:BU*EQ2*BC<-8F-S"QJPN%F-SC9!B16%QC6-)KH/U-^J
M=]^K_P!*                  #2OL'IWF!W-^8?\K@IK$QMQU(J&DN)"Q9"
MPU"PF*8TUJ%PLQC&PNV?!NU^N_17Z>_JSY
M                            .$25\&       !;Q;W[4
M         #ENE5M@       61YOM+:             !XU)Q8LXYIY6@
M           ]I7M4O9Q?O5                   ^(DXM5Q.9\@0
M      ?O'9)KO6OJ*@ "I^SS39      '7A;.C8    %!-XP      !>?>3T
MT                      I4L:TH      !<*>3>(                 '
M+=*K;    V66ZLV               .3Z5<V   !M<MSYL
M :-2<,+.:%S_ #0            ![2O:=>SZ_>J
M!XW)3,N?*D   'H5MRW.O?;0                  /P8IUW&HJ   #^TMR3
M>_=H                                      \+Y-UGRP[P_#'Y7F^?
MC=86XU%J6%B2*BTUBU!BS&D76-N*87.-D$$5A<8:G0;J;]5;[]7?I8
M           :6=@]-\P>YOR_A8:@Q("FL3'3&HM+$N)!%0L-0L)BF.BZA=G^
M&=E]@.A_U/\ W>/S
M          #A$E?!@       6\6]^U                      Y;I5;8
M     %D>;[2V@              ?CG-.3E!9S=L^8D            'T5O1^
M7KC+TH7]*@                    /QI.7AR!LY[W/\L           >R+V
M&7M#+[#:   *G[/--D      =>%LZ-@    4$WC       %Y]Y/30
M              "E2QK2@      %PIY-X@                 <MTJML
M#99;JS8               Y/I5S8   &URW/FP               !X+)R*L
MY2)JZ@          ^BMZ/2];5Z6Q^E:                       -/I*H%
MSXF@  ]9MM<YUNU:                   !XM)4ZN=04  'T99S;ZK*
M                                   /"^3=9<L>\/PM^3Y_GFDUC;A;
MA2U-00D$6F\5A,4C2+K%<;,+G&R""*Z!=4?JC?7J_P#2@
M TN[!Z:YB=R_ES_+2"%A2FH,2%+"PN&I%8U+42XD+%D+#4$&R7$>Q^PG0WZL
M_2\7G
MX1)7P8       %O%O?M0                     .6Z56V       !9'F^T
MMH                ^:C0"SGHFAJ:C)^:        #_ 'K:27?1>B"]#8^P
MM                        \FCFI9SE30=/*4        V'7HLO4"7H O]
M]    "I^SS39      '7A;.C8    %!-XP      !>?>3TT
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M3Y_GQ46I4UA;CJX45-00F(M-8M8I%D5%UBN-SA9C9!T"ZH_4^^?6'Z5
M          &F'8'3/,7N7\M_YW,!87'6H,5*4UB00&H6*PJ*BV%B6%A(K8?B
MG8O8?H3]7_K>'V0
M         !^1'Y(       /H:_L                      /SX_"
M !^RGZEH                  ^>C55-5:UN3P8\;/*3Y!/C(^?H?KU]7'V9
MZ>>P+[P;&+M)&W:_:4                           ,#7B-0+-64UU/$#
MR9/A:^1/S8_L/JJ^[CUH]RMV/C;-=TH]JM      'S\?Q       _0K]T
M  ^2@       ?46?ZJ                     !\P?XP      !]$?UT
M              /SX_"   !_M7TX               /SH_#   !_0?2T
M                !XS&K5FO,>)6>5GPY\V?G'[\?:5]X>OGO2[,QLVOT=
M                           ?D1B?LT                       !^?
M'YI]%0                                          \,Y+UCRT[P_"
MOY7G]#%8,:6I4UA;C;AH5-00F-&H:A<4BR+<;87"YQU.@'5'ZFWRZP_2H
M           TQ[!Z7YD=R?EC_.R&BPN) 6+K&V#%2FBXD$!J%QK&L:6POO7%
MN?=C.@_UK^UX/;
M
M
M
M
M
M                                                \-Y+UARW[O\
MPK^1['SX7%8:A,:6II+A;A;CH5-08I%&H:A<4BS&V+8MW^ZI_4N]_6/Z3
M          &F78'2G,KN3\JXK#474&-0T7$A8"Q=8VP8J4T7$@@-0N->V<=Y
MOV/Z!_7GT'K>Z
M
M
M
M
M
M                                               !X=R7K#EQW;^%
MOR?/\Z*QTA<5A8,:6IJ)<=7"W&C26#%(HU#4+BF-D6[^]5?J;>[K+]*
M       #3+L'I'F7W+^4<-1-,Z31N&HUK$A84N*P0%BZQMQ(4IJ%@@]BX_S3
ML?T%^O\ Z;U/H
M
M
M
M
M
M                                                 >'<EZPY<=V_
MA;\OS?/&-D:8U"XM08D:%342XZUA6-&DL1C9%&H:Q6$W?ZU_2G03JK]1_P"L
MV          (313LS\^\Z^VOR]_GK)HV;*FF=)LW"QK6)"PL+"P0%BZQMQ(4
MUZS\+F'9#H']@_5^E]0
M
M
M
M
M
M                                                       #P[DO
M6'+CNW\+?E^;YX QJ-3&L5AJ#$C0J:B7#6L:QM*EQ2"*-PNPW$>W.F/3?[#^
MN]'[8         ^?]GYW,_N3\GZE\[Z13<W<RK<5-FS1I*SI-FXNH7&H6%A8
M6" UC;Z=\;EG9#H#]C?9>A]<
M
M
M
M
M
M
M #P[DO6'+CNW\+?E^;YX $$5&IC6*PU!C44:9L6X76%1:5-8LP17T7I_;W]Z
MK_5&WO >]_Z,^0       8LZI<YZ;YR=N_E+XGZ7'C>)"PJ;F[E2XM&C9HTS
M4TFS<76-L1C::A8/1/D\F['= ?LO[KYWVP
M
M
M
M
M
M
M            /#N2]8<N.[?PM^7YOG@  01J16%0U"XD6Q85G4-8:N%1:E2X
MV0>B?)YCNWUM^D=J^#=W?L^#W@    !_!Y/!JUS?IG1CLS\X>.\BX!"XD*FY
M;-8D$-)Y,FBQ;#1HV:-,Z32:-Q=8VQ'WGS.2=B^@/V;Z#\S[X
M
M
M
M
M
M
M                            'AW)>L.7'=OX6_+\WSP   ((U,:QJ%AK
M$BHHTS<;K&W"HM2PL2?I>+W]B.(]N;#<3[8]JXYV+Z5\?E_]WC\X _EWXO./
MK<4\6Y'U[KURWJO6CF74'SWN?(PN<-2"9HUBL$*FY;-8D+"GDRFBQ;#1LT;*
MS4VF_M/G\A[$= _M'TCY/(P
M
M
M
M
M
M
M   /#N2]8<N.[?PM^7YOG@    01IC9C4-0N)%0&DN-UA;CI"I86$@S>7Z7T
MON?M^K],U^'[7S?EO=^)_CY/'C;BF%SC9!!%F%SAJ0LS::QJ*B:F:-PU"P0L
MSR2V(NH4V;-?6_.^[V&Z!_;'J/QN4
M
M
M
M
M
M
M           >'<EZPY<=V_A;\OS?/      BHK&S&H:Q6%BR*32:QMPMPT*F
MH(3&BF\5Q2+(J+K%<;,-9Q2"#&S#4QL@F;+BN-)J9HW#4$+#4S<W8AKZ;TOL
M]@^@/V]ZU\/EX
M
M
M
M
M
M                                                       'AW)>
ML.7'=OX6_+\WSP      (K&R*QJ&L5@QI:E36%N%N.A4U$19C18;A<4BR+<;
M87&S"YQL@@QLPUG&R)9;-84B&IFS<-0F*FOHO3^SU_Z"_;_L?P.;
M
M
M
M
M
M
M                                    >'<EZPY<=V_A;\OS?/
M  BL;(K&W%86#&EJ5-86X6XZ%34$)C1J&H7%(LBW&V+<&<=3%((,;,-9PL-3
M-)K&L:34S9O]OUOJ=>>@OW%[9QWG@
M
M
M
M
M
M
M             'AW)>L.7'=OX6_+\WSP        ,;(K'2%Q6%@QHIJ)<;<-
M7&BIJ#%(HU#6*PD68VQ;"X:SA9"008ZF%SA8:F:36&G['K?2ZY=!_N7W;C78
M8
M
M
M
M
M
M                                              'AW)>L.7'=OX6_
M+\WSP         ,;(TQK%86%Q(T*FHEQNL-,:-,V#&R*-0U"XIC9%L6PN&LX
MV8I!B8ZSA9C9^EX/>ZU]"_N?8'BW98
M
M
M
M
M
M
M                'AW)>L.7'=OX6_+\WSP          ,;(TQJ%Q:@Q(T*F
MHEPNL-(M*EB,;(HW#6)"8V1;%N*X:SC<PD+_ &>+V^KW1?[=V+XEVH
M
M
M
M
M
M
M                                         !X=R7K#EQW;^%OR_-\\
M           019&F-8K#4&-0+4U$N&M85%)HN*011N&L2$QLBV+K&S^CQ^?J
MCT?^V-E>']M
M
M
M
M
M
M
M>)<CZTY=]V_A;\3V/E@           ""-2*QK%8:Q(J*2IJ&L-7"HM2I<;((
MHW#6)"?VX]KJ/TE^U]E.']L@
M
M
M
M
M
M
M             >4?<X'RY[M_"_R'O\;             $$:F-8U#4+B144:9
MN+6.KA46I8EA(J*^@]3[74WI#]M^[\9[)
M
M
M
M
M
M
M                        ^,^AQSF)W3^(/(?O]<@             ""-3
M&L:AJ%Q(J*-,W&ZPMQJ+4OI?Q>;=2^D?VUZ5\CEP
M
M
M
M
M
M
M                               '\._5Y_=K?DS4+G_YT
M    $5%F-8U#6*P14!I-8V[0\)[SZ/\ 3_Z^_:\'T
M
M
M
M
M
M
M                                  !KGRWI_G9VY^.?DO?XZ
M        !%8V16-L+BL'[_J_9Z%]2_KS:S@_>(
M
M
M
M
M
M
M                                'X/L_+T0[/\ ROJ+S_\ ._\ E?&
M               (K&QK6TG!N^>@'5/ZR^K]+[@
M
M
M
M
M
M
M                                   \N^UP?0SM'\J:[\MZ:
M         'NG&.UM].KOU=[)Q_L0
M
M
M
M
M
M
M                          >0?>Z^TJ['_-&MW,>E?\->$
M  9-;"<2[@W5ZX_3/N/&^S0
M
M
M
M
M
M
M                      !\7]'CFJ/.>A-6.<=$>>?6X8           /M_
MF\JVCX1WIMEP3O\ ] ^7RL
M
M
M
M
M
M
M                        0GE/V^"ZZ<OZ;\"Y5U-X]R#KG^/R>J
M /Z,^QZU\#L'WWBW;&Q7$>X_8>/]A9-
M
M
M
M
M
M
M                                    #^#R>MY3]S@?E/W>!>:_9X5\
M%]3BGQ_T.._->[\+\CS>E_%Y/6']6?/^QZ_O?2>G]SZ_T.0?=_+Y5Z3\;FGJ
MGP^>^M_"Y]^GX?=
M
M
M
M
M
M                                     '__Q  T$   ! ,&!0(& P$!
M 0$    $!08' @,(  $P-T!0$146&" V8! 2$Q07-2%PD( Q(B/_V@ ( 0$
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M  !%8+6FY26GQ8]K1F#3*K1T6YI:]M&Y/7/5"%0Y WB<VAY<V,>FW)+9*O\
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M/%WJ:RD1S5)>9.:C2(V2JB!*Q-^=::UXQ>=)J*ZG<[=%TA0BM"#P PK%Z/\
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MM;E^W'C6&M.=K[SHN1'W1OO"Y0P-6A!X 85B]2VKE?/[$<]QI:4"S9LR?-L
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MUD:-%2:2)J^""&7#X5:9S8U%N:6K17HW;7ES8QZ;<DMDJ_R@P&:S8V"LC*?
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M9(25_]H " $# 0$_ >AD2YDTW94M<Q6I"5+/@D&)-@6Q/:Y03DO_ *8)D?\
MC*1$K<=:J_UBZ60/XIBEJ\)<M2<-+K'5$K</IG6CVIE4[ZOKKFCK'ZO4>J)>
MXJS1^LJ*R8>I4I"?#@E'/^+JZX1N2L1/O4\V9_/43A_X:Y<)W.6(C*SY1_F5
M.7_SS#XYZWA-BV.DN+-H_P#%(0L>"@1WF$V79:2Z;-H$G6FCIP?A+C^CK/\
M_0:/_P"%D?\ T1_1MG$,:"B;_P!ED9:OU<?T19)!']&6?B&PHZ<>!3+!!ZP7
MTO!L&Q59V;2X?NHNY_RD?&%;EK!7_80G!G14522.MN&NOJO PO<78J_=];E?
MR3P?_$ES,OSB9N$I"_ U]0C5PDN5-[/<X%]#Y?'";N#JP_ 5],O5PLN;)?\
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M%0^^\/#]</%Z+T/O/ 5%Z']AX"H>'WGAX>',/#P\/#F'AXO0\/#P\7H>',/
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M.VO?>']EX?V+T/OO#[WI0L?U>T*:V)2&EUZ. J2!@*J0GB*)US:=@-? +/\
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M]>VF+QV B\=@(O'8"+QV B\=@(O'8"+QV B\=@(O'8"+QV B\=@(O'8"+QV
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MO.8#J*4@8D@ :R2S1)EB3*ERA]1"4^ #GM)QZ;Q!<8&)$^_Q5>\/^*'WGB]
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M1=5VI.D'J^>ORG2ER5E"QV'0H:Q]@-S7_P"R4'\DW_QYN]>A_8<PXWGB]OO
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M#08>'AX>'AXLPM:- =5;2GPGRS^7V((;$90\/#P\/JAX>',/#ZH> J+V\\/
M5%Z J'&_>@*AXFRDSDW5#L.E/7]XTZ8F2U2E75=H(R(UCIZP4W;'H!E] %?[
MZE+?O=X<Q>B]#^P\/[#P^\YA]Z;^MF_[1?\ S'IDY=X^?,1ET<<CMI',1EWG
MY?WV*S\/+F&KL'ET*<CMI'(IT]WSZ!.1VTCD4Y^/E_>/7I":^M0Q%RKJ4MJN
MSUAL?CISTQCHQB\1 5#]</#[SP^N'AX"M1@+UCP@*U&'AX>*:9P=33S"6$N=
M+7B68)6E68RR?Y'[$J%W$8CRAQ#Q>AX>'AX>'B\8>'B] 5#C>>'@*B]%Z'WG
MB]$Q"9R;JO\ "=1ZONTQ,EJEJNJ[CH(UCIVS$\'9U C*[1TP(_BX)-[/6IW'
ML/ 5%Z']A_9>'A:PA"EGZB2HMGQ0_31R[Q\^8C+HXY';2.8C+O/R_OL5GX>7
M,-78/+H4Y';2.13I[OGT"<CMI'(IS\?+^\>W$\%;-JRS@UHU;8_55/6I!P<8
MI4E38-I .$/#QAV1CVQ>B]#Q>A]YX>',/ 4=<!>N K48O133!.IJ>:,1-DRI
M@Q?!:$J!=R^>L]OV)6F[B,O+\/'[WAX<0YB]#P\.(<Q>AXO0XAXO0%0^\\7H
M>+T7H<;TQ"9J;JNXZ0=M$3):I:KJNXZ^FT@J(2,U$)':<!$M(0A"!DA*4#L2
M&'EO/#^P\!47O8>'A]^N7<H:Q?[E+4*S;W92SGHRSZ:.7>/GS$9=''([:1S$
M9=Y^7]]BL_#RYAJ[!Y="G([:1R*=/=\^@3D=M(Y%.?CY?WC[KT\%NDM1.3SI
M4S)OUM-)F/\ \6>>)PQ+!1UP)D!4 P\8'JC'MB]%Z'ZX>'WGAX>'@*.N-ST[
MA[%L]8+W9' GMD*5)_\ X_#+#'[%3)=WC#W?+;;1#F'AXO0\.8>'B]#B',/#
MP\.(<Q>B]#[SF+T7H"HO1,0F8FZKN.D';QA:%2U75=QT$=-69*X:T:*7H54R
M2K^5*PI>?\*3O/#[[P_L/ 5#^P\/%NS.#L>TB^=)-EZ/VHX+3KOMWX=-'+O'
MSYB,NCCD=M(YB,N\_+^^Q6?AY<PU=@\NA3D=M(Y%.GN^?0)R.VD<BG/Q\O[Q
M_2%+X/="59</1TLWM;A)+NVJ2V9RU8!X>+T!9[8$R+T/#QAV1B.N N+PAXO0
M^\\/&X>H,VRYTD_V>J4$_P"SFH1,#_\ O.%U:,,R?L5-EW>,GW?+\.N'WGAX
M>'AX>'AX>'AS#P\7H<&',7HO0XWG,7H"H6E,P,KN.J%H*%,>XZ"-?3.YB3PE
MJH6S^KRILWL)3P0ZG^EP['T/O/#[SP^\\/#[[P\!4/O[JYO!V)5#3-7(E_\
M?(6?^%!&C ]-'+O'SYB,NCCD=M(YB,N\_+HOO'B-YQK\_NAQK\_NAQK\_NAQ
M'AXC[$=X\1O.-?G]T.-?G]T.-?G]T/UQWCQ'V3\/$0\.-?G]T=_-U9^'ES#5
MV#RZ%.1VTCD4Z>[Y] G([:1R*<_'R_O'])TD)K+*J&#S::HDOI(IYJ%@.VCU
MDZ2U\^Z[EX>'AX> J L]L"9%Z'ZX?7&'9&/; 7%X0\/#QN"J0BOK*4_VBG$P
M=:J=;-VW9RSAJ+Z/L9-E7.,GW3\/PZ\X>'A]YX>'B]#P\/#P\/#P\/%[7#C7
M#F+T!4.-YX6E*PQ\=6WQA22A1![CH/3&Y*2R*NH/UE(D)/\ *"M?_.CPAXO;
M[P^\\/O/#^P\7HO1NUG-9]-)TS*N^>R7*6"/&8G'JZ:.7>/GS$9=''([:1S$
M9=Y^70O?MW0^VSP\.8=]?)N=?SB]M^30\..G,-<.-L/OB]#F/CR3G1#F'V&Q
MAQMM\H[.5ZXO=7Q_"+W5\?PB]U?'\(O=7Q_"+W5\?PB]U?'\(O=7Q_"+W5\?
MPB]U?'\(O=7Q_"+W5\?PB]U?'\(O=7Q_"+W5\?PB]U?'\(<:OCRE[J^/X1>Z
MOC^$7NKX_A%[J^/X1>ZOC^$7NKX_A%[J^/X1>ZOC^$7NKX_A%[J^/X1>ZOC^
M$7NKX_A%[J^/X1>ZOC^$7NKX_AS!Q^6PB]%X[;&'.OVDZ>SYCFZL_#RYAJ[!
MY="G([:1R*=/=\^@3D=M(Y%.?CY?WC^DZ1>LBAJ 'X"ON*/[J)\B:Y/5?E2Q
MVL!G#Q>A^N'@&'AX> J+Y@3(O0_7#ZXP[(Q$!<.(L"L]2MB@GD\3ATRUXM]'
M/^@63U)$R^W\.MOL80^!RTB)\DR^,GW/^7MZM1[CH=X>'AX?>>'$/%Z'AX>'
MAX?KAX>'B]KAQ#P%1>AX4D+#&%)*2Q[NE[#D>KV93)R5,29ZO_>F\GL^CN#N
MWGAX<P^^\/O/#C><P_L;M9UZHH9#_JY,V:W^V6$!_P#L3\>FCEWCY\Q&71QR
M.VD<Q&7>?ET$XVV^47N;.>WMV>'COV\^E7&VWRASS5SM^,/&VVGDCEWCY\P'
M.QD-M)Y2]L8<[?AR:=/9\QR)R[Q\^CAD-M)Y$X1>B]%Z+T7HO1>B]%Z+T7H?
M/D7:+T7HO1>B]%Z+T7HO1>B]%Z+T7HO1>B]%Z+T7H&/*'([:1R*<_'RZ)[]N
MZ'&VWRA]0V^$7NS;MASLT.=9^,.=9]ASK,.8<[ 1>ZA#CKV\(<:^?Y1>B]%Z
M+T7HO1>B]T<XVV$/#CKV[XSZ.O1>B]%Z+T7HO0\8:SX?C&[BF]:W,6H![TB7
M+JD__P"O.ES)G_<B8,PSN^$!4!<7A#P\/UQ>AX>'AX"H"X$R+PAX?7'88<B+
M%K?Z1LJAJW!5-D(X33]-+^CG=?ZQ"OQ^QF>!RTB)\G@N,ERC_E_#4>X];]</
M#P\/#P\/#PXAS%Z'AX<0\7H>'AQ#Q>A^N',7H4 H,?'5"DE)8[;;=?2E+(-3
M4R9 _:S$([ 3QCW)<PED@)3@  E(U !@/#*'A]YX>'AX?>>'A]YX?><Q>C=1
M.X:V)X!<2$2I([D!:AW+F*'EATT<N\?/F(RZ..1VTCF(R[S\N@'YX_?MMU0X
M_/I!QMMMJA]6VW4W.W[]MLXV;D#EWCY\P'.QD-M)Y%]MMCKUN>63I[/F.1.7
M>/GT<,AMI/(GHH<H<CMI'(IS\?+H7;;3#B'YF[;/#]4.(VVU\Z/X\B,NSHMX
M=_9!Z,.@;;9<@->VS;U;3)K*.KI%AT55-/IU#JG2U2S_ ,WW0I"D*4A0NK0I
M25)4&4E27!!U$$%)U8@QB(O0%0%Q>$/#P\7H?KAX>'@*@+@+B\(!CT?6A?DU
MEFK5QI2A52 ^)ES&1. #Y(6):CUSL<<_L80#@<08J*<RS>3[G_+U'JU'N/6\
M/#]<7H>'AX>'AX>'AS#P\7H<0YAX>+T.(<Q>WCQAC!!!8]*;FZ>_4S*DC"0B
MZG_:37'P0%@_S"'$/#P\7H?>>+T/#P^\\/OO#Q73O6:RJGO^MJ)JQ_*I9*6Z
M@E@.H#IHY=X^?,1ET<<CMI',1EWGY<]?;;\X?NVVZN@':'[O+;MZ\>C/C#GG
M[^V<N\?/F YV,AMI/MN!!+_=M^/,$Z>SYCD3EWCY]'#(;:3R)Z*'*'([:1R*
M<_'RZ#<0Y[.=7M<8<Y/(#SZ*/(;=O2>CX^/X;^ZVC]0W1VO3@$)-6JHEN,+E
M6!5)"=:4\+<'4&)<&'C#\M[$1>@*@+AX>'AX>'ZXO0\/ 5UP%F-SMJ?T7:]'
M5*+2;_ U&CZ"=Q)A/5+<3<?K2QK+9XC[&YX'+2-<5%.91O)_5_\ )V]6H]QZ
M]YS#P\7H?KAX>'A]Z]#P\/#P\/#F'AX>'AS&"AC!#=)V/3^JT,I)#+F_33'S
M=>0[4H"0V@O#P\/#B',7H!B]ON8>'AS#[SF+T6G4>K6?63M*:>9=/\:Q<E_\
M:DX=W39R[Q\^8C+HXY';2.8C+O/RYX3T(#&?1).VWY=!O^?LG+O'SY@.=C(;
M:3[1/,DZ>SYCD3EWCY]'#(;:3R)Z*'*'([:1R*<_'RZ!?;;;JY^\/S<_ATCU
M\D#T2<NWD!M\_8]*M%P-JT%>,$UE(J2K# S*.9B7UF742QCD$:=#F+T.(?>:
M',!4!47X>'AX>'AXO0_7#QN.M;^E;%D%2GJ*/]#GN2Y,M(X*87SOR;MY6+S!
M,QP/V.(!#'$',:XJ:<RG6C]63_N=O5J/<<<[T/ON8>'AX!U1>AX>'$/#P\/#
MP\/#P\/#P\9QETC9M-ZU5RI9'T8/"3?]FC$@_P Y9'^*'U1>AX<P\/%Z'AS#
MP##[[F'AXO0\;JZC@[/ER/K5$]+C^"5QU?\ 'P7CH(Z;.7>/GS$9=''([:1S
M$9=Y^7.G_/HA]?X]#/J\>A@?8.7>/GS <[&0VTGV';FB=/9\QR)R[Q\^CAD-
MM)Y$]%#E#D=M(Y%.?CY<_<;;>?AT&\8;;;=7-=MO+D1MMMGT0=7)ZMMOQZ(.
M?9AMW\@,OAM\/8])E!ZWN<54I22NSJJ34\5-XF5,)IIHP!-T<,B:HX,)5XX"
M+T7GA^OQB\T!4.(?>;5#F+T!4!4/#P\/#P\;B+9%F6PB3-5=IK1"*69C@B:[
MTRSV+499?W4S5J)P^QY .!Q!S!TQ54QDF^C&4?\ @ZC_  ZCW''-X?KB]#[[
MP\/#P\/#]</#B'AX>'AX>'A^N'AX>,ND+$IN!IS.4./48C6)2?=_WCQNL7=4
M/#P\/#P\.8O0\/#P\/#P^^\/&ZJHX2OER >+3R0_^TF\=7_!P?WG+ILY=X^?
M,1ET<<CMI',1EWGY<XR@E^BAA&>VVWCT%MMM\8./1 C/;;;XP<N\?/F YV,A
MMI.^[<U3I[/F.1.7>/GT<,AMI/(GHH<H<CMI'(IS\?+GNS0[]#/KYJ<^0'1#
M\F-MMLNA_ER/5[%HT:+0H*VAF>Y5TL^G/5PLM2 H:BDF\",B!$V3,D39DB:D
MHFR9BY4U&90N6HI6@LX<+!!XS:7AH> J'$=_C#MU0%0XAXPWG,7H"H"H>'AX
M!.?YOK&HC08W)6V+;LB5-F*!JZ9J:L&DS$#B33@/U\N[,.B_PB1[OV/P(8X@
MY@Z8JZ4R3?1C*^*#J/5J.C(XYN(>'AX>'WWAX>'AX>'B]#PYB]#P\.(>+T/
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M\X4P2"5*X%*O6)20G%1F4YF74 %YJ9>& B]#]?C#F J J']AX"HO1A^<-O/
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M_P G]T5;1(3=III%91,S>JU"E%*0S-P,Q,R0S?LKV$!47H?8;SP%0%0X]AS
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M_'RZ!.1VTCD4Y^/ES1WY)GZ%;3MM^?)CFX_'H!7EAMW\@G>.7QY$9?#;;1T
M>0&7;RA 4"" 00000X(.8(T@_&-WVYI6YFWI\J5+:SJZ]5V<H9)DJ4.%I?=
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M^SJ$%4I3X)643?>EIA:)DM2Y<Q!0N6I:%RUA25H6DE*D+2H7DK27!<!0(ND
M@"'[H<_E 5#[SPX@$C3%Y\QX;?..*<C&(B] 5 5#[UZ+T/[.X/=YPW V);<[
MZ;BRJ"OFJ_7:$4M4L_MLA(G']=A+F'AKJIWV0("P4J *2""#B"#H,6E9JJ11
MFRG53J/:91.@_P /[JCV'%BIS#[SQ>]AX>'AX>'AX> 8>'&\\/#P\ P\(FJ0
M726\CVC3GW8M$JL2K"9Q3K^K_P#CY=<#'$?GS80 .WMVVZH?;;8]\.8O0%0^
M\\/#Q>B]#C><P%1>AQON8>'B] 5#Q6U'#S<#]&ATHU'6KOT=3=?V .7>/G]D
M!EWGY<MUZNCR-MMO+F Y@K5S,#7MMMASPCFPZ"9X[/SVV?H=6?AY<PU=@\NA
M3D=M(Y%.?CY= G([:1R*<_'RYZS?/[NB".2&K;KY8Y<B/PV^'/C^.WQY 9[=
MWL'7T.=7(#7R_I:W*>I5:=TM$@^K5TQ,JT4("KLFL*614EG3+EU(3=63=3ZR
M 2;\_%P<XPT0Q[=Y]A 5#C>>'$!1&F+P.8C#08Q$7H"MA%Z'[H> J J'W]P>
M[SAN L.W)WTV$NSZ^8K]=H12U2S^VR$F<H_382YIX>ZJ=]D" L%*@%)4"""'
M!!SPU1:EFJHSPTH%5,H]IDDZ#K0_NJ)_A478J"AO/#[SF']AX>'AX>'AX> 8
MO0^\\/#P\/$N<N6>*INK-)[MCUQ+K4GWQ=/[R<1X>\/^*$K2O%*@KL/,GB]#
MB',/#Q>AQ#F+T7H?><Q>B]%Z+T/O.8O1>AQOO#Q75'!HX-)XTS/J1I_WLO'5
M]@3EWCY_9 9=Y^7+'5MMIYBS?/[NCQHZ!&O;;;+GQ'-1T" _1*L_#RYAJ[!Y
M="G([:1R*<_'RZ!.1VTCD4Y^/ES(G1R0&G;;;1]@LN0&VW9SXG'D!EV[?C[&
M?(C+;;#Y]#;;;:.7M"AI;4HJJSJV7PM+625R)R'(="PSI4,4+265+6GC(6D*
M2R@(W4;GJO<S:]39E2%&6A1F4D_ZM323">!G.PXQ2+LY'U)R9DL$@)5O7H<'
M.&U1CVQW^,7H"H<0\/#P%'7%\',1V'[X<B J+T7H?KAS 5%^'C<'N\X;@;$M
MN?\ 3<6505\Q7Z[ZJ*6J6?VV0D3B?IL)<P\-=5.^R!2%@I4 I*@0I)#@@Y@C
M5%J66:,F=*!53*..E4DGZJOX/W58YW58L5/ 7 4#O/#[SF']AX!AX>'AX>+T
M Q>A]YX>'AX2M0+@D'6#MMW0BMFI]YECKP/B/F#Y0BME*]X*1_Q#X8_"$S$+
M]U:3V''PSY0S$CZP\_*#-&CXQ?)VV\X>'AX?KAX>'AX>+T.(<[;/%[NB]#C>
M<Q>@*@*B]#[SQ>B]#Q,F)EH4M60^)T =L+6J8LK5F=@.[+[ G+O'S^R R[S\
MN? :?#H#/F VVVQY8^>VW9S(#H [=7-!T  _12L_#RYAJ[!Y="G([:1R*<_'
MRZ!.1VTCD4Y^/ESL=%G\]OAR2>6/0IVV[.0TM[1S^/(#GIRY <QW?;DD;J;(
M4)"4IM:A"YUGS3@5EGFT:U8?1U 2&<M+G"7,]V^%+EKEKF2ILM4N;+4J7,EK
M29<R6M*F4A:"Q0I"@4J"DW@H,68@L=?C&6>'9#]_PB]#C3#:C':([_&+T!4.
M(>+V\%$?C%X'..PPY&<!4!4!4/#F J-P.[[A^!L.W)_TW%ET%H35?KM"*6J6
MK]MDF3/)^FPES#P]U4[[(*2E:2E0"DJ#*2<0H',$:OR,6K92J-1G2054RCVJ
MDJ/U5']S'BJ_PJQ8J<P\ ]<!>N H'>>'&\YA]]XO0\/#P\/#P\ P^^\/#P\/
M"9TQ.2U?[SCP,"LG#2%=H^YH%<K2A)["1]\>O#3+/^]^ CUU'[JOA]\>N2_W
M5?#[X];3^ZKX1ZYJ1XJ_"#5+T!(\3\Q'#S#]9O#[OGKB^3I)[<8?>>'AX>'A
MX>'AX>'AX>+T PYB]%Z'&\\7HO0%1>A]YXJ9_"J8>XG+K.O[NKM^P1R[Q\_L
M@,N\_+E3EV[?=S #H(_GMM\>>G$])MS,?8I6?AY<PU=@\NA3D=M(Y%.?CY=
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M7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[
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MCCRIJ'1,01,EDN'O/&V.\Y_* J+T!48?E&/;\(O$9X=N(@+U_" 1H.^^PB]
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M?]9^K+H:V8K^TY(IJE2OTG]5-_2+BZGI52DH2I:U!*$@J4I1 2E*0ZE*4<
M'))(  U1Z1=WQMV<NQ[+F'^AI$SZ:8#A:4Z4L%*\OZM+6D*D EIBP)RAA+N7
MMYX<0"1D8OZQ#I.ENV,1 5%Z K8PX[-Z]%Z+T8'V'@*AQ^4-O;A=PWJ8E6S;
M,IZL@+HJ*8/ZKI3/GI/]ITH0?U&:OI6$K[3'+O'SYB,NCCD=M(YB,N\_+FA#
M=,#;;;X<V(;[ #GAZ.5GX>7,-78/+H4Y';2.13GX^70)R.VD<BG/Q\N;D;:N
M5O:^<OL/O^[H_;OVPY#*"=NWD!EMM^?19/(#SVV[/L)Z1?1U0;N*"^BY26[2
M(/\ 1]H-@L8GU.L8$KI5DFZIE+IEJ,V6% S94VU+,K[%M"ILRTZ:925U),,N
M=)F9@YA22.*N6L<>5-0\N9+4DA2DD%3[S"+L=N&^0#G%W5]\8C\("H"H?NC;
M"'[_ (1>V,!47H<'/&&U'QV^4.1^!@3.^ H'\8?>]%?I4]9]7W,[IZD>M<61
M9-JSEXU7U9=#7+5_:LDTU0HO4X2IQ]9N3*GI3TE[OC7JG;G;%GM1RU*EVG5R
ME#],6DAZ62L'^JH((G*&%2II;B0%\.0>V'[OC#G\H"HO;SPX@$C*+^L1@<HQ
M@*@*@*V,..R-L(O0%;& J,_8>-P>X4RN!MNVY/TW%F4%GS4_J<E(JJI!_;9*
MD2%?J<%S$\-=3)^TYR[Q\^8C+HXY';2.8C+O/RYJ0W2S;;;:/LN.>'HY6?AY
M<PU=@\NA3D=M(Y%.?CY= G([:1R*<_'RYQERSQGES1QV^6VSPYY9FZ#.VWPY
M<="*SYAU:OL+Z1/1W0;N*"\G@Z6W:26?4*^[@H8GU2KN@J73+43=4RETZU&9
M+!"ILJ;:MDUUC5]39EIT\REK:289<Z3-S!&2D')<M8-^5-0I4N9+*%)*DJ!C
M$1>A]ZZ.SLBZ?8(!SB[J/C&(V<0%;"+T/W1MA#GM@*V,!4!6PAP<\8;4?'[X
MO%/4_? F=\7A'HL]*OK/J^YC=-4?I/%D65:L]7]9^K+H:Z8K^TY(IJE9_2OU
M4U7K-Q=3TEZ3?2"9/#[F[$F_2D*E6M72\>""@RJ&F6/VI=JF:G]5^H0>%X;@
M8>'AA!![=YS^4!4/O/#P"1IB\^8\-OG&!R,8B J J J'[MZ] 5L8?>W![@VX
M&V[<DX\6;9]GS4Y:4U54@Z<C(DJ&&$R9C<2G[4'+O'SYB,NCCD=M(YB,N\_+
MFQ'2F<9;;;?'[#"#H[/OY<<\/1RL_#RYAJ[!Y="G([:1R*<_'RZ!.1VTCD4Y
M^/ESC;M@CEW,/M^'XQARSB'CMZ3.VWCX\N.A#EMM^7+C7]A_2+Z.J#=O07T<
M'26[22U?T?:%W!0Q5ZI67053*:8HFZIE3*>8HS)84E4V5-M2S*^Q:^ILRTZ:
M925M),X.=)F:#F%)(P7+6&7*FH>7,EJ04K4%))SAHQ$/OW1V0Q[?8(>+NH^/
MWQB,\(O1>>'V,;:X<_E%^ J J,#LT-J/C]\.4ZQY1Z*?2MZUZON7W3U/Z5Q)
M%E6M/5_6OJRZ&NF*_M.2::I6?TK]3-_2;BZGI#TD>D%-CRYMA6/.2JU9J2BL
MJ4%Q9LI0]Q*A_;5I/%']G3QU-,4AKQ)<DDDNYS).DZR3B2<X:&U'QC+/X;UZ
M'!SC#1&/;O/L("H<;SPX@*(TQ>!S$8:#&(B] 5L(O0^]N!W!&;P-N6Y)^CXL
MV@H)B?UFE%35((_5Z9,D^_A,F"[=2K[4G+O'SYB,NCCD=M(YB,N\_+F[=)-&
M67Y\[(;HW*%:.SYGEQSP]'*S\/+F&KL'ET*<CMI'(IS\?+H$Y';2.13GX^7.
MB-6VVVOF3G7\_.'VQA]G_"'AQU^'XPXZ_#\8<=>W?#[;"'VV:'V_.'Z^99??
MTIMMY="D-RPRVV_/[$>D7T=4&[B@OHX.DMVDEJ_H^T+N"QBKU.L8%4RF6HFZ
MIE+IYBC,EA25394VU+,K[$M"ILRU*6925M),,N=)F#$$8WDD8+EK#+E3$.B9
M+*2%*2H$A4/&<-&(A]^[W0Q[=MM/L71%W5\=OE#D0%1>>._QCX?&'/Y0%1>@
M*C Z.\1Z*/2MZUZMN8W3U7Z5Q9%DVM/5_6L;LJAKIJO[5DBFJ5*_2N+*G?I-
MU=3T=Z0_2(BQ$S;%L::E=L+24U-0EE(LQ*AD-"JU23Q$92 >$7QBA,+4J:M<
MQ:EKF+65KF+45*6M1O+6I1=2E*425*4<23B28:',/O80QU^,=WA VT1>AP<X
M;48QU/'?XQ>@*AQ#P\/ 41%X'..P_?#D9P%1Z/\ < :O@;;MR2U*&F4-#,']
M:TIJ*A)_L^1E2S_6/?7]"PG9?:HY=X^?,1ET<<CMI',1EWGY<X9]MONZ0;GQ
M&VVWPZ-5H[/F>7'/#T<K/P\N8:NP>70IR.VD<BG/Q\N@3D=M(Y%.?CY<[;HL
M!]MMM71!\]OQY4=#';;;+E1]BO2+Z.J#=Q07D\'2V[22U>H5]U@L8J]3K+H*
METRU$W5,I=,M1F2PI*ILJ;:ME5MC6A4V7:=-,HZZDF&7.DS S'0I)#IF2UI9
M<J:B\B:E22%*2H$L8O1>AXSAHQ$/OW=6$,?R]@@'\(NGJ\H<C. J+T;8QEK\
MX<_E%Z+T>BCTL"K]6W,;IZG]*XLBR;6GJ_K7U95#7S%?VK)%-4K/Z5A)G'UF
MZJIZ,](GI$38B)MBV+-2NV%I*:FI2RD68A6@?557*!XB3A(<3)G&NIA:UK6J
M9-*US%J4M<Q9O*F*4ZE+6HDE2E$E2E$J4I3XDDP\/#B&AH>'WL/RPC'1CVQE
MGAV0\7H<'.&U1VB'Z_&+T!6PAWAX>'B\8]'_ */S:G VW;<AK-!$RBHEAC:!
M!=,^>G#]"R*$$?I753X3@&P& &  P9M ^U9R[Q\^8C+HXY';2.8C+O/RYSMM
MMK@CPVV^_HUORVV\N@&VVV[.B!["M'9\SRXYX>CE9^'ES#5V#RZ%.1VTCD4Y
M^/ET"<CMI'(IS\?+GFSP>B -?AMMV=$G+E1EV]#=7*C7W;>7?]B_2-Z.:#=Q
M0%:.#I;=I9:A9]H%."QBKU.LNB\NE67NJ92Z9:C,EA25394VU+,K[%KZFS+3
MIIM)6TDS@I\B8,01B%)(XJY:TLN5-052YLM25)6I*@8>&ACKB]%Z'$-#1B(?
M?NZOOAC[%T=G9#'M^$.1G%Z'C;&,OQB]'HF]+0J_5MR^ZBJ_2N+(LBUYZOZU
M]6705\Q7]KR135*S^E829OZ3<54]%>D;TC(L-$VQ;%FI7;"TW:FI2RDV8A0R
M&856J!XJ<J<$3%\8H3"YBYBU3)BU+F+4I:UK)4I:E$J4I2E$J4I2G*E$WBI\
M22(O-&!_#"&.L=\99X;SQ@8:&,/#[S#\HQT8]L/W1MA%Z'!V^<-J,=L/U^,7
MF@*V$/'H]]'R[75*MJVI:DV4E0724JP0NT5)R6O2FB2<_P#TDX#Z)R4I"0$I
M 2E("4I2&  P  &  &  RT?:PY=X^?,1ET<<CMI',1EWGY<[;;;;LANB6?[]
MLXVVV\>@MMMOO@C;;\NOH4#7^/LJT=GS/+CGAZ.5GX>7,-78/+H4Y';2.13G
MX^70)R.VD<BG/Q\N?-JVVV>,NA .C,NDSRFVWEW?8STC>CF@W<T%]'!TEO4D
MM7]'V@V"ABKU.LNB\NE67NJ92Z9:C,EA25394VU++M"Q:^ILRU*6925M(LRI
MTF9@01B% @W5RUI(F2IB;R9J%(4E:D%)AS#[S1B("HO0XAA#0Y$/O$ Q=U??
M#'\MG]BZ.SLAB.OX0[9P%0^PC/4?A'HF]+/K7JVY;=34_I7$D61:]0O^M?5E
M4%=-5_:LD4M2M7Z5A)G'UJXNJZ(](WI&18:9MBV+-3,MA:;E34H92;+2H9#,
M*K5 \5.5./I%\:ZF%S%3%K7,49BUDK6M9*EK6HNI2E$DDJ4Y4H\92G<DG##L
M^,8C\,8<?E#]?C%Z,/RC'M^$99X0\/&!B[#&'A]YNZ,>WX1\.V'V$7HP,-J.
M]Z//1],MQ<NU[7EJEV-+4#3TZ@4+M):#W%-(DX+6/U[7$87E!*4RTI0A(0A
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M:6F29TLJES9:D+0HH(,,.SLACK!^$/KPWGC PVHPY&</#P%0^^\/#"&,.1G
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MW/%$REL.15U*+I%9:A-HSKZ<IB4U-ZGDK&=ZGD22X!S 8 ) 2D!*4@!*0&
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M0(  Y(%1RS4^+ J/-B4I$J4$CB3 S]=*N+=/6?9$\74#9[:\+MO]Y8_OF_\
MU4'F3$.M9\'$F?5GGY6*U?)P*BLZGR%[9M7]LNV?'17L,9H6.JM/:G[Q(V$U
M?63V'W+EL\.D@]%0ZKB#U7$]BOM!E)S!^JVVY#;6B6CXPBU\)N4#^4+I(+D[
M;=HYI8'!6Q3T;5PG,(!-14>2BH/F$5=8OA=E(NKZV:4,^;YQ*W?[I&LX?[%7
M.G.$M9,-W5T=Q2@--_:ZH.?Y1_TI_3Z\5/@UA;L]KSCCY_P>#B?M'KI[3#'G
M=ETA@?%989'^):'%_P"+?ZH=QO&'C*\3O?4FX=;3_9;4E/W4NYN'9#C[S@.1
M"W5JD=NLH^(E2DG622DC84D@CVBD8A?M^]WUVW&S4N7DQ&SJK%-:28XS&KB5
MP8_6E#_V\^ER?;,YSM-,Z;XRW'."TN!OYQDH4?:RML _U8[*M]/FSE=X<M/S
MK=X+_P MQ+?_ #/PJVTMP*Y@>%*ME$=6Z;4W'87$Z[/^9[333S-P@.6[S3Z#
ML6RXAQ/VI)'W^814'RV)X9;8K;*MKA/$M.CWQES8%H)_QIV+&1W$8GAESA5R
MJVN4]K;@][>;W+0?XD[4G(^<87AC^*W2;=D0GK/.QT66IS4>)W(3M4KLDBSL
MV+&W;M;=.JVV(^<H^DM9$2M1S4?LRR\:*CDFI\:!4>5<=:93KNN(:1\9Q:4)
M^U1 JXTFP>WR\*Y]7Q;="G/\>37^.G]-FQE;6*U?.?=2C_ VES_F"GM,,5</
MN8MF!NU&BL_:ZI8)_J@=DYTYC^,NSK8@^)_5ZK/V<TE$>REWMXY[Y=W*YVZ[
M[JMNW:H[:)*C))).\F3]OB)<<1U%K1OZ*BG/V$4WB6(->]WUVCL%P[&_:G6@
MQ)B136D>,M;+Q2QP=;:<GVJ1K?8H4SIEB",GF+9[M <:5[2%J3]B!3&F=DN!
M<6MPSVH*'D@]OO2H[0@^KA;8YA5U ;O60H^@Z2RKU0Z$R?V9[*F0"#((D':"
M-W_L?(P*U?)Q45)J?&QW"4XG;=  7;(*F%;-;>IE1^*O=/57!V%4D%)*5 I4
MDD*2<B"#!!X$$01]5KH1@'A3O\KW:)M[=<6B%#)VX0<WL]J&#U3L+V^6E#QH
MJ/)14'R=_C^$X;*;F\;YP;6&O=GO44-SJ?\ $U1V\;[3]Q4IPZR2@;GKM6NK
M^Y:(2D\"7ECLJ\QW%[^?";]]2#/N3:N9:@[BTSJ(5PE04>W,^8-//,*UV'7&
M5_':6IM7]I!!^^K/3#&;6 XZB\;&U-RB51V.HU')X%97!W'95CIOAMQ";QMV
MQ</I>_L?VT .#VM0-ZS5O<6]TV';9]JX;/IM+2XF>!*28/8=D0?,(J#Y3$\+
MML5MC;7">UIU,<XRY&2T'[E)V+&1W$8GAESA5RJVN4]K;@][>;W+0?XD[4G(
M^;6EJ_>W#=M;HUW750D;AO*E'<E(E2CN K"<+9PFU3;M])9Z;[N]USCV(3U6
MT[D[945*/D8%1R34^-%1X[KS+""X^ZVRV-JW%I0G[5$"KW2_#K>4VR7+Q8G-
M/N3,_P!(L:QSWI;4,CGLF[TKQ6YD-*1:(X,IE<=KKFL?:@(_ZNOO/JUWW7'E
M_&=6IQ7VJ)/F%M?WMF?S:Z>9^:A9U#OS1U#GGFDU::8WC<)NV6[E.]:/<7?\
M(+1XP&T[\]D66D>%7D)Y_P '<,>YW,-YG<E<EI6>0Z>L?BT"")&8.PCAN(/D
M8%1Y.*BI-:WB:4X1!.)L)R) NT@;#D$OY<<DN=L*WJCZK/!,)>QG$&K-N0CK
MW#H_0L)(UUY^D9"&QO<4F<I(M[=JU8:MF$!#++:6VD#T4)$#/>=Y)S)DF3GY
M&*CR45'BDA()40 !)), #B2=@K$],\+L=9NV)Q!\2(9,6Z3\ZX((5_P4N;P2
MFL1TIQ?$=9*K@VS!_06NLTDC@M<EUS+:%+U#\0>;6]U<VC@=M7W6'!Z;2U(/
M&#JD:R>*52D["#6&Z<W+4-XDR+I'Z]G5;?':49-.>SF=\DUA^+8=B:=:SN4.
M*B5,GH/H_::5"XW:T%!W*(BH/F$5'DL3PRVQ6V5;W*>):='OC+FY:#_$G8L9
M'<1B>&7.%7*K:Y3VM.CWMYO<M!_B3M0<CYHA"G%I;0DJ6M24(2G,J4HPE(&\
MDF!6CV!HPFWUW85>OCW98S#:=H80> R*SZ:\YU0B(X5'E(J.236MXT5')>XC
M9X>C7NWT-92E$RXO]AM,K5PD"!Z1%8AIDZJ48<R&D[.?? 6X>U#0Z"/ZY<[4
M@U<7=S=KYRY?<?7Q<451^R-B1V) 'FUEB^(8>1X/<*#8_0K]T9/]162?6C55
MVUA^E]J]"+YOP5S9SJ-9Q@GM$%QOVZX&TK%-.MO(2XTM#K:A*5MJ"DGU%,@^
M2BH\G%0:DU-+0AU"VUI"T+24K2<PI*A!![#6,8:O#+Q;.997+ENL^DV3U2?C
MHZJO8K8H?59;<AF3L%:*8&,&PX%U(%]=A+MT=[8CW.WG^:!.M&1=4N"4ZO+%
M14>0BH\E%16,:68=A>LTV?#;L2.994-1M7\\]FE,'(H3KN#>E(SK%-(,3Q<D
M7+VHQNM69;8'"4R2X?G.J60>K R\Z0M;:DN-K4VM)E*T**5)/%*DP0>T&L*T
MVNK?5:Q-'A;60Y]$)N4#BH9-O91MYM>TJ6LFK+$+/$FN>LWT/HWZN2VS\5Q!
MA;:NQ0'$2(J*CR\5JU'D,3PRVQ6V5;7*>):=$<XRY&2T'^).Q8R.XC$\,N<*
MN56URGM:='O;S>Y:#_$G:@Y'S,$I(()!!!!!@@C80=Q&XUHWI&+T(L;Y83>)
M$,O'9<@;CP? _O1F.ED8-361J.'E=6HY)J1XEU=V]FT7KEY#+:=ZS$GXJ1M6
MK@E()K%-,77-9G#$<TC,>$N@%T[<VT9I;["K75V)-.NNO+4X\XMUQ6:EN**U
M'UJ42?.K+$;S#UZ]J\IN3TD=9M?[;9Z)]?6&XBL,TKM;K5:O0+1\Y:\S;K/[
M1S:]2Y3\_=0((!!!!$@C80=A'DXJ/)Q45C6&C$K-;8_\PU+ENKYX&:#\UP=$
M\#JJ]&E)*5%*A"DDI4#M!!@@]H.7U6.@^"^'WQQ%],VM@M);D9.7G60.T,"'
M5<%EG:"?'BH\A%1Y#$<4LL*8Y^]>#:<]1&UUU0]%IL=)9X^BF94I(SK&],+[
M$]=BUUK&R,C50KW=Y/\ /.IV [VFX3!*5J<'GUK=W-B\'[1Y;#J?30=HWI4#
M*5I.]*P4G>*P73-BZU;?%-6U?,!-P,K9P_/GWA7K):.?21DFA!@@R#F",Y!_
MTJ*BH\O%14>-B>&6V*VRK:Y3VM.B.<9<C):#_$G8H9'<1B>&7.%7*K:Y3VM.
MB>;>;G):#_$G:@Y'S,$I(()!!D$9$$;"#N(K1O207H18WR@+P"&73D+D#T3N
M#X'][M'2D&HJ*FLCV5J^5BH/)-8OI7;66NQ9:MU="4E4_F[*OG*29=(^*@@2
M,U@]&KR^NK]TO7;RG5YQ/50#Z+:!T4)[$@<3)S\^PO'[W#"$!7/VV^W<)@?T
M2\RT>P2@[T$YUAV*V>*-Z]LY"T@<XPN$NM^L3TD_/3*?4<O*Q4>3TKPOF'AB
M#*?<KA6J^!L0_&2^P.@&?G@SFL?586UN[=W#-JPG7>?<0TVGBI9@2=R1M4HY
M)2"HY"L*PYK"K"WL6<PRCIK_ %KJNDZZ?VUDD#T4PD9)'DH%1Y"*BHY=(-+;
M;"M>UM-6ZQ#,%,RQ;'^?4D])8_4H.M^L4WT=:]OKK$'U7-X\M]U7I*V)&Y"$
MB$H0-R4 )VF))^ <#THO,)*67=:ZL<AS*CTV1QMU'9_1*]S.[FR2JK&_M,18
M3<6;R76U;8R6VK>AQ'60L;P1\X2()Y(J*@^7BM7Q<3PRUQ6V5;W">UIT>^,.
M;EH/W*2<EC([B,3PRYPJY5;7*>UIT>]O-[EH/\2=J#D?,P2D@@D$&01D01L(
M.XBM&])!>A%C?+ O (9=.0N@-QX/C_-VCI2#RQ4$5-9'LJ/$CR%S<V]FRI^Y
M<2TT@9J4?L2 ,U*/HI2"3N%8UI/<7^O;VFM;6>P[GWQ_.*!Z"#^K2<QUU*F!
M\ -/.L.)=9<4TX@RE:"4J!]F[B-A&1D5@NE+=SJVV(%+-P<D/Y)9>.X*V!I9
M_L*.S5R3Y>*@^0N[5J]MG;9X2AY!2>*3Z*Q\Y"H4GM JZMG+2X>MG1"V5E![
M8V*'8H0I/81]5?H!@\EW&7DY)UK:S!'I9<^^/4/<4$<7@=GEH%0?(**4@J40
ME*05*42  !F22<@ ,R3ZZTDTR4YSEC@ZREO-#U^DD+7N*+4^@C^?'25^BU
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M)0.8,CEBH/+'#RL5%:7V&LVUB+8Z3<,W!&]"C[DH_LK)03MZ:!L3^^%E7?\
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MN)^#<!PLXMB3-M!YD>ZW*AZ+""-83N+AAM)&8*YW&DI2D!*0$I2 E*1L  @
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MX]+%61PU;5:OQ>3_ *TU^3AD>_8JZO\ HK5+7WJ?>W[X]E,_D_P5LRZ[?/\
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M]Y0\(MYS0=G/L3L=&].0= U500E2;6Z8O6&KJU<2\P\D*0XG,*'XI4DY*2H
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MU!J3OJ:FIXU%0>2>YJ/94>4TPT/U.=Q7"FNCFY>6;8ZF]5Q;H'H>DZT.IFM
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MK%"$GWM/I>3@5'+-3Q%1PK,5(J.!J3OK*H-3QJ:QO'+3 [0W%P=9Q4IMK=)
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MH>M2UGJM-IVK<6>JGUDD)"E5CV.W6.WA?=)1;H)%K;3*&6SQB IU< N.1),
M=%*0/K)]'=(G\$?U5:SM@ZKW=C>D[.>9G)+B1M&274@)400E2;:Y8NV&KFV=
M2ZRZD+0M!R(X'>% ]%250I*@01/F$FM;QIK(U')-3RP*S]=3[/&]M3V5/))K
M6K(U!J>-34FI&^HX5GR3W-1[/OJ/'OKVUPVU=O+MU+3#0DD[2?10A.U2UG)"
M!F3[36D.D%SCUV77-9NU:)%I;3T6DGTE;E/.1+B\]R$G52/K*M'=(G\$?U5:
MSM@ZKW=C>D[.>9G)+B1M&274@)400E2;:Y8NV&KFV=2ZRZD+0M!R(X'>% ]%
M250I*@01/F4FI\::R-1R34\L"L_74\<O&]M3QJ>234BH!K,5/&IJ34BHX5F.
M3OPJ/94'EO+RVP^V=N[MQ++#2=92E9^I*1M4M1R2E,E1.4R*TCTBN<>N]=14
MW9-*(M+:<DC9SKD9*?6.L=B!T$Y E7UE>CND3^"/ZJM9VP=5[NQO2=G/,SDE
MQ(VC)+J0$J((2I-M<L7;#5S;.I=9=2%H6@Y$<#O"@>BI*H4E0((GS2:GQIK*
MHY)J>6*S]=3X\\>634@U K,=M34U-9&HX5F.6ZNK>RMW;JZ=2RPRDJ<6K8.S
MM43DE*<U*A*02<])=(W\>NLBINP94?!;?9V<\\ 84ZH>L(2=5.94I?UENCND
M3^"/ZJM9VP=5[NQO2=G/,SDEQ(VC)+J0$J((2I-M<L7;#5S;.I=9=2%H6@Y$
M<#O"@>BI*H4E0((GS::GQIXUE4'DFIY8K/UU/<^-)]=3QK+DDU(-0*SJ:FIK
M(]E7#[-HPY<W+J66&4%;CJS"4)'XDY!*0)4H@)&M .D^DKV.W)0V5MX<RH^#
M,G(KC+GG@"9<4-@V-IR'2*U'ZR_1W2)_!']56L[8.J]W8WI.SGF9R2XD;1DE
MU("5$$)4FVN6+MAJYMG4NLNI"T+0<B.!WA0/14E4*2H$$3YQ-3XLU/94"H/)
M-3RQPK/UU/C9^NIY=:I!J*SIZX:MFG'WW$M,M(*W'%F$(0G:2>Y)R$FM*-)W
ML<?+#)4WAC*Y9:ZI?4,O"'AO.9YI!R:2=FN5*/UF.CND3^"/ZJM9VP=5[NQO
M2=G/,SDEQ(VC)+J0$J((2I-M<L7;#5S;.I=9=2%H6@Y$<#O"@>BI*H4E0((G
MSJ:D>+-3QJ!4'DUJGECA6?#[*D>-GZZFMO(Z^AAM;SRTMM-)4MQQ9 2E(S))
M,1%:5:4.XV^;:V*F\,97[FC-)N5C].\.'ZIL]40H],]'ZS/1_2*YP1[5S>L7
M5 OV\]4[.=9W)= V^BX!JJV)6BTO+>^8;N;5U#K+@E*D[N*5#:A8V*0H:R=^
M7GFM4CQ9-2-]1PJ.36\2.%>S[*GQGKAFV9<N+AU#++22IQQQ6JE('$GB8 &U
M2L@"8%:3Z5/8TXJVMM9G#$*Z*.JNY*3DZ_\ -G-MKT<BN5]7ZS7 \>N\#N-=
MKW6W<(\)M5&$.@9:R3!YMU(ZJP.Q84CHUAN)V>+6R;FS<UTG):# <:7\1U/H
MJVY[%#-!4G/SZ:GQ9-2*CMJ*FIY8J.%3QY;Z^M<.MG+N\=2RRV-IVJ5F0A"=
MJUJ@ZJ$YG,[)K2'26ZQQTH&LQ8-JEFV!ZQ$A+S\=9R#D.HW,)DZRU?6;X;BE
MYA-RFYLW-16Q:#FT\C>VZB>DG@>LD])!2H C M(K+&VN@>9NT#W:T61KC^<;
M.7.-=HZ2=C@$I*O/Y\:34C?4<.234^)C..66",<[<KEU8)8M4$<\\1P^(V#&
MNZKHISC67"#C&-WN-W//72X0F>8MD$\RPG@D>DL^FXKI*/!,)'UG++SMNZAY
MAQ;3K:@IMQ"BE:5#>%#,?],L\ZT?TT:NM2TQ8I8N,DMW?58>.P<[N9</QO>E
M?,R!^ )J?&FLO54<DUI#IG;8;SEI8:EU?9I4N9M[96_7(]]<'ZM)@'WQ?1U#
M=75Q>ON7-TZM]YPRI:S)]0W)2GT4I "1D!'UGN Z6WF$ZEO<:UW8#+FRKW9@
M?S"U>B-O-+Z&70+<DUA^)V6*,\_9/I=3 UT;'&E'T76STD':!/15M0I2<S\
MR:UO&O<0M,.85<7KZ&&AEK+VJ/Q4($J<6=R$!1VF(K']-+K$=>VP_7L[(RDK
MZMR^D[=922>:0<_<T&2"0M9!U?K0+2\NK!Y-Q:/K8>3L4@Q(^*I/56@[T+!2
M=XK!=.;>XU&,62+5Z(%TF?!G#&UQ.:F%$[QK-3G+8RI*D+2E:%)6A20I*TD*
M2I)&2@1(((V&<Y!'P'-34@ DD  $J),  ;2> [=PD[*QO3>RL=>WP[5OKH2D
MN3^:-*&6:P9?(^*T0C^=!RJ_Q*]Q-\W%Z^M]S8D')#:9G4;0(2A/8D9[3),G
MZT+"<?Q+!U?FKVLS,KM7I6PK.3"9ELGXS:D*.\D95A&F.&8EJM/GP"Z.6H\L
M<PL\&W\D^I+@;5N&M\!XMI;A6%ZS8<\,N1ES%LH*"3P=>S;1V@:[@C-NL7TE
MQ/%Y0ZYS%L=EJP2ELC^=,Z[QWG7)1.:4)V?6CX7I+BV%%*67R];C_9;@EQF.
M")(6U_PE)$GI UA>F^%W@2W>:V'/Y>^].V4?FO ='>?=DMI2/3.]"T.("VUI
M<0H2E:%!25#B% D'V>>DA(*E$)"05$J( 2 ))).0 $G,Y;3$5B>F>$6&LVRH
MW[Z9&I;*'- _.N,T>OFPZ?FBL5TJQ;%-9"G?!;8_[/;%2$J'!UR><=[03J;]
M0?6EV&+8CABM:RNW61,EL'695^VRO6;5ZRF>!!K#_P H"AJHQ.TUM@+]ID?6
MIAPZIXDH=3P"*L,=PG$M7P6]:4X8]Q<5S3\JW!IS56OM*-=,[SO\XOL8PS#@
M?#+UAI0_1:VN\<IR9;"G?;J1LDUB/Y0$#61AEH5G=<7?13_5MVSK*S@@J=1V
MHSRQ#&L3Q0_GEVXXB<F4^YL#A#+>JC*.L05;R=I^M0L=),:P^$L7SBFP(YI_
MW=H"9A*7=8H']&4;\^-G^4)62<0L =DNV:]7U^XO%4G9^G'V;+32[ ;N!X:+
M99RYN[0IF.TN&6(W>^Y1G @EIYI].NRZV\CX[2TN)_M()'F*W&VDE;JT-H&U
M3BPE(]:E0/OJ[TJP*SG6OVWEC+4M0;@D\ ML<T"/G.) B)W5>?E"2)3A]@3G
MD[>+C_(9G_GB/;E?:48W?RER]6RV?T5K%NB#M25(AU8W0MQ7#831))))DG,D
M[^.?UJK3SK*M=EUQE?QFEJ;5E\Y!!JVTJQZVZN(.NCXMP$7$_P!9Y*U^T+!I
MC\H&)H %Q:6;\;2CG6%D>O7=1/J;V;ISIG\H=FJ/",.N6AOYEUI_[-<6\Y\2
M,NVFM., <Z[MRQVNVRS&W]3SW^NT9;:1I1H^YU<38'[8=;_YC:?MWGU12<9P
MA8Z&*8<K('*\MY@\4\Y(]1@\0,Z%_8JB+VT,[(N&3,[(Z><Y1MKPFV_WAC^]
M;_\ 57A-M_O#']ZW_P"JC?623!O+4'MN&@?L*N^5*QC"49JQ3#D^N\MMW"7,
M_5G2])\ 1UL3M_ZFNYV?HT*[Y[\WM-\ ;ZK[[_\ 16SHGU<\&O\ O]M/?E"L
M4SX/873O]*MIB?[!?RX>S(4_^4&_7/@UC:,@R 75.W"A.^4EA)(W2B)VB,JN
M-+<?N=M^IE/Q;=MMC_&A/._:L]F^GKBXN%:]P^\^LYZSSJW5$\2I94<^/U?_
M /_$ '$0  $# @,$ PH%# L," ,"#P(! P0%$082(0 3(C$40$$'%2,P,D)0
M47:U)#9AE;(@,S4W4F!B<72VT]06-$-3@8:0D9:FLR5$8W!R=8*3H=76YA!%
M1E1SDK&T)F2 @Y2BTE6$HQ=EA:7!P\31\?#_V@ ( 0$ !C\"]#;V?,BPFOWV
M7(:C-Z<^-XP'3\>Q(]BB \0]E/W]3S+ZA.GLR6]?\M![5)$NNRI$AURH'KE4
M(L:.ROXSD2Q>&_9\'+EJB;*E/PHB?<NS*M?[KG'9@CVY%TD_=#ZC2T:FX?BC
M?GT><^[SY9CJ"-\K(O@;JNJ9>6W!6(T;E]9I-,+_ -S%D<^W_9;:YXIJ":JO
M@4BQTXN>D>.TEO4/DCYJ)LJ%B[$276_@ZO-:7^=IX%1/D33Y-LCV*L2/!>^5
MVN5,QNG);%*5+I===OC#7/G:?^GV0QQ'7A(50A(:O4$(21;H0JDBZ*BZHJ;(
M28OQ/=->*O50D_A$I2BJ?(J6V7+BRMK>WUR:X[R]6]SY?ERVOV[<.)''$NBJ
M+]/I+][=EW()&*>O(0_S[)O7:3-M:Z2::@H5O7T-Z(O%R7+E_!MLG3L/4B0F
MF;HC\R'?E>V^*?EOK:Z%:Z<[+F3OAAJIQD\[H<R+/5.7DH\%.S>=S4>0_=+E
ML]4)M-5>23Z;)YWY9H(S02_.Y$@VYJBV39.]^)*+()5MNDJ$8)%UY?!W3!_6
M]D7=V5=$U1?O5+OEB&CPR'FT]4(HO_P1]XKQ+\@@NQ"%6D5 QYC I\PT_P!%
MV0W&8/\ &#I#KSYV7O?A^K2T[%EOQ(-_X&BJ%DO>W;:RV15RHO0L-4R.G8DJ
M9*F*FO:K00;Z6[!]?;9%W7>6%?\ [M3C++PVTZ9*E]O%Q7XNS+PIKB)61NBH
M,>G4EFUDMY8P=ZJ+S42<(<W9H-N+%=837-X*3N-5_P#!1O3\'R4[$TV4BQ?B
M:Z_<5RI-CHEM ;DB"?Z(I==5U55V4SQ)7S,EN1%6*B1*OK55D75=OC%7?G>?
M^L;*C.*L1LHO-&JY4VT5?6N62E_Q[6'%V(ENM_"5><\O\!//&J)\B+;Y-ERX
MIJ*]GA.CO?S;Y@_YTU^7;CK,>3JJ^'I-+'FELOP:+'T3RD[;\U4=-K2:?A^6
M/:JQ9K#O)$MF:J&Z1-%7ZPJW+G:R(B5#"C9^MR'52;MSY,O0G<W9^[CV\[V1
M$FT^N0#[5Z/%E,\D\]J6CU[W_O:UK+?6R(C6)8;!*MLM0;E4[*OX3DUAEGM\
MI'%'\+1;;RG5"%/;^[A2F)0?^9@S3_;_ "=N]K%6I]-"V8>F2F6"-.7@FS-'
M'==+-B2JNB)L80%J-<>30>A15CQLWJ.1/6,>7\-EB0B]EQXMB&C42F4T%T1R
M8X_4I"?A"H=!8$EYV-AX4Y<?E;%TG$U1: M-U3S"EAE^Y_N>$8B1>W.19DNB
MJMUV5V0\Z^Z7E.O.&ZX7XS-5)?X5ZFBTFM52G6\V'.DL OR$V#B-FGR$*I\F
MPB_.AUAH=,E3A-*67_QX70I!%^&ZZX7KNFFP!7L.R8Z^?(I4EN4*_*D64D4@
M1.U.E.K;E?R=A&/7XL1\O[WJF:FN9NP$.6C<9PE[$9?<NNB:["XV8N-FB$!@
M2&!BO(A)+H2*G)4T^\M55;(FJJO)$^7Y-B&=B*";P<XL UJ,B_W!-PD?W1]M
MGU:LEB6PJB[&%"H$R:O(9%1?:@M7^ZW#"3''!^0G&"7MR\MC2&]3Z,V6B)!A
M-NN(/RNU!9G%^&V+2IS! 79>^E>J\X2YMOSY)L?B&/GW I\@MHG4Q=9=<9='
M47&C)LQ7UB0JA)_ NP]#Q/4R ;6:FO=\F41/-1NH#)$1_P A!^1478!J])I=
M5!/*-A7J;*-/E,5E1K_Y,04^380J352HCJVN3\?IL5+^IZ%O'U^52AMVY^NV
M:C5FG5'M4(LIHW@[?"1\V_:TULXV*VU_DYMY7*Q!I^F9&GGD64XGK9AM;R6]
M_P#9,G9-5V-K#M)EU1S5!ESR2!#OYI@T.^E/A^ XD(_E38Q[[K28QK^UJ*'0
M,J>I):*=17Y468J+ZMB=?=<?=-;FZZ9..&OK(S52)?E55ZWFHU9J-.UNK<:4
MX#!K_A(^96'?_M&RV!NNP(-;9TS/-IWLG?*N=D7(1>M!2$U==,Z(O"#3TYRA
MRBRIN:P(QV<RZ+EG ;D- 1?.?=8546Z@FJ(#S#K;[+@H3;K1BXVX*\B P51(
M5]8JJ?>*1F0@ "I&9*@B(BEU(E71!1-55=$38VRJG?:6%_@M%$9RYD\TI*&$
M$%1="$I6\37@TV)K#U)ATIKLDS26H2U3L(01&8K2KV@;<I/4?;LO?FN5&<"J
MJ]'-\@B(J\\D-G=Q Y)Y#(\D[$3K8N-&;;@+F P)1,23DHD*W%4]:+?8 9KC
ML^,"(G1:NG?%O*.@@CKR],;%$X;,RFDM^)+ UB2BOPST0IE*-)4>_P!T41]6
MGV03\!Z6?J39%HE:A37%3-T5'-S.%+*JYX,A&I8HEEXE9RZ*J*J)_)P&\^ZV
MRRT*FXZZ8MMM@FJD9FJ"(IVD2HB;.,4]QS$4T;INZ:HC!0_4Y4G$5I1_#B-S
M>S3G8VHDH,/PUY,TFX2E3LWE1.\K.GW458@*G-O8GGW7'G7%S..NF3CAEZS,
MU4B7Y55?0.]H=7FT_B0B::=S17514^O0W<\5_E^ZLGIIRV;8Q721E#H)5&DV
M9?M]V[!>/<.DO,E9D113S6>S;-0ZO&E.Y<QPR56)[6ERSPWT;?RCR5T -E51
M<CI)K]X._KM6B0$45(&7',TMY$_>(;6>4_ZO!M$B+:ZI?9R/A.D9^:)4:Q=$
MO:UVJ?'<NMEX@-Z4/*SD;54V5:W69DMI2S)$0]Q!#U9(3"-QKCR0U;5RW,R[
M?0 FV1 8KF$Q51(23DHDFJ+\J:[-MG4._4,+)T6LYI19=4L$U""<*HGD9GW6
MQRCX)1115MBL"]AR85DO)7I-.(OP9S0"K6M[K*CQVQ2WA57DW)B2&)4=T<S4
MB,Z#[+HKR)MUM2 Q^425/Y-MR;4ID:!$92[DF4\##(_(IN**9E\T4XB7045=
MCBX3A+5I"9A[XSD<C4X%Y(34?@F2T_R^A)R42/ELIURK2935[A#!=Q :M:V[
MA,Y(^9+)X0@)TK7-PEU]# \RX;3K9(;;K1D#@&*W$@,50A)%U146Z+RV;CU4
MAQ'3QRHHSC4*BV":>!J(H1&O;\-;EJO)#!-=FVHL](%2+*BTJIJ$:4IK9,L8
MU)6)ER6P)'=)ZR9G&6N7ITQJM2 YPC<:7"M*J)7Y(3(D@QLW,3EN, 2>22KI
ML<>@-AAV$O#O14954<3M59)@C4>_-$C,"ZW_ -Y+1=G),N0_*D.KF=D273?>
M<+UN.NJ1FORD2KZ&W]"JLJ#=4)Q@2SQ'[?\ >(CF>.]RM<VU-$OE)+[-1,7P
M.B'H*U:FB;T95Y9Y%/XY#/:IE&.3F);!&;'8)U(GQ:C$/D]%=%P4+[AQ$XFG
M1\YIU <'D0HO\FN[+FR6(D5@<[TF2Z###0WMF<=<(0!+JB754U5$Y[.PL(1D
MJDE,P+59@.-TYM>6:,Q=N3,5%O8SZ,SHA#T@"VZ77:G)GN(J[L'"RQXZ+YL:
M*WDCQQ]:--CFYDJKKZ+;BRW._P#2ARCT2H.GTEAM.R'4.-UKA1!%M\94<!2S
M;(+KL#<"9T6IJ-W*1.RLS$5$XMSJK4P$YYHQF2!Q.MM+PIZ84JQ/'I2AF9ID
M6S]1?]66.BIN@+L>DFPPME1',VFSD6C9L.4PKC\%=S5-\?\ "SD$2CWYY(:,
MD.HD\ZFQ&9*9F2D1$JD1$2W(B5=555U55U5=5]%#.HM1E4Z2EKG'<41<%-<C
M[2W9D-7_ ')]MQM5YCLU"QG$W#ET%*S3FU5A>29ID&Y.-^LW8BN"JKPQ&A39
MJ=3)D>?#>2[4F*Z#S1>M,P*J(0\C!;&!<)HA(J?R:CL&E*%?K(W!6X[O]SHA
MZI\*F#F1PP+RH\7.=T('7(Y;;ZM5 W6A)2CP&;LT^+?]XC(N7-;17G5=?)/+
M=+T<+C9$!@2&!@2B8&*W$A)+*)"J(HJBW1==FH.)!<K],2PI*4D2L1@]:/G8
M*@*:\$M1?55_;J *!MTZAU!F:TF5'FTX)$8R2^ZE1SLZR?/RARG95;(QXO2K
ME1K4^/3XC?[H^7$X7[VPT.9V0ZO8TR!N+]S;9V!A!HZ5#6X%59 @M3?345Z.
MWQLP06_"?A96@F)QCN&SDB2\[(D/&KCS[[AO/.N%J1N.N*1F9+JI$JJO:OH[
MI=#J+T,E5-\Q?/$E(GFR8IW9>]0D0[P/W,P+79FGXB1N@U4LH"^1+WIE&NB9
M'S7-"-?N):[K[F41*@;(0JBBJ(J*BW1475%14YHO\F@LVMS@8NB]'BA9R=,)
M$\B+&14,_4KA9&&U4=\ZVBWV=@P5*AT,KBL2,ZO2Y@<OA\L<JD!:_!F$;8RE
MD=Z39'/23=1I$Z13YC7DOQSRK9>8&.H.M%Y[3HFT::&*ILS3,7HU2YZV;;JP
M<-,DER3I2+=:>XNEW+E#7B(CBC8-@<;,7&W!$VW )" P),PF!#="$D5%$D6R
MIJGI)ZG8=W-<K Y@-]#5:5!<32SCP66:Z/[S%-&D6Z.20,5:4JA7)[TZ2MT#
M>*B-, JWW49@$%F.U^ T HJ\17);KZ1;B[Q:M1$5$*ERW"\ &E^]\E<YQ%M>
MS=G(MU4ECYUS[;^CR_A#8HLJFR<K4^)?]\9S%G:OH+[).,JNF=#N*?R9K]*P
MMN*M5DS-NS[[REP#Y+D(5M/D!]RV716RMO'72%R/L]4JM,?GS7UNX_(-3*R>
M2 )Y+;0)HVTV@MMCP@(IIZ5"+=:K0LWA*5)<5-PBK<CIS_$L0^:JWE.,Y<E)
MG>*CH].HLQ'<MDDPW;-SH1KYDF/=2%.P'@4X[MEW3IY5MZ.<J5;FM0XXW0$)
M<S\ERVC$1A/"2'B^Y;1<J7-Q0;$C1VGTS>T6@%P+&;<^&SQ]<^0WR;/_ +FR
MNY1%47CE:%Z59G4Z4_"F1SSLR8SA-.ME\A#V+R(5N)"JB2**JFS%)QFK<*:M
MFVJX"(W!D+R%)[::0WB7F^"=$)5N8Q!3B$P(3 Q0@,50A(22Z$*IHHJFJ*FB
MI_)E/U.KS&8,&.EW'WEMJODMMBES=>-=&V6A)UQ= %5V?I5$WU)P^N8#XLL^
MIAZY;@*NX8)/[S9-4)%7I#KUQ!OTNS4Z/-?@S6%N#S)6N/:VZ"W!YD^3C+HD
MV::&*[,TJM;FDXA7*#?%E@50O_DS-5W$DE_O)XR4U5.C.O*I-M>C#A1\E5Q"
M0>#IX'X&'F3A=J3HK=L?.&,'PEU+?6&S1]#J5;FN2Y"W1L?)8C-WON8K">#8
M:3U"ER7B<(SN2^EVX,S>U;#RK8H)G\(@HJZN4UTUX/6L1Q>C.+?+T=PR>V;J
ME%F-S(KFA9>%Z.[9%)B2RO&P\%]0-$NEC#,V0FO\F/TFI.;Z:\)= I;))TN:
M::7[=Q&%?KLIQ,@>2*.O*+1=,JS]F6U+H5.9N,*"VO8TVJ\;JI]<D.9GG;64
MD;$ #TS?DJ=OJV8H>,G3D0N%J)75S.28G8+=1YE)C?<RA19+/[LDALL\=M^.
MZV^P\ N,O,F+C3K9IF!QMP%4# Q5"$A51)%146WHE2)4042Y$NB(B<U5>Q$V
MD4+!;Z&[Q,S,0!90;\UQJD]CCG,5J"^#"RK#0U5N4V;KIFZZX2FXXX1&XX9+
M<C,R52(B7525555U7TT-2HLHF7.%)$<KE$FM(M]Q+8NB.ASRKPNM*JDRXV>N
MUF%2#66&T*;277$5P>PGXA+EZ5$O;P@BAM*0B^ *0*Y_)BG3X.ZJ.)'6_!Q<
MV9BG(:<$BHY5NBJBHXS#2SKPV,U99,'#D52K2W9LZ4>=U]XKK^"V ^2TRV/
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M;JM/-&G_ )7&UY.,NC9QET>!QLA,55%ZM/PA*=\%-0ZE2D+S9;(?#F _\:*
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M)[GGM- ^D7^,JIO-GGA4TN]$"RYAW,(C%UT%311D3"DO@7[VXV-U047JO?\
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MEN0J^J)<E34BN++#3;+0)8&F@%ML$]0@"((I\B)]03+[3;S1I8VG0%QLT]1
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MH+$&*%A0E!D;$\[E04.1(<SR)+MKO/N..EQ&O7X7ME1_=U;\3W//::!](O\
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MN]ISZHB>'@&RI$(;\7VQW:F_1S6!688"55P[,=!9\*^4=^R0Y4G4XG"0 FM
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M9O3.99:F YSWL\D;C;1:U0*E%JM+F!GCS(;B.-&G:*^<VZ"\+K+H@\R=P=;
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MMX^IT/E=NET.34LW+,*/2Y]*R=MCW!]G@]51 [XXTQ%*2[>\Z%"IL!2%/KR
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MU.0X/W.51WB%Y0)LVK@89BYRL2/ULB5I,V7,YT6%)14MQ^"5TLMN'/P;?9[
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M+LS*2EIB6MMY26KXA!J9NW434H-.R= A)GN;1[EZ8W?*LT[(O42;<$3 Q4#
MT0@,"2Q"0K="$D545%2RHMEV?ETZ'^PVMN\0SZ"RV$ W/NIE#NU"=1>)36&M
M.D..+G<DGJA.RZC 2L8?#5,1487I,!L%443O@V38R:8=S$%64VD8G>"/*?\
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M?V^/']6L'_\ #^WQX_JU@_\ X?V^/']6L'_\/[?'C^K6#_\ A_;X\?U:P?\
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M"3"PDI"["AZ9FSKI#<)LE%XEIP$4)NPC*.6I.1V@:: 6VVQ$&VP% !L 3*(
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M(9Q7"RN--=6KWL#5/SBPMZ#8A08S\R9*=!B-%BM&_(D/.+E!IEEI"<=<,M!
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M<$20X%GY.'*HKTK#=4<2^_BB2;R#(,40.^%.WC;4I$0-Z!L2Q; ) @/4Z][
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MEH=6J;5H+3@W\N%2UWS961<M6-/%3>Z758P],K*.TS#6\&YQZ6R\H5&>"$/
M<^6UT5EQ%1Q(L1_*NYFKF]%5G#%8;WE.K4)V'(M;.VI6)F2RJZ)(B2!:E1R5
M.%]ELK+;:LX7K#>[J%&FNPW=%0'@2Q1Y;-]5CS(Q-2HZ^<R\"K95MXFCXAII
MY)]%J4.IQ"\W?0WP?$3145";<R;MT"11-LB D455%H^(J:>>!6Z;#J<;B$B%
MN6P#VZ<R*J"^PI*S("]VWFW&R1"%43QF)(#+>\J-)9_9)243REG4<'73:!++
MF=ET\Y\%M-/"2AN2)=?$U[ TIZ[^'YB5>E@2FI=ZZJ2I,:;3R!:B5,%?+455
MRJWLNJ]<F4N.YGIN#8XX?8057(50$ED5E[+G)$>&8?>]Q10+C3FD4;CF+ZN5
MBJ4SGI^#(6^94D10*MU1'8L!+%SW$0*C*S#JR^U$);9A7ZJB8ZB,J4G#DOO5
M53 25>]%5-.BO.JEQ%N)5$;8#0;G55N2V%/$T47WMY5,,7PS4<QBKBC3@;[V
M/$F97+.TIR&"O.6WLEF592457KF(Z@R]OJ92GDP]1U0U-OH%()QDW65_>IM0
M*=4 LB:2^WRE^KQ-W0);/#'$<-48R"Z;YU&IM8>;5=1-IGO='$Q34)4EO,EB
M1>HN8NI+/":IW[CMCY)KH-2$4\TUL$WU'DDJBYY!CUF/AK$LCBX6:557B\OS
M6X,UPO/Y#&DDO'HRZN?(9_>@]$ELMR(TALV7V'@0VG6C3*8&!:$))S38JI2Q
M<DX<D.<):N.TITUX8TDM5)@E7+%E%ST9?7?9#?\ O&;QC6&/[GPGO[C1W$TF
M36EUFJB^5'A']9[')8WO:,0G]X7<Y_+,3?V-#^]#&'M0U[IB>-Q54&G=[ IT
MO]C]+45S-]#HMXA.-+^]2YHRYP6T^%:=0D8^J4>U7Q8FYI>\3CBX<CN<)#KP
MK598+)*Z<46- ,%RN'F] US"=30=U589ML/J.8H,]OPL">UVYX<L6GK(J;P1
M-DKMN$BU*AU5A8U1I,Z33IK"_N<F(\3+J(OG!G!5 TX7 RF*J)(OC\3X)D.)
MOJ-/:KE.%<V<H-4'H\UL/,1J+-BM.JG"6\J:KQI];\7B-Q@U;FU]&L+PB%<J
MH571P9MEYH24AFI$"AQHX(*BC93'J/[.ZS&RX@Q7'%:<+HJCE.PV2B['L*Z(
M[6"%N<965>AC $5!2D ?H%ONDT6*G?6@,C'Q&#("AS:'?P4\\NKC](<+*X5B
M-:<Z1.$C-/;%.I5[V!JGYQ86Z^O=/KL7^Z%5:=CX4:=1,T2E%F9EU7*29FWZ
MFJ'&BE<5[W(ZXF=FHBJ>BNZ-[98@]XO]0P'^1U3W_5O0I^TU$^C-\3W.?;+#
M_O%CT#"]LJ/[NK?B>YY[30/I%U"=5)SFYA4V')GS'5Y-18;)R)#G^@TV1?P;
M5_$\V_2*Y5)=04%_<6WG56/&'4N"+'W4=M+K8&Q2^GB:#A*!F%RKS0;D/HE^
MAP&D*149JHNB]$A-/O"*_7'!!I.(TVIU&IC Q:=2H4:GP8X^2S%B,BPR'RV;
M!+DO$2W(E555?1E'[I5.C\;*MT'$A-BFK)JI4:>[9/,=5VG//&JJN^IC*60$
M\54\(2GLTS"50WL,2/B6BUE79#0@)+G)(U1;J"&J7!H)$1OAS!F\;B?#S3>2
MGI-[XT?[GO35$Z;#;'U]$1TH)K9+NQ7+:67Q&&JH\]N:;/D=X*PJJHM][JPH
M1]Z\J77=0IG0ZB6BWZ'UO$F+)" 0T2ER)3+3E\DB:2(Q3HI92%;2Y[L:,JH0
MVWM[ISVDSI;IORIDAZ7)?<6[CTB0X3SSIKS4W'#(B7UK?Q%%5]K=U3$U\35%
M2 4<1*@#?>QA2MGRM4MN(>[-?!R'I-D%35/JJ[ABH(G1:Y3)5/,K9MR;[:HQ
M*!+IX6(_NI+6NCK0+M4:-46E8J%*G2J=-96]VI4)\X\@-41>%ULD1;)?GXB;
MA.4]D@XQ@*,<2-!;&M4@794/RU1!61".HQ[!X1Z0L1OBL-NM8GQ T]N:CT(J
M;150E%SOO4_@<-UJW,X:N%4%%+7:B.<0\T^K$ $C,R00 44B(B6R"*)JI*NB
M(FJKMA?#.[$)D2G-R*JJ"*$=8J"K-J6<A2[FYE/G%9,[ET9A@.0"*=1<:= 7
M&G0)MQLT0@<;-%$P,5NA"0JJ$BZ*BJB[=(B"1T.>9%"<U+HKGE% >+7B#4F#
M+Z\SVJXV[;K,?#6)9''PLTJJO%Y7FMPIKA>?R&-))>/1IU<^0S^]!Z)+9;D1
MI#9LOL/ AM.M&F4P,"T(231478JI2Q<D8<D.<):F[2G37AC22YDP2\,627E:
M,O+OLAO_ 'B(V[O&J' )MVK2QNBJ%[A!8/ETF5E4;Z[AK>/JA* -N,0XC(1X
ML5EN/'8:3*VTRT* VV"=@B*(GWA]SG\LQ-_8T/[T,8>U#7NF)XS%V)Q)0?IE
M&DK!)+:5.7E@4KGV=\I45"Y\-[(JZ*I$JD1*JD2K=25>:JO:J]J^/P[A1G.C
M-1G"51>#18U(BHLJJ2$)>%' A-/(PA*F\DDRRG$X*+$@0F0C0X,9B'$CMI9M
MB-&:%EAEM-; TT @"?<IZ#I'= @,(,7$;:4JLJ \(UJGL_!)#B\L]0I@[H43
MMI+AEQ.:^.PXAN$$/$>_PQ+1%\OOJ@][AM=!7^[#-.Y\AS944K(OB\'X/:-,
MM.I\NOS1$K^'J;_080.(F@&PS3I3@BO'NYJ$J() I=0IM)DMD5"IMJSB([+E
M*FQ'&[0KW&Q5.23,'A+>-M.OR 1>CJFP-- +;;8B#;8"@ V )E$ $;"(B*(@
MBB(B(EDT]!/Q)3+<B+*9=CR8[P"XR^P\"MNLNMDBB;;K9$#@$BB0JHJBWVJ^
M'+.%3#)*G0)!H7PBC32,HW$J)O'89B]3I)HECDPWB'@4>I5[V!JGYQ86Z]2L
M.Y7!I39=\<02@S)T:C1"%9*(X/UMZ:9-4^*?FR93;BID [1X4-EN-$B,,Q8L
M=D4!IB/';%IEEH$T!MIL1 !3011$3T7W1O;+$'O%_J& _P CJGO^K>A3]IJ)
M]&;XGN<^V6'_ 'BQZ!A>V5']W5OQ/<\]IH'TBZA,ID=W).Q=-CT%O*1"XD#B
MFU4TR\VSC1DI[PDME"H6LM_%5WNC3F?"S7"P]05,4TB1R;?J\QNXJMGY71X3
M;@&*BL.<T2*AIZ-KF%ZFGP.N4Z1!</+G5@W!^#RVQS#=Z'(1J6SQ(F^9"ZVV
MJE#J;6YJ%(GRZ;,:^YDPWSCNY;IJ&8%4"Y&%B31?$T1AUQ0@XJ!W"\M+"MW:
M@K;E*T+D7?B/!:SBJ&+3SR)F0B;/QN&L>QF[NTQ\L.U4DU58,U7)E,=).0MQ
MIHS&55.(G*DTG(=/$88K[KV_J/0DIM9)2(W.^U+^!RW'E)5+>2]V$_527=RP
M6ZWZUAO ,5VSU5?7$-6%+HO0(1.1:8V2\B;DSEEO*.N5RFMEII?ZO#&%\A%$
MF5!MZJJ*H*A1X-YE4+.N@&4-EUIE5_=W&A1"(D%1;;$0 !0  $00 !2PB(I9
M!$41$1$2R(ED^K:Q+%9R4[&D+IAJ(96QK5/W<2IMIJ2*3K2P)YEP*;TQ[A51
M4S^KI-?II[N?1JE#J<0M;;^%("0 G;FV9!D=#D;:D!(J*J+1\0TXL\&M4V'4
MXW$)$+<Q@'D:<4%(4>9SJT\%^!T#!=15.M8:P#$?NU363Q%6&P.X].F(<2E-
M.BGDO18237[%KN:HT261>+ZNA-R&=]2\/*N)JHA@)M$W2W&EA,."? X$FJNP
M6G&BS;R.K_ 0B=NIR:54F4>BR@RE]VV?[F\R7F/,E8VS[%35%%517:;,13;6
M[D*6@JC4R*J\+@^IP?)?:NNZ<NER%0,NLQ\-8ED<?"S2JJ^7E>:W"G.%Y_(8
MTDEX]&G5SY#/[T'HDMEN1&D-DR^P\*&TZT:93 P+0A)-%1=BJE+%R1AR0YPE
MJ;M*=->&-*+F3"KPQI1<]&7EWV0W_O"C4:EA<W5SR9!)X"#$%4WTM];IP-HO
M"%\SSB@RW=QP4VBT6EMY6(Z7<=)$WTN2=M]+D$B)F>=5->P 0&@LVV I]X?<
MY_+,3?V-#^]#&'M0U[IB>,PUA5HT1W$%9=J$E$+BZ#0V1X#%%\AV;48K@*26
M4HBY=054\?B+NA2VDWTY[]CE&(DX@B1MU+JSX:>1)E%#C"0DBH4"2!)8D]"8
MGP\#.^GK!*HT>P9W$J],^&0A9MQ(<HFR@$HZ[F6Z-E15%514LJ:*BZ*BIS14
M]?CH=0B&K4J!*8F1G$O=N1%=%]DT5%1;BX DEE1=-%VHM?B):+6Z53ZM'',A
MJ+-1B-2VP4AT4A%U!)41-473Q>-ZD+@N1V*PY1XA MVUC4( I &VO:+Y0RD9
MN1$\1#HJ=1CUB8QNZWC0FJU)4A5'6J5D)*'%6_9T9QRH<D5#J)-E?=IZ$'%<
M)C-6,%&<MP@1-X_0).0*HT5AS&D,Q8J(9CR,,LSLHYGUZE7O8&J?G%A;KPXD
MG1]W6L;$U4KF/A6:"TA)1F>($41E ;U4X2(76ID7-Q-((^B^Z-[98@]XO]0P
M'^1U3W_5O0I^TU$^C-\3W.?;+#_O%CT#"]LJ/[NK?B>YY[30/I%U"DX6:<)8
MV%:,#CS=^$:I7%"8\N7_ #:U2K$JKY1HB(E\WB(=.A-$_,J$J/"B,#Y3TF4Z
M###0_A..F()\J[8>PK#RJS1*9'ADX"**2)2#O)TNR\EF33D2B_">7T= Q;%:
M0(.,87PE0$!%*U2!9C2] \GI$)RG/YC%%>?Z4YF,D<R^(BSHKBM2H<AF7&='
MRFGX[@O,N)\H. ))^+:@8DBY48KE(I]4$!7-NEF1FWG&%7[N.X1,FBZB8$BZ
MHJ>-Q+A1_*B5JE2(S!DJY6)X(DBFR2MK:+4&8LA4\[=95NBKM(B2FR9DQ7G8
M\AD_+:?8,FG6RUMF Q45^5/$8EP#+>LW4F1Q%1P,[#TV&C<2JM-"JV)Z3"6$
M_841=U3'B*Z)P]9Q17VG-Y3^G+3:.NJ#WII:="AN@BZCTM&BGF*ZH[*<33DG
MU>)NZ#+:XY!#AJC$MOK+2M3JRZ@J.:SCW>UAIP2'6/+;5"OI]75GX[*NU3"I
MCB6!D#,X34,#"JLHJ<60J6[)D;L<V\?BQ^%2053Q%1P?*>S3<(3\\,3-,ZT6
MLD])9$$7C-(M1"H":\0LMOQ&N 5;'K+\N4\$>-%8=DR7W2RMLL, KKSKA+H(
M-MBIFO)$1=L2XK?5S^[%4D/Q6W"4BCTYM=Q3(JYE7]JT]J,QI8?!\(BFB?5U
M#&$IG+.Q?/4(A&*9AHE&-Z,QDNF\#I-1.H&YKD?:9A.:Y0+JKE.F(@/#F<@3
M$&[D.5EL+B=I-'H,AFZ(ZWVBX+;@2:54F59DQSMV[MYNZ[N0P2HF\8>1,S9_
MC$D$Q($ZS'PUB61Q\+-*JKQ>7YK<*:X7G\AC227CT:=7/D,OO0>B2V6Y$:0V
M3+[#PH;3K1IE,# M"$DT5%V.J4L7)&')#G"6INTITUX8TDM5)@E7+&DEST8?
M7?9#?^\")2:5'*5.FN(TPT-D^4C,UL+;38(3CKAJ@-@)&2V3883&1^I2<CM6
MJ.6Q2I HMFPOQ#$C9S",VMM%-TTWKKGWB]SG\LQ-_8T/[T,8>U#7NF)XQVE
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MH4.J-6LJ*10'W]W=%RN[LTL0HJ-OLN \R\ .LO-&+C3K3@H3;C;@JHFV8JA
M8JHD*HJ*J+U:C8*BNY9.*)O3:B(GKWHHQMN VZ*>9*J;D5QM577O>ZEE[/J\
M+X8R$46;4FWJHHV3)2("%.JBYEX1(H4=YIE5YON- B$1()"VV(@ "@  (@@
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M_::B?1F]1QA[4->Z8GBZ;&L2#3\&TMG5;H3CU3K<LG!]5P?:;5%[6K\OO&P
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M*;:C2718PO5I)\-*E/.+EI$MS*J][Y;SEH;[A(%/>7<FJ0G1*'U:H4FH-(_
MJD*73IK*\GHDU@XTEI?D<9=,%_'M7\*3T+?4:H/1@=(5'I4-;.P)HH0AP3(3
MC$D%RHF5W3J4'$F&YSD"J0',S;@\33[1?7HDMGR9$.0/ ^P>AIJF5P0,>E1<
MD#$, &QKU!)S,[$=+3I46_%(ID@K[A^V9LO@\C*\/'UM1+=U/%D^.9T2@H?/
M7=C4*H0*AQ::T=_N7YQMG&BJ-GY$:?B"OSGJC5:D^4B5)>6ZJJZ VV/DM1V
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M-45%3DJ+JBIL(PZ_-)H>3$TAJ#.7[D0FH_NQ^1I6[=BIL(U>BP)R)H3D)YZ
MZOX2BXDUHB^04:%>7#SV!)J5*DFNAK(B])8%?P7()R'2'Y5C@M[\-M53H.(:
M4\9<FEF-,2%__-I"M/\ _P"CV0A5%14145%NBHO)47M1>Q>WQ:D2H(BBD1$M
MA$4U555=$1$U55Y<UV7IN(:?G1/K,1Q:@]?[E6H*2" E[-YD]:J@Z[$%#H\V
M>?)'Y[C<!B_80MM]*?='\$TBESY:*H0H<LH'2G198@T)HH[SCCJY&VQDYG9Z
MF2K:P21%56^5-+=]JN23L3S 59$DRWZ0!=\N-'<*^\>+E*EWNYJTTNYS$_\
M?!W.?RS$W]C0^HX'_C+^>&(/1Q^TU$^C-ZCC#VH:]TQ/'_LDI<;>8CP:#\X$
M;!-_/H:IGJD+A'>.G%$$J,0%)<JLRV605V:M^I XV9 X!(8&"J)@8K<3 DU$
MA75%35%U3:+A_NE)*KE(#P3&)64W]<@CH@#46B(>^\8.U]%&I-AG)>^);MI&
M*SAZJ0JQ2Y*>"F07A>:S612:<MQLOMYD1V.\+;[)<+K8%IUIV3*>:C1V&R=?
MD/N RRRT"*1N.NN*(-M@*7(R)!%+JJI;:31.YJ,>OU5,[+N(Y D5"A%904J>
MW<#J[[9<0/<%,N@&)5%I2:VDUO$53EU>JS%19$V:XKCI(*90;!- :8:'@9CL
MBVPPVB-M-@"(/U3,F,ZY'DQW6WX[[)DV\R\T:.-/-. J$VXV8B8&*H0$B$BW
M38</8@?:9QQ2(PH]=1;3$,%H4'OK&'1.FA;^ZL4$00,AEQT2.\;,3JM7PY5V
M4>IU9@2($H+"I(#X**.M9D5 D1SR/QG+7:?:;='B%-JUA:KMJ$ZC3G8I$H$
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M185J=$U6ZHP^ FOEB7+9Z=W.:^,H.(TH.(E%F1HET;B5B.VD=XC6XMMS8L,
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M'<MK!9$1$\15O\ST#W>'CZ][ U3\XL+=<PE[,T'W7%]'=T;VRQ![Q?ZA@/\
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M_=S7GI-__LS/<?S,I\O9MNX<2-$;Y9(S#3 63LRM"*?[/Y/_ /_$ "X0 0$
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MP @@YI"3]W"4@")2?TP@6[OYU[,_/OAF[8+^8B>7*"DJUOK9DZWI/'?G-?\
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MH48IL= $=W:9;NHO[NH@#\/H*G9$42K&83K,GPY]F:R9,W]YKZR=9D>DR=$
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MM1"C=^"?#GV9K(]89/'^;$GM2V.TEY&S]$)_BE5 %$ \_.0X@34W;6)G?/\
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MH72(@<W0R1YY=Y*YRJ)^T'E^&& GLMDW3'=L@CSO> TD$3>/N&UPZ0=MP7]
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MVTE@_"XX=&A<VG)8VIT+Z.UW*CQ;*S%?[YO)\""K2 SF34'[,SF/'Q"!HTF
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M/#L!7<UB=I !$R%905#:FUM7S=N^UALTO:B*>RSTQ"!H<1!,W(O(1;O4A8Q
MN(B!E#Z&*IK!ET#S3X8"4$\!5_,=,SB/##KOPB^5TF1\$,G@AD\297/)DVE1
M;?;G$01,)?&W82(0;](0)?J9) %$(;^\E:BFI?((@REPR.?9D^,F3XS?WFLG
M29.LR/69/!,V992?REN8FS]!D<UT \?[7N>3]H!]I,=XH&TQ:.LHP/\ >\,
M$(X8W&_1#4,F)L-.:C:(,5 "N#6-^0CFP%*/**_L\.L(#$LNM -HB>X0QO=W
MU.@CPRO^Z>' ^2W,VN@Z/51KNOEU"F6QH.;]-SM()1I#M/VO2X.@<#"!#&B
M)6(_PJ?N7\((-+<,V5YA!7G8OBHD(S"RV6:1CDY>\<N*>**([@.% RUOS$L
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MLO#;NL8')HB(JF;L+%:HJ8!TN@ >=B^FIDW<8=C-?FALM/[)XQQ#&B (G *
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M$_ DABQ0)_/(/]IF-E06&9O/LR9.L,G@F3I,G6&1S[,GPXF3-_>:R89V ^(
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MV"HGD7RXM\=,4C<>1V>3,X'G!ID17DR4W7$,2"*7:.]2(/UA-^RG9:9T9+$
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MF=IV#U_VB/)PX9$VG7"AR3KD@)2>>:0Z3D?.[RFH^S2/Z< ](UKBGBO/<7E
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M?B>&H>F+Y!6IP.PI[P4S7\%EUH M$3W"'JM"UDT(LS5UE3EW-T4\01*MZ'5
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M9'K,G6=/LR?&1ZPR>"9'I,G69'MGV9/AQ,F;^\U]9'I,F3I,CG&"P&P4*[F
MXJ)&0FAX 1.R+&_3=1W\XW14I.UH!]N")$B1(D2)$B1(D2)$B1(D2)$B1(D2
M)$B1(D2)$B1(D2)$B1(D2)$C8EK8)J(&2E@B^L&+^I6Y- 7J8M7S]#+Z%RY1
M=6_;5%>2SI5B@(1P#R@4T//M2J;SE-:$!.T>T.,K?NYQ ^.B6@_;"=YA"!L+
M2C&8B_M+[&.(8T0 JP[*>>1&AY<./)+>-R)_=Y^W;4>X]5X)K,@$RQ7/+CRF
MZL5F#H V;EY*\]KQ( ;;8DI,'GD:3P'RG"!0YG!Z5HD1]<!V03K+C)AHOM+P
MXC:CSXP5 %5@&U7@#>]Z,>2/9S.Z2 -WS /PDX%TT'(0V,,2KH(R"'/"7\AL
M]W[I"!J"'[GI =H$+:+U1F@E#%$R%905#:FUM7QI-P(2/[+H* ,$O4G1\W:A
M<3GUL FR:$6*Q=>5"SE6>< (BO\ J]6@ICT-]SK,G69O[S6?AD>J,7DG@_T+
M_DS])$OS!\,I->Y %$#EK 8=Y$AL!&AX-42?&?9D')UF1[9]F3X<G69.LZ??
M1.L,G6=$Z3(]89'/LR?&)^,GQF_O-9.DR8VF*5+V7:.\*7 _\9>=RM84\ZO[
M2CK" P'PE 3* A!-H-I^ABB:%R4MIR^8'DGG'R-7RA)YTI8V\^@U(FC=\7&L
M,T/LX^E4O@@@L6(*;]L'6YH_=J4(=M+ ?M)C'$,:( X%2N#>P5=XW<^3KFX2
M)!=P*@M>Y6D2*=M^%L38!Y"C@^<!:HZ+1SYXT"*YMGI/%=ACY!Z:6IBZ$E!$
M$V9KO[D6U\#'I,8>FW4B-R].%&%\AM=< !*&RX+%YP(OVSP%7Y&*E4,&P5 3
M+JF*55,$B&I#UXV:])0T+7P@G#<HEUUY"9P9IAHW;PBH<KZ\]GYH +LQ=>1#
MKGU\[((E6]'JP$G6&/0^SK/ F;^\TY^&3JGZQ?WU_P!#GY,_25(P\;!,C*(4
M4IO./OG[M[N,(;%-V],G@GQGV9!R/6&1S[,GPY.LR/69O-9,G69.LR9.DR/6
M&;S[,GPXF3XS[,=MX;2'!&\^HBXU("X6 QFN2_M0LD=80&?_ )@^.(U[Z_T,
ML7(R8W<F[VQ;M!Y!+VL "2$5 (2IOT#HZ78U-8Z20]H/+!D@+<*D856H7VLZ
M8NMP5;-_]21_:28QQ#&B ++=IJP-1"\K!W3T$F!I"HI:$CW$M>&(*F&U"**Z
M'R7X18-^CQ=DA;1Y[GCU.-B.*" @<@R83_9>AT?&\C[3$1' 'HTOU;FOV 15
MX'* ##QM>Q_L_59/D()F;,6PZ\YH8+:-Z^ +8*L;\!\D]M&2R!;X$W7H]0E@
MHVQ'YHL Q8AS[^OX=)LE^0TEGFNB1S$!(7L XJ\-"+,Q=>1#C0)T\1$2O^KU
M9(F3K.B)GV=89.LS?WD'\=,>J?K%_>?Z ?WZ2,)7!!$01(CL1Y$Q..>6I:M%
MJ0%PDFNL,9E5)U"6_1:9.LS^?]\^S(9'K#-Y]F3X\$R/@W]YK)DZS)UF3K,C
MUF;S7UG9C8C5&F^3$>RDW9PC8'%/X99_:@=80&-U"KPH:N%3\OZ&<4X.&3X5
MY#Y>T7Q& '"P#D]"1!,$/+$E?'9;[0$@;0-L[M%AP" 4]L.I+'=*@(Y6]6E+
M]I!C'$,:( A<Y@H)3*DNI.Z>4C=D="GMCXM >Y;_ .UV4D_!/)"OJR"^<CT!
M--NK-DUWT/6U#R,0L<F\2=J %S :_8!$7E<(*/1;:.6R:*T\19/Q@V"H&9-0
MQ2*I@EM!L.N-P B ><!AWCE^L#YNIY _%N(TL/\ 33WZ,TJE[%[ F58\@@-(
MC4=@N:*D&9#C]E&+MQELTROL*@CQ-B%6<[:N#[F<[\((E?\ @^K/4R>"8XCG
MV=89.L^,WWR'3.O^@@\D?I,LX+"*5*810&N?K,.W"C:H9PZ+\I8:\HYF/G-"
M#I#K,CUF;_\ <^S)\9'K,WFOK)\>"9'P;S7UD\$R/6&3P)DLVBN;G&X8 !X3
MU-FL:=^B9A:0    0#0!P!^^ ZP@,L30,V;4B&[5IK+ 'Z "'&#0( U8H[@P
MA$'VPZ:D389YH(!H _:[&.(8T0 P;L=+;K0+OG3^Y8I+<5Q:4.'O8K7D6-7
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M.3(^"&3PG_AD3/\ &3I,G29/SGV9#'__  3\B?I6IXZQ.<I W\A/@QQ:1QY
MHM^6<&FOWN&5S^,<;X9D>L,WFN^3)UF;S7UDZS)DZSI!R>!G-=H(1=K)"*B(
M.* R*P,PD:+;.7H1N0"9/I.7?M<.L(#)[JVT0D=D4.Q>_P"AN8+X5T@0X6"G
M<$/&%W2!6N""4Q;>A(JIG8KIY+<:XQ'L[#BQS'#DTX: K^YYT'C'$,:(!\6$
MZ.6DB M4*^4CII2&UW^0;[E%IBY&XY;5?@AV]41[N"5PU-!&GR.!/WA.J8CQ
MF3N#%^,/RL%>8"M#T"E!]./-;)0=N'D;W =E)GX(TIEAK]@$0>!P  ]#J@Z?
MZ;<O:">1--:C6,5J2IW&H,N'XE?*#9'"/H*:P=R6O!R^HOD;$W:TC>W28M E
MP$8   ! "  0#CV76RYM"*,ETT3EVAW)8B(BO3/7V^SDS63)T3P0R>$XWG^,
MG29'I,GQG^@"4@?I8\8(V-O#+;G:\(#DRV&J!K@[\B @:&?]^H^GJ1'COQ3)
MUF;^\UWUD\$S?WFOK)UGA3'/E2Z0BVJ<LI<3V]ZY:SQZ6 \AF[M>3FN\ 0YC
M 0G*V,#"PH 0"!^V ZP@,4<@C0:(P\$A8U/Z%%RXADJH9&*3_)RG'8D-$P#4
M C4./0$L"+ET]P[C,>T'H>B03)P$(%0I+^Z'#H/&.(8T0 DT$^4J'<;]QAY1
MB.P52D%KL!NB0(>XWT'P. H_(KNGDD"%S2)CC14BMV)]!OZ1Q2ZD -%2Z>3;
MWLP::YL<;%5] -.C/4A'5>#'Y%9J).4K4Z) MX]$YPJWQH.2Q2)(\C@L\D,%
M "N_0<"#6P9$L)P>X&\A6I<#H&NFX"_/LYHH\^A%&=NY$,^[3G;2D2O5JMPB
M_&5VWFSDS63)DR>"9.LQZ&_O/\9.DR=/]!D) _3!PP)VY%3H<Y?D,+6U=:"*
M00&#8*4,R(BDA<D4%I&H R=JH?\ )@>XC^/!.B=9F_O-?63P3XS?WFLG58_)
MOAK8HU/=\+P#(V;41JI(<ACL9@9I\:J@RN#G6<B0[9ODJC%6E?VR'6$!G'0W
MAN_0X!A.P!;]"U4.^@JUB7=WPH/((<"G!2D1A]4/T L6S&]]PKV )?[1 6QV
MM"G$V2I@);]T!T'C'$,:(!QF@+6CH]2&PQZ]5!OTI2Y*1FT\GNI@+#IKN"LQ
M[DB]NQA>Z!)'.9*/)<L7K_"\AWVJX>BXQD:C: IA@A-7C+DQ51&A. (-NWGC
M #-K>I2:3QWO32U<72DHJJNWQ_WW>4B_'H1@2INY"TP29[!OHG0$S_OTDP0+
M-I=Y$MPH0?(N%J]:C3C!H>?GB,", JX#>Y7#>AD@;XC%7E=L%55OC)+=@B3H
M5?H0J&/3RBKZ9$PA+O+[1HIL^A%&8["(9]R:=P@$2OQYK,Y\97(OQE'#<OR9
M#MDR9/#,G6=#C?WFOK)U?ZR,J!^FCQPEIV3-77XI8^9([5RE-(B./L!O ?BU
MKS]*A<% V%44:'UO$YRH,6$><0+U4N2N@T.JZ6M&RH20@(;$Y'I,F3K,WFLG
M05YG*5G$4@J4;)C5,!.+,M6.\3P\+=, -@J'MR+:# J H?AP4P=RHV;+DJ*X
M>0-CN"^!  :L(QX*/V '[;#K" QDQ43L>OZ2'?H'?P<IT:R*]A@]V#APX<.'
M#APX<.'#APX<.'#APX<.'#APX<.'#APX<.'#APX<.'#APX<.'#APX<.,?+YH
M4MHA6WOR80W87&/!EJ'T% 6**2FD-"0RJ@]G4C4%"YXBI40(?NB@Z#QCB&-$
M ['G N-D8T1J'R8M8+-T/R"V"]1GN+4;D5T#FVGF\<07]^1P+OV6^''DHDCQ
M ,Y!*Z*NKT7ZL#MP&@%>D,WD'MNI*S])/L,;R*MH!$M/86Q[/G&_0A"F(>(V
M*&^1D:1-8.-TV:&T?2+D9(KL%T:Y=GWD?G[G,(9$,EBHB?YT"J+7\Y*<2ELH
M/$IE<$C>1()]9YB.-RKI0;2]IU4F70BC,W8F&'<M\ Q"(J7'JR5,ADS[R+C6
M0_/_ '_<9?G(9')XDR/68]#?WFLF?ZJ,2!^GKUBYF3W9Y[A[ZWA#7-4'1CS\
M?"Q 26CH!88*1P!H+DRM@INDC<_"SMVU&JU-H8V!O.&IG".^L8ND@B)PB*W:
MQ9CH8XR2$@\*:;GMLA[HD'4V\:5CGP7-GUBHZNZ%'>Z! (%$ O"E46R[QAO\
M_P"P_;L=80&""5Z1D#> PM/H*4BZ2K\M/:R:>_SOE'JY@"E_H,C>:WCE,Q1%
M:!LO:$=K,ZTY2PV\4U^Z,Z#QCB&-$ WNV=U$X;MD+?)$T=I98J4WB\50P^X/
MQ[)\J0K;[0'\H2(F5!_#J>%U+Z&)D)-O87NJVV<]Q4^0=@U,[5.2MT-RJDT>
M;- 3/^_23! ,=UP>T;;<)AWR$I@DMT-B#2A"/2-*_2+7,-MA3,28:+[2\.(V
M(\>136#NRUX.7U%\V_NJ0A:[Y@8..".(79V(#0B(*\BX:3 SJL"9[6Y#7R)]
M"*,E=;$,VG:REM!$K7HU4:)DR&1R_)G\C(/SE^<GQD<AD\,R=9CT-]\_U29T
M#^"2]9!UA 93C,(S5 +&T,.>>*UN1RY>4 JU3W\)Q*..F_5H:>WT'-I8\VCG
M$;KB?D9IGMU%! XD:6_LQ$>$?,701 @*QL'Y$H7#<KNG]T3H/&.(8T0"2M!"
MUL-J6PK0#R&H/2*Z0%K&U]QB-NY&NQ%,K1!WRHAA$(<N@;:2S;?1ZR6Q0A4:
M4: C\<&Q2%L4+1R Q7F"2HD;_P![YHUY$!254@T<PP^X4"*4I\V!M=Q]PWTI
M#?-AQ<*=@"JKY'$^:PF>K(^:Z_U>CRF1-?QEI^1LQ#0&B088UY6GP0EGOT[&
MC0]LU\R?8A1F.FS#.^>R!(@B5KU>K-TR=(9'/LR'C60?G*9#MDR&3Q(]88X;
M_P# >Z1_!&.L ZP@,=$?JRR0-$8(D8O%5H8Z!Z5I-AUYY9RB^5X)K4$B"B<<
MPDVE*.Q]]KWY@M?E$J?DAL-GH<%18@L$AH.I8GLPU%.HKXH]X!H/W2#H/&.(
M8T0#7$BW!>$.4CR4:D2*[I@<;K2+ML_%[6MH<BY:#[@4<V"!_1M&'"\F 9H'
M $IA\Y%&>D3TU[KE'<DN(\FR!(M %(K94:AYE!B%F8(H1E:=Y".% #!N];F;
MH;TV^G'C2 W*H."3Y _D"2H0$5 @B((W)$)== ^3HLAYC3)1-:6YADFX;Y'
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MK8PT0O9']H[.-$KP'&W[IG0>,<0QH@"0N8BT.4::5QO)JDWX$2N%7E8UFOV
M1%Y7""CVX9I6M@$<J:NH*4\F3MVW&48&$@;]+OQQM2>D^\G227D+>:@W:JUJ
MMT?*W+S2 .4*J@WD0#X&6^Q@F/&)O49V$"@L$#5@1+E1%$1&(Z1.1-;UL\BE
M4O:O:!RK'E$!E:<H^%0J&R7R.I9 C@"M\U1M@A]RZ/\ 2;**,[T&(9]R7=@
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M_0X;E<U+W(;4_?8M8P4K*"43\(NKJY95/"E/:.MB'H6,J8JC34--F$]A-?L
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M%8 1Z=HM/3($8W@;$!\)Q W?+RTI^(#AZ+MJ5  00WN6B8 :<W:$"[#Z-*0
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M1*7*!J<I MHR(4/($->.OWXEPW #?#<^(22]UCM@A68SNU4#=2]1>2GCE"6
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MAK$ ?BP^Z!BC'+ZR(ED9-#T8<L'.3#5$QJ-/I?[@ =80&,HFHX>Z.)M%IZ,
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MS25I!Z%9$('WY_#IX>EV?NEN&41S_,+L"54/M9HC/QS9ER&)?C_\<GY_O_\
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MZV\@9$-"(ZH=J+$$=.,LTE80>Q61" Z1>M2!=:GYT?/D.G\<,-N&M>K^@(D
MES[.O*D=#L,IY*WS% ++OKMI,CB'+[.5R]'\/]9/S_?_ .YQSKP3)TO1IR>+
M_6^!?O>J$&<H])@4IQUT+D9#N_M9@2# H!8GX2>&&3PS(^%'J"90"H8 VE #
M:Z,,M^,C0U=5H7\G]QXZP@,1>(R@1 ]7S1=DF1%<G:I:VIS^=AQ]$.  $ )
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MP2LET]3+!\IE"HM5S\,CU1EY)X4>M^<B_&+[;R3QHH5*LT\H  6 :F00
M @ : .#]T1UA 8G95K8DD_\ V!G(0C[B"&HK(L+G</,4:@,T@?;QQN7I:NQ
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MJU@3XR)[/8@!^C+-@P@+9 JV7JCI5M^\'OUP=!XQQ#&B 1,'+%E,[#"-3M%
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M\ID^,F/=US B_9$94N"AY-$BF2(0 ?ZCUYZ*1/!Z7*D=;L,_G_(878B5(/\
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M +\*<K9#7)QZ!S1+ALK26EH;R1O#EPU!%'P* $X>G.B%XCY^ 450'0<>#H!
M  ! T:_JJTG5NR"/>)I[C*"K2F/?^]J]X3:0?+>H\]F;<1X-GS7L_FY":FS:
MTQC1]47OMRB[XO%O1S[ZTVMG ZC2A6:H@\Q_:0";%$<^CZ%7QG$TR1XG56K!
M[Q*?>XD=_P"S&E&3ND3:@>R'?>G-#L$[L4V>22MAJ,E;[^<@H1P\* CN8,5B
M1KQ[$NA#F@@PNWZ(010&X4)4#",CN64<#+[\ANR "@H .M )<  T.W]/_P#_
MV@ , P$  @ #    $                   %,D'[4\$SE
M                            ?%&:MLM:J0
M
M
M
M
M
M                                                   ,@&FFR /Q
MMV_OT0                                    $.(        !Z.P
M
M
M
M
M
M
M      !6R< :@$V !\,'^%3\                                 !Y
M             3P
M
M
M
M
M
M                      "!:+#R +P PP >!G]Q6\
M             !S1@              #A0
M
M
M
M
M
M                                      .4X!#98?$!4 &D 3@,U.B:
M                              4R#AL               7
M
M
M
M
M
M                                                      /*"2G
M;1)1< ?@&B@ < W!N(                           !2@ "2<!@
M       !BP
M
M
M
M
M
M          !@ 08"4P#*(#:&;D TP 2 'X"4
M !+0PP  00,              !U@
M
M
M
M
M
M                          !T::*"!02R ;1#9114$VT0"!@X&:
M                  '000&&  ""!@,             R
M
M
M
M
M
M                                           !F2"910:*2F039(;,
M[:@FV" 0<'L                       .P0  "  P "20,!@
M ,>
M
M
M
M
M                                                           /
MR 0P0***:12D0"*"3!G; $T 0"#A@                      &F$"" "0
MV  00,!L           #0
M
M
M
M
M
M                6"" "F 00+##842 1038)Y0 F@2 ![X
M       DP$&T@00 2 &  2"#@-@          L
M
M
M
M
M
M                                *"8 0@@42" !88#"BP; "8!)J*DT
MR0 /                   'S02 $PD"" "  P "0!\!L         )P
M
M
M
M
M
M                                                 B$'1 "@$2PB
M3**3 8&5" #3 +!!4 FP!V                 !T9!0"0 F"@"0"0 V  0
M>!L         F
M
M
M
M
M
M     +00 &K "F@B&&01;2+20RA11;8>< 8@&F*0                % 0#
M"* 0 $T4 2 0 &  ""#P,        !P
M
M
M
M
M
M                      N" (  N( 6TD0PR"#013" E#*+)#X@+P T@
M            !720" 830""$FF@" 2 &P  00<-@       *
M
M
M
M
M
M                                      '0"000" %0 2P$R D0+*""
M80$X!#9*3F#\ "@              #$$#0"0!"8  0@BP"0"0 V   "3@,
M     P
M
M
M
M
M                                                       ?>""2
M""20&K "6&B &@!90 " 0F 91(;<Q8@Z              #80@J2"0 "2" 2
MD$2 0 00&   ""!@     !0
M
M
M
M
M
M           )#(*\02  20 S; 0 404P"#000 "48"+(#**:JP
M  !8P+"&%1 2" :10"4@F 2 "" PP  00,!@   '@
M
M
M
M
M
M                           !<+:9(D "0 02"V9(" 7J2B0:**#104R"
M;)#9G;<            $[.F,800C 2003 * 0CZ4"   0&&  "2!L,  !4
M
M
M
M
M
M                                            ,@\A;"+< "  "  6
MJ%)P!FD="#9132*2B01029(QP           V )9P!B "D120""!0R@ "B'R
M0 2  P ""!L!@ &
M
M
M
M
M
M $0"E59 ;5@    2EP      !LL""+8:1"D0"*"+!6          &P@  )*
M] "4("0E@       ,?B "0 V "00<!L @
M
M
M
M
M
M                  9B  4J9()8N  2L          -R 00+# 842#0 3-P
M         TG.$ 8!/0&@ 6 30          ]@0 0 &  2"#@,J
M
M
M
M
M
M                                  -S1>2"2]3*!), ,
M '*$"1188# RP0 ;<         *-FOTB#0,Z#B!60           !-P2 2
MP " 1\%@
M
M
M
M
M                                                   ""+*#P02'
M(P0+>              #^PR3+:102&5"*+         +_A@_PG2*)F T0
M          ! @"0"  P  00?0
M
M
M
M
M
M        4* 98"N" 0Z'6                /2&"01:"*20BI1:
M!0#P,_N**91(                -$T 0 0 V  "">
M
M
M
M
M
M                         "(;0## 40""(L                 BF0$B
M#9002" G!         ! "<!GYU;1P                 ,D6@2 2 &P  $
M
M
M
M
M
M                                         #9 )!:"8+#L &
M            "@$P T1+* (0"4X         &4 #@&8,HP
M    X@B0" "  P
M
M
M
M
M                                                          *9
M+ !:(2113YP                  !D&"B"& 18 "( =0         6F "0
M_P @                  !XI!, $ $$!AX
M
M
M
M                  Q]FG5(      #@   (
M
M                6@4R2 "D04BQ@                   #\$($$%,@TD4
M$"S@        #)MH@$#(                    0@A -H$@ @@#@
M
M
M
M                                <O@     5W     "@   4
M
M                                 &TP"V6$"4DB,
M      <F @$ @LD$RB@E8         )!-L$%                      *@
M$(!A @ $&@
M
M
M                                                -4        #V
M@   "@   4
M                                                  .D2F"R6P@4
M#@                     #L2@ $D I@D&40\@         4,)KX
M               6"T$A!,($$!
M
M
M
M    .L          "S@  "@   4
M
M      "$&0F0262F&.@                      <L8V $$ %, @@6T
M     &R@!                       6& 4$@(-I @D
M
M
M
M                    !\            !   "@   4
M
M                       !T4DP$B"VRBD                       #@
MEADP HA L@$ +         !"R<                        \D2&@D )AH
M8
M
M
M                                     -             =@  "@
M4
M                                         @4BBF$@44T
M                >D$,.B % (EADUT         ."(
M       4$@R6@$ !,(                             .VVVVVVVV
M                  #VVVVVVVVD
M
M                                                     #<
M        8   "@   4
M                                                         5N@
M2@$2P@&]                         !L @@-6 %-!$,,_@        %"
M                        /D @&$4 @@+
M                                   "@       (
M
M
M          #@      27     <   "@   4
M
M              145X"D B0D$                          )D 0 #<0
MMA,AJ<         D                         !FD@$ 0F@$&@
M                                                    "@
M (
M
M                           ,     -!8 ; 0 #    "@   4
M
M                                !@B/ 4 "%8
M        #8@@@$ *B %@)D=@                                  "\
M(6@$@"DP"@
M         "@       (
M
M                                           !8    %8     ;<!@
M   "@   4
M                                                ;KBL$C9V@#
M                          8DD$$D@-6 $L-&0
M                4@!4D$@  DT
M                          "@       (
M
M
M     !@       >6    "@   4
M
M     U;M<5@'U.F                            # @D  $@!FV @ @
M                                 06$,*@ D$ @
M                                           "@       (
M
M
M                  @   -         (    "@   4
M
M                     "Q>SI$BB@4 @
M :H $  @D%LRP$#4                                  "L8P@A& D@
MD
M"@       (
M
M       !)))))))<                  4    $              "@   4
M
M                                      !DPK4= C48L
M                  #.X $  $  M"& R
M       !3@#$ % BD\
M                 "@       (
M
M                        4                          4   #<
M           "@   4
M                                                       #H$#U
M;'H$:H                              =6K     D E@&R@
M                        # 34!Z $H0X
M                                  "@       (
M
M                                         4
M            "@              "@   4
M
M            "%= @<C8=$P                              #,2Q<
M@ D@DL,T@                                 @P">@-  L4
M                                                   "@
M(
M                                                          4
M                         0   !@              "@   4
M
M                             " $?KD-(O#<
M           >T 6< $$ D$$AAD                                #)
M$" 9T/$ <
M        "@       (
M
M               4                         !    -
M  "@   4
M                                               " $#I<QA%8
M                            #M@@4'SDD$$@$$-
M               !OA&D43<!H
M                         "@       (
M
M                                4                         "@
M   <               "@   4
M
M    D@0DB5+CN@                                ?T.D"R^<$@@@"
M(                                =_<44RB>IY
M                                          "@       (
M
M                                                 4
M               #    (               "@   4
M
M                    !I@@V$$4I<
M   #D @44FT7D@D$$5@                               4#/3JF"V3B
M@                                                          "
M@       (
M
M      4                         "    (               "@   4
M
M                                     !Y=!@&PD6@@
M                     :  %B"DT'\@$@@,
M       <G (P9>@TQ@
M                "@       (
M
M                       4                         "@   4
M          "@   4
M                                                      #DEKME
M PDA                                  "@D@A,4T@BO$$@3
M                        8 $ !V#7T$@
M                                 "@       (
M
M                                        4
M      "@   4               "@   4
M
M           "=XD/=)HR&                                   5@D$
M$IB6F05 @G\                              1M$ @X. :]
M                                                  "@       (
M
M                                                         4
M                       "@   4               "@   4
M
M                            #@7/$A?()G@
M             "#$@@@I(6@BE $Y                              $)
MM@@$'!X8
M       "@       (
M
M              4                         "@   4
M "@   4
M                                             " D"Y<@+L-8
M                               53P$$ I=64$58"8
M              "6AA- $  X
M                        "@       (
M
M                               4                         "@
M  4               "@   4
M
M  !>0DDC+<K=4                                   "D&8 @ %>NR
M6KU@                           !"644)I$@ T
M                                         "@       (
M
M                                                4
M              "@   4               "@   4
M
M                   #T'3TDD];I0
M      4 BT7D @O4P 23@                           "F >0"I--D$
M                                                          "@
M       (                    OY_C[
M       )#_K/                                       )0<@
M     4                         "@   4               "@   4
M
M                                    !T4 #>$$FKX
M                       "VDFPJ\$$EVD$ $
M     "@FP X0U )H
M               "@       (                 *G1     \$<
M                     +_<@   !/;P     /\ _P#_ /\ _P#^@    !__
M /\ _P#_ /\ 0     $^6W             %
M  H   %                H   %
M
M       94QH /T((.                                     !(H!%E
M,X()#J=)!                           5%%MAY %X"
M                                              H       "
M           T7         !%8                         HK
M '.            %             H    SO         "
M        %          0   %                H   %
M    "%6:@#@^(5              @   %                     #%KH
M                   P   J)9*F-! ^I!0
M            AA- ,,!Q ((1 H                          #"4 ALD/
MB K
M   H       "              &YX            'B
M     "2(           &\H          %             H   68
M  "                      %    H                    H     H
M %                  _8        & (                "
M          $,  K                     P   0\@2(9PI)&IP
M                             %(D%H)AD*P!! +1
M         !A!3@,HDI.!
M                    H       "             %7               "
MO                    "7               ?          %
M   H  L8           "                      %    H
M        H     H   %                 G            V-
M  =   #                    !   &H                   '(    '(
MU"93>$I'"                                      A $(A!-%/0()!
M*8                        #(,!*8!E$!P
M                                     H       "             Y
M                 "$                   ;                !&
M      %             H !0            "                      %
M    H                    H     H   %               #Y
M       'R              !X                   \    ]
M         "   '8 P!&!; ;YD*
M    %@H M$%(HIQ!)(O                        <%!  +9 ,LP
M                                                      H
M  "            \@                   H                 \(
M             #0        %             H 2             "
M                %    H                    H     H   %
M       '_                !H         %    X
M H    !                   '   ! !%&:$P3"*5O
M                      @DE E(@A%%^()&X
M!(HH-%)3()X
M           H       "                                 V
M           X                   2        %             H$H
M          "                      %    H                    H
M     H   %              2                  RX        %X   ^
M                 #X                        P   ' "O#0Y8Z"09%
M0                                       @EL(% )$ !CP(^
M                !@(%%%-(I2,@
M                            H       "           4
M          !T               [                    #8       %
M           H'              "                      %    H
M                H     H   %             #
M U         @   %                        #H
MH   X  0@X9_+N9++O                                       ;ED
MIA@H!,@(LP#X                     '!3 ((%AA$*
M                                             H       "
M    D                       %(             #X
M      J       %             N(              "
M       %    H                    H     H   %            '8
M       #0         %.        ?   $                         0
M                'P      #(+D".R=8+1
M              !HMLA%,M  M!!FY                     H(0*(!  L,
M
M  H       "         !H                        F
MP                              %             &
M "                      %    (         '          (     H
M%            >       C.:P"=!@       "(       "   "X
M        1      H                 "   'P  &[9",@0I3BL
M                                8%%-% LE((E(-KH
M       @!0")80)E%O
M                   H       "         Q
M   %            "                               %
M  X               "                      %          H   %
M             H   %           '8      8X       Y       Q
M  "    P                 (      =                 &   &   $0
M'_(;[)]#4Q                                       !)!HIAH!DHI
M$H(4                   [5H!301##(,(
M                                    H       "         H
M                     0           5
M     %                             "                      %
M         H   %                H   %           ;     '&
M    8P     $(      #P   8                &8      %
M       W        I+ [@+')&8?8
M       M) ,M,-!,E$(H!@                  0 ?$ (:2(89H
M                                                     H
M "        &X          %<M89P          Z          #0
M                      %                             "
M               %          H   %                H   %
M  '@     /            7P     H       (   +                %
M      #P                (   >   &Q%$)#?!7;/K
M                        %<@H!EE@I(@(@M!                 #0!
M"8 );29 H
M          H       "        :         !0X    "B          X
M      7            *>UHD               %
M         !MMMMMMI       'MMMMMMMO          H   %
M    H   %          W     _8             ?     &       (   #
M               $   #    0                X   X    P!)HH)?X&@
M(_                                        K%L$)LLD$I@ D!@
M             2!!((#5@!+!4
M                           H       "       #@        !7
M  ">         P         H          '_      (;P            !0
M                   #Y:0^          !0
M *   !0               *   !0        !     !F               P
M    !R      (@  !P               /0  !B   "               !P
M   6    -&H "302_P #<&
M  & "D""RV"F2T 4H              #M@D  DDAFR C\
M                                              "@       (
M   ,        #,         'T       #,        %          1@
M  ;(            4                  #R>               4
M                   "@   4               "@   4         (
M#$               "$     (      $   #               "@  !/
M!,               $   ,     (%,D$ 2,)\ ](
M                   "$0"4&P6F 6R2 4@             .Q, $@ @D$,P
M2@                                      !
M   !        (      "H       !Z@          ?@       ?@       8
M         "@         6H           4                 #]
M          4                         "@   4               "@
M  4        #H    1@                2@    $      =@  "@
M        #   #@    ,              #0         0V5I, D"XA7@A
M                                     ".B@4 V"TP"VV&D@
M    !J$6X $  $  L4@
M                             (      "        /@           #X
M       !       !D        "8           <@          4
M       !M@                 4                         "@   4
M              "@   4        !    !\                 "8    %@
M     "   #,              <   :!(   (              !@  #H
M " B"X)D D5 OL<                                        ,,$46
M@&$2F2R4Q/          !/*R@BK  @  D!
M                                              (      )@
M !\             .       #H      #@        !            !0
M       4                *@                  4
M          "@   4               "@   4        >@   "
M          -    !@     #    8              4   < $   $@
M           !       *4 0',B  3(%^@
M            2-!@2B$&0D0262E6@        Z@I4R0"U<  @ D
M
M   (      $       9              #X              .@        0
M             )          4               !0
M 4                         "@   4               "@   4
M  0    <                   #D   !X     "0   8             "8
M     ,    @             (   #       7@P@REY@ D"ML4
M                             "1C:D"T6DP$BBVBB$D     \R\D$%ZF
M4"28 $$W
M                    (     "4       (               '@      0
M      4        +@             !\         4               )
M                  4                         "@   4
M     "@   4       !T   #8                    ,    (      4
M /                 "8 #@  "4             0   +       "OT""B4
MY,$@DU(                                        1ALYL 4"BV$@T
M4TT#]/<7OD65'@@DN$@@47SB@
M                                     (     #        8
M        "@      '@    #(       #T               -@        4
M             #L                    4
M "@   4               "@   4       "    "
M  %    )      ,    @            !           <             4
M  0        <C[$TTV7IB$ 2(
M    #?!."O 2@$2T@&FF&@F2BD4 RRG<$ AT.DBR\@
M                                                      (
M#@                       !(       @    #@
M               4                                    4
M                  "@   4               "@   4       /    9
M                    @   "@     !   #@            +@  !@ #,
M              !X  "<        =SCCD@FFRIA@@!@
M                      :+8-41X"D 20D RVP4$0$0V@&& X@$$ H44%
M
M           (     ?@      =                 <      !      @
M     >@                T        4              /@
M         4                         "@   4               "@
M 4       ,    $                     !4   !      !@  #8
M      $   /   (   )@           #@  !          B#<9( "T"P-($X
M                                       #S]<!@B/"4 "V"@V66"4R
M 2"T$PV%8 @ %C@
M                            (     0       $
M8@     !X    #@       ,                          4
M    8                     4                         "@   4
M             "@   4           #X                          !\
M     #,   4            <   4   0                )
M   /40*CY$DRD45I$                                        ?3=
MKBL C9V@ 4@0F&P026 "T0DBBGL$$@M
M                                             (     (       H
M                 #       ,    ?@      !T                 9
M      4             !H                     4
M         "@   4               "@   4      "(   !
M           ,    $      (   )@          !@  !D   3@  #
M     ,   )@         "-B@A5G\@&@BB-\
M              "CV;MD5@"YND 2DV"RP"F00 4B"D46X@FX
M
M  (     (      !@                  @      <    ,       "@
M              !@       4              @
M4                         "@   4               "@   4      !
M                            (    (      8   "@           @
M"     @  ",               $           "Z,@FH/+$"0&R,
M                                %1>CI$BB@>-T0"@&@6F 6R2@2DT0
M@"_"@
M                   (    #       "@                 !@      (
M            #@                 "@       4             #
M                 4                         "@   4
M    "@   4      #    $                            ,      ?
M             9   "    #D   $          !4   0           #4'-D
M$T!ZD@0$V\                                       #L^K4] C$8E
MALB@4 V"4P62V$"@$B !8
M                                    (     @      "
M        !@      $    4       (                  !0       4
M           >@                     4
M"@   4               "@   4      !@   <
M  "@   "      "@  ",              :         *          !   #
MX            /OFT8@FAO:@FD#
M       3D#E;'HD:C!-L&46@R$2"2R4PP4 F2@
M                                                     (    "
M       __P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#Y      !    &
M   '                   &       %             $
M        %                          H   %                H
M%       @   !                        (    X      P   "
M    &   '     $    8              H              %>DCY M"3]!
MD&                                        %T(').'1&P&&3(%HI!
M@)$%MD )EHN                                             '_\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ \        @    "
M                             ,    P       0
M  0      !0                                   !0
M             *   !0               *   !0      .    0
M               ,    "      !P             "   ,P    !\
M        R   <             !Z",[:QQ32&.J!*
M                     %.N0TBX-R,@W<* +113"0**:*!:F
M                                                         *
M      @    ,                                  &            @
M                   @      !0             @
M   !0                         *   !0               *   !0
M   ,                             @   (      !@   <         "
M   &      .   ,@         P  !@              (300K1C_ "BC,?8\
M                                        #RM<UI%X[$8)@MT"4"B6
M$ T4PR
M               "@       (    !
M    "            (                   4       4             $
M                      4                         "@   4
M         "@   4      (    0                        $   "@
M   ,@  "@        5@  "      #@   (        #X   ,
M   6"F@'V7G^6T<?8@                                       !RB
M5+CM,+G9;!*BO 4@$2$@&4H
M                                "@       (    !@
M                     #@  !@       8                   ,
M  4             $                      4
M     "@   4               "@   4      (    8
M        8    @      #   #T        4   9       4            !
M@  !,               "0@$TC^F\1R0+CT
M                6D4)(9A@6[+@-41X"@ 2045
M                                                 "@       (
M                                      "@  #@       (
M           (       4             (                      4
M                      "@   4               "@   4      4
M0                            "@      "@   ,        8
M   4   &        "    @                $P@@VD<DR:"B!5
M                                 #+D6A)G"M6;]<5@D7.T "J
M
M      "@       (                                       "@  #
M@       8                   8       4             ,
M             4                         "@   4
M"@   4      4    $                            "@      "8   ,
M       "L   <       .@  "        +   #@                "+N$$
M&T3A$FL40$                                          '$B%) ,1
MJK=KBL VIT^@
M                       "@       (    !@
M            "@           <                           4
M       4                      4                         "@
M 4               "@   4      <                             <
M   #@       $   :       "   "T           !X       8   .
M             )0>  $V"*LPQ@#
M         "9D$0] %B+V9(D44*7
M                                        "@       (    !
M                             !@   0       8
M  (       4             4                      4
M             "@   4               "@   4      ,    ,
M                4   !        (   #       !    @       #@   <
M       (                      #8:#P0$VD4UBZ P
M                            0V@"+H F1;CI'!D
M                                                         "@
M      (     @                                 "    0       $
M                   4       4             4
M    4                         "@   4               "@   4
M   =@   (                        ,   !        #@  !       $@
M  ?        "L          "$  !X                   > B B"$&D"U\
MVO@                                           !'% E= @>_IC
M
M              "@       (    "@      !)))))))))))))))))))))))
M)))+@   ,       <                   4       4             4
M                     4                         "@   4
M        "@   4      #                            !,   !
M       #X          0         ,   9      "   #
M     !] ' $20@T@BKR(
M      68M4[\
M                               "@       (    !        @
M                         0       0                   <
M 4             4                      4
M    "@   4               "@   4      !@   0
M      #    #@       #<   (     "@   ,         (   #      1
M                       !<P$J @2D6D$5W
M
M                                                "@       (
M  !@                                      $       7
M         !\       4             4                      4
M                     "@   4               "@   4      #    (
M                        @   #         0   <     !@  !8
M   !   !@     ,   )@                    !-#* V G"4&D AD
M
M
M     "@       (    !4      #(                              0
M        @                 #        4             4
M            4                         "@   4               "
M@   4      !@   #                       #@   <         8
M     #    @         !@  #L     (   $                      ;!
MD"2&,$>4@TT%@
M
M                      "@       (     <       8
M                <       !                  !        4
M      4                      4                         "@
M4               "@   4      #@   !@                      #
M  8         5   "@    +@  $@         #H   $    !<   <
M               #HALD0450CPD"FD
M
M                                       "@       (     $
M  8                              )       !L
M-@       4             4                      4
M            "@   4               "@   4      !<   "@
M               @   <          @  #(        (           <   ;
M@   "   #                        8$D($B:B"#^$$$
M
M                                                        "@
M     (     4       #@                             "        $
M                 $        4             4
M   4                         "@   4               "@   4
M   (   #T                      0    <         #@   ,    ,
M(           3   !@   "@  !                        #:T$!@#ZT(
M080@T
M
M             "@       (     -        X
M       "        9@               !T        4             4
M                    4                         "@   4
M       "@   4       <    <                      ,    T
M    <        <  !,           #@  "@   +@  ?
M        &+P $HD\6A2#L"@
M
M                              "@       (              (
M                         <       !                4
M4             4                      4
M   "@   4               "@   4       <@   ,
M    !@   !@          8   ?       #@           "   #L       8
M                          4H&$@(,#B@C0>0
M
M                                               "@       (
M  !@       ?                 "<           ,        ,
M                 4             4                      4
M                    "@   4               "@   4       !@   7
M@                    "    "           2@      '@  !
M   !4   8  "\   <                          ;&D<@$AE#]4$0%
M
M
M    "@       (     "<       !                 6S@          (
M        (@             #0         4             4
M           4                         "@   4               "@
M   4            #                     '    ,           "   !
M   ,   &@                   #@  "8
M!800(P  @(=($^                                   =@
M
M                     "@       (      (        +@
M  !H"@          +         $             +          4
M     4                      4                         "@   4
M               "@   4       #0    ,                   !,
M,           !@  "(  0   0             ,   %@ "    @
M                  0DDBCT$@$-GB &
M     "H,O@        #
M                                      "@       (      1@
M   "<              ?@             @        +@           #\
M        4             4                      4
M           "@   4               "@   4        $    )@
M                 H           #,   $ #L  "T             ;
M@ =   ;@                           #L; &T;JD@A(=0,
M                      &R%</L8    ":3
M                                                       "@
M    (      !         <\            (H  ?          #D
M"X@         !&@          4             4
M  4                         "@   4               "@   4
M   =@    $                  =@   "             <   /     #@
M            "@  #D     4                             :; X 6:
M<4$@) +@                              #0!N$F(*X*SDL4P
M
M            "@       (      "(         *(          5\   #(
M        $          D         /@           4             4
M                   4                         "@   4
M      "@   4              4                 !H    6
M    /   "@!@  #              #L   $ (   0
M          !B84;DR#PF $-DL                              +#N O
MAD0A@B LK@
M                             "@       (       =          0L
M       /4     0@         -@         9       #X             4
M             4                      4
M  "@   4               "@   4        "\    "
M .@    D             "@    ;   :@              0    !L  "H
M                            3A#A>X&D9^P@AA
M           !<4D-\%]L^@D"P8
M                                              "@       (
M   !           1T:@   *<T      #H         !H          " #  #
MM9              4             4                      4
M                   "@   4               "@   4         =
M 7@              !X     @             "@  !,$   4
M    0   5    "                               !>!0'SW T"/VD@8
M                            "@F"@E_@: B) ?@
M
M   "@       (                     ".B!-          ;
M              TW@@               4             4
M          4                         "@   4               "@
M  4         "     "<              5     =@             !<
M3H   L               ;   "7@  !@
M   +X8N@;"$2 ->@"                           !5J@ $T@O\C1D34
M
M                    "@       (        )
M       X         /@                               4
M    4                      4                         "@   4
M              "@   4          0     1@            *X     ,
M             8   "@  #@                @  !\   /@
M                     5?2:$@^0FD%\PL
M >0%-D$ 2,)\$Y<
M                                     "@       (        "L
M                                  #\
M       4             4                      4
M          "@   4               "@   4          '@    #;@
M      +      5@               ,   7                    !X
MP   4                                 &=+Z!0DF, 0TKF
M                 !X$V5I @D"\ =@H
M                                                      "@
M   (         <@                         #<          =@
M                        4             4
M 4                         "@   4               "@   4
M     T      @4        88     "@                '@      )@
M             ,      "0                                 #TKCG
M (D'"@"" $                        ! B@""-)D $U L
M
M           "@       (         #D                         9@
M         "L                      :       4             4
M                  4                         "@   4
M     "@   4           +@      ,M@    72,      4
M    "       0                 8      #@
M             <]'=649& N<DD3@                       !'T&4 P/L
M@@ 3!@
M                            "@       (          +@
M             #\            '@                    !H       4
M            4                      4
M "@   4               "@   4           #X       "M'@+*(
M  #,                 !D      ,                 7      "
M                              #$UK[HAC7WGL8$X
M       #<!IJ@PDREY@ &8
M                                             "@       (
M     #E@                      /@            #X
M      ;@       4             4                      4
M                  "@   4               "@   4            2D
M                   ,@                         P
M    "@     )@                                   !P$%?O#L8J<8
M;!@                     'RBE,?4"BB2Y$;
M
M  "@       (           #4                     %D
M  .H                  #4        4             4
M         4                         "@   4               "@
M 4             !                   'L                   8
M  "                  #@     <
M     "(V@#+]6!S%S>!4                    "'N^6T83X$4PV4
M
M                   "@       (            *T
M  #T                8@                 )@        4
M   4                      4                         "@   4
M             "@   4             !,@                !L
M             ;@    '                  "T     0
M                       3A.H@)?H9B3N8:@                   #<V
M\?RP3B+D@FG@
M                                    "@       (             <
MP                 !'@                ![                88
M      4             4                      4
M         "@   4               "@   4              #C
M       ##@                          0
M !X                                     #6(-]$A7!1L0=#X
M             #*D=$SZ"R#<>(',
M                                                     "@
M  (              <X                4@                  #C@
M           ?D          4             4
M4                         "@   4               "@   4
M        !P              4@                     #X    <
M             (@   /@                                      6,
M5!WH&+D2_2!V                  :$&TCE NL40*CR@
M
M          "@       (               3*              +
M             !O4           (L           4             4
M                 4                         "@   4
M    "@   4                #W@          "U@
M     ?   !@                   #\  !@
M                5I+<BE 5\A;Z08                 &  DV"JND\"BA
M0
M                           "@       (                #&V@
M     'VL                        (=        !UH            4
M           4                      4
M"@   4               "@   4                  >X       &EX
M                      !AN<\                     8>AE@
M                                 .%A+BD58F\D)_3@
M   +Z#P0$6D4UBZ,B@
M             ;__ /\ _P#_ /\ P                      -_P#_ /\
M_P#_ /\ P                  %U]@DA$_".@
M     (H8G(./S8P      -__ /\ _P#_ /@     ?_\ _P#_ /\ _P#0
M                  /_ /\ _P#_ /\ Z                  W_P#_ /@
M              !?_P#_ .0                   !JK0DHZ'@
M                   !D                        -
M                             /#1@QW2*8(N5UQP              *:
M"("((0:2+7S<P
M
M
M
M
M
M                                               C!8\$GR0)!4CN
M"              F.D2? 0!"#23:\
M
M
M
M
M
M
M    #/Z*7@.001**U^P            /2$SQ "@2!*1:>
M
M
M
M
M
M
M                      8#R!!Z0P""I2>F0          *5200D.(#8"0)
M0R
M
M
M
M
M
M                                       #  <18=2&$ ;"#@
M   !U-.* 0$@% ; 1T0
M
M
M
M
M
M                                                         8
M/B*#2&0@!4N(        QR9!Z3 "&R!-1(<
M
M
M
M
M
M
M              #   !R;!("T$&ZP8     !BPN<#2,_800@2)A@
M
M
M
M
M
M
M                                8    .?282&$@[_J@  6U0H"=[@:
M#'[00&!0
M
M
M
M
M
M                                                 #     !AJ!2
MTPB#0@71Q/\ 3%T#80F0%KP #P
M
M
M
M
M
M
M        &       !T2,I%4BJ$7DA.Z+0$'R$T@L&'
M
M
M
M
M
M
M                          P       CNB'!CZ$<0R\KI?0(GD1@"&'4
M
M
M
M
M
M
M                                           &        $=BUX,/D
M@&"+E<<X!&@Y4$1
M
M
M
M
M
M
M P         _P4O)5@DB47XYJRA$T%P<
M
M
M
M
M
M
M                  &          'D6GTBH$-:&M?= (:^W@
M
M
M
M
M
M
M                                    P           \DP:D/0 J$#+
M]Z=C$
M
M
M
M
M
M                                                     &
M      ?D6&\ABEFT 9?JY@
M
M
M
M
M
M
M          #$            #DBB4MI(-U$!(@
M
M
M
M
M
M
M                            $              <^PPD/!![HE
M
M
M
M
M
M
M                                              4
M #GT&@ABH,4
M
M
M
M
M
M
M   /<                NB5MI'@
M
M
M
M
M
M
M                     9@                =00Z
M
M
M
M
M
M
M                                       *@                CR(
M
M
M
M
M
M
M                                                         C@
M              #@
M
M
M
M
M
M
M              !Y              9T
M
M
M
M
M
M
M                                 /            -H
M
M
M
M
M
M
M                                                  "YF@
M #D@
M
M
M
M
M
M
M         #(2(^VH&H$
M
M
M
M
M
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M2X2O"P*U0Y7- D/-U% F0_;%ZZ008F4F+MV8/8$L6C(A*\X;1V)J?\I-H;B
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M\\AEL,! 9$$JC8?$F'>W'B073$@U$8/$" H<+#F,EG\I2E%#\C..6((0J?\
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M4P%_^:<=V)(ZD5A Q,V.(-"0P6VUPW812VN@NL<;4(UY/GI4=1._G>C8>_\
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MI0B(3! 0OT?LX!0(L"@1$$2&53]CF )6P$[3<S,V,K1<9NP%* @\-H$&UPA
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M_ 6L\?)H+FW?^4(X9^DIABAZW[4%W<??WCZBF&A:G2@.O)LS]13&N:-LZ?-
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M[>OU$8>6E&V=/FA'#_Y&;^/O[S0=;=Z'4>90];]J&UCCY'WF ]M0NY19(4B
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MMM2X+:2603?\ Z5X.,Z)[[^#@)3;(7,D][)I%B"IXQ D=.62G<"0LL#1JUQ
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MO\]ZB+ DC'@1- D&A04(Z^0%BD"+@2"I'X8B!0-0#(A"(@B(B21%"" LXAE
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MI%&V=/FMH\X-&V=//:@.O7ST^D*02/)$%6]XT!2 4(P*2"JEVP@A .F"'\(
M"EE!(B72A$1$DB!HP BP(@9 $%PMDB9]4IA2AZP]GSE07=Q]_>/K+F;[:&9O
MZ^<J"[O2I'#-"F&C;.GS0CAQ0IAH>M_7VHQOR?Z_-3J M=V\$ >GN39I 2T1
M7*I$LD'Z36D5YI&0*P.Q*0D6 ?\ '?*!5BUP)!$1&O6_G6H:CZ^U".'ZC,WH
M.MN]2.&?H*8:&9OV_E":QQM]13#4M0]/>A-8XV^/_(&L\;_-'C 9F>PXJ>#)
M;_\ *YH] KP$ :K@:V%[5EY2$P!@-( "TH&I436.-OCZB->30=2//-M&SR?#
M1M'3V^:#HQBV/][T/6_K[>E!T8[4/6_;SI07=Q\]8HAA_M&V=//:@.&'H^<*
M"UGCY-!<V[_RA:/1M[4+4Z4!UCC:@M9X^34@.TF@2YGBP[5S2Z87F(EYO/8S
ML&#]*%UB\(8W0D@;),$;N&"J)+HSK +B8"FTH9SR3V?>@.O)\]/H*8:X+>=>
MU":QQM\4(UY/GI4=1._G>C8>_P#*'K?M0FL<;?%!:SQ\F@ZV[T;#T?7YH9F_
M;^4-KU\]:$:\GSTHVSI\UM7+X:&9OV_E#:QQ\BA&&33SV:AJ/K[4/1\YT;1T
M]OFC B286@"6D0$!40%" :DB*I; 2HA(.F"_X0 %+*"1$NE"(B))$#1$ D66
M!;8"(< FUE26QX/^T%W<?(^LIABI:AZ>]!=W'R/K*84KA/FZ*"YL^:_01K1M
MG3YJ#S1>*D@A#91QSH2A$0@ M%(I!#-3],3B*I!"!$;@$Q5065)<VA(G1#A!
M'T$:SQO07-N_\H1P_24PQ0];]J"[N/O[Q]13#0M3I0'7K;SK]13#1M'3V^:$
MUZV^L?XK+0TC"03 (25=+RE )"#&$99?_*V;EW;->\(V!<,FLF1Z,XMG_.U&
MT=/;YHV>3X:'K>A-8XV^/J%K/'R:#K;OYTH>C.+9_P [4;1T]OFC9Y/AH>I/
MGFR@Z,<XH>L/9\Y4-K''R*%,.:-HZ>?V@.&_1\X4,S>@ZV[TBA=>QD\VW(RY
MF@AOU?:7!/66L'Z<[*EH R!A+PP8!:"@/8!#&,!R &'2'J3O\^*#1C<X]O[1
MMG3YH#A^@IAHVCI[?- <- :\F_SWH.LG?SI1L.^)_E"U.E <,/1\X4%K/'R:
M"YMW_E&P]&:%J=*"ZQ&VU"->3YZ5'43OYWHV'O\ RA:G2A-8XV^* UGC?YH.
MMO3SR:-"&1@P()(6X" 1@48%Z2!*%L J2$8$F"_X0(E/HH9$+I0B(B21 T0
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M )04W+M95M$S:$1EY9H32-[":MTN:H0NR:,6QRMLQB2\9C,?<[(^R8>'J?\
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M@,!H:WVK=UF[^O#LI!02(7F?<2+D'!ZP$F88 D(7LC$*",-&T=//[6P9W/\
M)_E1U$[^=Z$<)_>GU$8Z-'$;Q\_M;P>.??K0=9._G2I'"/T$;^,O]H+FW?\
ME#L>C4M0]/>@N[CY%#-9XWH.MN]&P]'U^:'K?M0VL<?(H#6>-_FH:CZ^U19!
M(@N VZF!&!%DK0*19F_18L5D@287_"0 D04 9$+I7$B(T 0P $/@ @=8-H5
MEBXH'63OYTJ1PC0IA?-U&V=/F@.O)\]/IH89$!R&<NV7A^O%%C?< B%AB2):
M'++C5BH$H7(-@E#*"6H>GO07=Q\BN% :SQO07-N_\^@IAH9F_;^4-K''R/\
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M7KYZ5KT#:B38B528F7?WP@11&0T_I#?28!:6Z #.!>X=D^%0U'U]J'HCQO\
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M#U/T&+J!JMA;3&J@EB4-NB8L"[72(2#;I*HZBE6)O!!PV;@T/Y'YPC>6@FY
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M:;GY>%!T8YQ0]8>SYRH.U'?;N6H2!1&1" ,) P% 0&\C5YP0L1A-BP"+LO\
MCZ*  EP!LB.F1$A)$I(:C,1,HA)5:[\&$U&UCCY%#VB;[]R]!UD[^=*'HSBV
M?\[4;9T^: X?J/6'L^<J#P?-?\H>T3??N7H.LG?SI0]&<6S_ )VHVSI1L/+X
MHVCI[?- =>OGI0&L\;U#4?7VHV'?9]3WH9F_;^4-K''R*$:SQO4-1]?:C8>7
MQ6UOJZ7EW-R(,02(E&])YWZNV<GZV%$#=+XMU&BFPI$J(L,I * "Q ! 6TDM
M07=Q]_>*$8;=:-HZ>WS1L/1O0];]J"[N/O[Q0C#;K1MG3YH&C_&AF;\<]?\
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MZ! 8@T^Z/4YL](G;$@;]L6C#:P;[%QF;V.PJ^"Q&@ [)")WKNW_?OI9I!F0
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M[M0MF69+_:$O/CMY+:Q-^$U@@Q&NO%X6W& F_P"@'KYX-7%++D,<3-]8G-X
M'VW#"P,2SKHQBVO,6Z,7Z=,_YG:9?O&96LYW+%]+('%9Q;[ P%E+\;B\V_"/
MT""&W2U@N\+P(M&K[ D%]][H7M.L%M,;%I;Z7>G#KZ&M&\[>DEG2ZD)VK>?L
M*$=F0F^W;DRZ7MB6TQ>\[T<//3 &X_0. UEG&D(8XLCIAF?_ &<IL7](R1F&
M-SB/N):3L6HF78$.)'4>90]8?7SE0VL<?(JZ*)+X3N=&D+ [RSO8PKG2]&!)
MJ>Y8G&K;39&)DDWZVM"QMBM7$ZF.G^T2V/9\Y5O?&^?[RH&_@P:XQVI.B,:W
M'I_E"(E'%G/4[W:,9TVD]\T!]RYYUK>=X?>H;0];S_>]2F1Y7]GM0ZCS*&9O
MQSU_VL-XQFY_;;<4)NO>R.ES9I6Y#MBSF\BYZ5+E;^)P8\;C$Y/_ ,CWX.&D
M+(.31'-[;#JE"%T@)U5F%G1&M-HZ>WS0'7KYZ?49OX^>LT%S9W^_O0]HF^_<
MO0=9._G2AZ,XMG_.U&T=/;YK8OG!H>M^U!T8=]OCE0]8>SYRH;7KY%<*"UZ^
M30=;=_.E#T9YS0=2//-M&SR?#1MG2A->MOK&1$9$9$+)$!U&3251(EJRX[2]
M):\.%#^:"0KH1IKT+JV(WQ!($S%T<Z#$N_;AF5-HZ>?VN9V?.7.@N[TJ1PS0
MC7D^>E&T=//[6\'CGW]:"YMZ><OJ!K/&_P U#4?7VHV'?9_E#UOV\Z4;"FYQ
M[4;9T^:$<-#L>E#UOV\Z4;"FYQ[4;9T^: Z\GST^DPKRQFY(F\>$3:2A^_>9
MN_!"V!]#?Y/#CONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ON
MQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ON
MQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ON
MQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[5ONQ[4I'
M?9L7O)?CPQQ_!\S=]\[7!>9CR6 FRYTE26TL3LTMF(MKC&A^"$L%W<;N7FV@
M&88<DW@M$SE+&AA<[QO>=O>;ZQ$61O\ C))$HT9P3,&;3=&U[1:$,7-$Y6=B
M#$8V2,OX#ANPI.6TX<"20O:DB;<>_'7.EUV_@O@U:7L>R(D9T;?AHS$&]P;M
MZ[+R39H#"Z<#P+P);:Z2"!^(.+WMK_FRD96<SQVG*[9O? %9811V\->TZ,0Q
M^/F\/Z?I0X6"TN.N)<@78D$7"B96&9#7$72,*FQ#3TV!!T+3R^?T67AZ'X&G
M@L_2]D?9,/#U/T/9'V3#P]3\/:M@E>$;\KIB\$TI+TW&(G<6WWWS]DD@BQ*F
M(]_<+1%!%C%X%UVVVVFVRQ$?I&Q&3)MVN+Q>;& 6/MH2+R%I=.UR8-8V!]Y[
M-FTYMVF>,.!E$4;(HF\<=?L/(\&-;/-M&X=OZ!2QX&;ZW-[R; )_]BR[6#E=
M]3O]!*Q)S09,Z#+M0W?94C:79XBZ%I V2_/O(&K%,53&"T6+#!JEW?+K]CB+
M<[8P'$NS-Q,6^X%9SP!%I *(B!U&EK.#LH- UA%5 3:CG9ZXH#$NS-S_ #;B
MAV,3S/3^.MZ&9A[>=*$UCC:L@3=ITQVK0FVI[-IG>&ZKL)%KON'9>YSJW>=?
MFH=TQBYYUJ7?$8L^=*,;\G^OS0+9RQ$>G\J4B+[QC^_W;0C*<[-;WK<Z_P"4
M#GJ7/[5N3B)Z-<]EF]K^2O+-2ZCQ+GOVH=CT?:AZP]GSE6]XC[OF[-2Q#8EV
MMPP7$O\ D0DZ"C 2$'(X1S>VQ.%Z;E#W34$OA(TQ'#/S0C#1MG3YH#A]^F?I
M*88H>M^WG2@\'S7_ "AZ,G7O\T'6W?SI0]&>]!U(\\VUM'G!J6H>GO0=&'I\
M/>AZD]J$UCC;X^@S?Q\]9H.MN_G2AZ,]Z#K;T]_6AZ,XMG_.U&T=/;YH#A]^
MF:'9QM:YTA,D;=2:@Y; "88B^P6;AB;@4R]X3?M"XS9$$97\IR=I=RZV3*>@
M6LV3X,W=4+2IF8Q W5(X1H1AY>?RC;.GS6P9W/MGI1Q'!_RC?'L^<J"YL^:_
M01CHT<1P?\HWQ[/G*@N;<??_ "I'#/T$;^,O]H+FW?\ E&P]_P"4/6^\]?(K
M8/)\]*-LZ?- <-"F%H9GJ9\Z5K()8PE-1DFR F:& 14553*KF5;LYOM?W_F;
MO^0>9N^^>.9QLMI.&9G6(DM^ "MKS=F"(+JW@-77T L)WKQP;#D+E$1^4BU[
M[ESY:+YALWJ D,HG*-R&QG(X<P9#\!2#J7<-/2(XG3\!8E=,:7T+]]$!;%=Y
M\E\0'\.2[P$$M^V]UQ<)+: !@,'#WRZK^0ZD":GFS=>&VQ@N7()VZ+V.3$,Z
M./QLWA_3]&$P%UT\Z[.]!U9<;CBF8W,"1*$5SVZ1R"V]L1E((/TN7AZ'X&G@
ML_2]D?9,/#U/T/9'V3#P]3\-\V7&+(3E@E8C-_M 4!E^;NP E6+7;7H((.*N
MKM>%X+1S5_2#U\\&D@3&IZH-%7$AN(/M"$=1RSSG<WG;+6;FL)*[Y&"+8G:;
MOO"Y9"0F\(<SDAG:Z?84#IK&89&)PQ.=;W*2^EGKPZ>CI^=,$[">>#-\I.OV
M0@#8!SRQSGD_3CWP[O-M"%/6&["Q,63K;'V+6$@PSDN1F9N.:=?SU@7(XI&[
M243#?2/L$D,2QG&V3-J479H#D((-,$=/NH4"T9WPPR# 2H'GQ\V7"1(920:3
MW'O/*@M^U4]L]:EW]GVZ4%UVY_K\^U#L8[FOP8:F9!Q<3^>EJ$UCC:L(@V9.
MC)48'.2="W/FHT"=EY>3#S-]<Z>+LU\UHAM.YYRK5S&IGI_E;T<6;/FFNZ@.
MJ/&3O)V.-2D1?>,?W^[:+]KT?.7.C&_)_K\T%S;N5 QV1_I4)K/'W/9J8S[G
M^<8H4N-!LVLN@;=]:2_Y'_.@HP$A!R.$<WML / +HB'NK4)%X>-8#6>-Z#K;
MOYTJ1PS0C7KYZ4;1T]OFA'#]!3#'Q0]8>SYRH.U'?;N6H?$\U_V@ZV[^=*'H
MR=>_S0=;=_.E$+C_ 'J4;9T^:'1C=Y9:'K??AW^6H36.-JE,,4/6_;SI0>#Y
MK_E#VB;[]R]!UD[^=*71D\Z=J-NW"BKW:0;!-L0FP0$J##4$1;,U+!.V3MD1
M>6$"01N(B6%Q,FD[OQ@K'5T-^W<ZVL4:%A&F$\(AXMK3O!USK,&C+%YW$O<H
M#6>/D]*+KR>=:W@^OOUH+FWIYR^@C#1MG3YH>B/&_P T<1Z=O:B6Q]?CI0VL
M<?(^@&L\;U!M'=CSK1+8^OQTH;6./D?4+6>/DT%S;O\ RA:/1M[4;1T\_M;!
MY/\ /CG5IL"9=Q=;N>;KNEG)%!>2QL[RZ!386?\  >9N_P"0>9N^\L2B02S)
M)H'%08XN*599SG2[,VYO72?P E )=F)YZ&JJ$3<H (-TNU-EBUL9<N8/RRSM
MG(XCAKZFC8*@5,:3$CF$PZQ8&+0S^ <)L;.9A?X@P7<:L??5P:9X_!!?#)^'
M!<;$-(;RSD=#7*2)_*QYD;1P=9LEFTUF0(=-F\UCC.^<_C9O#^GZ(4HL&7,>
MZQ8-Z "D1)AJN<LW8X1;>N?ILO#T/P-/!9^E[(^R8>'J?H>R/LF'AZGX4Q*X
M,3-V+&^\6V"S)9NMY5Z[7AQCV^R07LQ=C6=ZV7?!</T_ER1-9F.47PEIJ!MA
MPO1-DFNZ& ?M.W4<2(;Y-5T@N_>$HV0[[3-W%I9U@,L/V%(.H"G=LUQJU,?G
M8A/-%XL1&^[B:3'_ +(RP$IQT7S>)W"Z?^#8V&&+9UO,K";(C9?_ -RB7QB.
MW>^W;>I)(F]]I>9+Y!$G"EF/SG<V+MM6'.<1PEVOV#=V+%]N7?:W.3[[DYCI
MX*)'H"@96T VQK']O4*)0C=)GHO2(UF='4(;)O=QHKP$CL,84SFYYRH9_5?S
MWWUO1V:/G+G0VL<;=7'>A3#'I_:(Q)S$]*$<FEFW+3L\Z@HLMFY!U0X7[41#
M6R3',F8.<YC% @A6&S97A9#.C:_'G=_GK1'5.YYRK_5=L_VB>H]GSE0+0RV,
MIZP;L<*$8<ZGGNWK>CLO#YRK>\GW^>5!<VX^_P#E0,=D?Z5?CQMW#^<ZM0MG
M;(89("]<Z/\ D6= #P2 J10PC.42:2W2"[@![*6())0-6L<?,\*'4>8T,S?C
MGK_M!<VX^_\ GT UGC?YH.I'GFVA'#])3"E#U)\\V4'1CM0];]O.E!X/FO\
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M8F(Q%OL! $;V<*PS$V2QQWOOB19-*2@)@H6R57&R!5,X"1 2I"!=$>SQB_\
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MJ6G66=^RK-#&;F]L<-'C3:P#:%'\4GOPH6UF\L[W]>52,J+MN?VO$N<R^.=
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MKG:M#];EX>A^!IX+/TO9'V3#P]3]#V1]DP\/4^_.N(%O.0PAD\)^T &+[DZ
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M_0#6>-Z#K;OYTH1P^;ZV>?YYQ^@Q<:'K??KYTH;6./D?49OXYZ^]!<VX^_\
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M(PVZGM4'#I_O]Y5!]!\_G.IS8WW[_-!L)&#=\'6@.'W]Z#?+"XWM0@#-!_\
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MS_>5;V.%S^WH#OVH_P H36^S6_FGU'J#YYI0VL<?(^GC]!&O6YYPH.MO/-M
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M;Y_O*MZFS4\Y<Z YOP\_M <)_:X4*8:'K?MYTH;6./D5%>/T"UGCY-!UMO\
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MQYRK_5=L_P!HGJ/9\Y4%B7B+_?3TS0XAC'#_ #%KT(SV8<WDX\.];5ZV>O\
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M->/)QC&;Z[(_\*!VMFELKF&UG@U(^QI U1?.F9F]XO(-M']V@"7*( -JEP
M)P#  ,"FUP1K5!E>-2R>F>568N,1:0WG4C.-:N:HNV$ZZ;[?('#;</+,<:PW
M'L]/BC&_)_K\UO4V:GG+G4.\1O<;K%SC%((A#OA'5[WUH6"91N!O)@-8AB-U
M"Q#G<9V;-MUW4J()TO#TS\5+K?C[Y_E#&%-S<]/YSH9=X2NV?[RHGJ/9\Y5O
M>OO_ )06M&,8_P ZT!P],ZZ6_E2-9X_WX6H=W<]^E?++^?-2['L^<J&UCCY%
M%_B].P"&XRS6B7>_\ 10;V+R$02HE@%I18GYRVYB6,B3,H$:];GG"C<YCYZT
M#*'L^<O2H4WO?Y2?/"G_ %DZA/4YU<^'^E#UA[/G*L-XQFY_;;<4#3+4N/+3
M=%"W<%GI['.C&_)_K\UL5/']BDJ[2!I&R:2P)9^(,&(BE2P)D)Q"S;EC"DH*
MD%*&!;0PL8H9HJDRDJTEK8&0@)8B@4*W"Z7$:VDBY4A @97,C<W2*<24PV:T
MZ)L"3!(JWM1N,6(4)!N"!LT%6QBU)4PN19!)HQ1/1,R(7N D!NE ]2?/-E)&
MT!'_  C@ RL3,8ME /Y8 8-+5G_1/YF[\%BY^K^N[(_!/,W?@+TA9>CNOJWB
M)LP(?B"!O)E&XSMOEOO@V+0-@=B(V9TUS$"YJ'7TTYZ)KJ7/Q@Q:]M/]VTI*
M6787=YJ&+S<FQ:!:6L.FTG5=J+%D6,Q]@41,[]0M&R$M&Y-U"-\FNYV,98%-
MH$$D/Q1 WDXXNC<#*3&N%C\48 V;-1FSOO:X-XF:(P9VZ.'26VME"9F?Q%,K
M;D3\1&L61!I:($;']75XVFX#^3F\/Z?F9/%]?UV7AZ'X&G@L_2]D?9,/#U/T
M/9'V3#P]3\,".9)2YS-K:X;D,GVY ',0.T,$SDT+6@-#]+($]F>''3ONJ1+R
M)D+X-T;Y6ZS]H2RX,ZXB#GLS QBKK.V_-\T8S^7HRV,QK(NL22RV;OV;I/S>
M+S8SFVEFU^KF&Q&F95G?,AJ@9^P(!BT\VYRB-<SQ?S8)AUDU;.O*9-C!Q1%&
MR*)O''7[ R'"'<GJI"[)3)?ZN\: ;<MWF)*+6Y_8$&EX6'0()-'+#$B,&/WL
M*HB[5*J-Q2,,2\#%&& W37S][883>%.=\=]\41U3N><J RQS7SY:K;$-MGC;
M3ESJZ+QBUQU)L:V*&:,:Q";Y+_VM[TL\S_*WHXLV?--=U&^G&YYRI2$NEEN.
M1-N2&;;,$CR86(\C6A@*VT-^;G>7V<*%B$8N7-[HQU:&Y3'$3K#4SD'?A[6[
M4.(ABUQV&W(H0WM.I"=,6YQLHEL>SYRK>^-\_P!Y4!S)W#SA0'&FI,]/3&M"
M-3"VM^B[\^M&,Z;2>^:_U+G/QH'-^&>G^4&L4=MPD1I$80#]]4%S,:LZ4+\X
M@H4CZ1JWSY**[MQ%"ZQQM4;).&.C)VJYI/"W9>\\OH(PR=:@W=SI_M 8F'9>
M'M?M4+#UL]<=1M4M;<<=2>\5"1V1_I0]0?/-*-,\AZOS0-)X+G&'EMH1LPNK
MD;N]JWO$?=\W9H+FWI1J'I4CD'>6>.SM4+#&[W%JXAZ>U",]2SYTK#><9L_R
M_6C:[W[EZ$\D[>U7$[;1):H J1)0E2>OO@2794!*_P"C'S-WX+%S]7]=V1^"
M>9N_ 6;-Q(WV_IUM>;TD,,=S3-]-=J-@;'XB&MMC<Y:F_*-M1?1J;UNMF+2=
M;7+WLFT9W<3@WOB(G\&.,3F0.$MNNVUX*2VKNL=?81-:6$P,R$ZYEE4MA4-
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M:F>G^5O1Q9L^::[J"P+'''70VXJ<)UGCB.G7A1QYP$41"]UU!83]T#*IOA8
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M;I>]\9UMEOEG?:MX-UQU#AIMO4RLA=5)SA12=[?&*&<(\;/;EI4B)>OO\U:
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MGZ7LC[)AX>I^A[(^R8>'J?F(.9W"[8U-39B]B-1&\T<B3P(==NN']/WGR#Q
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M\8T:L:KMHWPXY6VD"/6U[UX/#9UJ5!*@,Q8X7X6DMF^;;YJ(-UXPORU<^#-
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M,,M$),35OG@V%@KSS%#L>C[4/6'L^<JB WC SLVEPYZ8HU03MN;[AMQ;;>M
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M:-^-_>DN+5!AGS8VH1D1W6HGJ/9\Y4%W>G6EL433B*J&@1TS=-U*(H+>%/\
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M?S3ZV$[9&Y(;$)P!6#.,+P(26 ")KG_TA1 [, (I4BF/T0<8F"A2^T^MJ W
M$#;,[[E[\]-E0M)XKGG+;5A*2;5/+- <-"->3BC0EG-I'B)TS6H1_>3?^6J)
MH8;\Z0QGD+%^-!UMW\Z4.QZ/M0S-^S077;G^OS[59[;SC;Y^@C6>/O0=9._G
M2HV#&_VI+$6ZL]7THLKPDZW<>YQ+7@!1.P0YB0 !U8P@C2*&+'B&,EIEC$OT
MDSB"[.3TF:.@&:15N)AF-'_EL?N/,9-9")V;:,+<*DEO H!4,&RT1.)$P9<
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M_*%H]&WM0C)LN6;>;J&SWL]<>MJ\X>_EJN?#_2AZP]GSE07<[_?SA2 VAO\
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M!L85$TX6:E$,+";_ .I9A&D+"-R(5% )%6%;$W,+736DE,VXJN+%0@014_\
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M&DI4/*RS:_H03HCF"TNI:$4)V7+54D!40<16L0A]3)  #_Y__P#_Q  N$0$
M 0(#!@4% 0$! 0     !$2$Q $%187&!D:'P,+'!T>$0($!0\7!@D(#_V@ (
M 0(! 3\0_31,:)'YF,_0Q2L.)NF!+A-T> J@U9$"\EL*5N-W8@)7A+H.15,Q
MF:D(M2SU&KKJ,1&6%94IE+082$KVN4DI(SE+D-[R4P;"R"J(H*HG668EPX*X
M(@G2HD[46:S.%#.6-*20&&"90P6:X<A^!@H7@J01% 0H&1&*#"Q")%@,U "(
MN('>F(B:$P14[G)G(5HP;"X) TUF$8$BP-$+#Z@F%U((2-F2%4@: 5):W K
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MHBJ@"JQ@TQ)1:"4E1G F4$C0C5)LPN0*P*!B<E^1@$H$X;3&$ U"MH!&3(D
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M4<2)!2I$DY) SB!FLKE*P$R))10)*1+L$%6LP04LP#-^Q#<PZ7G\8@9)M^3
MR]>GI@;.-_<?G3&8B*W0M?5!,DD05/5(;E7(.0!()EL72*P1E(0Y50F4B/\
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M^?M@1L_D'M4P(2"!561#08P.AQ@$SX":\M,F C_S'H4 4*K8JL"4L+0*:2,
M600,HI"B^MDMJ=Z?S$%GYX6Q,N>9YWP)G&^GQ]4&Y.$MJ=?7"&4[J_/CH-S"
M<J7OW[X0RG=7Y\3=BNG+YC$S_$\_JARXG?GA>2.^G?3")<>]N)2RG&?CIB#9
MR_OKPQ%AAV_WRPAE.ZOS]L#<G"<J=>^> 80(B0@P1$1RW2-PQ8=Q2961"2I%
MUCB? ,\%&P8@!!$$_4@H!4@ *JL !55H!5<&7=H%)FC400:")CE[ 8.0" *
M "Q0^JF1Y>6'2\_C")<Q+G7?[WZXHYQOKU#I''"KW-2OB+91N[C"RU>GKX4#
M<G"<J=<+-N[V]IP(SG?7$,Q\_; C9_&,FE@D(*>40() ,8.YEH3>E 3,"84_
M^8P[XVZ0 X10GC,/$\8+^@9C3*%$EAC[G;''WG$-GD^^)ED=Z. -GZH-S",G
MGA1<IL[]/'0;F'2\'W_N%&6O3/\ OBUS\Y]# CPX>?U4RC=3"\H>CWQPB7'
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MC9+TA!?S@3.&4$ "H0 %5@)P9VPD*'69@H2%<9Q5!N'KSPZ7G\847./?K^)
MW)PG*G7"S;N]O:<"['>W$C<C=3HR>6(FS.QH^</!\1!N8ADOG[80RG=7Y\)3
M(\O+#I>?QC>'E[8&7KT],#9QO[CQ@8*TBB)!0C- U-1_Y>:4MP1H(T *(H<>
M*+N!E9B!@( 0 $82[-W<8EDGE[XA+D>.EM3"RU?/[T&X>O/#K<_<Q-[K7J>^
M MZ=?3$C9GZ-1PME&[N,++5Z>N$2YXZF4;J?&%Y5Z=\\(EQ-_B5W[Z=0]..)
M,Z;_ 'MPGZH-P=^$Y,;._G"64[NYQ%>2&)Q"&319+0Q8^"2>U$+9-DO3$%_-
M$1A76E@(5HQ$.5/MH;G'OUPZ7G\847/Q$&YA+:G7UPEE.[N<"EG$C<C=[/HF
M*K(]'KXB#<PZ7G\849>$ARXF)9)Y>^-X>7LX%F<L"9QOI\>&"( $"47"U%$9
M(1&$RJB2B#"4I2DJ+5?_ "Z4KVLC/$"DB"8I)J_ IFD*Y96FHOV)=F[V]HPO
M*'H]\<(EQ-_C0-R<)RIUPLV[O;VG"1]R'+B=^>'6Y^YB;A)WF>N YTZ_8EM3
M"\J],0ER/&@;DX2['9W;EA>5>G?/$)<CPXY]]UQ7OOIU^Q!N'KSP^8:GI!"$
M4R=9@B%!0226J1\J-DOS$%_+E@3)3(@LH,J-FX"$  ! $$06V-FS**REE.,_
M'3!K.7S@#GP>_+[4.7?>N'2\^_;")<>]OXB#<PG*G7"C*=U<"E,G*CYXINW5
MZ+Z\,573KD\GQ$-SCGATO/XPB7/"0Y1NIA9:O3UQO#R]G!K.7S@#9\$^TZ@E
M&(F2UI)$0B( 1)!,H2(&)91D4?\ EP@ &"MP'(/(BI!!W!#H$(BH446JE\$)
MRIU[YX66KY\O[B$N1XR#<G"<J=>^>$LIW=S]Z'+B=^>)E1GIWTPC T35PF92
MS&Q3"P$81%)5$DB(K$JR)@I"&%!,"D@FI1A!4(@P 4KM$*52*AF\,DW3"6U.
MOKA9MW>WM/CH-P=^$Y4Z]\\+RKWM\2-*;3OSQ7?NIYOK]8NR2>EDHB2PRM"<
M:"@DGU +%1LE^8E?R9L*KD2R*Y%('HX80 Q45&@ *&=U95^BF4;J87E#T>^.
M$2XX%+.#6<OG &S]JF4;J87DCOIWTQ"7$X?B(-S$2D2B)4%5 K0K+!",XA).
MQDJ+"9B2T1I$SDJFWS*N3BKL0AJ2*P8)M%YI.(<J[O:_3Q$-S#H>?O\ &$2Y
MX2V4;NXPLM7IZXD9IL^'!K.7S@1L_>VU-C#/;.TI*"*N!$6D 1)K:Q"PT00Q
M_P"6H* 5( "JK  55: 57%D@X&&;J(R+"7!D#<G$=IQPLVFR_+OAB,LYB/ @
M;DX3E3KWSPEE.[N?'0;AA.2F^O?7#))J4039YU(B34!8%=AME<U 24L- "K4
MD:)J0%BM0 0J3 W!3#+.9D=4"@F(4@U4S PE"[V)6:S%8:PH0 8*#@!8,@ (
M-0:#4K]@.75481A!)%&&HI9Q!V)F,F%%#4BS4P$#X1,L1$E3@F52I4?!*!W1
M%'Z-QB"+Y4 !G=DK1BM1G1B""S-(VEDPBDQ6+5 ,'@HD#,HW]#FLV"#QHF\/
M#"<J=>^>$LIW=SXM<X=U'D^^(V40\8&8! "M:$XT%!)/:A%BHV2_,07\=C@0
MZ0 5Y*H5D!0XY,SPL*Z@+JH"L (/M2[-WMA>5>G?/$)<C C/@]^6#6<OG C9
M^U3*-U,+RAZ/?'")<CQ$ Y<RI-35);V-\3U 4JF,R##DE=RE<2EV1 3)9"6X
M01=F1)38 ##*K0LQ "!)9HA,KT\7,412+$2ZO*4O1574$S>"</+YE)!!*5:
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MFST(X(ES[T&YATKQZ=UPHRW1;W\L=]SZ> @W#UYX3DQUPHRXG?G]KQ'#@"5
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MZ%JT+_E-]*=;#MVBZ1%/]:*ZU3+!()N*E85-S\10%4 JJ@ "JY$=,*]!X(W
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M^Y!N8=+S^,7L]M7^<<!;TZ^F!&S/UB:LCU!)X';S,@C J)JDV4W<;)>G9?\
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ML%U_PG-W'G_\1"BZ5OKP<K$D6\'+88]HIEL:;#!3E?;7E/+=G_MS))!!)N"
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M?+?X+Y'?-9K&F*7[Y>G^X4HH>.9T1#E"!)34\!#EQSPA<[GN/+$BSB?WUX8
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M"0PO_ N&@YI*JLJF 23G+CC.GMU,+RAZ/?'")<3?@4LXD;D;O9]$Q59'H]?
M0;F'2\_C"BYQ[]<2EE,5$,)9-9RTC52,K,L2='&24H:22,,%/\)S=QY__$+/
MRVL>U.E KX"!63)W4;S9?*:'^XG["N5@*"RL$2:KJI.(F]=YWZXY+;#O$OR#
MGAV-4>BCZ.*K,G)Y/I/A+91N[C$&S)M]?[C8)Y;>R<"-G$1S0RDRE(0"(@R0
M)_P8>=PE%84 B.QIBG)WP=D (V@!^AJ91NI\87DSOOLK_"V%&2;;F^2VZ^([
M]]./@+91N[C"\D=].^F$2YX>IV.,5+,M#J\9P-2N/486-Q? [/\ P( $16WE
MIDR609$37#I>?QC>'4]L3J,/+$.S&_OUPLM7SY?W$)<C INT:G+%-VZO1?7A
MBJZ=<GD^ @W,.EY_&# 9)-(FJ1+$QK_A.;N//_XA1*;%>CJTOX*VIU,H-\$T
MN930C_<$.7?>N)'D/?IB19Q._7 C9KR?F^(UK>^4Z-SKE%L:*WH()UK'$P['
M$9Z->NW$JQ6.#R?GPDY4=G?E& )F3CT7S-?^%#SN$HK"@$1V-,3V=TRL@!&T
M ?8ZV4;NXPO6;WIA(N1O^.G7P4NS=W&)9)Y>^$2X^#IMCV$L;!:(:^!J7QK*
M6Y.U!V?^#/D-SCWZX=+S^,<">)[8KN#WMGTQ#SC9/O/1PEE.[N?I*US1KBC%
M(U2O1]\0Y5W>U^G^(#\W<>?_ (-J=!UCW>. YT=O?G&)TKNPIE&ZGQB"S.Q\
MNXQ(N&T[]<"-GW[KA!R'?3KEAVM:5'.YSGKAV$W5/1Q"RE=WLU\!QN+F?_#!
M9W"44A04>>)R.ST* ";0A]RJ91NIWYX66KT]>],9Z;\=]U_G@)=F[V]HPO*'
MH]\<(EQ-_P!]?L2-1(6R:+6')@:E\:REN3M0=G]^14K/W>ME&[N,+R1WT[Z8
MN7-=/;$&PWG?KB2S7O6KSPAE.ZOTESKO][]<,LDZ^:8ARKN]K]/L$'H'+_"7
M-W'G_P"#8(*$5(P&"8)B86-L9*#<GYQ')3OGUQ)N";/+L=^ YT=O?G&+[<+9
M<NXQ!LSO[]<;!/+;V3@1M%>?'/"#<PG&F2<]2L[)9PW7+[3F5..(<J[O:_3[
M6I#BT1I @!*)B6%I_P .%G<)12% (COIB?CLZG*,$VA%?@:.4FYOYX6;=U_7
MR>&(X.T[ZQX*79N]O:,.R>/O&(2Y'VZG8:REN [4'@:E\:REN3M0=G]\:&)P
MAU63>-F2AA$-T][(Q5G#NIYH<_3"[E?N2[-W<8EDGE[XG4.%,0;&\OWQQ!E7
M#NOGA1EQ._/Z2YUW^]^N*LTWU\@Q#E7=W.'(62TWF5F=M_\ "<W<>?\ X-LG
MQ*-A8AF8$1%A^Q!N8VB>6SMG$FY.[OTP-GS[C%]N$/QB#9$V^?:[L1S$[Y],
M$-3/3;J>]J[<(;AZ\\<W5R5\\.P[U3F6X\\**W-2I3Z0J*@X28*=)4"27,G_
M (@+.X2BD* 1'?3%B_EH4* 10+7@DY4V/?OA#*=U?O@;DX3E)U[YX6;39?E[
M=,0VSTW^! W)PG*G7OGA9MW>WM/V:_<<I$7-DNC3P-3R,UL+<!VH.8?WJ;2&
MN1!R""FE:80BKI>?QA1<P*67$[()GEWRQ#L\7]]>&%EJFSORG[DNS=[8W3WM
MC$ZG$[Z8@V-Y?OCB#=S_ )Z<<*,N)WYX-<6?!JA5$P2PE6\6/\*S=QY_^#9J
M?+] $@D JH@227W(-S$BX;'OTQ!<G:>?<8$SC?3X^B<J.SORC%-J.OOU<1S$
M>^/3%,GE'\PAF0SM1^7:\L<#OHTVA7EQIAWC?;F4./KBBO)8<#"F R(RG_#A
M9W"44A0"([Z8G_\ ]B< $=0!+Z=!N'KSPZ:;/G"B_/[T&YB.2FN?MA1E-[=,
MK7L&_$/?=]E_ @;@\,)RDZ]\\)93N[GZ:]HPI0MEE<(\'4OC64MR=J#L_NP[
M0&U(5):H+.*:T'THFA0H$%8&-3ZH<N^]<+R1WT[Z81+CWMP*67O9BJ@G;;OI
MB+##M_OEA6_=7[DNS=[>T866KY]\<0>SW.">$K,*I+80Q)V*0?X3F[CS_P#!
ML1[B2M9<$DF+ (P"&YAT//W^,*,N^]?O0W,2+N#_ #TXX@LXG]CJ8 Y\^_+$
M#<G$<E'OCUQ3H.L>[QQ',1[X],;2NYOZ<HVX>M9TI.I4*(%D%@!_Q 6=PE%(
M 2)U%,3_ /\ LS@!-H ^QT&X>O/#I>?QA1EQ._/[T&Y.'2MYAJ=[:X49+NM[
MUX8[V\<N7@(-S"<F.N*[\DXHT6'8.E DX.OY&JH6/-D @_NE$)%(&0*&E2RB
M$RD(<<>^](QP[XQB9_B>?U0[-V%Y([Z=],(EQP*67O9B#9R_OKPQ%AAT?[Y.
M$,IW5^?M@;DX&R5.+@"RMU,UN@?\)S=QY_\ @V&**V3-%,2PH;2@13]FAR[[
MUPZ'G[_&%%S[T.7?>N)'D/?IB19Q/[Z\, ;.$&Y/SB.2G?/KA3Z49S%(*1 B
MF8(?\4"SN$HI "1.HIC+_P#_ "< (V@-^YT.7$[\\.EY_&%%S[T&YA.5-]L*
M+G$K3/MCP:E.M8,%LLTV>8>O9.LI4W#W!3#^Y2:P>J!=;*0U69*T^S<\ZGOU
MC'>OITQ,]QY_53*-U,+RAZ/?'")<C BSB#9R_OKPQ)ZG9ZX47/JXE MB:$K)
M42Q18;G^$YNX\_U0W[HIGY,7;UK#&+S>@S1[Y<-IQI\=*QYSCA3AY3G_ &,Y
M='I[XET>GOB^5OGTGAC@UK9?2EL::K#(EII#:-*:USO&FSC#<OE1B.)_P=+<
M--F73$WAK7;;=O#/<XFMG.L4H3?N,XP$GG6+7TX05RQ+H]/?$NCT]\2Z/3WQ
M_7I:T]T:XG?R<^'/3/%*+E/SIEY8W:4>Y\N?_'L:Q_;[M72^S*\QZ=?-UG%=
MMI)&VOO7+%XIW?..O&DXET>GOBI$B3:N]DO"F5?_ )&*LVJ[$&&TDUL4*,N^
M]?N0Y<3"\F>^],(ES[U,HW4^,069V/EW&)%PVG?KA"=>!49%;E"54EDO_%!9
MW"44@!(G44QP_P#U. "-X$>!T.7?>N'379\X1+CWM^]#<PZ7@^FVWOA6D;J^
ML[V<==WW:]@:BPL;EW!X&O8&:T-<VJ#_ ' CTR_0@)RNRTQ'.WW0-R?I.SUZ
M7Z<?K W)PEM3O3^87E7IWSQ"7(P(SX/?EB#9Q.^],0;N#WZ88E!#"*G$58DD
M2$%E/\*S=QY_I$];>?<X-DZ5IU;SQUU<=]\<0:]PZ7R*M-,01OF56(XL:V-A
MIBE:$MZ14G2^@S&:9^%&4R9;\HXWFT[18DL%M"8FN5FJUK63$39=+WYC7C+)
M?$;2N6=WWZ3GB%F-)V :UKPQGPGRRO3.U\UI^YGOKW\, L4HSH1 -:S2V1><
M10E)=*Z]Q.],1F+M,IC6)X3Q28B)]U-B3.W2&,X,!%@!B(JZ33,II8,X?!@2
M6L:UO>LS6:P9UUQ$H';G:YIY3B')SS(UO$&^7WQ4VO?97CGCGJZ9T7GRW3?O
MOKXF<3&>?OKTR<5U.3[XKJ<GWQ74Y/OBNIR??%=3D^^*ZG)]\5U.3[XKJ<GW
MQ74Y/OBNIR??%=3D^^*ZG)]\5U.3[XKJ<GWQ74Y/OB,V'*UFOF>L9GB5U.3[
MXKJ<GWQ74Y/OBNIR??%=3D^^*ZG)]\5U.3[XKJ<GWQ74Y/OBNIR??%=3D^^*
MZG)]\5U.3[XKJ<GWQ74Y/OC>2FA%XVU\J5B!\5IWWTQN\J;=W._&8<K:4-^6
MVELY7$4'I'*O"T:U(Q&V<R]>1EM Y8@2L4UX7GC%UKIBD96[7,AYTI$O_P E
MFMH2B!QNRQ!$)LD7).AV6]0PRLAU=VIAT//W^,*+GMSM]RV4;NXPO*OG[>6$
M2Y'Q]\);;BT!$690$@V$G_&!9W"44A0"([Z8RZ__ "< )M +X7H=F["\J[&_
M?+")<3?]Z'+B49PZ7G[[]AA$N1U.>(TKN]K\_LT; UJ6X#M4>!KV1K*6X#M0
M?[<3D*3$(J%Q4&I$@R'@P-P>&.^\^<_9!:*:82VH],+-N[V]IQ;9C/SO34FV
M1IU/\)S=QY_H5NE#T[#4O,;=DW=^CS"^R8H,KQ+A>"(O,*U@<5*<XIGGQ<\_
MQ*)E9R9F>JTS@)IA#9P>N9>NO",0Y([+1KK.R,KXKNV:RP5MOB:ZY_L]"+]]
MY;;8!=FE)KMA-TS=MA"C7TG2D=9KL3&>5+4"?2MY;ZOX@&YKF[*Q9M%5="8F
M(SX16:7:$Y-"V[&\C?RW3.4S^_MWW =RM:Z/IGGG9MQBL1MY1WY\,!'G+7>9
MF9NI0R_#S-SY_MT:[^LG?D>)3;\P[<G?.G@Z:=?3;TK3\6--_67OS/WN[;?.
MSW%M'(9R?+SKT]8S[],0QK:U/-<Z)&V:D6-52)RCH,WF*;K*&6UJOO>]+!#!
M<RL4FL$UJHL7KEF78Q!EJB@4*&T6-8B"T'UI#,1%ML6I>8&';HX K8H&0TK0
MI-:%9KB #1I0.,9S0KE:D1B#;S=(U[U7$FTM=@>EFI=M:HPQ<6')#/17;37*
M)PR;?G7=LK)5OB0OEKQSK?+EF'YQI-:M>>N=0R,M/!SZ<M.ZTC]9O\I:-Z<+
M6SQ%-/[5SOUU&8B+T<SRTYQ:-PC31T:^U:D7(F\170O=B<]-C!4FK%/UNSGW
MRIX$79#/28VURHS>D1BNAS?;%2(YF2;) 2ZDB82$3E1V=^48@V>+OUX8@FBL
MX\HMT-^"ZH. ^V&5R&MZ<9L\<.AY^_QA1<^Y;*-W<87E#T>^.$2XF_[:(O6F
M,*5"6H)"'_C +.\RBD !$>F)[OS@K)@3: _$Y3*-U,2R3R]\0ER/O0WYYX7E
M#L=EB?X82+B<)KT]?KJ4!K*6]6!X&O9&LI;@.U!_M0$ZS887,NL3*!8I%@:9
MU) P!H  ;&%Y.OQW3")<\.#2NN?.^.ZY<OG?B=:>6VOO'U0;@[\,%()RD &=
M43H)@O\ A.;N//\ .6[[@.Y6L.S?E2L;XMM<IK!5G2G77AMT,0D1%3+RC+A<
M8+_EI,11V+K:&26^K3C"532NQ)WPQMKGIGNZ7.=SG^NZ]\IDX8KYD\MSRYDX
M@B99MH9UB<]JQI-40\YH95*CN\KOY-JD1'HVM*U/),(*5C=:U)O?0L\L=Z^7
M-I3A3]UGOZY<['+ 1IWL+Y["E,04O>Z6R&E-;!F5I^/F;GS_ ,;0\=D5;$3Z
MS6DP8H)I5RKEG:&VN>R0-:S=2+-QRSB(OGC<&VT2SRFKEJ%)_"09RT,Z;0*$
MN=J8BK5WL(<BRQG3;FCNXS!M-::,._'>WK7G^4-7=%N56];1:N<>"G4K/+@&
MC=9I/ZIIWWTQ$^NL5Z;=M+S@I.6FP1WMK5O"OVI;+=P:ZY<&-ALYY7S-V^<Z
ML3^J(A<V#A6?/)!VE_O>M.7#A22DF_"$H+92S<"J!+(54<':42$( C0$%Y(0
M^D#<G"<J=>^>*=IU_O/!H*W>GN8EV#8QYR=<,KT=M&_+SPO)G?W[81+GW)=G
M?=HPO*O3OGB$N1])\XE42VBHL!008_XT%G>912  B/3$]O\ 3%9($V@-?BZ!
MN3A+:G>G\PO*'H]\<(EQ-_WJ91NI\87<K6SMVS7IA(I43ON^_&A:"6K,BPUT
M>!KV1K*6X#M0?[0-(\Y!""1S.R()V&'ZK91N[C"\D>F$2Y'B5,YWTZATCCB>
M^[<8PD3!I%1%$B!$L@JLK_A.;N//\U5M_/ZT\G$&^S6*.Y-F7&Z?H(I;<T(:
MZE=.$#6,1&=LC=L(8V038LXXY]FR.--_ZKKWRF3ABNR_=/D],01QV4I?7..%
M<@_.@B1X!G%<B=6VLMG?GF6YTBM(O9B']OOWURQ7=GK9TVA5R&2<6SF8XPQ7
M28F*&=&#\G,W/G_C!V>_'@?TQ&=OZ3QKKMKB-^JO!H!E1IE6/R:06VYUE36T
M%K+7#(DV%*UFLYC&DU:98AO6.GY#I6N?=L#)L;]S:M)F\D*^!8:YT,GC6EH&
M=K/ZHKI&C#.N338N30S^])BNK8I2E=,JVJ)&(<_[H[3F<OU-NZY'>_"3$10"
M,TN.]F&]=_@-5>%%XYWF:W^LIAY9(]FY-]61"8@LSL^&F#2Y>S@#GSIPV\/H
M@W!WXCDIWWGAA<!L\NQWX')*STGXX8EV)J/HTZXA4L\3D.[3"\J].^>$2Y'Q
M]L#<G"<I,":,.Y@$D0 !0,-L$4@H1!$1A$:B-$:C_P :%G>912  B/3%.X_@
M[(@3: I?@=+:GEWQPLM7SY?W$)<C[ULN7?EBU3A ]%_%DLG8.\4F.$#@]P?[
M,)(1$D$E:P8IHRDOWI=F[VPO*O3OGA$N)O\ "A!%Z6""IK43:O\ A>;N//\
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M78IB&<K-:YQH:R9F_+]6%69B\E*Y%JS&<ZM &('80%F)ZYB96FD'YV9N?/\
MQ!KKW?KKG%9, 7:W%,ZY4@N4O2K;\5BU+Q-M#=EGKG?$FI4I8V[*RA09F!/Q
M:1E;WFD7R%WFR+I8K%T'3G&;E!0Q?ON1[A*?@9<HRMP(VF(9@)FVW;--.%G/
MP+AUIER:96(SBPGZ83$H#G363C$3,0NV'Q(K;39EU+M<V39^DRK3/=I;KK@
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M!9GO1IC)Y'D/OB2SWN:X$;&I?Y[KB2@C?V1Y83E3KWSQ3M#C\]Z8DN=[[XV
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MB21KN^!GXU5Q-M_/W\B]K_@7[[D>X2E9OP[=.LNP'@A3C,\*MX9M9_X&F?\
M:[=]('=B&EVFS974U*E6A6M<M&_G3IE1TKO^9CEG?=7_ !PO2D5WNE<J>04?
M#J5&O+938Z[YVUU]N!EGSS_0]IK@:1-[9_+I.0ZM?":E&V4;?*NJF6!2G>U]
M_&+QK.683!O)9V1)/@Q$F4T3;$>>E*S65_/+RDD.;=U,SK-H\!8#2FVLZ1G;
M,=6*>E=]Z=[,5"1L: LY P5 K3(\#)-<ZTO#YL0TVVSZ;SONOZ O->&L7VY0
MY5SM]Z6->)G/3.8FFSQ B\"PPI&!@$G:L. LYW]SB7,DMG<=,:Q'O7/IAU%.
M9[> ERCR[W1Y8@1"0M-^^.(-(.^9PG %XMG]J8DS)#9W/3$WNM.I[XV7=_3V
MQ-PD[S]\2[D/J[;<\0W$WK\RO4OBB]-,QTA#WWXLQV84GVPTPAG_ "."SN$H
MI"@$1WTQD>:A63!C: U?E:)"V9KA-%#00 .&QAN &"K=1#*A_-JW:BRTNP>U
M%Y127L,?,% E%S$"I]"EM3RPLV^>(2Y'C0-R<)RIU[YX2RG=W/V1*2 F&9*0
ME?5ET7_']TYUO;TC5/UH9WHZTM.IIK$S U/P,W<>?CM/@V5F-^.;I32KK$2N
M>T_!8-V_K6]-R,L&)SL>=ZM*#IEGF'X^[K.R^V-<#(ZA:UM]ZVU!M0_!6D!G
M)>\5-UM8VT<4.GQWG;\$B+_RN;PBM?Q)")E9L7YGJE=*RJW^-R;;VB:W_&%-
M+6OOBU-\C-B61)$KE2_I6*CN<_WK0Y4SFKK2]W.A%0EC3.+N7)BB5WXM;J[\
MZ_X]YMA<SVSO:0G%M-W"_KHY23'@M*S:@%?>FI6<EF2^<ZZ6\L_6/T;7OOIC
M?G0WN7M39GX;3<ZFDS73EI6GC5[[S\LYIBY-*["+4C2]9V-Q\!R2(SWQT+RQ
M$TTG\\H.V6D9VXZE&[F^ I/;L&>#H6B_TH>6>=HXL;MP>"E:-)4[YK2:Q:1_
M._O97I=G$6K6U*W:S6<X*5B(B_WMW9LKN>DQF7?$>@IY^)@ $!0(B8(XG) M
M/"M(L 0$7V!EZXEW.#^>G'$\D3OAUPB7&^GD\_ 2VIY8TF'?'DXD;(=S_< 5
M7&S^^=<2)DG:9;=V\\L3>ZTZ^DXF71WJ8@N=[RF-T,;H]'SQ J80-1UDDM+_
M )%@"SN$HI"@$1WTQ+WK1%9$$;0&O&1+D?'Y.29-]VF["[%YXA*@JFK-1--=
M881R[*-B,% !^2B)PN:H54L-N&*H["B -O(JE%5*?L@;DX3E3KWSPLM4[R\=
M!N&'339\X3 FB-V$D \DEJ/!)2I*^RE7!556O^'YNX\_'":S6H3I(9[DM,ZD
MG\!2-([@[ZRM5EUY3K6)W%)S*_E4?//LTC>8&:+#QK4EY4I68FE7\#71M&4U
M2E367-BY^!Z^6><\2U*7PL[$F";;#;RM!D'X2UWGPUI>[<)BZ2&V=NNEJ9M/
M;\B=H=QY[-B3@:5X5HYSLDTTS*_NJ5M2^6=8_EJQA<X3NE(F]L]82ILG^P5F
MM,[07+?Y 1$NT.%YTKJ.Q)GPJ5]I@Z5FFV8,IBM:Y$\9#AYK6Q^D[37$Y,YL
MWRCVF>&?A:D1DQ"VR&<R72U,3$E6,O[>Y-8-GC&9I4W/2,JUH'@-F&NZG,VG
M(DK3'K3=>O>S\[.&F7/.E2SW'@7H1$>C84I5\UPF:ODG>4NLSLQLWUOZ1SZX
MOLHSG.=X]"A?P$(FB9TI4ONNQ2(M6/SRO&+>=XZVNQX%/<)V9VB::FW%3;')
MUH<]=)MXJ]8"BATBE014(3@#X*@$K*< J!DE]P\Z\CTW\\<9R^.<87E#T>^.
M$2XF_P !.5.O?/%.T./SWIB2R'O2N!%;G'K\8@OR=OICG<!GR>,[<2*K@]P\
M<)F9$!:7B53?^1(X6=PE%(4 B.^F)SG201D$D9364\?A=/CUQ/)$[X=<0ER/
MR)A^L -$L$4(_*21=7*2=Q9I-""6!W+2\<L4:*A&$PC%?QCP=$VQ6/!!0&YI
MB'Q"I5*WPD(XA@80   $ 0 !  4* !0BC$:5[\]T^! W!X83E)U[YX2RG=W/
MBJ JP%6<BJMR/("ABIO92T!:@4SC ?\ $,W<>?C'2\[J?RJ4RUQE 4H9TV93
M,9RTO)^!2)8IS?6:TO-*0.*K/2A'(YZ%!@A_+WTMP>-M(SS*I@9":96&D95B
M\^<T/X$#LTAG6^^VR\$CCT[VLQS\<*3,95EI6M)T=L7?PUK&^8@C4I%82=++
M)!YUS2S2G*6.D#^3&FS=39L[<$6<XKYTSF](M^XD'19IPKK2]((UF,5S9T"Q
M;GO:Z:?Y"9!/>LY>6PP!&ZK3NC2"ZS8KX36N?=>ZWK5_3ZQTYYTQ,TXL [-E
M(MD6V^$Y/#G$4OMFU7+QAUX.^UISIUH>"F662295R+L[M9C\XNS>U&V=:,T2
MSJ%V?O8@BO9.;DZ7(,W[#/G[TC=75X^!1%I-@BEI:TJ:V-[&^>-Z.SO7\XK/
MJD4HWH<*\;?>N6L5HV*;HRIO6D^-"E.. @+ 1 "@!.\">8.^/;%>MV[V\O+"
M]^Z_>[$1E&^_7[T&YA.2G?>>.$Y_/IB;A#WG;G@16YQZ_&)'H5./]X8.6<T
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M[W1BN<.ZCR??$SW'G]VKWMC[O[;83_R1>#B @,7\ 0'&#Q UB_(I!B7 19C
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M"93$9>!EH]-(=)?.UAW3/QJSIMK"GZ$2[,,HI @)(0P&.Y5J911&0%"P+(>
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MFU[?@]]WO;RQQBU\W<3SCJ^!.>L1?89Z\-WZ0ZZ0<FP@5##HI0X)F-H*,1
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MG.^OSB&8^?M@1L_6 TIY<3VC.IC@=U'K)U,6+5\[1YG?^::C$Y3#&%!0.@
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M'=O<4A+#>+FZBVOLE@KX$U*=U^.;%O "E,Z<:L.:H --*L^!WYZYS68A(O\
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M?GIIND239&W4ROLI?<%/]9LVOY_.W0,Z^"PFTML:;MN?FK?4[BCOM1DN5/U
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M]H)@5 %5@"JK8#-< 9">J) 4B8J&3]X>=2W?SB7,DMG<=,+RKT[YX34W2??
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M;/W#+UZ>D4YUP%V=Z_S"#<'?B')YU^>;B=3E+Z3T\.&YY!-8*M22$$+$1?\
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MNX=T>F)EG&S\],!<XWTQ[,-O;+)N=OT<A^4D/D=$!2RQ<&&2R!8. @"B"!
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MPAH"%?  !G0;,5(@@*1J@">$*6<&LY?. -G[0,YWUQF"-O?LXBV#WJ>V%%S
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MSCSQ(WKH-1Q*<XMA&W>J<_GA.$,IW5^LXES5:?9I@H +"*@5*'(4BIJIG_\
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MPBJE4I'8<Q!) :@0@-0D$31R:-14)3K E )(S^C$;=\OK@+>G7TPF/827+%
MP53 ).$#%B'G@)264$J2;8P*(XA#LLH93.O_ %#!LJP"CD410)@1)I9()1K@
M5C2Q/+19+1!$1)I41LC69F!;?HDJU@2<:<RCDT&'SU,=PBJD6!)RH/\ U&9.
M(0L6HPD5)>0=Y,#!5)@*-&:%$%\*^:SOI"E)!)ELS1_,IV:F(G@B(4* &$;2
MQ%I#@DB(J2:#@D4*+D1*&# CSH;_ -2P+L!#<X"F4DF5@$*'$H@R@S0JD #5
MA@:5)"942@2 @@ 1_)KQ.LK,$I#8H5(".!ZO!H+"2B%0&B-1@]6@4#R* K!=
MY)7_ -3P49&$J)<=<$P5#$0@K35G,F$N!1'H10"R"$**<B408'DA+AB@XRF0
MRHTPPJI$).=$=&6K3\';043H$# +D0@,'&TZ<+FK CB6484Z]$#2()1,K(S"
M1%EB.T:)@H2$<BPJ("@9"LJEE*K,S+*RRRO_ *JP92(+920'AJ0T:F(,.P(\
M3-0+DPF283 B2BZE5 *FH# C))2)-@23 B-2$%H @ "U!BRC427A1> ,X)B'
M2":VL6@"("H$&020U0FDW$08$ P\*3BXH @F1@*I*,U^E2H\&X$*4(F2*0FL
MJ^ LT)&E H!5%P24 9(O+SVMAGV1DN$0@8))$F64*RGH@*@*DSQ: Y23:]%E
MS1-),L'$$ )D !-%(P*I3"5I HE9H4Q 0B)(J42$4ZBJC%*J555O7_S^_\0
M+A !  $" P4( @,! 0       1$ (3%!\%%A<9&A$#! @;'!T>$@4&!P\9"
M_]H " $!  $_$/TQ%]%'@ 9J9E',2A.W8U3E\GB*4"0D$$M(9BBPJ!?J?B7\
M9"$)VJY%[0SM6ZH !<UGL\@EH2"!) 0B!H&'XW&I<("*J^5O$$@H33.3H4-
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M--.XG2G(50RCW@#&\V?*:>7 FH\216Z+F1FU$XG9P/:\$0(H)?M!\/()Y5M
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MB5?NG-D)2BY_8Z ,/1\E8FP$0JGX0#[:0"LTE0_!.5NM(8=,=<Z&8WXX\_\
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M2I2#(;USG_K!8132+(AX@#VM4^*6>_4O(HI"VQ1%<N1X42"@#?"D).R'5O\
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M:,C6_P"+O!HL(\L<#6EJ"_(@@]-64A+FZSAW\  EVQ4,%::!3M+1+1;0=)D
M/[;?:QWAK(PZL4)P44T3$CZ[$'$IV'G\_5*,M:V]L#"WIR?:*O>22^'N/LM(
M]SLP>%[4O)GI2)B/8@XD_=)RDZZYTEERU/:0<3)YF)DA1,!^X/M6VK_ZS$)
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M@Y(%_8BINH +=\9A)^O495_!@ -R:Q<-V AKA :*=2(Q%&AW(#EV*91PM]5
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ME/+W2D6R<=CYY\ZD8O)PUJ:D8/,_WWH#@]_;MJV N+=.= 4K"\0Q-^OTQO\
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MF4'\2;*4JT7%&VQ7E6R0E+VS=<QJD4 H:!$48GX)=W#X^(I>5^G<*91PM]5
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MTG*W6EF_6L)[%LN6HI>4/1UYU/-.MJO<:R!8\:(]1(E'>X.OCGC.9!TH0%,
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MYW2$J!J6?CJ4Y4-)'&IKF4YQ#QMIX=+9XY9X$HM<GSF;7H+L_/\ P6>"/M9
M#<_-U3A>'2&DS\#2D\## )V23^0B8WPAI)61;'!Y'AKC$#([LTSI!'!!X/\
M2_"# "10-#91"'K.NA)745*+Q6(43^]*25K"OK$Y5/T+I!FY(D*J*97(1XD
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MN$'M2S"_3WI$Q/P2[L<,.7Q2\K]-<ZA,2.W*7@*S WS'!_B*NE;^>N]16I"
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M9A::"G94I?3L_P"E==8$1D?N>&PTV7T5AVF4=UF1H &0^R.]Y?RD%CVPA+!
M<&T NF]J!NB#L?S+_>GNC/YA@'QN_P"7)FQ@B $"B@I89_??RQH[B)I2 M%,
MDN-4<XK^!IQE?S(4UK7<[80^"TE8=P<\:$!F;"<OWLN7E(43GKWE K1<!#W
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M*S#-P>7@V_;.Y[B&I&+@7=5.Z\+#V5BB<DHB!@_G%05.JB:O82GO(39XAR"
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M>UV454L7AM/Y2"U[82E@D.+W]JA!*3H!4*=Q8 ,Q4$ZI%;%8U '@_P!+\(,
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M%(\ 2)-DCGV92^][]0<P[X8C(S=_[1 QDD5ZQK/7M8)"XA)*DTGC%5W)R_\
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M;#\(9$J/?\D:(PMC@2$51XU3W'(52?G)U;%WN=)1@CW8CQ4@YV-!-U](1;1
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M7N*;6V2MXJL5^]W,!$[V>*HZ\4@:FQ<@1B [W"NTC#"H@W4 23^Q40->T#
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MRB;D2_?J>+&;"U5-5,M&QT$[$)4D(2 P3!\Q_,H+KD'^!M2D_!V  )@V8=-
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M3-1K[4D6R\ [*-YA=1*S$K(R#L"LXF:>=)/J DDHUI@DD^LAO06A=>PPXI[
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M8FQ *H4)DO4]P';EPI"0Q$;5,'F=G!6@O0*%2=Y==_J0X=47]6">AAIRM F
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2LQ%$(I5P0 C3    @C_G]__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>picture1number3a.jpg
<TEXT>
begin 644 picture1number3a.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 4@ X0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***X3Q?\>OAE\/M:;2/%/Q%\)^&
MM65%D:PUC7+6TG"MRK&.1PV#V..:5T,[NBO*O^&L?@A_T63X?_\ A46/_P =
MH_X:Q^"'_19/A_\ ^%18_P#QVF(]5HKS_P ._M#?"OQ=?+9:%\2_!^M7C'"V
M^G:]:W$A^BI(37?@Y&1R*8"T444@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HK \:?$#PO\-])35/%OB32/"VF22B!+S6KZ*SA:0@D('D906(5CC.<
M*?2N+C_:L^"<TB1Q_&'P#)(Y"JJ^)[(DD] !YO6A:NR!Z:L]3HI <C(Y%+0
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M  5/_9T\8:E%8OXPN=!FF<1QMK.FS0Q$GN9 K(@]W*@4HOG^'4<O=^+0\_\
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MY>ZKRT1].45QWQ0^,7@KX*^'6USQSXFT_P ,Z9DJDM]+M:5@,E(T&6D;'.U
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MWA2X-M=_%'3IW4?\PVSNKU._1X(G7MZT1]G&'*M_R_K^MQR]I*?,]OS/QO\
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M,V9\=W40X7TWD]0".' 4_:86,9?#RJ_II^MOUTN=V-ER5YS6ZD[>K=OU/%O
M_P#P3!_:)\=:#%J\7@I-&MIHQ+#'K5_#:SR CO$6WH?:0*>:\ ^*/PH\6_!;
MQC=^%?&NAW/A_7;4!GM;C:=RG[KHZDJZ'!PRD@X//%?T^5^=G_!:+X76.M_
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M=RY5E'4$9'-?M'K_ /P4I_9L\-W3V]S\4+.XE7_H'Z?>7:'Z/%"RG\Z^%?\
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M>^OIU+I1BDY3VL_OMI^)YA^PW_R=]\(_^QBM?_0J_HVK^<G]AO\ Y.^^$?\
MV,5K_P"A5_1M7H2_W>'K+\HGGQ_WB?\ AC^<C^<7]M[_ ).Z^+?_ &,5W_Z&
M:^Y/^"&O^L^,GTTG_P!O*^&_VWO^3NOBW_V,5W_Z&:O_ +&/[6FL_LB_%0>(
M+6V;5?#VH1K:ZSI(?:;B$'*NA/ D0DE2>#EE. Q(X\NDEAXQ?VH)?D_T.['I
MNK.W27ZG]%=?%'_!7K5H-/\ V.;^VE91+?ZU8V\()P2P=I#CU^6-J]#\*_\
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MTV-C_$NV*X4?4>0<?[+&M\/-5J+2ZKF7R_X%W\C*O%T:J;Z.S^?_  ;'K/\
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M*C,:2*3\TBJ0-H=MS@8'#=!TI*<HU%#ROZ6M^=_P*Y5*FY_UK?\ KYG[%?\
M!,7]K#6?VE_A!J=AXLN!>^+_  K/%:W5]@!KRWD4F&9P.-_R2*Q'78#U)I?^
M"M?_ "9;XB_["6G_ /I0M>!?\$/_  ??VVA_%+Q3+$R:9>3V6G6\A'$DD2RR
M2 ?031_]]5[[_P %:_\ DRWQ%_V$M/\ _2A:TS!)*+[\C^]Q_/<QP>\ET7-^
M3_+;Y'X05_4;X'_Y$KP__P!@^W_]%K7\N5?U&^!_^1*\/_\ 8/M__1:UTQ_@
MR]5^4C&7\:/H_P XC/'7@/P]\3/"FH>&O%6D6NNZ%J$?EW-C>)N1QG(/J&!
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M9_$;_@D[=>"/V3KG1?!UC%X\^+UYJ=I=W5]YL-JB0KO#PV[3.H2,!\DE@SD
MD#"JORUHG_!,']IFSUJPGF^&FR**XC=V_M[3#A0P)/%S7[XT5=.3IU?:K>Z?
MEI;3TT)DE*'LWVM]]_\ ,9$I6) >"  :_+7_ (*8?L5?&;]H+]HBS\3^ ?!O
M]O:''H-M9-=?VI96V)DEG9EVS3(W =><8YZU^IM%8RBI--]'?\&OU*@^2+BN
MJM_7W'Y1?\$X_P!A_P"-?P%_:6M/%?CKP7_8>@1Z7=VS7?\ :ME<8D=5"KLA
MF=N<'G&*_5VBBMI2<DD^G^;?ZF<8*+DUUU_!+]#XR_X*C?L^>/\ ]HSX.^%=
M#^'F@?\ "0ZI9:\M[<6_VRWMMD(MYDW;II$4_,ZC )//2OSO^'/_  3-_:3T
M'XA>&-3OOAQY%E9:I:W,\O\ ;NFMLC2569L"Y). #P!FOW=HJ*7[F?M([WO]
MUO\ (JJO:P]G+:UOOO\ YA7F/[3G@W6/B'^SO\1_#'A^S_M#7-7T&\LK*U\U
M(_-F>)E1=SD*N21RQ ]Z].HJ)Q52+@^II&3A)270_ '_ (=<?M._]$S_ /*_
MI?\ \DU^U7[*_@G6OAO^SC\.O"_B.R_L[7=)T6WM+VU\U)?*E5<,N]&96P>Z
MDBO5**VYFHN'?]+_ .9CRIR4NWZV_P CY>_;H_8ATC]L#P?9M;WD6A>.-'#_
M -EZK*A:)T;EK><#GRV(!# $H>0""RG\AO'W_!._]H3X>ZC);7/PUU768A(4
MCN] 5=0BE SAP(B64''\:J?4"OZ&J*PC!1;<>INYN22?0_ +X8_\$Q?V@_B3
M?6R2^##X2TZ7E]0\27"6RQ#KS$"TV?81_7%?3G[0/_!)G4O!_P  _"^C_"O2
M&\>?$'^UO/UO5I[FWLF:#R'&V(32JJ1*^WY068ELDG Q^L-%:R]Z/(M-OP=_
MT,HZ2YG_ %?0_%;]E3_@G?\ M!_#;]H[X=>*?$?P_P#[.T+2=9M[N]N_[:T^
M7RHE;+-L2X9FQZ*":_:FBBK<VX*'1-O[[?Y$*"4W/JTE]U_\S^<7]M[_ ).Z
M^+?_ &,5W_Z&:]L_X)Z_LC>&OVNOA[\8-"U>9M*US3SI<^CZU%&'>TE8788,
MN1OC?"[ER,[5(((!KQ/]M[_D[KXM_P#8Q7?_ *&:^Y/^"&O^L^,GTTG_ -O*
MPR^*G@[/^1?G$Z<;)QKR:_F_4^3/BA_P37_:"^&.I3PGP+<^*;%&VQZAX987
ML<P]1&O[U?\ @2#\N:F^&/\ P3._:#^)E_;QGP/-X5L)&Q)J'B25;-(1ZF(Y
MF/\ P&,U_0'15QTWU,I:[:'SE^QG^Q3X5_9!\)7$-C.==\6ZFJ_VIKTL>PR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\F_P!H
MK_@DS\7?B[\=/'/C31_$?@JVTO7-5GOK:&^OKQ)TC=L@.%M64-]&(]Z^CO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<+\=O$FI>#?@C\0
M=?T>Y^QZOI7A_4+ZSN-BOY4T=O(Z-M8%3AE!P00<<BOQO^%_[<'[:GQJU2\T
MWP-XGOO$U]9P_:)X+#P[I;-''N"[CFV'&2!^-3&7--P2U2O^?^1<H\L%4;T;
MM^7^9^Y5%?CU-\5O^"D%O"\K67B0JBEB$\+Z6[8'H!;DD^PYK-\/_P#!4K]I
M#X#^)[?2?B]X335E.))K/7=(;1]0:/D;HF1$0#/<Q,#C\:M6;LW8AWM=(_9>
MBO.O@'\=_"W[1WPSTWQMX1N7ETZ[S'+;S@+/:3KC?#*H)PRY'0D$$$$@@UZ+
M3E%Q=I$QDI*Z"BBBI*"BBB@ HHHH **** "BBB@ HKQ[]K_Q]KWPM_9G^(7B
MOPQ??V9K^E::UQ9WGDQR^5('49V2*RMP3P017@7_  2S_:.^(G[1WP]\;ZG\
M1/$/_"0WNFZI#;6LOV*VM?+C:+<5Q!&@//<@FE!\\IP7V4G][L$O<46_M-K[
ME<^WJ***8!167XG\3:5X+\.ZCKNNZA!I6CZ= US=WER^V.&-1EF8_2ORN^.7
M_!7/QSX^\7/X1_9^\,,%FD:WM-5N+!KW4KUNSV]J 50<' =9"1@D*<BHYO>Y
M%JRN73F>B/UEHK\?4\._\%(?%\,6K"7Q% LB[UC;4-*T]@.O,!="#[%0>U9P
M_;Y_:X_91\2V]G\8?#TFM:=*X00^(-,CMA,JX+"WO+951VP1DGS0,]*TTO:3
MLR=6KQ5S]DZ*\9_9=_:L\%?M7^!3K_A2=[>^M2L>IZ+=D"YL)"#@,!]Y&P=K
MCAL'H0RCV:G*+@[2)C)25T%%?/7[7G[:W@K]D3PS#-K(?6O%%_&S:9X=M) L
MLX''F2.01%$#QN()/(56P<?G?IO[9W[:'[6>L7,GPJT>?2M&1VCV>']+A%K&
M1R%DO+H,!)@C(#KGKM%91ESMJ"O8TE'E2<G:Y^RM%?CS=Z;_ ,%'_AS:3:Q(
M_B6[BB7<T<5SIFKN0/[L"M*S'V"DUW7[-_\ P5\U:T\61>$/CUH,.ELLWV23
MQ!8VSV\EI*#M(N[8YQSG<R;=N/N'DC6*4WRIZ]C.3<5S-:'ZF45174HM2T07
M^F7$=W#/;^?;3V["1)59<HRD9# @@C'7-?CI<?'[_@HBL\@32_&VP,=N/ EH
M>,\?\N=9WM)P:U1HE>'.GH?LS17X8_$+]N3]M?X3-8CQKKNM^%#?;S:C6/"5
MA;>?LQOV;[0;L;ESCID5T'AO]J3]OWQCH5EK6A+XLU?2+V/S;:^LO!%G+#,A
M_B1UL\$>XJMU=$[:,_:ZBOSM_8/^*G[6_C'XY-I_QKLO$EOX,_LJXD#ZKX7@
MTZ'[2&C\L>:EO&<X+_+NYYXXK]$JIQY4GW)4KMKL%%?*O_!1[]IO5OV9?@"=
M1\+Z@NG>,M9OHK#2[AH8YC#C]Y-+LD5E8!%*\@C,BU\I_P#!.7_@H1\3?BO^
MT$G@;XI^*5UVSUJQE&EEM.M;4Q7<8\P#,,29#QK)][/(7'6II?OIRA'=?Y7*
MJ?NH*<NO^=KGZK4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.5='4,K ^A!%?!7_  5C_9'U'XS^ ].^(WA.Q:^\3^%H7CO;.!<RW>GDER4
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M*X,9_NU3_"_R.O#_ ,:'JOS/DG_@A[_R(WQ5_P"PC8_^BI:_3>OS(_X(>_\
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MP!Z"OQ%_9X_Y2Y7'_8Y:[_Z#=UT4Y<V.C)+=2_0P<7# 3B^EORD?MY7YM?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS^YQGO7VY1141]R"IQV5W]^Y<O>ESO>R7R6QY=^TW\$?^&C/@?XF^'?]M?\
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MS'"Y. !R3R?4*WGRJ34-OZ_K]#&',X^]N%%%%06%%%?&'_!1[]M#QM^R!:^
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MU_LNSML2I-"JMOAA1N [#&<<U^G6K?\ (*O?^N+_ /H)K\6/^".?_)WFM_\
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M=[5G?\$/-0GD\)_%>Q9R;:*^L)D3L':.96/XA%_*OO']I[_DVSXK?]BIJO\
MZ22UKCHJGS37\M[=-8IBP$G.<:;_ )K7ZK7H^]C\0_V(9OVE(;[Q=_PSJ'-P
M8[;^VMB:<WRYD\G_ (_!CKYGW/Q[5^M/[#,W[1TVA>+/^&B0XU$7,']D;TT]
M?W6U_-_X\QC[VS[_ #Z=Z^//^"'/_(<^+O\ U[:9_P"A7-?K'754]Q);W2WZ
M>AR17-)]+/[].OW_ ((_%3]NS_E*-H7_ &$_#W\X*_8/XH6/B34_ASXDMO!^
MJ?V+XKDL)AI5_P"5'*(;K83$2DBLI&X '(/!-?CY^W9_RE&T+_L)^'OYP5^U
M=>?2CS8)1O:[G^AV5)<N+YK7M&'Y'YI?\$T?VYOB/\8OC%XF^'GQ:U_^U]3>
MS:XTLRV%M:/#- Y$\)$,:;B5;=\P./*:OTMK\4?VRM"N_P!BW_@H9I'Q(T:!
MHM'U.]B\20I$N%<.Q2^@!Z98^:?83+7[1:/JUIK^DV6IV$ZW-C>P)<V\R'*R
M1NH96'L00:Z8R]KAX5;6>S]5_5O.QC./LZ\Z=]'JO1_TG\SY%_X*<?M5>(?V
M9?@_HG_"%:K'I/C/7M2$-K<-!%.T5O$N^9Q'*K*>3&G*G'F<<UZ/^POXB^(W
MC;]F[PUXJ^*&NOKOB37P^I1N]G;VWDVKG$"!88T4Y0"3)!/[S&< 5^=?[=%Y
M=_M>?\%#O#7PGTF=Y--TF6#0V:,Y$;$^??2CW5,@_P#7&OV'T?2;30=)LM,L
M($MK&S@2W@AC&%CC10JJ!Z  "HP_\"55_;>GHNWKH_O*K?QHTU]E:^K_ ,M5
M\D7*Y7XJ?$S0_@[\/->\:>)+@VVBZ-:M<W#*,NV.%1!W9F*J!W+"NJKQ/]K_
M /9WN_VI/@O=^ +7Q*OA5;N\M[F:]:S-T&2)M^S8)$ZL%.<_P]*RJ<_+[F_]
M:_+<TI\O-[^W]:?/8_/'3/VT/VM/VU_'>I:=\$=.C\)^'K-AYAM8;<K;QL<*
M;F[N%(WG!.V(*2 <*<$UM^.?!O\ P4&^ OAZY\4+X[_X2VPM(S<7D.G30:B\
M,:C+$PSP!F &<^6&/?MFOM3]F'X*^%?V%?@>GA?7?&>C[6OI[Z[UW4/+TQ)W
M<@+D22L!M157[W\/:NHU#]L;X$6/RS?%_P $R!N,0Z[;3#_QQS6LU&*Y:3UL
MM7W_ ,KF<7*3YJBTOLNQXG_P3U_;[;]K*RU3PWXIL;32?'VD0"Y?[#E;?4+;
M<%,L:,2496*AER1\RD=2%^Q]0E>#3[F1#M=(F93CH0"17XE_\$]=0L=-_P""
ME%S!X=N(9M!NKO7+>VDMCF*6U"S/$4P?ND(A'MBOVQU;_D%7O_7%_P#T$TL0
M[X>-9*SE&_H]5^@J6E>5*]U&5OEH?CK^S7_P5?\ 'OAGQ5XMO?C%XGF\6:);
M:/,VE:1;:7:6TEQJ'GQ"-!)#"NT;#*2SD@ $X)P#VVH>./\ @H)^TA WB/PK
MHEQX%\*WG[RRL+=K+3V$>?E.ZY87#9&#N.%;J  <5X3_ ,$I_AWX=^(7[7;+
MXCTJ#5XM'TNYU6SAN5W1I<I+$J2%>C%=[$9R <'J!7[JUM*"Y(2ENU^KW[O\
MDD.4FJM2,=D_\M%V7ZMGXR^"_P!OO]H[]DOXR6GA3X["\UG2E:/[?INJPP&Y
MCMW/_'Q;7,0_>8YZLZMM9?E/(_9#2]3M=:TRTU"RF6XLKN%+B"9/NR1NH96'
ML00:_+K_ (+A^';7['\)]=5%6^\S4+)W"\O'B%U!/H#NX_VC7W-^Q;?3:E^R
M7\))[AS)*?#5DI9N20L04?H!44I^UHR<OBC*WWW_ ,E][%4C[.K'E>DHW^YV
M_P _P,C]LS]KS0?V1/AJNMWL"ZMXCU%VM]&T7S-AN9  6=R 2L: @L?=0.6K
M\[O GQ:_;L_;&$_B'P5J%SI'AAK@I'/8+:Z981,."D;R?O9@#D'YI,'@FN<_
MX*BZY??%[]NC3/ <5PP@T^+3M$MDSE4EN2LCOCU)G0'_ '!Z5^R_@3P5I/PX
M\&:+X7T*U2RT?2+2.SM84& J(H )]2<9)[DDUE1CSTW7GU;27DNOY/Y^6MUI
M.$U1CV3;]=E_7;ST_-WP?^UI^TS^Q_XHTJR_:9\/S:W\/]4N!:CQ+#';RR63
M'@,);;Y7&,L8Y0)" 2I^7!\0_P""4-U%??MT:]<P.)8)M)U22.1>C*9XB"/P
MK]BOB/\ #[0OBKX&UKPGXFL(]2T35K9K>YMY!V(X93V93AE8<@@$=*_&[_@D
MIIJ:/^VWJUA&[2):Z-J4"NW5@LT2@G\JNC+FQ%I;J,K>:MU\UWZW)JQMAVX[
M.4;^M]+>NNGEYG[:T444 <)\;_C1X:_9_P#AIK'C?Q9<M!I.G1Y\N(!I;B5C
MA(8U)&79L <@#J2 "1^6]K^V=^UY^VCXLU.V^"FD'PWX?M"0\>FQ6X6%"?E\
M^]N1CS,<XC*$C.%.,UT/_!;KXD7;:W\.? 4-P5L4MY];N8 ?OR,WDPL1_LA9
ML?[YK[W_ &,OA'IWP5_9I\!^'K&WCAGDTV&_OY$',UW.BR2NQ[G+;1Z*JCH!
M4T8JK&=:6R=DOOW^:?X%5I>S<*4=VKM^6FWWK\>Q^=WC+Q!_P4 _9?TF7Q5K
MNJW7B'PU8XGO92;/58%0=?-4#SD0 <LNT#KN%?:/["/[=6E_M?\ AJ^L[ZPB
MT'QWH\:/J&FPN6@GC)P+B GYMF[@J<E"0,G()^IKFVBO+>6WN(DF@E0QR1R*
M&5U(P00>H(KXI_9?_P"":J_LP_'ZY^(NE?$5M0TV:*[MAX?71?( @F.4C,WV
MAL["$.=G.SM6E.7O.%3X;.S[/HOG]V]^C,ZD?=4H?%=:=UU^[[_R/M/4-0MM
M)L+F^O;B.UL[:-IIIYF"I&B@EF8GH  23[5^5?Q:_P""EGQ=_:!^*3_#[]F/
M0Y5A#LL.K"SCGO;Q%.&FQ,#%;P\]7&>5)9"=H^F?^"K7Q*NOAY^R!KEM8SM;
MW7B2]M]$WH<-Y3[I)1]&CB=3[,:\]_X(T_"?3_#?[/\ J_CMK>-M9\2:G+ +
MG'SK:V^$6,'L/,\UCZ_+Z"LZ4?;3FY/W8?B]/\U^/D:U)>QA"R]Z?X+7_)_@
M>177PX_X*-^%[5M=@\2W6I7.#))I\6I:=<NG<@0R#RR1CHF?0 UZ;^Q7_P %
M.-3^('CR'X5_&G2XO#_C.2<V-IJJ0&V6:Y4[3;W,+?ZJ8L" 1A2QV[5.,_HK
M7X[_ /!9KX8VO@?XR>!_B)HR_P!GW_B"UDCNI;?Y&-S:-'LFR.=^R5%S_P!,
MUIJJJ<XJ:O%NWFO3^MQ>S=2$N5^\M?7U_K:Y^Q%?E9^U=^WC\4_@G^WC)X/A
M\;+I/PRL-1TEKZP;2K68+:216\ESF0PM,<AY#\K;AGY<<5^B7[/?Q!E^*WP,
M\!>+[C'VK6=%M;RXV]!,T2^8!_P/=7XZ?M\:#9^*O^"F=[HNHQF;3]2U30K.
MYC5BI:*2WM4< CD9!/(J^65/&0I;ZM>3U7X"IRC/#5*C7V;^:U6WF?0_BG]L
M+]J+]KO7-03]FKP?=:#X%LIC NO7$-LDUV1P2TUT?*3C!\N/+KQECG%>-?$+
MXW?MQ_L>WVEZYX^U;4#I-Y<!$_M3['J=C<,!N,+O$6,9(!X#(Q )4\$C]E_#
M/AG2?!?A_3]"T+3K?2='T^%;>ULK2,)%#&HP%4#I7SY_P4>\.VGB3]B[XF1W
M:*WV2SBOH6*Y*213QLI'H>"/H37/5DL/!U(:VU=^JZ_\-MT-*<76FH3TOVZ=
MO^'W.X_93_:(TW]J#X*:+XZL+;^S[BXW6VH:?OW_ &6ZC.)$![KR&4_W67/-
M1_M7?M*:+^RK\']0\;:M;-J-P)%M-.TQ'V->73@E$W8.U0%9F;!PJG )P#\@
M_P#!$>^FD^#/Q#LV<F"'7XY47T9[=0Q_'8OY5WO_  5X^$GB#XE_LTV.I^'[
M2;4&\,:JNIWMK;J6;[,8I(WD"CD["ZL?1=Q[5MC?W>L-+\ORO:_W79E@_P!Y
MI+7XOG:]OOM\SYO^'OQ0_;G_ &U+>Z\2>"M6MO!O@V65XX)X%@L;0,AY2)V5
M[B3G@L"RY!&1R*9X\^,'[<7[$TEGKWCO4(/&?@U9EBEN+A(+ZS=FZ*\J*EQ$
M>< L54G &[I6[^P+_P %-?AS\+?@_H'PT^(UO>^''T598K;7+6V:YM9HFD:0
M>8D8,B."Y'"L#C.1G%?=.N>)?A+^VA\*?$G@C0_'>CZ_8:U8F&X72+V&6\ME
M)!60PMED96 (WKP15U8NG=T-;?._KV_3S(IR53^-I?\ #T[_ *^1J?LM_M'Z
M!^U-\(].\;:'$UD[NUKJ&FR.'>RND +Q%AC<,,K*V!E64X!R!X)_P5*_:*^(
M7[.7PO\ !VK_  [\0?\ "/:AJ&L-:W,WV*WN?,B$#L%Q-&X'(!R #7KO[)/[
M(6@?L@^'=?T;P[K^K:Y9ZO=1WCKJOE9BD5-AV[%7J-N<_P!T5\M_\%N/^2*_
M#[_L87_])I*PQDDDG3TUC^+5UZ;KT-<,GM/M+\G8^J?V'OB7XD^,'[+?@;Q?
MXNU+^U_$6I0SO=WGD10^85N944[(U5!A54< =*X3]OO]N*#]D'PGIEMI.G6^
MM>.-=$AT^UNBWV>WC3 :>8*06&2 $!&XYY&TUJ?\$T_^3)/AE_U[W7_I7-7Q
MQ_P6L^$GB"?Q)X)^)-K:W%WX=AL#H]Y-&I:.SE$S21E_[HD\Q@#TR@'4C.V/
M]RNX+2+E;T6OZV7STU(P7O4N:6K2OZO_ ("N_D.\%Z'_ ,%!/VB-!MO%</C!
M?"&CWZ"YL([J6VT[S8FY4K'#$T@7!X\W!(P>>#67<?MH?M6?L3_$#2],^.VF
MKXL\,WK?(\T5OF:)3AWM;J  %QD$I+DX(R%W U]!?LY_\%9?@_XP\*Z/I7CF
MYN/ 'B.W@BMIOM5L\UA,X&W='+&&V*<9_>!0N<9.,U[/\=/A#\+_ /@H%\++
M+1K7QM:ZEI-AJ27T>J>%KVWNGCE6-T,9;YPN1(<@\\"JJ1E3E>DKQ3];K_,F
MG)5(VJNS:]+/_ASOM>\>:A\2_P!G74_%OPFNOMNKZOX?EO?#DRK'EKAX28 5
ME^0,'P"K\ @@]Z_$_P#;?G_:?FM_!_\ PT6'$0>Z_L3>FFK\V(O/_P"/,?\
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M]H^]Y/\ M?WN]>0_L6W'[7</P]UD?L^"0^%O[3;[=MCTEO\ 2_*CS_Q^#?\
M<\O[OR_CFOT^_P""FW_)CWQ,_P"N5E_Z76]>)_\ !%#_ )-W\9_]C0__ *2V
M]9X:.E6-_A2^>L=^YT5W>,)_S2EIT6E].W;T/IK]C:7XSS?!XM\=PP\=?VC.
M/F6S4_9<)Y?%I^[Z[_?U[5^9'@7_ )3(3_\ 8Y:A_P"B9J_:NOQ4\"_\ID)_
M^QRU#_T3-3IRYL?1=K:?K QJ1Y<#65[Z_FI_TC]/_P!LS5?B#X<_9S\7:_\
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MPTL'_P Q/R_]L,,5OA_5_E,^U]6_Y!5[_P!<7_\ 037XL?\ !'/_ ).\UO\
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M /*_JG_R37,^//V!?V-/A;IMOJ'C'PUI'A6PN)?(ANM8\67]K'))M+;%9[L
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M(5\Z?L9_\%5/AQX/^"_AKP3\2H]2T+5O#ME'IT.HVMHUS;74$0"Q'"9='"
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M>]K)=[Z?E<_4C]B?0[CPY^R5\)[&[4I./#UK,RL,%?,3S "/4!Q7Y7_MK_\
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M ,*+XA\2Z1JZHLG]IWELR6LD*F,;89D4C>DW)&>O/2OM?_AUQ^S%_P!$S_\
M*_JG_P DU^=FCS?$;_@DS^TU>S7FDSZ[X"U<M;K+G9#J]D&+1LDF"J7$6<E3
MT)8?=<,?M^W_ ."P?[/\OATZB\OB:&]"Y_LAM)S<DXZ!@YB_.2G*<*D8U(=E
M==FM/^#ZB4)TY.G/OH^Z8_Q]^P[^Q+\*I;*+QGHV@^$Y+U7:U76O&%]:&<+@
M,4\R[&[&Y<XZ9%?7_@>QT/3/!>@V?AAH7\-V]A!%IC6\QFC-JL:B(K(22Z[
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M_P!C/=_^B+>M,)MB?E_[8+$[T/G_ .WGI_\ P4V_Y,>^)G_7*R_]+K>O$_\
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MK##;P($CB10 J*HX"@   < "IZ*%HK('J[O<S/$GA?1O&6C7&D:_I-CKFDW
MVS6.I6R7$$H]&1P5/XBO')/V%?V?I-2^W'X2>%Q-G.U;(+%_W['R?I7NU%+K
M<=]+&/X3\&Z!X#T:+2/#6AZ=X>TJ(DQV.EVD=M I/4A$  S]*V***J[>Y.VQ
MQ#? WX;R>,?^$M;X?>%F\5?:!=?VZ=%MC?><.DGG[-^__:SFNWHHI;*RV'UO
MU,?Q9X.T#QYH<VB^)M#TWQ%H\Y5I=/U:TCNK>0JP92T<@*D@@$9'! -0^#/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ?"7_@'=?_)->NO#K/G]B/\ X$CM7"^8_P J^\_3"BOS/_X>9?$__H ^$O\
MP#NO_DFC_AYE\3_^@#X2_P# .Z_^2:?_ !#G/OY8_P#@2'_JOF/9?>?IA17Y
MG_\ #S+XG_\ 0!\)?^ =U_\ )-'_  \R^)__ $ ?"7_@'=?_ "31_P 0YS[^
M6/\ X$@_U7S'LOO/TPHK\S_^'F7Q/_Z /A+_ , [K_Y)H_X>9?$__H ^$O\
MP#NO_DFC_B'.??RQ_P# D'^J^8]E]Y^F%%?F?_P\R^)__0!\)?\ @'=?_)-'
M_#S+XG_] 'PE_P" =U_\DT?\0YS[^6/_ ($@_P!5\Q[+[S],**_,_P#X>9?$
M_P#Z /A+_P  [K_Y)H_X>9?$_P#Z /A+_P  [K_Y)H_XASGW\L?_  )!_JOF
M/9?>?IA17YG_ /#S+XG_ /0!\)?^ =U_\DT?\/,OB?\ ] 'PE_X!W7_R31_Q
M#G/OY8_^!(/]5\Q[+[S],**_,_\ X>9?$_\ Z /A+_P#NO\ Y)H_X>9?$_\
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M^ =U_P#)-'_$.<^_EC_X$@_U7S'LOO/TPHK\S_\ AYE\3_\ H ^$O_ .Z_\
MDFC_ (>9?$__ * /A+_P#NO_ ))H_P"(<Y]_+'_P)!_JOF/9?>?IA17YG_\
M#S+XG_\ 0!\)?^ =U_\ )-'_  \R^)__ $ ?"7_@'=?_ "31_P 0YS[^6/\
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M_P#DFC_AYE\3_P#H ^$O_ .Z_P#DFC_B'.??RQ_\"0?ZKYCV7WGZ845^9_\
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MI_\ BJ;+X(LHN3K)_P# 4_\ Q5*\Q5^#FM2T5+R/:YH_U\XC_P"@G_R2G_\
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M:9SXFW'_ *\3_P#'*ZK^T)+B''F'/UK"U#3Y)LDN?SH_U\XC_P"@G_R2G_\
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MTLX?Q!N_[<\?^SUZ?XP^(C+;DB7)QZUY/J7BR75K@IO/)]:/]?.(_P#H)_\
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M.+=@:T3_ -NG_P!G1)\(XH^NM'_P$_\ LZ]"%ILDR#5G["MPN,\T?Z^<1_\
M03_Y)3_^1#_6+-/^?O\ Y+'_ "/.H?@W'.N5UL_^ G_V=))\'8XSAM;(_P"W
M3_[.O1XX%LNIP*K7<:W7S T?Z^<1_P#03_Y)3_\ D0_UBS3_ )^_^2Q_R//9
M/A)!&N3KG_DI_P#9TV'X2PSC*:WG_MT_^SKK+Z%MI )I='C=&ZFC_7SB/_H)
M_P#)*?\ \B'^L6:?\_?_ "6/^1R3?"1%;!U@_P#@+_\ 9T2_"6.)-QUDD?\
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MJ?VH8?6MS[/&R?/Q69?:9')_JZ "SU0R,.M;$4C78"BL>QTWR^2*V+>86K#
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M8U8M8XY5Y/-0-;B.?Y^%H KZCYD[[EZ4MM&^S 8Y^M7+YT2'$7)JO8*[,":
M*4UG(DP9B<5/-&LD.!R:T[Z R1\"LZV3R7PU &+-:R0OG&*U]/FRH!YK1N((
MF@W<52M6A5\4 6I+Q84Z 5774HKAMO>JFK3'!"=*S[6-D;S#0!=U#1G9O,'3
MK5RSD\NWVC[V*+74A-\C5#>7 A;Y!0!C7TCPW)9SQFK%LT5VHVC+5%?6\MZ,
MXXJ_X?L8[=@9* ..\>:?,UBX0$<5\K>,K2XTW4))79@,U]N>*E@N(2H KYC^
M+GA=[CS6B7/6@#Y\U;Q(]PVPR$_4T>'0T]_'W&:R]7T&XM;PEE(&:Z?PA#''
M-&9.#F@#ZC^$-BBQQ$KV%>^62(UN(QCI7B'PPN(_LL8CZXKUFPNI(V% &M):
MBU^;:/RKAOC5>"3X<:DH_P">3?RKLKJ_+18/6N#^, 4_#G4V[^4W\J /QA\?
M<^,-0S_ST;^=8-;WC[_D<=0_ZZ-_.L&@EA1110(*=']]13:='_K :!G6Z3;[
MHQQ6GY<:D9K,TVZ86X&*DD+R/G/%!1KJNU<J:BNIIMF QJO;W7EX!.:M-(LB
MYH S89I?,^8FMNPU06[#<:J)#&W?FH9+4;^#0!Z;X=UN)E!)%=7!XA167!%>
M1:6ZVZ\/S]:W=/N9))E^;B@#W/P_KPD"XKM[/4Y&B&*\>\.S>6J$FO3M#U:W
M:W52PS0!N2:H_EY[U9T75G9CNJO'Y$RTL+1V\GR@8H MZQ))<$%>!4>GAD7#
MGFGS76]>!4<&^1J %O K=!S4=JP@&34UQ&!C<>:5;>-XL9YH IRZSMDV@U:C
MO(KI=I/-4VT'<Q8&J[64EK)QF@"W=6Z1Y(JNC#RR#39/,DXYJ!H9%Y/2@",6
M8EN.>E:!L8K50^<&J.\KR.M),TEPG4T :9N!)'M!JI-J7V2-@352SCFCDP<X
MI=0M?.4T <AXDUMKG>@-<]H<,O\ :<; G[U:_B#2FB)<54\/W217T8;'!H ^
MN_@O,T-M"6[ 5[E+XA B"].*\(^#]S'<0PJ&[5[@VBJ\(;VH L6&L"5N#S7G
M/Q8_9M\,_%)I;[:VCZU(2YU"T129&( S*A^^,*.A4^_)SVT=G]C?(K2CNBZ8
M!YKT,#F&*RVLL1@ZCA-=5^O1KR>ATX?$UL+-5*,N5GYO_$[X8:S\*_$<FEZM
M"3&Q)MKQ%(BN4'\2GUY&5Z@GZ$^T_LN_MFZ[\&;RRT#Q%/-K/@9F">2_SSZ>
M#_%">I4=3&>./EP2<_3_ (H\)6'CG0[O2-8MENK&X7#(W4'LRGLP/(-?#_QH
M_9]U?X2R+>K+_:FA2OM2\1"&B.>%E'8GL1P?8\5_0F3<29=QAAO[+S>"55[=
MI/O%_9EY?==72_1L%FF&SJE]4QJ2G^?FNS/UX\*>+M&\=:#::WX?U*WU;2KI
M=T5U:N&4^H/HP/!4X((((!%:]?D!^S#^T9JG[/\ XX@G,LUSX6OI535=.4Y#
M)T\U ?\ EH@Y'3=C:2,Y'ZWZ#KVG>*-%L]7TB\AU#3;R(36]U VY)$/0@_YQ
M7Y#Q1PS6X<Q*C?FI2^&7Z/S7XK7NE\9FN5SRVK:]X/9_H_,T****^)/#"BBB
M@ HHJKJFI6VBZ;=ZA>S+;V=I"\\\S X2-5+,QQZ $TTG)V6X]]$>5?M*?M%Z
M/^SWX--[/LO/$%ZKII>FG/[V0#EWP>(U)&3U.0!R>/R+U[7M4\9>(+W5M5NI
MM2U?4)VFGGDY>61CZ#\@!P. !7=_M&?&:]^.7Q2U3Q#,S)IZD6VG6H=F2&W3
MA=N0#\QRYR!RY^E<[H.EIIMK'?RO_I4R-Y<?(\M#D9/J6&<=L$'G/'],Y9A<
M)P'DKQV+5Z\TKKJY;J"[)=7ZO6R1^F86G2R'!.O57OR_/I%?J/L;>#2M',3(
MOVN;F:3.3CL@]AU/J?H*P980UQN4]ZM:C#/<2-M)Q2Z?H,['<Q-?SSF>98C-
ML7/&8EWE+[DNB7DNA^>8K$U,75E6JO5_U8U+'4/L\(5O2J]UJ"W#;:;?:9+#
M$<9KG\R)-@YKRSE.NTO3UD^;-6[RX-HNT5CV,TJQ@AB!4LET9#AN: (Y+QG8
ML*@G9YXS5K[$9.5'%1^68<YZ4 4+'3Y/.SS7216+[1ZU7T^YCW?=K66Z"XP*
M &1Z>^WGI4%S8X4D#FM3[<HCYIL,B3MSTH Y.::2UFSDXK<T_5DDAVO@TNM6
M4;+\JC-8D-J\;&@#5NK6.\8E5%5&L39J6J2W62/N:DN)#(N#S0!C2SO<2[ <
M5?M],DVAB2:C2V$<N[%;$>H1QQ8XH IHRQ-M88JR+%9EW*:R;^\\R7Y!5ZQN
M76,4 66A%NG-9UU.O8 &K,TSS-BHVLQMRPH 6Q4R\YXJ/4YXX5([TV2Z6UC(
M4X^E9C3?:)/FYH 8LS.QP*G\GSAAJT;>R1H\A1534$:V0L.#0!5>-;53S@UG
MOKOERXW<5EZA?RNQ!<_G69)(NTDMS0!TEUKT0A.<=*X;6-:5YB5;%0:K=MM.
MTUQ]Y<2N[=: .F_X2*2/@2$?C33XGF4GYR?QKBV\]F&":VM/MRT>7ZT =%;^
M*6F7:QXK)U28W#$JW6LG46^RY*G%8R:I.\V 3B@#H;6.:'DL2*K:GJC1YYJ2
MWN9&MLD<UQWB&ZD\QAN- %76=0:XDX-9>2>IHW$]>:2@5P-'<&ES[4;>:!'U
MI_P3C9?^%H3[N02:_4K7M/$DJO'QQVK\K?\ @GBPC^)TV?4U^L%PHDA5L]J"
MC&@:5$V9-3_9652[=*BCD43XSWJ]-NVY'(H SH;AEN!CI5^]F6:,#H<5#'=1
MJ=IC&?I3+J3OC% "K;NT9/48HL[GRY=I%6=.D#IC.:EN+5>6  - $SW$:IDF
MLJ\D1^4J*8MN()XJ-_N87DT 3V,AF^1CD5%=::T;[E)IUC$\9R1BM%I RXZF
M@##ED"KM;DU';LTC;<<5;FMP9,XJ:UA7<.,4 1KIXC^8&JVH1[5W9Z5JWK>3
M'GM7-WMXT\FP&@""/6S')LZBMZQNTG0<<FL:WT-G.\KS6O96OD, 1C% $EWH
M<ETI<9Q7GOB[0T$<@D0'\*]BMKR)8=N><5RWB+2EOBW&0: /BSXD:;#:W#XC
M"C/I7,^';6.XND XYKW;XO>"=\+LD?/TKQ;0=)DM-65#G[U 'T]\)-+2&*,G
MD8KU:?8I55 %>=?#%#;V<9(SQ7?32><P.,4 6/LK2*.,BN2^-$*1?#74AT/E
M-_*O0M("-$0>3[UP/Q^)3X>ZD N!Y;?RH _%+QYQXPU#_KHW\ZPJW/'7_(W:
MA_UT;^=8=!+"BBB@04J_*P-)2;2>] SJM)G22 +WQ5C:^_':N=TF1EF SQ73
M;QLSGF@8U;8NW6K<=NRK@$U':89AS6O#&G<T#,*X6:-L@FJKWDXXYKI;BW$@
M.!5"1885.\#- &;:WLZR DG%=CHNHG:N>M<D;N$MA<5JZ?=;<8H ]/T_7?*M
M\;L&M+1_$DJW ^<[<^M>;+?,RA5-=#H-O/<;2,XH ]XT/Q LT:@OS]:ZNSD6
M8!AS7DFA6LJ;-S$&O5?"ZAH5#'- &QM'EYQ2)J*V_!49K3:)5CP!65<68:3.
M* *UPTMY)\F<59M=/F!&215RUCCACW#K5*\U9HY-JT ; A%O!EC6#?:@@DQU
MJV)IKN(#)J.'0UD8E^M %6"\63' %6)9%D3&!FBXTH6[#'2AHQ&H/6@"A):E
M<G'%.LX TG-6Y9!)'C%06\;;CCB@#76"!8^0,UCWD2R3;5-66BE/<XJ@\;1W
M )S0!F>*+%8=.9L<XKQF34)(=1PO&&KW#Q),LVGLO4XKR"XT[%\7V\9H ^C?
MV?=>=KB&-V/:OKTW1&GHR\_+7PW\'KX66HPX..17VCX=U!;S38PQSQ0 ^"8W
M3%35KR?LZYI]O"BW&0*T+RT$D8(XXH S([PJU5]3LK37K.>ROK>.[L[A#'+#
M*NY74]013I+=HF-36N%Y85492A)2B[-#3<7='P'\=O@S>?"3Q.R1))-X?O"7
ML;IOFX[Q.< ;Q^HP?4#U_P#8E_:L'PDUA?!_BBY;_A$-1F_<7,KG&FSL?O<G
M"Q,3\WH?F_O9^@OB%X6TSX@>&+O1-4B\RUG7AU WQ..CH2#AAZ_4=":_/3XA
M>!=0^''BJ[T34,/)#AXIU4A)XV&5=<]NH/H0P[5_2G#^;87C3+9Y5F?\6*^;
M2VFO-/?_ "=C]*R_&4LZPSPF*^-?CYKS[_\ !/W CD6:-71E=& 964Y!!Z$&
MG5\G?\$^_CG-\0OA]<^$-8NVN-;\.A1 \K9>6R/"?7RR-A]BE?6-?@&;9;6R
MC&U,%6W@]^ZZ/YK4_/\ %X:>#KRH3W04445Y!R!7QS_P4:^-'_"+^!['P!IT
M^W4M?Q<7VP_-'9(W"^H\R1<9':*0'K7U]J%_!I=A<WMT_E6UM$TTLF"=J*"6
M.!R> >E?BM\9OB5=?%SXF:_XIN?.2.^N7:V@FD+F" $B./))QA<9QQG. *_4
M?#_)5F69_6JJ]RC9^LOL_=O\D?39#@UB,3[67PPU^?3_ #,;P=H)\1:Y%;D
MP1@S39SC8O8X(/)(7@\;LUTNN6_ES,J *JC"JHP !P *Z3PCH9\)^#5N9,&\
MU-5N&QGY8L9C7GV);/\ M#TKFM2NO,D<GDUCQYGCS7,WAZ4OW5'W5YR^T_OT
M7DO,G/,<\5B73B_=AI\^K_0PYF>)2:;;^(&A^4FJ&K:DRY45@H\L\V1DBOS0
M^;.^CUF.=</SFJ\MM;2-O &:R=/MFV N,5/+=)#E<T 6I+R.,;5 J6QM_MD@
MQ6"\S22#'2NDT6X2W3<W!H VET\PPYK*O(U#'<*=J/B3YMJMQ6:=0%P>N30!
M<MVCB;WK2B9)%SBLJWM?-YJX)X[;AFH ?<3#. *FL9 #DG%,\R"2,MGFN;OM
M:^SW&Q6P,T ==>3)MSFLK[4C28Q5*WOOM"#+9J[:PPELDT 7%8,.!3X[7<V2
M*L11Q;>.M1W%QY*G% %74@D,9(&#6)#=JTA!Z4:A>/,V,\4EA;H[9:@"_ L+
M."P%;"P0M'\F,USFH+]GY2K.DZEMP':@#9ALOFR:AU*%ECP*;=:PL2G8>:Q;
MC6I9,@GB@"O<H>0359<PD&GM<&9LDU%=7$<<?)YH V+76HH(\,16?K.N1R1G
M!%<=J>K+&Q^?%8T^M^8I"ODT 7=4U(%S@UB7%XYZ,35.ZDFDDSDXJ2&2*-?W
MC\T 0R2O(<,:S+Z$(K-FI]2U"-6Q&:SY)C<1D$T 9?\ :'ES8[5KP:PL<-8-
MY9E6+"H1N*XS0!>U#5%FDQ5O2;6&3#$"L'^SYI&RJDUJVT=Q9PECD4 :>K:A
M%8PD*!7GVI7AO)B>U6-9U"6:8J6K*W'ZT"8&BBB@D*7)I*4T ?4W_!/=-WQ,
MFYQR:_5MV+1K&K<XK\I_^">:[OB5-]3_ "K]5Q&=RL/2@LSS82QR;CS6I93D
MD(ZYIL<IDDVM4EPT=K(&H N3Z6BKY@4>M8%]G<5%=%_:2S0 #FL]K47#<#F@
M#*L9VA?%:\DK-'4%SI;VZ[P*+7S&X8<4 ,%KYW)XIIACM7!)S5]B%7 X-9T]
ML\DF6/% &AN2:#*@"LF4R-)A:U+=52/ YK.O6>WERJY% ",?(P7J6&Y@?H>:
MAEF%U'@C!I+6SA3[S8- %^ZA^V0X7GBN;DLOLET"XXSWKJ;61;=QW6GZAI\=
M]&2H&: (-/N(9HP !FH=0C"$[33;.S^QL<\5!?W(W\&@"OYC0G<6J[:R?:D^
M:LQ@TG7I6C'M@LRR]<4 >>_%2.&*S?H>*^?;>UCDU;>!_%7K/Q2U61ED5FXK
MRO0\7.I!5Y.: />OAW<(L$:-Z5Z,T230YC%>;^%=)FAMT<#'%>@:!*58+(>*
M )-/E>UGPQ.*P_C@L=U\-=28]?*;^5=U-:VSKN4#-><?'*3R?ASJ2AO^6;?R
MH _%+X@J%\9:B!T\UOYU@5O>/#N\8:B?^FC?SK!H)84444""BBB@">SD,<P/
M2NLMVCDMP>^*XW<<BMW369H^M!2-.%F6;CI6Y"I,8)K!MVVR#(K:68>6,&@9
M;DF"PFN8U&8S2%0:V6ADG! -5#HY5]S'- &1#IS_ 'AFM.S#Q, U;$)MX8<$
M D5D7EX!-@#% &_ITD9D4-7HNA7EO;6X(QFO'+>Z;<"O6NKTRZE,(R3B@#TZ
M'Q)MF"J>*] \+^)/)"EFXKY^BOGCD!W9-=IH>I331J QH ^DK#7H;J$$$$TR
MXO0[8 Q7 ^$)I"H#,:[9;<R@$4 3Q3'!]*S;Z0+)NQFM.WMR.&J>33895Y H
M SM-UA1\I6KTUXY;*<"J4UC';-E1BKEG(CKSS0!,LWVA/FZU/8V8F?#<BJ<L
MR0R8 J]:76WE10!8O]%2./*]:H6MA\W-7+G5&/!Z5&NH(PP.#0!(UJB\5FZG
M;QJ..M7'WMR#6+JBS$YR: ,+6866%B.17 7=PL<Q##O7I-P/,MR'KS7Q5;^4
M69.#0!T'@_7EL]2CVGN*^R/A?KQU&RB!.>*_/?P_>21Z@A9R,&OL/X)^*[>&
M*".289X[T ?2XC6/:U3RW!*8!JM;3)?6Z/&=PQ4OE<#(H K2!FYZU-';B6,\
M<UI6]O')"21S4<&V.4K[T <G>QR13,O.,UX=^U5\/7\2^"(_$-M%NOM&),F!
MRUNQ^;_ODX;V&[UKZCOM+@DCWX&<5B26*2*\31J\; JRL,@@]01W%>QE&95<
MHQU+&TMX/;NNJ^:T.O"8F6$KQK0Z?TS\[?@=\6-0^"OQ,T?Q38EWCMY1'>6Z
M8_TBU8CS8^>,E>A/1@I[5^S'ASQ!8^+/#^G:UI<ZW.G:A;QW5O,O\4;J&4_D
M>E?C7\=/AJ/A7\0[S2(=QTZ9%N[)G.6\EB0 ?=65USWVY[U]N?\ !-OXJ2^(
M/ FL>";ZY22?0I1<6*,Q\S[-*264#^ZLG?/_ "U XXK]MX]R^AFV64L^PFMD
MK^<);7\XM_B^Q]IGM"&*PT,=2Z6^Y_Y,^R:***_GH^ /GS]NKXA'P'^SSK4$
M+A+S7I$TB+YV!VR M+]WK^[1QR0/F&<_=/Y8^%](CU[7K.RFD,,$C%II%'S"
M-06?;QUVJ<9XSC.!S7V/_P %.O&GVKQ5X.\*12?+96DNI3JIX+2OL3/N!"__
M 'W[BOC;2M0_LFSO;H. [!+<#O\ ,=Y;/_;/'_ J_I#AW_A X0JY@M)R4I?-
M^[#]'\S] R]_4<JE76[N_P!$>L>+O$GVP.X(^;)PO05Y[]M\Z9@36:WB!KA0
M"^<U)&JM&7#\U_.#;;NS\_*FMQ)R5;)K/T]MC<C\:6ZCEEN,9)&:=<0O;PY
MYI :3WVV,A3S60WFS39).*I0WSK(0U6_[0"KTP: -BT6.-1O/-)=WRQ\*V*R
M$N&F[TR2%I&ZF@#4A'VK)S4T-G)YF1G%4]/D%N0&:NJT]XY(QCDT 1I,UK![
MXK-82WDW4XK0U'<>@XHTB,M)\PH 0PFWAP2:Y^]L_.FR.N:[34+/SU 5:J6^
M@[/GD% %+1]-RHW&M*>S^S88&K"^5 ,# JM>:@@X- $MO<-MJM=73OE0*;;W
M0;@"I6E5<Y6@#)FA?J11 SIT%79&$[8 Q5B.WCB3+&@#,N6:1?FX%9K,8S\A
M-;5T\<GR@U'!I@DYQQ0!CPR2R3?,3BM<V,;0[B_-33:6L2[L[:PKZZ:%BJR<
M4 1WT@M\X:N8U+4FYR_%6=3OSM8EJX75]4+,P#\T 2ZI=&5CAZJV\@@^9C6.
M]R^XL6S5&_U";;\I(H ZJ;5D=2%QFL>19)Y"=Q"YK&TN:::8;FR,UT]Q+%;V
M>>-V* ,^:WCB7+-DU0FU 1\*,UF7FI/-<E03C-;&GV$<RJ7ZT 5DN&N."M7;
M;3XY,$FM(:7%&N1P:;#9C?UQ0!KZ7I<'EY.*P?%E[%91LJ8K2DN19PME\<5Y
MQXBU%[NZ;Y\C- &9<3?:)"W2HZ**"0HHHH$%+NI!1_%5(#ZH_P"">[%?B5-C
MU-?JPMSMP.^*_*C_ ()ZC/Q,FP.YK]4FAW2+]*DLEM_GDW9YJVVF"_D&6I(M
M/=4R*DC\R%Q\V* +S:&MK#E3DXK'9IH9L+G%=!#(S1_.^ZJUQ<1!L",$^M %
M22X?R0).:N6<,4EJQR,XK/U&8/'P,5GV]Q<*,!B!0!;DA/VC ;C-0ZA,;=?6
MEMUEDFR6)YI-2;^%ER: *"7SA,BK5G-]L;:ZYIEN8XOOIQ6S8?9FP549H QM
M2L?LZDI\M9$*RR3#YB>:ZS6D1H3AL5SVG K<<C(S0!IOB.V&>&Q4%KJ#)N&[
M-6]7M2]KN0X.*Y""29;K86.,T 7]2U>?S"%SBI-/@DO!ELYK072T: .ZY/6I
MK&ZAMF*[0,4 5VL6C !-5=4U*+3+-M^,XJYJFJ1_PMBO(_BEXF:TLY-DO.*
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M_-6!>7C6\PYR* -A(W1/45D:M<B/@BM&VU+SH0 .U9&HPM<3=.* ,:XD,JD
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M84[B7/%8^JW:QD@4 6M;UPS)M#8KF78LVXG)HDE,C9-1DF@04M!HH)"BBB@
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M[1\4)Q[G^0K]5=4MW@G&WIB@HKP1/YO)XK2DC,D>W'%9\+,O)%7X-2CQM;%
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M0]+::96)QS0!ZMX+TF-80P7M7?>'[57O43'&:X70+PZ=;JO7BO1O!L9OKA)
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MZ;I;V7SOS71K!ZBJUY=*OR8H S[F\,^(U6D72U$>YA5^WM8\!\<U-<8:/ H
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MS)J7_I5)7SAXRT7[1XHOI\_>V?HBBOH[X_?\EW^(_P#V,FI?^E4E>!>*G/\
M;ETH/]W_ -!%?K7'G_)-X3_%#_TW(]S,W_LE/U7Y,Y,6)C?&>!5AHQMQ5I83
MG)IJQ@R<FOYW/DS-DL68Y .:TK&P=E&1BM:UAC"C(S5O8@7*KB@#-95A7! K
M.N]2$)PN*O7\PY '-<_)8RS3$]10!I07AN%R:@FNC&V!3/)>UCQBL]I#)-@G
MB@#8MT6Y^\*N26XABRM0Z>%\L<BGW$C!3CD4 8]Q?R0R<5/;7[RK@U2NF)<Y
M%6M/V'KQ0 7%N\S94XJWI]T;#[S9J.XN%A![UD7%S)<286@#J)M<\]=JFLB\
MO9XVW#I4FDV:+S*U3ZI);QIA>: ,9O$$Y^7&*?',;A<LV*S)V'FY459M=S$=
MA0!?CA9NC&J]Q8AY.:TH66&/L355Y#))D4 0PPBUY5<U9^V2[,8XIV\;>13E
MFC"X.* ,FYNF5JB-T77%7+R%)CD&JZ6ZI[T 5X]-^T-D]*O0Z=%;KDGFA6*\
M+2F&21>30!'+=+'PIJNC>9(":K7UN\,G!S2V\A7KQ0!L_;C;Q[5ZU4FUJ2/)
M)Q3-R*I9VK!U2^$K%4H CU+4)+V8Y;BJ-"@]Z#02%%%% @HHHH **** "BBB
M@ HSFBANU SZY_X)NW!M_BC,?<_R%?K9<!;AE9O2OR$_X)YW MOB9.S' R:_
M435_B%:::NUWP0*"CIM0>""$Y8+7EGBWQY'HK.5D''O7*>./B]''&_E2G\Z^
M?/&7Q0?49'0R')H [SXA?&)KY'C5_;K7A>N:[)>2,Q;.:RM6U5YF+;LUDK=/
M-D'F@"'6)O,C)!KEKC6#$=E:>M3/%D#I7--9O=/OZ4 :$=V9N :T;/2UNOO&
ML*& PMUK3M]0:+ !H MS:7%9S CFNHT*=8VC8=017-HQN.6.:OVMT+5@ <T
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MUXW5 UO)&X):@#JEN-W(-5IH5FDR1699W$I8#-;2+NCS0 ]%18\5EW5TR.0
M:T%P.":K74D*]: *4MP&A^;BLP:;#=29;FKMSMF&%I;6,0KDT 4=0\$PW5JS
M)UQ7D_B#PO)I]X1SC->\0W#R1E1TKE_$6BB[8OMR: .)\-E[54PQ&*]M^'?B
M=[>:,,W&17C/DM8S$$< UKZ1XJCLI5 ;!S0!^AOP[UZUO=-B#.NXBO@G]L!5
M'[17BW:>/]$_](X:]2\ ?%9[%H@9&*_6O#OVAM:'B'XP:]J .1,+?K[6\2_T
MK];\,_\ D<5?^O3_ /2H'NY.[8B7I^J/NK_@F?\ \D)U[_L9)_\ TEM:*/\
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MV:VDW9[5<MH6SDC-2S2 +R.: &V;&UCR35'5-4-PICI+B\#*54\U1^RM(=U
M'+:M9F-RX'/6M[X?^*#IM]&K/QFHM;M_]')(YQ7FTNM/INI#J/FH ^[]&UA=
M7T>/:<_+7G/Q(\#G5K&X;9N)![5'\%?%7]J:?'&3N./6O6]0TTW5BXV<$4 ?
MDO\ '+PC)HFK2D(5^;TK!^'.N-IMY'DD8-?6'[2GPW^T32S>7WSTKY%N-/\
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M"1<]ZLR7R?<H Y[4K<W",@&:\V\4^&65C*5QCFO89(D3YS7)^,&6:U<1C/%
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ME^TF5C/-8[:3=W4FXDXH UYM5$D! .*Q7CDDDR#3[G39X5 ':IK.*3R^1S0
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MS7F<4K1OG-;VEZD8V!)K\JC)Q?,MSZIVVEL>HZ1>>3)EFXK$^.&H)/\ #K4
M&_Y9-_*J4>L+]FSGG%<;\5M?\_P+J";N?+;^5?K.2X[ZYA_??O1/D\90]C/W
M=F?E#XX_Y&[4,?\ /1OYUB5L^,FW>*;T_P#31OYUC5]$>:%%%%(04444 %%%
M% !1110 4444 &,T<BBE^]0!+%=/'WJY%?;QAJS>E/B^]04B\9-K9QFK5O=%
MNH(JHS+M%2I<1HOO0,W[-HUVL6 ->H?#_P 6-ITBH&XS7B<,WF.,' KKM!OA
M:[26YH ^PO"NO#4(4.<G%=C"IG7&*\)^&/B:'"*T@_.O=]%U"*= 5(- %NQL
M_L[[R*L7UP\R;5'%,N;@=C4,=XN<&@""UN#:O\PIUY-]M7TJ:2-)SQ36C2$
M$T 0V6D*S;BPK56R",%!&*I)D?,IXIK7DBN!0!IS:.K1DD@UE26L=NU6_MDO
ME\GBJTC"7J>: $CFVM\@IUS<3L,8-0QJ5DZ5NZ?8F[7D4 9MG))#R0:L32&9
M<DUH7>FO''P*Q)%E1\$<4 0'36N9#M&:GBTEH3\RD5K:;MA&YN:??789OE%
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M/[()QXXES_>-?=VJ,/)!'I2++']J)&.#BL^\U8W#8#9-8T;-.Q7/%+!;/'=
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M+FZH_.[Q0^_Q'>'_ &V_G675O7)/-UFY;.?F-5*_63Y,****0@HHHH ****
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M848C./K7D2X9Q2=U)'6LRI=4+\1O@GH^O12SQ^6LP!(QBOD_Q7H&I>$=6D1
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MHW4/VB,XYH Y+FCI5BZMW@D.1@5 WS#B@D3%%+_#BDH$%%%% !1110 4444
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MMN-0DCEDC8C.>E=M\(_@^-7,4\L>[//(KZA\/^ +30;1 (U! ]*_0NED?/\
MD<_\-_"+Z;!#&$P..U?/'[25N;7XT^(HCU46W_I-$:^Q8];L=%7+,J[:^,_V
MAM8CU_XP:_?Q$-'+]GP1[6\:_P!*_6?#7_D;U?\ KV__ $J!M3T9]T_\$T/^
M2$Z[_P!C)/\ ^DMK11_P30_Y(3KO_8R3_P#I+:T5\GQ9_P CS%?XOT1$OB9\
M&_'[_DNWQ'_[&34O_2J2M_P++/#X5LF7.SY\?]]M6!\?O^2[?$?_ +&34O\
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MN!^90XIGQ+M8K/QMJ,,*!(T\H!0.G[I*^EK?3(=-LDMH%"H@P,5\X?%A=OQ
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M*H*S)HV60.:N1LL>=PJG?7@9L"@#6MKI5A 8U"\"S2;U-9F]I8^*LVGF=,T
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MO_(WJ_\ 7M_^E0.7$:01^I/_  30_P"2$Z[_ -C)/_Z2VM%'_!-#_DA.N_\
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M1"+;%DFLV^U+;&&S6>/$6[Y,T 3ZI.$3 K$:[VYS6DTJ7()8U@:M<)'D*>:
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MGH\:RE,R]237GXC%PHJR>I[^79/6QTE)JT3F/ 'P\A\,V<;N@,Q&22*[=V/
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M_P"":'_)"==_[&2?_P!);6BC_@FA_P D)UW_ +&2?_TEM:*^4XK_ .1YBO\
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M!BN?)_ASTKT*[T *K1%<8KU_X8^&X;'PK!'C.4 _2N7\>6D>DS2,O% 'Q_\
M'C1#9V\I'%?%GC!?+N9#[U]H_M#>(@UK*/K7P]XIU);N\D7/4T <9<MYTC#-
M0?9RO)Y%6Y+0B7<*==,L-N2>M &5]E\R88'-6=0N&L]/=2<<5F0ZL%N<>]3:
MTS75DS=L4 >=73>9=2-[U%3Y_EF<4R@@**** "BBB@ HHHH **** "BBB@ H
MHHH *2E%'&>: "M"QMT;DFJ<,+2.,=*ZK0/"L^I,JQAB304A+578!(R:]Z^
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M5M)'F$A:AL8?)ZCF@#KOA^[6E]"7..17WY\"=02YA@4-S@5^=&GZH]O>QXX
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MY[UFS:U/J=PS%CR:/.FC..30!)?6,98$'%.CM46'WJI-)/-P :?;QSA@#G%
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MFEU)4MI"'J*WNH0.!S0!F312VY9AQ4^D,US, _K5^9TFCY'%5[>2&WD&P<T
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MA0 ^>^63@&IK601KNS6!>$Q2<5>T[?,HR: -&ZD$Z\"HK%9!, 0<5H6=GYC
M$9K;_LM(8]P6@#/:2.&,%Q67?7B2?<7%,UII5D(!XJ*U7S8N02: (]WG+C%,
MATN3S0PX%3*RV\F2IJ]%?)(N!Q0!#<;;>'YN35*&:-V.%I^J2G&,YJK8S(.H
MH R?$'1B*X;4)E5@=N2#7H^L1I/&V!S7"7UFJ3'=TS3%J>N_";6$O-)2/HX'
M2O1[9MK<]:\3^&^H6^G7B*)552>A->\QPQ36ZR(<Y&>*_(\[P;PN);Z2/KL#
M6]K32ZHLPS@U5U2%+JW>.1596&.13 VQC4-Q,64U\[KNCT'V/FCXQ_L^MJ4T
MNHZ;M5^6*@5X+"UWX5U#[/<AHW0X]*_0+:9 0PW*>QKPSXZ_"G3[ZSDO[;;'
M< ;B/>ON<FSFI&2PU?5=#Q,7@E).=/<P/AO\2H[,()9OUKZ#\.>+;'6[=1O5
MBPK\]I/[1T>Z*%F7:>M>T_"3QA<PR0B:?T[U^BZ'SUFM&?2WB[P-!K%J[Q1*
M21V%?,7Q&^'+V,TA,)!!Z@5]I>!=8LM3TM!(RNQ%<I\2?!MOJ22,D>?PI"/B
MOPOX\U/P'<"(R,( >C5ZOIGQODNK,D L2.M<%\5? DL4LGEIMQ[5Y[X=U";1
M;C[-=?=SBN667X/$.U:%VSUL)BI1_=MZ&?\ %G3=0\3:X]\HW+G.,5YE<6TM
MG(5E0J?>OI0+%<1[MJD$>E<YXB\$V6K0.R)MFQQBO46%C3@HTMD77P?/><&>
M%8[]J2M37=!N-$N&613MSP<5EUSO31GBRBXNS"BBBI)"ESQ244#+EG-MP*VH
M1E-W>N;C;8P-;5G>;U"]Z"BQ'.6D*,:F:W,;!EJ&SMV^U!I.%S6E>7$<> G-
M  MR60*PJ7RUV@YQ4$*_:$X'--82HVT]* .CT>'S>,9J:ZM75B4XJKH=YY+
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M9J4;WIW+G%>SYG$6(;A"I(Z5G:M>*T+@<G%+N%M;D$\U@W4S'?SD4AF!<?\
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M[^\1FA(4GN* ,3P_X+21E+J>?:O4/#_@."55&WCZ5Z/I?PC:&&-MO.*ZS1O
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M<ATV.23YC3[95=?EJ&X66%LK0!/>:?%"F5P35&&8[]IZ5+YDLRX:FPVA+9H
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MQ7PG$]&/)"JMSW<LF[N#V-2W;:U3R8\F7/I44H$)-9/B/6%T;2)[EVQA2:^
MBG*2C'=GO\R6I\:_'W36OO%CA%S\_P#6L2PT7[-X?FWKSM-=;JFL0^+O%4QQ
MNPY_G75:QX.:/PM/,D? 0GI[5^WX2$J>'A&6]CXFM+FJ2:/CS51_Q-)Q[FJU
M7M>0QZU<KC&&-4:ZSG84444 %/B0S2*BCECBF9[5TO@G21J&I)N&0#5I7=BX
MQ<I*)VO@?P1%#&ES+\Q/."*]"CC2%0J*%%,MH5M;=(U& !3L5ZD8**LCZFE3
M5*/+$=WK+\47GV/2Y&SBM3C(KE/'#--;B$'K2F_=N*M+DIMF#X+QJ&J9QN+-
M7VO\%?"ZK:Q2E.P-?+/PE\*B2^A)7)R*^UO"\B:!H*L%P0M>5UN?+O5W+OQ$
M\1C0])=!)MPOK7P[\2/$3ZUK$JB4L"WK7KWQD\=7%[)-$&.WI7SU;V\U]K*D
MJ6!:A*[L$5S-1[G?_#"R70[J.[9=V3DFOL/P;>0ZUI<4J$'BOEC3+%H[5$ Q
MQ7LWPG\4)I+"VN)-L?O7A\193]9PRK4E><?R/K<-%48J)[=;V:[>E5=7UNTT
M.W=Y9%# =*Y_Q!\0K:T7;:N)"1VKRCQ5KEUK4C.TA5?[M?"X#(:^*:E57+$S
MKXZ%/2.K,[X@^-I=:U!EBDQ$#BJ6B2I)#^\EYKE-3MIO.) )J[HMG<S,%!8"
MOTW#T(8:FJ5-:(^8E4E4DY2.J5XFFVJ^>:](\$>'%U$H2,_A7->#_ \EY,A8
M9S7TS\-/ <%K$K2 #ZUT$%KP5X5MM-17*@'Z5V]Q)$L6%[5/=6-K:Q!8V7(J
MO:K!)A6:@#$FU>6W8[<@54FU1[X[68FNUD\.VMQ"6R*Y^XT&.&;Y#TH Y/5M
M*D,19>:XMO#,M_>8=3C->M7BI%'M;I5&V2!I,H 3F@# T_PA'8QH^WG%=1IJ
M11Q_,!FK<ZK]GP1S60TAA?G@4 :$DRS2;%6AX4M_G)YI+62';N4Y:JUZ9)V(
M'2@".ZU(R?*HX%)!,K !CS6>T,B28 S5B'2[A\, : -ZQC:3 Q\M;=OHMG,N
MZ3&:S-*AEC4!UQ5V^NE@A(4\XH @U2.UMUV1!<U%H^DM>9..,UQVLZU(DS$$
M\&K&B^.WMUV <T =5J4$FG,<#BIM-F^V1X9MM<_<>)#?$>9QFM+3YE\H%#0!
M<N/"<=RQ?<#7R9\:[,6/Q.UF%>B^3^L,9KZLDUV2W)4=*^5OC1-]I^)>L2?W
MO)_]$I7V'"[MC9_X7^<3GK_"?7W[ HQ\'=8_[#TW_I/;T4[]@C_DC^L?]AZ;
M_P!)[>BO'SC_ '^MZFE/X$?'_P 95'_"W_'/_8=OO_2AZPH9 NFHN.F?YFNC
M^,:C_A;WCC_L.WW_ *4/6+9VZS6*C///\S7U>?/_ (3:7K'_ -)9STOC9@M-
MY<N0M3S:EY<6<4W481;O40MVGAZ<5^>'8:&E:GYIQ6C)?[3CI7.VP^QO5UKK
MSAP* &:BR,VXUG?:!R-N15QH6GDQVJQ_98C3.W- &?:LN_[N*U86Y&*RKA6C
M;"K5S3XY&Y;I0!K;@R\\TQ62-JBFRJX!YJNMO(S9.<4 =#:W"-'CI6;>Q&20
ME359I'@48-2176!DT 0ONBP*T;+;(O-9=Q>":3"]:6*22$9SQ0!?NK02/P*O
M:7HHDP2:R[;4@S8:M-;YDP4.!0!>NK7['C:<BGQ[9H\'&:KK<&X7YSDTR20P
MY(.!0!A>(+H6#' K"COGOVP#BMK6-MYP>35*STW[.=VWB@"QIL,D,HS6_>0?
M:K;[V#BLJ&Y0-@\&K^YI(\*: .>O+?[+G+YKDM>_TB-E5JZW7-/F920:XG4(
MWM]Q<T >;:[9S0SD@DC-9<TF8"&':NC\2:E"JMR,UP5UJOF2%0>* ,S4+59)
MB15FSN?L: ;JCG?<">AHL=/-Q)\S<4 :$&J%6SBNETKQ1Y>%%<S?6J6T. 1F
ML*&^DCN."<9H ^A?"^M"]FC&.]?7OPA6.&QA<CM7PO\ #:^,UY"#ZBOM_P"'
M*L-%C(;!VT =UXN\?1Z#;E@>0*^;OB'^TP\,DL"%O3K6Y\:+B\6WD\N0XQ7Q
M_P"(/.N-1D\YB>: -3QY\1Y_%"R<L2U>=>&_"#W&I&YN%RI.>:ZB#[):X:4
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ML&9HY/#_   ?EKT#Y<^6O&E@;>Z=QU!KTWX-^(!<:9]GD?##C%<)\2F\N:3
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M0Z6TAVJ*L+));_,A(-1[67H.*FC!; (KU+'T+5]R>UU>3>/,8GZUN6]U%<J
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M0.E<YJ-PMQ<87@9H**]KIZM(&-=)'=K#;>6O7%9BQ"*$,#S5C2X3<3#=TS0
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MS GUH^*'C">\U:94<XW'O4/@V%+_  TGWJJ,>9V+A%S=C/U33KN\PP+5CR^
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M,<5IVI,S<U/';1K'CBF+(EJW% &S;S>4O-,FU+RZRI-1W+2Q:C"W#$4 :/\
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MM:'4DNY-H.:NS^'C>P%L4 <AIMTS-R:VX;Q8W -4'T.2UN"JBM6W\.S/#YC
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M,B02>AK$ODGCX4FBR\P*2Q- &@+A;:3&>*?>2?:(>*PKV\\F3K3X]6)C  H
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M"PE2.0 FMN:$_9]ZC H IZA<((PHP3BK6CPI+'\W%9+Q^;)C.:N*LL(&W.*
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MF<5X_P#$:)8_&6H*O*_N_P#T6M>[D_\ O$O3]495-CZC_8Q&WX7ZI_V&9?\
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MMB&X2U4*.#42L&X%075FV0P- &FT9NDR#51HF@SDU+IH.,%JLWFF&Y7Y'.:
M,*Z=-W.&ID-[%%_ #^%2SZ4]NWS9-5T10V"N: +9UGY<(@'X4^SOGFD^>FI
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M7B1&/B*[XX^3_P! %>U_$U?^+D>+/^PM=_\ HYZ\BUR^MX?$-U%(!O&W_P!
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MUPDS#!J2WTE+J+<>: #3-2W39"8%=-)J]LUKM<+G%<C+";%B%K-O;B9\X)H
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MP=O% %O6([=H=RD9Q7%7$G[P@=*O:E-)]W<<5FG./>@1HZ#'YEP170W%FUL
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MR,,!6XQTYKI+C7/M<)Y[5S$EX4N"?>@#KM+\N%06-:_VB&9-JXKC[><S1\Y
MK4TN+]\,L2/K0!:NHPK<"H-S*IK=EL0T>0.:RYH6C;&* ,N6![EL <5LZ/9_
M95RU5X[A+8_,*;)J+3-MC- %G6E$BDKVKF)9I(R:Z>.WD>/+56FTLR9^7]*
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M7KGRIEY%9&CV$T<:ECFM<VV[K0!G3[8U.T<U26ZF5L+5^]A*=N*6Q6/<-XH
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M=!9P"&/)KE?%5\JL02 *!GGVO0K-(2%K#;$*D$5U-U=6K*V3DUQFN7&YF$=
M&%XBDC*G'-<#JEJ+AB0*[B:Q:=27-<WJEN+?=M- &=HX6Q8;JZ1KQ&CR/2N1
MMUDFN.>E=18VH* /0!0N-0V-TJ);SS/N\5IWUC;^M4&CBMTRO- #9)7;C-3V
MJR,PR>*I(S3/\HK5A_=+EC0!,ZC;S6KX?AB^T#<:YVYU!5;&<UJ:%.T\R[:
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M7W_81D_]%144_P#9Q&WP1??]A%__ $5%16%;^(QK8\6\<(/^$U\0?]A"X_\
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M',/EQS0!]/CQ#_;E@K(>HJOID$GG]2>:\Z\+^,$M;6.+MC%>D>'=>@DP[;:
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MLR"2&R.-W%.D2._D&UJ *Z6H53*),_[-<M\566Z^'NIAHQD1M_*O0+K2EL;
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MY%;%M#*W7-5M265.BT 6=&<LPR>:Z&XG\NW^]SBN+LKF2%^1BM*XU(>4-S4
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M+:R?+736]Q]H R<&DN+#<2QP: ,.WO9$7#5()UD;FGW5J58@"J3V[V[;CTH
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M=M ' :YXT;0H&C4[2HQ7BGB_XC7%],X5R>?6NN^)M\CS2[>.M>-92:\PP[T
M;&DWUUJ$WS9(-=E#8Q1VX\P<D51\.Z?!'$'QCBJ'B?Q(+(E%.,4 5?$.FQR*
MQ3]*XH1R6MQZ#-;4'BA)CA^:;J$D$T>\#!H (_+O(=K 9JFWA\+(748%4[>]
M\N; ;BM<ZMMCP3GB@#.N[=X5PIQ64]V\;8)S5N_U-Y&(452@M7F?+# H F74
M!M^8<UIZ5"+YAAL5D7END8X/-6-)N'M7#*>* .AO-)%LN36/<VLC_<Z5HW6H
M2WD>/056TR]#2&-QF@#,\N2W;.>:6]DVVI9ADU+X@D-O)E1Q4%K(M];[6'-
M&;IC>=<9'7-=F)_+L]DC#&*Y>.$:=+D#O4TEU)>,%!P* )&C22X_=^M;&GV#
M;ES1H^BG:'//>M:.1890I7F@#>TT/8Q!H^&Q71^&?%>IVNIQ$N?*##-<3=:Y
M]D4?*35K3O%<87[N#0!]BZ!XZL-3TY()9%#[<')I+G0;/5%?8H<'TKY8T76K
M^XO$^SRD#/K7TKX"NIH=($ERVX[: /%/B[X7M]!\R5(^:\/TWQ));ZE@G:,U
M]$_&+5H=0:6,C-?-&H66-4!13C=0![%ILYU*.)P>,5Z'HNL_8;58_;%>?>#]
M/9M+5L]!70VD^V;RV!- '8369U)?-C')I-/5+"8;_O"K6DWB6]MU[5491>7F
M1P,T >O_  YU*6YN(P#\N:^F=#\G^R5+#YL5\M_#T&VGC"U]4>$; WVDISVH
M Y_5(9KF0B$X%8[?:+&0;S@UW>I6 TU21@FN,UIVFW<8H V_#^M!<+),OTKH
MI(XKI-Z'+5X'>7E[9W>4DP,UV_A7Q>X5$E;<: .PN)#%D..!6'\2-<6/X>ZC
M'&PSY;?RKIYE35+'Y!AB*\^^)&CRV7@S4"S9!1OY4 ?D[X\WW/C/4&/_ #T;
M^=4K6(*H#&MWQ]"(?$U^P'.]JY%;IF;KB@"WJ%FLAX-6=,MUAY-4/M6& )S5
M^WW3+Q0!95R;M-A[U],_!>\DCM4XYQ7SEHMFK7:>8<<U]2_!^UM4M4QR<4 ,
M^*FJ2_9VW\#%>#S:M&)FYYKZ!^,%I";%C[5\K:T_V>[8*>] &O>SI=' ZU7A
MTUA("OK6/;WC;A71:7?AF4$9H [_ ,$R&WDCR>:][\.R375JH4$C%>#>%[=K
MBXCVJ>M?2/@>P:&S0E>W>@#'U[2[N.)F08K@[AI(9F,K<UZ_XFO/+A91CI7D
M>I0/?7C >M $(U=D8!.:L_VE=3=2=M6+7P^J(">35Z&T"C&WB@#+D4/&2W6N
M=N9GCNL _+FMS79'MHSL0BN.DGN)9>E ':Z;)%)$,_>K?TZW3&6/%<=HR-'#
MODXJ6Z\0/&WEQG\J -[5[J..3:M8<S"608'-+:QRW[;FS4US&+$AF[4 ;6D6
M;+&'/RCWK.\2:L8<HI&:@M_$$DWR)PM4[R'[5-E^: ,5;F69B2":OZ?8W,TR
MY!VYK1M[:VMR-RUJ+J4$,/R+0!MZ:T&EVX9V&ZN:\7^(EN$(CY-86M>)1&Q7
M<?SJ+1_+U.0%^10!B;[NXD/!"FM72[=U;!/-=C-H]M'9Y106Q7*SS&SG.!0!
MO0VS1IN8\56FN)7D\N(&H]-NI]2D5.BUU$>FQ6,8D;EJ .8N[!X8#++QWKC[
MS6HVF\M#\V<=:[7Q)JRWD30HN.U>8ZE8M:3&1<DYS0!U,*R_8][-FLQ;R9IB
MJ=,U6TO4+F\41$$+TKI[71?+A,C8'&: *IOF@B!+?-5C3=2:Z;YC6'=S*UT8
M\\YK8TJR90&44 =':SE9%R<"MJ^O)C8@1'G%8$<>Q07XHN->^SQE5&10!'81
MW#7#&8\$U]A_ ^/;\+M% Z?OO_1\E?#MYXBN&DPBXK[<_9S:2X^#7AZ27[[?
M:,_^!$M;4OB$SZK^"8V^%;K_ *_7_P#1<=%2?!D;?"]U_P!?C?\ H"45$_B8
MSS3Q1'_Q4VK_ /7Y-_Z&:^-/CU8N_P 4-;D7_IA_Z(CK[3\31D^)-5/_ $]R
M_P#H9KY)^,D:-\3M<5CS^Y_]$1UK4^%$H\:;4)K<[#P*NVJ+=#+=:MZMIL3'
M*U4LH3"WL*YRAT^GHO..*DL;%2WRL!575+^1,@"FZ1<222#)Q0!LWD/EQXSD
MXKFY;J6&8UU[0^9%R037-ZU;B,?*.: +6FWAN,!JV&T^&:/.1FN8T@M6S^_V
MY7- $@L)4;]V>*NQ^9"O[RJ-OJ;VY_>+5BXU-;B,X&#0!%-<0[OFXK"UC585
M4@'-5-<N94!V9KA[[4IEF.\G% &EJ&HEF.W.*P;RZ))+&I_[2A,9+'FN:UC4
MM\A$9H EO=6$*, >:X?6KR:\F/S<5=U":4Y-<S>3OYF : -6S,D$>=XJ&XOY
M"V"U1V<,LD?)XJO=VKJ2<T 6DVLF6Y-9&HQAF.!2_;O(^4M36OD=N!F@#%EA
MGC;* UL:/J;VN/-J_ 89H^5YJO-IZ3,=I H ZG2M8M+PA6%+KUG!Y)>+ KFK
M6V-G\RDU+>:J_E%6)H SX[Z2WFP#WJY=7;W$.&K-MU$LI8\U8OIO+BP : *)
M41L3FH?MPAE&#6==74A<]A4$>68$F@#VSX;:]F:-<XYKZ9TY9+[1UVMD%:^/
MO #%+J+![U]=>#[K9HR9/\- 'E/Q"T5HVD+&O(ET_P#TXX'>O:OB9J"M)(H8
M9KS"T\M9&=B/6@#8LU-O9XSCBN'\0V4M[</WYKH;W7EC^56'YUG"Z21MQH Y
MB'16A^8TV]9T7:*Z:8I(IP16<;>.23!H Y$>8LN2#5R%GE8#-;.H:.=A9$_*
ML>.WEADZ8H V[72(VCWMR:JWA\D%40G'I5W29F/RN>*VOL%N4W-C- ' LCS2
M?,"*NP0B*KVN1Q0$F,5CQ3/-Q0!NV\T;1L!UQ5:WA"2&3H*BT^W=926/%7KI
M0$(4X- &??.EYD5F+)]FDP.!5]+=H22]5[N%3&6[T $]RDZ@#EJFTFU8S!F'
M&:S=#L)KR\X^[FNV98;&(*>&Q0!H6-U' F"<52U"]0RY05GJDEU-\AXS5^XM
MDM[;+_>Q0!3NKQ6C!;DU=T6T&H,H53DU1T?2VU6ZQU7->K^%_!ZVS1$)W':@
M#H?AWX)>29#MR17L,RMI.GF(C:,56\%64.FJLDA XJG\1/$426<GE,,@=J /
M'?B)(9IG96S7"6.DQWDXW+\V:9JWC S:D\<I^7=73Z%Y%U&LD8^:@#L/#^G?
M8[, =,5I6UA&SENC5)H=L9(1GIBIFMY(YSCI0!3U"\>S7 Z5I^'KL389NM9F
MJPF9=J_>IVDYL?O\4 >Q^"M02&Z3)QS7U/X%UD?V4FUATKXI\,W[3W2A#SFO
MI;X>WD\-BGF-\N* /3-0O&NY,=16+JEFKQ' YJS#J<+, #DTZX!F^8<B@#S3
M5]%D+LW:L&'46T^^1!SS7I^J6OGQE0N#7+CP>9+KS&7/.: /1_!]VM]IZDL%
M..]8OQ>;9X+O^<CRVZ?2JMJTVG1B*+BI_'D9F^'6H&8C=Y3?RH _)#XD:A&O
MBB_&?XV_G7#_ &Z/S.*[CQ]H/VGQAJ'/'F-_.N1O_#WV=<CD^U #(Y/.<8-;
M5G(Z* !S6+I=JZR@,IQFNNA6"&$''S8H GTJUEFN4;.!FOICX/\ EPQHKR#.
M/6OEI=<:WD^05WOP_P#B!<6M_$K,0N: /HCXKV"W&FLR9(Q7R7XCLS'?."#U
MK[#L;B'Q5I"H3N8K7E/CGX6B&22?: .M 'AMG;+)@ 5U_AW0TED4L.*RM0L5
MTR8JHY!K8\.ZLRRHI4T >P^$]*MK7RV Y%>IV.O+96>!QQ7F7A9?M$:-NQQ7
M630E8,;NU %'7_%K7$S)VKF_[4VSY'4U:NM.WS,1R:HMI,@G5L8% '26%T\T
M8]*U8?+C7+\54T>%%A 8C-.U0-L(CH RM>O+:3Y%'-8\.EHWSA:;>6<OG;VZ
M5NZ-+;&'8Y^:@#-6'>/+48H7PZL.99/K74VNDQ23AUZ59UBRC6U(R,XH Y"#
M48;>38HZ<4W5 +Q0<@"LNZV6]TW4G-0W%U(V,<+0!?L;-(5)')J];^4A)<Y-
M8\=TZPX3K5K3+.:XDW2'B@"W=0_:CB)3BH&TN98SUK;#0V( [U!>:HHA)44
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MFUNO[+A"H?FK[2_9YD>\^#^@3.<LWVC/_@1(*UI[B9]._!U=OAFY_P"OQO\
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MLVU0<4 :NJ,K<DYK,M[J-),#KFJ#:DTT>&SFM7P]I?VV8$\\T 7[.Z7S&+C
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MT%M2T%G'/RT ?,FM7$3:@V\]ZT='DL_E(/-8_P 0-%GTW4)6P1R:Q?#]ZXE
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M&*M7'B!+;Y155O$"S*0: ,R>]:U^4MBHX;Y))!O.:J:BQNI25IUKI[*H9N*
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M,4 <OX3\$O*\9*U[_P"&=+72;!,D @57M_#MKI<(*E00*PM<\1+9Y42@ >]
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MPQM^^\'[/^XG9G_VM75:=^R;\380#+X9P?\ L(6O_P =K]$?+H\N@#\^KO\
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M^2*_<#RZ/+H _#2/_@G'^T?'P/AWQ_V'--_^2*>O_!.']HMF^;X=?^5O3O\
MY(K]R/+H\N@#\/H_^";'[0!(+?#_ !Z_\3K3_P#Y(K5M_P#@G9\?;=0!\/\
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M$[?C\]X7C^'V^//7^V=/'_MQ6S:_L _'>*W"GX? -_V&-/\ _C]?LGY='ET
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M ,*^Y_[#>G?_ "17/3_\$U_VD9)2?^%<Y'_8<TW_ .2:_=CRZ/+H _#O3_\
M@F_^T.JA9_AYM'_8;TX_RN*_4_\ 8Q^&>O?"']FOP?X2\3V']EZYI_VS[1:>
F='+L\R\GE7YXV93E74\$]?6O=?+H\N@!+<;8S]:*>J[110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>picture4.jpg
<TEXT>
begin 644 picture4.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 4@ X0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ<=M'I'BS262#6=(5]RQNP)6:+)R8GPV,\@JRG.,G(_X*;?\F/?$S_KE9?\
MI=;U^7O_  2A^(-WX+_;%\.Z;%*5LO$EI=:7<Q[L*V(FFC..Y#PKCZGUK]0O
M^"FW_)CWQ,_ZY67_ *76]7C8KV2G'K;[[_T_F&!;^L1@^DE]W]77R/Y^:_IA
M_9M_Y-W^&'_8L:;_ .DL=?S/5_3#^S;_ ,F[_##_ +%C3?\ TECKKC_N\_\
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M$KXE>'?A#X)U/Q=XLOGTSP]IJJ]W>):S7!B5G" E(D9R,L,D*<=3@<U\^?\
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M'E CN/->(D'@@$5PX6'MYN4GU?R4;W_*_P"'1';B9^Q@HKLGZM[?G;\>K%\
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M*O7,=IK>ES&>RF<#)0,55D;&3M=5) )&0#7ZC_\ #YSX$_\ 0(\;?^"RV_\
MDFO'OVN/^"EWP,_:(_9[\7>!K71/%9U74+=7TZ2]T^!(HKI'5XW+"=BHR,$@
M'@D=ZJM*27-!;=/ZZDTDF^6;WZ_UT/+?^"9?[=VM_#/QYHOPL\9ZK+J'@36)
MDLM-DNF+MI-RQVQ*C$Y$+L0I7HI(8;1NS^TM?RM0S26\R2Q.T<L;!D=3@J0<
M@@^M?TU_ GQI+\1O@IX#\4SG-QK&AV5]-G_GI) C/_X\37=+]Y2]H]T[/Y[?
MD_P.2/N5.1;-7]+;_??\SNJ***Y3H"OYVOV]OC-_PO+]J?QMKL$_GZ397/\
M9&FD'*_9[?,893Z.XDD_X'7[:?MK?&8? ?\ 9E\<>*HIA#J8LC8Z:>_VJ?\
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M5PWG7 #A6]UC\M/^ 5&$BZ-%REO:WSEO_P"W?@:8J2JU5".U_P ([?H?-_\
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M761\.] DT)=8\DWH>_N+D2>5OV8\Z1]N/,;IC.>>@KE_V_O^3-?BQ_V!F_\
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M_L"1_P#H35WQ_@R]5^4C@E_'CZ2_.)\8_P#!<C_D'?!W_KKJO\K2O@;]C?\
MY.N^$G_8SV'_ */6OTC_ ."VO@^XU+X1_#[Q+%"9(=*UB:TFD49\L7$0()]
M3 !]2*_)KX=^-KWX;>/O#GBS3E5[_0]1M]1@1R0K/%(KA3[';@^QKFP$U3KW
MEM&>OX/\F=F,BZF'C&.[BU^,C^H>O"_VY_\ DS_XM_\ 8O7/_H->7>$?^"L7
M[.FO>&K+4-6\5WGAG4Y8@T^DWFCWDTL#XY7?#$\;#/0AN1C..E?%W[>7_!4*
M/XW^&;_X=_#"TNM.\)7H\K5-9OT$=Q?H&_U44>3Y<1P"2WS,#@A1G=CB8N4)
M4ENTU_3*H27-&H]EK_2/SMK^D3]C7_DT_P"$7_8KZ?\ ^B%K^;NOZ1/V-?\
MDT_X1?\ 8KZ?_P"B%KT8_P"[S]8_E(XY?Q8^C_-'Y5_\%F--FM/VKM,NG#^5
M=^&;1HRW3Y9KA2![<?F37SU^R#^SC#^U3\9(/ 4OBA?"3SV4]W%?&Q^V;VB
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M3E/Y?=_P;KY&)XT\%:%\1/"^H>'/$VE6NMZ'J$?E7-C>1AXY%Z].Q!P01R"
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MD%3W2/YT/#?[!O[0?BJ]-K9?"7Q)!*,?-J5J+&/_ +[G*+V]:^YOV8?^"/\
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MUX_T3^P-;EUVXO$M?M<%SF%HH55MT+NO)1N,YXZ5]:T5-)^QING'9JWW-/\
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MLGAGP!\0DEA@U>&[DT.6,X#W$+HTR$=R(V1_^_M?DPJM(P5069C@ =37T/\
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M8HQ459!1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7GW[07P_P!1^+'P-\=^#-(F
MM;?5->T:ZTZVFO6984DDC*J7*JS!<GG"D^U>@T5$XJ<7%[,J,G&2DNA^*W_#
ME3XW_P#0T_#_ /\ !C??_(=?JU^S)\,=5^"_P#\#^!];N+.ZU;0].6TN9M/=
MW@=P2<H756(Y[J*]/HK;F?*X]'_7ZF7*G)3ZK];?Y!1114%A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5^;7[=7_!-GXF_M._'Z\\<>%M=\)V&DS6%M:K#K%W=1SAHU
M(8D1V[KCGCYJ_26BLY04G%OH[_@U^I<9.*:77_AS\@/!'_!$7QQ>7B_\)A\1
M?#^DVH(+?V';3WSL,\@>:L(''?GZ&OTH_9Q_9G\$?LN>!1X9\%V4B+*XFO=2
MO&#W5]*!C?*X ' X"@!1S@<G/J]%;\[2<5U,>5-IOH%%%%06%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M':OA+_@M5\7);J3P!\)],=I9IG;7+ZWBR68DF&V7 ZY)G./]VOO7]E/X-Q?
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M ).\UO\ [%N]_P#2BWK]LJ_$W_@CG_R=YK?_ &+=[_Z46]?ME6U3^'2_P_\
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M$31SR!-V!G ;&<<U^]-%.ZPM-25GK^41U.7ZU4Y7=:?G(_$7]AO_ )2C7?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUM(\'Z1XU70OA^ITN:_M'TRTF40R.#<,9'A:0 KNZ-QVQ7Z::/</>:/8SO\
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M^9^>.F?MH?M:?MK^.]2T[X(Z='X3\/6;#S#:PVY6WC8X4W-W<*1O."=L04D
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M!/.X)&RY])6K]A*KV3I0CS.\VKOR]%_6GGJ'M%4G)15HK3U_K\_(_*?X!_\
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M$C]KK9XDTR'5H-&TRYU:TM[@;HA<I+$L;LIX;;YA(!XR >U944YUY0OIRO\
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MTKP*2>YVQKS7YQ?\%&O^4D7A[_>T/_T8M:U(>SQU""Z3_21S\SG@ZTGOR/\
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M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIMNS?02TV&QQI#&L<:JD:@*JJ,  = !7%>*/@;\-_&WB!=>\1?#[PMK^N*$
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MGW\L?_ D'^J^8]E]Y^F%%?F?_P /,OB?_P! 'PE_X!W7_P DT?\ #S+XG_\
M0!\)?^ =U_\ )-'_ !#G/OY8_P#@2#_5?,>R^\_3"BOS/_X>9?$__H ^$O\
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M*_,__AYE\3_^@#X2_P# .Z_^2:/^'F7Q/_Z /A+_ , [K_Y)H_XASGW\L?\
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M6/\ X$@_U7S'LOO/TPHK\S_^'F7Q/_Z /A+_ , [K_Y)H_X>9?$__H ^$O\
MP#NO_DFC_B'.??RQ_P# D'^J^8]E]Y^F%%?F?_P\R^)__0!\)?\ @'=?_)-'
M_#S+XG_] 'PE_P" =U_\DT?\0YS[^6/_ ($@_P!5\Q[+[S],**_,_P#X>9?$
M_P#Z /A+_P  [K_Y)H_X>9?$_P#Z /A+_P  [K_Y)H_XASGW\L?_  )!_JOF
M/9?>?IA17YG_ /#S+XG_ /0!\)?^ =U_\DT?\/,OB?\ ] 'PE_X!W7_R31_Q
M#G/OY8_^!(/]5\Q[+[S],**_,_\ X>9?$_\ Z /A+_P#NO\ Y)H_X>9?$_\
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M^ =U_P#)-'_$.<^_EC_X$@_U7S'LOO/TPHK\S_\ AYE\3_\ H ^$O_ .Z_\
MDFC_ (>9?$__ * /A+_P#NO_ ))H_P"(<Y]_+'_P)!_JOF/9?>?IA17YG_\
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M_*!_]TU]YT4?Z^<1_P#03_Y)3_\ D0_UBS3_ )^_^2Q_R/@S_AUK_P!5-_\
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M1_\ 03_Y)3_^1#_6+-/^?O\ Y+'_ "/@S_AUK_U4W_R@?_=-'_#K7_JIO_E
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MC_D?!G_#K7_JIO\ Y0/_ +IH_P"'6O\ U4W_ ,H'_P!TU]YT4?Z^<1_]!/\
MY)3_ /D0_P!8LT_Y^_\ DL?\CX,_X=:_]5-_\H'_ -TT?\.M?^JF_P#E _\
MNFOO.BC_ %\XC_Z"?_)*?_R(?ZQ9I_S]_P#)8_Y'P9_PZU_ZJ;_Y0/\ [IH_
MX=:_]5-_\H'_ -TU]YT4?Z^<1_\ 03_Y)3_^1#_6+-/^?O\ Y+'_ "/@S_AU
MK_U4W_R@?_=-'_#K7_JIO_E _P#NFOO.BC_7SB/_ *"?_)*?_P B'^L6:?\
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MJ;_Y0/\ [IH_X=:_]5-_\H'_ -TU]YT4?Z^<1_\ 03_Y)3_^1#_6+-/^?O\
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M\H'_ -TTV3_@ELXC8I\3%9\':K:#@$]@3]I./RK[UHH_U\XC_P"@G_R2G_\
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M\;/V'/B#\*)+F^TVT;Q=X<0EEO=+0M/$G8RP?>'&22NY0!DL.E>&^$_&6N>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME]R71+R70_/,5B:F+JRK57J_ZL%%%%>6<H4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9^O:
M#IWBC1;S2-7LX=0TV\B,-Q:SKN21#U!'^<5H45492A)2B[-#3<7='Y!_M2?L
MXZC^S_XXDABCFN?"M^S2:7?M\WR]X9&P!YB_J,'U ]#_ &)?VK!\)-87P?XH
MN6_X1#49OW%S*YQIL['[W)PL3$_-Z'YO[V?T+^*OPQT3XP>!]1\+Z]#YEG=K
M\DRJIDMY!]V6,D'#+Z^A(/!-?CU\7_A5K'P7\?:EX5UM5:YM2K17$:D1W,3#
M*2IGJ"./8AAU!K^E.'\VPO&F6SRK,_XL5\VEM->:>_\ D['Z5E^,I9UAGA,5
M\:_'S7GW_P""?MC'(LT:NC*Z, RLIR"#T(-.KY._X)]_'.;XA?#ZY\(:Q=M<
M:WX="B!Y6R\MD>$^OED;#[%*^L:_ ,VRVME&-J8*MO![]UT?S6I^?XO#3P=>
M5">Z"BBBO(.0*^.?^"C7QH_X1?P/8^ -.GVZEK^+B^V'YH[)&X7U'F2+C([1
M2 ]:^OM0OX-+L+F]NG\JVMHFFEDP3M102QP.3P#TK\5OC-\2KKXN?$S7_%-S
MYR1WUR[6T$TA<P0 D1QY).,+C..,YP!7ZCX?Y*LRS/ZU57N4;/UE]G[M_DCZ
M;(<&L1B?:R^&&OSZ?YFO^SI\'KKXX_%;2O#4/[NR^:[U"<J66*VCP6) (/S$
MJ@P1S(O2OV.T?2;/P_I-EI>G6Z6FGV4"6UO;Q_=BC10J*/8  ?A7S-_P3_\
M@J/AW\*CXJOXE_MGQ2$N4)4@Q68&85Y'\6YI"1P0R?W:^I:QX\SQYKF;P]*7
M[JC[J\Y?:?WZ+R7F3GF.>*Q+IQ?NPT^?5_H%%%%?FA\V%%%% !1110 4444
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MA-;)7\X2VOYQ;_%]C[3/:$,5AH8ZETM]S_R9]DT445_/1\ ?/G[=7Q"/@/\
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MYGMKNVE6:&:,X:-U(*L#Z@@&OZ-X%JK.,@Q&55G?EO'TC-77W/FL??Y--8K
MSPT^EU\G_P &Y^[U%87@7Q1#XX\$Z!XAM]HAU6P@O55?X?,C#8_#./PHK^=J
ME.5*;IS5FG9_(^"E%Q;B]T?ES^WCXC'B#]I?Q'&CK)#IL-M8HRL3]V%7<>V'
M=Q@>E?3G_!,G0WM?A9XJU9@H%YK MU^7#$10H<Y[C,I ]P:^+OVG+LWO[0OQ
M#D,BR[=:N8]RX_@<KCCTVX_"OT+_ ."?]C]E_9GT.7#C[5>7DOS#@XF9./;Y
M/SS7]$<5_P"Q\'X;#QZJG'_R7F_-'V^9/V65TX+KRK\+_H?1M%%%?SF?#!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<9KDGD:A+&> &R#
M]1FNSKCO&8\NY!V_>4-N^AQ5Q7,[,F3LKE,2 TOWJS([IE7@TC:GMZBE*B^@
M*HC3VFDK,&LJ/O5*NL0-U8"LG3DB[HO456748&_C%2+=1-T<5G9E$M%(&4]#
M2T@"EW4E%(8_-%,I<T7"PZBBBF(**** $Q28IU% #**<U-^IQ04.5L4^HO,1
M>K+^=,?4($ZN/SH$6EIX-94FN01YPP-59->W<**123.ABF$<JG.2.:ZJPS]C
MASUV@UYYI=Q)=70((SVS[G']:])1=B*HZ 8JZ?4F6@ZBBBMC,**** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\FK^"/^W[_TNN*_6N//^2;PG^*'_IN1[F9O_9*?JOR9[U1117\[GR84444
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MWR?U-:-9^A'_ (EL8_NEA^IK0KNCLCD>X44450@HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_AJCQO\ ]N/_ *0V]?K97Y)_MT9_X:H\;?\ ;C_Z0V]?K?AG_P CBK_UZ?\
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M[= _XRH\;<_\^/\ Z0V]?K?AG_R.*O\ UZ?_ *5 ]3+OXK]/U1]:_P#!,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_)3]N@?\94>-O\
MMQ_](;>OUKK\D_VZ?^3J/&_'_/C_ .D-O7ZWX9_\CBK_ ->W_P"E0/1P/\1^
MG^1];?\ !,__ )(3KO\ V,D__I+:T4?\$S_^2$Z]_P!C)/\ ^DMK17R/%O\
MR/<5_B_R.?$?Q9'P;\?C_P 7V^(_'_,R:E_Z525^E_["_P#R:OX)_P"W[_TN
MN*_-#X_-_P 7V^(__8R:E_Z525^E_P"PO_R:OX)_[?O_ $NN*_6N//\ DG,)
M_BA_Z;D=F*?[F/\ 70]YHHHK^>#R@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** $9MJDGH*\W\8:MB1R6&#\W![=OTKO-6N/
ML]B_.UF^4'ZUXAXZU;=)*<]2:Z:,;NYE-]#B/%FOG<_S5YAJ5Z]W,1GJ:VO$
MFI>8[<YJ#P-X=F\3>(+>VC4L7<#U[UVR:A$<(GK_ .SW\*XKQO[=U&+?%$W[
MJ-APS>I]A7T?6?X?T6'P_H]KI]NH$<*!?J>Y_.M&O+E)R=V:A1114B"BBB@
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M)/\ ^DMK17R7%G_(\Q7^+_(PK_Q9'P;\?L_\+V^(_P#V,FI?^E4E?I?^PO\
M\FK^"?\ M^_]+KBOS1^/W_)=OB/_ -C)J7_I5)7Z7?L+_P#)J_@G_M^_]+KB
MOUKCS_DG,)_BA_Z;D=5=_NT>\T445_/!YP4444 %%%% !1110 4444 %%%%
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MSN1U# BI*\N^#?CH:U9+8S,"X&4Y[]Q_6O4::=S"2Y78****9(4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@#SWXE?#1/$UN][8 1Z@O+)T$O\
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M -*I*_2[]A?_ )-8\$_]OW_I=<5^L<=_\DYA/\4/_3<B;GO-%%%?ST,****
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MM%?)\6?\CS%?XO\ (9\&_'[_ )+M\1_^QDU+_P!*I*_2[]A?_DUCP3_V_?\
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M'A36MQ:***LS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\CW.BBBOT ^1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO1XV)!RJL,>F,?TKT)+EF92^&YTE%%%,Q"BBB@ HHHH **** "BBB@ HHHH
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M3[UZ=\,-3\J^MRS87< :6)CU.F#NK'U?2U4TNZ%Y80RCN,'\.*MUSF(4444
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M-M89D8>R]OQKW?PGX#T;P7;B/3;55DQAIW^:1OQKH:*PE-RW ****@ HHHH
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M/]GZ7!"2"X7+,!U)Y)KS<'@'A8*E&;WNWW\CNK8GVCYK>1?HHHKVSS0HHHH
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MH?PHGPG\?%_XOI\1NO\ R,FI?^E4E?I3^PW_ ,FM^"O^WW_TNN*_-KX]*/\
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M4^K_ /@FK_R0O7?^QDG_ /26UHI?^":XQ\"]=_[&.?\ ]);6BOEN*-<ZQ/\
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M0_ ?7M%9IM#N5U&$<B-F"2?D>#^!KEI+;Q9I,GE7.E7J$#.?);'Y]*ZU2O\
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MOX2Z?JOGY'JXF+QM&%6'QT]_./7]&?5E%%%>\>8%%%% !1110 4444 %%%%
M!1110 4444 %?EK^VF!_PTQXQ_[<_P#TB@K]2J_+G]M%?^,EO&/_ &Y_^D4%
M?H'!+MF,_P# _P#TJ)R8GX%ZGU#_ ,$Z_P#DB>M_]C#/_P"DUM13O^"=W'P5
MUK_L89__ $FMJ*^?X@_Y&E?_ !&U+X$?%/QP7_B]7C__ +&#4/\ TIDK]#?V
M,/\ DVKP?_V^?^ED]?GO\;E_XO1X^_[&#4/_ $IDK]"OV,^/V;/!_P#V^?\
MI9/7W7%#OE%#UC_Z2SDH?Q&>U4445^2GH!1110 4444 %%%% !1110 4444
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M$C1#./2MVBMY)35I*YDI..J*MCIEIID?EVEM%;)_=C0+5JBBA)+1"W"BBBF
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MM?\ 8P3_ /I-;44[_@GJ,?!?6O\ L8)O_2:VHKP<^_Y&=?U-:7P(^+_C:/\
MB\_C[C_F/ZA_Z4R5^@_[&O\ R;;X0_[?/_2R>OS\^-B_\7F\>\?\Q^__ /2B
M2OT$_8W_ .3;_"'_ &^?^ED]?;<2N^4T/6/_ *2SFH_Q&>T4445^5G<%%%%
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M\;/8Z***_-CL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX=26:,#4+H!Y#W5>R_U_&O0*PG+F9;?0****S)"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX?"CY=^*RG_A:'C#_L,WG_H]Z^SOV8>/@;X:_P"WG_TIEKXV^*B_\7/\7_\
M88O/_1[U]E?LR<? _P -_P#;S_Z4RU[F9O\ V2'JOR9E3^)GJ-%%%?)G0%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*\$QT]VCZ3HJKI=S]LT^WF[L@)^O>K59""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KD/&VK+&OV=2#L&6_WCT_(<UT>K7XTZS>
M4XW?=0'N37BWB_Q$ \AWYY."?YU<5U#R,76-4!N",_**N?!.Q?7_ !M=:JX)
MAMU(1CT] /YUY]JNI,T$K[N6X%>Y? #2UL_#$\X7!E<#/T'/\Z=K*YH]K(]2
MHHHK,S"BBB@ HHHH *^"/VGES\<O$O\ V[?^DT5?>]?!O[3:Y^.'B3_MV_\
M2:*O=R?_ 'B7I^J,JFQ[M^QB-OPOU3_L,R_^B(**?^QJ,?##5/\ L,2_^B(*
M*X<=_O,_4N/PH^8_BE&/^%G>+O\ L,7G_HYZ^QOV9QM^"/AL?]?/_I3+7Q_\
M4%_XN9XMX_YB]W_Z.>OL']FOCX*>'/\ MY_]*9:]G,G_ ++#U7Y,RA\3/3J*
M**^7-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#G?&VK+I.EQESA)I-C'..,$X_2OGSQEXSP[(6&]N?I6)^UY
M\>HK2&30]/E*06K9EF1L-))C&%]AS]?PKY]\(_$[4/&FASWEU$6>UD$'FJ>)
M?3\:\//L@QTZ,,='6#LK=5?9_,ZLISC!O$RPC?O+6_3S7R/2]2\3/-J<T0;Y
M2H)&>]=[\&/!!\8>(HWF4FTB.^4_[([?CT_.O)]'TR:ZD,\W^LDQ^'M7V'\!
M=-MM/\+R>4,RNX+'VP/TSFO9PU.6'PU.E/=(JO*,ZDIQV/38XUBC5$4*BC 4
M= *=115G&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <;\
M3M)-[HIN57+0\-_NGO\ GBOG[SFL]0!^ZRM7U==6Z7=O)#(,I(I4CZU\R^/-
M'.BZQ-$1C:Q'^'Z8KII^]%Q%L[GO'P_U(:AH*8))4]^^>?YYKIZ\8^#7B8!Q
M:.PP3M]\'I^ /\Z]GKEVT+EN%%%%,D**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH XOXC7S6]O&H( 568_4\#^M?/&NWTNI7YB4G!->W?%:
M8B5DS@>4O\S7BLT:VL,UPWWVX6NF.R0+JSGM0/G7T%I%R-P%?6W@#1SH?A.Q
MMV39(4\QU]">:^=_@WX3;Q1XTCN)5S:VY\U\^@Z#\3@5]4@!0 !@5-5ZV0^E
MA:***P$%%%% !1110 5\)?M,(&^-WB0_]>W_ *315]VU\+_M*+GXU^(_^W;_
M -)HJ]K*7:N_3]49U-CW']CE=OPQU/\ [#$O_HF"BG_L>C'PSU/_ +"\O_HF
M&BN+&_[Q/U*CLCYI^)Z_\7*\6_\ 87N__1SU]??LV\?!;P[_ -O'_I3+7R/\
M35_XN1XL_P"PM=_^CGKZZ_9QX^#/A[_MX_\ 2F6O6S!_[-#U7Y,SA\1Z5111
M7SAL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5PGQ@\>Q^!_!VI72.!<K"2I_NYX'XUUVK:DFEV;S-@MT1<XW'TKP+
MXD^)(KJWN!=)'=(Q)995#*Y^A[5XF8YE3P3C%ZMM77EU^_8[L-A)XE2Y=.WK
M_P  ^'XUN_BQ\0&DO=[:1:L;BZN&!VL.RY/<]/I76B2!;C[%IUI#8V9E+B&W
M0*H]^.]='XHU5I$:*)$@M\_+#"H52?H*H^'M EN+F- A:XF8# YQ[5Z+S:MQ
M#B8U^7DHT]HWZ_U]QSX7)Z62T94V^:I+=G9>&=]X=L<;/L7)P"<"O;/ACXT;
MP_=+#(?W+<'/3Z5Z5\'_ (:VW@+PPD<D*G4+I0UPQ&3TX3Z"L?XA?"5)%EU+
M0XO+E'SR6L8Z^Z#^E>E*4:FAG>S/3]/U"#4K99X'W(P_$>QJS7SSX&^(%QX=
MOEMKMF1,[2&_D:]YTO5K?5[59X'# CD9Z5SM.+LP:ZHNT444$A1110 4444
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MO+OA[H?B72?%1T[R)8TB;]XY^Z@_O9_SFOH&DJN;2S&G8!T'>EHHJ1!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% #659%*L RD8((X-<K>_"WPSJ%X+F73
M5\T'(*.RC\@:ZRBFFUL!'!"EM"D4:[8T4*JCL!4E%%( HHHH **** "BBB@
MKX[^/RY^+6N_]L/_ $GCK[$KY ^/2Y^+&NG_ *X?^B(Z]' _Q'Z?Y$2V/7?V
M6QCX?ZA_V%)/_145%._9?7;X!O\ _L)R?^BHJ*YL1_%D4MCP;X@*?^$]\2?]
MA.Y_]&M7TW\"/^24Z'_VW_\ 1\E?-?CZ,?\ "=>(_P#L)7/_ *-:OI;X&#'P
MLT0?]=__ $?)7=BOX,?E^1$=SO****\DT"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /(/C'> )( ^<MM*^FT?_7KB/@IHJ:EXP69A
MGRSYGM@?_7(K4^*UYYD_7.[+'\2:U/V?[=?M%U-CG81^HKIG[L+"AU9[=111
M7,,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\&?^2;:/_P!MO_1SUU5_X:)6YVM%%%>>6%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5!?2"&SGD/ 5&/Z5/63XFN/(TB8?WQM(SCCO^E-:
MNPF?-'Q'96U*;;]W/%>O_ 6+;X7F?&/G"_D,_P!:\1\;77VC4'QT+5] ?!BU
M^S>#5]6F8_HM=-;9(<?A.\HHHKE **** "BBB@ HHHH **** "BBB@ HHHH
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M<+;;NRPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.?Q:3/
MQ U4_P#7+_T4E?1E?//Q67/C[5.?^>7_ **2NBC\0F>@? I=OA&[_P"OY_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>,?$)0?&%_\ ]L__ $6M>SUX]X^CW>+;\_\ 7/\ ]%K6D-Q,ZWX4\>';C_KZ
M;_T!**?\+EV^'[C_ *^F_P#0$HJ9;C.&\01YU[4N/^7F3_T(UZ9X%&WPK8C_
M '__ $8U>>:ZO_$[U#_KXD_]"->B^"N/#-G_ ,#_ /0VJI; ;E%%%9@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5Y)XZCW>*KXX_N?^BUKUNO
M+/&JY\37G_ /_0%JX[@=-\,UVZ#/_P!?+?\ H*44_P"'(VZ)/_U\-_Z"M%*6
MX'':W&#K5_\ ]?$G_H1KT'P:-OANS'^__P"AM7":S'_Q.+[_ *[R?^A&N\\(
MC'AVT'^__P"AM3EL!LT445 !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %>8^,D#>)+P_[G_H"UZ=7FWBY,^(KL_P"Y_P"@+51W Z+X>KMT6;_K
MX;_T%:*=X"7;H\W_ %W;_P!!6BD]P.8U:/\ XFU[_P!=W_\ 0C7;>%1C0;4?
M[W_H9KD=4CSJ=V?^FS_^A&NP\,C;HEL/][_T(TWL!J4445(!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %>>^*DSKUT?]W_ - %>A5PGB:/=K=R
M?]W_ -!%4@-KP2NW29?^NY_]!6BI/!R[=,E'_38_^@K12>X&!J4?_$PNO^NK
M?S-=7X>&-'MQ_O?^A&N;U"/_ $^Y_P"NK?S-=-H0QI4 _P![_P!"-'0"_111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB_$*9UBX/^[_Z"
M*[2N1UU,ZK.?]W_T$4T!J>%%VZ?)_P!=3_(44_PRNVPD_P"NI_D**&!D7T>;
MRX/_ $T;^==#HPVZ;"/][_T(UCW<?^E3?[[?SK:TL8L8A]?YFCH!;HHHI %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S&LQ[M2F/^[_Z"*Z>N
M?U1,WTI^G\A30%SP^NVS<?\ 30_R%%2:*NVU?_?/\A10P*5Q'_I$O^\?YUJZ
M>-MI&/K_ #-4YH\S/_O'^=7K0;;=!]?YT@)J*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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0= "6XVQGZT4]5VBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>prospectussummary1b.jpg
<TEXT>
begin 644 prospectussummary1b.jpg
M_]C_X  02D9)1@ ! 0( @0"!  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         "!     0
M ($    !    1TE-4" R+C$P+C,T   R,#(U.C R.C U(#$T.C,R.C,P  $
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M0   ;6YT<E)'0B!865H@!^D  @ % !, '  R86-S<$U31E0
M                     /;6  $     TRUL8VUS
M                                           -9&5S8P   2    !
M8W!R=    6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@
M   48EA96@   >P    49UA96@   @     4<E120P   A0    @9U120P
M A0    @8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD
M9    GP    D;6QU8P         !    #&5N55,    D    ' !' $D 30!0
M "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE
M;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(
M     /;6  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[
MH?___:(   /<  # ;EA96B        !OH   ./4   .06%E:(        "2?
M   /A   ML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8
M /*G   -60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@
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M P$1  (1 0,1 ?_$ !X    & P$!               %!@<("0,$"@(!_\0
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M$?!DQ(EA07%?XH2R,4IOF DR3\ <F$Z(PR46  #.2XKPC;6EPTB9X\WQ$
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MWJZI7NKHY2  #D> R!*;)*\= 29'L182&R.4+ A 74'2( KT0VD<)7N4)U
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M)*M00M.I25@=UTBWAB.E,9A##2$V;N$*6 24=R-K=#B77XT0J\XTMJ0#V4[
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MO[L?(_9<_P#CU1_+FO\ \MA%#[+SBTMHKM1UK("?%FG=2N@WC6W)]OUXXWY
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M-F=-A\KZ9,>.>6\\([3-U%*G=+?B-AOB11)].JX@2&7T*:EI9*W&7&]12\$
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MD2*WG%J,B+-EQZ<PPE#T>',=22IQW6%K2RXVH DA/+-K6Q1QRJ72@ ?HH$,
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M(79N^H)4F]MU6OOCM'YSC\).$M7<HC;42HU>%+IL'EL!*D-+94A;RB ;N6=
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M<:Z$AZ!),<*W\/\ &4[^Q.^^,U3E94SA4*#)46DTO.3U7C,J%T'G/JC+NO\
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M25^*R3A50X6S,JQJC46Z<F8Y&/,#<934GGI2KQ;(4%(4+:5!1!/6QOC+>?\
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MF&6&/HF'!%GQU)?<0WRUAYYGZ!_5XU&^H;#'%/*U-_A+X=YU@M\@5NH4MRH
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MGJDTG9YD,G<JVL%[K\^_$U?DWQ5V6/,,V2WI_*8X39%3>""F@EGJ"@U81&Q
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MU\EA(#]/^&-7 ]=_\,?CD^O'X],?CD^G_I@*LJDG0#'NE?R._O5Y)7!(/O\
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ML@B:K&6+' @:/G-K$)K#Q%>O> >C N.B?/WL2K0.A'Y-%VD&3H1 CV8MJ%K
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MWT\8T,TH$@=G&$(14PJ9?'U&'"-90 HM,EF;D@:A63/$9X;8C24VZ/&5:A*
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M2KP09AW&)9?I^M C.AF/.;?3=71$N%0O:$B>7Q''> %C5\-R G9A@0K*2AX
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MI3Y,'8# 8"Z=O;(*,624=C9N%LXR"K9!45(C9>L&&1EKMSTCCZ__V@ , P$
M @ #    $)!DEITDDH)T(?(&/(! )(! )  ! - @$     (\E0 4V )(()()
M))!(  @ ) N  ,$8PUO+C$!  (!)!()(  ( :R(@ ()C 5E7X2! )(!))!!
M   ,!F;@! /L^#VPQD!(!(!!()!(   !LL< !(.JP-KRG^ ) !!)( )!   !
ML?P^ ((T'A..H,!((! )! !   -D_&V"@(.3L;#_ *:@ 00" "00   "+#2C
M*T"#?$76A+NB0 0022  0  "H%= /4"#8UFNYF @00022"" 0  2G+,4RD"#
M7;HF>P%B22"2 00 "   <A0I3L"#5ST7(=Y 2222 0000 " +8;$:H""?L>W
M[[N@ 22 " 00  #7>V.29 !",H)YAV$  " 20 0   !="$*(  ,!>OZW:-(
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M*@%.(8% >U#<7INPQD.8T<>KHOQ0'65PCQZ5R!X0 NE<$ISZ7:?'?0-AJ/\
MX4'9>?W]\SWP20LBT('H*DZN\X]K/TA(7BD(X$Z\)VR6^ PY>7@Y 49PIF?\
MH,2Y>3B"=%I/9HG,@((Q6-::80$#U/;$.#O6CIXB$54#C*K0FFZS :#J98<,
MLI6(E; .5T"JSM6_^"H/?IQ>,"=<">H[].>5O]N<^*&X/%2]>OO),[W%1W28
M13-G7V&U(!6L%"L 4YWQ&]4@-830[U7.?0<" 0@Q!K%"B!5$IP''=R'HD:SF
MQ($Z<60"(0%KU #(7JILYD@P$[!A>F]GQWKA99%HM3S#.S?A.04LCL5>U[]7
MIQ<7-0$&0&92]>S7B9'LJ!\LN)BY,@DS,Y9O3R[\!HT6@;XHE'T].?\ -XC5
M0*X:MZF.O&+ZJ=(&,TWN5BWXU07^^Y]^ 5#L\N^?)QV\^@HGRYC*D?'P7Q.F
M;[.KT_/O%?ZQ$#H>L?1,[<^S@_FE>#(T<;7+W>&-UR>43#%BQ;G"R$9_'09\
MWNH$%M0],+E@0:.*GW4^8D2.$XZ)^7,(I %JQ$@!&"&;S0<:H3$U<X\^(IH*
M)O 2L LRR]./#8Q*QH"-:^FW%EVP$IH+0@-8 4F)"O%:10J ""'(^C!9EDJD
MH.[>CQ =!RZ&<?GDXR?B+\?&Z/-3,Y+? =?OT]AH0=^??B)T^>.W]^>S"U#6
MV=^4=-]T#XSDR/9%ZW1+C/L8.ZT=^AZ\0F-6P0A"X7NN$MSV-C@!)F"%C2D_
M,B82,4%6HEX),(*5/!KM#?HHK<*8&64T3JU&3\A:*@ 0P", Z,-&!34J]L[G
M7KQ5_-"(([@)@4AO P*KX\="LQ3LG!U%:"P-(B@A2N1*<+6GF"!D4"""K>%[
M<PI4+, 14 %+ 'I:--)HYUI[<0HZX^T(<=Y?$^-.4.VAN4OUW\]<T?W3VE9K
M%WCG74?MW/MUZ=>:/G_?WG_@.J!"S6N5JD!N-+#/(]K[0,,32K %0<K2$14&
MZB!%*4"1Y:T 90F4 : 8 :SB56_(8R)6HX P\QB9!9 A4<7L0,&>"N[3>_0/
M/,<;ZO(]*@PDM,,18*2IDY!@*)3HTS/E[2&27$V!7%;,1K1Q#$7"CF@?OL.=
M"A7F8(PPF2 <&H7&>(Q(1@,9$9B5;D-HH8(3Z^M\<$!P#W[YO]Y<;6KJ]^W+
MA&1_#R<F9#;>D_[X8QPE&=[WZ=>"F3S2X6VS'T_40E*G=Z^/O!9(1\^' Z18
MH!4% H:,3U!@<0GY3N/!"P56,7><.9_0JU!A +EK7M@B$]-H1 .R!'&,+4<:
M&9"( 4T'P<RR$$2[;=9ESQMW=7'B7'"ND=@L@*CB%BLT]#C:;5@SY&I'A<1+
MRKK5#&(/0M&</%6;0HZ R+@],#_JS,!,&*X@ H/#+1.Q,D6&$;DU#53=AQ)/
MC504XKK$PSNV&[)A>["4X8^GZZ]>IZ<U]?WP1KK/[?S^G%19CV?29]!_/]&>
M[KYR&/'^.W*T(-B%,H(-SFZ=M*:!2_PZA V 6H\8(:)02W!7(9\3'7)N(%C,
M>M:8UTCBZ#V0"Y2$ $JWC'Q[)E\MZ!DN09OC] 774*SY_3E%U7)"D$ZXT)R
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MG[&@1F3\\R-:"X\>O:9?UMY T![4+4LQ_'KU.!,'O,+16\ $"#!3(1,T9Y9
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M0)!*4&GO,IF02-+. D7"4C*RO<)-H:1>EXT8,C =WIQW&"$049KH+#-[#A'
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M_\0 *!$! 0 " @$#! (# 0$      1$A,0!!46%Q@1"1H;$@0,'1\.'Q_]H
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MB"ZQVY%QT!V=M1%P9Q'I(J.@_*&9P- FXJ[3[.W>IG1Q:I8S;MLUTICO<X-
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MQI]_65[6J8QG7%7_ *G[^_I9U]=WQ^SZ,*(4,H6^3RD]\<2+5/E9E:,9I([
M.$GD%<E"<@[A1V8<@BQP&.1B8<F2TPO2T%+2ZA(<AR"F$,+A2Z!<[%$7(&4"
M6<9X?(\B;-/^;KCV619F%-CD#B4Q$SA8ZR90AU1>1\ &?%G@F*ZV'"5*@8$V
M)KTP@1XT2A)<,LA495X!EY=\N3*]V]\\>6'^+^QJ^?V_1R)YX!$!DWDW>^1.
MPM,!CT<^:^TMPJAZ&D2YTGA?EC"$)F[??;^/'IPAF_"UC,$A?UGBHA214RM
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MN 3<'2^!^EA>XCXH8U9P3KQYHP&G0(PS@<_J3KU!F@AE%1?#MU<[@F1,D 0
ME:8$*54 &X(AR! +YE_(*'RT9QAY?FX3+:=P0"DAQ\FNHHU#2BX(8>%%,QD"
MV&I)2$"K8,1>"\ME"*H05Y8Q9=N=00(BX$N-N ]F-46SVCCSU1C53^^,X_L%
M@=2?&CW_ 'R($&2D$P.KJ,WUKGK/M/GQUK?WWQI,J>LW^_4_WPGJ_/\ N_6@
MQOU_]_SPR11U@[B++">>!4[*]S?\K ;E"&/OOFX>92IDBWI *<WZ>8G<;.X]
M39Z\=EI*905H !/-@DAD&("UA<94G0\)PP3?*7#7$*LX:"M6*-HQ $R3!PSI
MN\NY*S%*CJY81E\%Z;+J(6XYPIJ)18!(#$P8G+O?-$$&1[<*=@T2Z630I %3
M)8DSCE_;3;0H&%T*$N7>*C3 M89I#7%4/4':B0EQ94')X%05JR]D0 @8WB:[
M0Q1*?&<8\_V$*3.#[H4^_P# T>W_ '1^CV^O09>^%#9$\6L.KL"+<C6<6WTW
MR,:Q=*+YIB?SV*YA5,1-:Y.4B#KZ9\:T"86D7QZ\9$WW.O (H%RD0S,+1H5D
M@6O0(5D[&IULTEE:UB4#NR\L3G]R#)P:N#)5LF"3@8PW14B<D?CX$&"#G$'+
M< S15%"&T0L#2&@\#C3/,@[A)1(1C"+"YPH4!ED8O!#8P!<ODG5 A,ATYO#A
M0L"+$'#1%-^C4+'3C5*YI34AB%<B%@$4X$R4E\XY4)'U?S>U]=^O]C 1 0W=
MA%]S]^SCXST\Y\^WI^^7C7_E7+"]==S1R"CDF,*-CWX_\,9^I2.\>.9EF-L.
M]WNRN_OGB."9LLLZ\>WI9UQJH9:]8N"[BPR;F=<4H^/0VZE_D:CG!06@ 8?<
M;'U^F"^.0Q(=8( $D$BH0<\RFL"/\%5 3%PO I_><-E2 74BO%\U%Y.,04BD
MB0*$!JD.*5% &)0B@?#'@QNP1,.R0R@=(R80",Z0CA&3B0<(!3C3!)T1/:F$
M<9:MF7 3$HQQWPTS(! Y[%0Z:W("%\3"U!.TJZ-7E[^!3+%DP6D5,X.A 2(+
MC=R1@VRZP=9@*F* !BG]@X9\]^%_[JZSKD/'=^?/\"!L3?K)N^>NIRZ9)FZT
M 7KTE\FI4D]J:/&"[OKG?P8-B0PQ.B].O%=9!Y12K&$Q*$W,%>O2X7ABA@V^
MC<S7?SF.N&2/QC3==?;^(5"ND (#&! 3;IGUV+QP,&1*<=L#<,<M=;M\B0&#
M",61QR3<CBHAG"T#6N!$LMTF,P8E$!D%)LAC5X284&"K#C$A5 Z;\Q$$'KBK
M ,T%!M B#36C0XIKQW/.:& 38URN@XC9[$ M56QR#2J]F"-&:'H<!385* .G
M'&[0X^DC!6#P7"K2@X0Q^,CN"V[#84."BE'(A4 8+), XQ_8.),5=T5<N<GI
MU^/X61Q;F UDN06+)87E-#"D50 Q<KA*.9C/!!PJ]J8>].INF,:.0(9KL.VB
MX2&U\0]>-<K<>?;S,TSVQBWE,#AJC7)>LX(#Z%<XK*@M$?$W=9SW,3MY&HR<
M!)/^_/I_':<\00",UZSO.:A].PH9./DJS@!I0\$OCP6SUT$0^4XX*V]%)C4)
M51;EL$Q:(-[5"HI##AP@..2"+&"E$/(5"&()2TR,O'"UD472(HVZ1&CI,\NJ
M2+EH522%>D)1%,D07/5,+"FB99+46(*Q@$0FY&N<Y'*O"@)$RWC;&,3A-"VE
MJA8[&1)98$$#08IG/*E$@%_R>/[&KY_;]=9.OG\=\(HI)P1RUTD<19!,<J"S
MH5&@^!<YQ?\ /' 'J)9%LE4]WWWGA,-E\PZ<]I+B%O24XX*#*'(ZQ"M\D2:F
M'FG-K*+EMO5CL#J2D2A%"Y[[-2+@D/0OF@2H4MZ8&V2_ECGF $?<]^G^#"@H
M!I0NTAH@K4/IX]V'DR'VUR@8G!SZ:7&9!M"UE(KWQM0 C10, >+K+H#A;SF#
MW!\H!<="L'9J^D3"V3R10 BP1, VM5"N. (I.N)[)%+**RO9<9:KC*ZXT]($
M*<"0H'(D;QOS1[OX)0(*B&7%+#@4_G[4BX1<8?@@9#J BYHJ5?\ (T5$0L95
M/S1("<K(5) @\&CC1#93WC?LOEM?[&KY_;_ 1,\N3TWYB2=-IM.)DM"(>#X,
M.,V:3A7!(QC$:Y0C#+'&%WF)%PEAF8;->*VN!R9XP:Z5;AP^IK)DP4PUO!+L
M:?C5NWS<O=6\)F&<)L82-LWAOY@8#"T7#&/<.T[^^N#*VN3CJ3U=[<Y3K^&[
MX_9]''.DQO'+5_=JC%.S5W48&_\ V1*<!+:("J0XBX!J!Q601RJ/ 9+E.'JC
MD=00IA+E'*U$30JA!$XPXPF8/ .F:P $J5.F3=;1&!F(FQX91Z!G$"W%"!17
MF!TBP&=O1I$O:J< JX*Q,F(W#5-!M#X,LD(Q47Y?A(4(3JVI#S:GAN< ("$"
M817\C?=M^?[&KY_;] ;& H&4Y2X,($]1V/+@J#T"Q$EIE?/07GC'H]2DR=9R
M+O+$E"%1'0\,T\[+?4=<0C K+AKIGS2GK4XOH$,PO1H0*NIJHX54AI8+F"XI
MC<KCTV-I '[N.G67X-7A;YV=2]Z$S,(A]CBQPF1"Q/1U#6!P+HIR@V9)\_,B
MW=)GK@+G]_\ EOQCSKESX9)G'V/Q^?IN^/V?2)/_ (Y.2J<S[#!*P"$7 YC+
MR,CN5%( ES+PZ#!8%C88*:,L</":;76CX9YMJM<Z-]S!13(4B)EY0=H<S![B
M[P0'BC4J(E1L9%HIA<]\%'^X+894Y VG@;^EJ!6 @ A@TD/>4@)'R$5X$W[G
MMA(Z,)2M1G#'TL=X@D0J@& I!4&@!06*X T64!* M!XYMN*;Z_L:OG]OT5>3
MI"GC+J.4P?!>"!I ;"ZUM&<7\<I,CK*[6^H$U7 L!KD,'(K50;VJ=-,S/PQP
M20L&O)FF=.+9F=<20*$@(I5T*H[P/?0*-UI5_&;=U\NL\@T*:TQ'T9ZD7T\
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M1MY;_P ].V!-.SV*+;]5.6Q7QUH\:W46E":[!3*JCUF!K BT865+Z0XF<6E
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MX@CARSFGJ<6VV';((* ^>&&G $8'!" ,6,=!2_9:,<^TW)HWL3AMNA!I2LH
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M/KS/N5A=^72CT/!V+V?1#$EE#'BVY5% LGHQ$4H_LQ[;O+W09PCA.BC 4:\
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M%ZY* HK*;N'["IH@>M_=_L]_3*PBJ(#2.A-=YQL4_%>>ZR[1(05.!,E@2+-
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MIHN^N$V$&*RK.ZL8GQ)Q2EHSA1&#$L3OR)4[%:[,0*('I5P9AQP+HS5'V8/
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M78>P7$KQ)6K  S4MB!LA2G7VL*\*LR'8$6 $1DMMAPT30U,E:ARH )PR^,9
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M\0V#AY$529JK_#SFY(</$CY<%*2PRFL&!Y<I)P)@F>O #O!J+9XXY1PF4
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MPB.C B(EF+&HA:J@K6J=% Z>(F.3R?A6Y#H\'<FEF':8C]@7M7"# @OK8O\
M)T_5?@%P,$ -F\R&;&M$!F#$J25<(!A\@-L,1$*0UDM?WR%)\@.V?0Y:"*"C
M2H%A0&L3O. P@H.8$T*PZ $.%W)/)DR$FT8*\#751);D$:0$.R9,Y") WTD]
MW/NP]B47KBJAV#3N?1""R^CVZ==_].^ ?X,@ ,34@UKKQ>,M008A0XT"DW:P
M<<,&R;=J !1"VQ%2_>=#1@*0AT2\UY7)TJ+%!([N1'P),^'D1B.Q'*,S"GAF
MU&--IV3> IC$KJZ ^*" K;R+A494-'H\E/0AWPTS@JI+T?DQGXP4I-71%SI
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MBE^PB2I^13AW1,"[+[[]OORDX4'21LD9-NA@@@4\&V-0 @T=5J'%M,Z66'L
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M^%!V)CH&X3B@0.;8CN8*R[3PG!?&D-DM=I=M;Q'#$2+R$: (L1^JM#Z:-:!
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M @XN+T!>SBIW8%%5</N )90 =H @&GG@^HU"L/P+,/C>IQ5E\?\ ;]MQP2F
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MAG(1+/$GJ^9]^?NCQX\>.!5R#2R79=PGQ;5-.I!E2S&@I4(>3 %_R?OEEB4
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&9=[^O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>prospectussummary2c.jpg
<TEXT>
begin 644 prospectussummary2c.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "L +D# 2(  A$! Q$!_\0
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MQU^1]54445H>05[^PM]4LIK2[B6>VF4I)&_1E/4&IE58U55 55&  . *=10
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' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>prospectussummary3c.jpg
<TEXT>
begin 644 prospectussummary3c.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 7^$-\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"Q2N?_ $KM*_:NN^I!1C3:ZJ_XM?H<D).4I)]'^B"BBBN<U"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 ?S:?M@?\G5_%[_ +&O4_\ TIDKZ@_X(L_\G1^)/^Q2N?\ TKM*^7_VP/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSLOLR_6WY,^_OVY_^3/_ (M_]B]<_P#H-?SEU_1I^W/_ ,F?_%O_ +%ZY_\
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MNOBW_P!C%=_^AFO+EIB(VZI_@U;\V>BM:$K]&OQ3O^2/H_\ X(L_\G1^)/\
ML4KG_P!*[2OVKK\5/^"+/_)T?B3_ +%*Y_\ 2NTK]JZ]6M_#I?X?_;I'GT_B
MGZ_H@HHHKD-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH S/$WAW3_&'AW5-"U:V6\TO4[62SNK=^DD4BE74_4$U_.#^U!^S_ *U^
MS/\ &;7?!.KQR/!;R&;3;UEPMY9L3Y4H/J0,-CHRL.U?THUX5^UM^R'X0_:W
M\!C1M>SINN609])UZWC#364A'((XWQM@;D)&< @@@$83BU)5(^C\U_P/\S:,
MDXNG+Y>3_P"#U^1^#O[-O[0WB;]F/XJ:=XV\,LLLL(,%YI\S$0WULQ&^%\=
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MPO,=M[?D<@7"CF&/U4_.<$$+U/[ VMK#8VL-M;0QV]M"BQQ0Q*%1% P%4#@
M 8Q7;?V4&NK_  6_W_\ !.36I-/HOQ?^7ZV/-?VHM+N-:_9M^*5C:)YES/X8
MU)(T_O-]FDP/QK^::OZH[JVBO+>6WG19894,;HPR&4C!!_"OY_/VT?V&_&?[
M,/CK5KNWTB\U3X=3SM+INO6T1DBAB9LK#.1GRW7(7YL!\97N!YOP5KO9I+YJ
M_P"=]#T?CI**W3;^^WY6_$^Z/^"./QJ\*1_ _6O =_KFGZ=XCL=:FO8K&ZN%
MBEN+>6.+$B!B-^&1P=N<?+GJ*_1V*:.==T;K(N<94@BOY6J_;?\ X(S_ /)J
M.J?]C/=_^B+>O3?[]2GMRI?A:)YJ_<M07VF_QO(_,?\ ;P^#]W\%?VJ/'>CR
MPM%87]])K&G/C"R6UPQD7;[*Q=/JAKH/^"=?[2>G_LT?M%66JZ_*8/"VM6S:
M1JDX&1;H[*T<Q'HCHN?]DMC)XK]:?V[/V*=+_:[\ PBTF@TGQWHZL^D:I,#Y
M;@\M;S8&?+8@<@$HW(!&Y6_"SXL_!?QM\#?%4WA[QSX=O?#^IQD[%N8_W<ZC
M^.*0961?]I21^-<&%F\.U3?33U5K?EO_ ,,=N(@JZ<UUU]'O^>J^X_IHTG5K
M'7M,M=1TV\@U#3[J-9K>ZM9%DBE1AE65E)# CH17SS^W/^U9X?\ V9_@SK<D
MFIP?\)IJMG+:Z'I2N&GDE=2@F*=1''G<6. 2H7.2!7X(^%?BOXW\"6<MIX:\
M8Z_X>M9<F2#2M4GM4?/7*QN <U@ZMJ]]KVH3W^IWMQJ-].V^6ZNY6EED;U9F
M))/UIUH>T3@MG_7],5*7LVI/=?U_2*A)8DDY-?M1_P $;_@W=^!O@'K?C74;
M9K>Y\87ZM:AUP6L[<,B/]&D>;'J #WKXI_8G_P"";OC+]H+7]-\1>,M-O/"W
MPVB=)I9[Q&AN=43@^7;J<-L88S+]W!.TL1@?N/H.A:?X7T2PT?2;.'3]+L($
MMK6TMUVQPQ(H544=@  *[5^ZA)/>6GHM_P!/NOY'(_WLTULM?5_U^-O,\F_;
M1TN?6?V3?BU:VR%YF\-WKJJC).R(N1^2FOYOZ_J?U'3[?5M/NK&\B6>TNHFA
MFB<95T8$,I]B":_G>_;(_9+\2?LI_%&_TJ\L[B?PE>3O)H>M;2T5Q 22L;/C
M E0<,O7C(X(->;\-9M]4E]U_\]/F>A\5*RW3?XV_RU^1^B'_  1T^/WAO4O@
MY=_"V]U2VLO%.E:C/=6=C/($>[M9<.6C!^^5?S P&2 5/>OOGQU\0O#'PQ\/
MW&N>+->T_P .Z1 ,O=ZE<+"GT&X_,Q[*,DG@"OY>*W/"OA/Q%\2O$UGH?A_3
M+_Q#KMZXC@L[.-III#]!G@#J3P ,G KMJ2E5:Y5K9+[M#CA&-)/F>FK^_4^G
M?^"CO[86C?M9?$S1QX7L9(?"WAF*>VL;^Y4I-?-*R&24H?N)^[7:I^;&2V"=
MJ_,?@/\ Y'GP[_V$;?\ ]&K7O7[4W[%NK_LH?##X;ZEXIO%D\7>)Y;U[W3[=
M@\%A'$L!CBWC[\G[QRS [>@7(7<W@O@/_D>?#O\ V$;?_P!&K58*,85X0B[V
MDOOOK^)..<I8:<VK7B[>B37Z']1=?C1_P6F^&USH?QT\*>-$B/\ 9^O:.+-I
M O'VBV=MP)]2DL6/H?2OV7KQ#]L/]F73?VK/@MJ/@^YFCL=7B<7ND:C(N1;7
M: A2V.=C LC8[,2.0*X:T7[LUKRN_P"#3_!G;2:NXOJK?K^:/Y\/A3\0+WX4
M_$OPOXRT]?,O-"U*#4(XR<"3RW#%"?1@"/QK^DSX1?%SPQ\</ .E>,/".IPZ
MGI&H1!P8V!>%\#=%(O\ #(IX*GI7\W7Q8^$/B[X'^-+SPMXUT2YT36+8_P"K
MF7Y)DR0)(G^[(AQPRDC\0:S?"/Q!\4_#^XFN/"_B75_#=Q,-LDND7\MJS@=
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M:+_A(M2CL[1F'WX+96!<>QDED7ZQFOSN_9/_ &-_'/[5WC"WL]%L9M/\+0S
M:GXDN(B+:U08+*I.!)+CI&ISR"<+DC^@GX;_  ^T3X4^!-#\(>'+466BZ/:I
M:6T/4[5'+,>[,<L3W))KNC^[IR;WEHO2][_A;SU..7[R:2V6K_R_7Y'P[_P6
MIO+NW_9L\*00LRVT_BB$3A>AQ;7!4'\?Y5^+M?T??MA?L[P?M0? ?7O!!FCM
M-4DVWFEW<H^2&[CR8RW'"L"R,1R%<XK^>;XC?#7Q/\)/%U_X8\7Z+=:#KED^
MV6TNTVG'9E/1T/4,I((Y!->93]VI-/J[K[DOT_(]"?O4XM=-/Q;_ %_,_HS_
M &78?#MO^SG\-D\*"(:!_8%F;;R<8.8E+%L?Q[]V[ONW9YKK/B'\1O#7PG\(
MW_B?Q=K-KH.AV*;YKR[?:OLJCJS'H%4$D\ $U_.A\*?VJ/BU\#].DT[P1X]U
MC0=-<EOL$<HEME8G)98I R*Q/4@ FMS1;?XY_MR?$&ST?^T/$'Q!U8/D/?7#
MO::<C'YI&)_=VZ<<X SC !.!7=6<J]1RI[R=_3^OD<5%1HTU&H]%IZ_U\S"_
M:F^*VG?'#]H3QSXYTBVGM-+UG4#-:QW./,\M45%9@.A(3=CG&<9.,U](?\$=
M/^3O)/\ L7+W_P!#AKYM_::^!=Q^S=\9-7^'UWJ4>KW>EP6C37D*%$>26VCE
M8*#SM!D(!/) !P,XKZ2_X(Z?\G>2?]BY>_\ H<-3@XQBE&&RBU]T65B^9^])
M6;<7][3/VJ\::EJ&B^#M=U#28(KK5+2PGGM()@2DDRQLR*V"#@L #@YYK\??
M^'V'Q>_Z$OP3_P!^+S_Y(K]FR P((R*_#[_@H!_P3S\4_!;QMK/C3P/HUUKG
MPXU"62\86$1DDT=F)9XI449$(YVR8P!@,00"W)*3A4O)^ZU]S_X/Z>9U1BI0
MLMU^*_X'Z^1^FG["7[54O[67P9;Q)JL>F6/B>ROI;/4M.TS>J0X.Z)@KLS ,
MA')."0V.E>[^*?".A^.-%N-'\1:/8:]I-P,36.I6R7$,@]T<$'\J_F4^'OQ.
M\7?"?7EUKP;XDU/PSJ@&TW.F73PLZY!V/M.'7(&5;(..17M>L?\ !1S]I#7-
M)ETVY^*>I1V\B;&>SM+6VFQC'$T42R ^X8&NJIRR7NKY?UWW.:GS1>K_ *_X
M!C?MS?#+PO\ !_\ :H\=^%/!JB+P_97$3P6RR;Q;-)!'(\()YPCNR@'D  'I
M7I/_  2>M;JX_;5\*O;)(T<-C?R7!3HL?V9URWMN9!]2*^6-)T;Q#\1_%*66
MFV>I>)O$6IS,PAMXY+JZN96)9FP,LS'DD_4FOVI_X)H_L+W_ .S/H-_XS\;0
MQQ^/]<@%N+)65QIEKD,8BPR#([!2V"0-J@=\WA(NC"\WLFO5M6_4G%25:7+%
M;M?@UK^'WGVAXK\.VOC#POK&@WR[[+5+.:RG7&<QR(48?DQK^8_XD> ]3^%_
MC[Q#X2UF(PZIHM]+8SJ00"R,5W#/52 &![@@U_4+7Y__ /!1_P#X)XW/[0$G
M_"Q?AU;P+X]@B$>H::SB)=6B480JQ(59E VC<0&4 $@J,\,TX5%46VS_ $?R
MU^_R.R+4H.F_5?K]^GW'@7_!'G]J+1/ >K:]\)_$^H0Z9#KUVE_HMQ<N$B:[
M*B.2 L> SJL97U*$=2 ?U]K^6SQ1X5UKP3KMWHOB#2;W1-7M&V3V.H0-#-$?
M1D8 BNZT?]J3XR>'])CTS3/BMXTL-/B01Q6UOK]TB1*!@*@$GR@#L,5W2J*K
M%/K;[^WX:''&FZ;:Z?D?LO\ \%)?VO;K]F7X4V=IX0UZVT_XC:O=QBRA,45Q
M)#;*<RS-&X90IP$!(Y+<=#C\T/\ AZM^TM_T/5K_ ."*Q_\ C-?*VN:]J?B?
M5KG5-8U&[U;4[EM\]Y?3M--*WJSL26/N37W5^P'_ ,$X/$_Q8\8:3XW^(^B7
M&@_#ZPD2[BLM1B,4^L.I#(BQL,B G!9R!N'"YR67.A2E)MS>G7R_K\6:5:D4
MDHK7\_Z_!'ZZ_ ?4O$NL_!;P-J/C&;S_ !5>:-:W.IR>4L6;AXE=QL4!5P3C
M  '%?D-_P60^&MQX7_::T_Q6L)%AXHTB%Q-CAKBW_=2+]0@@/_ A7[9JH50J
MC '  KY^_;<_95L_VL_@S<^'$FAL?$NGR?;M$OY@=D5P%(,;D<^7(I*G&<?*
MV#M K'$^]-58+9WMY.ZM\KW\[&F']V/LYO=6OYZ/\T?@I\"?BG<_!/XQ>$/'
M5K&9WT/48KMX5ZRQ XE0?[R%E_&OZ1OAK\2O#?Q=\%Z9XK\)ZK!K&AZC$)8;
MB!@<>J,.JNIX93R""#7\TOQ)^&/BGX0>+KWPQXQT2[T#6[-MLEK=IC(R0'1N
MCH<<.I*D=":A\(_$;Q9\/VG?POXHUGPVUP,3-I&H36ID&",-Y;#/4]?6NF-1
M2I\OS7]?(PE3<:G-UV?]?,_HD_::_:G\$?LM>!;G7?%&H0OJ;Q-_9FAQ2#[5
MJ$H'"HO4+G&YR-J@^N ?YX/B=\0-2^*WQ#\1^,=8$2ZGKE_-?W"0KMC5I&+;
M5'H,X'?BN\^!O[/_ ,2_VOOB-_9^A07VLW4LBMJ?B#4G>2"S0_\ +2>9L\X!
MPN2S8P :QOVC_A-%\"_CAXN\!07DNHPZ'=BV2[F4*\PV*VX@<#.[IVKEY.6H
MI3W:=O32_P":UZ]-F;\]X.,-DU?UUM^OZ]#ZT_X(L_\ )T?B3_L4KG_TKM*_
M:NOQ4_X(L_\ )T?B3_L4KG_TKM*_:NO1K?PZ7^'_ -ND<E/XI^OZ(****Y#<
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAK\.]8_M;PI\/?"OAC5?+:'[=HVB6UI/Y;8+)OC0-M.!D9QP*[FBB@ HHHH
M**** /-=8_9G^#_B'5KS5-5^%/@C4]3O)6GN;R\\.6<LT\C'+.[M&2S$DDDG
M))K<\#_!_P !_#&:[F\'>"?#OA.:[54N9-#TF"R:95)*AS$B[@"3C/3)KKJ*
M%IL#][<X+XF? /X<?&18_P#A-_!.A^)I8T\N.XU"R1YXE/4)+C>H^A%>;>&_
M^"?/[.WA2]-U9?"C1)Y>/EU+S;Z/C_8G=U[^E?0U%)>[JAO7<JZ7I=EH>GV]
MAIUG!86-N@CAM;6)8XHE'1550  /05:HHJM]6+;1!7)_$+X2^"OBSI\=CXT\
M)Z/XIM8B3$FK64=QY1(P2A8$H?=2#7645+2>XTVMCYRTW_@G7^SEI>J&_A^%
M6DO/DMLN9KB>'DY_U4DA3'MMKW+PCX)\._#_ $:/2/#&@Z;X<TJ,EDL=)M([
M:$$]2$0 9/KBMNBJN[6)LKW."\6? 'X8>/M:EUGQ/\./"/B/5Y55)-0U;0K6
MZN'51A09)(RQ ' YX%2>#?@3\-?AWK']K>%/A[X5\,:KY;0_;M&T2VM)_+;!
M9-\:!MIP,C..!7<T4EIL-Z[A1110!Y3XX_93^#GQ(O+B\\1_#+POJ=_<-NFO
MFTR)+F0^K2H Y_$UP6F_\$X?V;]+O%NH?A9IKR+T6YN[J=/Q224J?Q%?2=%)
M)1V&VWN<IX#^%'@KX6VDEMX.\):)X6@EQYJZ/I\5KYF.[E%&X^YS75T453;>
MY-K;!1112&<IX]^$_@KXIVD5MXR\):)XI@AR8EUC3XKKRB>I0NIVGW&*\7U#
M_@G#^S?JEXUU-\+--21N2MO=W4$?X(DH4?@*^DZ*5DM1W>QY=X!_9=^$7POO
M(;SPM\-O#.CZA"<Q7\.FQ-=)GTF8%Q_WU7J-%%5=O<FR6P4444AG*_$#X5>#
M/BOIJ:?XS\*Z/XILXR6CBU:RCN!$Q&-R%@2AQW7!KQW3_P#@G;^SEI>J'4(?
MA5I+S[BVRXFN)X>3G_5/(4Q[;<5]&44EH[H;U5F9'A7PCH7@;18-'\.:+I^@
M:3!GRK'2[5+:!,]<(@"C\JY3Q+^SM\*?&>N76M>(/ACX-UW6+HAKC4-2T"TN
M+B8A0H+R/&68@ #D] !7H5%-ZN[$M%9'$^"_@A\.?AMJDNI^$? 'A?PMJ4L)
MMY+S1=&MK.9XR0Q0O&BDJ2JG&<94>E=M113NP"BBBD 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4^&/^PAJ'_I2]=M-)QFWT7ZHY*DFI02ZO]&?8M%%%8FP4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK&A;:/<D #W(K^9;QMXNU'X@>,M<\3:M+YVIZQ>S7]R_K)*Y=L>V3Q7[&_\
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M.ST]1XQ^(?B+5KX\L=#@@L8E]@)5F)^N1GT%='+/E3D_0PYHN344?//[8?\
MP5 T_P#:A^"^J_#^T^'ESH NKNWN$U*?5EG(6*0/@QB%>2!_>X]Z^!*_2O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117$_&SQ=JW@/X2^+=?T'
M1[[7]=L=.FDT_3--M9+F>XN2I$2+'&"S?.5S@<#)Z"HJ2Y(N5KV+A'GDHKJ?
MA]_P4Z^-7_"XOVL/$<-K/YVC^%P-!M-I^7=$29V^IF:09[A5KS/]CWX)K^T)
M^T9X+\%W,+3:3=7@N-3"LR_Z'$#),-RD%=RJ4!!!!<55OOV6_COJ5[<7=U\(
M?B%<75Q(TLLTGAB^+.['+,3Y7)))-?HK_P $@?V7?$_PYUCQQX]\<>%=6\+Z
MFT4>CZ;:ZWI\MG,8R1+/(J2JI*DK$H8#'##UK7!TU32Y]>57?F_^#)_<9XN;
MJ-\G71>2V_!'T=_PZX_9B_Z)G_Y7]4_^2:/^'7'[,7_1,_\ ROZI_P#)-?55
M%2,_._\ ;#_X)H?!WPS^SCXUU[X;^"FT3Q9HUG_:4%PNJ7USNCB(>9-DLSJ<
MQ!\<9R!7XSU_5#>V<&HV<]I<QK-;3QM%+&XR'5A@@^Q!K^>/XQ?L2?%OP/\
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M7_8Q67_H$U?1_P"R?HNH>'/V9?A=I>K6%SI>IV?ARQ@N;*\A:&:"185#(Z,
MRL#P01D5X;_P5:\!^)OB)^R['I7A3P[JWB?5!KUI-]AT:QENY_+"2Y?9&I;:
M,C)QCD5>9>]4G;^=?^EH6!TC&_\ *_\ TEGX05_2)^QK_P FG_"+_L5]/_\
M1"U^"'_#)WQO_P"B-_$#_P )>^_^-5^_G[)^BZAX<_9E^%VEZM87.EZG9^'+
M&"YLKR%H9H)%A4,CHP#*P/!!&175%_N)+SC^4CF?\6/H_P!#U>OPJ_X*[_\
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M[Y&XV^W?Y2-MSM;&>N#Z5GBINK551]97^^YKA8JG%POM&Q^2WAO_ )&+2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_*38_P#QBC_B&&<_\_:7WS_^0#_5''?SP^]__(GZVT5^27_#=/QQ_P"AW_\
M*38__&*/^&Z?CC_T._\ Y2;'_P",4?\ $,,Y_P"?M+[Y_P#R ?ZHX[^>'WO_
M .1/UMHK\DO^&Z?CC_T._P#Y2;'_ .,4?\-T_''_ *'?_P I-C_\8H_XAAG/
M_/VE]\__ ) /]4<=_/#[W_\ (GZVT5^27_#=/QQ_Z'?_ ,I-C_\ &*/^&Z?C
MC_T._P#Y2;'_ .,4?\0PSG_G[2^^?_R ?ZHX[^>'WO\ ^1/UMHK\DO\ ANGX
MX_\ 0[_^4FQ_^,4?\-T_''_H=_\ RDV/_P 8H_XAAG/_ #]I??/_ .0#_5''
M?SP^]_\ R)^MM%?DE_PW3\<?^AW_ /*38_\ QBC_ (;I^./_ $.__E)L?_C%
M'_$,,Y_Y^TOOG_\ (!_JCCOYX?>__D3];:*_)+_ANGXX_P#0[_\ E)L?_C%'
M_#=/QQ_Z'?\ \I-C_P#&*/\ B&&<_P#/VE]\_P#Y /\ 5''?SP^]_P#R)^MM
M%?DE_P -T_''_H=__*38_P#QBC_ANGXX_P#0[_\ E)L?_C%'_$,,Y_Y^TOOG
M_P#(!_JCCOYX?>__ )$_6VBOR2_X;I^./_0[_P#E)L?_ (Q1_P -T_''_H=_
M_*38_P#QBC_B&&<_\_:7WS_^0#_5''?SP^]__(GZVT5^27_#=/QQ_P"AW_\
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M_*38_P#QBC_B&&<_\_:7WS_^0#_5''?SP^]__(GZVT5^27_#=/QQ_P"AW_\
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M_*38_P#QBC_B&&<_\_:7WS_^0#_5''?SP^]__(GZVT5^27_#=/QQ_P"AW_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\+Z\0?\ /GIO_?J3_P".4?\ "^O$'_/GIO\ WZD_^.5YM11_K=GW_07+\/\
M(/[;S'_G\STG_A?7B#_GSTW_ +]2?_'*/^%]>(/^?/3?^_4G_P <KS:BC_6[
M/O\ H+E^'^0?VWF/_/YGI/\ POKQ!_SYZ;_WZD_^.4?\+Z\0?\^>F_\ ?J3_
M ..5YM11_K=GW_07+\/\@_MO,?\ G\STG_A?7B#_ )\]-_[]2?\ QRC_ (7U
MX@_Y\]-_[]2?_'*\VHH_UNS[_H+E^'^0?VWF/_/YGI/_  OKQ!_SYZ;_ -^I
M/_CE'_"^O$'_ #YZ;_WZD_\ CE>;44?ZW9]_T%R_#_(/[;S'_G\STG_A?7B#
M_GSTW_OU)_\ '*/^%]>(/^?/3?\ OU)_\<KS:BC_ %NS[_H+E^'^0?VWF/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117*_%#XDZ-\)? ^J>*
M-=G\JQL8BPC7'F3R'[D2#NS' ';G)P 2-:-*I7J1I4HWE)V275LN$)5)*$%=
MLX[]I']HC1_V>?!JZC>1_;M:OM\>EZ:"1Y\B@;F8]D7<I8]>0!R:_*+XG?%3
MQ+\8/%$VO>*-1>^O'RL4?2*WCW$B.)?X5&3QU[DDY-7?C/\ &37_ (X^-KGQ
M'K\JAV'E6MI%_JK6$$E8T_,DD\DDFOGKXI?%,^'0VDZ)./[58?O[N,_\>H/\
M*'_GH?7^ 'CYN4_I7+<OR_@/*_KV/2E7EVWN]H1\N[]7M9'Z?A</AN'\+]8K
MZU'_ %9?J:'C[XK6G@]I+*TB2_U8?*T;$^7!UY?!R6_V1CU)'0^"ZUKNH>(]
M0DOM3NY;RZ?@R2'.!V51T51V48 '  JDS%V+,2S$Y)/4TE?AN?<18WB"O[7$
MNT5\,5LO\WW?Y+0^#S#,J^95.:J]%LNB_P"#YA1117RYY(4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?W;)'S>:9A/,*[FW[JV7E_F^H4445\B>0%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'HGPB\?CPWJ']F7[A=+NVXD9L""3H&R>-IX!ST
MX.>"#]'Z'KFI>$]<M-4TN[FTW5+&42P7$+%9(G!ZC_#\*^+*^AOA#XR/B3P^
M+*Y.;_3E6)F./WL?.QOJ -IX[ DDM7[KX><0RE-Y)BW>,D^2_P",?1J[7S74
M^[X>S%W^I57=/;]4?O#\!_BY9_&[X7Z1XJM42">X4Q7EJC9^SW"<2)],X(S_
M  LI[UZ#7YC?\$__ ([+\.OB))X/U6=8M"\2NJ1R2OM2WO "(S_VTXC/OL["
MOTYK\ZXJR1Y%F<Z$5^[E[T/\+Z?)Z?CU/G,UP3P.)E37PO5>G_ V"BBBOCSQ
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***PO'7BZT\ ^"]<\1WVW[+I5G
M+>.K.%W[$+! ?5B H]R*TITY59JG!7;=EZLJ,7)J*W9^7?[=7Q&;Q]^T%K%K
M%,[Z?H"KI,"%U90Z9,Q 7@'S&<'.3\HSC&T?%?QX\3'3]'M-#A8K+?\ ^D7&
M,C]RK81?0AG4GU'E+ZUZSJFI7.M:E=ZA>S-<7EW,\\\S8R\C,69CCU))KY7^
M(VN?\)!XRU.Y1U>!9/)A*.60HGRAE)[-@M_P(U_1G&E59#P[0RJB[.5H^JBK
MR?S=K^K/T+.)K Y?#"P>]E\EO^/YG-T445_-Y^=A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %='\/O%'_")>*;2]=B+1CY-R "
M<Q,1N.!U(X8#N5%<Y171A\14PM:%>B[2BTT_-&E.I*E-3@[-:GV-^\M;CAC'
M+&W#*>58'J"/>OVK^"/CZ+XG_"7PIXGC<.^H6$;3[<X6=1LF49Y.)%<9/I7X
M4_#77?\ A(/!>FS,ZO<0I]FF ZAD^49]RNUC_O5^H'_!,_Q\^K?#_P 2>$IS
MEM'NUNX"68GRYP<KSP 'C)X/)<\=S_0O'-*&<\/X?-J7V>67RFDFOE*Q]]G<
M8XS 4\5'I9_)_P#!L?9M%%%?SD?GH4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?.'_!0#Q!<:'^S=JL-O.T!U*]MK)RN060OYC+D=,B/GU&1WKZ/KXY_P""
MF^J>3\)O"NG;<_:-;%QNQT\N"5<=?^FOIV_/ZOA2BJ^>82#_ )T_NU_0]/+(
M\^,I+S_+4_-;5=2;1M'U'4$D\J:TM)KB%O\ IJD;-'^&X+7R-7TK\66V?#O6
M2&96VQ ;3CK,@(_(FOFJOMO$ZNYYI1HWTC"_S<G^B1['$53FQ,(=E^;84445
M^/'R@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110![7^S[J/F:;K5@\O$4T4\4>/[RLLA_\ '(Z^]?\ @G;KTVD_M$0V4;,(
MM4TRYMI%QD':%E!_.+K[D=Z_.7X$7$</C*X1_O363HG^]O1OY*:^X_V-]5&C
M_M,> [AGV![N2WSQ_P M89(@.?7?C\>.:_HSA]O'<$UZ,M>6-1+Y+F7YGWN!
ME[;)YP?12_S/U_HHHK^<SX(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OA#
M_@J1<2+;_#6$-^Z=M2=EQU(%J ?_ !X_G7W?7P9_P5*_YIE_W$__ &TK[W@3
M_DHL-_V__P"D2/9R?_?J?S_)GYE?'*\>V\$K&O2XNHXF^@#/_-17S_7O/QZ_
MY$^S_P"O]/\ T7)7@U>AXB/_ (79?X8FV>.^,?H@HHHK\R/ "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .X^"L37'Q'TV
M,/L!BN&/&<A8)'Q_X[7V'\"M2DTCXU^ KR,9:+7K$E?[P\] 1TXR"1^-?(/P
M,_Y*=IG_ %PO/_26:OK/X0_\E9\%?]ANR_\ 1Z5_1?A_[W#^+A+;FG_Z1$^X
MR5_[%43[O\D?MQ1117\Z'PX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?!G
M_!4K_FF7_<3_ /;2OO.O@S_@J5_S3+_N)_\ MI7WO G_ "46&_[?_P#2)'KY
M3IC8?/\ )GYA_'K_ )$^S_Z_T_\ 1<E>#5[S\>O^1/L_^O\ 3_T7)7@U>AXB
M?\CV7^&)MG3OBWZ(****_,CP@HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***5(VD8!5
M+'T H 2BNET?X=:_KA'V?3Y0AZ/(NT?F:[?1OV=]6O& O+J*USV'S?RKU\/E
M&/Q6M&BVO3_,XZF,P]'XYH\CHKZ7T?\ 9,MKF,&XU9B?]A2/Z5=N/V0]/7A-
M8D!]67_ZU?0QX+SJ4>94E]Z/->>8%.W/^#/ENBOI"\_8[NFS]AUV&1NRR*17
MGGC+]GGQAX.A>>6P-W;+UDM_GP/7BO*Q7#N:X*+E6H.RZK7\CJI9I@ZSY85%
M?[OS/,J*5XVC8JZE6!P0>HI*^</4"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .]^!G_)3M,_ZX7G_ *2S5]9_
M"'_DK/@K_L-V7_H]*^3/@7_R4[3?^N%Y_P"DLU?6?PA_Y*SX*_[#=E_Z/2OZ
M*\/?^1#BO\4O_2(GVF3.V$J>K_)'[<4445_.I\6%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?!G_!4K_FF7_<3_\
M;2OO.O@S_@J5_P TR_[B?_MI7WO O_)18;_M_P#](D>GEO\ O</G^3/S$^/7
M_(GV?_7^G_HN2O!:]Y^/7_(GV?\ U_I_Z+DKP:N_Q#_Y'LO\,?R-<U_WE^B"
MBBBOS,\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "@ L< 9-/@@DN95CC4N['  KUKX<_#".21+S4EW%>1&
M1Q7I8' 5L?55.DOF<U?$0P\>:9A> _A/>>)F6XO-UK9=02/F:OH+PKX5L/#M
MG';65NL:KU;')]S5BRME55CC4(B\  <5I><L"$ X ')K]LR?)<-EL>9*\NK?
MZ=CX?&8ZKBG9NR[%FXNELH>.O:L-Y&N)"Q.:9-<-=S9_A[5-&HC3<:]R=1U7
M9;(X8QY?4D4")<GK5VPMM[>9)T[53A7S&WOT["M.&3<1QBMZ23=V9S-:W;IC
M@5J6S=*Q[<]*U+=NE>_19Y\T/U*XV1A<\UFK<^]1:Q=_O, U0%S7/5K^^S2%
M/W3:AO-D@.:V[><,HYKC5N?>MK2KSSDVYY%;X>O=V,ZE/2YO[ X..AZUX)^T
MGX-?7- &JPQYN=/.UN.?+S_C7N]O+TK$U3[-JE[<V<H$MM(GENI'J,&L,XP=
M/,L'+"S^UI\^C^3+P5:6%K*K'H?GW17>?%_X<7/P^\331;";"8EX) .-I[5P
M=?REBL+5P5>>'K*THNS/UJC5A7IJI!W3"BBBN0V"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#O?@7_R4[3/^N%Y_Z2S5]9_"
M$_\ %V/!7_8;LO\ T>E?)GP+_P"2G:;_ -<+S_TEFKZS^$/_ "5GP5_V&[+_
M -'I7]$^'W_(AQ7^*7_I$3ZO*W_LT_5_DC]N****_G8^4"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KX,_X*E?\TR_[B?\ [:5]YU\&?\%2O^:9?]Q/_P!M
M*^]X%_Y*+#?]O_\ I$CT<O\ ]YA\_P F?F'\>O\ D3[/_K_3_P!%R5X-7O7Q
MZ_Y$^S_Z_P!/_1<E>"UW^(?_ "/9?X8_D:9GKB'Z(****_,SR@HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG#^[1PLK>4(+_P!N0O\ 63*J6E.B[>48K]3XB_X7]\3_ /HI'B[_ ,'MU_\
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MN_\ X[2_\,C_  F_Z%3_ ,J-W_\ ':/]?^&O^@27_@%/_P"2%_K-E7_/E_\
M@,?\SX<_X7]\3_\ HI'B[_P>W7_QRC_A?WQ/_P"BD>+O_![=?_'*^XQ^R/\
M"?\ Z%3_ ,J-W_\ ':/^&1_A-_T*G_E1N_\ X[1_K_PU_P! DO\ P"G_ /)!
M_K-E7_/A_P#@,?\ ,^'/^%_?$_\ Z*1XN_\ ![=?_'*/^%_?$_\ Z*1XN_\
M![=?_'*^Y1^R+\)O^A4_\J-W_P#':/\ AD7X3?\ 0I_^5&[_ /CM'^OW#7_0
M)+_P"G_\D'^LV5?\^'_X#'_,^&O^%_?$_P#Z*1XN_P#![=?_ !RC_A?WQ/\
M^BD>+O\ P>W7_P <K[F_X9%^$W_0I_\ E2N__CM'_#(OPE_Z%/\ \J5W_P#'
M:/\ 7[AK_H$E_P" 4_\ Y(/]9LJ_Y\/_ ,!C_F?#/_"_OB?_ -%(\7?^#VZ_
M^.4?\+^^)_\ T4CQ=_X/;K_XY7W./V1?A+_T*?\ Y4KO_P".T?\ #(GPE_Z%
M/_RI7?\ \=H_U^X:_P"@27_@%/\ ^2#_ %FRK_GP_P#P&/\ F?#'_"_OB?\
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M!C_F?!__  O[XG_]%(\7?^#VZ_\ CE'_  O[XG_]%(\7?^#VZ_\ CE?=Y_9
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MM'_#'_PC_P"A2_\ *E>?_':/]?N&O^@27_@%/_Y(/]9LJ_Y\/_P&/^9\(?\
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M_K+E,M'1?_@,?\SY3TK]N#XU:2J(OC1[F)?X+JPM92>,<L8]WZ]?QKUOX?\
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M ..UCW/[,'PQCX7PUC_M_NO_ ([6;X]X;C_S"2_\ I__ "0_]:,I_P"?#_\
M 8_YGR%_PO[XG_\ 12/%W_@]NO\ XY1_PO[XG_\ 12/%W_@]NO\ XY7UM_PS
M)\-.WAO_ ,GKG_XY36_9E^&O;PW_ .3]S_\ '*C_ %_X:_Z!)?\ @%/_ .2'
M_K-E/_/A_P#@,?\ ,^2_^%_?$_\ Z*1XN_\ ![=?_'*/^%_?$_\ Z*1XN_\
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M_P" 4_\ Y(/]9LJ_Y\/_ ,!C_F?&'_"_OB?_ -%(\7?^#VZ_^.4?\+^^)_\
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M\0W0MM,L;B_G)QY=O&7/<\XZ=#^5>G^&_P!F/Q9K"K)J#6NB1, <7#[Y.?\
M97./Q(K]7CPKPKP\E/,ZJE+^_+\H1U?SN?9+*,FRU<V+G=^;_P#;5_P3H-6_
M;L^-6J;@OBR.Q0_P6FG6R_J8RWZUQVJ?M-?%C6,_:/B'X@0'J+:^> ?^0RM>
MKV/[*/AVW8_:]7U&\]!$$B'\F_G706'[,?@B##26U[=>TMRP'_CH%9_ZV<'X
M/_=\,G_AI17YV%_;624/X=*_I!?K8^<O^%Z?$G_HH7BK_P '5S_\71_PO3XD
M_P#10O%7_@ZN?_BZ^I&^ /@#_H7(Q_V\S?\ Q=30_L^_#QAA_#L>?7[3/_\
M%TO^(@<.?] DO_ *?_R0O]9<K_Y\O_P&/^9\J_\ "]/B3_T4+Q5_X.KG_P"+
MH_X7I\2?^BA>*O\ P=7/_P 77U>W[.OP^ZCP]'C_ *^9O_BZAF_9]^'T?'_"
M.1_^!,__ ,71_P 1 X<_Z!)?^ 4__D@_UERO_GR__ 8_YGRM_P +T^)/_10O
M%7_@ZN?_ (NC_A>GQ)_Z*%XJ_P#!U<__ !=?5<7[//P_F0D>'(\_]?,__P 7
M5=_V>_ @;CP['C_KXF_^+H_XB!PY_P! DO\ P"G_ /)!_K+E?_/E_P#@,?\
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M+H_XB!PY_P! DO\ P"G_ /)!_K+E?_/E_P#@,?\ ,^3_ /A>GQ)_Z*%XJ_\
M!U<__%T?\+T^)/\ T4+Q5_X.KG_XNOJ=?V>/ 18Y\/1X_P"OB;_XNFQ?L^^
M/-VMX>C(_P"OF;_XNC_B('#G_0)+_P  I_\ R0?ZRY7_ ,^7_P" Q_S/EK_A
M>GQ)_P"BA>*O_!U<_P#Q='_"]/B3_P!%"\5?^#JY_P#BZ^LI_P!G+X?"/<GA
MV,<?\_,W_P 76:?@!X#'_,O)_P"!$W_Q='_$0.'/^@27_@%/_P"2#_67*_\
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MG_XNNEL_"NAROA["/_OIO\:T1X(\/L<#3XQ_P)O\:/\ B('#G_0)+_P"G_\
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M7*_^?+_\!C_F8O\ PO3XD_\ 10O%7_@ZN?\ XNC_ (7I\2?^BA>*O_!U<_\
MQ==#!X2TEFPUC&?Q/^-:,/@/1I!_R#X_^^F_QH_XB!PY_P! DO\ P"G_ /)!
M_K+E?_/E_P#@,?\ ,XW_ (7I\2?^BA>*O_!U<_\ Q='_  O3XD_]%"\5?^#J
MY_\ BZ[&;P'H\?\ RX1_FW^-0GP3HX4_Z#'GZG_&C_B('#G_ $"2_P# *?\
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M;,2JS0.'0D8R P.,C(K27"O"O$*<\LJJ,O[DOSA+5?*PWE&3YDN;"3Y7Y/\
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M+? __H2/_*M??_'Z/]?N&O\ H$E_X!3_ /D@_P!9,J_Y\O\ \!C_ )GYH?\
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M_P"/T?Z_<-?] DO_  "G_P#)!_K)E7_/E_\ @,?\S\T/^%_?$_\ Z*1XN_\
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M ,<H_P"%_?$__HI'B[_P>W7_ ,<K]+_^&%O@?_T)'_E6OO\ X_1_PPM\#_\
MH2/_ "K7W_Q^C_7[AK_H$E_X!3_^2#_63*O^?+_\!C_F?FA_PO[XG_\ 12/%
MW_@]NO\ XY1_PO[XG_\ 12/%W_@]NO\ XY7Z7_\ #"WP/_Z$C_RK7W_Q^C_A
MA;X'_P#0D?\ E6OO_C]'^OW#7_0)+_P"G_\ )!_K)E7_ #Y?_@,?\S\T/^%_
M?$__ **1XN_\'MU_\<H_X7]\3_\ HI'B[_P>W7_QROTO_P"&%O@?_P!"1_Y5
MK[_X_1_PPM\#_P#H2/\ RK7W_P ?H_U^X:_Z!)?^ 4__ )(/]9,J_P"?+_\
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MF5?\^7_X#'_,_-#_ (7]\3_^BD>+O_![=?\ QRC_ (7]\3_^BD>+O_![=?\
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M:^_^/T?\,+? _P#Z$C_RK7W_ ,?H_P!?N&O^@27_ (!3_P#D@_UDRK_GR_\
MP&/^9^:'_"_OB?\ ]%(\7?\ @]NO_CE'_"_OB?\ ]%(\7?\ @]NO_CE?I?\
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M7J.F_L$_#RSP;F_UZ_;()$ES&B\'IA8P>>_/TQ7H2S7@?*OW5*C&;750Y_\
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MLW_##^#PJ%_[B%U_\=H_U[X;_P"@27_@%/\ ^2)_UHRG_GQ+_P !C_F?)/\
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M_@%/_P"2(_UFRK_GP_\ P&/^9\#_ /"_OB?_ -%(\7?^#VZ_^.4?\+^^)_\
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MB")3\\5]I\<>\<]X1&1U_0=><^__  __ ."F7AC4U6'QCX:OM#GY'VG37%U
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M<-!CM+]O[/U2VYL]4BC#R09ZJ5R-Z'NN1Z@@U^<OQ2^%NM_"+Q9/H6N1#S5
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MBDX..*LZQX@%DK,3BO+?%OBQ;W<JM0!Q'B34GN[Q\MD UFK@19ZU3U61EG+
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M6B1RIN3LMS+U[45TFW\F,@W#]?:N1A@,DF]CDDY)J::22^N&ED.YF-:%G:9
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M:?BHY&P#0!#,^*S;JX"YJ>ZFVYKG[^\Y-6D9MCY[D,U5VN!65<:@%SS6=+K
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MI&""#U!%?=9!Q?F.1N--2YZ7\C_]M>Z_+R/H,NSO$Y>U%/FAV?Z=C\E/@?\
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MB1@]F=RJ#W85^,/Q ^(&N_$_Q7?>(_$5\]_J=VV6=N%1?X41?X5 X %?5?\
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M+<'V1>:PKKQ9J>H 1Z5I<UP[<;F& *Q47\39UNRV.\OO%;QJ6@@BMT'0MUK
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M/A#%X&TN/5-1B#:]=)E@W_+LA_@'N>Y_#MSY7^SC\/\ ^W-<?Q#>1YLM/8"
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M?NY^]#T?3Y/3TL^I\_FV"^HXEQC\+U7IV^04445\6>,%?!O_  5(_P":9?\
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MJ5)59N<W=O<*=116!F%%%+0 4N!2T4 )BEHHH 3%&VEHH 3;24ZD- #:***
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MWL#Y$&UB,#CF1HC\Q_A. 3ROV!7Y6_\ !0#X@GQG^T!>Z;$V;+P];1Z='@$
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M*/CM0!+)'SQ2QHQ89%6UA#+FA0%/- %E9@8-N.:I>:5R*MK(B]:1K=6;<.E
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MVG'0^]5J]B\>> %UB%KRS4)>J.1VD'H?>O'YH7MY&CD4I(IPRL,$&@!M%%%
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M*** .R^%&L)H_BZV=^DGR9]*^@K^]W,=AW'UKY/MKA[6X2:,X=#D&OH3X?\
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MMC1Y)H"X-,:3SC3OLYI?LYH$,\XU/'<^M1>2:1E\OK0/4FN+I=G)K#OIO,.
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M5O#6K[/.I0_FA)?C%_H?4</3Y<8UWB_T/J[_ ()HZB;CX(Z[:,6)MM?E*\#
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M_P"FOKV_/[&KP^-JOMN(,2^S2^Z*1QYO/GQU1^GY(****^'/'"BBB@ HHHH
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M2@04YJ;4BCO3 15IU%%, J1.E,%/4T /6EIM.JD J]>:EJ*I!3 6F4[--I,
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M_P#TI';@O]ZI?XE^9\%? '_DN_PX_P"QDTW_ -*HZ_:FOQ6^ /\ R7?X<?\
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M /(V:G_V#6_]'0U]T_L/_P#)TG@?_?N__2.>OZ*X9_Y(O%?X:W_I+/M,"_\
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M^5=@[(HZBH&DB]12'H<9+X/@?_EDOY5GW/@6!@<1+^5>B*L;]Q3_ +*C9XH
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M_P"QDG_]);6OK:OA^+O^1[B_\7^1CF7^]U/4****^1/-"BBB@ HHHH ****
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M(A++N].U<=K'B&3QY\7%L(V+65D^ HZ9!KU+1+=?#'PSO[P#!$)P?PXKQ?\
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MWM+D-P'648(]1Z?2M2:YFFL\&)K28\(-YP?8-V/UKA=,:\>SCN;_ $JWMBP
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M$;>/O#WG8,?V^'=G_?%?C>>9E*G44Z3UA=GU^%P<:E*4*BNI:'Z_?#WP8?\
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MSW\.=%N/M$>BQ33YR/M # ?2OE,1P+BH5+4:B<>[W/>CQQ0C2<JU%\W9;?\
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M9^H:@D:G%4IM251UK$U;4E\MOFI\HN:QS_C+Q.+2)SOQ7@'B+XK-;WDD?F<
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M9_\ P4P_Y+OH/_8MP?\ I5=5^F>'G_(]C_AD>QE+MB5Z,?\ L#?\SW_VX_\
MMQ7UHW2ODK]@7_F>_P#MP_\ ;BOK5NE>;QY_R46)_P"W/_2(G/FFN+G\OR0R
MG4E*.M? 'E"4BTK"D% "U(O2HZD7I0,6BBEIB!>M2U$O6I:8"4Y:2G52 *<#
M3:44,!U*.](.:=MJ1@*6DZ4M PIK4II#0 E%%%,04JTT_6EI@/[TH:F;J"U
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MULGB+3?$VH.VG0"/3H#\LA7:"!Z#TKR).522;/M\*_J]*RAKWZ'C7C[1M/\
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M!JI):H^!?%W[+?Q%\&Q-+=:!-<1+U>U_> ?E7E=U:S6<S17$3PRJ<%)%((_
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MS21I.G2SR8$DSDE1V [5H:SK45NLC2%>F ,\?E51M'<W2E4DDCS'QU;P6LV
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M]RU\-_MS?\E:TG_L"0_^C[BOTSP\_P"1Y'_#(]C*W_M*]&>T_P#!+7_FIO\
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M7F[1QS6N1]ZJ,-_+9Y"L1B@#W'^W(F_C'YTV\UZ-(_O<8]:\77Q-<=-U6O\
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MD]D;[Z'Z<?L1^&WTGX>Z4'38[)O_ #K)_P""H"BY^&/AQ_E+QW6#GKC%>V?
M7PN/#/A>PMBNT1Q*!GZ5\X_\%-_$$7]@:'I:N/,,IDV9YQZU_,65U7CN+J=:
M/\S?YGU%6/L\&T^Q^=U=S\/?C-XF^&]VDFF7S/;ALM;3$E#_ (5PU%?T^?+'
MZ+_!G]MC0/%$,5CK;+I]TP"O'<,-K?0GAOIBNJ^*'[._PE^,6D7.K 0Z#J3+
MN&H:>0N6/0NG(8>PQ7Y?*Q4@@X/J*ZS2_BIXHT?27TVWU>X%DV,0LY(7'<4
M9?B_0HO#/B2_TR"]CU"*WE*+<1C < ]<5CT^>9[F9Y9&+R.<LQ[FF4 %%%%
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M_O/F.BE=&C=D8%64X(/:DK\W/T4**** "BBB@ HHHH [WX%_\E.TS_KA>?\
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MF@W=S5?RW49"@_TJ>01JY.=QQD GI4$D9P"O7Z\5!)2N)'CD1E&&Z'-/C83
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M'_C0]5^9\%? '/\ PO;X<?\ 8R:;_P"E4=?M17XK_ $?\7V^''/_ #,FF_\
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MJ:!7I/P=^ OB;XSZLMMI%LR6@/[V[D!V*/ZU0^#/PQO/BQXZL-$M5.R1P9G
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M[_V,D_\ Z2VM?6U?)<6_\CW%?XOT1R8O^/+U"BBBOD3D"BBB@ HHHH ****
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MVN-V*TH9,XKG=/D+**W;8]*ZT[GR<X\DK%]>E+3%Z4[-,S%I<TVEH 6BDHH
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M K[:K'\3>%[/Q/I\EM<QJ=PP&Q0!^)?C;16L+R4,A4@^E<5N^8@&ONW]I_\
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MI14(*R"BBBN<T"BBB@!\,+W$R11J7DD8*JCJ2> *^T_AOX)TOX+_  Q-SJ9
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M\FY>+O\ MS_]+(*]S(/^1Q@_^OE/_P!*1K1_B1]4?!?P!Q_PO;X<?]C)IO\
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M "1N*_PU?_26>E2?[AKU/UPHHHK^>#S0KX-_X*D?\TR_[B?_ +:5]Y5\&_\
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M9PGG$LNQ4L!B7:$GIY/_ ()\$44Z2-X9&1U*.IP588(--IG[D%%%% !1110
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MBB@"E>_=-<5XB^ZWTKM;W[IKBO$7W6^E5'<B>QQ1_P!8:^*_VC,?\+E\0_\
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M@U9GB"Y-8UYJB1JRMVH [WP5XEVE$+X=37M/AOQ@RL@,GZU\>Z1XD,&N!4?
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M_I'/7PM^S[_R-FI_]@UO_1T-?=7[$'_)T?@?_?N__2.>OZ&X:_Y(W%?X:O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5[2].OO$%];V%HDES-(P5(QD]:KV5E-J%U';V\;2S2':JJ,DU]B?L^?!=?"
M5HFIZA"K:C(N<L,^6/2O+S#'PP-+G>LNB/9RO+:F95E".D5NS?\ @/\ !:S^
M'.FI?WT22:LR[GE89V>PK$_:'^.":%I\VF6$O^ERKM&T_=]ZWOC5\6K7P3H[
MQ1R W##"H#R37Q)K^NW7B+4YKV[D+R2-GD]/:OD<MP%3,:_UW%ZKI_78^NS;
M'4LLHK X31]?Z[E*XN)+J9Y96+R.<EC7I/[.^IOIWQ,TX*V%E.UJ\RKO?@:I
M;XF:1C^_7VF-BI86I%[69\-@F_K5-KNOS/KO]JS4+FR^&2W-I.\$R,K!XVP1
M7FW[-/[96L^$-:M=&\3W+7VDSL(O.E.2F>.<]J[;]K"\2+X7^43\S[0*^&LX
MY'!KP.&8\N"?JSW^)M,:EY(^T?VW/@'IOV&+XE^$XHUT^[*F]AA'RJ3T<8]<
MBOBZOOO]D/X@6GQ<^%>J?#[7W$\D<30KYAR2A'# >W]*^,OBMX#NOAMX[U70
M;I-K6\Q"'U4\@_E7UI\D<C1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %;OA?QOK/@Z9I-*O9+;?]Y5/!_"L*B@"]K6MWGB"_DO+Z9IYWZLU4:**
M "BBB@ HHHH [SX3_$"7P?K4<4SDZ?.=LBYX7T(K[S^'>J6>N:2@#JY9?E([
MCL:_-"OJG]D7Q]->7SZ1=/O:W4&,D_PD_P"-?H/"F:NCB%A*FTMC\VXPRE5L
M-+&4M)1W_P SO_VHOA6/%/@N74+>'.HZ6#(I Y:/JP_ 9-?"[ JQ!&".*_5K
MQ@8VT]BZ!XG0K(IZ$$8(K\R/B)HO_"/^--5LL8"3,0/8G-='&>!A3K0Q4/M:
M/]'_ %V.3@3,9UZ$\)4^SJOGNOO_ #.<HHHK\V/U0[WX%_\ )3M,_P"N%Y_Z
M235]:_"'_DK'@K_L-V7_ */2ODKX%_\ )3M,_P"N%Y_Z2S5]:_"'_DK'@K_L
M-V7_ */2OZ#X!_Y$>*_Q2_\ 2(GEXIVJ1/VVHHHK^?#U K\E/VZ,_P##5'C;
M_MQ_](;>OUKK\E/VZ/\ DZCQM_VX_P#I#;U^M>&G_(XJ_P#7M_\ I4#KPSM-
M^A]:_P#!,_\ Y(3KO_8R3_\ I+:U];5\E?\ !,__ )(3KO\ V,D__I+:U]:U
M\EQ9_P CS%?XO\C&K\;"BBBODC(**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *S/$44D^BW<<?#&,@9K3J.:/S8W0]&&*J+L[B>Q^7FJ?"*#XE?'1? ^OW
M$UK97MRRRM'@,,'/&>YK]#_A7\'_  K\&O#,6A>%=,CTZS0#>RC,DS?WW;JQ
M-?*?QKLO^$0_:0\/:W&/+1[F)W(&.<[6_2OMR*420K*/NLH;/MBM:O\ $9A3
M5]^A\I>/? =CXOUC5M-U6(/IPG9BCG@]^*\%^)O@Q)_"X\(P11MI=K(9;669
M?GC]MV.17U3XZM1)KEUY!YD)R?>O(O$%@))95N%W$5X<JCIRT/LZ-)58VF?'
M^C_!63PYJ"7DFHK-."=L: D+GZUOZ/X#%YXNL[N9W+1R>82.!\H)/\J]BU;1
MT+?+&>?:MGX<>"XIO$8N+U%:&&"61HVZ%0AZ_G6D<4Y--LN6%4(-1B>$_LW^
M$?$%W\=O$WB&\M3_ &>X4V]P^>1MQQFO8/COX?E\0^'YXH1B3&Y<>HYKUCPS
MH%MHOA5[N*%8!*2%51@!1P *X_7(S<M*"VY3DA3ZUX6(J.=3F/4P.'5*CR7N
M?G=XX\-ZWI>N1Z_IGG6<LC+'<HJX42@\[O8CD?7VKZ"\%V=UXB\,Q74T*O=0
M\-A<=1U%=[K'A&TN&N([B%4CN/E8LN0".C8]C^E9GANUE\(RRV[MNWG!(&%(
M[8%=[QMX+35'%#!>SF[/1E6ST&1RK-$"W8[>E:=OX/WL&DBB)+;B_E@'-=K8
MV-O=PAH\(WUP*L-H[K&0#D_6LWC&=:PJ.;30;:%@&\O;CTZ&H[S3X"I15#D^
M@Z5N7&FI&"'8AO6J4R1QX1!N<G'!YK%XAO<U]BDMS&728H%!V+N[C%=%JVGO
M=7=BY  %I%N^H!_IBI+/P^5"2W0:).H#\,WL!6M-BXN"0GEA45%&<\ 8KGJ2
M3C85.E>:9B1Z:%D/&7/&.V*F:U&<!1TXXK66&-E!&#QVJ*16615"!>,US6.^
M,;%%T**3LY_AS6?+<$Y&.O!]JNWUP-KA?E;IDUD1S,BA7^8J!ENF::*T*6N*
MHV+MR&ZUN>'0L<(SP,5D7FVZ;<1R!Q5S291%$WS$@ TY!'<Y;X[&V70;&\WK
M'<),$7)Y93UKQF.\.M74%I;@R,#RPY%=)\2+#5_B%\1EL(Q(FE686-?0M_$:
M] MOA[8^#--M7BB42L,LYZTXZ1L=U/NB"2Q.D^$8K5R//DP  >:^T/V+O#YT
MWPUJ-T5(WLJ _05\8Z1#-XD\01K@E(3@?G7Z0?!3PU_PBO@'3K<ILEE02OGK
MS7HY=#GK\RZ(\CB.LJ6#C2>\G^1Z%NHW5$&-/+8KZFQ^9#MU)FF^8*56W4#%
MS1110 C-MIOF4>6:38:>@M0+$TTT$4>U4(C;Y5-?)/\ P4C8M\#]#_[&.#_T
MFNJ^M7^Z:^2?^"D7_)#]#_[&*#_TFNJ^OX3_ .1WA?\ $51?[V)\L?L+Y_X:
MH\$_]OW_ *0W%?K77Y*?L+_\G4>"?^W[_P!(;BOUKKZ7Q+_Y&]+_ *]K_P!*
MF=>)=YKT"BBBOR4Y K\&^:_>2OP<K]X\+?\ F-_[A_\ MYW85VYC]0/@Z?\
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M9)__ $EM:^M:^(XL_P"1YBO\7^1K5^-A1117R1D%%%% !1110 4444 %%%%
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M#C_6,1V_6JNJ3?;M;+?>6)"-N><GCI6A_P )A:QZ;!Y<+SSN,;8US@^I/:O
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M4>-HWGF;<<UQ4,8574T 48FW28/K6G=Z6MQ:[AUQ6),QAN/;-;EG=%H=N>*
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MA]#5.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQWQBN(OM2=?-WJ22, XZ5EKT+E%&IH=]$L:I^^^7@'@XKI?[2%N,/'<3C'4
M"N!\.ZY&MTL,K+&Q/.[O7J.D^7.B@X9 *?,+V;>B9DKJT%PVPV,IV_WW_P *
MN1,!_JH8[<GJ8T&[\SS71V^AQNV0OTJ5M!$98X'-*[%[,Y];?S#OW-+GJS<F
MDDL55B5&2W6M-;+R9-O\-0R0;7;YORJ3:--K<KQPB-<=!Z47$:>3P=K8Y/:E
M=F56 7<>F*H7EV/LHW$+CJ,U)3,>\=$W%OG;Z<5CM-YLQV[=WIZUJ2.)&QG(
MS67'&YE;&-NX]J$9OL#@PJ1U8U9LTVPR'';FHIHSMR2<>]6+)3]GE],8IO8<
M=SB-)4Z?J5W(&8RO*6&[GOVKK9KI[BW!N"7&,9/.*P6M2UTWE\2!NXKIM+M9
M;A0DH!'IBI4CTJ4-#T#]G?X9MXG\41-)$#:0L)II,>AX%?<MO&L,:QJ-J(NU
M1["O-?V?_!8\,^"8;ATVW5[AVXYQV%>I[!7UF H*A23:U9^99SC'C,4[/W8Z
M(:HSCCBG[0:7I17HGB";1Z4H&.E%% PHHHH **** $*@]:-H]*6B@"O(H&>.
M*^1O^"D?_)$]$';_ (2*#_TFNJ^NKK[HKY$_X*0M_P 61T0?]3%!_P"DUS7V
M/"?_ ".L+_B%#2HCY9_87_Y.H\$_]OW_ *0W%?K77Y*_L+_\G3^"?^W[_P!(
M;BOUJKZ7Q*_Y&]+_ *]K_P!*F=%9WD%%%%?DQ@%?@Y7[QU^#E?N_A=_S&_\
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M4PT[<*:33 2BBB@844FZDW4"'4TT4W-(!:*%HSS0 H-.IE.S1< W5XU^U_\
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MJ5U)(A49S533='>:0-(.* ,^UMYKR7+9ZUU.FZ684&15NWTI8<%16CC8O(H
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MVD@RCQG(Q7H7A?4H=WFQS -VK\S?A[\:?$'P_D$=O/\ :;'/S6TQROX5](^
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M3J3V3/%S/-JN&7L*2U:W);&UCL[2*WC4)'$H55'; JQ2 8I:^D/A!U(:3-%
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M^^JQIO$EBS9+QG\: +'E&9JT[&PSC(_2L>+Q1IT1YDC'XUH6_CK2X>#+'^=
MU8Z>RT\\8%;]G:8QQ7$1?$[285YFC_.K*?&#1H\9G3-2/0](MX=JBM&W7FO+
M/^%V:(G_ "W4GO1_POS1HC_K@?PH"Z[GJ%XN5-<SJ,66/:N+N/V@M&.=KY_"
ML6Z^.VERG@M^5-";1Z/;VW JRUN/3->4#X\:=&. Q/TJ-_V@+# PCGZ"D!ZC
M)9[JKM9#TKRZ3X_6O\,,A/TJ+_A?D/:WD^FVG<#U9;+/;-21V/7BO(F^/:?P
MVDI_X#3?^%]2AOEL9??@TN89[$VGY'3M6;>V?EJ3CG%>7-\>+MN%TV;\C52Y
M^,^I7& FF3#WP:3E=#6YWK:G/9R85F'I6UHNL7$\P#.:\3N/B+JEPQ(TV;/T
MJ6P^).N6DF4TR9OJ*\>M0G-NQ]O@,UPV'@HU+_<?5NCSR[5)8UV&GL\B@EN*
M^2K'XZ>(K<#&B2-CU.*V;?\ :-\30K\GAUC]7K*&&J1>IUXC.L'45HW^X^L(
MY/+/)J5;P;P :^3)/VCO&,WW/#RK]7-4Y/CWX]D8F+1HDYXRQ-=<*<HO='SN
M(Q="LM$_N/MW39^!SFNDLVW 5\!)^T-\2;-0XTVW55/.[-?2/PL^.%_KL.F1
MZC8;)+G +1MD UW1I.:]UW/GY5XP=I)H][WA5+$X JO_ &Q9KD&XC!_WA5?Q
MI,;'P??7:G:5A9L^G%?!VAZE>ZY=7EQ=ZI?R,[L8XUG('WOY40I<VK*E-IV2
M/O=_$%@J_-=1C_@0KF]?\0Z7Y+;KR(#_ 'Q7R4ND:9<WK17&NWEN BY_?LPW
M8Y'6G'P_X;MY$^T:W=W49)R%=OP[UJJ"74GGD^AVOQ)OM'OUD472.?\ 9(->
M?:>VFVZX\T#W-/O- \(S1F2*^GA."1&<L<^E<:]C &;:F1GC)KMC6E37*CDE
MAXSES,[&^N-.8'_2D7_@0_QKAO$&@V6J$[=110?<5-]DA7I&OY4GV>)>D:_E
M5_6IM:$_587NSED^']DN2=4!R>V*UM+\/:;I9!:]\S_/L*TMJKP% _"F]/:L
M_;U.YI]7I]C?M=:TJW5 #N(Z?(Q_I7=^&?C/I?A]5!M+B8C^ZA%>1,WO4+..
M[?K4RJRDK,<:,8NZ/IJU_:NTRUC7_B2WCGTX']:=-^U]:\B/P[<D?[4JBOE]
MI%_O#\ZB:1/[Z_G7-R0-_>[GTC<_M;/(#M\/A?\ ?N5K*N?VJ+V3.W1K51VW
M7//\J^?))XEZR(/^!"H)+VW'6>,'_?%/EB%GW/=IOVFM5;)73[&,^\K'^0JG
M)^TMKK-E/[/C _V7/]*\-DU&U&?])B_[[%0MJ=H/^7B/\#FCW0Y6>[K^U%XH
MB^Y=Z>@_Z]W-*?VLO&,8^35;5/\ =L<_S:OG^35[-?\ EX7\C_A4$FM67/[_
M /\ '6_PH]SR#V;\_P 3Z"D_:Z\<'IXA:/\ ZYZ?'_4U1N/VL/',F3_PEVII
M_LQ6MNO\U->!OKUE_P ]2?\ @!JO)X@LQWD/_ :/W?D+V;['MUQ^TYXWG!#^
M+]>/^X\*?R2LBX_: \47&?-\3^)W^FJ%/Y 5Y WB.T])?^^1_C4$GB2U[+*?
MP'^-/FAW%[)?RGJ=U\9=:N%(?6/$,H/7S-9F_P :P[CXA74V[S3?W&[KYVJW
M#?\ LU<!)XG@'2*0_E4$GBJ+_GWD_P"^A1SP[C]C_=.XF\9"3.[3]_\ OW<S
M?S:FQW0O$$PB6$-_ I) QQWYK@6\4)SBV;_OH5U_A^Z^VZ/;S;=F[=\N<]&(
MK]0\/)1EFM1+_GV__2H'7AX\DKV/T_\ ^":'_)"==_[&2?\ ]);6OK6ODK_@
MFA_R0G7?^QDG_P#26UKZUKX3BS_D>8K_ !?HCIEN%%%%?)$A1110 4444 %%
M%% !1110 4444 %%%% !7YH_\%+_ /DNVA?]BW!_Z575?I=7YH_\%+_^2[:%
M_P!BW!_Z575?I7A[_P CR/\ AD.]@_8*Z>.O^W'_ -N*^LVKY,_8*Z>.O^W'
M_P!N*^LZX..?^2AQ/_;G_I$3*3NQC-3:5J2O@A#=PHWBF-U-)2 LJU2+4,=2
MK0!)113@*+@-HIVVC;1<!M%.VT;:+@-I"*<1BDHN VBEVTA&* &,O!K$U9OE
M:MUONFL#6OE1OI0!Y=XSEQ&_-?,OQ2N?W<@SW-?1GCF?;&Y^M?,GQ&\V^D>*
M")YG)^[&I)_2KC\1S5-#R'[Q/U-#+TKO?"OP+\:>*-AM=&FCC<\23#:/UKVK
MPK^Q3<;4F\1:NL"=6BA'/TS7<D9<W8^46A9Y %7<?05VO@KX(^+_ !Y.BZ9I
M$QA8X\^7Y$'XFOMKPI\%? 7A4*MGI<>H728!FN!N-0_%KXM6WPYL?[.L(H8K
MZ5,I'& !&/4BK45U%)2WV/G'4/V<;#X>R6LNN:S!J%[]Y[*W.53V8UI)J",R
MQ0*L4*#"HO  KD]7\77&O74TDDVZ61MS,:GL9C$B#=R>IKLA%16A.YNWMTJQ
MLSM\W89KA/%S*UJV!DD9KI;N8*JEN17+>(&62,C.,CBJD"/G/QHWV?4TD'&Q
MP?UKZ.^#<B-KFBS \.5/Z5\Z_$9?]*D"\$$U[C^S[??VE;Z!*GS%7"-]0<5\
MQF,=F?5Y1/5Q/L/04.I?$;043+!)@QQ[5]875^(-G3YA@U\V_#S2%M_&"W#?
M*Z1%ES7LS:OYV%<_=KSL//V<;H].O!5)7Z'1ZM-:RZ?^]*Q_*2&;BO,]<TB>
M.UF$9W1R'<"IX-1_$;6S<Z)+##(V_! VFO#=#^/6M>%;IM-NHEOTA)VA^OL*
M[XXR,O=F<,LMGR\])G7ZUH5R(V='>/;M 'KCKBKFGZ>]O;Q) 'W<-\QR>E=9
MX)\7Z1X^T.S^U)&EZ=V]EXQZ\5I2:+IJS6S6-XCACN*YR<5V1Y9ZQ9YLXU(.
MTU8XZ&WDMV>:.(2.W#%AR,C!R:F\0:6MQHD1$H+JH2-,_=!X)Q6IXKO?[+O
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MZ3E,W4P%&3_E1Z#\ _\ DJFE?]<+S_TDFK["^$J_\75\&<?\QJR_]'I7Q[\
M_P#DJND_]<;S_P!))J^QOA+_ ,E4\&=/^0U9?^CTK]BX)E;)L3_BE_Z0BL3_
M !(G[0T445^&GJ!7Y*_MT?\ )T_C;_MQ_P#2&WK]:J_)7]NC_DZ?QM_VX_\
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M4I%&UTN'38U\H #''%7FE?SD,F=N.,U$"WEY+"/<!\I]:CO(VD4.902OIWK
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M:?%)IUL;2R.X1Q,Q8C#$$DDDY)!/7O7E;=:]&\(?\B[:?\#_ /0VK]3\./\
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ME(1\*_ '_DNWPX_[&33?_2J.OVGK\6/@#_R7;X<?]C)IO_I5'7[3U^D^)O\
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M,T (%9EQBI(8ST-+#,%ZT[S '!'2@!9(UV8/6H8Y/+4BI)GW8Q1-:GR=PZT
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MMSYN_87_ .3I_!/_ &_?^D-Q7ZU5^2O["_\ R=/X)_[?O_2&XK]:J^B\2O\
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M\)^/++Q-I2733A#CRVMSRV<=#7U>&Q%+'1Y:FDUU/AL9A:^6SYZ6M-].QB>
M?AC>_%"ZN$T&S8- NZ0RN%1?09]36!\=OASKGPSL-/M=7BCB6Z)DC\N3?TZ@
M^_->S>&OBHGP1749K31EG?4&4C<^Q5 'TKQO]I?XTR?%N\T>1['[";:-P567
M>&)(YZ#'2O#S13HTIQE;8]O+I1KSA.-SQF-JLQM5*-JLQM7P)]@78VJQ&U4X
MVJQ&U %Q&JQ&U5(VJQ&U %M35B-JJ(:L1M0!90U8C:JJFIXVH LJ:F4U70U,
MAH L*:E6H%:I5H G6I5-0*:E4T 2T4@I: "BBB@ HHHH **** ,C6OWEQ9Q8
MSNE%?1GP*L?,\2;L<1Q 5\[W"^=K^G1]?GSBOJ/X V>Z\O9R.F%KV,/[M"3/
M&Q/O8B*.>_;4OOL_@JWMP<>9*H^O-?'N@Q:?)>8U)V2W _@ZYKZ;_;BU'+:1
M9@_Q[L?G7RXN]%&;?/N0:YY[1.REO)^?Z'2ZIHWAUHXYK&^94Z.DG+9JS#I/
MA!BV[4K@<<93I7(B1NT'Z5T?@#PG/XZ\66&B1A;=[I]HD9>@]:4?>DHQ6K-9
M/E3DWHC,\06^D0I%_9DTDS<[]ZXIOAM=-^V-_:J2M;[>/*ZY]:^H5_8?N%QO
M\06R_P#;*O-OC#X!D^"^HV.FR7T=\\T>\>7;K\HS[UU/"3@G.>B7I_F<OUJ,
MFHPU?]>1P\VE^#%B#B[O2Q!^18^<]JBLX?!FV+[2+\NJ?/M  +?ETJ)O$TZR
M(#OCW' S;H*:WB:]+/Y32NBG&Y8$Q_*L^6GW_#_@E^TJ=OQ_X!#KT?A=;&9=
M-6\:[S\ADQLZG/;TQ7'L,'GBNLE\4W[0S%;B2-XQGYHT'X=*YN:^GED9V?+,
M<DX%8U%%6L_P_P"":PE)_$OZ^XI-4+'WJ\;^=>DF/P%,;5+H=)C_ -\C_"L=
M#74SV8>M1-6BVK7?/[[_ ,=7_"H9-2NFSF8_D/\ "GH/4SV4]@:9Y;D<*WY&
MK,EW.V<RM^>*KM-+G_72CZ.1_6EH&I$T,G/[MO\ ODU#);R?\\W_ .^35DW5
MPOW;F<?25O\ &F-J5XO2\N/^_P W^--6)U*,D,@ZQM_WR:A:)_[C?D:NR:A=
MGK=SG_MJW^-5I+N=LYGE/U<T:%:E9K:9ND3GZ*:3^S[INEM,?HAHDD=NKL?J
M34##=UYH5A.Y*='OVZ65P?I$W^%1OH.I'II]U_WY;_"JTD:_W5_*H6C7LJ_E
M5:=A:EB30=2[V%R/K$W^%59-)O%^];2K_O*143*!V%1,/:C06H26<J_>"K_O
M.H_F:]!\)J8_#]JI*D_/]U@1]]NXKSAJ]&\(_P#(NVG_  /_ -#:OU3PY_Y&
MU7_KV_\ TJ -V/U&_P"":'_)"==_[&2?_P!);6OK6ODK_@FA_P D)UW_ +&2
M?_TEM:^M:^+XL_Y'F*_Q?Y&L=@HHHKY,H**** "BBB@ HHHH **** "BBB@
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M"Q"XP!74Z',L6T,1UKLB>>XN-CT?2YPC9[$XK:-QYH*Y( YKFM-E9@NU1M/
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M>B?G04444 %%%% 'MGP-0+I\K>K55^.F/*MSWWUK?!6R,>AB4C <DUS/QLU
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MI+:JTCHSN)'&=H4-M7YB'!X'6OXJ\.^&=/T".]T?6Y+Z[>Y$9MI&3<J;6R2
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M\%+_ /DNVA?]BW!_Z575?I=7YH_\%+_^2[:%_P!BW!_Z575?I/A]_P CR/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ4"@'=V#@=1[]:_+KXM_!_Q%\&?%,VB>(+1H)%.8I@,QS+V93WKL-CB****
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MD>?7U-?,%O</:W$4T9VR1L'4^A!R*]6U[]H[Q#K'A>/2D"VLFW9+<1<,XZ4
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M2^996.+:$CI@<_UKPFIITU35D=6:YK6S:LJU9)-*V@4445J>*%%%% !1110
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MO+UZ)<XY'?WK](O!L^^PB/7BF@9U'523UI*=]X&FU*("BBBJ **** "BBB@
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MMQQDUDS=,@6#>QX*T32 -MC&,=ZDF8K\JGVS58X3YB<U+-H^96DE%NKR2':
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MTX_N]:N,G!WCH3."J+EFKH]IU#]J=8X%\W3DWJ@W,3@EMO)_.OG3XB?$F_\
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M+'3)+9R(YQ\JJ.A]Z"#Q/XS7D&CJJ/B229OE %?1_P"R7"Z_#B0NY8FXX'_
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MA<HE])$<[8\\CCVS7Z)^!O"]KX \#:5HUI&(X;.!(0 /0 9K\R?^"9_PQO\
MXH?%[6?B9K8>=+5F\N63)S*W7'TK]0_$E\+>.%-P!8]*CXI:]3GI)N;F_0X/
MX@A78N1D*,UY1JWA72O$,1DEMH][< J.:];\=0F6RE/<KUKQ;0];5=3N;!V_
M>1\J":\;,X6M(^JRN7V3S7Q)\/1ILS^4O Z9KC[C0Y86(*YKZ*\00Q7UGYH
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MUS(3G<[']:]*@O<.3>L_)%C1=(N=8NHX88V<L0.!7W1\$?AC8^!_!_\ :=W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KUC]GWQ%K_A/Q,;_2<K%C#EON_6O/_"_AR?Q)J26\0^3.7;'0
M5]&^'=#MO#^GQPQ1A HY/K7+6K>S5EN?<\-</O-:GMJ^E*/X^1O75]/J5]/J
M.H3-/=S'<\CG/X5YQ\2O'Z:3:M;V[YG<8 ':NMAW>(]9ATR.Z2SB8_OKF0X6
M).YKC_VK/AKX?\%ZSH]_X9U9M3T^^ME\T.I#)*HPQ]\D$\>M<U&BYOGD?:\2
M<04\OH_4,%I*UM.B/"KBX>ZF>61BSL<DFHZ**],_$FW)W84444""BBB@ HHH
MH *Z[X4^ ;WXE>.-,T.RA,IFE7S#V5 <DG\*Y&OO_P#8)^#'_"-Z#=>.M9B\
MB2Y79:^9QB/N?QP* /JS0] @^'OP]@T^W58X[6W"#''05^2?QR\5R^,/BAK5
M]*S$"X:-58YP%./Z5^H_Q+\2SZEX1U)[!\A87"LO/8U^17B%I'UZ_:4YD,[E
ML^NXT 9[=:2E:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#TS]FW_DLNA?\
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M,5(U"(&*-J@4V0X*U)364-UJA"@YYI:3:-N.U-\M: 'T5&RA!D=:56^7)ZT
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M]\M]?2OIL43NNGVD8BBD8 D9 Y;\2>0.]?-+LJXR0/J:_3_3_!UC86H1(U!
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MOQKWCX?V?^BSR8PHC8X_"OGOQUM;Q/(B=Y"#C@"OJ&?/+8](\#W;S:'%V9<
M\UWVGW7EA ZY!_.O'_AWJ#+(]JV1_$/>O6K%C=6+!,>:AW#/>KZ!U+MW<*(R
MQ8[6..!TKQKXM'R8Q(BD8SAL]:]=NKE)X3+T4#[O:O(/B3<0WFB3D N_4*>"
M.:+!)Z#/'4<<7@OPXN\(3:*""23@\UX_81QM<32L^W#8QZXKUWXEPLFC:% C
M;A'9QJ03WVBO(+2 >=(H8$%MK9/3Z5#".QU^A[&A#$$._5<=*]ET&$VVB(7"
MXV\@C''K7DWA*W6XNH8]Q&6VE>_'>O9-6D6STU$ VX7!'KQ211Y_XME=YG8M
MC/08Z+531;=V5#G((^0CI3-:FDFE+L3E3QZ;:M>'XY)&4,<(O";>F*.H'<Z+
M$T\2[#NBQCCUJY,J-&[[O+7E2&Z\56TT&.T;;R&X&WIFHIF+1NP89Y7#59)A
MW2JROO!W;R%\OGY?6LI5BBF;< WS?)MX./>M:11\QQY;*VT=\CUJC':H]Q(6
M4#;C81U.:!#[6X$DQ:3;Y>W:J^^?6G2,D=_YA7:@&W8W3/K21S112'S=IBZ!
M0.=W^%-:07VJQ95EMH_OKW)[<T".LTW,2JZ@_+QA>G-:LV9&PK[G[#N168LB
MAXB,@1CE1T.:N-(3+N #$#Y=OZT#,S5[<%?*!97 +[FSCKTK@[Q0EX8F.Y9,
MEW[#TXKT?6H3+'C<RLW('3%>4Z^KG4",X\QMN5Z+[GT%,1/<QHRQ@L'4G]XV
M.0,?K6+J7V=@J(PR" =X_A]JOS71@LVP5DX"G S^-<[=2[8V8$3A<A4 P3]*
M'L(H:QI,=XO[M ^>/F]*P8_#)CU:+:?W)&TCIT]*ZH*OEY1]X RJXQ^%=1X#
M\$KXLUJVC+[+>$^9(?3/45DY*.K-8Q<G:)Q.L?"]?$"+Y*'RBH=G9#E<>OI7
MF/Q MKIM/C\/:/;2V6DP/F28@_OCW-?H/<:1I>GV L;2WCSMP?\ Z]<OJ'P[
MT:ZA,;VT9D?KM' KA>+\M#VHY;HKRU/A;PGIJ:2K&%/-90 !(,?C7;QV<$C%
MU._^+RP/O'M7L?C3X)V3HWV5 A_V>#7F#>!]0T6Z6-T=T^Z#W_.M:>)A4T1Q
MU\#5HN^Z&ZIH^_38^%57&]LGE<5RJ:'Y<CR,F5(W*Y[5VTB2VL?ES*4 X'F<
MY)[5F"W9/FD4+@\EAP!75<\]KN5=/T_-L9 "R.,(1_.JLC>6LJ Y![CUK<W-
M#"P1\$-QZ8K%N)#&L@5MA[+ZY-.XA?#\<C77S<,W#,O4"NR:3Y0&1MY&T#./
MQKG?"L:V[R$X ^]\W))KI;K;(DCDL"?F'M[4F.QR&LLLSR+C$?52W.37%W,(
MNM2\O!DW')(ZYKN+W#-(1A#&<)_C7+:9:A]4D8AEV'(84D!:U#Q,=/NK'2[0
MD23$!V)Y'M7U9\'4VZ0J[5,G=N]?&^GPKJ7Q9M82,)"O&>]?8OP\E^P3(H(5
M<5Y%>7[S4^KP%%?5V[:LS_C=;FW\FX-NRKC&X=/QKSG1+3S(Q<N564@Y![5[
M[X^TL>,-$DMQAV XKPB2SN-%CE@N 8MC<EJ[:$U*-ET/%Q5-QES6&N&^\&8K
MM.T@=Z+1W:9R0-[#)9O:D_>\XR.1C'3ZU8M\V\; A2BGC=UYKI. B;][(QZC
ML%'(]Z%3S&( &,9\PGDGTI([A&8ACAQU(' %1VLB32,!A=I("MW]Z "Y7$CG
M(\S&<+61):M<3@\L%.0#U-75C::8A&W*AVL:M01R1.& !9. >X!H =Y9CVJ0
M2" 2RC%.OF&4V)S@87-2F3S+B/)^4'''\5)>HOGA,$G&#G^&@#G]6;R8RG "
MG[P/K7*ZI]W'.[=CT&*ZK6(PWRX 8C@-W(KDM61OEPS-_>'H?2@#;\$JRWT"
M9/S-@KZ"OHGQ8WV?PM:A<H%AZFOGGP?F6_MUDY4,&X/<'I7NWQ%OS!X=M #A
M7B VGW[U0F>0R+]INII),%.. .M9U_LCN#]GG8F7!(;/RCO6Q)"$M03(OF$8
M9L=#6%;?O5N+O'FHHV+N&..YJD2<[K-UNU!R5;RAU"G';K7HO[-<^WQI 'SM
MDW#=]>U>5ZK(BM/)&6)7.W)X/M7H/[.L[?\ "7:?+M*H9%#;O6J6X=#Z*T"9
M-'\12*,C]YM;GMGTKSGXN:>L>J7# ?+NX&/>O0O$T*Z;XS((.UGSD>M97Q@L
MUW-*B??0'UILA7*_[.WB9UN+K2)3N63YXSG^(=17O%?('@?6I=!\36MU&-H6
M;G'''>OKNVN$O+>*=.5D4,#^%<=:.S.FDWLQ^*2G4A&*YS<2DI:*0F,HI2*2
M@05Y'^UD,_L_^*?^W7_TKAKURO)/VKN?@#XI_P"W7_TKAKV<F_Y&>&_Z^0_]
M*1%3X&?$?P'4_P#"\/AY_P!C%IW_ *4QU^R5?CG\"5_XO=\/?^QBT[_TICK]
MC*^ZX_E?$T/\+_,SPGPL****_*CO"OPTVFOW+K\.]E?L/A[*WUK_ +<_]O/.
MQGV?F?=?@'16E^'/A5\'#:3:'_R"E2WFD,N3BNF^&-Q:R?"_P@C$;UT>S!_"
M!*V)[6TF4\K7Q>)G_M%2_P#,_P S'ET/*9+619#\M1-&ZGI7H\VAVLA/(JA<
M:#;1@D]*S4T*QS>CWQ4F)SQVKJ/"JB/5R5Z,,U@W-I!:R;D(R*TO#>HQ#4HU
M# 'TS4S2M<TIOE=CUR1?W*GVKGM4^;=6^LGF6:GVK$ODRQXKC.A',W*?,36=
M,,ULW2 $C%9=PN#0,J$XI >U))]XXYH6@1*M2JW(J ''>IDZ^M R] V16UI\
MQ7 K&MUXK6LU^85 &TH\Q:=]GX)(I+6KX7<O2FA,ATF\-O<8/3-='J$8NK0G
MVKD'S#-N]ZZO2[D7-OMZUIL)F-:OL#1MUS5J606MJ[=,C-,N+=H[P^A-9WBR
M]^RV)7/.,52UT,6<C/,;[5&/;.*Z3P7'Y.I,/6N8T9#)=!CWYKI?#K&/7%6M
M*G8(ZW.@^(FGF\T=P.N*\CNI&AM8;0N6/4@GI7O6N0^=8G(R-N3FOGS5KCSM
M<N=HPJMM KP<PD_9QAW?X+4]; QYJG-V'R3>4M9EQJ6S/-27LQ6,Y-9>@Z?+
MXH\36FFQDA9'S(P_A0<D_E7R<N:I/E1];&FHP<Y;(]"T>^3PCX'OO$-SQ-,A
M2V5OYUXQH\DUYKUW=NYF=OF)SGK78_&SQ3;ZE=#1K-]FGV""-0O0L.]<OX-M
M?)L7N0=Q?D<<FON\)AUAZ2IKY^I\#B*OMZKF=2L(^TQ;1A0OS\]^U;GF\(#@
M@ =ZS$7SK%'!Q*PZXJ;39_.V%NB_>XKL.<Z>_P!RZ<DP?Y(UY^M8T4PDL%<*
M S'J>]7=4D632%4#'MGK6?:MYUNJ[<?, !BI*ZFN(GM=#^7[\O)('\JXGQM;
M_P!GZ")@<R_>W-ZBO1+M77RD RB8&W/%>?\ QKO!:^%92A59,=QG@^E ,^4?
M%FN?;([N>5MNUG#1Y^Z?:N\\(6[V7[-^FD-M6\EFN7;/JQ_H*^;O%?B!X[_6
MH\L%'(YXS@@_C7T==RG3?@7X4M"V EG&6]<D9/\ .DF1]H\\ERL:JS$KD'/8
MCMQ6HWFYA&XANV3GGVK*AA965G]< ^H/2M)E>-HT'RL>G?)J/,Z+:6+B[V95
M#$MCTYQWI_EM)<MM)P.O][;VJM&K-< 9*MUV^W>K,,<K7#HK8"\E>^.U# BC
M:6.:0#JWWCC)SCBM/3KJ6/> >/;IGO5)=R>:4+,>064?Q>]1VUQ-'"P5CM)/
M0<9[TT9R.W6\>XL8T+XC!&/3'8YK,UJT>XV/M!=6^ZW][VJM9W;?8PKL"@ (
MS]W [_G5A[F21(O,;#YR QSSGC%69G$^)/#9O&5O+^?&1_GVK@KC3I-+NF4J
MP0D[=OZU[3JPD'DL0WF8VJ.XXYKG-6TH7$I26,99>_8>M*R*NSS^SD5XV.[#
M$8(]>>*T+1ECA#[N?O;.^?2J6J:/+I<KOLW1$]1V%.LKA)(#A<.3EE[9J1GH
M>BWP:&./S""?E)]!7FOQDT%/M;20G[X.XXR/RKK-&O8H?*#-QG!!/'O4'Q"6
M"Y=(@VZ-UR7QR..*T,SP7P--]ENY;)^5W8![@'TKT^S\5V^CZ;%8W\<JM&VQ
M76,LKKGALCICWKSVZTUM'\1B:/#9.<;<9YKJ-19I($YVQX ;R^<'WK"I352S
MNTT:PDXIZ7,_Q]I+Z+J46I6D8EL[G&[;V8]":RM+O9+A7W E&P"%/'6N[TFW
M@OM,FMIW$L4BLH9OX2!QQ7#2:'=Z?<R6TNZ,+C&WJX/0UX>-P[IR4X;,^KRW
M%*M'V4WJOR-X3/JJ1*WSRG]VL,8P..@P*[_P[\.EM8XI[QB@^]]G08.[_>ST
MK>^$OP?NM)L?[3U&)S<SH602#'E@C^==)XBU'3O!MI+<:G<+#M7>J?>8\?YY
MKJPN%Y5[2>YPX_'<W[JD]%N<==QQV]S)=D,BJN!N;)%9UOJSZM?;+5V*IS)(
MJX_*O-M;^(FJ?$'5FT_24:WL-^6DQ\S+GL/ZUZEX3TIO#6A2L,;V7:689S[&
MO64>Y\\Y\VQ2UJ\>*$VT.T%C^\('-<[-8_:)D)CPK<G'.?:NDN+=YOOCYL\_
MTI%MR%$A4';SM Q2L..ASG]A)'>8$0"YV^Q)KN/"?AV*29F,8;:,KCMCJ:IK
M$MQ<AA$,?=]OKBO0/!=J%SNC4@C:3V%/8HUX;.*+36QPSC&/;MFN,;1T^U[2
M-RJV N,8SU.:]#D(@LR&BSL;[Q''/2N?NDB:^C(1@LG7=TQWQ68,A2RBL?+"
M*"",[N@X[&IRH\R3YE*XSUXYIM^D:W"*&;"@<GMCIQ5:1E\XJ&.3V ZDTBRA
M#;?:KO:&.W..3T]ZZI;?R=-4] >>>M8VBV\373AB5/;C.16W?>6UD.2#G&WO
M2*.)\01RBYR6.<=S^=<+.&;4)5X8'L>*[CQ 7,WW@3T'/YUPS?\ (4D&1M_/
M@U40.@^-LW_%B_#HSL\S5 F._(Z5[9^SK%]E\+W,I. (E4-]!7BGQ6C%U\'?
M"<9[Z\F5/H$8U[5X%N$\-_"N6Z9PK/QG'%/8QU<Y+T.3^)VM1ZAKWE0-ED.T
M+U&ZO,_C;XD_L[P_::3"NV27YG_*M;2)F\1^+9;LD""!MS<G'YUYC\0M5_X2
MSQF\4/*/,L,>.P'4U)3>A[7^R?X4;R=/+INEN)Q*V>N,U]*_$R)KS6+@8.S:
M%'M@5R_[-/AU=/VW(BS%;P!5.. <5U?C::6XN&=1C>QYK>*T,[65CLOA?JG]
MH^#[5"<O;DQ-^%?*_P"VDO\ Q=+2_P#L#1?^CYZ]V^#6I-8ZY?Z5*^%F7S(P
M?4=?TKP_]M!?^+I:7C_H#1?^CYZ^FX07)G*?]V1I4?-2/8O^"8XQ_P +)_[A
MO_MU7W-7P[_P3,7;_P +(_[AO_MU7W%7E\7.^=UW_A_](B=>'_A(****^/.@
M_'W]NK_DZOQU_OV?_I%!7'^!%)\.Y_Z;-_2NM_;L;_C*SQW_ +]G_P"D4%<A
MX 8_\(\!_P!-F_I7[CG[_P",5PZ_NTO_ $E'ET?X[^9T\:G9FH&0L>E6=Q5<
M4R,_-@BOPX]0GM9@L91J;YH5B*7R?E+"JS1G?0!>,>^/<*@61F8*:EA+*NTT
MBQYDS0!/]C95#4W=M/-:,'[R+'I5"Y7YB* (Y/FZ57=&W8I?F4\5-N$BCUH
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M 4444 %%%% 'HWP,_P"1FU+_ +![?^CHJ^X/V%?^3J_ O^_>?^D4]?#OP/\
M^1EU+_L'M_Z.BK[?_83;_C*SP)_OWG_I%/7[CD#_ .,5Q"_NU?\ TD\RK_'7
MR/V%HHHK\./3"OCK_@H8,_\ " ?]Q#_VVK[%KX\_X*$KN_X0'_N(?^VU>_D.
MF8TOG_Z2S*K\#/S,_:T'_%N=._["L?\ Z)FKY-KZU_:V7;\.--_["T?_ *)F
MKY*KHXC=\>_1$T?@"BBBOF#<**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.7$?PRO^Q"NW_A-/^W+_ -KU]1-7S!^Q*,?\)G_VY?\ M>OJ!JXN+-<YK_\
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MLIT(.4&?KBO%Q,?>N?89;-2I\G8]$T_6GLYP&Y5O>D\?>&(]?T=[R&$),HW
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M &J?^2"^)_\ MU_]*H:];*/^1CAO\</_ $I$S^!GQ7\"U_XO=\/>/^9BT_\
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M4;.HF').:L6/AZYU319&,VTK[<''K7>/8P7,,:D>;"W3G)^E3>&=#6..:PE
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MEFJS+SUJ.5O)DIEGN7D=*6:02,0W6@#1L9@5JC?N5F.*ACF:'@587]\<L.:
M(HR/XJ:1M;CI5N: ;014#1[NE $32&E56"[J3;AL&KFY?)XH HRL6'-5D8J]
M3O(&R*:T>5R* $<@\U*LR^7[U7&2V*E,/I0!#-ESD=:;'N9L'K4^WVIT2@2
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MN/AKIO\ V%XO_1,U?(=;\0.^.?HA4?A"BBBOFS8**** "BBB@ HHHH ****
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M(C6A9[HACL]J_**2+0R\WF <UT$<$2# YJY%M517+;34[)6,B.Q<J(PNYVX
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MKP7XBM=4M?G,38DA/W94/WD/L1^N#VKH_C/X7M-#\1VNI:5\VAZY;)J-DRC
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M4=^:\):N#$755IA3^%$#U&W2I6[U%7,:,K-_Q\-[*/U)ICU*BM)/(%!9B0H
M[\4^2RN%SF"0?\!--7)*+U U698VC.&5E..C#%5WH*-?05VR$[MG[GK]6/\
MA7NOAVUNU^%TDC@K'*."1C$9YX^NW'XUX9I,8#.6XC^1<^GR@_UKZF35+?P[
M\(;/9;K<6UU8K"QN%R$WA^1^0(K5*YI2[^:_S_0^4?$^?,2,L3A7/TR,#]:[
M[X9VCS^++&1,GRCDA?3%<)XDLS;ZTMLSJ_"C*].7!'Z U[A^SU)9-XDUA64(
MPTY_+WC.YBP%5:[:,Z?Q7]?R,'XEF6\\?6ZNN#;1  DY^4=_Q.3^-<OX1+3:
M!!(PY>25OSE8UL_$+Q&+KQ]J,S((5M[:2+:.,D G)]ZR?!7S>%]/]0A!^H8@
MU][P7*V/F_[C_P#2HG-C.W:WX(_2W_@G.-OP1UO_ +&*?_TFMJ^J*^6?^"=7
M'P3UO_L89_\ TFMJ^IJ^4XAUS7$?XC:C_#04445\Z;!1110 4444 %%%% !1
M110 4444 %%%% !7YW?\%$AGXUZ)_P!B]!_Z4W-?HC7YY?\ !0Y2?C5HO_8O
MP?\ I3<U]IPB[9HO\+.;$? 5_P!B=?\ D<_^W+_VO7TZW>OF7]BL;?\ A,L_
M].?_ +7KZ:-<?%#OF]9_X?\ TF)%'X$1M5:8=JMMTJM,/:ODF;F5=KUK$NH\
M$YKH;I<YK)N8NN:P:-DS%9?FX%.6IY(\-BH_*.X =:R<+FBERG2:/<?V/X7U
M6](VR2KY,;?6LOPGMN)(F(.XD#)[^]7/%LZZ;I.F:<>!L\V5>Y)Z9IG@:&.X
M8,. IR,U]!AJ?LZ21YE2?/.YZ[9Q1C270< J1^E?%7Q@5H?%P(&]DEQ[#FOM
M6.,+IZ\D?+FOB_\ :!A;3?$1F.3%Y_3O]*T9,BA9S#^T+,YQALYSQ7T):?O+
M&&0'AD'(]:^<H%$<-I*%QN )&>E?0^B?OM)LSC/R#(-7$@R/C$OVSP3YQ7<0
MA#9]0*^:/!US]EG@,DV()I01#U&<\U]2^)H&U;PS?63'[N6R!DG-?(&FAK34
M)]*=@K6UYNC;J1SFA^0NI[]\89(_MUE*HR$A4[3T.5%>9V\BP2-<)'EL8_ ^
MU>A_%V14^PL'R6A08/3&!FO,[J]BBA5D5@,X#9R#4L1[3\-&%OX6U:^WE6=@
MBO\ AS7):IJ!OKB1P-N\E0P[&NBTN].F_">$QX66Y<NNX8'6N):ZCD;]R#D\
M L> :11O6DQ^RJJP[SPI)')/K76^'5>SL\,N"O\ %)U.?>L+PW;+)"&899!A
MCG//TKH(YWMX3'MWR(/O%>3S5!<TUE<@QK\JG+ YYR:@VLK%$SM_C*>M);^;
M;VY0ELG+9;U]*SY+PQRLH/!.7*GO30F30_-<2+N+&''F)^' J"98S*T9X9<-
MN)X^F:9##)(V=PSN&]1UI\MIN=H0Y!5?,/;C\:&29%U(%F$8'#[CN'08[5?T
MF,RSJ5&_/#''W1ZU UI$UT(V8B1R=O/RX'OVK8M=D<R(J [CLRASCCJ:0SH+
M"(Q[2A&.,Y&.*W6PJJR@C'(QWK*T]=JK]U^@(S_#[5JW4@AC0ID;!G&,Y%!1
MRWB2Z9F'*[5^;GJ#7F>M3)>2,9#N;^,-TKMO&^J(D:JI+R9W@*,$&O*]4O)[
MS <^8C9++QQS28$-\_RC>^]C]Y3Z5DSWNZ)ADJ4P%4'C%:ME:W_B>^BTRSC:
M>YN?D10,%1ZD]A7LND_L^Z?I^G)_:MR;VZ90K*@P@]<>M93J*&YU4J$ZSM$^
M>M-LGO[IA_"!A?0<UUAS;VZI R^4.&;^=>XQ_!?0X8TAM$:#8O3-<UK7P5#1
MO%:73(2>!6'UJG%V>ATRR^M;34\)\:>&XM6TA&C!E'FR@<=#FO/;?X4F^OQ)
MM9]O_/,8*GWKZCO/A#K+1^4AC,>]GQG&<U!I?PEUJ&Y_U,<:-RS*_4UI[>E)
M:LSCA\1':)\_6.EZQH6X0%I5C^_'WK9TGXHR:+)LO8VAD'56[#UKWC_A2U])
M(SNT6Z3[VT\UP/Q)_9HU76-->.U>*2X8?0BN*LL+4TO9GKX>MC</;2Z,:?6X
M_$$R2K)O#>_/-=9I9%K'%'",;1RV>E>':A\/?'7PY:.3[#)=01H WE?-TKJ/
M#OC:YU.U(DA>TF7[T<H*D_G7CU,/R.Z=T?3TL:L1&S5F>T0ZEYTFS.[U]*M(
M>\2A?5J\QTGQA'#,$F?YO2O3] O(+Z%0@R3S6/+W-))=#I;)9A:@L.M.N+&.
MY3;-$CH>NX5?TJS,D9ED.$' R*CNDVJ0,FG9QV,;1J.TD<+XF^%&FZU"S6A%
MM/U^7BN#/@?5/#$;QSVK319P)8QFO8(Y)()LCD>E='H]U!?*T<R*P(_B%=E'
M&SC9/4\O%993DG*&Y\1?%KP\O]BW5PZ8:)2?F'?M6M^S;X_?5O#@L6?,L9*\
MGTKZ-^(WP6T;QE:7,#%[7S1@LG3\J\R^'_[*T7@'4))K'6W:)CG9)'6V(Q$*
ML=-SFP-">'F^;X6=WI#O<-M+XP>374:7<+;7*$2<ANU1:;X6DTE,L@NOH*U8
MKRW5@LUNL9SZ8KSM#VI236A6^)FAIJ&F0ZBD:L\8^M>3O&LDPYVH00X%?0=O
M]GU;3Y+4H"K#CTKPOQ!8MX?UZ2VG&R)AF-?QKWL+5YHJ)\ECJ3C+G2*+VJJH
M10<X R?X10\?V=85! YVCC.<FK32I,P );U<\8]J>55GCQCS&X51TXKT3R"#
M:^THRX)R#D8!I68>20%$9Z#\*N36YE11L;@<@GOWI+J-?+1DC5789W>E2(K+
M&?LQR^20-P ZX["J%Q&T,._YEW#*KT_.M.:%85&)"5^\ !US5.^618"N""WW
MNV/I0!S-TWEQ/E RYR<GUKEKR0*[$G#9X*]A74ZD52 $1_-R$).,D5R6HY6-
MG.,L/G44P-KP: NIV[[E5BV,5Z[\5KF.VT:!]^6$"A3GG->.>$P_VF)L*J[@
MV>NVNW^.FJ>2NE0,1C[*&*C^+T-4)GF6@EKR\VE&5@V6;/6K_C>=(-+V .C]
M-N?UK&\"S&;4I20Q3?RK=JN>/,&94.[&,_AFJ6Q)S&K-G1XR6SD<C'2NK^$[
M'[9:X#$*X(;WKC]:D/\ 9\46=JD'Y@*Z[X0[([I"%8G=G:3B@?0^T[Z,ZG'H
MIVE@8E!Y[U2UM5:2]7=\JG%6/"=]]OL[$ $_9UW XK,NIWGDN&8D>8QK01XK
MXCA6UUQN=^XDG_ZU;'A>\:*XAFC7:5Y4CV-9WC*%?[29_-X4D#BI?"]T 4C*
M?/\ 7C\*RZ@SZGT>^&IZ3;7.<LZ\_7%6B:Y/X<WQFTV2U8\QX9?H:ZWBN&I'
MEE8ZX.\1M%#45F4-)I*5J2@05Y1^U-_R0?Q/_P!NO_I5#7J]>5?M2<_ GQ-_
MVZ_^E4->KE7_ ",,/_CC_P"E(B?PL^,?@:O_ !>OX?\ _8PZ?_Z4QU^OU?D-
M\#U/_"ZO '_8P:?_ .E,=?KS7V7&SOB*/^%_F3A?A84445^;'8%?B7MK]M*_
M%#::_4^!Y6^L_P#;G_MQPXK[)]E>!]'U&3P'X;>-_D;3;8@>WE+BKTGAW49,
M[B35OX=^)X8?A_X:A89,>EVJ_B(E%:UQXNMTZ*,U\WB)R]M/3J_S.6R.8;P;
M=2=6 _"E_P"$'D;[TG-:MQXR!SL0"EL]=GN59R,+VKG<Y;CL8LWA-;7.YLTL
M.EV\(&<9J/7M:F\P@-BN2O/%)M<AI/FHYFQV/</ =_%L\M6!QQ78WR@KGVKP
M+X4>*OM6L2P[LC.:]]D820*WJ*YZB=]3H.>NUZUA7AY(KH;]>N*P;I.M9EF8
MW<TQF%+.W:H6.<4")1\S5<M5)<51CZ\UJ6,>2#4L9L6,6%K1MV$<ZCWJK;KM
MCQBF-<;9U&>]2,[JT0/;BFM$":-)D#VXYYQ4[#YC5W,RE):^9FL^ZT]E8,!6
M_'&&Q5EK,21T<P;'/27#+IY4GM7GK1LU[+NZYKU.?3PT;+BN!U:S^RWYX^]7
M339G)&AX?C_>56O9OL_BFV^N*T_#L1Y.*PO$<PB\36F/[PJ9:L<-SV:T<2V:
M?2O'?B_9^7<PS8_CP<>]>N:3)OL8C_LUQ/Q.T5M76"!>&D=?F]!GDUY&.@Y4
M9**UW.W"S5.I&3V.!M)ET#PK<:D?EN+H>3;YX(7^)J\YMY))/,MW<R%R3C-=
M5X[UR#4;LV<+!+*R411*.^.I_&N(L\PW;2'@=02.HKJP>'^KT5%[O5^O]:'+
M6JNM-S9P&K;X?%J1A2J@\<\9STKVS377^STXR%48&:\G\;6L:ZA#<1D&3<,$
M#^5>F^&9"^B6A8X8]<#FNPYQNL&2*(.!DGCKWJ;3F6[MX]VU<=>:=J@)A,BC
ME/:JFD2%D8D%2>P'%,#H;,LL<@497&.1Q6OX>5?,9E&#CDDUFZ:ACB*R<CLI
M-:^@VYA8XX=CG;Z5+&C*^)VN+I.@RQN=NZ,YP/:OC'6KB26^DE5M\:MC.WC\
M*^B_VC];$5JEKG]XP['^=?,UY^ZCE4,QSR#GM[5)6[.$T.S6Y^.6I7I'^ITU
M&Z<Y)(_/ KT:^42,JDYV\<'GGUKBO"LJOXMUR[SDK;PP8!YX+'K^-=:VZ8HB
MD2\XX]/6B(EHKHG$:^8BCY@?E)';W-:<%NDDR[CMXY8=.*6STU$5%<A\C!/I
M4M\Z)*%RH&,EE'<8Q1H)]V/A5);@ '=CYL]L^F*T[>TCA20\1LO'S=#D=1[5
MFZ6X-P&; (Y5AGD_2M,[;G.2$ !4'U!')H%YB6,$,JEB?D/RD-GMW%:"V:-;
M-(S?*1N5?XA[?C52W>** DE5.,%,DYP>/SIT=XD=J&9P2V&:,'HWIFBP%\VL
M(MAN^=NN,Y//:GFSCCQT;G'!SSGC\JK+=0*H(8%MV0,^O4U,U];KL"OOR=F5
M)XYZFF%Q7A42!%(+,, ^^.M5FA;[3A>O4#M@8S4TU] LXC5U.5(W \<>M5)M
M0$DP"LJ_Q=?EP#C'UIB*LUI)-</]\\Y90<<=JK;9%C8C<Q4X?U#8XYJS)<;I
M'4-NV?,PS@'/I26UNS+*2?.ZJ^XXY]O6F(S(99E9]I^4 C('&>XJ/SBUNT;A
MG@8<8'&,<U>MX?,)*#,9.T8XP1UJ*2U<PR;AF/J&'&%[U-BD^YC7EC#Y:RPN
M8/XN!\NT=*T;'6/+C:0Q@O"F_@;1P1@_B":=_8CM'\_$7!#$<$=A46JV$EG8
MW"!2LQB\M5_O%G4 >W6ERCYE:Z-O28['3H;634V6"35Y0GF28&8R< >VXUS_
M ,0O NFKX9M];M],AT'4H=3^S&"'.;E"#\V#U*X&2/6MGQ=X=MO$%G?6-["7
MLK,16RF-L,I49R#V.:P]/\.-]IB^W:K?:H85"0"\DWE,CH*X*M*K*O&47HC6
MG.*IN+6K*^AZ/"UM--\N=N Q_BSU--718[57;S%7/&._'I73KIH@L[A%&PLV
MU5 SQ63Y!DC<2+@\%E'0>E=NI@EW*+,!%MCW,?O'UZ=*>+,IY98[N<?+WSZ_
M2M-;>.&V1L#=UVXXW8Z9I)F\N1% WQ=%&,<$\FEJ5T#[*%V ;5R-NY3W'>HV
ML2UV-KX9AD<\5>=8Y/*"D-D!3@XP/>E6'=-RH7(SN7[HQ1L/9E_3+/=-M498
M'<0I[?6NHT^1UMID&2R=QZU@:;&/.;! _B/8<YXJ^9S#OV[E .TY/<]ZDHEW
M--:LH!,>2-RCMWJC<*VY(7 PHSZ?3FKMN66-BKD0M]WT]Z@N"6@$C,,9&,],
M=J16@R^M?/C1AM$D8SC&.<=/>IM)PLN=HSC;G']*1I':2 M\K*>XZGG^E20[
MK?4L%^HX8CM0%RT,,TF$W-U&>P]!63J+;8,#AL\Y[^M:$EX\?FMY8;/.?TXK
MF]5U#;#L (.<%CUQ0D%T<[XA59)%_P">;9^;T';%<Q;PAM2?<69AS_C72:HL
M;;0-Q!]^?;%8]G!YEZW#%LYY//O5C1VVM7D.B^!+&_E^8VLLDP4?WMA"@?CB
MO);'39O#_A^+3X'QJ>KR-<7$FWGYCDY_.O0/B!.DWAG0--;.'F>:5B<?NUP<
M?RKD;*4WUY+J<LH;)*1<\!14F33;*3>'8;>WM=*C'[R5OG*GJ!UKZQ^!NA)I
M>EI)Y6U(5&..M?/WA'3?[2UC^T'0L&&$!&>.F:^K?#\*Z7X/.!Y;.<D]#C&*
MJ-V$MBCJGG:[K[3R-BVB;:#V^E5M6UI8[B". C"\!>N*IZQK2VMGN0[&_A3/
M?N367X>@6ZO?-ER>_P"-6W8A&YXJ$=O8I*V<2)DX[5\Y?%!Q-K]N1T%JH'_?
M;U]!^.+P-I9&/E48ZU\Z^.IC<:M V.ENH^OS-7U/#,O^%%>C%):'UE_P37&/
M^%B_]P[_ -NJ^VJ^)_\ @FV,?\+%_P"X=_[=5]L5X?%#OF];_MW_ -)B>C0_
MAH****^5-S\<OV\F_P",L/'G^_9_^D4%8'PL!;PRQ_Z;O_(5N?MY_P#)V7CW
M_?L__2*"LCX2C/A-_P#KX?\ DM?M&>O_ (QB@O*G_P"DGFTOX[^9U:QD')Y%
M6/E"=*K/*R<$4GF[EXK\7/2';4R=PJNT:L^!TILCENG6FJQW4 7(5$(JG<#,
MNX58,NY<56;+&@!57;S4L,V).!Q35DPN#3HR%.: )YILKQ1 R[>:9N5^*.E
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M* "BBB@ HHHH *]%^$?AW[=>O?2IE(^$S7GD<9DD5!U8XKZ1^'FAKI6@P)M
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M-(P &2> !7>^#?!2P[+V]7+X^6-AT]Z9X+\*^8XO;E?E_@4_SKOU&W@# I;
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MB,?!76O^Q@G_ /2:VKZBKYC/]<TK_P"(UI? @HHHKP#4**** "BBB@ HHHH
M**** "BBB@ HHHH *_/7_@H4N?C1HO\ V+\/_I3<U^A5?GS_ ,%!A_Q>;1O^
MP!#_ .E-S7V'"KMF2]&<]?X"K^Q>O_(X_P#;G_[7KZ:[5\T_L9_\SA_VY_\
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MK6\<ZP+S6+JV9\*AZ,<<^M:KW8DR5V9BSC5+\&7[AST.:[&WA2UMU,:X8'D
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MRP2/S+.Z_P!8S&M4O]I_@%%%%:GAA1110 4444 %%%% !1110 4444 %%%%
M!110.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]5_9=_Y+EX=_W+S_
M -))J_0OX<J/^%A>%_\ L*6O_HY:_/7]EGGXZ^'/]R\_]))J_1'X<K_Q<'PQ
M_P!A2U_]&K7V^2O_ &.IZO\ )'+4^)'Z@T445\0=05^8'[9BY_:3\8?]N?\
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M _\ PB?B75I'^58)2"?0 XKZ3^+'B@V=G'IEN?\ 2+GAO9<\U\D?MA2?V)\
M_$4B?*\EOY2GW8X_K6-1\QM3T3;/R,D+RV[2M]^YF9_S/_UZ_8?]A7P^-(^%
M^E)MV[H@Q[5^2']GB77-(T]1GYXT(]\\U^VO[-.BC2? NFQ!<;85&/PH3U$>
MKZI\L 'O73^'8=NG0]N,US&I+ED7&?FQ79:='Y5M&N,?+6Y$B1>)/:IOO U
MW6I%?MBD8M",FWFHIGQ&WI5AEW"JEU\L1[T!'<Y:!S>>+CW%O&!^)KKYI/+M
M1VKD/#8WZQ?S=2TOZ#BNFU27;;J/:E$WENC&9/.N/6O$/VXK?;\'=(/_ %'8
M1_Y+W%>[Z;$6;/J:\4_;L79\']&4=M<AS_X#W%>[DNF8T?4QJ_"T?._[&:X_
M:3\'_P#;Y_Z1SU^G]?F+^QL/^,D?"'_;Y_Z1SU^G5>EQ@[X^'^!?^E2%A_@8
M4445\,=05^*VROVIK\7=IK]-X+E;ZQ_V[_[<<6)Z'U9X(/\ Q1NA?]>$'_HM
M:WE-<]X);_BD-$]K&#_T6M;@;O7Q>*E^_GZO\S",&6-PI&?%0&2FR2';7+SH
MT]DR4S#FO-O&4WVS5[.V!RTDRCCZUW$EQL1S[5Y[:L=8^)&DVX^8><&/YUO1
MDN8PJTGRZGVCX5MQ:>'[&(#&V)?Y5K5!8Q^39PI_=0#]*GKTA!3EIM+0 ZBB
MBH **** "GTRG+0P,'QAHL^K:<CV;".^MG$T#$X^8=L^]<YX;^,FDZA?Q:5?
MR+9ZHTAA"@[HW<'! 8< Y[$]Q@FN^GC\V%TSC<,9KYC\._"G4-#^*!2ZO8$@
MLS)=/*RA]T6(B"H8'#<'GMS@UK%RE'EM>WX;'7AZ5"3<JL[/HN^C]>MOO$\?
M?%[6X?B-*]G*L$=A,T,*;%(VC(;=D<[B!],<5],:/>G4=+L[HKM,T*2;?3<H
M./UKXC\3:C%K_C*_N+2-@EQ<,\:=\%@?\/\ OH5]I^%[.73_  YIEM-_KH;:
M-'^H4 URQDY;O^KL]O-<-2P]*')%)WM]T8W^YW^9KT4@Z4M6?.!7PC_P5,UG
MR]#\":4&YDN+FY*_[JHH/_CQK[NK\T_^"HFM?:/BEX6TT-D6NE-(5]"\K?T
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M "@G!W9[UN0[%F#%SA1@IG/--:B+*Q^9="4)N>/[C =">OTKMM!MRZIG[W!
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M]Z\P\70 QSDC>,YR3TJ0,'P5=(NL1-OP"P^51TP:O?M)71D\76JJV\?8X>%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%:?A_0;GQ%J"VMLNYNK'T% '3_##27GU W1'R
M+P*]KU;4HM'\/3S%PNV,X^N*Y/P?HL.C6(C4\J>37+?%7Q&6C2QCD^]RP%>;
M)>VJ6/VG U8Y!D[J/XFOQ9YQJ5TU[?33,<EV)JNJ[F SC/>DHKTC\8E)SDY/
M=BLNUB,YI***"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQT7%=O7+7=YG=AU:F%%%%<YTA79>!=%MM4\];N9;9 C.&;;EB"  ,]>I..N
M<5L?#3P#8SV-QXH\3,T'AZR/$><-=2=HU_K69X\^)'_"67R/9:59Z/;0KY<2
M6J8;8.@8]#^5;Q2A[TC.5Y:(Z/4M"?X<-I_B"QO;.XN8Y<QB')965%8[N/NG
M<1C.<?4&L'7/CMX_U^ZEFN/%>IPK(3_H]I<-!"H/8(F !_DUR$FK7$L;HS*0
MPP3MYJE1.I?X= C&VY+=7,U](7N9I+AR<[IG+G/XU%116!H%-_G71>#_  #X
M@\?7PM="TR:^8'#S*-L,7N\A^51]37I1A\*_ &3>SVOC3QZG10";#36]>?\
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MXVB3'W'1<>RQ[OZFO4?#0']BV^U<+EQC_@9K[+AAVQDW_=?YQ/.J_"C]#O\
M@GX,?!K6?^P_-_Z3VU?3=?,_[ /_ "1O6?\ L/3?^D]O7TQ7S.=:YC6]3KI_
M @HHHKQ30**** "BBB@ HHHH **** "BBB@ HHHH *^!?V^EW?&+1_\ L P_
M^E%Q7WU7P3^WO_R6#1_^P%#_ .E%Q7U'#;MCUZ,PK? 5?V/%V_\ "7?]N?\
M[7KZ/Q7SI^Q^O_(V_P#;I_[6KZ-VUS9_)?VE5^7_ *2B*?PH9UZU$RCFIV7B
MHV!KYVZ+*<BCDU7^\V*NR+FH&BI710L*_9[2YG/\*E1]37F&I+Y4QPV69CR3
MFO4-:C-MH(120[_-GVKR>^7=?97GYORKU:$>6!RU/B-O2X7F15/(->H>$H<2
M*",<>E>?Z)&RLA^]Z>AKT_P?$=C,W4=*V9*W.DF(CCP2 ,]:Q-6VWEK.&R(P
M.,5JWCJQ*G[JC)K'%PMU))$>F.F*DIGQS^T#HC:?JEGJELK QRF.0@=%-6_A
M?K2P7VUV 5AE<GD>M>B_&#PW'JT%W:E=N]"1(>U?-WA#79--N9K>;_6VTFUR
MW7TXHZF'0^CKW4EF8N7^0 @(!W]37F^H:QLUB9%WL@&XR= ?:M.#6VO-,619
M4$K9[]O_ -5<%XBF?;YK.8H><^IQ6IFSRWXDM-H_Q LM1SBTO@UG-S]TGE"?
MQKI?@Q9_V?H?C*[8%)LI". 0>ISFL3QD(]=TN1&4&4X =CDY'*D>E=;\+E%U
M\)]3N0V'N;KRY-QZ,@J>I70IV;*F7=0T@Y<YXSZ@5V_A&\\N-8_,P%Y#,.3[
M9KAK&'<S;U8ODC8.A /!S7<^$8UM!^^9'+M\N>P]*+:B1V@ODMX##''D,,AO
M0ULZ?-)=1E582KC8VP]#BN+EUKRYA!;[@LC9SU&:](\)Z*]OIPN)D"[^2!Z^
MM58.IBO;BV264YCVDK^\XR<5QE]<&>Z<"388V&R0CAOI78^*KUV9Q$<K&=K*
M/6O-9%N+F_=4=HS'\QW'L>U0QF]IY,UP$=MT8'WE');/3!_G7>Z#H;W$R/(<
MPX^?=USVKB?#MJR721,P;C=N[?2O5M'A,FQ2<HPPS+V-'05M35L;..SDCVJ0
M!PR]0WUK=2'+ JH)'&5JK;6Z0RJ0V1T(;J3VJU)(%SQC([&D:HHZA=);PRR>
M;M*9!#&O ?'&I_VIJ$R!UC,;;59CPWTKU/Q;J7^ARF.0%2"N1V->)M"FH:DV
M"7V/AL]S4L9/X3\-"2Z,LFTM&<Y8X5OIZUW:V\=DLDC':JKN1EYRWI65X?L5
MAF$4>"4^]N/K74:E8K'IY611A%!#8X/M4E(X#X?Z39^)?BN9=1'VF*RC\]8V
M'#OVKZ*O-3MVC5FMP&4< =J^,_%WBW4/ /C2+5K#<D+#RY=O>O1O#7Q6F\30
MQS2ZS%# .612"_TKR:]^?78^LR^,94O=W/HM614CD"H-RYY%4X[Z&\N@C%#&
MO5<#FO,)_BE!-D>:!'MV*H/0"J.C^/OM6L;(2L=JO4YY-<$Y1<CUE3<8NY[E
M<VNER1J)+2%NYR@K)DT31YI.-/MP#P?W8YKA[SXC6Z,5-PN /[U10_%+3DDC
M1K@$CL#5.<3G5&1Z)]AT^U5Q#:1QJBY.U0 *YN'4+;4())<*6W[4XZ5RVM?%
M^Q\F2QMW_?W!^9L]!7+_ /"P+-V:"R#/';_??H,USRDF]#KC3G".IZB^I16L
MF'E 51R>I-7M/U"WO>53BO%E\8-J4PYVKGOWKI='\7QV[[=QP*30[L]BLUMX
M^3)]ZKTKVB19,R_0FO.K'Q);72YDG /95/-6;2\BFF+ABP_VJT2.>VMS9UK6
M+*!6"%2U<+=".ZG)6902<E35;QSXFM+'.[&[L:\^CO?[4GW1WKK[+FN=WD]3
MH458],M]+A:7=*ZX_P!DTFI:3#*I2+ )' %<KI<DUNWRW7F?[U;-OJSPGYW$
MC^OI3MW)9''IMUIC JI\I>M:]KJ0:,!V4'W:H/[8CO%(ES@?PTP0VMS&0$4'
MVZU#CJ$9-*S-^WNH[B+:[*?QI'3R3E,?7%9(MH[-%._+'MZ5"U].S-AML8J&
MBD^IT'F$J  6;UK9TV^V%=^>/4UQ::]MVHA)/<BM"&_CD :0G/UJ5=$RU1W-
MUY=Y&2%4-C.:X;QIX%L_&.F2VMTGFY!V\UMZ;J2,P';W-:F5F^8#';BM8RUN
MC%PTLSX.\8_#GQ/\+==EO+ 2I;J^Y)$S@#/2NL\+_%#3/'\8T[6PMEJT8VQ7
MC<*Y]&KZWU7P];^)+&6TNH4>-QM);GBOD;XZ?L]W'A:X?5](C9X8R6VQ@\5[
M.&Q721X6*P:^*!U=C;WW@^81NO[D-G:IRK \[E]17H5C<KJ&EB57!<CYN.WI
M7SI\,OC T AT'Q.";93A)V.7B],'TKWC2U_L^&/RIUFMI3N22,_*X->TK-71
M\_*+CHRO=3-'YA!;#CY?I[UYMXN(@LY%[8Y!.2U>B^+IGL[7S0WRCDD#ICM7
MFOBZXAU&Q\Z%OGP<#%2!P'AMGCUR)0H&Z4'GM71_$6 W'Q*8OA(EBCR!U) Z
MUQ_AR8?\)-;)(?D,@)[<@UUWC*03>/6GC;YFC4KNI]!,G:Z%S,80P(!X8C''
MI3_L[NQC"@J!T]*9I8"S%Y K)R6P<<U8W%6DF*J"4X8'@CTJF!R/B)A)=-$_
MRG=@-G@U[G\)=)6.ZTN)%;<NU@WK7AS1C5/$$86,E0V2H]J^D_A':I#J$4BD
ME8DW<]!Q26X2V.Z\:7:37TQ9L%0!@]Q7F=YL^U2%OGRWR@&NJ\17R7%U)(2P
MW'MTZUSVIV\<*] Q)&2.U5(A%;2;@K,<$KENK#I7:^%I"MVJ_>#$\#M7!Q_N
MYHV3=C=QGG-=GX7D,EU;L.#N^F*(C/4[6S*F1AG"@9:KF@W)M_%$,F[Y8V Z
M^M/:$QVDC#&7C!(JI86K1%+@],^E:="6>E:];BWOBR\))\PK-K8DD&KZ!:W@
M.648;\*QLBO,FN61V)W0M(U(Q%)FH&%>9?M*<_!7Q%_V[?\ I3%7IN:\T_:1
M_P"2+^(O^W;_ -*8J]#+_P#?*/\ BC^:)ELSY+^"Z_\ %XO G3_D/6'_ *4)
M7ZNU^4_P9'_%X/ O_8>L?_2A*_5BOI>*G>M2]'^84-F%%%%?#G4%?CAL^E?L
M?7XZX]J_0>$W;V__ &[_ .W')B.A]7^'9DE\">'D.,C3;<?^0EK#U31O.9F4
M$"MWP=9^9X/T!B,C^S[?_P!%K6I)I^X8(S7D5'RU9>K.-GEEWH;KD@&L6YLY
M8B< UZ[=:0"#A":PKW0-V?EIJ2)/,VG>-L-FI([P$ 9YKI-2\+ELD+S[US=[
MHLMJ2<&JNACFG##K73_#G4OL>O*I. _'6N#DDDBZ@U?\/ZB;;5K9\_Q4%1>I
M]?6LOG6*-UXK+OUW9I?"MU]JTM#ZK4M\O7BN%[V.A',7GRY]:S5_UG-:M\OS
M&J,<7[P&D]BC1LE/I5F9MJG-,M\1Q@U1O[P+N /%0,9=7 P>:SI+@,U5[BZW
M-P<U")"S4%6->VF Q6U:W7 KF[9NE:]O)MQ4#L=;I=QYC 5V-D=D8/?%>?:'
M=+]J52>]>F6ML)+3/7BKBC)LA.J>6Q!/%2'4A)"<FL'45:&8@ U$'=8&(!)J
MM!:[F)XHNPTQ -</??-)[UTFMNQN#N&,5S4OS3&M8D2['I?PSN?W06O0]2RM
MF_T[UY;\.;@1W.TUZEJA#:?(?]FLI;E7T/G7QH@7Q!)Q\K,>?>N:L8UCU3+[
M@V[*\<5O>-F-SK&]!O"R;6K.N)(I5); >/IBK6QG/21SRW,FH>*KD2Y"0$_Y
M%;EQL>9?*!"]2<]#_6N3TJ1K'6[TR?.DB\.1S@FM+[0T>#OYQ@8'K3()O%NM
M+9QJH&\,".O2JOAF.55-P[ KG@9YK&U25[I0CJH96ZXY'-;VFZLEO:K$$8J#
MDLJYQ]:!G6_:%D@^<A"HR2U<?K6I30Z+J<OW(F0D/CJ,&NH^W0:G9O@Y. /F
M&,UYG\6+YM*\."T\W<7?)VMQS_2@1\X^/&2\\)ZHT2[7V>=NZYP>?ZU\M>._
M',&I6\6D6O.X@22=..N*^M[Y+=[:59U_<LC(RC^+/&:^'OB%X9/A/Q=>6T;;
MH?,+Q'_9STK&<I15D:0BI/5GOWP9CDBT>XG8!6E(CCX[#TKV71[5XXA+(BG!
MY'0GZ_6O,/A7:[/#>F,1M4PAR!WKU&WU(21HB@E0?X?\:I[CBN56+EY)(L>8
MD50>2!R.>U4C'(C?. ?X>!\OUJ[-(%56 +-UP!QR*K332&;.[_9S[?2JZ$/<
MCCF,<CG:H+#&<9'%46EFN7;"C)RV.OX5:5S]H90=V[[Q [=JOZ3 1NP!GJ>.
M_H:ANX="_P"&?"8NX_\ 2,;?7H?7.:[NZ:TTFQ5DMH]JKN..,\=ZKZ''Y=BH
MZ@') 'XCFN?\;:U+N6-/F(Z@  ?C5$W.7\1:V;Z_;,?[O. %/!S5;2]--U?*
MHA8Y.T+[^N:GL=/:YO!D!L\=/E^M>B^%=%6U)D>-6)'RJWW5]3FC80[P[H45
MC"SR(?,^\%'! Q@]JTAY.ULC+YQE<?=/0&A[IFDD13N8'@=,#TK5T/19;B(/
M(%:0'DL/Q'% &CX9T-)H5E9,2GJ /E+5V=U):Z/:)O#+$#DJ0.AI;&*+3[5&
M P, DCH:X'X@>+$AD,2<C!0+G.3Q@TR3C?B+XL76-2:W1RL:G;\W7/85P5N8
M_M;R!MQ'(D'+9[\5->2?;+AS(<D\A,\@CO3=-MUD:1S\F#QC^[C&3^= CJ_
MEN)-8BEWE-C_ "@CJ,?I77_$^1IH;=A.P; +!3\V?:N8\(L(;K*C<1QA>AYX
MYKH/'A1K6%U^=LC*]P3P:?0'JC#LQJ$$,(BO0R[L+NP<D]*N:E'JS2*QVR/_
M  KWZ<D5DJ\J^7'$WS'@$=,^IJ9]4N+:1$# OMR2IXQQFL[=BC.UG4KS3XW!
M.9U4JI;LI-8EC=3W4)\WYY>Y#<$$<_E46LW,]]?/)O;RQ\O)Y"YZ5?TJW,-M
MS+F)NHQQMQ3L(TK6(M;(A49QT'&,>]7^)"CB/!7#^G/]VG*S-"BOTZX([CH*
M2XN#(R.<EQR!TYQR*-6,=),LDBDCA!GY1@'([_C72Z-X/DN[7^T)U6.)E*HH
M'!P?O5BZ#I=QKVOVUO%M="<,W]U>-Q(KJOCAXWB\"^#VMK9E2XD3RHE4=.V:
MJV@TFW8YV;^S)O,BD<GGCYL;<5!#IUD8R!<%6)Y.>/:OG/\ X2Z[C.]KF3=G
M)Y[U3U#XP2Z7P]VP/H36-T:>SMU/IY-*M_*RL^7ZG/3-:9M8)(8E6;IUSV]Z
M^4[7X[3%<"Z8U>A^/4T; ?:>/I5V,[]$SZ/N-,F>5RLB,O(P3Z]ZI_V'=QQK
MRIRW][)KPR']H)UQF=&K5M_V@> V^-A]:I1%S)=3V&\TN];R'V;F0<8.3[U2
METV[\XL8&)'&<9.*\]M?V@8VR&\O\#6M;_'>T8@E5]\-1REZG1K9W'[S,#*3
MRQVDYP.!52.WEMF=O*VK]X\9R:AMOC9IK')4C/O5Z'XP:/)D%<+^%!.IXAXF
MDFE\>WS1Q./+5$R0?3K7H/PIL_,O&9XWRS #!Z^QKJ?^$J\)W5TUPZIYK=6*
MBM32/&'A?3W!A,0.[/3'- 7?8VO%6H-]CB@7Y"O'O]*P]/\ ,^V D[1NYYY7
MBM6;Q;H5\2&FB(;GK3H-8T%EQYT?M\PJ6-2"<11MYC#*\=>GUKFM1F?6+@V4
M'[NTR=SUULEYHEW$(UG0' _CJC=:;836YBMKD1*?O,&&36?*7SHR+.^M=(F6
M")5<*1M.<<^]5_B0WG:KI\FW :Q0C/\ OR5J6_ANS^U1$7655N2QZU#\5KBS
MN-:TU;)A)'#I\<3,O]X22$_S%?19#[N,7HR7)2/HW_@G@NW_ (3_ /[A_P#[
M<U]D5\=?\$\_^9__ .X?_P"W-?8M>+G[OF57Y?\ I*/0I? @HHHKY\U/QB_;
M[;_C+CQ__OV?_I%;UC_"&3;X3/K]I?\ DM:O[?G_ "=QX_\ ]^S_ /2&WK'^
M$*%O"+-_T\O_ "6OUK.7_P 8[07E3_(\^G_&?S.Z:XW @U7\T9YHV9YJ!OO5
M^2GH$K88],T[;A:;".3FGR-Z4 -:0[:CCD(:GK'NI&A*.* +<>6J98AUI+51
MW%+(_EMCI0! RE6.#2),8VQ3))MLGM368,P- "S-YS''6BU.)!NZ5'NVO4BR
M+VZT 7Y%3((JO,J'ZU$9CNQ2[21F@!O&<5(%&WWJ/:.32J_S"@"*ZW(M16J[
MCFK%TV]<8J&W7#8H ED7O3H6!X)HFC*_2DAC^:@"=&PW!IX8;^:JLS+-@5,(
MVW9S0!HPLOE$52D_B(Z5(JLOTJ-LJ3F@!L>)%.:CG4 <4<KG'2F2-E<]Z *Y
MC.[-68F!7!J.-MQP:&^20"@"7Z&G0L5;!IC9&"*/,SVH 2:3RI<]13UN!N4U
M%/&9%S5;#=J -:2='CZUD7D@;O3C(6CQGFLRXD.Z@!&4=14T+;A@U%&N\C%6
MEB\ME- $&TQR&K,<FY<=ZEGA7:&%0(AZT $J%^E)#"<U/Y9QD4J4 $/RR#-;
M$<B^3UK(?[N>],6[95(H @U1AYAYK)\PQN"#5V]<R-[U4DC^7- '9^';H31
M,>:Z5(QM.*\^T"Z,4@&:[6WO-R#F@![2LLN!ZUH6Z--R!52.,3-6M8XCX(H
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ME^"/B%*98['4GW*W"7#'D'T;_&O(_CCX]TGQ%XT^QVLWFR:;"R-LE!#.3\I
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MR1_6/^P]-_Z3V]?2E?.9QKCZWJ=5/X$%%%%>.:!1110 4444 %%%% !1110
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MBF&:_N$12VY1\J]_0FLK3M)CM;[*J2W<XRRJ?6F0]RQX7T);6832J68C&6Z
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M G_C+KP!S_'>?^D-Q7Q=\*?^0UJ'_7D?_1L=?9W_  3_ #_QEY\/_P#?O?\
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M_P#7 _\ H5>>AC7H/QL.W6=._P"O<_\ H1KSD2=JX,T?^VU?4F.R+ :GYZ5
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M_P"D-Q7ZAE+_ .$&MZ3_ ".&I_%7R/VJHHHK\O.XS?$3;-'N#_N_^A"OC_\
M:^FW_P#")_\ ;W_[1KZZ\7-L\/W9_P!S_P!#6OC7]K*;?_PBO/\ S]?^T:[\
M"[8B/S_)DRV/@?\ ;0;/PNTO_L,Q?^B)Z^,:^ROVS&S\+]+YS_Q.(O\ T1/7
MQK5Y@[U_DA0V"BBBO-+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#U_X=6Z1Z6G'7FL3
MXIL-T:@]ZV_ ;8TN/Z5SGQ-8FXCKAC_%/U#&24<CC%+HC@Z***[C\O"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /6OV4?^2_>%?K<_P#I++7Z:> U_P"*Y\._]A&W_P#1
MJU^97[*7_)?O"G^_<?\ I-+7Z=^ T_XKCP[_ -A&W_\ 1JU]-EK_ -GGZO\
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M <&@"W'>';C-599 Q)-/MU$K "DO;,Q\CI0 D,@%0W2[GR#21\#%/:-BNZ@
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M =C\,/\ D,7_ /UYG_T;'7V5_P $^3_QE_\ #[_?O?\ TAN*^-/AC_R%[_\
MZ\S_ .C8Z^R?^"?)_P",P/A]_OWO_I#<5^F94_\ A#J^D_R.*I_%7R/VOHHH
MK\S.TPO'#;/"]ZW^Y_Z&M?%G[5%P&_X1CG_GZ_\ :-?9OQ#;9X/U _\ 7/\
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M56$QFT]:=CBG=\$\4NP]AQ0B6P08]Z?NSVYI50'J:?&F#GM5&;8*N<]JL11
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M*EE\**ZV,NBBBNH^'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8JRPHHHH ***/;DGVH *U=/\,7M\HD"B*,]&?BMCP[X9"JEQ=@,V,JG^-=0
M%  &!6<I6T'8Q-)\.PZ0?,D?S9<=2.GTJ_),7Z&EFW22''2GPVV.6ZT]+78F
MGLB&. R<]*G2%4Y/\ZDQM6HI9"1@"E=R':R(IL!N*;UH8%NU*JGCBM-D*]RO
M<0^8IS7+:HH60J1Q7;^3E237!^))MMTR@XJXOF0K69SNJ66Y69"2*YUIRK$=
M,5VL*B:(AN:Y/Q!I;P2&6,$KWJQE-[EEYS5BQU8K<1\_Q5@R7NW(8X/I5!=2
MVW"?-CYA67M-2^5L]TN9!-:QMC^$5!8VNZ3/O4=I-YVD6S@YR@K3T^';C/\
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M(*^@J\ _8K7;\+=5_P"PS+_Z(@KW^O&S#_>JGJ*'PH****\\L**** "BBB@
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M>?E<9JK--UH N++\N0*?]J.*S893GVJ9FXH T4N,CB@3'=5&.8(.:4S;FXH
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M4?\ Z*EKIP;M7AZC>QP?[+_S?'+PUC_IY_\ 266OOFO@7]EGYOCAX=_[>/\
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M_P#HY*YZ#_?0]5^9UGGGP7^;XF^%N.FL67_HY:_2.OS;^!_S?$OPS[:O9?\
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M &T;@,G6F1W!#'L*SUD^7K3XY/>@">>4B3(J19PZ\U3DE'>HC<#H* +/G8)
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M;_\ HB"O>:\W&?[Q/U-H[!1117$4%%%% !1110 4444 %%%% !1110 4444
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M'F.: +CR%N]))_J\U4$_RT[[6,%30!;M)ANP34LD@!ZUC"YVR9S5CS_,&<T
M.N&^;(J>V?<,&JC+NYS3EDVT 73*8VQFDEE\Q>#S5'SRS\TYI-K#TH G4G'6
MGKG%53/[T)=#.#0!<W#:>:K228;&::TFYN#Q3/O&@"RBLL>X5")3NY-/6Y")
MM-499N<B@"ZTA7O4D,P5LYK.%QN%212<T :KW6_ %.56"]:I1L-P-7//X H
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M!_P3D;_C,7X>#_IK??\ I!<5\>>#SB\N_P#KW_\ 9TKZ_P#^"<#9_;&^'?\
MUUOO_2"XK[++Y?\ "=47E+\CFE\:/W,HHHKXTZ3S3]I!MGP7\1'_ *]__2F*
MOS;^+<^[^RN?^>O_ +)7Z/?M--L^!_B1O3[-_P"E,5?FA\5+C=_9?_;7_P!D
MK6E\:$SYQ_::?=X#L!_U$H__ $5+7S+7TG^TI)N\"V(_ZB4?_HJ6OFRG6^($
M%%%%8C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#L/!MR/),>>AJ#QG:D,DH''<UG^&;
MKR;S:3PU=;K5FM]I[#'.,BN=^[.Y]?07UO+W36Z/.:*5U,;%3U!Q25T'R 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!ZK^RO_ ,G">!_^O_\ ]D:OUY\(1_\ %6:)_P!?
MT'_HQ:_(7]EC_DX3P+_V$%_]!:OV \(Q_P#%5Z+_ -?L/_HQ:]3"_P .1$MS
M[4HHHKRRPKX'_:XPOQ8UXYQ^]MO_ $E2OOBO@?\ :^^7XH:X?^FUM_Z2I7JY
M<[59>GZHSGL?G[^TW*/^$LTKG_ER_P#:C5X[YG?->D?M6:E]F\::2OKIX/\
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M79>#;R/3-35(E2.-E(VJ !^58EU<#L>:KV-]Y.HPMG^+%+8+7/<+;6(I%Y<
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MS7!?&CQEY5LFD6TF"XP^#T6NCU'6H=!TN6[=^Q(XQ7SYJ6I2Z]JDU[*V2['
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M;XB?]=;'_P!(+>N*^$#!O"[_ /7R_P#):['_ (*2M_QF-\1/^NMC_P"D%O7
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M+274@P.*ZO3--7R@2.: ,<:8>XJS::.LTJ@+WK7FB6-L8K<\,Z/]HF5BO&:
M.B\%>'UMT1RO%>CPS);PXZ#%9.FVJVMNHQC JCKNL+:PM\V.* ,CQIX@\E6"
M-S7EMU=27$Q=SDU8\1Z\;N](!R,^M4/-#+0!+YP7DFL37KH-&2IJ:_NA"#S7
M+:A?%V89R* *?VP^8035>XQG(IK#=S4<N=N<Y% $J-Y?/8TV>< 9JK]H^4BJ
MMQ<G810!S_BR^#1E >6KDJT-<F,UZP[+6?0 4444 3"X\N/:@P>YJ&BB@ HH
MHH **** "BBB@#;\)G%Y=?\ 7#_V=*^OO^";K9_;&^'?_76^_P#2"XKX_P#"
MYQ=77_7#_P!G6OKS_@FTW_&8_P ._P#KK??^D%Q7UF!E_L-1>4OR,)?$C]TZ
M***^3-SRG]J9MGP'\3G_ *]?_2J&OS#^)D^[^S?^VG_LE?IM^U@VS]G_ ,4M
MZ?9?_2N&ORX^(EQN_L__ +:?^RUI3^)"9X+^T8^[P38_]A%/_14M?.E?0G[0
MDF[P79#_ *B"?^BY*^>Z=3X@04445D,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )[&;
M[/=(_8&O1--NDN(5#'.>E>:5WOA#2Y-8LX_+E"LIP0>U93CS;'MY;C(X:34]
MF9?C#PW/:?\ $PC@;[*YP7"_+GZURU?26GZEI]IIJZ+JJ1O#(-OS#K7GOCCX
M/R66Z^T,FZM#\QA'++]*N*LK,\[%5(5:TITU9,\OHITD;PR%'4HZG!5A@TVJ
M.4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#U3]EG_DX;P)_P!A)?\ T%J_8?PFI_X2K1O^OV'_
M -&+7X[_ ++/_)PW@+_L)Q_R-?LAX43_ (JC1_\ K\A_]#%>CAO@D1+<^Q:*
M**\XL*^!OVQ?E^)6M'_IO:_^DJU]\U\#?MF#;\0M8/\ T\VO_I*M>C@7:I+T
M_5$2V/S+_:]D/_"=:/C_ *!H_P#1LE>$;C7NG[6D;2>.-(('']G#_P!&O7A_
MV9O3]*QK?Q)#6PSS&'>E\YJ=]E?T_2G?87]#^58AH,\]O7%'VA_4U(-/D]#^
M5.739">E $?VIO4THO''<U+_ &:_H?RIRZ6[=C^5 $(OG'<T?;W]ZMC2&]*>
MNBN>U %+[>Y[FG?;GK070SZ4]=#_ -DTP,X7TGO4BWTGJ36@-%]J>-)Q_#2&
M4DOI/4BE.I.O<U=.F#'2J<]GY?O0%@74F9@,U]+?LV:QY-S$&/<5\NM"585[
M5\#=5-G?0KGC<*28-:'Z4>&]0$EDC9XP*[/PW&\EUY[ B->F?6O,?AO(;_3+
M:0@LK ?C7JD3%8E4$1J!T%7LM2>MCH)-2501NYKGK^>1I&8/G\:)%C93N9A[
MYJE-IJR'*7#J?KFG%QB)W94N-7N+)LLK%?6G6OBZVNLQN^QCQM/>E;3;@<"=
M9!Z,*R-2\*B\R6A"O_?B.#6G-V86+.J:7#=9FMV"OUX[UG6>ISV$FR3=BLY8
M]5\.L1N-W;9Z-]X5=%];ZG'G&V3N#P11<#=^UQ7\>#S6'?1RV+$J6*'H?2F0
MK)!)\IR*OJK7411ER#0!#8:\& CD;/IFIKV3<-RG(KD]2C:QN6(X7/%7-.U4
M3*(W//:IN4:*WNT]:GCON>#6!>2&&3(Z&B.\Z528'3?;,U#)==>:QUO/>AKF
MJN(T&N:A:^:/H:H-<4SS/,:@9MVVH,RY)JU]JW+US6)"V[@5:WGH!3$3,Q\P
M'WK6M[S]VO-9"L$7<W3ZTV&^63[IXI,#?^U>]21W7;-8?VKWIPNO>I Z#[9\
MO6F_;:PS>>AH6\YIBL;WVKWK4L;C_1>IZUR/VSBM2SNC]C H,Y(W(;G]XS9Z
M#-8LUY\S'/4TDE\8[>0]SP*Q9KOY:&7'074+[<QYKPKXN7IFU>U0'.W)Q7K%
M_>?>(KPGXBWWG>(\9^ZM<\V=$"E!/R3S72Z+)\F0>]<=;R9_&NHTJ;9&.*S-
M#IIKG;#C.1BO.]>=9O$VEK*,QF6NNN+P!,9P:X'Q-<>5J5A,>B3"BPF>OVMR
MB*>U>H^ [D#0>.A<UXC#>C:3Z\]:]9\#7'_%.P^Y)K2.Y%38[R&Z^;&35U+G
MGK7/07-7%NPHYZUK?4YI;&T;SMGM56:\ZUG27G.<U2GO:&$31DO O>J,VH;F
M/-9,^H'GFJZW.YZ"S>\[>E8]_@;JL1S;5'TK-OKC)-,1%!\\W?K75:;-Y<B=
M:Y"SF'F9/K7217 4J:$#9O3SI*I#C>K#!5N0167YUOI[LEM:1Q\9W*H4?I41
MN_EJM)Y4C[V0,WJ:HS2'2ZG<3*1YV#G $(W'\ZB:&24C>-_JTS9_04XW0"X'
M%1-=<4[FES06XV*J^@Q\O J.2Z]ZQ9-8A6<0^:OFGHN>:S'\2I)-%'''(V\D
M;@.%QZU '2R7NT]:JO?#U-9$E\34+7G7UH&:-Q>>]4&O#'(K@_=.:IRW?6J%
MQ=\5G)EK<]0L[P.J,#D, :ZFRN!L'<UYMX?N_,LH#GM7:V]Q]GA5FX8]!6E]
M#)K4VK[4#;Q@+D,?2O*/C9=^;X7M<Y_X_$Z_[DE=M<:@9,YKSGXRW D\,VH_
MZ?%/_CCUK1]V<17N;O[&IW?&+3SZ>9_Z3SU^@M?GO^Q;\WQ?LSZ;_P#TGGK]
M"*,:[SCZ?JRX[!1117GEA7Y-^+VV^(KL?[G_ * M?K)7Y+>./E\47H_W/_0%
MKU<"[*?R_4SD>G:'+_Q(]/Z_\>T?_H(J_P"</>LG0Y%_L/3LC_EVC_\ 015M
MI1Z5PR^)@6O.^M>0_&[XD)9V_P#8MI+\[',[9X_W:Z3XC>/H/!^DML8&]E&(
MUS]W_:-?(/BKQ1+J&H2SNYD8L2<G)KBKU.5<J._"T>9\\MD7M2U0W# O)]UL
MG'2L*^U?RR?+.4[KFJ']I95FSN5ZY;56N(K@/9LQ8GB/J&]JX(JY[?-8W]0U
M?<"&.*RX]&G\12^7;P><_4GH!]36[8:';V=JEYKL;FX="T5DI_\ 0S_2M^+Q
M';Z99QV]K$D?[L%BH RQ%5L2YW'>!?@WID-PM[K %S'$<D'F,'^Z!_$?KP*]
M+N_$T=O)%#:1K:VL9 2*/@8Z<UP/A_Q(]QH<,+OS'(V>>I)SFF:AJ&^51NQS
MZT3;Y36G%/<R?VC]8>32]#EA;;+'<,V[N/EKCO"NK'5+%7< /T;'K4?QBUHZ
MA)I^G+\SKF0@<X'05E^#;>33V(=B0_.WT-.W-33>YRTTZ=5P6QWD*^2ROG!S
M6X9S<69C<Y*$,H/45A1+N96S\N,UUNEV<6H:3.XC_P!(5"5(/MG%9*/8Z*BT
M,SX;7]Q'\3-(EMB3*U\@7;W&[!_2OO?[0*^1?V8?!:ZEXBNO$5S'F&P^2'<.
MLI'7\!_.OJ/[3_G->K1CRP/G,1/FJ:=#4:534,FQJH?:J8UU[UN<Q8FAC;/%
M49M-@DZK3FNJB:[ [T[L13F\/6SMG8/RJG<>%;:12-@K6^V+ZTGVQ/6KNQ<J
M.+U/X>VMRK#R\Y]JX76_@A97K,3%@^U>UM<H:A>2-NN*KVC1FZ46?+VL_LYP
MS$F,$?A7%:I^SC<1Y,2Y^@Q7V=)' W]VJLNGV\G4"GSWW)]E;9GP=J7P(U6U
MW;8WP/3FN;OOACK%GG,+GZJ:_0>?0+27JBG\*S+KP7839S$OY47CV*Y:BV9\
M)^%?#5]9:AF6$@9KT;4&,>FA2,<5]#ZS\.]-C@=UB0-USBO!/'UNNG7$D*G@
M4M.@U?[1Y;K$GSM7-W#?,:W-6D#,WI7/3-\U2S2(WM2&F-2EN]26/@7,T?\
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MJ\)_8U_Y(_\ ]OF?_)>"O=JY,3_&D:1V"BBBN8H**** "BBB@ HHHH ****
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M)44 3ZIJA<$ UC?:-QR>:BN)3)DYJJLI6@"\9 5-5VF/(/2HP^>])O#*1WH
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M** "BBB@ HHHH **** "BBB@#U+]EO\ Y.&\ _\ 85B_K7[+>%E_XJ;2./\
ME\A_]#%?C3^RW_R</\/_ /L+0C]:_9[PO'CQ+I)_Z>X?_0Q7?A_@9+/KBBBB
MN H*^!?VU/E\=ZLW_3U:_P#I**^^J^ _VW?D\9ZFW_3Y:C_R4%=V#=IR]/\
M(B6Q^<_[1MBMYXJTUR,XL@/_ "(]>4#1T_N"O7_CO)N\1V'_ %Z?^SM7FV\=
M*SJ?&R;LS%TB/^Z*>-'3CY?TK34T[?65@,O^RE'\.*<NEKZ5HF04>90!G_V:
MM/73D';]*M^9^%+OI:A<J_84]*46:^E6=U-+4 1BU2FF!%[5)YE1M)0 QHE]
M,5$R@=*D:3%02/0!'(<9XK,N^<U?D:L^Z[TF6C+F&:[CX:Z@UE?(0?FSQ]:X
MF4=171>!91_;]C&3P\R@_3(I1W1IT/T^^&.H-8^'].MBPW+"A8^Y&37I4=X6
MC#$]J\8^&=P=06(Y^11R?I7J2W>WO6M1K0R2U9HM<23,"3M7TJ99MO>L=M05
M?O,!56;7H8^C;C4:O8>G4Z07'O39M22%<LX%<A+XER."%JE)JQN,Y;)JE#N+
MF['3:AK$-U"R;AGUKD[RZ6*0AQM]'%5Y)V0D@Y%5IKH31E7YK39 NY)'XL-G
M="WN?E!^Y)V-=!#XF5H\)@GUK@;R%)5,,B[D[>HJC%J4NCW"0S-NC;A'/\JG
MFL5RG;ZA<?:@Q?G-8@F:VFX.,4L>H+*HYJ&>19?K2'H;0O%O+?!(+"J'V@QR
M;2:SH;HPMBGWDH9?,7J*:8&M'=>]3?:?>N;AOOF%75NNG-:(DU6G]30MSM[U
MF&YR.M,^T?,.:8C?L[KYCR*N_:AUS6'!,%7.:=-?B&$N6H ?XBU[[-;F-&^8
M\5#X;U(S6I!.3WKCM7U W$S,3Q5SPM?!69<UQJ?-4-K>Z>@+=>]/%YGO6&MY
M[T];SWKJ,39^UTHN_>L0W@SUH6\]Z0&]]L/K6M;7>VU7!KCA>=!FMB&ZQ"@S
M5HSD:M]>%847/7FL:XO.#R*CU"^S)C/05CW5X,=:G<T6P:A=?NV.:\'\77AN
M/$5P?[O%>O:G>#RSSVKPO6K@S:U=-U._%<\MS>)IV<F0O:NDL9L1]C7(VDF
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ML".,5+>MPZ6+\LRB!O+QNQP6/%1^8HCR!D]^>,U \B+&=IW=P,4Q&79C?M)
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M#5RUCJGG[F)SMJ^MYMY*X7WI6+N>CZ+K&[ =\D]\UTBZ@)(".IQQ7E.EZDK
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M"]J/^GQ?_0'KQNB6X!1114@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0#@@T44 =7I
M^I>;9ID_,!BL'5E NV8=&YJ*WO&MP1U%,N+AKALF@"*BBB@"1;B18S&'8(>J
MYJ.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ]1_9=_Y.(^'O_88@_P#0J_:;PRO_ !4FE<?\O<7_
M *&*_%C]EW_DXCX>?]AJW_\ 0Q7[7^&X_P#BHM+X_P"7J+_T,5V4?A8F?5-%
M%%<8PKX#_;E;;XLU$_\ 3[:_^DE??E? /[=WR>)+]O\ I_M1_P"2E=F&^*7I
M_D3(_.CXZ2;O$=A_UZ?^SM7G :N_^.$F?$5C_P!>H_\ 0VKSG?43^)DEKS*/
M,JL)*#)Q4"+._P";VI=WO5428I1)F@";S*=YF*KEZ:9*E@6O,%-+U!YE)YE
M$ADIK/41DIN^D ]VJ%FI6:HV:@8UCGJ:IW-6F[U3N#04C.EX)K6\&R"/Q)8-
MG:!*#FLF8\U/H4WD:Q:OV$@I1W1HC]&/A+XFBBT>%(P3GJS=Z]5AU+SHP<XS
M7@OPIOK.32K;:NTX&=IXKUZWN4\L;6XK:=K&?VC8D5)/XVJLUDK?\M?TJK]L
M']ZF27;=LU',^X61+)I[=I%J#[+(O\2GZ&JMSJ+K\ISBJ$EPS?-%(0WH36JN
M0WT-A]RQD9K.EGVL1FLV35IU)5R:8+_=]XYI-E),M74GG+][##H:Y[Q!YM]8
M2H3B=!N0^]:,TIQE3GUJG</YO!X/K46Z&GF9O@_Q1_:5N8W;$T9VNIZY%;K:
MD5F()XKS#61)X7\1)?Q BVN#B4#H#ZUUWVY;RV6:-LY&::$=3]H5^0:?]H^3
MK7+V>J$<,:TEO0R\&JL*Y9:;9(/2IUO,XYK+DGW+UJ);HKGFG<1O?;/>G?:N
M1SS6#]L]ZEANB[4^8#J8[H^6.:R=4U/=\@/%,FO/)AZ\US]U>%F))K.I+2PT
M)>W0R>:E\.7X2]VYZU@7UU\QYIFD7GEWZ'/>N..DKFO0]36Z]Z=]J]ZPUN_E
M%/\ MAKN,C9^U>]!NO>L;[5[T&Z]Z0&RMY\PYK<ANAM7GH,UQ<=U\X'O6O\
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MI;R4*GRQK6;N+'K5A9?*BVK]X]37&=Q8N)BI/S9/YU4!.3D\T;_7FEC4R,
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M#''>H9&;<P'4]!UXJ[B-!95=P""I8G[O0?C4S3*IR>-QVC'/-933;7P"4SP
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M_G$'K3UF)[U2W4+-7BFA=+9H#[>]1)("OO4<DF* +/G<]:5I\CK5'S.:4R4
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MP"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVQO2N3^U4?:R#Q0G8'&YTLUT6^60'ZU2F<KRIR*SX]4.T*WS#WIWVA7SL/\
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MIO\ 4?\  OZ5DB?WK5F-]31\ZG+<>]9GVCWH^T>]0,UUN.G-=IX%N#NN,'C
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MFW1AD!!QS^GK7>Z)J"W,)0X'&/K28'*ZU9[D.,,V,^U<G/NMG([9[5Z/K%@
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M Z1LU'TI<TT\T +(^U#7+ZK)OGQ6U>7'EJ<FN;FD\R0M0 RBBB@ HHI54L<
M9H 2KMCIKW4@!!"U/INGAF!<9KJM-L41EP* +?AG01"Z_+Q7IVFPK!"!@=*Y
M[1XE55(Q71I,%CQ0 VZVL>*R+Q"N:MSW'S=:K33"13GK0!DJY63%6=I91S52
MXX?(J>WN!C!H E6$YZU86'BH6E"KG-)'>#N: ,3X@';H*#_ILO\ (U['_P $
MRV_XS-^''_7:_P#_ $WW%>)^/+@2:.H'_/93^AKVK_@F2W_&9WPX_P"NU_\
M^F^XKU<,_P!U+T?Y&<MS]ZZ***\HT/GO]OYMG[)'CMO3[!_Z7V]?C!K5SN\G
MG^]_2OV:_P""@[;?V0?'Q_Z\/_3A;5^*FJ39\K\?Z4UN!R7Q(DWZ' ,_\O*_
M^@M7G%=_\0)-VCPC_IX7_P!!:N H8!1112 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYY JC<2#<,BE$;,[79FBC>1#\RC(KAI[N6ZD::5MSMU)KLM7?=:2C_9-</\
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MR@"XLV6ZTYIBO>J(DP:<TW% %Q9JD6;WK-$U/6;B@"\TWO2^9Q5'S>*3SBM
M%W[1MIK3;N]4FFW4J24 6O.]Z:UQ[U6DDJ#SC0!?6YV]Z;)<;N]4_-S4;34
M66F]Z:TW'6JC38J)KB@"R\N:3?[U5:88ZU$UQ[T 76N=HZU UY\W6J3S%JC^
M8F@"])<;N],W[ZB6,^M2+A>M #E7:>:L!AMJO)(-M0+<'.* -"W8O(!VKL]#
MC$2@UR^CV_F,":ZRV_=(.U &[]J$:Y!XKG-?U,>6P#4^ZU'R4//%<CJVH&60
M@&@#.O+HM(3FHHYLU%*<G--5L4 6]W.0:F6;Y:I!^.M-\W% $TUQS49FS5>1
M]U1E\4 6PV::7JNLO:C?S[4 2^9VI#)MJ,FFO]V@#+U:<MP#675S4@?,JG0
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M4 %%%% 'IG[,?_)Q?PS_ .QBL1_Y'2OW7T.,_P!MZ?\ ]?$?_H0K\)_V9/\
MDXSX8_\ 8R:?_P"E"5^\&BJ/[9L/^OB/_P!"%;0V8CWVBBBL1A7Y\?\ !2)O
M+MG;I_Q-[4?^2;U^@]?GK_P4N;R],W>NLVH_\DY*VI]?01^7?Q8DW:Y:<_\
M+N/_ $)JXG=76?%"7=K5K_U[C_T)JX[=4O<1/OIP>JV^E#TA%G=2[J@#T;J
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M& 36LMYN[UREG/M6KZWF!UJ&4:MU<?*>:Y34KS;/R:TKB^#(>:Y74+G=/UH
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MMQCF@"Q]LSGTH^TEN<D^E1QVJJ, 5*L**.F* NB);@R<CD4Y;@#H3Z4CO&G
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M*U-4F\RW4?[7]#670 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 >E?LR_P#)QGPP_P"QFTX?^3,=?O1H\?\ Q.+'
M_KO'_P"A"OP6_9G_ .3C/A=_V-&F#_R:CK]\M(CQJUD?^FZ?^A"M8;"/;:**
M*R&%?GC_ ,%.F\O0U;_J-VH_\DI:_0ZOSN_X*C_N_#,3>NO6@_\ )*:M(=1'
MY6_$F3=K%MS_ ,L!_P"A-7);ZZ'XA2;M6M_^N _]"-<QNI!8GW&EW5!NIV[W
MH))PU*&J#=2[J )]U&ZH=WO1NH FW4TM4>[WI-U R3=2;JCW49I"'[J;NINZ
MDW4Q@S5&QI2:830,C8TQC3FJ-J0S6\/7!AN@<XKT2WUXQPX5N<>M>8::VVX'
M.*Z^UP4#9K&9T4SHK?Q!=V\XDCF93]:ZJR\>2&,>:I=AUVC->=?:-O&*>MRR
M'(/-91DXFTHJ>YZG;^,K2Z&W>4?IM;@_K5V.^CDC)5MP^M>3KJHG4+,H;W-3
MPZA/9G?:SLZ]XG.?RKHC4[G/*GV/2S=$$A6./K4;7A;J>:Y#3?%<=R-DO[N3
MW-:PO PR#FKN96-A;SC!.13'N-O0\5D/<[>1TIOVS<N:8C6^U^]1B?YB0:R/
MM=31W *Y-- :IN.0Q-(;ST-9,EYNX[4S[12; V1=>].^U5C_ &FC[3[U &O]
MJH^U5D?:O>C[3[T :<ESQUJK).6JE+=[5JI-J01>.M1)I&D8N1?9MW4XIT(1
M3N9LUSLVJ.3P<4P7[GJU9<YNJ:.HDU!1QOP*6/7(HU]37)FZ+>](9&;MFHYF
M:\J.FN->+?=.*SIM4EF/WSBL5R_I1&TF>14ZE+38V%NG'.XG\:>NJ2QGAB*S
MU9MHIK$]S18.8VEU5I% 8T];I3GFN>9]O\5*MPR=\BM%-HR<$RCKUTTNH.>0
M%X%1V=YV)YJ]))%<??2JSZ9"QRAV&M%-=3)TWT+:7&Y>M/:;*U36W>/H<U%=
M7#6L9)0M]*NZ(Y676G]ZBDN/EYK"_P"$D,;'_1V;\*Z718;?Q%I\ID!CDQA<
M<$&K6I#NMS,M[Z*&[#,X QZUO:+XHL[:\.Z4 $8ZURLGA==/D=[N?>H/ IJ7
M$**WV>!3M[FIO8=CU>PUB+4CB"4-6U#;HN"[;C7B=CX@FBG&U I_V375Z7\0
M!N\F88/3=5IDM/<],6X2%>!@56FU1FX7.*Q(=8BN(]R-OS[U(MUNYQ5$&B;M
MCU)I/M1 K.-P!UICWBT :?VL^M/6\]ZQ6NQ2?:Z0S;>[]#3/M?O60;H8IOVG
MWH!&NUU[TW[5CO65]JIK7% S7^V'U_6GK?$=S^=8?VJC[4: .@&I'OS3AJ*'
MU%<[]J_SFE6Z]Z!&^UX&Z&HS<>]8OVNE^UB@9K_:,=Z7[7[UD?:AZT?:AZT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4Y]*<N >M5?.I?.H O+)CO3_ #"S DX%41<>].^T>] &@&'&33_.&.N*RVO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/TE_X(\2>9XO\>GKC[!_Z+O:_5:ORA_X(T2>;XL^(9_N_P!G?^B[ZOU>JGT
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M^3:? )]=%T\_^24%>WUXA^Q7_P FQ_#P^NA:<?\ R2@KV^D]QA1112 ****
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M.TK\ :_?[_@J-_R8G\3?^X9_Z<[2OP!H **** "BBB@ HHHH **** "BBB@
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M\PT :OVKWH^U>]97F&CS#0!J_:O>C[5[UE>8:/,- &K]J]Z/M7O65YAH\PT
M?J!_P17?S?%'Q)/]W^S?_0+ZOUFK\DO^")#%O$GQ//I_9?\ Z!?U^MM, HHH
MI %?SZ_\%!9O+_:\\>KZ?8/_ $WVU?T%5_/3_P %$V*?MC?$ ?\ 8/\ _3?;
M4^@'SQ)+EV/O3?,JON-&Z@"QYGO2^9[U6W4;J +'F4OF>]5MU&XT 6A)3O.J
MGN-&XT"+;3>]1-)FH=QI,F@9)NHW5'DT9-("3=2[O>HLFC)I@3!J=YE0;C1N
MH G\RDW5#NHW47 G\RE$Q%5]U&ZBX%CS:D6XQWJGNHW&@"Y--E,9JON]ZCW&
MDR:+BL2[Z<)*@R:,FG<+#]QI=U1T9J2B3=2[O>HLFC)H"Y+N]Z/, J+)HH"X
M\R'M3"2:**!!1DT44 &:,FBB@ R:,FBB@!0Q'>G"4BF44 2B8TX35!10.Y:%
MQ[T_[1QUR*I9I=QH"Y,VW=D4]9,=*K;C1NIB+BS'UIPN*H[C2[S0(O?:*7[1
M5#>:-YH&7O.I/.]ZI>8:-YH N^</6CSO>J6\T;S0!=\ZCSJI;S1O- %WSJ3S
MJI[S1O- %SSJ7SJI;S1O- %WSJ//]ZI;S1O- %[S_>CSJH[S1O-("]YU'G51
MWFC>:8%_[11]HJAYAH\PT 7_ +12_:/>L_S#1YAH T/M'O1]HK/\PT>8: -'
M[1[T?:/>L[S#1YAH T/M'O1]H]Z_8?\ 9CD_9[_;H_99\._"G4M-L=)\3>']
M+@M[G3;79:ZC;SQ1B-KZU?!\Q6;+L3O&9,2@EAN_.S]L#]C7QA^R/XR^RZDL
MFL>$KU\:7XDAA*0S\$^5(.1', #E">0,C(Z 'A/G^]2QW&%'-9GF&CS#2 _H
MW_8J_P"37OAL?7P_II_\DH*]OKQ#]BC_ )-9^&)]?#FF'_R1@KV^FP"BBBD
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M;-_\31_PK'QC_P!"GKG_ (+9O_B: .:HKI?^%8^,?^A3US_P6S?_ !-?1_\
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M/^%7^,O^A2UW_P %LW_Q- ',T5TW_"K_ !G_ -"CKO\ X+9O_B:/^%7^,_\
MH4==_P#!;-_\30!S-%=-_P *O\9_]"CKO_@MF_\ B:7_ (5;XS_Z%'7O_!9-
M_P#$T <Q173_ /"K?&?_ $*.O?\ @LF_^)H_X5;XS_Z%'7O_  63?_$T <Q1
M73_\*M\9_P#0HZ]_X+)O_B:/^%6^-/\ H4->_P#!9-_\30!S%%=/_P *M\:?
M]"AKW_@LG_\ B:/^%6^-/^A0U[_P63__ !- ',45U'_"K/&G_0H:]_X+)_\
MXFC_ (59XT_Z%#7O_!9/_P#$T <O174?\*L\:?\ 0H:]_P""R?\ ^)H_X59X
MT_Z%#7O_  63_P#Q- '+T5U'_"J_&O\ T*&O?^"R?_XFC_A5?C7_ *%#7O\
MP63_ /Q- '+T5U'_  JOQK_T*&O?^"R?_P")H_X57XU_Z$_7O_!9/_\ $T <
MO174?\*K\:_]"?KW_@LG_P#B:/\ A5?C7_H3]>_\%D__ ,30!R]%=1_PJOQK
M_P!"?KW_ (+)_P#XFE_X55XV_P"A/U__ ,%D_P#\30!RU%=3_P *J\;?]"?K
M_P#X+)__ (FC_A57C;_H3]?_ /!9/_\ $T <M174_P#"J?&W_0GZ_P#^"R?_
M .)H_P"%4^-O^A.U_P#\%<__ ,30!RU%=3_PJGQM_P!"=K__ (*Y_P#XFC_A
M5/C;_H3M?_\ !7/_ /$T <M174_\*I\;?]"=K_\ X*Y__B:/^%4^-O\ H3M?
M_P#!7/\ _$T <M174_\ "J?&W_0G:_\ ^"N?_P")H_X53XV_Z$[7_P#P5S__
M !- 'Z#_ /!%E=VK_$X^D^B?^A7E?KQ7Y0_\$</!^N^&]4^)C:QHFHZ4)9M&
M,9OK62'?M:\W8W 9QD9QTR*_5W</44P%HI-P]11N'J*0"U^&7_!6Y=O[1WAL
M?]2G;?\ I9>5^YFX>HK\4_\ @J[X#\2^(/VB/#MQI7A[5=3MU\+6\;36=E+*
M@87=X2I*J1G!!Q[BGT ^!**ZK_A4_C?_ *$WQ!_X*Y__ (BC_A4_CC_H3?$'
M_@KG_P#B*0'*T5U7_"I_''_0F^(/_!7/_P#$4?\ "IO''_0F^(/_  5S_P#Q
M% '*T5U?_"I?''_0F>(/_!7/_P#$4?\ "I?''_0F>(/_  5S_P#Q% '*45U?
M_"I?''_0F>(/_!7/_P#$4?\ "I?''_0F>(/_  5S_P#Q% '*45U?_"I?'/\
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M_P#\10!R=%=9_P *C\=?]"7XA_\ !5/_ /$4?\*C\=?]"7XA_P#!5/\ _$4
M<G176?\ "HO'7_0E>(O_  53_P#Q%'_"HO'7_0E>(O\ P53_ /Q% ')T5UG_
M  J+QU_T)7B+_P %4_\ \12_\*B\=_\ 0E>(O_!5/_\ $4 <E176_P#"H?'?
M_0E>(O\ P53_ /Q%'_"H?'?_ $)7B+_P53__ !% ')45UO\ PJ'QW_T)7B+_
M ,%4_P#\11_PJ'QW_P!"5XB_\%4__P 10!R5%=;_ ,*A\=_]"5XB_P#!5/\
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MQ+_X*+C_ .(H XZBNQ_X4Q\0?^A%\2_^"BX_^(H_X4Q\0?\ H1?$O_@HN/\
MXB@#CJ*[+_A2_P 0?^A$\3?^">X_^(H_X4O\0?\ H1/$W_@GN/\ XB@#C:*[
M+_A2_P 0?^A$\3?^">X_^(H_X4O\0?\ H1/$W_@GN/\ XB@#C:*[+_A2_P 0
MO^A$\3?^">X_^(H_X4O\0O\ H1/$W_@GN/\ XB@#]L_^"4H_XPU\&GU^V_\
MIQO*^PZ^3?\ @F#H.I>&_P!D'P=8ZMI]UI=]']LWVU["T,BYU"[(RK $9!!^
MA%?6.X>M,!:*3</6C</6D!\ _P#!:K_DUCPM_P!CG:_^D-]7XK5^WG_!8KPS
MK'BS]F7PS9Z'I-]K-VGB^UE:WT^V>>14%E>@L50$@991GW'K7X[?\*5^(?\
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M]"#XH_\ !-<__$4?\*1^(O\ T(/BC_P37/\ \10!Q=%=I_PI'XB_]"#XH_\
M!-<__$4O_"D?B+_T(/BC_P $US_\10!Q5%=K_P *1^(O_0@^*/\ P37/_P 1
M1_PI'XB_]"#XH_\ !-<__$4 <517:_\ "D/B-_T('BC_ ,$US_\ $4?\*0^(
MW_0@>*/_  37/_Q% '%45VO_  I#XC?]"!XH_P#!-<__ !%'_"D/B-_T('BC
M_P $US_\10!Q5%=K_P */^(W_0@>*/\ P37/_P 11_PH_P"(W_0@>*/_  37
M/_Q% '%45VO_  H_XC?]"!XH_P#!-<__ !%+_P */^(__0@>*/\ P37/_P 1
M0!Q-%=M_PH_XC_\ 1/\ Q1_X)KG_ .(H_P"%'_$?_HG_ (H_\$US_P#$4 <3
M17;?\*/^(_\ T3_Q3_X);G_XBC_A1WQ'_P"B?^*?_!+<_P#Q% $/PG^$?BWX
MW^-K+PGX*T6XUS6[KYA#" %C0$!I)'/RQH,C+,0!D#J17Z(^ _\ @B#JUYI<
M,_C'XGVNF7[Q R6.CZ6UTD;D]/.>1-P Q_ .2?3GZT_X)K_LUV'P%_9WT75+
MK2S:>,_%5M'J>K3W$12X5&RT$# L=H1''R\'<S;@#D#ZSH _$;]H;_@D7\2?
M@_X;O/$'A/6;?XD:99(9;BWL[)[;4 @"99+?=)YF"7R%<G"9P<X'PA7]5%?B
MY_P5*_8_OO"/QUM?%?@#POJ%_I7BZ&2\O+/1]/EG6VO48"9OD4A1)O1\?WC)
MQC% 'Y]45VW_  HWXC_]$_\ %/\ X);G_P"(H_X4;\2/^B?^*?\ P2W/_P 1
M0!Q-%=O_ ,*-^)'_ $3[Q3_X);G_ .(H_P"%&_$C_HGWBG_P2W/_ ,10!Q%%
M=O\ \*-^)'_1/O%/_@EN?_B*/^%&?$C_ *)]XJ_\$MS_ /$4 <117;_\*,^)
M'_1/O%7_ ();G_XBC_A1GQ(_Z)]XJ_\ !+<__$4 <117;_\ "B_B3_T3[Q5_
MX);G_P"(H_X47\2?^B>^*O\ P2W/_P 10!Q%%=O_ ,*+^)/_ $3WQ5_X);G_
M .(H_P"%%_$G_HGOBK_P2W/_ ,10!Q%%=Q_PHOXD_P#1/?%7_@EN?_B*/^%%
M_$G_ *)[XJ_\$MS_ /$4 </17<?\*+^)/_1/?%7_ ();G_XBC_A17Q)_Z)[X
MJ_\ !)<__$4 </17<?\ "BOB5_T3WQ5_X)+G_P"(H_X45\2O^B>^*O\ P27/
M_P 10!P]%=Q_PHKXE?\ 1/?%7_@DN?\ XBC_ (43\2O^B>>*O_!)<_\ Q% '
M#T5W'_"B?B5_T3SQ5_X)+G_XBC_A1/Q*_P"B>>*O_!)<_P#Q% '#T5W'_"B?
MB5_T3SQ5_P""2Y_^(I?^%$_$O_HGGBO_ ,$ES_\ $4 <-17<_P#"B?B7_P!$
M\\5_^"2Y_P#B*/\ A1/Q+_Z)YXK_ /!)<_\ Q% '#45W/_"B/B7_ -$\\5_^
M"2Y_^(H_X41\2_\ HGGBO_P27/\ \10!PU%=S_PHCXE_]$\\5_\ @DN?_B*/
M^%#_ !+_ .B=^*__  27/_Q% '#45W/_  H?XE_]$[\5_P#@DN?_ (BC_A0_
MQ+_Z)WXK_P#!)<__ !% '#45W/\ PH?XE_\ 1._%?_@DN?\ XBE_X4/\3/\
MHG?BS_P27/\ \10!PM%=U_PH?XF?]$[\6?\ @DN?_B*/^%#_ !,_Z)WXL_\
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M9_X([K_XW1_PH/XG?]$Y\6_^".Z_^-T <)17=_\ "@_B=_T3GQ;_ .".Z_\
MC='_  H/XG?]$Y\6_P#@CNO_ (W0!PE%=Y_PH/XG?]$Y\6_^".Z_^-T?\*#^
M)W_1./%O_@CNO_C= '!T5WG_  H/XG?]$X\6_P#@CNO_ (W1_P *#^)W_1./
M%O\ X([K_P"-T <'17>?\*!^)_\ T3CQ;_X([K_XW1_PH'XG_P#1./%O_@CN
MO_C= '!T5WG_  H'XG_]$X\7?^"*Z_\ C=+_ ,*!^*'_ $3?Q=_X(KK_ .-T
M <%17>_\* ^*'_1-_%W_ ((KK_XW1_PH#XH?]$W\7?\ @BNO_C= '!45WO\
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M (*7?LSVGQ^_9YU74['3FN?&GA6)]2TF2W@:6>5!@SVP5 68.@R !]]$Z#-
M'X'T5Z!_PSU\5/\ HFGC#_P0W7_QNC_AGKXJ?]$T\8?^"&Z_^-T >?T5Z!_P
MSS\5/^B:>,/_  0W7_QNC_AGGXJ?]$S\8?\ @ANO_C= 'G]%>@?\,\_%3_HF
M?C#_ ,$-U_\ &Z/^&>?BI_T3/QA_X(;K_P"-T >?T5Z!_P ,\_%3_HF?C#_P
M0W?_ ,;H_P"&>?BK_P!$S\8?^""[_P#C= 'G]%>@?\,\_%7_ *)GXP_\$%W_
M /&Z/^&>?BK_ -$S\8?^""[_ /C= 'G]%>@_\,\?%7_HF?C'_P $%W_\;H_X
M9X^*O_1,_&/_ ((+O_XW0!Y]17H/_#/'Q5_Z)GXQ_P#!!=__ !NC_AG?XJ_]
M$R\8_P#@@N__ (W0!Y]17H/_  SO\5?^B9>,?_!!=_\ QNC_ (9W^*O_ $3+
MQC_X(+O_ .-T >?45Z#_ ,,[_%7_ *)EXQ_\$%W_ /&Z/^&=_BM_T3+QC_X(
M+O\ ^-T >?45Z#_PSO\ %;_HF7C'_P $%W_\;H_X9W^*W_1,O&/_ ((+O_XW
M0!Y]17H7_#.WQ6_Z)EXR_P#!!=__ !NC_AG;XK?]$Q\9?^""[_\ C= 'GM%>
MA?\ #.WQ6_Z)CXR_\$%W_P#&Z/\ AG;XK?\ 1,?&7_@@N_\ XW0!Y[17H7_#
M.OQ7_P"B8^,O_!!=_P#QNC_AG7XK_P#1,?&7_@@N_P#XW0!Y[17H7_#.OQ7_
M .B8^,O_  07?_QNC_AG7XK_ /1,?&7_ ((+O_XW0!Y[17H7_#.OQ7_Z)CXR
M_P#!!=__ !NC_AG7XK_]$Q\9?^""[_\ C= 'GM%>A?\ #.OQ7_Z)CXR_\$%W
M_P#&Z7_AG3XL?]$P\9?^$_=__&Z //**]#_X9S^+'_1,/&7_ (3]W_\ &Z/^
M&<_BQ_T3#QE_X3]W_P#&Z //**]#_P"&<_BQ_P!$P\9?^$_=_P#QNC_AG/XL
M?]$P\9?^$_=__&Z //**]#_X9S^+'_1,/&7_ (3]W_\ &Z/^&<_BQ_T3#QE_
MX3]W_P#&Z //**]#_P"&<_BQ_P!$O\9_^$_=_P#QNC_AG/XL?]$O\9_^$_=_
M_&Z //**]#_X9S^+'_1+_&?_ (3]W_\ &Z/^&<OBS_T2_P 9_P#A/W?_ ,;H
M \\HKT3_ (9Q^+/_ $2_QG_X3]W_ /&Z/^&<?BS_ -$O\9_^$_=__&Z +/[+
MW/[3'PD_[&[2/_2V*OZ)+./_ $N#_?7^=?@Q^S9\ ?B=I/[17PLOK[X<>+;*
MQM?%6E33W-QH=U''%&MY$6=V,>%4 $DG@ 5^^EM9RK<1$Q. '!SM/K5(#JJ*
M3-&:D!:_-O\ X+.+_P 62T8_]399_P#I!=U^D>:_/W_@KIX"\2^.O@OH]KX:
M\.ZMXANU\46LS0:592W+K&+*Z4N5C4D*"RC/3)'K30'XM45Z)_PSA\6O^B7>
M-/\ PG[O_P"-T?\ #.'Q:_Z)=XT_\)^[_P#C=(#SNBO1?^&;_BU_T2[QI_X3
MUW_\;H_X9O\ BU_T2[QI_P"$]=__ !N@#SJBO1?^&;_BU_T2[QI_X3UW_P#&
MZ/\ AF_XM?\ 1+O&G_A/7?\ \;H \ZHKT7_AF_XM_P#1+?&G_A/7?_QNC_AF
M_P"+?_1+?&G_ (3UW_\ &Z /.J*]%_X9O^+?_1+?&G_A/7?_ ,;H_P"&;OBW
M_P!$M\:?^$]=_P#QN@#SJBO1?^&;OBW_ -$M\:?^$]=__&Z/^&;OBW_T2WQI
M_P"$]=__ !N@#SJBO1?^&;OBW_T2WQI_X3UW_P#&Z7_AFWXN?]$M\:?^$]=_
M_&Z /.:*]&_X9M^+G_1+?&G_ (3UW_\ &Z/^&;?BY_T2WQI_X3UW_P#&Z /.
M:*]&_P"&;?BY_P!$L\:_^$]=_P#QNC_AFWXN?]$L\:_^$]=__&Z /.:*]&_X
M9M^+G_1+/&O_ (3UW_\ &Z/^&;?BY_T2SQK_ .$]=_\ QN@#SFBO1O\ AFSX
MN?\ 1+/&O_A/7G_QNC_AFSXN?]$L\:_^$]>?_&Z /.:*]&_X9L^+G_1+/&O_
M (3UY_\ &Z7_ (9K^+O_ $2SQK_X3UY_\;H \XHKT?\ X9K^+O\ T2OQK_X3
MMY_\;H_X9K^+O_1*_&O_ (3MY_\ &Z /.**]'_X9K^+O_1*_&O\ X3MY_P#&
MZ/\ AFOXN_\ 1*_&W_A.WG_QN@#SBBO1_P#AFOXN_P#1*_&W_A.WG_QNC_AF
MOXN_]$K\;?\ A.WG_P ;H \XHKT?_AFOXN_]$K\;?^$[>?\ QNC_ (9J^+W_
M $2OQM_X3MY_\;H \XHKT?\ X9J^+W_1*_&W_A.WG_QNC_AFKXO?]$K\;?\
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M1XW_ /"<O/\ XW1_PS+\8/\ HE'C?_PG+S_XW0!YM17I7_#,OQA_Z)1XX_\
M"<O/_C='_#,OQA_Z)1XX_P#"<O/_ (W0!YK17I7_  S+\8?^B4>./_"<O/\
MXW1_PS+\8?\ HE'CC_PG+S_XW0!YK17I7_#,OQA_Z)1XX_\ "<O/_C='_#,O
MQA_Z)1XX_P#"<O/_ (W0!YK17I7_  S)\8?^B3^./_"<O/\ XW1_PS'\8O\
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M_":O?_C5'_#+7QH_Z)%X\_\ ":O?_C5 'F%%>G_\,M?&C_HD7CS_ ,)J]_\
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M4N-W^RN0.V<#YU_:F_X)B_$G]FWP_=>*+.[M_'7A*TRUS?:;;O'<6J9?]Y-
M2VU JJ68,P4MSP-U?O)3)H4N(GBE19(G4JR.,A@>"".XH _E:HK[*_;=_85\
M8?#G]H?7[3X;?#_Q)K_@S4%34K Z'HUU=068ESOMMZ(5^1U; SPA3/->#?\
M#*_QJ_Z)!X]_\)F]_P#C5 'EU%>H_P##*_QJ_P"B0>/?_"9O?_C5'_#*WQJ_
MZ(_X]_\ "9O?_C5 'EU%>H_\,K?&K_HC_CW_ ,)F]_\ C5'_  RM\:O^B/\
MCW_PF;W_ .-4 >745ZC_ ,,K?&K_ *(_X]_\)F]_^-4?\,J_&O\ Z(_X]_\
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M_P#"8OO_ (U0!Y917J?_  RC\;?^B.^/_P#PF+[_ .-4?\,H_&W_ *([X_\
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M=K?W.GO7V]7YX?\ !:L?\8\>%C_U--K_ .DE]3NPLC\[O^&N/^I4_P#*C_\
M:J/^&N?^I4_\J/\ ]JKYWHI7861]$_\ #77_ %*?_E2_^U4?\-=?]2G_ .5+
M_P"U5\[447861]$_\-=?]2G_ .5+_P"U4H_:\Q_S*?\ Y4O_ +57SK11=A9'
MT5_PUY_U*?\ Y4O_ +51_P ->?\ 4I_^5+_[57SK11=A9'T5_P ->?\ 4I_^
M5+_[52_\-??]2G_Y4O\ [57SI11=A9'T9_PU]_U*?_E2_P#M5'_#7W_4I_\
ME2_^U5\YT47861]&C]L#_J4O_*E_]JH_X; _ZE+_ ,J7_P!JKYRHHNPLCZ-_
MX; _ZE+_ ,J7_P!JH_X; _ZE+_RI?_:J^<J*+L+(^CO^&PO^I2_\J7_VFC_A
ML+_J4O\ RI?_ &FOG&BB["R/H[_AL+_J4O\ RI?_ &FE_P"&PO\ J4O_ "I?
M_::^<**+L+(^D/\ AL3_ *E'_P J7_VFC_AL3_J4?_*E_P#::^;Z*+L+(^D/
M^&Q/^I1_\J7_ -II?^&QO^I1_P#*G_\ ::^;J*+L+(^D?^&QO^I1_P#*G_\
M::/^&QO^I1_\J?\ ]IKYNHHNPLCZ2'[8V/\ F4?_ "I__::/^&R/^I0_\J?_
M -IKYMHHNPLCZ2_X;(_ZE#_RI_\ VFC_ (;(_P"I0_\ *G_]IKYMHHNPLCZ3
M'[9'_4H?^5/_ .TTO_#9/_4H?^5/_P"TU\UT47861]*?\-D_]2A_Y4__ +30
M/VRL?\RA_P"5/_[37S711=A9'TK_ ,-E_P#4H?\ E3_^TT?\-E_]2A_Y4_\
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M"R/J+_AMW_J2_P#RJ_\ VFC_ (;=_P"I+_\ *K_]IKY=HHNPLCZC_P"&WO\
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MH:?XQ\,ZA\/?@Q=77V2^4P:EXLVO;LT6?FBM5.' 8<&1L<$A1SN !Y+\6O\
M@H59W_Q2\77&G>#A?Z<VK77V6Z&K*OGPB5A')A8F W* >&8<\$]:Y3_AX!_U
M(?\ Y6/_ +17R'13%8^O/^'@'_4A_P#E8_\ M%'_  \ _P"I#_\ *Q_]HKY#
MHH"Q]>?\/ /^I#_\K'_VBC_AX!_U(?\ Y6/_ +17R'10%D?7G_#P#_J0_P#R
ML?\ VBC_ (> ?]2'_P"5C_[17R'10%D?7O\ P\"_ZD/_ ,K'_P!HH_X>!?\
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MJ* L?8O_  \,_P"I _\ *S_]STH_X*'?]2!_Y6?_ +GKXYHH"Q]C?\/#O^I
M_P#*S_\ <]'_  \._P"I _\ *S_]SU\<T4!8^QQ_P4/Q_P R!_Y6?_N>E_X>
M(?\ 5/\ _P K/_W/7QO10%C[(_X>(?\ 5/\ _P K/_W/1_P\0_ZI_P#^5G_[
MGKXWHH"Q]D_\/$?^J?\ _E:_^YZ/^'B7_5/_ /RM?_<]?&U% 6/Z(?V$/B1_
MPMS]FSPOXG_L[^R?MGVK_1?/\[9LO+B/[VU<YV9Z=Z^A/+]Z^2/^"58_XPJ\
M"'_K_P#_ $Y7=?75 6&>7[T>7[T^B@+'R5_P4J^,G_"B_@7H6O?V/_;?VCQ)
M!8_9_M/V?;NM;I]V[8^?]7C&._7BOS8_X>+?]4^_\K7_ -SU]N_\%JO^36/"
MW_8YVO\ Z0WU?BM0%C[,_P"'BW_5/O\ RM?_ '/1_P /%O\ JGW_ )6O_N>O
MC.B@+'V9_P /%O\ JGW_ )6O_N>E_P"'B_\ U3[_ ,K7_P!SU\944!8^S?\
MAXO_ -4^_P#*U_\ <]'_  \7_P"J??\ E:_^YZ^,J* L?9P_X*,?]4]_\K7_
M -ST?\/&?^J>_P#E:_\ N>OC&B@+'V=_P\9_ZI[_ .5K_P"YZ4?\%&L?\T]_
M\K7_ -SU\844!8^T/^'C7_5/?_*W_P#<]'_#QK_JGO\ Y6__ +GKXOHH"Q]H
M?\/&O^J>_P#E;_\ N>E_X>.?]4\_\K?_ -SU\744!8^T?^'CG_5//_*W_P#<
M]'_#QS_JGG_E;_\ N>OBZB@+'VC_ ,/'/^J>?^5O_P"YZ7_AX]_U3S_RM_\
MW/7Q;10%C[2_X>/?]4\_\K?_ -ST?\/'O^J>?^5O_P"YZ^+:* L?:8_X*/X_
MYIY_Y6__ +GI?^'D'_5//_*W_P#<]?%=% 6/M3_AY!_U3S_RM_\ W/1_P\@_
MZIY_Y6__ +GKXKHH"Q]J_P##R+_JG?\ Y6__ +GH_P"'D7_5._\ RM__ '/7
MQ510%C[5_P"'D7_5._\ RM__ '/2C_@I'C_FG?\ Y6__ +GKXIHH"Q]K?\/)
M/^J=_P#E;_\ N>C_ (>2?]4[_P#*W_\ <]?%-% 6/M;_ (>2?]4[_P#*W_\
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MF7_5-_\ RN__ '-2_P##S3_JF_\ Y7?_ +FKX=HH"Q]Q?\/-/^J;_P#E=_\
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M_JFO_E>_^YJ^%J* L?=/_#SW_JFO_E>_^YJ_1;_@G1\=/^&AO@EK?B/^Q/[
M^R^(9]/^S?:_M.[;;6TF_=L3&?-QC'\/7GC\ *_:G_@BI_R:SXI_['.Z_P#2
M&QH"Q]^>7[T>7[T^B@+'AW[:GQ,_X4Q^S-XR\9?V;_;']F_8_P#0O/\ (\SS
M+V"+[^UL8\S/W3G&.^:_+/\ X>?_ /5-/_*]_P#<U?HG_P %1O\ DQ/XF_\
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M\/3_ /JF/_E?_P#N6O@FB@+'WM_P]/\ ^J8_^5__ .Y:/^'I_P#U3'_RO_\
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M'JW_ %2__P N#_[EKX#HH"Q]^_\ #UC_ *I=_P"7!_\ <M'_  ]8_P"J7?\
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M]RT?\/9_^J5_^7%_]RU^>]% 6/T)_P"'M'_5*_\ RXO_ +EH_P"'M'_5*_\
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M<>5C&.^<\8KZIK\Y_P#@M$O_ !C_ *"?^INM/_2&\H"QX#_P]V_ZI1_Y<?\
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M?]4E_P#+D_\ N2C_ (?!?]4E_P#+D_\ N2OSCHH _1S_ (?!?]4E_P#+D_\
MN2E_X?"?]4D_\N3_ .Y*_.*B@#]'?^'PG_5)/_+D_P#N2C_A\)_U23_RY/\
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M/G/^J/\ _ES_ /W'2_\ #YW_ *H]_P"7/_\ <=?F?10!^F'_  ^=_P"J/?\
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MH_\ N.OS'HH _3C_ (?4?]4<_P#+H_\ N.@?\%J<?\T<_P#+H_\ N.OS'HH
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MH _47_A]U_U1?_RZO_N*E_X?>?\ 5%__ "ZO_N*ORYHH _4;_A]Y_P!47_\
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M*?\ EU__ '%7Y844 ?JA_P /R?\ JBG_ )=?_P!Q4?\ #\G_ *HI_P"77_\
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MGU^.U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]I_^FR[KY7KZ=_X)HR>3^VU\.']/[2_]-MU0!Z]_P6FE$W[4GA8C_H3;4?\
MD]?5\"5]V?\ !8R?[1^TUX9;_J4+4?\ D[>U\)T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'ZC?\$.Q_Q,_BZ?3^R/_0;^OUBK\H/^"'*_Z?\
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M%% !1110 5^?'_!:L?\ &-'A8_\ 4W6H_P#)*^K]!Z_/O_@M6/\ C&/PL?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_:G_@BI_P FL^*?^QSNO_2&QK\5
MJ_:G_@BI_P FL^*?^QSNO_2&QH ^_P"BBB@#Y5_X*C?\F)_$W_N&?^G.TK\
M:_?[_@J-_P F)_$W_N&?^G.TK\ : "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KZ2_X)RR>3^V9\/7]/[0_]-US7S;7T1_P3ZE\G]KSP$_I]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ6W/_DK=5^8]?H[_ ,%'KS[1\#]#7.?^*B@/_DM=4 ?G%1110 4444 %%%%
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MZ"/RDM*_.*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M10 4444 %%%% !7P!_P6K_Y-9\+?]CG:_P#I#?5]_P!? '_!:O\ Y-9\+?\
M8YVO_I#?4 ?BM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^@/\
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M ,$5/^36?%/_ &.=U_Z0V-?BM7[4_P#!%3_DUGQ3_P!CG=?^D-C0!]_T444
M?*O_  5&_P"3$_B;_P!PS_TYVE?@#7[_ '_!4;_DQ/XF_P#<,_\ 3G:5^ -
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %=G\%&V?&7P$WIK]@?_)B.N,KKO@^VSXM>"6_NZY8G_R82@#Z@_X*,7/V
MC_A7O^S_ &A_[;5\8U]<?M]77VC_ (03G.W[?_[;U\CT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'JO[)W_)TWP;_['/1O
M_2Z&OZ4Z_FL_9._Y.F^#?_8YZ-_Z70U_2G0 4444 %? '_!:O_DUGPM_V.=K
M_P"D-]7W_7P!_P %J_\ DUGPM_V.=K_Z0WU 'XK4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>S_ +',GD_M'^$7]/MG_I'/7C%>N?LG2^3^T!X6
M?T^U?^DDU '??\% YOM'QET9O^H!"/\ R8N:^9:^BOVZ)_M'Q:TENO\ Q(X1
M_P"3%Q7SK0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?JI_P0Q_
MYK9_W!/_ &_K]5*_*O\ X(8_\UL_[@G_ +?U^JE !1110 5^ /\ P5'_ .3[
M/B9_W#/_ $V6E?O]7X _\%1_^3[/B9_W#/\ TV6E 'RK1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!^@/_!/R[^S_  :UE?\ J/S'_P E[:OS^K[F
M_87O/L_PEU9<X_XGDQ_\E[>OAF@ HHHH **** "BBB@ HHHH **** "BBB@
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MGVCX=:<N?^8K&?\ R#-0!\H4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?O]_P2X_Y,3^&7_<3_P#3I=U]55\J_P#!
M+C_DQ/X9?]Q/_P!.EW7U50 4444 ? '_  6J_P"36/"W_8YVO_I#?5^*U?M3
M_P %JO\ DUCPM_V.=K_Z0WU?BM0 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* /I3QI>;OV<[>+/_,-L!^30U\UU[SXKO-_P-@BS_P N%D/R:*O!J "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#]_O^"7'_ "8G\,O^XG_Z=+NO
MJJOE7_@EQ_R8G\,O^XG_ .G2[KZJH **** /@#_@M5_R:QX6_P"QSM?_ $AO
MJ_%:OVI_X+5?\FL>%O\ L<[7_P!(;ZOQ6H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *]V_9=N?L_P#PDW.-WV7_ -JUX37L/[/=U]G_ +?YQN^S_P#M
M2@#SOQ\V_P =>(V]=2N3_P"16K"K8\9-YGC#76_O7\Y_\B-6/0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?M3_P $5/\ DUGQ3_V.=U_Z0V-?
MBM7[4_\ !%3_ )-9\4_]CG=?^D-C0!]_T444 ?*O_!4;_DQ/XF_]PS_TYVE?
M@#7[_?\ !4;_ ),3^)O_ '#/_3G:5^ - !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %;O@%MGCKPXWIJ5L?_(JUA5L
M>#6\OQAH3?W;^ _^1%H ]>_:BN?M'_",\YV_:O\ VE7A->P_M"77VC^P.<[?
MM'_M.O'J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#U7]D[_DZ;X-_]CGHW_I=#7]*=?S6?LG?\G3?!O_L<]&_]+H:_I3H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _I3_ &3O^36?@W_V)FC?^D,->JUY5^R=_P FL_!O_L3-
M&_\ 2&&O5: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX _P""U?\
MR:SX6_['.U_](;ZOO^O@#_@M7_R:SX6_['.U_P#2&^H _%:BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KUWXO7GVCPW;+G_E[4_^./7D5>A?$.\^
MT:+"N<_Z0I_\=:@#SVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _53_ ((8_P#-;/\ N"?^W]?JI7Y5_P#!#'_FMG_<$_\ ;^OU4H ****
M"OQ6_P""U?\ R=-X5_[$RU_]+KZOVIK\5O\ @M7_ ,G3>%?^Q,M?_2Z^H ^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ]5_9._Y.F^#?_8YZ-_Z70U_2G7\U
MG[)W_)TWP;_['/1O_2Z&OZ4Z "BBB@ KX _X+5_\FL^%O^QSM?\ TAOJ^_Z^
M /\ @M7_ ,FL^%O^QSM?_2&^H _%:BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KI?AO+Y/C33G]/,_\ 1;5S5;7@R7R?$MF_IO\ _0&H WOB]/\
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MPW<KG_E[8_\ CB5Y%7H7P\O/L^BS+G'^D,?_ !U:\]H **** "BBB@ HHHH
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M $-/P_\ _!C??_(='_#E3XW_ /0T_#__ ,&-]_\ (= 'P!17W_\ \.5/C?\
M]#3\/_\ P8WW_P AT?\ #E3XW_\ 0T_#_P#\&-]_\AT ? %%??\ _P .5/C?
M_P!#3\/_ /P8WW_R'1_PY4^-_P#T-/P__P#!C??_ "'0!\ 45]__ /#E3XW_
M /0T_#__ ,&-]_\ (='_  Y4^-__ $-/P_\ _!C??_(= 'P!17W_ /\ #E3X
MW_\ 0T_#_P#\&-]_\AT?\.5/C?\ ]#3\/_\ P8WW_P AT ? %%??_P#PY4^-
M_P#T-/P__P#!C??_ "'1_P .5/C?_P!#3\/_ /P8WW_R'0!\ 45]_P#_  Y4
M^-__ $-/P_\ _!C??_(='_#E3XW_ /0T_#__ ,&-]_\ (= 'P!17W_\ \.5/
MC?\ ]#3\/_\ P8WW_P AT?\ #E3XW_\ 0T_#_P#\&-]_\AT ? %%??\ _P .
M5/C?_P!#3\/_ /P8WW_R'1_PY4^-_P#T-/P__P#!C??_ "'0!\ 45]__ /#E
M3XW_ /0T_#__ ,&-]_\ (='_  Y4^-__ $-/P_\ _!C??_(= 'P!17W_ /\
M#E3XW_\ 0T_#_P#\&-]_\AT?\.5/C?\ ]#3\/_\ P8WW_P AT ? %%??_P#P
MY4^-_P#T-/P__P#!C??_ "'1_P .5/C?_P!#3\/_ /P8WW_R'0!\ 45]_P#_
M  Y4^-__ $-/P_\ _!C??_(='_#E3XW_ /0T_#__ ,&-]_\ (= 'P!17W_\
M\.5/C?\ ]#3\/_\ P8WW_P AT?\ #E3XW_\ 0T_#_P#\&-]_\AT ? %%??\
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M^*+S[1I\:YS^]!_0U]L?\.5/C?\ ]#3\/_\ P8WW_P AU:NO^",/QON8PO\
MPE/@ 8.?^0C??_(= 'Y[45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]
M#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0
MT_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-
M/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3
M\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_
M#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P
M_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/
M_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_
M /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__
M /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\
M_P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\
M\&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_
M  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P
M8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\
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M_0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\
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M /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\
M\&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\
M_P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P
M8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_
M  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C
M??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\
M!C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]
M_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &
M-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_
M ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8W
MW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\
MR'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??
M_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(
M='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\
MAT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT
M?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'
M1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_
MPY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='
M_#E3XW_]#3\/_P#P8WW_ ,AT ??_ /P2X_Y,3^&7_<3_ /3I=U]55XI^QG\%
M=<_9V_9L\'_#WQ)=:?>ZUH_VSSY]+DDDMV\V\GG78SHC'"RJ#E1R#U')]KH
M**** /@#_@M5_P FL>%O^QSM?_2&^K\5J_H)_P""A7[+_BK]K+X+Z+X0\(W^
MCZ=J5EX@AU6276YI8H3$EM<Q%08XI#NW3)QC& >>@/YZ_P##E3XW_P#0T_#_
M /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__
M /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\
M_P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\
M\&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_
M  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P
M8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\
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M_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\
MR'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\
MAT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(
M= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'
M0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT
M ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(=
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M[_Y#H_X<J?&__H:?A_\ ^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\
MY#H_X<J?&_\ Z&GX?_\ @QOO_D.@#X HK[__ .'*GQO_ .AI^'__ (,;[_Y#
MH_X<J?&__H:?A_\ ^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\ Y#H_
MX<J?&_\ Z&GX?_\ @QOO_D.@#X HK[__ .'*GQO_ .AI^'__ (,;[_Y#H_X<
MJ?&__H:?A_\ ^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\ Y#H_X<J?
M&_\ Z&GX?_\ @QOO_D.@#X HK[__ .'*GQO_ .AI^'__ (,;[_Y#H_X<J?&_
M_H:?A_\ ^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\ Y#H_X<J?&_\
MZ&GX?_\ @QOO_D.@#X HK[__ .'*GQO_ .AI^'__ (,;[_Y#H_X<J?&__H:?
MA_\ ^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\ Y#H_X<J?&_\ Z&GX
M?_\ @QOO_D.@#X HK[__ .'*GQO_ .AI^'__ (,;[_Y#H_X<J?&__H:?A_\
M^#&^_P#D.@#X HK[_P#^'*GQO_Z&GX?_ /@QOO\ Y#H_X<J?&_\ Z&GX?_\
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M^-4 ?S645_2G_P ,G_!#_HC?P_\ _"7L?_C5'_#)_P $/^B-_#__ ,)>Q_\
MC5 '\UE%?TI_\,G_  0_Z(W\/_\ PE['_P"-4?\ #)_P0_Z(W\/_ /PE['_X
MU0!_-917]*?_  R?\$/^B-_#_P#\)>Q_^-4?\,G_  0_Z(W\/_\ PE['_P"-
M4 ?S645_2G_PR?\ !#_HC?P__P#"7L?_ (U1_P ,G_!#_HC?P_\ _"7L?_C5
M '\UE%?TI_\ #)_P0_Z(W\/_ /PE['_XU1_PR?\ !#_HC?P__P#"7L?_ (U0
M!_-917]*?_#)_P $/^B-_#__ ,)>Q_\ C5'_  R?\$/^B-_#_P#\)>Q_^-4
M?S645_2G_P ,G_!#_HC?P_\ _"7L?_C5'_#)_P $/^B-_#__ ,)>Q_\ C5 '
M\UE%?TI_\,G_  0_Z(W\/_\ PE['_P"-4?\ #)_P0_Z(W\/_ /PE['_XU0!_
M-917]*?_  R?\$/^B-_#_P#\)>Q_^-4?\,G_  0_Z(W\/_\ PE['_P"-4 ?S
M645_2G_PR?\ !#_HC?P__P#"7L?_ (U1_P ,G_!#_HC?P_\ _"7L?_C5 '\U
ME%?TI_\ #)_P0_Z(W\/_ /PE['_XU1_PR?\ !#_HC?P__P#"7L?_ (U0!_-9
M17]*?_#)_P $/^B-_#__ ,)>Q_\ C5'_  R?\$/^B-_#_P#\)>Q_^-4 ?S64
M5_2G_P ,G_!#_HC?P_\ _"7L?_C5'_#)_P $/^B-_#__ ,)>Q_\ C5 '\UE%
M?TI_\,G_  0_Z(W\/_\ PE['_P"-4?\ #)_P0_Z(W\/_ /PE['_XU0!_-917
M]*?_  R?\$/^B-_#_P#\)>Q_^-4?\,G_  0_Z(W\/_\ PE['_P"-4 ?S645_
M2G_PR?\ !#_HC?P__P#"7L?_ (U1_P ,G_!#_HC?P_\ _"7L?_C5 '\UE%?T
MI_\ #)_P0_Z(W\/_ /PE['_XU1_PR?\ !#_HC?P__P#"7L?_ (U0!_-917]*
M?_#)_P $/^B-_#__ ,)>Q_\ C5'_  R?\$/^B-_#_P#\)>Q_^-4 ?S645_2G
M_P ,G_!#_HC?P_\ _"7L?_C5'_#)_P $/^B-_#__ ,)>Q_\ C5 '\UE%?TI_
M\,G_  0_Z(W\/_\ PE['_P"-4?\ #)_P0_Z(W\/_ /PE['_XU0!_-917]*?_
M  R?\$/^B-_#_P#\)>Q_^-4?\,G_  0_Z(W\/_\ PE['_P"-4 ?S645_2G_P
MR?\ !#_HC?P__P#"7L?_ (U1_P ,G_!#_HC?P_\ _"7L?_C5 '\UE%?TI_\
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M /PE['_XU0!_-917]*?_  R?\$/^B-_#_P#\)>Q_^-4?\,G_  0_Z(W\/_\
MPE['_P"-4 ?S645_2G_PR?\ !#_HC?P__P#"7L?_ (U1_P ,G_!#_HC?P_\
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M_0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\
MT-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]
M#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0
MT_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-
M/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3
M\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_
M#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P
M_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/
M_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_
M /\ !C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__
M /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\
M_P &-]_\AT ? %%??_\ PY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\
M\&-]_P#(= 'P!17W_P#\.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_
M  8WW_R'0!\ 45]__P##E3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P
M8WW_ ,AT ? %%??_ /PY4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\
M!C??_(= 'P!17W__ ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C
M??\ R'0!\ 5H:#+Y.K0/Z;O_ $$U]W_\.5/C?_T-/P__ /!C??\ R'4EO_P1
M9^-\$RO_ ,)3\/\ C_J(WWI_UYT ?"GBB?[1J$;=?W0'ZFL>OT%NO^"+GQON
M9 W_  E/@ 8&/^0C??\ R'4/_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY
M4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5
M/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3
MXW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^
M-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C
M?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW
M_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-_
M_0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5/C?_
M -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]
M#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^-_\
MT-/P_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-
M/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0
MT_#_ /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_
M#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5/C?_ -#3
M\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3XW_]#3\/
M_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^-_\ T-/P
M_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C?_T-/P__
M /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW_P#0T_#_
M /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY4^-__0T_#_\
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M ,.5/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\
M_#E3XW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\
MPY4^-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\
M.5/C?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##
ME3XW_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ? %%??_ /PY
M4^-__0T_#_\ \&-]_P#(='_#E3XW_P#0T_#_ /\ !C??_(= 'P!17W__ ,.5
M/C?_ -#3\/\ _P &-]_\AT?\.5/C?_T-/P__ /!C??\ R'0!\ 45]_\ _#E3
MXW_]#3\/_P#P8WW_ ,AT?\.5/C?_ -#3\/\ _P &-]_\AT ? %%??_\ PY4^
M-_\ T-/P_P#_  8WW_R'1_PY4^-__0T_#_\ \&-]_P#(= 'P!17W_P#\.5/C
M?_T-/P__ /!C??\ R'1_PY4^-_\ T-/P_P#_  8WW_R'0!\ 45]__P##E3XW
M_P#0T_#_ /\ !C??_(='_#E3XW_]#3\/_P#P8WW_ ,AT ?$_A>\^SZ?(N<?O
M2?T%<Q7Z$VO_  1A^-]M&5_X2GP <G/_ "$;[_Y#JK_PY4^-_P#T-/P__P#!
MC??_ "'0!\ 45]__ /#E3XW_ /0T_#__ ,&-]_\ (='_  Y4^-__ $-/P_\
M_!C??_(= 'P!17W_ /\ #E3XW_\ 0T_#_P#\&-]_\AT?\.5/C?\ ]#3\/_\
MP8WW_P AT ? %%??_P#PY4^-_P#T-/P__P#!C??_ "'1_P .5/C?_P!#3\/_
M /P8WW_R'0!\ 45]_P#_  Y4^-__ $-/P_\ _!C??_(='_#E3XW_ /0T_#__
M ,&-]_\ (= 'P!17W_\ \.5/C?\ ]#3\/_\ P8WW_P AT?\ #E3XW_\ 0T_#
M_P#\&-]_\AT ? %%??\ _P .5/C?_P!#3\/_ /P8WW_R'1_PY4^-_P#T-/P_
M_P#!C??_ "'0!\ 45]__ /#E3XW_ /0T_#__ ,&-]_\ (='_  Y4^-__ $-/
MP_\ _!C??_(= 'P!17W_ /\ #E3XW_\ 0T_#_P#\&-]_\AT?\.5/C?\ ]#3\
M/_\ P8WW_P AT ? %%??_P#PY4^-_P#T-/P__P#!C??_ "'1_P .5/C?_P!#
M3\/_ /P8WW_R'0!\ 45]_P#_  Y4^-__ $-/P_\ _!C??_(='_#E3XW_ /0T
M_#__ ,&-]_\ (= 'P!17W_\ \.5/C?\ ]#3\/_\ P8WW_P AT?\ #E3XW_\
M0T_#_P#\&-]_\AT ? %%??\ _P .5/C?_P!#3\/_ /P8WW_R'1_PY4^-_P#T
M-/P__P#!C??_ "'0!\ 45]__ /#E3XW_ /0T_#__ ,&-]_\ (='_  Y4^-__
M $-/P_\ _!C??_(= 'P!17W_ /\ #E3XW_\ 0T_#_P#\&-]_\AT?\.5/C?\
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M_!?P#X1U.6WGU+P_X?T_2KJ6T9FA>6"VCB=D+*I*ED."0#C&0.E=K0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YW?\%LO^3>_ _\
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M+^&]D( ^6&63 D/'\3)G'&3Q6L[TVW+;OW\[=C*+YTK;]NWE?N?KK17YJ_\
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MO7MW_!5S_DR+QI_U]Z=_Z6PU.(BO9*5_M+\X_P!?(*+?M&K='^3.*_X(S_\
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M -)I*]E_X)4_\F1^"?\ KYU#_P!+)JG#136(;Z27Y1'7;7L5Z_\ MQR.M?\
M!''X":E:F*TG\6:3+SB:UU2-S^(DB88_ 5^=G[07P5\>_P#!-O\ :$T74/#/
MB6:2.1#?:+K<*^4;B$,!)!/'D@X. Z\JP93QG _?JOQ^_P""S?Q1T/QU\3/
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M4_6NBORPU+XM?M1?\%";J:+X--<?#'X7V?[@:_>7;V$M_*N S/<1!I2<@_)
M"JYPY)Q7D'QN_8[_ &J/V7?"=Y\2$^)UYK-I8$27]SX=\07QNK=">99%D5-T
M8.-V"V,Y(P"1DWR:U-%_6MAQ]_2&K_K0_:ZBOC__ ()J_M=:K^U)\)M2M_%<
ML4_C3PS/';7UU$BQ_;(9%)AG*+@*QV.K  #*9 &<#Z-^,GQ8T/X'?#'Q#XY\
M1R,FDZ-;&>18\>9*V0J1)GC<[E5&>["KK+V-^=Z;_+<5)NM916NWS.SHK\CO
M _Q4_:V_X*+^(=:N_ OB5/A7\/[&?RC/8W#VD<3=1$+B-3//-L(+8*H..$W
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MNH^4$J1@-M'L/[:'_)I7Q?\ ^Q7U#_T0U1C(.%&:?9_D7A9J=6-NZ_,^(/\
M@AS_ ,@/XN?]?&F_^@W%?J-7X*?L-?M2>+?@;X9\:>#OAKX5N/%'Q+\9W=G#
MI"+#YL5LL:3>9*R Y9AO4@'" !F8X7#?0NL?\$^OVR/BU"=;\7_&&SM]2N?W
MYTN\\17NVW<C[FR"$PQXSC$65':NW$2<I*26B45?SLMN]NIRT8J*:;U;>GSZ
M_H?K-17XK_L\_M4_&C]CG]IRV^&7Q;US5-7T![^+3M2L=7O&O%MEE*B*[MIG
M)8( RO@':RELJ&P1^J'[57@WQ)X\_9_\9Z9X-US5/#OBI;%KK3+[1KV6UN//
MBQ(L8DC8-B3;L(ST>N:I)0HJO%WC_EN;TTY5?8RT>GX['K%%?F5_P2%_:E\3
M?$/5O&WP^\=^*-6\2ZNB)K&F76N7TMW.(QB*>(/*Q;:"8F"YXRY]:_36M9PY
M+/HU?^OGH9QES-KJG8**_,__ (*]_M.>*/A[J7@3X?\ @3Q1J_AO69UDU?4)
M]#OI;2X,9)B@C+Q,&*LPF)7/55/I7UQX)UB]_9?_ &/K+7?B#J^K>)-6\.Z
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MFDGRP=V?KG63XL\+:7XX\,:MX>UNT6_T?5;62RO+5R0)89%*NN1R,@GD<U\
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M<\3^-[?59M4M->FTZ)K&^,">4MO XRH!R=TC<_2OK'_@KU_R9O?_ /8:L/\
MT)JY3_@BO_R;#XH_[&VX_P#22TJ<'%2>*;6UO_<96(;2HV\__;C?U3_@CO\
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MDN*_1&OSN_X+9?\ )O?@?_L:%_\ 22XKGK_ O6/_ *4C:C\3]'^3/CG]F/\
M:,_:O^'7PCT[1/A1X(UC7/!<,\[VUY9^$9]0C:1I"9 )D0@X8D8SQTKTK4OV
MIO\ @H!XFA73[7P-XJT>64[?M%MX#>)N>,;YH65?KP1ZU]D?\$F?^3*?#'_8
M0U#_ -*7K[%KMJQM))ZZ+\D<E*5XW2MJ_P V?D7^SG_P2W^)?Q6^)*>/?VAK
MR:VLFN1=76FWE\+O4M588(661698XS@ _,7P-H5>&'ZI>-O ]EXV^'^N>$)9
M9M,TW5=-FTMY+#:DD$4D9C/EY4J"%/&00,#BNBKP;]N+XX:E^SS^S-XN\8Z(
M%&NQI%9Z?(ZAA%--(L8D((P=@8L >"5 /6L*U2,:7(U[O;O?3\=NQT48R=53
M3][OVZ_\$\U^"_P5^ G_  3?F\17%S\2ETZZ\0Q0;X_%FIVHN/+A,A'DQQQH
M[ F0YP&Z+TK3U+_@J9^S1I^\)\0I+QUXVVVB7YSSV)@ /YU\0_\ !/7]AO2/
MVNK37OBS\7=4U3Q#9OJ;VL=D;QUEU"955I9;B8'S-OSJ %93D')P #^D7AW]
MB?X">%[&.UL_A#X0FBC&T-J.DQ7LGXO.'8GW)K:<9JWM'K9?\#\#&,H2;=-:
M7W]-#\@OVG/C1X0^-7[>WA[QU\/[V:[TJZU'1B+J6V:!C/$\2$[7 /&U>3Z5
M^]-?A9^VQX1\.>!?^"B6GZ-X6T72_#VDV]_HA73]'M([:"-V$+-B.,!023D\
M<YK]TZSHV^JQY=N:7Z?TBJO-]9ES?RP_)GXJ?MV?\I1M"_["?A[^<%?M77XJ
M?MV?\I1M"_["?A[^<%?M748?_=(_XI_FBZ_^\O\ PP_(^0_^"KG_ "9%XT_Z
M^]._]+8:\Z_X(K_\FP^*/^QMN/\ TDM*]%_X*N?\F1>-/^OO3O\ TMAKSK_@
MBO\ \FP^*/\ L;;C_P!)+2ML'MB?E^<"<1_RY^?_ +<>:?\ !<#QK<PZ?\+?
M",<A6SN);S5)X^S.@CCB/X"27\ZU?V=?^"H_P&^"/P.\$^!QHGBY)]&TR&WN
MFM=-MS')<[=T[J3< D-(7;) )S6!_P %PO"ETTGPJ\3(C-9*+[3I7Q\JR'RI
M$'U($G_?)KZJ_91^"/P.^*G[-_PX\3GX4^ ]1N;W1+87=S+X;L9)'N401S[V
M\K);S$?)/)-98;F]A4?][7_R:WX6_ =>WM::_NZ?A?\ &YYS_P /G/@3_P!
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MW-*WII;\+'36O];G_AC?UUO^.Y^''[ OA_3?$7_!2!H]3L8;^.UU#6+R%+A
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M ,%P3%>CZEOM'_?0K]JJ_-W_ (+4?",Z]\*_!_Q#M8=UQX?OVTZ\9?\ GWN
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MBMIKEA;1[A*PEQ'-,KC]YOZCGM7UI_P6X_Y(K\/O^QA?_P!)I*]E_P""5/\
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MD4R]QQL]10H3ACZ=/JF_2]XV_7Y7)<XSP52?1I?=9W_3YGVE_P /G/@3_P!
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M.OX:Z+^TD?C98ZOXGM?%!U275S8QW5N+#SI P<;/(W[3O8D>9GD\U[Q\7/\
MDE/C3_L"WO\ Z(>O"K[_ (*'?#FS_:57X(1Z+XHO?%9U2/2?MEM:VS6(F958
MDN;@/M7)W'9D;6X->Z_%S_DE/C3_ + M[_Z(>O*Q/^XRY/@Y7;[O\K'H4?\
M>US?%=7^_P#SN?D__P $2/\ DMWQ _[%U?\ TICK]8_BE\/K+XL?#GQ)X-U&
M[NK'3]=L9=/N+BQ95G2.12K%"RLH.">H-?DY_P $2/\ DMWQ _[%U?\ TICK
M[\_X*"_'K5_V=OV9/$'B3P[)]G\17<T.EZ?=%=WV>28G=* >-RHKE<\;@N<]
M*]#&2C&C3YE=-6^^31Q81.5:IRNWO7^Z,7<Y'X-_#/X _P#!-VS\16EQ\2XM
M/N=>,-Q/%XHU*U-X4B#A1%%%&CLO[QOX3R:N:A_P5._9HL=P3X@37K*<;;?0
M[_GGL6@ /YU\:?\ !/+]@/P[^TUX6O\ XN?%R^U'Q';W^H316NF_;9$:[9#B
M6>YF!\QB7) "LI^4DDYQ7Z*Z%^Q;\!O#MG':VGP@\&RQQC :^T>&\D_%YE=C
M]2:)J>GM'K9?EI^%BHN#O[-:7?\ P?Q/R"^)7Q9\,?%S_@I=X>\<^!+R6YT/
M4O%.A207,ENT#,ZFVCDRC $?,K#D<U^\M?A9\?O#&A>#?^"I6GZ-X:TG3M"T
M:U\5Z"L.GZ5;1V]O"2+5F"QQ@*N6))P.I-?NG2IV^ITN7:[_ "B75O\ 697W
MM']3\.K;1;#Q%_P5TN+#5+.#4+&7QW.9+>Y0/&^TLRY4\'#*#SZ5^XE?B1X=
M_P"4PC_]CU<_R>OVXK+#?[A1_K[,1XC_ 'ZM_761\6?\%=M-M[[]C75)YHP\
MMEK%A/"V/NL9#&3_ -\NP_&JG_!'NXDF_8^C1W++%K]\B _PKB)L#\6)_&M7
M_@K7_P F6^(O^PEI_P#Z4+6-_P $=O\ DT$_]C%>_P#H,-/!_P#,3\O_ &PS
MQ3UP_P _RF?<5%%%,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#XI_X*]?\F;W_P#V&K#_ -":OSD_
M9'^/7[37PM^'>I:7\&/!VJ^(?#,VIO<W-S8^%YM31;HQ1*R&5$(!V+&=N<\@
M]Z_1O_@KU_R9O?\ _8:L/_0FKE/^"*__ ";#XH_[&VX_])+2L\'%R>):=K-?
M/2'_  Y>(=E1T[_G(^=K_P#:R_;]U:W-K;^ /%&F2R' N+?P!*&7\98&4?B*
M3X0_\$T?C;^T=\2E\:?'_4KS1]-EE66\;4;U;C5+U!R(HU0LL"8ROS%=@^ZA
M[?L716T;1?-:[_K^NQG*\ERWLC'T_P )Z;HOA&#PUI,"Z3I-K9"PM8;10HMX
ME38@0$$?*,8SGI7R5\'/V7?@/_P3Q\4:CXPO/B/+IMYJU@U@O_"8:I9QYC\Q
M9&\E5CC9F)09 STZ5] ?M,?%>;X'? /QQXYM84N+W1M-DFM8Y 2C3G"1;@/X
M=[+GVS7Y0_L(?LGO^WIXX\7_ !+^+WB'5-:TVQNTBGC6X*SZC=,-Y1I.L<2)
MM&U,'YE"E0M1"4IUI.#UMJWV=U_G]Y4HQC1CS;7LDNZL_P -#] -6_X*B?LT
MZ3++%_PL7[9+&2"MIHU_("1Z/Y&T_4'%?EW_ ,%)/V@/ G[1'QZT'Q9\/=1G
MO[&'1(+.XN)K22V83I/,V '4$X5TY_PK]?/"O[#7P \'V*6EC\)/"MQ$G1M5
MT]=0D/U>XWL?Q-?E+_P5F\ ^%/AS^TMH>E>$/#FC>&-/;P[;32V6B6,5I$93
M<3@NR1JHW$!>2,X HC95Z7?FT^YFL+N%3T_5'[?Z',]QHFGRR'<[V\;,?4E0
M37XQ_P#!9C_DZSPW_P!BS:_^E-S7[,^'?^1?TO\ Z]8O_0!7XS?\%F/^3K/#
M?_8LVO\ Z4W-;_\ ,;1_Q_YF>%_W:7^%?G$_:.R_X\X/^N:_RKP7]O[_ ),U
M^+'_ &!F_P#0TKWJR_X\X/\ KFO\J\%_;^_Y,U^+'_8&;_T-*\_'?[O5])?D
MQX'XJ7_;OZ'R3_P0]_Y$;XJ_]A&Q_P#14M=+_P %J_&MSH_P)\&^&X)6CCUK
M7#-<*N<21P1$A3[;Y$/U45S7_!#W_D1OBK_V$;'_ -%2UM?\%L_"ESJ'P9\!
M>((4=X-+UN2VFVC(03PDJQ].8<?\"%=68_9_[A_^VF67[2_[B?\ MQP/['7_
M  4E^!_[-_[//A;P-?:/XJ;6+-))M2FL=/@>*:YDD9V8,9U+#!502!PH]*]I
M_P"'SGP)_P"@1XV_\%EM_P#)-:O_  3_ /A!\%_B]^R7X#UN_P#AAX)UG68;
M>2PU&[OO#UG/</<0R,A,CM&69BH5LDY(8&OHC_AD[X(?]$;^'_\ X2]C_P#&
MJWK\WM9<V_\ 6WEV\C*C;V:Y?Z[W\[[^9^-=M\<O#OC'_@I=X<^)'P]MK[3=
M$UGQ5I[B&]A2&;,_E0W6Y59E^=GE/WN=V:_=?Q-_R+>J_P#7I+_Z :^4]:\<
M?L=_"[XY6'P^N/!_@K2/B/#?V<-K;V7@E3)%=2^6UOLGCMBJMEXR&##:3R1B
MOJSQ-_R+>J_]>DO_ * :XZUHX#DBM$I6?R6GR_4[:=WBU.6[Y?S>OS/Q9_X(
MTZ+8:I^U9JMQ>6<%U-I_AFZN;22:,,8)?/MX]Z$_=;9(ZY'.&([U^W%?BI_P
M19_Y.C\2?]BE<_\ I7:5^U=>A6_ATO\ #_[=(XJ?Q3]?T1^57_!<C3H%;X07
MX3%RW]J0%_5!]E8#\R?SK[U_8[F>X_93^$;R,7?_ (1?3QN/7BW0#]!7PG_P
M7(_Y!WP=_P"NNJ_RM*^Z/V-?^33_ (1?]BOI_P#Z(6N7#?[M47]]?^W'5B/C
MHO\ NO\ ]*L?''_!;W_DE_PS_P"PS<_^B!7U;^P/_P F;_";_L"1_P#H35\I
M?\%O?^27_#/_ +#-S_Z(%?5O[ __ "9O\)O^P)'_ .A-66'^&O\ XX_^D&=;
M^)1_P2_]*/?J***T&?D1_P %P+>=?B)\+IV)^S/I5XB#G&Y9D+?HR5^A'[$%
MU!>?LB?".2W $8\.VD9P<_,J!6_\>!KYQ_X+&_!BZ\>? +1_&FG6[7%WX/OF
MDN0BY(LYPJ2-Q_==82?0;CVJ+_@CU\?K#QK\#;CX:7=TJ^(?"<\DL%N[?--8
MS2%U=?79([J<= 4]:6$7[JK16ZE?Y:O_ -N_!]@Q.E2G5Z-6]'HOT_%'Z!44
M44P"J6M1R3:-?QQ?ZUK>14Q_>*G%?EY_P4@_;S^(_P ,?V@++P)\)/%[:6NG
M6$2:I%:V5M=%[V5BPC_>Q.=RQF/A>[XZBOTL^&UOKEK\._#$/BB[.H>)$TRV
M74[ID5#+=>4OFMM4!1E]W  'H*SY?K%"4EHG=?GJO+_-%.7L:T8O??\ +_/\
MS\1_^"3MQ%8_MLZ'#=@&>73]1AC8G&)!"S$_DK#\:_=ROP3^)MG??L+_ /!0
MZ367M91I>FZ__;-J%7'GZ9<LQ=4[$B.26/\ WD-?NSX9\2:9XQ\.Z;KNC7D6
MHZ3J5O'=VEW VY)8G4,K ^A!%=$9^VPU.IY6?D]_U:^3,IQ5+$U(+9NZ_+\D
MG\S3HHKA/CK\4M.^"WP@\6>-=3N$MK?1]/EGC+D#S)MI$4:YZLSE5 ]2*PJ3
M5.#F^AM"+J24%U.[HK\Q_P#@EW^TW\=/VD/B_P"(QXW\8S:[X0T723)-"VGV
MD"_:I9%6$;HHE;[JS'&<?+TK].*WE!Q2;ZJYC&2DVET_RN?FI_P6]_Y)?\,_
M^PS<_P#H@5[_ /\ !+G_ ),<^'7UU#_TON*\ _X+>_\ )+_AG_V&;G_T0*]_
M_P""7/\ R8Y\.OKJ'_I?<5GA?X>)_P <?_2#3$?\N/1_G(^K*_(G_@L[\9'\
M3?$;P;\)].N%,.DQ#4[]2X5/M4_R0JQ/"[8]S9)QB:OUHUS6K/PYHM_JVH3K
M;6%C;R75Q,_2.-%+,Q]@ 37X,?"WX2ZY_P %*?VMO&UV^M-X;M]0-SK-QJ4E
MG]K^R6ZNL=O#LWQ[C@QH/F'"D\XK'E=6M&FE=+WG\OZ;^1IS*E2E4?7W5\_Z
MM\S];O@%\0O@M\$?@SX/\#6?Q4\#E-%TZ*WED7Q#9@2S8W2R?ZS^*0NWXU\;
M?\%?9OAS\5OA[X2\9^%/''A?7?$&@W;6-Q9Z9K-M<3RVDXSN"(Y9MDB+TZ"1
MC4?_  XQ_P"JV?\ EJ?_ ';4-W_P0UFBM9GM_C.L\ZHQCB;PML#MCA2WVPX!
M/?!QZ5IB'[9NI+>]_P#/[]49T/W*4([6M_7YGV-_P3P^-G_"\OV5?".I7-QY
M^M:/&=$U++9;SH %5F]WB,3_ %8U]*5^/7_!'GXL77P[^.'C#X1ZXS6G]M1O
M+!;2G'EZA:EA(@'JT>_/_7$5^PM=59J;56.TU?\ S_&_R.>DG33I/>+M_E^&
MGJ%%%%<YN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^$__
M  5LAFM_VTM7DG),4FEZ?)%G/W/*VG_QY6K]R/#UQ#=^'],GMP!!+:Q/'@Y&
MTH"/TK\K_P#@M=\&+I=8\$_%.SMVDLW@;0=1D49$3JS2VY/^\'F&?]D#O7V#
M_P $Z?C]8?';]F/PQBZ63Q#X;MH]%U:W9LR*\2A8Y"/22-5;/3.X?PFC"ZX:
M<.L9-_)M_P#VOWCQ+_?TY='&WS27^3^X^GZ***!!37^ZWTK\C_C1^W9\8_&O
M[;\WPZ^$GCE[3PK-KEKH=K#:Z=:7"LP*1W,@>2)F*[_-.<XVKD<5^N#<1D$Y
M..M1\=!5EM*_Y+_,<O<JND]U:_\ 7R/Q8_X)6?\ )^7B3_L&:K_Z41U^U-?B
MI_P2N=5_;R\1!F +:;JH4$]3Y\9P/P!_*OVKJZ?^[T/\*_-A5_WFO_B?Y(_$
M?P[_ ,IA'_['JY_D]?LA\4_%1\"_#'Q=XD'WM'TB[U <9YBA=_\ V6OQO\._
M\IA'_P"QZN?Y/7[#?&?PS-XT^#_CGP_;[O/U70[ZQCV]=TD#H,?BU<B;650:
M_E?_ *3$W]UYI-2VNO\ TJ1^27_!''P3%XZ_:4\5>,]7S?WNAZ6]Q%-.-[?:
MKF389<G^+8)AGK\YK]GZ_&__ ((I^+K;1?CEXY\,W3>3=:MHJS0*_!9[>8;E
M^NV5CCT4U^R%>G4TITDMK?\ MS."%W4J.6]_T1X;^U1^Q]X)_:\T70M-\97F
ML:<NC7$EQ:W.B30Q3?.H5D8RQ2#:<*< #E1S7H'P=^%NF?!/X9>'_ VBWE_?
MZ5HEO]EMKC4Y$DN&3<6&]D55.-V!A1P!7$_M1_M7>#_V2?"&E>(O&-GJ^H6N
MI7WV""WT6&*6;?Y;.6(DEC&T!<$YSEAQ76_ [XP:3\?/A;H7CW0K'4=.TC6$
MDDM[?5HXX[@*DC1Y98W=1DH2,,>".G2N>'PSY-KJ_K;3\#:?Q1YM[.WI?7\3
M\?\ _@J!-';_ +?UI+*ZQ11VVD,[N<*H!!))["O2/VU_VPO$W[8/Q*M/@!\#
M#+J&AWET;2\O[20*-8D7)8!_X;5 K,6SA\$_= SYS_P4\Y_X*!6(/(\C2/YB
MO2_^"AG[#^K_  *\6#X]_!A9]+L+6Z&H:G8Z:"'TBX#;OM<(_P">);[RXPA/
M382$YZ/+]7INK\'M*E__  )?A_7II/F]O4]G\?)"WW/\?ZWW^Z_V-?V/?#7[
M(_P[73+'R]3\5Z@J2:UKA3#7$@'$<>>5B0D[5[\D\FOH.OE']@G]N'2?VLO
MXL-4>#3?B/I$*_VIIRD*MT@P/M<(_N,2-R_P,<="I/U=7=5YN;WO^!;R.:ER
M\NG_  ;^?]?@%%%%8FQ^*W_!-G_E(QXB_P!W6_\ T::_:FOQ6_X)L_\ *1CQ
M%_NZW_Z--?M36>'_ -SP_P#@7YL4_P#>:_\ C?Y(_$7_ (*$7DWQN_X*-V7@
MBYE?[#;W>D>&XE7.528QO(0/7=</^0K]L-+TRUT73+33[&!+:RM(4@@AC&%C
MC50JJ!V   K\2OVW5;X1?\%/+?Q3J0:+3SK.B:^DK8P8$$ =A[!H9!_P&OV]
MCD6:-9(V#HP#*RG((/0UK0M]2A;=N5_73];CK_[U*_:-O3_AK7(-2T^VU?3[
MJPO84N;.ZB:":&0961&!#*1W!!(K\3/V"[J;X$?\%);OP3:2.NG3:CJWAJ96
M)R\49E:(GWWP1_K7[=22+%&SNP5%&2S'  ]:_$+]CW=\8_\ @J1/XFTPFXT[
M^W]9UUITZ?9R)]C' Z$R1C_@5+#_ .^1MUC*_I_PU[#K6^J3OO=6]=?UL?M_
M1110(_,3_@N%_P B;\*?^O\ O_\ T7#7U/\ \$YO">D^%?V./AP=*L8K-M2L
M3J-XZ#YI[B1SND8]S@ >P4 <"OEC_@N%_P B;\*?^O\ O_\ T7#7UU^P%-'<
M?L:_"=HI%D4:,B$J00&#N"/J""/PJ<-_"K?XE^08C^)07]V7_I7_  Y] U^'
M'[8.GQ_ 7_@IM'KFBK]DC?7-+U\1P?+\TIC:<?\  W$I/^^:_<>OPZ_;JND^
M,'_!2I- TD+<NNIZ1H64&X-(/*$@/^ZSL#_NFG1O]=H<N_-^'_#\H5?]TKWV
MY?Q_X:Y^O'[3GC2X^'?[.WQ(\2V4ABO=-T"\GMI!_#+Y+!#^#$5^./\ P3A_
M:N^&?[)^N>--=\<Z=K5]K&J06]I83:3:13F*$,[S!B\J8W-Y73.=E?L'^U=X
M3N?&W[,OQ/T*PC:2\N_#MZEO&@R7D$+,JCZD ?C7YF?\$=_"?PX^)&K_ !'\
M,^-O!WAOQ3JD<-IJ&GC7=*M[QTB5I(YO+,J,5&7ASCCD44+^WJ\N_*OSE?\
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M!(+LV"0.,5ZO_P /G/@3_P! CQM_X++;_P"2:ZW]B7X+_!+XL?LK_#?Q#/\
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MHWAFR\:6]I,TLNC>$CITHMU=5D'G_9T!7<4X#<\=:@_X*D_\F0^/_P#?L/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ\=I"G![KE_&5_U.3!ZSG+H^;\(V_0\Z_P""*_\ R;#XH_[&VX_])+2OIO\
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M([D#T%?J)7YD?\$/?^1&^*O_ &$;'_T5+7Z;UZ6(^-+RC_Z2C@PWP-_WI?\
MI3/Q/_X*P6D>D_MR:'=VH\FXN-)TRYD=>"9%GE0-]=L:_E7[6Q-F%&)_A!/Y
M5^+'_!7+_D]?PU_V =._]*KBOVFA&;=!_LC^5<U+_<U;^>?YHZ*O^]?]NQ_(
M_$']F"U7]H__ (*AS:YK:_;[9=>U'6]DJY&VW\PVRGV4K#C/]T"OW"K\0?V(
M9C\'/^"FMQX>U;-N\FJZOH9:7 ^<^;Y?_?3(F,==PK]OJ5+_ '.A;;E_'_AK
M?@.I_O=:^]_P_P"'N>3_ +5WPZL_BM^SA\1/#5Y LXN=&N)8-RYV7$2&6%Q[
MB1$/X5^=?_!$3QY=0^+?B3X+>5FLKBRM]7AB/W4DC?RG(]V$D>?]P5^E7[0W
MC&U^'_P(^('B&\E$4.GZ%>3;B1R_DL$49[EBH'N17YB?\$1?"=S=?$[XC>)=
MKBSLM(@T_=CY3)--OQGU @/YBC"_[S53VY/_ )*WXI?@&)O]7IM;\W_R-_PO
M^)]7_P#!4[]G/Q'\?O@'8W'A&RDU77O#%^=1&FP#=+=6[1LDJQK_ !./E8*.
M2%(&20#\?_L<_P#!5)?V?_ .F?#;XC^$+[4-+T,/;6NI:256\A0.2(98)"JL
M5)8;@ZD  %2<FOTR^./[6'PK_9OO=)M/B-XH/AV?58Y);-?[.N[H2JA4.<P1
M.!@LO!QUJ'XB?LV_!G]IC2;36?%'@K1_$B:A;13P:NL+6UW)"RAHR+B,I*%P
M0<%N_2HI\T>>4-8R>OJM-_E^9<^67+&>DDM/3?\ 7\CSG2OVMOV;?VQ/".I>
M 9O&EHT.NP+:W&BZNTFF7,NX@B.-I H=\@?ZIF->J_ ']FCP%^S-H>J:3X!T
MZYTVPU*X6ZN(KB\EN<R!=H8%V.. .GI7Y_\ [7W_  21\(^#?AQXF\=?##7-
M1TV31+.;4[C0=6D%Q!)#$N]UAEP'1@JL1O+[C@97K7?_ /!''X_>)?B1\//%
MO@;Q'?SZK'X4:U?3+JZ<O)';3"0>06/)5#%\N>@;:.  -J?+4Y^7222OYJ_Z
M?/J9U%*"BY:QOIY/^K?>9'_!;W_DE_PS_P"PS<_^B!7T]_P3K_Y,K^%7_8.D
M_P#2B6OF'_@M[_R2_P"&?_89N?\ T0*^GO\ @G7_ ,F5_"K_ +!TG_I1+66&
M_AXC_''_ -("O_&H_P""7_I2/D/_ (+&?LT^*?$^K>'_ (M^'-.N-6TW3=-.
MFZQ':H9)+1$D>2.<J.?+_>.&;HNU2>#FKOP"_P""S_AQ]#T[2?BOX7U#3]3A
MC2"36]""W%O/@8,LD+,KQ].0ADR<X Z5]I^+OVRO@]X#^+<'PQU[Q?\ V?XW
MN+BVM(]+;3+QPTEP$\D><L)BPV]>=^!GDC!K-^*_["?P*^,]U->^(_AYIB:I
M,6=]1TK?87#N>KNT#)YC>[AJ5/FIP:CK!MOY];/Y_EY&M2U22<M))+[NFGHC
ME-6\6?LU?\%$/"]EX5D\46/BN*UNQ?PZ2EW-IU^)41E+"%O+E90LC9(!7WKW
M;X2_"GP[\$?A_I?@OPG;36>@:8)!:P3W#SL@>1I&&]R6/S.W4\=*_(G]NS_@
MG#:_LH^$[?XF?#[Q5J5QHEK?0Q36>HLHO+*1V/ERQ3QA0P#A1C:&7@Y;G'Z&
M?\$Z?CAKOQ\_9;T#7O$UPU[K]C<3Z5=WK_>N3"1LD;U8HR;CW8$]ZVI\LX3]
MGI9KF7W:_BOO]3&IS0E!3U3V?WZ?@SZ:J*ZA^TVTL.]H_,0IO3JN1C(]ZEKS
MS]H;XGO\%_@?XW\<0P+=7.AZ7-=P0OG:\P7$8;';>5S[9KGJRC&G*4]DG<WI
MQ<IJ,=VSYT^$/[*/P)_X)]^,;WQU??$>XTZ]U.QDT]3XPU2SB5E9TD8Q!8HV
M9\QCIGC/%=)JW_!4+]FG2)I83\1OM<L9(*VFCW\BDCT<0;3]0<5^?'[#?[+U
MS_P4 ^)7C#XB?%WQ%JFKZ9IT\2W2I/MGO[B3+"+?C]W"B+C:F,!E"[0*_3SP
MG^PO^S_X-L4M+#X2>%[F->C:M8KJ,A^KW'F,?SKH:FHQ51]-%V6_ZW,>:$I2
M<-==7W9^1O\ P4R_:$^'W[2'QB\-^)_A[J$^HVUKHBV-W+/:26Y$BSRNHPZ@
MGB3KTK]S_!T[W7A'0YI6WR26,#LQ[DQJ2:_%3_@KM\/_  E\-_V@_#&F>#_#
M6B^%K&3PU#/-9Z'80V<32FYN!O9(E4%BJJ,D9P!Z5^U'@?\ Y$KP_P#]@^W_
M /1:U.'M]6E;^;]97+Q'-]8AS?R_I&Q^+O\ P5&M8K[]OFWMKB-98)K728Y(
MV'#*>"#]0:_;73]/M=(T^VL;&VBL[*VC6&"W@0)'$BC"JJC@    "OQ/_P""
MG?\ RD#L?^N&C_S%?MQ48?\ W1?XZGYD5?\ >Y?X(?DSP[]N'3H-4_9#^+D-
MR@DC7PY=S@$?QQH9$/X,H/X5\6_\$.[B1O#GQ:@+DQ+=Z<X3L&*3@G\@/RK[
M<_;0_P"32OB__P!BOJ'_ *(:OB#_ ((<_P#(#^+G_7QIO_H-Q6F'_B5_\$?_
M $H,1_#I?XG^2.P_X+7>,+G2_@?X)\.P2M'%J^N-/.JD@2)!"V%/J-TJG'JH
M]*]D_P""77P\LO ?[&_@ZY@@6.]\0-/J]Y*!@RN\K)&3](HXQ^'O7AW_  6X
M\.SW?PA^'>N(K&"QUN:UD(Z S0%ES_WY-?0G_!-+Q=;>+OV+OAVT$BM+IL$^
MFSH",H\4[@ ^F4V-]&%1AK\E>V_,ONY5^%[?,K$?'0OM9_?=_I<^GZ_#W_@I
M5X3TGPK^WY:/I5E'9?VHNF:C=K$,+)</(5>3'8ML4G'4Y/4FOW"K\3_^"HEY
M!=?M^:*D,T<KP6>DQ2K&X8QOYK-M;'0X93@]B#WITO\ >\.U_,ONL_\ @?@1
M7_W2NO[K/VPHHHH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.[_ (+9?\F]
M^!_^QH7_ -)+BOT1HK.I#G5O-/[G<N$N5W]?Q5CXZ_X),_\ )E/AC_L(:A_Z
M4O7V+11714GSN_DOP5C"$>16\W^+N%>+?MC? J?]H_\ 9V\6^!K&:.WU:\B2
MXT^28X3[3"ZR1JQ[*Q7:3V#$U[316$X*I%Q9O"3A)21^(?[)?[:?B[_@GSJ'
MB#X9_$7P'J$^EO?&[DL9&^S7MC,5".\>X%98W"*1@@'&X,0>?HS4_P#@J5\0
M/V@KN3P?^SQ\)-2NO$-T@0:QJC+,+$-P9&B4>4@'9Y9-N1RIZ5^CVN>&M(\3
M6ZP:QI5EJL"G*QWUNDR@^H# U/IFDV.BV:6FGV=O86L8PD%K$L:*/95  K5R
M=2WM=;=M#-)0;]GIZZGX _&SX*^)_@7^UYX.T?QIXC'BGQ9J=YI>LZIJ"[B#
M<3W +H&;EPI4C=@9]!TK^@FBBE%VIJGV;?R=K+Y)6$XWJ.I?=)?=>[^=S\IO
M^"K_ .RWX[NOBQHOQF\"Z/?ZU;BUA@U :7 T\]C<0,3%.44%MA7:-P&%,?.,
MBNB_9_\ ^"O6O_$CXB>!_ .O_#.SAU76=1MM*NM6MM5>)$>1PC2"W:%B.3G:
M9/;-?IO12H_NO=>L;WMZN[U\RJO[SWEI*UK^FVGE_6Y\A_\ !5S_ ),B\:?]
M?>G?^EL->=?\$5_^38?%'_8VW'_I):5^@-%51?LO:]>?\/A_^1_$*G[SD_N_
M\'_,\>_:O_9UTO\ :B^"NL^!]0F6RNY=MUINH,N[[)=IGRY,=U.2K <E7;'-
M?EK\%?VDOC+_ ,$Q=>U+X?\ Q$\#W6L>#Y[II+>WFE:&(2<;IK&YVLCHPP63
M'7&=C;L_M74-Y9V^H6[P74$=S _#1S('4_4&LXITY.4'ONN_]?Y%2:G%1ETV
M\OZ_S[GY?_$+_@MA9WNA-9_#SX;W[^(KI/+AGUNY0Q02G@$11;FFYZ#<F?TJ
M7_@FK^QCX[7XK7GQ[^+5E=:;JDS7%QIEEJ:&.\N+FXW"6[EC.#&,.X56 )+D
MX "EOTFT7P/X<\-S--I'A_2]*F;[TEE91PL?J545MUK!JG)S2]ZUK]D][?U^
M2,YWG'D;]W\_7^OU/)?VM_\ DUOXM?\ 8K:E_P"DSU^>W_!#G_D.?%W_ *]M
M,_\ 0KFOUCHJ:?[N<I_S*WY_YEU'[2G&GV=_R_R"OQO_ ."VG_)<_ 7_ &+I
M_P#2F2OV0HK&=/GE&5_A=_P:_4TA/EC)6W5OQ3_0Q/ __(E>'_\ L'V__HM:
M^+O^"L'[+GB;X]_#'P[XC\&:;-K>O^%)IVDTNU4M/<6LRIYAB4<NZM&AVCD@
MMC)P#]V45KB/W\G+9WO_ %^7H94/W,5'>RM^%C\:?@K_ ,%9/&?[/7PYT7X=
M^*_A@FLWOAVW33X)[B_DTVX6&,;8TEB:%_F50%S\O '&>:_8C0M2.LZ'I^H&
M/RC=V\<_EYSMW*&QGOC-7J*TE-SNYZR?7^NY"CRV4=ET"OS$_P""X7_(F_"G
M_K_O_P#T7#7Z=U^8G_!<+_D3?A3_ -?]_P#^BX:X<1\,?\2_,[,/\;])?^DL
M\D^!/Q4^.7_!/_X6^%_%4/AX_$;X*>+-.@UDQY>-=,N)4&^/S5#_ &=MV.65
MD<8( 8MCK_B'_P %M-6UCPS<6'@?X:KHNO7,7EQ:EJ6I_:UMG/&4A6)?,([9
M8#.,J1Q7WM^Q H;]D'X1@C(/ART!!_W!7JVG^!_#FDZD^H6/A_2[*_?[UU;V
M4<<I^KA<_K7=7B_:2A)W2;7G;M<XJ,E[.,XK5I/ROWM_6I^8G_!,_P#8C\97
MGQ./QT^*UA>6$T<DUUI-GJRLMY>7<N=]Y*C#*J-S%=W+,P;& "WZK444I2NE
M&*LELAJ+NY2=V]V?B/\ \$Z_^4DEY_UWUS_T&6OVXHHK."Y*-*C_ "1MZ[_Y
ME-7JU*G\SOZ:)?H>!_MJ_LMV?[6'P5O/"WGQ6'B"SE%_HU_,#LAN5!&U\<['
M4LIQG&0<$J!7YL_ 7]L;XM?\$Z))_A?\4O %]J7AR&>1[*WN93;RV^6S(UK-
MM:.>$DEL#C<Q(89(K]HJK:AIMIJUJ]M?6L-Y;/\ >AN(Q(C?4$8-*/-3DW!Z
M2W7<N5IQ49+;9]C\N/BC_P %H)?$FBR:+\*OAWJ$?B/4$^SV]]J\JR-!(W ,
M=O$&\UN?ERP&<95NE=9_P2[_ &)?%OPY\2:E\8_B;9W&F^(M0MY(=+TN_P#^
M/I!,0TUS.IY1V'RA3\P#/N R*_0O0_!OA_PPSMH^A:;I+/\ >:QLXX2?KM K
M9K2'+3;FE[S5K^7E_7XV9G.\TH-^ZG?U:V_K_@G@G[;G[-I_:F^ 6K>$+2>*
MUUV&5-1TB>?B,7488*KGLKJSH3VW9YQBOS>_9N_;<^(O_!/JSD^%'Q7^'.I3
MZ);7,DUG'*WV6ZM S$R^2S*8[B)G)8$,!EF(<@@#]G*K:AIMIJUJ]M?6L-Y;
M/]Z&XC$B'Z@C%9QYJ<I.+TENC234XJ,NFWE_7ZGYD_$W_@M/I>J>'Y=.^&7P
M^UB7Q+>)Y%O<:X\:QP2,,!EBB9VF()X7*YX^E:O_  2D_8Z\8_#C7=;^+GQ"
MTZZT34]3M&LM+TV_4I=%)'5YKB5#\R$E%55;#<L2 "I/Z(Z'X,\/^&69M'T+
M3=)9OO-8V<<)/UV@5LUI#EIMS2]YJU^R\OZ_2V<N::4&]$[^K6W]?\$\G_:B
M_9]TK]IOX+Z[X$U.46DMTHGL+[;N-I=IS%+CN,Y##NK,.,U^57P;_: ^-'_!
M+OQ+JO@;Q]X)N-:\&75TTD,,DKQ6[2< SV-UL9&5EP60CJ!G8VZOVMJ*ZM8+
MZ!X+F&.XA<8:.50RGZ@UG%.G)R@]]UW_ *_R[&DFIQ49+;;R_K_/NS\P?'G_
M  6TTZXT$VW@/X:ZA)XAN$\N*76[I!!!*1@$1Q;FFYQ\N4SZU!_P3A_8V\?Z
MQ\9+G]H'XN65WIM])+<7FG6>IQF*[N[N?<)+J2(@&- '?:I )+ @!5&[]+M%
M\"^&_#=PT^D^'M*TN=OO2V5E%"Q^I50>Y_.MRM(-4Y<Z7O;>E^W]?DC.=YQY
M&_=_/U.#^/?_ "0SXB?]B[J'_I-)7Y??\$0?^2G_ !,_[ ]M_P"CS7Z^T5%-
M>SJRJ]U;_P!*_P RJO[RE&EV=_R_R"OR,_X+A?\ (^?"O_L&WW_HV*OUSHK.
M<.:47?9W_!K]2XRY5)=_\T_T.'^!?_)$?A[_ -B[I_\ Z31U\K_\%6/V8/$?
M[0'PAT/6O!VG2ZSXB\*7,L_]FVXW37-K*JB41+_&ZF.-@HY(# 9. ?N"BML1
M_M$Y3VN[_C<SPU\/",-[*WX6/QD^!W_!5CQK^S7\.-(^&_BSX8KK-WX>A%E;
MRW5[)IES'"O"1RQM"^64?+GY> ,C.2?TI_:$^#\/[7G[+]]X:D==)O=>TZWU
M&QE8[UMKH!9HMQQDKN^5B!G:3BO<J**G[Z+53=]?Z\[/Y!3O2FG#9=/Z^ZWF
M?BO^SW^U5\4_^":E]J7PW^)GP[OKWPU/>-<P12R&!HI#M$DMK/M:.>-@ =H.
M,_Q*=P/N?CS_ (+:>&FT&2+P+\.]9N_$$R;(3KDL45O%(1@,5B9VD ./E&S/
MJ*_2^\L[?4+=H+J".Y@;[T<R!U/U!K)T7P/X;\-S--I'A_2]+F;[TEE91PL?
MJ544FY5$E4?SV&E&#;@OD?FK_P $P/V2?'J_%G5OCS\2]-NM%N+I;E]-M=0A
M,-U=W%RQ\ZY:(@%$VLX7<!N\S(X )_4:BBKE)-1C%6459>A$8ZRDW=MW85YA
M^TY\*D^-GP!\=>"S&LEQJFERI:[AP+E!O@;\)$0UZ?16%2'M(.'<WIS=.:FN
MA_.#^R_X%U3XW?'CX:?#.]DFN-&76S-)8R?=AB^62\P.VZ.WP?=17]'JJ$4*
MHPH& !VI:*Z74O3C#M=_?;_(PY$JCFNO_!_S/R8_X+-> +WP?\2_AK\6=%:2
MSNY(SITEY"<&&YMW\ZW<'^\0[X_ZY"O1/^"+7PI?2_AMXV^)-]&QO/$&H+IU
MK+)R6@@&Z1@?1I)"#[Q5^D=%94?W,9QWO>WE=IO]5Z,NM^]<7VM?SLG;[OZW
M"OQ"^/G_ "EZM?\ L=] _E9U^WM%52?L\1"O_+T^:?Z!/WJ4J7?_ "?^85^4
MW_!5_P#9;\=W7Q8T7XS>!='O]:MQ:PP:@-+@:>>QN(&)BG**"VPKM&X#"F/G
M&17ZLT5E*+<HSB[.+NBXR24HM735F?F1^S__ ,%>M?\ B1\1/ _@'7_AG9PZ
MKK.HVVE76K6VJO$B/(X1I!;M"Q')SM,GMFO>_P#@JY_R9%XT_P"OO3O_ $MA
MKZ\HJJJ52"C:SO>_S3M;Y?B13O3DWTM:WW]?G^!^?W_!%?\ Y-A\4?\ 8VW'
M_I):5^@-%%;U:GM)*5NB7W)+]"(1Y%;U_%W/Q0_:^_Y2T:;_ -C%X;_]%VE?
MM?1164/<HQH]F_QM_D:U'[2HZGDE]RL%%%%(D**** "BBB@ HHHH **** "B
MBB@ HHHH **** /SA_X+<?\ )%?A]_V,+_\ I-)7LO\ P2I_Y,C\$_\ 7SJ'
M_I9-7US112_=JHOYVGZ627Z!4_><G]W_ (/^85\'?\%COAS_ ,)7^R_9>)8H
M]USX7UB&=W Y$$P,+CZ;VA/_  &OO&BLJD/:*WFG]SN:4Y\DK^OXJQ\+?\$>
M?B7_ ,)A^RU-X<FEWW?A75I[0*6RP@FQ/&?IN>51_N55_P""F_["^J?M%:7I
M_CWP';K<>.=$MS;7&G[@C:E: EE5">/-1BQ4$C<&(SD**^\Z*VK_ +Z2ELU;
M[TK7^?7U,J/[E-;IW^YN]OD?DI\$?^"MWB?X,Z+;>!?C3X!U;4=9T9!:OJ2.
M;;4-J@!5N+>91F3'5]RD\97.2>>_:*_X*,>.OVS=#NOA+\(?AWJ=I:ZUB&\>
M-C=ZA=0;@2FR-=L$9/WV+,"O4J,Y_7G7/"^C>)H5BUC2;'58E^ZE];),H^@8
M&I='T+3?#]J+;2].M=-MATALX%B3\E %*5JW\77OTO\ U^/4<?W7\+3MY'S+
M_P $\?V2;K]E'X-S6FO-%)XS\03K?:L(6#I;[5VQ6ZL.&V L21QN=L$@ U!_
MP5)_Y,A\?_[]A_Z6P5]7T45[U]]-OPM_D.A:@TUK_P $_/[_ ((K_P#)L/BC
M_L;;C_TDM*^]=8TFS\0:3>Z7J-NEW87L#VUQ;R#*R1NI5E(]""1^-7**TK25
M9ZK2R7W)+\;$4TZ>SZM_C<_%CQG\(?C%_P $N?CQ=^//!&G7'B3X<7!=#=>6
M\MK+9LV?LU[LYBD3Y=LAP"0",Y9*]T7_ (+@>%/^$=,S?"[61KVWBS&IQ&UW
M8_Y[[-V,_P#3*OTRZ\&N?/P\\*MJ7]HGPSHYU#.[[7]@B\W.,9W[<]/>LH\W
M*H2=TMNY<N5R<TK-[]C\>?!?PE^+?_!4/]H>R^(/C/19O#GPY@,43W7EO';1
MV,;EA:VC-S-(Y+;I!D L6./E2OVBM;:*RMHK>"-8H(4$<<:C 50, #\*D P,
M 8%+6EU&"IP5DOS?<BSE-U)N[_0_$?P[_P IA'_['JY_D]?MQ116=)>SH0H?
MR]?DE^A53]Y7G6_FZ?-O]3Y^_;^_Y,U^+'_8&;_T-*^2?^"'O_(C?%7_ +"-
MC_Z*EK]-Z**?[N=2?\T4O2SN*HO:*"_E;?WJP5^1G_!<+_D?/A7_ -@V^_\
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M%^RCR;JUOZ^ZY^3GP7_X+!>++%O"7@7Q7\-+?4-;\^VTBXU1=3>T8DLL7F/
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M5\^+OQ=C'AKX7> ;?PWJM^#$DEF9-8U')_YX*(T4-]8V]L'FOUTUOPCH7B8
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M%X>">)/A3))KT485GTW5PEM/(!\QVO$6B&>V9"/4U^J%86I> _#.L:@M_?\
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ML=HK]+OV,?V7;#]D_P""]EX4BGCO]<NI#?:SJ$8.V>Z90"$SSL15"KG&0,D
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M&D_>JNIY17W!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'H .!4U;4Y1I5.>*Z-/SNK+T2UT\V95$ZE-PD^JMY=_5O37R"BBBLRPHHHH
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M_B#P;97D@2]:QMH[!SGAPM[NCAD<%6,8;=R"<U] W7B3_@I?HL9N;FUNKF)
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M,!RQVBOTN_8Q_9=L/V3_ (+V7A2*>._URZD-]K.H1@[9[IE (3/.Q%4*N<9
MR0"QKW"QL;;3;9+>SMXK6W3A8H$"(OT X%3UK%QIQ<8+?=]S.5YR4I/;9=CX
MW_X*8?L@ZM^U#\+=+O\ PE&EQXT\+RRSV=F[A/ML$@42PAB0 ^41ER<94CC=
MD?)_[.__  5'\2?LT^%M.^&'QB^'FL3S^'H5LX+I!]EU"*!0!%%+;S*H8J,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#PG]JG]CGP9^UYIGA^Q\8ZGKVFQ:)---;MH=Q#$SM(JA@_FPR9&$&,8[U
MZ9\*_ASIOPA^'/ASP5H\]U<Z5H5E'86TU\ZO.\:# +E552WT4#VKJJ*4?=32
MZZ_,'[S3?31?F%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;.T/Y3-MSM.,]<'TKJ:=FMQ!1112&%%%% !1110 4444 %%%% !17GW[07Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445Q.I?'#X<Z-XP3PGJ'C_PO8^*7FCMUT.YUFVCOC+)CRXQ 7#[FW+M&,G<,
M=:-W9;ATN=M1110 4444 %%%% !1110 4444 %%%% !15#7=>TSPOH]WJVLZ
MC::1I5G&9KF^OIUA@@0=6=V(50/4G%8_@?XH^#/B=!=S^#O%VA>+(;1E2XDT
M/4H;U868$J',3-M) . >N#1OL&QT]%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY!(;B558&0N691OROR-P3TTTJ5IQIZ1BKZ[ZO06M.E&4]7)VTVT5S[+\*_\
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MOQ6_;+_9_O\ _@G/\<?!OQ+^$>HWEAH&H3R-;6T\S2?9IHRK26DC9S)#(C#
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MWZ?YFE1<D*<E]IM?<KGZ-5XA\:?VU/@Q^S_J1TSQGXXLK/65^]I=G')>74?
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M(.:YKX6?\%*?@#\6O$5GH.G>+Y-)U>\D$-M;ZW9R6BS.>BB4@Q@D\ %@22
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M ?P?URZT35?&BZIK-JVR>ST.UDO?*8'!5I$'EA@0<KOW#'(K9^"/[=WP4_:
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MF0N.SHV01[9'!!K6^)?C[2?A;X U_P 6ZY=QV6EZ/9R7<TTIP/E4D*/5F.%
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MF_L+-^U-;^'_ !7+^SQ:6]QISW4"ZNTC:9N$H1C$,7;!L;2WW>.M?4/]H?\
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MP3K_ .3*_A5_V#I/_2B6OHVO4Q7^\5/5_F>=A/\ =Z?^%?D%%%%<IU!1110
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M2?B-_P %6[^U^)"QWMM+XQU-3;W^#'+-"9A:1,"<%=T<*A>APJXP<5^Y*@*
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M%?X2ZAJGQ$\:_$Z[B<:=8V7]C6TSKQ-<3.DLNT^J)&N?^NHHPVN)G);*+O\
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M9KSW4;.,@7UXS[0I/9(O-'MN2O*]/_;/,/\ P35O_A,U\?\ A*!K*Z/$F_\
M>?V2Y-R6_P!T,KPX_NLHK]+?^";?P3_X4G^RCX6AN8/)UGQ"IUZ_W##;IP#$
MI]"L(B&/7-=,8*->K66T4E'_ +>5_P#TG\48N3E0IT7O)W?I'3\_P9]">/?
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M0WQ__P!C&O\ Z315GA_BK^B_.)M7_A4?\4O_ $E'GG_!<;4)_P"TOA#8[O\
M1O*U.?;_ +6;9<_E7WS^QKIL&D_LG_".WM@HB/ABPE.P8&YX%=OQW,?QKY2_
MX+0?"6^\6?!?PKXXL+=[@>%M0DBO=@SY=M<A5\P^PDCB7_@=>F_\$N/CYI/Q
M:_9CT#PX+V+_ (2;P?$-*OK$N/,$*D_9Y0O4H8]JY_O(PJL-_!JT^JDG\M?_
M ))(G$?Q*4^CBUZ/M\[-_,^Q**@O;VWTVSGN[N>.UM8(VEEGF<(D:*,LS,>
M  22:_+KX(_MP?%[]H3]OP>$?"OBYI?A.=6NI18QZ79E3IL"-AC,83*!(57G
M?G]X!D4H>_55);O7R5N_]=&*?N4W5>R_'T_KJC]$/CW_ ,D,^(G_ &+NH?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *_$_P#:0_Y2^:7_ -C?X=_]!LZ_;"OQ)_:UO(O"'_!6*RU;5G%GI\/B
M7P_?/<2<*(52U+/D]AM;GV-7AG;'4&^_ZHJ?^ZUO0_;:OBG_ (*]?\F;W_\
MV&K#_P!":OM4,& (.0>AKXJ_X*]?\F;W_P#V&K#_ -":N#%?PU_BC_Z4C:A\
M3])?^DLI_P#!';_DT$_]C%>_^@PU]P2';&Q'4"OA_P#X([?\F@G_ +&*]_\
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M@-@'TR/6HP_\6O\ X(_^E!B/@HOIS/\ ])M^;/U&K\0_VU_^4J4/_8>\._\
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MS^0&22 ":RQ4504X[M76O7Y>?8>'DZ_*]D['Y,?\$<9'E_:ZUIY0!(WAN]+
M=,_:+?-?KM\>_P#DAGQ$_P"Q=U#_ -)I*_(?_@C;)YW[6VL/C&[PS>-CZSV]
M?KQ\>_\ DAGQ$_[%W4/_ $FDI8__ '-?X'^<C;"OFQC=[^^OT/R^_P""(/\
MR4_XF?\ 8'MO_1YK]?:_(+_@B#_R4_XF?]@>V_\ 1YK]?:ZJOP4_3_VYG!2^
M.IZ_^VQ/R,_X+A?\CY\*_P#L&WW_ *-BK]._@7_R1'X>_P#8NZ?_ .DT=?F)
M_P %PO\ D?/A7_V#;[_T;%7Z=_ O_DB/P]_[%W3_ /TFCKGPO^Z3_P ?ZS-<
M1_O4/\'_ ,@=Q1110:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQD\5VG[,7_!(VZT'QU!XV^-WB*S\4WT%S]L31-/DEGBN9\[A)=3R*K2?-DE
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M!QO3\:_3+]G[X ^$OV:_AK8^"_!]J\5C 3+/=7!#3WD[ ;YI6 &6.!T
M  %>D45NI<L>6.B,7'F?,]3@/CM\$_#?[0WPOUGP-XJAD?2]108F@(6:VE4[
MHYHR1PRL >00>0002*_,_0O^"=/[5G[-GB*_D^#OQ&L)-*NI/O6NH-:>>H&%
M:>UE1HMPY PSXSP:_6^BLU'EDY1TOOYFCES147K8_-SPI_P3>^+_ ,;/$EIJ
MG[3/Q;NO$FB6LRW$?AO2;Z66.5@.025CC@]#Y2%B"<,IYJQ'_P $S/%7AW]M
MS2?BGX6F\'Z)\.--UBSOK;1()[B.ZB@ABC5U6,0&/<65C_K.<Y)R:_1NBM(R
MY)QG%6Y?^!_D93BJD)0EJG_7ZA7YT_ W_@G/\2?AG^W!)\9-4UOPK/X8;6M6
MU$6EI=W+7OEW27"QC8UNJ;@9EW?/@8.">_Z+44H/DFJBW2:^_<N7O0=-[,1A
ME2*_.[]C7_@G9\2/V=_VGKOXC>(];\+7NB307T:V^EW=S)<YF;*95[=%P._S
M?G7Z)45,?=G[1;V:^3"7O0]F]KI_-;!7R9_P43_9+\7_ +7'P]\+:#X/U'1-
M-O-+U1KZ9]<GFBC9#"R84Q12$G+#J ,=Z^LZ*F<%-6?D_N=RHR<7='D_[*?P
MGU?X%_L]^"O FO7-E=ZOHMHT%Q-ISN]NS&5WRC.B,1AAU4=Z]8HHK:<W4DYR
MW>IE3@J<%".RT"BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** ,/QOX)T/XC^$]5\,^)--AU;0M4@:WN[.<961#
M].00<$$8((!!!%?F/XP_X)0_%;X0^-;GQ%^SY\3VTRWDW!;>[OYM/OHX\@B$
MRPJ4G7(_B"#@9!ZU^JE%3RVESK1E<WN\CU1^2VL?L(?MG_'"$:/\0_BG#!X>
M=E6XMK[7IYHI$!!W>1"FR1AU&\CD=17W'^R#^Q3X+_9"\-W,.C22ZWXGU%%7
M4_$%X@228+R(XT&1%$#SMR23C<S8&/H:BM8RY4U'2YG*/,US:V"OSL_93_X)
MU_$CX%_M;S_%+7M;\+7?A^274G%MIUW<O=8N X3Y7MT7C<,_/ZXS7Z)T5G'W
M:BJK=)KY/<<O?A[-[73^:V"N.^+WPE\-?''X>:QX+\6V/V[1-4B\N15.V2-@
M<I)&W\+JP# ^H[C(KL:*4HJ:Y9;%QDXNZ/R&U+_@EC^T)\#O%]]J7P6^(\)L
M9B%CN+359])OGCSD),BCRV _WR#UVCI7=>#?^"9?QI^,WB"PO?VC?BW>ZQX=
MM91<#0[35KB^E=CG*AI (H.N-R!R1D#;P1^G]%7%\MKZV[ZDR]Z]M+]C\YO#
M7_!,SQ3X&_;<TSXH^&KCPGI/PWTW58[NUT:&XN5NXH%@"%!'Y!3=NR?]9SG.
M<U^C-%%$6XTU3Z+_ ('^1/*N=SZO_@_YGR#^VM_P3I\+?M87">)--U >$?'T
M,0B.IK!YL%]&HPJ7" @Y' $BG('!#  #YDT7]E#]O3X:Z:GAWP[\4;:ZT94$
M,;QZ\TR0H!@!#<0^9& .@0#&.*_5FBHC'ENEL^G0TE+FLWNNI^9'P7_X)*^(
MO$'Q 3QK^T-XY7QC=+*LTFEVEW/=O>E<;1<74P5MHQ@HJG(QAP.*_3.WMXK.
MWBMX(DA@B4)''&H544#   Z "I**TYO=45HD9\OO.3U9^=O[;W_!.SXD?M*?
MM&V?C_PQK?A:QT:&QL[9H-6N[F.XW1.[,0L=NZX(88^;\J_1"-2D:J>H %.H
MJ8^[3]FMKM_-[CE[T^=[V2^XR/%WA/2?'?A?5?#NO6,6I:-JEL]I=VDPRLL3
M@AE/IP>HY'45^9/B/_@E3\6O@SXZN/$7[/7Q4&DVTI.+>_O)K&[2/((A9XD:
M.X7/]\(.GRGK7ZFT5/+:7.M&7S7CR/5'Y8>(/V5_V\_C)I,OA_Q?\4=-T_1)
ME\J=&U06ZSQD$,K_ &2#=(""<J_![U]6?L3_ +!OAG]C_2[^]746\3>-=4C$
M-[K4D(A2.(-N\F"/)*ID L226*@\ !1]1T5I&7+?ET;,Y+FM?9!1114E'P__
M ,%'/V'_ !W^U]JW@2Z\&ZMX=TV/08+R*Y&N7,\1<RM"5V>5#)D#RVSG'4=:
M^FOV<_ASJ7PA^!/@7P5K$]K<ZKH6DP6%S-8NSP/(BX)0LJL5^J@^U>C440]R
M#@MF[_G_ )A+WY*;W2M^7^04444 ?G%^R_\ \$X?B5\%/VNT^*>N:YX4NO#R
MW6HSFVT^[N7N]MPDJH-KVZKD&09^?L<9K]':**(^[3A26T59>@/WIRJ/>3NS
MXX_;8_X)O^&/VJK[_A*M&U%/"'C]8Q')?^3YEMJ"JN$6X0$$,  !(N2%X*MA
M<?-VD?LJ_M[_  ]TY?#FA?%*WN]'"B))EUYIEA0< (UQ#YJ #LH&!TK]6**F
M,>6Z6SZ="I2YK-[KJ?F;\#?^"2NMZE\0D\<?M!^-4\:WRRK.^E6MS-=_;77&
MW[5=3!691C!C5>0 -^,@_I?#"EO$D42+'&BA51!@*!P !V%/HK3F]U16B1GR
MZN3W/S]_;>_X)A2_'CQW+\1OAIKEGX:\8W)1[^RU!I([:ZE0 +.DL:LT4N%&
M?E(8@'Y3DMYOH_[+W[?6L::OAN_^,$6C:/'B,WTNNNT[)GDK-%"9R<?WF&>.
M17ZE45G"*@N5;=NAI*3D^9[]^I^=GB;_ ()*Z99_L\^)]!T'6+3Q-\7==N+>
M>;QAXH:2)$VSK)*L8196C#*&R?F9B?F;& /H7]@G]G'Q+^RW\"#X*\5WVE:A
MJO\ :MQ?>=H\LLL&R18PHS)'&V[Y#GY<=.:^CJ*TC)QYK?:_X&WW&4HJ7*W]
MG_@[_>?*G_!1#]E/Q;^UM\+?#GAKPAJ.BZ;?:;K*ZC+)K<\T431B"6/"F**0
MELR#J , \UW_ .QG\$]<_9W_ &<?"G@#Q)=:?>ZSI)NC//I<DDENWFW4LJ[6
M=$8_+( <J.0>O6O;**47R1E%?::;^2L7+W^6_3_@_P"85\Z?MI?L7^'_ -L3
MP7IVGWNI/X>\1Z/(\NF:S' )A&' $D4D>5W(VU3PP(*@@]0?HNBLY14E9E1D
MXNZ/RC\#_P#!-#]J;X;ZEIUEX?\ C5IUAX6L[M)18V7B35;1'C#AF'D)!L!8
M9XR1SUK]4-8M'U#2;VUC*K)/ \2EN@+*0,^W-7**NI^\I^SEMK^.A$/W=3VD
M=]/P_P"'/S^_X)Y?\$_?B'^R7\5-?\3>+]9\,ZC8:AH[:?%'HEU<2RB0S1/E
MA)!&-N$/0DYQQ7Z T45<IN2BGTT_%O\ 4F,5%MKK_E;]#XT_;H_X)TZ7^UKJ
MEEXKT;7E\+>-K2V%H\UQ 9K6^A4L460 AD92QPXSP<%3P0G[!/[*?QF_9MUO
MQ"OQ(\?6OBOP]/8Q6NDZ?9ZO>W<=HR.22(IXT2,;<#Y,^E?9E%13_=7Y>M_Q
M_P"'+J?O+<W2WX?\,>)_M5?LF^#/VM/ J:%XG22RU*S+2Z7K=HH^T6,A SC/
M#HV!N0\' P00&'P%IO\ P3Y_:\^ ,EQIWPK^*D$WAUI6,5O9:S-9J0>3(]M(
MIC1CCG:S'WK]::*E1Y6W'2^Y3ES)*6MC\HM%_P""6?QS^.7BRQU7X]_%;[1I
ML/S&*+49]3O44D%HHA(HBA!]5+ $?=-?IA\*OA7X9^"O@/2O!WA#34TK0M-C
MV0PJ<LQ)RTCL>6=B22QZDUUM%:<UH\JT1GRWES/5A7Y=_M??\$I?'OQK_:!\
M3^.? VN>%--T77'CNI+76+JYBF2X\M5E.([>1<,REL[LY8\5^HE%9."<E+JC
M52:3CT9R/PC^'MK\)_A=X4\&V95K?0M,M[ .O\9CC"L__ B"?QKF?VH_@N/V
MA/@'XR\!));P7FK6>+*>Z)$45TC"2%G*@D*)$7. 3C/!KU2BKK?O^;GZD4OW
M/+R=#\Y/V"_^"9_C/]FKXX'QYX[U?PSJL5GITT&G0Z+<7$TB7$FU#(WFP1@
M1F1>"3\]?HW115RFY))]/\[_ *D1BHMM=0HHHJ"PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX4445!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
